PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Slomski, A				Slomski, Anita			Ketamine to Help Treat Cocaine Use Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					717	717		10.1001/jama.2019.12353	http://dx.doi.org/10.1001/jama.2019.12353			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454041				2022-12-28	WOS:000483652500009
J	Hu, FB; Otis, BO; McCarthy, G				Hu, Frank B.; Otis, Brett O.; McCarthy, Gina			Can Plant-Based Meat Alternatives Be Part of a Healthy and Sustainable Diet?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint explores the potential for plant-based meat alternatives to improve human diets, alleviate concern about the contamination that industrial meat production creates, and create a healthy and sustainable food source for the increasing global population but cautions that the health and environmental benefits remain to be proven.	[Hu, Frank B.; Otis, Brett O.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [McCarthy, Gina] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [McCarthy, Gina] Harvard TH Chan Sch Publ Hlth, Ctr Climate Hlth & Global Environm, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Hu, FB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	fhu@hsph.harvard.edu			NIH [HL60712, HL118264, DK112940]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Hu's research is funded by NIH grants HL60712, HL118264, and DK112940.	Bao W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-119; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Godfray HCJ, 2018, SCIENCE, V361, DOI 10.1126/science.aam5324; Guasch-Ferre M, 2019, CIRCULATION, V139, P1828, DOI 10.1161/CIRCULATIONAHA.118.035225; Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008; Heller M.C., 2018, MEATS BURGER LIFE CY; The Intergovernmental Panel on Climate Change, CLIM CHANG LAND IPCC; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Zheng Y, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2110	9	55	55	9	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2019	322	16					1547	1548		10.1001/jama.2019.13187	http://dx.doi.org/10.1001/jama.2019.13187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0VU	31449288				2022-12-28	WOS:000498673500008
J	Cree, BAC; Bennett, JL; Kim, HJ; Weinshenker, BG; Pittock, SJ; Wingerchuk, DM; Fujihara, K; Paul, F; Cutter, GR; Marignier, R; Green, AJ; Aktas, O; Hartung, HP; Lublin, FD; Drappa, J; Barron, G; Madani, S; Ratchford, JN; She, DW; Cimbora, D; Katz, E; Shuey, N; Milanov, I; Kaprelyan, A; Tarnev, I; Haralanov, L; Carruthers, R; Munoz, M; Quinones, J; Vargas, J; Rodriguez, J; Nytrova, P; Vachova, M; Mares, J; Haldre, S; Gross-Paju, K; Ziemssen, T; Zettl, UK; Klotz, L; Bergh, FT; Lau, A; Dioszeghy, P; Satori, M; Vecsei, L; Achiron, A; Karni, A; Vaknin-Dembinsky, A; Saida, T; Misu, T; Baba, M; Tamaoka, A; Nohara, C; Yokoyama, K; Farfan, FC; Orta, DSJ; Rodriguez, I; Rivera, JG; Odainic, O; Willoughby, E; Alva, EP; Villegas, J; Czlonkowska, A; Selmaj, K; Tutaj, A; Rusek, S; Zakrzewska-Pniewska, B; Maciejowski, M; Rejdak, K; Belova, A; Sazonov, D; Khabirov, F; Bakhtiyarova, K; Kairbekova, E; Shcherbonosova, T; Chefranova, Z; Boyko, A; Rozhdestvenskiy, A; Pokhabov, D; Zakharova, M; Drulovic, J; Leepan, EB; Henning, F; Kim, BJ; Kim, SM; Oh, JY; Oreja-Guevara, C; Lin, CC; Wu, SL; Liu, AB; Tiamkao, S; Tanprawate, S; Prayoonwiwat, N; Siva, A; Yildirim, KA; Gedizlioglu, M; Terzi, M; Soysal, A; Levy, M; Javed, A; Greenberg, B; Bernitsas, E; Hutton, G; Tullman, M; Honeycutt, W; Scagnelli, J; Apperson, M; Lynch, S; Bashir, K; Rensel, M; Lindsey, J; Wesley, S; Flanagan, E; Zabeti, A; Eubank, G; Felton, W				Cree, Bruce A. C.; Bennett, Jeffrey L.; Kim, Ho Jin; Weinshenker, Brian G.; Pittock, Sean J.; Wingerchuk, Dean M.; Fujihara, Kazuo; Paul, Friedemann; Cutter, Gary R.; Marignier, Romain; Green, Ari J.; Aktas, Orhan; Hartung, Hans-Peter; Lublin, Fred D.; Drappa, Jorn; Barron, Gerard; Madani, Soraya; Ratchford, John N.; She, Dewei; Cimbora, Daniel; Katz, Eliezer; Shuey, Neil; Milanov, Ivan; Kaprelyan, Ara; Tarnev, Ivaylo; Haralanov, Lyubomir; Carruthers, Robert; Munoz, Mario; Quinones, Jairo; Vargas, Jose; Rodriguez, Jesus; Nytrova, Petra; Vachova, Marta; Mares, Jan; Haldre, Sulev; Gross-Paju, Katrin; Ziemssen, Tjalf; Zettl, Uwe Klaus; Klotz, Luisa; Bergh, Florian Then; Lau, Alexander; Dioszeghy, Peter; Satori, Maria; Vecsei, Laszlo; Achiron, Anat; Karni, Arnon; Vaknin-Dembinsky, Adi; Saida, Takahiko; Misu, Tatsuro; Baba, Masayuki; Tamaoka, Akira; Nohara, Chiyoko; Yokoyama, Kazumasa; Castro Farfan, Freddy; Juan Orta, Daniel San; Rodriguez, Ildefonso; Gongora Rivera, Juan; Odainic, Olesea; Willoughby, Ernest; Pretell Alva, Edwin; Perez Villegas, Julio; Czlonkowska, Anna; Selmaj, Krzysztof; Tutaj, Andrzej; Rusek, Stanislaw; Zakrzewska-Pniewska, Beata; Maciejowski, Maciej; Rejdak, Konrad; Belova, Anna; Sazonov, Denis; Khabirov, Farit; Bakhtiyarova, Klara; Kairbekova, Ekaterina; Shcherbonosova, Tatiana; Chefranova, Zhanna; Boyko, Alexey; Rozhdestvenskiy, Alexey; Pokhabov, Dmitry; Zakharova, Maria; Drulovic, Jelena; Leepan, Edward Bernard; Henning, Franclo; Kim, Byoung Joon; Kim, Sung Min; Oh, Jee Young; Oreja-Guevara, Celia; Lin, Chou-Ching; Wu, Shey-Lin; Liu, An-Bang; Tiamkao, Somsak; Tanprawate, Surat; Prayoonwiwat, Naraporn; Siva, Aksel; Yildirim, Kadriye Agan; Gedizlioglu, Muhtesem; Terzi, Murat; Soysal, Aysun; Levy, Michael; Javed, Adil; Greenberg, Benjamin; Bernitsas, Evanthia; Hutton, George; Tullman, Mark; Honeycutt, William; Scagnelli, John; Apperson, Michelle; Lynch, Sharon; Bashir, Khurram; Rensel, Mary; Lindsey, John; Wesley, Sarah; Flanagan, Eoin; Zabeti, Aram; Eubank, Geoffrey; Felton, Warren, III		N MOmentum Study Investigators	Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial	LANCET			English	Article							RITUXIMAB; OCRELIZUMAB; DESIGN	Background No approved therapies exist for neuromyelitis optica spectrum disorder (NMOSD), a rare, relapsing, autoimmune, inflammatory disease of the CNS that causes blindness and paralysis. We aimed to assess the efficacy and safety of inebilizumab, an anti-CD19, B cell-depleting antibody, in reducing the risk of attacks and disability in NMOSD. Methods We did a multicentre, double-blind, randomised placebo-controlled phase 2/3 study at 99 outpatient specialty clinics or hospitals in 25 countries. Eligible participants were adults (>= 18 years old) with a diagnosis of NMOSD, an Expanded Disability Status Scale score of 8.0 or less, and a history of at least one attack requiring rescue therapy in the year before screening or at least two attacks requiring rescue therapy in the 2 years before screening. Participants were randomly allocated (3:1) to 300 mg intravenous inebilizumab or placebo with a central interactive voice response system or interactive web response system and permuted block randomisation. Inebilizumab or placebo was administered on days 1 and 15. Participants, investigators, and all clinical staff were masked to the treatments, and inebilizumab and placebo were indistinguishable in appearance. The primary endpoint was time to onset of an NMOSD attack, as determined by the adjudication committee. Efficacy endpoints were assessed in all randomly allocated patients who received at least one dose of study intervention, and safety endpoints were assessed in the as-treated population. The study is registered with ClinicalTrials.gov, number NCT02200770. Findings Between Jan 6, 2015, and Sept 24, 2018, 230 participants were randomly assigned to treatment and dosed, with 174 participants receiving inebilizumab and 56 receiving placebo. The randomised controlled period was stopped before complete enrolment, as recommended by the independent data-monitoring committee, because of a clear demonstration of efficacy. 21 (12%) of 174 participants receiving inebilizumab had an attack versus 22 (39%) of 56 participants receiving placebo (hazard ratio 0.272 [95% CI 0.150-0.496]; p<0.0001). Adverse events occurred in 125 (72%) of 174 participants receiving inebilizumab and 41 (73%) of 56 participants receiving placebo. Serious adverse events occurred in eight (5%) of 174 participants receiving inebilizumab and five (9%) of 56 participants receiving placebo. Interpretation Compared with placebo, inebilizumab reduced the risk of an NMOSD attack. Inebilizumab has potential application as an evidence-based treatment for patients with NMOSD. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Cree, Bruce A. C.; Green, Ari J.] Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, San Francisco, CA 94158 USA; [Green, Ari J.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Bennett, Jeffrey L.] Univ Colorado, Anschutz Med Campus, Sch Med, Aurora, CO USA; [Kim, Ho Jin] Natl Canc Ctr, Res Inst & Hosp, Seoul, South Korea; [Weinshenker, Brian G.; Pittock, Sean J.] Mayo Clin, Rochester, MN USA; [Wingerchuk, Dean M.] Mayo Clin, Scottsdale, AZ USA; [Fujihara, Kazuo] Fukushima Med Univ, Dept Multiple Sclerosis Therapeut, Fukushima, Japan; [Fujihara, Kazuo] Southern Tohoku Res Inst Neurosci, Multiple Sclerosis & Neuromyelitis Opt Ctr, Koriyama, Fukushima, Japan; [Paul, Friedemann] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Paul, Friedemann] Charite Univ Med Berlin, Berlin, Germany; [Cutter, Gary R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Marignier, Romain] Lyon Univ Hosp, Serv Neurol Sclerose Plaques Pathol Myeline & Neu, Lyon, France; [Aktas, Orhan; Hartung, Hans-Peter] Heinrich Heine Univ, Med Fac, Dusseldorf, Germany; [Lublin, Fred D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Drappa, Jorn; Madani, Soraya; Ratchford, John N.; She, Dewei; Cimbora, Daniel; Katz, Eliezer] Viela Bio, Gaithersburg, MD USA; [Barron, Gerard] MedImmune, Cambridge, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; National Cancer Center - Korea (NCC); Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Fukushima Medical University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Alabama System; University of Alabama Birmingham; CHU Lyon; Heinrich Heine University Dusseldorf; Icahn School of Medicine at Mount Sinai; AstraZeneca; Medimmune	Cree, BAC (corresponding author), Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, San Francisco, CA 94158 USA.	bruce.cree@ucsf.edu	Nytrova, Petra/O-9099-2017; Karni, Arnon/B-1774-2019; Cutter, Gary/AAY-5392-2021; Aktas, Orhan/B-7623-2009; Levy, Michael/A-3268-2011; TERZİ, Murat/AAA-1284-2021; Devlikamova, Farida/AAE-8586-2020; Weinshenker, Brian G/ABH-6146-2020; Boyko, Alexey N/Z-2106-2018; Carruthers, Robert/I-7148-2019; Psychalinos, Costas/I-3336-2013; Soysal, Aysun/AAX-7696-2021; Lau, Alexander Y/N-2485-2015; Paul, Friedemann/ABF-9415-2020; Cree, Bruce C/AAV-6109-2020; yokoyama, kazumasa/AAR-6441-2021; San Juan, Daniel/AAU-3348-2020; Siva, Aksel/A-5132-2016; Vecsei, Laszlo/ABA-6137-2021; Henning, Franclo/ABB-7717-2020; Rodriguez-Leyva, Ildefonso/G-8398-2018	Nytrova, Petra/0000-0003-4885-602X; Cutter, Gary/0000-0002-8455-980X; Aktas, Orhan/0000-0002-2020-9210; Levy, Michael/0000-0002-7969-8346; TERZİ, Murat/0000-0002-3586-9115; Weinshenker, Brian G/0000-0001-5806-6203; Psychalinos, Costas/0000-0002-0817-7228; Lau, Alexander Y/0000-0002-5933-9290; Cree, Bruce C/0000-0001-7689-2533; San Juan, Daniel/0000-0001-6685-5851; Siva, Aksel/0000-0002-8340-6641; Rodriguez-Leyva, Ildefonso/0000-0002-3316-1471; paul, friedemann/0000-0002-6378-0070	MedImmune; Viela Bio	MedImmune(AstraZenecaMedimmune); Viela Bio	MedImmune and Viela Bio.	Agius MA, 2019, MULT SCLER J, V25, P235, DOI 10.1177/1352458517740641; Bennett JL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000104; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bretz F, 2009, STAT MED, V28, P586, DOI 10.1002/sim.3495; Chen D, 2016, J CLIN MED, V5, DOI 10.3390/jcm5120107; Ciron J, 2018, REV NEUROL-FRANCE, V174, P255, DOI 10.1016/j.neurol.2017.11.005; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Cree BAC, 2016, MULT SCLER J, V22, P862, DOI 10.1177/1352458515620934; Cree BAC, 2015, MULT SCLER RELAT DIS, V4, P536, DOI 10.1016/j.msard.2015.07.017; Damato V, 2016, JAMA NEUROL, V73, P1342, DOI 10.1001/jamaneurol.2016.1637; Fujihara K, 2012, CLIN EXP ALLERGY, V3, P58, DOI [10.1111/j.1759-1961.2012.00030.x, DOI 10.1111/J.1759-1961.2012.00030.X]; Genentech, 2018, OCR PRESCR INF; Genentech, 2019, RIT PRESCR INF; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Palanichamy A, 2014, J IMMUNOL, V193, P580, DOI 10.4049/jimmunol.1400118; Patra K, 2016, THER INNOV REGUL SCI, V50, P375, DOI 10.1177/2168479015619203; Paul F, 2018, EXPERT OPIN INV DRUG, V27, P265, DOI 10.1080/13543784.2018.1443077; Perumal JS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000061; Pittock SJ, 2019, NEW ENGL J MED, V381, P614, DOI 10.1056/NEJMoa1900866; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Schiopu E, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1021-2; Trebst C, 2014, J NEUROL, V261, P1, DOI 10.1007/s00415-013-7169-7; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	28	255	266	1	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1352	1363		10.1016/S0140-6736(19)31817-3	http://dx.doi.org/10.1016/S0140-6736(19)31817-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC9RJ	31495497				2022-12-28	WOS:000489613700030
J	Greenberg, RS; Long, HK; Swigut, T; Wysocka, J				Greenberg, Rachel S.; Long, Hannah K.; Swigut, Tomek; Wysocka, Joanna			Single Amino Acid Change Underlies Distinct Roles of H2A.Z Subtypes in Human Syndrome	CELL			English	Article							FLOATING-HARBOR SYNDROME; HISTONE VARIANT H2A.Z; NEURAL CREST SPECIFICATION; TRANSCRIPTIONAL REGULATION; READ ALIGNMENT; CELL-CYCLE; CHROMATIN; SRCAP; RECOGNITION; ASSOCIATION	The developmental disorder Floating-Harbor syndrome (FHS) is caused by heterozygous truncating mutations in SRCAP, a gene encoding a chromatin remodeler mediating incorporation of histone variant H2A.Z. Here, we demonstrate that FHS-associated mutations result in loss of SRCAP nuclear localization, alter neural crest gene programs in human in vitro models and Xenopus embryos, and cause craniofacial defects. These defects are mediated by one of two H2A.Z subtypes, H2A.Z.2, whose knock-down mimics and whose overexpression rescues the FHS phenotype. Selective rescue by H2A.Z.2 is conferred by one of the three amino acid differences between that H2A.Z subtypes, S38/T38. We further shy H2A.Z.1 and H2A.Z.2 genomic occupancy patterns are qualitatively similar, but quantitatively distinct, and H2A.Z.2 incorporation at AT-rich enhancers and expression of their associated genes are both sensitised to SRCAP truncations. Altogether, our results illuminate the mechanism underlying a human syndrome and uncover selective functions of H2A.Z subtypes during development.	[Greenberg, Rachel S.; Long, Hannah K.; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Greenberg, Rachel S.; Long, Hannah K.; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	wysocka@stanford.edu	Long, Hannah/A-6301-2013	Long, Hannah/0000-0002-5694-0398	NIH [R35 GM131757]; Stinehart-Reed Foundation; Howard Hughes Medical Institute; NSF Graduate Research Fellowship Program (NSF GRFP); Ruth L. Kirschstein NRSA F31 from NIDCR [1F31DE025534]; Wellcome Trust, Sir Henry Wellcome Postdoctoral Fellowship [106051/Z/14/Z]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE025534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM131757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stinehart-Reed Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Ruth L. Kirschstein NRSA F31 from NIDCR; Wellcome Trust, Sir Henry Wellcome Postdoctoral Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. D. Kingsley, M. Fuller, S. Prescott, and the Wysocka lab members for comments on the manuscript. We thank Dr. S. Wu for his work on RT-PCR experiments and C. Jensen for help with the migration assays. We thank Drs. C. Reid and J. Chang for their advice on in situ hybridizations. This work was supported by NIH (R35 GM131757), the Stinehart-Reed Foundation (to J.W.), the Howard Hughes Medical Institute (to J.W.), NSF Graduate Research Fellowship Program (NSF GRFP) (to R.S.G.), Ruth L. Kirschstein NRSA F31 from NIDCR (1F31DE025534 to R.S.G.), and Wellcome Trust, Sir Henry Wellcome Postdoctoral Fellowship (106051/Z/14/Z to H.K.L.).	Alexa A., 2018, TOPGO ENRICHMENT ANA; Arduini BL, 2009, DEVELOPMENT, V136, P1987, DOI 10.1242/dev.033209; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Bhat N, 2013, DEV BIOL, V373, P107, DOI 10.1016/j.ydbio.2012.10.012; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; Bowerman S, 2016, BIOPHYS J, V110, P327, DOI 10.1016/j.bpj.2015.12.015; Buschbeck M, 2017, NAT REV MOL CELL BIO, V18, P299, DOI 10.1038/nrm.2016.166; Calo E, 2018, NATURE, V554, P112, DOI 10.1038/nature25449; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chakravarthy S, 2006, J BIOL CHEM, V281, P25522, DOI 10.1074/jbc.M602258200; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Devotta A, 2016, DEV BIOL, V415, P371, DOI 10.1016/j.ydbio.2016.02.010; Dryhurst D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-86; Dubey A, 2017, CURR PATHOBIOL REP, V5, P79, DOI 10.1007/s40139-017-0128-8; Dunn CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0040-17.2017; Eirin-Lopez JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-31; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fryns JP, 1996, CLIN GENET, V50, P217; Hersh JH, 1998, AM J MED GENET, V76, P58, DOI 10.1002/(SICI)1096-8628(19980226)76:1<58::AID-AJMG10>3.0.CO;2-O; Hong JJ, 2014, MOL CELL, V53, P498, DOI 10.1016/j.molcel.2014.01.010; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Horikoshi N, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160127; Horikoshi N, 2013, ACTA CRYSTALLOGR D, V69, P2431, DOI 10.1107/S090744491302252X; Hu N, 2014, DEV BIOL, V396, P159, DOI 10.1016/j.ydbio.2014.09.034; Jones C. Michael, 2008, V461, P385, DOI 10.1007/978-1-60327-483-8_28; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kong YW, 2014, CHEM BIOL, V21, P488, DOI 10.1016/j.chembiol.2014.02.013; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Goff C, 2013, HUM MUTAT, V34, P88, DOI 10.1002/humu.22216; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang XP, 2016, NAT STRUCT MOL BIOL, V23, P317, DOI 10.1038/nsmb.3190; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Monsoro-Burq A. H., 2007, CSH PROTOC; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Morrison JA, 2017, ELIFE, V6, DOI 10.7554/eLife.28415; Nikkel SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-63; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Osakabe A, 2018, NUCLEIC ACIDS RES, V46, P7675, DOI 10.1093/nar/gky540; PATTON MA, 1991, J MED GENET, V28, P201, DOI 10.1136/jmg.28.3.201; Pegoraro C, 2013, WIRES DEV BIOL, V2, P247, DOI 10.1002/wdev.76; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Punzeler S, 2017, EMBO J, V36, P2263, DOI 10.15252/embj.201695757; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Sargent TD, 2006, ADV EXP MED BIOL, V589, P32; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; Sive H.L., 2000, EARLY DEV XENOPUS LA, P249; Vardabasso C, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1073417; Vardabasso C, 2015, MOL CELL, V59, P75, DOI 10.1016/j.molcel.2015.05.009; White SM, 2010, AM J MED GENET A, V152A, P821, DOI 10.1002/ajmg.a.33294; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou CY, 2016, ANNU REV BIOPHYS, V45, P153, DOI 10.1146/annurev-biophys-051013-022819	76	39	39	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1421	+		10.1016/j.cell.2019.08.002	http://dx.doi.org/10.1016/j.cell.2019.08.002			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491386	Green Accepted, Bronze			2022-12-28	WOS:000483983000016
J	Roca, FJ; Whitworth, LJ; Redmond, S; Jones, AA; Ramakrishnan, L				Roca, Francisco J.; Whitworth, Laura J.; Redmond, Sarah; Jones, Ana A.; Ramakrishnan, Lalita			TNF Induces Pathogenic Programmed Macrophage Necrosis in Tuberculosis through a Mitochondrial-Lysosomal-Endoplasmic Reticulum Circuit	CELL			English	Article							PERMEABILITY TRANSITION PORE; CATHEPSIN-D; CELL-DEATH; CYCLOPHILIN-D; ACID SPHINGOMYELINASE; INFLAMMATORY RESPONSE; MEDIATES RESISTANCE; INDUCED APOPTOSIS; BAX; FAMILY	Necrosis of infected macrophages constitutes a critical pathogenetic event in tuberculosis by releasing mycobacteria into the growth-permissive extracellular environment. In zebrafish infected with Mycobacterium marinum or Mycobacterium tuberculosis, excess tumor necrosis factor triggers programmed necrosis of infected macrophages through the production of mitochondrial reactive oxygen species (ROS) and the participation of cyclophilin D, a component of the mitochondrial permeability transition pore. Here, we show that this necrosis pathway is not mitochondrion-intrinsic but results from an inter-organellar circuit initiating and culminating in the mitochondrion. Mitochondrial ROS induce production of lysosomal ceramide that ultimately activates the cytosolic protein BAX. BAX promotes calcium flow from the endoplasmic reticulum into the mitochondrion through ryanodine receptors, and the resultant mitochondrial calcium overload triggers cyclophilin-D-mediated necrosis. We identify ryanodine receptors and plasma membrane L-type calcium channels as druggable targets to intercept mitochondrial calcium overload and necrosis of mycobacterium-infected zebrafish and human macrophages.	[Roca, Francisco J.; Whitworth, Laura J.; Redmond, Sarah; Jones, Ana A.; Ramakrishnan, Lalita] Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge CB2 OQH, England; [Redmond, Sarah; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Redmond, Sarah] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	University of Cambridge; University of Washington; University of Washington Seattle; Case Western Reserve University	Roca, FJ; Ramakrishnan, L (corresponding author), Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge CB2 OQH, England.; Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	froca@mrc-lmb.cam.ac.uk; lr404@cam.ac.uk		Jones, Ana/0000-0002-9602-4917; Ramakrishnan, Lalita/0000-0003-0692-5533; Whitworth, Laura/0000-0002-8232-4601	NIH MERIT award [R37AI054503]; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503] Funding Source: NIH RePORTER	NIH MERIT award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Green, J. Prudent, P. Vandenabeele, and A. Whitworth for advice and discussion; D. Raible for providing plasmids containing GCaMP3; N. Goodwin, R. Keeble, and J. Cameron for zebrafish husbandry; I. Smallwood, N. Goodwin, and R. Keeble for genotyping mutants; and A. Pagan, D. Tobin, and C. Televantos for editing the manuscript. This work was supported by an NIH MERIT award (R37AI054503) and a Wellcome Trust Principal Research Fellowship to L.R. S.R. was a Mary Gates Undergraduate Research Scholar for part of the study.	Adams KN, 2014, J INFECT DIS, V210, P456, DOI 10.1093/infdis/jiu095; Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Albihn A, 2007, INT J CANCER, V121, P1821, DOI 10.1002/ijc.22866; Antony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124263; Appelqvist H, 2012, ANN CLIN LAB SCI, V42, P231; Athanasiadis EI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02305-6; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Becattini B, 2004, CHEM BIOL, V11, P1107, DOI 10.1016/j.chembiol.2004.05.022; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berg RD, 2016, CELL, V165, P139, DOI 10.1016/j.cell.2016.02.034; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bonneau B, 2013, BBA-MOL CELL RES, V1833, P1755, DOI 10.1016/j.bbamcr.2013.01.021; Cambier CJ, 2014, CELL, V159, P1497, DOI 10.1016/j.cell.2014.11.024; Chatteriee S, 2008, BBA-GEN SUBJECTS, V1780, P370, DOI 10.1016/j.bbagen.2007.08.010; Chemaly ER, 2018, CELL CALCIUM, V69, P46, DOI 10.1016/j.ceca.2017.07.001; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cui GF, 2017, PESTIC BIOCHEM PHYS, V142, P91, DOI 10.1016/j.pestbp.2017.01.010; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davenport B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00375; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1_6; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Dumitru CA, 2009, J MOL MED, V87, P1123, DOI 10.1007/s00109-009-0514-8; Ebina-Shibuya R, 2017, J BIOL CHEM, V292, P18098, DOI 10.1074/jbc.M117.808535; Espinosa-Parrilla JF, 2015, MOL CELL NEUROSCI, V64, P104, DOI 10.1016/j.mcn.2014.12.004; Esterberg R, 2014, J NEUROSCI, V34, P9703, DOI 10.1523/JNEUROSCI.0281-14.2014; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Fernandez-Sanz C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.526; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Huang CC, 2014, CLIN INFECT DIS, V58, P765, DOI 10.1093/cid/cit948; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Iwasaki A, 2015, BIOORG MED CHEM LETT, V25, P5295, DOI 10.1016/j.bmcl.2015.09.044; Jacobson AR, 2006, MOL PHARMACOL, V70, P259, DOI 10.1124/mol.106.022491; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Karch J, 2017, ELIFE, V6, DOI 10.7554/eLife.30543; Karch J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130520; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kirchmaier S, 2013, DEVELOPMENT, V140, P4287, DOI 10.1242/dev.096081; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lisak DA, 2015, BBA-MOL CELL RES, V1853, P2104, DOI 10.1016/j.bbamcr.2015.03.002; Lopez-Erauskin J, 2012, BRAIN, V135, P3584, DOI 10.1093/brain/aws292; Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073; Min CK, 2012, BIOCHEM J, V447, P371, DOI 10.1042/BJ20120705; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Naon D, 2014, BBA-MOL CELL RES, V1843, P2184, DOI 10.1016/j.bbamcr.2014.05.011; Pagan A.J, 2014, COLD SPRING HARBOR P, V5; Pagan AJ, 2015, CELL HOST MICROBE, V18, P15, DOI 10.1016/j.chom.2015.06.008; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Penna E, 2018, CELL CALCIUM, V69, P73, DOI 10.1016/j.ceca.2017.08.008; Pozzan T, 2009, BBA-BIOENERGETICS, V1787, P1317, DOI 10.1016/j.bbabio.2008.11.012; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sampson SL, 2011, VACCINE, V29, P4839, DOI 10.1016/j.vaccine.2011.04.066; Smolina N, 2014, CELL CALCIUM, V56, P269, DOI 10.1016/j.ceca.2014.08.001; Srivastava S, 2014, IMMUNOL REV, V262, P179, DOI 10.1111/imr.12217; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Takaki K, 2012, CELL REP, V2, P175, DOI 10.1016/j.celrep.2012.06.008; Taniguchi M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.82; Thuong NTT, 2017, J INFECT DIS, V215, P1020, DOI 10.1093/infdis/jix050; Tischner D, 2012, APOPTOSIS, V17, P1197, DOI 10.1007/s10495-012-0756-8; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Valm AM, 2017, NATURE, V546, P162, DOI 10.1038/nature22369; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vervliet T, 2016, ONCOGENE, V35, P5079, DOI 10.1038/onc.2016.31; Vervliet T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09641; Vervliet T, 2014, J CELL SCI, V127, P2782, DOI 10.1242/jcs.150011; Walton EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138949; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zazueta C, 1999, J BIOENERG BIOMEMBR, V31, P551, DOI 10.1023/A:1005464927366; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	106	80	88	10	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1344	+		10.1016/j.cell.2019.08.004	http://dx.doi.org/10.1016/j.cell.2019.08.004			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474371	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000483983000011
J	Nelson, HD; Fu, RW; Zakher, B; Pappas, M; McDonagh, M				Nelson, Heidi D.; Fu, Rongwei; Zakher, Bernadette; Pappas, Miranda; McDonagh, Marian			Medication Use for the Risk Reduction of Primary Breast Cancer in Women Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SURGICAL ADJUVANT BREAST; BONE-MINERAL DENSITY; CONTINUING OUTCOMES RELEVANT; ITALIAN RANDOMIZED-TRIAL; VERTEBRAL FRACTURE RISK; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; BOWEL PROJECT; MULTIPLE OUTCOMES; CARDIOVASCULAR EVENTS	IMPORTANCE Medications to reduce risk of breast cancer are effective for women at increased risk but also cause adverse effects. OBJECTIVE To update the 2013 US Preventive Services Task Force systematic review on medications to reduce risk of primary (first diagnosis) invasive breast cancer in women. DATA SOURCES Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, EMBASE, and MEDLINE (January 1, 2013, to February 1, 2019); manual review of reference lists. STUDY SELECTION Discriminatory accuracy studies of breast cancer risk assessment methods; randomized clinical trials of tamoxifen, raloxifene, and aromatase inhibitors for primary breast cancer prevention; studies of medication adverse effects. DATA EXTRACTION AND SYNTHESIS Investigators abstracted data on methods, participant characteristics, eligibility criteria, outcome ascertainment, and follow-up. Results of individual trials were combined by using a profile likelihood random-effects model. MAIN OUTCOMES AND MEASURES Probability of breast cancer in individuals (area under the receiver operating characteristic curve [AUC]); incidence of breast cancer, fractures, thromboembolic events, coronary heart disease events, stroke, endometrial cancer, and cataracts; and mortality. RESULTS A total of 46 studies (82 articles [> 5 million participants]) were included. Eighteen risk assessment methods in 25 studies reported low accuracy in predicting the probability of breast cancer in individuals (AUC, 0.55-0.65). In placebo-controlled trials, tamoxifen (risk ratio [RR], 0.69 [95% CI, 0.59-0.84]; 4 trials [n = 28 421]), raloxifene (RR, 0.44 [95% CI, 0.24-0.80]; 2 trials [n = 17 806]), and the aromatase inhibitors exemestane and anastrozole (RR, 0.45 [95% CI, 0.26-0.70]; 2 trials [n = 8424]) were associated with a lower incidence of invasive breast cancer. Risk for invasive breast cancer was higher for raloxifene than tamoxifen in 1 trial after long-term follow-up (RR, 1.24 [95% CI, 1.05-1.47]; n = 19 747). Raloxifene was associated with lower risk for vertebral fractures (RR, 0.61 [95% CI, 0.53-0.73]; 2 trials [n = 16 929]) and tamoxifen was associated with lower risk for nonvertebral fractures (RR, 0.66 [95% CI, 0.45-0.98]; 1 trial [n = 13 388]) compared with placebo. Tamoxifen and raloxifene were associated with increased thromboembolic events compared with placebo; tamoxifen was associated with more events than raloxifene. Tamoxifen was associated with higher risk of endometrial cancer and cataracts compared with placebo. Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. CONCLUSIONS AND RELEVANCE Tamoxifen, raloxifene, and aromatase inhibitors were associated with lower risk of primary invasive breast cancer in women but also were associated with adverse effects that differed between medications. Risk stratification methods to identify patients with increased breast cancer risk demonstrated low accuracy.	[Nelson, Heidi D.; Fu, Rongwei; Zakher, Bernadette; Pappas, Miranda; McDonagh, Marian] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Fu, Rongwei; Zakher, Bernadette] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	nelsonh@ohsu.edu			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500009I]; US Preventive Services Task Force (USPSTF)	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services; US Preventive Services Task Force (USPSTF)	This research was funded under contract HHSA290201500009I, Task Order 7, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force (USPSTF).	Abramson N, 2006, JNCI-J NATL CANCER I, V98, P904, DOI 10.1093/jnci/djj262; Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x; Amir E, 2003, J MED GENET, V40, P807, DOI 10.1136/jmg.40.11.807; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Boughey JC, 2010, J CLIN ONCOL, V28, P3591, DOI 10.1200/JCO.2010.28.0784; Boyle P, 2004, EUR J CANCER PREV, V13, P183, DOI 10.1097/01.cej.0000130014.83901.53; Brentnall AR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0653-5; Brisson J, 2000, CANCER EPIDEM BIOMAR, V9, P911; Bruno S, 2005, BMJ-BRIT MED J, V330, P932, DOI 10.1136/bmj.38391.663287.E0; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Chalas E, 2005, AM J OBSTET GYNECOL, V192, P1230, DOI 10.1016/j.ajog.2004.12.083; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Chlebowski RT, 2007, JNCI-J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224; Christodoulakos GE, 2006, MATURITAS, V53, P413, DOI 10.1016/j.maturitas.2005.07.003; Cohen FJ, 2000, OBSTET GYNECOL, V95, P104, DOI 10.1016/S0029-7844(99)00554-2; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Corbelli J, 2014, J WOMENS HEALTH, V23, P746, DOI 10.1089/jwh.2014.4742; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cuzick J, 2014, LANCET, V383, P1040; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Day R, 2001, J NATL CANCER I, V93, P1615, DOI 10.1093/jnci/93.21.1615; Decarli A, 2006, J NATL CANCER I, V98, P1686, DOI 10.1093/jnci/djj463; Decensi A, 2005, CIRCULATION, V111, P650, DOI 10.1161/01.CIR.0000154545.84124.AC; DeCensi A, 2013, ANN ONCOL, V24, P2753, DOI 10.1093/annonc/mdt244; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Duvernoy CS, 2005, MENOPAUSE, V12, P444, DOI 10.1097/01.GME.0000151653.02620.89; Ensrud KE, 2008, J BONE MINER RES, V23, P112, DOI 10.1359/JBMR.070904; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Forbes JF, 2016, LANCET, V387, P866, DOI 10.1016/S0140-6736(15)01129-0; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2007, JNCI-J NATL CANCER I, V99, P1657, DOI 10.1093/jnci/djm228; Goldstein SR, 2005, MENOPAUSE, V12, P160, DOI 10.1097/00042192-200512020-00010; Goldvaser H, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx141; Goss PE, 2011, NEW ENGL J MED, V365, P1361; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grady D, 2008, J NATL CANCER I, V100, P854, DOI 10.1093/jnci/djn153; Hackett J, 2018, BREAST CANCER RES TR, V170, P633, DOI 10.1007/s10549-018-4775-1; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmberg C, 2017, CANCER PREV RES, V10, P625, DOI 10.1158/1940-6207.CAPR-17-0076; Johnell O, 2004, J FAM PRACTICE, V53, P789; Johnston CC, 2000, ARCH INTERN MED, V160, P3444, DOI 10.1001/archinte.160.22.3444; Jolly EE, 2003, MENOPAUSE, V10, P337, DOI 10.1097/01.GME.0000058772.59606.2A; Kaplan CP, 2012, BREAST CANCER RES TR, V133, P357, DOI 10.1007/s10549-012-1960-5; Kaplan CP, 2005, PREV MED, V41, P7, DOI 10.1016/j.ypmed.2004.09.041; Keech CA, 2005, CURR MED RES OPIN, V21, P135, DOI 10.1185/030079904X18045; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Li KR, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1073-0; Liede A, 2017, BREAST CANCER RES TR, V165, P433, DOI 10.1007/s10549-017-4332-3; Lippman ME, 2006, CLIN CANCER RES, V12, P5242, DOI 10.1158/1078-0432.CCR-06-0688; Lufkin EG, 1998, J BONE MINER RES, V13, P1747, DOI 10.1359/jbmr.1998.13.11.1747; Martinez KA, 2016, PATIENT, V9, P149, DOI 10.1007/s40271-015-0134-z; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Matsuno RK, 2011, J NATL CANCER I, V103, P951, DOI 10.1093/jnci/djr154; Maunsell E, 2014, J CLIN ONCOL, V32, P1427, DOI 10.1200/JCO.2013.51.2483; McClung MR, 2006, MENOPAUSE, V13, P377, DOI 10.1097/01.gme.0000188736.69617.4f; Meiser B, 2017, HERED CANCER CLIN PR, V15, DOI 10.1186/s13053-017-0075-8; Meunier PJ, 1999, OSTEOPOROSIS INT, V10, P330, DOI 10.1007/s001980050236; Morii H, 2003, OSTEOPOROSIS INT, V14, P793, DOI 10.1007/s00198-003-1424-1; Moyer VA, 2013, ANN INTERN MED, V159, P698, DOI [10.7326/0003-4819-159-10-201311190-00717, 10.7326/0003-4819-159-10-201311190-00718]; Nelson HD., 2019, MEDICATION USE RISK; Nelson HD, 2013, ANN INTERN MED, V158, P604, DOI 10.7326/0003-4819-158-8-201304160-00005; Nelson HD, 2009, ANN INTERN MED, V151, P703, DOI [10.7326/0000605-200911170-00147, 10.7326/0003-4819-151-10-200911170-00147]; Nickelsen T, 1999, PSYCHONEUROENDOCRINO, V24, P115, DOI 10.1016/S0306-4530(98)00041-9; Palacios S, 2004, AM J OBSTET GYNECOL, V191, P121, DOI 10.1016/j.ajog.2003.10.701; Petracci E, 2011, JNCI-J NATL CANCER I, V103, P1037, DOI 10.1093/jnci/djr172; Pinsky PF, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.03.031; Powles T, 1998, LANCET, V352, P98; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Reimers LL, 2015, BREAST J, V21, P377, DOI 10.1111/tbj.12418; Reis SE, 2001, J NATL CANCER I, V93, P16, DOI 10.1093/jnci/93.1.16; Richardson H, 2007, Curr Oncol, V14, P89; Rockhill B, 2003, J CLIN EPIDEMIOL, V56, P856, DOI 10.1016/S0895-4356(03)00124-0; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Roetzheim RG, 2015, BREAST, V24, P51, DOI 10.1016/j.breast.2014.11.006; Ropka ME, 2010, J CLIN ONCOL, V28, P3090, DOI 10.1200/JCO.2009.27.8077; Runowicz CD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.067; Sestak I, 2014, LANCET ONCOL, V15, pE587; Silverman SL, 2004, J AM GERIATR SOC, V52, P1543, DOI 10.1111/j.1532-5415.2004.52420.x; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Skandarajah AR, 2017, BREAST, V32, P93, DOI 10.1016/j.breast.2017.01.002; Smith SG, 2016, ANN ONCOL, V27, P575, DOI 10.1093/annonc/mdv590; Smith SG, 2017, BRIT J GEN PRACT, V67, pE414, DOI 10.3399/bjgp17X689377; Spagnolo F, 2016, J CLIN ONCOL, V34, P139, DOI 10.1200/JCO.2015.63.4972; Tamimi RM, 2010, CANCER-AM CANCER SOC, V116, P4944, DOI 10.1002/cncr.25386; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tice JA, 2015, J CLIN ONCOL, V33, P3137, DOI 10.1200/JCO.2015.60.8869; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; US Preventive Services Task Force (USPSTF), 2018, METH PROC; USPSTF, 2016, FIN REC STAT BREAST; Vacek PM, 2011, BREAST CANCER RES TR, V130, P291, DOI 10.1007/s10549-011-1576-1; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 2003, J NATL CANCER I, V95, P160, DOI 10.1093/jnci/95.2.160; Veronesi U, 2002, LANCET, V359, P1122, DOI 10.1016/S0140-6736(02)08159-X; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Warwick J, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0451-5; Waters EA, 2010, CANCER EPIDEM BIOMAR, V19, P443, DOI 10.1158/1055-9965.EPI-09-0930	115	40	45	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					868	886		10.1001/jama.2019.5780	http://dx.doi.org/10.1001/jama.2019.5780			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479143	Bronze			2022-12-28	WOS:000486437200016
J	Blair, A; Saffidine, A				Blair, Alan; Saffidine, Abdallah			AI surpasses humans at six-player poker	SCIENCE			English	Editorial Material									[Blair, Alan; Saffidine, Abdallah] Univ New South Wales, Sch Comp Sci & Engn, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Blair, A (corresponding author), Univ New South Wales, Sch Comp Sci & Engn, Sydney, NSW 2052, Australia.	blair@cse.unsw.edu.au; abdallahs@cse.unsw.edu.au		Blair, Alan/0000-0002-1039-4766				Brown N, 2018, SCIENCE, V359, P418, DOI 10.1126/science.aao1733; Certicky M., 2017, 13 ART INT INT DIG E; Fang F, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P2589; Fernandez J. M. F., 2018, IEEE T GAMES; Johanson M, 2013, P 2013 INT C AUTONOM, P271; Lisy V., 2016, 13 AAAI C ART INT, P544; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; van den Herik HJ, 2002, ARTIF INTELL, V134, P277, DOI 10.1016/S0004-3702(01)00152-7	11	7	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					864	865		10.1126/science.aay7774	http://dx.doi.org/10.1126/science.aay7774			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467208				2022-12-28	WOS:000483975800025
J	Mahase, E				Mahase, Elisabeth			Breast cancer risk associated with HRT increases with longer use, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Collaborative Group on Hormonal Factors in Breast Cancer, 2019, LANCET; MHRA, 2014, HORM REPL THER UPD A; National Institute for Health and Care Excellence (NICE), 2015, MEN DIAGN MAN	3	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2019	366								l5332	10.1136/bmj.l5332	http://dx.doi.org/10.1136/bmj.l5332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9ID	31471329				2022-12-28	WOS:000483893700003
J	Phimister, EG				Phimister, Elizabeth G.			Making Asthma Crystal Clear	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material															NIAID NIH HHS [U19 AI077439] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cummings R. D., 2017, ESSENTIALS GLYCOBIOL, V3rd, DOI [10.1101/glycobiology.3-.034, DOI 10.1101/GLYCOBIOLOGY.3-.034]; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Persson EK, 2019, SCIENCE NEW YORK NY, V24, P364; Su JY, 2018, MOLECULES, V23, DOI 10.3390/molecules23112931; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					882	884		10.1056/NEJMcibr1908064	http://dx.doi.org/10.1056/NEJMcibr1908064			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461600				2022-12-28	WOS:000484431200017
J	Burt, LA; Billington, EO; Rose, MS; Raymond, DA; Hanley, DA; Boyd, SK				Burt, Lauren A.; Billington, Emma O.; Rose, Marianne S.; Raymond, Duncan A.; Hanley, David A.; Boyd, Steven K.			Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINERAL DENSITY; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; OLDER WOMEN; HR-PQCT; OSTEOPOROSIS; FRACTURES; MARKERS; ADULTS; FALLS	IMPORTANCE Few studies have assessed the effects of daily vitamin D doses at or above the tolerable upper intake level for 12 months or greater, yet 3% of US adults report vitamin D intakes of at least 4000 IU per day. OBJECTIVE To assess the dose-dependent effect of vitamin D supplementation on volumetric bone mineral density (BMD) and strength. DESIGN, SETTING, AND PARTICIPANTS Three-year, double-blind, randomized clinical trial conducted in a single center in Calgary, Canada, from August 2013 to December 2017, including 311 community-dwelling healthy adults without osteoporosis, aged 55 to 70 years, with baseline levels of 25-hydroxyvitamin D (25[OH]D) of 30 to 125 nmol/L. INTERVENTIONS Daily doses of vitamin D-3 for 3 years at 400 IU (n = 109), 4000 IU (n = 100), or 10000 IU (n = 102). Calcium supplementation was provided to participants with dietary intake of less than 1200 mg per day. MAIN OUTCOMES AND MEASURES Co-primary outcomes were total volumetric BMD at radius and tibia, assessed with high resolution peripheral quantitative computed tomography, and bone strength (failure load) at radius and tibia estimated by finite element analysis. RESULTS Of 311 participants who were randomized (53% men; mean [SD] age, 62.2 [4.2] years), 287 (92%) completed the study. Baseline, 3-month, and 3-year levels of 25(OH)D were 76.3, 76.7, and 77.4 nmol/L for the 400-IU group; 81.3, 115.3, and 132.2 for the 4000-IU group; and 78.4, 188.0, and 144.4 for the 10000-IU group. There were significant groupxtime interactions for volumetric BMD. At trial end, radial volumetric BMD was lower for the 4000 IU group (-3.9 mg HA/cm(3) [95% CI, -6.5 to -1.3]) and 10000 IU group (-7.5 mg HA/cm(3) [95% CI, -10.1 to -5.0]) compared with the 400 IU group with mean percent change in volumetric BMD of -1.2% (400 IU group), -2.4% (4000 IU group), and -3.5% (10000 IU group). Tibial volumetric BMD differences from the 400 IU group were -1.8 mg HA/cm(3) (95% CI, -3.7 to 0.1) in the 4000 IU group and -4.1 mg HA/cm(3) in the 10000 IU group (95% CI, -6.0 to -2.2), with mean percent change values of -0.4% (400 IU), -1.0% (4000 IU), and -1.7% (10000 IU). There were no significant differences for changes in failure load (radius, P = .06; tibia, P = .12). CONCLUSIONS AND RELEVANCE Among healthy adults, treatment with vitamin D for 3 years at a dose of 4000 IU per day or 10000 IU per day, compared with 400 IU per day, resulted in statistically significant lower radial BMD; tibial BMD was significantly lower only with the 10000 IU per day dose. There were no significant differences in bone strength at either the radius or tibia. These findings do not support a benefit of high-dose vitamin D supplementation for bone health; further research would be needed to determine whether it is harmful.	[Burt, Lauren A.; Billington, Emma O.; Raymond, Duncan A.; Hanley, David A.; Boyd, Steven K.] Univ Calgary, Cumming Sch Med, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Rose, Marianne S.] Alberta Hlth Serv, Res Facilitat, Calgary, AB, Canada	University of Calgary; Alberta Health Services (AHS); University of Calgary	Boyd, SK (corresponding author), Univ Calgary, McCaig Inst Bone & Joint Hlth, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	skboyd@ucalgary.ca	Boyd, Steven K/E-9595-2010	Boyd, Steven K/0000-0002-2930-5997; Burt, Lauren/0000-0002-0348-5643	Pure North S'Energy Foundation	Pure North S'Energy Foundation	Funding was provided by Pure North S'Energy Foundation in response to an investigator-initiated research grant proposal.	Aloia J, 2015, J CLIN ENDOCR METAB, V100, P4140, DOI 10.1210/jc.2015-2548; Aloia JF, 2018, CLIN ENDOCRINOL, V89, P742, DOI 10.1111/cen.13848; [Anonymous], 1988, LANCET, V2, P349; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Biodex Medical Systems Inc, 2017, BIOSW PORT BAL SYST; Bolland MJ, 2018, LANCET DIABETES ENDO, V6, P847, DOI [10.1016/S2213-8587(18)30265-1, 10.1016/s2213-8587(18)30265-1]; Bouillon R, 2017, ENDOCRIN METAB CLIN, V46, P1119, DOI 10.1016/j.ecl.2017.07.014; Burt L, 2013, J BONE MINER RES, V28; Burt LA, 2018, CONTEMP CLIN TRIALS, V67, P68, DOI 10.1016/j.cct.2018.02.009; Coffman CJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013096; Ellouz R, 2014, BONE, V63, P147, DOI 10.1016/j.bone.2014.03.001; Grimnes G, 2012, OSTEOPOROSIS INT, V23, P201, DOI 10.1007/s00198-011-1752-5; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Hansen KE, 2015, JAMA INTERN MED, V175, P1612, DOI 10.1001/jamainternmed.2015.3874; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jorde R, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-1; Khaw KT, 2017, LANCET DIABETES ENDO, V5, P438, DOI 10.1016/S2213-8587(17)30103-1; Macdonald HM, 2018, J BONE MINER RES, V33, P1464, DOI 10.1002/jbmr.3442; Malihi Z, 2016, AM J CLIN NUTR, V104, P1039, DOI 10.3945/ajcn.116.134981; Manske SL, 2017, J BONE MINER RES, V32, P1514, DOI 10.1002/jbmr.3128; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Nakamichi Y, 2018, J STEROID BIOCHEM, V177, P70, DOI 10.1016/j.jsbmb.2017.11.005; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pop LC, 2017, OSTEOPOROSIS INT, V28, P377, DOI 10.1007/s00198-016-3735-z; Reid IR, 2017, J INTERN MED, V282, P452, DOI 10.1111/joim.12651; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rooney MR, 2017, JAMA-J AM MED ASSOC, V317, P2448, DOI 10.1001/jama.2017.4392; Samelson EJ, 2019, LANCET DIABETES ENDO, V7, P34, DOI [10.1016/s2213-8587(18)30308-5, 10.1016/S2213-8587(18)30308-5]; Sanders KM, 2013, CALCIFIED TISSUE INT, V92, P191, DOI 10.1007/s00223-012-9679-1; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Smith LM, 2018, J INTERN MED, V284, P685, DOI 10.1111/joim.12825; Takeda S, 1999, ENDOCRINOLOGY, V140, P1005, DOI 10.1210/en.140.2.1005; Vieth R, 2001, AM J CLIN NUTR, V73, P288; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Wellek S, 2012, HUM HERED, V73, P14, DOI 10.1159/000334085; Wu HY, 2009, NUTR RES, V29, P255, DOI 10.1016/j.nutres.2009.03.006	39	130	137	7	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					736	745		10.1001/jama.2019.11889	http://dx.doi.org/10.1001/jama.2019.11889			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454046	Green Published, Bronze			2022-12-28	WOS:000483652500021
J	Cook, R; Davidson, P; Martin, R				Cook, Rob; Davidson, Peter; Martin, Rosie		NIHR Dissemination Ctr	Antiretroviral treatment can reduce the risk of HIV transmission between male partners to 'zero'	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study A Rodger, V Cambiano, T Bruun, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.	[Cook, Rob; Martin, Rosie] Bazian, Economist Intelligence Unit Healthcare, London, England; [Davidson, Peter] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com			NIHR Research for Patient Benefit Programme [PB-PG-1013-32069]	NIHR Research for Patient Benefit Programme	This project was funded by the NIHR Research for Patient Benefit Programme (project number PB-PG-1013-32069).	Cohen MS, 2019, LANCET, V393, P2366, DOI 10.1016/S0140-6736(19)30701-9; NICE, 2018, HIV INF AIDS SCEN ES	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2019	366								l4915	10.1136/bmj.l4915	http://dx.doi.org/10.1136/bmj.l4915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HE	31455630				2022-12-28	WOS:000483891100001
J	Gupta, R; Wood, DA				Gupta, Rajeev; Wood, David A.			Primary prevention of ischaemic heart disease: populations, individuals, and health professionals	LANCET			English	Review							INTENSIVE GLUCOSE CONTROL; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; DIETARY FATS; RISK-FACTORS; MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE; POLICY STATEMENT; POOLED ANALYSIS; URINARY SODIUM	Ischaemic heart disease has a multifactorial aetiology and can be prevented from developing in populations primordially, and in individuals at high risk by primary prevention. The primordial approach focuses on social determinants of health in populations: political, economic, and social factors, principally unplanned urbanisation, illiteracy, poverty, and working and living conditions. Implementation of the UN Sustainable Development Goals can lead to major improvements in cardiovascular health, and adequate health-care financing and universal health care are important for achieving these goals. Population-level interventions should focus on tobacco control, promotion of healthy foods (fruits, vegetables, legumes, and nuts), curbing unhealthy foods (saturated fats, trans fats, refined carbohydrates, excessive salt, and alcohol), promotion of physical activity in everyday living, and control of ambient and indoor pollution. At the individual level, identification of people at high multifactorial risk and guideline-driven management of hypertension, LDL cholesterol, and diabetes is required. Strategies to improve adherence to healthy lifestyles and drug therapies are essential and can be implemented at health system, health care, and patient levels with use of education, technology, and personalised approaches. Improving quality of medical education with a focus on ischaemic heart disease prevention for physicians, nurses, allied health workers, and the public is required.	[Gupta, Rajeev] Rajasthan Univ Hlth Sci, Acad Res Dev Unit, Jaipur, Rajasthan, India; [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Dept Prevent Cardiol & Internal Med, Jaipur, Rajasthan, India; [Wood, David A.] Natl Univ Ireland Galway, Natl Inst Prevent & Cardiovasc Hlth, Galway, Ireland; [Wood, David A.] Imperial Coll, Natl Heart & Lung Inst, London, England	Eternal Heart Care Centre & Research Institute; Ollscoil na Gaillimhe-University of Galway; Imperial College London	Gupta, R (corresponding author), Eternal Heart Care Ctr & Res Inst, M Floor, Jaipur 302017, Rajasthan, India.	drrajeev.gupta@eternalheart.org						Aaron KJ, 2013, MAYO CLIN PROC, V88, P987, DOI 10.1016/j.mayocp.2013.06.005; Alageel S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015375; Angell SY, 2015, LANCET, V385, P825, DOI 10.1016/S0140-6736(14)62256-X; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Aspry KE, 2018, CIRCULATION, V137, pE821, DOI 10.1161/CIR.0000000000000563; Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bhavnani SP, 2017, J AM COLL CARDIOL, V70, P2696, DOI 10.1016/j.jacc.2017.10.018; Blenkinsopp A, 2003, J PUBLIC HEALTH MED, V25, P144, DOI 10.1093/pubmed/fdg030; Carey RM, 2018, J AM COLL CARDIOL, V72, P1278, DOI 10.1016/j.jacc.2018.07.008; Chopra HK, 2018, CSI TXB CARDIOLOGY I, P377; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Christoforou A, 2016, J EPIDEMIOL COMMUN H, V70, P1140, DOI 10.1136/jech-2015-206997; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Deaton A, 2013, GREAT ESCAPE: HEALTH, WEALTH, AND THE ORIGINS OF INEQUALITY, P59; Deaton C, 2019, ESC TXB CARDIOVASCUL, P898; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Downs SM, 2013, B WORLD HEALTH ORGAN, V91, P262, DOI 10.2471/BLT.12.111468; Echouffo-Tcheugui JB, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000866; Erickson J, 2017, ANN INTERN MED, V166, P257, DOI 10.7326/M16-2020; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Ferdinand KC, 2017, J AM COLL CARDIOL, V69, P437, DOI 10.1016/j.jacc.2016.11.034; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Fletcher GF, 2018, J AM COLL CARDIOL, V72, P1622, DOI 10.1016/j.jacc.2018.08.2141; Galea S., 2018, HLTH 50 THOUGHTS FDN, P231; Gaziano TA, 2019, BRAUNWALDS HEART DIS, V11th, P1; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Gulati S, 2017, CURR DIABETES REV, V13, P438, DOI 10.2174/1573399812666160811165712; Gupta R, 2019, RUHS J HLTH SCI, V4, P3; Gupta R, 2014, INDIAN J MED RES, V139, P657; Gupta R, 2011, CARDIOL CLIN, V29, P15, DOI 10.1016/j.ccl.2010.10.005; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; He F. J., 2013, BMJ, V346; Hogan DR, 2018, LANCET GLOB HEALTH, V6, pE152, DOI 10.1016/S2214-109X(17)30472-2; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hyseni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177535; India State Level Dis Burden, 2019, LANCET PLANET HEALTH, V3, pE26, DOI 10.1016/S2542-5196(18)30261-4; Jennings C, 2016, ESC HDB PREVENTIVE C, P183; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Joseph P, 2018, HEART, V104, P581, DOI 10.1136/heartjnl-2017-311609; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kalkhoran S, 2018, J AM COLL CARDIOL, V72, P1030, DOI 10.1016/j.jacc.2018.06.036; Karmali KN, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006887.pub4; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kubzansky LD, 2018, J AM COLL CARDIOL, V72, P1382, DOI 10.1016/j.jacc.2018.07.042; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Kwok CS, 2014, INT J CARDIOL, V173, P20, DOI 10.1016/j.ijcard.2014.02.026; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Livesey Geoffrey, 2019, Mayo Clin Proc Innov Qual Outcomes, V3, P52, DOI 10.1016/j.mayocpiqo.2018.12.007; Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792; Mackay DF, 2010, HEART, V96, P1525, DOI 10.1136/hrt.2010.199026; Mahmoud AN, 2019, EUR HEART J, V40, P607, DOI 10.1093/eurheartj/ehy813; Marmot M., 2015, HLTH GAP CHALLENGE U, P77; MARMOT M, 1999, SOCIAL DETERMINANTS, V896, P1; Marmot M, 2019, BMJ-BRIT MED J, V351, pi251; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marten R, 2018, LANCET, V391, P2400, DOI 10.1016/S0140-6736(18)31219-4; Martin SS, 2015, J AM COLL CARDIOL, V65, P1361, DOI 10.1016/j.jacc.2015.01.043; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Musunuru K, 2019, CELL, V177, P132, DOI 10.1016/j.cell.2019.02.015; National Cancer Institute, NCI DICT CANC TERMS; Nicklas TA, 1997, ANN NY ACAD SCI, V817, P208, DOI 10.1111/j.1749-6632.1997.tb48208.x; Nugent R, 2018, LANCET, V391, P2029, DOI 10.1016/S0140-6736(18)30667-6; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Ogedegbe G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005983; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pahigiannis K, 2019, CIRCULATION, V139, P1957, DOI 10.1161/CIRCULATIONAHA.118.035408; Pennells L, 2019, EUR HEART J, V40, P621, DOI 10.1093/eurheartj/ehy653; Phillips E, 2015, MED EDUC ONLINE, V20, DOI 10.3402/meo.v20.26150; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Raber I, 2019, LANCET, V393, P2155, DOI 10.1016/S0140-6736(19)30541-0; Rajagopalan S, 2018, J AM COLL CARDIOL, V72, P2054, DOI 10.1016/j.jacc.2018.07.099; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Rees K, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009825.pub3; Ridker PM, 2019, BRAUNWALDS HEART DIS, P876; Riegel B, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006997; Rose G., 1992, STRATEGY PREVENTIVE; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Salehi-Abargouei A, 2013, NUTRITION, V29, P611, DOI 10.1016/j.nut.2012.12.018; Santschi V, 2011, ARCH INTERN MED, V171, P1441, DOI 10.1001/archinternmed.2011.399; Seidelmann SB, 2018, LANCET PUBLIC HEALTH, V3, pE419, DOI 10.1016/S2468-2667(18)30135-X; Srivastava G, 2018, NAT REV ENDOCRINOL, V14, P12, DOI 10.1038/nrendo.2017.122; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Starodubov VI, 2018, LANCET, V392, P1138, DOI 10.1016/S0140-6736(18)31485-5; Temple NJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010039; Thompson DR, 2002, INT J CARDIOL, V83, P233, DOI 10.1016/S0167-5273(02)00064-5; Topol E., 2019, DEEP MED ARTIFICIAL, P137; Topol E., 2015, PATIENT WILL SEE YOU, P275; Tronieri JS, 2019, CURR OBES REP, V8, P128, DOI 10.1007/s13679-019-00341-5; Ueda P, 2017, LANCET DIABETES ENDO, V5, P196, DOI 10.1016/S2213-8587(17)30015-3; United Nations, 2015, TRANSF OUR WORLD 203; Uthman OA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011163.pub2; van de Vijver S, 2012, ETHNIC HEALTH, V17, P651, DOI 10.1080/13557858.2012.754409; Vanuzzo D, 2015, ESC TXB PREVENTIVE C, P77; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; WHO, 2015, WHO GUID REC DIG INT; WHO, 2018, BACKGR DOC GLOB ACT; WHO, 2018, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; WHO Global Health Workforce Alliance, 2010, GLOB EXP COMM HLTH W; (WHO) World Health Organisation, 2015, GUID SUG INT AD CHIL; Willett WC, 2012, J INTERN MED, V272, P13, DOI 10.1111/j.1365-2796.2012.02553.x; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; World Health Organization, 2010, Global recommendations on physical activity for health; World Health Organization, 2014, HLTH ALL POL HELS DE; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2010, TEACH PUBL HLTH MED; World Health Organization, 2017, WHO REP GLOB TOB EP; Yu E, 2018, J AM COLL CARDIOL, V72, P914, DOI 10.1016/j.jacc.2018.02.085; Yun LR, 2017, J PHYS ACT HEALTH, V14, P552, DOI 10.1123/jpah.2016-0616; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Zelniker TA, 2019, CIRCULATION, V139, P2022, DOI 10.1161/CIRCULATIONAHA.118.038868; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X; Zhao D, 2015, NAT REV CARDIOL, V12, P301, DOI 10.1038/nrcardio.2015.28	126	48	49	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					685	696		10.1016/S0140-6736(19)31893-8	http://dx.doi.org/10.1016/S0140-6736(19)31893-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT6UU	31448740				2022-12-28	WOS:000483011200033
J	Schupke, S; Neumann, FJ; Menichelli, M; Mayer, K; Bernlochner, I; Wohrle, J; Richardt, G; Liebetrau, C; Witzenbichler, B; Antoniucci, D; Akin, I; Bott-Flugel, L; Fischer, M; Landmesser, U; Katus, HA; Sibbing, D; Seyfarth, M; Janisch, M; Boncompagni, D; Hilz, R; Rottbauer, W; Okrojek, R; Mollmann, H; Hochholzer, W; Migliorini, A; Cassese, S; Mollo, P; Xhepa, E; Kufner, S; Strehle, A; Leggewie, S; Allali, A; Ndrepepa, G; Schuhlen, H; Angiolillo, DJ; Hamm, CW; Hapfelmeier, A; Tolg, R; Trenk, D; Schunkert, H; Laugwitz, KL; Kastrati, A				Schuepke, S.; Neumann, F. -J; Menichelli, M.; Mayer, K.; Bernlochner, I.; Woehrle, J.; Richardt, G.; Liebetrau, C.; Witzenbichler, B.; Antoniucci, D.; Akin, I.; Bott-Fluegel, L.; Fischer, M.; Landmesser, U.; Katus, H. A.; Sibbing, D.; Seyfarth, M.; Janisch, M.; Boncompagni, D.; Hilz, R.; Rottbauer, W.; Okrojek, R.; Moellmann, H.; Hochholzer, W.; Migliorini, A.; Cassese, S.; Mollo, P.; Xhepa, E.; Kufner, S.; Strehle, A.; Leggewie, S.; Allali, A.; Ndrepepa, G.; Schuehlen, H.; Angiolillo, D. J.; Hamm, C. W.; Hapfelmeier, A.; Toelg, R.; Trenk, D.; Schunkert, H.; Laugwitz, K. -L; Kastrati, A.			Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; CLOPIDOGREL; OUTCOMES; TRIALS	Background The relative merits of ticagrelor as compared with prasugrel in patients with acute coronary syndromes for whom invasive evaluation is planned are uncertain. Methods In this multicenter, randomized, open-label trial, we randomly assigned patients who presented with acute coronary syndromes and for whom invasive evaluation was planned to receive either ticagrelor or prasugrel. The primary end point was the composite of death, myocardial infarction, or stroke at 1 year. A major secondary end point (the safety end point) was bleeding. Results A total of 4018 patients underwent randomization. A primary end-point event occurred in 184 of 2012 patients (9.3%) in the ticagrelor group and in 137 of 2006 patients (6.9%) in the prasugrel group (hazard ratio, 1.36; 95% confidence interval [CI], 1.09 to 1.70; P=0.006). The respective incidences of the individual components of the primary end point in the ticagrelor group and the prasugrel group were as follows: death, 4.5% and 3.7%; myocardial infarction, 4.8% and 3.0%; and stroke, 1.1% and 1.0%. Definite or probable stent thrombosis occurred in 1.3% of patients assigned to ticagrelor and 1.0% of patients assigned to prasugrel, and definite stent thrombosis occurred in 1.1% and 0.6%, respectively. Major bleeding (as defined by the Bleeding Academic Research Consortium scale) was observed in 5.4% of patients in the ticagrelor group and in 4.8% of patients in the prasugrel group (hazard ratio, 1.12; 95% CI, 0.83 to 1.51; P=0.46). Conclusions Among patients who presented with acute coronary syndromes with or without ST-segment elevation, the incidence of death, myocardial infarction, or stroke was significantly lower among those who received prasugrel than among those who received ticagrelor, and the incidence of major bleeding was not significantly different between the two groups.	[Schuepke, S.; Mayer, K.; Janisch, M.; Hilz, R.; Cassese, S.; Xhepa, E.; Kufner, S.; Ndrepepa, G.; Schuehlen, H.; Schunkert, H.; Kastrati, A.] Deutsch Herzzentrum Munich, Dept Cardiol, Munich, Germany; [Schuepke, S.; Mayer, K.; Janisch, M.; Hilz, R.; Cassese, S.; Xhepa, E.; Kufner, S.; Ndrepepa, G.; Schuehlen, H.; Kastrati, A.] Tech Univ Munich, Munich, Germany; [Schuepke, S.; Sibbing, D.; Schuehlen, H.; Laugwitz, K. -L; Kastrati, A.] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany; [Bernlochner, I.; Okrojek, R.; Laugwitz, K. -L] Ludwig Maximilians Univ Munchen, Klinikum Rechts Isar, Med Klin & Poliklin 1, Dept Cardiol Angiol & Pulmonol, Munich, Germany; [Sibbing, D.] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Dept Cardiol, Munich, Germany; [Hapfelmeier, A.] Tech Univ Munich, Sch Med, Inst Med Informat Stat & Epidemiol, Munich, Germany; [Neumann, F. -J; Hochholzer, W.; Leggewie, S.; Trenk, D.] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany; [Woehrle, J.; Rottbauer, W.] Ulm Univ Hosp, Dept Cardiol, Ulm, Germany; [Richardt, G.; Allali, A.; Toelg, R.] Heart Ctr Bad Segeberg, Bad Segeberg, Germany; [Liebetrau, C.; Moellmann, H.; Hamm, C. W.] Kerckhoff Campus Justus Liebig Univ, Heart Ctr, Giessen, Germany; [Hamm, C. W.] DZHK, Partner Site Rhine Main, Bad Nauheim, Germany; [Witzenbichler, B.; Strehle, A.] Helios Amper Klinikum Dachau, Dept Cardiol & Pneumol, Dachau, Germany; [Akin, I.] Univ Clin Mannheim, Dept Cardiol, Mannheim, Germany; [Akin, I.; Katus, H. A.] DZHK, Partner Site Heidelberg Mannheim, Mannheim, Germany; [Bott-Fluegel, L.] Klinikum Landkreis Erding, Dept Cardiol, Erding, Germany; [Fischer, M.] Univ Med Ctr Regensburg, Dept Internal Med 2, Regensburg, Germany; [Landmesser, U.] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany; [Landmesser, U.] Berlin Inst Hlth, Berlin, Germany; [Landmesser, U.] DZHK, Partner Site Berlin, Berlin, Germany; [Schuehlen, H.] Vivantes Auguste Viktoria Klinikum, Berlin, Germany; [Katus, H. A.] Univ Clin Heidelberg, Dept Cardiol, Heidelberg, Germany; [Akin, I.; Katus, H. A.] DZHK, Partner Site Heidelberg Mannheim, Heidelberg, Germany; [Seyfarth, M.] Helios Univ Hosp, Dept Cardiol, Wuppertal, Germany; [Seyfarth, M.] Univ Witten Herdecke, Wuppertal, Germany; [Menichelli, M.; Boncompagni, D.; Mollo, P.] Osped Fabrizio Spaziani, Dept Cardiol, Frosinone, Italy; [Antoniucci, D.; Migliorini, A.] Careggi Univ Hosp, Florence, Italy; [Angiolillo, D. J.] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA	German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Technical University of Munich; University of Munich; University of Munich; Technical University of Munich; Universitats Herzzentrum Freiburg; Ulm University; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; University of Regensburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Witten Herdecke University; University of Florence; Azienda Ospedaliero Universitaria Careggi; State University System of Florida; University of Florida	Schupke, S (corresponding author), Deutsch Herzzentrum Munich, Lazarettstr 36, D-80636 Munich, Germany.	schuepke@dhm.mhn.de	Xhepa, Erion/N-4435-2016; Menichelli, Maurizio/AAF-8525-2021; Xhepa, Erion/GQA-5562-2022; Seidler, Tim/ABH-8333-2020; Bongiovanni, Dario/AAB-9161-2021; Akin, Ibrahim/AAF-1356-2020; Parodi, Guido/R-9346-2016	Xhepa, Erion/0000-0002-0728-2819; Seidler, Tim/0000-0002-6158-5087; Bongiovanni, Dario/0000-0002-4162-1482; Parodi, Guido/0000-0002-9718-9107; Schuhlen, Helmut/0000-0001-8630-4264; Stadler, Stefan/0000-0002-8783-618X; kupka, danny/0000-0002-6125-4114; Kerle, Irina/0000-0002-3650-488X; Sossalla, Samuel/0000-0001-8034-2673; Thurmann, Petra/0000-0001-9724-1422; Weckbach, Ludwig T/0000-0002-0981-2246; von Scheidt, Moritz/0000-0001-7159-8271; Sinnecker, Daniel/0000-0002-8116-9750; Kessler, Thorsten/0000-0003-3326-1621; Poller, Wolfgang/0000-0002-2805-6634				Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; James SK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3527; Kohli P, 2014, J AM COLL CARDIOL, V63, P225, DOI 10.1016/j.jacc.2013.09.023; Lemesle G, 2015, J THROMB HAEMOST, V13, P931, DOI 10.1111/jth.12907; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Motovska Z, 2018, J AM COLL CARDIOL, V71, P371, DOI 10.1016/j.jacc.2017.11.008; Motovska Z, 2016, CIRCULATION, V134, P1603, DOI 10.1161/CIRCULATIONAHA.116.024823; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Schulz S, 2014, J CARDIOVASC TRANSL, V7, P91, DOI 10.1007/s12265-013-9527-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wittfeldt A, 2013, J AM COLL CARDIOL, V61, P723, DOI 10.1016/j.jacc.2012.11.032; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	20	368	379	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2019	381	16					1524	1534		10.1056/NEJMoa1908973	http://dx.doi.org/10.1056/NEJMoa1908973			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JF0NV	31475799				2022-12-28	WOS:000491085100006
J	Taggart, DP; Pagano, D				Taggart, David P.; Pagano, Domenico			Expansion or contraction of stenting in coronary artery disease?	LANCET			English	Editorial Material							INTERVENTION		[Taggart, David P.] Univ Oxford, John Radcliffe Hosp, Dept Cardiac Surg, Oxford OX3 9DU, England; [Pagano, Domenico] Univ Birmingham, Univ Hosp Birmingham, Dept Cardiothorac Surg, Birmingham, W Midlands, England	University of Oxford; University of Birmingham	Taggart, DP (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiac Surg, Oxford OX3 9DU, England.	david.taggart@ouh.nhs.uk						Farkouh ME, 2019, J AM COLL CARDIOL, V73, P629, DOI 10.1016/j.jacc.2018.11.001; Freemantle N, 2018, EUR J CARDIO-THORAC, V53, P915, DOI 10.1093/ejcts/ezy140; Head SJ, 2018, LANCET, V391, P939, DOI 10.1016/S0140-6736(18)30423-9; Makikallio T, 2016, LANCET, V388, P2742; Park DW, 2018, J AM COLL CARDIOL, V72, P2813, DOI 10.1016/j.jacc.2018.09.012; Pinho-Gomes AC, 2018, J AM COLL CARDIOL, V71, P591, DOI 10.1016/j.jacc.2017.11.068; Sousa-Uva M, 2019, EUR J CARDIO-THORAC, V55, P4, DOI 10.1093/ejcts/ezy289; Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227; Stone GW, 2018, 1 PRES 4 YEAR EXCEL; Taggart DP, 2006, ANN THORAC SURG, V82, P1966, DOI 10.1016/j.athoracsur.2006.06.035; Thuijs DJFM, 2019, LANCET, V394, P1325, DOI 10.1016/S0140-6736(19)31997-X; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1299	1300		10.1016/S0140-6736(19)32040-9	http://dx.doi.org/10.1016/S0140-6736(19)32040-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9RJ	31488370				2022-12-28	WOS:000489613700004
J	Blaes, AH; Shenoy, C				Blaes, Anne H.; Shenoy, Chetan			Is it time to include cancer in cardiovascular risk prediction tools?	LANCET			English	Editorial Material							HEART-DISEASE; SURVIVORS		[Blaes, Anne H.] Univ Minnesota, Dept Med, Div Hematol Oncol, Box 736 UMHC, Minneapolis, MN 55455 USA; [Shenoy, Chetan] Univ Minnesota, Dept Med, Div Cardiol, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Blaes, AH (corresponding author), Univ Minnesota, Dept Med, Div Hematol Oncol, Box 736 UMHC, Minneapolis, MN 55455 USA.	blaes004@umn.edu	Shenoy, Chetan/AAF-9363-2020	Shenoy, Chetan/0000-0001-8877-4999	NHLBI NIH HHS [K23 HL132011] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Armenian SH, 2016, J CLIN ONCOL, V34, P1122, DOI 10.1200/JCO.2015.64.0409; Blaes Anne H, 2018, Am Soc Clin Oncol Educ Book, V38, P764, DOI 10.1200/EDBK_208509; Bradshaw PT, 2016, EPIDEMIOLOGY, V27, P6, DOI 10.1097/EDE.0000000000000394; Chow EJ, 2018, J CLIN ONCOL, V36, P44, DOI 10.1200/JCO.2017.74.8673; Chow EJ, 2015, J CLIN ONCOL, V33, P394, DOI 10.1200/JCO.2014.56.1373; Feldman DR, 2018, CLIN GENITOURIN CANC, V16, pE761, DOI 10.1016/j.clgc.2018.01.011; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Law W, 2017, CURR ONCOL, V24, pE348, DOI 10.3747/co.24.3684; Miller KD, 2019, CA CANC J CLIN; Strongman H, 2019, LANCET, V394, P1041, DOI 10.1016/S0140-6736(19)31674-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	12	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					986	988		10.1016/S0140-6736(19)31886-0	http://dx.doi.org/10.1016/S0140-6736(19)31886-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31443925	hybrid			2022-12-28	WOS:000487038700007
J	Wu, QS; Soluyanov, AA; Bzdusek, T				Wu, QuanSheng; Soluyanov, Alexey A.; Bzdusek, Tomas			Non-Abelian band topology in noninteracting metals	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; PHASE; CLASSIFICATION; DEFECTS	Electron energy bands of crystalline solids generically exhibit degeneracies called band-structure nodes. Here, we introduce non-Abelian topological charges that characterize line nodes inside the momentum space of crystalline metals with space-time inversion ( PT) symmetry and with weak spin-orbit coupling. We show that these are quaternion charges, similar to those describing disclinations in biaxial nematics. Starting from two-band considerations, we develop the complete many-band description of nodes in the presence of PT and mirror symmetries, which allows us to investigate the topological stability of nodal chains in metals. The non-Abelian charges put strict constraints on the possible nodal-line configurations. Our analysis goes beyond the standard approach to band topology and implies the existence of one-dimensional topological phases not present in existing classifications.	[Wu, QuanSheng] Ecole Polytech Fed Lausanne, Inst Phys, CH-1015 Lausanne, Switzerland; [Wu, QuanSheng] Ecole Polytech Fed Lausanne, Natl Ctr Computat Design & Discovery Novel Mat MA, CH-1015 Lausanne, Switzerland; [Soluyanov, Alexey A.] Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Soluyanov, Alexey A.] St Petersburg State Univ, Dept Phys, St Petersburg 199034, Russia; [Bzdusek, Tomas] Stanford Univ, Dept Phys, McCullough Bldg, Stanford, CA 94305 USA; [Bzdusek, Tomas] Stanford Univ, Stanford Ctr Topol Quantum Phys, Stanford, CA 94305 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich; Saint Petersburg State University; Stanford University; Stanford University	Bzdusek, T (corresponding author), Stanford Univ, Dept Phys, McCullough Bldg, Stanford, CA 94305 USA.; Bzdusek, T (corresponding author), Stanford Univ, Stanford Ctr Topol Quantum Phys, Stanford, CA 94305 USA.	bzdusek@stanford.edu	Wu, QuanSheng/AAL-3118-2021; Bzdušek, Tomáš/U-4786-2018; Wu, QuanSheng/Q-2316-2016	Wu, QuanSheng/0000-0002-9154-4489; Bzdušek, Tomáš/0000-0001-6904-5264; Wu, QuanSheng/0000-0002-9154-4489	NCCR MARVEL; NCCR QSIT; SNSF; Microsoft Research; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4302]	NCCR MARVEL; NCCR QSIT; SNSF(Swiss National Science Foundation (SNSF)); Microsoft Research(Microsoft); Gordon and Betty Moore Foundation's EPiQS Initiative	Q.W. acknowledges the support of NCCR MARVEL. A.A.S. acknowledges the support of NCCR MARVEL, NCCR QSIT, and SNSF Professorship grants, and of Microsoft Research. T.B. was supported by the Gordon and Betty Moore Foundation's EPiQS Initiative, grant GBMF4302.	Ahn J, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021013; Ahn J, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.106403; [Anonymous], 2007, PRINCIPLES CONDENSED; Atiyah M. F., 1964, TOPOLOGY, V3, P3, DOI [10.1016/0040-9383(64)90003-5, DOI 10.1016/0040-9383(64)90003-5]; Baez J., 1994, GAUGE FIELDS KNOTS G; Benalcazar WA, 2017, SCIENCE, V357, P61, DOI 10.1126/science.aah6442; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bian G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10556; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bouhon A., 2019, ARXIV190710611CONDMA; Burganov B, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.197003; Burkov AA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235126; Burkov A. A., 2012, PHYS REV B, V84; Bzdusek T, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.155105; Bzdusek T, 2016, NATURE, V538, P75, DOI 10.1038/nature19099; Catalano S, 2014, APL MATER, V2, DOI 10.1063/1.4902138; Chan YH, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.205132; Chen YG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7593; DAS SG, 1976, PHYS REV B, V13, P3978, DOI [10.1103/PhysRevB.13.3978, 10.1063/1.30430]; Fang C, 2016, CHINESE PHYS B, V25, DOI 10.1088/1674-1056/25/11/117106; Fang C, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.081201; Fecko M., 2006, DIFFERENTIAL GEOMETR; Feng X, 2018, PHYS REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.014202; Flototto D, 2018, NANO LETT, V18, P5628, DOI 10.1021/acs.nanolett.8b02105; Gong C, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.106403; Gresch D, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.075146; Hatcher A, 2002, ALGEBRAIC TOPOLOGY; Heikkila TT, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/9/093019; Horava P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.016405; Ivashko O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08664-6; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Kammler DR, 2008, METALL MATER TRANS A, V39A, P2815, DOI 10.1007/s11661-008-9642-y; Kim Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.036806; King PDC, 2014, NAT NANOTECHNOL, V9, P443, DOI [10.1038/nnano.2014.59, 10.1038/NNANO.2014.59]; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Kitaev A, 2009, AIP CONF PROC, V1134, P22, DOI 10.1063/1.3149495; KLEMAN M, 1977, J PHYS LETT-PARIS, V38, pL195, DOI 10.1051/jphyslet:019770038010019500; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Madsen LA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.145505; Marzari N, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.1419; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Mostofi AA, 2014, COMPUT PHYS COMMUN, V185, P2309, DOI 10.1016/j.cpc.2014.05.003; Nakahara M., 2003, GEOMETRY TOPOLOGY PH; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; POENARU V, 1977, J PHYS-PARIS, V38, P887, DOI 10.1051/jphys:01977003808088700; Prasad V, 2005, J AM CHEM SOC, V127, P17224, DOI 10.1021/ja052769n; Ryu S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065010; SALINGAROS N, 1981, J MATH PHYS, V22, P226, DOI 10.1063/1.524893; SALINGAROS N, 1984, J MATH PHYS, V25, P738, DOI 10.1063/1.526260; Schoop LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11696; SCHOTTMILLER JC, 1958, J PHYS CHEM-US, V62, P1446, DOI 10.1021/j150569a024; Sethna JP, 2006, ENTROPY ORDER PARAME; Sichkar SM, 2012, PHYS STATUS SOLIDI B, V249, P2118, DOI 10.1002/pssb.201248099; Soluyanov AA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235401; Sun XQ, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.106402; Tiwari A., 2019, ARXIV190300018CONDMA; TOULOUSE G, 1977, J PHYS LETT-PARIS, V38, pL67, DOI 10.1051/jphyslet:0197700380206700; Wang SS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01986-3; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Wu Q. -S., 2019, MAT CLOUD ARCH; Wu QS, 2018, COMPUT PHYS COMMUN, V224, P405, DOI 10.1016/j.cpc.2017.09.033; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Yan QH, 2018, NAT PHYS, V14, P461, DOI 10.1038/s41567-017-0041-4; Yi CJ, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.201107; Yu R, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.036401; Yu R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.036807; Yu R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075119; ZAK J, 1989, PHYS REV LETT, V62, P2747, DOI 10.1103/PhysRevLett.62.2747; Zhu ZM, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031003	71	75	75	8	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2019	365	6459					1273	+		10.1126/science.aau8740	http://dx.doi.org/10.1126/science.aau8740			101	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JA1AC	31467188	Green Accepted, Green Submitted			2022-12-28	WOS:000487547400039
J	Winnubst, J; Bas, E; Ferreira, TA; Wu, ZH; Economo, MN; Edson, P; Arthur, BJ; Bruns, C; Rokicki, K; Schauder, D; Olbris, DJ; Murphy, SD; Ackerman, DG; Arshadi, C; Baldwin, P; Blake, R; Elsayed, A; Hasan, M; Ramirez, D; Dos Santos, B; Weldon, M; Zafar, A; Dudman, JT; Gerfen, CR; Hantman, AW; Korff, W; Sternson, SM; Spruston, N; Svoboda, K; Chandrashekar, J				Winnubst, Johan; Bas, Erhan; Ferreira, Tiago A.; Wu, Zhuhao; Economo, Michael N.; Edson, Patrick; Arthur, Ben J.; Bruns, Christopher; Rokicki, Konrad; Schauder, David; Olbris, Donald J.; Murphy, Sean D.; Ackerman, David G.; Arshadi, Cameron; Baldwin, Perry; Blake, Regina; Elsayed, Ahmad; Hasan, Mashtura; Ramirez, Daniel; Dos Santos, Bruno; Weldon, Monet; Zafar, Amina; Dudman, Joshua T.; Gerfen, Charles R.; Hantman, Adam W.; Korff, Wyatt; Sternson, Scott M.; Spruston, Nelson; Svoboda, Karel; Chandrashekar, Jayaram			Reconstruction of 1,000 Projection Neurons Reveals New Cell Types and Organization of Long-Range Connectivity in the Mouse Brain	CELL			English	Article							PHASEOLUS-VULGARIS LEUKOAGGLUTININ; PRIMARY MOTOR CORTEX; CORTICOTHALAMIC PROJECTIONS; THALAMIC NUCLEI; RAT; AXONS; ANTEROGRADE; PATHWAYS; CIRCUIT; PARALLEL	Neuronal cell types are the nodes of neural circuits that determine the flow of information within the brain. Neuronal morphology, especially the shape of the axonal arbor, provides an essential descriptor of cell type and reveals how individual neurons route their output across the brain. Despite the importance of morphology, few projection neurons in the mouse brain have been reconstructed in their entirety. Here we present a robust and efficient platform for imaging and reconstructing complete neuronal morphologies, including axonal arbors that span substantial portions of the brain. We used this platform to reconstruct more than 1,000 projection neurons in the motor cortex, thalamus, subiculum, and hypothalamus. Together, the reconstructed neurons constitute more than 85 meters of axonal length and are available in a searchable online database. Axonal shapes revealed previously unknown subtypes of projection neurons and suggest organizational principles of long-range connectivity.	[Winnubst, Johan; Bas, Erhan; Ferreira, Tiago A.; Economo, Michael N.; Arthur, Ben J.; Bruns, Christopher; Rokicki, Konrad; Schauder, David; Olbris, Donald J.; Murphy, Sean D.; Ackerman, David G.; Arshadi, Cameron; Baldwin, Perry; Blake, Regina; Elsayed, Ahmad; Hasan, Mashtura; Ramirez, Daniel; Dos Santos, Bruno; Weldon, Monet; Zafar, Amina; Dudman, Joshua T.; Hantman, Adam W.; Korff, Wyatt; Sternson, Scott M.; Spruston, Nelson; Svoboda, Karel; Chandrashekar, Jayaram] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Wu, Zhuhao] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Edson, Patrick] Leap Sci LLC, Hooksett, NH 03106 USA; [Gerfen, Charles R.] NIMH, Intramural Res Program, Bethesda, MD 20892 USA; [Bas, Erhan] Amazon Web Serv, Seattle, WA 98101 USA; [Bruns, Christopher] Environm Syst Res Inst, Redlands, CA 92373 USA	Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Amazon.com	Chandrashekar, J (corresponding author), Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA 20147 USA.	chandrashekarj@janelia.hhmi.org	Wu, Zhuhao/I-5852-2018; Ferreira, Tiago/AFM-8050-2022	Economo, Michael/0000-0001-9893-1505; Wu, Zhuhao/0000-0002-2471-0555; Korff, Wyatt/0000-0001-8396-1533; Ferreira, Tiago/0000-0001-6866-1540; Chandrashekar, jayaram/0000-0001-6412-0114; Rokicki, Konrad/0000-0002-2799-9833; Arshadi, Cameron/0000-0002-1885-080X	National Institute of Mental Health (NIMH)/NIH [U01MH114824]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH114824] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Gordon M. Shepherd and Giorgio Ascoli for valuable feedback on the manuscript; Nathan Clack for helpful comments and technical assistance; Janelia Experimental Technologies, especially Daniel Flickinger, Vasily Goncharov, and Christopher McRaven, for optical design, construction, and support; Janelia Virus Services, especially Kimberley Ritola, for viral reagents; Janelia Histology, especially Monique Copeland, Brenda Shields, and Amy Hu; and Janelia Vivarium, especially Salvatore DiLisio, Jared Rouchard, and Sarah Lindo, for animal care and surgical assistance. We would also like to thank Amanda Collins, Najla Masoodpanah, Rinat Rachel Mohar, and Takako Ohashi for additional reconstruction work. We are also grateful to the Allen Institute for Brain Science for providing the Allen Mouse Common Coordinate Framework. This work was conducted as part of the MouseLight Project Team at Janelia Research Campus. Z.W.' s research is supported by the National Institute of Mental Health (NIMH)/NIH (grant U01MH114824) for the BRAIN Initiative Cell Census Network (BICCN) Program. This work was supported by the Howard Hughes Medical Institute.	Acciai L, 2016, NEUROINFORMATICS, V14, P353, DOI 10.1007/s12021-016-9310-0; Aggleton JP, 2015, PROG BRAIN RES, V219, P65, DOI 10.1016/bs.pbr.2015.03.003; Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ascoli GA, 2016, BIOESSAYS, V38, P969, DOI 10.1002/bies.201600067; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Bosch-Bouju C, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00163; Braitenberg V, 1991, ANATOMY CORTEX STAT; Bria A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-316; Cembrowski MS, 2018, ELIFE, V7, DOI 10.7554/eLife.37701; Chalfoun J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04567-y; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chi JY, 2018, CELL METAB, V27, P226, DOI 10.1016/j.cmet.2017.12.011; Chou XL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03581-6; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DESCHENES M, 1994, BRAIN RES, V664, P215, DOI 10.1016/0006-8993(94)91974-7; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Economo MN, 2018, NATURE, V563, P79, DOI 10.1038/s41586-018-0642-9; Economon MN, 2016, ELIFE, V5, DOI 10.7554/eLife.10566; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Eng CHL, 2017, NAT METHODS, V14, P1153, DOI 10.1038/nmeth.4500; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gilbert TL, 2018, MOLECULAR-GENETIC AND STATISTICAL TECHNIQUES FOR BEHAVIORAL AND NEURAL RESEARCH, P51, DOI 10.1016/B978-0-12-804078-2.00003-9; Gong H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12142; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guo ZCV, 2017, NATURE, V545, P181, DOI 10.1038/nature22324; Han YY, 2018, NATURE, V556, P51, DOI 10.1038/nature26159; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hintiryan H, 2016, NAT NEUROSCI, V19, P1100, DOI 10.1038/nn.4332; Hoerder-Suabedissen A, 2018, CEREB CORTEX, V28, P1882, DOI 10.1093/cercor/bhy036; Hooks BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05780-7; Hunnicutt BJ, 2014, NAT NEUROSCI, V17, P1276, DOI 10.1038/nn.3780; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Johnson H, 2007, USING INSIGHT TOOLKI, V57, P11; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kebschull JM, 2016, NEURON, V91, P975, DOI 10.1016/j.neuron.2016.07.036; Kikinis R., 2014, INTRAOPERATIVE IMAGI, P277, DOI DOI 10.1007/978-1-4614-7657-3_19; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; KISVARDAY ZF, 1994, EUR J NEUROSCI, V6, P1619, DOI 10.1111/j.1460-9568.1994.tb00553.x; Kita T, 2012, J NEUROSCI, V32, P5990, DOI 10.1523/JNEUROSCI.5717-11.2012; Kuramoto E, 2015, CEREB CORTEX, V25, P221, DOI 10.1093/cercor/bht216; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lin HM, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00086; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; LUPPI PH, 1990, BRAIN RES, V534, P209, DOI 10.1016/0006-8993(90)90131-T; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Naber PA, 1998, J COMP NEUROL, V393, P284; Oberlaender M, 2011, P NATL ACAD SCI USA, V108, P4188, DOI 10.1073/pnas.1100647108; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Parent M, 2006, J COMP NEUROL, V496, P202, DOI 10.1002/cne.20925; Peng HC, 2015, NEURON, V87, P252, DOI 10.1016/j.neuron.2015.06.036; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Ropireddy D, 2011, BRAIN STRUCT FUNCT, V216, P1, DOI 10.1007/s00429-010-0291-8; Shah S, 2018, CELL, V174, P363, DOI 10.1016/j.cell.2018.05.035; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shepherd GMG, 2002, P NATL ACAD SCI USA, V99, P6340, DOI 10.1073/pnas.052151299; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Shima Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13503; Sita LV, 2007, NEUROSCIENCE, V148, P949, DOI 10.1016/j.neuroscience.2007.07.010; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Svoboda K, 2011, NEUROINFORMATICS, V9, P97, DOI 10.1007/s12021-011-9097-y; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; Turner RS, 2000, J NEUROSCI, V20, P7096, DOI 10.1523/JNEUROSCI.20-18-07096.2000; Urbain N, 2007, NEURON, V56, P714, DOI 10.1016/j.neuron.2007.10.023; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Wu H, 2014, ELIFE, V3, DOI 10.7554/eLife.02444; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; YORKE CH, 1975, J COMP NEUROL, V164, P233, DOI 10.1002/cne.901640206; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang XB, 2017, SCIENCE, V356, P853, DOI 10.1126/science.aam7100; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	91	152	154	8	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					268	+		10.1016/j.cell.2019.07.042	http://dx.doi.org/10.1016/j.cell.2019.07.042			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31495573	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000486618500028
J	Liu, Y; You, YL; Lu, ZK; Yang, J; Li, PP; Liu, L; Xu, HN; Niu, YM; Cao, XT				Liu, Yang; You, Yuling; Lu, Zhike; Yang, Jiang; Li, Panpan; Liu, Lun; Xu, Henan; Niu, Yamei; Cao, Xuetao			N-6-methyladenosine RNA modification-mediated cellular metabolism rewiring inhibits viral replication	SCIENCE			English	Article							GENE-EXPRESSION; METHYLATION; TRANSCRIPTOME; DEMETHYLASE; MACROPHAGE; ITACONATE; PACKAGE; ALKBH5; STAT1; HOST	Host cell metabolism can be modulated by viral infection, affecting viral survival or clearance. Yet the cellular metabolism rewiring mediated by the N-6-methyladenosine (m(6)A) modification in interactions between virus and host remains largely unknown. Here we report that in response to viral infection, host cells impair the enzymatic activity of the RNA m(6)A demethylase ALKBH5. This behavior increases the m(6)A methylation on alpha-ketoglutarate dehydrogenase (OGDH) messenger RNA (mRNA) to reduce its mRNA stability and protein expression. Reduced OGDH decreases the production of the metabolite itaconate that is required for viral replication. With reduced OGDH and itaconate production in vivo, Alkbh5-deficient mice display innate immune response-independent resistance to viral exposure. Our findings reveal that m(6)A RNA modification-mediated down-regulation of the OGDH-itaconate pathway reprograms cellular metabolism to inhibit viral replication, proposing potential targets for controlling viral infection.	[Liu, Yang; You, Yuling; Yang, Jiang; Li, Panpan; Liu, Lun; Xu, Henan; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Dept Immunol,Ctr Immuno, Beijing 100005, Peoples R China; [Liu, Yang; Cao, Xuetao] Nankai Univ, Coll Life Sci, Natl Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lu, Zhike] Westlake Univ, Sch Life Sci, Hangzhou 310024, Zhejiang, Peoples R China; [Niu, Yamei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100005, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nankai University; Westlake University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University	Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Dept Immunol,Ctr Immuno, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Natl Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org		LIU, Yang/0000-0002-5636-030X	National Natural Science Foundation of China [81788101]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences	This work is supported by grants from the National Natural Science Foundation of China (81788101) and the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2016-12M-1-003).	Aik W, 2014, NUCLEIC ACIDS RES, V42, P4741, DOI 10.1093/nar/gku085; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Gerlach RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078912; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ilic N, 2017, P NATL ACAD SCI USA, V114, pE3434, DOI 10.1073/pnas.1617922114; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Liu S, 2018, NAT IMMUNOL, V19, P41, DOI 10.1038/s41590-017-0003-0; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-; Ma LJ, 2017, GENOME RES, V27, P385, DOI 10.1101/gr.212563.116; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Olive AJ, 2016, NAT REV MICROBIOL, V14, P221, DOI 10.1038/nrmicro.2016.12; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Stuart SD, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-4; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Wang CM, 2017, J EXP MED, V214, P3597, DOI 10.1084/jem.20170856; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830	30	88	95	10	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1171	+		10.1126/science.aax4468	http://dx.doi.org/10.1126/science.aax4468			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31439758				2022-12-28	WOS:000485780800048
J	Johnson, NF; Leahy, R; Restrepo, NJ; Velasquez, N; Zheng, M; Manrique, P; Devkota, P; Wuchty, S				Johnson, N. F.; Leahy, R.; Restrepo, N. Johnson; Velasquez, N.; Zheng, M.; Manrique, P.; Devkota, P.; Wuchty, S.			Hidden resilience and adaptive dynamics of the global online hate ecology	NATURE			English	Article							BEHAVIORS	Online hate and extremist narratives have been linked to abhorrent real-world events, including a current surge in hate crimes(1-6) and an alarming increase in youth suicides that result from social media vitriol(7); inciting mass shootings such as the 2019 attack in Christchurch, stabbings and bombings(8-11); recruitment of extremists(12-16), including entrapment and sex-trafficking of girls as fighter brides(17); threats against public figures, including the 2019 verbal attack against an anti-Brexit politician, and hybrid (racistanti-women-anti-immigrant) hate threats against a US member of the British royal family(18); and renewed anti-western hate in the 2019 post-ISIS landscape associated with support for Osama Bin Laden's son and Al Qaeda. Social media platforms seem to be losing the battle against online hate(19,20) and urgently need new insights. Here we show that the key to understanding the resilience of online hate lies in its global network-of-network dynamics. Interconnected hate clusters form global 'hate highways' that-assisted by collective online adaptations-cross social media platforms, sometimes using 'back doors' even after being banned, as well as jumping between countries, continents and languages. Our mathematical model predicts that policing within a single platform (such as Facebook) can make matters worse, and will eventually generate global 'dark pools' in which online hate will flourish. We observe the current hate network rapidly rewiring and self-repairing at the micro level when attacked, in a way that mimics the formation of covalent bonds in chemistry. This understanding enables us to propose a policy matrix that can help to defeat online hate, classified by the preferred (or legally allowed) granularity of the intervention and top-down versus bottom-up nature. We provide quantitative assessments for the effects of each intervention. This policy matrix also offers a tool for tackling a broader class of illicit online behaviours(21,22) such as financial fraud.	[Johnson, N. F.; Leahy, R.; Restrepo, N. Johnson] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Velasquez, N.] George Washington Univ, Elliott Sch Int Affairs, Washington, DC 20052 USA; [Zheng, M.; Manrique, P.] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; [Devkota, P.; Wuchty, S.] Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA	George Washington University; George Washington University; University of Miami; University of Miami	Johnson, NF (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.	neiljohnson@gwu.edu	Zheng, Minzhang/AAD-2861-2019	Zheng, Minzhang/0000-0003-2689-9539; Velasquez, Nicolas/0000-0002-0170-5294	US Air Force (AFOSR) [FA9550-16-1-0247]	US Air Force (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	N.F.J. is supported by US Air Force (AFOSR) grant FA9550-16-1-0247.	Amend A., 2018, ANAL TERRORISTS SOCI; Beirich H, 2017, YEAR HATE EXTREMISM; Berman M., 2016, PROSECUTORS SAY ACCU; Cullors Patrisse, 2017, ONLINE HATE IS DEADL; Foster M, 2019, RACIST ONLINE ABUSE; GILL P, 2015, POLITICAL VIOLENCE, P1; Gill P, 2015, TERRORISM ONLINE POL; Gill P, 2017, CRIMINOL PUBLIC POL, V16, P99, DOI 10.1111/1745-9133.12249; Gill P, 2014, J FORENSIC SCI, V59, P425, DOI 10.1111/1556-4029.12312; Grinberg N, 2019, SCIENCE, V363, P374, DOI 10.1126/science.aau2706; Havlin S, 2014, EUR PHYS J-SPEC TOP, V223, P2087, DOI 10.1140/epjst/e2014-02251-6; Hedstrom P, 2000, AM J SOCIOL, V106, P145, DOI 10.1086/303109; Hohmann James, 2018, WASH POST; Jarrett TC, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026116; John A, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9044; Johnson NF, 2016, SCIENCE, V352, P1459, DOI 10.1126/science.aaf0675; KrebsOnSecurity, 2019, DEL FAC CYB GROUPS H; Martinez A. G, 2018, WANT FACEBOOK CENSOR; O'Brien S. A, 2019, MODERATING INTERNET; Pagliery J., 2017, SUSPECT C SHOOTING W; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Panin A, 2015, RUSSIAN STUDENTS TAR; Reitman J, 2018, LAW ENFORCEMENT FAIL; Schuurman B, 2017, STUD CONFL TERROR, V42, P771; Southern Poverty Law Center (SPLC), 2018, EXTR GROUPS; Stanley H E, 1988, INTRO PHASE TRANSITI; Wakefield J, 2019, CHRISTCHURCH SHOOTIN; Wong J. C, 2019, ANTIVAXX MOBS DOCTOR; Yan H., 2017, CAMPUS KILLING SUSPE	29	62	63	14	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					261	+		10.1038/s41586-019-1494-7	http://dx.doi.org/10.1038/s41586-019-1494-7			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31435010				2022-12-28	WOS:000485415400055
J	Abbink, P; Mercado, NB; Nkolola, JP; Peterson, RL; Tuyishime, H; McMahan, K; Moseley, ET; Borducchi, EN; Chandrashekar, A; Bondzie, EA; Agarwal, A; Belli, AJ; Reimann, KA; Keele, BF; Geleziunas, R; Lewis, MG; Barouch, DH				Abbink, Peter; Mercado, Noe B.; Nkolola, Joseph P.; Peterson, Rebecca L.; Tuyishime, Hubert; McMahan, Katherine; Moseley, Edward T.; Borducchi, Erica N.; Chandrashekar, Abishek; Bondzie, Esther A.; Agarwal, Arshi; Belli, Aaron J.; Reimann, Keith A.; Keele, Brandon F.; Geleziunas, Romas; Lewis, Mark G.; Barouch, Dan H.			Lack of therapeutic efficacy of an antibody to alpha(4)beta(7) SIVmac251-infected rhesus macaques	SCIENCE			English	Article							REPLICATION	Sustained virologic control of human immunodeficiency virus type 1 (HIV-1) infection after discontinuation of antiretroviral therapy (ART) is a major goal of the HIV-1 cure field. A recent study reported that administration of an antibody against alpha(4)beta(7) induced durable virologic control after ART discontinuation in 100% of rhesus macaques infected with an attenuated strain of simian immunodeficiency virus (SIV) containing a stop codon in nef. We performed similar studies in 50 rhesus macaques infected with wild-type, pathogenic SIVmac251. In animals that initiated ARTduring either acute or chronic infection, anti-alpha(4)beta(7) antibody infusion had no detectable effect on the viral reservoir or viral rebound after ART discontinuation. These data demonstrate that anti-alpha(4)beta(7) antibody administration did not provide therapeutic efficacy in the model of pathogenic SIVmac251 infection of rhesus macaques.	[Abbink, Peter; Mercado, Noe B.; Nkolola, Joseph P.; Peterson, Rebecca L.; Tuyishime, Hubert; McMahan, Katherine; Moseley, Edward T.; Borducchi, Erica N.; Chandrashekar, Abishek; Bondzie, Esther A.; Agarwal, Arshi; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Belli, Aaron J.; Reimann, Keith A.] Univ Massachusetts, Med Sch, MassBiol, Boston, MA 02126 USA; [Keele, Brandon F.] Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Geleziunas, Romas] Gilead Sci, Foster City, CA 94404 USA; [Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Barouch, Dan H.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gilead Sciences; BIOQUAL Inc.; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Chandrashekar, Abishek/P-2610-2019; Mercado, Noe/ABE-8247-2020	Chandrashekar, Abishek/0000-0001-7821-5552; Tuyishime, Hubert/0000-0001-8717-4692; Mercado, Noe/0000-0001-7769-7326; Moseley, Edward/0000-0003-4334-5618; Apraku Bondzie, Esther/0000-0001-9409-5052; Abbink, Peter/0000-0003-1978-088X	National Institutes of Health [AI124377, AI126603, AI126683, AI128751, AI129797, HHSN261200800001E, OD010976]; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI128751, UM1AI124377, UM1AI126603, U24AI126683, R01AI129797] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge support from the National Institutes of Health (AI124377, AI126603, AI126683, AI128751, AI129797, HHSN261200800001E, OD010976) and the Ragon Institute of MGH, MIT and Harvard.	Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Cicala C, 2000, P NATL ACAD SCI USA, V97, P1178, DOI 10.1073/pnas.97.3.1178; Dahabieh MS, 2015, ANNU REV MED, V66, P407, DOI 10.1146/annurev-med-092112-152941; Davenport MP, 2019, NAT REV IMMUNOL, V19, P45, DOI 10.1038/s41577-018-0085-4; Di Mascio M, 2019, SCIENCE, V365, P1025, DOI 10.1126/science.aav6695; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Gortu G., 2009, CURR MOL MED, V9, P836; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Iwamoto N, 2019, SCIENCE, V365, P1033, DOI 10.1126/science.aaw7765; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	18	23	24	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1029	+		10.1126/science.aaw8562	http://dx.doi.org/10.1126/science.aaw8562			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488689	Green Accepted			2022-12-28	WOS:000484732700047
J	Di Mascio, M; Lifson, JD; Srinivasula, S; Kim, I; DeGrange, P; Keele, BF; Belli, AJ; Reimann, KA; Wang, Y; Proschan, M; Lane, HC; Fauci, AS				Di Mascio, M.; Lifson, J. D.; Srinivasula, S.; Kim, I.; DeGrange, P.; Keele, B. F.; Belli, A. J.; Reimann, K. A.; Wang, Y.; Proschan, M.; Lane, H. C.; Fauci, A. S.			Evaluation of an antibody to alpha(4)beta(7) in the control of SIVmac239-nef-stop infection	SCIENCE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; INTEGRIN ALPHA(4)BETA(7); MACAQUES; DISCOVERY; RECEPTOR; SUBSETS; DISEASE; TISSUES	Treatment of SIV-infected rhesus macaques with short-term antiretroviral therapy (ART) and partially overlapping infusions of antibody to integrin a 4 0 7 was reported to induce durable posttreatment viral suppression. In an attempt to replicate those observations, we treated macaques infected with the same virus and with the same ART and monoclonal antibody (mAb) regimens (anti-alpha(4)beta(7) versus control mAb). Sequencing demonstrated that the virus used was actually SlVmac239-nef-stop, not wild-type SIVmac239. A positive correlation was found at 2 weeks after infection between the frequency of repair of attenuated Nef-STOP virus to pathogenic Nef-OPEN and plasma SIV RNA levels. Levels of plasma viremia before the first antibody infusion and preinfection levels of alpha(4)beta(hi)(7) CD4(+) T cells, but not treatment with antibody to alpha(4)beta(7), correlated with levels of viral replication upon discontinuation of all treatments. Follow-up plasma viremia, peripheral blood CD4(+) T cell counts, and lymph node and rectal tissue viral load were not significantly different between anti-U4 17 and control mAb groups.	[Di Mascio, M.] NIAID, Div Clin Res, AIDS Imaging Res Sect, NIH, Bethesda, MD 20892 USA; [Lifson, J. D.; Keele, B. F.] Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Srinivasula, S.] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Frederick, MD 21702 USA; [Kim, I.] Frederick Natl Lab Canc Res, Appl Dev Res Directorate, Frederick, MD 21702 USA; [DeGrange, P.] NIAID Frederick, Battelle Charles River Integrated Res Facil, Frederick, MD 21702 USA; [Belli, A. J.; Reimann, K. A.] Univ Massachusetts, Med Sch, MassBiol, Boston, MA 02126 USA; [Proschan, M.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20852 USA; [Wang, Y.; Lane, H. C.; Fauci, A. S.] NIAID, Lab Immunoregulat, Div Intramural Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Boston; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Di Mascio, M (corresponding author), NIAID, Div Clin Res, AIDS Imaging Res Sect, NIH, Bethesda, MD 20892 USA.	mdimascio@niaid.nih.gov			federal funds from the National Cancer Institute, National Institutes of Health [HSN261200800001E];  [P51OD011106];  [R24OD010976];  [U24AI126684]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Genotyping assays were performed with support from P51OD011106. Antibody to alpha<INF>4 beta 7</INF> and control antibodies were provided by the NIH NHP Reagent Resource supported by R24OD010976 and U24AI126684. This work was supported in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of any trade names, commercial products, or organizations imply endorsement by the U.S. government.	Abbink P, 2019, SCIENCE, V365, P1029, DOI 10.1126/science.aaw8562; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Arthos J, 2018, CURR HIV-AIDS REP, V15, P127, DOI 10.1007/s11904-018-0382-3; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Byrareddy SN, 2015, J IMMUNOL, V194, P5968, DOI 10.4049/jimmunol.1402866; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Calenda G, 2018, J IMMUNOL, V200, P810, DOI 10.4049/jimmunol.1701150; CHAKRABARTI L, 1995, VIROLOGY, V213, P535, DOI 10.1006/viro.1995.0026; Cicala C, 2000, P NATL ACAD SCI USA, V97, P1178, DOI 10.1073/pnas.97.3.1178; Connick E, 2014, J IMMUNOL, V193, P5613, DOI 10.4049/jimmunol.1401161; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Guzzo C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam7341; Hansen SG, 2017, NATURE, V547, P123, DOI 10.1038/nature22984; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Iwamoto N, 2019, SCIENCE, V365, P1033, DOI 10.1126/science.aaw7765; Karl JA, 2017, IMMUNOGENETICS, V69, P211, DOI 10.1007/s00251-017-0969-7; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Klatt NR, 2012, J VIROL, V86, P1203, DOI 10.1128/JVI.06033-11; LINDMO T, 1986, METHOD ENZYMOL, V121, P678; Liyanage NPM, 2014, VIROLOGY, V450, P359, DOI 10.1016/j.virol.2013.12.003; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; Namazi G, 2018, J INFECT DIS, V218, P1954, DOI 10.1093/infdis/jiy479; Okoye AA, 2018, NAT MED, V24, P1430, DOI 10.1038/s41591-018-0130-7; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Prall TM, 2017, IMMUNOGENETICS, V69, P325, DOI 10.1007/s00251-017-0977-7; Sivro A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6354; Srinivasula S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187912; Tincati C, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0103-1; Yacoub W, 2018, ALIMENT PHARM THER, V47, P906, DOI 10.1111/apt.14548	29	21	21	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1025	+		10.1126/science.aav6695	http://dx.doi.org/10.1126/science.aav6695			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488688				2022-12-28	WOS:000484732700046
J	Cooper, N; Ghanima, W				Cooper, Nichola; Ghanima, Waleed			Immune Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							POPULATION-BASED COHORT; LONG-TERM TREATMENT; VENOUS THROMBOEMBOLISM; RECEPTOR-AGONISTS; ADULT PATIENTS; PURPURA; SPLENECTOMY; EFFICACY; SAFETY; ROMIPLOSTIM	Immune thrombocytopenia in patients who present with serious bleeding is treated with platelet transfusions, glucocorticoids, and intravenous immune globulin. In patients without serious bleeding, treatment decisions are guided by the platelet count and other factors. Commonly used agents include glucocorticoids, thrombopoietin-receptor agonists, and rituximab.	[Cooper, Nichola] Imperial Coll, Hammersmith Hosp, Dept Med, Du Cane Rd, London W12 0HS, England; [Ghanima, Waleed] Ostfold Hosp Trust, Dept Med, Kalnes, Norway; [Ghanima, Waleed] Ostfold Hosp Trust, Dept Hematol Oncol, Kalnes, Norway; [Ghanima, Waleed] Ostfold Hosp Trust, Dept Res, Kalnes, Norway; [Ghanima, Waleed] Oslo Univ Hosp, Dept Hematol, Oslo, Norway; [Ghanima, Waleed] Univ Oslo, Inst Clin Med, Oslo, Norway	Imperial College London; University of Oslo; University of Oslo	Cooper, N (corresponding author), Imperial Coll, Hammersmith Hosp, Dept Med, Du Cane Rd, London W12 0HS, England.	n.cooper@imperial.ac.uk						Adelborg K, 2019, J THROMB HAEMOST, V17, P912, DOI 10.1111/jth.14446; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Bao WL, 2010, BLOOD, V116, P4639, DOI 10.1182/blood-2010-04-281717; Boyle S, 2013, BLOOD, V121, P4782, DOI 10.1182/blood-2012-12-467068; Bussel J, 2018, AM J HEMATOL, V93, P921, DOI 10.1002/ajh.25125; Rocha AMC, 2011, HAEMATOL-HEMATOL J, V96, P1560, DOI 10.3324/haematol.2011.046417; Chaturvedi S, 2018, BLOOD, V131, P1172, DOI 10.1182/blood-2017-09-742353; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Cheng YF, 2003, NEW ENGL J MED, V349, P831, DOI 10.1056/NEJMoa030254; Chugh S, 2015, LANCET HAEMATOL, V2, pE75, DOI 10.1016/S2352-3026(15)00003-4; Efficace F, 2016, AM J HEMATOL, V91, P995, DOI 10.1002/ajh.24463; Frederiksen H, 1999, BLOOD, V94, P909, DOI 10.1182/blood.V94.3.909.415k02_909_913; Frederiksen H, 2017, EUR J INTERN MED, V37, pE23, DOI 10.1016/j.ejim.2016.09.001; Ghanima W, 2019, HAEMATOLOGICA, V104, P1112, DOI 10.3324/haematol.2018.212845; Ghanima W, 2015, LANCET, V385, P1653, DOI 10.1016/S0140-6736(14)61495-1; Ghanima W, 2012, BLOOD, V120, P960, DOI 10.1182/blood-2011-12-309153; Godeau B, 2002, LANCET, V359, P23, DOI 10.1016/S0140-6736(02)07275-6; Gonzalez-Lopez TJ, 2015, AM J HEMATOL, V90, pE40, DOI 10.1002/ajh.23900; Jurczak W, 2018, BRIT J HAEMATOL, V183, P479, DOI 10.1111/bjh.15573; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Khellaf M, 2014, BLOOD, V124, P3228, DOI 10.1182/blood-2014-06-582346; Khellaf M, 2013, HAEMATOLOGICA, V98, P881, DOI 10.3324/haematol.2012.074633; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2013, BRIT J HAEMATOL, V161, P411, DOI 10.1111/bjh.12260; Lucchini E, 2019, HAEMATOLOGICA, V104, P1124, DOI 10.3324/haematol.2019.218883; Matzdorff A, 2018, ONCOL RES TREAT, V41, P1, DOI 10.1159/000492187; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; Mithoowani S, 2016, LANCET HAEMATOL, V3, pE489, DOI 10.1016/S2352-3026(16)30109-0; Najaoui A, 2012, EUR J HAEMATOL, V88, P167, DOI 10.1111/j.1600-0609.2011.01718.x; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Neunert CE, 2018, HEMATOL-AM SOC HEMAT, P568, DOI 10.1182/asheducation-2018.1.568; Newland A, 2016, BRIT J HAEMATOL, V172, P262, DOI 10.1111/bjh.13827; Norgaard M, 2016, BRIT J HAEMATOL, V174, P639, DOI 10.1111/bjh.13787; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Page LK, 2007, BRIT J HAEMATOL, V138, P245, DOI 10.1111/j.1365-2141.2007.06635.x; Park YH, 2016, ACTA HAEMATOL-BASEL, V135, P162, DOI 10.1159/000442703; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Piel-Julian ML, 2018, J THROMB HAEMOST, V16, P1830, DOI 10.1111/jth.14227; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Qu YK, 2014, INT SURG, V99, P286, DOI 10.9738/INTSURG-D-13-00175.1; Gonzalez-Porras JR, 2015, BRIT J HAEMATOL, V169, P111, DOI 10.1111/bjh.13266; Rodeghiero F, 2008, AM J HEMATOL, V83, P91, DOI 10.1002/ajh.21109; Rodeghiero F, 2016, AM J HEMATOL, V91, P39, DOI 10.1002/ajh.24234; Rodeghiero F, 2013, BLOOD, V121, P2596, DOI 10.1182/blood-2012-07-442392; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Rorholt M, 2017, HAEMATOLOGICA, V102, P1333, DOI 10.3324/haematol.2016.157008; Sailer T, 2006, HAEMATOLOGICA, V91, P1041; Schoonen WM, 2009, BRIT J HAEMATOL, V145, P235, DOI 10.1111/j.1365-2141.2009.07615.x; Stasi R, 2008, BLOOD, V112, P1147, DOI 10.1182/blood-2007-12-129262; Thomsen RW, 2010, J THROMB HAEMOST, V8, P1413, DOI 10.1111/j.1538-7836.2010.03849.x; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep39003; Wong RSM, 2017, BLOOD, V130, P2527, DOI 10.1182/blood-2017-04-748707; Yong M, 2010, EUR J INTERN MED, V21, P12, DOI 10.1016/j.ejim.2009.10.003; Zufferey A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6020016	55	142	151	11	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					945	955		10.1056/NEJMcp1810479	http://dx.doi.org/10.1056/NEJMcp1810479			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW9PR	31483965	Green Published			2022-12-28	WOS:000485326200009
J	Demczko, MM				Demczko, Matthew M.			A Wave	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Demczko, Matthew M.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Demczko, Matthew M.] Nemours Alfred I duPont Hosp Children, Div Diagnost Referral Serv & Solid Organ Transpla, 1600 Rockland Rd, Wilmington, DE 19803 USA	Jefferson University; Nemours Alfred I. duPont Hospital for Children	Demczko, MM (corresponding author), Nemours Alfred I duPont Hosp Children, Div Diagnost Referral Serv & Solid Organ Transpla, 1600 Rockland Rd, Wilmington, DE 19803 USA.	mdemczko@nemours.org		Demczko, Matthew/0000-0003-0232-9611					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					815	816		10.1001/jama.2019.12599	http://dx.doi.org/10.1001/jama.2019.12599			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479141				2022-12-28	WOS:000486437200008
J	Hensley, MK; Bauer, ME; Admon, LK; Prescott, HC				Hensley, Matthew K.; Bauer, Melissa E.; Admon, Lindsay K.; Prescott, Hallie C.			Incidence of Maternal Sepsis and Sepsis-Related Maternal Deaths in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hensley, Matthew K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Bauer, Melissa E.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Admon, Lindsay K.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Prescott, Hallie C.] VA Ctr Clin Management Res, HSR&D Ctr Innovat, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hensley, MK (corresponding author), Univ Michigan, Dept Internal Med, Taubman Clin 3916, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	hematthe@med.umich.edu		Prescott, Hallie/0000-0002-8442-6724; Admon, Lindsay/0000-0003-2059-9711	National Institutes of Health/National Institute of General Medical Sciences [K08 GM115859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM115859] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Prescott is supported by grant K08 GM115859 from the National Institutes of Health/National Institute of General Medical Sciences.	Acosta CD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001672; [Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; Bonet M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0321-6; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Kendle AM, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2019.02.002; Kuklina EV, 2008, MATERN CHILD HLTH J, V12, P469, DOI 10.1007/s10995-007-0256-6	6	15	18	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					890	892		10.1001/jama.2019.9818	http://dx.doi.org/10.1001/jama.2019.9818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479129	Green Published, Bronze			2022-12-28	WOS:000486437200018
J	Mahase, E				Mahase, Elisabeth			Teenager diagnosed with optic neuropathy resulting from poor diet despite normal BMI	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Harrison R, 2019, ANN INTERN MED, DOI [10.7326/L19-0361.31476767, DOI 10.7326/L19-0361.31476767]	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5361	10.1136/bmj.l5361	http://dx.doi.org/10.1136/bmj.l5361			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481359				2022-12-28	WOS:000485434400005
J	Smallwood, N; Miller, A; Walden, A; Hew, M; Tay, TR; Rahman, NM				Smallwood, Nicholas; Miller, Ashley; Walden, Andrew; Hew, Mark; Tay, Tunn Ren; Rahman, Najib M.			Should point-of-care ultrasonography replace stethoscopes in acute respiratory failure?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHEST ULTRASOUND; LUNG ULTRASOUND; PNEUMONIA		[Smallwood, Nicholas] East Surrey Hosp, Redhill, Surrey, England; [Miller, Ashley] Royal Shrewsbury Hosp, Shrewsbury, Salop, England; [Walden, Andrew] Royal Berkshire Hosp, Reading, Berks, England; [Hew, Mark] Alfred Hosp, Resp Med, Melbourne, Vic, Australia; [Hew, Mark] Monash Univ, Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Tay, Tunn Ren] Changi Gen Hosp, Dept Resp & Crit Care Med, Singapore, Singapore; [Rahman, Najib M.] Churchill Hosp, Oxford Ctr Resp Med, Oxford, England; [Rahman, Najib M.] Oxford NIHR Biomed Res Ctr, Oxford, England	East Surrey Hospital; Royal Berkshire Hospital; Florey Institute of Neuroscience & Mental Health; Monash University; Changi General Hospital; University of Oxford; University of Oxford	Smallwood, N (corresponding author), East Surrey Hosp, Redhill, Surrey, England.; Hew, M (corresponding author), Alfred Hosp, Resp Med, Melbourne, Vic, Australia.; Hew, M (corresponding author), Monash Univ, Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	nicholas.smallwood@nhs.net; m.hew@alfred.org.au	Miller, Ashley/AAN-7315-2020	Miller, Ashley/0000-0002-6665-1514; Rahman, Najib M/0000-0003-1195-1680; Smallwood, Nicholas/0000-0002-4286-3256				Bataille B, 2014, CHEST, V146, P1586, DOI 10.1378/chest.14-0681; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Blaivas M, 2012, AM J EMERG MED, V30, P338, DOI 10.1016/j.ajem.2010.12.016; Blehar DJ, 2015, ACAD EMERG MED, V22, P574, DOI 10.1111/acem.12653; Hew M, 2016, EUR RESPIR REV, V25, P230, DOI 10.1183/16000617.0047-2016; Hew Mark, 2015, BMJ Open, V5, pe007838, DOI 10.1136/bmjopen-2015-007838; Hopstaken RM, 2004, CLIN RADIOL, V59, P743, DOI 10.1016/j.crad.2004.01.011; Laursen CB, 2014, LANCET RESP MED, V2, P638, DOI 10.1016/S2213-2600(14)70135-3; Lichtenstein DA, 2008, CHEST, V134, P117, DOI 10.1378/chest.07-2800; Long L, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005713; Marik PE, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-38; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Self WH, 2013, AM J EMERG MED, V31, P401, DOI 10.1016/j.ajem.2012.08.041; Silva S, 2013, CHEST, V144, P859, DOI 10.1378/chest.13-0167; Simel DL, 2009, RATIONAL CLIN EXAMIN; Smallwood Nicholas, 2016, Acute Med, V15, P193; Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4; Wallbridge P, 2018, RESP MED, V141, P26, DOI 10.1016/j.rmed.2018.06.018; Wallbridge Peter D, 2017, JRSM Open, V8, p2054270417695055, DOI 10.1177/2054270417695055	19	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2019	366								l5225	10.1136/bmj.l5225	http://dx.doi.org/10.1136/bmj.l5225			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9ID	31471372	Green Submitted			2022-12-28	WOS:000483893700001
J	Park, JR; Kreissman, SG; London, WB; Naranjo, A; Cohn, SL; Hogarty, MD; Tenney, SC; Haas-Kogan, D; Shaw, PJ; Kraveka, JM; Roberts, SS; Geiger, JD; Doski, JJ; Voss, SD; Maris, JM; Grupp, SA; Diller, L				Park, Julie R.; Kreissman, Susan G.; London, Wendy B.; Naranjo, Arlene; Cohn, Susan Lerner; Hogarty, Michael D.; Tenney, Sheena C.; Haas-Kogan, Daphne; Shaw, Peter John; Kraveka, Jacqueline M.; Roberts, Stephen S.; Geiger, James Duncan; Doski, John J.; Voss, Stephan D.; Maris, John M.; Grupp, Stephan A.; Diller, Lisa			Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-DOSE CHEMOTHERAPY; PEDIATRIC-ONCOLOGY-GROUP; PHASE-I; CHILDREN; THERAPY; CLASSIFICATION; FEASIBILITY; I-131-MIBG; PROGNOSIS; MELPHALAN	IMPORTANCE Induction chemotherapy followed by high-dose therapy with autologous stem cell transplant and subsequent antidisialoganglioside antibody immunotherapy is standard of care for patients with high-risk neuroblastoma, but survival rate among these patients remains low. OBJECTIVE To determine if tandem autologous transplant improves event-free survival (EFS) compared with single transplant. DESIGN, SETTING, AND PARTICIPANTS Patients were enrolled in this randomized clinical trial from November 2007 to February 2012 at 142 Children's Oncology Group centers in the United States, Canada, Switzerland, Australia, and New Zealand. A total of 652 eligible patients aged 30 years or younger with protocol-defined high-risk neuroblastoma were enrolled and 355 were randomized. The final date of follow-up was June 29, 2017, and the data analyses cut-off date was June 30, 2017. INTERVENTIONS Patients were randomized to receive tandem transplant with thiotepa/cyclophosphamide followed by dose-reduced carboplatin/etoposide/melphalan (n = 176) or single transplant with carboplatin/etoposide/melphalan (n = 179). MAIN OUTCOMES AND MEASURES The primary outcome was EFS from randomization to the occurrence of the first event (relapse, progression, secondary malignancy, or death from any cause). The study was designed to test the 1-sided hypothesis of superiority of tandem transplant compared with single transplant. RESULTS Among the 652 eligible patients enrolled, 297 did not undergo randomization because they were nonrandomly assigned (n = 27), ineligible for randomization (n = 62), had no therapy (n = 1), or because of physician/parent preference (n = 207). Among 355 patients randomized (median diagnosis age, 36.1 months; 152 [42.8%] female), 297 patients (83.7%) completed the study and 21 (5.9%) were lost to follow-up after completing protocol therapy. Three-year EFS from the time of randomization was 61.6% (95% CI, 54.3%-68.9%) in the tandem transplant group and 48.4% (95% CI, 41.0%-55.7%) in the single transplant group (1-sided log-rank P = .006). The median (range) duration of follow-up after randomization for 181 patients without an event was 5.6 (0.6-8.9) years. The most common significant toxicities following tandem vs single transplant were mucosal (11.7% vs 15.4%) and infectious (17.9% vs 18.3%). CONCLUSIONS AND RELEVANCE Among patients aged 30 years or younger with high-risk neuroblastoma, tandem transplant resulted in a significantly better EFS than single transplant. However, because of the low randomization rate, the findings may not be representative of all patients with high-risk neuroblastoma.	[Park, Julie R.] Seattle Childrens Hosp, Dept Pediat, M-S MB-8-501,POB 5371, Seattle, WA 98145 USA; [Park, Julie R.] Univ Washington, Seattle, WA 98195 USA; [Kreissman, Susan G.] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [London, Wendy B.; Diller, Lisa] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat, Boston, MA 02115 USA; [Naranjo, Arlene; Tenney, Sheena C.] Univ Florida, Dept Biostat, Childrens Oncol Grp, Stat & Data Ctr, Gainesville, FL USA; [Cohn, Susan Lerner] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Hogarty, Michael D.; Maris, John M.; Grupp, Stephan A.] Univ Penn, Dept Pediat, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA; [Haas-Kogan, Daphne] Dana Farber Brigham & Womens Canc Ctr, Dept Radiat Oncol, Boston, MA USA; [Haas-Kogan, Daphne] Harvard Med Sch, Boston, MA 02115 USA; [Shaw, Peter John] Childrens Hosp Westmead, Bone Marrow Transplant, Sydney, NSW, Australia; [Kraveka, Jacqueline M.] Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA; [Roberts, Stephen S.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY USA; [Geiger, James Duncan] CS Mott Childrens Hosp, Michigan Med, Sect Pediat Surg, Ann Arbor, MI USA; [Doski, John J.] UT Hlth San Antonio, Dept Surg, San Antonio, TX USA; [Doski, John J.] UT Hlth San Antonio, Dept Pediat, San Antonio, TX USA; [Voss, Stephan D.] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Duke University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Children's Oncology Group (COG); State University System of Florida; University of Florida; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Sydney; Medical University of South Carolina; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Harvard University; Boston Children's Hospital; Harvard Medical School	Park, JR (corresponding author), Seattle Childrens Hosp, Dept Pediat, M-S MB-8-501,POB 5371, Seattle, WA 98145 USA.	julie.park@seattlechildrens.org	London, Wendy/ABD-4624-2021; shaw, peter John/D-8255-2011; Park, Julie/HGC-0199-2022; London, Wendy Beth/ABA-8948-2021	shaw, peter John/0000-0003-0101-4482; London, Wendy Beth/0000-0003-3571-6538; Tenney, Sheena/0000-0002-3255-8450	National Institutes of Health, National Cancer Institute [U10 CA180899]; National Clinical Trials Network Operations Center [U10 CA180886]; St Baldrick's Foundation; NATIONAL CANCER INSTITUTE [U10CA180899, U10CA180886] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Clinical Trials Network Operations Center; St Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health, National Cancer Institute (Grant No. U10 CA180899 to Children's Oncology Group Statistics and Data Center), National Clinical Trials Network Operations Center (Grant U10 CA180886), and St Baldrick's Foundation.	Berthold F, 2018, BRIT J CANCER, V119, P282, DOI 10.1038/s41416-018-0169-8; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Cohen LE, 2014, BONE MARROW TRANSPL, V49, P502, DOI 10.1038/bmt.2013.218; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Desai AV, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27372; DuBois SG, 2015, BRIT J CANCER, V112, P644, DOI 10.1038/bjc.2015.12; DuBois SG, 2015, CLIN CANCER RES, V21, P2715, DOI 10.1158/1078-0432.CCR-14-3240; Garaventa A, 2009, EUR J CANCER, V45, P2835, DOI 10.1016/j.ejca.2009.06.010; Gay F, 2018, HAEMATOLOGICA, V103, P197, DOI 10.3324/haematol.2017.174573; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; George RE, 2005, J CLIN ONCOL, V23, P6466, DOI 10.1200/JCO.2005.05.582; Granger M, 2012, PEDIATR BLOOD CANCER, V59, P902, DOI 10.1002/pbc.24207; Guerra JA, 2017, BONE MARROW TRANSPL, V52, P1543, DOI 10.1038/bmt.2017.166; Gurney JG, 2007, PEDIATRICS, V120, pE1229, DOI 10.1542/peds.2007-0178; Irwin MS, 2015, PEDIATR CLIN N AM, V62, P225, DOI 10.1016/j.pcl.2014.09.015; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kraal KCJM, 2017, EUR J CANCER, V76, P188, DOI 10.1016/j.ejca.2016.12.013; Kreissman SG, 2013, LANCET ONCOL, V14, P999, DOI 10.1016/S1470-2045(13)70309-7; Kushner BH, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1016704; Kushner BH, 2014, CLIN CANCER RES, V20, P1375, DOI 10.1158/1078-0432.CCR-13-1012; Ladenstein R, 2017, LANCET ONCOL, V18, P500, DOI 10.1016/S1470-2045(17)30070-0; London WB, 2017, CANCER-AM CANCER SOC, V123, P4914, DOI 10.1002/cncr.30934; Lorch A, 2007, J CLIN ONCOL, V25, P2778, DOI 10.1200/JCO.2006.09.2148; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Meany HJ, 2014, PEDIATR BLOOD CANCER, V61, P1932, DOI 10.1002/pbc.25134; Moreno L, 2017, PEDIATR BLOOD CANCER, V64, P25, DOI 10.1002/pbc.26192; Moreno L, 2013, PEDIATR BLOOD CANCER, V60, P1135, DOI 10.1002/pbc.24452; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Oing C, 2018, ONCOL RES TREAT, V41, P365, DOI 10.1159/000489135; Ozkaynak MF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01355; Palumbo A, 2014, NEW ENGL J MED, V371, P895, DOI 10.1056/NEJMoa1402888; Park JR, 2011, J CLIN ONCOL, V29, P4351, DOI 10.1200/JCO.2010.34.3293; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pinto NR, 2015, J CLIN ONCOL, V33, P3008, DOI 10.1200/JCO.2014.59.4648; Pritchard J, 2005, PEDIATR BLOOD CANCER, V44, P348, DOI 10.1002/pbc.20219; Schmidt ML, 2000, J CLIN ONCOL, V18, P1260, DOI 10.1200/JCO.2000.18.6.1260; Seif AE, 2013, BONE MARROW TRANSPL, V48, P947, DOI 10.1038/bmt.2012.276; Shimada H, 2003, Pathologica, V95, P240; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	41	115	119	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					746	755		10.1001/jama.2019.11642	http://dx.doi.org/10.1001/jama.2019.11642			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454045	Green Published, Bronze			2022-12-28	WOS:000483652500022
J	Capodanno, D; Angiolillo, DJ				Capodanno, Davide; Angiolillo, Dominick J.			Dual antithrombotic therapy for atrial fibrillation and PCI	LANCET			English	Editorial Material									[Capodanno, Davide] AOU Policlin Vittorio Emanuele, Div Cardiol, I-95100 Catania, Italy; [Angiolillo, Dominick J.] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA	Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; State University System of Florida; University of Florida	Capodanno, D (corresponding author), AOU Policlin Vittorio Emanuele, Div Cardiol, I-95100 Catania, Italy.	dcapodanno@unict.it	Capodanno, Davide/AAP-4949-2020					[Anonymous], 2019, THROMB HAEMOST; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Capodanno D, 2019, J AM COLL CARDIOL; Capodanno D, 2018, NAT REV CARDIOL, V15, P480, DOI 10.1038/s41569-018-0049-1; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Liu Q, 2015, J BIOPHARM STAT, V25, P206, DOI 10.1080/10543406.2014.923738; Lopes RD, 2019, JAMA CARDIOL, V4, P747, DOI 10.1001/jamacardio.2019.1880; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Sibbing D, 2019, JACC-CARDIOVASC INTE, V12, P1521, DOI 10.1016/j.jcin.2019.03.034; Urban P, 2019, CIRCULATION, V140, P240, DOI 10.1161/CIRCULATIONAHA.119.040167; Vranckx P, 2019, LANCET, V394, P1335, DOI 10.1016/S0140-6736(19)31872-0	11	8	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1300	1302		10.1016/S0140-6736(19)31954-3	http://dx.doi.org/10.1016/S0140-6736(19)31954-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9RJ	31492502				2022-12-28	WOS:000489613700005
J	Frank, RG; Nichols, LM				Frank, Richard G.; Nichols, Len M.			Medicare Drug-Price Negotiation - Why Now . . . and How	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A targeted bargaining strategy using tried and tested arbitration techniques could help Medicare balance drug innovation and affordability. Such negotiation could lower excessively high prices, even as parts of the market where competition works well are left alone.	[Frank, Richard G.] Harvard Univ, Med Sch, Boston, MA 02115 USA; [Nichols, Len M.] George Mason Univ, Fairfax, VA 22030 USA	Harvard University; Harvard Medical School; George Mason University	Frank, RG (corresponding author), Harvard Univ, Med Sch, Boston, MA 02115 USA.							Anderson-Cook A, 2019, PRICES SPENDING SP D; [Anonymous], 2018, 2018 ANN REP BOARDS; Institute for Clinical and Economic Review, 2018, QALY REW CAR MOST IM; MedPAC, 2018, DRUGS PAYM SYST BA B; Wenzl M, 2018, PHARM REIMBURSEMENT	5	12	12	4	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2019	381	15					1404	1406		10.1056/NEJMp1909798	http://dx.doi.org/10.1056/NEJMp1909798			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9YG	31483959				2022-12-28	WOS:000489631900003
J	Xue, H; Yao, TH; Cao, M; Zhu, GJ; Li, Y; Yuan, GY; Chen, Y; Lei, M; Huang, J				Xue, Han; Yao, Tonghui; Cao, Mi; Zhu, Guanjun; Li, Yan; Yuan, Guiyong; Chen, Yong; Lei, Ming; Huang, Jing			Structural basis of nucleosome recognition and modification by MLL methyltransferases	NATURE			English	Article							HISTONE H3K4 METHYLASES; COMPASS FAMILY; REVEALS; DOMAIN; RBBP5	Methyltransferases of the mixed-lineage leukaemia (MLL) family-which include MLL1, MLL2, MLL3, MLL4, SET1A and SET1B-implement methylation of histone H3 on lysine 4 (H3K4), and have critical and distinct roles in the regulation of transcription in haematopoiesis, adipogenesis and development(1-6). The C-terminal catalytic SET (Su(var.)3-9, enhancer of zeste and trithorax) domains of MLL proteins are associated with a common set of regulatory factors (WDR5, RBBP5, ASH2L and DPY30) to achieve specific activities(7-9). Current knowledge of the regulation of MLL activity is limited to the catalysis of histone H3 peptides, and how H3K4 methyl marks are deposited on nucleosomes is poorly understood. H3K4 methylation is stimulated by mono-ubiquitination of histone H2B on lysine 120 (H2BK120ub1), a prevalent histone H2B mark that disrupts chromatin compaction and favours open chromatin structures, but the underlying mechanism remains unknown(10-12). Here we report cryo-electron microscopy structures of human MLL1 and MLL3 catalytic modules associated with nucleosome core particles that contain H2BK120ub1 or unmodified H2BK120. These structures demonstrate that the MLL1 and MLL3 complexes both make extensive contacts with the histone-fold and DNA regions of the nucleosome; this allows ease of access to the histone H3 tail, which is essential for the efficient methylation of H3K4. The H2B-conjugated ubiquitin binds directly to RBBP5, orienting the association between MLL1 or MLL3 and the nucleosome. The MLL1 and MLL3 complexes display different structural organizations at the interface between the WDR5, RBBP5 and MLL1 (or the corresponding MLL3) subunits, which accounts for the opposite roles of WDR5 in regulating the activity of the two enzymes. These findings transform our understanding of the structural basis for the regulation of MLL activity at the nucleosome level, and highlight the pivotal role of nucleosome regulation in histone-tail modification.	[Xue, Han; Yao, Tonghui; Zhu, Guanjun; Chen, Yong] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,State Key Lab Mol, Shanghai, Peoples R China; [Cao, Mi; Yuan, Guiyong; Lei, Ming; Huang, Jing] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Shanghai Inst Precis Med, Shanghai, Peoples R China; [Li, Yan] Chinese Acad Sci, Shanghai Adv Res Inst, Natl Facil Prot Sci Shanghai, ZhangJiang Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Huang, J (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Shanghai Inst Precis Med, Shanghai, Peoples R China.	huangjing@shsmu.edu.cn		chen, yong/0000-0001-5857-6086; Yao, Tonghui/0000-0003-3988-693X	National Key R&D Program of China [2017YFA0504504, 2016YFA0501803]; National Natural Science Foundation of China [31570766, U1632130]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [2017YZ004]; SHIPM-sigma fund [BJ1-7009-18-1303, JY201805]; Shanghai Institute of Precision Medicine, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine and Chinese Academy of Sciences Facility-based Open Research Program; Thousand Young Talents Program of China; Hundred Talents Program of Shanghai Jiao Tong University School of Medicine	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; SHIPM-sigma fund; Shanghai Institute of Precision Medicine, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine and Chinese Academy of Sciences Facility-based Open Research Program; Thousand Young Talents Program of China(Chinese Academy of Sciences); Hundred Talents Program of Shanghai Jiao Tong University School of Medicine	We thank the staff of the Electron Microscopy System and the Database and Computation System of the National Facility for Protein Science in Shanghai (NFPS), Zhangjiang Laboratory for their assistance with the electron microscopy instruments and data pre-processing. We thank members of the NFPS Large-scale Protein Preparation System and Mass Spectrometry System for instrument support and technical assistance. This work was supported by the National Key R&D Program of China (2017YFA0504504 and 2016YFA0501803), the National Natural Science Foundation of China (31570766 and U1632130), the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (2017YZ004), the SHIPM-sigma fund No. BJ1-7009-18-1303 and JY201805 from Shanghai Institute of Precision Medicine, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine and Chinese Academy of Sciences Facility-based Open Research Program. J.H. is a recipient of the Thousand Young Talents Program of China and a recipient of the Hundred Talents Program of Shanghai Jiao Tong University School of Medicine.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson CJ, 2019, CELL REP, V26, P1681, DOI 10.1016/j.celrep.2019.01.058; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hsu PL, 2018, CELL, V174, P1106, DOI 10.1016/j.cell.2018.06.038; Jang S, 2019, GENE DEV, V33, P620, DOI 10.1101/gad.323790.118; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; Mittal A, 2018, NUCLEIC ACIDS RES, V46, P3802, DOI 10.1093/nar/gky199; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poepsel S, 2018, NAT STRUCT MOL BIOL, V25, P154, DOI 10.1038/s41594-018-0023-y; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Qu QH, 2018, CELL, V174, P1117, DOI 10.1016/j.cell.2018.07.020; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shinsky SA, 2015, J BIOL CHEM, V290, P25819, DOI 10.1074/jbc.M115.684142; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Valencia-Sanchez MI, 2019, MOL CELL, V74, P1010, DOI 10.1016/j.molcel.2019.03.029; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Worden EJ, 2019, CELL, V176, P1490, DOI 10.1016/j.cell.2019.02.002; Yao TH, 2019, CELL RES, V29, P330, DOI 10.1038/s41422-019-0146-7; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	43	78	81	4	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					445	+		10.1038/s41586-019-1528-1	http://dx.doi.org/10.1038/s41586-019-1528-1			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31485071				2022-12-28	WOS:000486647800056
J	[Anonymous]				[Anonymous]			Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material														luo, juhua/0000-0002-8901-4462					0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					I20	I20		10.7326/P19-0011	http://dx.doi.org/10.7326/P19-0011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31499525				2022-12-28	WOS:000486101400001
J	Ofri, D				Ofri, Danielle			Empathy in the age of the electronic medical record	LANCET			English	Editorial Material									[Ofri, Danielle] NYU, Bellevue Hosp, Sch Med, New York, NY 10016 USA	Bellevue Hospital Center; New York University	Ofri, D (corresponding author), NYU, Bellevue Hosp, Sch Med, New York, NY 10016 USA.	danielle.ofri@nyumc.org		Ofri, Danielle/0000-0001-9865-7104				Moore J, 2008, BRIT J GEN PRACT, V58, P210, DOI 10.3399/bjgp08X279571; Toll E, 2012, JAMA-J AM MED ASSOC, V307, P2497, DOI 10.1001/jama.2012.4946; Topol E., 2019, DEEP MED ARTIFICIAL	3	2	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2019	394	10201					822	823		10.1016/S0140-6736(19)32036-7	http://dx.doi.org/10.1016/S0140-6736(19)32036-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV0US	31498090				2022-12-28	WOS:000483994700012
J	Chen, H; Zhang, XL; Zhang, YY; Wang, DF; Bao, DL; Que, YD; Xiao, WD; Du, SX; Ouyang, M; Pantelides, ST; Gao, HJ				Chen, Hui; Zhang, Xian-Li; Zhang, Yu-Yang; Wang, Dongfei; Bao, De-Liang; Que, Yande; Xiao, Wende; Du, Shixuan; Ouyang, Min; Pantelides, Sokrates T.; Gao, Hong-Jun			Atomically precise, custom-design origami graphene nanostructures	SCIENCE			English	Article							ELECTRONIC-PROPERTIES; SINGLE; SHEETS	The construction of atomically precise carbon nanostructures holds promise for developing materials for scientific study and nanotechnology applications. Here, we show that graphene origami is an efficient way to convert graphene into atomically precise, complex nanostructures. By scanning tunneling microscope manipulation at low temperature, we repeatedly fold and unfold graphene nanoislands (GNIs) along an arbitrarily chosen direction. A bilayer graphene stack featuring a tunable twist angle and a tubular edge connection between the layers is formed. Folding single-crystal GNIs creates tubular edges with specified chirality and one-dimensional electronic features similar to those of carbon nanotubes, whereas folding bicrystal GNIs creates well-defined intramolecular junctions. Both origami structural models and electronic band structures are computed to complement analysis of the experimental results. The present atomically precise graphene origami provides a platform for constructing carbon nanostructures with engineered quantum properties and, ultimately, quantum machines.	[Chen, Hui; Zhang, Xian-Li; Zhang, Yu-Yang; Wang, Dongfei; Bao, De-Liang; Que, Yande; Xiao, Wende; Du, Shixuan; Pantelides, Sokrates T.; Gao, Hong-Jun] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Chen, Hui; Zhang, Xian-Li; Zhang, Yu-Yang; Wang, Dongfei; Bao, De-Liang; Que, Yande; Xiao, Wende; Du, Shixuan; Pantelides, Sokrates T.; Gao, Hong-Jun] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing 100190, Peoples R China; [Zhang, Yu-Yang; Bao, De-Liang; Pantelides, Sokrates T.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Zhang, Yu-Yang; Bao, De-Liang; Pantelides, Sokrates T.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA; [Ouyang, Min] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Vanderbilt University; Vanderbilt University; University System of Maryland; University of Maryland College Park	Du, SX; Gao, HJ (corresponding author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.; Du, SX; Gao, HJ (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Beijing 100190, Peoples R China.	sxdu@iphy.ac.cn; hjgao@iphy.ac.cn	Wang, Dongfei/AAA-2485-2021; Xiao, Wende/AAM-3204-2020; Du, Shixuan/K-7145-2012; Zhang, Y. Y./F-2078-2011; Bao, Deliang/L-8177-2017; Bao, Deliang/AAT-5840-2021; Que, Yande/N-9556-2013	Du, Shixuan/0000-0001-9323-1307; Zhang, Y. Y./0000-0002-9548-0021; Bao, Deliang/0000-0002-5070-4765; Que, Yande/0000-0002-5267-4985; Chen, Hui/0000-0002-3369-8113; Pantelides, Sokrates/0000-0002-2963-7545; Xiao, Wende/0000-0003-4786-719X	National Natural Science Foundation of China [61888102, 51872284]; National Key Research and Development Projects of China [2016YFA0202300, 2018YFA0305800]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB30000000]; CAS Pioneer Hundred Talents Program; Beijing Nova Program [Z181100006218023]; International Partnership Program of the Chinese Academy of Sciences [112111KYSB20160061]; Office of Naval Research [N000141712885]; National Science Foundation [DMR1608720]; U.S. Department of Energy [DE-FG02-09ER46554]; McMinn Endowment; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Projects of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS Pioneer Hundred Talents Program; Beijing Nova Program(Beijing Municipal Science & Technology Commission); International Partnership Program of the Chinese Academy of Sciences; Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); McMinn Endowment; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was financially supported by the National Natural Science Foundation of China (nos. 61888102 and 51872284), National Key Research and Development Projects of China (2016YFA0202300 and 2018YFA0305800), the Strategic Priority Research Program of the Chinese Academy of Sciences (no. XDB30000000), the CAS Pioneer Hundred Talents Program, the Beijing Nova Program (no. Z181100006218023), and the International Partnership Program of the Chinese Academy of Sciences (no. 112111KYSB20160061). M. O. acknowledges support from the Office of Naval Research (N000141712885) and National Science Foundation (DMR1608720), Work at Vanderbilt University (S.T.P., Y.-Y.Z., and D.-L.B.) was supported by the U.S. Department of Energy (grant DE-FG02-09ER46554) and the McMinn Endowment. Computations at Vanderbilt University were carried out at the National Energy Research Scientific Computing Center, a DOE Office of Science User Facility supported by the Office of Science of the U.S. Department of Energy (contract no. DE-AC02-05CH11231).	Akius K., 2018, ARXIV181209501CONDMA; Al-Mulla T, 2015, NAT MATER, V14, P366, DOI 10.1038/nmat4258; Allen MJ, 2009, CHEM COMMUN, P6285, DOI 10.1039/b911972h; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Chen YT, 2012, NANO LETT, V12, P1996, DOI 10.1021/nl2045952; Chico L, 1996, PHYS REV LETT, V76, P971, DOI 10.1103/PhysRevLett.76.971; Costa AT, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/47001; EBBESEN TW, 1995, ADV MATER, V7, P582, DOI 10.1002/adma.19950070618; Feng J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165407; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Georgakilas V, 2015, CHEM REV, V115, P4744, DOI 10.1021/cr500304f; Hallam T, 2015, NANO LETT, V15, P857, DOI 10.1021/nl503460p; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Hyun WJ, 2013, ADV MATER, V25, P4729, DOI 10.1002/adma.201302063; Joung D, 2017, NANO LETT, V17, P1987, DOI 10.1021/acs.nanolett.6b05412; Kim K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245433; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Li JY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05846; Li L, 2006, CARBON, V44, P1544, DOI 10.1016/j.carbon.2005.12.031; Luican A, 2009, SOLID STATE COMMUN, V149, P1151, DOI 10.1016/j.ssc.2009.02.059; Mark GI, 1998, PHYS REV B, V58, P12645, DOI 10.1103/PhysRevB.58.12645; Meng L, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205405; Meunier V, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.025005; Miskin MZ, 2018, P NATL ACAD SCI USA, V115, P466, DOI 10.1073/pnas.1712889115; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Mu JK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500533; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Ouyang M, 2002, ACCOUNTS CHEM RES, V35, P1018, DOI 10.1021/ar0101685; Ouyang M, 2001, SCIENCE, V291, P97, DOI 10.1126/science.291.5501.97; Ouyang M, 2001, SCIENCE, V292, P702, DOI 10.1126/science.1058853; Patra N, 2009, NANO LETT, V9, P3766, DOI 10.1021/nl9019616; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Peurifoy SR, 2018, J AM CHEM SOC, V140, P9341, DOI 10.1021/jacs.8b04119; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Prada E, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.106802; Queisser F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.046601; Rainis D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165403; Roy HV, 1998, SURF SCI, V407, P1, DOI 10.1016/S0039-6028(97)01032-7; Roy HV, 1998, J APPL PHYS, V83, P4695, DOI 10.1063/1.367257; Schniepp HC, 2008, ACS NANO, V2, P2577, DOI 10.1021/nn800457s; Segawa Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.2; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v; Terrones H, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/6/062501; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Wang B, 2018, ADV MATER, V30, DOI 10.1002/adma.201707449; Wang B, 2017, NANO LETT, V17, P1467, DOI 10.1021/acs.nanolett.6b04459; Wang MS, 2011, ACS NANO, V5, P8769, DOI 10.1021/nn2027566; Wang YX, 2017, NANO LETT, V17, P6708, DOI 10.1021/acs.nanolett.7b02773; Wei DC, 2008, ADV MATER, V20, P2815, DOI 10.1002/adma.200800589; Xie YE, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195426; Xu WA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701084; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Zhu SZ, 2014, ACS NANO, V8, P2864, DOI 10.1021/nn500025t	55	108	108	29	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1036	+		10.1126/science.aax7864	http://dx.doi.org/10.1126/science.aax7864			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488691	Green Submitted			2022-12-28	WOS:000484732700049
J	Schaefer, NK; Shapiro, B				Schaefer, Nathan K.; Shapiro, Beth			New middle chapter in the story of human evolution	SCIENCE			English	Editorial Material							POPULATIONS; HISTORY		[Schaefer, Nathan K.; Shapiro, Beth] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Schaefer, Nathan K.; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Shapiro, B (corresponding author), Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA.; Shapiro, B (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	bashapir@ucsc.edu		Schaefer, Nathan/0000-0001-5881-7329				Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Slatkin M, 2016, P NATL ACAD SCI USA, V113, P6380, DOI 10.1073/pnas.1524306113	12	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					981	982		10.1126/science.aay3550	http://dx.doi.org/10.1126/science.aay3550			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488673				2022-12-28	WOS:000484732700027
J	Wilson, ST; Hawco, NJ; Armbrust, EV; Barone, B; Bjorkman, KM; Boysen, AK; Burgos, M; Burrell, TJ; Casey, JR; DeLong, EF; Dugenne, M; Dutkiewicz, S; Dyhrman, ST; Ferron, S; Follows, MJ; Foreman, RK; Funkey, CP; Harke, MJ; Henke, BA; Hill, CN; Hynes, AM; Ingalls, AE; Jahn, O; Kelly, RL; Knapp, AN; Letelier, RM; Ribalet, F; Shimabukuro, EM; Tabata, RKS; Turk-Kubo, KA; White, AE; Zehr, JP; John, S; Karl, DM				Wilson, Samuel T.; Hawco, Nicholas J.; Armbrust, E. Virginia; Barone, Benedetto; Bjorkman, Karin M.; Boysen, Angela K.; Burgos, Macarena; Burrell, Timothy J.; Casey, John R.; DeLong, Edward F.; Dugenne, Mathilde; Dutkiewicz, Stephanie; Dyhrman, Sonya T.; Ferron, Sara; Follows, Michael J.; Foreman, Rhea K.; Funkey, Carolina P.; Harke, Matthew J.; Henke, Britt A.; Hill, Christopher N.; Hynes, Annette M.; Ingalls, Anitra E.; Jahn, Oliver; Kelly, Rachel L.; Knapp, Angela N.; Letelier, Ricardo M.; Ribalet, Francois; Shimabukuro, Eric M.; Tabata, Ryan K. S.; Turk-Kubo, Kendra A.; White, Angelicque E.; Zehr, Jonathan P.; John, Seth; Karl, David M.			Kilauea lava fuels phytoplankton bloom in the North Pacific Ocean	SCIENCE			English	Article							ORGANIC NITROGEN; STATION ALOHA; NITRATE; SEAWATER; HAWAII; VOLUME; CARBON; MODEL; SEA; DIVERSITY	From June to August 2018, the eruption of KTlauea volcano on the island of Hawai'i injected millions of cubic meters of molten lava into the nutrient-poor waters of the North Pacific Subtropical Gyre. The lava-impacted seawater was characterized by high concentrations of metals and nutrients that stimulated phytoplankton growth, resulting in an extensive plume of chlorophyll a that was detectable by satellite. Chemical and molecular evidence revealed that this biological response hinged on unexpectedly high concentrations of nitrate, despite the negligible quantities of nitrogen in basaltic lava. We hypothesize that the high nitrate was caused by buoyant plumes of nutrient-rich deep waters created by the substantial input of lava into the ocean. This large-scale ocean fertilization was therefore a unique perturbation event that revealed how marine ecosystems respond to exogenous inputs of nutrients.	[Wilson, Samuel T.; Barone, Benedetto; Bjorkman, Karin M.; Burgos, Macarena; Burrell, Timothy J.; Casey, John R.; DeLong, Edward F.; Dugenne, Mathilde; Ferron, Sara; Foreman, Rhea K.; Funkey, Carolina P.; Shimabukuro, Eric M.; Tabata, Ryan K. S.; White, Angelicque E.; Karl, David M.] Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanogr Res & Educ, Dept Oceanog, Honolulu, HI 96822 USA; [Hawco, Nicholas J.; Kelly, Rachel L.; John, Seth] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Armbrust, E. Virginia; Boysen, Angela K.; Hynes, Annette M.; Ingalls, Anitra E.; Ribalet, Francois] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Casey, John R.; Dutkiewicz, Stephanie; Follows, Michael J.; Hill, Christopher N.; Jahn, Oliver] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Dyhrman, Sonya T.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Dyhrman, Sonya T.; Harke, Matthew J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Henke, Britt A.; Turk-Kubo, Kendra A.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Knapp, Angela N.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Letelier, Ricardo M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Hawaii System; University of Hawaii Manoa; University of Southern California; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Columbia University; Columbia University; University of California System; University of California Santa Cruz; State University System of Florida; Florida State University; Oregon State University	Wilson, ST (corresponding author), Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanogr Res & Educ, Dept Oceanog, Honolulu, HI 96822 USA.; Hawco, NJ (corresponding author), Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	stwilson@hawaii.edu; hawco@usc.edu	Hawco, Nicholas/GSE-4005-2022; Ferrón, Sara/AAZ-9401-2021; Karl, David/AFP-3837-2022; Knapp, Angela N/A-2194-2009; Letelier, Ricardo/A-6953-2009	Ferrón, Sara/0000-0002-1573-3077; Knapp, Angela N/0000-0001-5575-3382; Letelier, Ricardo/0000-0003-3376-4026; Armbrust, Virginia/0000-0001-7865-5101; White, angelicque/0000-0002-0938-7948; John, Seth/0000-0002-8257-626X; Kelly, Rachel/0000-0002-3459-5159; Ribalet, Francois/0000-0002-7431-0234; Hawco, Nicholas/0000-0002-5897-0830; Burrell, Timothy/0000-0002-6288-576X; Bjorkman, Karin M/0000-0003-2379-394X; Ingalls, Anitra/0000-0003-1953-7329; Wilson, Samuel/0000-0002-7289-0909; Boysen, Angela/0000-0001-8193-630X; Hynes, Annette/0000-0001-9610-5883; Casey, John/0000-0002-8630-0551	Simons Foundation [329108, 574495, 602538]; Gordon and Betty Moore Foundation [3794]; NSF [OCE-1842012, OCE-1756524, OCE-1537314]; NASA [80NSSC17K0561]; Balzan Prize for Oceanography	Simons Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Balzan Prize for Oceanography	Supported by Simons Foundation grants 329108 (D.M.K, E.F.D., E.V.A., S.T.D., M.J.F., A.E.I., A.E.W., J.P.Z., S.J.), 574495 (F.R.), and 602538 (N.H.); Gordon and Betty Moore Foundation grant 3794 and the Balzan Prize for Oceanography (D.M.K.); and NSF grants OCE-1842012 (D.M.K. and E.F.D.), OCE-1756524 (S.T.W.), and OCE-1537314 (A.N.K.). The modeling component was supported by NASA grant 80NSSC17K0561 (O.J., S.D. and C.N.H.).	Alexander H, 2015, P NATL ACAD SCI USA, V112, pE5972, DOI 10.1073/pnas.1518165112; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barber RT, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002726; BENDER M, 1987, LIMNOL OCEANOGR, V32, P1085, DOI 10.4319/lo.1987.32.5.1085; Bender SJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00003; Berrisford P., 2011, ERA REPORT SERIES, V1; Bishop JM, 2017, J HYDROL-REG STUD, V11, P194, DOI 10.1016/j.ejrh.2015.10.008; Bottjer D, 2017, LIMNOL OCEANOGR, V62, P200, DOI 10.1002/lno.10386; Boyle EA, 2005, GEOCHIM COSMOCHIM AC, V69, P933, DOI 10.1016/j.gca.2004.07.034; BRULAND KW, 1980, EARTH PLANET SC LETT, V47, P176, DOI 10.1016/0012-821X(80)90035-7; Bryan SE, 2010, EARTH-SCI REV, V102, P207, DOI 10.1016/j.earscirev.2010.07.001; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Carrillo JH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001892; Casciotti KL, 2008, DEEP-SEA RES PT II, V55, P1661, DOI 10.1016/j.dsr2.2008.04.017; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; COFFIN MF, 1993, GEOLOGY, V21, P515, DOI 10.1130/0091-7613(1993)021<0515:STSEDO>2.3.CO;2; Cullen JJ, 2015, ANNU REV MAR SCI, V7, P207, DOI 10.1146/annurev-marine-010213-135111; Dutkiewicz S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002342; Dutkiewicz S, 2015, BIOGEOSCIENCES, V12, P4447, DOI 10.5194/bg-12-4447-2015; Feely RA, 1996, GEOCHIM COSMOCHIM AC, V60, P2297, DOI 10.1016/0016-7037(96)00099-3; Ferron S, 2016, LIMNOL OCEANOGR-METH, V14, P610, DOI 10.1002/lom3.10116; Ferron S, 2015, GEOPHYS RES LETT, V42, P3421, DOI 10.1002/2015GL063555; Follett CL, 2018, ISME J, V12, P1543, DOI 10.1038/s41396-017-0012-x; Foreman RK, 2019, LIMNOL OCEANOGR-METH, V17, P277, DOI 10.1002/lom3.10312; Frollje H, 2016, GEOCHIM COSMOCHIM AC, V189, P110, DOI 10.1016/j.gca.2016.06.001; German C. R., 2018, EOS T AM GEOPHYS UN; Govindaraju K., 1994, GEOSTANDARD NEWSLETT, V18, P1, DOI [DOI 10.1046/J.1365-2494.1998.53202081.X-I1, 10.1046/J.1365-2494.1998.53202081.X-I1]; Govindaraju K, 1994, GEOSTANDARD NEWSLETT, V18, P1; Granger J, 2004, LIMNOL OCEANOGR, V49, P1763, DOI 10.4319/lo.2004.49.5.1763; Harke MJ, 2019, ISME J, V13, P118, DOI 10.1038/s41396-018-0262-2; Harke MJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01279; Huebert B, 1999, BIOGEOCHEMISTRY, V47, P111, DOI 10.1023/A:1006276011055; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Knapp AN, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003878; Lagerstrom ME, 2013, MAR CHEM, V155, P71, DOI 10.1016/j.marchem.2013.06.001; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Y, 2014, GEOCHIM COSMOCHIM AC, V129, P13, DOI 10.1016/j.gca.2013.12.031; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maritorena S, 2010, REMOTE SENS ENVIRON, V114, P1791, DOI 10.1016/j.rse.2010.04.002; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; McIlvin MR, 2011, ANAL CHEM, V83, P1850, DOI 10.1021/ac1028984; Meinicke P, 2015, BIOINFORMATICS, V31, P1382, DOI 10.1093/bioinformatics/btu843; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Moberg EA, 2012, LIMNOL OCEANOGR-METH, V10, P278, DOI 10.4319/lom.2012.10.278; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Neal CA, 2019, SCIENCE, V363, P367, DOI 10.1126/science.aav7046; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Resing JA, 2002, GEOCHIM COSMOCHIM AC, V66, P1925, DOI 10.1016/S0016-7037(01)00897-3; SANSONE FJ, 1995, J GEOPHYS RES-OCEANS, V100, P13555, DOI 10.1029/95JC01120; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Sosik HM, 2007, LIMNOL OCEANOGR-METH, V5, P204, DOI 10.4319/lom.2007.5.204; Swalwell JE, 2011, LIMNOL OCEANOGR-METH, V9, P466, DOI 10.4319/lom.2011.9.466; Treguer P, 2018, NAT GEOSCI, V11, P27, DOI 10.1038/s41561-017-0028-x; Turk-Kubo KA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01616; U. S. Geological Survey Hawaiian Volcano Observatory, 2018, PREL AN ONG LOW E RI; Ward BA, 2012, LIMNOL OCEANOGR, V57, P1877, DOI 10.4319/lo.2012.57.6.1877; Wiegner TN, 2016, MAR POLLUT BULL, V103, P63, DOI 10.1016/j.marpolbul.2015.12.046; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	59	20	23	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1040	+		10.1126/science.aax4767	http://dx.doi.org/10.1126/science.aax4767			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488692				2022-12-28	WOS:000484732700050
J	Davis, LG; Madsen, DB; Becerra-Valdivia, L; Higham, T; Sisson, DA; Skinner, SM; Stueber, D; Nyers, AJ; Keen-Zebert, A; Neudorf, C; Cheyney, M; Izuho, M; Iizuka, F; Burns, SR; Epps, CW; Willis, SC; Buvit, I				Davis, Loren G.; Madsen, David B.; Becerra-Valdivia, Lorena; Higham, Thomas; Sisson, David A.; Skinner, Sarah M.; Stueber, Daniel; Nyers, Alexander J.; Keen-Zebert, Amanda; Neudorf, Christina; Cheyney, Melissa; Izuho, Masami; Iizuka, Fumie; Burns, Samuel R.; Epps, Clinton W.; Willis, Samuel C.; Buvit, Ian			Late Upper Paleolithic occupation at Cooper's Ferry, Idaho, USA, similar to 16,000 years ago	SCIENCE			English	Article							LATE PLEISTOCENE; NORTH-AMERICA; DOSE-RATE; SINGLE; LUMINESCENCE; CLOVIS; SITE; IRSL; LAKE; TECHNOLOGY	Radiocarbon dating of the earliest occupational phases at the Cooper's Ferry site in western Idaho indicates that people repeatedly occupied the Columbia River basin, starting between 16,560 and 15,280 calibrated years before the present (cal yr B.P.). Artifacts from these early occupations indicate the use of unfluted stemmed projectile point technologies before the appearance of the Clovis Paleoindian tradition and support early cultural connections with northeastern Asian Upper Paleolithic archaeological traditions. The Cooper's Ferry site was initially occupied during a time that predates the opening of an ice-free corridor (<= 14,800 cal yr B.P.), which supports the hypothesis that initial human migration into the Americas occurred via a Pacific coastal route.	[Davis, Loren G.; Skinner, Sarah M.; Cheyney, Melissa; Burns, Samuel R.; Buvit, Ian] Oregon State Univ, Dept Anthropol, 238 Waldo Hall, Corvallis, OR 97331 USA; [Madsen, David B.] Univ Texas Austin, Texas Archeol Res Lab, Austin, TX 78758 USA; [Becerra-Valdivia, Lorena; Higham, Thomas] Sch Archaeol, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, 1 South Parks Rd, Oxford OX1 3TG, England; [Sisson, David A.] Bur Land Management, Cottonwood Field Off, 2 Butte Dr, Cottonwood, ID 83522 USA; [Stueber, Daniel] Univ Victoria, Dept Anthropol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada; [Nyers, Alexander J.] Northwest Archaeometr, POB 2427, Corvallis, OR 97339 USA; [Keen-Zebert, Amanda; Neudorf, Christina] Desert Res Inst, Div Earth & Ecosyst Sci, 2215 Raggio Pkwy, Reno, NV 89512 USA; [Izuho, Masami; Iizuka, Fumie] Tokyo Metropolitan Univ, Fac Humanities & Social Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan; [Iizuka, Fumie] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA USA; [Epps, Clinton W.] Oregon State Univ, Dept Fisheries & Wildlife, 104 Nash Hall, Corvallis, OR 97331 USA; [Willis, Samuel C.] Oregon Pk & Recreat Dept, Stewardship Sect, 725 Summer St NE,Suite C, Salem, OR 97301 USA	Oregon State University; University of Texas System; University of Texas Austin; University of Oxford; University of Victoria; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Tokyo Metropolitan University; University of California System; University of California Merced; Oregon State University	Davis, LG (corresponding author), Oregon State Univ, Dept Anthropol, 238 Waldo Hall, Corvallis, OR 97331 USA.	loren.davis@oregonstate.edu	Masami, Izuho/AAI-1009-2020; Epps, Clinton/AAX-3971-2021	Masami, Izuho/0000-0002-6598-1562; Epps, Clinton/0000-0001-6577-1840; Davis, Loren/0000-0003-0283-9822; Neudorf, Christina/0000-0002-4449-2655; Keen-Zebert, Amanda/0000-0002-8684-7004; Nyers, Alexander/0000-0003-4735-0553; Sisson, David/0000-0001-9467-3828; Becerra-Valdivia, Lorena/0000-0001-5501-5347	Bureau of Land Management's Cottonwood field office [1422-D-065-A-96-0007]; University of Alberta [1422-D-065-A-96-0007]; Oregon State University [L09AC15147, L14AC00232]; Bernice Peltier Huber Charitable Trust; Keystone Archaeological Research Fund; Oregon State University; Ministry of Education, Culture, Sports, Science and Technology, Japan [1802]; General Frederick West Lander Endowment; NERC [NRCF010002] Funding Source: UKRI	Bureau of Land Management's Cottonwood field office; University of Alberta(University of Alberta); Oregon State University; Bernice Peltier Huber Charitable Trust; Keystone Archaeological Research Fund; Oregon State University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); General Frederick West Lander Endowment; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Cooper's Ferry project work in area A was funded through challenge cost share agreements between the Bureau of Land Management's Cottonwood field office and the University of Alberta (1997; agreement 1422-D-065-A-96-0007) and with Oregon State University (2009 to 2019; assistance agreements L09AC15147 and L14AC00232), by the Bernice Peltier Huber Charitable Trust, the Keystone Archaeological Research Fund, and Oregon State University. M. I. was funded from a Grant-in-Aid for Scientific Research on Innovative Areas (grant no. 1802 for FY2016-2020) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. A. K.-Z. received support from the General Frederick West Lander Endowment.	Adachi Noboru, 2015, EMERGENCE DIVERSITY, P406; ADOVASIO JM, 1990, AM ANTIQUITY, V55, P348, DOI 10.2307/281652; [Anonymous], 1983, AAPG BULL, V67, P841; [Anonymous], 2010, INT MONOGRAPHS PREHI; [Anonymous], 1993, USDA HDB, V18; Balbas AM, 2017, GEOLOGY, V45, P583, DOI 10.1130/G38956.1; Becerra-Valdivia L, 2018, P NATL ACAD SCI USA, V115, P7000, DOI 10.1073/pnas.1803624115; Birkeland P.W., 1984, GEOL MAG, DOI DOI 10.1017/S0016756800031617; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Butler B.Robert., 1969, TEBIWA, V12, P35; Buylaert JP, 2011, GEOCHRONOMETRIA, V38, P432, DOI 10.2478/s13386-011-0047-0; Clark J, 2014, J ARCHAEOL SCI, V52, P12, DOI 10.1016/j.jas.2014.07.030; Davis A, 2012, LEARN DOING, P47; Davis LG, 2004, GEOARCHAEOLOGY, V19, P685, DOI 10.1002/gea.20020; Davis LG, 2014, AM ANTIQUITY, V79, P596, DOI 10.7183/0002-7316.79.4.596; Davis Loren G., 1998, CURR RES PLEISTOCENE, V15, P12; Deviese T, 2018, QUATERNARY SCI REV, V198, P171, DOI 10.1016/j.quascirev.2018.08.023; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; Dillehay TD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602778; Dillehay TD, 2012, QUATERNARY RES, V77, P418, DOI 10.1016/j.yqres.2012.02.003; Durcan JA, 2015, QUAT GEOCHRONOL, V28, P54, DOI 10.1016/j.quageo.2015.03.012; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Erlandson JM, 2011, QUATERN INT, V239, P28, DOI 10.1016/j.quaint.2011.02.030; FLADMARK KR, 1979, AM ANTIQUITY, V44, P55, DOI 10.2307/279189; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Goebel T., 2011, YENISEI YUKON INTERP; Graf KE, 2017, CURR ANTHROPOL, V58, pS583, DOI 10.1086/693388; Halligan JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600375; Hanson MA, 2012, QUATERNARY SCI REV, V31, P67, DOI 10.1016/j.quascirev.2011.11.009; Hokkaido Archaeological Operation Center, 2001, SHIR SIT; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; Jenkins DL, 2012, SCIENCE, V337, P223, DOI 10.1126/science.1218443; KIESER WE, 1986, NUCL INSTRUM METH B, V15, P718, DOI 10.1016/0168-583X(86)90398-8; Kudo Y., 2006, CURR RES PLEISTOCENE, V23, P11; Lee GK, 2019, ARCHAEOL ANTHROP SCI, V11, P2453, DOI 10.1007/s12520-018-0703-x; Lesnek AJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5040; Li B, 2014, GEOCHRONOMETRIA, V41, P178, DOI 10.2478/s13386-013-0160-3; Li B, 2013, QUAT GEOCHRONOL, V17, P1, DOI 10.1016/j.quageo.2013.03.006; Li B, 2011, RADIAT MEAS, V46, P29, DOI 10.1016/j.radmeas.2010.10.002; Liritzis I, 2013, MEDITERR ARCHAEOL AR, V13, P1; Llamas B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501385; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Margold M, 2019, QUATERNARY RES, V92, P469, DOI 10.1017/qua.2019.10; Moreno-Mayar JV, 2018, NATURE, V553, P203, DOI 10.1038/nature25173; Morisaki K., 2015, EMERGENCE DIVERSITY, P376; Morrison R.B., 1991, QUATERNARY NONGLACIA, P283; Murray AS, 2003, RADIAT MEAS, V37, P377, DOI 10.1016/S1350-4487(03)00053-2; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Nagai K, 2007, ANTHROPOL SCI, V115, P223, DOI 10.1537/ase.061211; Natsuki D., 2018, RONSHU OSHOROKKO, V5, P59; Overstreet DF, 2003, GEOARCHAEOLOGY, V18, P91, DOI 10.1002/gea.10052; Ozbun T.L, 2004, MARMES ROCKSHELTER F, P159; Pinotti T, 2019, CURR BIOL, V29, P149, DOI 10.1016/j.cub.2018.11.029; Potter BA, 2018, SCIENCE, V359, P1224, DOI 10.1126/science.aar8233; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Ramsey CB, 2004, RADIOCARBON, V46, P17, DOI 10.1017/S0033822200039308; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Sato H, 2011, QUATERN INT, V237, P93, DOI 10.1016/j.quaint.2011.01.006; Scheib CL, 2018, SCIENCE, V360, P1024, DOI 10.1126/science.aar6851; Schwede M. L., 1966, THESIS; Sellet F., 1993, LITHIC TECHNOLOGY, V18, P106, DOI [10.1080/01977261.1993.11720900, DOI 10.1080/01977261.1993.11720900]; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Smedley RK, 2015, RADIAT MEAS, V79, P33, DOI 10.1016/j.radmeas.2015.06.003; Thomsen KJ, 2008, RADIAT MEAS, V43, P1474, DOI 10.1016/j.radmeas.2008.06.002; Toth L, 2009, NATO SCI PEACE SECUR, P267, DOI 10.1007/978-90-481-2792-4_12; vonderBeeck M, 1997, 8TH CONFERENCE ON SOFTWARE ENGINEERING ENVIRONMENTS - PROCEEDINGS, P131, DOI 10.1109/SEE.1997.591825; WAITT RB, 1985, GEOL SOC AM BULL, V96, P1271, DOI 10.1130/0016-7606(1985)96<1271:CFPCJF>2.0.CO;2; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Waters MR, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4505; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Williams TJ, 2020, PALEOAMERICA, V6, P4, DOI 10.1080/20555563.2019.1606668; Williams TJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5954	76	71	73	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					891	+		10.1126/science.aax9830	http://dx.doi.org/10.1126/science.aax9830			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467216				2022-12-28	WOS:000483975800040
J	Rushworth, RL; Torpy, DJ; Falhammar, H				Rushworth, R. Louise; Torpy, David J.; Falhammar, Henrik			Adrenal Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUBJECTIVE HEALTH-STATUS; ADDISONS-DISEASE; GLUCOCORTICOID THERAPY; PREMATURE MORTALITY; INSUFFICIENCY; HYPERPLASIA; HYDROCORTISONE; RISK; MANAGEMENT; DIAGNOSIS	Glucocorticoid replacement therapy prolongs the survival of patients with adrenal insufficiency, but life-threatening adrenal crises still develop in many such patients. This review examines the pathophysiology, epidemiology, and treatment of adrenal crises.	[Rushworth, R. Louise] Sch Med, Sydney, NSW, Australia; [Rushworth, R. Louise] Univ Notre Dame Australia, Darlinghurst, NSW, Australia; [Torpy, David J.] Royal Adelaide Hosp, Endocrine & Metab Unit, North Terrace, Adelaide, SA, Australia; [Torpy, David J.] Univ Adelaide, North Terrace, Adelaide, SA, Australia; [Falhammar, Henrik] Menzies Sch Hlth Res, Tiwi, NT, Australia; [Falhammar, Henrik] Royal Darwin Hosp, Tiwi, NT, Australia; [Falhammar, Henrik] Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Stockholm, Sweden; [Falhammar, Henrik] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Notre Dame Australia; Royal Adelaide Hospital; University of Adelaide; Charles Darwin University; Menzies School of Health Research; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Falhammar, H (corresponding author), Karolinska Inst, D2 04, SE-17176 Stockholm, Sweden.	henrik.falhammar@ki.se	Falhammar, Henrik/AAD-4329-2019	Falhammar, Henrik/0000-0002-5622-6987				Akarca FK, 2017, TURK J EMERG MED, V17, P157, DOI 10.1016/j.tjem.2017.05.007; Allolio B, 2015, EUR J ENDOCRINOL, V172, pR115, DOI 10.1530/EJE-14-0824; Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Balyura M, 2015, P NATL ACAD SCI USA, V112, P2527, DOI 10.1073/pnas.1500242112; Bancos I, 2015, LANCET DIABETES ENDO, V3, P216, DOI 10.1016/S2213-8587(14)70142-1; Barroso-Sousa R, 2018, JAMA ONCOL, V4, P173, DOI 10.1001/jamaoncol.2017.3064; Bensing S, 2008, CLIN ENDOCRINOL, V69, P697, DOI 10.1111/j.1365-2265.2008.03340.x; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bird S, 2007, AUST FAM PHYSICIAN, V36, P859; Bleicken B, 2008, EUR J ENDOCRINOL, V159, P811, DOI 10.1530/EJE-08-0578; Bornstein SR, 2016, J CLIN ENDOCR METAB, V101, P364, DOI 10.1210/jc.2015-1710; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Bowden SA, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/1739831; Buning JW, 2017, METABOLISM, V71, P7, DOI 10.1016/j.metabol.2017.02.005; Burger-Stritt S, 2018, CLIN ENDOCRINOL, V89, P22, DOI 10.1111/cen.13608; Burger-Stritt S, 2016, FRONT HORM RES, V46, P171, DOI 10.1159/000443918; Burman P, 2013, J CLIN ENDOCR METAB, V98, P1466, DOI 10.1210/jc.2012-4059; Chapman SCE, 2016, CLIN ENDOCRINOL, V84, P664, DOI 10.1111/cen.12991; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; Chrisp GL, 2018, CLIN ENDOCRINOL, V89, P577, DOI 10.1111/cen.13826; Cortet C, 2017, ANN ENDOCRINOL-PARIS, V78, P535, DOI 10.1016/j.ando.2017.10.008; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Daae E, 2018, ENDOCRINE, V62, P3, DOI 10.1007/s12020-018-1723-0; DINNEEN S, 1993, J CLIN INVEST, V92, P2283, DOI 10.1172/JCI116832; El-Maouche D, 2018, J CLIN ENDOCR METAB, V103, P2336, DOI 10.1210/jc.2018-00208; Erichsen MM, 2009, EUR J ENDOCRINOL, V160, P233, DOI 10.1530/EJE-08-0550; Falhammar H, 2015, ENDOCRINE, V50, P32, DOI 10.1007/s12020-015-0656-0; Falhammar H, 2014, J CLIN ENDOCR METAB, V99, pE2715, DOI 10.1210/jc.2014-2957; Forss M, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-8; Gargya A, 2016, INTERN MED J, V46, P356, DOI 10.1111/imj.12998; Gidlof S, 2013, LANCET DIABETES ENDO, V1, P35, DOI 10.1016/S2213-8587(13)70007-X; Hahner S, 2007, J CLIN ENDOCR METAB, V92, P3912, DOI 10.1210/jc.2007-0685; Hahner S, 2018, ANN ENDOCRINOL-PARIS, V79, P164, DOI 10.1016/j.ando.2018.04.015; Hahner S, 2015, CLIN ENDOCRINOL, V82, P497, DOI 10.1111/cen.12609; Hahner S, 2015, J CLIN ENDOCR METAB, V100, P407, DOI 10.1210/jc.2014-3191; Hahner S, 2013, EUR J ENDOCRINOL, V169, P147, DOI 10.1530/EJE-12-1057; Hahner S, 2010, EUR J ENDOCRINOL, V162, P597, DOI 10.1530/EJE-09-0884; Hajsheikholeslami F, 2013, INT J ENDOCRINOL MET, V11, P117, DOI 10.5812/ijem.5374; Hsieh S, 2011, J CLIN ENDOCR METAB, V96, pE925, DOI 10.1210/jc.2011-0015; Iwasaku M, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0208-0; Kampmeyer D, 2016, EUR J INTERN MED, V35, pE27, DOI 10.1016/j.ejim.2016.07.008; Kampmeyer D, 2016, EUR J INTERN MED, V33, pE13, DOI 10.1016/j.ejim.2016.04.006; Keenan DM, 2009, AM J PHYSIOL-REG I, V297, pR515, DOI 10.1152/ajpregu.00200.2009; Leblicq C, 2011, J PEDIAT, V158; Lewandowski KC, 2008, THYROID RES, V1, DOI 10.1186/1756-6614-1-7; Lovas K, 2002, CLIN ENDOCRINOL, V56, P581, DOI 10.1046/j.1365-2265.2002.01466.x; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Major A, 2018, INTERN MED J, V48, P360, DOI 10.1111/imj.13720; Mallappa A, 2016, ENDOCR DEV, V30, P42, DOI 10.1159/000439329; Meyer G, 2018, ENDOCRINE, V60, P355, DOI 10.1007/s12020-017-1513-0; MOLANDER N, 1982, ARCH DIS CHILD, V57, P572, DOI 10.1136/adc.57.8.572; Nour MA, 2018, INT J PEDIATR ENDOCR, DOI 10.1186/s13633-018-0063-4; Odenwald B, 2016, EUR J ENDOCRINOL, V174, P177, DOI 10.1530/EJE-15-0775; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; Puar THK, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.08.021; Quinkler M, 2015, EUR J INTERN MED, V26, P75, DOI 10.1016/j.ejim.2014.11.006; Ramamoorthy S, 2016, RHEUM DIS CLIN N AM, V42, P15, DOI 10.1016/j.rdc.2015.08.002; Remmelts HHF, 2012, RESP MED, V106, P905, DOI 10.1016/j.rmed.2012.02.008; Repping-Wuts HJWJ, 2013, EUR J ENDOCRINOL, V169, P17, DOI 10.1530/EJE-12-1094; Roque C, 2017, ENDOCRINOL DIAB META, DOI 10.1530/EDM-17-0002; Rushworth RL, 2015, HORM METAB RES, V47, P637, DOI 10.1055/s-0035-1548869; Rushworth RL, 2015, HORM METAB RES, V47, P427, DOI 10.1055/s-0034-1395680; Rushworth RL, 2018, HORM RES PAEDIAT, V89, P341, DOI 10.1159/000481660; Rushworth RL, 2018, ENDOCR PRACT, V24, P437, DOI 10.4158/EP-2017-0117; Rushworth RL, 2017, ENDOCRINE, V55, P336, DOI 10.1007/s12020-016-1204-2; Rushworth RL, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5748264; Rushworth RL, 2015, CLIN ENDOCRINOL, V83, P999, DOI 10.1111/cen.12825; Rushworth RL, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-79; Saevik AB, 2018, J INTERN MED, V283, P190, DOI 10.1111/joim.12699; Shepherd LM, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0196-0; Smans LCCJ, 2016, CLIN ENDOCRINOL, V84, P17, DOI 10.1111/cen.12865; Smrecnik M, 2018, OSTEOPOROSIS INT, V29, P1675, DOI 10.1007/s00198-018-4508-7; Sorgdrager FJH, 2018, J CLIN ENDOCR METAB, V103, P3411, DOI 10.1210/jc.2018-00582; Strandqvist A, 2014, J CLIN ENDOCR METAB, V99, P1425, DOI 10.1210/jc.2013-3326; Sychev DA, 2018, DRUG DES DEV THER, V12, P1147, DOI 10.2147/DDDT.S149069; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Venkatesh B, 2018, NEW ENGL J MED, V378, P797, DOI 10.1056/NEJMoa1705835; Vidmar AP, 2018, J PEDIATR ENDOCR MET, V31, P213, DOI 10.1515/jpem-2017-0435; White K, 2010, EUR J ENDOCRINOL, V162, P115, DOI 10.1530/EJE-09-0559	81	74	78	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					852	861		10.1056/NEJMra1807486	http://dx.doi.org/10.1056/NEJMra1807486			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IV7FE	31461595				2022-12-28	WOS:000484431200012
J	Safford, H; Brown, A				Safford, Hannah; Brown, Austin			How to bring science into politics	NATURE			English	Editorial Material									[Safford, Hannah] Univ Calif Davis, Environm Engn, Davis, CA 95616 USA; [Safford, Hannah; Brown, Austin] Univ Calif Davis, Policy Inst Energy Environm & Econ, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Safford, H (corresponding author), Univ Calif Davis, Environm Engn, Davis, CA 95616 USA.; Safford, H (corresponding author), Univ Calif Davis, Policy Inst Energy Environm & Econ, Davis, CA 95616 USA.								0	7	7	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					681	682		10.1038/d41586-019-02372-3	http://dx.doi.org/10.1038/d41586-019-02372-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31439901				2022-12-28	WOS:000483405500059
J	Amambua-Ngwa, A; Amenga-Etego, L; Kamau, E; Amato, R; Ghansah, A; Golassa, L; Randrianarivelojosia, M; Ishengoma, D; Apinjoh, T; Maiga-Ascofare, O; Andagalu, B; Yavo, W; Bouyou-Akotet, M; Kolapo, O; Mane, K; Worwui, A; Jeffries, D; Simpson, V; D'Alessandro, U; Kwiatkowski, D; Djimde, AA				Amambua-Ngwa, Alfred; Amenga-Etego, Lucas; Kamau, Edwin; Amato, Roberto; Ghansah, Anita; Golassa, Lemu; Randrianarivelojosia, Milijaona; Ishengoma, Deus; Apinjoh, Tobias; Maiga-Ascofare, Oumou; Andagalu, Ben; Yavo, William; Bouyou-Akotet, Marielle; Kolapo, Oyebola; Mane, Karim; Worwui, Archibald; Jeffries, David; Simpson, Vikki; D'Alessandro, Umberto; Kwiatkowski, Dominic; Djimde, Abdoulaye A.			Major subpopulations of Plasmodium falciparum in sub-Saharan Africa	SCIENCE			English	Article							POPULATION-STRUCTURE; DIVERSITY; EVOLUTION; GENOME	Understanding genomic variation and population structure of Plasmodium falciparum across Africa is necessary to sustain progress toward malaria elimination. Genome clustering of 2263 P. falciparum isolates from 24 malaria-endemic settings in 15 African countries identified major western, central, and eastern ancestries, plus a highly divergent Ethiopian population. Ancestry aligned to these regional blocs, overlapping with both the parasite's origin and with historical human migration. The parasite populations are interbred and shared genomic haplotypes, especially across drug resistance loci, which showed the strongest recent identity-by-descent between populations. A recent signature of selection on chromosome 12 with candidate resistance loci against artemisinin derivatives was evident in Ghana and Malawi. Such selection and the emerging substructure may affect treatment-based intervention strategies against P. falciparum malaria.	[Amambua-Ngwa, Alfred; Kolapo, Oyebola; Mane, Karim; Worwui, Archibald; Jeffries, David; D'Alessandro, Umberto] LSHTM, Med Res Council Unit Gambia, Banjul, Gambia; [Amenga-Etego, Lucas] Univ Ghana, WACCBIP, Accra, Ghana; [Kamau, Edwin; Andagalu, Ben] Kenya Govt Med Res Ctr, US Army Med Res Directorate Africa, Walter Reed Project, Kisumu, Kenya; [Kamau, Edwin; Simpson, Vikki] US Mil HIV Res Program, Walter Reed Army Inst Res, Silver Spring, MD USA; [Amato, Roberto; Kwiatkowski, Dominic; Djimde, Abdoulaye A.] Wellcome Sanger Inst, Hinxton, England; [Amato, Roberto; Simpson, Vikki; Kwiatkowski, Dominic] Univ Oxford, Big Data Inst, MRC Ctr Genom & Global Hlth, Oxford, England; [Ghansah, Anita] NMIMR, Accra, Ghana; [Golassa, Lemu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Ishengoma, Deus] NIMR, Tanga, Tanzania; [Apinjoh, Tobias] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon; [Maiga-Ascofare, Oumou] BNITM, Hamburg, Germany; [Yavo, William] Univ Felix Houphouet Boigny, Unite Sci Pharmaceut & Biol, Abidjan, Cote Ivoire; [Bouyou-Akotet, Marielle] Univ Hlth Sci, Fac Med, Libreville, Gabon; [Kolapo, Oyebola] Univ Lagos, Dept Zool, Lagos, Nigeria; [Djimde, Abdoulaye A.] Univ Sci Techn & Technol Bamako, Malaria Res & Training Ctr, Bamako, Mali	University of London; London School of Hygiene & Tropical Medicine; University of Ghana; Kenya Medical Research Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Wellcome Trust Sanger Institute; University of Oxford; Addis Ababa University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Bernhard Nocht Institut fur Tropenmedizin; University of Lagos; University of Science & Technology of Bamako	Djimde, AA (corresponding author), Wellcome Sanger Inst, Hinxton, England.; Djimde, AA (corresponding author), Univ Sci Techn & Technol Bamako, Malaria Res & Training Ctr, Bamako, Mali.	adjimde@icermali.org	Golassa, Lemu/AAJ-2204-2021; Amambua-Ngwa, Alfred/AHD-7882-2022; Amambua-Ngwa, Alfred/ABA-7305-2020; Amambua-Ngwa, Alfred/HGU-8062-2022	Amambua-Ngwa, Alfred/0000-0003-4478-3601; Amambua-Ngwa, Alfred/0000-0003-4478-3601; OYEBOLA, KOLAPO/0000-0002-1003-2570; Maiga Ascofare, Oumou/0000-0003-2947-5651; Apinjoh, Tobias/0000-0001-9889-7271; Amato, Roberto/0000-0001-8633-9221; Kamau, Edwin/0000-0002-5761-7883	DELTAS Africa Initiative, an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome (DELGEME grant) [107740/Z/15/Z]; U. K. government; Armed Forces Health Surveillance Center (AFHSB) and its Global Emerging Infections Surveillance (GEIS) Section [P0209_15_KY]; Wellcome [206194, 090770/Z/09/Z]; MRC Centre for Genomics and Global Health - Medical Research Council [G0600718, M006212]; MRC Centre for Genomics and Global Health - Department for International Development (DFID) [G0600718, M006212]; MRC [MR/M006212/1, MC_EX_MR/K02440X/1, G0600718] Funding Source: UKRI	DELTAS Africa Initiative, an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome (DELGEME grant); U. K. government; Armed Forces Health Surveillance Center (AFHSB) and its Global Emerging Infections Surveillance (GEIS) Section; Wellcome; MRC Centre for Genomics and Global Health - Medical Research Council; MRC Centre for Genomics and Global Health - Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A.A.-N., L.A.-E., A.G., L.G., D.I., T.A., O.M.-A., B.A., Y.W., M.B.-A., and A.A.D. are currently supported through the DELTAS Africa Initiative, an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA), and are also supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from Wellcome (DELGEME grant 107740/Z/15/Z) and the U. K. government. Sample collection in Kenya was funded by Armed Forces Health Surveillance Center (AFHSB) and its Global Emerging Infections Surveillance (GEIS) Section, Grant P0209_15_KY. The views expressed in this publication are those of the authors and not necessarily those of AAS, NEPAD Agency, Wellcome, the U.S. Army or the Department of Defense, or the U. K. government. The investigators have adhered to the policies for protection of human subjects as prescribed in AR-70. Sequencing was undertaken in partnership with MalariaGEN and the Parasites and Microbes program at the Wellcome Sanger Institute with funding from Wellcome (206194; 090770/Z/09/Z) and by the MRC Centre for Genomics and Global Health which is jointly funded by the Medical Research Council and the Department for International Development (DFID) (G0600718 to D. K.; M006212).	Amambua-Ngwa A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28017-5; Anderson T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000054; Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Bei AK, 2018, J INFECT DIS, V217, P622, DOI 10.1093/infdis/jix580; Bogreau H, 2006, AM J TROP MED HYG, V74, P953; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Caye K, 2016, MOL ECOL RESOUR, V16, P540, DOI 10.1111/1755-0998.12471; Chang HH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005348; Cowell AN, 2018, SCIENCE, V359, P191, DOI 10.1126/science.aan4472; Duffy CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34078-3; Ghansah A, 2014, SCIENCE, V345, P1297, DOI 10.1126/science.1259423; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Henden L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007279; Henriques G, 2015, ANTIMICROB AGENTS CH, V59, P2540, DOI 10.1128/AAC.04067-14; Hodgson JA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004393; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kapesa A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202031; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li WT, 2017, J BIOINF COMPUT BIOL, V15, DOI 10.1142/S0219720017500172; Loy DE, 2017, INT J PARASITOL, V47, P87, DOI 10.1016/j.ijpara.2016.05.008; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Miles A, 2017, NATURE, V552, P96, DOI 10.1038/nature24995; Patin E, 2017, SCIENCE, V356, P543, DOI 10.1126/science.aal1988; Rao JK, 2009, PREV CHRONIC DIS, V6; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; World Health Organization, 2018, WORLD MAL REP 2018	32	43	45	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		813	+		10.1126/science.aav5427	http://dx.doi.org/10.1126/science.aav5427			140	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439796	Green Submitted, Green Accepted			2022-12-28	WOS:000482464000052
J	Seymour, F; Harris, NL				Seymour, Frances; Harris, Nancy L.			Reducing tropical deforestation	SCIENCE			English	Editorial Material							DRIVERS		[Seymour, Frances; Harris, Nancy L.] World Resources Inst, 10 G St NE, Washington, DC 20002 USA		Seymour, F (corresponding author), World Resources Inst, 10 G St NE, Washington, DC 20002 USA.	frances.seymour@wri.org						Austin KG, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf6db; Blackman A, 2017, P NATL ACAD SCI USA, V114, P4123, DOI 10.1073/pnas.1603290114; Boyd W., 2018, JURISDICTIONAL APPRO; Busch J, 2017, REV ENV ECON POLICY, V11, P3, DOI 10.1093/reep/rew013; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Kroeger A., 2017, ELIMINATING DEFOREST; Lawrence D, 2015, NAT CLIM CHANGE, V5, P27, DOI [10.1038/nclimate2430, 10.1038/NCLIMATE2430]; LOVEJOY TE, 2018, SCI ADV, V4, DOI DOI 10.1126/SCIADV.AAT2340; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Newton P., 2016, World Development Perspectives, V4, P5, DOI 10.1016/j.wdp.2016.11.011; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Seymour F., 2016, WHY FORESTS WHY NOW, DOI DOI 10.7864/J.CTT1HFR179; Taylor R., 2018, WORKING PAPER; Turubanova S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aacd1c; Tyukavina A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2993; Tyukavina A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601047	18	89	89	5	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		756	+		10.1126/science.aax8546	http://dx.doi.org/10.1126/science.aax8546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439784				2022-12-28	WOS:000482464000030
J	Vesely, MCA; Pallis, P; Bielecki, P; Low, JS; Zhao, J; Harman, CCD; Kroehling, L; Jackson, R; Bailis, W; Licona-Limon, P; Xu, H; Iijima, N; Pillai, PS; Kaplan, DH; Weaver, CT; Kluger, Y; Kowalczyk, MS; Iwasaki, A; Pereira, JP; Esplugues, E; Gagliani, N; Flavell, RA				Vesely, Maria Carolina Amezcua; Pallis, Paris; Bielecki, Piotr; Low, Jun Siong; Zhao, Jun; Harman, Christian C. D.; Kroehling, Lina; Jackson, Ruaidhri; Bailis, Will; Licona-Limon, Paula; Xu, Hao; Iijima, Norifumi; Pillai, Padmini S.; Kaplan, Daniel H.; Weaver, Casey T.; Kluger, Yuval; Kowalczyk, Monika S.; Iwasaki, Akiko; Pereira, Joao P.; Esplugues, Enric; Gagliani, Nicola; Flavell, Richard A.			Effector T(H)17 Cells Give Rise to Long-Lived T-RM Cells that Are Essential for an Immediate Response against Bacterial Infection	CELL			English	Article							TISSUE-RESIDENT; TH17 CELLS; EXPRESSION; PLASTICITY; GENE; ESTABLISHMENT; CHEMOKINE; SURVIVAL; SUBSETS; IL-23	Adaptive immunity provides life-long protection by generating central and effector memory T cells and the most recently described tissue resident memory T (T-RM) cells. However, the cellular origin of CD4 T-RM cells and their contribution to host defense remain elusive. Using IL-17A tracking-fate mouse models, we found that a significant fraction of lung CD4 T-RM cells derive from IL-17A-producing effector (T(H)17) cells following immunization with heat-killed Klebsiella pneumonia (Kp). These exT(H)17 T-RM cells are maintained in the lung by IL-7, produced by lymphatic endothelial cells. During a memory response, neither antibodies, gamma delta T cells, nor circulatory T cells are sufficient for the rapid host defense required to eliminate Kp. Conversely, using parabiosis and depletion studies, we demonstrated that exT(H)17 T-RM cells play an important role in bacterial clearance. Thus, we delineate the origin and function of airway CD4 T-RM cells during bacterial infection, offering novel strategies for targeted vaccine design.	[Vesely, Maria Carolina Amezcua; Pallis, Paris; Bielecki, Piotr; Low, Jun Siong; Zhao, Jun; Harman, Christian C. D.; Kroehling, Lina; Jackson, Ruaidhri; Bailis, Will; Xu, Hao; Iijima, Norifumi; Pillai, Padmini S.; Iwasaki, Akiko; Pereira, Joao P.; Esplugues, Enric; Gagliani, Nicola; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Vesely, Maria Carolina Amezcua; Harman, Christian C. D.; Iwasaki, Akiko; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Zhao, Jun; Kluger, Yuval] Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Zhao, Jun; Kluger, Yuval] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Licona-Limon, Paula] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Ciudad De Mexico, Mexico; [Kaplan, Daniel H.] Univ Pittsburgh, Dept Dermatol & Immunol, Pittsburgh, PA 15261 USA; [Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Kluger, Yuval] Yale Univ, Appl Math Program, New Haven, CT 06511 USA; [Kowalczyk, Monika S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Med Dept 1, D-20246 Hamburg, Germany; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, D-20246 Hamburg, Germany; [Gagliani, Nicola] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, S-17176 Stockholm, Sweden; [Pillai, Padmini S.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Pillai, Padmini S.] MIT, Dept Chem Engn, Cambridge, MA 02142 USA; [Esplugues, Enric] Principe Felipe Res Ctr CIPF, Lab Mol & Cellular Immunol, Valencia 46012, Spain	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Universidad Nacional Autonoma de Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Prince Felipe Research Center	Gagliani, N; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.; Gagliani, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Med Dept 1, D-20246 Hamburg, Germany.; Gagliani, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, D-20246 Hamburg, Germany.; Gagliani, N (corresponding author), Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, S-17176 Stockholm, Sweden.	n.gagliani@uke.de; richard.flavell@yale.edu	Iwasaki, Akiko/Z-1591-2019; Esplugues, Enric/AAD-4245-2020; Zhao, Jun/AAT-2086-2021	Iwasaki, Akiko/0000-0002-7824-9856; Gagliani, Nicola/0000-0001-8514-1395; Esplugues, Enric/0000-0002-8130-0413; Low, Jun Siong/0000-0002-1775-0778; AMEZCUA VESELY, MARIA CAROLINA/0000-0001-9631-1249	HHMI; Karolinska Institute Professor fellowship; NIH [RO1AI113040, R01AR060744, R01HG008383, R01GM131642, R01DK103744]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113040, R01AI127429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM131642] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Karolinska Institute Professor fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jason Weinstein, Lidia Bosurgi, Jacek Puchalka, Liang Shan, Angel Solis, Nancy Ruddle, and Aviv Regev for helpful discussion, and Roni Nowarski for disucssion and microscopy assistance. We thank Katie Bolland for assistance during TCR-seq analysis, Brigitta Stockinger for providing the Fate mice and Ewa Menet and Geoffrey Lyon for sorting assistance. We would also like to thank Judy Stein for the design of iFate plasmids, and Jon Alderman, Caroline Lieber, and the Amezcua Vesely family for general assistance. We acknowledge support from HHMI for M.C.A.V. and R.A.F.; Karolinska Institute Professor fellowship for N.G., NIH RO1AI113040 for J.P.P., NIH R01AR060744 for D.H.K.; NIH R01HG008383 and R01GM131642 for Y.K.; and NIH R01DK103744 for C.T.W.	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen K, 2011, IMMUNITY, V35, P997, DOI 10.1016/j.immuni.2011.10.018; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Glennie ND, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006349; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kirsch IR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9122; Layman AAK, 2017, SCI REP-UK, V7, DOI 10.1038/srep39649; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2016, J IMMUNOL, V196, P3920, DOI 10.4049/jimmunol.1502337; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schlapbach C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007828; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	54	64	64	4	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1176	+		10.1016/j.cell.2019.07.032	http://dx.doi.org/10.1016/j.cell.2019.07.032			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442406	Green Accepted, Bronze			2022-12-28	WOS:000482191000014
J	Singh, CA; Sakthivel, P				Singh, Chirom A.; Sakthivel, Pirabu			Laryngocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Singh, Chirom A.; Sakthivel, Pirabu] All India Inst Med Sci, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sakthivel, P (corresponding author), All India Inst Med Sci, New Delhi, India.	pirabusakthivel@gmail.com	Sakthivel, Pirabu/AAZ-7939-2021	Sakthivel, Pirabu/0000-0002-6941-9892					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2018	379	23					E40	E40		10.1056/NEJMicm1807310	http://dx.doi.org/10.1056/NEJMicm1807310			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HD1HA	31442019				2022-12-28	WOS:000452259200012
J	Meccariello, A; Salvemini, M; Primo, P; Hall, B; Koskiniot, P; Dalikova, M; Gravina, A; Gucciar, MA; Forlenza, F; Gregoriou, ME; Ippolito, D; Monti, SM; Petrella, V; Perrotta, MM; Schmeing, S; Ruggiero, A; Scolari, F; Giordano, E; Tsoumani, KT; Marec, F; Windbichler, N; Nagaraju, J; Arunkumar, KP; Bourtzis, K; Mathiopoulos, KD; Ragoussis, J; Vitagliano, L; Tu, ZJ; Papathanos, PA; Robinson, MD; Saccone, G				Meccariello, Angela; Salvemini, Marco; Primo, Pasquale; Hall, Brantley; Koskiniot, Panagiota; Dalikova, Martina; Gravina, Andrea; Gucciar, Michela Anna; Forlenza, Federica; Gregoriou, Maria Eleni; Ippolito, Domenica; Monti, Simona Maria; Petrella, Valeria; Perrotta, Maryanna Martina; Schmeing, Stephan; Ruggiero, Alessia; Scolari, Francesca; Giordano, Ennio; Tsoumani, Konstantina T.; Marec, Frantisek; Windbichler, Nikolai; Nagaraju, Javaregowda; Arunkumar, Kallare P.; Bourtzis, Kostas; Mathiopoulos, Kostas D.; Ragoussis, Jiannis; Vitagliano, Luigi; Tu, Zhijian; Papathanos, Philippos Aris; Robinson, Mark D.; Saccone, Giuseppe			Maleness-on-the-Y (MoY) orchestrates male sex determination in major agricultural fruit fly pests	SCIENCE			English	Article							CERATITIS-CAPITATA; GENE; EXPRESSION; PROVIDES; GENOME	In insects, rapidly evolving primary sex-determining signals are transduced by a conserved regulatory module controlling sexual differentiation. In the agricultural pest Ceratitis capitata (Mediterranean fruit fly, or Medfly), we identified a Y-linked gene, Maleness-on-the-Y (MoY), encoding a small protein that is necessary and sufficient for male development. Silencing or disruption of MoY in XY embryos causes feminization, whereas overexpression of MoY in XX embryos induces masculinization. Crosses between transformed XY females and XX males give rise to males and females, indicating that a Y chromosome can be transmitted by XY females. MoY is Y-linked and functionally conserved in other species of the Tephritidae family, highlighting its potential to serve as a tool for developing more effective control strategies against these major agricultural insect pests.	[Meccariello, Angela; Salvemini, Marco; Primo, Pasquale; Gravina, Andrea; Gucciar, Michela Anna; Forlenza, Federica; Ippolito, Domenica; Petrella, Valeria; Perrotta, Maryanna Martina; Giordano, Ennio; Saccone, Giuseppe] Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy; [Hall, Brantley; Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Koskiniot, Panagiota; Bourtzis, Kostas; Mathiopoulos, Kostas D.] Joint FAO IAEA, Div Nucl Tech Food & Agr, Insect Pest Control Lab, A-1400 Vienna, Austria; [Koskiniot, Panagiota; Gregoriou, Maria Eleni; Tsoumani, Konstantina T.; Mathiopoulos, Kostas D.] Univ Thessary, Dept Biochem & Biotechnol, Larisa 41500, Greece; [Dalikova, Martina; Marec, Frantisek] Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice 37005, Czech Republic; [Dalikova, Martina] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Monti, Simona Maria; Ruggiero, Alessia; Vitagliano, Luigi] CNR, IBB, I-80134 Naples, Italy; [Schmeing, Stephan; Robinson, Mark D.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Schmeing, Stephan; Robinson, Mark D.] Univ Zurich, SIB Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland; [Scolari, Francesca] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pevia, Italy; [Windbichler, Nikolai] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Arunkumar, Kallare P.] Ctr DNA Fingerprinting & Diagnost, Lab Mol Genet, Ctr Excellence Genet & Genom Silkmoths, Hyderabad 500039, India; [Ragoussis, Jiannis] McGill Univ, Dept Human Genet & Bioengn, Montreal, PQ H3A 0G1, Canada; [Ragoussis, Jiannis] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Papathanos, Philippos Aris] Univ Perugia, Dept Expt Med, Sect Genom & Genet, I-06132 Perugia, Italy; [Papathanos, Philippos Aris] Hebrew Univ Jeruswem, Dept Entomol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	University of Naples Federico II; Virginia Polytechnic Institute & State University; International Atomic Energy Agency; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; University of Pavia; Imperial College London; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); McGill University; University of Perugia	Saccone, G (corresponding author), Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy.; Robinson, MD (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.; Robinson, MD (corresponding author), Univ Zurich, SIB Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland.; Papathanos, PA (corresponding author), Univ Perugia, Dept Expt Med, Sect Genom & Genet, I-06132 Perugia, Italy.; Papathanos, PA (corresponding author), Hebrew Univ Jeruswem, Dept Entomol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	p.papathanos@mail.huji.ac.il; mark.robinson@imls.uzh.ch; giuseppe.saccone@unina.it	Ragoussis, Ioannis/AAD-9790-2022; Dalikova, Martina/J-5722-2015; Koskinioti, Panagiota/R-3416-2018; Robinson, Mark D./O-2254-2019; saccone, giuseppe/F-8627-2013; Salvemini, Marco/AAJ-5560-2021; Mathiopoulos, Kostas/K-9548-2019; Papathanos, Philippos/ABE-4869-2021; Scolari, Francesca/ABC-2285-2020; Marec, Frantisek/G-7943-2014; Ruggiero, Alessia/GRJ-9538-2022	Dalikova, Martina/0000-0002-0266-8894; Koskinioti, Panagiota/0000-0002-4321-1217; Robinson, Mark D./0000-0002-3048-5518; saccone, giuseppe/0000-0002-9835-3693; Mathiopoulos, Kostas/0000-0002-2875-5697; Scolari, Francesca/0000-0003-3085-9038; Marec, Frantisek/0000-0002-6745-5603; Ruggiero, Alessia/0000-0002-3508-385X; Meccariello, Angela/0000-0001-9706-5764; Ragoussis, Ioannis/0000-0002-8515-0934; Gucciardino, Michela Anna/0000-0002-9306-186X; Ippolito, Domenica/0000-0002-8793-5065; Primo, Pasquale/0000-0002-8700-8042; Gregoriou, Maria-Eleni/0000-0001-9979-2631; Hall, Brantley/0000-0001-7553-8209; Schmeing, Stephan/0000-0001-9735-2931; SALVEMINI, Marco/0000-0003-2297-9267	Coordination Research Projects (CRP) of the Joint FAO/IAEA Division; University of Naples Federico II [R-Dept-Biol-2015-18, STAR2013_25]; SNSF [31003A_143883, 31003A_175841]; University of Zurich; BBSRC [BB/P000843/1]; NIH [AI121284, AI123338]; MIUR [79 04.02.2014]; Compute Canada [WST-164-AB]; Genome Canada GIN [244819]; Fulbright Stavros Niarchos Greek Diaspora Fellowship; Hellenic IKY Fellowship; OMIC-Engine, a Greek Research Infrastructure Program on Synthetic Biology; Czech Science Foundation [17-17211S, 17-13713S]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121284, R01AI123338] Funding Source: NIH RePORTER	Coordination Research Projects (CRP) of the Joint FAO/IAEA Division; University of Naples Federico II; SNSF(Swiss National Science Foundation (SNSF)); University of Zurich; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIUR(Ministry of Education, Universities and Research (MIUR)); Compute Canada; Genome Canada GIN; Fulbright Stavros Niarchos Greek Diaspora Fellowship; Hellenic IKY Fellowship; OMIC-Engine, a Greek Research Infrastructure Program on Synthetic Biology; Czech Science Foundation(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This paper is dedicated to the memory of Javaregowda Nagaraju, with whom the project was initiated. We thank L.C. Polito, who initiated the Medfly research in Naples and led the first studies on Medfly sex determination and L. Gaudio for very stimulating encouragements. We thank C. Caceres, S. Ahmad, and J. Morrow for fly samples and methods; B. Carvalho and S. Aceto for bioinformatic support; D. Bopp, A. Pagliuca, and L. Rabinow for discussions and manuscript reviewing. This study was supported by Coordination Research Projects (CRP) of the Joint FAO/IAEA Division. This research was supported by grants R-Dept-Biol-2015-18 to G.S. and M.S., STAR2013_25 to M.S., fellowships to AM. and P.P. from the University of Naples Federico II. M.D.R. acknowledges support from the SNSF (project numbers 31003A_143883 and 31003A_175841), and S. S. and M.D.R. from the University of Zurich Research Priority Program Evolution in Action. N.W. was funded by the BBSRC under the research grant BB/P000843/1. Z.T. was supported by NIH grants AI121284 and AI123338 P.A.P. was supported by RLM award from MIUR (D.M. no. 79 04.02.2014). J.R. was supported by Compute Canada (WST-164-AB), Genome Canada GIN (244819), and Fulbright Stavros Niarchos Greek Diaspora Fellowship. K.T.T. was supported by a Hellenic IKY Fellowship. M.-E.G. and K.D.M. were supported by OMIC-Engine, a Greek Research Infrastructure Program on Synthetic Biology. M.D. and F.M. acknowledge support from the Czech Science Foundation (grants 17-17211S and 17-13713S respectively)	ANLEITNER JE, 1992, CHROMOSOMA, V101, P271, DOI 10.1007/BF00346005; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; BANKS GK, 1995, GENETICS, V140, P697; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bopp D, 2014, SEX DEV, V8, P20, DOI 10.1159/000356458; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; CARABAJALPALADINO, 2014, BMC GENET S2, V15, DOI DOI 10.1186/1471-2156-15-67-S15; Chapman JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023501; Criscione F, 2016, ELIFE, V5, DOI 10.7554/eLife.19281; Dyck V.A., 2006, STERILE INSECT TECHN; Gabrieli P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-12; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; HOLMES DS, 1973, BIOCHEMISTRY-US, V12, P2330, DOI 10.1021/bi00736a023; Kandul NP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07964-7; Kato A, 2006, BIOTECH HISTOCHEM, V81, P71, DOI 10.1080/10520290600643677; Krosch MN, 2012, MOL PHYLOGENET EVOL, V64, P513, DOI 10.1016/j.ympev.2012.05.006; Krylov V, 2007, CYTOGENET GENOME RES, V116, P110, DOI 10.1159/000097427; Krzywinska E, 2016, SCIENCE, V353, P67, DOI 10.1126/science.aaf5605; Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2015, BIOINFORMATICS, V31, P2885, DOI 10.1093/bioinformatics/btv290; Meccariello A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10347-5; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Pane A, 2002, DEVELOPMENT, V129, P3715; Papanicolaou A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1049-2; Papathanos PA, 2018, CRISPR J, V1, P88, DOI 10.1089/crispr.2017.0012; Petrella V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2088-x; Qin YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116424; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagri E, 2017, SCI REP-UK, V7, DOI 10.1038/srep45634; Salvemini M, 2006, INSECT MOL BIOL, V15, P341, DOI 10.1111/j.1365-2583.2006.00651.x; Salvemini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114191; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Sharma A, 2017, SCIENCE, V356, P642, DOI 10.1126/science.aam5498; Willhoeft U, 1996, GENETICS, V144, P737	40	56	59	12	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2019	365	6460					1457	+		10.1126/science.aax1318	http://dx.doi.org/10.1126/science.aax1318			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8QM	31467189	Green Submitted, Green Accepted			2022-12-28	WOS:000488838600049
J	Wang, H; Nakamura, M; Abbott, TR; Zhao, DH; Luo, KW; Yu, C; Nguyen, CM; Lo, A; Daley, TP; La Russa, M; Liu, YX; Qi, LS				Wang, Haifeng; Nakamura, Muneaki; Abbott, Timothy R.; Zhao, Dehua; Luo, Kaiwen; Yu, Cordelia; Nguyen, Cindy M.; Lo, Albert; Daley, Timothy P.; La Russa, Marie; Liu, Yanxia; Qi, Lei S.			CRISPR-mediated live imaging of genome editing and transcription	SCIENCE			English	Article							GENES; LOCI; DYNAMICS; PLATFORM	We report a robust, versatile approach called CRISPR live-cell fluorescent in situ hybridization (LiveFISH) using fluorescent oligonucleotides for genome tracking in a broad range of cell types, including primary cells. An intrinsic stability switch of CRISPR guide RNAs enables LiveFISH to accurately detect chromosomal disorders such as Patau syndrome in prenatal amniotic fluid cells and track multiple loci in human T lymphocytes. In addition, LiveFISH tracks the real-time movement of DNA double-strand breaks induced by CRISPR-Cas9-mediated editing and consequent chromosome translocations. Finally, by combining Cas9 and Cas13 systems, LiveFISH allows for simultaneous visualization of genomic DNA and RNA transcripts in living cells. The LiveFISH approach enables real-time live imaging of DNA and RNA during genome editing, transcription, and rearrangements in single cells.	[Wang, Haifeng; Nakamura, Muneaki; Abbott, Timothy R.; Zhao, Dehua; Luo, Kaiwen; Yu, Cordelia; Nguyen, Cindy M.; Lo, Albert; Daley, Timothy P.; La Russa, Marie; Liu, Yanxia; Qi, Lei S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Luo, Kaiwen] Zhejiang Univ, ZJU UOE Inst, Sch Med, Haining, Peoples R China; [Yu, Cordelia] Castilleja Sch, Palo Alto, CA 94301 USA; [Daley, Timothy P.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, ChEM H Inst, Stanford, CA 94305 USA	Stanford University; Zhejiang University; Stanford University; Stanford University; Stanford University	Qi, LS (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Qi, LS (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Qi, LS (corresponding author), Stanford Univ, ChEM H Inst, Stanford, CA 94305 USA.	stanley.qi@stanford.edu	Qi, Lei S/AAC-5088-2019	Lo, Albert/0000-0003-4838-9433; Luo, Kaiwen/0000-0002-1597-1219; Qi, Lei S/0000-0002-3965-3223	NSF GRFP; Li Ka Shing Foundation; National Institutes of Health Common Fund 4D Nucleome Program [U01 EB021240]; Pew Scholar Foundation; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021240] Funding Source: NIH RePORTER	NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Li Ka Shing Foundation; National Institutes of Health Common Fund 4D Nucleome Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	T.R.A. acknowledges support from NSF GRFP. L.S.Q acknowledges funding support from the Li Ka Shing Foundation. This work is partly supported by the National Institutes of Health Common Fund 4D Nucleome Program (U01 EB021240), the Pew Scholar Foundation, and the Alfred P. Sloan Foundation.	Al-Romaih K, 2003, CANCER GENET CYTOGEN, V144, P91, DOI 10.1016/S0165-4608(02)00929-9; BATY BJ, 1994, AM J MED GENET, V49, P175, DOI 10.1002/ajmg.1320490204; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Gandhi M, 2012, P NATL ACAD SCI USA, V109, P9454, DOI 10.1073/pnas.1205759109; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2018, CELL, V173, P665, DOI 10.1016/j.cell.2018.02.033; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liao HK, 2017, CELL, V171, P1495, DOI 10.1016/j.cell.2017.10.025; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Mattapally S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010239; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin PW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14725; Ren JT, 2017, ONCOTARGET, V8, P17002, DOI 10.18632/oncotarget.15218; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Wang HF, 2018, CELL, V175, P1405, DOI 10.1016/j.cell.2018.09.013; Yang KS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10129	31	110	115	24	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2019	365	6459					1301	+		10.1126/science.aax7852	http://dx.doi.org/10.1126/science.aax7852			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JA1AC	31488703				2022-12-28	WOS:000487547400046
J	Januzzi, JL; Prescott, MF; Butler, J; Felker, GM; Maisel, AS; McCague, K; Camacho, A; Pina, LL; Rocha, RA; Shah, AM; Williamson, KM; Solomon, SD; Aslam, A; Vora, K; Desai, S; Foucauld, J; Modi, M; Wang, D; Berk, M; Martinez-Castrilon, M; Kraus, D; Grena, P; Sanchez, E; Lloret, R; Aggarwala, G; Anglade, M; Eaves, W; Gianfagna, R; Schwartz, M; Joshi, N; Galtes, I; Somodevilla, G; Jackson, R; Lewis, G; Peters, M; Lupovitch, S; Phillips, A; Chhabra, A; Perez, G; Venugopal, C; Lyandres, Y; King, A; Bradley, A; Dakour, R; Braden, S; Muneer, B; Bart, B; Kapadia, S; Shah, N; Nadar, V; Murthy, S; McFarland, R; Steuter, J; Iftikhar, F; Patel, D; Browning, C; White, A; Montgomery, R; Woolf, K; Soverow, J; Lewis, N; Fragoso, V; Harris, B; Fischer, S; Mouhaffel, A; Saxena, S; Gorton, S; Grover-McKay, M; Carr, J; Malhotra, V; Oghlakian, G; Williams, K; Abraham, J; Arora, V; Bogaev, R; Friedman, K; Seiler, F; Forsythe, J; Abboy, C; Khalid, A; Isserman, S; Williams, R; Schwartz, S; Cotts, W; Srivastava, S; Palac, R; Gandhi, P; Sharma, S; Kim, N; Nixon, W; Schneider, P; Saini, S; Agostino, RD; Walia, J				Januzzi, James L., Jr.; Prescott, Margaret F.; Butler, Javed; Felker, G. Michael; Maisel, Alan S.; McCague, Kevin; Camacho, Alexander; Pina, Lleana L.; Rocha, Ricardo A.; Shah, Amil M.; Williamson, Kristin M.; Solomon, Scott D.; Aslam, Ahmad; Vora, Kishor; Desai, Sunil; Foucauld, Jean; Modi, Mayank; Wang, David; Berk, Martin; Martinez-Castrilon, Melvin; Kraus, David; Grena, Paul; Sanchez, Eulogio; Lloret, Ramon; Aggarwala, Gaurav; Anglade, Moise; Eaves, William; Gianfagna, Robert; Schwartz, Michael; Joshi, Nikhil; Galtes, Israel; Somodevilla, Guillermo; Jackson, Richard; Lewis, Gregory; Peters, Michael; Lupovitch, Steven; Phillips, Andrea; Chhabra, Anil; Perez, Guido; Venugopal, Chandra; Lyandres, Yuly; King, Anthony; Bradley, Arden; Dakour, Ramzi; Braden, Stephen; Muneer, Basharat; Bart, Bradley; Kapadia, Shaival; Shah, Neerav; Nadar, Venkatesh; Murthy, Sandhya; McFarland, Rebecca; Steuter, John; Iftikhar, Faizan; Patel, Dharmesh; Browning, Christine; White, Alex; Montgomery, Richard; Woolf, Kevin; Soverow, Jonathan; Lewis, Neil; Fragoso, Veronica; Harris, Barry; Fischer, Stuart; Mouhaffel, Assad; Saxena, Sanjeev; Gorton, Sidney; Grover-McKay, Maleah; Carr, Jeffrey; Malhotra, Vinay; Oghlakian, Gerard; Williams, Kenneth; Abraham, Jacob; Arora, Vikram; Bogaev, Roberta; Friedman, Keith; Seiler, Frederic; Forsythe, John; Abboy, Chandar; Khalid, Adnan; Isserman, Steven; Williams, Robert; Schwartz, Steven; Cotts, William; Srivastava, Sunny; Palac, Robert; Gandhi, Parul; Sharma, Sanjiv; Kim, Nomita; Nixon, William; Schneider, Preston; Saini, Satinder; Agostino, Ronald D.; Walia, Jasjit		PROVE-HF Investigators	Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	European-Society-of-Cardiology (ESC) Congress	SEP 02, 2019	Paris, FRANCE	European Soc Cardiol			LEFT-VENTRICULAR DYSFUNCTION; RESYNCHRONIZATION THERAPY; IMPROVEMENT; ENALAPRIL; PROGRESSION	Key PointsQuestionDo changes in NT-proBNP correlate with changes in cardiac structure and function in patients with heart failure with reduced ejection fraction (HFrEF) treated with sacubitril-valsartan? FindingsIn this prospective study of 794 patients with HFrEF who initiated therapy with sacubitril-valsartan, change in log(2)-NT-proBNP concentrations over 12 months correlated with changes in left ventricular (LV) ejection fraction (r=-0.381), LV end-diastolic volume index (r=0.320), LV end-systolic volume index (r=0.405), left atrial volume index (r=0.263), and ratio of early diastolic filling/early diastolic annular velocity (r=0.269). MeaningIn this exploratory analysis of patients with HFrEF treated with sacubitril-valsartan, reduction in NT-proBNP was weakly yet significantly correlated with improvements in markers of cardiac volume and function at 12 months. ImportanceIn patients with heart failure and reduced ejection fraction (HFrEF), treatment with sacubitril-valsartan reduces N-terminal pro-b-type natriuretic peptide (NT-proBNP) concentrations. The effect of sacubitril-valsartan on cardiac remodeling is uncertain. ObjectiveTo determine whether NT-proBNP changes in patients with HFrEF treated with sacubitril-valsartan correlate with changes in measures of cardiac volume and function. Design, Setting, and ParticipantsProspective, 12-month, single-group, open-label study of patients with HFrEF enrolled in 78 outpatient sites in the United States. Sacubitril-valsartan was initiated and the dose adjusted. Enrollment commenced on October 25, 2016, and follow-up was completed on October 22, 2018. ExposuresNT-proBNP concentrations among patients treated with sacubitril-valsartan. Main Outcomes and MeasuresThe primary outcome was the correlation between changes in log(2)-NT-proBNP concentrations and left ventricular (LV) EF, LV end-diastolic volume index (LVEDVI), LV end-systolic volume index (LVESVI), left atrial volume index (LAVI), and ratio of early transmitral Doppler velocity/early diastolic annular velocity (E/e) at 12 months. ResultsAmong 794 patients (mean age, 65.1 years; 226 women [28.5%]; mean LVEF=28.2%), 654 (82.4%) completed the study. The median NT-proBNP concentration at baseline was 816 pg/mL (interquartile range [IQR], 332-1822) and 455 pg/mL (IQR, 153-1090) at 12 months (difference, P<.001). At 12 months, the change in log(2)-NT-proBNP concentration was correlated with changes in LVEF (r=-0.381 [IQR, -0.448 to -0.310]; P<.001), LVEDVI (r=0.320 [IQR, 0.246 to 0.391]; P<.001), LVESVI (r=0.405 [IQR, 0.335 to 0.470]; P<.001), LAVI (r=0.263 [IQR, 0.186 to 0.338]; P<.001), and E/e (r=0.269 [IQR, 0.182 to 0.353]; P<.001). At 12 months, LVEF increased from 28.2% to 37.8% (difference, 9.4% [95% CI, 8.8% to 9.9%]; P<.001), while LVEDVI decreased from 86.93 to 74.15 mL/m(2) (difference, -12.25 mL/m(2) [IQR, -12.92 to -11.58]; P<.001) and LVESVI decreased from 61.68 to 45.46 mL/m(2) (difference, -15.29 mL/m(2) [95% CI, -16.03 to -14.55]; P<.001). LAVI and E/e ratio also decreased significantly. The most frequent adverse events were hypotension (17.6%), dizziness (16.8%), hyperkalemia (13.2%), and worsening kidney function (12.3%). Conclusions and RelevanceIn this exploratory study of patients with HFrEF treated with sacubitril-valsartan, reduction in NT-proBNP concentration was weakly yet significantly correlated with improvements in markers of cardiac volume and function at 12 months. The observedreverse cardiac remodeling may provide a mechanistic explanation for the effectsof sacubitril-valsartan in patients with HFrEF. Trial RegistrationClinicalTrials.gov Identifier: NCT02887183 This exploratory cohort study of patients with heart failure with reduced ejection fraction (HFrEF) assesses the association between change in N-terminal pro-B-type natriuretic peptide (NT-proBNP) after starting sacubitril-valsartan and changes in left ventricular ejection fraction, diastolic volume, and other measures of physiologic cardiac function.	[Januzzi, James L., Jr.; Camacho, Alexander] Massachusetts Gen Hosp, Yawkey 5984,55 Fruit St, Boston, MA 02114 USA; [Januzzi, James L., Jr.] Baim Inst Clin Res, Boston, MA 02215 USA; [Prescott, Margaret F.; McCague, Kevin; Rocha, Ricardo A.; Williamson, Kristin M.] Novartis Pharmaceut, E Hanover, NJ USA; [Butler, Javed] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Felker, G. Michael] Duke Univ, Med Ctr, Durham, NC USA; [Felker, G. Michael] Duke Clin Res Inst, Durham, NC USA; [Maisel, Alan S.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Pina, Lleana L.] Detroit Med Ctr, Detroit, MI USA; [Shah, Amil M.; Solomon, Scott D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Aslam, Ahmad] Northwest Houston Heart Ctr, Tomball, TX USA; [Vora, Kishor] Res Integr LLC, Owensboro, KY USA; [Desai, Sunil] Clin Trials Amer, Cary, NC USA; [Foucauld, Jean] Cardiol Partners Clin Res Inst, Wellington, FL USA; [Modi, Mayank] Berks Cardiologists, Wyomissing, PA USA; [Wang, David] Maryland Cardiovasc Specialists, Baltimore, MD USA; [Berk, Martin] Cardiol & Intervent Vasc Associates, Dallas, TX USA; [Martinez-Castrilon, Melvin] Infinite Clin Res, Doral, FL USA; [Kraus, David] Stern Cardiovasc Ctr, Germantown, TN USA; [Grena, Paul] Cardiol Consultants Philadelphia, Yardley, PA USA; [Sanchez, Eulogio] Cardiovasc & Vein Ctr Florida, Bradenton, FL USA; [Lloret, Ramon] Cardiovasc Ctr South Florida LLP, Miami, FL USA; [Aggarwala, Gaurav] Grace Res LLC Texas, Huntsville, TX USA; [Anglade, Moise] Cardiol Partners Clin Res Inst, Lake Worth, FL USA; [Eaves, William] Grace Res LLC Louisiana, Bossier City, LA USA; [Gianfagna, Robert] Catholic Hlth Syst Trinity Med Cardiol, Buffalo, NY USA; [Schwartz, Michael] DuPage Med Grp, Winfield, IN USA; [Joshi, Nikhil] Sherman Clin Res, Sherman, TX USA; [Galtes, Israel] Homestead Cardiac & Vein Ctr, Homestead, FL USA; [Somodevilla, Guillermo] Cordova Res Inst LLC, Miami, FL USA; [Jackson, Richard] Dominion Med Associates Inc, Richmond, VA USA; [Lewis, Gregory] Massachusetts Gen Hosp, Canc Ctr, Partners Healthcare, Boston, MA 02114 USA; [Peters, Michael] Methodist Hlth Syst Phys Clin, Omaha, NE USA; [Lupovitch, Steven] Northwest Heart Clin Res, Arlington Hts, IL USA; [Phillips, Andrea] Phillips Med Serv PLLC, Jackson, MS USA; [Chhabra, Anil] Grace Res LLC Louisiana, Shreveport, LA USA; [Perez, Guido] Biomed Res Inst, Miami, FL USA; [Venugopal, Chandra] Cardiol Partners Clin Res Inst, Belle Glade, FL USA; [Lyandres, Yuly] Premier Cardiol Consultants PLLC, Lake Success, NY USA; [King, Anthony] Borgess Med Ctr, Portage, MI USA; [Bradley, Arden] Stuart Cardiol Grp, Stuart, FL USA; [Dakour, Ramzi] DiscoveResearch Inc, Beaumont, TX USA; [Braden, Stephen] DiscoveResearch Inc, Bryan Off 2, Bryan, TX USA; [Muneer, Basharat] Fox Valley Clin Res Ctr, Aurora, IL USA; [Bart, Bradley] Hennepin Healthcare Syst Inc, Minneapolis, MN USA; [Kapadia, Shaival] Bon Secours Hlth Syst Virginia, Midlothian, VA USA; [Shah, Neerav] Cardiol Partners Clin Res Inst LLC, Palm Beach Gardens, FL USA; [Nadar, Venkatesh] Capital Area Res, Camp Hill, PA USA; [Murthy, Sandhya] Montefiore Hlth Syst Inc, Bronx, NY USA; [McFarland, Rebecca] Baptist Hlth Kentucky, Louisville, KY USA; [Steuter, John] Bryan Hlth, Lincoln, NE USA; [Iftikhar, Faizan] North Texas Res Associates, Mckinney, TX USA; [Patel, Dharmesh] Stem Cardiovasc Ctr, Germantown, TN USA; [Browning, Christine] Bon Secours Hlth Syst Virginia, Richmond, VA USA; [White, Alex] Progress Med Res, Port Orange, FL USA; [Montgomery, Richard] Triad Clin Trials LLC, Greensboro, NC USA; [Woolf, Kevin] Hillsboro Cardiol Pc, Hillsboro, OR USA; [Soverow, Jonathan] Univ Calif Los Angeles Hlth, Sylmar, CA USA; [Lewis, Neil] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Fragoso, Veronica] Texas Ctr Drug Dev, Houston, TX USA; [Harris, Barry] Integrat Res Associates Inc, Ft Lauderdale, FL USA; [Fischer, Stuart] Los Alamitos Cardiovasc, Los Alamitos, CA USA; [Mouhaffel, Assad] Clin Trials Amer, West Monroe, LA USA; [Saxena, Sanjeev] Appalachian Cardiovasc Associates, Ft Payne, AL USA; [Gorton, Sidney] Belzoni Clin Res, Belzoni, MS USA; [Grover-McKay, Maleah] HCP Clin Res LLC, DaVita, Long Beach, CA USA; [Carr, Jeffrey] Cardiovasc Associates East Texas, Tyler, TX USA; [Malhotra, Vinay] MultiCare Hlth Syst, Tacoma, WA USA; [Oghlakian, Gerard] Mercy Res & Dev Missouri, Springfield, MO USA; [Williams, Kenneth] St Agnes Med Grp, Catonsville, MD USA; [Abraham, Jacob] Providence Hlth & Serv Oregon, Portland, OR USA; [Arora, Vikram] Grandview Med Ctr, Alabama Cardiovasc Grp, Birmingham, AL USA; [Bogaev, Roberta] Adv Heart Failure Ctr Virginia, Bon Secours Hlth Syst, Richmond, VA USA; [Friedman, Keith] Johns Hopkins Hlth Syst, Columbia, MD USA; [Seiler, Frederic] St Lawrence Hlth Syst, New York, NY USA; [Forsythe, John] Cascade Phys PC, Tualatin, OR USA; [Abboy, Chandar] VitaLink Res Upstate, Greenville, SC USA; [Khalid, Adnan] Catholic Hlth Initiat Nebraska, Lincoln, NE USA; [Isserman, Steven] Clin Trials Amer, Hickory, NC USA; [Williams, Robert] Western Michigan Univ, Kalamazoo, MI 49008 USA; [Schwartz, Steven] Southern New Hampshire Hlth, Nashua, NH USA; [Cotts, William] Advocate Christ Med Ctr, Advocate Hlth Care, Oak Lawn, IL USA; [Srivastava, Sunny] Pentucket Med, Haverhill, MA USA; [Palac, Robert] White River Junct VA Med Ctr, White River Jct, VT USA; [Gandhi, Parul] VA Connecticut Healthcare, West Haven, CT USA; [Sharma, Sanjiv] Cent Cardiol Med Clin, Bakersfield, CA USA; [Kim, Nomita] Avant Res Associates LLC Texas, Austin, TX USA; [Nixon, William] Avant Res Associates LLC Alabama, Guntersville, AL USA; [Schneider, Preston] Bozeman Montana Hosp & Hlth Syst, Bozeman, MT USA; [Saini, Satinder] Avant Res Associates Louisiana, Crowley, LA USA; [Agostino, Ronald D.] Long Isl Cardiovasc Consultants, Lake Success, NY USA; [Walia, Jasjit] New Jersey Heart, Linden, NJ USA	Harvard University; Massachusetts General Hospital; Novartis; University of Mississippi; University of Mississippi Medical Center; Duke University; Duke University; University of California System; University of California San Diego; Detroit Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; University of California System; University of California Los Angeles; Hunter Holmes McGuire Veterinary Affairs Medical Center; DaVita; Western Michigan University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Januzzi, JL (corresponding author), Massachusetts Gen Hosp, Yawkey 5984,55 Fruit St, Boston, MA 02114 USA.; Januzzi, JL (corresponding author), Baim Inst Clin Res, Boston, MA 02215 USA.	JJanuzzi@partners.org	Felker, Michael/AAX-2288-2021; Januzzi, James/Y-2436-2019	Camacho, Alexander/0000-0002-8832-5744; Felker, Gary/0000-0002-5931-1239	Novartis Pharmaceuticals Inc.; Hutter Family Professorship; NHLBI [K08HL116792, R01HL135008, R01HL143224]	Novartis Pharmaceuticals Inc.; Hutter Family Professorship; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by Novartis Pharmaceuticals Inc. Dr Januzzi is supported in part by the Hutter Family Professorship. Dr Shah is supported by research grants from the NHLBI (K08HL116792, R01HL135008, and R01HL143224).	Daubert MA, 2019, JACC-HEART FAIL, V7, P158, DOI 10.1016/j.jchf.2018.10.014; Gaggin Hanna K, 2013, Congest Heart Fail, V19, P135, DOI 10.1111/chf.12016; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y; Januzzi JL, 2018, AM HEART J, V199, P130, DOI 10.1016/j.ahj.2017.12.021; Kang DH, 2019, CIRCULATION, V139, P1354, DOI 10.1161/CIRCULATIONAHA.118.037077; Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007; KONSTAM MA, 1992, CIRCULATION, V86, P431, DOI 10.1161/01.CIR.86.2.431; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; MacMahon S, 1997, LANCET, V349, P375; Martens P, 2018, CARDIOVASC THER, V36, DOI 10.1111/1755-5922.12435; Mathias A, 2016, J AM COLL CARDIOL, V68, P1268, DOI 10.1016/j.jacc.2016.06.051; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Solomon SD, 2010, CIRCULATION, V122, P985, DOI 10.1161/CIRCULATIONAHA.110.955039; Tsutamoto T, 2001, J AM COLL CARDIOL, V37, P1228, DOI 10.1016/S0735-1097(01)01116-0; Udelson JE, 2011, J AM COLL CARDIOL, V57, P1477, DOI 10.1016/j.jacc.2011.01.009; Weiner RB, 2013, EUR J HEART FAIL, V15, P342, DOI 10.1093/eurjhf/hfs180; Zile MR, 2016, J AM COLL CARDIOL, V68, P2425, DOI 10.1016/j.jacc.2016.09.931	20	261	265	2	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1085	1095		10.1001/jama.2019.12821	http://dx.doi.org/10.1001/jama.2019.12821			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	JB8LM	31475295	Green Published, Bronze			2022-12-28	WOS:000488821100021
J	Hodge, RD; Bakken, TE; Miller, JA; Smith, KA; Barkan, ER; Graybuck, LT; Close, JL; Long, B; Johansen, N; Penn, O; Yao, ZZ; Eggermont, J; Hollt, T; Levi, BP; Shehata, SI; Aevermann, B; Beller, A; Bertagnolli, D; Brouner, K; Casper, T; Cobbs, C; Dalley, R; Dee, N; Ding, SL; Ellenbogen, RG; Fong, O; Garren, E; Goldy, J; Gwinn, RP; Hirschstein, D; Keene, CD; Keshk, M; Ko, AL; Lathia, K; Mahfouz, A; Maltzer, Z; McGraw, M; Nguyen, TN; Nyhus, J; Ojemann, JG; Oldre, A; Parry, S; Reynolds, S; Rimorin, C; Shapovalova, NV; Somasundaram, S; Szafer, A; Thomsen, ER; Tieu, M; Quon, G; Scheuermann, RH; Yuste, R; Sunkin, SM; Lelieveldt, B; Feng, D; Ng, L; Bernard, A; Hawrylycz, M; Phillips, JW; Tasic, B; Zeng, HK; Jones, AR; Koch, C; Lein, ES				Hodge, Rebecca D.; Bakken, Trygve E.; Miller, Jeremy A.; Smith, Kimberly A.; Barkan, Eliza R.; Graybuck, Lucas T.; Close, Jennie L.; Long, Brian; Johansen, Nelson; Penn, Osnat; Yao, Zizhen; Eggermont, Jeroen; Hollt, Thomas; Levi, Boaz P.; Shehata, Soraya I.; Aevermann, Brian; Beller, Allison; Bertagnolli, Darren; Brouner, Krissy; Casper, Tamara; Cobbs, Charles; Dalley, Rachel; Dee, Nick; Ding, Song-Lin; Ellenbogen, Richard G.; Fong, Olivia; Garren, Emma; Goldy, Jeff; Gwinn, Ryder P.; Hirschstein, Daniel; Keene, C. Dirk; Keshk, Mohamed; Ko, Andrew L.; Lathia, Kanan; Mahfouz, Ahmed; Maltzer, Zoe; McGraw, Medea; Thuc Nghi Nguyen; Nyhus, Julie; Ojemann, Jeffrey G.; Oldre, Aaron; Parry, Sheana; Reynolds, Shannon; Rimorin, Christine; Shapovalova, Nadiya V.; Somasundaram, Saroja; Szafer, Aaron; Thomsen, Elliot R.; Tieu, Michael; Quon, Gerald; Scheuermann, Richard H.; Yuste, Rafael; Sunkin, Susan M.; Lelieveldt, Boudewijn; Feng, David; Ng, Lydia; Bernard, Amy; Hawrylycz, Michael; Phillips, John W.; Tasic, Bosiljka; Zeng, Hongkui; Jones, Allan R.; Koch, Christof; Lein, Ed S.			Conserved cell types with divergent features in human versus mouse cortex	NATURE			English	Article							LONG NONCODING RNAS; HUMAN BRAIN; SINGLE; INTERNEURONS; REVEALS; SEQ; TRANSCRIPTION; NEOCORTEX; NEURONS	Elucidating the cellular architecture of the human cerebral cortex is central to understanding our cognitive abilities and susceptibility to disease. Here we used single-nucleus RNA-sequencing analysis to perform a comprehensive study of cell types in the middle temporal gyrus of human cortex. We identified a highly diverse set of excitatory and inhibitory neuron types that are mostly sparse, with excitatory types being less layer-restricted than expected. Comparison to similar mouse cortex single-cell RNA-sequencing datasets revealed a surprisingly well-conserved cellular architecture that enables matching of homologous types and predictions of properties of human cell types. Despite this general conservation, we also found extensive differences between homologous human and mouse cell types, including marked alterations in proportions, laminar distributions, gene expression and morphology. These species-specific features emphasize the importance of directly studying human brain.	[Hodge, Rebecca D.; Bakken, Trygve E.; Miller, Jeremy A.; Smith, Kimberly A.; Barkan, Eliza R.; Graybuck, Lucas T.; Close, Jennie L.; Long, Brian; Penn, Osnat; Yao, Zizhen; Levi, Boaz P.; Shehata, Soraya I.; Bertagnolli, Darren; Brouner, Krissy; Casper, Tamara; Dalley, Rachel; Dee, Nick; Ding, Song-Lin; Fong, Olivia; Garren, Emma; Goldy, Jeff; Hirschstein, Daniel; Lathia, Kanan; Maltzer, Zoe; McGraw, Medea; Thuc Nghi Nguyen; Nyhus, Julie; Oldre, Aaron; Parry, Sheana; Reynolds, Shannon; Rimorin, Christine; Shapovalova, Nadiya V.; Somasundaram, Saroja; Szafer, Aaron; Thomsen, Elliot R.; Tieu, Michael; Sunkin, Susan M.; Feng, David; Ng, Lydia; Bernard, Amy; Hawrylycz, Michael; Phillips, John W.; Tasic, Bosiljka; Zeng, Hongkui; Jones, Allan R.; Koch, Christof; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA 98109 USA; [Johansen, Nelson; Quon, Gerald] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Eggermont, Jeroen; Hollt, Thomas; Mahfouz, Ahmed; Lelieveldt, Boudewijn] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Hollt, Thomas; Mahfouz, Ahmed; Lelieveldt, Boudewijn] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Aevermann, Brian; Keshk, Mohamed; Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA USA; [Beller, Allison; Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Cobbs, Charles] Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA USA; [Ellenbogen, Richard G.; Ko, Andrew L.; Ojemann, Jeffrey G.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Gwinn, Ryder P.] Swedish Neurosci Inst, Epilepsy Surg & Funct Neurosurg, Seattle, WA USA; [Ko, Andrew L.; Ojemann, Jeffrey G.] Harborview Med Ctr, Reg Epilepsy Ctr, Seattle, WA USA; [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Yuste, Rafael] Columbia Univ, Dept Biol Sci, Neurotechnol Ctr, New York, NY 10027 USA	Allen Institute for Brain Science; University of California System; University of California Davis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; J. Craig Venter Institute; University of Washington; University of Washington Seattle; Swedish Medical Center; University of Washington; University of Washington Seattle; Swedish Medical Center; Harborview Medical Center; University of California System; University of California San Diego; Columbia University	Lein, ES (corresponding author), Allen Inst Brain Sci, Seattle, WA 98109 USA.	edl@alleninstitute.org	Mahfouz, Ahmed/ABC-4161-2020; Bakken, Trygve E./R-4622-2017	Mahfouz, Ahmed/0000-0001-8601-2149; Bakken, Trygve E./0000-0003-3373-7386; McGraw, Medea/0000-0001-5267-489X; Reynolds, Shannon/0000-0002-8756-2625; Bernard, Amy/0000-0003-2540-1153; Quon, Gerald/0000-0002-1716-0153; Barkan, Eliza/0000-0001-7871-4327; Ding, Song-Lin/0000-0002-7072-5272; Ko, Andrew/0000-0002-6253-9891; Dee, Nick/0000-0002-2831-9254; Long, Brian/0000-0002-7793-5969; Feng, David/0000-0002-4920-8123	Allen Institute for Brain Science; US National Institutes of Health [U01 MH114812-02]; Silicon Valley Community Foundation [2018-182730]; NSF CAREER award [1846559]; NWO-AES [12721, 12720]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH114812] Funding Source: NIH RePORTER	Allen Institute for Brain Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Silicon Valley Community Foundation; NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NWO-AES; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the Tissue Procurement, Tissue Processing and Facilities teams at the Allen Institute for Brain Science for assistance with the transport and processing of postmortem and neurosurgical brain specimens; the Technology team at the Allen Institute for assistance with data management; our collaborators at the Swedish Medical Center and Harborview Medical Center in Seattle for coordinating human neurosurgical tissue collections; M. Vawter, J. Davis and the San Diego Medical Examiner's Office for assistance with postmortem tissue donations; and the Molecular Biology, Histology and Imaging teams at the Allen Institute for Brain Science for performing chromogenic in situ hybridization experiments. A. M. Yanny provided technical assistance with RNAscope experiments. This work was funded by the Allen Institute for Brain Science and by US National Institutes of Health grant U01 MH114812-02 to E.S.L. Funding from NWO-AES projects 12721: Genes in Space and 12720: VANPIR (principal investigator A. Vilanova) for development of the Cytosplore Viewer is gratefully acknowledged. We thank B. van Lew for scripting and narration of Cytosplore instructional and use-case videos. Support for the development of NS-Forest v. 2 and the provisional cell ontology was provided by the Chan-Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation (2018-182730). G.Q. is supported by NSF CAREER award 1846559. This publication is part of the Human Cell Atlas (https://www.humancellatlas.org/publications).The authors thank the Allen Institute founder, Paul G. Allen, for his vision, encouragement and support.	Aevermann BD, 2018, HUM MOL GENET, V27, pR40, DOI 10.1093/hmg/ddy100; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bakken T, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1977-1; Bakken TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209648; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; BELICHENKO PV, 1995, NEUROREPORT, V6, P1869, DOI 10.1097/00001756-199510020-00012; Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Boldog E, 2018, NAT NEUROSCI, V21, P1185, DOI 10.1038/s41593-018-0205-2; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Crow M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03282-0; de No RL, 1922, TRAB LAB BIOL U MADR, V20, P41; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ecker JR, 2017, NEURON, V96, P542, DOI 10.1016/j.neuron.2017.10.007; Eyal G, 2016, ELIFE, V5, DOI 10.7554/eLife.16553; Foley NM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0140; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gabbott PLA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00028; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hollt T, 2016, COMPUT GRAPH FORUM, V35, P171, DOI 10.1111/cgf.12893; Hollt T, 2018, IEEE T VIS COMPUT GR, V24, P739, DOI 10.1109/TVCG.2017.2744318; Johansen N, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1766-4; Kalmbach BE, 2018, NEURON, V100, P1194, DOI 10.1016/j.neuron.2018.10.012; Kilduff TS, 2011, TRENDS NEUROSCI, V34, P10, DOI 10.1016/j.tins.2010.09.005; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Lake BB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04426-w; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin Y., 2018, BIORXIV, DOI [10.1101/229815, DOI 10.1101/229815]; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Paul A, 2017, CELL, V171, P522, DOI 10.1016/j.cell.2017.08.032; Poorthuis RB, 2018, CELL REP, V23, P951, DOI 10.1016/j.celrep.2018.03.111; Raghanti MA, 2013, AM J PRIMATOL, V75, P415, DOI 10.1002/ajp.22082; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; Szegedi V, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000237; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; VonEconomo C, 2009, CELLULAR STRUCTURE OF THE HUMAN CEREBRAL CORTEX, P1; Werner MS, 2017, NAT STRUCT MOL BIOL, V24, P596, DOI 10.1038/nsmb.3424; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhu YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05882-0	67	545	551	16	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					61	+		10.1038/s41586-019-1506-7	http://dx.doi.org/10.1038/s41586-019-1506-7			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31435019	Green Accepted, Green Submitted			2022-12-28	WOS:000483967700035
J	Hondele, M; Sachdev, R; Heinrich, S; Wang, J; Vallotton, P; Fontoura, BMA; Weis, K				Hondele, Maria; Sachdev, Ruchika; Heinrich, Stephanie; Wang, Juan; Vallotton, Pascal; Fontoura, Beatriz M. A.; Weis, Karsten			DEAD-box ATPases are global regulators of phase-separated organelles	NATURE			English	Article							RNA; COMPLEX	The ability of proteins and nucleic acids to undergo liquid-liquid phase separation has recently emerged as an important molecular principle of how cells rapidly and reversibly compartmentalize their components into membrane-less organelles such as the nucleolus, processing bodies or stress granules(1,2). How the assembly and turnover of these organelles are controlled, and how these biological condensates selectively recruit or release components are poorly understood. Here we show that members of the large and highly abundant family of RNA-dependent DEAD-box ATPases (DDXs)(3) are regulators of RNA-containing phase-separated organelles in prokaryotes and eukaryotes. Using in vitro reconstitution and in vivo experiments, we demonstrate that DDXs promote phase separation in their ATP-bound form, whereas ATP hydrolysis induces compartment turnover and release of RNA. This mechanism of membrane-less organelle regulation reveals a principle of cellular organization that is conserved from bacteria to humans. Furthermore, we show that DDXs control RNA flux into and out of phase-separated organelles, and thus propose that a cellular network of dynamic, DDX-controlled compartments establishes biochemical reaction centres that provide cells with spatial and temporal control of various RNA-processing steps, which could regulate the composition and fate of ribonucleoprotein particles.	[Hondele, Maria; Sachdev, Ruchika; Heinrich, Stephanie; Vallotton, Pascal; Weis, Karsten] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Wang, Juan; Fontoura, Beatriz M. A.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Texas System; University of Texas Southwestern Medical Center Dallas	Weis, K (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	karsten.weis@bc.biol.ethz.ch	Heinrich, Stephanie/AAL-1508-2020; Vallotton, Pascal/A-3633-2009	Heinrich, Stephanie/0000-0003-1607-4525; Vallotton, Pascal/0000-0002-0795-8719; Hondele, Maria/0000-0002-2733-2561	Human Frontier Science Program (HFSP) postdoctoral fellowship [LT000914/2015]; ETH postdoctoral fellowship [FEL-37-14-2]; EMBO long-term fellowship [ALTF 290-2014, EMBOCOFUND2012, GA-2012-600394, ALTF 870-2014]; Swiss National Science Foundation [SNF 31003A_179275, 31003A_159731]	Human Frontier Science Program (HFSP) postdoctoral fellowship(Human Frontier Science Program); ETH postdoctoral fellowship; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We would like to thank G. Stojanovski and M. Martinovic for technical assistance. We are grateful to A. Sachs and J. Liphardt for plasmids, S. Jonas, M. Jinek, P. Kimming, E. Dultz, S. Khawaja, C. Weber and M. Zedan for their critical reading of this manuscript, ScopeM and J. Kusch for help with microscopy, M. Linsenmeier and A. Kuffner for discussions of image and protein sequence analysis, and members of the Weis laboratory for discussions and comments. M.H. was supported by a Human Frontier Science Program (HFSP) postdoctoral fellowship (LT000914/2015) and an ETH postdoctoral fellowship (FEL-37-14-2). S.H. and M.H. acknowledge support from an EMBO long-term fellowship (ALTF 290-2014, EMBOCOFUND2012, GA-2012-600394 to S.H.; ALTF 870-2014 to M.H.). This work was supported by the Swiss National Science Foundation (SNF 31003A_179275 and 31003A_159731 to K.W.).	Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Franzmann TM, 2019, J BIOL CHEM, V294, P7128, DOI 10.1074/jbc.TM118.001190; Galganski L, 2017, NUCLEIC ACIDS RES, V45, P10350, DOI 10.1093/nar/gkx759; Gao Z., 2016, ELIFE, V5, P568; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kroschwald S., 2017, MATTERS, DOI [10.19185/MATTERS.201702000010, DOI 10.19185/MATTERS.201702000010]; Langdon E. M., 2018, SCIENCE, V157; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Mor A, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.69, 10.1038/NMICROBIOL.2016.69]; Mugler CF, 2016, ELIFE, V5, DOI 10.7554/eLife.18746; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nott TJ, 2016, NAT CHEM, V8, P570, DOI [10.1038/NCHEM.2519, 10.1038/nchem.2519]; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Ozgur S, 2015, FEBS J, V282, P850, DOI 10.1111/febs.13198; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Valentin-Vega YA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25996; Vallotton P, 2017, TRAFFIC, V18, P840, DOI 10.1111/tra.12530; Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115; Xiol J, 2014, CELL, V157, P1698, DOI 10.1016/j.cell.2014.05.018	33	151	154	5	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					144	+		10.1038/s41586-019-1502-y	http://dx.doi.org/10.1038/s41586-019-1502-y			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31435012				2022-12-28	WOS:000483967700051
J	Voelker, R				Voelker, Rebecca			First Therapy for Rare Joint Tumor Is Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					807	807						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KM0ZB	31479124				2022-12-28	WOS:000513845400002
J	Beddoe, RH; Andrews, KG; Magne, V; Cuthbertson, JD; Saska, J; Shannon-Little, AL; Shanahan, SE; Sneddon, HF; Denton, RM				Beddoe, Rhydian H.; Andrews, Keith G.; Magne, Valentin; Cuthbertson, James D.; Saska, Jan; Shannon-Little, Andrew L.; Shanahan, Stephen E.; Sneddon, Helen F.; Denton, Ross M.			Redox-neutral organocatalytic Mitsunobu reactions	SCIENCE			English	Article							NUCLEOPHILIC-SUBSTITUTION; SECONDARY ALCOHOLS; PHOSPHINE OXIDES; CATALYTIC WITTIG; HYDROXYL-GROUPS; REDUCTION; ENONES; GREEN; MILD; ACID	Nucleophilic substitution reactions of alcohols are among the most fundamental and strategically important transformations in organic chemistry. For over half a century, these reactions have been achieved by using stoichiometric, and often hazardous, reagents to activate the otherwise unreactive alcohols. Here, we demonstrate that a specially designed phosphine oxide promotes nucleophilic substitution reactions of primary and secondary alcohols in a redox-neutral catalysis manifold that produces water as the sole by-product. The scope of the catalytic coupling process encompasses a range of acidic pronucleophiles that allow stereospecific construction of carbon-oxygen and carbon-nitrogen bonds.	[Beddoe, Rhydian H.; Andrews, Keith G.; Magne, Valentin; Cuthbertson, James D.; Saska, Jan; Shannon-Little, Andrew L.; Denton, Ross M.] Univ Nottingham, Sch Chem, GlaxoSmithKline Carbon Neutral Labs Sustainable C, Nottingham NG7 2GA, England; [Shanahan, Stephen E.] Jealotts Hill Int Res Ctr, Jealotts Hill, Bracknell RG42 6EY, Berks, England; [Sneddon, Helen F.] GlaxoSmithKline, Green Chem, Med Res Ctr, Stevenage SG1 2NY, Herts, England	University of Nottingham; GlaxoSmithKline	Denton, RM (corresponding author), Univ Nottingham, Sch Chem, GlaxoSmithKline Carbon Neutral Labs Sustainable C, Nottingham NG7 2GA, England.	ross.denton@nottingham.ac.uk	Beddoe, Rhydian/X-5689-2019; Denton, Ross/D-5913-2011	Beddoe, Rhydian/0000-0002-5775-0529; Cuthbertson, James/0000-0003-3820-6816; Sneddon, Helen/0000-0003-1042-7692; Denton, Ross/0000-0003-1267-1971; Andrews, Keith/0000-0002-0886-0246; Shannon-Little, Andrew/0000-0003-3305-6361	EPSRC [EP/R030693/1, EP/L015633/1]; Leverhulme Trust [RPG-2014-190]; Syngenta; GlaxoSmithKline; School of Chemistry, University of Nottingham; EPSRC [EP/S035990/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Syngenta(Syngenta); GlaxoSmithKline(GlaxoSmithKline); School of Chemistry, University of Nottingham; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge funding from the EPSRC (grants EP/R030693/1 and EP/L015633/1), the Leverhulme Trust (RPG-2014-190), Syngenta, GlaxoSmithKline, and The School of Chemistry, University of Nottingham.	Akai S, 2010, ORG LETT, V12, P4900, DOI 10.1021/ol102053a; An J, 2014, ORG BIOMOL CHEM, V12, P2993, DOI 10.1039/c4ob00032c; ANGELOV CM, 1988, PHOSPHORUS SULFUR, V37, P125, DOI 10.1080/03086648808079026; Bates RW, 2003, SYNTHETIC COMMUN, V33, P633, DOI 10.1081/SCC-120015819; Becerra-Figueroa L, 2014, J ORG CHEM, V79, P4544, DOI 10.1021/jo500562w; Beddoe RH, 2018, ORG BIOMOL CHEM, V16, P7774, DOI 10.1039/c8ob01929k; Brown JR, 2011, BIOORGAN MED CHEM, V19, P5585, DOI 10.1016/j.bmc.2011.07.034; Bunrit A, 2015, J AM CHEM SOC, V137, P4646, DOI 10.1021/jacs.5b02013; Buonomo JA, 2015, ANGEW CHEM INT EDIT, V54, P13041, DOI 10.1002/anie.201506263; CAPRETTA A, 1993, CAN J CHEM, V71, P96, DOI 10.1139/v93-014; Caputo CB, 2013, SCIENCE, V341, P1374, DOI 10.1126/science.1241764; CASTRO BR, 1983, ORG REACTIONS, V29, P1; Chatterjee S, 2014, J ORG CHEM, V79, P8067, DOI 10.1021/jo5012575; Chen XN, 2014, ORG LETT, V16, P3912, DOI 10.1021/ol501648a; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Constable DJC, 2002, GREEN CHEM, V4, P521, DOI 10.1039/b206169b; Corominas A, 2013, SYNTHETIC COMMUN, V43, P2062, DOI 10.1080/00397911.2012.686003; Curzons AD, 2001, GREEN CHEM, V3, P1, DOI 10.1039/b007871i; Davey S, 2013, NAT CHEM, V5, P355, DOI 10.1038/nchem.1629; Denton RM, 2011, J ORG CHEM, V76, P6749, DOI 10.1021/jo201085r; Dhakal B, 2017, J ORG CHEM, V82, P9263, DOI 10.1021/acs.joc.7b01850; Doni E, 2013, J AM CHEM SOC, V135, P10934, DOI 10.1021/ja4050168; Dryzhakov M, 2016, SYNTHESIS-STUTTGART, V48, P935, DOI 10.1055/s-0035-1560396; Dunn NL, 2012, J AM CHEM SOC, V134, P11330, DOI 10.1021/ja302963p; EGGERT H, 1976, J ORG CHEM, V41, P71, DOI 10.1021/jo00863a016; FEIXAS J, 1994, TETRAHEDRON, V50, P8539, DOI 10.1016/S0040-4020(01)85572-1; Gaunt MJ, 1998, J ORG CHEM, V63, P4172, DOI 10.1021/jo980823v; Giovanelli E, 2006, TETRAHEDRON LETT, V47, P8457, DOI 10.1016/j.tetlet.2006.09.148; Gopinath R, 2003, J ORG CHEM, V68, P2944, DOI 10.1021/jo0266902; Guo HC, 2018, CHEM REV, V118, P10049, DOI 10.1021/acs.chemrev.8b00081; Guo J, 2012, SYNLETT, P1696, DOI 10.1055/s-0031-1290406; Hamid MHSA, 2009, J AM CHEM SOC, V131, P1766, DOI 10.1021/ja807323a; He P, 2012, ORG LETT, V14, P5134, DOI 10.1021/ol302430h; HELLWINKEL D, 1978, CHEM BER-RECL, V111, P13, DOI 10.1002/cber.19781110103; Hilton MC, 2018, SCIENCE, V362, P799, DOI 10.1126/science.aas8961; Hirose D, 2016, CHEM SCI, V7, P5148, DOI 10.1039/c6sc00308g; Hirose D, 2016, ORG LETT, V18, P4036, DOI 10.1021/acs.orglett.6b01894; Hirose D, 2013, ANGEW CHEM INT EDIT, V52, P4613, DOI 10.1002/anie.201300153; Huy PH, 2016, SYNLETT, V27, P2631, DOI 10.1055/s-0036-1588633; Ingold C.K., 1953, STRUCTURE MECH ORGAN; Ivanova IS, 2018, RUSS J GEN CHEM+, V88, P1867, DOI 10.1134/S1070363218090177; Jin J, 2015, NATURE, V525, P87, DOI 10.1038/nature14885; Krautwald S, 2013, SCIENCE, V340, P1065, DOI 10.1126/science.1237068; Lao ZQ, 2016, BEILSTEIN J ORG CHEM, V12, P2577, DOI 10.3762/bjoc.12.253; Larrosa I, 2006, J AM CHEM SOC, V128, P14042, DOI 10.1021/ja0662671; Li D, 2010, ORG LETT, V12, P1756, DOI 10.1021/ol100365c; Li ZL, 2017, CHEMISTRYSELECT, V2, P8076, DOI 10.1002/slct.201701537; Longwitz L, 2019, PURE APPL CHEM, V91, P95, DOI 10.1515/pac-2018-0920; Lorenz S, 2016, CHEMCATCHEM, V8, P3203, DOI 10.1002/cctc.201600755; Marcyk PT, 2019, ANGEW CHEM INT EDIT, V58, P1727, DOI 10.1002/anie.201812894; Marsden SP, 2008, ORG LETT, V10, P2589, DOI 10.1021/ol800921n; Martin-Matute B, 2005, J AM CHEM SOC, V127, P8817, DOI 10.1021/ja051576x; MITSUNOBU O, 1967, B CHEM SOC JPN, V40, P2380, DOI 10.1246/bcsj.40.2380; MITSUNOBU O, 1981, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-1981-29317; Nacsa ED, 2013, ORG LETT, V15, P38, DOI 10.1021/ol302970c; Nagasawa S, 2017, CHEM-EUR J, V23, P10276, DOI 10.1002/chem.201702512; Nawrat CC, 2015, J AM CHEM SOC, V137, P11270, DOI 10.1021/jacs.5b07678; Nishiyama T, 1999, CAN J CHEM, V77, P258, DOI 10.1139/cjc-77-2-258; Nykaza TV, 2017, J AM CHEM SOC, V139, P6839, DOI 10.1021/jacs.7b03260; Ohtsuka Y, 1997, B CHEM SOC JPN, V70, P483, DOI 10.1246/bcsj.70.483; Pavan MP, 2009, EUR J ORG CHEM, V2009, P5927, DOI 10.1002/ejoc.200900865; Powell DA, 2004, J AM CHEM SOC, V126, P7788, DOI 10.1021/ja047433c; Pronin SV, 2013, NATURE, V501, P195, DOI 10.1038/nature12472; Pulis AP, 2013, J AM CHEM SOC, V135, P16054, DOI 10.1021/ja409100y; Renard PY, 2003, ANGEW CHEM INT EDIT, V42, P2389, DOI 10.1002/anie.200250270; Schiwek CH, 2018, CHEM COMMUN, V54, P9139, DOI 10.1039/c8cc05172k; Sibbald PA, 2009, ORG LETT, V11, P1147, DOI 10.1021/ol9000087; Stankevic M, 2013, TETRAHEDRON, V69, P73, DOI 10.1016/j.tet.2012.10.064; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Sundararaju B, 2012, CHEM SOC REV, V41, P4467, DOI 10.1039/c2cs35024f; Swamy KCK, 2009, CHEM REV, V109, P2551, DOI 10.1021/cr800278z; But TYS, 2006, J AM CHEM SOC, V128, P9636, DOI 10.1021/ja063141v; Tang XP, 2014, CHEM COMMUN, V50, P7340, DOI 10.1039/c4cc02171a; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Wang ZX, 1997, J AM CHEM SOC, V119, P11224, DOI 10.1021/ja972272g; Watson AJA, 2010, SCIENCE, V329, P635, DOI 10.1126/science.1191843; Wee AGH, 2003, TETRAHEDRON-ASYMMETR, V14, P897, DOI 10.1016/S0957-4166(03)00079-X; Wu LP, 2016, CHEM-US, V1, P32, DOI 10.1016/j.chempr.2016.05.002; Yan T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6602; YE MC, 1988, PHOSPHORUS SULFUR, V39, P79, DOI 10.1080/03086648808072858	80	91	91	7	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					910	+		10.1126/science.aax3353	http://dx.doi.org/10.1126/science.aax3353			204	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467220	Green Accepted			2022-12-28	WOS:000483975800044
J	Dyer, C				Dyer, Clare			NHS pensions: law firm invites doctors forced to join 2015 scheme to join claim against government	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4510	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2019	366								l5307	10.1136/bmj.l5307	http://dx.doi.org/10.1136/bmj.l5307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HJ	31462449				2022-12-28	WOS:000483891600009
J	Gerada, C				Gerada, Clare			Clare Gerada: Preventing suicide in medical staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net						Gerada C., 2018, BMJ OPINION	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2019	366								l5231	10.1136/bmj.l5231	http://dx.doi.org/10.1136/bmj.l5231			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HE	31455600				2022-12-28	WOS:000483891100002
J	Witiw, CD; O'Toole, JE				Witiw, Christopher D.; O'Toole, John E.			Electric shocks and weakness of the right hand in a young man: Hirayama disease	LANCET			English	Editorial Material									[Witiw, Christopher D.; O'Toole, John E.] Rush Univ, Med Ctr, Dept Neurol Surg, Chicago, IL 60612 USA	Rush University	O'Toole, JE (corresponding author), Rush Univ, Med Ctr, Dept Neurol Surg, Chicago, IL 60612 USA.	john_otoole@rush.edu							0	3	3	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					684	684		10.1016/S0140-6736(19)31784-2	http://dx.doi.org/10.1016/S0140-6736(19)31784-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UU	31448739				2022-12-28	WOS:000483011200032
J	English, MA; Soenksen, LR; Gayet, RV; de Puig, H; Angenent-Mari, NM; Mao, AS; Nguyen, PQ; Collins, JJ				English, Max A.; Soenksen, Luis R.; Gayet, Raphael V.; de Puig, Helena; Angenent-Mari, Nicolaas M.; Mao, Angelo S.; Nguyen, Peter Q.; Collins, James J.			Programmable CRISPR-responsive smart materials	SCIENCE			English	Article							NUCLEIC-ACID DETECTION; DNA HYDROGEL; PLATFORM; APTAMER; CONDUCTIVITY; RESISTANCE; GRAPHENE; RELEASE	Stimuli-responsive materials activated by biological signals play an increasingly important role in biotechnology applications. We exploit the programmability of CRISPR-associated nucleases to actuate hydrogels containing DNA as a structural element or as an anchor for pendant groups. After activation by guide RNA-defined inputs, Cas12a cleaves DNA in the gels, thereby converting biological information into changes in material properties. We report four applications: (i) branched poly(ethylene glycol) hydrogels releasing DNA-anchored compounds, (ii) degradable polyacrylamide-DNA hydrogels encapsulating nanoparticles and live cells, (iii) conductive carbon-black-DNA hydrogels acting as degradable electrical fuses, and (iv) a polyacrylamide-DNA hydrogel operating as a fluidic valve with an electrical readout for remote signaling. These materials allow for a range of in vitro applications in tissue engineering, bioelectronics, and diagnostics.	[English, Max A.; Gayet, Raphael V.; Angenent-Mari, Nicolaas M.; Collins, James J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [English, Max A.; Soenksen, Luis R.; Gayet, Raphael V.; de Puig, Helena; Angenent-Mari, Nicolaas M.; Mao, Angelo S.; Collins, James J.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Soenksen, Luis R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Soenksen, Luis R.; de Puig, Helena; Angenent-Mari, Nicolaas M.; Mao, Angelo S.; Nguyen, Peter Q.; Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Gayet, Raphael V.] MIT, Microbiol Grad Program, Cambridge, MA 02139 USA; [Mao, Angelo S.; Nguyen, Peter Q.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Collins, James J.] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Collins, James J.] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Collins, James J.] Harvard Program MIT Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Collins, JJ (corresponding author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA.; Collins, JJ (corresponding author), Harvard Program MIT Hlth Sci & Technol, Cambridge, MA 02139 USA.	jimjc@mit.edu		Angenent-Mari, Nicolaas/0000-0001-5993-0091; Soenksen, Luis Ruben/0000-0001-7890-7209; English, Max/0000-0001-6238-6920; /0000-0002-5368-6996; Nguyen, Peter/0000-0002-0935-6404; Gayet, Raphael/0000-0001-6857-5941	Defense Threat Reduction Agency [HDTRA1-14-1-0006]; Paul G. Allen Frontiers Group; Wyss Institute for Biologically Inspired Engineering, Harvard University; CONACyT [342369/408970]; MIT-TATA Center fellowship [2748460]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Paul G. Allen Frontiers Group; Wyss Institute for Biologically Inspired Engineering, Harvard University; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MIT-TATA Center fellowship	This work was supported by the Defense Threat Reduction Agency (grant HDTRA1-14-1-0006), the Paul G. Allen Frontiers Group, and the Wyss Institute for Biologically Inspired Engineering, Harvard University (J.J.C., L.R.S., H.P., A.S.M.). L.R.S. was also supported by CONACyT (grant 342369/408970), and N.M.A-.M. was supported by an MIT-TATA Center fellowship (2748460).	ARTHUR M, 1990, ANTIMICROB AGENTS CH, V34, P2024, DOI 10.1128/AAC.34.10.2024; Badu-Tawiah AK, 2015, LAB CHIP, V15, P655, DOI 10.1039/c4lc01239a; Barker K, 2016, J BIOMAT SCI-POLYM E, V27, P22, DOI 10.1080/09205063.2015.1103590; Cai W, 2017, BIOSENS BIOELECTRON, V98, P466, DOI 10.1016/j.bios.2017.07.025; Cangialosi A, 2017, SCIENCE, V357, P1126, DOI 10.1126/science.aan3925; Chang YY, 2018, ANAL CHEM, V90, P8241, DOI 10.1021/acs.analchem.8b01766; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Ding SY, 2016, NAT REV MATER, V1, DOI [10.1038/natrevmats.2016.71, 10.1038/natrevmats.2016.21]; Fu E, 2010, LAB CHIP, V10, P918, DOI 10.1039/b919614e; Gao M, 2011, SOFT MATTER, V7, P1741, DOI 10.1039/c0sm00915f; Gjorevski N, 2016, NATURE, V539, P359, DOI 10.1038/nature20168; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hajian R, 2019, NAT BIOMED ENG, V3, P427, DOI 10.1038/s41551-019-0371-x; He Y, 2015, RSC ADV, V5, P78109, DOI 10.1039/c5ra09188h; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Kahn JS, 2015, NANO LETT, V15, P7773, DOI 10.1021/acs.nanolett.5b04101; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Lee HH, 2005, NANOTECHNOLOGY, V16, P2436, DOI 10.1088/0957-4484/16/10/074; Li SY, 2018, CELL RES, V28, P491, DOI 10.1038/s41422-018-0022-x; Li SH, 2013, BIOMATERIALS, V34, P460, DOI 10.1016/j.biomaterials.2012.09.040; Lin DC, 2004, J BIOMECH ENG-T ASME, V126, P104, DOI 10.1115/1.1645529; Liu BW, 2016, CURR OPIN COLLOID IN, V26, P41, DOI 10.1016/j.cocis.2016.09.001; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Ma XZ, 2017, ACS APPL MATER INTER, V9, P1995, DOI 10.1021/acsami.6b12327; Magro L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00758-9; Manohar S, 2008, NANO LETT, V8, P4365, DOI 10.1021/nl8022143; Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663; Na W, 2018, BIOSENS BIOELECTRON, V108, P9, DOI 10.1016/j.bios.2018.02.040; Okolie CE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0490-9; Parant H, 2017, CARBON, V119, P10, DOI 10.1016/j.carbon.2017.04.014; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Pawlyta M, 2015, CARBON, V84, P479, DOI 10.1016/j.carbon.2014.12.030; Previtera ML, 2014, JOVE-J VIS EXP, V90; Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/NMAT3922, 10.1038/nmat3922]; Qin M, 2018, ADV MATER, V30, DOI 10.1002/adma.201800468; Qureshi NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085873; Rosales AM, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.12; Sicilia G, 2014, BIOMATER SCI-UK, V2, P203, DOI 10.1039/c3bm60126a; Spahr M.E., 2016, POLYM POLYM COMPOSIT; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Sugimoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20485-z; Sun L, 2016, J AM CHEM SOC, V138, P14772, DOI 10.1021/jacs.6b09345; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Venkatesh S, 2009, BIOCONJUGATE CHEM, V20, P1773, DOI 10.1021/bc900187b; Wang KW, 2018, MACROMOLECULES, V51, P9758, DOI 10.1021/acs.macromol.8b01505; Wei B, 2008, ANGEW CHEM INT EDIT, V47, P331, DOI 10.1002/anie.200704143; Wei XF, 2015, ANAL CHEM, V87, P4275, DOI 10.1021/acs.analchem.5b00532; Xing YZ, 2011, ADV MATER, V23, P1117, DOI 10.1002/adma.201003343; Xu YX, 2010, ACS NANO, V4, P7358, DOI 10.1021/nn1027104; Xu YX, 2010, ACS NANO, V4, P4324, DOI 10.1021/nn101187z; Yang HH, 2008, J AM CHEM SOC, V130, P6320, DOI 10.1021/ja801339w; Zhu Z, 2010, ANGEW CHEM INT EDIT, V49, P1052, DOI 10.1002/anie.200905570	55	165	171	106	660	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		780	+		10.1126/science.aaw5122	http://dx.doi.org/10.1126/science.aaw5122			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439791	Green Published			2022-12-28	WOS:000482464000046
J	Gonzalez, WG; Zhang, HW; Harutyunyan, A; Lois, C				Gonzalez, Walter G.; Zhang, Hanwen; Harutyunyan, Anna; Lois, Carlos			Persistence of neuronal representations through time and damage in the hippocampus	SCIENCE			English	Article							CELL ASSEMBLIES; MEMORY; DYNAMICS; EXPERIENCE; MOUSE	How do neurons encode long-term memories? Bilateral imaging of neuronal activity in the mouse hippocampus reveals that, from one day to the next, similar to 40% of neurons change their responsiveness to cues, but thereafter only 1% of cells change per day. Despite these changes. neuronal responses are resilient to a lack of exposure to a previously completed task or to hippocampus lesions. Unlike individual neurons, the responses of which change after a few days, groups of neurons with inter- and intrahemispheric synchronous activity show stable responses for several weeks. The likelihood that a neuron maintains its responsiveness across days is proportional to the number of neurons with which its activity is synchronous. Information stored in individual neurons is relatively labile, but it can be reliably stored in networks of synchronously active neurons.	[Gonzalez, Walter G.; Zhang, Hanwen; Harutyunyan, Anna; Lois, Carlos] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Lois, C (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	clois@caltech.edu		Gonzalez, Walter/0000-0003-1310-9323; Harutyunyan, Anna/0000-0002-6165-5639; Zhang, Hanwen/0000-0001-7609-2122	American Heart Association [17POST33670151]; Della Martin Foundation; Burroughs Wellcome Fund PDEP [1016194, 1018228]; CASI awards; National Institute of Neurological Disorders and Stroke [R01NS104925]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS104925] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Della Martin Foundation; Burroughs Wellcome Fund PDEP(Burroughs Wellcome Fund); CASI awards; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	W.G.G. was supported by the American Heart Association (grant 17POST33670151), the Della Martin Foundation, and the Burroughs Wellcome Fund PDEP (grants 1016194 and 1018228) and CASI awards. The project was funded by the National Institute of Neurological Disorders and Stroke (grant R01NS104925 to C.L.).	Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Ben-Shaul Y, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0377-3; Billeh YN, 2014, J NEUROSCI METH, V236, P92, DOI 10.1016/j.jneumeth.2014.08.011; Boehringer R, 2017, NEURON, V94, P642, DOI 10.1016/j.neuron.2017.04.014; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gonzalez W., 2019, PERSISTENCE NEURONAL, DOI [10.22002/d1.1229, DOI 10.22002/D1.1229]; Hainmueller T, 2018, NATURE, V558, P292, DOI 10.1038/s41586-018-0191-2; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hebb Donald O., 1949, ORG BEHAV; Kay K, 2016, NATURE, V531, P185, DOI 10.1038/nature17144; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kinsky NR, 2018, CURR BIOL, V28, P3578, DOI 10.1016/j.cub.2018.09.037; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Liberti WA, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6806; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Mankin EA, 2015, NEURON, V85, P190, DOI 10.1016/j.neuron.2014.12.001; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sheintuch L, 2017, CELL REP, V21, P1102, DOI 10.1016/j.celrep.2017.10.013; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Tanaka KZ, 2018, SCIENCE, V361, P392, DOI 10.1126/science.aat5397; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zaremba JD, 2017, NAT NEUROSCI, V20, P1612, DOI 10.1038/nn.4634; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhou P, 2018, ELIFE, V7, DOI 10.7554/eLife.28728; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	36	40	41	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		821	+		10.1126/science.aav9199	http://dx.doi.org/10.1126/science.aav9199			65	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439798	Green Accepted, Green Submitted			2022-12-28	WOS:000482464000054
J	Dong, MB; Wang, GC; Chow, RD; Ye, LP; Zhu, LY; Dai, XY; Park, JJ; Kim, HR; Errami, Y; Guzman, CD; Zhou, XY; Chen, KY; Renauer, PA; Du, YY; Shen, J; Lam, SZ; Zhou, JJ; Lannin, DR; Herbst, RS; Chen, S				Dong, Matthew B.; Wang, Guangchuan; Chow, Ryan D.; Ye, Lupeng; Zhu, Lvyun; Dai, Xiaoyun; Park, Jonathan J.; Kim, Hyunu R.; Errami, Youssef; Guzman, Christopher D.; Zhou, Xiaoyu; Chen, Krista Y.; Renauer, Paul A.; Du, Yaying; Shen, Johanna; Lam, Stanley Z.; Zhou, Jingjia J.; Lannin, Donald R.; Herbst, Roy S.; Chen, Sidi			Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells	CELL			English	Article							CANCER-IMMUNOTHERAPY; FUNCTIONAL GENOMICS; IMMUNE CHECKPOINTS; RNA; EXPRESSION; CAR; IDENTIFICATION; TRANSCRIPTION; DETERMINANTS; TECHNOLOGIES	CD8 T cells play essential roles in anti-tumor immune responses. Here, we performed genome-scale CRISPR screens in CD8 T cells directly under cancer immunotherapy settings and identified regulators of tumor infiltration and degranulation. The in vivo screen robustly re-identified canonical immunotherapy targets such as PD-1 and Tim-3, along with genes that have not been characterized in T cells. The infiltration and degranulation screens converged on an RNA helicase Dhx37. Dhx37 knockout enhanced the efficacy of antigen-specific CD8 T cells against triple-negative breast cancer in vivo. Immunological characterization in mouse and human CD8 T cells revealed that DHX37 suppresses effector functions, cytokine production, and T cell activation. Transcriptomic profiling and biochemical interrogation revealed a role for DHX37 in modulating NF-kappa B. These data demonstrate high-throughput in vivo genetic screens for immunotherapy target discovery and establishes DHX37 as a functional regulator of CD8 T cells.	[Dong, Matthew B.; Wang, Guangchuan; Chow, Ryan D.; Ye, Lupeng; Zhu, Lvyun; Dai, Xiaoyun; Park, Jonathan J.; Kim, Hyunu R.; Errami, Youssef; Guzman, Christopher D.; Zhou, Xiaoyu; Chen, Krista Y.; Renauer, Paul A.; Du, Yaying; Shen, Johanna; Lam, Stanley Z.; Zhou, Jingjia J.; Chen, Sidi] Yale Univ, Dept Genet, Sch Med, 333 Cedar St, New Haven, CT 06520 USA; [Dong, Matthew B.; Wang, Guangchuan; Chow, Ryan D.; Ye, Lupeng; Zhu, Lvyun; Dai, Xiaoyun; Park, Jonathan J.; Kim, Hyunu R.; Errami, Youssef; Guzman, Christopher D.; Zhou, Xiaoyu; Chen, Krista Y.; Renauer, Paul A.; Du, Yaying; Shen, Johanna; Lam, Stanley Z.; Zhou, Jingjia J.; Chen, Sidi] Yale Univ, Integrated Sci & Technol Ctr, Syst Biol Inst, 850 W Campus Dr, West Haven, CT 06516 USA; [Dong, Matthew B.; Wang, Guangchuan; Chow, Ryan D.; Ye, Lupeng; Zhu, Lvyun; Dai, Xiaoyun; Park, Jonathan J.; Kim, Hyunu R.; Errami, Youssef; Guzman, Christopher D.; Zhou, Xiaoyu; Chen, Krista Y.; Renauer, Paul A.; Du, Yaying; Shen, Johanna; Lam, Stanley Z.; Zhou, Jingjia J.; Chen, Sidi] Yale Univ, Ctr Canc Syst Biol, Integrated Sci & Technol Ctr, 850 W Campus Dr, West Haven, CT 06516 USA; [Dong, Matthew B.; Chow, Ryan D.; Park, Jonathan J.; Chen, Sidi] Yale Univ, Sch Med, Yale MD PhD Program, 333 Cedar St, New Haven, CT 06510 USA; [Dong, Matthew B.; Guzman, Christopher D.; Chen, Sidi] Yale Univ, Sch Med, Immunobiol Program, 333 Cedar St, New Haven, CT 06510 USA; [Dong, Matthew B.; Guzman, Christopher D.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA; [Guzman, Christopher D.; Renauer, Paul A.; Chen, Sidi] Yale Univ, Combined Program Biol & Biomed Sci, Sch Med, 333 Cedar St, New Haven, CT 06510 USA; [Chen, Krista Y.; Shen, Johanna; Lam, Stanley Z.; Zhou, Jingjia J.] Yale Univ, The Coll, New Haven, CT 06520 USA; [Lannin, Donald R.] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Lannin, Donald R.] Yale Univ, Sch Med, Breast Canc Program, 333 Cedar St, New Haven, CT 06510 USA; [Herbst, Roy S.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Herbst, Roy S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lannin, Donald R.; Herbst, Roy S.] Smilow Canc Hosp, 35 Pk St, New Haven, CT 06510 USA; [Lannin, Donald R.; Herbst, Roy S.; Chen, Sidi] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Yale Liver Ctr, 333 Cedar St, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Yale Ctr Biomed Data Sci, 333 Cedar St, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Chen, S (corresponding author), Yale Univ, Dept Genet, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.; Chen, S (corresponding author), Yale Univ, Integrated Sci & Technol Ctr, Syst Biol Inst, 850 W Campus Dr, West Haven, CT 06516 USA.; Chen, S (corresponding author), Yale Univ, Ctr Canc Syst Biol, Integrated Sci & Technol Ctr, 850 W Campus Dr, West Haven, CT 06516 USA.; Chen, S (corresponding author), Yale Univ, Sch Med, Yale MD PhD Program, 333 Cedar St, New Haven, CT 06510 USA.; Chen, S (corresponding author), Yale Univ, Sch Med, Immunobiol Program, 333 Cedar St, New Haven, CT 06510 USA.; Chen, S (corresponding author), Yale Univ, Combined Program Biol & Biomed Sci, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.; Chen, S (corresponding author), Yale Univ, Sch Med, Yale Comprehens Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA.; Chen, S (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06510 USA.; Chen, S (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06510 USA.; Chen, S (corresponding author), Yale Univ, Sch Med, Yale Liver Ctr, 333 Cedar St, New Haven, CT 06510 USA.; Chen, S (corresponding author), Yale Univ, Sch Med, Yale Ctr Biomed Data Sci, 333 Cedar St, New Haven, CT 06510 USA.	sidi.chen@yale.edu	Wang, Guangchuan/AAK-6197-2021; CHEN, SIDI/D-8284-2016; Zhu, Lv-yun/Y-5105-2019; Chow, Ryan/ABF-1119-2021	CHEN, SIDI/0000-0002-3819-5005; Zhu, Lv-yun/0000-0003-2288-5981; Chow, Ryan/0000-0002-1872-6307; Errami, Youssef/0000-0002-0432-4331; Ye, Lupeng/0000-0003-3901-6598; Park, Jonathan/0000-0001-5887-3953; ZHOU, XIAOYU/0000-0002-2304-4191; Zhou, Jingjia/0000-0001-7125-0259; Chen, Krista/0000-0003-4324-1747; Du, Yaying/0000-0002-3213-5722	Yale SBI/Genetics Startup Fund; NIH/NCI [DP2CA238295-01, R01CA231112-01, R33CA225498-01A1, RF1DA048811, U54CA209992-8697, P50CA196530-A10805, P50CA121974-A08306]; Damon Runyon Dale Frey Award [DFS-13-15]; Melanoma Research Alliance [412806, 16-003524]; St-Baldrick's Foundation [426685]; Breast Cancer Alliance; Cancer Research Institute (CLIP); AACR [499395, 17-20-01-CHEN]; Mary Kay Foundation [01781]; V Foundation [V2017-022]; Ludwig Family Foundation; DoD [W81XWH-17-1-0235]; Sontag Foundation (Chen DSA); Chenevert Family Foundation; Yale SPORE in Lung Cancer [P50CA196530]; Yale MSTP training grant from NIH [T32GM007205]; Yale PhD training grant from NIH [T32GM007499]; CRI Irvington Postdoctoral Fellowship; RJ Anderson Postdoctoral Fellowship; C Revson Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA225498, R01CA231112, DP2CA238295, U54CA209992, P50CA196530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499, T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RF1DA048811] Funding Source: NIH RePORTER	Yale SBI/Genetics Startup Fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Dale Frey Award; Melanoma Research Alliance; St-Baldrick's Foundation; Breast Cancer Alliance; Cancer Research Institute (CLIP); AACR; Mary Kay Foundation; V Foundation; Ludwig Family Foundation; DoD(United States Department of Defense); Sontag Foundation (Chen DSA); Chenevert Family Foundation; Yale SPORE in Lung Cancer; Yale MSTP training grant from NIH; Yale PhD training grant from NIH; CRI Irvington Postdoctoral Fellowship; RJ Anderson Postdoctoral Fellowship; C Revson Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the Chen laboratory, as well as various colleagues in the Department of Genetics, Systems Biology Institute, Immunobiology Program, BBS Program, Cancer Center and Stem Cell Center at Yale for assistance and/or discussion. We thank the Center for Genome Analysis, Center for Molecular Discovery, Pathology Tissue Services, Histology Services, High Performance Computing Center, West Campus Analytical Chemistry Core and West Campus Imaging Core, and Keck Biotechnology Resource Laboratory at Yale for technical support. S.C. is supported by Yale SBI/Genetics Startup Fund, NIH/NCI (DP2CA238295-01, R01CA231112-01, R33CA225498-01A1, RF1DA048811, U54CA209992-8697, P50CA196530-A10805, P50CA121974-A08306), Damon Runyon Dale Frey Award (DFS-13-15), Melanoma Research Alliance (412806, 16-003524), St-Baldrick's Foundation (426685), Breast Cancer Alliance, Cancer Research Institute (CLIP), AACR (499395, 17-20-01-CHEN), The Mary Kay Foundation (01781), The V Foundation (V2017-022), Ludwig Family Foundation, DoD (W81XWH-17-1-0235), Sontag Foundation (Chen DSA), and Chenevert Family Foundation. R.S.H. is supported by Yale SPORE in Lung Cancer (P50CA196530). M.B.D., R.D.C., and J.J.P. are supported by the Yale MSTP training grant from NIH (T32GM007205). C.D.G. and P.R. are supported by Yale PhD training grant from NIH (T32GM007499). G.W. is supported by CRI Irvington and RJ Anderson Postdoctoral Fellowships. X.D. is supported by a C Revson Postdoctoral Fellowship.	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Beil-Wagner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21377; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Chia J, 2009, P NATL ACAD SCI USA, V106, P9809, DOI 10.1073/pnas.0903815106; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Clementi R, 2005, BLOOD, V105, P4424, DOI 10.1182/blood-2004-04-1477; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox MA, 2011, TRENDS IMMUNOL, V32, P180, DOI 10.1016/j.it.2011.01.004; Dai XY, 2019, NAT METHODS, V16, P247, DOI 10.1038/s41592-019-0329-7; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dumontet E, 2015, J CLIN IMMUNOL, V35, P692, DOI 10.1007/s10875-015-0213-x; Esensten JH, 2017, ANNU REV PATHOL-MECH, V12, P305, DOI 10.1146/annurev-pathol-052016-100304; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Ghoneim HE, 2016, TRENDS MOL MED, V22, P1000, DOI 10.1016/j.molmed.2016.10.002; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gravano DM, 2013, J AUTOIMMUN, V45, P68, DOI 10.1016/j.jaut.2013.06.004; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hirata H, 2013, J NEUROSCI, V33, P14638, DOI 10.1523/JNEUROSCI.1157-13.2013; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jackson HJ, 2016, NAT REV CLIN ONCOL, V13, P370, DOI 10.1038/nrclinonc.2016.36; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson LA, 2017, CELL RES, V27, P38, DOI 10.1038/cr.2016.154; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Kelderman S, 2014, MOL ONCOL, V8, P1132, DOI 10.1016/j.molonc.2014.07.011; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kurktschiev PD, 2014, J EXP MED, V211, P2047, DOI 10.1084/jem.20131333; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Laumont CM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau5516; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lun Aaron T L, 2016, F1000Res, V5, P2122; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2016, CLIN CANCER RES, V22, P1875, DOI 10.1158/1078-0432.CCR-15-1433; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mortaz E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00365; Nijman SMB, 2015, NAT CHEM BIOL, V11, P942, DOI 10.1038/nchembio.1963; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Restifo NP, 2016, NAT REV CANCER, V16, P121, DOI 10.1038/nrc.2016.2; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Roychowdhury A., 2019, NUCLEIC ACIDS RES; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharon E, 2014, CHIN J CANCER, V33, P434, DOI 10.5732/cjc.014.10122; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Srivastava S, 2015, TRENDS IMMUNOL, V36, P494, DOI 10.1016/j.it.2015.06.004; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swart M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00233; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tsantikos E, 2009, J IMMUNOL, V183, P2484, DOI 10.4049/jimmunol.0804346; Tscharke DC, 2015, NAT REV IMMUNOL, V15, P705, DOI 10.1038/nri3905; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valori M, 2017, CLIN IMMUNOL, V175, P75, DOI 10.1016/j.clim.2016.11.018; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	109	109	112	6	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1189	+		10.1016/j.cell.2019.07.044	http://dx.doi.org/10.1016/j.cell.2019.07.044			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442407	Green Accepted, Bronze			2022-12-28	WOS:000482191000015
J	Lok, P; Dijk, S				Lok, Pat; Dijk, Stijntje			Edzard Ernst blames rise in measles on increased popularity of complementary and alternative therapies	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ernst E, 2019, COPERNICUS, DOI [10.1007/978-3-030-12601-8, DOI 10.1007/978-3-030-12601-8]; IACOBUCCI G, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3560; Johnson SB, 2018, JAMA ONCOL, V4, P1375, DOI 10.1001/jamaoncol.2018.2487; National Institute for Health and Care Excellence (NICE), 2017, PARK DIS AD; NHS, 2018, COMPLEMENTARY ALTERN; Public Health England, 2017, PHE MEASL GUID; Schmidt K, 2003, VACCINE, V21, P1044, DOI 10.1016/S0264-410X(02)00628-X; Wise J, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5219	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2019	366								l5263	10.1136/bmj.l5263	http://dx.doi.org/10.1136/bmj.l5263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DJ	31439613				2022-12-28	WOS:000482882300009
J	Iglesias, JF; Muller, O; Heg, D; Roffi, M; Kurz, DJ; Moarof, I; Weilenmann, D; Kaiser, C; Tapponnier, M; Stortecky, S; Losdat, S; Eeckhout, E; Valgimigli, M; Odutayo, A; Zwahlen, M; Juni, P; Windecker, S; Pilgrim, T				Iglesias, Juan F.; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J.; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Stortecky, Stefan; Losdat, Sylvain; Eeckhout, Eric; Valgimigli, Marco; Odutayo, Ayodele; Zwahlen, Marcel; Juni, Peter; Windecker, Stephan; Pilgrim, Thomas			Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial	LANCET			English	Article							BARE-METAL STENTS; CORONARY-ARTERY-DISEASE; OUTCOMES; THROMBOSIS; ULTRATHIN; DESIGN; THIN	Background Newer-generation drug-eluting stents that combine ultrathin strut metallic platforms with biodegradable polymers might facilitate vascular healing and improve clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (PCI) compared with contemporary thin strut second-generation drug-eluting stents. We did a randomised clinical trial to investigate the safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stents versus thin strut durable polymer everolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI. Methods The BIOSTEMI trial was an investigator-initiated, multicentre, prospective, single-blind, randomised superiority trial at ten hospitals in Switzerland. Patients aged 18 years or older with acute STEMI who were referred for primary PCI were eligible to participate. Patients were randomly allocated (1:1) to either biodegradable polymer sirolimus-eluting stents or durable polymer everolimus-eluting stents. Central randomisation was done based on a computer-generated allocation sequence with variable block sizes of 2, 4, and 6, which was stratified by centre, diabetes status, and presence or absence of multivessel coronary artery disease, and concealed using a secure web-based system. Patients and treating physicians were aware of group allocations, whereas outcome assessors were masked to the allocated stent. The experimental stent (Orsiro; Biotronik; Bulach, Switzerland) consisted of an ultrathin strut cobalt-chromium metallic stent platform releasing sirolimus from a biodegradable polymer. The control stent (Xience Xpedition/Alpine; Abbott Vascular, Abbott Park, IL, USA) consisted of a thin strut cobalt-chromium stent platform that releases everolimus from a durable polymer. The primary endpoint was target lesion failure, a composite of cardiac death, target vessel myocardial reinfarction (Q-wave and non-Q-wave), and clinically-indicated target lesion revascularisation, within 12 months of the index procedure. All analyses were done with the individual participant as the unit of analysis and according to the intention-to-treat principle. The trial was registered with ClinicalTrials.gov, number NCT02579031. Findings Between April 26, 2016, and March 9, 2018, we randomly assigned 1300 patients (1623 lesions) with acute myocardial infarction to treatment with biodegradable polymer sirolimus-eluting stents (649 patients and 816 lesions) or durable polymer everolimus-eluting stents (651 patients and 806 lesions). At 12 months, follow-up data were available for 614 (95%) patients treated with biodegradable polymer sirolimus-eluting stents and 626 (96%) patients treated with durable polymer everolimus-eluting stents. The primary composite endpoint of target lesion failure occurred in 25 (4%) of 649 patients treated with biodegradable polymer sirolimus-eluting stents and 36 (6%) of 651 patients treated with durable polymer everolimus-eluting stents (difference -1.6 percentage points; rate ratio 0.59, 95% Bayesian credibility interval 0.37-0.94; posterior probability of superiority 0.986). Cardiac death, target vessel myocardial reinfarction, clinically-indicated target lesion revascularisation, and definite stent thrombosis were similar between the two treatment groups in the 12 months of follow-up. Interpretation In patients with acute STEMI undergoing primary PCI, biodegradable polymer sirolimus-eluting stents were superior to durable polymer everolimus-eluting stents with respect to target lesion failure at 1 year. This difference was driven by reduced ischaemia-driven target lesion revascularisation in patients treated with biodegradable polymer sirolimus-eluting stents compared with durable polymer everolimus-eluting stents. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Iglesias, Juan F.; Roffi, Marco] Geneva Univ Hosp, Div Cardiol, Geneva, Switzerland; [Muller, Olivier; Eeckhout, Eric] Lausanne Univ Hosp, Dept Cardiol, Lausanne, Switzerland; [Heg, Dik; Losdat, Sylvain] Univ Bern, Clin Trials Unit Bern, Bern, Switzerland; [Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Kurz, David J.] Triemli Hosp, Dept Cardiol, Zurich, Switzerland; [Moarof, Igal] Kantonsspital, Dept Cardiol, Aarau, Switzerland; [Weilenmann, Daniel] Kantonsspital, Dept Cardiol, St Gallen, Switzerland; [Kaiser, Christoph] Basel Univ Hosp, Dept Cardiol, Basel, Switzerland; [Tapponnier, Maxime] Hop Valais, Dept Cardiol, Sion, Switzerland; [Stortecky, Stefan; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas] Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland; [Odutayo, Ayodele; Juni, Peter] Univ Toronto, St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst,Dept Med, Toronto, ON, Canada; [Odutayo, Ayodele; Juni, Peter] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Bern; Triemli Hospital; Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Basel; University of Bern; University Hospital of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Windecker, S (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Pilgrim, Thomas/AAS-9120-2021; Zwahlen, Marcel/AFF-8559-2022; Iglesias, Juan F./ABB-1115-2020; Juni, Peter/Q-8700-2016; Valgimigli, Marco/AAE-9103-2019; Kaiser, Christoph/AAA-9284-2022; Stortecky, Stefan/AAS-9140-2021	Pilgrim, Thomas/0000-0001-8721-4068; Zwahlen, Marcel/0000-0002-6772-6346; Iglesias, Juan F./0000-0002-1669-6036; Juni, Peter/0000-0002-5985-0670; Valgimigli, Marco/0000-0002-4353-7110; Heg, Dik/0000-0002-8766-7945; Kurz, David/0000-0002-3921-6939; Stortecky, Stefan/0000-0002-5076-0177	Biotronik (Bulach, Switzerland)	Biotronik (Bulach, Switzerland)	The authors would like to thank Florim Cuculi, Stephane Cook, and Alexios Karagiannis for their valuable contribution to the present study. This trial was supported by a dedicated research grant from Biotronik (Bulach, Switzerland). The steering committee (JFI, OM, EE, PJ, SW, and TP) and study statisticians (DH and SL) are solely responsible for the design and conduct of the study and all study analyses. The principal investigators (JFI, OM, and TP) vouch for the integrity and completeness of the study data and analyses and for the fidelity of this report to the study protocol and made the decision to submit the manuscript for publication.	Ali ZA, 2017, LANCET, V390, P760, DOI 10.1016/S0140-6736(17)31470-8; Bangalore S, 2018, CIRCULATION, V138, P2216, DOI 10.1161/CIRCULATIONAHA.118.034456; Bangalore S, 2013, CIRC-CARDIOVASC INTE, V6, P378, DOI 10.1161/CIRCINTERVENTIONS.113.000415; Buiten RA, 2019, JAMA CARDIOL, V4, P659, DOI 10.1001/jamacardio.2019.1776; de Waha A, 2015, EUROINTERVENTION, V10, P1425, DOI 10.4244/EIJV10I12A247; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Iglesias JF, 2018, EUROINTERVENTION, V14, P692, DOI 10.4244/EIJ-D-17-00734; Iglesias JF, 2017, EXPERT REV MED DEVIC, V14, P773, DOI 10.1080/17434440.2017.1378091; Jensen LO, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003610; Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036; Kandzari DE, 2018, J AM COLL CARDIOL, V72, P3287, DOI 10.1016/j.jacc.2018.09.019; Kandzari DE, 2017, LANCET, V390, P1843, DOI 10.1016/S0140-6736(17)32249-3; Kastrati A, 2001, CIRCULATION, V103, P2816; Kok MM, 2018, EUROINTERVENTION, V14, P915, DOI 10.4244/EIJ-D-18-00336; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Pache J, 2003, J AM COLL CARDIOL, V41, P1283, DOI 10.1016/S0735-1097(03)00119-0; Piccolo R, 2019, LANCET, V393, P2503, DOI 10.1016/S0140-6736(19)30474-X; Pilgrim T, 2016, EUROINTERVENTION, V12, pE1343, DOI 10.4244/EIJY15M12_09; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Raber L, 2019, EUR HEART J, V40, P1909, DOI 10.1093/eurheartj/ehz074; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Sabate M, 2016, LANCET, V387, P357, DOI 10.1016/S0140-6736(15)00548-6; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sarno G, 2014, J AM COLL CARDIOL, V64, P16, DOI 10.1016/j.jacc.2014.04.022; von Birgelen C, 2018, LANCET, V392, P1235, DOI 10.1016/S0140-6736(18)32001-4; von Birgelen C, 2016, LANCET, V388, P2607, DOI 10.1016/S0140-6736(16)31920-1; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Willink R, 2005, MEASUREMENT, V38, P61, DOI 10.1016/j.measurement.2005.01.001; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	30	101	101	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1243	1253		10.1016/S0140-6736(19)31877-X	http://dx.doi.org/10.1016/S0140-6736(19)31877-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8XK	31488372	Green Submitted, Green Accepted			2022-12-28	WOS:000488862500029
J	Oh, ES; Needham, DM; Nikooie, R; Wilson, LM; Zhang, A; Robinson, KA; Neufeld, KJ				Oh, Esther S.; Needham, Dale M.; Nikooie, Roozbeh; Wilson, Lisa M.; Zhang, Allen; Robinson, Karen A.; Neufeld, Karin J.			Antipsychotics for Preventing Delirium in Hospitalized Adults A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							ELDER LIFE PROGRAM; POSTOPERATIVE DELIRIUM; HALOPERIDOL PROPHYLAXIS; DOUBLE-BLIND; SUBSYNDROMAL DELIRIUM; OLDER; PLACEBO; METAANALYSIS; SURGERY; RISK	Background: Delirium is an acute disorder marked by impairments in attention and cognition, caused by an underlying medical problem. Antipsychotics are used to prevent delirium, but their benefits and harms are unclear. Purpose: To conduct a systematic review evaluating the benefits and harms of antipsychotics for prevention of delirium in adults. Data Sources: PubMed, Embase, CENTRAL, CINAHL, and PsycINFO from inception through July 2019, without restrictions based on study setting, language of publication, or length of follow-up. Study Selection: Randomized, controlled trials (RCTs) that compared an antipsychotic with placebo or another antipsychotic, and prospective observational studies with a comparison group. Data Extraction: One reviewer extracted data and graded the strength of the evidence, and a second reviewer confirmed the data. Two reviewers independently assessed the risk of bias. Data Synthesis: A total of 14 RCTs were included. There were no differences in delirium incidence or duration, hospital length of stay (high strength of evidence [SOE]), and mortality between haloperidol and placebo used for delirium prevention. Little to no evidence was found to determine the effect of haloperidol on cognitive function, delirium severity (insufficient SOE), inappropriate continuation, and sedation (insufficient SOE). There is limited evidence that second-generation antipsychotics may lower delirium incidence in the postoperative setting. There is little evidence that short-term use of antipsychotics was associated with neurologic harms. In some of the trials, potentially harmful cardiac effects occurred more frequently with antipsychotic use. Limitations: There was significant heterogeneity in antipsychotic dosing, route of antipsychotic administration, assessment of outcomes, and adverse events. There were insufficient or no data available to draw conclusions for many of the outcomes. Conclusion: Current evidence does not support routine use of haloperidol or second-generation antipsychotics for prevention of delirium. There is limited evidence that second-generation antipsychotics may lower the incidence of delirium in postoperative patients, but more research is needed. Future trials should use standardized outcome measures. Primary Funding Source: Agency for Healthcare Research and Quality. (PROSPERO: CRD42018109552)	[Oh, Esther S.; Needham, Dale M.; Nikooie, Roozbeh; Robinson, Karen A.; Neufeld, Karin J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Wilson, Lisa M.; Zhang, Allen] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Neufeld, Karin J.] Johns Hopkins Bayview Med Ctr, Dept Psychiat, A4 Ctr Suite 457,4940 Eastern Ave, Baltimore, MD 21224 USA; [Oh, Esther S.] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Mason F Lord Bldg Ctr Tower,5200 Eastern Ave, Baltimore, MD 21224 USA; [Robinson, Karen A.] Johns Hopkins Univ, Sch Med, Dept Med, 1830 East Monument St,Room 8068, Baltimore, MD 21287 USA; [Needham, Dale M.; Nikooie, Roozbeh] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, 1830 East Monument St,Fifth Floor, Baltimore, MD 21287 USA; [Wilson, Lisa M.; Zhang, Allen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 North Broadway,Sixth Floor, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Neufeld, KJ (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Psychiat, A4 Ctr Suite 457,4940 Eastern Ave, Baltimore, MD 21224 USA.	LisaWilson@jhmi.edu; kneufel2@jhmi.edu			Agency for Healthcare Research and Quality [PROSPERO: CRD42018109552]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42018109552)	Abdelgalel EF, 2016, EGYPT J ANAESTH, V32, P473, DOI 10.1016/j.egja.2016.05.008; Al-Qadheeb NS, 2016, CRIT CARE MED, V44, P583, DOI 10.1097/CCM.0000000000001411; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 2015, J AM COLL SURGEONS, V220, P136, DOI 10.1016/j.jamcollsurg.2014.10.019; [Anonymous], 2014, AHRQ PUBLICATION, V10(12)-EHC063-EF; [Anonymous], 2018, MOB NETW PUBL; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellelli G, 2014, J AM GERIATR SOC, V62, P1335, DOI 10.1111/jgs.12885; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Chen CCH, 2017, JAMA SURG, V152, P827, DOI 10.1001/jamasurg.2017.1083; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fick DM, 2017, J AM GERIATR SOC, V65, P2158, DOI 10.1111/jgs.14942; Fukata S, 2014, SURG TODAY, V44, P2305, DOI 10.1007/s00595-014-0859-7; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Gross AL, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0552-4; Hakim SM, 2012, ANESTHESIOLOGY, V116, P987, DOI 10.1097/ALN.0b013e31825153cc; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Herling SF, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.C.D009783.pub2, 10.1002/14651858.CD009783.pub2]; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hshieh TT, 2018, PSYCHIAT CLIN N AM, V41, P1, DOI 10.1016/j.psc.2017.10.001; Hshieh TT, 2017, ANN SURG, V265, P647, DOI 10.1097/SLA.0000000000001952; Inouye SK, 2016, ALZHEIMERS DEMENT, V12, P766, DOI 10.1016/j.jalz.2016.03.005; Inouye SK, 2015, J AM GERIATR SOC, V63, P142, DOI 10.1111/jgs.13281; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Jones RN, 2019, JAMA INTERN MED, V179, P231, DOI 10.1001/jamainternmed.2018.6975; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Kaneko Tetsuya, 1999, Yonago Acta Medica, V42, P179; Khan BA, 2018, J AM GERIATR SOC, V66, P2289, DOI 10.1111/jgs.15640; Larsen KA, 2010, PSYCHOSOMATICS, V51, P409, DOI 10.1176/appi.psy.51.5.409; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Network for Investigation of Delirium: Unifying Scientists (NIDUS), 2018, DEL RES CAT; Neufeld KJ, 2016, J AM GERIATR SOC, V64, P705, DOI 10.1111/jgs.14076; Neufeld KJ, 2019, ANTIPSYCHOTICS FOR T; Nikooie R, 2019, ANN INTERN MED, V171, P485, DOI 10.7326/M19-1860; Oh ES, 2017, JAMA-J AM MED ASSOC, V318, P1161, DOI 10.1001/jama.2017.12067; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Page VJ, 2013, LANCET RESP MED, V1, P515, DOI 10.1016/S2213-2600(13)70166-8; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Prakanrattana U, 2007, ANAESTH INTENS CARE, V35, P714, DOI 10.1177/0310057X0703500509; Rover C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0091-1; Rose L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016371; Rubin FH, 2006, J AM GERIATR SOC, V54, P969, DOI 10.1111/j.1532-5415.2006.00744.x; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Santos Eduardo, 2017, JBI Database System Rev Implement Rep, V15, P1440, DOI 10.11124/JBISRIR-2017-003391; Schrijver EJM, 2018, AGE AGEING, V47, P48, DOI 10.1093/ageing/afx124; Scottish Intercollegiate Guidelines Network (SIGN), 2019, SIGN PUBL, V157; Siddiqi N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub3; Sieber F, 2019, BRIT J ANAESTH, V122, P480, DOI 10.1016/j.bja.2018.12.021; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; U.S. Food and Drug Administration, 2014, PUBLIC HLTH ADVISORY; van den Boogaard M, 2018, JAMA-J AM MED ASSOC, V319, P680, DOI 10.1001/jama.2018.0160; Wang W, 2012, CRIT CARE MED, V40, P731, DOI 10.1097/CCM.0b013e3182376e4f; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Zayed Y, 2019, J CRIT CARE, V50, P280, DOI 10.1016/j.jcrc.2019.01.009	57	44	46	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					474	+		10.7326/M19-1859	http://dx.doi.org/10.7326/M19-1859			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB4LK	31476766				2022-12-28	WOS:000488527900005
J	Wright, S; Mudway, I				Wright, Stephanie; Mudway, Ian			The Ins and Outs of Microplastics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INGESTION; EXPOSURE; FIBERS		[Wright, Stephanie; Mudway, Ian] Kings Coll London, MRC Ctr Environm & Hlth, 150 Stamford St, London SE1 9NH, England	University of London; King's College London	Wright, S (corresponding author), Kings Coll London, MRC Ctr Environm & Hlth, 150 Stamford St, London SE1 9NH, England.	stephanie.wright@kcl.ac.uk			Medical Research Council [MR/R026521/1] Funding Source: Medline; MRC [MR/M501669/1, MR/R026521/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Catarino AI, 2018, ENVIRON POLLUT, V237, P675, DOI 10.1016/j.envpol.2018.02.069; Claessens M, 2013, MAR POLLUT BULL, V70, P227, DOI 10.1016/j.marpolbul.2013.03.009; Cox KD, 2019, ENVIRON SCI TECHNOL, V53, P7068, DOI 10.1021/acs.est.9b01517; Dris R, 2017, ENVIRON POLLUT, V221, P453, DOI 10.1016/j.envpol.2016.12.013; Schwabl P, 2019, ANN INTERN MED, V171, P453, DOI 10.7326/M19-0618; Steffens KJ, 1995, ABSORPTION ORALLY AD; Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113; Vianello A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45054-w; VOLKHEIMER G, 1975, ANN NY ACAD SCI, V246, P164, DOI 10.1111/j.1749-6632.1975.tb51092.x; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068	10	2	3	5	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					514	+		10.7326/M19-2474	http://dx.doi.org/10.7326/M19-2474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB4LK	31476769				2022-12-28	WOS:000488527900009
J	Padmanaban, V; Krol, I; Suhail, Y; Szczerba, BM; Aceto, N; Bader, JS; Ewald, AJ				Padmanaban, Veena; Krol, Ilona; Suhail, Yasir; Szczerba, Barbara M.; Aceto, Nicola; Bader, Joel S.; Ewald, Andrew J.			E-cadherin is required for metastasis in multiple models of breast cancer	NATURE			English	Article							TGF-BETA; EXPRESSION; CELLS; DISSEMINATION; GROWTH; PLASTICITY; PROSTATE; SURVIVAL; INVASION; CYCLE	Metastasis is the major driver of death in patients with cancer. Invasion of surrounding tissues and metastasis have been proposed to initiate following loss of the intercellular adhesion protein, E-cadherin(1,2), on the basis of inverse correlations between in vitro migration and E-cadherin levels(3). However, this hypothesis is inconsistent with the observation that most breast cancers are invasive ductal carcinomas and express E-cadherin in primary tumours and metastases(4). To resolve this discrepancy, we tested the genetic requirement for E-cadherin in metastasis using mouse and human models of both luminal and basal invasive ductal carcinomas. Here we show that E-cadherin promotes metastasis in diverse models of invasive ductal carcinomas. While loss of E-cadherin increased invasion, it also reduced cancer cell proliferation and survival, circulating tumour cell number, seeding of cancer cells in distant organs and metastasis outgrowth. Transcriptionally, loss of E-cadherin was associated with upregulation of genes involved in transforming growth factor-beta (TGF beta), reactive oxygen species and apoptosis signalling pathways. At the cellular level, disseminating E-cadherin-negative cells exhibited nuclear enrichment of SMAD2/3, oxidative stress and increased apoptosis. Colony formation of E-cadherin-negative cells was rescued by inhibition of TGF beta-receptor signalling, reactive oxygen accumulation or apoptosis. Our results reveal that E-cadherin acts as a survival factor in invasive ductal carcinomas during the detachment, systemic dissemination and seeding phases of metastasis by limiting reactive oxygen-mediated apoptosis. Identifying molecular strategies to inhibit E-cadherin-mediated survival in metastatic breast cancer cells may have potential as a therapeutic approach for breast cancer.	[Padmanaban, Veena; Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Krol, Ilona; Szczerba, Barbara M.; Aceto, Nicola] Univ Basel, Canc Metastasis Lab, Dept Biomed, Basel, Switzerland; [Krol, Ilona; Szczerba, Barbara M.; Aceto, Nicola] Univ Hosp Basel, Basel, Switzerland; [Suhail, Yasir; Bader, Joel S.; Ewald, Andrew J.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr,Canc Invas & Me, Baltimore, MD 21205 USA	Johns Hopkins University; University of Basel; University of Basel; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Ewald, AJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD 21205 USA.; Ewald, AJ (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Ewald, AJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr,Canc Invas & Me, Baltimore, MD 21205 USA.	andrew.ewald@jhmi.edu	Padmanaban, Veena/AAA-6882-2021; Suhail, Yasir/M-7280-2018; Aceto, Nicola/O-2484-2014	Suhail, Yasir/0000-0002-1296-9738; Aceto, Nicola/0000-0001-9579-6918; Padmanaban, Veena/0000-0002-4810-2597	Breast Cancer Research Foundation/Pink Agenda [BCRF-16-048, BCRF-17-048, BCRF-18-048]; Metastatic Breast Cancer Network; National Institutes of Health/National Cancer Institute [U01CA217846, U54CA2101732, 3P30CA006973]; Jayne Koskinas Ted Giovanis Foundation for Health and Policy; Breast Cancer Research Foundation; European Research Council; Swiss National Science Foundation; Swiss Cancer League; Basel Cancer League; two Cantons of Basel through ETH Zurich; University of Basel; Twisted Pink, Hope Scarves; Isaac and Lucille Hay Fellowship; NATIONAL CANCER INSTITUTE [P30CA006973, U01CA217846] Funding Source: NIH RePORTER	Breast Cancer Research Foundation/Pink Agenda; Metastatic Breast Cancer Network; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jayne Koskinas Ted Giovanis Foundation for Health and Policy; Breast Cancer Research Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Basel Cancer League; two Cantons of Basel through ETH Zurich; University of Basel; Twisted Pink, Hope Scarves; Isaac and Lucille Hay Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Ewald Laboratory for critical discussions and J. C. Ramirez for assistance in quantifying the area of metastases and cryo-sectioning. We thank H. Zhang from the Johns Hopkins School of Public Health Flow Cytometry Core Facility and H. Hao from the Microarray and Deep Sequencing Core Facility for technical assistance. A.J.E. received support for this project through grants from: The Breast Cancer Research Foundation/Pink Agenda (BCRF-16-048, BCRF-17-048, BCRF-18-048), the Metastatic Breast Cancer Network, Twisted Pink, Hope Scarves and the National Institutes of Health/National Cancer Institute (U01CA217846, U54CA2101732, 3P30CA006973). V.P. was supported in part by an Isaac and Lucille Hay Fellowship. J.S.B. received support for this project through a grant from the National Institutes of Health/National Cancer Institute (U01CA217846). Both A.J.E. and J.S.B. received support from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy and the Breast Cancer Research Foundation, private foundations committed to critical funding of cancer research. The opinions, findings, conclusions and recommendations expressed in this Letter are those of the authors and not necessarily those of the Jayne Koskinas Ted Giovanis Foundation for Health and Policy or the Breast Cancer Research Foundation, or their respective directors, officers or staff. Research in the Aceto laboratory is supported by the European Research Council, the Swiss National Science Foundation, the Swiss Cancer League, the Basel Cancer League, the two Cantons of Basel through ETH Zurich and the University of Basel.	ADAMSON GM, 1992, ARCH BIOCHEM BIOPHYS, V294, P223, DOI 10.1016/0003-9861(92)90161-O; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Badea TC, 2003, J NEUROSCI, V23, P2314; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Davies S. R, 1994, J EXP THER ONCOL, V7, P327; Day ML, 1999, J BIOL CHEM, V274, P9656, DOI 10.1074/jbc.274.14.9656; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; Kerksick Chad, 2005, J Int Soc Sports Nutr, V2, P38, DOI 10.1186/1550-2783-2-2-38; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SA, 2016, BRIT J CANCER, V114, P199, DOI 10.1038/bjc.2015.347; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu RM, 2015, REDOX BIOL, V6, P565, DOI 10.1016/j.redox.2015.09.009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nguyen-Ngoc KV, 2015, METHODS MOL BIOL, V1189, P135, DOI 10.1007/978-1-4939-1164-6_10; Reed AEM, 2016, J PATHOL, V238, P489, DOI 10.1002/path.4668; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Sosa MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7170; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xu YX, 2017, P NATL ACAD SCI USA, V114, P11494, DOI 10.1073/pnas.1618091114; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700	45	329	340	23	256	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					439	+		10.1038/s41586-019-1526-3	http://dx.doi.org/10.1038/s41586-019-1526-3			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31485072	Green Accepted			2022-12-28	WOS:000486647800055
J	Rubin, R				Rubin, Rita			Modest Calorie Reduction Can Improve Cardiometabolic Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News feature discusses research into the cardiometabolic benefits of a modest reduction in calorie intake.					Rubin, Rita/AAD-1259-2020						0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1032	1032		10.1001/jama.2019.12314	http://dx.doi.org/10.1001/jama.2019.12314			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31461122				2022-12-28	WOS:000488821100002
J	Chayed, Z; Kamaleswaran, S; Bygum, A				Chayed, Zahraa; Kamaleswaran, Shailajah; Bygum, Anette			A spot diagnosis! Aplasia cutis congenita in monozygotic twins	LANCET			English	Editorial Material									[Chayed, Zahraa; Kamaleswaran, Shailajah; Bygum, Anette] Odense Univ Hosp, Dept Dermatol, DK-5000 Odense C, Denmark; [Chayed, Zahraa; Kamaleswaran, Shailajah; Bygum, Anette] Odense Univ Hosp, Allergy Ctr, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Chayed, Z (corresponding author), Odense Univ Hosp, Dept Dermatol, DK-5000 Odense C, Denmark.; Chayed, Z (corresponding author), Odense Univ Hosp, Allergy Ctr, DK-5000 Odense C, Denmark.	zacha15@student.sdu.dk		Bygum, Anette/0000-0002-3004-0180					0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2019	394	10201					868	868		10.1016/S0140-6736(19)32006-9	http://dx.doi.org/10.1016/S0140-6736(19)32006-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV0US	31498100				2022-12-28	WOS:000483994700029
J	Iacobucci, G				Iacobucci, Gareth			Pharmacists could be allowed to prescribe high dose statins under NHS plan	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ference BA, 2019, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2019.14120.31475726, DOI 10.1001/JAMA.2019.14120.31475726]; Mahase E, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l538031481358	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5447	10.1136/bmj.l5447	http://dx.doi.org/10.1136/bmj.l5447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488418				2022-12-28	WOS:000485441400010
J	Ide, S				Ide, Satoshi			Frequent observations of identical onsets of large and small earthquakes	NATURE			English	Article							1992 LANDERS; NUCLEATION; FAULT; RUPTURE; PREDICTABILITY; FORESHOCKS; CALIFORNIA; MODEL; ZONE	Every gigantic earthquake begins as a tiny rock failure at almost a point, followed by successive slip of the complex fault system, before radiating strong shaking from a vast rupture area extending over hundreds of kilometres. Whether the growth process of the rupture of a large earthquake is predictable and whether it produces observable signatures different from that of smaller events(1-5) are fundamental questions related to the potential for earthquake early warning and probabilistic forecasting. Inspired by a recent discovery that large earthquakes might have seismic waves, and probably rupture processes, that are almost identical to those of smaller events(6-8), we show that such similarity characterized by large cross-correlation is a common feature of earthquakes in the Tohoku-Hokkaido subduction zone, Japan. A systematic comparison of 15 years of high-sensitivity seismograph records for approximately 100,000 events reveals 80 extremely similar and 390 very similar pairs of large (moment magnitude M > 4.5) and small (M < 4.0) earthquakes, co-located within about 100 metres. An extremely high similarity is observed for pairs of subduction-type earthquakes (170 of 899 large events) separated by a long period of up to 15 years, whereas for pairs of other types of large earthquakes only the foreshocks and aftershocks are similar. This frequently occurring similarity between different-sized subduction-type earthquakes suggests repeated cascading rupture processes in a widespread hierarchical structure(9-12) along the plate interface and indicates a specific but probabilistically limited predictability of the final size of the earthquake (that is, the location and a set of possible sizes of an earthquake are well predicted, but its final size is not at all well constrained).	[Ide, Satoshi] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan	University of Tokyo	Ide, S (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan.	ide@eps.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS KAKENHI [16H02219]; MEXT KAKENHI [16H06477]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funding from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, under its Earthquake and Volcano Hazards Observation and Research Program, JSPS KAKENHI 16H02219 and MEXT KAKENHI 16H06477. All data were obtained from the NIED Hi-net data server. Figures were prepared using the Generic Mapping Tools.	ABERCROMBIE R, 1994, B SEISMOL SOC AM, V84, P725; Aochi H, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006034; Ben-Zion Y, 2003, PURE APPL GEOPHYS, V160, P677, DOI 10.1007/PL00012554; Bouchon M, 2011, SCIENCE, V331, P877, DOI 10.1126/science.1197341; Candela T, 2009, PURE APPL GEOPHYS, V166, P1817, DOI 10.1007/s00024-009-0521-2; Chen KH, 2008, EARTH PLANET SC LETT, V276, P262, DOI 10.1016/j.epsl.2008.09.021; DIETERICH JH, 1992, TECTONOPHYSICS, V211, P115, DOI 10.1016/0040-1951(92)90055-B; DODGE DA, 1995, J GEOPHYS RES-SOL EA, V100, P9865, DOI 10.1029/95JB00871; ELLSWORTH WL, 1995, SCIENCE, V268, P851, DOI 10.1126/science.268.5212.851; Ide S, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003591; IIO Y, 1992, GEOPHYS RES LETT, V19, P477, DOI 10.1029/92GL00179; KING G, 1983, PURE APPL GEOPHYS, V121, P761, DOI 10.1007/BF02590182; McGuire JJ, 2008, B SEISMOL SOC AM, V98, P1067, DOI 10.1785/0120070154; McLaskey GC, 2013, J GEOPHYS RES-SOL EA, V118, P2982, DOI 10.1002/jgrb.50232; Meier MA, 2017, SCIENCE, V357, P1278, DOI 10.1126/science.aan5643; Meier MA, 2016, GEOPHYS RES LETT, V43, P7991, DOI 10.1002/2016GL070081; Mori J, 1996, GEOPHYS RES LETT, V23, P2437, DOI 10.1029/96GL02491; Nadeau RM, 1998, B SEISMOL SOC AM, V88, P790; Noda H, 2013, J GEOPHYS RES-SOL EA, V118, P2924, DOI 10.1002/jgrb.50211; OHNAKA M, 1992, TECTONOPHYSICS, V211, P149, DOI 10.1016/0040-1951(92)90057-D; OKUBO PG, 1987, J GEOPHYS RES-SOLID, V92, P345, DOI 10.1029/JB092iB01p00345; Okuda T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06168-3; Okuda T, 2018, EARTH PLANETS SPACE, V70, DOI 10.1186/s40623-018-0903-8; Schorlemmer D, 2018, SEISMOL RES LETT, V89, P1305, DOI 10.1785/0220180053; Shibazaki B, 2002, GEOPHYS J INT, V149, P572, DOI 10.1046/j.1365-246X.2002.01601.x; SHIBAZAKI B, 1995, GEOPHYS RES LETT, V22, P1305, DOI 10.1029/95GL01196; Singh SK, 1998, B SEISMOL SOC AM, V88, P1171; Suzuki T, 2014, J GEOPHYS RES-SOL EA, V119, P2100, DOI 10.1002/2013JB010871; Uchida N, 2013, EARTH PLANET SC LETT, V374, P81, DOI 10.1016/j.epsl.2013.05.021; Uchida N, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031263; Uchide T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007122; UMEDA Y, 1990, TECTONOPHYSICS, V175, P81, DOI 10.1016/0040-1951(90)90131-Q	32	23	24	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					112	+		10.1038/s41586-019-1508-5	http://dx.doi.org/10.1038/s41586-019-1508-5			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31485057				2022-12-28	WOS:000483967700044
J	Martin, JC; Chang, C; Boschetti, G; Ungaro, R; Giri, M; Grout, JA; Gettler, K; Chuang, LS; Nayar, S; Greenstein, AJ; Dubinsky, M; Walker, L; Leader, A; Fine, JS; Whitehurst, CE; Mbow, ML; Kugathasan, S; Denson, LA; Hyams, JS; Friedman, JR; Desai, PT; Ko, HM; Laface, I; Akturk, G; Schadt, EE; Salmon, H; Gnjatic, S; Rahman, AH; Merad, M; Cho, JH; Kenigsberg, E				Martin, Jerome C.; Chang, Christie; Boschetti, Gilles; Ungaro, Ryan; Giri, Mamta; Grout, John A.; Gettler, Kyle; Chuang, Ling-shiang; Nayar, Shikha; Greenstein, Alexander J.; Dubinsky, Marla; Walker, Laura; Leader, Andrew; Fine, Jay S.; Whitehurst, Charles E.; Mbow, M. Lamine; Kugathasan, Subra; Denson, Lee A.; Hyams, Jeffrey S.; Friedman, Joshua R.; Desai, Prerak T.; Ko, Huaibin M.; Laface, Ilaria; Akturk, Guray; Schadt, Eric E.; Salmon, Helene; Gnjatic, Sacha; Rahman, Adeeb H.; Merad, Miriam; Cho, Judy H.; Kenigsberg, Ephraim			Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy	CELL			English	Article							INNATE LYMPHOID-CELLS; HUMAN INTESTINAL MACROPHAGES; T-CELLS; MAINTENANCE THERAPY; INFLAMED MUCOSA; GENE-EXPRESSION; DENDRITIC CELLS; RNA-SEQ; HETEROGENEITY; INFLAMMATION	Clinical benefits of cytokine blockade in ileal Crohn's disease (iCD) are limited to a subset of patients. Here, we applied single-cell technologies to iCD lesions to address whether cellular heterogeneity contributes to treatment resistance. We found that a subset of patients expressed a unique cellular module in inflamed tissues that consisted of IgG plasma cells, inflammatory mononuclear phagocytes, activated T cells, and stromal cells, which we named the GIMATS module. Analysis of ligand-receptor interaction pairs identified a distinct network connectivity that likely drives the GIMATS module. Strikingly, the GIMATS module was also present in a subset of patients in four independent iCD cohorts (n = 441), and its presence at diagnosis correlated with failure to achieve durable corticosteroid-free remission upon anti-TNF therapy. These results emphasize the limitations of current diagnostic assays and the potential for single-cell mapping tools to identify novel biomarkers of treatment response and tailored therapeutic opportunities.	[Martin, Jerome C.; Chang, Christie; Boschetti, Gilles; Grout, John A.; Leader, Andrew; Laface, Ilaria; Akturk, Guray; Salmon, Helene; Gnjatic, Sacha; Rahman, Adeeb H.; Merad, Miriam; Kenigsberg, Ephraim] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Martin, Jerome C.; Chang, Christie; Boschetti, Gilles; Grout, John A.; Leader, Andrew; Laface, Ilaria; Akturk, Guray; Salmon, Helene; Gnjatic, Sacha; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Martin, Jerome C.; Chang, Christie; Boschetti, Gilles; Grout, John A.; Leader, Andrew; Salmon, Helene; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Ungaro, Ryan; Ko, Huaibin M.] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA; [Giri, Mamta; Gettler, Kyle; Chuang, Ling-shiang; Nayar, Shikha; Cho, Judy H.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Greenstein, Alexander J.] Icahn Sch Med Mt Sinai, Dept Colorectal Surg, New York, NY 10029 USA; [Dubinsky, Marla] Icahn Sch Med Mt Sinai, Susan & Leonard Feinstein IBD Clin Ctr, Dept Pediat, New York, NY 10029 USA; [Walker, Laura; Gnjatic, Sacha; Rahman, Adeeb H.; Merad, Miriam] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA; [Fine, Jay S.; Whitehurst, Charles E.; Mbow, M. Lamine] Boehringer Ingelheim Pharmaceut, Immunol & Resp Dis Res, Ridgefield, CT 06877 USA; [Kugathasan, Subra] Emory Univ, Sch Med, Div Pediat Gastroenterol, Atlanta, GA USA; [Denson, Lee A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Denson, Lee A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Hyams, Jeffrey S.] Connecticut Childrens Med Ctr, Div Digest Dis Hepatol & Nutr, Hartford, CT USA; [Friedman, Joshua R.; Desai, Prerak T.] Janssen Res & Dev, Spring House, PA USA; [Ko, Huaibin M.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Schadt, Eric E.; Rahman, Adeeb H.; Kenigsberg, Ephraim] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schadt, Eric E.; Kenigsberg, Ephraim] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol Oncol, New York, NY 10029 USA; [Cho, Judy H.] CHU Nantes Hotel Dieu, CRTI, ITUN, UMR1064, 30 Blvd Jean Monnet, F-44093 Nantes 1, France	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Boehringer Ingelheim; Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Connecticut Children's Medical Center; Johnson & Johnson; Janssen Pharmaceuticals; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Nantes Universite; CHU de Nantes	Merad, M; Kenigsberg, E (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Cho, JH (corresponding author), Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA.; Kenigsberg, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Kenigsberg, E (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Cho, JH (corresponding author), CHU Nantes Hotel Dieu, CRTI, ITUN, UMR1064, 30 Blvd Jean Monnet, F-44093 Nantes 1, France.	miriam.merad@mssm.edu; judy.cho@mssm.edu; ephraim.kenigsberg@mssm.edu	giri, mamta/ABC-2895-2020; Desai, Prerak/ABF-8529-2020; Akturk, Guray/AAD-3825-2020; Martin, Jerome/GZG-4189-2022; Ko, Huai-Bin/AAO-2767-2020; Akturk, Guray/A-3192-2013; Kenigsberg, Ephraim/AAM-5690-2020; Chuang, Ling-shiang/GNH-1836-2022	Akturk, Guray/0000-0001-7032-8085; Ko, Huai-Bin/0000-0003-1062-2383; Akturk, Guray/0000-0001-7032-8085; Chuang, Ling-shiang/0000-0001-5054-1305; Martin, Jerome/0000-0003-0068-8776; Nayar, Shikha/0000-0001-8519-4569; Walker, Laura/0000-0003-4944-1993; Whitehurst, Charles/0000-0003-3112-5458; Gnjatic, Sacha/0000-0001-5643-9520; Boschetti, Gilles/0000-0003-4039-7607; Chang, Christie/0000-0002-7651-7220	"Prix pour les jeunes chercheurs'' de la Fondation Bettencourt-Schueller; Philippe Foundation; Crohn's and Colitis Foundation; NIH K23 Career Development Award [K23KD111995-01A1]; Sanford J. Grossman Charitable Trust; Boehringer Ingelheim Pharmaceuticals;  [U01 DK062429];  [U01 DK062422];  [R01 DK106593];  [R56AI137244];  [U24 AI118644];  [U19 AI128949];  [S10 OD023547-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI128949, R56AI137244, U24AI118644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK062429, U01DK062429, R01DK106593, K23DK111995, U01DK062422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023547] Funding Source: NIH RePORTER	"Prix pour les jeunes chercheurs'' de la Fondation Bettencourt-Schueller; Philippe Foundation; Crohn's and Colitis Foundation; NIH K23 Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford J. Grossman Charitable Trust; Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); ; ; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank the patients who participated in the study. The authors would like to warmly thank Dr. Jean-Frederic Colombel (co-director of the Feinstein IBD Center, Mount Sinai Hospital, New York, NY) for invaluable discussions and insights on Crohn's disease. The authors would also like to thank Dr. Emilie Grasset (Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY) for critical insights on B cells analysis. We thank Dr. Andrew Chess for fruitful discussions. J.C.M. is supported by "Prix pour les jeunes chercheurs'' de la Fondation Bettencourt-Schueller and by the Philippe Foundation; R.U. is supported by a Career Development Award from the Crohn's and Colitis Foundation and an NIH K23 Career Development Award (K23KD111995-01A1). J.H.C. is funded by U01 DK062429, U01 DK062422, R01 DK106593, and the Sanford J. Grossman Charitable Trust. M.M. is funded by R56AI137244, U24 AI118644, U19 AI128949, and Boehringer Ingelheim Pharmaceuticals. This work utilized a mass cytometry instrumentation at the Human Immune Monitoring Center supported by S10 OD023547-01. The work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai.	Abraham C, 2017, GASTROENTEROLOGY, V152, P374, DOI 10.1053/j.gastro.2016.10.018; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Anginot A, 2013, J IMMUNOL, V190, P5526, DOI 10.4049/jimmunol.1201885; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bamba S, 2003, AM J PHYSIOL-GASTR L, V285, pG529, DOI 10.1152/ajpgi.00050.2003; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Baran Y., 2018, BIORXIV, DOI [10.1101/437665, DOI 10.1101/437665]; Barone F, 2009, MUCOSAL IMMUNOL, V2, P495, DOI 10.1038/mi.2009.106; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bilsborough J., 2016, AM J GASTROENTEROL S, V3, P27, DOI [10.1038/ajgsup.2016.18, DOI 10.1038/ajgsup.2016.18]; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Danese S, 2016, GUT, V65, P1233, DOI 10.1136/gutjnl-2016-311717; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hayatsu N, 2017, IMMUNITY, V47, P268, DOI 10.1016/j.immuni.2017.07.008; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Kugathasan S, 2017, LANCET, V389, P1710, DOI 10.1016/S0140-6736(17)30317-3; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levin AD, 2016, J CROHNS COLITIS, V10, P989, DOI 10.1093/ecco-jcc/jjw053; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mowat AM, 2017, NAT MED, V23, P1258, DOI 10.1038/nm.4430; Neurath MF, 2017, NAT REV GASTRO HEPAT, V14, P269, DOI 10.1038/nrgastro.2016.208; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Okuno T, 2002, SCAND J GASTROENTERO, V37, P317, DOI 10.1080/003655202317284228; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Peters LA, 2017, NAT GENET, V49, P1437, DOI 10.1038/ng.3947; Powell N, 2015, GASTROENTEROLOGY, V149, P456, DOI 10.1053/j.gastro.2015.04.017; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Remark R, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf6925; Remedios KA, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau2042; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sander J, 2017, IMMUNITY, V47, P1051, DOI 10.1016/j.immuni.2017.11.024; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Simoni Y, 2017, IMMUNITY, V46, P760, DOI 10.1016/j.immuni.2017.04.026; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; Spencer J, 2016, MUCOSAL IMMUNOL, V9, P1113, DOI 10.1038/mi.2016.59; Team RC., 2022, LANG ENV STAT COMP; Thiesen S, 2014, J LEUKOCYTE BIOL, V95, P531, DOI 10.1189/jlb.0113021; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai CM, 2008, J IMMUNOL, V181, P4570, DOI 10.4049/jimmunol.181.7.4570; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Uo M, 2013, GUT, V62, P1734, DOI 10.1136/gutjnl-2012-303063; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wong MT, 2016, IMMUNITY, V45, P442, DOI 10.1016/j.immuni.2016.07.007; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	90	235	239	6	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1493	+		10.1016/j.cell.2019.08.008	http://dx.doi.org/10.1016/j.cell.2019.08.008			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474370	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000483983000021
J	O'Dowd, A				O'Dowd, Adrian			NHS leaders are underwhelmed at extra 6.2bn pound for NHS in next financial year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4977; Royal College of General Practitioners, 2019, LETT RESP REV 2019	2	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5446	10.1136/bmj.l5446	http://dx.doi.org/10.1136/bmj.l5446			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488435				2022-12-28	WOS:000485441400009
J	Sim, I				Sim, Ida			Mobile Devices and Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TECHNOLOGY; ACCURACY; PLATFORM; SENSOR; APPS	Mobile health involves sensors, mobile apps, social media, and location-tracking technology used in disease diagnosis, prevention, and management. This article provides an overview of key functional and regulatory aspects; the article is accompanied by an explanatory video, an illustrated glossary, and an audio interview with the author.	[Sim, Ida] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sim, I (corresponding author), Univ Calif San Francisco, 1545 Divisadero St,Suite 308, San Francisco, CA 94143 USA.	ida.sim@ucsf.edu		Sim, Ida/0000-0002-1045-8459				Adler-Milstein J, 2019, J AM MED INFORM ASS; Agency for Healthcare Research and Quality, 2014, MULT CHRON COND CHAR; Akili Interactive, 2017, AK ACH PRIM EFF ENDP; AliveCor, KARDIAMOBILE; [Anonymous], 2019, GUID DIG SEC PRIV; [Anonymous], RESEARCHSTACK SDK BU; [Anonymous], PROJECT HEALTHDESIGN; Apple, APPL WATCH SER; Baron KG, 2017, J CLIN SLEEP MED, V13, P351, DOI 10.5664/jcsm.6472; Barrett MA, 2017, ANN ALLERG ASTHMA IM, V119, P415, DOI 10.1016/j.anai.2017.08.002; Bauman M., 2017, MULTIPLE CHRONIC CON; Brooks GC, 2015, CIRC-HEART FAIL, V8, P905, DOI 10.1161/CIRCHEARTFAILURE.115.002062; Centers for Disease Control and Prevention, 2018, HLTH LIT UND LIT NUM; Centers for Medicare & Medicaid Services (CMS) HHS, 2017, FED REGISTER, V82, P52976; Clinical Trials Transformation Initiative, 2018, CTTI REC DEC CLIN TR; Comscore, 2014, IPHONE US EARN HIGH; Coppetti T, 2017, EUR J PREV CARDIOL, V24, P1287, DOI 10.1177/2047487317702044; Coravos A, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0090-4; Day S., 2019, 2018 YEAR END FUNDIN; Empatica, EMBRACE2 SEIZ DET; Endeavour Partners, 2017, INSIDE WEARABLES SCI; Express Scripts, 2019, EXPR SCRIPTS SIMPL D; FDA Center for Devices and Radiological Health, 2018, 510 K CLEAR; FDA Center for Devices and Radiological Health, 2018, DIG HLTH SOFTW PREC; Freespira, SOLUTION PANIC ATTAC; Gao J, 2013, CONF REC ASILOMAR C, P86, DOI 10.1109/ACSSC.2013.6810235; Goel Mayank, 2016, P 2016 CHI C HUM FAC; Goncalves C, 2018, INVENTIONS-BASEL, V3, DOI 10.3390/inventions3010014; Hafezi H, 2015, IEEE T BIO-MED ENG, V62, P99, DOI 10.1109/TBME.2014.2341272; He L, 2018, J BIOMED INFORM, V83, P103, DOI 10.1016/j.jbi.2018.05.007; HealthIT.gov, 2019, NOT PROP RUL IMPR IN; Korinek EV, 2018, J BEHAV MED, V41, P74, DOI 10.1007/s10865-017-9878-3; Kumar S, 2013, AM J PREV MED, V45, P228, DOI 10.1016/j.amepre.2013.03.017; Luik Annemarie I, 2017, Curr Sleep Med Rep, V3, P48, DOI 10.1007/s40675-017-0065-4; Majumder S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17112496; Makhni Sonya, 2017, Digit Biomark, V1, P64, DOI 10.1159/000479017; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; May M, 2018, J PAIN, V19, P699, DOI 10.1016/j.jpain.2018.01.006; MC10, BIOSTAMP NPOINT WEAR; McLaren R, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0167-0; Milani RV, 2016, PROG CARDIOVASC DIS, V58, P579, DOI 10.1016/j.pcad.2016.01.001; Moore RC, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1562; Noah B, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0002-4; NODE, HLTH HOM PAG; Omada Health, DIG THER CHRON DIS; Open mHealth, OP SOURC DAT INT TOO; Pasquale Frank, 2015, BLACK BOK SOC SECRET; Pauwels E, 2018, SEARCHING PRIVACY IN; Pear Therapeutics, RED MED PRESCR DIG T; Perry Brian, 2018, Digit Biomark, V2, P11, DOI 10.1159/000486347; Pew Research Center Global Attitudes Project, 2019, SMARTPHONE OWNERSHIP; Pourmand A, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0708-2; Rainie L., 2017, DIGITAL DIVIDES FEED; Rampey B. D., 2016, SKILLS US UNEMPLOYED; Research 2 Guidance, 2018, RES 2 GUIDANCE; ResearchKit, INTR RESEARCHKIT; Richman B, 2018, NEW ENGL J MED, V379, P1694, DOI 10.1056/NEJMp1806848; Rosenbaum L, 2018, NEW ENGL J MED, V378, P101, DOI 10.1056/NEJMp1716206; Rovini E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00555; Sage Bionetworks, 2017, PARK DIS DIG BIOM DR; Saleheen N, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P999, DOI 10.1145/2750858.2806897; Sheon Amy R, 2018, Digit Biomark, V2, P139, DOI 10.1159/000494365; Sheridan K, 2018, PRESCRIPTION APPS AR; Shiffman S., 2016, OXFORD HDB SUBSTANCE, P466; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Simblett S, 2018, J MED INTERNET RES, V20, DOI 10.2196/10480; Singh S, 2020, TELEMED E-HEALTH, V26, P327, DOI 10.1089/tmj.2018.0271; StatCounter, 2019, MOB OP SYST MARK SHA; Statista, WEAR US PEN RAT US 2; Tidepool, PLAC YOUR DIAB DAT; Toscos T, 2019, J AM MED INFORM ASS; Vargas-Cuentas NI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188826; Walz LC, 2014, J ANXIETY DISORD, V28, P925, DOI 10.1016/j.janxdis.2014.09.022; Wen D, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6874; Whitney RL, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10291; Xcertia, MHEALTH APP GUID; Zhang XZ, 2019, MED CARE, V57, pS115, DOI 10.1097/MLR.0000000000001092	77	179	185	13	101	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					956	968		10.1056/NEJMra1806949	http://dx.doi.org/10.1056/NEJMra1806949			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IW9PR	31483966				2022-12-28	WOS:000485326200010
J	Owens, DK; Davidson, KW; Krist, AH; Barry, MJ; Cabana, M; Caughey, AB; Doubeni, CA; Epling, JW; Kubik, M; Landefeld, CS; Mangione, CM; Pbert, L; Silverstein, M; Tseng, CW; Wong, JB				Owens, Douglas K.; Davidson, Karina W.; Krist, Alex H.; Barry, Michael J.; Cabana, Michael; Caughey, Aaron B.; Doubeni, Chyke A.; Epling, John W., Jr.; Kubik, Martha; Landefeld, C. Seth; Mangione, Carol M.; Pbert, Lori; Silverstein, Michael; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Medication Use to Reduce Risk of Breast Cancer US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SURGICAL ADJUVANT BREAST; ITALIAN RANDOMIZED-TRIAL; VERTEBRAL FRACTURE RISK; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; MULTIPLE OUTCOMES; CARDIOVASCULAR EVENTS; RALOXIFENE EVALUATION; PREDICTION MODEL; BOWEL PROJECT	IMPORTANCE Breast cancer is the most common nonskin cancer among women in the United States and the second leading cause of cancer death. The median age at diagnosis is 62 years, and an estimated 1 in 8 women will develop breast cancer at some point in their lifetime. African American women are more likely to die of breast cancer compared with women of other races. OBJECTIVE To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on medications for risk reduction of primary breast cancer. EVIDENCE REVIEW The USPSTF reviewed evidence on the accuracy of risk assessment methods to identify women who could benefit from risk-reducing medications for breast cancer, as well as evidence on the effectiveness, adverse effects, and subgroup variations of these medications. The USPSTF reviewed evidence from randomized trials, observational studies, and diagnostic accuracy studies of risk stratification models in women without preexisting breast cancer or ductal carcinoma in situ. FINDINGS The USPSTF found convincing evidence that risk assessment tools can predict the number of cases of breast cancer expected to develop in a population. However, these risk assessment tools perform modestly at best in discriminating between individual women who will or will not develop breast cancer. The USPSTF found convincing evidence that risk-reducing medications (tamoxifen, raloxifene, or aromatase inhibitors) provide at least a moderate benefit in reducing risk for invasive estrogen receptor-positive breast cancer in postmenopausal women at increased risk for breast cancer. The USPSTF found that the benefits of taking tamoxifen, raloxifene, and aromatase inhibitors to reduce risk for breast cancer are no greater than small in women not at increased risk for the disease. The USPSTF found convincing evidence that tamoxifen and raloxifene and adequate evidence that aromatase inhibitors are associated with small to moderate harms. Overall, the USPSTF determined that the net benefit of taking medications to reduce risk of breast cancer is larger in women who have a greater risk for developing breast cancer. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends that clinicians offer to prescribe risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse medication effects. (B recommendation) The USPSTF recommends against the routine use of risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, in women who are not at increased risk for breast cancer. (D recommendation) This recommendation applies to asymptomatic women 35 years and older, including women with previous benign breast lesions on biopsy (such as atypical ductal or lobular hyperplasia and lobular carcinoma in situ). This recommendation does not apply to women who have a current or previous diagnosis of breast cancer or ductal carcinoma in situ.	[Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, 616 Serra St,Encina Hall,Room C336, Stanford, CA 94305 USA; [Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Cabana, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, NY USA; [Epling, John W., Jr.] Virginia Tech Carilion Sch Med, Roanoke, VA USA; [Kubik, Martha] Temple Univ, Philadelphia, PA 19122 USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Pbert, Lori] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Northwell Health; Virginia Commonwealth University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Oregon Health & Science University; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Owens, DK (corresponding author), Stanford Univ, 616 Serra St,Encina Hall,Room C336, Stanford, CA 94305 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x; American Academy of Family Physicians (AAFP), CLIN PREV SERV REC M; American Cancer Society, 2017, BREAST CANC FACTS FI; American Cancer Society, 2018, CANC FACTS FIG 2018; Amir E, 2003, J MED GENET, V40, P807, DOI 10.1136/jmg.40.11.807; [Anonymous], 2014, Obstet Gynecol, V123, P1394, DOI 10.1097/01.AOG.0000450757.18294.cf; [Anonymous], 2017, Obstet Gynecol, V130, pe110, DOI 10.1097/AOG.0000000000002296; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Boughey JC, 2010, J CLIN ONCOL, V28, P3591, DOI 10.1200/JCO.2010.28.0784; Boyle P, 2004, EUR J CANCER PREV, V13, P183, DOI 10.1097/01.cej.0000130014.83901.53; Brentnall AR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0653-5; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Centers for Disease Control and Prevention, 2018, WHAT CAN I DO RED MY; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Chlebowski RT, 2007, JNCI-J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Corbelli J, 2014, J WOMENS HEALTH, V23, P746, DOI 10.1089/jwh.2014.4742; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cuzick J, 2014, LANCET, V383, P1040; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Cuzick J, 2014, LANCET, V383, P1041, DOI 10.1016/S0140-6736(13)62292-8; Day R, 2001, J NATL CANCER I, V93, P1615, DOI 10.1093/jnci/93.21.1615; Decarli A, 2006, J NATL CANCER I, V98, P1686, DOI 10.1093/jnci/djj463; Decensi A, 2005, CIRCULATION, V111, P650, DOI 10.1161/01.CIR.0000154545.84124.AC; DeCensi A, 2013, ANN ONCOL, V24, P2753, DOI 10.1093/annonc/mdt244; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Duvernoy CS, 2005, MENOPAUSE, V12, P444, DOI 10.1097/01.GME.0000151653.02620.89; Ensrud KE, 2008, J BONE MINER RES, V23, P112, DOI 10.1359/JBMR.070904; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fagerlin A, 2011, BREAST CANCER RES TR, V127, P681, DOI 10.1007/s10549-011-1450-1; Fagerlin A, 2010, BREAST CANCER RES TR, V119, P613, DOI 10.1007/s10549-009-0618-4; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Forbes JF, 2016, LANCET, V387, P866, DOI 10.1016/S0140-6736(15)01129-0; Freedman AN, 2011, J CLIN ONCOL, V29, P2327, DOI 10.1200/JCO.2010.33.0258; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Goldvaser H, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx141; Goss PE, 2011, NEW ENGL J MED, V365, P1361; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grady D, 2008, J NATL CANCER I, V100, P854, DOI 10.1093/jnci/djn153; Kaplan CP, 2005, PREV MED, V41, P7, DOI 10.1016/j.ypmed.2004.09.041; Keech CA, 2005, CURR MED RES OPIN, V21, P135, DOI 10.1185/030079904X18045; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Lippman ME, 2006, CLIN CANCER RES, V12, P5242, DOI 10.1158/1078-0432.CCR-06-0688; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Matsuno RK, 2011, J NATL CANCER I, V103, P951, DOI 10.1093/jnci/djr154; Maunsell E, 2014, J CLIN ONCOL, V32, P1427, DOI 10.1200/JCO.2013.51.2483; McKay A, 2005, BREAST CANCER RES TR, V94, P153, DOI 10.1007/s10549-005-6932-6; Melnikow J, 2005, CANCER-AM CANCER SOC, V103, P1996, DOI 10.1002/cncr.20981; Moyer VA, 2013, ANN INTERN MED, V159, P698, DOI [10.7326/0003-4819-159-10-201311190-00717, 10.7326/0003-4819-159-10-201311190-00718]; National Cancer Institute (NCI), 2018, BRCA MUT CANC RISK G; National Cancer Institute (NCI), 2017, BREAST CANC RISK ASS; National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; Nelson HD., 2019, MEDICATION USE RISK; Nelson HD, 2019, JAMA-J AM MED ASSOC, V322, P868, DOI 10.1001/jama.2019.5780; Paterniti DA, 2005, ETHNIC DIS, V15, P365; PDQ&reg;Screening and Prevention Editorial Board National Cancer Institute (NCI), PDQ BREAST CANC PREV; Petracci E, 2011, JNCI-J NATL CANCER I, V103, P1037, DOI 10.1093/jnci/djr172; Powles T, 1998, LANCET, V352, P98; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Rockhill B, 2003, J CLIN EPIDEMIOL, V56, P856, DOI 10.1016/S0895-4356(03)00124-0; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Sestak I, 2014, LANCET ONCOL, V15, pE587; Sestak I, 2014, LANCET ONCOL, V15, P1460, DOI 10.1016/S1470-2045(14)71035-6; Silverman SL, 2004, J AM GERIATR SOC, V52, P1543, DOI 10.1111/j.1532-5415.2004.52420.x; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Smith SG, 2016, ANN ONCOL, V27, P575, DOI 10.1093/annonc/mdv590; Spagnolo F, 2016, J CLIN ONCOL, V34, P139, DOI 10.1200/JCO.2015.63.4972; Tamimi RM, 2010, CANCER-AM CANCER SOC, V116, P4944, DOI 10.1002/cncr.25386; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tice JA, 2015, J CLIN ONCOL, V33, P3137, DOI 10.1200/JCO.2015.60.8869; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1428, DOI 10.1093/jnci/dji290; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; US Preventive Services Task Force (USPSTF), 2018, REC PRIM CAR PRACT; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 2003, J NATL CANCER I, V95, P160, DOI 10.1093/jnci/95.2.160; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074	94	68	68	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					857	867		10.1001/jama.2019.11885	http://dx.doi.org/10.1001/jama.2019.11885			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479144	Bronze			2022-12-28	WOS:000486437200015
J	Voelker, R				Voelker, Rebecca			New Antibacterial Should Be Used With Caution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					807	807		10.1001/jama.2019.12939	http://dx.doi.org/10.1001/jama.2019.12939			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KM0ZB	31479126				2022-12-28	WOS:000513845400003
J	Onwuneme, G				Onwuneme, Gloria			Meet the occupational therapist: Niamh O'Flaherty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Onwuneme, Gloria] United Lincolnshire Hosp NHS Trust, Lincoln, England		Onwuneme, G (corresponding author), United Lincolnshire Hosp NHS Trust, Lincoln, England.	gn.onwuneme@yahoo.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l4890	10.1136/bmj.l4890	http://dx.doi.org/10.1136/bmj.l4890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477577				2022-12-28	WOS:000485431800002
J	Sperber, A				Sperber, Amanda			Sexual violence, HIV, and conflict in South Sudan	LANCET			English	Editorial Material																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					723	724		10.1016/S0140-6736(19)32002-1	http://dx.doi.org/10.1016/S0140-6736(19)32002-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UW	31478491				2022-12-28	WOS:000483011400014
J	Arpaia, R; Caprara, S; Fumagalli, R; De Vecchi, G; Peng, YY; Andersson, E; Betto, D; De Luca, GM; Brookes, NB; Lombardi, F; Salluzzo, M; Braicovich, L; Di Castro, C; Grilli, M; Ghiringhelli, G				Arpaia, R.; Caprara, S.; Fumagalli, R.; De Vecchi, G.; Peng, Y. Y.; Andersson, E.; Betto, D.; De Luca, G. M.; Brookes, N. B.; Lombardi, F.; Salluzzo, M.; Braicovich, L.; Di Castro, C.; Grilli, M.; Ghiringhelli, G.			Dynamical charge density fluctuations pervading the phase diagram of a Cu-based high-T-c superconductor	SCIENCE			English	Article							D-WAVE SUPERCONDUCTIVITY; X-RAY-SCATTERING; LIQUID BEHAVIOR; NORMAL-STATE; ORDER; TEMPERATURE; INHOMOGENEITY; SEPARATION	Charge density modulations have been observed in all families of high-critical temperature (T-c) superconducting cuprates. Although they are consistently found in the underdoped region of the phase diagram and at relatively low temperatures, it is still unclear to what extent they influence the unusual properties of these systems. Using resonant x-ray scattering, we carefully determined the temperature dependence of charge density modulations in YBa2Cu3O7-delta and Nd1+xBa2-xCu3O7-delta for several doping levels. We isolated short-range dynamical charge density fluctuations in addition to the previously known quasi-critical charge density waves. They persist up to well above the pseudogap temperature T*, are characterized by energies of a few milli-electron volts, and pervade a large area of the phase diagram.	[Arpaia, R.; Fumagalli, R.; De Vecchi, G.; Peng, Y. Y.; Braicovich, L.; Ghiringhelli, G.] Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy; [Arpaia, R.; Andersson, E.; Lombardi, F.] Chalmers Univ Technol, Dept Microtechnol & Nanosci, Quantum Device Phys Lab, SE-41296 Gothenburg, Sweden; [Caprara, S.; Di Castro, C.; Grilli, M.] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Caprara, S.; Di Castro, C.; Grilli, M.] CNR ISC, I-00185 Rome, Italy; [Betto, D.; Brookes, N. B.; Braicovich, L.] ESRF, European Synchrotron, F-38043 Grenoble, France; [De Luca, G. M.] Univ Napoli Federico II, Dipartimento Fis E Pancini, Complesso Monte St Angelo, I-80126 Naples, Italy; [De Luca, G. M.; Salluzzo, M.] CNR SPIN, Complesso Monte St Angelo, I-80126 Naples, Italy; [Ghiringhelli, G.] Politecn Milan, CNR SPIN, Dipartimento Fis, I-20133 Milan, Italy; [Peng, Y. Y.] Peking Univ, Sch Phys, Int Ctr Quantum Mat, CN-100871 Beijing, Peoples R China	Polytechnic University of Milan; Chalmers University of Technology; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); European Synchrotron Radiation Facility (ESRF); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Polytechnic University of Milan; Peking University	Arpaia, R; Ghiringhelli, G (corresponding author), Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy.; Arpaia, R (corresponding author), Chalmers Univ Technol, Dept Microtechnol & Nanosci, Quantum Device Phys Lab, SE-41296 Gothenburg, Sweden.; Ghiringhelli, G (corresponding author), Politecn Milan, CNR SPIN, Dipartimento Fis, I-20133 Milan, Italy.	riccardo.arpaia@chalmers.se; giacomo.ghiringhelli@polimi.it	Ghiringhelli, Giacomo/D-1159-2014; Caprara, Sergio/M-7683-2013; salluzzo, marco/C-5919-2009; Arpaia, Riccardo/Y-1247-2019; Grilli, Marco/C-6309-2009; Wahlberg, Eric/AAY-8511-2020; peng, yingying/K-1805-2015	Ghiringhelli, Giacomo/0000-0003-0867-7748; Caprara, Sergio/0000-0001-8041-3232; salluzzo, marco/0000-0001-8372-6963; Arpaia, Riccardo/0000-0003-4687-2376; Grilli, Marco/0000-0001-5607-7996; Wahlberg, Eric/0000-0002-2723-0688; Lombardi, Floriana/0000-0002-3478-3766; peng, yingying/0000-0002-2657-3590	ERC-P-ReXS project of the Fondazione CARIPLO [2016-0790]; Regione Lombardia (Italy); Swedish Research Council (VR) [2017-00382]; University of Rome Sapienza [RM11715C642E8370, RM11816431DBA5AF]	ERC-P-ReXS project of the Fondazione CARIPLO(Fondazione Cariplo); Regione Lombardia (Italy)(Regione Lombardia); Swedish Research Council (VR)(Swedish Research Council); University of Rome Sapienza	Supported by ERC-P-ReXS project 2016-0790 of the Fondazione CARIPLO and Regione Lombardia (Italy); the Swedish Research Council (VR) under the project 2017-00382 "Evolution of nanoscale charge order in superconducting YBCO nanostructures" (R. A.); and the University of Rome Sapienza, under the projects Ateneo 2017 prot. RM11715C642E8370 and Ateneo 2018 prot. RM11816431DBA5AF (S. C., C. D. C., and M. G.).	Andergassen S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.056401; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; ANDERSON PW, 1990, PHYS REV LETT, V64, P1839, DOI 10.1103/PhysRevLett.64.1839; Arpaia R, 2018, PHY REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.024804; Arpaia R, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.064525; Badoux S, 2016, NATURE, V531, P210, DOI 10.1038/nature16983; Becca F, 1996, PHYS REV B, V54, P12443, DOI 10.1103/PhysRevB.54.12443; Bianconi A, 1996, PHYS REV LETT, V76, P3412, DOI 10.1103/PhysRevLett.76.3412; Bluschke M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05434-8; Brookes NB, 2018, NUCL INSTRUM METH A, V903, P175, DOI 10.1016/j.nima.2018.07.001; Cai RG, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.181601; Campi G, 2015, NATURE, V525, P359, DOI 10.1038/nature14987; Caprara S, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.224511; Castellani C, 1997, Z PHYS B CON MAT, V103, P137, DOI 10.1007/s002570050347; CASTELLANI C, 1995, PHYS REV LETT, V75, P4650, DOI 10.1103/PhysRevLett.75.4650; Chaix L, 2017, NAT PHYS, V13, P952, DOI 10.1038/NPHYS4157; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Comin R, 2016, ANNU REV CONDEN MA P, V7, P369, DOI 10.1146/annurev-conmatphys-031115-011401; Croft TP, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.224513; Neto EHD, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.161114; Gerber S, 2015, SCIENCE, V350, P949, DOI 10.1126/science.aac6257; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Grbic MS, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144508; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014533; Hussey NE, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/12/123201; Jang H, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.224513; Kaminski A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207003; Kohsaka Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.097004; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Miao H, 2017, P NATL ACAD SCI USA, V114, P12430, DOI 10.1073/pnas.1708549114; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Montiel X, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.104510; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Peng YY, 2017, NAT PHYS, V13, P1201, DOI 10.1038/NPHYS4248; Rice TM, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016502; Sachdev S, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.115147; Salluzzo M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134521; Seibold G, 2000, EUR PHYS J B, V13, P87, DOI 10.1007/s100510050013; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; Wu T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7438; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345	51	69	69	6	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					906	+		10.1126/science.aav1315	http://dx.doi.org/10.1126/science.aav1315			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467219	Green Submitted			2022-12-28	WOS:000483975800043
J	Sacks, CA				Sacks, Chana A.			Multiple Renal Arteries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					862	862		10.1056/NEJMicm1902894	http://dx.doi.org/10.1056/NEJMicm1902894			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461596				2022-12-28	WOS:000484431200013
J	His, M				His, Mathilde			Stand out as a speaker	SCIENCE			English	Editorial Material									[His, Mathilde] Int Agcy Res Canc, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	His, M (corresponding author), Int Agcy Res Canc, Lyon, France.			His, Mathilde/0000-0003-3850-8291					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		834	834		10.1126/science.365.6455.834	http://dx.doi.org/10.1126/science.365.6455.834			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439800				2022-12-28	WOS:000482464000056
J	Wallingford, JB				Wallingford, John B.			The 200-year effort to see the embryo	SCIENCE			English	Editorial Material									[Wallingford, John B.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Wallingford, JB (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	wallingford@austin.utexas.edu			NICHD; NHLBI	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	I thank J. Wellman and J. Wittbrodt for thoughtful conversations and E. Roberson and D. Dickinson for critical reading. This work is supported by the NICHD and by the NHLBI.	BURNSIDE MB, 1968, DEV BIOL, V18, P537, DOI 10.1016/0012-1606(68)90025-0; Harland RM, 2018, SCIENCE, V360, P967, DOI 10.1126/science.aat8413; Hopwood N, 2005, HIST SCI, V43, P239, DOI 10.1177/007327530504300302; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; JACOBSON AG, 1976, J EXP ZOOL, V197, P191, DOI 10.1002/jez.1401970205; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Landecker H, 2006, ISIS, V97, P121, DOI 10.1086/501105; McDole K, 2018, CELL, V175, P859, DOI 10.1016/j.cell.2018.09.031; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Stramer BM, 2015, J CELL SCI, V128, P9, DOI 10.1242/jcs.165019; von Baer K. E., 1866, AUTOBIOGRAPHY KE VON; Wellmann J, 2018, HIST PHIL LIFE SCI, V40, DOI 10.1007/s40656-018-0223-0; Wellmann Janina, 2017, FORM BECOMING EMBRYO	15	8	8	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		758	759		10.1126/science.aaw7565	http://dx.doi.org/10.1126/science.aaw7565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439785				2022-12-28	WOS:000482464000031
J	Choudhury, SR; Babes, L; Rahn, JJ; Ahn, BY; Goring, KAR; King, JC; Lau, A; Petri, B; Hao, XG; Chojnacki, AK; Thanabalasuriar, A; McAvoy, EF; Tabaries, S; Schraeder, C; Pate, KD; Siegel, PM; Kopciuk, KA; Schriemer, DC; Muruve, DA; Kelly, MM; Yipp, BG; Kubes, P; Robbins, SM; Senger, DL				Choudhury, Saurav Roy; Babes, Liane; Rahn, Jennifer J.; Ahn, Bo-Young; Goring, Kimberly-Ann R.; King, Jennifer C.; Lau, Arthur; Petri, Bjorn; Hao, Xiaoguang; Chojnacki, Andrew K.; Thanabalasuriar, Ajitha; McAvoy, Erin F.; Tabaries, Sebastien; Schraeder, Christoph; Pate, Kamala D.; Siegel, Peter M.; Kopciuk, Karen A.; Schriemer, David C.; Muruve, Daniel A.; Kelly, Margaret M.; Yipp, Bryan G.; Kubes, Paul; Robbins, Stephen M.; Senger, Donna L.			Dipeptidase-1 Is an Adhesion Receptor for Neutrophil Recruitment in Lungs and Liver	CELL			English	Article							RENAL MEMBRANE DIPEPTIDASE; SITE-DIRECTED MUTAGENESIS; LEUKOCYTE ADHESION; LYMPHOCYTE BINDING; LEUKOTRIENE D-4; PHAGE DISPLAY; CELL-ADHESION; MOUSE MODEL; SEPSIS; SEQUESTRATION	A hallmark feature of inflammation is the orchestrated recruitment of neutrophils from the bloodstream into inflamed tissue. Although selectins and integrins mediate recruitment in many tissues, they have a minimal role in the lungs and liver. Exploiting an unbiased in vivo functional screen, we identified a lung and liver homing peptide that functionally abrogates neutrophil recruitment to these organs. Using biochemical, genetic, and confocal intravital imaging approaches, we identified dipeptidase-1 (DPEP1) as the target and established its role as a physical adhesion receptor for neutrophil sequestration independent of its enzymatic activity. Importantly, genetic ablation or functional peptide blocking of DPEP1 significantly reduced neutrophil recruitment to the lungs and liver and provided improved survival in models of endotoxemia. Our data establish DPEP1 as a major adhesion receptor on the lung and liver endothelium and identify a therapeutic target for neutrophil-driven inflammatory diseases of the lungs.	[Choudhury, Saurav Roy; Babes, Liane; Rahn, Jennifer J.; Ahn, Bo-Young; Goring, Kimberly-Ann R.; King, Jennifer C.; Hao, Xiaoguang; Schraeder, Christoph; Kopciuk, Karen A.; Schriemer, David C.; Robbins, Stephen M.; Senger, Donna L.] Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB T2N 4N1, Canada; [Babes, Liane; Lau, Arthur; Petri, Bjorn; Chojnacki, Andrew K.; Thanabalasuriar, Ajitha; McAvoy, Erin F.; Pate, Kamala D.; Muruve, Daniel A.; Kelly, Margaret M.; Yipp, Bryan G.; Kubes, Paul] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada; [Petri, Bjorn] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Mouse Phen Resource Lab, Calgary, AB T2N 4N1, Canada; [Petri, Bjorn] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Schraeder, Christoph; Schriemer, David C.; Robbins, Stephen M.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Pate, Kamala D.; Kubes, Paul] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Kopciuk, Karen A.; Robbins, Stephen M.; Senger, Donna L.] Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Muruve, Daniel A.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB T2N 4N1, Canada; [Kelly, Margaret M.] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada; [Yipp, Bryan G.] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB T2N 4N1, Canada; [Tabaries, Sebastien; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kopciuk, Karen A.] Alberta Hlth Serv, Canc Control Alberta, Dept Canc Epidemiol & Prevent Res, Calgary, AB T2S 3C3, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; McGill University; Alberta Health Services (AHS); University of Calgary	Senger, DL (corresponding author), Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB T2N 4N1, Canada.; Senger, DL (corresponding author), Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB T2N 4N1, Canada.	senger@ucalgary.ca	Kelly, Margaret M/G-4128-2012	Kelly, Margaret M/0000-0002-1629-3210; Robbins, Stephen/0000-0001-7475-1665; Thanabalasuriar, Ajitha/0000-0001-6281-3013; Senger, Donna/0000-0003-2403-3395	Canadian Cancer Society; CIHR Team Grant in Health Challenges in Chronic Inflammation; CIHR; Kids Cancer Care Foundation	Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR Team Grant in Health Challenges in Chronic Inflammation(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Kids Cancer Care Foundation	This work has been supported by Canadian Cancer Society grants (to S.M.R. and D.L.S.), a CIHR Team Grant in Health Challenges in Chronic Inflammation (to P.K.), a CIHR grant (to S.M.R.), and a generous donation from the Robert C. Westbury Endowment (to D.L.S.). S.R.C. was supported by a studentship from the Kids Cancer Care Foundation. A.L. is an Alberta Innovates Health Solutions (AIHS) Postdoctoral Fellow. P.M.S. is aMcGill University William Dawson Scholar. D.A.M. is a Tier II Canada Research Chair (CRC) in Inflammation, Personalized Medicine, and Kidney Disease. B.G.Y. is a Tier IICRC in Pulmonary Immunology. P.K. is an AIHS Scientist, Tier I CRC in Leukocyte Recruitment in Inflammatory Disease and holds the Snyder Chair in Critical Care Medicine, Cumming School of Medicine, University of Calgary. We would like to thank the following cores at the University of Calgary: Kenichi Ito from the Centre for Genome Engineering for genotyping the DPEP1 mouse colonies, the SAMS Centre for providing MS services, and the Live Cell Imaging Resource Lab within the Snyder Institute under the leadership of Dr. Pina Colarusso. We also thank Evelyn Lailey for providing human neutrophils and Leah Auramenko for performing blood counts at the Health Science Animal Resource Centre.	ADACHI H, 1989, J BIOCHEM-TOKYO, V105, P957, DOI 10.1093/oxfordjournals.jbchem.a122787; ADACHI H, 1993, BIOCHIM BIOPHYS ACTA, V1163, P42, DOI 10.1016/0167-4838(93)90276-W; AIRAS L, 1993, J IMMUNOL, V151, P4228; AIRAS L, 1995, J EXP MED, V182, P1603, DOI 10.1084/jem.182.5.1603; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Babes L, 2016, METHODS MOL BIOL, V1458, P203, DOI 10.1007/978-1-4939-3801-8_15; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; Brown K Alun, 2006, Discov Med, V6, P118; CAMPBELL BJ, 1984, J BIOL CHEM, V259, P4586; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; Essler M, 2002, P NATL ACAD SCI USA, V99, P2252, DOI 10.1073/pnas.251687998; Fox-Robichaud A, 2000, HEPATOLOGY, V31, P1123, DOI 10.1053/he.2000.6961; Genga KR, 2017, J INNATE IMMUN, V9, P441, DOI 10.1159/000477419; Girbl T, 2018, IMMUNITY, V49, P1062, DOI 10.1016/j.immuni.2018.09.018; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Habib GM, 2003, FASEB J, V17, P1313, DOI 10.1096/fj.02-0899fje; Habib GM, 1999, ADV EXP MED BIOL, V469, P295; Habib GM, 1998, P NATL ACAD SCI USA, V95, P4859, DOI 10.1073/pnas.95.9.4859; Hanna S, 2012, ANN NY ACAD SCI, V1250, P50, DOI 10.1111/j.1749-6632.2011.06389.x; Hein Z, 2009, EXP CELL RES, V315, P348, DOI 10.1016/j.yexcr.2008.10.038; HELLMAN P, 1994, AIDS RES HUM RETROV, V10, P391, DOI 10.1089/aid.1994.10.391; HEYWOOD SP, 1995, ANAL BIOCHEM, V226, P10, DOI 10.1006/abio.1995.1184; Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3; Hothorn T, 2008, J STAT SOFTW, V28, P1; Iskander KN, 2013, CRIT CARE MED, V41, P159, DOI 10.1097/CCM.0b013e3182676322; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; KAHAN FM, 1983, J ANTIMICROB CHEMOTH, V12, P1; Kellum JA, 2018, NAT REV NEPHROL, V14, P217, DOI 10.1038/nrneph.2017.184; Keynan S, 1997, BIOCHEM J, V326, P47, DOI 10.1042/bj3260047; Keynan S, 1996, BIOCHEMISTRY-US, V35, P12511, DOI 10.1021/bi961193z; KEYNAN S, 1994, FEBS LETT, V349, P50, DOI 10.1016/0014-5793(94)00637-7; KEYNAN S, 1995, ANTIMICROB AGENTS CH, V39, P1629, DOI 10.1128/AAC.39.7.1629; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; KROPP H, 1982, ANTIMICROB AGENTS CH, V22, P62, DOI 10.1128/AAC.22.1.62; Lau A, 2018, J CLIN INVEST, V128, P2894, DOI 10.1172/JCI96640; Lee EKS, 2018, CELL HOST MICROBE, V23, P121, DOI 10.1016/j.chom.2017.11.009; Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li JH, 2014, CRIT CARE MED, V42, pE85, DOI 10.1097/01.ccm.0000435672.45564.1f; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Marki A, 2015, J LEUKOCYTE BIOL, V98, P503, DOI 10.1189/jlb.3MR0115-011R; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Mizgerd JP, 1996, J EXP MED, V184, P639, DOI 10.1084/jem.184.2.639; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Nitanai Y, 2002, J MOL BIOL, V321, P177, DOI 10.1016/S0022-2836(02)00632-0; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Patel KD, 1998, BLOOD, V92, P3904, DOI 10.1182/blood.V92.10.3904.422k41_3904_3911; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Rajotte D, 1999, J BIOL CHEM, V274, P11593, DOI 10.1074/jbc.274.17.11593; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Salmi M, 2006, BLOOD, V108, P1555, DOI 10.1182/blood-2005-11-4599; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Team RC., 2013, R LANG ENV STAT COMP; Thornton E. E., 2012, CURR PROTOC CYTOM, V12, P28; Vianna RCS, 2004, SHOCK, V21, P115, DOI 10.1097/01.shk.0000111828.07309.26; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Yipp BG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8929; Yoshida K, 2006, AM J RESP CRIT CARE, V174, P689, DOI 10.1164/rccm.200502-276OC	88	46	50	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1205	+		10.1016/j.cell.2019.07.017	http://dx.doi.org/10.1016/j.cell.2019.07.017			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442408	Bronze			2022-12-28	WOS:000482191000016
J	Reith, G; Wardle, H; Gilmore, I				Reith, Gerda; Wardle, Heather; Gilmore, Ian			Gambling harm: a global problem requiring global solutions	LANCET			English	Editorial Material							HEALTH		[Reith, Gerda] Univ Glasgow, Sch Social & Polit Sci, Glasgow, Lanark, Scotland; [Wardle, Heather] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England; [Gilmore, Ian] Univ Liverpool, Liverpool Ctr Alcohol Res, Liverpool, Merseyside, England	University of Glasgow; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool	Wardle, H (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England.	heather.wardle@lshtm.ac.uk						[Anonymous], 2017, ECONOMIST; Brandt A, 2007, CIGARETTE CENTURY; Coroners Court of Victoria, 2013, COR PREV UN GAMBL RE; Cowlishaw S, 2016, EUR ADDICT RES, V22, P90, DOI 10.1159/000437260; Gambling Compliance, 2019, AFR GAMBL OUTL 2019; Igadwah L, 2019, MATIANGI FIRES WARNI; Karlsson A, 2018, J BEHAV ADDICT, V7, P1091, DOI 10.1556/2006.7.2018.112; Liggero R., WHY AFRICA IS NEW BI; Mbula R, 2019, CS MATIANGI WARNS BE; Reith, 2018, ADDICTIVE CONSUMPTIO; The World Health Organisation, 2017, WHO FOR ALC DRUGS AD; van Schalkwyk MCI, 2019, LANCET, V393, P1680, DOI 10.1016/S0140-6736(19)30704-4; Wardle H., 2019, PROBLEM GAMBLING SUI; Wardle H, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1807; Wardle Heather, 2018, MEASURING GAMBLING R	15	14	14	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1212	1214		10.1016/S0140-6736(19)31991-9	http://dx.doi.org/10.1016/S0140-6736(19)31991-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8XK	31443927	Green Accepted			2022-12-28	WOS:000488862500007
J	Whiffin, N; Ware, JS; O'Donnell-Luria, A				Whiffin, Nicola; Ware, James S.; O'Donnell-Luria, Anne			Improving the Understanding of Genetic Variants in Rare Disease With Large-scale Reference Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPACT		[Whiffin, Nicola; Ware, James S.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Whiffin, Nicola; Ware, James S.] Royal Brompton & Harefield NHS Fdn Trust, Cardiovasc Res Ctr, London, England; [Whiffin, Nicola; Ware, James S.] Imperial Coll London, MRC London Inst Med Sci, London, England; [Whiffin, Nicola; Ware, James S.; O'Donnell-Luria, Anne] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [O'Donnell-Luria, Anne] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [O'Donnell-Luria, Anne] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	O'Donnell-Luria, A (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.	odonnell@broadinstitute.org	W, Nicola/AAG-3227-2020; Ware, James S/G-5139-2012	W, Nicola/0000-0003-1554-6594; Ware, James S/0000-0002-6110-5880; O'Donnell-Luria, Anne/0000-0001-6418-9592	Medical Research Council (United Kingdom); National Institute for Health Research Imperial Biomedical Research Centre, a Rosetrees/Stoneygate Imperial College Research Fellowship; Wellcome Trust [107469/Z/15/Z]; Boston Children's Hospital Office of Faculty Development Fellowship; National Institutes of Health [K12 HD052896, UM1 HG008900]; MRC [MC_UP_1102/20] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Imperial Biomedical Research Centre, a Rosetrees/Stoneygate Imperial College Research Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Boston Children's Hospital Office of Faculty Development Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are supported by the Medical Research Council (United Kingdom), the National Institute for Health Research Imperial Biomedical Research Centre, a Rosetrees/Stoneygate Imperial College Research Fellowship (Dr Whiffin), theWellcome Trust (107469/Z/15/Z; DrWare), the Boston Children's Hospital Office of Faculty Development Fellowship, and National Institutes of Health (K12 HD052896 and UM1 HG008900; Dr O'Donnell-Luria).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Minikel EV, 2016, NEURON, V92, P336, DOI 10.1016/j.neuron.2016.09.054; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Walsh Roddy, 2017, Genet Med, V19, P192, DOI 10.1038/gim.2016.90; Whiffin N, 2017, GENET MED, V19, P1151, DOI 10.1038/gim.2017.26	8	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1305	1306		10.1001/jama.2019.12891	http://dx.doi.org/10.1001/jama.2019.12891			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31469401				2022-12-28	WOS:000489331900018
J	Voelker, R				Voelker, Rebecca			Pigs Model Human Brains, Snake Fangs Inspire Microneedles, and Canines Advance Cardiac Imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News article discusses how pigs, rear-fanged snakes, and dogs may help improve our understanding of brain connectivity, vaccine delivery, and myocardial oxygenation.											0	0	0	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1130	1131		10.1001/jama.2019.12580	http://dx.doi.org/10.1001/jama.2019.12580			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31483445				2022-12-28	WOS:000488822800002
J	D'Anci, KE; Uhl, S; Giradi, G; Martin, C				D'Anci, Kristen E.; Uhl, Stacey; Giradi, Gina; Martin, Constance			Treatments for the Prevention and Management of Suicide A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; DIALECTICAL BEHAVIOR-THERAPY; COLLABORATIVE ASSESSMENT; IDEATION; RISK; REDUCTION; KETAMINE; ADULTS	Background: Suicide is a growing public health problem, with the national rate in the United States increasing by 30% from 2000 to 2016. Purpose: To assess the benefits and harms of nonpharmacologic and pharmacologic interventions to prevent suicide and reduce suicide behaviors in at-risk adults. Data Sources: MEDLINE, EMBASE, PsycINFO, and other databases from November 2011 through May 2018. Study Selection: Systematic reviews (SRs) and randomized controlled trials (RCTs) that assessed nonpharmacologic or pharmacologic therapies for adults at risk for suicide. Data Extraction: One investigator abstracted data and assessed study quality, and a second investigator checked abstractions and assessments for accuracy. Data Synthesis: Eight SRs and 15 RCTs were included. The evidence for psychological interventions suggests that cognitive behavioral therapy (CBT) reduces suicide attempts, suicidal ideation, and hopelessness compared with treatment as usual (TAU). Limited evidence suggests that dialectical behavior therapy (DBT) reduces suicidal ideation compared with wait-list control or crisis planning. The evidence for pharmacologic treatments suggests that ketamine reduces suicidal ideation with minimal adverse events compared with placebo or midazolam. Lithium reduces rates of suicide among patients with unipolar or bipolar mood disorders compared with placebo. However, no differences were observed between lithium and other medications in reducing suicide. Limitation: Qualitative synthesis of new evidence with existing meta-analyses, methodological shortcomings of studies, heterogeneity of nonpharmacologic interventions, and limited evidence for pharmacologic treatments and harms. Conclusion: Both CBT and DBT showed modest benefit in reducing suicidal ideation compared with TAU or wait-list control, and CBT also reduced suicide attempts compared with TAU. Ketamine and lithium reduced the rate of suicide compared with placebo, but there was limited information on harms. Limited data are available to support the efficacy of other nonpharmacologic or pharmacologic interventions. Primary Funding Source: U.S. Department of Veterans Affairs Veterans Health Administration. (PROSPERO: CRD42018104978)	[D'Anci, Kristen E.; Uhl, Stacey; Giradi, Gina; Martin, Constance] Plymouth Meeting Penn, Plymouth Meeting, PA 19462 USA; [D'Anci, Kristen E.; Uhl, Stacey; Giradi, Gina; Martin, Constance] Plymouth Meeting Penn, Ctr Clin Evidence & Guidelines, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA		D'Anci, KE (corresponding author), Plymouth Meeting Penn, Ctr Clin Evidence & Guidelines, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA.	kdanci@ecri.org			U.S. Department of Veterans Affairs Veterans Health Administration	U.S. Department of Veterans Affairs Veterans Health Administration(US Department of Veterans Affairs)	By the U.S. Department of Veterans Affairs Veterans Health Administration.	Andreasson K, 2016, DEPRESS ANXIETY, V33, P520, DOI 10.1002/da.22472; Andreoli A, 2016, J PERS DISORD, V30, P271, DOI 10.1521/pedi_2015_29_196; Aquin JP, 2017, CAN J PSYCHIAT, V62, P473, DOI 10.1177/0706743717694836; Ballard M, 2017, RES SYNTH METHODS, V8, P92, DOI 10.1002/jrsm.1229; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Bryan CJ, 2017, J AFFECT DISORDERS, V212, P64, DOI 10.1016/j.jad.2017.01.028; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Collings S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5032-6; Fan W, 2017, ONCOTARGET, V8, P2356, DOI 10.18632/oncotarget.13743; Goodman M, 2016, J CLIN PSYCHIAT, V77, pE1591, DOI 10.4088/JCP.15m10235; Gotzsche PC, 2017, J ROY SOC MED, V110, P404, DOI 10.1177/0141076817731904; Grunebaum MF, 2018, AM J PSYCHIAT, V175, P327, DOI 10.1176/appi.ajp.2017.17060647; Guille C, 2015, JAMA PSYCHIAT, V72, P1192, DOI 10.1001/jamapsychiatry.2015.1880; Hawton K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012189; Hawton K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011777; Jobes DA, 2017, PSYCHIATRY, V80, P339, DOI 10.1080/00332747.2017.1354607; Leavey K, 2017, COGN BEHAV THERAPY, V46, P353, DOI 10.1080/16506073.2017.1332095; McMain SF, 2017, ACTA PSYCHIAT SCAND, V135, P138, DOI 10.1111/acps.12664; Mousavi Seyed Ghafur, 2017, Adv Biomed Res, V6, P38, DOI 10.4103/2277-9175.204586; Riblet NBV, 2017, BRIT J PSYCHIAT, V210, P396, DOI 10.1192/bjp.bp.116.187799; Schunemann H, GRADE HDB HDB GRADIN; Substance Abuse and Mental Health Services Administration Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health, 2018, NSDUH SER; U. S. Department of Veterans Affairs, 2013, GUID GUID; U.S. Preventive Services Task Force, 2020, PROC MAN; US Department of Veterans Affairs, VA DOD CLIN PRACT GU; van Spijker BAJ, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8595; Wilkinson ST, 2018, AM J PSYCHIAT, V175, P150, DOI 10.1176/appi.ajp.2017.17040472; Witt K, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1458-0; Yovell Y, 2016, AM J PSYCHIAT, V173, P491, DOI 10.1176/appi.ajp.2015.15040535	29	51	52	3	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2019	171	5					334	+		10.7326/M19-0869	http://dx.doi.org/10.7326/M19-0869			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV9VD	31450239				2022-12-28	WOS:000484610900006
J	Nunez-Mulder, L; Chan, J				Nunez-Mulder, Laura; Chan, Jaime			The habitats of a medical student	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nunez-Mulder, Laura] Univ Cambridge, Cambridge, England; [Chan, Jaime] Univ Bristol, Bristol, Avon, England	University of Cambridge; University of Bristol	Nunez-Mulder, L (corresponding author), Univ Cambridge, Cambridge, England.	laura.nunez-mulder@hotmail.co.uk						Ghani R., 2014, BMJ-BRIT MED J, V348, pg1380, DOI [10.1136/sbmj.g1380, DOI 10.1136/SBMJ.G1380]	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l2426	10.1136/sbmj.l2426	http://dx.doi.org/10.1136/sbmj.l2426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477566				2022-12-28	WOS:000485431800001
J	Nunez-Mulder, L				Nunez-Mulder, Laura			Growing older and wiser	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lauranunezmulder@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l4961	10.1136/bmj.l4961	http://dx.doi.org/10.1136/bmj.l4961			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477565				2022-12-28	WOS:000485431800003
J	Ohanesian, A				Ohanesian, Adriane			Picturing health: health services in refugee camps are helping South Sudanese women tell their stories of sexual violence	LANCET			English	Editorial Material																			0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					725	730		10.1016/S0140-6736(19)31969-5	http://dx.doi.org/10.1016/S0140-6736(19)31969-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UW	31478492				2022-12-28	WOS:000483011400015
J	Colucci, F				Colucci, Francesco			The immunological code of pregnancy	SCIENCE			English	Editorial Material									[Colucci, Francesco] Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Cambridge CB2 0SW, England; [Colucci, Francesco] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Ctr Trophoblast Res, Cambridge CB2 0SW, England	University of Cambridge; University of Cambridge	Colucci, F (corresponding author), Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Cambridge CB2 0SW, England.; Colucci, F (corresponding author), Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Ctr Trophoblast Res, Cambridge CB2 0SW, England.	fc287@medschl.cam.ac.uk	Colucci, Francesco/F-2844-2010	Colucci, Francesco/0000-0001-5193-6376	Wellcome Trust [200841/Z/16/Z.]	Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by Wellcome Trust grant 200841/Z/16/Z.	Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Burotto M, 2018, SEMIN ONCOL, V45, P164, DOI 10.1053/j.seminoncol.2018.03.003; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Filipovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06918-3; Gamliel M, 2018, IMMUNITY, V48, P951, DOI 10.1016/j.immuni.2018.03.030; Kieckbusch J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4359; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Robertson SA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00478; Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Walejko JM, 2018, METABOLITES, V8, DOI 10.3390/metabo8010010	15	17	17	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					862	863		10.1126/science.aaw1300	http://dx.doi.org/10.1126/science.aaw1300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467207	Green Submitted			2022-12-28	WOS:000483975800024
J	Roberts, N				Roberts, Neil			How humans changed the face of Earth	SCIENCE			English	Editorial Material							HOLOCENE		[Roberts, Neil] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England; [Roberts, Neil] Univ Oxford, Sch Archaeol, Oxford, England	University of Plymouth; University of Oxford	Roberts, N (corresponding author), Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England.; Roberts, N (corresponding author), Univ Oxford, Sch Archaeol, Oxford, England.	c.n.roberts@plymouth.ac.uk						ArchaeoGLOBE Project, 2019, SCIENCE, V365, P897; Goldewijk KK, 2017, EARTH SYST SCI DATA, V9, P927, DOI 10.5194/essd-9-927-2017; Harrison S. P., 2019, GEOSCI MODEL DEV DIS, DOI [10.5194/gmd-2019-125, DOI 10.5194/GMD-2019-125]; IPCC, 2019, CLIM CHANG LAND SUMM; Kaplan JO, 2017, LAND-BASEL, V6, DOI 10.3390/land6040091; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Li F., 2018, GLOB CHANGES MAG, V26, P32; Rackham O, 2003, ANCIENT WOODLAND ITS; Roberts N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18646-7; Ruddiman WF, 2016, REV GEOPHYS, V54, P93, DOI 10.1002/2015RG000503; Smith BD, 2013, ANTHROPOCENE, V4, P8, DOI 10.1016/j.ancene.2013.05.001	11	9	9	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					865	866		10.1126/science.aay4627	http://dx.doi.org/10.1126/science.aay4627			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467209				2022-12-28	WOS:000483975800026
J	Nagai, M; Noguchi, R; Takahashi, D; Morikawa, T; Koshida, K; Komiyama, S; Ishihara, N; Yamada, T; Kawamura, YI; Muroi, K; Hattori, K; Kobayashi, N; Fujimura, Y; Hirota, M; Matsumoto, R; Aoki, R; Tamura-Nakano, M; Sugiyama, M; Katakai, T; Sato, S; Takubo, K; Dohi, T; Hase, K				Nagai, Motoyoshi; Noguchi, Ryotaro; Takahashi, Daisuke; Morikawa, Takayuki; Koshida, Kouhei; Komiyama, Seiga; Ishihara, Narumi; Yamada, Takahiro; Kawamura, Yuki, I; Muroi, Kisara; Hattori, Kouya; Kobayashi, Nobuhide; Fujimura, Yumiko; Hirota, Masato; Matsumoto, Ryohtaroh; Aoki, Ryo; Tamura-Nakano, Miwa; Sugiyama, Machiko; Katakai, Tomoya; Sato, Shintaro; Takubo, Keiyo; Dohi, Taeko; Hase, Koji			Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses	CELL			English	Article							REGULATORY T-CELLS; ORAL TOLERANCE; GLUCOSE-METABOLISM; LYMPH-NODES; HOMEOSTASIS; MICE; NUTRITION; DIET; IGA; REGENERATION	Nutritional status potentially influences immune responses; however, how nutritional signals regulate cellular dynamics and functionality remains obscure. Herein, we report that temporary fasting drastically reduces the number of lymphocytes by similar to 50% in Peyer's patches (PPs), the inductive site of the gut immune response. Subsequent refeeding seemingly restored the number of lymphocytes, but whose cellular composition was conspicuously altered. A large portion of germinal center and IgA(+) B cells were lost via apoptosis during fasting. Meanwhile, naive B cells migrated from PPs to the bone marrow during fasting and then back to PPs during refeeding when stromal cells sensed nutritional signals and upregulated CXCL13 expression to recruit naive B cells. Furthermore, temporal fasting before oral immunization with ovalbumin abolished the induction of antigen-specific IgA, failed to induce oral tolerance, and eventually exacerbated food antigen-induced diarrhea. Thus, nutritional signals are critical in maintaining gut immune homeostasis.	[Nagai, Motoyoshi; Noguchi, Ryotaro; Takahashi, Daisuke; Koshida, Kouhei; Komiyama, Seiga; Ishihara, Narumi; Yamada, Takahiro; Muroi, Kisara; Hattori, Kouya; Kobayashi, Nobuhide; Fujimura, Yumiko; Hirota, Masato; Matsumoto, Ryohtaroh; Dohi, Taeko; Hase, Koji] Keio Univ, Fac Pharm, Div Biochem, Tokyo 1058512, Japan; [Nagai, Motoyoshi; Noguchi, Ryotaro; Takahashi, Daisuke; Koshida, Kouhei; Komiyama, Seiga; Ishihara, Narumi; Yamada, Takahiro; Muroi, Kisara; Hattori, Kouya; Kobayashi, Nobuhide; Fujimura, Yumiko; Hirota, Masato; Matsumoto, Ryohtaroh; Dohi, Taeko; Hase, Koji] Keio Univ, Grad Sch Pharmaceut Sci, Tokyo 1058512, Japan; [Nagai, Motoyoshi; Noguchi, Ryotaro; Kawamura, Yuki, I; Sugiyama, Machiko; Dohi, Taeko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Dept Gastroenterol, Res Inst, Chiba 2728516, Japan; [Morikawa, Takayuki; Takubo, Keiyo] Natl Ctr Global Hlth & Med, Res Inst, Dept Stem Cell Biol, Tokyo 1628655, Japan; [Aoki, Ryo] Keio Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo 1608582, Japan; [Aoki, Ryo] Ezaki Glico Co Ltd, Inst Hlth Sci, Osaka 5558502, Japan; [Tamura-Nakano, Miwa] Natl Ctr Global Hlth & Med, Res Inst, Communal Lab, Tokyo 1628655, Japan; [Sugiyama, Machiko] Yokohama City Univ, Grad Sch Med Life Sci, Lab Immunobiol, Yokohama, Kanagawa 230045, Japan; [Katakai, Tomoya] Niigata Univ, Grad Sch Med & Dent Sci, Dept Immunol, Niigata 9518510, Japan; [Sato, Shintaro] Osaka Univ, Res Inst Microbial Dis, BIKEN Innovat Vaccine Res Alliance Labs, Mucosal Vaccine Project, Osaka 5650871, Japan; [Sato, Shintaro; Hase, Koji] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Tokyo 1088639, Japan	Keio University; Keio University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Keio University; Ezaki Glico Co., Ltd.; National Center for Global Health & Medicine - Japan; Yokohama City University; Niigata University; Osaka University; University of Tokyo	Hase, K (corresponding author), Keio Univ, Fac Pharm, Div Biochem, Tokyo 1058512, Japan.; Hase, K (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Tokyo 1058512, Japan.; Hase, K (corresponding author), Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Tokyo 1088639, Japan.	hase-kj@pha.keio.ac.jp	Takubo, Keiyo/AAX-5546-2020; Katakai, Tomoya/AAX-1434-2021; Takahashi, Daisuke/C-3799-2019	Takubo, Keiyo/0000-0002-1736-7592; Takahashi, Daisuke/0000-0001-8624-1160; Sato, Shintaro/0000-0001-5156-3354; Takahiro, Yamada/0000-0003-2613-5600; Kobayashi, Nobuhide/0000-0002-8410-4821; Hirota, Masato/0000-0001-8184-3170	AMED-Crest [16gm1010004h0101, 17gm1010004h0102, 18gm1010004h0103]; Japan Society for the Promotion of Science [17KT0055, 16H01369, 18H04680, 25293114, 26116709]; Keio Gijuku Academic Development Funds; SECOM Science and Technology Foundation; Takeda Science Foundation; Science Research Promotion Fund, the Promotion and Mutual Aid Corporation for Private Schools of Japan; Daiichi Sankyo Foundation of Life Science; Terumo Foundation for Life Science and Arts; Nagase Science Technology Foundation; Tokyo Biochemical Research Foundation; National Center for Global Health and Medicine [26-110, 30-1006]; Yoshida Scholarship Foundation; Keio University	AMED-Crest; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio Gijuku Academic Development Funds; SECOM Science and Technology Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Science Research Promotion Fund, the Promotion and Mutual Aid Corporation for Private Schools of Japan; Daiichi Sankyo Foundation of Life Science; Terumo Foundation for Life Science and Arts; Nagase Science Technology Foundation; Tokyo Biochemical Research Foundation; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Yoshida Scholarship Foundation(Yoshida Scholarship Foundation); Keio University	We thank Yuuki Obata, Yutaka Nakamura, Naomi Hoshina, Hiroaki Shiratori, Yuma Kabumoto, Hiyori Tanabe, Seiji Minegishi, and Teruki Hagiwara for technical support as well as Michio Tomura, Heiichiro Udono and Yun-Gi Kim for their valuable discussion and technical consultation. This work was supported by AMED-Crest (16gm1010004h0101 and 17gm1010004h0102; 18gm1010004h0103 to K. Hase), the Japan Society for the Promotion of Science (17KT0055, 16H01369, 18H04680, 25293114, and 26116709 to K. Hase), Keio Gijuku Academic Development Funds (to K. Hase), the SECOM Science and Technology Foundation (to K. Hase), the Takeda Science Foundation (to K. Hase.), the Science Research Promotion Fund, the Promotion and Mutual Aid Corporation for Private Schools of Japan (to K. Hase), Daiichi Sankyo Foundation of Life Science (to K. Hase), Terumo Foundation for Life Science and Arts (to K. Hase), Nagase Science Technology Foundation (to K. Hase), The Tokyo Biochemical Research Foundation (to K. Hase), the National Center for Global Health and Medicine (26-110 and 30-1006 to Y. I. K), Yoshida Scholarship Foundation (to M. N.), and Keio University Doctorate Student Grantin-Aid Program (to M. N.).	Abbas A. K., 2014, CELLULAR MOL IMMUNOL, P299; Aghamohammadi A, 2009, J CLIN IMMUNOL, V29, P130, DOI 10.1007/s10875-008-9229-9; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cesta MF, 2006, TOXICOL PATHOL, V34, P599, DOI 10.1080/01926230600865531; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hu DD, 2019, PEDIATR RES, V85, P518, DOI 10.1038/s41390-018-0156-z; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kaufman DR, 2011, J IMMUNOL, V187, P1877, DOI 10.4049/jimmunol.1101248; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kunisada Y, 2017, EBIOMEDICINE, V25, P154, DOI 10.1016/j.ebiom.2017.10.009; Kunisawa J, 2015, CELL REP, V13, P122, DOI 10.1016/j.celrep.2015.08.063; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Lycke NY, 2017, MUCOSAL IMMUNOL, V10, P1361, DOI 10.1038/mi.2017.62; Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oh M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00367; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Okada T, 2017, J CLIN BIOCHEM NUTR, V61, P100, DOI 10.3164/jcbn.17-9; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rangan P, 2019, CELL REP, V26, P2704, DOI 10.1016/j.celrep.2019.02.019; Raybuck AL, 2018, J IMMUNOL, V200, P2627, DOI 10.4049/jimmunol.1701321; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SCHAFFER F M, 1991, Immunodeficiency Reviews, V3, P15; Schmidt TH, 2013, J EXP MED, V210, P1099, DOI 10.1084/jem.20122574; Schweighoffer E, 2018, CURR OPIN CELL BIOL, V51, P8, DOI 10.1016/j.ceb.2017.10.002; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Sreedhar A, 2017, ONCOTARGET, V8, P95504, DOI 10.18632/oncotarget.20762; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Suto H, 2009, INT IMMUNOL, V21, P467, DOI 10.1093/intimm/dxp014; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Tomura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06030; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; VanCott JL, 1996, J IMMUNOL, V156, P1504; Varanasi SK, 2017, J IMMUNOL, V199, P1748, DOI 10.4049/jimmunol.1700472; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wagenaar L, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800369; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yamaki K, 2014, IMMUNOL RES, V58, P106, DOI 10.1007/s12026-013-8478-8; Yamamoto M, 1998, J IMMUNOL, V160, P2188; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhang M, 2004, CELL MOL IMMUNOL, V1, P447	78	65	68	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1072	+		10.1016/j.cell.2019.07.047	http://dx.doi.org/10.1016/j.cell.2019.07.047			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442401	Bronze			2022-12-28	WOS:000482191000007
J	Soucie, JM				Soucie, J. Michael			Global Hemophilia Care: Data for Action	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Soucie, J. Michael] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Soucie, J. Michael] Synergy Amer, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Soucie, JM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E64, Atlanta, GA 30333 USA.	msoucie@cdc.gov						Evatt B, 2005, GUIDE DEV NATL PATIE; Evatt BL, 2006, HAEMOPHILIA, V12, P13, DOI 10.1111/j.1365-2516.2006.01256.x; Evatt BL, 2002, HAEMOPHILIA, V8, P153, DOI 10.1046/j.1365-2516.2002.00616.x; Iorio A, 2019, ANN INTERN MED, V171, P540, DOI 10.7326/M19-1208; JONES PK, 1991, ANN INTERN MED, V114, P641, DOI 10.7326/0003-4819-114-8-641; Mahlangu J, 2018, HAEMOPHILIA, V24, P15, DOI 10.1111/hae.13510; Manco-Johnson MJ, 2018, AM J HEMATOL, V93, pE137, DOI 10.1002/ajh.25076; Skinner MW, 2012, HAEMOPHILIA, V18, P1, DOI 10.1111/j.1365-2516.2012.02822.x; Soucie JM, 2010, AM J PREV MED, V38, pS475, DOI 10.1016/j.amepre.2009.12.023; Soucie JM, 1998, AM J HEMATOL, V59, P288, DOI 10.1002/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I	10	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2019	171	8					585	586		10.7326/M19-2535	http://dx.doi.org/10.7326/M19-2535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD4JV	31499524				2022-12-28	WOS:000489944700021
J	Ding, KY; Wang, JJ; Zhou, YX; Tian, H; Lu, L; Mazzarello, R; Jia, CL; Zhang, W; Rao, F; Ma, E				Ding, Keyuan; Wang, Jiangjing; Zhou, Yuxing; Tian, He; Lu, Lu; Mazzarello, Riccardo; Jia, Chunlin; Zhang, Wei; Rao, Feng; Ma, Evan			Phase-change heterostructure enables ultralow noise and drift for memory operation	SCIENCE			English	Article							PLANE-WAVE; CRYSTALLIZATION; NETWORK; COHP	Artificial intelligence and other data-intensive applications have escalated the demand for data storage and processing. New computing devices, such as phase-change random access memory (PCRAM)-based neuro-inspired devices, are promising options for breaking the von Neumann barrier by unifying storage with computing in memory cells. However, current PCRAM devices have considerable noise and drift in electrical resistance that erodes the precision and consistency of these devices. We designed a phase-change heterostructure (PCH) that consists of alternately stacked phase-change and confinement nanolayers to suppress the noise and drift, allowing reliable iterative RESET and cumulative SET operations for high-performance neuro-inspired computing. Our PCH architecture is amenable to industrial production as an intrinsic materials solution, without complex manufacturing procedure or much increased fabrication cost.	[Ding, Keyuan; Rao, Feng] Shenzhen Univ, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China; [Ding, Keyuan] Shenzhen Univ, Coll Optoelect Engn, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Shenzhen 518060, Peoples R China; [Wang, Jiangjing; Zhou, Yuxing; Zhang, Wei] Xi An Jiao Tong Univ, Ctr Adv Mat Performance Nanoscale, State Key Lab Mech Behav Mat, Xian 710049, Shaanxi, Peoples R China; [Wang, Jiangjing] Yulin Univ, Sch Chem & Chem Engn, Yulin 719000, Peoples R China; [Tian, He] Zhejiang Univ, Ctr Electron Microscopy, Sch Mat Sci & Engn, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Lu, Lu; Jia, Chunlin] Xian Jiaetong Univ, Sch Microelect, State Key Lab Mech Behav Mat, Xian 710049, Shaanxi, Peoples R China; [Mazzarello, Riccardo] Rhein Westfal TH Aachen, JARA FIT, Inst Theoret Solid State Phys, D-52074 Aachen, Germany; [Mazzarello, Riccardo] Rhein Westfal TH Aachen, JARA HPC, D-52074 Aachen, Germany; [Jia, Chunlin] Forschungszentrum Julich, Ernst Ruska Ctr Microscopy & Spect Electrons, D-52425 Julich, Germany; [Rao, Feng] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, State Key Lab Funct Mat Informat, Shanghai 200050, Peoples R China; [Ma, Evan] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Shenzhen University; Shenzhen University; Xi'an Jiaotong University; Yulin University; Zhejiang University; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; Chinese Academy of Sciences; Shanghai Institute of Microsystem & Information Technology, CAS; Johns Hopkins University	Rao, F (corresponding author), Shenzhen Univ, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China.; Zhang, W (corresponding author), Xi An Jiao Tong Univ, Ctr Adv Mat Performance Nanoscale, State Key Lab Mech Behav Mat, Xian 710049, Shaanxi, Peoples R China.; Rao, F (corresponding author), Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, State Key Lab Funct Mat Informat, Shanghai 200050, Peoples R China.; Ma, E (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	wzhangO@mail.xjtu.edu.cn; fengrao@szu.edu.cn; ema@jhu.edu	Wang, Jiangjing/AAD-2136-2021; Tian, He/AAS-7880-2020; Mazzarello, Riccardo/G-4502-2014; xjtu, campnano/Q-1904-2015; Zhou, Yuxing/AAA-3958-2020; Zhang, Wei/P-3546-2019; Zhang, Wei/I-3541-2012	Wang, Jiangjing/0000-0001-7327-8159; Mazzarello, Riccardo/0000-0003-2319-375X; Zhou, Yuxing/0000-0001-8061-3867; Zhang, Wei/0000-0002-0720-4781; Ding, Keyuan/0000-0002-4234-4341; Rao, Feng/0000-0002-6922-5393; Tian, He/0000-0003-2108-3100; Ma, Evan/0000-0002-7468-4340	National Natural Science Foundation of China [11474249, 61622408, 61774123]; Major Provincial Basic Research Program of Guangdong [2017KZDXM070]; Science and Technology Foundation of Shenzhen [JCYJ20180507182248605]; 111 Project 2.0 [BP2018008]; U.S. Department of Energy (DOE) DOE-BES-DMSE [DE-FG02-16ER46056]; National 973 Program of China [2015CB654901]; Deutsche Forschungsgemeinschaft (DFG) [SFB 917]; National Supercomputing Center TianHe-2 (A) in Guangzhou; HPC platform; International Joint Laboratory for Micro/Nano Manufacturing and Measurement Technologies at Xi'an Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Provincial Basic Research Program of Guangdong; Science and Technology Foundation of Shenzhen; 111 Project 2.0; U.S. Department of Energy (DOE) DOE-BES-DMSE(United States Department of Energy (DOE)); National 973 Program of China(National Basic Research Program of China); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Supercomputing Center TianHe-2 (A) in Guangzhou; HPC platform; International Joint Laboratory for Micro/Nano Manufacturing and Measurement Technologies at Xi'an Jiaotong University	F.R. thanks the National Natural Science Foundation of China (61622408), the Major Provincial Basic Research Program of Guangdong (2017KZDXM070), and the Science and Technology Foundation of Shenzhen (JCYJ20180507182248605). W.Z. thanks the support of National Natural Science Foundation of China (61774123) and 111 Project 2.0 (BP2018008). E.M. is supported at Johns Hopkins University by U.S. Department of Energy (DOE) DOE-BES-DMSE under grant DE-FG02-16ER46056. H.T. thanks the National 973 Program of China(2015CB654901) and the National Natural Science Foundation of China (11474249). RM. and C.J. acknowledge funding from Deutsche Forschungsgemeinschaft (DFG) within SFB 917 ("Nanoswitches"). The authors also acknowledge the support by National Supercomputing Center TianHe-2 (A) in Guangzhou and by the HPC platform and the International Joint Laboratory for Micro/Nano Manufacturing and Measurement Technologies at Xi'an Jiaotong University.	Ambrogio S, 2018, NATURE, V558, P60, DOI 10.1038/s41586-018-0180-5; Boniardi M, 2019, PHYS STATUS SOLIDI-R, V13, DOI 10.1002/pssr.201800634; Boniardi M, 2010, IEEE T ELECTRON DEV, V57, P2690, DOI 10.1109/TED.2010.2058771; Boybat I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04933-y; Caravati S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014201; Cassinerio M, 2013, ADV MATER, V25, P5975, DOI 10.1002/adma.201301940; Chong TC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2181191; Deringer VL, 2011, J PHYS CHEM A, V115, P5461, DOI 10.1021/jp202489s; DRONSKOWSKI R, 1993, J PHYS CHEM-US, V97, P8617, DOI 10.1021/j100135a014; Fantini P, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2215621; Feldmann J, 2019, NATURE, V569, P208, DOI 10.1038/s41586-019-1157-8; Fong SW, 2017, IEEE T ELECTRON DEV, V64, P4374, DOI 10.1109/TED.2017.2746342; Fuller EJ, 2019, SCIENCE, V364, P570, DOI 10.1126/science.aaw5581; Giannopoulos I, 2018, INT EL DEVICES MEET; Goedecker S, 1996, PHYS REV B, V54, P1703, DOI 10.1103/PhysRevB.54.1703; Hegedus J, 2010, PHYS STATUS SOLIDI A, V207, P510, DOI 10.1002/pssa.200982664; Hu YC, 2018, P NATL ACAD SCI USA, V115, P6375, DOI 10.1073/pnas.1802300115; Hutter J, 2014, WIRES COMPUT MOL SCI, V4, P15, DOI 10.1002/wcms.1159; Ielmini D, 2018, NAT ELECTRON, V1, P333, DOI 10.1038/s41928-018-0092-2; Jiang T.-T., 2019, ARXIV190410601CONDMA; Jiang TT, 2019, APL MATER, V7, DOI 10.1063/1.5102075; Kim W., 2016, INT EL DEV M, V2016; Koelmans WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9181; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kuhne TD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.066401; Kuzum D, 2012, NANO LETT, V12, P2179, DOI 10.1021/nl201040y; Le Gallo M, 2018, NAT ELECTRON, V1, P246, DOI 10.1038/s41928-018-0054-8; Lee S. H., 2004, VLSI, V2004, P20; Ma RS, 2019, 2D MATER, V6, DOI 10.1088/2053-1583/ab34fb; Maintz S, 2016, J COMPUT CHEM, V37, P1030, DOI 10.1002/jcc.24300; Maintz S, 2013, J COMPUT CHEM, V34, P2557, DOI 10.1002/jcc.23424; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Mitrofanov KV, 2019, PHYS STATUS SOLIDI-R, V13, DOI 10.1002/pssr.201900105; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Orava J, 2012, NAT MATER, V11, P279, DOI [10.1038/NMAT3275, 10.1038/nmat3275]; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rao F, 2017, SCIENCE, V358, P1423, DOI 10.1126/science.aao3212; Rao F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10040; Raty JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8467; Rios C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau5759; Salinga M, 2018, NAT MATER, V17, P681, DOI 10.1038/s41563-018-0110-9; Sebastian A, 2018, J APPL PHYS, V124, DOI 10.1063/1.5042413; Sebastian A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01481-9; Shen JB, 2019, ACS APPL MATER INTER, V11, P5336, DOI 10.1021/acsami.8b18473; Simpson RE, 2011, NAT NANOTECHNOL, V6, P501, DOI [10.1038/NNANO.2011.96, 10.1038/nnano.2011.96]; Sun ZM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055507; Tuma T, 2016, NAT NANOTECHNOL, V11, P693, DOI [10.1038/nnano.2016.70, 10.1038/NNANO.2016.70]; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; Wong HSP, 2010, P IEEE, V98, P2201, DOI 10.1109/JPROC.2010.2070050; Wright CD, 2018, NAT ELECTRON, V1, P212, DOI 10.1038/s41928-018-0061-9; Wright CD, 2013, ADV FUNCT MATER, V23, P2248, DOI 10.1002/adfm.201202383; Wright CD, 2011, ADV MATER, V23, P3408, DOI 10.1002/adma.201101060; Xia MJ, 2015, ACS APPL MATER INTER, V7, P7627, DOI 10.1021/acsami.5b00083; Xia QF, 2019, NAT MATER, V18, P309, DOI 10.1038/s41563-019-0291-x; Xie YJ, 2018, ADV MATER, V30, DOI 10.1002/adma.201705587; Xiong F, 2011, SCIENCE, V332, P568, DOI 10.1126/science.1201938; Zalden P, 2019, SCIENCE, V364, P1062, DOI 10.1126/science.aaw1773; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang W, 2019, NAT REV MATER, V4, P150, DOI 10.1038/s41578-018-0076-x	60	157	159	53	383	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2019	366	6462					210	+		10.1126/science.aay0291	http://dx.doi.org/10.1126/science.aay0291			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD5HS	31439757				2022-12-28	WOS:000490014700037
J	Dumitru, OA; Austermann, J; Polyak, VJ; Fornos, JJ; Asmerom, Y; Gines, J; Gines, A; Onac, BP				Dumitru, Oana A.; Austermann, Jacqueline; Polyak, Victor J.; Fornos, Joan J.; Asmerom, Yemane; Gines, Joaquin; Gines, Angel; Onac, Bogdan P.			Constraints on global mean sea level during Pliocene warmth	NATURE			English	Article							ICE-VOLUME; DYNAMIC TOPOGRAPHY; MEDITERRANEAN SEA; MARINE; TEMPERATURE; MIOCENE; RECORD; SHEET; OCEAN; ANTARCTICA	Reconstructing the evolution of sea level during past warmer epochs such as the Pliocene provides insight into the response of sea level and ice sheets to prolonged warming(1). Although estimates of the global mean sea level (GMSL) during this time do exist, they vary by several tens of metres(2-4), hindering the assessment of past and future ice-sheet stability. Here we show that during the mid-Piacenzian Warm Period, which was on average two to three degrees Celsius warmer than the pre-industrial period(5), the GMSL was about 16.2 metres higher than today owing to global ice-volume changes, and around 17.4 metres when thermal expansion of the oceans is included. During the even warmer Pliocene Climatic Optimum (about four degrees Celsius warmer than pre-industrial levels)(6), our results show that the GMSL was 23.5 metres above the present level, with an additional 1.6 metres from thermal expansion. We provide six GMSL data points, ranging from 4.39 to 3.27 million years ago, that are based on phreatic overgrowths on speleothems from the western Mediterranean (Mallorca, Spain). This record is unique owing to its clear relationship to sea level, its reliable U-Pb ages and its long timespan, which allows us to quantify uncertainties on potential uplift. Our data indicate that ice sheets are very sensitive to warming and provide important calibration targets for future ice-sheet models(7).	[Dumitru, Oana A.; Onac, Bogdan P.] Univ S Florida, Sch Geosci, Karst Res Grp, Tampa, FL 33620 USA; [Austermann, Jacqueline] Columbia Univ, Lamont Doherty Earth Observ, Dept Earth & Environm Sci, Palisade, NY USA; [Polyak, Victor J.; Asmerom, Yemane] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Fornos, Joan J.; Gines, Joaquin; Gines, Angel] Univ Illes Balears, Earth Sci Res Grp, Palma De Mallorca, Spain; [Onac, Bogdan P.] Babes Bolyai Univ, Dept Geol, Cluj Napoca, Romania	State University System of Florida; University of South Florida; University of New Mexico; Universitat de les Illes Balears; Babes Bolyai University from Cluj	Onac, BP (corresponding author), Univ S Florida, Sch Geosci, Karst Res Grp, Tampa, FL 33620 USA.; Onac, BP (corresponding author), Babes Bolyai Univ, Dept Geol, Cluj Napoca, Romania.	bonac@usf.edu	; Onac, Bogdan P./F-9061-2010	Dumitru, Oana-Alexandra/0000-0001-9901-5621; Onac, Bogdan P./0000-0003-2332-6858	NSF [AGS 1602670, EAR 0326902, OCE-0825293 "PLIOMAX"]; MINECO [CGL2013-48441-P, CGL2016-79246-P]; Cave Research Foundation; Geological Society of America; Geological Society of America, and the Fred L. and Helen M. Tharp Endowed Scholarship (School of Geosciences, University of South Florida); PALSEA working group; Vetlesen Foundation	NSF(National Science Foundation (NSF)); MINECO(Spanish Government); Cave Research Foundation; Geological Society of America; Geological Society of America, and the Fred L. and Helen M. Tharp Endowed Scholarship (School of Geosciences, University of South Florida); PALSEA working group; Vetlesen Foundation	We thank the owner and personnel of Coves d'Arta for granting permission and offering logistic support during the field research conducted for this study. We thank F. L. Forray and G. Lucia for helping with the coring process. B.P.O. and V.J.P. are funded by a collaborative NSF grant (AGS 1602670). Additional research costs were covered by a NSF grant (EAR 0326902 to Y.A. and V.J.P.) and MINECO grants (CGL2013-48441-P and CGL2016-79246-P to J.J.F.). O.A.D. received student research grants from the Cave Research Foundation, the Geological Society of America, and the Fred L. and Helen M. Tharp Endowed Scholarship (School of Geosciences, University of South Florida). J.A. thanks the PALSEA working group and the NSF (grant OCE-0825293 "PLIOMAX") for facilitating discussions at regular meetings, and the Vetlesen Foundation for support.	Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; Bierman PR, 2016, NATURE, V540, P256, DOI 10.1038/nature20147; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Church J.A., 2013, CLIM CHANG 2013 PHYS; Creveling JR, 2017, QUATERNARY SCI REV, V163, P193, DOI 10.1016/j.quascirev.2017.03.003; de Boer B, 2010, ANN GLACIOL, V51, P23, DOI 10.3189/172756410791392736; De Schepper S, 2014, EARTH-SCI REV, V135, P83, DOI 10.1016/j.earscirev.2014.04.003; Decker DD, 2018, TECTONICS, V37, P208, DOI 10.1002/2017TC004675; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dorale JA, 2010, SCIENCE, V327, P860, DOI 10.1126/science.1181725; Dutton A, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4019; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Edwards TL, 2019, NATURE, V566, P58, DOI 10.1038/s41586-019-0901-4; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Flament N, 2013, LITHOSPHERE-US, V5, P189, DOI 10.1130/L245.1; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Haywood AM, 2013, CLIM PAST, V9, P191, DOI 10.5194/cp-9-191-2013; Just J, 2011, GEO-MAR LETT, V31, P51, DOI 10.1007/s00367-010-0213-z; Kendall RA, 2005, GEOPHYS J INT, V161, P679, DOI 10.1111/j.1365-246X.2005.02553.x; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Ludwig K.R., 2012, USERS MANUAL ISOPLOT, V5, P1, DOI DOI 10.1016/S0016-7037(98)00059-3; LUDWIG KR, 1994, GEOCHIM COSMOCHIM AC, V58, P5031, DOI 10.1016/0016-7037(94)90229-1; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Morlighem M, 2017, GEOPHYS RES LETT, V44, P11051, DOI 10.1002/2017GL074954; Moucha R, 2017, GLOBAL PLANET CHANGE, V149, P72, DOI 10.1016/j.gloplacha.2017.01.004; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Naish TR, 2009, PHILOS T R SOC A, V367, P169, DOI 10.1098/rsta.2008.0223; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Passchier S, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002061; Polyak VJ, 2018, NAT GEOSCI, V11, P860, DOI 10.1038/s41561-018-0222-5; POMAR L, 1991, SEDIMENTOLOGY, V38, P243, DOI 10.1111/j.1365-3091.1991.tb01259.x; Pomar L., 1979, ACTA GEOL HISP, V14, P293; Pomar L., 1995, SEQUENCE STRATIGRAPH, P87, DOI DOI 10.1007/978-94-015-8583-5_4; Raymo ME, 2018, EARTH-SCI REV, V177, P291, DOI 10.1016/j.earscirev.2017.11.022; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; Rohling EJ, 2014, NATURE, V510, P432, DOI 10.1038/nature13488; Rovere A, 2014, EARTH PLANET SC LETT, V387, P27, DOI 10.1016/j.epsl.2013.10.030; Rovere A, 2016, EARTH-SCI REV, V159, P404, DOI 10.1016/j.earscirev.2016.06.006; Rowley DB, 2013, SCIENCE, V340, P1560, DOI 10.1126/science.1229180; Schoene B, 2006, GEOCHIM COSMOCHIM AC, V70, P426, DOI 10.1016/j.gca.2005.09.007; Shakun JD, 2018, NATURE, V558, P284, DOI 10.1038/s41586-018-0155-6; Shakun JD, 2015, EARTH PLANET SC LETT, V426, P58, DOI 10.1016/j.epsl.2015.05.042; Stap LB, 2016, EARTH PLANET SC LETT, V439, P1, DOI 10.1016/j.epsl.2016.01.022; Stocchi P, 2018, QUATERNARY SCI REV, V185, P122, DOI 10.1016/j.quascirev.2018.01.004; Williams T, 2010, EARTH PLANET SC LETT, V290, P351, DOI 10.1016/j.epsl.2009.12.031; Winnick MJ, 2015, GEOLOGY, V43, P879, DOI 10.1130/G36999.1; Yuan HL, 2016, SOLID EARTH SCI, V1, P74, DOI 10.1016/j.sesci.2016.04.001; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	53	40	41	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2019	574	7777					233	+		10.1038/s41586-019-1543-2	http://dx.doi.org/10.1038/s41586-019-1543-2			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD2DB	31471591				2022-12-28	WOS:000489784200044
J	Buie, V; Swoboda, A; Bao, J				Buie, Vanessa; Swoboda, April; Bao, Jean			Breast Mass in an African American Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER		[Buie, Vanessa; Bao, Jean] Univ Chicago, Dept Surg, Sect Gen Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Swoboda, April] Rush Univ, Med Ctr, Dept Med, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA	University of Chicago; Rush University	Bao, J (corresponding author), Univ Chicago, Med Ctr, 5841 S Maryland Ave,MC4052, Chicago, IL 60637 USA.	jbao@surgery.bsd.uchicago.edu						American Cancer Society (ACS), 2019, KEY STAT BREAST CANC; American College of Radiology (ACR), 2018, ACR APPR CRIT EV SYM; Cardoso F, 2018, ANN ONCOL, V29, P405, DOI 10.1093/annonc/mdx651; Cloyd JM, 2013, ANN SURG ONCOL, V20, P1545, DOI 10.1245/s10434-013-2918-5; National Comprehensive Cancer Network (NCCN), 2018, CLIN PRACT GUID ONC; O'Malley C, 2005, BREAST CANCER RES TR, V93, P145, DOI 10.1007/s10549-005-4517-z; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Zaenger D, 2016, CLIN BREAST CANCER, V16, P101, DOI 10.1016/j.clbc.2015.11.005	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1307	1308		10.1001/jama.2019.12698	http://dx.doi.org/10.1001/jama.2019.12698			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31465087				2022-12-28	WOS:000489331900019
J	Livingston, EH				Livingston, Edward H.			The Role of Bariatric Surgery in Managing the Macrovascular Complications of Obesity-Related Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							Y GASTRIC BYPASS; GLUCOSE CONTROL; HEMOGLOBIN A(1C); ASSOCIATION; MANAGEMENT		[Livingston, Edward H.] JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA; [Livingston, Edward H.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Livingston, EH (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	edward.livingston@jamanetwork.org						Aminian A, 2019, JAMA-J AM MED ASSOC, V322, P1271, DOI 10.1001/jama.2019.14231; Cefalu WT, 2019, DIABETES CARE, V42, pS61, DOI 10.2337/dc19-S006; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fisher DP, 2018, JAMA-J AM MED ASSOC, V320, P1570, DOI 10.1001/jama.2018.14619; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ikramuddin S, 2018, JAMA-J AM MED ASSOC, V319, P266, DOI 10.1001/jama.2017.20813; Jakobsen GS, 2018, JAMA-J AM MED ASSOC, V319, P291, DOI 10.1001/jama.2017.21055; O'Brien MJ, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6125; Qaseem A, 2018, ANN INTERN MED, V168, P569, DOI 10.7326/M17-0939; Reges O, 2018, JAMA-J AM MED ASSOC, V319, P279, DOI 10.1001/jama.2017.20513; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	12	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1259	1260		10.1001/jama.2019.14577	http://dx.doi.org/10.1001/jama.2019.14577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31475294				2022-12-28	WOS:000489331900013
J	Marcantonio, ER				Marcantonio, Edward R.			Old Habits Die Hard: Antipsychotics for Treatment of Delirium	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		[Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Marcantonio, ER (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, CO 216,330 Brookline Ave, Boston, MA 02215 USA.		Marcantonio, Edward R/U-3929-2017	Marcantonio, Edward R/0000-0002-2911-4250				Agar MR, 2017, JAMA INTERN MED, V177, P34, DOI 10.1001/jamainternmed.2016.7491; Girard TD, 2018, NEW ENGL J MED, V379, P2506, DOI 10.1056/NEJMoa1808217; Herzig SJ, 2017, J AM GERIATR SOC, V65, P2580, DOI 10.1111/jgs.15066; Hshieh TT, 2015, JAMA INTERN MED, V175, P512, DOI 10.1001/jamainternmed.2014.7779; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Marcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501; Nikooie R, 2019, ANN INTERN MED, V171, P485, DOI 10.7326/M19-1860; Oh ES, 2019, ANN INTERN MED, V171, P474, DOI 10.7326/M19-1859; Oh ES, 2017, JAMA-J AM MED ASSOC, V318, P1161, DOI 10.1001/jama.2017.12067; U.S. Department of Health and Human Services Agency for Healthcare Research and Quality, 2014, AHRQ PUBLICATION, V534	10	2	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					516	517		10.7326/M19-2624	http://dx.doi.org/10.7326/M19-2624			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB4LK	31476768				2022-12-28	WOS:000488527900010
J	Schwabl, P; Koppel, S; Konigshofer, P; Bucsics, T; Trauner, M; Reiberger, T; Liebmann, B				Schwabl, Philipp; Koeppel, Sebastian; Koenigshofer, Philipp; Bucsics, Theresa; Trauner, Michael; Reiberger, Thomas; Liebmann, Bettina			Detection of Various Microplastics in Human Stool A Prospective Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							PARTICLES; BIVALVES; RISK	Background: Microplastics are ubiquitous in natural environments. Ingestion of microplastics has been described in marine organisms, whereby particles may enter the food chain. Objective: To examine human feces for the presence of microplastics to determine whether humans involuntarily ingest them. Design: Prospective case series in which participants completed a food diary and sampled stool according to step-by-step instructions. Setting: Europe and Asia. Participants: Eight healthy volunteers aged 33 to 65 years. Measurements: After chemical digestion, Fourier-transform infrared microspectroscopy was used to analyze the presence and shape of 10 common types of microplastic in stool samples. Results: All 8 stool samples tested positive for microplastics. A median of 20 microplastics (50 to 500 mu m in size) per 10 g of human stool were identified. Overall, 9 plastic types were detected, with polypropylene and polyethylene terephthalate being the most abundant. Limitations: There were few participants, and each provided only 1 sample. The origin and fate of microplastics in the gastrointestinal tract were not investigated. Conclusion: Various microplastics were detected in human stool, suggesting inadvertent ingestion from different sources. Further research on the extent of microplastic intake and the potential effect on human health is needed. Primary Funding Source: None.	[Schwabl, Philipp; Koenigshofer, Philipp; Bucsics, Theresa; Trauner, Michael; Reiberger, Thomas] Med Univ Vienna, Vienna, Austria; [Koeppel, Sebastian; Liebmann, Bettina] Environm Agcy Austria, Vienna, Austria	Medical University of Vienna	Schwabl, P (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	philipp.schwabl@meduniwien.ac.at; bettina.liebmann@umweltbundesamt.at	Reiberger, Thomas/H-7613-2019	Reiberger, Thomas/0000-0002-4590-3583; Schwabl, Philipp/0000-0002-7183-8076; Trauner, Michael/0000-0002-1275-6425				Alexander J, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4501; Barboza LGA, 2018, MAR POLLUT BULL, V133, P336, DOI 10.1016/j.marpolbul.2018.05.047; Avio CG, 2015, ENVIRON POLLUT, V198, P211, DOI 10.1016/j.envpol.2014.12.021; Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; Catarino AI, 2018, ENVIRON POLLUT, V237, P675, DOI 10.1016/j.envpol.2018.02.069; Cho Y, 2019, ENVIRON POLLUT, V245, P1107, DOI 10.1016/j.envpol.2018.11.091; Cox KD, 2019, ENVIRON SCI TECHNOL, V53, P7068, DOI 10.1021/acs.est.9b01517; CUMMINGS JH, 1992, GASTROENTEROLOGY, V103, P1783, DOI 10.1016/0016-5085(92)91435-7; de Sa LC, 2018, SCI TOTAL ENVIRON, V645, P1029, DOI 10.1016/j.scitotenv.2018.07.207; Deng YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46687; Hartmann NB, 2019, ENVIRON SCI TECHNOL, V53, P1039, DOI 10.1021/acs.est.8b05297; Hurley R, 2018, NAT GEOSCI, V11, P251, DOI [10.1038/s41561-018-0080-1, 10.1038/s]; Karami A, 2017, SCI REP-UK, V7, DOI [10.1038/srep46173, 10.1038/s41598-017-05828-6]; Karami A, 2017, SCI TOTAL ENVIRON, V578, P485, DOI 10.1016/j.scitotenv.2016.10.213; Kershaw PJ, 2016, REP STUD GESAMP, V93; Kosuth M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194970; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; Machado AAD, 2018, GLOBAL CHANGE BIOL, V24, P1405, DOI 10.1111/gcb.14020; Mason SA, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00407; Pauly JL, 1998, CANCER EPIDEM BIOMAR, V7, P419; PlasticsEurope,, 2019, PLAST FACTS 2019 AN; Prata JC, 2018, ENVIRON POLLUT, V234, P115, DOI 10.1016/j.envpol.2017.11.043; Reineke JJ, 2013, P NATL ACAD SCI USA, V110, P13803, DOI 10.1073/pnas.1305882110; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Schmidt C, 2013, J CONTROL RELEASE, V165, P139, DOI 10.1016/j.jconrel.2012.10.019; Schymanski D, 2018, WATER RES, V129, P154, DOI 10.1016/j.watres.2017.11.011; Silva AB, 2018, ANAL CHIM ACTA, V1017, P1, DOI 10.1016/j.aca.2018.02.043; Van Cauwenberghe L, 2014, ENVIRON POLLUT, V193, P65, DOI 10.1016/j.envpol.2014.06.010; von Moos N, 2012, ENVIRON SCI TECHNOL, V46, P11327, DOI 10.1021/es302332w; Wright SL, 2017, ENVIRON SCI TECHNOL, V51, P6634, DOI 10.1021/acs.est.7b00423; Yang DQ, 2015, ENVIRON SCI TECHNOL, V49, P13622, DOI 10.1021/acs.est.5b03163	31	426	444	98	490	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					453	+		10.7326/M19-0618	http://dx.doi.org/10.7326/M19-0618			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB4LK	31476765				2022-12-28	WOS:000488527900002
J	Chen, Z; Zhou, CM; Yuan, XL; Xiao, SH				Chen, Zhe; Zhou, Chuanming; Yuan, Xunlai; Xiao, Shuhai			Death march of a segmented and trilobate bilaterian elucidates early animal evolution	NATURE			English	Article							BIOTURBATION; TRACES	The origin of motility in bilaterian animals represents an evolutionary innovation that transformed the Earth system. This innovation probably occurred in the late Ediacaran period-as evidenced by an abundance of trace fossils (ichnofossils) dating to this time, which include trails, trackways and burrows(1-3). However, with few exceptions(4-8), the producers of most of the late Ediacaran ichnofossils are unknown, which has resulted in a disconnection between the body-and trace-fossil records. Here we describe the fossil of a bilaterian of the terminal Ediacaran period (dating to 551-539 million years ago), which we name Yilingia spiciformis (gen. et sp. nov). This body fossil is preserved along with the trail that the animal produced during a death march. Yilingia is an elongate and segmented bilaterian with repetitive and trilobate body units, each of which consists of a central lobe and two posteriorly pointing lateral lobes, indicating body and segment polarity. Yilingia is possibly related to panarthropods or annelids, and sheds light on the origin of segmentation in bilaterians. As one of the few Ediacaran animals demonstrated to have produced long and continuous trails, Yilingia provides insights into the identity of the animals that were responsible for Ediacaran trace fossils.	[Chen, Zhe; Yuan, Xunlai] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Chen, Zhe; Zhou, Chuanming; Yuan, Xunlai] Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Nanjing, Jiangsu, Peoples R China; [Zhou, Chuanming] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, CAS Key Lab Econ Stratig & Palaeogeog, Nanjing, Jiangsu, Peoples R China; [Yuan, Xunlai] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xiao, Shuhai] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Virginia Polytechnic Institute & State University	Yuan, XL (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China.; Yuan, XL (corresponding author), Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Nanjing, Jiangsu, Peoples R China.; Yuan, XL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Xiao, SH (corresponding author), Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA.	xlyuan@nigpas.ac.cn; xiao@vt.edu	Xiao, Shuhai/A-2190-2009	Xiao, Shuhai/0000-0003-4655-2663; Chen, Zhe/0000-0002-7038-3591	Chinese Academy of Sciences [XDB26000000, XDB18000000, QYZDJ-SSW-DQC009]; National Key Research and Development Program of China [2017YFC0603101]; National Natural Science Foundation of China [41372009]; National Science Foundation [EAR-1528553]; National Geographic Society [9564-14]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society)	This research was supported by Chinese Academy of Sciences (XDB26000000, XDB18000000 and QYZDJ-SSW-DQC009), National Key Research and Development Program of China (2017YFC0603101), National Natural Science Foundation of China (41372009), National Science Foundation (EAR-1528553) and National Geographic Society (9564-14).	Bottjer D.J., 2000, GSA TODAY, V10, P1; Buatois LA, 2016, TOP GEOBIOL, V39, P27, DOI 10.1007/978-94-017-9600-2_2; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; Canfield DE, 2009, P NATL ACAD SCI USA, V106, P8123, DOI 10.1073/pnas.0902037106; Chen Z, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao6691; Chipman AD, 2010, BIOESSAYS, V32, P60, DOI 10.1002/bies.200900130; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Couso JP, 2009, INT J DEV BIOL, V53, P1305, DOI 10.1387/ijdb.072425jc; Davis GK, 1999, TRENDS CELL BIOL, V9, pM68, DOI 10.1016/S0962-8924(99)01663-3; dos Reis M, 2015, CURR BIOL, V25, P2939, DOI 10.1016/j.cub.2015.09.066; Droser ML, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P125; Dunn FS, 2018, BIOL REV, V93, P914, DOI 10.1111/brv.12379; Ekdale A.A., 1984, SOC EC PALEONTOL MIN; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Evans SD, 2019, GEOBIOLOGY, V17, P490, DOI 10.1111/gbi.12351; Fedonkin MA, 2007, GEOL SOC SPEC PUBL, V286, P157, DOI 10.1144/SP286.12; Gehling JG, 2014, J PALEONTOL, V88, P284, DOI 10.1666/13-054; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; Gold DA, 2015, EVOL DEV, V17, P315, DOI 10.1111/ede.12168; Ivantsov AY, 2013, STRATIGR GEO CORREL+, V21, P252, DOI 10.1134/S0869593813030039; Ivantsov AY, 2011, PALEONTOL J+, V45, P237, DOI 10.1134/S0031030111030063; Jensen S, 2006, INT CONF PARA PROC, P15; Liu YH, 2014, EVOL DEV, V16, P155, DOI 10.1111/ede.12076; Mangano M.G., 2016, TRACE FOSSIL RECORD, V1; Minelli A, 2013, ARTHROPOD BIOL EVOLU; Okada Y, 2014, GONDWANA RES, V25, P1027, DOI 10.1016/j.gr.2013.05.001; Seilacher A., 2007, TRACE FOSSIL ANAL; Seilacher A., 1994, BIOSTABILIZATION SED, P97; Tarhan LG, 2018, EARTH-SCI REV, V178, P177, DOI 10.1016/j.earscirev.2018.01.011; Zhao FC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16304-6	30	48	64	6	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					412	+		10.1038/s41586-019-1522-7	http://dx.doi.org/10.1038/s41586-019-1522-7			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31485079				2022-12-28	WOS:000486647800049
J	Usher, AD				Usher, Ann Danaiya			Gavi sets US$7.4 billion replenishment target	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2019	394	10201					817	818		10.1016/S0140-6736(19)32044-6	http://dx.doi.org/10.1016/S0140-6736(19)32044-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV0US	31498088				2022-12-28	WOS:000483994700010
J	Mahase, E				Mahase, Elisabeth			Vegetarian and pescatarian diets are linked to lower risk of ischaemic heart disease, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															UK Medical Research Council; Wellcome Trust's Our Planet Our Health team	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust's Our Planet Our Health team(Wellcome Trust)	The study, funded by the UK Medical Research Council and the Wellcome Trust's Our Planet Our Health team, had a number of limitations, including that diet groups were self reported and the study was limited mainly to white European participants.	Tong TYN, 2019, BMJ-BRIT MED J, V366	1	0	0	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5397	10.1136/bmj.l5397	http://dx.doi.org/10.1136/bmj.l5397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488424				2022-12-28	WOS:000485441400005
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: (I can't get no) patient satisfaction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Grant P, 2019, OXFORD MAIL     0728; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Levene LS, 2019, BRIT J GEN PRACT, V69, pE546, DOI 10.3399/bjgp19X704549; Oliver G, 2019, OXFORD MAIL     0806	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5236	10.1136/bmj.l5236	http://dx.doi.org/10.1136/bmj.l5236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481531	Bronze			2022-12-28	WOS:000485434400002
J	Wasswa, H				Wasswa, Henry			Uganda records fourth death from Ebola as DRC grapples with epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2019	366								l5344	10.1136/bmj.l5344	http://dx.doi.org/10.1136/bmj.l5344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9ID	31471283	Bronze			2022-12-28	WOS:000483893700006
J	van Schalkwyk, MCI; Barlow, P; Stuckler, D; Rae, M; Lang, T; Hervey, T; McKee, M				van Schalkwyk, May C. I.; Barlow, Pepita; Stuckler, David; Rae, Maggie; Lang, Tim; Hervey, Tamara; McKee, Martin			Assessing the health effects of a "no deal" Brexit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AUSTERITY		[van Schalkwyk, May C. I.; McKee, Martin] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; London Sch Econ, Dept Hlth Policy, London, England; [Barlow, Pepita] Univ Cambridge, Bennett Inst Publ Policy, Cambridge, England; [Stuckler, David] Univ Bocconi, Dept Policy Anal & Publ Management, Milan, Italy; [Stuckler, David] Univ Bocconi, Dondena Res Ctr, Milan, Italy; [Rae, Maggie] Fac Publ Hlth, London, England; [Lang, Tim] City Univ London, Ctr Food Policy, Sch Hlth Sci, London, England; [Hervey, Tamara] Univ Sheffield, Sch Law, Sheffield, S Yorkshire, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science; University of Cambridge; Bocconi University; Bocconi University; City University London; University of Sheffield	van Schalkwyk, MCI (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England.	may.vanschalkwyk@lshtm.ac.uk		Stuckler, David/0000-0002-1288-8401; Barlow, Pepita/0000-0002-7959-4360	ESRC [ES/S00730X/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2018, LANCET, V392, P1599, DOI 10.1016/S0140-6736(18)32768-5; [Anonymous], 2019, SUNDAY TIMES; Blouin C, 2009, LANCET, V373, P502, DOI 10.1016/S0140-6736(08)61777-8; Carroll R., 2019, GUARDIAN; Connelly T, 2019, RTE             0330; DHSC, 2019, EU EX OP READ GUID A; Fahy N, 2019, LANCET, V393, P949, DOI 10.1016/S0140-6736(19)30425-8; Fahy N, 2017, LANCET, V390, P2110, DOI 10.1016/S0140-6736(17)31926-8; Glinka E, 2019, BBC NEWS; Helm T, 2019, GUARDIAN; Hiam L, 2018, J EPIDEMIOL COMMUN H, V72, P404, DOI 10.1136/jech-2017-210401; Islam F, 2019, BBC NEWS; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Khan S., 2019, INDEPENDENT; Lang T, 2019, LANCET; Lang T, 2018, J PUBLIC HEALTH-UK, V40, pE608, DOI 10.1093/pubmed/fdy073; Loopstra R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1775; Millstone E, 2017, WILL BRIT PUBLIC ACC; Nicholl D, 2019, GUEST BLOG D NICHO 2; Office for Budget Responsibility, 2019, FISC RISKS REP; PARSONS A, 2019, SKY NEWS, DOI DOI 10.1007/S40243-019-0141-4; Parveen N, 2019, GUARDIAN; Read R, 2019, HEALTH SOC CARE COMM, V27, P676, DOI 10.1111/hsc.12684; Roman-Urrestarazu A, 2019, HEALTH POLICY, V123, P521, DOI 10.1016/j.healthpol.2019.04.005; Shipman T, 2019, SUNDAY TIMES; UK Government, 2019, ADV SCH PREP BREX; UK Government, 2019, DHSC SINGL DEP PLAN; UK Government, 2019, BREX OP READ GUID HL	28	13	13	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l5300	10.1136/bmj.l5300	http://dx.doi.org/10.1136/bmj.l5300			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31466943	Green Accepted			2022-12-28	WOS:000483892600004
J	Han, D; Li, J; Tan, WH				Han, Da; Li, Juan; Tan, Weihong			CRISPR propels a smart hydrogel	SCIENCE			English	Editorial Material							PLATFORM; APTAMER		[Han, Da; Li, Juan; Tan, Weihong] Shanghai Jiao Tong Univ, IMM, Renji Hosp, Sch Med, Shanghai 200240, Peoples R China; [Han, Da; Li, Juan; Tan, Weihong] Shanghai Jiao Tong Univ, Coll Chem & Chem Engn, Shanghai 200240, Peoples R China; [Han, Da; Tan, Weihong] Chinese Acad Sci, ICBM, Hangzhou 310022, Zhejiang, Peoples R China; [Han, Da; Tan, Weihong] Univ Chinese Acad Sci, Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China; [Li, Juan; Tan, Weihong] Hunan Univ, Coll Biol, Coll Chem & Chem Engn, Mol Sci & Biomed Lab MBL,State Key Chemo Biosensi, Changsha 410082, Hunan, Peoples R China; [Tan, Weihong] Univ Florida, Dept Chem, UF Genet Inst, Ctr Res Bio Nano Interface,Hlth Canc Ctr, Gainesville, FL 32611 USA; [Tan, Weihong] Univ Florida, Dept Physiol & Funct Gen, UF Genet Inst, Ctr Res Bio Nano Interface,Hlth Canc Ctr, Gainesville, FL 32611 USA; [Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hunan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Li, J (corresponding author), Shanghai Jiao Tong Univ, IMM, Renji Hosp, Sch Med, Shanghai 200240, Peoples R China.; Li, J (corresponding author), Shanghai Jiao Tong Univ, Coll Chem & Chem Engn, Shanghai 200240, Peoples R China.; Li, J (corresponding author), Hunan Univ, Coll Biol, Coll Chem & Chem Engn, Mol Sci & Biomed Lab MBL,State Key Chemo Biosensi, Changsha 410082, Hunan, Peoples R China.	lijuan@fzu.edu.cn; tan@chem.ufl.edu	Han, Da/AAT-2116-2020; Tan, Weihong/AAA-4536-2020					English MA, 2019, SCIENCE, V365, P780, DOI 10.1126/science.aaw5122; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Kahn JS, 2015, NANO LETT, V15, P7773, DOI 10.1021/acs.nanolett.5b04101; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Li J, 2016, CHEM SOC REV, V45, P1410, DOI 10.1039/c5cs00586h; Lu CH, 2013, NANO LETT, V13, P1298, DOI 10.1021/nl400078g; Yang HH, 2008, J AM CHEM SOC, V130, P6320, DOI 10.1021/ja801339w; Zhu Z, 2010, ANGEW CHEM INT EDIT, V49, P1052, DOI 10.1002/anie.200905570	8	9	9	29	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		754	755		10.1126/science.aay4198	http://dx.doi.org/10.1126/science.aay4198			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439783				2022-12-28	WOS:000482464000029
J	Plichta, DR; Graham, DB; Subramanian, S; Xavier, RJ				Plichta, Damian R.; Graham, Daniel B.; Subramanian, Sathish; Xavier, Ramnik J.			Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships	CELL			English	Review							REGULATORY T-CELLS; PROTEIN-COUPLED RECEPTOR; GUT MICROBIOME; ULCERATIVE-COLITIS; ANTIGEN DISCOVERY; CROHNS-DISEASE; E. COLI; INDUCTION; ACID; COLONIZATION	The current understanding of inflammatory bowel disease (IBD) pathogenesis implicates a complex interaction between host genetics, host immunity, microbiome, and environmental exposures. Mechanisms gleaned from genetics and molecular pathogenesis offer clues to the critical triggers of mucosal inflammation and guide the development of therapeutic interventions. A complex network of interactions between host genetic factors, microbes, and microbial metabolites governs intestinal homeostasis, making classification and mechanistic dissection of involved pathways challenging. In this Review, we discuss these challenges, areas of active translation, and opportunities for development of next-generation therapies.	[Plichta, Damian R.; Graham, Daniel B.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Harvard Med Sch, Boston, MA 02115 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Graham, Daniel B.; Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Subramanian, Sathish] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	xavier@molbio.mgh.harvard.edu			NIDDK NIH HHS [P30 DK043351] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aden K, 2018, J EXP MED, V215, P2868, DOI 10.1084/jem.20171029; Amininejad L, 2018, GASTROENTEROLOGY, V154, P2165, DOI 10.1053/j.gastro.2018.02.028; Ananthakrishnan AN, 2017, CELL HOST MICROBE, V21, P603, DOI 10.1016/j.chom.2017.04.010; Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Aschard H, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008018; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Bentzen AK, 2016, NAT BIOTECHNOL, V34, P1037, DOI 10.1038/nbt.3662; Bhattarai Y, 2018, CELL HOST MICROBE, V23, P775, DOI 10.1016/j.chom.2018.05.004; Bradley CP, 2017, CELL HOST MICROBE, V22, P697, DOI 10.1016/j.chom.2017.10.007; Britton GJ, 2019, IMMUNITY, V50, P212, DOI 10.1016/j.immuni.2018.12.015; Brown EM, 2019, CELL HOST MICROBE, V25, P668, DOI 10.1016/j.chom.2019.04.002; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Bunker JJ, 2017, SCIENCE, V358, DOI 10.1126/science.aan6619; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Contijoch EJ, 2019, ELIFE, V8, DOI 10.7554/eLife.40553; DANIEL P, 1989, CLIN CHIM ACTA, V181, P255, DOI 10.1016/0009-8981(89)90231-3; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Denson LA, 2018, GASTROENTEROLOGY, V154, P2097, DOI 10.1053/j.gastro.2018.02.016; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Graham DB, 2018, NAT MED, V24, P1762, DOI 10.1038/s41591-018-0203-7; Gurry T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30783-1; Hansen LBS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07019-x; Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hoyles L, 2018, NAT MED, V24, P1070, DOI 10.1038/s41591-018-0061-3; Ismail AS, 2016, CELL HOST MICROBE, V19, P470, DOI 10.1016/j.chom.2016.02.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Joglekar AV, 2019, NAT METHODS, V16, P191, DOI 10.1038/s41592-018-0304-8; Jones EM, 2019, CELL SYST, V8, P254, DOI 10.1016/j.cels.2019.02.009; Jost M, 2017, MOL CELL, V68, P210, DOI 10.1016/j.molcel.2017.09.012; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kaval KG, 2018, MBIO, V9, DOI 10.1128/mBio.00066-18; Kearney SM, 2018, CELL REP, V24, P1842, DOI 10.1016/j.celrep.2018.07.032; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Lavoie S, 2019, ELIFE, V8, DOI 10.7554/eLife.39982; LERNER A, 1989, ACTA PAEDIATR SCAND, V78, P384, DOI 10.1111/j.1651-2227.1989.tb11097.x; Li GD, 2019, NAT METHODS, V16, P183, DOI 10.1038/s41592-018-0305-7; Limon JJ, 2019, CELL HOST MICROBE, V25, P377, DOI 10.1016/j.chom.2019.01.007; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lu E, 2019, NATURE, V567, P244, DOI 10.1038/s41586-019-1003-z; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Malhi H, 2017, CURR OPIN PHARMACOL, V37, P80, DOI 10.1016/j.coph.2017.09.008; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; McKenzie C, 2017, IMMUNOL REV, V278, P277, DOI 10.1111/imr.12556; Mendes-Soares H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.8102; Milshteyn A, 2018, CELL HOST MICROBE, V23, P725, DOI 10.1016/j.chom.2018.05.013; Misra B, 2018, J CROHNS COLITIS, V12, pS317; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04365-8; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Paramsothy S, 2017, J CROHNS COLITIS, V11, P1180, DOI 10.1093/ecco-jcc/jjx063; Paun A, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8125; Penagini F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060334; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Plichta DR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.152, 10.1038/nmicrobiol.2016.152]; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Ramachandran G, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0103; Reese AT, 2018, ELIFE, V7, DOI 10.7554/eLife.35987; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roager HM, 2019, GUT, V68, P83, DOI 10.1136/gutjnl-2017-314786; Roda G, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.63; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schirmer M, 2019, NAT REV MICROBIOL, V17, P497, DOI 10.1038/s41579-019-0213-6; Schirmer M, 2018, CELL HOST MICROBE, V24, P600, DOI 10.1016/j.chom.2018.09.009; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Seok SH, 2018, J BIOL CHEM, V293, P1994, DOI 10.1074/jbc.RA117.000631; Shepherd ES, 2018, NATURE, V557, P434, DOI 10.1038/s41586-018-0092-4; Skelly AN, 2019, NAT REV IMMUNOL, V19, P305, DOI 10.1038/s41577-019-0144-5; Smillie CS, 2018, CELL HOST MICROBE, V23, P229, DOI 10.1016/j.chom.2018.01.003; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stein RR, 2018, ELIFE, V7, DOI 10.7554/eLife.30916; Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; Vandenbroucke K, 2010, MUCOSAL IMMUNOL, V3, P49, DOI 10.1038/mi.2009.116; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Vila AV, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8914; Wang GD, 2013, AM J PHYSIOL-GASTR L, V304, pG855, DOI 10.1152/ajpgi.00421.2012; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wegorzewska MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9079; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007; Woodruff LBA, 2017, NUCLEIC ACIDS RES, V45, P1567, DOI 10.1093/nar/gkx032; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang N, 2013, J PHYSIOL-LONDON, V591, P4581, DOI 10.1113/jphysiol.2013.257436; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yao LN, 2018, ELIFE, V7, DOI 10.7554/eLife.37182; Yilmaz B, 2019, NAT MED, V25, P323, DOI 10.1038/s41591-018-0308-z; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	117	103	104	8	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1041	1056		10.1016/j.cell.2019.07.045	http://dx.doi.org/10.1016/j.cell.2019.07.045			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442399	Green Accepted, Bronze			2022-12-28	WOS:000482191000005
J	Kocarnik, J				Kocarnik, Jonathan			Cancer's global epidemiological transition and growth	LANCET			English	Editorial Material									[Kocarnik, Jonathan] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Kocarnik, Jonathan] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Kocarnik, J (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.; Kocarnik, J (corresponding author), Fred Hutchinson Canc Res Ctr, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	kocarnik@uw.edu						Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cavalli F, 2016, LANCET, V387, pE13, DOI 10.1016/S0140-6736(16)00233-6; Dagenais GR, 2020, LANCET, V395, P785, DOI 10.1016/S0140-6736(19)32007-0; Fitzmaurice C, 2018, JAMA ONCOL, V4, P1553, DOI 10.1001/jamaoncol.2018.2706; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Franceschi S, 2013, MOL ONCOL, V7, P1, DOI 10.1016/j.molonc.2012.10.010; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Rebbeck TR, 2018, CANCER DISCOV, V8, P803, DOI 10.1158/2159-8290.CD-17-1415; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Turnbull C, 2018, NAT GENET, V50, P1212, DOI 10.1038/s41588-018-0202-0	12	5	6	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					757	758		10.1016/S0140-6736(19)32046-X	http://dx.doi.org/10.1016/S0140-6736(19)32046-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	31492504				2022-12-28	WOS:000519536900006
J	Polyakova, M; Hua, LM				Polyakova, Maria; Hua, Lynn M.			Local Area Variation in Morbidity Among Low-Income, Older Adults in the United States A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC DISEASE PREVALENCE; LIFE EXPECTANCY; GEOGRAPHIC-VARIATION; US COUNTIES; SOCIOECONOMIC INEQUALITIES; SOCIAL DETERMINANTS; MORTALITY-RATES; HEALTH; DISPARITIES; TRENDS	Background: Recent studies have reported that low-income adults living in more affluent areas of the United States have longer life expectancies. Less is known about the relationship between the affluence of a geographic area and morbidity of the low-income population. Objective: To evaluate the association between the prevalence of chronic conditions among low-income, older adults and the economic affluence of a local area. Design: Cross-sectional association study. Setting: Medicare in 2015. Participants: 6 363 097 Medicare beneficiaries aged 66 to 100 years with a history of low-income support under Medicare Part D. Measurements: Adjusted prevalence of 48 chronic conditions was computed for 736 commuting zones (CZs). Factor analysis was used to assess spatial covariation of condition prevalence and to construct a composite condition prevalence index for each CZ. The association between morbidity and area affluence was measured by comparing the average of condition prevalence index across deciles of median CZ house values. Results: The mean age of study participants was 77.7 years (SD, 8.2); 67% were women, and 61% were white. The crude prevalence of 48 chronic conditions ranged from 72.5 per 100 for hypertension to 0.6 per 100 for posttraumatic stress disorder. The prevalence of these 48 chronic conditions was highly spatially correlated. Composite condition prevalence was on average substantially lower in more affluent CZs. Limitation: Low-income status measured on the basis of receipt of Medicare Part D low-income subsidies and not capturing persons not enrolled in Medicare Part D. Conclusion: Low-income, older adults living in more affluent areas of the country are healthier, and areas with poor health in the low-income, older adult population tend to have a high prevalence of most chronic conditions. Primary Funding Source: National Institute on Aging.	[Polyakova, Maria] Stanford Univ, Sch Med, Redwood Bldg,Room T111,150 Governors Lane, Stanford, CA 94305 USA; [Polyakova, Maria] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hua, Lynn M.] Univ Penn, Wharton Sch, 204 Colonial Penn Ctr,3641 Locust Walk, Philadelphia, PA 19104 USA	Stanford University; National Bureau of Economic Research; University of Pennsylvania	Polyakova, M (corresponding author), Stanford Univ, Sch Med, Redwood Bldg,Room T111,150 Governors Lane, Stanford, CA 94305 USA.	maria.polyakova@stanford.edu			National Institute on Aging [R21AG052833, P01AG005842-29, K01AG05984301]; NATIONAL INSTITUTE ON AGING [R21AG052833, P01AG005842, K01AG059843] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging grants R21AG052833, P01AG005842-29, and K01AG05984301.	Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Burt C, 1939, BRIT J EDUC PSYCHOL, V9, P188; Case A, 2017, BROOKINGS PAP ECO AC, P397; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Medicare & Medicaid Services, CHRON COND; Centers for Medicare & Medicaid Services, CMS STAT REF BOOKL; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; Currie J, 2016, SCIENCE, V352, P708, DOI 10.1126/science.aaf1437; Currie J, 2016, J ECON PERSPECT, V30, P29, DOI 10.1257/jep.30.2.29; Davids BO, 2014, J RACIAL ETHN HEALTH, V1, P2, DOI 10.1007/s40615-013-0001-3; DiStefano C., 2009, PRACT ASSESS RES EVA, V14, P1, DOI DOI 10.10/1531-7714; Dowd JB, 2014, INT J EPIDEMIOL, V43, P983, DOI 10.1093/ije/dyu120; Duggan JE, 2008, IMF STAFF PAPERS, V55, P566, DOI 10.1057/imfsp.2008.21; Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918; Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Finkelstein A, 2017, NEW ENGL J MED, V376, P608, DOI 10.1056/NEJMp1613238; Finkelstein A, 2016, Q J ECON, V131, P1681, DOI 10.1093/qje/qjw023; Fuchs VR, 2004, J HEALTH ECON, V23, P653, DOI 10.1016/j.jhealeco.2004.04.004; Kawachi I., 2014, SOCIAL EPIDEMIOLOGY, V2, P290; Kershaw KN, 2011, AM J EPIDEMIOL, V174, P537, DOI 10.1093/aje/kwr116; Kitagawa EM, 1973, DIFFERENTIAL MORTALI; Leonard T, 2016, EPIDEMIOLOGY, V27, P518, DOI 10.1097/EDE.0000000000000470; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lleras-Muney A, 2018, J ECON LIT, V56, P1080, DOI 10.1257/jel.20171383; Lochner K, 2001, AM J PUBLIC HEALTH, V91, P385, DOI 10.2105/AJPH.91.3.385; Lochner KA, 2003, SOC SCI MED, V56, P1797, DOI 10.1016/S0277-9536(02)00177-6; Lochner Kimberly A, 2013, Medicare Medicaid Res Rev, V3, DOI 10.5600/mmrr.003.03.b02; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Mokdad AH, 2017, JAMA-J AM MED ASSOC, V317, P388, DOI 10.1001/jama.2016.20324; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Purcell PJ, 2008, J PENSION PLANNING C, V34, P58; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; Roth GA, 2017, JAMA-J AM MED ASSOC, V317, P1976, DOI 10.1001/jama.2017.4150; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; Skinner J, 2012, HBK ECON, P45, DOI 10.1016/B978-0-444-53592-4.00002-5; Snyder SE, 2006, REV ECON STAT, V88, P482, DOI 10.1162/rest.88.3.482; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Thorpe KE, 2006, HEALTH AFFAIR, V25, pW378, DOI 10.1377/hlthaff.25.w378; Waldron Hilary, 2013, Soc Secur Bull, V73, P1; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Wilper AP, 2008, ANN INTERN MED, V149, P170, DOI 10.7326/0003-4819-149-3-200808050-00006; Woolf SH, 2011, HEALTH AFFAIR, V30, P1852, DOI 10.1377/hlthaff.2011.0685	56	2	2	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					464	+		10.7326/M18-2800	http://dx.doi.org/10.7326/M18-2800			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB4LK	31499522	Green Accepted			2022-12-28	WOS:000488527900004
J	Agostini, M; Bakalyarov, AM; Balata, M; Barabanov, I; Baudis, L; Bauer, C; Bellotti, E; Belogurov, S; Bettini, A; Bezrukov, L; Borowicz, D; Brudanin, V; Brugnera, R; Caldwell, A; Cattadori, C; Chernogorov, A; Comellato, T; D'Andrea, V; Dernidova, EV; Di Marco, N; Domula, A; Doroshkevich, E; Egorov, V; Falkenstein, R; Fomina, M; Gangapshev, A; Garfagnini, A; Giordano, M; Grabrnayr, P; Gurentsov, V; Gusev, K; Hakenmuller, J; Hegai, A; Heise, M; Hemmer, S; Hiller, R; Hofmann, W; Hult, M; Inzhechik, LV; Csathy, JJ; Jochum, J; Junker, M; Kazalov, V; Kermaidic, Y; Kihm, T; Kirpichnikov, IV; Kirsch, A; Kish, A; Klimenko, A; Kneissl, R; Knopfle, KT; Kochetov, O; Kornoukhov, VN; Krause, P; Kuzminov, VV; Laubenstein, M; Lazzaro, A; Lindner, M; Lippi, I; Lubashevskiy, A; Lubsandorzhiev, B; Lutter, G; Macolino, C; Majorovits, B; Maneschg, W; Miloradovic, M; Mingazheva, R; Misiaszek, M; Moseev, P; Nemchenok, I; Panas, K; Pandola, L; Pelczar, K; Pertoldi, L; Piseri, P; Pullia, A; Ransom, C; Riboldi, S; Rumyantseva, N; Sada, C; Sala, E; Salamida, F; Schmitt, C; Schneider, B; Schonert, S; Schutz, AK; Schulz, O; Schwarz, M; Schwingenheuer, B; Selivanenko, O; Sheychik, E; Shirchenko, M; Simgen, H; Smolnikov, A; Static, L; Stukov, D; Vanhoefer, L; Vasenko, AA; Veresnikova, A; von Sturm, K; Wagner, V; Wegrntann, A; Wester, T; Wiesinger, C; Wojcik, M; Yanovich, E; Zhitnikov, I; Zhukov, SV; Zinatulina, D; Zschocke, A; Zsigmond, AJ; Zuber, K; Zuzel, G				Agostini, M.; Bakalyarov, A. M.; Balata, M.; Barabanov, I.; Baudis, L.; Bauer, C.; Bellotti, E.; Belogurov, S.; Bettini, A.; Bezrukov, L.; Borowicz, D.; Brudanin, V.; Brugnera, R.; Caldwell, A.; Cattadori, C.; Chernogorov, A.; Comellato, T.; D'Andrea, V.; Dernidova, E. V.; Di Marco, N.; Domula, A.; Doroshkevich, E.; Egorov, V.; Falkenstein, R.; Fomina, M.; Gangapshev, A.; Garfagnini, A.; Giordano, M.; Grabrnayr, P.; Gurentsov, V.; Gusev, K.; Hakenmueller, J.; Hegai, A.; Heise, M.; Hemmer, S.; Hiller, R.; Hofmann, W.; Hult, M.; Inzhechik, L. V.; Csathy, J. Jarticsko; Jochum, J.; Junker, M.; Kazalov, V.; Kermaidic, Y.; Kihm, T.; Kirpichnikov, I. V.; Kirsch, A.; Kish, A.; Klimenko, A.; Kneissl, R.; Knoepfle, K. T.; Kochetov, O.; Kornoukhov, V. N.; Krause, P.; Kuzminov, V. V.; Laubenstein, M.; Lazzaro, A.; Lindner, M.; Lippi, I.; Lubashevskiy, A.; Lubsandorzhiev, B.; Lutter, G.; Macolino, C.; Majorovits, B.; Maneschg, W.; Miloradovic, M.; Mingazheva, R.; Misiaszek, M.; Moseev, P.; Nemchenok, I.; Panas, K.; Pandola, L.; Pelczar, K.; Pertoldi, L.; Piseri, P.; Pullia, A.; Ransom, C.; Riboldi, S.; Rumyantseva, N.; Sada, C.; Sala, E.; Salamida, F.; Schmitt, C.; Schneider, B.; Schonert, S.; Schutz, A-K; Schulz, O.; Schwarz, M.; Schwingenheuer, B.; Selivanenko, O.; Sheychik, E.; Shirchenko, M.; Simgen, H.; Smolnikov, A.; Static, L.; Stukov, D.; Vanhoefer, L.; Vasenko, A. A.; Veresnikova, A.; von Sturm, K.; Wagner, V.; Wegrntann, A.; Wester, T.; Wiesinger, C.; Wojcik, M.; Yanovich, E.; Zhitnikov, I.; Zhukov, S. V.; Zinatulina, D.; Zschocke, A.; Zsigmond, A. J.; Zuber, K.; Zuzel, G.		GERDA Collaboration	Probing Majorana neutrinos with double-beta decay	SCIENCE			English	Article							PHASE-II; GERDA EXPERIMENT; GE-76; SEARCH; DETECTORS; VETO; MASS	A discovery that neutrinos are Majorana fermions would have profound implications for particle physics and cosmology. The Majorana character of neutrinos would make possible the neutrinoless double-beta (0 nu beta beta) decay, a matter-creating process without the balancing emission of antimatter. The GERDA Collaboration searches for the 0 nu beta beta decay of Ge-76 by operating bare germanium detectors in an active liquid argon shield. With a total exposure of 82.4 kg.year, we observe no signal and derive a lower half-life limit of T-1/2 > 0.9 x 10(26) years (90% C.L.). Our T-1/2 sensitivity, assuming no signal, is 1.1 x 10(26) years. Combining the latter with those from other 0 nu beta beta decay searches yields a sensitivity to the effective Majorana neutrino mass of 0.07 to 0.16 electron volts.	[Agostini, M.; Comellato, T.; Gusev, K.; Csathy, J. Jarticsko; Krause, P.; Lazzaro, A.; Schonert, S.; Schwarz, M.; Wiesinger, C.] Tech Univ Munich, Phys Dept, D-85748 Munich, Germany; [Bakalyarov, A. M.; Gusev, K.; Stukov, D.; Zhukov, S. V.] Kurchatov Inst, Natl Res Ctr, Moscow 123182, Russia; [Balata, M.; Di Marco, N.; Junker, M.; Laubenstein, M.; Macolino, C.; Pelczar, K.] INFN Lab Nizl Gran Sasso, I-67100 Assergi, Italy; [Balata, M.; Di Marco, N.; Junker, M.; Laubenstein, M.; Macolino, C.; Pelczar, K.] Gran Sasso Sci Inst, I-67100 Assergi, Italy; [Barabanov, I.; Bezrukov, L.; Doroshkevich, E.; Gangapshev, A.; Gurentsov, V.; Inzhechik, L. V.; Kazalov, V.; Kornoukhov, V. N.; Kuzminov, V. V.; Lubsandorzhiev, B.; Moseev, P.; Selivanenko, O.; Veresnikova, A.; Yanovich, E.] Russian Acad Sci, Inst Nucl Res, Moscow 117312, Russia; [Baudis, L.; Hiller, R.; Kish, A.; Miloradovic, M.; Mingazheva, R.; Ransom, C.] Univ Zarich, Phys Inst, CH-8057 Zurich, Switzerland; [Bauer, C.; Hakenmueller, J.; Hegai, A.; Heise, M.; Hofmann, W.; Kermaidic, Y.; Kihm, T.; Kirsch, A.; Klimenko, A.; Knoepfle, K. T.; Lindner, M.; Maneschg, W.; Schwingenheuer, B.; Simgen, H.; Smolnikov, A.; Wagner, V.; Wegrntann, A.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Bellotti, E.] Univ Milano Bicocca, Dipartimento Fis, I-20126 Milan, Italy; [Bellotti, E.; Cattadori, C.] INFN Milano Bicocca, I-20126 Milan, Italy; [Belogurov, S.; Chernogorov, A.; Dernidova, E. V.; Kirpichnikov, I. V.; Kornoukhov, V. N.; Vasenko, A. A.] Inst Theoret & Expenatental Phys, Moscow N7259, Russia; [Bettini, A.; Brugnera, R.; Garfagnini, A.; Pertoldi, L.; Sada, C.; von Sturm, K.] Univ Padua, Dipartimento Fis & Astronomia, I-35121 Padua, Italy; [Bettini, A.; Brugnera, R.; Garfagnini, A.; Hemmer, S.; Lippi, I.; Pertoldi, L.; Sada, C.; Static, L.; von Sturm, K.] INFN Padova, I-135131 Padua, Italy; [Borowicz, D.; Brudanin, V.; Egorov, V.; Fomina, M.; Gusev, K.; Klimenko, A.; Kochetov, O.; Lubashevskiy, A.; Nemchenok, I.; Rumyantseva, N.; Sheychik, E.; Shirchenko, M.; Smolnikov, A.; Zhitnikov, I.; Zinatulina, D.] Joint Inst Nucl Res, Dubna 141980, Russia; [Caldwell, A.; Kneissl, R.; Majorovits, B.; Sala, E.; Schulz, O.; Vanhoefer, L.; Zsigmond, A. J.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [D'Andrea, V.; Giordano, M.; Salamida, F.] INFN Lab Nazl Gran Sasso, I-67100 Laquila, Italy; [D'Andrea, V.; Giordano, M.; Salamida, F.] Univ Aquila, I-67100 Laquila, Italy; [Domula, A.; Schneider, B.; Wester, T.; Zuber, K.] Tech Univ Dresden, Inst Kern & Teilchenphys, D-01069 Dresden, Germany; [Falkenstein, R.; Grabrnayr, P.; Jochum, J.; Schmitt, C.; Schutz, A-K; Zschocke, A.] Eberhard Karls Univ Tabingen, Phys Inst, D-72076 Tubingen, Germany; [Hult, M.; Lutter, G.] JRC Geel, European Commiss, B-2440 Geel, Belgium; [Misiaszek, M.; Panas, K.; Wojcik, M.; Zuzel, G.] Jagiellonian Univ, Inst Phys, PL-40348 Krakow, Poland; [Pandola, L.] INFN Lab Nazl Sud, I-95123 Catania, Italy; [Piseri, P.; Pullia, A.; Riboldi, S.] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy; [Piseri, P.; Pullia, A.; Riboldi, S.] INFN, I-20133 Milan, Italy	Technical University of Munich; National Research Centre - Kurchatov Institute; Gran Sasso Science Institute (GSSI); Russian Academy of Sciences; Institute for Nuclear Research of the Russian Academy of Sciences; Max Planck Society; University of Milano-Bicocca; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Joint Institute for Nuclear Research - Russia; Max Planck Society; Gran Sasso Science Institute (GSSI); University of L'Aquila; Technische Universitat Dresden; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Jagiellonian University; Istituto Nazionale di Fisica Nucleare (INFN); University of Milan; Istituto Nazionale di Fisica Nucleare (INFN)	Knopfle, KT (corresponding author), Max Planck Inst Kernphys, D-69117 Heidelberg, Germany.		Lubsandorzhiev, Bayarto/B-4090-2016; von Sturm, Katharina/AAT-9041-2021; Kish, Alexander/I-6213-2019; Shirchenko, Mark/AAO-1761-2020; Rumyantseva, Nadya/AAC-1615-2021; Lubashevskiy, Alexey/GYD-3068-2022; Lindner, Manfred/HCI-4657-2022; Salamida, Francesco/GOE-5140-2022; Shevchik, Egor/ABD-4943-2020; Fomina, Maria/AAC-1626-2021; Kazalov, Vladimir V/V-6021-2018; Pandola, Luciano/AAS-8443-2021; Agostini, Matteo/T-4931-2019; D'Andrea, Valerio/AAC-7951-2020; Bakalyarov, Alexander/AAI-1026-2020; Lutter, Guillaume/AAF-8063-2019; Majorovits, Bela/AAN-2470-2020; Doroshkevich, Eugene/AAN-7084-2020; Bezrukov, Leonid B/M-5654-2013; Zinatulina, Daniya/R-9132-2016; Zhitnikov, Igor/AAO-1843-2020; Laubenstein, Matthias/C-4851-2013; Piseri, Paolo/A-1561-2011	Lubsandorzhiev, Bayarto/0000-0001-6134-354X; von Sturm, Katharina/0000-0002-0980-3462; Kish, Alexander/0000-0002-1648-3727; Rumyantseva, Nadya/0000-0002-2183-4309; Lubashevskiy, Alexey/0000-0002-3712-8249; Lindner, Manfred/0000-0002-3704-6016; Salamida, Francesco/0000-0002-9306-8447; Shevchik, Egor/0000-0001-9065-9375; Fomina, Maria/0000-0001-6244-9450; Agostini, Matteo/0000-0003-1151-5301; D'Andrea, Valerio/0000-0003-2037-4133; Majorovits, Bela/0000-0003-0409-2785; Bezrukov, Leonid B/0000-0002-4605-8705; Zhitnikov, Igor/0000-0001-9579-1789; Laubenstein, Matthias/0000-0001-5390-4343; Zinatulina, Daniya/0000-0001-5526-6146; Gusev, Konstantin/0000-0002-0495-0551; Sala, Elena/0000-0002-2983-5875; Kornoukhov, Vasily/0000-0003-4891-4322; Pertoldi, Luigi/0000-0002-0467-2571; Chernogorov, Andrey/0000-0003-3721-2165; Piseri, Paolo/0000-0001-8611-4735; Comellato, Tommaso/0000-0003-3780-5139	German Federal Ministry for Education and Research (BMBF); German Research Foundation (DFG) via the Excellence Cluster Universe; German Research Foundation (DFG) [SFB1258]; Italian Istituto Nazionale di Fisica Nucleare (INFN); Max Planck Society (MPG); Polish National Science Center (NCN) [UMO-2016/21/B/ST2/01094]; Foundation for Polish Science [TEAM/2016-2/2017]; Russian Foundation for Basic Research (RFBR); Swiss National Science Foundation (SNF); European Union [690575, 674896]	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) via the Excellence Cluster Universe(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Italian Istituto Nazionale di Fisica Nucleare (INFN)(Istituto Nazionale di Fisica Nucleare (INFN)); Max Planck Society (MPG)(Max Planck Society); Polish National Science Center (NCN); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Union(European Commission)	The GERDA experiment is supported financially by the German Federal Ministry for Education and Research (BMBF), the German Research Foundation (DFG) via the Excellence Cluster Universe and the SFB1258, the Italian Istituto Nazionale di Fisica Nucleare (INFN), the Max Planck Society (MPG), the Polish National Science Center (NCN) under grant UMO-2016/21/B/ST2/01094, the Foundation for Polish Science (TEAM/2016-2/2017), the Russian Foundation for Basic Research (RFBR), and the Swiss National Science Foundation (SNF). The institutions also acknowledge internal financial support. This project has received funding or support from the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreements 690575 and 674896, respectively.	Ackermann KH, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2330-0; Agostini M, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.132503; Agostini M, 2018, EUR PHYS J C, V78, DOI 10.1140/epjc/s10052-018-5812-2; Agostini M, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3681-5; Agostini M, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3627-y; Agostini M, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3409-6; Agostini M, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-014-3253-0; Agostini M, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2583-7; Agostini M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.122503; Agostini M, 2012, J PHYS CONF SER, V375, DOI 10.1088/1742-6596/375/1/042009; Agostini M, 2012, J PHYS CONF SER, V375, DOI 10.1088/1742-6596/375/1/042027; Agostini M, 2012, J PHYS CONF SER, V368, DOI 10.1088/1742-6596/368/1/012047; Agostini M, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/08/P08013; Ahmad QR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.011301; Albert JB, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.072701; Alduino C, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.132501; Alvis SI, 2019, PHYS REV C, V100, DOI 10.1103/PhysRevC.100.025501; [Anonymous], 2005, KATRIN DESIGN REPORT; Aseev VN, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.112003; Azzolini O, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.232502; Barabanov I, 2009, NUCL INSTRUM METH A, V606, P790, DOI 10.1016/j.nima.2009.04.006; Barea J, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.034304; Baudis L, 2015, J INSTRUM, V10, DOI 10.1088/1748-0221/10/12/P12005; Baudis L, 2013, NUCL INSTRUM METH A, V729, P557, DOI 10.1016/j.nima.2013.08.003; COWAN CL, 1956, SCIENCE, V124, P103, DOI 10.1126/science.124.3212.103; Csathy JJ, 2011, NUCL INSTRUM METH A, V654, P225, DOI 10.1016/j.nima.2011.05.070; Del Oro S., 2018, POS NEUTEL2017; Eguchi K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.021802; Esteban I, 2019, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2019)106; Freund K, 2016, EUR PHYS J C, V76, DOI 10.1140/epjc/s10052-016-4140-7; Fukuda Y, 1998, PHYS REV LETT, V81, P1562, DOI 10.1103/PhysRevLett.81.1562; Gunther M, 1997, PHYS REV D, V55, P54, DOI 10.1103/PhysRevD.55.54; Horoi M, 2016, PHYS REV C, V93, DOI 10.1103/PhysRevC.93.024308; Hyvarinen J, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.024613; Kraus C, 2005, EUR PHYS J C, V40, P447, DOI 10.1140/epjc/s2005-02139-7; Vaquero NL, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.142501; Lubashevskiy A, 2018, EUR PHYS J C, V78, DOI 10.1140/epjc/s10052-017-5499-9; Malorana E., 1937, NUOVO CIMENTO, V14, P171; Maneschg W, 2008, NUCL INSTRUM METH A, V593, P448, DOI 10.1016/j.nima.2008.05.036; Menndez J., 2009, NUCL PHYS A, V818, P139, DOI [10.1016/i.nuclphysa.2008.12.005, DOI 10.1016/I.NUCLPHYSA.2008.12.005]; Mount BJ, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.032501; Mustonen MT, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.064302; Planck Collaboration, 2020, AA, V641, pA6, DOI [10.1051/0004-6361/201833910(2020b), DOI 10.1051/0004-6361/201833910]; Riboldi S., 2015, P 4 INT C ADV NUCL I, DOI [10.1109/ANJMMIA.2015.7465549, DOI 10.1109/ANJMMIA.2015.7465549]; SCHECHTER J, 1980, PHYS REV D, V22, P2227, DOI 10.1103/PhysRevD.22.2227; Simkovic F, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.045501; Stefanik D, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.055502; Tanabashi M, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.030001; Yao JM, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.024316	55	83	86	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2019	365	6460					1445	+		10.1126/science.aav8613	http://dx.doi.org/10.1126/science.aav8613			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8QM	31488705	Bronze, Green Submitted			2022-12-28	WOS:000488838600046
J	Iacobucci, G				Iacobucci, Gareth			"Some exercise is good, more is better," say medical chiefs in new guidance	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L1884	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2019	366								l5470	10.1136/bmj.l5470	http://dx.doi.org/10.1136/bmj.l5470			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1KD	31494580				2022-12-28	WOS:000485449600001
J	Fogarty, ND; Marhaver, KL				Fogarty, Nicole D.; Marhaver, Kristen L.			Coral spawning, unsynchronized	SCIENCE			English	Editorial Material							ACROPORA; CYCLES		[Fogarty, Nicole D.] Univ N Carolina, Dept Biol & Marine Biol, Ctr Marine Sci, 5600 Marvin K Moss Lane, Wilmington, NC 28409 USA; [Marhaver, Kristen L.] CARMABI Fdn, POB 2090, Willemstad, Curacao	University of North Carolina; University of North Carolina Wilmington	Fogarty, ND (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Ctr Marine Sci, 5600 Marvin K Moss Lane, Wilmington, NC 28409 USA.	fogartyn@uncw.edu; kristen@marhaverlab.com	Marhaver, Kristen L/B-4948-2011	Marhaver, Kristen L/0000-0002-8953-1902	National Science Foundation [OCE-1538469, IOS-1848671]	National Science Foundation(National Science Foundation (NSF))	Supported by National Science Foundation grants OCE-1538469 to N.D.F and IOS-1848671 to K.L.M.	Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Brady AK, 2009, CORAL REEFS, V28, P677, DOI 10.1007/s00338-009-0498-4; Chamberland VF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17555-z; Craggs J, 2017, ECOL EVOL, V7, P11066, DOI 10.1002/ece3.3538; dela Cruz Dexter W., 2017, Scientific Reports, V7, P13985, DOI 10.1038/s41598-017-14546-y; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Keith SA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0011; Levitan DR, 2011, EVOLUTION, V65, P1254, DOI 10.1111/j.1558-5646.2011.01235.x; Lin CH, 2017, CORAL REEFS, V36, P1269, DOI 10.1007/s00338-017-1622-5; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Shlesinger T, 2019, SCIENCE, V365, P1002, DOI 10.1126/science.aax0110; Shoguchi E, 2013, GENE, V515, P426, DOI 10.1016/j.gene.2012.12.038; Sweeney AM, 2011, J EXP BIOL, V214, P770, DOI 10.1242/jeb.043406; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; van Woesik R., 2009, P R SOC B, V277, P715, DOI DOI 10.1098/RSPB.2009.1524; Wolstenholme J, 2018, INVERTEBR REPROD DEV, V62, P98, DOI 10.1080/07924259.2018.1434245	16	13	13	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					987	988		10.1126/science.aay7457	http://dx.doi.org/10.1126/science.aay7457			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488677				2022-12-28	WOS:000484732700031
J	Narasimhan, VM; Patterson, N; Moorjani, P; Rohland, N; Bernardos, R; Mallick, S; Lazaridis, L; Nakatsuka, N; Olalde, I; Lipson, M; Kim, AM; Olivieri, LM; Coppa, A; Vidale, M; Mallory, J; Moiseyev, V; Kitov, E; Monge, J; Adamski, N; Alexi, N; Broomandkhoshbacht, N; Candilio, F; Callan, K; Cheronet, O; Culleton, BJ; Ferry, M; Fernandes, D; Freilih, S; Gamarra, B; Gaudio, D; Hajdinjak, M; Harney, E; Harper, TK; Keatin, D; Lawson, AM; Mah, M; Mandl, K; Michel, M; Novak, M; Oppenheimer, J; Rai, N; Sirak, K; Slon, V; Stewardson, K; Zalzala, F; Zhang, Z; Akhatov, G; Bagashev, AN; Bagnera, A; Baitanayev, B; Bendezu-Sarmiento, J; Bissembaev, AA; Bonora, GL; Chargynov, TT; Chikisheva, T; Dashkovskiy, PK; Derevianko, A; Dobes, M; Douka, K; Dubova, N; Duisengali, MN; Enshin, D; Epimakhov, A; Fribus, AV; Fuller, D; Goryachev, A; Gromov, A; Grushin, SP; Hanks, B; Judd, M; Kazizov, E; Khokhlov, A; Krygin, AP; Kupriyanova, E; Kuznetsov, P; Luiseli, D; Maksudov, F; Mamedov, AM; Mamirov, TB; Meiklejohn, C; Merrett, DC; Micheli, R; Mochalov, O; Mustafokulov, S; Nayak, A; Pettener, D; Potts, R; Razhev, D; Rykun, M; Sarno, S; Savenkova, TM; Sikhymbaeva, K; Slepchenko, SM; Soltobaev, OA; Stepanova, N; Svyatko, S; Tabaldiev, K; Teschler-Nicola, M; Tishkin, AA; Tkachev, VV; Vasilyev, S; Veleminsky, P; Voyakin, D; Yermolayeva, A; Zahir, M; Zubkov, VS; Zubova, A; Shinde, VS; Lalueza-Fox, C; Meyer, M; Anthony, D; Boivin, N; Thangaraj, K; Kennett, DJ; Frachetti, M; Pinhasi, R; Reich, D				Narasimhan, Vagheesh M.; Patterson, Nick; Moorjani, Priya; Rohland, Nadin; Bernardos, Rebecca; Mallick, Swapan; Lazaridis, Losif; Nakatsuka, Nathan; Olalde, Iffigo; Lipson, Mark; Kim, Alexander M.; Olivieri, Luca M.; Coppa, Alfredo; Vidale, Massimo; Mallory, James; Moiseyev, Vyacheslav; Kitov, Egor; Monge, Janet; Adamski, Nicole; Alexi, Neel; Broomandkhoshbacht, Nasreen; Candilio, Francesca; Callan, Kimberly; Cheronet, Olivia; Culleton, Brendan J.; Ferry, Matthew; Fernandes, Daniel; Freilih, Suzanne; Gamarra, Beatriz; Gaudio, Daniel; Hajdinjak, Mateja; Harney, Eadaoin; Harper, Thomas K.; Keatin, Denise; Lawson, Ann Marie; Mah, Matthew; Mandl, Kirsten; Michel, Megan; Novak, Mario; Oppenheimer, Jonas; Rai, Niraj; Sirak, Kendra; Slon, Viviane; Stewardson, Kristin; Zalzala, Fatma; Zhang, Zhao; Akhatov, Gaziz; Bagashev, Anatoly N.; Bagnera, Alessandra; Baitanayev, Bauryzhan; Bendezu-Sarmiento, Julio; Bissembaev, Arman A.; Bonora, Gian Luca; Chargynov, Temirlan T.; Chikisheva, Tatiana; Dashkovskiy, Petr K.; Derevianko, Anatoly; Dobes, Miroslav; Douka, Katerina; Dubova, Nadezhda; Duisengali, Meiram N.; Enshin, Dmitry; Epimakhov, Andrey; Fribus, Alexey V.; Fuller, Dorian; Goryachev, Alexander; Gromov, Andrey; Grushin, Sergey P.; Hanks, Bryan; Judd, Margaret; Kazizov, Erlan; Khokhlov, Aleksander; Krygin, Aleksander P.; Kupriyanova, Elena; Kuznetsov, Pavel; Luiseli, Donata; Maksudov, Farhod; Mamedov, Asian M.; Mamirov, Talgat B.; Meiklejohn, Christopher; Merrett, Deborah C.; Micheli, Roberto; Mochalov, Oleg; Mustafokulov, Samariddin; Nayak, Ayushi; Pettener, Davide; Potts, Richard; Razhev, Dmitry; Rykun, Marina; Sarno, Stefania; Savenkova, Tatyana M.; Sikhymbaeva, Kulyan; Slepchenko, Sergey M.; Soltobaev, Oroz A.; Stepanova, Nadezhda; Svyatko, Svetlana; Tabaldiev, Kubatbek; Teschler-Nicola, Maria; Tishkin, Alexey A.; Tkachev, Vitaly V.; Vasilyev, Sergey; Veleminsky, Petr; Voyakin, Dmitriy; Yermolayeva, Antonina; Zahir, Muhammad; Zubkov, Valery S.; Zubova, Alisa; Shinde, Vasant S.; Lalueza-Fox, Carles; Meyer, Matthias; Anthony, David; Boivin, Nicole; Thangaraj, Kumnarasamy; Kennett, Douglas J.; Frachetti, Michael; Pinhasi, Ron; Reich, David			The formation of human populations in South and Central Asia	SCIENCE			English	Article							ANCIENT HUMAN GENOMES; BRONZE-AGE; SEQUENCING LIBRARIES; HUMAN-EVOLUTION; GANJ-DAREH; HISTORY; AGRICULTURE; ADMIXTURE; RECONSTRUCTION; DOMESTICATION	By sequencing 523 ancient humans, we show that the primary source of ancestry in modern South Asians is a prehistoric genetic gradient between people related to early hunter-gatherers of Iran and Southeast Asia. After the Indus Valley Civilization's decline, its people mixed with individuals in the southeast to form one of the two main ancestral populations of South Asia, whose direct descendants live in southern India. Simultaneously, they mixed with descendants of Steppe pastoralists who, starting around 4000 years ago, spread via Central Asia to form the other main ancestral population. The Steppe ancestry in South Asia has the same profile as that in Bronze Age Eastern Europe, tracking a movement of people that affected both regions and that likely spread the distinctive features shared between Indo-Iranian and Balto-Slavic languages.	[Narasimhan, Vagheesh M.; Rohland, Nadin; Bernardos, Rebecca; Mallick, Swapan; Lazaridis, Losif; Nakatsuka, Nathan; Olalde, Iffigo; Lipson, Mark; Kim, Alexander M.; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Callan, Kimberly; Ferry, Matthew; Harney, Eadaoin; Lawson, Ann Marie; Mah, Matthew; Michel, Megan; Oppenheimer, Jonas; Sirak, Kendra; Stewardson, Kristin; Zalzala, Fatma; Zhang, Zhao; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Patterson, Nick; Rohland, Nadin; Mallick, Swapan; Mah, Matthew; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Patterson, Nick] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA; [Moorjani, Priya] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Moorjani, Priya] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Mallick, Swapan; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Callan, Kimberly; Ferry, Matthew; Harney, Eadaoin; Lawson, Ann Marie; Mah, Matthew; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Zalzala, Fatma; Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Nakatsuka, Nathan] Harvard Med Sch, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Kim, Alexander M.] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Olivieri, Luca M.; Vidale, Massimo; Bagnera, Alessandra; Micheli, Roberto] Italian Archaeol Miss Pakistan, ISME Int Assoc Mediterranean & Oriental Studies, Saidu Sharif Swat 19200, Pakistan; [Coppa, Alfredo] Sapienza Univ, Dept Environm Biol, I-00185 Rome, Italy; [Vidale, Massimo] Univ Padua, Dept Cultural Heritage Archaeol & Hist Art Cinema, I-35139 Padua, Italy; [Mallory, James] Queens Univ Belfast, Sch Nat & Built Environm, Belfast BT7 1NN, Antrim, North Ireland; [Moiseyev, Vyacheslav; Gromov, Andrey; Svyatko, Svetlana; Zubova, Alisa] Russian Acad Sci, Peter Great Museum Anthropol & Ethnog Kunstkamera, St Petersburg 199034, Russia; [Kitov, Egor; Dubova, Nadezhda; Vasilyev, Sergey] Russian Acad Sci, Inst Ethnol & Anthropol, Ctr Phys Anthropol, Moscow 119991, Russia; [Kitov, Egor; Akhatov, Gaziz; Baitanayev, Bauryzhan; Bissembaev, Arman A.; Kazizov, Erlan; Mamirov, Talgat B.; Voyakin, Dmitriy; Yermolayeva, Antonina] A Kh Margulan Inst Archaeol, Alma Ata 050010, Kazakhstan; [Kitov, Egor] AI Farabi Kazakh Natl Univ, Alma Ata 050040, Kazakhstan; [Monge, Janet] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA; [Alexi, Neel] Univ Calif Berkeley, Dept Elect Engn & Comp Engn, Berkeley, CA 94720 USA; [Candilio, Francesca; Cheronet, Olivia; Fernandes, Daniel; Gamarra, Beatriz; Gaudio, Daniel; Keatin, Denise; Novak, Mario; Sirak, Kendra; Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 4, Ireland; [Candilio, Francesca] Soprintendenza Archeol Belle Arti & Paesaggio Cit, I-09124 Cagliari, Italy; [Cheronet, Olivia; Fernandes, Daniel; Gamarra, Beatriz; Gaudio, Daniel] Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland; [Cheronet, Olivia; Fernandes, Daniel; Freilih, Suzanne; Mandl, Kirsten; Teschler-Nicola, Maria; Pinhasi, Ron] Univ Vienna, Dept Evolutionary Anthropol, A-1090 Vienna, Austria; [Culleton, Brendan J.; Kennett, Douglas J.] Penn State Univ, Inst Energy & Environm, University Pk, PA 16802 USA; [Fernandes, Daniel] Univ Coimbra, Dept Life Sci, CIAS, P-3000456 Coimbra, Portugal; [Gamarra, Beatriz] Catalan Inst Human Paleoecol & Social Evolut IPHE, Tarragona 43007, Spain; [Hajdinjak, Mateja; Slon, Viviane; Meyer, Matthias] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Harney, Eadaoin] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Harper, Thomas K.; Kennett, Douglas J.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Novak, Mario] Inst Anthropol Res, Zagreb 10000, Croatia; [Rai, Niraj; Thangaraj, Kumnarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Rai, Niraj] Birbal Sahni Inst Palaeosci, Lucknow 226007, Uttar Pradesh, India; [Sirak, Kendra] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Bagashev, Anatoly N.; Enshin, Dmitry; Goryachev, Alexander; Razhev, Dmitry; Slepchenko, Sergey M.] RAS, Inst Problems Northern Dev, Tyumen Sci Ctr SB, Tyumen 625003, Russia; [Bendezu-Sarmiento, Julio] Embassy France Kabul, CNRS, EXT500, Directeur Delegat Archaol Francaise Afghanistan D, Kabul, Afghanistan; [Bissembaev, Arman A.; Duisengali, Meiram N.] Aktobe Reg Hist Museum, Aktobe 030006, Kazakhstan; [Bonora, Gian Luca] ISMEO Int Assoc Mediterranean & Oriental Studies, Archaeol Asia Dept, I-00186 Rome, Italy; [Chargynov, Temirlan T.; Soltobaev, Oroz A.] Kyrgyz Natl Univ, Bishkek 720033, Kyrgyzstan; [Chikisheva, Tatiana; Derevianko, Anatoly; Stepanova, Nadezhda] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Novosibirsk 630090, Russia; [Dashkovskiy, Petr K.] Altai State Univ, Natl & State Confess Relat, Dept Polit Hist, Barnaul 656049, Russia; [Dobes, Miroslav] Czech Acad Sci, Inst Archaeol, Prague 11801, Czech Republic; [Douka, Katerina; Nayak, Ayushi; Zahir, Muhammad; Boivin, Nicole] Max Planck Inst Sci Human Hist, Dept Archaeol, D-07745 Jena, Germany; [Douka, Katerina] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3QY, England; [Epimakhov, Andrey] RAS, Ural Branch, Inst Hist & Archaeol, Ekaterinburg 620990, Russia; [Epimakhov, Andrey] South Ural State Univ, Chelyabinsk 454080, Russia; [Fribus, Alexey V.] Kemerovo State Univ, Dept Archaeol, Kemerovo 650043, Russia; [Fuller, Dorian] UCL, Inst Archaeol, London WC1H 0PY, England; [Fuller, Dorian] Northwest Univ, Sch Cultural Heritage, Xian 710069, Shanxi, Peoples R China; [Fuller, Dorian; Grushin, Sergey P.] Altai State Univ, Dept Archaeol Ethnog & Museol, Barnaul 656049, Russia; [Hanks, Bryan; Judd, Margaret] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Khokhlov, Aleksander; Kuznetsov, Pavel; Mochalov, Oleg] Samara State Univ Social Sci & Educ, Samara 443099, Russia; [Krygin, Aleksander P.] West Kazakhstan Reg Ctr Hist & Archaeol, Uralsk 090000, Kazakhstan; [Kupriyanova, Elena] Chelyabinsk State Univ, Sci & Educ Ctr Study Problem Nat & Man, Chelyabinsk 454021, Russia; [Luiseli, Donata] Univ Bologna, Dept Cultural Heritage, I-48121 Ravenna, Italy; [Maksudov, Farhod; Mustafokulov, Samariddin] Uzbek Acad Sci, Inst Archaeol Res, Samarkand 140151, Uzbekistan; [Mamedov, Asian M.] Ctr Res Restorat & Protect Hist & Cultural Herita, Aktobe 030007, Kazakhstan; [Meiklejohn, Christopher] Univ Winnipeg, Dept Anthropol, Winnipeg, MB R3B 2E9, Canada; [Merrett, Deborah C.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Micheli, Roberto] MiBAC Minist & Beni & Attivita Culturali Soprinte, Belle Arti & Paesaggio Friuli Venezia Giulia, I-34135 Trieste, Italy; [Mustafokulov, Samariddin] Afrosiab Museum, Samarkand 140151, Uzbekistan; [Pettener, Davide; Sarno, Stefania] Univ Bologna, Alma Mater Studiorum, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy; [Potts, Richard] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Rykun, Marina] Natl Res Tomsk State Univ, Tomsk 634050, Russia; [Savenkova, Tatyana M.] F Voino Yasenetsky Krasnoyarsk State Med Univ, Krasnoyarsk 660022, Russia; [Sikhymbaeva, Kulyan] Cent State Museum Republ Kazakhstan, Alma Ata 050010, Kazakhstan; [Svyatko, Svetlana] Queens Univ Belfast, CHRONO Ctr Climate Environm & Chronol, Belfast BT7 1NN, Antrim, North Ireland; [Tabaldiev, Kubatbek] Kyrgyz Turkish Manas Univ, Bishkek, Kyrgyzstan; [Teschler-Nicola, Maria] Nat Hist Museum Vienna, Dept Anthropol, A-1010 Vienna, Austria; [Tishkin, Alexey A.] Altai State Univ, Dept Archaeol Ethnog & Museol, Lab Interdisciplinary Studies Archaeol Western Si, Barnaul 656049, Russia; [Tkachev, Vitaly V.] RAS, Ural Branch, Inst Steppe, Orenburg 460000, Russia; [Vasilyev, Sergey] RAS, Ctr Egyptol Studies, Moscow 119991, Russia; [Veleminsky, Petr] Natl Museum, Dept Anthropol, Prague 11579, Czech Republic; [Voyakin, Dmitriy] Archaeol Expertise LLP, Alma Ata 050060, Kazakhstan; [Zahir, Muhammad] Hazara Univ, Dept Archaeol, Mansehra 21300, Pakistan; [Zubkov, Valery S.] NF Katanov Khakassia State Univ, Abakan 655017, Russia; [Shinde, Vasant S.] Deccan Coll Postgrad & Res Inst, Dept Archaeol, Pune 411006, Maharashtra, India; [Lalueza-Fox, Carles] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona 08003, Spain; [Anthony, David] Hartwick Coll, Anthropol Dept, Oneonta, NY 13820 USA; [Kennett, Douglas J.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Frachetti, Michael] Washington Univ, Dept Anthropol, St Louis, MO 63112 USA; [Frachetti, Michael] Washington Univ, Spatial Anal Interpretat & Explorat Lab, St Louis, MO 63112 USA; [Michel, Megan; Reich, David] Max Planck Harvard Res Ctr Archaeosci Ancient Med, Cambridge, MA 02138 USA; [Broomandkhoshbacht, Nasreen] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; [Gamarra, Beatriz] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona 43007, Spain; [Gamarra, Beatriz] URV, Area Prehist, Tarragona 43002, Spain; [Michel, Megan] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Sapienza University Rome; University of Padua; Queens University Belfast; Russian Academy of Sciences; The Kunstkamera; Russian Academy of Sciences; N.N. Miklukho-Maklai Institute of Ethnology & Anthropology; Al-Farabi Kazakh National University; University of Pennsylvania; University of California System; University of California Berkeley; University College Dublin; University College Dublin; University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade de Coimbra; Max Planck Society; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Institute for Anthropological Research Zagreb; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Emory University; Russian Academy of Sciences; Tyumen Scientific Center of the Russian Academy of Sciences; Jasup Balasagyn Kyrgyz National University; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Altai State University; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Prague; University of Oxford; Institute of History & Archaeology of the Ural Branch of the Russian Academy of Sciences; Russian Academy of Sciences; South Ural State University; Kemerovo State University; University of London; University College London; Northwest University Xi'an; Altai State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Samara State University of Social Sciences & Education; Chelyabinsk State University; University of Bologna; Academy of Sciences of Uzbekistan; Institute of Archaeological Studies Named After Y. Gulyamov; University of Winnipeg; Simon Fraser University; University of Bologna; Smithsonian Institution; Smithsonian National Museum of Natural History; Tomsk State University; Krasnoyarsk State Medical University; Queens University Belfast; Kyrgyz Turkish Manas University; Altai State University; Russian Academy of Sciences; Russian Academy of Sciences; Centre Egyptological Studies, Russian Academy of Sciences; National Museum; Hazara University; Katanov Khakass State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of California System; University of California Santa Barbara; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Santa Cruz; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Harvard University	Narasimhan, VM; Reich, D (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Patterson, N; Reich, D (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Patterson, N (corresponding author), Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA.; Reich, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Pinhasi, R (corresponding author), Univ Vienna, Dept Evolutionary Anthropol, A-1090 Vienna, Austria.; Frachetti, M (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63112 USA.; Frachetti, M (corresponding author), Washington Univ, Spatial Anal Interpretat & Explorat Lab, St Louis, MO 63112 USA.; Reich, D (corresponding author), Max Planck Harvard Res Ctr Archaeosci Ancient Med, Cambridge, MA 02138 USA.	vagheesh@mail.harvard.edu; nickp@broadinstitute.org; frachetti@wustl.edu; ron.pinhasi@univie.ac.at; reich@genetics.med.harvard.edu	Slepchenko, Sergey/AAN-5737-2020; Khokhlov, Aleksander/F-4737-2017; Dubova, Nadezhda A/E-8597-2016; Novak, Mario/AAW-6417-2021; Zubova, Alisa A/Q-5357-2016; LALUEZA-FOX, CARLES/AAG-5341-2020; Candilio, Francesca/C-8634-2019; Tatyana, Savenkova/AAD-6127-2019; Fribus, Alexey/AAF-3036-2019; Olalde, Iñigo/N-6928-2018; Chargynov, Temirlan/C-8034-2018; Степанова, Nadezhda Stepanova/ABA-4422-2020; KAZIZOV, YERLAN/AAE-1478-2022; Gamarra, Beatriz/J-1969-2017; Fribus, Alexey V/U-1322-2017; Frachetti, Michael/AAZ-1273-2020; Fuller, Dorian/AAF-7400-2019; Epimakhov, Andrey V/N-8603-2014; Maksudov, Farhod/L-3079-2016; Moiseyev, Vyacheslav/AAD-2659-2019; Mamirov, Talgat/AAB-6802-2020; Tkachev, Vitaly/AAX-6560-2020; Kim, Alexander M./B-9142-2013; Maksudov, Farhod/O-9583-2019; Slepchenko, Sergey M/H-3454-2017; Razhev, Dmitry/AAD-3668-2019; Kitov, Egor/Z-6293-2019; Vasilyev, Sergey/ABI-5494-2020; Anatoly, Bagashev/V-7975-2018; Petr, Dashkovskiy/AAH-1161-2020; Pinhasi, Ron/AAT-1531-2020; Rykun, Marina P./D-8464-2017; Novak, Mario/AAX-1795-2021; Rai, Niraj/AAO-7618-2021; Enshin, Dmitry/AAO-1367-2020; Kitov, Egor/F-2489-2017; Tishkin, Alexey A./A-7059-2016; Douka, Katerina/L-3287-2014	Khokhlov, Aleksander/0000-0003-0442-9616; Dubova, Nadezhda A/0000-0002-4340-1037; Zubova, Alisa A/0000-0002-7981-161X; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Candilio, Francesca/0000-0002-4668-1361; Olalde, Iñigo/0000-0002-2660-6807; Степанова, Nadezhda Stepanova/0000-0003-4017-5641; KAZIZOV, YERLAN/0000-0001-9866-6596; Gamarra, Beatriz/0000-0003-3764-497X; Fribus, Alexey V/0000-0003-3208-0319; Fuller, Dorian/0000-0002-4859-080X; Epimakhov, Andrey V/0000-0002-0141-1026; Maksudov, Farhod/0000-0002-8492-0634; Mamirov, Talgat/0000-0003-2975-0115; Tkachev, Vitaly/0000-0002-6355-1745; Maksudov, Farhod/0000-0002-8492-0634; Slepchenko, Sergey M/0000-0002-9365-3849; Kitov, Egor/0000-0002-0159-3288; Vasilyev, Sergey/0000-0003-0128-6568; Pinhasi, Ron/0000-0003-1629-8131; Rai, Niraj/0000-0002-1251-9390; Enshin, Dmitry/0000-0001-6970-2359; Kitov, Egor/0000-0002-0159-3288; Gromov, Andrey/0000-0002-3263-3801; Douka, Katerina/0000-0002-0558-0011; Veleminsky, Petr/0000-0003-3691-7817; Nayak, Ayushi/0000-0001-6990-3302; Novak, Mario/0000-0002-4567-8742; Savenkova, Savenkova, Reis, Reis, Tat'ana/0000-0002-0426-6522; Chargynov, Temirlan/0000-0002-6210-9250; Oppenheimer, Jonas/0000-0001-7973-6173; Tishkin, Alexei/0000-0002-7769-136X; mallick, swapan/0000-0002-4531-4439; Harper, Thomas Kelley/0000-0002-4969-1653; Callan, Kimberly/0000-0003-3170-8514; Frachetti, Michael/0000-0001-6906-4334; Bonora, Gian Luca/0000-0001-5170-206X; Lawson, Ann Marie/0000-0003-0990-2329; Goracev, Aleksandr/0000-0001-6952-5567; Grushin, Sergei/0000-0002-5404-6632; BOIVIN, NICOLE/0000-0002-7783-4199; Michel, Megan/0000-0002-5484-7974; Nakatsuka, Nathan/0000-0002-5091-4914; Erzanova, Al'bina/0000-0002-2241-228X; Bernardos, Rebecca/0000-0003-4625-3727; Yermolayeva, Antonina/0000-0003-0354-0304; coppa, alfredo/0000-0002-7708-2484; Freilich, Suzanne/0000-0003-0472-6311; Hajdinjak, Mateja/0000-0002-4064-0331; Patterson, Nick/0000-0003-0302-684X; Harney, Eadaoin/0000-0001-9385-7297	Burroughs Wellcome Fund CASI award; NIGMS [GM007753]; Russian Science Foundation [14-50-00036]; Russian Foundation for Basic Research [18-09-00779]; European Research Council [ERC-2011-AdG 295733]; Ministry of Education and Sciences of the Russian Federation [33.1907, 33.5494]; NSF Archaeometry program [BCS-1460369]; NSF Archaeology program [BCS-1725067]; NCP fund of the Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [MLP0117]; Max Planck Society; National Science Foundation HOMINID grant [BCS-1032255]; National Institutes of Health [GM100233]; Allen Discovery Center grant; John Templeton Foundation [61220]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM100233] Funding Source: NIH RePORTER	Burroughs Wellcome Fund CASI award(Burroughs Wellcome Fund); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); European Research Council(European Research Council (ERC)European Commission); Ministry of Education and Sciences of the Russian Federation(Ministry of Education and Science, Russian Federation); NSF Archaeometry program; NSF Archaeology program(National Science Foundation (NSF)); NCP fund of the Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi; Max Planck Society(Max Planck SocietyFoundation CELLEX); National Science Foundation HOMINID grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Discovery Center grant; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.P. carried out this work while a fellow at the Radcliffe Institute for Advanced Study at Harvard University. P.M. was supported by a Burroughs Wellcome Fund CASI award. N.N. is supported by a NIGMS (GM007753) fellowship. T.C. and A.D. were supported by the Russian Science Foundation (project 14-50-00036). T.M.S. was supported by the Russian Foundation for Basic Research (grant 18-09-00779) "Anthropological and archaeological aspects of ethnogenesis of the population of the southern part of Western and Central Siberia in the Neolithic and Early Bronze Age." D.P., S.S., and D.L. were supported by European Research Council ERC-2011-AdG 295733 grant (Langelin). O.M. was supported by a grant from the Ministry of Education and Sciences of the Russian Federation No. 33.1907, 2017/1H4 "Traditional and innovational models of a development of ancient Volga population' A.E. was supported by a grant from the Ministry of Education and Sciences of the Russian Federation No. 33.5494, 2017/BP "Borderlands of cultural worlds (Southern Urals from Antiquity to Early Modern period)." Radiocarbon dating work supported by the NSF Archaeometry program BCS-1460369 to D. Ken. and B.J.C. and by the NSF Archaeology program BCS-1725067 to DKen. K.Th. was supported by NCP fund (MLP0117) of the Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi. NBo., A.N., and M.Z. were supported by the Max Planck Society. D. Re. is an Investigator of the Howard Hughes Medical Institute, and his ancient DNA laboratory work was supported by National Science Foundation HOMINID grant BCS-1032255, by National Institutes of Health grant GM100233, by an Allen Discovery Center grant, and by grant 61220 from the John Templeton Foundation.	Abdulganeev M. T., 1997, SOURCES HIST ALTAI R, P69; Alciati G., 1967, ISMEO REPORTS MEMOIR, VVIII, P1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allaby RG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0429; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Anthony DW, 2015, ANNU REV LINGUIST, V1, P199, DOI 10.1146/annurev-linguist-030514-124812; Antonini C. S., 1964, E W, V14, P13; Antonini C. Silvi, 1972, ISMEO REPORTS MEMOIR, VVII; Arslanova F. K., 1974, DEPTHS CENTURIES, P46; Arslanova F. K., 1969, ARCH REPORT UNPUB; Arslanova F. K., 2013, ARCH KH MARGULAN I A; Avanessova N. A., 2007, 9 INT C CULT NOM CEN, P13; Bagnera A., 2015, ACT REPORTS MEMOIRS, VV; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Bellwood P., 2013, ENCY GLOBAL HUMAN MI; Bobomulloyev S., 2015, ZAP IIMK, V11, P47; Bobomulloyev S., 2014, REPORTS ACAD SCI REP, V3, P39; Bonora G. L., 1997, S ASIAN ARCHEOL ISIA, P485; Briggs AW, 2012, METHODS MOL BIOL, V840, P143, DOI 10.1007/978-1-61779-516-9_18; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Callieri P., 1989, ISMEO REPORTS MEMOIR, VXXIII, P1; CALLIERI P, 1990, PAKISTAN ARCHAEOLOGY, V25, P183; Callieri P., 2000, E W, V50, P191; Castaldi E., 1968, ACCAD NAZ LINCEI; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chaubey G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127655; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Ciern V., 1999, THESIS; Coon C.S., 1957, 7 CAVES ARCHAEOLOGIC; COON C.S., 1951, CAVE EXPLORATIONS IR; Cortesi E., 2008, PAL ORIENT, V34, P5, DOI [DOI 10.3406/PALE0.2008.5254, 10.3406/paleo.2008.5254, DOI 10.3406/PALEO.2008.5254]; Costantini L., 2008, PRAGDHARA, V18, P167; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Daly KG, 2018, SCIENCE, V361, P85, DOI 10.1126/science.aas9411; Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Dani A. H., 1994, HIST CIVILIZATIONS C; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Denisov E. P., 1999, KSIROV BURIAL GROUND; Dobes M., 1991, PRAEHISTORICA, V17, P75; Douka K, 2017, J HUM EVOL, V107, P86, DOI 10.1016/j.jhevol.2017.03.003; DOUMANI PAULA, 2014, THESIS; Doumani PN, 2015, ARCHAEOL RES ASIA, V1-2, P17, DOI 10.1016/j.ara.2015.01.001; Dupree L., 1981, NOTES SHORTUGAI HARA; [Еньшин Дмитрий Николаевич Enshin D.N.], 2015, [Вестник археологии, антропологии и этнографии, Vestnik arkheologii, antropologii i etnografii], P15; Epimakhov A. V., 2016, B ARCHEOL ANTHR ETHN, V34, P60; Epimakhov A. V., 2005, EARLY COMPLEX SOC N, V1; Evdokimov V. V., 1980, WORKS KARAGANDS DETA; Faccenna D., 1995, ISMEO REPORTS MEMOIR, VXXIII, P2; Fortson B. W., 2011, INDO EUROPEAN LANGUA; Frachetti MD, 2008, PASTORALIST LANDSCAPES AND SOCIAL INTERACTION IN BRONZE AGE EURASIA, P1; Frachetti MD, 2017, NATURE, V543, P193, DOI 10.1038/nature21696; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Frenez D, 2018, ARCHAEOL RES ASIA, V15, P13, DOI 10.1016/j.ara.2017.08.002; Fribus A. V., 2017, P 5 21 ALL RUSS ARCH, P370; Fritsch C. C., 1997, E W, V47, P41; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fuller DQ, 2017, HUMAN DISPERSAL AND SPECIES MOVEMENT: FROM PREHISTORY TO THE PRESENT, P304; Galinsky KJ, 2016, AM J HUM GENET, V98, P456, DOI 10.1016/j.ajhg.2015.12.022; Gallego-Llorente M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31326; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Genna G., 1965, EAST WEST, V15, P161; Giosan L, 2012, P NATL ACAD SCI USA, V109, pE1688, DOI 10.1073/pnas.1112743109; Gregg MW., 2012, INT J HUMANITIES, V19, P56; Gryaznov M. P., 1999, NAUK SAINT PETERSBG; Gursan-Salzmann A., 2016, NEW CHRONOLOGY BRONZ; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Handikovdi H., 1977, P NATL MUSEUM PRAG B, VB33, P159; Hellenthal G, 2016, AM J HUM GENET, V98, P396, DOI 10.1016/j.ajhg.2015.12.025; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Hermes TR, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1273; Hiebert Fredrik T, 2003, CENTRAL ASIAN VILLAG; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Isakov T. M., 1989, SOV ARKHEOLOGIJA, V1, P145; Ivanov G. P., 1988, SOC SCI UZB TASHKENT, V10, P44; Jarrige J.-F., 2011, PALE ORIENT, V37, P7, DOI DOI 10.3406/PALE0.2011.5420; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kiselev S. V., 1951, ANCIENT HIST SO SIBE; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kosintsev P. A., 1999, ECOLOGY ANCIENT MODE, P100; Kozintsev AG, 2009, ARCHAEOL ETHNOL ANTH, V37, P125, DOI 10.1016/j.aeae.2010.02.014; Krause R., 2013, MULTIDISCIPLINARY IN; Krishnamurti Bhadriraju, 2003, DRAVIDIAN LANGUAGES; Kushaev G., 1983, ARCH REPORT UNPUB; Kuzmina E. E., 2008, ARYANS WAY S; Lamberg-Karlovsky C.C., 1973, E W, V23, P21; Larin O. V., 2005, AFANASIEVO CULTURE A; Lazaridis I, 2017, NATURE, V548, P214, DOI 10.1038/nature23310; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Leontyev N. V., 1989, MINUSINSK, V1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Libby W. F., 1951, RADIOCARBON DATING; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; Lister DL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196652; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Lohse JC., 2014, J TEX ARCHEOL HIST, V1, P94; Lyonnet B., 1996, MEM FRENCH ARCHAEOL, V7; Mahadevan I., 2018, WALKING UNICORN SOCI, P359; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; MarYashev A. A., 1993, ROSA, V1, P5; Maryashev A. N., 1993, ROSSIYASKAYA ARKHEOL, P5; Maryashev A. N., 1984, ARCH REPORT UNPUB; Maryashev A. N., 1988, ARCH REPORT UNPUB; Maryashev A. N., 2002, IZVESTIA, V1, P23; MarYashev K. M., 1988, ANCIENT MEMORIALS N, P24; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; McClure SB, 2010, RADIOCARBON, V52, P25, DOI 10.1017/S0033822200045008; McNeilI J., 2015, CAMBRIDGE WORLD HIST; McNeill J., 2015, CAMBRIDGE WORLD HIST; Meikelejohn C., 1992, PAL ORIENT, V18, P83, DOI [10.3406/paleo.1992.4574, DOI 10.3406/PALEO.1992.4574]; Meiklejohn C, 2017, J ARCHAEOL SCI-REP, V12, P165, DOI 10.1016/j.jasrep.2017.01.036; Merrett DC., 2004, BIOARCHAEOLOGY EARLY; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Minniti C, 2019, INT J OSTEOARCHAEOL, V29, P538, DOI 10.1002/oa.2750; Mittnik A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02825-9; Molodin V. I., 2014, B NOVOSIB STATE U SE, P136; Molodin V. I., 1985, BARABA BRONZE AGE; Moorjani lab, 2019, ZENODO, DOI [10.5281/zenodo.3263997, DOI 10.5281/ZENODO.3263997]; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P5652, DOI 10.1073/pnas.1514696113; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Moreno-Mayar JV, 2018, SCIENCE, V362, DOI 10.1126/science.aav2621; Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917; Narasimhan V. M., FORMATION HUMAN POPU; Narasimhan V.M., 2018, BIORXIV, DOI [10.1101/292581, DOI 10.1101/292581]; Noci F., 1997, ISLAO REPORTS MEMOIR, VXXIII, P3; O'Connell JF, 2018, P NATL ACAD SCI USA, V115, P8482, DOI 10.1073/pnas.1808385115; Olalde I, 2019, SCIENCE, V363, P1230, DOI 10.1126/science.aav4040; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Olivieri L. M., 2014, ACT REPORTS MEMOIRS, VII; Olivieri L. M., 2017, P 14 INT C AMS NUCL; Olivieri L. M., 2016, P 29 S AS ART ARCH C; Olivieri L. M., 2015, PA HERIT, V7, P73; Olivieri LM, 2016, VESTN DREVNEI ISTOR, V76, P559; Olivieri LM, 2015, ANC CIVILIZ SCYTHIA, V21, P183, DOI 10.1163/15700577-12341280; Panyushkina IP, 2008, RADIOCARBON, V50, P459, DOI 10.1017/S0033822200053558; Pardini E., 1977, E W, V27, P207; Parpola Asko, 2015, ROOTS HINDUISM EARLY; Parzinger H., 2009, EURASIA ANTIQ, V15, P67; Passarello P., 1984, REV ANTROPOL, VLXV, P5; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Petraglia MD, 2007, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/1-4020-5562-5_1; Potemkina TM, 2006, ANTHR ARCHEOL EURAS, V45, P7, DOI 10.2753/AAE1061-1959450101; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; RALPH EK, 1955, SCIENCE, V121, P149, DOI 10.1126/science.121.3136.149; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Renaud G, 2013, BIOINFORMATICS, V29, P1208, DOI 10.1093/bioinformatics/btt117; Renfrew Cohn, 2002, EXAMINING FARMING LA; Rice D. T., 1937, EXCAVATIONS TEPE HIS, p[XXI, 478], DOI [10.1017/S0003598X00014174, DOI 10.1017/S0003598X00014174]; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Rohland N, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0050-5; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Saag L, 2017, CURR BIOL, V27, P2185, DOI 10.1016/j.cub.2017.06.022; Salvatori S, 2001, S ASIAN ARCHAEOLOGY, V1, P281; Salvatori S., 1975, E W, V25, P333; Santos GM, 2004, RADIOCARBON, V46, P165, DOI 10.1017/S0033822200039485; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Silva M, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0936-9; Sirak KA, 2017, BIOTECHNIQUES, V62, P283, DOI 10.2144/000114558; Skochina S. N., 2017, BR REPORTS I ARCHEOL, P242; Skochina S. N, 2012, VESTNIK ARKHEOLOGII, V4, P43; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; SMITH PEL, 1990, WORLD ARCHAEOL, V21, P323, DOI 10.1080/00438243.1990.9980111; Southworth F., 2005, 7 ESCA HARV KYOT ROU; Spengler RN, 2014, QUATERN INT, V348, P147, DOI 10.1016/j.quaint.2014.03.039; Spengler RN, 2013, ENVIRON ARCHAEOL, V18, P211, DOI 10.1179/1749631413Y.0000000008; Stacul G., 1966, E W, V16, P37; Stacul G., 1978, E W, V28, P137; Stacul G., 1975, E W, V25, P291; Stacul G., 1980, E W, V30, P55; Stacul Giorgio, 1977, E W, V27, P151; Stepanova N. F., 2013, ARCHAEOL STUD STEPPE, P61; Stepanova N. F., 2012, ANTIQ SIB CENT ASIA, V16, P8; Stevens CJ, 2016, HOLOCENE, V26, P1541, DOI 10.1177/0959683616650268; Stloukal M., 1981, ENEOLITHIC SKELETONS; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Teploukhov S. A., 1929, CLASSIFICATION ANCIE, VIV; Tkachev A. A., 2009, UFA ARCHEOL HER, V9, P72; Tkachev A. A., 2002, CENTRAL KAZAKHSTAN B; Tosi M., 1967, E W, V18, P9; Tosi M., 1983, ISMEO REPORTS MEMOIR, V19, P183; Tosi M., 1969, E W, P283; Tucci G., 1964, E W, V14, P27; Tucci Giuseppe, 1977, E W, V27, P11; Tucci Giuseppe, 1958, E W, V9, P292; Tusa S., 1981, E W, V31, P99; Unterlander M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14615; Usmanova E. R., 2005, BURIAL GROUND LISAKO; Vadetskaya N. F., 2014, AZBUKA BARNAUL, P301; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Varfolomeev V., 1989, QUESTIONS ARCHEOLOGY, P76; Veleminsk P., 1997, SKELETON GRAVE 4 81; Vidale M., 2016, ACT FIELD SCH REPORS, VIII; Vidale M, 2018, ARCHAEOL RES ASIA, V15, P110, DOI 10.1016/j.ara.2017.12.001; Vidale M, 2017, ANTIQUITY, V91, P389, DOI 10.15184/aqy.2017.23; Vinogradova N., 2001, E W, V51, P9; Vinogradova N. M., 2011, VDI, V4, P84; Vinogradova N. M., 2015, ARCHEOL REV ANC E NE, V2, P21; Voigt M. M., 1983, HASANLU, VI; von Weinzierl R., 1895, MITTEILUNGEN ANTHR G, V25, P29; Wang CC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08220-8; Yang MA, 2017, CURR BIOL, V27, P3202, DOI 10.1016/j.cub.2017.09.030; Zahir Muhammad, 2016, COMPANION S ASIA, P274; Zapotocky M., 1999, ARCHEOLOGICKE VYZKUM, P7; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zubova A. V., 2014, POPULATIONS W SIBERI; Zubova D. V., 2014, ARYANS EURASIAN STEP; Еньшин Дмитрий Николаевич, 2014, [Вестник археологии, антропологии и этнографии, Vestnik arkheologii, antropologii i etnografii], P14	227	219	220	20	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					999	+	eaat7487	10.1126/science.aat7487	http://dx.doi.org/10.1126/science.aat7487			359	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488661	Green Accepted, Green Submitted			2022-12-28	WOS:000484732700038
J	Whitman, E				Whitman, Elizabeth			A LAND WITHOUT WATER	NATURE			English	News Item																			0	9	9	7	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					20	23		10.1038/d41586-019-02600-w	http://dx.doi.org/10.1038/d41586-019-02600-w			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31485066	Bronze			2022-12-28	WOS:000483967700017
J	Mahase, E				Mahase, Elisabeth			NICE recommends gene therapy for inherited retinal dystrophy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence (NICE), 2019, VOR NEP TREAT INH RE	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l5394	10.1136/bmj.l5394	http://dx.doi.org/10.1136/bmj.l5394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1FO	31484640				2022-12-28	WOS:000485437600012
J	[Anonymous]				[Anonymous]			Hasty Generalizations (Reprinted from JAMA, vol 3, pg 268-269, 1884)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1884, JAMA, V3, P268	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					897	897		10.1001/jama.2018.15495	http://dx.doi.org/10.1001/jama.2018.15495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479128				2022-12-28	WOS:000486437200028
J	Suter, TACS; Jaworski, A				Suter, Tracey A. C. S.; Jaworski, Alexander			Cell migration and axon guidance at the border between central and peripheral nervous system	SCIENCE			English	Review							PIAL BASEMENT-MEMBRANE; BOUNDARY CAP CELLS; PNS TRANSITIONAL ZONE; MOTOR-NEURON SOMATA; SCHWANN-CELLS; SPINAL-CORD; BASAL LAMINA; EXIT POINTS; OLIGODENDROCYTE MIGRATION; TRANSCRIPTION FACTOR	The central and peripheral nervous system (CNS and PNS, respectively) are composed of distinct neuronal and glial cell types with specialized functional properties. However, a small number of select cells traverse the CNS-PNS boundary and connect these two major subdivisions of the nervous system. This pattern of segregation and selective connectivity is established during embryonic development, when neurons and glia migrate to their destinations and axons project to their targets. Here, we provide an overview of the cellular and molecular mechanisms that control cell migration and axon guidance at the vertebrate CNS-PNS border. We highlight recent advances on how cell bodies and axons are instructed to either cross or respect this boundary, and present open questions concerning the development and plasticity of the CNS-PNS interface.	[Suter, Tracey A. C. S.; Jaworski, Alexander] Brown Univ, Dept Neurosci, Div Biol & Med, Providence, RI 02912 USA; [Suter, Tracey A. C. S.; Jaworski, Alexander] Robert J & Nancy D Carney Inst Brain Sci, Providence, RI 02912 USA	Brown University	Jaworski, A (corresponding author), Brown Univ, Dept Neurosci, Div Biol & Med, Providence, RI 02912 USA.; Jaworski, A (corresponding author), Robert J & Nancy D Carney Inst Brain Sci, Providence, RI 02912 USA.	alexander_jaworski@brown.edu		Suter, Tracey/0000-0002-7091-2297; Jaworski, Alexander/0000-0002-4596-5450	NIH [F31 NS098643, T32 GM077995, RI-INBRE P20 GM103430, R01 NS095908]; Rhode Island Foundation; New Frontiers Award from the Rhode Island Neuroscience Consortium; Brown University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430, T32GM077995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095908, F31NS098643] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; New Frontiers Award from the Rhode Island Neuroscience Consortium; Brown University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants F31 NS098643 (T. A. C. S. S.), T32 GM077995 (T. A. C. S. S.), RI-INBRE P20 GM103430 (A. J.), and R01 NS095908 (A. J.); a grant from the Rhode Island Foundation and a New Frontiers Award from the Rhode Island Neuroscience Consortium to A. J.; and funding from Brown University.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Barry DS, 2014, INT J BIOCHEM CELL B, V46, P76, DOI 10.1016/j.biocel.2013.11.013; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BLAKEMORE WF, 1975, J NEUROCYTOL, V4, P573, DOI 10.1007/BF01351538; BLAKEMORE WF, 1976, NEUROPATH APPL NEURO, V2, P21, DOI 10.1111/j.1365-2990.1976.tb00559.x; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; Bonanomi D, 2019, NEURON, V102, P602, DOI 10.1016/j.neuron.2019.02.034; Bossing T, 2002, DEVELOPMENT, V129, P4205; Broihier HT, 2004, DEVELOPMENT, V131, P5233, DOI 10.1242/dev.01394; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Cariboni A, 2011, HUM MOL GENET, V20, P336, DOI 10.1093/hmg/ddq468; Chaudhry N, 2017, J NEUROSCI, V37, P5885, DOI 10.1523/JNEUROSCI.1822-16.2017; Choe Y, 2012, NEURON, V73, P698, DOI 10.1016/j.neuron.2011.11.036; Clark JK, 2014, DEV DYNAM, V243, P1116, DOI [10.1002/DVDY.24158, 10.1002/dvdy.24158]; Coulpier F, 2010, J NEUROSCI, V30, P5958, DOI 10.1523/JNEUROSCI.0017-10.2010; Coulpier F, 2009, GLIA, V57, P1450, DOI 10.1002/glia.20862; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; COULY GF, 1992, DEVELOPMENT, V114, P1; Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; Fontenas L, 2019, CELL REP, V27, P115, DOI 10.1016/j.celrep.2019.03.013; Forni PE, 2015, FRONT NEUROENDOCRIN, V36, P165, DOI 10.1016/j.yfrne.2014.09.004; Fraher JP, 2007, J ANAT, V211, P600, DOI 10.1111/j.1469-7580.2007.00807.x; Fraher JP, 1997, J NEUROCYTOL, V26, P41, DOI 10.1023/A:1018511425126; FRAHER JP, 1992, PROG NEUROBIOL, V38, P261, DOI 10.1016/0301-0082(92)90022-7; FRAHER JP, 1990, J ANAT, V170, P131; Frob F, 2012, GLIA, V60, P806, DOI 10.1002/glia.22310; Garrett AM, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmol.2010.00003, 10.3389/fnmol.2016.00003]; Giacobini P, 2007, J NEUROSCI, V27, P431, DOI 10.1523/JNEUROSCI.4979-06.2007; GILMORE SA, 1982, BRAIN RES, V239, P365, DOI 10.1016/0006-8993(82)90515-7; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Golding JP, 1997, MOL CELL NEUROSCI, V9, P381, DOI 10.1006/mcne.1997.0647; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gruner HN, 2019, NEUROSCIENCE, V402, P116, DOI 10.1016/j.neuroscience.2019.01.017; Halfter W, 2002, J NEUROSCI, V22, P6029; Halfter W, 2014, MECH DEVELOP, V133, P1, DOI 10.1016/j.mod.2014.07.003; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Jasmin L, 2000, J NEUROSCI, V20, P9215; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kim M, 2017, DEV BIOL, V432, P178, DOI 10.1016/j.ydbio.2017.09.038; Kim M, 2015, DEV BIOL, V399, P68, DOI 10.1016/j.ydbio.2014.12.014; Koeppen AH, 2017, J NEUROPATH EXP NEUR, V76, P969, DOI 10.1093/jnen/nlx087; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kucenas S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020511; Kucenas S, 2009, J NEUROSCI, V29, P15187, DOI 10.1523/JNEUROSCI.4193-09.2009; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; Laumonnerie C, 2014, DEVELOPMENT, V141, P594, DOI 10.1242/dev.099606; Layden MJ, 2006, DEV BIOL, V291, P253, DOI 10.1016/j.ydbio.2005.12.009; Lee H, 2015, EXP NEUROL, V269, P17, DOI 10.1016/j.expneurol.2015.03.024; Lee H, 2013, EXP NEUROL, V249, P83, DOI 10.1016/j.expneurol.2013.08.010; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Liu XF, 2013, ANAT REC, V296, P995, DOI 10.1002/ar.22717; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; MARTINSGREEN M, 1986, J EMBRYOL EXP MORPH, V98, P219; Mauti O, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-28; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Moreno-Bravo JA, 2019, NEURON, V101, P625, DOI 10.1016/j.neuron.2018.12.024; Moreno-Bravo JA, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.159400; Myshrall TD, 2012, J NEUROPATH EXP NEUR, V71, P1047, DOI 10.1097/NEN.0b013e318274a128; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; NICHOLS EL, 2019, NAT COMMUN, V10, DOI DOI 10.1038/S41467-019-08421-9; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Nishizumi H, 2015, DEV NEUROBIOL, V75, P594, DOI 10.1002/dneu.22268; O'Brien D, 1998, J NEUROCYTOL, V27, P247, DOI 10.1023/A:1006932931160; Ohayon D, 2016, CELL REP, V17, P1473, DOI 10.1016/j.celrep.2016.10.016; Pingault V, 2013, AM J HUM GENET, V92, P707, DOI 10.1016/j.ajhg.2013.03.024; Radomska KJ, 2017, CURR OPIN NEUROBIOL, V47, P209, DOI 10.1016/j.conb.2017.11.003; Santiago-Medina M, 2015, DEVELOPMENT, V142, P486, DOI 10.1242/dev.108266; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Schwarting GA, 2006, J NEUROSCI, V26, P6834, DOI 10.1523/JNEUROSCI.1728-06.2006; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Sims TJ, 1997, BRAIN RES, V763, P141, DOI 10.1016/S0006-8993(97)00501-5; SIMS TJ, 1983, BRAIN RES, V276, P17, DOI 10.1016/0006-8993(83)90544-9; Smith CJ, 2016, GLIA, V64, P1138, DOI 10.1002/glia.22987; Smith CJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001961; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Suter TACS, 2017, DEV BIOL, V430, P1, DOI 10.1016/j.ydbio.2017.08.005; Taroc EZM, 2017, BIOL OPEN, V6, P1552, DOI 10.1242/bio.029074; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Toba Y, 2008, DEV NEUROBIOL, V68, P487, DOI 10.1002/dneu.20594; Treloar HB, 2010, NEUROBIOLOGY OLFACTI; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; Wray S, 2010, J NEUROENDOCRINOL, V22, P743, DOI 10.1111/j.1365-2826.2010.02034.x; Wu ZH, 2019, NEURON, V101, P635, DOI 10.1016/j.neuron.2018.12.025; Yajima H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-40; Yung AR, 2018, CELL REP, V22, P1666, DOI 10.1016/j.celrep.2018.01.068; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zarbalis K, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-2; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zhu Y, 2015, J NEUROSCI, V35, P9211, DOI 10.1523/JNEUROSCI.0156-15.2015	97	19	20	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					881	+	eaaw8231	10.1126/science.aaw8231	http://dx.doi.org/10.1126/science.aaw8231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467195	Green Accepted			2022-12-28	WOS:000483975800035
J	Paggio, A; Checchetto, V; Campo, A; Menabo, R; Di Marco, G; Di Lisa, F; Szabo, I; Rizzuto, R; De Stefani, D				Paggio, Angela; Checchetto, Vanessa; Campo, Antonio; Menabo, Roberta; Di Marco, Giulia; Di Lisa, Fabio; Szabo, Ildiko; Rizzuto, Rosario; De Stefani, Diego			Identification of an ATP-sensitive potassium channel in mitochondria	NATURE			English	Article							K+-CHANNEL; CALCIUM; MECHANISM; LIVER; ROS	Mitochondria provide chemical energy for endoergonic reactions in the form of ATP, and their activity must meet cellular energy requirements, but the mechanisms that link organelle performance to ATP levels are poorly understood. Here we confirm the existence of a protein complex localized in mitochondria that mediates ATP-dependent potassium currents (that is, mitoK(ATP)). We show that-similar to their plasma membrane counterparts-mitoK(ATP) channels are composed of pore-forming and ATP-binding subunits, which we term MITOK and MITOSUR, respectively. In vitro reconstitution of MITOK together with MITOSUR recapitulates the main properties of mitoK(ATP). Overexpression of MITOK triggers marked organelle swelling, whereas the genetic ablation of this subunit causes instability in the mitochondrial membrane potential, widening of the intracristal space and decreased oxidative phosphorylation. In a mouse model, the loss of MITOK suppresses the cardioprotection that is elicited by pharmacological preconditioning induced by diazoxide. Our results indicate that mitoK(ATP) channels respond to the cellular energetic status by regulating organelle volume and function, and thereby have a key role in mitochondrial physiology and potential effects on several pathological processes.	[Paggio, Angela; Campo, Antonio; Di Marco, Giulia; Di Lisa, Fabio; Rizzuto, Rosario; De Stefani, Diego] Univ Padua, Dept Biomed Sci, Padua, Italy; [Checchetto, Vanessa; Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy; [Menabo, Roberta; Di Lisa, Fabio; Szabo, Ildiko] CNR, Inst Neurosci, Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Rizzuto, R; De Stefani, D (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	rosario.rizzuto@unipd.it; diego.destefani@gmail.com	checchetto, vanessa/ABI-6145-2020; Szabo, Ildiko/AAW-5972-2021; De Stefani, Diego/I-7715-2015	checchetto, vanessa/0000-0001-8911-6146; Szabo, Ildiko/0000-0002-3637-3947; De Stefani, Diego/0000-0003-3796-8907; Campo, Antonio/0000-0001-6390-1293; Rizzuto, Rosario/0000-0001-7044-5097	University of Padova; Italian Ministry of Education, University and Research (FIRB) [2015795S5W]; European Union [294777]; NIH [1P01AG025532-01A1]; Italian Association for Cancer Research (AIRC) [IG18633, IG20286]; Telethon-Italy [GGP16029]; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	University of Padova; Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to P. Bernardi, V. Petronilli, T. Pozzan, L. Scorrano and M. Zoratti for helpful discussion, to F. Caicci and F. Boldrin for electron microscopy, to A. Montagna for immunofluorescence, to L. Carraretto for help with expression of MITOK in E. coli, to L. Cendron for the help with thermal shift assay, and to M. Ruzzene and L. Cesaro for the help with the radioactive assay. This work was supported by grants from the University of Padova (Assegno junior 2015 and SID 2016 to D.D.S., STARS@UNIPD WiC grant 2017 to R. R. and UNIPD funds for research equipment 2015), the Italian Ministry of Education, University and Research (FIRB to R.R. PRIN no. 2015795S5W to I.S.), the European Union (ERC mitoCalcium, no. 294777 to R.R.), NIH (Grant no. 1P01AG025532-01A1 to R.R.), the Italian Association for Cancer Research (AIRC IG18633 to R.R. and IG20286 to I.S.), and Telethon-Italy (GGP16029 to R.R.).	Ardehali H, 2004, P NATL ACAD SCI USA, V101, P11880, DOI 10.1073/pnas.0401703101; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Ashok Y, 2015, PROTEIN ENG DES SEL, V28, P539, DOI 10.1093/protein/gzv049; Augustynek B, 2017, HANDB EXP PHARMACOL, V240, P103, DOI 10.1007/164_2016_79; Bednarczyk P, 2004, J MEMBRANE BIOL, V199, P63, DOI 10.1007/s00232-004-0676-9; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cang CL, 2015, CELL, V162, P1101, DOI 10.1016/j.cell.2015.08.002; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113; Choma K, 2009, J BIOENERG BIOMEMBR, V41, P323, DOI 10.1007/s10863-009-9233-7; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Dahlem YA, 2004, BBA-BIOENERGETICS, V1656, P46, DOI 10.1016/j.bbabio.2004.01.003; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Foster DB, 2012, CIRC RES, V111, P446, DOI 10.1161/CIRCRESAHA.112.266445; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garlid KD, 2001, IUBMB LIFE, V52, P153, DOI 10.1080/15216540152845948; Garlid KD, 1997, CIRC RES, V81, P1072; Garlid KD, 2012, J MOL CELL CARDIOL, V52, P578, DOI 10.1016/j.yjmcc.2011.12.011; Granatiero Veronica, 2014, Cold Spring Harb Protoc, V2014, P86, DOI 10.1101/pdb.prot072843; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Leanza L, 2017, CANCER CELL, V31, P516, DOI 10.1016/j.ccell.2017.03.003; Lee SY, 2017, J AM CHEM SOC, V139, P3651, DOI 10.1021/jacs.6b10418; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Liu YG, 1998, CIRCULATION, V97, P2463, DOI 10.1161/01.CIR.97.24.2463; Nessa A, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00029; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; PAUCEK P, 1992, J BIOL CHEM, V267, P26062; Rosselin M, 2017, EMBO REP, V18, P451, DOI 10.15252/embr.201642931; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato T, 2000, CIRCULATION, V101, P2418, DOI 10.1161/01.CIR.101.20.2418; Schaedler TA, 2015, BIOCHEM SOC T, V43, P943, DOI 10.1042/BST20150118; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHLUTER KD, 1991, AM J PHYSIOL, V261, pH416, DOI 10.1152/ajpheart.1991.261.2.H416; Schwarzlander M, 2012, PLANT CELL, V24, P1188, DOI 10.1105/tpc.112.096438; Smith CO, 2017, BIOCHEM J, V474, P2067, DOI 10.1042/BCJ20160623; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; Teardo E, 2017, PLANT PHYSIOL, V173, P1355, DOI 10.1104/pp.16.01359; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Walters AM, 2012, CIRC RES, V111, P1222, DOI 10.1161/CIRCRESAHA.112.265660; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wojtovich AP, 2013, AM J PHYSIOL-HEART C, V304, pH1439, DOI 10.1152/ajpheart.00972.2012; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	50	114	118	12	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					609	+		10.1038/s41586-019-1498-3	http://dx.doi.org/10.1038/s41586-019-1498-3			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31435016	Green Accepted			2022-12-28	WOS:000483405500044
J	Worth, T				Worth, Tammy			EFFICACY Unpicking the entourage effect	NATURE			English	Editorial Material																		Baron EP, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0862-2; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Fukumoto S, 2008, STRESS HEALTH, V24, P3, DOI 10.1002/smi.1158; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; Lewis MA, 2018, PLANTA MED, V84, P225, DOI 10.1055/s-0043-122240; Pamplona FA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00759; Russo EB, 2017, ADV PHARMACOL, V80, P67, DOI 10.1016/bs.apha.2017.03.004; Santiago M., 2019, PREPRINT BIORXIV, DOI [10.1101/569079, DOI 10.1101/569079]; World Health Organization, 2018, WHO TECH REP SER, V1013	9	11	11	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					S12	S13		10.1038/d41586-019-02528-1	http://dx.doi.org/10.1038/d41586-019-02528-1			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31462791	Bronze			2022-12-28	WOS:000483405500017
J	Schwab, T				Schwab, Tim			US opioid prescribing: the federal government advisers with recent ties to big pharma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PAIN; MEDICINE; HEALTH					timschwab2020@gmail.com						Argoff CE, 2018, PAIN MED, V19, P97, DOI 10.1093/pm/pnx285; Basken P, 2017, CHRONICLE HIGHE 0425; Bernstein L., 2019, WASHINGTON POST; Bicket MC, 2019, AM J SURG, DOI [10.1016/j.amjsurg.2019.04.01031023548, DOI 10.1016/J.AMJSURG.2019.04.01031023548]; Carlson J., 2018, MINNEAPOLIS STAR TRI; Dzau VJ, 2016, JAMA-J AM MED ASSOC, V316, P1659, DOI 10.1001/jama.2016.14117; Dzau VJ, 2014, JAMA-J AM MED ASSOC, V312, P1507, DOI 10.1001/jama.2014.12986; Dzau VJ, 2019, BMJ; Dzau VJ, 2019, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2019.1105131310651, DOI 10.1001/JAMA.2019.1105131310651]; Dzua Victor, 2015, NAT AC NAT AC SCI EX; Fauber J, MILWAUKEE J SENTINEL; Fauber J, 2014, MILWAUKEE J SENTINEL; Fuster V, 2017, J AM COLL CARDIOL, V70, P3140, DOI 10.1016/j.jacc.2017.11.009; Hakim D, 2019, NY TIMES; Institute of Medicine, 2009, CONFLICT INTEREST ME, DOI DOI 10.17226/12598; Institute of Medicine Committee on Advancing Pain Research Care and Education, 2011, REL PAIN AM BLUEPR T; Johnson SR, 2014, MOD HEALTHC; Krane EJ, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1623; Leshner AI, 2019, JAMA-J AM MED ASSOC, V321, P2071, DOI 10.1001/jama.2019.5523; Lowenstein M, 2019, AM J EMERG MED, DOI [10.1016/j.ajem.2019.02.02530803850, DOI 10.1016/J.AJEM.2019.02.02530803850]; Medtronic, US MED TECHN REL PAI; Meier Barry, 2007, NY TIMES; Moon S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j280; National Academies of Sciences, 2012, REP TREAS NAT AC SCI; National Academies of Sciences, 2009, REP TREAS NAT AC SCI; National Academies of Sciences, 2016, REP TREAS NAT AC SCI; National Academies of Sciences, 2018, REP TREAS YEAR END D; National Academies of Sciences, 2017, REP TREAS NAT AC SCI; National Academies of Sciences Engineering and Medicine, 2017, GLOB HLTH FUT ROL US, DOI [10.17226/24737, DOI 10.17226/24737]; National Academy of Medicine, ACT COLL COUNT US OP; National Academy of Medicine Health and Medicine Division, EV BAS CLIN PRACT GU; Perrone M, 2016, PROPAINKILLER ECHO C; Polomano RC, 2008, PAIN MANAG NURS, V9, pS3, DOI 10.1016/j.pmn.2007.11.002; Polomano Rosemary C, 2017, Am J Nurs, V117, pS12, DOI 10.1097/01.NAJ.0000513527.71934.73; Securities and Exchange Commission, MEDTR FORM 10 K FISC; Securities and Exchange Commission, 2014, MEDTR FORM 3 FIL V D; Sridhar D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2666; Sun E, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5909; Thomas K, 2019, TOP CANC DOCTOR FORC; US Health and Human Services. Center for Medicare Systems, OPENPAYMENTS DAT; US Senate Homeland Security and Government Affairs Committee, 2018, MIN STAFF REP FUEL E; Walco GA, 2017, J PAIN, V18, P1270, DOI 10.1016/j.jpain.2017.06.001; Walters Joanna, 2019, GUARDIAN; Wyden R, 2016, COMMUNICATION    JUL; Yu JA, 2019, J ONCOL PRACT, V15, P36, DOI 10.1200/JOP.18.00234	45	5	5	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2019	366								l5167	10.1136/bmj.l5167	http://dx.doi.org/10.1136/bmj.l5167			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DJ	31439544				2022-12-28	WOS:000482882300005
J	Soutourina, J				Soutourina, Julie			Mammalian Mediator as a Functional Link between Enhancers and Promoters	CELL			English	Editorial Material								In this issue of Cell, Casellas and colleagues provide insights into the structural and functional aspects of the mammalian multi-subunit Mediator complex, a conserved and essential transcriptional coregulator. Combining cryo-EM, genetic, and genomic analyses, the work sheds light on Mediator's mode of action as a functional bridge between enhancers and promoters.	[Soutourina, Julie] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, F-91198 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Soutourina, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, F-91198 Gif Sur Yvette, France.	julie.soutourina@cea.fr	Soutourina, Julie/F-8305-2014	Soutourina, Julie/0000-0001-5218-2350				Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; El Khattabi L, 2019, CELL, V178, P1145, DOI 10.1016/j.cell.2019.07.011; Jeronimo C, 2016, MOL CELL, V64, P455, DOI 10.1016/j.molcel.2016.09.002; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Petrenko N, 2016, MOL CELL, V64, P443, DOI 10.1016/j.molcel.2016.09.015; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Soutourina J, 2018, NAT REV MOL CELL BIO, V19, P262, DOI 10.1038/nrm.2017.115; Tsai KL, 2017, NATURE, V544, P196, DOI 10.1038/nature21393	10	6	6	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1036	1038		10.1016/j.cell.2019.07.040	http://dx.doi.org/10.1016/j.cell.2019.07.040			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442397	Green Published, Bronze			2022-12-28	WOS:000482191000003
J	Al Saleh, AS; Sidiqi, MH; Gertz, MA				Al Saleh, Abdullah S.; Sidiqi, M. Hasib; Gertz, Morie A.			Joint Pain and Proteinuria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMYLOID ARTHROPATHY; MULTIPLE-MYELOMA	A 66-year-old man had bilateral carpal tunnel syndrome and 6 years of chronic joint pain and stiffness of the shoulders, hips, and knees. He reported occasional bruising around his eyes; physical examination showed raised soft tissue masses around the sternoclavicular joints and scapulae, and laboratory examination was notable for significant levels of protein and albumin. What is the diagnosis and what would you do next?	[Al Saleh, Abdullah S.; Sidiqi, M. Hasib; Gertz, Morie A.] Mayo Clin Rochester, Dept Internal Med, Div Hematol, Rochester, MN USA; [Al Saleh, Abdullah S.] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia	Mayo Clinic; King Saud Bin Abdulaziz University for Health Sciences	Gertz, MA (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	gertz.morie@mayo.edu		Al Saleh, Abdullah S./0000-0003-1111-556X				Alpay N, 2009, AMYLOID, V16, P226, DOI 10.3109/13506120903421785; [Anonymous], 1974, Br Med J, V1, P297; Elsaman AM, 2013, SEMIN ARTHRITIS RHEU, V43, P405, DOI 10.1016/j.semarthrit.2013.07.004; Fautrel B, 2002, J RHEUMATOL, V29, P1473; GERTZ MA, 1989, MAYO CLIN PROC, V64, P1505, DOI 10.1016/S0025-6196(12)65706-1; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Kuhn A, 2015, DTSCH ARZTEBL INT, V112, P423, DOI 10.3238/arztebl.2015.0423; M'Bappe P, 2012, BEST PRACT RES CL RH, V26, P459, DOI 10.1016/j.berh.2012.07.003; Nam Jackie, 2009, Curr Rheumatol Rep, V11, P371; Vaxman I, 2019, ACTA HAEMATOL-BASEL, V141, P93, DOI 10.1159/000495455	10	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2019	322	15					1512	1513		10.1001/jama.2019.12704	http://dx.doi.org/10.1001/jama.2019.12704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI4ST	31486835				2022-12-28	WOS:000493458400022
J							Collaborative Grp Hormonal Factors	Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence	LANCET			English	Article							INITIATIVE CLINICAL-TRIAL; ESTROGEN-PLUS-PROGESTIN; POSTMENOPAUSAL WOMEN	Background Published findings on breast cancer risk associated with different types of menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term effects. We bring together the epidemiological evidence, published and unpublished, on these associations, and review the relevant randomised evidence. Methods Principal analyses used individual participant data from all eligible prospective studies that had sought information on the type and timing of MHT use; the main analyses are of individuals with complete information on this. Studies were identified by searching many formal and informal sources regularly from Jan 1, 1992, to Jan 1, 2018. Current users were included up to 5 years (mean 1.4 years) after last-reported MHT use. Logistic regression yielded adjusted risk ratios (RRs) comparing particular groups of MHT users versus never users. Findings During prospective follow-up, 108 647 postmenopausal women developed breast cancer at mean age 65 years (SD 7); 55 575 (51%) had used MHT. Among women with complete information, mean MHT duration was 10 years (SD 6) in current users and 7 years (SD 6) in past users, and mean age was 50 years (SD 5) at menopause and 50 years (SD 6) at starting MHT. Every MHT type, except vaginal oestrogens, was associated with excess breast cancer risks, which increased steadily with duration of use and were greater for oestrogen-progestagen than oestrogen-only preparations. Among current users, these excess risks were definite even during years 1-4 (oestrogen-progestagen RR 1.60, 95% CI 1.52-1.69; oestrogen-only RR 1.17, 1.10-1.26), and were twice as great during years 5-14 (oestrogen-progestagen RR 2.08, 2.02-2.15; oestrogen-only RR 1.33, 1.28-1.37). The oestrogen-progestagen risks during years 5-14 were greater with daily than with less frequent progestagen use (RR 2.30, 2.21-2.40 vs 1.93, 1.84-2.01; heterogeneity p<0.0001). For a given preparation, the RRs during years 5-14 of current use were much greater for oestrogen-receptor-positive tumours than for oestrogen-receptor-negative tumours, were similar for women starting MHT at ages 40-44, 45-49, 50-54, and 55-59 years, and were attenuated by starting after age 60 years or by adiposity (with little risk from oestrogen-only MHT in women who were obese). After ceasing MHT, some excess risk persisted for more than 10 years; its magnitude depended on the duration of previous use, with little excess following less than 1 year of MHT use. Interpretation If these associations are largely causal, then for women of average weight in developed countries, 5 years of MHT, starting at age 50 years, would increase breast cancer incidence at ages 50-69 years by about one in every 50 users of oestrogen plus daily progestagen preparations; one in every 70 users of oestrogen plus intermittent progestagen preparations; and one in every 200 users of oestrogen-only preparations. The corresponding excesses from 10 years of MHT would be about twice as great. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.	[Collaborative Grp Hormonal Factors] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford	Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford OX3 7LF, England.		Negri, Eva Vanna Lorenza/AAC-5698-2019; Ghiasvand, Reza/H-4944-2019; Heuch, Ivar/A-4510-2008	Negri, Eva Vanna Lorenza/0000-0001-9712-8526; Ghiasvand, Reza/0000-0002-5466-7308; Heuch, Ivar/0000-0003-3386-9688; van den Brandt, Piet/0000-0001-8781-8099; Pirie, Kirstin/0000-0002-0561-4904	Cancer Research UK; Medical Research Council; MRC [G9900923, G0700474, MR/K02700X/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK and the Medical Research Council.	Abderrahman B, 2016, EXPERT REV ENDOCRINO, V11, P81, DOI 10.1586/17446651.2016.1128324; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2001, J MED SCREEN, V8, P29, DOI 10.1136/jms.8.1.29; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 2019, LANCET, V394, P1139, DOI [10.1016/S0140-6736(19)32033-4, 10.1016/S0140-6736(19)32033-1]; Breen N, 2011, CANCER-AM CANCER SOC, V117, P5450, DOI 10.1002/cncr.26218; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Chlebowski RT, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv327; European Medicines Agency, GUID CLIN INV MED PR; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Gapstur SM, 2015, LANCET, V385, P1835, DOI 10.1016/S0140-6736(14)61687-1; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; McTiernan A, 2005, JNCI-J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279; McTiernan A, 2009, J CLIN ONCOL, V27, P6135, DOI 10.1200/JCO.2008.21.7166; National Institute of Clinical Excellence, MEN DIAGN MAN; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1407, DOI 10.1093/aje/kwn090; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2015, CLIMACTERIC, V18, P121, DOI 10.3109/13697137.2014.947254; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; US Food and Drug Administration, MENOPAUSE; WHO International Agency for Research on Cancer, CI5PLUS CANC INC 5 C	25	264	273	4	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2019	394	10204					1159	1168		10.1016/S0140-6736(19)31709-X	http://dx.doi.org/10.1016/S0140-6736(19)31709-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8TF	31474332	Green Published, hybrid			2022-12-28	WOS:000488848800027
J	Saylor, BZ; Gibert, L; Deino, A; Alene, M; Levin, NE; Melillo, SM; Peaple, MD; Feakins, SJ; Bourel, B; Barboni, D; Novello, A; Sylvestre, F; Mertzman, SA; Haile-Selassie, Y				Saylor, Beverly Z.; Gibert, Luis; Deino, Alan; Alene, Mulugeta; Levin, Naomi E.; Melillo, Stephanie M.; Peaple, Mark D.; Feakins, Sarah J.; Bourel, Benjamin; Barboni, Doris; Novello, Alice; Sylvestre, Florence; Mertzman, Stanley A.; Haile-Selassie, Yohannes			Age and context of mid-Pliocene hominin cranium from Woranso-Mille, Ethiopia	NATURE			English	Article							WEST-CENTRAL AFAR; AUSTRALOPITHECUS-AFARENSIS; HADAR FORMATION; RIFT; VEGETATION; FOSSILS; GEOLOGY; RECORD; VALLEY; FEJEJ	A fossil hominin cranium was discovered in mid-Pliocene deltaic strata in the Godaya Valley of the northwestern Woranso-Mille study area in Ethiopia. Here we show that analyses of chemically correlated volcanic layers and the palaeomagnetic stratigraphy, combined with Bayesian modelling of dated tuffs, yield an age range of 3.804 +/- 0.013 to 3.777 +/- 0.014 million years old (mean +/- 1s) for the deltaic strata and the fossils that they contain. We also document deposits of a perennial lake beneath the deltaic sequence. Mammalian fossils associated with the cranium represent taxa that were widespread at the time and data from botanical remains indicate that the vegetation in the lake and delta catchment was predominantly dry shrubland with varying proportions of grassland, wetland and riparian forest. In addition, we report high rates of sediment accumulation and depositional features that are typical of a steep topographic relief and differ from younger Woranso-Mille fossil localities, reflecting the influence of active rift processes on the palaeolandscape.	[Saylor, Beverly Z.] Case Western Reserve Univ, Dept Earth Environm & Planetary Sci, Cleveland, OH 44106 USA; [Gibert, Luis] Univ Barcelona, Dept Mineral Petr & Geol Aplicada, Fac Ciencies Terra, Barcelona, Spain; [Deino, Alan] Berkeley Geochronol Ctr, Berkeley, CA USA; [Alene, Mulugeta] Addis Ababa Univ, Sch Earth Sci, Addis Ababa, Ethiopia; [Levin, Naomi E.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Melillo, Stephanie M.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Peaple, Mark D.; Feakins, Sarah J.] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA USA; [Bourel, Benjamin; Barboni, Doris; Novello, Alice; Sylvestre, Florence] Aix Marseille Univ, CNRS, IRD, INRA,Coll France,CEREGE, Aix En Provence, France; [Mertzman, Stanley A.] Franklin & Marshall Coll, Dept Earth & Environm, Lancaster, PA 17604 USA; [Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Cleveland, OH 44106 USA	Case Western Reserve University; University of Barcelona; Berkeley Geochronolgy Center; Addis Ababa University; University of Michigan System; University of Michigan; Max Planck Society; University of Southern California; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Franklin & Marshall College; Cleveland Museum of Natural History	Haile-Selassie, Y (corresponding author), Cleveland Museum Nat Hist, Cleveland, OH 44106 USA.	yhaileselassie@cmnh.org	Barboni, Doris/A-6908-2010; Feakins, Sarah/K-4149-2012; Levin, Naomi E/B-4124-2010	Barboni, Doris/0000-0001-7753-1254; Feakins, Sarah/0000-0003-3434-2423; Levin, Naomi E/0000-0001-5703-3717; Gibert, Luis/0000-0002-4207-3465; Saylor, Beverly/0000-0002-1825-8953; Melillo, Stephanie/0000-0002-1154-1772	Spanish Government [CGL2016-79458-P]; Catalan Government [2017-SGR 824]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [659596]; US National Science Foundation [1124705, 1124716, 1125157, 1125345, 1322017]	Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; US National Science Foundation(National Science Foundation (NSF))	We thank the Authority for Research and Conservation of Cultural Heritage for permission to conduct field and laboratory work, the Afar people of Woranso-Millle for their hospitality, and the project's fieldwork crew members for their tireless support of field activities; M. Atkins and I. Van Orman for assistance with the preparation of tephrochemical samples and J. Fournelle for assistance with their analysis. This research was supported by grants from the Spanish Government CGL2016-79458-P, Catalan Government 2017-SGR 824, the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 659596 and the US National Science Foundation (1124705, 1124716, 1125157, 1125345, 1322017).	Alene M, 2017, LITHOS, V282, P187, DOI 10.1016/j.lithos.2017.03.005; [Anonymous], 2003, ORIGIN SPREAD GRASS; ASFAW B, 1987, J HUM EVOL, V16, P611, DOI 10.1016/0047-2484(87)90016-9; Bonnefille R, 2004, P NATL ACAD SCI USA, V101, P12125, DOI 10.1073/pnas.0401709101; BONNEFILLE R, 1987, PALAEOGEOGR PALAEOCL, V60, P249, DOI 10.1016/0031-0182(87)90035-6; Bonnefille R, 2010, GLOBAL PLANET CHANGE, V72, P390, DOI 10.1016/j.gloplacha.2010.01.015; Campisano CJ, 2008, GEOL SOC AM SPEC PAP, V446, P179, DOI 10.1130/2008.2446(08); Deino AL, 2019, QUATERNARY SCI REV, V215, P213, DOI 10.1016/j.quascirev.2019.05.009; Deino AL, 2011, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-90-481-9956-3_4; Deino AL, 2010, J HUM EVOL, V58, P111, DOI 10.1016/j.jhevol.2009.11.001; DiMaggio EN, 2015, SCIENCE, V347, P1355, DOI 10.1126/science.aaa1415; Elliot T., 1986, SEDIMENTARY ENV FACI, P113; FLEAGLE JG, 1991, J HUM EVOL, V21, P145, DOI 10.1016/0047-2484(91)90005-G; Foged N., 1975, SOME LITTORAL DIATOM; Friis I., 2010, ATLAS POTENTIAL VEGE; Haile-Selassie Y, 2019, NATURE, V573, P214, DOI 10.1038/s41586-019-1513-8; Haile-Selassie Y, 2016, J HUM EVOL, V100, P35, DOI 10.1016/j.jhevol.2016.08.003; Haile-Selassie Y, 2015, NATURE, V521, P483, DOI 10.1038/nature14448; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Haile-Selassie Y, 2010, AM J PHYS ANTHROPOL, V141, P406, DOI 10.1002/ajpa.21159; Kappelman J, 1996, J HUM EVOL, V30, P139, DOI 10.1006/jhev.1996.0010; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Lahitte P, 2003, EARTH PLANET SC LETT, V207, P103, DOI 10.1016/S0012-821X(02)01130-5; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lee H, 2017, RAPID COMMUN MASS SP, V31, P1633, DOI 10.1002/rcm.7947; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; Liddy HM, 2016, EARTH PLANET SC LETT, V449, P430, DOI 10.1016/j.epsl.2016.05.005; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; Mertzman S.A., 2000, OREGON GEOL, V62, P99; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Middleton G.V., 1976, MARINE SEDIMENT TRAN, P197, DOI DOI 10.1234/12345678; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Niespolo EM, 2017, QUAT GEOCHRONOL, V39, P205, DOI 10.1016/j.quageo.2016.09.004; Prentice IC, 1996, CLIM DYNAM, V12, P185, DOI 10.1007/BF00211617; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Quade J, 2008, GEOL SOC AM SPEC PAP, V446, P1, DOI 10.1130/2008.2446(01); Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Saylor BZ, 2016, J HUM EVOL, V93, P25, DOI 10.1016/j.jhevol.2015.12.007; Saylor BZ, 2016, VERTEBR PALEOBIOL PA, P13, DOI 10.1007/978-94-017-7429-1_2; Sournia A, 1968, DIATOMEES PLANCTONIQ; Stab M, 2016, TECTONICS, V35, P2, DOI 10.1002/2015TC003893; TAIEB M, 1976, NATURE, V260, P289, DOI 10.1038/260289a0; WALTER RC, 1993, J HUM EVOL, V25, P229, DOI 10.1006/jhev.1993.1046; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; Winters YD, 2013, ASTROBIOLOGY, V13, P1065, DOI 10.1089/ast.2012.0952; Wynn JG, 2008, GEOL SOC AM SPEC PAP, V446, P87, DOI 10.1130/2008.2446(04)	50	12	12	2	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					220	+		10.1038/s41586-019-1514-7	http://dx.doi.org/10.1038/s41586-019-1514-7			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31462773	Green Submitted			2022-12-28	WOS:000485415400046
J	Wade, L				Wade, Lizzie			IN SEARCH OF SAC BALAM	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					966	970		10.1126/science.365.6457.966	http://dx.doi.org/10.1126/science.365.6457.966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488670				2022-12-28	WOS:000484732700015
J	Grace, RF; Rose, C; Layton, DM; Galacteros, F; Barcellini, W; Morton, DH; van Beers, EJ; Yaish, H; Ravindranath, Y; Kuo, KHM; Sheth, S; Kwiatkowski, JL; Barbier, AJ; Bodie, S; Silver, B; Hua, L; Kung, C; Hawkins, P; Jouvin, MH; Bowden, C; Glader, B				Grace, Rachael F.; Rose, Christian; Layton, D. Mark; Galacteros, Frederic; Barcellini, Wilma; Morton, D. Holmes; van Beers, Eduard J.; Yaish, Hassan; Ravindranath, Yaddanapudi; Kuo, Kevin H. M.; Sheth, Sujit; Kwiatkowski, Janet L.; Barbier, Ann J.; Bodie, Susan; Silver, Bruce; Hua, Lei; Kung, Charles; Hawkins, Peter; Jouvin, Marie-Helene; Bowden, Chris; Glader, Bertil			Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RED-CELL DISTORTION; EXTREME HEMOLYSIS; PK DEFICIENCY; BLOOD-CELL	Background Pyruvate kinase deficiency is caused by mutations in PKLR and leads to congenital hemolytic anemia. Mitapivat is an oral, small-molecule allosteric activator of pyruvate kinase in red cells. Methods In this uncontrolled, phase 2 study, we evaluated the safety and efficacy of mitapivat in 52 adults with pyruvate kinase deficiency who were not receiving red-cell transfusions. The patients were randomly assigned to receive either 50 mg or 300 mg of mitapivat twice daily for a 24-week core period; eligible patients could continue treatment in an ongoing extension phase. Results Common adverse events, including headache and insomnia, occurred at the time of drug initiation and were transient; 92% of the episodes of headache and 47% of the episodes of insomnia resolved within 7 days. The most common serious adverse events, hemolytic anemia and pharyngitis, each occurred in 2 patients (4%). A total of 26 patients (50%) had an increase of more than 1.0 g per deciliter in the hemoglobin level. Among these patients, the mean maximum increase was 3.4 g per deciliter (range, 1.1 to 5.8), and the median time until the first increase of more than 1.0 g per deciliter was 10 days (range, 7 to 187); 20 patients (77%) had an increase of more than 1.0 g per deciliter in the hemoglobin level at more than 50% of visits during the core study period, with improvement in markers of hemolysis. The response was sustained in all 19 patients remaining in the extension phase, with a median follow-up of 29 months (range, 22 to 35). Hemoglobin responses were observed only in patients who had at least one missense PKLR mutation and were associated with the red-cell pyruvate kinase protein level at baseline. Conclusions The administration of mitapivat was associated with a rapid increase in the hemoglobin level in 50% of adults with pyruvate kinase deficiency, with a sustained response during a median follow-up of 29 months during the extension phase. Adverse effects were mainly low-grade and transient.	[Grace, Rachael F.] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA; [Grace, Rachael F.] Harvard Med Sch, Boston, MA 02115 USA; [Barbier, Ann J.; Bodie, Susan; Hua, Lei; Kung, Charles; Hawkins, Peter; Jouvin, Marie-Helene; Bowden, Chris] Agios Pharmaceut, Cambridge, MA USA; [Rose, Christian] Hop St Vincent de Paul, Lille, France; [Galacteros, Frederic] Ctr Hosp Univ Henri Mondor, Unite Malad Genet Globule Rouge, Creteil, France; [Layton, D. Mark] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England; [Barcellini, Wilma] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Morton, D. Holmes] Cent Penn Clin, Belleville, PA USA; [Kwiatkowski, Janet L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kwiatkowski, Janet L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [van Beers, Eduard J.] Univ Med Ctr Utrecht, Van Creveldklin, Utrecht, Netherlands; [Yaish, Hassan] Univ Utah, Salt Lake City, UT USA; [Ravindranath, Yaddanapudi] Wayne State Univ, Childrens Hosp Michigan, Sch Med, Detroit, MI USA; [Kuo, Kevin H. M.] Univ Toronto, Toronto, ON, Canada; [Sheth, Sujit] Weill Cornell Med Coll, New York, NY USA; [Silver, Bruce] Bruce A Silver Clin Sci & Dev, Dunkirk, MD USA; [Glader, Bertil] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Agios Pharmaceuticals; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Imperial College London; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Utrecht University; Utrecht University Medical Center; Utah System of Higher Education; University of Utah; Children's Hospital of Michigan; Wayne State University; University of Toronto; Cornell University; Stanford University	Grace, RF (corresponding author), Boston Childrens Hosp, 450 Brookline Ave,Dana 3-106, Boston, MA 02215 USA.	rachael.grace@childrens.harvard.edu	kuo, kevin/GXM-4399-2022; Kuo, Kevin/AAV-5580-2021	Barcellini, Wilma/0000-0003-1428-9944; van Beers, Eduard/0000-0002-3934-7189; Grace, Rachael/0000-0001-7302-0449; Kuo, Kevin/0000-0002-6744-9238				Canu G, 2016, BLOOD CELL MOL DIS, V57, P100, DOI 10.1016/j.bcmd.2015.12.009; Chou R, 2001, AM J HEMATOL, V67, P197, DOI 10.1002/ajh.1107; DEGRUCHY GC, 1960, BLOOD, V16, P1371, DOI 10.1182/blood.V16.4.1371.1371; Grace RF, 2018, BLOOD, V131, P2183, DOI 10.1182/blood-2017-10-810796; Grace RF, 2015, AM J HEMATOL, V90, P825, DOI 10.1002/ajh.24088; Kung C, 2017, BLOOD, V130, P1347, DOI 10.1182/blood-2016-11-753525; LAKOMEK M, 1994, ENZYME PROTEIN, V48, P149, DOI 10.1159/000474982; MENTZER WC, 1971, J CLIN INVEST, V50, P688, DOI 10.1172/JCI106539; NATHAN DG, 1968, NEW ENGL J MED, V278, P73, DOI 10.1056/NEJM196804042781411; NATHAN DG, 1965, NEW ENGL J MED, V272, P118, DOI 10.1056/NEJM196501212720302; NECHELES TF, 1966, ARCH INTERN MED, V118, P75, DOI 10.1001/archinte.118.1.75; OSKI FA, 1964, NEW ENGL J MED, V270, P1023, DOI 10.1056/NEJM196405142702001; PAGLIA DE, 1968, J CLIN INVEST, V47, P1929, DOI 10.1172/JCI105883; Rider NL, 2011, AM J HEMATOL, V86, P827, DOI 10.1002/ajh.22118; SHOJANIA AM, 1968, J LAB CLIN MED, V71, P41; TANAKA KR, 1962, BLOOD, V19, P267, DOI 10.1182/blood.V19.3.267.267; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; van Beers EJ, 2019, HAEMATOLOGICA, V104, pE51, DOI 10.3324/haematol.2018.196295; van Straaten S, 2018, HAEMATOLOGICA, V103, pE82, DOI 10.3324/haematol.2017.177857; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; Yang H, 2019, CLIN PHARM DRUG DEV, V8, P246, DOI 10.1002/cpdd.604; ZANELLA A, 1993, BRIT J HAEMATOL, V83, P485, DOI 10.1111/j.1365-2141.1993.tb04675.x; Zanella A, 2000, BEST PRACT RES CL HA, V13, P57, DOI 10.1053/beha.1999.0057; Zanella A, 2007, BLOOD REV, V21, P217, DOI 10.1016/j.blre.2007.01.001	25	62	61	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					933	944		10.1056/NEJMoa1902678	http://dx.doi.org/10.1056/NEJMoa1902678			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW9PR	31483964	Green Published, Bronze			2022-12-28	WOS:000485326200008
J	Kaszeta, D				Kaszeta, Dan			Restrict use of riot-control chemicals	NATURE			English	Editorial Material							CS		[Kaszeta, Dan] Strongpoint Secur London, London, England		Kaszeta, D (corresponding author), Strongpoint Secur London, London, England.	director@strongpointsecurity.co.uk						Clarot F, 2003, FORENSIC SCI INT, V137, P45, DOI 10.1016/S0379-0738(03)00282-2; JONES GRN, 1972, NATURE, V235, P257, DOI 10.1038/235257a0; Kluchinsky TA, 2001, J MICROCOLUMN SEP, V13, P186, DOI 10.1002/mcs.1040; MacIntosh AR, 2019, APPL ERGON, V75, P178, DOI 10.1016/j.apergo.2018.10.004; National Research Council, 2014, AC EXP GUID LEV SEL, V16; [No title captured]; [No title captured]	7	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					27	29		10.1038/d41586-019-02594-5	http://dx.doi.org/10.1038/d41586-019-02594-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0KI	31481785				2022-12-28	WOS:000483967700019
J	van Oosten, ASG; Chen, XY; Chin, LK; Cruz, K; Patteson, AE; Pogoda, K; Shenoy, VB; Janmey, PA				van Oosten, Anne S. G.; Chen, Xingyu; Chin, LiKang; Cruz, Katrina; Patteson, Alison E.; Pogoda, Katarzyna; Shenoy, Vivek B.; Janmey, Paul A.			Emergence of tissue-like mechanics from fibrous networks confined by close-packed cells	NATURE			English	Article							PACKING	The viscoelasticity of the crosslinked semiflexible polymer networks-such as the internal cytoskeleton and the extracellular matrix-that provide shape and mechanical resistance against deformation is assumed to dominate tissue mechanics. However, the mechanical responses of soft tissues and semiflexible polymer gels differ in many respects. Tissues stiffen in compression but not in extension(1-5), whereas semiflexible polymer networks soften in compression and stiffen in extension(6,7). In shear deformation, semiflexible polymer gels stiffen with increasing strain, but tissues do not(1-8). Here we use multiple experimental systems and a theoretical model to show that a combination of nonlinear polymer network elasticity and particle (cell) inclusions is essential to mimic tissue mechanics that cannot be reproduced by either biopolymer networks or colloidal particle systems alone. Tissue rheology emerges from an interplay between strain-stiffening polymer networks and volume-conserving cells within them. Polymer networks that soften in compression but stiffen in extension can be converted to materials that stiffen in compression but not in extension by including within the network either cells or inert particles to restrict the relaxation modes of the fibrous networks that surround them. Particle inclusions also suppress stiffening in shear deformation; when the particle volume fraction is low, they have little effect on the elasticity of the polymer networks. However, as the particles become more closely packed, the material switches from compression softening to compression stiffening. The emergence of an elastic response in these composite materials has implications for how tissue stiffness is altered in disease and can lead to cellular dysfunction(9-11). Additionally, the findings could be used in the design of biomaterials with physiologically relevant mechanical properties.	[van Oosten, Anne S. G.; Chin, LiKang; Cruz, Katrina; Patteson, Alison E.; Pogoda, Katarzyna; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [van Oosten, Anne S. G.; Chen, Xingyu; Chin, LiKang; Cruz, Katrina; Patteson, Alison E.; Pogoda, Katarzyna; Shenoy, Vivek B.; Janmey, Paul A.] Univ Penn, Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA; [Chen, Xingyu; Shenoy, Vivek B.] Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA; [Patteson, Alison E.] Syracuse Univ, Dept Phys, Syracuse, NY USA; [Pogoda, Katarzyna] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland; [Janmey, Paul A.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Janmey, Paul A.] Univ Penn, Dept Phys, Philadelphia, PA 19104 USA; [van Oosten, Anne S. G.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Syracuse University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of Pennsylvania; University of Pennsylvania; Leiden University; Leiden University - Excl LUMC	Janmey, PA (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.; Shenoy, VB; Janmey, PA (corresponding author), Univ Penn, Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA.; Shenoy, VB (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.; Janmey, PA (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.; Janmey, PA (corresponding author), Univ Penn, Dept Phys, Philadelphia, PA 19104 USA.	vshenoy@seas.upenn.edu; janmey@pennmedicine.upenn.edu	Shenoy, Vivek/ABD-5075-2021; Chen, Xingyu/HGA-9489-2022; Pogoda, Katarzyna/AAD-2057-2020	Pogoda, Katarzyna/0000-0001-6994-3435; Patteson, Alison/0000-0002-4004-1734	NIH [R01GM09697, U54-CA193417, EB017753]; NSF Center for Engineering Mechanobiology through grants NSF MRSEC [CMMI-154857, DMR-1720530, R01CA232256, U01CA202177]; Fulbright Science and Technology Award; Prins Bernhard Cultuurfonds-Kuitse Fonds; National Science Center, Poland [UMO2017/26/D/ST4/00997]; Polish-American Fulbright Commission;  [NSF-DMR-1120901]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Center for Engineering Mechanobiology through grants NSF MRSEC; Fulbright Science and Technology Award; Prins Bernhard Cultuurfonds-Kuitse Fonds; National Science Center, Poland(National Science Centre, Poland); Polish-American Fulbright Commission; 	We acknowledge R. Wells and M. Perepelyuk for collection of rat blood, S. Diamond and R. Li for surplus blood products and D. Iwamoto for reading the manuscript. This work was supported by NIH R01GM09697, NIH U54-CA193417, EB017753 and NSF-DMR-1120901 (to P. A. J., L. C., A. E. P., K. P., K. C. and A. S. G. v. O.), by the NSF Center for Engineering Mechanobiology (CMMI-154857) through grants NSF MRSEC/DMR-1720530 R01CA232256 and U01CA202177 (X. C. and V. B. S.), by a Fulbright Science and Technology Award (A. S. G. v. O.) and by Prins Bernhard Cultuurfonds-Kuitse Fonds (A. S. G. v. O.). K. P. acknowledges partial support from the National Science Center, Poland under grant number UMO2017/26/D/ST4/00997 and from the Polish-American Fulbright Commission.	Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; BERNAL JD, 1960, NATURE, V188, P910, DOI 10.1038/188910a0; BERRYMAN JG, 1983, PHYS REV A, V27, P1053, DOI 10.1103/PhysRevA.27.1053; Bi DP, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021011; BOUCHER Y, 1990, CANCER RES, V50, P4478; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Perez MF, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0146588, 10.1371/journal.pone.0165590]; Freed AD, 2005, J BIOMECH ENG-T ASME, V127, P587, DOI 10.1115/1.1934145; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Park JA, 2015, NAT MATER, V14, P1040, DOI [10.1038/NMAT4357, 10.1038/nmat4357]; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Schotz EM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0726; SCOTT GD, 1969, J PHYS D APPL PHYS, V2, P863, DOI 10.1088/0022-3727/2/6/311; Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667; Vahabi M, 2016, SOFT MATTER, V12, P5050, DOI 10.1039/c6sm00606j; van Oosten ASG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19270; Wang HL, 2014, BIOPHYS J, V107, P2592, DOI 10.1016/j.bpj.2014.09.044; Wyss HM, 2011, AM J PHYSIOL-CELL PH, V300, pC397, DOI 10.1152/ajpcell.00438.2010	20	68	68	7	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					96	+		10.1038/s41586-019-1516-5	http://dx.doi.org/10.1038/s41586-019-1516-5			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31462779				2022-12-28	WOS:000483967700041
J	Wise, J				Wise, Jacqui			Postnatal checks for new mothers need to be properly funded, charity tells government	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5438	10.1136/bmj.l5438	http://dx.doi.org/10.1136/bmj.l5438			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488399				2022-12-28	WOS:000485441400007
J	Witze, A				Witze, Alexandra			Ocean drillers chart an ambitious new course	NATURE			English	News Item																			0	0	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					17	18		10.1038/d41586-019-02551-2	http://dx.doi.org/10.1038/d41586-019-02551-2			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31481776	Bronze			2022-12-28	WOS:000483967700016
J	Mahase, E				Mahase, Elisabeth			Cancer overtakes CVD to become leading cause of death in high income countries	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dagenais GR, 2019, LANCET; Yusuf S, 2019, LANCET	2	15	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5368	10.1136/bmj.l5368	http://dx.doi.org/10.1136/bmj.l5368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481521				2022-12-28	WOS:000485434400006
J	Beletsky, L; Wakeman, SE; Fiscella, K				Beletsky, Leo; Wakeman, Sarah E.; Fiscella, Kevin			Practicing What We Preach - Ending Physician Health Program Bans on Opioid-Agonist Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Beletsky, Leo] Northeastern Univ, Bouve Coll Hlth Sci, Sch Law, Boston, MA 02115 USA; [Beletsky, Leo] Northeastern Univ, Hlth Justice Act Lab, Boston, MA 02115 USA; [Wakeman, Sarah E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Beletsky, Leo] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Fiscella, Kevin] Univ Rochester, Med Ctr, Dept Family Med, Rochester, NY 14642 USA; [Fiscella, Kevin] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, Rochester, NY 14642 USA	Northeastern University; Northeastern University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Diego; University of Rochester; University of Rochester	Beletsky, L (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Sch Law, Boston, MA 02115 USA.; Beletsky, L (corresponding author), Northeastern Univ, Hlth Justice Act Lab, Boston, MA 02115 USA.; Beletsky, L (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.		Fiscella, Kevin Anthony/AFO-3350-2022	Fiscella, Kevin Anthony/0000-0003-3613-8012; Beletsky, Leo/0000-0003-0726-0676				DuPont RL, 2009, J SUBST ABUSE TREAT, V37, P1, DOI 10.1016/j.jsat.2009.03.010; Maglione MA, 2018, EFFECTS MEDICATION A; National Academies of Science Engineering and Medicine, 2019, MED OP US DIS SAV LI; Schindler SD, 2004, EUR ADDICT RES, V10, P80, DOI 10.1159/000076118; Wollman SC, 2019, AM J DRUG ALCOHOL AB, V45, P11, DOI 10.1080/00952990.2018.1517262	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					796	798		10.1056/NEJMp1907875	http://dx.doi.org/10.1056/NEJMp1907875			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461593				2022-12-28	WOS:000484431200005
J	Dyer, O				Dyer, Owen			Johnson and Johnson ordered to pay $572m in landmark opioid liability case	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l5319	10.1136/bmj.l5319	http://dx.doi.org/10.1136/bmj.l5319			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31466996				2022-12-28	WOS:000483892600007
J	Madhusoodanan, J				Madhusoodanan, Jyoti			ENVIRONMENT A greener grass	NATURE			English	Editorial Material																		Bauer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120016; Butsic V, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaeade; Butsic V, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/044023; Dillis C., 2019, PREPRINT BIORXIV, DOI [10.1101/618934, DOI 10.1101/618934]; Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163; Mills E, 2012, ENERG POLICY, V46, P58, DOI 10.1016/j.enpol.2012.03.023; NFD, 2018, 2018 CANNABIS ENERGY	7	2	2	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					S8	S9		10.1038/d41586-019-02526-3	http://dx.doi.org/10.1038/d41586-019-02526-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31462788	Bronze			2022-12-28	WOS:000483405500015
J	Sohn, E				Sohn, Emily			SAFETY Balancing act	NATURE			English	Editorial Material																		Beale C, 2018, CANNABIS CANNABINOID, V3, P94, DOI 10.1089/can.2017.0047; Bell C, 2015, J MED TOXICOL, V11, P422, DOI 10.1007/s13181-015-0501-0; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Di Forti M, 2019, LANCET PSYCHIAT, V6, P427, DOI 10.1016/S2215-0366(19)30048-3; Filbey FM, 2016, HUM BRAIN MAPP, V37, P3431, DOI 10.1002/hbm.23250; Gruber SA, 2012, PSYCHOL ADDICT BEHAV, V26, P496, DOI 10.1037/a0026269; Hall KE, 2018, ACAD EMERG MED, V25, P526, DOI 10.1111/acem.13393; Memedovich K Ally, 2018, CMAJ Open, V6, pE339, DOI 10.9778/cmajo.20180023; Monte AA, 2019, ANN INTERN MED, V170, P531, DOI 10.7326/M18-2809; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; Solowij N, 2019, EUR ARCH PSY CLIN N, V269, P17, DOI 10.1007/s00406-019-00978-2; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; Wang GS, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0971; Yucel M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.201	15	2	2	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					S16	S18		10.1038/d41586-019-02530-7	http://dx.doi.org/10.1038/d41586-019-02530-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31462789	Bronze			2022-12-28	WOS:000483405500019
J	Ratzan, RM				Ratzan, Richard M.			How to Fix the Premedical Curriculum-Another Try	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Arts and Medicine feature reviews the case made by physician-essayist Lewis Thomas that all prospective medical students be required to know classical Greek language and literature before medical school acceptance and broadens the argument, calling on medical school admissions committees to require an undergraduate major in humanities as a basis for medical education.	[Ratzan, Richard M.] Hartford Hosp, POB 270026, Hartford, CT 06127 USA	Hartford Hospital	Ratzan, RM (corresponding author), Hartford Hosp, POB 270026, Hartford, CT 06127 USA.	rmratzan@gmail.com						Cowper WS, 1870, ILIAD HOMER, VII, P336; Cowper WS, 1870, WORKS W COWPER ESQ C, VXII, P336; Gunderman RB, 2008, ACAD MED, V83, P1158, DOI 10.1097/ACM.0b013e31818c6515; Homer, 1916, ILIAD HOMER TRANSLAT; Homer, 2000, ILIAD; Homer, ILIAD, V24, P468; Kaufmann W, 1970, I THOU, P112; THOMAS L, 1978, NEW ENGL J MED, V298, P1180, DOI 10.1056/NEJM197805252982106	8	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					710	711		10.1001/jama.2019.11480	http://dx.doi.org/10.1001/jama.2019.11480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454022				2022-12-28	WOS:000483652500001
J	Fang, CC; Li, JX; Zhang, MH; Zhang, YH; Yang, F; Lee, JZ; Lee, MH; Alvarado, J; Schroeder, MA; Yang, YYC; Lu, BY; Williams, N; Ceja, M; Yang, L; Cai, M; Gu, J; Xu, K; Wang, XF; Meng, YS				Fang, Chengcheng; Li, Jinxing; Zhang, Minghao; Zhang, Yihui; Yang, Fan; Lee, Jungwoo Z.; Lee, Min-Han; Alvarado, Judith; Schroeder, Marshall A.; Yang, Yangyuchen; Lu, Bingyu; Williams, Nicholas; Ceja, Miguel; Yang, Li; Cai, Mei; Gu, Jing; Xu, Kang; Wang, Xuefeng; Meng, Ying Shirley			Quantifying inactive lithium in lithium metal batteries	NATURE			English	Article							ELECTROLYTES; INTERFACES; INSIGHTS; ANODES	Lithium metal anodes offer high theoretical capacities (3,860 milliampere-hours per gram)(1), but rechargeable batteries built with such anodes suffer from dendrite growth and low Coulombic efficiency (the ratio of charge output to charge input), preventing their commercial adoption(2,3). The formation of inactive ('dead') lithium- which consists of both (electro)chemically formed Li+ compounds in the solid electrolyte interphase and electrically isolated unreacted metallic Li-0 (refs(4,5))-causes capacity loss and safety hazards. Quantitatively distinguishing between Li+ in components of the solid electrolyte interphase and unreacted metallic Li-0 has not been possible, owing to the lack of effective diagnostic tools. Optical microscopy(6), in situ environmental transmission electron microscopy(7,8), X-ray microtomography(9) and magnetic resonance imaging(10) provide a morphological perspective with little chemical information. Nuclear magnetic resonance(11), X-ray photoelectron spectroscopy(12) and cryogenic transmission electron microscopy(13,14) can distinguish between Li+ in the solid electrolyte interphase and metallic Li-0, but their detection ranges are limited to surfaces or local regions. Here we establish the analytical method of titration gas chromatography to quantify the contribution of unreacted metallic Li-0 to the total amount of inactive lithium. We identify the unreacted metallic Li-0, not the (electro)chemically formed Li+ in the solid electrolyte interphase, as the dominant source of inactive lithium and capacity loss. By coupling the unreacted metallic Li-0 content to observations of its local microstructure and nanostructure by cryogenic electron microscopy (both scanning and transmission), we also establish the formation mechanism of inactive lithium in different types of electrolytes and determine the underlying cause of low Coulombic efficiency in plating and stripping (the charge and discharge processes, respectively, in a full cell) of lithium metal anodes. We propose strategies for making lithium plating and stripping more efficient so that lithium metal anodes can be used for next-generation high-energy batteries.	[Fang, Chengcheng; Zhang, Yihui; Lee, Min-Han; Alvarado, Judith; Yang, Yangyuchen; Meng, Ying Shirley] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Li, Jinxing; Zhang, Minghao; Lee, Jungwoo Z.; Lu, Bingyu; Ceja, Miguel; Wang, Xuefeng; Meng, Ying Shirley] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Yang, Fan; Williams, Nicholas; Gu, Jing] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA; [Alvarado, Judith; Schroeder, Marshall A.; Xu, Kang] US Army, Res Lab, Sensors & Elect Devices Directorate, Electrochem Branch, Adelphi, MD USA; [Yang, Li; Cai, Mei] Gen Motors Res & Dev Ctr, Warren, MI USA	University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); General Motors	Meng, YS (corresponding author), Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA.; Meng, YS (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.	shirleymeng@ucsd.edu	Yang, Fan/AAA-2074-2020; Xu, Kang/ABG-3307-2020; Lee, Minhan/AAD-2758-2021; Schroeder, Marshall/AAO-6157-2020; Lu, Bingyu/HCH-3826-2022	Lee, Minhan/0000-0001-9093-4891; Lu, Bingyu/0000-0003-3475-4911; Ceja, Miguel/0000-0002-3038-6755; Schroeder, Marshall/0000-0002-8160-2833; Yang, Fan/0000-0003-1514-3779; Fang, Chengcheng/0000-0002-2316-4679	Office of Vehicle Technologies of the US Department of Energy through the Advanced Battery Materials Research (BMR) Program (Battery500 Consortium) [DE-EE0007764]; US National Science Foundation (NSF) [ECCS-1542148]; NSF Major Research Instrumentation Program [CHE-1338173]; US Department of Energy, Office of Science, Basic Energy Science (BES) [DE FG02 87ER-45332]	Office of Vehicle Technologies of the US Department of Energy through the Advanced Battery Materials Research (BMR) Program (Battery500 Consortium)(United States Department of Energy (DOE)); US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); US Department of Energy, Office of Science, Basic Energy Science (BES)(United States Department of Energy (DOE))	This work was supported by the Office of Vehicle Technologies of the US Department of Energy through the Advanced Battery Materials Research (BMR) Program (Battery500 Consortium) under contract DE-EE0007764. Cryo-FIB was performed at the San Diego Nanotechnology Infrastructure, a member of the National Nanotechnology Coordinated Infrastructure, which is supported by the US National Science Foundation (NSF) (grant ECCS-1542148). We acknowledge the UC Irvine Materials Research Institute for the use of the cryo-electron microscopy and XPS facilities, funded in part by the NSF Major Research Instrumentation Program under grant CHE-1338173. The partial pressure measurements and analysis were done using a unique RGA based high vacuum gas evolution system developed under the guidance of I. K. Schuller's laboratory at UC San Diego. The development of this system were supported by the US Department of Energy, Office of Science, Basic Energy Science (BES) under grant DE FG02 87ER-45332. C.F. thanks D. M. Davies for his suggestions on the manuscript and Shuang Bai for her assistance with the TEM experiment. J.L. thanks W. Wu for helping on figure design.	Alvarado J, 2019, ENERG ENVIRON SCI, V12, P780, DOI 10.1039/c8ee02601g; Aurbach D, 1999, ELECTROCHEM COMMUN, V1, P324, DOI 10.1016/S1388-2481(99)00064-8; Bai P, 2016, ENERG ENVIRON SCI, V9, P3221, DOI 10.1039/c6ee01674j; Bhattacharyya R, 2010, NAT MATER, V9, P504, DOI [10.1038/NMAT2764, 10.1038/nmat2764]; Chandrashekar S, 2012, NAT MATER, V11, P311, DOI [10.1038/nmat3246, 10.1038/NMAT3246]; Chen KH, 2017, J MATER CHEM A, V5, P11671, DOI 10.1039/c7ta00371d; Chen X, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2049; Cheng X. B., 2015, ADV SCI, V3, P1; Drenik A, 2017, PHYS SCRIPTA, VT170, DOI 10.1088/1402-4896/aa878b; Harry KJ, 2014, NAT MATER, V13, P69, DOI [10.1038/NMAT3793, 10.1038/nmat3793]; Hu YY, 2013, NAT MATER, V12, P1130, DOI [10.1038/NMAT3784, 10.1038/nmat3784]; Lee H, 2018, CHEMSUSCHEM, V11, P3821, DOI 10.1002/cssc.201801445; Lee H, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201704391; Li S, 2018, ADV MATER, V30, DOI 10.1002/adma.201706375; Li YZ, 2017, SCIENCE, V358, P506, DOI 10.1126/science.aam6014; Lin DC, 2017, NAT NANOTECHNOL, V12, P194, DOI [10.1038/nnano.2017.16, 10.1038/NNANO.2017.16]; Lu DP, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400993; Lu J, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.11; Mehdi BL, 2015, NANO LETT, V15, P2168, DOI 10.1021/acs.nanolett.5b00175; Saint J, 2005, SOLID STATE IONICS, V176, P189, DOI 10.1016/j.ssi.2004.05.021; Steiger J, 2014, ELECTROCHIM ACTA, V136, P529, DOI 10.1016/j.electacta.2014.05.120; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Wang XF, 2017, NANO LETT, V17, P7606, DOI 10.1021/acs.nanolett.7b03606; Wood KN, 2017, ACS ENERGY LETT, V2, P664, DOI 10.1021/acsenergylett.6b00650; Wood S. M., 2018, ADV ENERGY MATER, V8, P1; Xu C, 2014, J MATER CHEM A, V2, P7256, DOI 10.1039/c4ta00214h; Xu K, 2004, CHEM REV, V104, P4303, DOI 10.1021/cr030203g; Xu W, 2014, ENERG ENVIRON SCI, V7, P513, DOI 10.1039/c3ee40795k; Yin XS, 2018, NANO ENERGY, V50, P659, DOI 10.1016/j.nanoen.2018.06.003; YOSHIMATSU I, 1988, J ELECTROCHEM SOC, V135, P2422, DOI 10.1149/1.2095351; Zachman MJ, 2018, NATURE, V560, P345, DOI 10.1038/s41586-018-0397-3; Zheng  J., 2016, ADV ENERGY MATER, V6; Zheng JM, 2017, ADV SCI, V4, DOI 10.1002/advs.201700032	33	508	514	78	748	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2019	572	7770					511	+		10.1038/s41586-019-1481-z	http://dx.doi.org/10.1038/s41586-019-1481-z			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS5UZ	31435056	Green Submitted			2022-12-28	WOS:000482219600042
J	Eshed, Y; Lippman, ZB				Eshed, Yuval; Lippman, Zachary B.			Revolutions in agriculture chart a course for targeted breeding of old and new crops	SCIENCE			English	Review							DETERMINATE GROWTH HABIT; GREEN-REVOLUTION; GENETIC ARCHITECTURE; NATURAL VARIATION; FLOWERING TIME; LOCUS; PLANT; DOMESTICATION; FLORIGEN; TOMATO	The dominance of the major crops that feed humans and their livestock arose from agricultural revolutions that increased productivity and adapted plants to large-scale farming practices. Two hormone systems that universally control flowering and plant architecture, florigen and gibberellin, were the source of multiple revolutions that modified reproductive transitions and proportional growth among plant parts. Although step changes based on serendipitous mutations in these hormone systems laid the foundation, genetic and agronomic tuning were required for broad agricultural benefits. We propose that generating targeted genetic variation in core components of both systems would elicit a wider range of phenotypic variation. Incorporating this enhanced diversity into breeding programs of conventional and underutilized crops could help to meet the future needs of the human diet and promote sustainable agriculture.	[Eshed, Yuval] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel; [Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Lippman, Zachary B.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY USA	Weizmann Institute of Science; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Eshed, Y (corresponding author), Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel.; Lippman, ZB (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY USA.; Lippman, ZB (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY USA.	yuval.eshed@weizmann.ac.il; lippman@cshl.edu		Lippman, Zachary/0000-0001-7668-9025	Howard Hughes Medical Institute, an Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture [2016-67013-24452]; National Science Foundation [IOS-1556171]; National Science Foundation Plant Genome Research Program [IOS-1546837, IOS-1732253]; ISF [1788/14, 2731/16]; BARD, the United States-Israel Binational Agricultural Research and Development Fund [IS-5120-18C]	Howard Hughes Medical Institute, an Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); ISF(Israel Science Foundation); BARD, the United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation)	This work was supported by the Howard Hughes Medical Institute, an Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture (no. 2016-67013-24452 to Z.B.L.), a National Science Foundation grant (no. IOS-1556171 to Z.B.L.), the National Science Foundation Plant Genome Research Program (grant nos. IOS-1546837 and IOS-1732253 to Z.B.L.), ISF (grant nos. 1788/14 and 2731/16 to Y.E.), and BARD, the United States-Israel Binational Agricultural Research and Development Fund (research grant no. IS-5120-18C to Z.B.L. and Y.E.).	Abelenda JA, 2016, CURR BIOL, V26, P872, DOI 10.1016/j.cub.2016.01.066; Abelenda JA, 2014, TRENDS PLANT SCI, V19, P115, DOI 10.1016/j.tplants.2013.09.010; Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; [Anonymous], 2015, P 12 INT WHEAT GEN S; Bassel GW, 2004, PLANT PHYSIOL, V136, P2782, DOI 10.1104/pp.103.034876; BELL AD, 1993, PLANT FORM ILLUSTRAT; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; Bhargava A, 2007, GENET RESOUR CROP EV, V54, P167, DOI 10.1007/s10722-005-3011-0; Bhattacharya A, 2010, J PLANT GROWTH REGUL, V29, P249, DOI 10.1007/s00344-009-9126-3; Birchler JA, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.20, 10.1038/nplants.2015.20]; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Blumel M, 2015, CURR OPIN BIOTECH, V32, P121, DOI 10.1016/j.copbio.2014.11.023; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; CHAILAKHYAN MK, 1975, BIOL PLANTARUM, V17, P1, DOI 10.1007/BF02921064; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Chen X, 2019, PLANT PHYSIOL, V180, P2091, DOI 10.1104/pp.19.00328; Cheng A, 2017, BIOL REV, V92, P188, DOI 10.1111/brv.12225; Chuck GS, 2011, P NATL ACAD SCI USA, V108, P17550, DOI 10.1073/pnas.1113971108; COBER ER, 1995, CROP SCI, V35, P361, DOI 10.2135/cropsci1995.0011183X003500020011x; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Dhanasekar P, 2015, MOL GENET GENOMICS, V290, P55, DOI 10.1007/s00438-014-0899-0; ELKIND Y, 1991, HORTSCIENCE, V26, P1074, DOI 10.21273/HORTSCI.26.8.1074; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Guo L, 2018, CURR BIOL, V28, P3005, DOI 10.1016/j.cub.2018.07.029; Hall SS, 2016, SCI AM, V314, P56, DOI 10.1038/scientificamerican0316-56; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hedden P, 2015, J PLANT GROWTH REGUL, V34, P740, DOI 10.1007/s00344-015-9546-1; Hickey JM, 2017, NAT GENET, V49, P1297, DOI 10.1038/ng.3920; Hickey LT, 2019, NAT BIOTECHNOL, V37, P744, DOI 10.1038/s41587-019-0152-9; Hills CB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01906; Hirano K, 2017, P JPN ACAD B-PHYS, V93, P220, DOI 10.2183/pjab.93.014; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; Huang XH, 2016, NATURE, V537, P629, DOI 10.1038/nature19760; Illouz-Eliaz N, 2019, PLANT CELL, V31, P1506, DOI 10.1105/tpc.19.00235; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; King RW, 2003, ANNU REV PLANT BIOL, V54, P307, DOI 10.1146/annurev.arplant.54.031902.135029; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Kwak M, 2012, ANN BOT-LONDON, V110, P1573, DOI 10.1093/aob/mcs207; LANG A, 1977, P NATL ACAD SCI USA, V74, P2412, DOI 10.1073/pnas.74.6.2412; Langewisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094150; Lemmon ZH, 2018, NAT PLANTS, V4, P766, DOI 10.1038/s41477-018-0259-x; Lewington A., 2003, PLANTS PEOPLE; Li LF, 2016, CURR TOP DEV BIOL, V119, P63, DOI 10.1016/bs.ctdb.2016.02.002; Li S, 2018, NATURE, V560, P595, DOI 10.1038/s41586-018-0415-5; Li S, 2018, PLANT J, V96, P761, DOI 10.1111/tpj.14066; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00465; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Liu DX, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1518-8; Liu YF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005818; Lu SJ, 2017, NAT GENET, V49, P773, DOI 10.1038/ng.3819; Ma XS, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008191; McGarry RC, 2012, PLANT SCI, V188, P71, DOI 10.1016/j.plantsci.2012.03.002; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Nelson MN, 2017, NEW PHYTOL, V213, P220, DOI 10.1111/nph.14094; Nitcher R, 2013, MOL GENET GENOMICS, V288, P261, DOI 10.1007/s00438-013-0746-8; Ogiso-Tanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075959; Ortega R, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00824; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; RICK CM, 1978, SCI AM, V239, P77; Rodriguez-Leal D, 2017, CELL, V171, P470, DOI 10.1016/j.cell.2017.08.030; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Saxena RK, 2017, THEOR APPL GENET, V130, P1773, DOI 10.1007/s00122-017-2924-2; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shavrukov Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01950; Shelef O, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02069; Shepon A, 2018, P NATL ACAD SCI USA, V115, P3804, DOI 10.1073/pnas.1713820115; Si ZF, 2018, J EXP BOT, V69, P2543, DOI 10.1093/jxb/ery093; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Stitzer MC, 2018, NEW PHYTOL, V220, P395, DOI 10.1111/nph.15350; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Taylor CM, 2019, PLANT CELL ENVIRON, V42, P174, DOI 10.1111/pce.13320; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thapa R, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8110272; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Varkonyi-Gasic E, 2019, PLANT BIOTECHNOL J, V17, P869, DOI 10.1111/pbi.13021; Wallace JG, 2018, ANNU REV GENET, V52, P421, DOI 10.1146/annurev-genet-120116-024846; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weller JL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00207; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Ye MW, 2018, NAT PLANTS, V4, P651, DOI 10.1038/s41477-018-0218-6; Yeager AF, 1927, J HERED, V18, P263, DOI 10.1093/oxfordjournals.jhered.a102869; Zhang CZ, 2019, NAT GENET, V51, P374, DOI 10.1038/s41588-018-0319-1; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	98	109	116	31	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2019	366	6466					705	+	eaax0025	10.1126/science.aax0025	http://dx.doi.org/10.1126/science.aax0025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JM9BA	31488704				2022-12-28	WOS:000496500400040
J	Ference, BA; Bhatt, DL; Catapano, AL; Packard, CJ; Graham, I; Kaptoge, S; Ference, TB; Guo, Q; Laufs, U; Ruff, CT; Cupido, A; Hovingh, GK; Danesh, J; Holmes, MV; Smith, GD; Ray, KK; Nicholls, SJ; Sabatine, MS				Ference, Brian A.; Bhatt, Deepak L.; Catapano, Alberico L.; Packard, Chris J.; Graham, Ian; Kaptoge, Stephen; Ference, Thatcher B.; Guo, Qi; Laufs, Ulrich; Ruff, Christian T.; Cupido, Arjen; Hovingh, G. Kees; Danesh, John; Holmes, Michael V.; Smith, George Davey; Ray, Kausik K.; Nicholls, Stephen J.; Sabatine, Marc S.			Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATURALLY RANDOM ALLOCATION; CORONARY-HEART-DISEASE; MENDELIAN RANDOMIZATION; LDL-C; WIDE ASSOCIATION; METAANALYSIS; CHOLESTEROL; INSTRUMENTS; LIPIDS; PCSK9	IMPORTANCE The relationship between exposure to lower low-density lipoprotein cholesterol (LDL-C) and lower systolic blood pressure (SBP) with the risk of cardiovascular disease has not been reliably quantified. OBJECTIVE To assess the association of lifetime exposure to the combination of both lower LDL-C and lower SBP with the lifetime risk of cardiovascular disease. DESIGN, SETTING, AND PARTICIPANTS Among 438952 participants enrolled in the UK Biobank between 2006 and 2010 and followed up through 2018, genetic LDL-C and SBP scores were used as instruments to divide participants into groups with lifetime exposure to lower LDL-C, lower SBP, or both. Differences in plasma LDL-C, SBP, and cardiovascular event rates between the groups were compared to estimate associations with lifetime risk of cardiovascular disease. EXPOSURES Differences in plasma LDL-C and SBP compared with participants with both genetic scores below the median. Genetic risk scores higher than the median were associated with lower LDL-C and lower SBP. MAIN OUTCOMES AND MEASURES Odds ratio (OR) for major coronary events, defined as coronary death, nonfatal myocardial infarction, or coronary revascularization. RESULTS The mean age of the 438 952 participants was 65.2 years (range, 40.4-80.0 years), 54.1% were women, and 24980 experienced a first major coronary event. Compared with the reference group, participants with LDL-C genetic scores higher than the median had 14.7-mg/dL lower LDL-C levels and an OR of 0.73 for major coronary events (95% CI, 0.70-0.75; P < .001). Participants with SBP genetic scores higher than the median had 2.9-mm Hg lower SBP and an OR of 0.82 for major coronary events (95% CI, 0.79-0.85, P < .001). Participants in the group with both genetic scores higher than the median had 13.9-mg/dL lower LDL-C, 3.1-mm Hg lower SBP, and an OR of 0.61 for major coronary events (95% CI, 0.59-0.64; P < .001). In a 4 x 4 factorial analysis, exposure to increasing genetic risk scores and lower LDL-C levels and SBP was associated with dose-dependent lower risks of major coronary events. In a meta-regression analysis, combined exposure to 38.67-mg/dL lower LDL-C and 10-mm Hg lower SBP was associated with an OR of 0.22 for major coronary events (95% CI, 0.17-0.26; P < .001), and 0.32 for cardiovascular death (95% CI, 0.25-0.40; P < .001). CONCLUSIONS AND RELEVANCE Lifelong genetic exposure to lower levels of low-density lipoprotein cholesterol and lower systolic blood pressure was associated with lower cardiovascular risk. However, these findings cannot be assumed to represent the magnitude of benefit achievable from treatment of these risk factors.	[Ference, Brian A.; Ference, Thatcher B.; Guo, Qi; Cupido, Arjen] Univ Cambridge, Ctr Nat Randomized Trials, Two Worts Causeway, Cambridge CB1 8RN, England; [Ference, Brian A.; Kaptoge, Stephen; Guo, Qi; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Bhatt, Deepak L.] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA; [Catapano, Alberico L.] Univ Milan, Multimed IRCCS, Dept Pharmacol & Biomol Sci, Milan, Italy; [Packard, Chris J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Graham, Ian] Trinity Coll Dublin, Sch Med, Dublin, Ireland; [Laufs, Ulrich] Univ Leipzig, Dept Cardiol, Leipzig, Germany; [Ruff, Christian T.; Sabatine, Marc S.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Thrombolysis Myocardial Infarct TIMI Study Grp, Boston, MA 02115 USA; [Cupido, Arjen; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Holmes, Michael V.] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, MRC Populat Hlth Res Unit, Oxford, England; [Holmes, Michael V.] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Ray, Kausik K.] Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Nicholls, Stephen J.] Monash Univ, Melbourne, Vic, Australia	University of Cambridge; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; IRCCS Multimedica; University of Milan; University of Glasgow; Trinity College Dublin; Leipzig University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; University of Oxford; University of Bristol; Imperial College London; Monash University	Ference, BA (corresponding author), Univ Cambridge, Ctr Nat Randomized Trials, Two Worts Causeway, Cambridge CB1 8RN, England.	baf29@medschl.cam.ac.uk	Holmes, Michael/AAA-2208-2021; Davey Smith, George/A-7407-2013; Sabatine, Marc/AAJ-6751-2020	Davey Smith, George/0000-0002-1407-8314; Sabatine, Marc/0000-0002-0691-3359; Cupido, Arjen/0000-0003-3300-8124	National Institute for Health Research Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; Medical Research Council; British Heart Foundation; National Institute for Health Research; Imperial NIHR Biomedical Research Centre; MRC [MC_UU_00011/1] Funding Source: UKRI	National Institute for Health Research Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr Ference is supported by the National Institute for Health Research Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. Dr Danesh is supported by the Medical Research Council, British Heart Foundation, and the National Institute for Health Research. Dr Holmes is supported by the Medical Research Council and the British Heart Foundation. Dr Davey Smith is supported by the Medical Research Council and the British Heart Foundation. Dr Ray is supported by the Imperial NIHR Biomedical Research Centre.	Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Duncan MS, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011433; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Ference BA, 2017, JAMA-J AM MED ASSOC, V318, P947, DOI 10.1001/jama.2017.11467; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Ference BA, 2014, HYPERTENSION, V63, P1182, DOI 10.1161/HYPERTENSIONAHA.113.02734; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571; Kraja AT, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001778; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Packard CJ, 2015, VASC PHARMACOL, V71, P37, DOI 10.1016/j.vph.2015.03.008; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; Robinson JG, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009778; Rodgers A, 2005, CIRCULATION, V112, P3384, DOI 10.1161/CIRCULATIONHA.105.537472; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779	29	84	85	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2019	322	14					1381	1391		10.1001/jama.2019.14120	http://dx.doi.org/10.1001/jama.2019.14120			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JE1GT	31475726	Green Published, Bronze			2022-12-28	WOS:000490441900020
J	Bhatt, DL; Steg, PG; Mehta, SR; Leiter, LA; Simon, T; Fox, K; Held, C; Andersson, M; Himmelmann, A; Ridderstrale, W; Chen, J; Song, Y; Diaz, R; Goto, S; James, SK; Ray, KK; Parkhomenko, AN; Kosiborod, MN; McGuire, DK; Harrington, RA				Bhatt, Deepak L.; Steg, Philippe Gabriel; Mehta, Shamir R.; Leiter, Lawrence A.; Simon, Tabassome; Fox, Kim; Held, Claes; Andersson, Marielle; Himmelmann, Anders; Ridderstrale, Wilhelm; Chen, Jersey; Song, Yang; Diaz, Rafael; Goto, Shinya; James, Stefan K.; Ray, Kausik K.; Parkhomenko, Alexander N.; Kosiborod, Mikhail N.; McGuire, Darren K.; Harrington, Robert A.		THEMIS Steering Comm Investigators	Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial	LANCET			English	Article							ELEVATION MYOCARDIAL-INFARCTION; DRUG-ELUTING STENTS; DOUBLE-BLIND; ANTIPLATELET THERAPY; PLATELET INHIBITION; POOLED ANALYSIS; CLOPIDOGREL; ASPIRIN; OUTCOMES; RIVAROXABAN	Background Patients with stable coronary artery disease and diabetes with previous percutaneous coronary intervention (PCI), particularly those with previous stenting, are at high risk of ischaemic events. These patients are generally treated with aspirin. In this trial, we aimed to investigate if these patients would benefit from treatment with aspirin plus ticagrelor. Methods The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) was a phase 3 randomised, double-blinded, placebo-controlled trial, done in 1315 sites in 42 countries. Patients were eligible if 50 years or older, with type 2 diabetes, receiving anti-hyperglycaemic drugs for at least 6 months, with stable coronary artery disease, and one of three other mutually non-exclusive criteria:a history of previous PCI or of coronary artery bypass grafting, or documentation of angiographic stenosis of 50% or more in at least one coronary artery. Eligible patients were randomly assigned (1:1) to either ticagrelor or placebo, by use of an interactive voice-response or web-response system. The THEMIS-PCI trial comprised a prespecified subgroup of patients with previous PCI. The primary efficacy outcome was a composite of cardiovascular death, myocardial infarction, or stroke (measured in the intention-to-treat population). Findings Between Feb 17, 2014, and May 24, 2016, 11 154 patients (58% of the overall THEMIS trial) with a history of previous PCI were enrolled in the THEMIS-PCI trial. Median follow-up was 3.3 years (IQR 2.8-3.8). In the previous PCI group, fewer patients receiving ticagrelor had a primary efficacy outcome event than in the placebo group (404 [7.3%] of 5558 vs 480 [8.6%] of 5596; HR 0.85 [95% CI 0.74-0.97], p=0.013). The same effect was not observed in patients without PCI (p=0.76, p(interaction)=0.16). The proportion of patients with cardiovascular death was similar in both treatment groups (174 [3.1%] with ticagrelor vs 183 (3.3%) with placebo; HR 0.96 [95% CI 0.78-1.18], p=0.68), as well as all-cause death (282 [5.1%] vs 323 [5.8%]; 0.88 [0.75-1.03], p=0.11). TIMI major bleeding occurred in 111 (2.0%) of 5536 patients receiving ticagrelor and 62 (1.1%) of 5564 patients receiving placebo (HR 2.03 [95% CI 1.48-2.76], p<0.0001), and fatal bleeding in 6 (0.1%) of 5536 patients with ticagrelor and 6 (0.1%) of 5564 with placebo (1.13 [0.36-3.50], p=0.83). Intracranial haemorrhage occurred in 33 (0.6%) and 31 (0.6%) patients (1.21 [0.74-1.97], p=0.45). Ticagrelor improved net clinical benefit:519/5558 (9.3%) versus 617/5596 (11.0%), HR=0.85, 95% CI 0.75-0.95, p=0.005, in contrast to patients without PCI where it did not, p(interaction)=0.012. Benefit was present irrespective of time from most recent PCI. Interpretation In patients with diabetes, stable coronary artery disease, and previous PCI, ticagrelor added to aspirin reduced cardiovascular death, myocardial infarction, and stroke, although with increased major bleeding. In that large, easily identified population, ticagrelor provided a favourable net clinical benefit (more than in patients without history of PCI). This effect shows that long-term therapy with ticagrelor in addition to aspirin should be considered in patients with diabetes and a history of PCI who have tolerated antiplatelet therapy, have high ischaemic risk, and low bleeding risk. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA 02115 USA; [Steg, Philippe Gabriel] Univ Paris, Hop Bichat, AP HP,INSERM,U1148, French Alliance Cardiovasc Trials,Dept Hosp Univ, Paris, France; [Steg, Philippe Gabriel; Fox, Kim] Royal Brompton Hosp, Natl Heart & Lung Inst, London, England; [Ray, Kausik K.] Imperial Coll London, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London, England; [Mehta, Shamir R.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Mehta, Shamir R.] McMaster Univ, Hamilton, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Simon, Tabassome] Sorbonne Univ, Hop St Antoine, AP HP, Dept Clin Pharmacol,Clin Res Platform URCEST CRB, Paris, France; [Held, Claes] Uppsala Univ, Uppsala Clin Res Ctr, Dept Med Sci, Cardiol, Uppsala, Sweden; [Andersson, Marielle; Himmelmann, Anders; Ridderstrale, Wilhelm] AstraZeneca BioPharmaceut Res & Dev, Late Stage Dev, Cardiovasc Renal & Metab, Molndal, Sweden; [Chen, Jersey] AstraZeneca BioPharmaceut Res & Dev, Late Stage Dev, Cardiovasc Renal & Metab, Gaithersburg, MD USA; [Song, Yang] Baim Inst Clin Res, Boston, MA USA; [Diaz, Rafael] Estudios Clin Latino Amer, Dept Med, Rosario, Santa Fe, Argentina; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa, Japan; [James, Stefan K.] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [James, Stefan K.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Parkhomenko, Alexander N.] Inst Cardiol, Emergency Cardiol Dept, Kiev, Ukraine; [Kosiborod, Mikhail N.] Univ Missouri Kansas City, St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Kosiborod, Mikhail N.] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [McGuire, Darren K.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Harrington, Robert A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; Imperial College London; McMaster University; Population Health Research Institute; McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Uppsala University; Tokai University; Uppsala University; Uppsala University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	Bhatt, DL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu	Zateyshchikov, Dmitry A/D-6575-2012; Kaidashev, Igor/L-2606-2019; Boldueva, Svetlana/AAH-3862-2019; Magnitskaya, Olga/B-1111-2016; Rasputina, Lesia/AAE-5764-2019; McGuire, Darren K./AAL-4172-2021; Zateyshchikov, Dmitry/AGN-8590-2022; Goto, Shinya/ABD-6487-2020; Khomazyuk, Tetyana Anastasievna/AAZ-8588-2021; Bueno, Hector/I-3910-2015; Song, Yang/HGU-4953-2022; Held, Claes/AAA-3973-2021; Kosiborod, Mikhail/HDO-1541-2022; Haro, Josep Maria/D-1423-2011; Goto, Shinya/AAU-6045-2020; Reis, Gilmar/I-4500-2013; Alshehri, Abdullah/AAS-9771-2020; Libov, Igor/GRN-8152-2022; GUERRERO, DIEGO BELLIDO/C-9446-2017; cornel, jan hein/Y-7065-2019; Nicolau, Jose C/E-1487-2012; Reznik, Elena Vladimirovna/N-6856-2016; Leiter, Lawrence/AAG-4059-2020; Khovaeva, Yaroslava/C-8617-2018; Khasanov, Niiaz/W-7678-2019; Shvarts, Yury Григорьевич/AAB-4929-2022; Ma, Ronald/C-2788-2009; Dzhaiani, Nino/AAQ-1757-2021; Arat-Özkan, Alev/A-8073-2016; Maslovskyi, Valentyn/GQO-9125-2022; Maslovskyi, Valentyn/V-3896-2019; Viktorova, vic-inna@mail.ru I.A./A-4663-2017; De Cosmo, Salvatore/J-7420-2016; Barbarash, Olga/A-4834-2017; Repin, Alexey/J-6150-2017; Mannucci, Edoardo/K-6749-2016; Yakushin, Sergey/N-4165-2013	Zateyshchikov, Dmitry A/0000-0001-7065-2045; Kaidashev, Igor/0000-0002-4708-0859; Boldueva, Svetlana/0000-0002-1898-084X; Magnitskaya, Olga/0000-0001-6670-9029; Rasputina, Lesia/0000-0003-1230-4039; Zateyshchikov, Dmitry/0000-0001-7065-2045; Khomazyuk, Tetyana Anastasievna/0000-0002-2368-5116; Bueno, Hector/0000-0003-0277-7596; Held, Claes/0000-0001-9402-7404; Kosiborod, Mikhail/0000-0002-3750-9789; Haro, Josep Maria/0000-0002-3984-277X; Goto, Shinya/0000-0002-6821-1504; Reis, Gilmar/0000-0002-4847-1034; Alshehri, Abdullah/0000-0002-0795-1760; GUERRERO, DIEGO BELLIDO/0000-0003-0631-2710; cornel, jan hein/0000-0002-1006-2112; Nicolau, Jose C/0000-0002-9680-3689; Reznik, Elena Vladimirovna/0000-0001-7479-418X; Khovaeva, Yaroslava/0000-0003-1186-3867; Khasanov, Niiaz/0000-0002-7760-0763; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Ma, Ronald/0000-0002-1227-803X; Dzhaiani, Nino/0000-0003-4982-3174; Arat-Özkan, Alev/0000-0001-8064-7231; Maslovskyi, Valentyn/0000-0001-5184-1799; Maslovskyi, Valentyn/0000-0001-5184-1799; Viktorova, vic-inna@mail.ru I.A./0000-0001-8728-2722; Kosmacheva, Elena/0000-0001-8600-0199; Pressman, Gregg/0000-0002-0992-1805; De Cosmo, Salvatore/0000-0001-8787-8286; Gazmuri, Raul J./0000-0002-3848-7227; Garcia-Lledo, Alberto/0000-0002-8986-2584; Basiak, Marcin/0000-0003-0674-5612; Koranyi, Laszlo/0000-0002-5733-9350; De Luca, Leonardo/0000-0002-8552-1272; Petrov, Ivo/0000-0002-9989-0730; Demchenko, Elena/0000-0002-7173-0575; Shalaev, Sergei/0000-0003-2724-4016; Kunz Sebba Barroso Souza, Weimar/0000-0002-1265-1930; Barbarash, Olga/0000-0002-4642-3610; Wilderman, Igor/0000-0003-0499-2791; ELBAZ, Meyer/0000-0002-3520-7883; WU, YEN-WEN/0000-0003-1520-1166; Lomakin, Nikita/0000-0001-8830-7231; Schernthaner, Gerit-Holger/0000-0002-9587-1727; Shutemova, Elena/0000-0002-5324-3570; Alexey, Panov/0000-0003-3356-3873; Repin, Alexey/0000-0001-7123-0645; Marcucci, Rossella/0000-0001-9549-7176; Mannucci, Edoardo/0000-0001-9759-9408; WU, CHIH-CHENG/0000-0002-9690-6573; mcmurray, john/0000-0002-6317-3975; Rha, Seung-Woon/0000-0001-9456-9852; Yakushin, Sergey/0000-0001-7202-742X; Jeong, Myung Ho/0000-0003-2424-810X; Wolzt, Michael/0000-0001-6049-1890; Pella, Daniel/0000-0001-9999-6271; Zurakowski, Aleksander/0000-0002-5135-6598; Sztembis, Rafal/0000-0003-3188-6214; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	AstraZeneca	AstraZeneca(AstraZeneca)	AstraZeneca.	Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2019, NEW ENGL J MED, V380, P1825, DOI 10.1056/NEJMoa1901778; Bhatt DL, 2019, CLIN CARDIOL, V42, P498, DOI 10.1002/clc.23164; Bhatt DL, 2018, LANCET, V391, P913, DOI 10.1016/S0140-6736(18)30424-0; Bhatt DL, 2016, J AM COLL CARDIOL, V67, P2732, DOI 10.1016/j.jacc.2016.03.529; Bhatt DL, 2012, LANCET, V380, P1453, DOI 10.1016/S0140-6736(12)61021-6; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2002, AM J CARDIOL, V90, P625, DOI 10.1016/S0002-9149(02)02567-5; Bonaca MP, 2016, J AM COLL CARDIOL, V67, P2719, DOI 10.1016/j.jacc.2016.03.524; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Connolly SJ, 2018, LANCET, V391, P205, DOI 10.1016/S0140-6736(17)32458-3; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Hahn JY, 2018, LANCET, V391, P1274, DOI 10.1016/S0140-6736(18)30493-8; Head SJ, 2018, LANCET, V391, P939, DOI 10.1016/S0140-6736(18)30423-9; James S, 2010, EUR HEART J, V31, P3006, DOI 10.1093/eurheartj/ehq325; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Motovska Z, 2018, LANCET, V391, P1240, DOI 10.1016/S0140-6736(18)30612-3; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Steg PG, 2019, NEW ENGL J MED, V381, P1309, DOI 10.1056/NEJMoa1908077; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wiviott SD, 2013, LANCET, V382, P605, DOI 10.1016/S0140-6736(13)61451-8; Yusuf S, 2001, NEW ENGL J MED, V345, P494	31	114	116	7	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2019	394	10204					1169	1180		10.1016/S0140-6736(19)31887-2	http://dx.doi.org/10.1016/S0140-6736(19)31887-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8TF	31484629	Green Submitted			2022-12-28	WOS:000488848800028
J	Rispoli, M; Lukin, A; Schittko, R; Kim, S; Tai, ME; Leonard, J; Greiner, M				Rispoli, Matthew; Lukin, Alexander; Schittko, Robert; Kim, Sooshin; Tai, M. Eric; Leonard, Julian; Greiner, Markus			Quantum critical behaviour at the many-body localization transition	NATURE			English	Article							THERMALIZATION; ENTANGLEMENT; SYSTEM	Phase transitions are driven by collective fluctuations of a system's constituents that emerge at a critical point(1). This mechanism has been extensively explored for classical and quantum systems in equilibrium, whose critical behaviour is described by the general theory of phase transitions. Recently, however, fundamentally distinct phase transitions have been discovered for out-of-equilibrium quantum systems, which can exhibit critical behaviour that defies this description and is not well understood(1). A paradigmatic example is the many-body localization (MBL) transition, which marks the breakdown of thermalization in an isolated quantum many-body system as its disorder increases beyond a critical value(2-11). Characterizing quantum critical behaviour in an MBL system requires probing its entanglement over space and time(4,5,7), which has proved experimentally challenging owing to stringent requirements on quantum state preparation and system isolation. Here we observe quantum critical behaviour at the MBL transition in a disordered Bose-Hubbard system and characterize its entanglement via its multi-point quantum correlations. We observe the emergence of strong correlations, accompanied by the onset of anomalous diffusive transport throughout the system, and verify their critical nature by measuring their dependence on the system size. The correlations extend to high orders in the quantum critical regime and appear to form via a sparse network of many-body resonances that spans the entire system(12,13). Our results connect the macroscopic phenomenology of the transition to the system's microscopic structure of quantum correlations, and they provide an essential step towards understanding criticality and universality in non-equilibrium systems(1,7,13).	[Rispoli, Matthew; Lukin, Alexander; Schittko, Robert; Kim, Sooshin; Tai, M. Eric; Leonard, Julian; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu		Kim, Sooshin/0000-0002-8745-2733	National Science Foundation; Gordon and Betty Moore Foundations EPiQS Initiative; Air Force Office of Scientific Research MURI programme; Army Research Office MURI programme; NSF Graduate Research Fellowship Program; Swiss National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundations EPiQS Initiative; Air Force Office of Scientific Research MURI programme; Army Research Office MURI programme; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We acknowledge discussions with D. Abanin, E. Altman, H. Bernien, C. Chiu, S. Choi, E. Demler, A. Hebert, W. W. Ho, V. Kasper, V. Khemani, J. Kwan, L. Santos and J. Schmiedmayer. We were supported by grants from the National Science Foundation, the Gordon and Betty Moore Foundations EPiQS Initiative, an Air Force Office of Scientific Research MURI programme, an Army Research Office MURI programme and the NSF Graduate Research Fellowship Program. J.L. acknowledges support from the Swiss National Science Foundation.	Agarwal K, 2017, ANN PHYS-BERLIN, V529, DOI 10.1002/andp.201600326; Agarwal K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.160401; [Anonymous], [No title captured]; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Bordia P, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041047; Choi JY, 2016, SCIENCE, V352, P1547, DOI 10.1126/science.aaf8834; D'Alessio L, 2016, ADV PHYS, V65, P239, DOI 10.1080/00018732.2016.1198134; De Roeck W, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.155129; Dumitrescu PT, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.110604; Goremykina A, 2018, ANAL SOLVABLE RENORM; Grover T., 2014, CERTAIN GEN CONSTRAI; Hodgman SS, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.240402; Huse DA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174202; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Khemani V, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021013; Liu HC, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.023827; Lucioni E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230403; Luschen HP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.260401; Luschen HP, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011034; Luitz DJ, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.060201; Lukin A, 2019, SCIENCE, V364, P256, DOI 10.1126/science.aau0818; Nandkishore R, 2017, ANN PHYS-BERLIN, V529, DOI 10.1002/andp.201600181; Nandkishore R, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064203; Neill C, 2016, NAT PHYS, V12, P1037, DOI [10.1038/NPHYS3830, 10.1038/nphys3830]; Pal A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174411; Potter AC, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031033; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Schweigler T, 2017, NATURE, V545, P323, DOI 10.1038/nature22310; Serbyn M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.127201; Setiawan F, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.104205; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; Tauber UC, 2017, ANNU REV CONDEN MA P, V8, P185, DOI 10.1146/annurev-conmatphys-031016-025444; Vosk R, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031032	33	83	83	4	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					385	+		10.1038/s41586-019-1527-2	http://dx.doi.org/10.1038/s41586-019-1527-2			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31485075	Green Accepted, Green Submitted			2022-12-28	WOS:000486647800043
J	Davidson, KW; McGinn, T				Davidson, Karina W.; McGinn, Thomas			Screening for Social Determinants of Health: The Known and Unknown	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLLABORATION; QUALITY	This Viewpoint reviews evidence of the effects of screening for social determinants of health and emphasizes the need to assess if screening leads to improvements in case finding, referral to and receipt of social services, and patient outcomes without patient harms.	[Davidson, Karina W.; McGinn, Thomas] Northwell Hlth, Long Isl City, NY USA; [Davidson, Karina W.; McGinn, Thomas] Hofstra Univ, Donald & Barbara Zucker Sch Med, Long Isl City, NY USA	Northwell Health; Hofstra University	Davidson, KW (corresponding author), Northwell Hlth, Feinstein Inst Med Res, 130 E 59th St,Ste 14C, New York, NY 10022 USA.	kdavidson2@northwell.edu	Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X	National Library of Medicine of the National Institutes of Health [R01LM012836]	National Library of Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grant R01LM012836 from the National Library of Medicine of the National Institutes of Health.	Barrett M, 2018, HEALTH AFFAIR, V37, P525, DOI 10.1377/hlthaff.2017.1315; Berkowitz SA, 2016, BMJ QUAL SAF, V25, P164, DOI 10.1136/bmjqs-2015-004521; de la Vega PB, 2019, MED CARE, V57, pS133, DOI 10.1097/MLR.0000000000001029; CLEAR Collaboration, 2019, CLEAR TOOLKIT; Garg A, 2016, JAMA-J AM MED ASSOC, V316, P813, DOI 10.1001/jama.2016.9282; Gold R, 2018, ANN FAM MED, V16, P399, DOI 10.1370/afm.2275; Katz A, 2018, ANN FAM MED, V16, P217, DOI 10.1370/afm.2236; Schickedanz A, 2019, MED CARE, V57, pS197, DOI 10.1097/MLR.0000000000001051; Vest JR, 2019, AM J PREV MED, V56, pE125, DOI 10.1016/j.amepre.2018.11.009	9	47	47	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1037	1038		10.1001/jama.2019.10915	http://dx.doi.org/10.1001/jama.2019.10915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31465095				2022-12-28	WOS:000488821100010
J	Manson, JE; Aragaki, AK; Bassuk, SS; Chlebowski, RT; Anderson, GL; Rossouw, JE; Howard, BV; Thomson, CA; Stefanick, ML; Kaunitz, AM; Crandall, CJ; Eaton, CB; Henderson, VW; Liu, SM; Luo, JH; Rohan, T; Shadyab, AH; Wells, G; Wactawski-Wende, J; Prentice, RL				Manson, JoAnn E.; Aragaki, Aaron K.; Bassuk, Shari S.; Chlebowski, Rowan T.; Anderson, Garnet L.; Rossouw, Jacques E.; Howard, Barbara V.; Thomson, Cynthia A.; Stefanick, Marcia L.; Kaunitz, Andrew M.; Crandall, Carolyn J.; Eaton, Charles B.; Henderson, Victor W.; Liu, Simin; Luo, Juhua; Rohan, Thomas; Shadyab, Aladdin H.; Wells, Gretchen; Wactawski-Wende, Jean; Prentice, Ross L.		WHI Investigators	Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							OVARIAN CONSERVATION; LONG-TERM; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; HORMONE-THERAPY; HYSTERECTOMY; MORTALITY; CANCER; BENEFITS; RISKS	Background: Whether health outcomes of menopausal estrogen therapy differ between women with and without bilateral salpingo-oophorectomy (BSO) is unknown. Objective: To examine estrogen therapy outcomes by BSO status, with additional stratification by 10-year age groups. Design: Subgroup analyses of the randomized Women's Health Initiative Estrogen-Alone Trial. (ClinicalTrials.gov: NCT00000611) Setting: 40 U.S. clinical centers. Participants: 9939 women aged 50 to 79 years with prior hysterectomy and known oophorectomy status. Intervention: Conjugated equine estrogens (CEE) (0.625 mg/d) or placebo for a median of 7.2 years. Measurements: Incidence of coronary heart disease and invasive breast cancer (the trial's 2 primary end points), all-cause mortality, and a "global index" (these end points plus stroke, pulmonary embolism, colorectal cancer, and hip fracture) during the intervention phase and 18-year cumulative follow-up. Results: The effects of CEE alone did not differ significantly according to BSO status. However, age modified the effect of CEE in women with prior BSO. During the intervention phase, CEE was significantly associated with a net adverse effect (hazard ratio for global index, 1.42 [95% CI, 1.09 to 1.861) in older women (aged >= 70 years), but the global index was not elevated in younger women (P trend by age = 0.016). During cumulative follow-up, women aged 50 to 59 years with BSO had a treatment-associated reduction in all-cause mortality (hazard ratio, 0.68 [CI, 0.48 to 0.961), whereas older women with BSO had no reduction (P trend by age = 0.034). There was no significant association between CEE and outcomes among women with conserved ovaries, regardless of age. Limitations: The timing of CEE in relation to BSO varied; several comparisons were made without adjustment for multiple testing. Conclusion: The effects of CEE did not differ by BSO status in the overall cohort, but some findings varied by age. Among women with prior BSO, in those aged 70 years or older, CEE led to adverse effects during the treatment period, whereas women randomly assigned to CEE before age 60 seemed to derive mortality benefit over the long term.	[Manson, JoAnn E.; Bassuk, Shari S.] Harvard Med Sch, Brigham & Womens Hosp, 900 Commonwealth Ave,3rd Floor, Boston, MA 02215 USA; [Aragaki, Aaron K.; Anderson, Garnet L.; Prentice, Ross L.] Fred Hutchinson Canc Res Ctr, Clin Coordinating Ctr, Womens Hlth Initiat, 1100 Fairview Ave North M3-A410,POB 19024, Seattle, WA 98109 USA; [Chlebowski, Rowan T.] Los Angeles Biomed Res Inst, 1124 West Carson St,N16, Torrance, CA 90502 USA; [Rossouw, Jacques E.] NHLBI, NIH, 6701 Rockledge Ave,10th Floor, Bethesda, MD 20892 USA; [Howard, Barbara V.] MedStar Hlth Res Inst, 26331 Rookery Lake Dr, Bonita Springs, FL 34134 USA; [Thomson, Cynthia A.] 3950 South Country Club Rd,Suite 330, Tucson, AZ 85714 USA; [Stefanick, Marcia L.] Stanford Univ, Stanford Prevent Res Ctr, Med Sch Off Bldg,1265 Welch Rd,Room X308, Palo Alto, CA 94305 USA; [Kaunitz, Andrew M.] Univ Florida, Coll Med, 653-1 West 8th St, Jacksonville, FL 32209 USA; [Crandall, Carolyn J.] Univ Calif Los Angeles, David Geffen Sch Med, 1100 Glendon Ave,Suite 850,Room 858, Los Angeles, CA 90024 USA; [Eaton, Charles B.] Brown Univ, Ctr Primary Care & Prevent, Care England Med Grp & Specialty Serv, Second Floor,111 Brewster St, Pawtucket, RI 02860 USA; [Henderson, Victor W.] Stanford Univ, 259 Campus Dr,MC 5405, Stanford, CA 94305 USA; [Liu, Simin] Brown Univ, 121 South Main St,2nd Floor, Providence, RI 02912 USA; [Luo, Juhua] Indiana Univ, 1025 East 7th St, Bloomington, IN 47405 USA; [Rohan, Thomas] Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Shadyab, Aladdin H.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr 0725, La Jolla, CA 92093 USA; [Wells, Gretchen] Univ Kentucky, 900 South Limestone,Wethington Bldg,Suite 326, Lexington, KY 40536 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Womens Hlth Initiat Northeast Reg Ctr, 401 Kimball Tower, Buffalo, NY 14214 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MedStar Health Research Institute; Stanford University; State University System of Florida; University of Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brown University; Stanford University; Brown University; Indiana University System; Indiana University Bloomington; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University of Kentucky; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 900 Commonwealth Ave,3rd Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu	Kaunitz, Andrew/AAL-8448-2020; Henderson, V/AAW-4744-2021; Liu, Simin/GSN-4159-2022; Wactawski-Wende, Jean/AGH-5457-2022; Liu, Simin/I-3689-2014	Wactawski-Wende, Jean/0000-0003-3096-9595; Liu, Simin/0000-0003-2098-3844	National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services	The WHI program is funded by the National Heart, Lung, and Blood Institute; National Institutes of Health; and U.S. Department of Health and Human Services. Wyeth Ayerst donated the study drugs.	Adelman MR, 2018, AM J OBSTET GYNECOL, V218, P269, DOI 10.1016/j.ajog.2017.07.037; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Chan JK, 2014, OBSTET GYNECOL, V123, P65, DOI 10.1097/AOG.0000000000000061; Chen RJ, 2008, MENOPAUSE, V15, P517, DOI 10.1097/gme.0b013e3181591dc9; Chubaty A, 2011, MATURITAS, V69, P69, DOI 10.1016/j.maturitas.2011.02.004; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; Doll KM, 2016, JAMA SURG, V151, P875, DOI 10.1001/jamasurg.2016.0804; Einarsson J., 2017, ARE HYSTERECTOMY VOL; Faubion SS, 2016, J WOMENS HEALTH, V25, P200, DOI 10.1089/jwh.2015.5656; Gierach GL, 2014, MENOPAUSE, V21, P592, DOI [10.1097/gme.0000000000000118, 10.1097/GME.0000000000000118]; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Ingelsson E, 2011, EUR HEART J, V32, P745, DOI 10.1093/eurheartj/ehq477; Jacoby VL, 2011, ARCH INTERN MED, V171, P760, DOI 10.1001/archinternmed.2011.121; JUDD HL, 1974, J CLIN ENDOCR METAB, V39, P1020, DOI 10.1210/jcem-39-6-1020; JUDD HL, 1974, AM J OBSTET GYNECOL, V118, P793, DOI 10.1016/0002-9378(74)90490-6; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Laughlin GA, 2000, J CLIN ENDOCR METAB, V85, P645, DOI 10.1210/jc.85.2.645; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Manzoli L, 2004, MATURITAS, V49, P241, DOI 10.1016/j.maturitas.2004.02.003; Mytton J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j372; Parker WH, 2013, OBSTET GYNECOL, V121, P709, DOI 10.1097/AOG.0b013e3182864350; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Phipps AI, 2009, MENOPAUSE, V16, P576, DOI 10.1097/gme.0b013e31818ffe28; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Robinson WR, 2016, AM J EPIDEMIOL, V184, P388, DOI 10.1093/aje/kwv448; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Temkin SM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00089; VanderWeele TJ, 2011, ANN INTERN MED, V154, P680, DOI 10.7326/0003-4819-154-10-201105170-00008	34	21	21	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					406	+		10.7326/M19-0274	http://dx.doi.org/10.7326/M19-0274			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31499528	Green Accepted			2022-12-28	WOS:000486101400014
J	Lin, YC; Guo, YR; Miyagi, A; Levring, J; MacKinnon, R; Scheuring, S				Lin, Yi-Chih; Guo, Yusong R.; Miyagi, Atsushi; Levring, Jesper; MacKinnon, Roderick; Scheuring, Simon			Force-induced conformational changes in PIEZO1	NATURE			English	Article							ACTIVATED ION-CHANNEL; MECHANOTRANSDUCTION CHANNEL; MECHANOSENSITIVITY; MUTATIONS; MECHANISM; MEMBRANE; PRESSURE; PROTEINS; TENSION; PATCH	PIEZO1 is a mechanosensitive channel that converts applied force into electrical signals. Partial molecular structures show that PIEZO1 is a bowl-shaped trimer with extended arms. Here we use cryo-electron microscopy to show that PIEZO1 adopts different degrees of curvature in lipid vesicles of different sizes. We also use high-speed atomic force microscopy to analyse the deformability of PIEZO1 under force in membranes on a mica surface, and show that PIEZO1 can be flattened reversibly into the membrane plane. By approximating the absolute force applied, we estimate a range of values for the mechanical spring constant of PIEZO1. Both methods of microscopy demonstrate that PIEZO1 can deform its shape towards a planar structure. This deformation could explain how lateral membrane tension can be converted into a conformation-dependent change in free energy to gate the PIEZO1 channel in response to mechanical perturbations.	[Lin, Yi-Chih; Miyagi, Atsushi; MacKinnon, Roderick] Weill Cornell Med, Dept Anesthesiol, New York, NY 10065 USA; [Lin, Yi-Chih; Miyagi, Atsushi; Scheuring, Simon] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Guo, Yusong R.; Levring, Jesper; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Rockefeller University	Scheuring, S (corresponding author), Weill Cornell Med, Dept Anesthesiol, New York, NY 10065 USA.; Scheuring, S (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.; MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA.	mackinn@mail.rockefeller.edu; sis2019@med.cornell.edu	Yi-Chih, Lin/M-6367-2019; Scheuring, Simon/L-9125-2018	Scheuring, Simon/0000-0003-3534-069X; Guo, Yusong/0000-0002-8563-3397; LIN, YI-CHIH/0000-0002-6498-215X; Levring, Jesper/0000-0002-8916-4241	Howard Hughes Medical Institute Funding Source: Medline; NCCIH NIH HHS [DP1 AT010874] Funding Source: Medline; National Center for Complementary & Integrative Health [DP1AT010874] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ando T, 2014, CHEM REV, V114, P3120, DOI 10.1021/cr4003837; Andolfo I, 2015, AM J HEMATOL, V90, P921, DOI 10.1002/ajh.24117; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Demolombe S, 2013, BIOPHYS J, V105, P833, DOI 10.1016/j.bpj.2013.07.018; Fotiou E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9085; Garcia R, 1999, PHYS REV B, V60, P4961, DOI 10.1103/PhysRevB.60.4961; Gaub BM, 2017, NANO LETT, V17, P2064, DOI 10.1021/acs.nanolett.7b00177; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; Guzman HV, 2015, BEILSTEIN J NANOTECH, V6, P369, DOI 10.3762/bjnano.6.36; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Haselwandter CA, 2018, ELIFE, V7, DOI 10.7554/eLife.41968; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Lacroix JJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04405-3; Legleiter J, 2006, P NATL ACAD SCI USA, V103, P4813, DOI 10.1073/pnas.0505628103; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miyagi A, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4950777; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Moroni M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03502-7; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Rode B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00429-3; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Wang YF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03570-9; Weisstein E. W., SPHERICAL CAP MATHWO; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Wu J, 2017, TRENDS BIOCHEM SCI, V42, P57, DOI 10.1016/j.tibs.2016.09.004; Wu J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12939; Zhang W, 2015, CELL, V162, P1391, DOI 10.1016/j.cell.2015.08.024; Zhao QC, 2018, NATURE, V554, P487, DOI 10.1038/nature25743; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	46	110	113	8	92	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					230	+		10.1038/s41586-019-1499-2	http://dx.doi.org/10.1038/s41586-019-1499-2			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31435018	Green Accepted			2022-12-28	WOS:000485415400048
J	Wang, L; Zhou, H; Zhang, MM; Liu, WH; Deng, T; Zhao, QC; Li, YR; Lei, JL; Li, XM; Xiao, BL				Wang, Li; Zhou, Heng; Zhang, Mingmin; Liu, Wenhao; Deng, Tuan; Zhao, Qiancheng; Li, Yiran; Lei, Jianlin; Li, Xueming; Xiao, Bailong			Structure and mechanogating of the mammalian tactile channel PIEZO2	NATURE			English	Article							ION CHANNELS; MUTATIONS; MECHANISM; PRESSURE; TOUCH; MSCL	PIEZO2 is a mechanosensitive cation channel that has a key role in sensing touch, tactile pain, breathing and blood pressure. Here we describe the cryo-electron microscopy structure of mouse PIEZO2, which is a three-bladed, propeller-like trimer that comprises 114 transmembrane helices (38 per protomer). Transmembrane helices 1-36 (TM1-36) are folded into nine tandem units of four transmembrane helices each to form the unusual non-planar blades. The three blades are collectively curved into a nano-dome of 28-nm diameter and 10-nm depth, with an extracellular cap-like structure embedded in the centre and a 9-nm-long intracellular beam connecting to the central pore. TM38 and the C-terminal domain are surrounded by the anchor domain and TM37, and enclose the central pore with both transmembrane and cytoplasmic constriction sites. Structural comparison between PIEZO2 and its homologue PIEZO1 reveals that the transmembrane constriction site might act as a transmembrane gate that is controlled by the cap domain. Together, our studies provide insights into the structure and mechanogating mechanism of Piezo channels.	[Wang, Li; Zhang, Mingmin; Liu, Wenhao; Deng, Tuan; Zhao, Qiancheng; Li, Yiran; Xiao, Bailong] Tsinghua Univ, Sch Pharmaceut Sci, Tsinghua Peking Joint Ctr Life Sci,IDG McGovern I, State Key Lab Membrane Biol,Beijing Adv Innovat C, Beijing, Peoples R China; [Zhou, Heng; Lei, Jianlin; Li, Xueming] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, MOE Key Lab Prot Sci,Beijing Adv Innovat Ctr Stru, Beijing, Peoples R China; [Zhang, Mingmin; Liu, Wenhao; Xiao, Bailong] Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing, Peoples R China	Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing; Tsinghua University	Xiao, BL (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Tsinghua Peking Joint Ctr Life Sci,IDG McGovern I, State Key Lab Membrane Biol,Beijing Adv Innovat C, Beijing, Peoples R China.; Li, XM (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, MOE Key Lab Prot Sci,Beijing Adv Innovat Ctr Stru, Beijing, Peoples R China.; Xiao, BL (corresponding author), Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing, Peoples R China.	lixueming@tsinghua.edu.cn; xbailong@mail.tsinghua.edu.cn	Zhao, Qiancheng/AAY-6658-2021	Zhou, Heng/0000-0002-6267-1585	National Key R&D Program of China [2016YFA0500402, 31825014, 31630090, 2015CB910102, 31570730, 2016YFA0501102, 2016YFA0501902]; National Natural Science Foundation of China [2016YFA0500402, 31825014, 31630090, 2015CB910102, 31570730, 2016YFA0501102, 2016YFA0501902]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank A. Patapoutian for sharing the mouse Piezo2 cDNA and the Tsinghua University Branch of the China National Center for Protein Sciences (Beijing) for providing cryo-EM facility support. This work was supported by grant numbers 2016YFA0500402, 31825014, 31630090 and 2015CB910102 to B.X. and 31570730, 2016YFA0501102 and 2016YFA0501902 to X.L., from either the National Key R&D Program of China or the National Natural Science Foundation of China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Chiang CS, 2004, BIOPHYS J, V86, P2846, DOI 10.1016/S0006-3495(04)74337-4; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; Haselwandter CA, 2018, ELIFE, V7, DOI 10.7554/eLife.41968; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Lu W, 2017, SCIENCE, V355, DOI 10.1126/science.aal3729; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moroni M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03502-7; Murthy SE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9897; Murthy SE, 2017, NAT REV MOL CELL BIO, V18, P771, DOI 10.1038/nrm.2017.92; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Szczot M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9892; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wang YF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03570-9; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Wu J, 2017, CELL REP, V21, P2357, DOI 10.1016/j.celrep.2017.10.120; Zeng WZ, 2018, SCIENCE, V362, P464, DOI 10.1126/science.aau6324; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang MM, 2019, CELL REP, V26, P1419, DOI 10.1016/j.celrep.2019.01.056; Zhang TX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01712-z; Zhao QC, 2019, FEBS J, V286, P2461, DOI 10.1111/febs.14711; Zhao QC, 2018, NATURE, V554, P487, DOI 10.1038/nature25743; Zhao QC, 2016, NEURON, V89, P1248, DOI 10.1016/j.neuron.2016.01.046; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	46	119	124	19	130	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					225	+		10.1038/s41586-019-1505-8	http://dx.doi.org/10.1038/s41586-019-1505-8			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31435011				2022-12-28	WOS:000485415400047
J	Adam, D				Adam, David			A tech tool to help in the lab	NATURE			English	Editorial Material																			0	0	0	4	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					151	153		10.1038/d41586-019-02620-6	http://dx.doi.org/10.1038/d41586-019-02620-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0KI	31481786	Bronze			2022-12-28	WOS:000483967700053
J	Sall, J; Brenner, L; Bell, AMM; Colston, MJ				Sall, James; Brenner, Lisa; Bell, Amy M. Millikan; Colston, Michael J.			Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREVENTION STRATEGIES; LITHIUM TREATMENT; BIPOLAR DISORDER; UNITED-STATES; BEHAVIOR; THERAPY; RATES; INTERVENTIONS; DEPRESSION	Description: In May 2019, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved an update to the 2013 joint clinical practice guideline for assessing and managing patients who are at risk for suicide. This guideline provides health care providers with a framework by which to screen for, evaluate, treat, and manage the individual needs and preferences of VA and DoD patients who may be at risk for suicide. Methods: In January 2018, the VA/DoD Evidence-Based Practice Work Group convened to develop a joint VA/DoD guideline including clinical stakeholders and conforming to the National Academy of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel drafted key questions, systematically searched and evaluated the literature through April 2018, created algorithms, and advanced 22 recommendations in accordance with the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Recommendations: This synopsis, which includes 3 clinical practice algorithms, summarizes the key recommendations of the guideline related to screening and evaluation, risk management and treatment, and other management methods. Risk management and treatment recommendations address both pharmacologic and nonpharmacologic approaches for patients with suicidal ideation and behavior. Other management methods address lethal means safety (such as restricting access to firearms, poisons, and medications and installing barriers to prevent jumping from lethal heights) and population health strategies.	[Sall, James] Vet Hlth Adm, Washington, DC USA; [Sall, James] Texas A&M Univ, Corpus Christi, TX USA; [Brenner, Lisa] Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Brenner, Lisa] Univ Colorado, Anschutz Med Campus,1700 North Wheeling St, Aurora, CO 80045 USA; [Bell, Amy M. Millikan] Army Publ Hlth Ctr, 8252 Blackhawk Rd, Aberdeen Proving Ground, MD 21010 USA; [Colston, Michael J.] Ft Belvoir Community Hosp, 9300 DeWitt Loop, Ft Belvoir, VA 22060 USA; [Sall, James] 926 Oak Bluff Trail, New Braunfels, TX 78132 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Texas A&M University System; University of Colorado System; University of Colorado Anschutz Medical Campus	Sall, J (corresponding author), 926 Oak Bluff Trail, New Braunfels, TX 78132 USA.	james.sall@va.gov	Brenner, Lisa A./AAG-2442-2019		VA	VA(US Department of Veterans Affairs)	The development of this guideline was funded by the VA. The DoD and VA paid expenses for their experts to travel to the Washington, DC, area to review the evidence on suicide and develop treatment recommendations.	Agency for Healthcare Research and Quality, 2012, AHRQ PUBL; Alphs L, 2004, SCHIZOPHRENIA BULL, V30, P577, DOI 10.1093/oxfordjournals.schbul.a007102; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Anestis MD, 2015, AM J PUBLIC HEALTH, V105, P2049, DOI 10.2105/AJPH.2015.302753; Anestis MD, 2015, AM J PUBLIC HEALTH, V105, P2059, DOI 10.2105/AJPH.2014.302465; Anestis MD, 2013, J AFFECT DISORDERS, V148, P42, DOI 10.1016/j.jad.2012.11.045; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baldessarini RJ, 2003, J CLIN PSYCHIAT, V64, P44; Baldessarini RJ, 2006, BIPOLAR DISORD, V8, P625, DOI 10.1111/j.1399-5618.2006.00344.x; Barkin SL, 2008, PEDIATRICS, V122, pE15, DOI 10.1542/peds.2007-2611; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Bryan CJ, 2017, J AFFECT DISORDERS, V212, P64, DOI 10.1016/j.jad.2017.01.028; Centers for Disease Control and Prevention, CDC WEB BAS INJ STAT; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2019, WEB BAS INJ STAT QUE; Chen WJ, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-191; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Cleveland Emily C, 2017, Inj Epidemiol, V4, P33, DOI 10.1186/s40621-017-0130-y; Collings S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5032-6; Crawford MJ, 2011, BRIT J PSYCHIAT, V198, P379, DOI 10.1192/bjp.bp.110.083592; Crifasi CK, 2018, AM J PUBLIC HEALTH, V108, P532, DOI 10.2105/AJPH.2017.304262; Ernst CL, 2004, HARVARD REV PSYCHIAT, V12, P14, DOI 10.1080/10673220490425924; Evans K, 1999, PSYCHOL MED, V29, P19, DOI 10.1017/S003329179800765X; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Gotzsche PC, 2017, J ROY SOC MED, V110, P404, DOI 10.1177/0141076817731904; Grunebaum MF, 2018, AM J PSYCHIAT, V175, P327, DOI 10.1176/appi.ajp.2017.17060647; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Gunnell D, 1997, J EPIDEMIOL COMMUN H, V51, P175, DOI 10.1136/jech.51.2.175; Hassanian-Moghaddam H, 2017, ARCH SUICIDE RES, V21, P138, DOI 10.1080/13811118.2015.1004473; Hatcher S, 2011, BRIT J PSYCHIAT, V199, P310, DOI 10.1192/bjp.bp.110.090126; Hawton K, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001764, 10.1002/14651858.CD001764]; Hawton K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012189; Hawton K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f403; Ilgen MA, 2016, PAIN, V157, P1079, DOI 10.1097/j.pain.0000000000000484; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Knipe DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172893; Kruesi MJP, 1999, J AM ACAD CHILD PSY, V38, P250, DOI 10.1097/00004583-199903000-00010; Large M, 2018, PSYCHOL MED, V48, P1119, DOI 10.1017/S0033291717002537; Leavey K, 2017, COGN BEHAV THERAPY, V46, P353, DOI 10.1080/16506073.2017.1332095; Louzon SA, 2016, PSYCHIAT SERV, V67, P517, DOI 10.1176/appi.ps.201500149; Lubin G, 2010, SUICIDE LIFE-THREAT, V40, P421, DOI 10.1521/suli.2010.40.5.421; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; MCLEAVEY BC, 1994, SUICIDE LIFE-THREAT, V24, P382; McMain SF, 2017, ACTA PSYCHIAT SCAND, V135, P138, DOI 10.1111/acps.12664; McManus BL, 1997, AM J EMERG MED, V15, P357, DOI 10.1016/S0735-6757(97)90124-8; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Miller M, 2013, AM J EPIDEMIOL, V178, P946, DOI 10.1093/aje/kwt197; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; Muller-Oerlinghausen Bruno, 2005, Arch Suicide Res, V9, P307, DOI 10.1080/13811110590929550; Naidoo SS, 2014, S AFR FAM PRACT, V56, P263, DOI 10.1080/20786190.2014.980159; Ono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074902; Oquendo MA, 2011, AM J PSYCHIAT, V168, P1050, DOI 10.1176/appi.ajp.2011.11010163; Pirkis J, 2013, INT J EPIDEMIOL, V42, P541, DOI 10.1093/ije/dyt021; Pruitt LD, 2017, CAL YEAR 2016 ANN RE; Rodgers P., UNDERSTANDING RISK P; Runeson B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180292; Runyan CW, 2016, WEST J EMERG MED, V17, P8, DOI 10.5811/westjem.2015.11.28590; SALKOVSKIS PM, 1990, BRIT J PSYCHIAT, V157, P871, DOI 10.1192/bjp.157.6.871; Shah R, 2014, J GEN INTERN MED, V29, P1148, DOI 10.1007/s11606-014-2843-8; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Simonetti JA, 2018, AM J PREV MED, V55, P445, DOI 10.1016/j.amepre.2018.04.014; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Stone DM, 2018, MMWR-MORBID MORTAL W, V67, P617, DOI 10.15585/mmwr.mm6722a1; Sueki H, 2015, CRISIS, V36, P267, DOI 10.1027/0227-5910/a000322; Tarrier N, 2008, BEHAV MODIF, V32, P77, DOI 10.1177/0145445507304728; Turner RM, 2000, COGN BEHAV PRACT, V7, P413, DOI 10.1016/S1077-7229(00)80052-8; U. S. Department of Defense Defense Casualty Analysis System, 2011, ACT DUT MIL DEATHS Y; U. S. Department of Veterans Affairs, ROCK MOUNT MIRECC SU; VA National Suicide Data Report, VA NAT SUIC DAT REP; Vijayakumar L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-850; Wilkinson ST, 2018, AM J PSYCHIAT, V175, P150, DOI 10.1176/appi.ajp.2017.17040472; Zalsman G, 2016, LANCET PSYCHIAT, V3, P646, DOI 10.1016/S2215-0366(16)30030-X	75	32	34	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2019	171	5					343	+		10.7326/M19-0687	http://dx.doi.org/10.7326/M19-0687			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV9VD	31450237				2022-12-28	WOS:000484610900007
J	Chapurin, N; Gelbard, A				Chapurin, Nikita; Gelbard, Alexander			Epiglottitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chapurin, Nikita; Gelbard, Alexander] Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University	Gelbard, A (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.	alexander.gelbard@vumc.org	Chapurin, Nikita/AAP-4954-2020; Gelbard, Alexander/K-1976-2014	Gelbard, Alexander/0000-0003-0078-1305					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					E15	E15		10.1056/NEJMicm1816761	http://dx.doi.org/10.1056/NEJMicm1816761			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461597				2022-12-28	WOS:000484431200001
J	Yoneshiro, T; Wang, Q; Tajima, K; Matsushita, M; Maki, H; Igarashi, K; Dai, ZP; White, PJ; McGarrah, RW; Ilkayeva, OR; Deleye, Y; Oguri, Y; Kuroda, M; Ikeda, K; Li, HX; Ueno, A; Ohishi, M; Ishikawa, T; Kim, K; Chen, Y; Sponton, CH; Pradhan, RN; Majd, H; Greiner, VJ; Yoneshiro, M; Brown, Z; Chondronikola, M; Takahashi, H; Goto, T; Kawada, T; Sidossis, L; Szoka, FC; McManus, MT; Saito, M; Soga, T; Kajimura, S				Yoneshiro, Takeshi; Wang, Qiang; Tajima, Kazuki; Matsushita, Mami; Maki, Hiroko; Igarashi, Kaori; Dai, Zhipeng; White, Phillip J.; McGarrah, Robert W.; Ilkayeva, Olga R.; Deleye, Yann; Oguri, Yasuo; Kuroda, Mito; Ikeda, Kenji; Li, Huixia; Ueno, Ayano; Ohishi, Maki; Ishikawa, Takamasa; Kim, Kyeongkyu; Chen, Yong; Sponton, Carlos Henrique; Pradhan, Rachana N.; Majd, Homa; Greiner, Vanille Juliette; Yoneshiro, Momoko; Brown, Zachary; Chondronikola, Maria; Takahashi, Haruya; Goto, Tsuyoshi; Kawada, Teruo; Sidossis, Labros; Szoka, Francis C.; McManus, Michael T.; Saito, Masayuki; Soga, Tomoyoshi; Kajimura, Shingo			BCAA catabolism in brown fat controls energy homeostasis through SLC25A44	NATURE			English	Article							CHAIN AMINO-ACIDS; ADIPOSE-TISSUE; COLD-EXPOSURE; METABOLISM; IDENTIFICATION; THERMOGENESIS; CONTRIBUTES; EXPRESSION; HUMANS; OBESE	Branched-chain amino acid (BCAA; valine, leucine and isoleucine) supplementation is often beneficial to energy expenditure; however, increased circulating levels of BCAA are linked to obesity and diabetes. The mechanisms of this paradox remain unclear. Here we report that, on cold exposure, brown adipose tissue (BAT) actively utilizes BCAA in the mitochondria for thermogenesis and promotes systemic BCAA clearance in mice and humans. In turn, a BAT-specific defect in BCAA catabolism attenuates systemic BCAA clearance, BAT fuel oxidation and thermogenesis, leading to diet-induced obesity and glucose intolerance. Mechanistically, active BCAA catabolism in BAT is mediated by SLC25A44, which transports BCAAs into mitochondria. Our results suggest that BAT serves as a key metabolic filter that controls BCAA clearance via SLC25A44, thereby contributing to the improvement of metabolic health.	[Yoneshiro, Takeshi; Wang, Qiang; Tajima, Kazuki; Oguri, Yasuo; Kuroda, Mito; Ikeda, Kenji; Li, Huixia; Kim, Kyeongkyu; Chen, Yong; Sponton, Carlos Henrique; Pradhan, Rachana N.; Greiner, Vanille Juliette; Yoneshiro, Momoko; Brown, Zachary; McManus, Michael T.; Kajimura, Shingo] UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Yoneshiro, Takeshi; Wang, Qiang; Tajima, Kazuki; Oguri, Yasuo; Kuroda, Mito; Ikeda, Kenji; Li, Huixia; Kim, Kyeongkyu; Chen, Yong; Sponton, Carlos Henrique; Pradhan, Rachana N.; Majd, Homa; Yoneshiro, Momoko; Brown, Zachary; Kajimura, Shingo] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94131 USA; [Yoneshiro, Takeshi; Wang, Qiang; Tajima, Kazuki; Oguri, Yasuo; Kuroda, Mito; Ikeda, Kenji; Li, Huixia; Kim, Kyeongkyu; Chen, Yong; Sponton, Carlos Henrique; Pradhan, Rachana N.; Yoneshiro, Momoko; Brown, Zachary; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Matsushita, Mami] Tenshi Coll, Dept Nutr, Sapporo, Hokkaido, Japan; [Maki, Hiroko; Igarashi, Kaori; Ueno, Ayano; Ohishi, Maki; Ishikawa, Takamasa; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Dai, Zhipeng; Szoka, Francis C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [White, Phillip J.; McGarrah, Robert W.; Ilkayeva, Olga R.; Deleye, Yann] Duke Univ, Duke Mol Physiol Inst, Durham, NC USA; [Ikeda, Kenji] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Greiner, Vanille Juliette; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Chondronikola, Maria] Washington Univ, Ctr Human Nutr, St Louis, MO 63110 USA; [Takahashi, Haruya; Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Lab Mol Funct Food, Grad Sch Agr, Uji, Kyoto, Japan; [Sidossis, Labros] Rutgers State Univ, Dept Kinesiol & Hlth, Sch Arts & Sci, New Brunswick, NJ USA; [Saito, Masayuki] Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	University of California System; University of California San Francisco; Keio University; University of California System; University of California San Francisco; Duke University; Tokyo Medical & Dental University (TMDU); University of California System; University of California San Francisco; Washington University (WUSTL); Kyoto University; Rutgers State University New Brunswick; Hokkaido University	Kajimura, S (corresponding author), UCSF Diabet Ctr, San Francisco, CA 94143 USA.; Kajimura, S (corresponding author), Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94131 USA.; Kajimura, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	shingo.kajimura@ucsf.edu	Kajimura, Shingo/AAC-5090-2019; Goto, Tsuyoshi/AAY-2344-2020; Sidossis, Labros/AAN-9546-2021; Sponton, Carlos Henrique/M-9156-2013; Yoneshiro, Takeshi/V-3856-2019; mcmanus, michael/AAB-1239-2020; White, Phillip J/H-3048-2019; Deleye, Yann/AAH-3989-2020; Chondronikola, Maria/ABH-6994-2020	Kajimura, Shingo/0000-0003-0672-5910; Goto, Tsuyoshi/0000-0003-1283-147X; Sidossis, Labros/0000-0001-8313-7966; Sponton, Carlos Henrique/0000-0003-4284-8176; Yoneshiro, Takeshi/0000-0001-5298-5831; mcmanus, michael/0000-0003-3013-6569; White, Phillip J/0000-0002-0957-425X; Deleye, Yann/0000-0002-8545-679X; Oguri, Yasuo/0000-0002-7435-6961; Pradhan, Rachana/0000-0001-7352-8111; Kim, Kyeongkyu/0000-0002-9533-6142; KURODA, Mito/0000-0001-7752-3334; Brown, Zachary/0000-0002-1665-0310; Majd, Homa/0000-0002-2048-1839	NIH [DK97441, DK112268, U19CA179513, P30 DK063720]; Edward Mallinckrodt Jr. Foundation; American Diabetes Association Pathways Award [1-16-INI-17]; AMED-CREST from the Japan Agency for Medical Research and Development; JSPS Fellowships; NATIONAL CANCER INSTITUTE [U19CA179513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097441, P30DK063720, P30DK056341, R01DK112268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr. Foundation; American Diabetes Association Pathways Award; AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. B. Newgard for the initial metabolomics analysis, E. Kunji for liposome study, Y. Seo and T. Huynh for the PET-CT scan, Y. Cheng and E. Green for HEK293S cells, E. T. Chouchani and E. Mills for cell respiration studies, and X. Lu and K. Shinoda for technical help. This work was supported by the NIH (DK97441 and DK112268) and the Edward Mallinckrodt Jr. Foundation to S. K., the American Diabetes Association Pathways Award (1-16-INI-17) to P. J. W., the AMED-CREST from the Japan Agency for Medical Research and Development to T. S., and the NIH (U19CA179513 and P30 DK063720) to M. T. M. T. Y. and M. K. are supported by the JSPS Fellowships.	Balkow Aileen, 2016, J Biol Methods, V3, pe48, DOI 10.14440/jbm.2016.123; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Chondronikola M, 2016, CELL METAB, V23, P1200, DOI 10.1016/j.cmet.2016.04.029; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Neinast MD, 2019, CELL METAB, V29, P417, DOI 10.1016/j.cmet.2018.10.013; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Sustarsic EG, 2018, CELL METAB, V28, P159, DOI 10.1016/j.cmet.2018.05.003; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wallace M, 2018, NAT CHEM BIOL, V14, P1021, DOI 10.1038/s41589-018-0132-2; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; White PJ, 2018, CELL METAB, V27, P1281, DOI 10.1016/j.cmet.2018.04.015; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	37	189	193	23	124	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					614	+		10.1038/s41586-019-1503-x	http://dx.doi.org/10.1038/s41586-019-1503-x			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31435015	Green Submitted, Green Accepted			2022-12-28	WOS:000483405500045
J	Weiland, M; Desai, N				Weiland, Meagan; Desai, Nirja			GEOGRAPHY OF LOSS	SCIENCE			English	Editorial Material																			0	1	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		736	737		10.1126/science.365.6455.736	http://dx.doi.org/10.1126/science.365.6455.736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439775				2022-12-28	WOS:000482464000012
J	Youngs, P				Youngs, Paul			Pension tax crisis: reform needs to be swift to tackle doctors' sense of injustice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Youngs, Paul] BMA Pens Comm, London, England		Youngs, P (corresponding author), BMA Pens Comm, London, England.	paul.youngs@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2019	366								l5195	10.1136/bmj.l5195	http://dx.doi.org/10.1136/bmj.l5195			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DJ	31439592				2022-12-28	WOS:000482882300006
J	Jafar, TH; Samad, Z; Bloomfield, GS				Jafar, Tazeen H.; Samad, Zainab; Bloomfield, Gerald S.			Parallel community solutions for cardiovascular risk reduction	LANCET			English	Editorial Material							BLOOD-PRESSURE; LOW-INCOME; COST-EFFECTIVENESS; TRIAL; HYPERTENSION; MANAGEMENT; COUNTRIES; PROGRAM; CARE		[Jafar, Tazeen H.] Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore 169857, Singapore; [Jafar, Tazeen H.; Samad, Zainab] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Samad, Zainab; Bloomfield, Gerald S.] Duke Univ, Div Cardiol, Durham, NC USA; [Jafar, Tazeen H.; Bloomfield, Gerald S.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA	National University of Singapore; Aga Khan University; Duke University; Duke University	Jafar, TH (corresponding author), Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore 169857, Singapore.; Jafar, TH (corresponding author), Aga Khan Univ, Dept Med, Karachi, Pakistan.; Jafar, TH (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.	tazeen.jafar@duke-nus.edu.sg		Samad, Zainab/0000-0003-2422-3199				Anand TN, 2019, LANCET GLOB HEALTH, V7, pE761, DOI 10.1016/S2214-109X(19)30077-4; Augustovski F, 2018, VALUE HEALTH, V21, P1357, DOI 10.1016/j.jval.2018.06.003; Bahiru E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009868.pub3; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Geldsetzer P, 2019, LANCET, V394, P652, DOI 10.1016/S0140-6736(19)30955-9; He J, 2017, JAMA-J AM MED ASSOC, V318, P1016, DOI 10.1001/jama.2017.11358; Jafar TH, 2011, CIRCULATION, V124, P1615, DOI 10.1161/CIRCULATIONAHA.111.039990; Koopmans L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3812-4; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Linnemayr Sebastian, 2012, Rand Health Q, V1, P2; Oparil S, 2016, CIRCULATION, V134, P1308, DOI 10.1161/CIRCULATIONAHA.116.023263; Peiris D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213708; Schwalm JD, 2019, LANCET, V394, P1231, DOI 10.1016/S0140-6736(19)31949-X; Tian MY, 2015, CIRCULATION, V132, P815, DOI 10.1161/CIRCULATIONAHA.115.015373	15	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1207	1208		10.1016/S0140-6736(19)31995-6	http://dx.doi.org/10.1016/S0140-6736(19)31995-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8XK	31488366				2022-12-28	WOS:000488862500004
J	Aminian, A; Zajichek, A; Arterburn, DE; Wolski, KE; Brethauer, SA; Schauer, PR; Kattan, MW; Nissen, SE				Aminian, Ali; Zajichek, Alexander; Arterburn, David E.; Wolski, Kathy E.; Brethauer, Stacy A.; Schauer, Philip R.; Kattan, Michael W.; Nissen, Steven E.			Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-STYLE INTERVENTION; BARIATRIC SURGERY; GASTRIC BYPASS; ATRIAL-FIBRILLATION; WEIGHT-LOSS; RISK	IMPORTANCE Although metabolic surgery (defined as procedures that influence metabolism by inducing weight loss and altering gastrointestinal physiology) significantly improves cardiometabolic risk factors, the effect on cardiovascular outcomes has been less well characterized. OBJECTIVE To investigate the relationship between metabolic surgery and incident major adverse cardiovascular events (MACE) in patients with type 2 diabetes and obesity. DESIGN, SETTING, AND PARTICIPANTS Of 287438 adult patients with diabetes in the Cleveland Clinic Health System in the United States between 1998 and 2017, 2287 patients underwent metabolic surgery. In this retrospective cohort study, these patients were matched 1:5 to nonsurgical patients with diabetes and obesity (body mass index [BMI] >= 30), resulting in 11435 control patients, with follow-up through December 2018. EXPOSURES Metabolic gastrointestinal surgical procedures vs usual care for type 2 diabetes and obesity. MAIN OUTCOMES AND MEASURES The primary outcome was the incidence of extended MACE (composite of 6 outcomes), defined as first occurrence of all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation. Secondary end points included 3-component MACE (myocardial infarction, ischemic stroke, and mortality) and the 6 individual components of the primary end point. RESULTS Among the 13722 study participants, the distribution of baseline covariates was balanced between the surgical group and the nonsurgical group, including female sex (65.5% vs 64.2%), median age (52.5 vs 54.8 years), BMI (45.1 vs 42.6), and glycated hemoglobin level (7.1% vs 7.1%). The overall median follow-up duration was 3.9 years (interquartile range, 1.9-6.1 years). At the end of the study period, 385 patients in the surgical group and 3243 patients in the nonsurgical group experienced a primary end point (cumulative incidence at 8-years, 30.8% [95% CI, 27.6%-34.0%] in the surgical group and 47.7% [95% CI, 46.1%-49.2%] in the nonsurgical group [P < .001]; absolute 8-year risk difference [ARD], 16.9% [95% CI, 13.1%-20.4%]; adjusted hazard ratio [HR], 0.61 [95% CI, 0.55-0.69]). All 7 prespecified secondary outcomes showed statistically significant differences in favor of metabolic surgery, including mortality. All-cause mortality occurred in 112 patients in the metabolic surgery group and 1111 patients in the nonsurgical group (cumulative incidence at 8 years, 10.0% [95% CI, 7.8%-12.2%] and 17.8% [95% CI, 16.6%-19.0%]; ARD, 7.8% [95% CI, 5.1%-10.2%]; adjusted HR, 0.59 [95% CI, 0.48-0.72]). CONCLUSIONS AND RELEVANCE Among patients with type 2 diabetes and obesity, metabolic surgery, compared with nonsurgical management, was associated with a significantly lower risk of incident MACE. The findings from this observational study must be confirmed in randomized clinical trials.	[Aminian, Ali; Brethauer, Stacy A.; Schauer, Philip R.] Cleveland Clin, Dept Gen Surg, Bariatr & Metab Inst, Cleveland, OH 44195 USA; [Zajichek, Alexander; Kattan, Michael W.] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Arterburn, David E.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Wolski, Kathy E.; Nissen, Steven E.] Cleveland Clin, Coordinating Ctr Clin Res, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Brethauer, Stacy A.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Kaiser Permanente; Cleveland Clinic Foundation; University System of Ohio; Ohio State University	Nissen, SE (corresponding author), Cleveland Clin, JB-20,9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org	Kattan, Michael/AAF-9735-2021	Kattan, Michael/0000-0002-3840-4161; Schauer, Philip/0000-0002-4029-7537	Medtronic; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK105960]	Medtronic(Medtronic); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partially funded by an unrestricted grant from Medtronic. Dr Arterburn was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant R01-DK105960.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Aggarwal R, 2016, OBES SURG, V26, P1030, DOI 10.1007/s11695-015-1866-5; Alonso A, 2015, AM HEART J, V170, P770, DOI 10.1016/j.ahj.2015.07.026; [Anonymous], 2018, RMS REGRESSION MODEL; Batterham RL, 2016, DIABETES CARE, V39, P893, DOI 10.2337/dc16-0145; Benotti PN, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005126; Carlsson LMS, 2017, LANCET DIABETES ENDO, V5, P271, DOI 10.1016/S2213-8587(17)30061-X; Chondronikola M, 2016, J INTERN MED, V280, P476, DOI 10.1111/joim.12527; Daigle CR, 2018, SURG OBES RELAT DIS, V14, P652, DOI 10.1016/j.soard.2018.01.008; Douros JD, 2019, ENDOCR REV, V40, P1394, DOI 10.1210/er.2018-00183; Fisher DP, 2018, JAMA-J AM MED ASSOC, V320, P1570, DOI 10.1001/jama.2018.14619; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Ikramuddin S, 2018, JAMA-J AM MED ASSOC, V319, P266, DOI 10.1001/jama.2017.20813; Imam TH, 2017, AM J KIDNEY DIS, V69, P380, DOI 10.1053/j.ajkd.2016.09.020; Jamaly S, 2019, EUR HEART J, V40, P2131, DOI 10.1093/eurheartj/ehz295; Jamaly S, 2016, J AM COLL CARDIOL, V68, P2497, DOI 10.1016/j.jacc.2016.09.940; Johnson BL, 2013, J AM COLL SURGEONS, V216, P545, DOI 10.1016/j.jamcollsurg.2012.12.019; Jones NR, 2019, HEART, V105, P1799, DOI 10.1136/heartjnl-2019-314931; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Milinovich A, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.01.13; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; O'Brien R, 2018, ANN INTERN MED, V169, P300, DOI 10.7326/M17-2383; R Core Team, 2018, R LANG ENV STAT COMP; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Schauer PR, 2017, NEW ENGL J MED, V376, P641, DOI 10.1056/NEJMoa1600869; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Sundstrom J, 2017, CIRCULATION, V135, P1577, DOI 10.1161/CIRCULATIONAHA.116.025629; van Buuren S, 2011, J STAT SOFTW, V45, P1; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Young L, 2019, SURG ENDOSC, V33, P1654, DOI 10.1007/s00464-018-6458-8	31	171	174	8	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1271	1282		10.1001/jama.2019.14231	http://dx.doi.org/10.1001/jama.2019.14231			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31475297	Bronze, Green Published			2022-12-28	WOS:000489331900015
J	Urwin, JW; Emanuel, EJ				Urwin, John W.; Emanuel, Ezekiel J.			The Relative Value Scale Update Committee: Time for an Update	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCURACY	This Viewpoint discusses how problems with the methodology, structure, and recommendations of the Relative Value Scale Update Committee can lead to outdated or inaccurate physician payment data and lower quality of care, and calls for the use of empirical data and patient-specific outcomes to inform physician reimbursement.	[Urwin, John W.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Urwin, John W.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,11th & 14th Floors, Philadelphia, PA 19104 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,11th & 14th Floors, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						American Medical Association, INTR RUC; Chan DC, 2019, NEW ENGL J MED, V380, P1546, DOI 10.1056/NEJMsa1807379; Gao YN, 2018, HEALTH SERV RES, V53, P4353, DOI 10.1111/1475-6773.12857; GLASER WA, 1989, HEALTH AFFAIR, V8, P129, DOI 10.1377/hlthaff.8.3.129; Government Accountability Office, 2015, MED PHYS PAYM RAT BE; JOSEPHS RA, 1995, ORGAN BEHAV HUM DEC, V61, P202, DOI 10.1006/obhd.1995.1016; Nurok M, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2019.11163, DOI 10.1001/JAMA.2019.1116331380934]; Urwin JW, 2019, HEALTH AFFAIR, V38, P1079, DOI 10.1377/hlthaff.2018.05456; Zuckerman S., 2016, COLLECTING EMPIRICAL	9	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1137	1138		10.1001/jama.2019.14591	http://dx.doi.org/10.1001/jama.2019.14591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8LY	31498373				2022-12-28	WOS:000488822800014
J	Voelker, R				Voelker, Rebecca			Green Vegetables, Herbs, and Oils May Help Stabilize Patients Taking Warfarin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News article discusses recent research that shows increasing their vitamin K intake could help patients who take warfarin to maintain stable anticoagulation.											0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1128	1129		10.1001/jama.2019.13060	http://dx.doi.org/10.1001/jama.2019.13060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31483449				2022-12-28	WOS:000488822800001
J	Whellan, DJ				Whellan, David J.			Answering the Clinical Research Challenge in a Growing Health System	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Whellan, David J.] Thomas Jefferson Univ, Jefferson Clin Res Inst, 1015 Chestnut St,Suite 317, Philadelphia, PA 19107 USA	Jefferson University	Whellan, DJ (corresponding author), Thomas Jefferson Univ, Jefferson Clin Res Inst, 1015 Chestnut St,Suite 317, Philadelphia, PA 19107 USA.	David.Whellan@jefferson.edu						Christensen MC, 2009, J HEALTH POLIT POLIC, V34, P1011, DOI 10.1215/03616878-2009-034; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Drain PK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192413; Ehrhardt S, 2015, JAMA-J AM MED ASSOC, V314, P2566, DOI 10.1001/jama.2015.12206; Getz K, 2005, TUFTS CTR STUDY DRUG, V7, P1; Grover A, 2014, NEW ENGL J MED, V370, P2360, DOI 10.1056/NEJMp1403609; Jeong S, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2025-1; Kramer JM, 2012, CLIN PHARMACOL THER, V91, P535, DOI 10.1038/clpt.2011.341; Meador KJ, 2015, NEUROLOGY, V85, P1171, DOI 10.1212/WNL.0000000000001818; Morris M, JOINING FORCES COMMU	10	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					430	+		10.7326/M19-1656	http://dx.doi.org/10.7326/M19-1656			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31499526				2022-12-28	WOS:000486101400018
J	Hardy, J; Baggott, C; Fingleton, J; Reddel, HK; Hancox, RJ; Harwood, M; Corin, A; Sparks, J; Hall, D; Sabbagh, D; Mane, S; Vohlidkova, A; Martindale, J; Williams, M; Shirtcliffe, P; Holliday, M; Weatherall, M; Beasley, R				Hardy, Jo; Baggott, Christina; Fingleton, James; Reddel, Helen K.; Hancox, Robert J.; Harwood, Matire; Corin, Andrew; Sparks, Jenny; Hall, Daniela; Sabbagh, Donah; Mane, Saras; Vohlidkova, Alexandra; Martindale, John; Williams, Mathew; Shirtcliffe, Philippa; Holliday, Mark; Weatherall, Mark; Beasley, Richard		PRACTICAL Study Team	Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial	LANCET			English	Article							EXACERBATIONS	Background In adults with mild asthma, a combination of an inhaled corticosteroid with a fast-onset long-acting beta-agonist (LABA) used as reliever monotherapy reduces severe exacerbations compared with short-acting beta-agonist (SABA) reliever therapy. We investigated the efficacy of combination budesonide-formoterol reliever therapy compared with maintenance budesonide plus as-needed terbutaline. Methods We did a 52-week, open-label, parallel-group, multicentre, superiority, randomised controlled trial at 15 primary care or hospital-based clinical trials units and primary care practices in New Zealand. Participants were adults aged 18-75 years with a self-reported doctor's diagnosis of asthma who were using SABA for symptom relief with or without maintenance low to moderate doses of inhaled corticosteroids in the previous 12 weeks. We randomly assigned participants (1:1) to either reliever therapy with budesonide 200 mu g-formoterol 6 mu g Turbuhaler (one inhalation as needed for relief of symptoms) or maintenance budesonide 200 mu g Turbuhaler (one inhalation twice daily) plus terbutaline 250 mu g Turbuhaler (two inhalations as needed). Participants and investigators were not masked to group assignment; the statistician was masked for analysis of the primary outcome. Six study visits were scheduled: randomisation, and weeks 4, 16, 28, 40, and 52. The primary outcome was the number of severe exacerbations per patient per year analysed by intention to treat (severe exacerbations defined as use of systemic corticosteroids for at least 3 days because of asthma, or admission to hospital or an emergency department visit because of asthma requiring systemic corticosteroids). Safety analyses included all participants who had received at least one dose of study treatment. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12616000377437. Findings Between May 4, 2016, and Dec 22, 2017, we assigned 890 participants to treatment and included 885 eligible participants in the analysis:437 assigned to budesonide-formoterol as needed and 448 to budesonide maintenance plus terbutaline as needed. Severe exacerbations per patient per year were lower with as-needed budesonide-formoterol than with maintenance budesonide plus terbutaline as needed (absolute rate per patient per year 0.119 vs 0.172; relative rate 0.69, 95% CI 0.48-1.00; p=0.049). Nasopharyngitis was the most common adverse event in both groups, occurring in 154 (35%) of 440 patients receiving as-needed budesonide-formoterol and 144 (32%) of 448 receiving maintenance budesonide plus terbutaline as needed. Interpretation In adults with mild to moderate asthma, budesonide-formoterol used as needed for symptom relief was more effective at preventing severe exacerbations than maintenance low-dose budesonide plus as-needed terbutaline. The findings support the 2019 Global Initiative for Asthma recommendation that inhaled corticosteroid-formoterol reliever therapy is an alternative regimen to daily low-dose inhaled corticosteroid for patients with mild asthma. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Hardy, Jo; Baggott, Christina; Fingleton, James; Sparks, Jenny; Hall, Daniela; Sabbagh, Donah; Mane, Saras; Vohlidkova, Alexandra; Martindale, John; Williams, Mathew; Shirtcliffe, Philippa; Holliday, Mark; Beasley, Richard] Med Res Inst New Zealand, Wellington 6242, New Zealand; [Fingleton, James; Beasley, Richard] Capital & Coast Dist Hlth Board, Wellington, New Zealand; [Reddel, Helen K.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia; [Hancox, Robert J.] Waikato Hosp, Hamilton, New Zealand; [Hancox, Robert J.] Univ Otago, Dunedin, New Zealand; [Harwood, Matire] Univ Auckland, Auckland, New Zealand; [Corin, Andrew] Clin Horizons, Tauranga, New Zealand; [Weatherall, Mark] Univ Otago Wellington, Wellington, New Zealand	Medical Research Institute Of New Zealand; University of Sydney; Woolcock Institute of Medical Research; Waikato Hospital; University of Otago; University of Auckland; University of Otago	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6242, New Zealand.	richard.beasley@mrinz.ac.nz	Reddel, Helen/AAC-3394-2020; Reddel, Helen/ABD-6338-2021; Weatherall, Mark/Y-6824-2019	Reddel, Helen/0000-0002-6695-6350; Weatherall, Mark/0000-0002-0051-9107; Hassan, summer/0000-0002-6185-9906; Baggott, Christina/0000-0002-3581-4472; Ebmeier, Stefan/0000-0001-7570-7172; Fingleton, James/0000-0001-9148-196X; Eathorne, Allie/0000-0002-0706-044X; Oldfield, Karen/0000-0003-4734-8488; Mane, Saras/0000-0002-9977-2523	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	Health Research Council of New Zealand.	Bateman ED, 2018, NEW ENGL J MED, V378, P1877, DOI 10.1056/NEJMoa1715275; Beasley R, 2019, NEW ENGL J MED, V380, P2020, DOI 10.1056/NEJMoa1901963; Charles T, 2007, J ALLERGY CLIN IMMUN, V119, P811, DOI 10.1016/j.jaci.2006.11.700; Cochrane MG, 2000, CHEST, V117, P542, DOI 10.1378/chest.117.2.542; Dusser D, 2007, ALLERGY, V62, P591, DOI 10.1111/j.1398-9995.2007.01394.x; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fingleton J, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000217; Fingleton J, 2012, THORAX, V67, P667, DOI 10.1136/thoraxjnl-2012-201966; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; O'Byrne PM, 2018, NEW ENGL J MED, V378, P1865, DOI 10.1056/NEJMoa1715274; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Pilcher J, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2015-000097; Price D, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.9; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Reddel HK, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01046-2019; Reddel HK, 2017, LANCET, V389, P157, DOI 10.1016/S0140-6736(16)31399-X; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sobieraj DM, 2018, JAMA-J AM MED ASSOC, V319, P1485, DOI 10.1001/jama.2018.2769	23	127	130	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					919	928		10.1016/S0140-6736(19)31948-8	http://dx.doi.org/10.1016/S0140-6736(19)31948-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX7CE	31451207				2022-12-28	WOS:000485840600023
J	Kim, SG; Becattini, S; Moody, TU; Shliaha, PV; Littmann, ER; Seok, R; Gjonbalaj, M; Eaton, V; Fontana, E; Amoretti, L; Wright, R; Caballero, S; Wang, ZMX; Jung, HJ; Morjaria, SM; Leiner, IM; Qin, WG; Ramos, RJJF; Cross, JR; Narushima, S; Honda, K; Peled, JU; Hendrickson, RC; Taur, Y; van den Brink, MRM; Pamer, EG				Kim, Sohn G.; Becattini, Simone; Moody, Thomas U.; Shliaha, Pavel V.; Littmann, Eric R.; Seok, Ruth; Gjonbalaj, Mergim; Eaton, Vincent; Fontana, Emily; Amoretti, Luigi; Wright, Roberta; Caballero, Silvia; Wang, Zhong-Min X.; Jung, Hea-Jin; Morjaria, Sejal M.; Leiner, Ingrid M.; Qin, Weige; Ramos, Ruben J. J. F.; Cross, Justin R.; Narushima, Seiko; Honda, Kenya; Peled, Jonathan U.; Hendrickson, Ronald C.; Taur, Ying; van den Brink, Marcel R. M.; Pamer, Eric G.			Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus	NATURE			English	Article							INTESTINAL MICROBIOTA; COLONIZATION RESISTANCE; BIOSYNTHESIS; NISIN; BACTERIOCIN; ANNOTATION; DOMINATION; DISCOVERY	Intestinal commensal bacteria can inhibit dense colonization of the gut by vancomycin-resistant Enterococcus faecium (VRE), a leading cause of hospital-acquired infections(1,2). A four-strained consortium of commensal bacteria that contains Blautia producta BPSCSK can reverse antibiotic-induced susceptibility to VRE infection(3). Here we show that BPSCSK reduces growth of VRE by secreting a lantibiotic that is similar to the nisin-A produced by Lactococcus lactis. Although the growth of VRE is inhibited by BPSCSK and L. lactis in vitro, only BPSCSK colonizes the colon and reduces VRE density in vivo. In comparison to nisin-A, the BPSCSK lantibiotic has reduced activity against intestinal commensal bacteria. In patients at high risk of VRE infection, high abundance of the lantibiotic gene is associated with reduced density of E. faecium. In germ-free mice transplanted with patient-derived faeces, resistance to VRE colonization correlates with abundance of the lantibiotic gene. Lantibiotic-producing commensal strains of the gastrointestinal tract reduce colonization by VRE and represent potential probiotic agents to re-establish resistance to VRE.	[Kim, Sohn G.; Becattini, Simone; Moody, Thomas U.; Seok, Ruth; Gjonbalaj, Mergim; Eaton, Vincent; Caballero, Silvia; Wang, Zhong-Min X.; Jung, Hea-Jin; Leiner, Ingrid M.; van den Brink, Marcel R. M.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Immunol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA; [Kim, Sohn G.; Caballero, Silvia; Peled, Jonathan U.; van den Brink, Marcel R. M.; Pamer, Eric G.] Weill Cornell Med Coll, New York, NY 10065 USA; [Moody, Thomas U.; Littmann, Eric R.; Fontana, Emily; Amoretti, Luigi; Wright, Roberta; Leiner, Ingrid M.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, 1275 York Ave, New York, NY 10021 USA; [Shliaha, Pavel V.; Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Microchem & Prote Core Lab, 1275 York Ave, New York, NY 10021 USA; [Morjaria, Sejal M.; Taur, Ying; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, 1275 York Ave, New York, NY 10021 USA; [Qin, Weige; Ramos, Ruben J. J. F.; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Donald B & Catherine C Marron Canc Metab Ctr, 1275 York Ave, New York, NY 10021 USA; [Narushima, Seiko; Honda, Kenya] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Honda, Kenya] Keio Univ, Med & Chem Innovat Ctr, JSR, Tokyo, Japan; [Honda, Kenya] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Peled, Jonathan U.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA; [Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; RIKEN; Keio University; RIKEN; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.; Pamer, EG (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.; Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, 1275 York Ave, New York, NY 10021 USA.; Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, 1275 York Ave, New York, NY 10021 USA.	egpamer@uchicago.edu	Wang, Zhongmin/GLU-9473-2022; van den Brink, Marcel R. M./HGB-9434-2022	Wang, Zhongmin/0000-0002-5538-1969; Shliaha, Pavel/0000-0003-3092-0724; van den Brink, Marcel/0000-0003-0696-4401; Ramos, Ruben/0000-0002-3350-0437; Kim, Sohn/0000-0002-6513-0442; Becattini, Simone/0000-0001-5985-0403; Amoretti, Luigi/0000-0002-4625-5119; Peled, Jonathan/0000-0002-4029-7625	US National Institutes of Health (NIH) [RO1 AI42135, RO1 AI95706, UO1 AI124275, P30 CA008748]; Tow Foundation; Lucille Castori Center for Microbes, Inflammation and Cancer; Medical Scientist Training Program grant from the National Institute of General Medical Sciences, NIH [T32GM07739]; Early Postdoc Mobility Fellowship from the Swiss National Science Foundation; Irvington Fellowship from the Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI124275, R01AI095706, R01AI042135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, T34GM007823] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tow Foundation; Lucille Castori Center for Microbes, Inflammation and Cancer; Medical Scientist Training Program grant from the National Institute of General Medical Sciences, NIH; Early Postdoc Mobility Fellowship from the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Irvington Fellowship from the Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants RO1 AI42135, RO1 AI95706, UO1 AI124275, and P30 CA008748 from the US National Institutes of Health (NIH) and the Tow Foundation and Lucille Castori Center for Microbes, Inflammation and Cancer to E.G.P. S.G.K. is supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences, NIH (award T32GM07739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program). S.B. was supported by an Early Postdoc Mobility Fellowship from the Swiss National Science Foundation and an Irvington Fellowship from the Cancer Research Institute. We thank members of the Pamer laboratory for discussions and comments on the manuscript.	Becattini S, 2017, J EXP MED, V214, P1973, DOI 10.1084/jem.20170495; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caballero S, 2017, CELL HOST MICROBE, V21, P592, DOI 10.1016/j.chom.2017.04.002; Caballero S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005132; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Dobson A, 2011, FEMS MICROBIOL ECOL, V76, P602, DOI 10.1111/j.1574-6941.2011.01069.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Frieden T., 2019, CENT DIS CONTROL PRE, V114, DOI CS239559-B; Gilmore MS, 2014, ENTEROCOCCI COMMENSA; Hatziioanou D, 2017, MICROBIOL-SGM, V163, P1292, DOI 10.1099/mic.0.000515; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Kang DH, 1999, LETT APPL MICROBIOL, V29, P206, DOI 10.1046/j.1365-2672.1999.00620.x; Kim S, 2017, IMMUNOL REV, V279, P90, DOI 10.1111/imr.12563; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lebreton F, 2017, CELL, V169, P849, DOI 10.1016/j.cell.2017.04.027; Mattick ATR, 1944, NATURE, V154, P551, DOI 10.1038/154551a0; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Montalban-Lopez M, 2015, HYDROCARBON LIPID MI; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Shi YX, 2011, J AM CHEM SOC, V133, P2338, DOI 10.1021/ja109044r; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, P3872, DOI 10.1093/nar/gkv278; Taur Y, 2015, BEST PRACT RES CL HA, V28, P155, DOI 10.1016/j.beha.2015.10.013; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wattam AR, 2018, METHODS MOL BIOL, V1704, P79, DOI 10.1007/978-1-4939-7463-4_4; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200	44	106	109	21	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					665	+		10.1038/s41586-019-1501-z	http://dx.doi.org/10.1038/s41586-019-1501-z			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31435014	Green Accepted			2022-12-28	WOS:000483405500056
J	Mahase, E				Mahase, Elisabeth			Stop funding expensive pneumonia vaccine, MSF urges vaccine alliance	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		MSF, 2019, GAV SHOULD STOP AW S	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2019	366								l5303	10.1136/bmj.l5303	http://dx.doi.org/10.1136/bmj.l5303			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HE	31455606				2022-12-28	WOS:000483891100004
J	Winzeler, EA				Winzeler, Elizabeth A.			A roadmap for malaria research	SCIENCE			English	Editorial Material									[Winzeler, Elizabeth A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Winzeler, EA (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	ewinzeler@ucsd.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113	NIH [5R01AI090141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH grant 5R01AI090141.	Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Howick VM, 2019, SCIENCE, V365, P774, DOI 10.1126/science.aaw2619; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Ross LS, 2019, CELL HOST MICROBE, V26, P35, DOI 10.1016/j.chom.2019.06.001; World Malaria Report WHO, WORLD MAL REP; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	7	2	2	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		753	754		10.1126/science.aay5963	http://dx.doi.org/10.1126/science.aay5963			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439782				2022-12-28	WOS:000482464000028
J	Thuijs, DJFM; Kappetein, AP; Serruys, PW; Mohr, FW; Morice, MC; Mack, MJ; Holmes, DR; Curzen, N; Davierwala, P; Noack, T; Milojevic, M; Dawkins, KD; da Costa, BR; Juni, P; Head, SJ				Thuijs, Daniel J. F. M.; Kappetein, A. Pieter; Serruys, Patrick W.; Mohr, Friedrich-Wilhelm; Morice, Marie-Claude; Mack, Michael J.; Holmes, David R., Jr.; Curzen, Nick; Davierwala, Piroze; Noack, Thilo; Milojevic, Milan; Dawkins, Keith D.; da Costa, Bruno R.; Juni, Peter; Head, Stuart J.		SYNTAX Extended Survival	Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial	LANCET			English	Article							EVEROLIMUS-ELUTING STENTS; CARDIAC-SURGERY SYNTAX; INCOMPLETE REVASCULARIZATION; POOLED ANALYSIS; OUTCOMES; SYNERGY; TAXUS; ANGIOGRAPHY; MORTALITY; CABG	Background The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-generation paclitaxel-eluting stents with coronary artery bypass grafting (CABG) in patients with de-novo three-vessel and left main coronary artery disease, and reported results up to 5 years. We now report 10-year all-cause death results. Methods The SYNTAX Extended Survival (SYNTAXES) study is an investigator-driven extension of follow-up of a multicentre, randomised controlled trial done in 85 hospitals across 18 North American and European countries. Patients with de-novo three-vessel and left main coronary artery disease were randomly assigned (1:1) to the PCI group or CABG group. Patients with a history of PCI or CABG, acute myocardial infarction, or an indication for concomitant cardiac surgery were excluded. The primary endpoint of the SYNTAXES study was 10-year all-cause death, which was assessed according to the intention-to-treat principle. Prespecified subgroup analyses were performed according to the presence or absence of left main coronary artery disease and diabetes, and according to coronary complexity defined by core laboratory SYNTAX score tertiles. This study is registered with ClinicalTrials.gov, NCT03417050. Findings From March, 2005, to April, 2007, 1800 patients were randomly assigned to the PCI (n=903) or CABG (n=897) group. Vital status information at 10 years was complete for 841 (93%) patients in the PCI group and 848 (95%) patients in the CABG group. At 10 years, 244 (27%) patients had died after PCI and 211 (24%) after CABG (hazard ratio 1.17 [95% CI 0.97-1.41], p=0.092). Among patients with three-vessel disease, 151 (28%) of 546 had died after PCI versus 113 (21%) of 549 after CABG (hazard ratio 1.41 [95% CI 1.10-1.80]), and among patients with left main coronary artery disease, 93 (26%) of 357 had died after PCI versus 98 (28%) of 348 after CABG (0.90 [0.68-1.20], P-interaction=0.019). There was no treatment-by-subgroup interaction with diabetes (P-interaction=0.66) and no linear trend across SYNTAX score tertiles (P-trend=0.30). Interpretation At 10 years, no significant difference existed in all-cause death between PCI using first-generation paclitaxel-eluting stents and CABG. However, CABG provided a significant survival benefit in patients with three-vessel disease, but not in patients with left main coronary artery disease. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Thuijs, Daniel J. F. M.; Kappetein, A. Pieter; Milojevic, Milan; Head, Stuart J.] Erasmus Univ, Dept Cardiothorac Surg, Med Ctr, NL-3015 GD Rotterdam, Netherlands; [Kappetein, A. Pieter] Medtronic, Maastricht, Netherlands; [Serruys, Patrick W.] Imperial Coll London, Dept Cardiol, London, England; [Mohr, Friedrich-Wilhelm; Davierwala, Piroze; Noack, Thilo] Heart Ctr Leipzig, Univ Dept Cardiac Surg, Leipzig, Germany; [Morice, Marie-Claude] Ramsay Gen Sante, Hop Prive Jacques Cartier, Cardiovasc Inst Paris Sud, Dept Cardiol, Massy, France; [Mack, Michael J.] Baylor Univ, Med Ctr, Dept Cardiothorac Surg, Dallas, TX USA; [Holmes, David R., Jr.] Mayo Clin, Dept Cardiovasc Dis & Internal Med, Rochester, MN USA; [Curzen, Nick] Univ Southampton, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Curzen, Nick] Univ Southampton, Sch Med, Southampton, Hants, England; [Dawkins, Keith D.] Shockwave Med Inc, Santa Clara, CA USA; [da Costa, Bruno R.; Juni, Peter] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dept Med, Toronto, ON, Canada; [da Costa, Bruno R.] Univ Bern, Inst Primary Hlth Care, Bern, Switzerland; [Head, Stuart J.] Medtronic, Minneapolis, MN USA	Erasmus University Rotterdam; Erasmus MC; Medtronic; Imperial College London; Heart Center Leipzig GMBH; Jacques Cartier Private Hospital; UDICE-French Research Universities; Universite Paris Saclay; Baylor University; Baylor University Medical Center; Mayo Clinic; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Bern; Medtronic	Thuijs, DJFM (corresponding author), Erasmus Univ, Dept Cardiothorac Surg, Med Ctr, NL-3015 GD Rotterdam, Netherlands.	d.thuijs@erasmusmc.nl	Beyersdorf, Friedhelm/AAK-3718-2020; curzen, nick/AAD-8161-2020; Noack, Thilo/AAW-6632-2021; Juni, Peter/Q-8700-2016; Milojevic, Milan/AAU-2632-2020; Stefanini, Giulio/K-7406-2016	Beyersdorf, Friedhelm/0000-0003-2975-2751; Juni, Peter/0000-0002-5985-0670; Milojevic, Milan/0000-0003-1948-9179; Sabate Tenas, Manel/0000-0002-2316-3705; Curzen, Nick/0000-0001-9651-7829; Ensminger, Stephan/0000-0002-9508-3261; CARRIE, didier/0000-0003-2479-8144; Noack, Thilo/0000-0003-0245-0147; Stefanini, Giulio/0000-0002-3558-6967; CRUZ-GONZALEZ, IGNACIO/0000-0001-9742-6072; Banning, Adrian/0000-0002-2842-7861; Bochenek, Andrzej/0000-0002-3046-3001	Boston Scientific Corporation (Marlborough, MA, USA) - German Heart Research Foundation (Frankfurt am Main, Germany)	Boston Scientific Corporation (Marlborough, MA, USA) - German Heart Research Foundation (Frankfurt am Main, Germany)	The SYNTAX trial was supported by Boston Scientific Corporation (Marlborough, MA, USA) during the first 5-years of follow-up. The SYNTAX Extended Survival study was funded by the German Heart Research Foundation (Frankfurt am Main, Germany) for 5-10 years of follow-up. We thank all research coordinators, cardiothoracic surgeons, and cardiologists at participating hospitals who contributed to the SYNTAX Extended Survival study.	Bangalore S, 2015, NEW ENGL J MED, V372, P1213, DOI 10.1056/NEJMoa1412168; Buszman PE, 2016, JACC-CARDIOVASC INTE, V9, P318, DOI 10.1016/j.jcin.2015.10.044; Doenst T, 2019, J AM COLL CARDIOL, V73, P964, DOI 10.1016/j.jacc.2018.11.053; Farkouh ME, 2019, J AM COLL CARDIOL, V73, P629, DOI 10.1016/j.jacc.2018.11.001; Farooq V, 2013, CIRCULATION, V128, P141, DOI 10.1161/CIRCULATIONAHA.113.001803; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Garcia S, 2013, J AM COLL CARDIOL, V62, P1421, DOI 10.1016/j.jacc.2013.05.033; Gersh BJ, 2005, NEW ENGL J MED, V352, P2235, DOI 10.1056/NEJMe058053; Head SJ, 2014, EUR HEART J, V35, P2821, DOI 10.1093/eurheartj/ehu213; Head SJ, 2018, LANCET, V392, P818, DOI 10.1016/S0140-6736(18)31779-3; Head SJ, 2018, LANCET, V391, P939, DOI 10.1016/S0140-6736(18)30423-9; Head SJ, 2012, JACC-CARDIOVASC INTE, V5, P618, DOI 10.1016/j.jcin.2012.02.013; Head SJ, 2012, EUR J CARDIO-THORAC, V41, P535, DOI 10.1093/ejcts/ezr105; Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Makikallio T, 2016, LANCET, V388, P2742; Milojevic M, 2016, J AM COLL CARDIOL, V67, P42, DOI 10.1016/j.jacc.2015.10.043; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Park DW, 2018, J AM COLL CARDIOL, V72, P2813, DOI 10.1016/j.jacc.2018.09.012; Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447; Serruys PW, 2019, EUROINTERVENTION, V15, pE244, DOI 10.4244/EIJ-D-18-00980; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sianos Georgios, 2005, EuroIntervention, V1, P219; Sousa-Uva M, 2019, EUR J CARDIO-THORAC, V55, P4, DOI 10.1093/ejcts/ezy289; Stefanini GG, 2013, LANCET, V382, P1879, DOI 10.1016/S0140-6736(13)61782-1; Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Zhang YJ, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0144-8	31	262	279	1	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1325	1334		10.1016/S0140-6736(19)31997-X	http://dx.doi.org/10.1016/S0140-6736(19)31997-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC9RJ	31488373				2022-12-28	WOS:000489613700027
J	Whitley, HP; Smith, WD				Whitley, Heather P.; Smith, Warren D.			Sex-based differences in medications for heart failure	LANCET			English	Editorial Material							ASPIRIN		[Whitley, Heather P.] Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, Auburn, AL 36849 USA; [Smith, Warren D.] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA; [Whitley, Heather P.] Baptist Hlth Syst, Montgomery Family Med Residency Program, Montgomery, AL 36117 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Whitley, HP (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, Auburn, AL 36849 USA.; Whitley, HP (corresponding author), Baptist Hlth Syst, Montgomery Family Med Residency Program, Montgomery, AL 36117 USA.	whitlhp@auburn.edu		Whitley, Heather/0000-0001-5124-4484				Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Cavallari LH, 2006, ANN PHARMACOTHER, V40, P812, DOI 10.1345/aph.1G569; Lam CSP, 2013, EUR J HEART FAIL, V15, P928, DOI 10.1093/eurjhf/hft045; Liu Katherine A., 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.01.708; National Institutes of Health, 1994, FED REGISTER, V59, P1408; Ouwerkerk W, 2017, EUR HEART J, V38, P1883, DOI 10.1093/eurheartj/ehx026; Pleym H, 2003, ACTA ANAESTH SCAND, V47, P241, DOI 10.1034/j.1399-6576.2003.00036.x; Rademaker M, 2001, Am J Clin Dermatol, V2, P349, DOI 10.2165/00128071-200102060-00001; Rathore SS, 2002, NEW ENGL J MED, V347, P1403, DOI 10.1056/NEJMoa021266; Santema BT, 2019, LANCET, V394, P1254, DOI 10.1016/S0140-6736(19)31792-1; U.S. Food and Drug Administration, 1993, Fed Regist, V58, P39406; Whitley HP, 2009, AM FAM PHYSICIAN, V80, P1254	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1210	1212		10.1016/S0140-6736(19)31812-4	http://dx.doi.org/10.1016/S0140-6736(19)31812-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8XK	31447115				2022-12-28	WOS:000488862500006
J	Yasuda, S; Kaikita, K; Akao, M; Ako, J; Matoba, T; Nakamura, M; Miyauchi, K; Hagiwara, N; Kimura, K; Hirayama, A; Matsui, K; Ogawa, H				Yasuda, Satoshi; Kaikita, Koichi; Akao, Masaharu; Ako, Junya; Matoba, Tetsuya; Nakamura, Masato; Miyauchi, Katsumi; Hagiwara, Nobuhisa; Kimura, Kazuo; Hirayama, Atsushi; Matsui, Kunihiko; Ogawa, Hisao		AFIRE Investigators	Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIPLATELET THERAPY; ORAL ANTICOAGULANT; JAPANESE PATIENTS; ARTERY-DISEASE; FOCUSED UPDATE; RIVAROXABAN	Background There are limited data from randomized trials evaluating the use of antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease. Methods In a multicenter, open-label trial conducted in Japan, we randomly assigned 2236 patients with atrial fibrillation who had undergone percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) more than 1 year earlier or who had angiographically confirmed coronary artery disease not requiring revascularization to receive monotherapy with rivaroxaban (a non-vitamin K antagonist oral anticoagulant) or combination therapy with rivaroxaban plus a single antiplatelet agent. The primary efficacy end point was a composite of stroke, systemic embolism, myocardial infarction, unstable angina requiring revascularization, or death from any cause; this end point was analyzed for noninferiority with a noninferiority margin of 1.46. The primary safety end point was major bleeding, according to the criteria of the International Society on Thrombosis and Hemostasis; this end point was analyzed for superiority. Results The trial was stopped early because of increased mortality in the combination-therapy group. Rivaroxaban monotherapy was noninferior to combination therapy for the primary efficacy end point, with event rates of 4.14% and 5.75% per patient-year, respectively (hazard ratio, 0.72; 95% confidence interval [CI], 0.55 to 0.95; P<0.001 for noninferiority). Rivaroxaban monotherapy was superior to combination therapy for the primary safety end point, with event rates of 1.62% and 2.76% per patient-year, respectively (hazard ratio, 0.59; 95% CI, 0.39 to 0.89; P=0.01 for superiority). Conclusions As antithrombotic therapy, rivaroxaban monotherapy was noninferior to combination therapy for efficacy and superior for safety in patients with atrial fibrillation and stable coronary artery disease. (Funded by the Japan Cardiovascular Research Foundation; AFIRE UMIN Clinical Trials Registry number, ; and ClinicalTrials.gov number, .) Patients with atrial fibrillation and stable coronary artery disease were assigned to receive either rivaroxaban monotherapy or combination therapy with rivaroxaban plus a single antiplatelet agent. At 2 years, monotherapy was noninferior to combination therapy with respect to ischemic events and superior with respect to major bleeding.	[Yasuda, Satoshi; Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Hirayama, Atsushi] Osaka Police Hosp, Dept Cardiol, Osaka, Japan; [Kaikita, Koichi] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan; [Matsui, Kunihiko] Kumamoto Univ Hosp, Dept Gen Med, Kumamoto, Japan; [Akao, Masaharu] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa, Japan; [Matoba, Tetsuya] Kyushu Univ Hosp, Dept Cardiovasc Med, Fukuoka, Fukuoka, Japan; [Nakamura, Masato] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo, Japan; [Miyauchi, Katsumi] Juntendo Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Kimura, Kazuo] Yokohama City Univ, Med Ctr, Cardiovasc Ctr, Yokohama, Kanagawa, Japan	National Cerebral & Cardiovascular Center - Japan; Osaka Police Hospital; Kumamoto University; Kumamoto University; Kitasato University; Kyushu University; Toho University; Juntendo University; Tokyo Women's Medical University; Yokohama City University	Yasuda, S (corresponding author), Natl Cerebral & Cardiovasc Ctr, Japan Cardiovasc Res Fdn, 6-1 Kishibe Shimmachi, Suita, Osaka 5658565, Japan.	yasuda.satoshi.hp@ncvc.go.jp	Kuwabara, Masanari/O-9844-2017; 将大, 田北/AAK-8626-2020	Kuwabara, Masanari/0000-0002-6601-4347; 	Japan Cardiovascular Research Foundation; AFIRE UMIN	Japan Cardiovascular Research Foundation; AFIRE UMIN	Funded by the Japan Cardiovascular Research Foundation; AFIRE UMIN Clinical Trials Registry number, UMIN000016612; and ClinicalTrials.gov number, NCT02642419.	Ancedy Y, 2016, INT J CARDIOL, V203, P987, DOI 10.1016/j.ijcard.2015.11.090; Angiolillo DJ, 2018, CIRCULATION, V138, P527, DOI 10.1161/CIRCULATIONAHA.118.034722; Angiolillo DJ, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004395; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Hicks T, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000279; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; January CT, 2019, HEART RHYTHM, V16, pE66, DOI 10.1016/j.hrthm.2019.01.024; Lamberts M, 2014, CIRCULATION, V129, P1577, DOI 10.1161/CIRCULATIONAHA.113.004834; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Matsumura-Nakano Y, 2019, CIRCULATION, V139, P604, DOI 10.1161/CIRCULATIONAHA.118.036768; Mehta SR, 2018, CAN J CARDIOL, V34, P214, DOI 10.1016/j.cjca.2017.12.012; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Tanigawa T, 2013, DRUG METAB PHARMACOK, V28, P59, DOI 10.2133/dmpk.DMPK-12-RG-034; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; van Rein N, 2019, CIRCULATION, V139, P775, DOI 10.1161/CIRCULATIONAHA.118.036248; Yasuda S, 2018, INT J CARDIOL, V265, P108, DOI 10.1016/j.ijcard.2018.04.131	19	213	213	2	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1103	1113		10.1056/NEJMoa1904143	http://dx.doi.org/10.1056/NEJMoa1904143			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ4PY	31475793	Bronze			2022-12-28	WOS:000487066900005
J	Rubin, R				Rubin, Rita			Using Telemedicine to Treat Opioid Use Disorder in Rural Areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News story discusses the use of telemedicine to treat opioid use disorder in rural areas.					Rubin, Rita/AAD-1259-2020						0	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1029	1031		10.1001/jama.2019.12574	http://dx.doi.org/10.1001/jama.2019.12574			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31461125				2022-12-28	WOS:000488821100001
J	Kampjut, D; Sazanov, LA				Kampjut, Domen; Sazanov, Leonid A.			Structure and mechanism of mitochondrial proton-translocating transhydrogenase	NATURE			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; ESCHERICHIA-COLI; HYDRIDE TRANSFER; NADP(H)-BINDING DOMAINS; CATALYTIC-PROPERTIES; CRYSTAL-STRUCTURE; PURIFICATION; VALIDATION; COMPONENTS; KINETICS	Proton-translocating transhydrogenase (also known as nicotinamide nucleotide transhydrogenase (NNT)) is found in the plasma membranes of bacteria and the inner mitochondrial membranes of eukaryotes. NNT catalyses the transfer of a hydride between NADH and NADP+, coupled to the translocation of one proton across the membrane. Its main physiological function is the generation of NADPH, which is a substrate in anabolic reactions and a regulator of oxidative status; however, NNT may also fine-tune the Krebs cycle(1,2). NNT deficiency causes familial glucocorticoid deficiency in humans and metabolic abnormalities in mice, similar to those observed in type II diabetes(3,4). The catalytic mechanism of NNT has been proposed to involve a rotation of around 180 degrees of the entire NADP(H)-binding domain that alternately participates in hydride transfer and proton-channel gating. However, owing to the lack of high-resolution structures of intact NNT, the details of this process remain unclear(5,6). Here we present the cryo-electron microscopy structure of intact mammalian NNT in different conformational states. We show how the NADP(H)-binding domain opens the proton channel to the opposite sides of the membrane, and we provide structures of these two states. We also describe the catalytically important interfaces and linkers between the membrane and the soluble domains and their roles in nucleotide exchange. These structures enable us to propose a revised mechanism for a coupling process in NNT that is consistent with a large body of previous biochemical work. Our results are relevant to the development of currently unavailable NNT inhibitors, which may have therapeutic potential in ischaemia reperfusion injury, metabolic syndrome and some cancers(7-9).	[Kampjut, Domen; Sazanov, Leonid A.] IST Austria, Klosterneuburg, Austria	Institute of Science & Technology - Austria	Sazanov, LA (corresponding author), IST Austria, Klosterneuburg, Austria.	sazanov@ist.ac.at	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989; Kampjut, Domen/0000-0002-6018-3422	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant [665385]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant	We thank R. Thompson, G. Effantin and V.-V. Hodirnau for their assistance with collecting NADP+, NADPH and apo datasets, respectively. Data processing was performed at the IST high-performance computing cluster. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement no. 665385.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bizouarn T, 2005, BBA-BIOENERGETICS, V1708, P404, DOI 10.1016/j.bbabio.2005.04.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fjellstrom O, 1999, BIOCHEMISTRY-US, V38, P415, DOI 10.1021/bi9817111; Fjellstrom O, 1997, BIOCHEMISTRY-US, V36, P11331, DOI 10.1021/bi970958f; GLAVAS NA, 1995, BBA-BIOENERGETICS, V1231, P297, DOI 10.1016/0005-2728(95)00089-2; GLAVAS NA, 1995, BIOCHEMISTRY-US, V34, P7694, DOI 10.1021/bi00023a016; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HU X, 1995, BBA-BIOENERGETICS, V1229, P64, DOI 10.1016/0005-2728(94)00187-A; HUTTON M, 1994, EUR J BIOCHEM, V219, P1041, DOI 10.1111/j.1432-1033.1994.tb18587.x; Jackson JB, 2015, FEBS LETT, V589, P2027, DOI 10.1016/j.febslet.2015.06.027; Jackson JB, 2012, BBA-BIOENERGETICS, V1817, P1839, DOI 10.1016/j.bbabio.2012.04.006; Johansson T, 2005, J MOL BIOL, V352, P299, DOI 10.1016/j.jmb.2005.07.022; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letts J. A, MOL CELL; Letts JA, 2016, J BIOL CHEM, V291, P24657, DOI 10.1074/jbc.M116.735142; Leung JH, 2015, SCIENCE, V347, P178, DOI 10.1126/science.1260451; Li S, 2018, REDOX BIOL, V18, P246, DOI 10.1016/j.redox.2018.07.017; Mather OC, 2004, BIOCHEMISTRY-US, V43, P10952, DOI 10.1021/bi0497594; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008; Obiozo UM, 2007, J BIOL CHEM, V282, P36434, DOI 10.1074/jbc.M705433200; Padayatti PS, 2017, STRUCTURE, V25, P1111, DOI 10.1016/j.str.2017.05.022; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHELPS DC, 1984, BIOCHEMISTRY-US, V23, P4475, DOI 10.1021/bi00314a037; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; Pravda L, 2018, NUCLEIC ACIDS RES, V46, pW368, DOI 10.1093/nar/gky309; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Santos LRB, 2017, MOL METAB, V6, P535, DOI 10.1016/j.molmet.2017.04.004; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; SAZANOV LA, 1995, BBA-BIOENERGETICS, V1231, P304; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Sundaresan V, 2003, BIOCHEMISTRY-US, V42, P12143, DOI 10.1021/bi035006q; TONG RCW, 1991, BIOCHIM BIOPHYS ACTA, V1080, P19, DOI 10.1016/0167-4838(91)90106-A; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Vandock KP, 2011, J MEMBRANE BIOL, V242, P89, DOI 10.1007/s00232-011-9379-1; Venning JD, 2000, J BIOL CHEM, V275, P19490, DOI 10.1074/jbc.M000577200; Venning JD, 1998, EUR J BIOCHEM, V257, P202, DOI 10.1046/j.1432-1327.1998.2570202.x; WU LNY, 1986, METHOD ENZYMOL, V126, P353; YAMAGUCHI M, 1993, J BIOL CHEM, V268, P17871; YAMAGUCHI M, 1990, BIOCHEMISTRY-US, V29, P4136, DOI 10.1021/bi00469a017; Yamaguchi M, 1997, BBA-BIOENERGETICS, V1318, P225, DOI 10.1016/S0005-2728(96)00139-9; YAMAGUCHI M, 1989, BIOCHEMISTRY-US, V28, P6050, DOI 10.1021/bi00440a049; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	55	37	38	2	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					291	+		10.1038/s41586-019-1519-2	http://dx.doi.org/10.1038/s41586-019-1519-2			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31462775				2022-12-28	WOS:000485415400061
J	Eaton, L				Eaton, Lynn			Sixty seconds on... defibrillators	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		CE Safety, 2019, SUDD CARD ARR YOU CO	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2019	366								l5338	10.1136/bmj.l5338	http://dx.doi.org/10.1136/bmj.l5338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9ID	31471282				2022-12-28	WOS:000483893700005
J	Fox, K; Hawks, J				Fox, Keolu; Hawks, John			Use ancient remains more wisely	NATURE			English	Editorial Material									[Fox, Keolu] Univ Calif San Diego, Biol Anthropol, San Diego, CA 92103 USA; [Hawks, John] Univ Wisconsin, Anthropol, Madison, WI USA	University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Fox, K (corresponding author), Univ Calif San Diego, Biol Anthropol, San Diego, CA 92103 USA.	pkfox@ucsd.edu; jhawks@wisc.edu	Hawks, John/H-5737-2015	Hawks, John/0000-0003-3187-3755				Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Casey MJ, 2018, TRUTH MACHINE BLOCKC; Claw KG, 2018, HUM BIOL, V89, P177, DOI 10.13110/humanbiology.89.3.01; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; de Leon MSP, 2018, P NATL ACAD SCI USA, V115, P4128, DOI 10.1073/pnas.1717873115; Douka K, 2017, J HUM EVOL, V107, P86, DOI 10.1016/j.jhevol.2017.03.003; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Kolodny Annette, 2012, SEARCH 1 CONTACT VIK; Korlevic P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22472-w; McGrath K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47299-x; Prendergast ME, 2019, SCIENCE, V365, P44, DOI 10.1126/science.aaw6275; Reich D, 2018, WHO WE ARE WE GOT HE; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213	13	20	21	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					581	583		10.1038/d41586-019-02516-5	http://dx.doi.org/10.1038/d41586-019-02516-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31462783	Bronze			2022-12-28	WOS:000483405500030
J	Nguyen, T				Tien Nguyen			SPORT Working out with weed	NATURE			English	Editorial Material							CANNABIS											Borgelt LM, 2013, PHARMACOTHERAPY, V33, P195, DOI 10.1002/phar.1187; Gillman AS, 2015, SPORTS MED, V45, P1357, DOI 10.1007/s40279-015-0362-3; Huestis MA, 2011, SPORTS MED, V41, P949, DOI 10.2165/11591430-000000000-00000; Le Strat Y, 2011, AM J EPIDEMIOL, V174, P929, DOI 10.1093/aje/kwr200; Powell BJ, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00003; Sparling PB, 2003, NEUROREPORT, V14, P2209, DOI 10.1097/00001756-200312020-00015; Trinh KV, 2018, CLIN J SPORT MED, V28, P350, DOI 10.1097/JSM.0000000000000471	7	2	2	4	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					S14	S15		10.1038/d41586-019-02529-0	http://dx.doi.org/10.1038/d41586-019-02529-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31462793	Bronze			2022-12-28	WOS:000483405500018
J	Kim, TH; Tsang, B; Vernon, RM; Sonenberg, N; Kay, LE; Forman-Kay, JD				Kim, Tae Hun; Tsang, Brian; Vernon, Robert M.; Sonenberg, Nahum; Kay, Lewis E.; Forman-Kay, Julie D.			Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation	SCIENCE			English	Article							NEURONAL RNA GRANULES; NMR-SPECTROSCOPY; STRESS GRANULES; PROTEIN; CONDENSATION; RECOGNITION; REVEALS; MEDIATE; COMPLEX; REGION	Membraneless organelles involved in RNA processing are biomolecular condensates assembled by phase separation. Despite the important role of intrinsically disordered protein regions (IDRs), the specific interactions underlying IDR phase separation and its functional consequences remain elusive. To address these questions, we used minimal condensates formed from the C-terminal disordered regions of two interacting translational regulators, FMRP and CAPRIN1. Nuclear magnetic resonance spectroscopy of FMRP-CAPRIN1 condensates revealed interactions involving arginine-rich and aromatic-rich regions. We found that different FMRP serine/threonine and CAPRIN1 tyrosine phosphorylation patterns control phase separation propensity with RNA, including subcompartmentalization, and tune deadenylation and translation rates in vitro. The resulting evidence for residue-specific interactions underlying co-phase separation. phosphorylation-modulated condensate architecture, and enzymatic activity within condensates has implications for how the integration of signaling pathways controls RNA processing and translation.	[Kim, Tae Hun; Tsang, Brian; Vernon, Robert M.; Kay, Lewis E.; Forman-Kay, Julie D.] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada; [Kim, Tae Hun; Tsang, Brian; Kay, Lewis E.; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kim, Tae Hun; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Kim, Tae Hun; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; McGill University; McGill University	Forman-Kay, JD (corresponding author), Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada.; Forman-Kay, JD (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	forman@sickkids.ca		Tsang, Brian/0000-0002-7615-5397; Kim, Tae Hun/0000-0002-0344-6265	CIHR Banting Postdoctoral Fellowship; Restracomp Fellowship from the Hospital for Sick Children; CIHR Vanier Scholarship; Canadian Institutes for Health Research [FDN-148375]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-06718]; Canada Research Chairs program; Canada Foundation for Innovation; Princess Margaret Cancer Foundation	CIHR Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Restracomp Fellowship from the Hospital for Sick Children; CIHR Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Princess Margaret Cancer Foundation(University of Toronto)	Supported by a CIHR Banting Postdoctoral Fellowship and a Restracomp Fellowship from the Hospital for Sick Children (T.H.K.), a CIHR Vanier Scholarship (B.T.), and Canadian Institutes for Health Research grant FDN-148375, Natural Sciences and Engineering Research Council of Canada grant RGPIN-2016-06718, and the Canada Research Chairs program (J.D.F.-K.). The 800-Hz NMR spectrometer was funded by the Canada Foundation for Innovation and the NMR Core Facility was supported by the Princess Margaret Cancer Foundation.	Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Avanzino BC, 2017, P NATL ACAD SCI USA, V114, P9611, DOI 10.1073/pnas.1704390114; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bermel W, 2006, PROG NUCL MAG RES SP, V48, P25, DOI 10.1016/j.pnmrs.2005.09.002; Bermel W, 2006, J MAGN RESON, V178, P56, DOI 10.1016/j.jmr.2005.08.011; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Brady JP, 2017, P NATL ACAD SCI USA, V114, pE8194, DOI 10.1073/pnas.1706197114; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; De Rubeis S, 2011, J NEURODEV DISORD, V3, P257, DOI 10.1007/s11689-011-9087-2; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ditlev JA, 2018, J MOL BIOL, V430, P4666, DOI 10.1016/j.jmb.2018.08.003; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hubstenberger A, 2017, MOL CELL, V68, P144, DOI 10.1016/j.molcel.2017.09.003; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; McFleder RL, 2017, CELL REP, V20, P683, DOI 10.1016/j.celrep.2017.06.078; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Nakayama K, 2017, ELIFE, V6, DOI 10.7554/eLife.29677; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pelletier J, 2019, ANNU REV BIOCHEM, V88, P307, DOI 10.1146/annurev-biochem-013118-111042; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shatsky IN, 2018, TRENDS BIOCHEM SCI, V43, P882, DOI 10.1016/j.tibs.2018.04.011; Sheu-Gruttadauria J, 2018, CELL, V173, P946, DOI 10.1016/j.cell.2018.02.051; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shirai YT, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00286; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Towers ER, 2011, J CELL SCI, V124, P1145, DOI 10.1242/jcs.076141; Tsang B, 2019, P NATL ACAD SCI USA, V116, P4218, DOI 10.1073/pnas.1814385116; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Webster MW, 2018, MOL CELL, V70, P1089, DOI 10.1016/j.molcel.2018.05.033; Wiederhold K, 2010, BIOCHEM SOC T, V38, P1531, DOI 10.1042/BST0381531; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Wu YH, 2016, ACTA CRYSTALLOGR D, V72, P718, DOI 10.1107/S2059798316004903; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020	52	125	125	9	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		825	+		10.1126/science.aax4240	http://dx.doi.org/10.1126/science.aax4240			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439799	Green Published			2022-12-28	WOS:000482464000055
J	Nishikawa, T; Matsuzawa, T; Ohta, K; Uchida, N; Nishimura, T; Ide, S				Nishikawa, T.; Matsuzawa, T.; Ohta, K.; Uchida, N.; Nishimura, T.; Ide, S.			The slow earthquake spectrum in the Japan Trench illuminated by the S-net seafloor observatories	SCIENCE			English	Article							LOW FREQUENCY EARTHQUAKES; TOHOKU-OKI EARTHQUAKE; SLIP EVENTS; PLATE BOUNDARY; SUBDUCTION; TREMOR; SANRIKU; ZONE; NUCLEATION; PARAMETERS	Investigating slow earthquake activity in subduction zones provides insight into the slip behavior of megathrusts, which can provide important clues about the rupture extent of future great earthquakes. Using the S-net ocean-bottom seismograph network along the Japan Trench, we mapped a detailed distribution of tectonic tremors, which coincided with very-low-frequency earthquakes and a slow slip event. Compiling these and other related observations, including repeating earthquakes and earthquake swarms, we found that the slow earthquake distribution is complementary to the Tohoku-Oki earthquake rupture. We used our observations to divide the megathrust in the Japan Trench into three along-strike segments characterized by different slip behaviors. We found that the rupture of the Tohoku-Oki earthquake, which nucleated in the central segment, was terminated by the two adjacent segments.	[Nishikawa, T.; Ohta, K.; Nishimura, T.] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan; [Matsuzawa, T.] Natl Res Inst Earth Sci & Disaster Resilience, Tsukuba, Ibaraki, Japan; [Uchida, N.] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi, Japan; [Uchida, N.] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi, Japan; [Ide, S.] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan	Kyoto University; National Research Institute for Earth Science & Disaster Resilience; Tohoku University; Tohoku University; University of Tokyo	Nishikawa, T (corresponding author), Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan.	nishikawa.tomoaki.68s@st.kyoto-u.ac.jp	Nishimura, Takuya/G-2789-2013; Matsuzawa, Takanori/C-1907-2018; Uchida, Naoki/D-6103-2012	Nishimura, Takuya/0000-0002-2469-8146; Matsuzawa, Takanori/0000-0003-0440-251X; Ohta, Kazuaki/0000-0002-5869-7838; Nishikawa, Tomoaki/0000-0001-5775-4565; Uchida, Naoki/0000-0002-4220-9625	JSPS KAKENHI [18J01056, 16H06477, 15K05260, 16K05536, 16H02219, 17H05418]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by JSPS KAKENHI (18J01056, 16H06477, 15K05260, 16K05536, 16H02219, and 17H05418).	Asano Y, 2008, EARTH PLANETS SPACE, V60, P871, DOI 10.1186/BF03352839; Bassett D, 2016, NATURE, V531, P92, DOI 10.1038/nature16945; Bertiger W, 2010, J GEODESY, V84, P327, DOI 10.1007/s00190-010-0371-9; Burgmann R, 2018, EARTH PLANET SC LETT, V495, P112, DOI 10.1016/j.epsl.2018.04.062; Clift P, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000127; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Dixon TH, 2014, P NATL ACAD SCI USA, V111, P17039, DOI 10.1073/pnas.1412299111; Gao X, 2017, NATURE, V543, P416, DOI 10.1038/nature21389; Holtkamp S, 2014, EARTH PLANET SC LETT, V390, P234, DOI 10.1016/j.epsl.2013.10.033; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Ide S, 2013, TECTONOPHYSICS, V600, P1, DOI 10.1016/j.tecto.2012.10.018; Ide S, 2010, NATURE, V466, P356, DOI 10.1038/nature09251; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; Iinuma T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13506; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; Ito Y, 2013, TECTONOPHYSICS, V600, P14, DOI 10.1016/j.tecto.2012.08.022; Katakami S, 2018, J GEOPHYS RES-SOL EA, V123, P9676, DOI 10.1029/2018JB016651; Kato A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24792; Kato A, 2014, GEOPHYS RES LETT, V41, P5868, DOI 10.1002/2014GL061053; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Kato N, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003001; Kawasaki I, 2001, TECTONOPHYSICS, V330, P267, DOI 10.1016/S0040-1951(00)00245-6; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI 10.1090/qam/10666; Liu X, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4396; Llenos AL, 2009, EARTH PLANET SC LETT, V281, P59, DOI 10.1016/j.epsl.2009.02.011; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Marsan D, 2013, J GEOPHYS RES-SOL EA, V118, P4900, DOI 10.1002/jgrb.50323; Matsuzawa T, 2015, GEOPHYS RES LETT, V42, P4318, DOI 10.1002/2015GL063959; Miyaoka K., 2012, ZISIN, V65, P205, DOI [10.4294/zisin.65.205, DOI 10.4294/ZISIN.65.205]; Mochizuki K, 2008, SCIENCE, V321, P1194, DOI 10.1126/science.1160250; Nadeau RM, 1998, B SEISMOL SOC AM, V88, P790; Nakajima J, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006101; Nishikawa T, 2018, J GEOPHYS RES-SOL EA, V123, P7950, DOI 10.1029/2018JB015642; Nishimura T, 2004, GEOPHYS J INT, V157, P901, DOI 10.1111/j.1365-246X.2004.02159.x; Nishimura T, 2014, PROG EARTH PLANET SC, V1, DOI 10.1186/s40645-014-0022-5; Nishimura T, 2013, J GEOPHYS RES-SOL EA, V118, P3112, DOI 10.1002/jgrb.50222; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2016, SCIENCE, V353, P253, DOI 10.1126/science.aaf1512; Ohta K, 2019, GEOPHYS RES LETT, V46, P4591, DOI 10.1029/2019GL082468; Reverso T, 2015, EARTH PLANET SC LETT, V412, P25, DOI 10.1016/j.epsl.2014.12.012; Rolandone F, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao6596; Ruiz S, 2014, SCIENCE, V345, P1165, DOI 10.1126/science.1256074; Shibazaki B, 2007, GEOPHYS J INT, V171, P191, DOI 10.1111/j.1365-246X.2007.03434.x; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Socquet A, 2017, GEOPHYS RES LETT, V44, P4046, DOI 10.1002/2017GL073023; Tanaka S, 2019, GEOPHYS RES LETT, V46, P5217, DOI 10.1029/2019GL082817; Tanioka Y, 1996, GEOPHYS RES LETT, V23, P1549, DOI 10.1029/96GL01479; Tsuru T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001664; Uchida N, 2004, TECTONOPHYSICS, V385, P1, DOI 10.1016/j.tecto.2004.04.015; Uchida N, 2016, SCIENCE, V351, P488, DOI 10.1126/science.aad3108; Uchida N, 2013, EARTH PLANET SC LETT, V374, P81, DOI 10.1016/j.epsl.2013.05.021; Ueno H., 2002, Q J SEISMOL, V65, P123; Wang KL, 2014, TECTONOPHYSICS, V610, P1, DOI 10.1016/j.tecto.2013.11.024; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Zhuang J, 2002, J AM STAT ASSOC, V97, P369, DOI 10.1198/016214502760046925	55	87	87	6	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		808	+		10.1126/science.aax5618	http://dx.doi.org/10.1126/science.aax5618			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439795				2022-12-28	WOS:000482464000051
J	Noe, F; Olsson, S; Kohler, J; Wu, H				Noe, Frank; Olsson, Simon; Koehler, Jonas; Wu, Hao			Boltzmann generators: Sampling equilibrium states of many-body systems with deep learning	SCIENCE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; MONTE-CARLO METHOD; FREE-ENERGY; TRANSITION; DYNAMICS	Computing equilibrium states in condensed-matter many-body systems, such as solvated proteins, is a long-standing challenge. Lacking methods for generating statistically independent equilibrium samples in "one shot:" vast computational effort is invested for simulating these systems in small steps, e.g., using molecular dynamics. Combining deep learning and statistical mechanics, we developed Boltzmann generators, which are shown to generate unbiased one-shot equilibrium samples of representative condensed-matter systems and proteins. Boltzmann generators use neural networks to learn a coordinate transformation of the complex configurational equilibrium distribution to a distribution that can be easily sampled. Accurate computation of free-energy differences and discovery of new configurations are demonstrated, providing a statistical mechanics tool that can avoid rare events during sampling without prior knowledge of reaction coordinates.	[Noe, Frank; Olsson, Simon; Koehler, Jonas; Wu, Hao] FU Berlin, Dept Math & Comp Sci, Arnimallee 6, D-14195 Berlin, Germany; [Noe, Frank] FU Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany; [Noe, Frank] Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA; [Wu, Hao] Tongji Univ, Sch Math Sci, Shanghai 200092, Peoples R China	Free University of Berlin; Free University of Berlin; Rice University; Tongji University	Noe, F (corresponding author), FU Berlin, Dept Math & Comp Sci, Arnimallee 6, D-14195 Berlin, Germany.; Noe, F (corresponding author), FU Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany.; Noe, F (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.	frank.noe@fu-berlin.de	Olsson, Simon/O-5804-2019	Olsson, Simon/0000-0002-3927-7897; Wu, Hao/0000-0002-2170-0618; Noe, Frank/0000-0003-4169-9324; Kohler, Jonas/0000-0002-7256-2892	European Commission [ERC CoG 772230]; Deutsche Forschungsgemeinschaft [CRC1114/A04, GRK2433 DAEDALUS]; MATH+ Berlin Mathematics Research Center [AA1x8, EF1x2]; Alexander von Humboldt Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MATH+ Berlin Mathematics Research Center; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We acknowledge funding from the European Commission (ERC CoG 772230 "ScaleCell"), the Deutsche Forschungsgemeinschaft (CRC1114/A04, GRK2433 DAEDALUS), the MATH+ Berlin Mathematics Research Center (AA1x8, EF1x2), and the Alexander von Humboldt Foundation (postdoctoral fellowship to S.O.)	Abadi M., 2016, TENSORFLOW LARGE SCA; Behler J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.146401; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Chen M, 2015, P NATL ACAD SCI USA, V112, P3235, DOI 10.1073/pnas.1418241112; Dinh Laurent, 2015, P 3 INT C LEARN REPR; Dinh Laurent, 2016, ARXIV160508803; Eastman P, 2013, J CHEM THEORY COMPUT, V9, P461, DOI 10.1021/ct300857j; FRENKEL D, 1984, J CHEM PHYS, V81, P3188, DOI 10.1063/1.448024; Frenkel D., 2001, UNDERSTANDING MOL SI, DOI [10.1038/nature14539, DOI 10.1038/NATURE14539]; Frenkel D.D., 1996, UNDERSTANDING MOL SI, DOI DOI 10.1016/B978-012267351-1/50003-; Gomez-Bombarelli R, 2018, ACS CENTRAL SCI, V4, P268, DOI 10.1021/acscentsci.7b00572; Goodfellow I, 2020, COMMUN ACM, V63, P139, DOI 10.1145/3422622; Grathwohl W., 2018, ARXIV 1810 01367; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893; Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432; HOOVER WG, 1968, J CHEM PHYS, V49, P3609, DOI 10.1063/1.1670641; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; Karras T., 2018, P 7 INT C LEARN REPR; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Kingma D. P., 2018, NIPS 18 P 31 INT C N; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Klimovich PV, 2015, J COMPUT AID MOL DES, V29, P397, DOI 10.1007/s10822-015-9840-9; Kuhn H, 1955, NAV RES LOGIST Q, V2, P83, DOI [10.1002/nav.3800020109, DOI 10.1002/NAV.3800020109]; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Nilmeier JP, 2011, P NATL ACAD SCI USA, V108, pE1009, DOI 10.1073/pnas.1106094108; Noe F, 2021, BOLTZMANN GENERATORS, DOI [10.5281/zenodo.3242635, DOI 10.5281/ZENODO.3242635]; Noe F, 2017, CURR OPIN STRUC BIOL, V43, P141, DOI 10.1016/j.sbi.2017.02.006; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Perez-Hernandez G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811489; Rackers JA, 2018, J CHEM THEORY COMPUT, V14, P5273, DOI 10.1021/acs.jctc.8b00529; Rezende DJ, 2015, PR MACH LEARN RES, V37, P1530; Rupp M, 2012, PHYS REV LETT, V108, DOI [10.1103/PhysRevLett.108.236402, 10.1103/PhysRevLett.108.058301]; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Scherer MK, 2015, J CHEM THEORY COMPUT, V11, P5525, DOI 10.1021/acs.jctc.5b00743; Schutt K., 2007, ADV NEURAL INF PROCE, V30, P992; Schutt K., 2017, ADV NEURAL INFORM PR, V30, P992; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Smith JS, 2017, CHEM SCI, V8, P3192, DOI 10.1039/c6sc05720a; Tabak EG, 2010, COMMUN MATH SCI, V8, P217; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; van den Oord A., 2018, P 35 INT C MACH LEAR; WANG CC, 1986, PHYS REV LETT, V57, P1647, DOI 10.1103/PhysRevLett.57.1647; Wang J, 2019, ACS CENTRAL SCI, V5, P755, DOI 10.1021/acscentsci.8b00913; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; Ytreberg FM, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2174008; Zhu ZW, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.100201	50	199	200	12	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1001	+	eaaw1147	10.1126/science.aaw1147	http://dx.doi.org/10.1126/science.aaw1147			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488660	Green Submitted			2022-12-28	WOS:000484732700040
J	Shlesinger, T; Loya, Y				Shlesinger, Tom; Loya, Yossi			Breakdown in spawning synchrony: A silent threat to coral persistence	SCIENCE			English	Article							CLIMATE-CHANGE; REPRODUCTIVE PATTERNS; SCLERACTINIAN CORALS; PHENOLOGY; ECOLOGY; SHIFTS	The impacts of human and natural disturbances on coral reefs are typically quantified through visible damage (e.g., reduced coral coverage as a result of bleaching events), but changes in environmental conditions may also cause damage in less visible ways. Despite the current paradigm, which suggests consistent, highly synchronized spawning events, corals that reproduce by broadcast spawning are particularly vulnerable because their reproductive phenology is governed by environmental cues. Here, we quantify coral spawning intensity during four annual reproductive seasons, alongside laboratory analyses at the polyp, colony, and population levels, and we demonstrate that, compared with historical data, several species from the Red Sea have lost their reproductive synchrony. Ultimately, such a synchrony breakdown reduces the probability of successful fertilization, leading to a dearth of new recruits, which may drive aging populations to extinction.	[Shlesinger, Tom; Loya, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Zool, IL-69978 Tel Aviv, Israel	Tel Aviv University	Shlesinger, T (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Sch Zool, IL-69978 Tel Aviv, Israel.	tomshlez@gmail.com	Loya, Joseph/AAJ-9014-2020; Loya, Yossi/J-3039-2012; Shlesinger, Tom/I-9535-2019	Loya, Yossi/0000-0001-6870-9444; Shlesinger, Tom/0000-0003-1977-8421	Israel Science Foundation (ISF) [1191/16]; Israel Taxonomy Initiative; Rieger Foundation; PADI Foundation; IUI	Israel Science Foundation (ISF)(Israel Science Foundation); Israel Taxonomy Initiative; Rieger Foundation; PADI Foundation; IUI	This study was funded by Israel Science Foundation (ISF) grant no. 1191/16 to Y.L. and doctoral grants from the Israel Taxonomy Initiative, Rieger Foundation, PADI Foundation, and IUI to T. S.	Armoza-Zvuloni R, 2012, MAR POLLUT BULL, V64, P1556, DOI 10.1016/j.marpolbul.2012.05.020; Asch RG, 2015, P NATL ACAD SCI USA, V112, pE4065, DOI 10.1073/pnas.1421946112; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bak RPM, 1999, AM ZOOL, V39, P56; Fogarty ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030486; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Foster T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03175-2; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Jamodiong EA, 2018, ZOOL STUD, V57, DOI 10.6620/ZS.2018.57-46; Kaniewska P, 2015, ELIFE, V4, DOI 10.7554/eLife.09991; Keith SA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0011; Levitan DR, 2014, MAR ECOL PROG SER, V515, P1, DOI 10.3354/meps11063; Levitan DR, 2011, EVOLUTION, V65, P1254, DOI 10.1111/j.1558-5646.2011.01235.x; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Loya Y, 2004, CORAL HEALTH AND DISEASE, P1; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Nozawa Y, 2015, CORAL REEFS, V34, P1199, DOI 10.1007/s00338-015-1338-3; Nozawa Y, 2012, BIOL BULL-US, V222, P192, DOI 10.1086/BBLv222n3p192; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Porte C, 2006, COMP BIOCHEM PHYS C, V143, P303, DOI 10.1016/j.cbpc.2006.03.004; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rapuano H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42670; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Shaked Y., 2018, SCI REPORT YEAR 2017; Shlesinger T, 2018, ECOLOGY, V99, P421, DOI 10.1002/ecy.2098; Shlesinger T, 2016, CORAL REEFS, V35, P1357, DOI 10.1007/s00338-016-1468-2; Shlesinger Y, 1998, MAR BIOL, V132, P691, DOI 10.1007/s002270050433; SHLESINGER Y, 1985, SCIENCE, V228, P1333, DOI 10.1126/science.228.4705.1333; Sweeney AM, 2011, J EXP BIOL, V214, P770, DOI 10.1242/jeb.043406; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Tamir R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42329; Tarrant AM, 2004, MAR ECOL PROG SER, V269, P121, DOI 10.3354/meps269121; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; van Woesik R, 2010, P R SOC B, V277, P715, DOI 10.1098/rspb.2009.1524; Vargas-Angel B, 2006, CORAL REEFS, V25, P110, DOI 10.1007/s00338-005-0070-9; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x	41	58	58	8	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1002	+		10.1126/science.aax0110	http://dx.doi.org/10.1126/science.aax0110			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488683				2022-12-28	WOS:000484732700041
J	Rosenbaum, L				Rosenbaum, Lisa			Perilous Politics - Morbidity and Mortality in the Pre-Roe Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Aiken ARA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2011; BARTLETT RH, 1969, NEW ENGL J MED, V281, P747, DOI 10.1056/NEJM196910022811401; Khazan O., 2018, ATLANTIC; Stone Lombardi K., 1996, NY TIMES	4	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					893	895		10.1056/NEJMp1910010	http://dx.doi.org/10.1056/NEJMp1910010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IW9PR	31483960	Bronze			2022-12-28	WOS:000485326200002
J	Solis, AG; Bielecki, P; Steach, HR; Sharma, L; Harman, CCD; Yun, S; de Zoete, MR; Warnock, JN; To, SDF; York, AG; Mack, M; Schwartz, MA; Dela Cruz, CS; Palm, NW; Jackson, R; Flavell, RA				Solis, Angel G.; Bielecki, Piotr; Steach, Holly R.; Sharma, Lokesh; Harman, Christian C. D.; Yun, Sanguk; de Zoete, Marcel R.; Warnock, James N.; To, S. D. Filip; York, Autumn G.; Mack, Matthias; Schwartz, Martin A.; Dela Cruz, Charles. S.; Palm, Noah W.; Jackson, Ruaidhri; Flavell, Richard A.			Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity	NATURE			English	Article							ENDOTHELIN-1 GENE; HYPOXIA; EXPRESSION; SIGNAL; MECHANOTRANSDUCTION; MACROPHAGES; MECHANISMS; RECEPTORS; SUCCINATE; FIBROSIS	Direct recognition of invading pathogens by innate immune cells is a critical driver of the inflammatory response. However, cells of the innate immune system can also sense their local microenvironment and respond to physiological fluctuations in temperature, pH, oxygen and nutrient availability, which are altered during inflammation. Although cells of the immune system experience force and pressure throughout their life cycle, little is known about how these mechanical processes regulate the immune response. Here we show that cyclical hydrostatic pressure, similar to that experienced by immune cells in the lung, initiates an inflammatory response via the mechanically activated ion channel PIEZO1. Mice lacking PIEZO1 in innate immune cells showed ablated pulmonary inflammation in the context of bacterial infection or fibrotic autoinflammation. Our results reveal an environmental sensory axis that stimulates innate immune cells to mount an inflammatory response, and demonstrate a physiological role for PIEZO1 and mechanosensation in immunity.	[Solis, Angel G.; Bielecki, Piotr; Steach, Holly R.; York, Autumn G.; Palm, Noah W.; Jackson, Ruaidhri; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Sharma, Lokesh; Dela Cruz, Charles. S.] Yale Sch Med, Dept Internal Med Pulm Crit Care & Sleep Med, New Haven, CT USA; [Harman, Christian C. D.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Yun, Sanguk; Schwartz, Martin A.] Yale Univ, Dept Internal Med Cardiol, Yale Cardiovasc Res Ctr, New Haven, CT USA; [Yun, Sanguk; Schwartz, Martin A.] Yale Univ, Dept Cell Biol, Yale Cardiovasc Res Ctr, New Haven, CT USA; [Yun, Sanguk; Schwartz, Martin A.] Yale Univ, Yale Cardiovasc Res Ctr, Dept Biomed Engn, New Haven, CT USA; [de Zoete, Marcel R.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Warnock, James N.] Univ Georgia, Sch Chem Mat & Biomed Engn, Athens, GA 30602 USA; [To, S. D. Filip] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med Nephrol 2, Regensburg, Germany; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Utrecht University; University System of Georgia; University of Georgia; Mississippi State University; University of Regensburg; Howard Hughes Medical Institute; Yale University	Jackson, R; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Flavell, RA (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA.	ruaidhri.jackson@yale.edu; richard.flavell@yale.edu	de Zoete, Marcel/ABA-7918-2021	Palm, Noah/0000-0001-7262-9455; Sharma, Lokesh/0000-0003-3040-9029; Steach, Holly/0000-0003-0018-3129; de Zoete, Marcel/0000-0002-6561-5810; Warnock, James/0000-0003-0323-2504	Howard Hughes Medical Institute; Blavatnik Family Foundation; Searle Scholars Program; Leukemia Research Foundation; Gruber Foundation; NIH [T32 GM007499, HL RO1 75092, R01GM122984]; Crohn's and Colitis Foundation; American Society for Microbiology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499, R01GM122984] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Blavatnik Family Foundation; Searle Scholars Program; Leukemia Research Foundation; Gruber Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; American Society for Microbiology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Alderman, C. Lieber, C. Hughes, E.H.-P. and P. Rainey for help in facilitating this work; B. Kazmierczak for providing the P. aeruginosa; M. Roulis for insightful comments and reagents; L. Orr for helpful insight regarding statistical analysis; I. Odell for help with computational software; C. Rothlin and Dr. C. Abraham for continued support and feedback as this work progressed; P.-M. Chen for help and reagents related to hypoxia studies. This work was supported by the Howard Hughes Medical Institute and the Blavatnik Family Foundation (R.A.F.). This work was supported in part by the Searle Scholars Program, the Leukemia Research Foundation, the Gruber Foundation and the NIH (R01GM122984). R. J. was supported in part by the Crohn's and Colitis Foundation. M.A.S. was supported by the NIH (HL RO1 75092). A.G.S. was supported in part by an NIH training grant (T32 GM007499) and the American Society for Microbiology.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Abshire MY, 2011, J LEUKOCYTE BIOL, V89, P251, DOI 10.1189/jlb.0710395; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Bassotti G, 2014, WORLD J GASTROENTERO, V20, P37, DOI 10.3748/wjg.v20.i1.37; Cheng TH, 2001, J MOL CELL CARDIOL, V33, P1805, DOI 10.1006/jmcc.2001.1444; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Glogowska E, 2017, BLOOD, V130, P1845, DOI 10.1182/blood-2017-05-786004; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hsiai TK, 2003, FASEB J, V17, P1648, DOI 10.1096/fj.02-1064com; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Li MX, 2012, FEBS LETT, V586, P3888, DOI 10.1016/j.febslet.2012.08.036; Lindsey AS, 2019, PULM CIRC, V9, DOI 10.1177/2045894019826941; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; McWhorter FY, 2015, CELL MOL LIFE SCI, V72, P1303, DOI 10.1007/s00018-014-1796-8; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Murthy SE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9897; Novak J, 2004, OPT LETT, V29, P77, DOI 10.1364/OL.29.000077; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Phillips JE, 2012, PULM PHARMACOL THER, V25, P281, DOI 10.1016/j.pupt.2011.10.001; Pritchard MT, 2005, J LEUKOCYTE BIOL, V78, P630, DOI 10.1189/jlb.0404220; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; Schipke KJ, 2011, JOVE-J VIS EXP, DOI 10.3791/3316; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Wu J, 2017, CELL REP, V21, P2357, DOI 10.1016/j.celrep.2017.10.120; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102	40	177	186	20	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					69	+		10.1038/s41586-019-1485-8	http://dx.doi.org/10.1038/s41586-019-1485-8			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31435009	Green Accepted			2022-12-28	WOS:000483967700036
J	Rimmer, A				Rimmer, Abi			Almost half of consultant anaesthetists have had a car accident or near miss on their commute home because of fatigue	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, NATL SURVEY OUT HOUR, DOI [10.1111/anae.14819, DOI 10.1111/ANAE.14819]	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5341	10.1136/bmj.l5341	http://dx.doi.org/10.1136/bmj.l5341			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481414				2022-12-28	WOS:000485434400004
J	Merten, M				Merten, Martina			Polio: getting ready for the day after eradication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												info@martina-merten.de						[Anonymous], 2019, B CHIPS PROGRAMME; Bahl S, 2018, INDIAN J PEDIATR, V85, P124, DOI 10.1007/s12098-017-2586-8; Khan F, 2018, MMWR-MORBID MORTAL W, V67, P524, DOI 10.15585/mmwr.mm6718a4; McKinsey, 2016, ER POL NIG; Touray K, 2016, J INFECT DIS, V213, pS67, DOI 10.1093/infdis/jiv493	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2019	366								l5235	10.1136/bmj.l5235	http://dx.doi.org/10.1136/bmj.l5235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DN	31444165				2022-12-28	WOS:000482882800004
J	Wan, L; Essuman, K; Anderson, RG; Sasaki, Y; Monteiro, F; Chung, EH; Nishimura, EO; DiAntonio, A; Milbrandt, J; Dangl, JL; Nishimura, MT				Wan, Li; Essuman, Kow; Anderson, Ryan G.; Sasaki, Yo; Monteiro, Freddy; Chung, Eui-Hwan; Nishimura, Erin Osborne; DiAntonio, Aaron; Milbrandt, Jeffrey; Dangl, Jeffery L.; Nishimura, Marc T.			TIR domains of plant immune receptors are NAD(+)-cleaving enzymes that promote cell death	SCIENCE			English	Article							STRUCTURAL BASIS; CALCIUM; EDS1	Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors activate cell death and confer disease resistance by unknown mechanisms. We demonstrate that plant Toll/interleukin-1 receptor (TIR) domains of NLRs are enzymes capable of degrading nicotinamide adenine dinucleotide in its oxidized form (NAD(+)). Both cell death induction and NAD(+)cleavage activity of plant TIR domains require known self-association interfaces and a putative catalytic glutamic acid that is conserved in both bacterial TIR NAD(+)-cleaving enzymes (NADases) and the mammalian SARM1 (sterile alpha and TIR motif containing 1) NADase. We identify a variant of cyclic adenosine diphosphate ribose as a biomarker of TIR enzymatic activity. TIR enzymatic activity is induced by pathogen recognition and functions upstream of the genes enhanced disease susceptibility 1 (EDS1) and N requirement gene 1 (NRGI), which encode regulators required for TIR immune function. Thus, plant TIR-NLR receptors require NADase function to transduce recognition of pathogens into a cell death response.	[Wan, Li; Anderson, Ryan G.; Monteiro, Freddy; Chung, Eui-Hwan; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Wan, Li; Anderson, Ryan G.; Monteiro, Freddy; Chung, Eui-Hwan; Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Essuman, Kow; Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Monteiro, Freddy] CSIC IRTA UAB UB, CRAG, Barcelona 08193, Spain; [Nishimura, Erin Osborne] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [DiAntonio, Aaron; Milbrandt, Jeffrey] Washington Univ, Sch Med, Needleman Ctr Neurometab & Axonal Therapeut, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA; [Nishimura, Marc T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Colorado State University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Colorado State University	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.; Dangl, JL (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.; Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.; Milbrandt, J (corresponding author), Washington Univ, Sch Med, Needleman Ctr Neurometab & Axonal Therapeut, St Louis, MO 63110 USA.; Milbrandt, J (corresponding author), Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA.; Nishimura, MT (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	jmilbrandt@wustl.edu; jdangl@email.unc.edu; marcusn@colostate.edu	Monteiro, Freddy/E-4043-2019	Monteiro, Freddy/0000-0002-9080-6715; Dangl, Jeffery/0000-0003-3199-8654; DiAntonio, Aaron/0000-0002-7262-0968; Chung, Eui-Hwan/0000-0002-5048-8142; Essuman, Kow/0000-0002-6781-7248; Milbrandt, Jeffrey/0000-0002-5477-7689; Nishimura, Marc Tad/0000-0003-4666-6900; Osborne Nishimura, Erin/0000-0002-4313-4573	National Science Foundation [IOS-1758400]; National Institutes of Health [GM107444, RF1AG013730, R01NS087632]; Colorado State University; NIH Ruth L. Kirschstein NRSA fellowship [F32GM108226]; Gordon and Betty Moore Foundation [GBMF4725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124877, R01GM107444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG013730, R01AG013730] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University; NIH Ruth L. Kirschstein NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Science Foundation (grant IOS-1758400 to J.L.D. and M.T.N.) and National Institutes of Health (grants GM107444 to J.L.D., RF1AG013730 to J.M., and R01NS087632 to J.M. and A.D.). J.L.D. is a Howard Hughes Medical Institute (HHMI) Investigator. M.T.N. was supported by startup funds from Colorado State University. R.G.A. was supported by an NIH Ruth L. Kirschstein NRSA fellowship (F32GM108226). K.E. was an HHMI Medical Research Fellow. F.M. is supported by a grant from the Gordon and Betty Moore Foundation (GBMF4725) to the Two Blades Foundation.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Demarest TG, 2019, ANNU REV CANC BIOL, V3, P105, DOI 10.1146/annurev-cancerbio-030518-055905; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Huh SU, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006376; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Nishimura MT, 2017, P NATL ACAD SCI USA, V114, pE2053, DOI 10.1073/pnas.1620973114; Pajuelo D, 2018, CELL REP, V24, P429, DOI 10.1016/j.celrep.2018.06.042; Qi T, 2018, P NATL ACAD SCI USA, V115, pE10979, DOI 10.1073/pnas.1814856115; Schreiber KJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005769; Shao ZQ, 2016, PLANT PHYSIOL, V170, P2095, DOI 10.1104/pp.15.01487; Shidore T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006442; Tang JY, 2018, J BIOL CHEM, V293, P1504, DOI 10.1074/jbc.RA117.000178; Wagner S, 2013, CELL HOST MICROBE, V14, P619, DOI 10.1016/j.chom.2013.11.006; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Zhang XX, 2017, ANNU REV PHYTOPATHOL, V55, P205, DOI 10.1146/annurev-phyto-080516-035250	24	187	192	14	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		799	+		10.1126/science.aax1771	http://dx.doi.org/10.1126/science.aax1771			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439793	Green Accepted, Green Submitted			2022-12-28	WOS:000482464000049
J	Ekelund, U; Tarp, J; Steene-Johannessen, J; Hansen, BH; Jefferis, B; Fagerland, MW; Whincup, P; Diaz, KM; Hooker, SP; Chernofsky, A; Larson, MG; Spartano, N; Vasan, RS; Dohrn, IM; Hagstromer, M; Edwardson, C; Yates, T; Shiroma, E; Anderssen, SA; Lee, IM				Ekelund, Ulf; Tarp, Jakob; Steene-Johannessen, Jostein; Hansen, Bjorge H.; Jefferis, Barbara; Fagerland, Morten W.; Whincup, Peter; Diaz, Keith M.; Hooker, Steven P.; Chernofsky, Ariel; Larson, Martin G.; Spartano, Nicole; Vasan, Ramachandran S.; Dohrn, Ing-Mari; Hagstromer, Maria; Edwardson, Charlotte; Yates, Thomas; Shiroma, Eric; Anderssen, Sigmund A.; Lee, I-Min			Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BEHAVIOR; DISEASE; ADULTS; RISK	OBJECTIVE To examine the dose-response associations between accelerometer assessed total physical activity, different intensities of physical activity, and sedentary time and all cause mortality. DESIGN Systematic review and harmonised meta-analysis. DATA SOURCES PubMed, PsycINFO, Embase, Web of Science, Sport Discus from inception to 31 July 2018. ELIGIBILITY CRITERIA Prospective cohort studies assessing physical activity and sedentary time by accelerometry and associations with all cause mortality and reported effect estimates as hazard ratios, odds ratios, or relative risks with 95% confidence intervals. DATA EXTRACTION AND ANALYSIS Guidelines for meta-analyses and systematic reviews for observational studies and PRISMA guidelines were followed. Two authors independently screened the titles and abstracts. One author performed a full text review and another extracted the data. Two authors independently assessed the risk of bias. Individual level participant data were harmonised and analysed at study level. Data on physical activity were categorised by quarters at study level, and study specific associations with all cause mortality were analysed using Cox proportional hazards regression analyses. Study specific results were summarised using random effects meta-analysis. MAIN OUTCOME MEASURE All cause mortality. RESULTS 39 studies were retrieved for full text review; 10 were eligible for inclusion, three were excluded owing to harmonisation challenges (eg, wrist placement of the accelerometer), and one study did not participate. Two additional studies with unpublished mortality data were also included. Thus, individual level data from eight studies (n=36 383; mean age 62.6 years; 72.8% women), with median follow-up of 5.8 years (range 3.0-14.5 years) and 2149 (5.9%) deaths were analysed. Any physical activity, regardless of intensity, was associated with lower risk of mortality, with a non-linear dose-response. Hazards ratios for mortality were 1.00 (referent) in the first quarter (least active), 0.48 (95% confidence interval 0.43 to 0.54) in the second quarter, 0.34 (0.26 to 0.45) in the third quarter, and 0.27 (0.23 to 0.32) in the fourth quarter (most active). Corresponding hazards ratios for light physical activity were 1.00, 0.60 (0.54 to 0.68), 0.44 (0.38 to 0.51), and 0.38 (0.28 to 0.51), and for moderate-to-vigorous physical activity were 1.00, 0.64 (0.55 to 0.74), 0.55 (0.40 to 0.74), and 0.52 (0.43 to 0.61). For sedentary time, hazards ratios were 1.00 (referent; least sedentary), 1.28 (1.09 to 1.51), 1.71 (1.36 to 2.15), and 2.63 (1.94 to 3.56). CONCLUSION Higher levels of total physical activity, at any intensity, and less time spent sedentary, are associated with substantially reduced risk for premature mortality, with evidence of a non-linear dose-response pattern in middle aged and older adults.	[Ekelund, Ulf; Tarp, Jakob; Steene-Johannessen, Jostein; Hansen, Bjorge H.; Anderssen, Sigmund A.] Norwegian Sch Sport Sci, Dept Sports Med, POB 4014, N-0806 Oslo, Norway; [Ekelund, Ulf] Norwegian Inst Publ Hlth, Dept Chron Dis & Ageing, Oslo, Norway; [Jefferis, Barbara] UCL, Inst Epidemiol & Hlth Care, Dept Primary Care & Populat Hlth, London, England; [Fagerland, Morten W.] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Whincup, Peter] St Georges Univ London, Populat Hlth Res Inst, London, England; [Diaz, Keith M.] Columbia Univ, Dept Med, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY USA; [Hooker, Steven P.] San Diego State Univ, Coll Hlth & Human Serv, San Diego, CA 92182 USA; [Chernofsky, Ariel; Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Spartano, Nicole] Boston Univ, Sch Med, Dept Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Dohrn, Ing-Mari; Hagstromer, Maria] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Hagstromer, Maria] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Edwardson, Charlotte; Yates, Thomas] Karolinska Univ Hosp, Funct Area Occupat Therapy & Physiotherapy, Allied Hlth Profess, Stockholm, Sweden; [Edwardson, Charlotte; Yates, Thomas] Univ Leicester, Coll Life Sci, Diabet Res Ctr, Leicester, Leics, England; [Edwardson, Charlotte; Yates, Thomas] Univ Leicester, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Shiroma, Eric] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Lee, I-Min] NIA, Neuroepidemiol Sect, NIH, Bethesda, MD 20892 USA; [Lee, I-Min] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Lee, I-Min] Harvard Med Sch, Boston, MA 02115 USA; Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Norwegian School of Sport Sciences; Norwegian Institute of Public Health (NIPH); University of London; University College London; University of Oslo; St Georges University London; Columbia University; California State University System; San Diego State University; Boston University; Boston University; Boston University; Boston University; Boston University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Ekelund, U (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, POB 4014, N-0806 Oslo, Norway.; Ekelund, U (corresponding author), Norwegian Inst Publ Hlth, Dept Chron Dis & Ageing, Oslo, Norway.	Ulf.ekelund@nih.no	Shiroma, Eric/AAV-5487-2021; Jefferis, Barbara/AAE-5186-2020; Ekelund, Ulf/AAE-8471-2019; Dohrn, Ing-Mari/AAC-9940-2019; Lee, I-Min/ABD-5409-2021; Ramachandran, Vasan/Y-2527-2019	Shiroma, Eric/0000-0003-4920-2642; Jefferis, Barbara/0000-0002-0850-3177; Ekelund, Ulf/0000-0003-2115-9267; Ramachandran, Vasan/0000-0001-7357-5970; Diaz, Keith/0000-0003-0190-0548; Hooker, Steven/0000-0001-9969-6244; Whincup, Peter/0000-0002-5589-4107; Dohrn, Ing-Mari/0000-0003-2593-550X; Tarp, Jakob/0000-0002-9186-7077; Yates, Thomas/0000-0002-5724-5178; Edwardson, Charlotte/0000-0001-6485-9330	Stockholm County Council; Swedish National Centre for Research in Sports; European Union; Folksam Research Foundation, Sweden - British Heart Foundation [PG/13/86/30546, RG/13/16/30528]; National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI) [N01-HC25195]; Health and Human Services [N268201500001I, R01-AG047645, R01-HL131029]; American Heart Association [15GPSGC24800006]; Norwegian Directorate for Public Health; Norwegian School of Sport Sciences - Research Council of Norway [249932/F20, U01-NS041588, R01-NS061846]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health; Coca-Cola Company; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East Midlands - National Institutes of Health (NIH) [CA154647, CA047988, CA182913, HL043851, HL080467, HL099355]; British Heart Foundation [RG/13/16/30528] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA182913, U01CA182913] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131029] Funding Source: NIH RePORTER	Stockholm County Council(Stockholm County Council); Swedish National Centre for Research in Sports; European Union(European Commission); Folksam Research Foundation, Sweden - British Heart Foundation; National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Health and Human Services; American Heart Association(American Heart Association); Norwegian Directorate for Public Health; Norwegian School of Sport Sciences - Research Council of Norway; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Coca-Cola Company; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East Midlands - National Institutes of Health (NIH); British Heart Foundation(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	There was no specific funding for this work. The individual studies contributing to this harmonised meta-analysis were funded: the ABC-study was funded by Stockholm County Council, Swedish National Centre for Research in Sports, and project ALPHA, which received funding from the European Union in the framework of the Public Health Programme and Folksam Research Foundation, Sweden; the British Regional Heart Study was funded by project and programme grants from the British Heart Foundation (PG/13/86/30546 and RG/13/16/30528); the Framingham Heart Study's data collection and analysis was funded by the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)-N01-HC25195; Health and Human Services (N268201500001I; R01-AG047645; R01-HL131029); and American Heart Association (15GPSGC24800006); the Norwegian National Physical Activity Surveillance Study was supported by the Norwegian Directorate for Public Health and the Norwegian School of Sport Sciences. JT is funded by the Research Council of Norway (249932/F20); the REGARDS study was supported by a cooperative agreement U01-NS041588 and investigator initiated grant R01-NS061846 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health. Additional funding was provided by an unrestricted research grant from the Coca-Cola Company; the Walking Away from type 2 Diabetes study was supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East Midlands; the Women's Health Study was funded by the National Institutes of Health (NIH) grants; CA154647, CA047988, CA182913, HL043851, HL080467, and HL099355. The funders of the individual studies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Allison DB, 1997, AM J EPIDEMIOL, V146, P672; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Bakrania Kishan, 2017, Prev Med Rep, V5, P285, DOI 10.1016/j.pmedr.2017.01.013; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Buchman AS, 2012, ARCH INTERN MED, V172, P444, DOI 10.1001/archinternmed.2011.1477; Centers for Disease Control and Prevention, ACT PEOPL HLTH NAT; Chastin SFM, 2018, BRIT J SPORT MED; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Clark BK, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0309-y; Colley RC, 2011, J SPORT SCI, V29, P783, DOI 10.1080/02640414.2011.557744; Diaz KM, 2017, ANN INTERN MED, V167, P465, DOI 10.7326/M17-0212; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Discacciati A, 2017, RES SYNTH METHODS, V8, P149, DOI 10.1002/jrsm.1194; Dohrn IM, 2018, J SCI MED SPORT, V21, P702, DOI 10.1016/j.jsams.2017.10.035; Duncan S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198587; Ensrud KE, 2014, J AM GERIATR SOC, V62, P2079, DOI 10.1111/jgs.13101; Evenson KR, 2016, AM J EPIDEMIOL, V184, P621, DOI 10.1093/aje/kww070; Evenson Kelly R, 2015, Prev Med Rep, V2, P750; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Jefferis BJ, 2019, BRIT J SPORT MED, V53, P1013, DOI 10.1136/bjsports-2017-098733; JOHNSON CL, 2013, VITAL HLTH STAT 2, V2, P161; Kaminsky LA, 2015, MAYO CLIN PROC, V90, P1515, DOI 10.1016/j.mayocp.2015.07.026; Keadle SK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1210; Klenk J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153779; Koolhaas CM, 2017, PREV MED, V95, P59, DOI 10.1016/j.ypmed.2016.11.021; LaMonte MJ, 2018, J AM GERIATR SOC, V66, P886, DOI 10.1111/jgs.15201; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Lee IM, 2018, CIRCULATION, V137, P203, DOI 10.1161/CIRCULATIONAHA.117.031300; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Liu Q, 2009, COMPUT STAT DATA AN, V53, P4157, DOI 10.1016/j.csda.2009.05.001; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; Murabito JM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001379; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Patterson R, 2018, EUR J EPIDEMIOL, V33, P811, DOI 10.1007/s10654-018-0380-1; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Stamatakis E, 2018, BRIT J SPORT MED; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; U.S. Department of Health and Human Services, 2018, 2018 PHYS ACTIVITY G; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; White IR, 2009, STATA J, V9, P40, DOI 10.1177/1536867X0900900103; WHO, 2021, GLOB ACT PLAN PHYS A, DOI DOI 10.1016/J.JPOLMOD.2006.06.007; Wong SL, 2011, J PHYS ACT HEALTH, V8, P587, DOI 10.1123/jpah.8.4.587	48	509	515	21	96	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2019	366								l4570	10.1136/bmj.l4570	http://dx.doi.org/10.1136/bmj.l4570			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DG	31434697	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000482882000001
J	Kolodny, A				Kolodny, Andrew			Clarification of Reporting of Potential Conflicts of Interest in JAMA Articles	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							GOVERNMENT		[Kolodny, Andrew] Brandeis Univ, Heller Sch Social Policy & Management, 415 South St, Waltham, MA 02453 USA	Brandeis University	Kolodny, A (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, 415 South St, Waltham, MA 02453 USA.	akolodny@brandeis.edu						[Anonymous], 2019, JAMA, V322, P1215, DOI 10.1001/jama.2019.14523; Kolodny A, 2018, JAMA-J AM MED ASSOC, V319, P1620, DOI 10.1001/jama.2018.0745; Kolodny A, 2017, JAMA-J AM MED ASSOC, V318, P1537, DOI 10.1001/jama.2017.14567	3	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1214	1215		10.1001/jama.2019.12743	http://dx.doi.org/10.1001/jama.2019.12743			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31483441				2022-12-28	WOS:000488822800036
J	DiTroia, SP; Percharde, M; Guerquin, MJ; Wall, E; Collignon, E; Ebata, KT; Mesh, K; Mahesula, S; Agathocleous, M; Laird, DJ; Livera, G; Ramalho-Santos, M				DiTroia, Stephanie P.; Percharde, Michelle; Guerquin, Marie-Justine; Wall, Estelle; Collignon, Evelyne; Ebata, Kevin T.; Mesh, Kathryn; Mahesula, Swetha; Agathocleous, Michalis; Laird, Diana J.; Livera, Gabriel; Ramalho-Santos, Miguel			Maternal vitamin C regulates reprogramming of DNA methylation and germline development	NATURE			English	Article							DEMETHYLATION DYNAMICS; METHYLOME LANDSCAPES; CELL; MECHANISMS; EXPRESSION; ERASURE; TET1	Development is often assumed to be hardwired in the genome, but several lines of evidence indicate that it is susceptible to environmental modulation with potential long-term consequences, including in mammals(1,2). The embryonic germline is of particular interest because of the potential for intergenerational epigenetic effects. The mammalian germline undergoes extensive DNA demethylation(3-7) that occurs in large part by passive dilution of methylation over successive cell divisions, accompanied by active DNA demethylation by TET enzymes(3,8-10). TET activity has been shown to be modulated by nutrients and metabolites, such as vitamin C11-15. Here we show that maternal vitamin C is required for proper DNA demethylation and the development of female fetal germ cells in a mouse model. Maternal vitamin C deficiency does not affect overall embryonic development but leads to reduced numbers of germ cells, delayed meiosis and reduced fecundity in adult offspring. The transcriptome of germ cells from vitamin-C-deficient embryos is remarkably similar to that of embryos carrying a null mutation in Tet1. Vitamin C deficiency leads to an aberrant DNA methylation profile that includes incomplete demethylation of key regulators of meiosis and transposable elements. These findings reveal that deficiency in vitamin C during gestation partially recapitulates loss of TET1, and provide a potential intergenerational mechanism for adjusting fecundity to environmental conditions.	[DiTroia, Stephanie P.; Percharde, Michelle; Wall, Estelle; Ebata, Kevin T.; Mesh, Kathryn; Laird, Diana J.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [DiTroia, Stephanie P.; Percharde, Michelle; Wall, Estelle; Ebata, Kevin T.; Mesh, Kathryn; Laird, Diana J.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Percharde, Michelle] MRC London Inst Med Sci LMS, London, England; [Percharde, Michelle] Imperial Coll London, Fac Med, ICS, London, England; [Guerquin, Marie-Justine; Livera, Gabriel] Univ Paris Diderot, Univ Paris Saclay,Univ Paris Sud, Sorbonne Paris Cite, INSERM,UMR967,CEA,DRF,iRCM,SCSR,LDG, Fontenay Aux Roses, France; [Collignon, Evelyne; Ramalho-Santos, Miguel] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Collignon, Evelyne; Ramalho-Santos, Miguel] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Mahesula, Swetha; Agathocleous, Michalis] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Mahesula, Swetha; Agathocleous, Michalis] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [DiTroia, Stephanie P.] Broad Inst MIT & Harvard, Med & Populat Genet, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Imperial College London; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ramalho-Santos, M (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Ramalho-Santos, M (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA.; Ramalho-Santos, M (corresponding author), Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.; Ramalho-Santos, M (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	mrsantos@lunenfeld.ca		Collignon, Evelyne/0000-0001-7617-5905; Ebata, Kevin/0000-0001-7166-7513; DiTroia, Stephanie/0000-0002-6847-6780; Percharde, Michelle/0000-0001-7928-4955; GUERQUIN, Marie-Justine/0000-0002-1752-7250	Diabetes Research Center grant; NIH [R01OD012204, R01GM123556, P30 DK063720]; National Science Foundation Graduate Research Fellowship Program [1650113]; Institut Universitaire de France; National Institutes of Health (NIH) [R21ES023297, R01ES028212]; Canada 150 Research Chair; MRC [MC_UP_1605/4] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Diabetes Research Center grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Institut Universitaire de France; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada 150 Research Chair; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Conti, R. Blelloch, P. Rinaudo, M. Lorincz, S. Fisher, L. Selleri and members of the Santos laboratory for input and critical reading of the manuscript. We thank E. Chow and members of the UCSF Center for Advanced Technology for assistance with sequencing; B. Soygur for meiotic spread protocol and reagents; Y. Zhang and L. Shen for technical advice on RRBS. We are grateful to S. Henikoff for providing the pA-MN and yeast tRNA spike-ins, and to S. Henikoff and T. Fazzio for providing technical help with performing CUT& RUN experiments. Flow cytometry data were generated in the UCSF Parnassus Flow Cytometry Core, which is supported by a Diabetes Research Center grant and NIH grant P30 DK063720. S.P.D. was supported by the National Science Foundation Graduate Research Fellowship Program under grant no. 1650113. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. G. L. was partly supported by Institut Universitaire de France. This work was supported by National Institutes of Health (NIH) grants R21ES023297 and R01ES028212 to D.J.L., and NIH grants R01OD012204 and R01GM123556, and a Canada 150 Research Chair to M.R.-S.	Abby E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10324; Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; ALSHARIF NZ, 1994, TOXICOLOGY, V92, P39, DOI 10.1016/0300-483X(94)90166-X; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arora R, 2016, J CELL SCI, V129, P2493, DOI 10.1242/jcs.189910; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boekelheide K, 2012, ENVIRON HEALTH PERSP, V120, P1353, DOI 10.1289/ehp.1204934; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Cross CE, 1999, BRIT MED BULL, V55, P691, DOI 10.1258/0007142991902565; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Drouin G, 2011, CURR GENOMICS, V12, P371, DOI 10.2174/138920211796429736; Ebata KT, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0143-3; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Faire M, 2015, DEV BIOL, V403, P69, DOI 10.1016/j.ydbio.2015.04.006; FRANKS LM, 1970, J REPROD FERTIL, V21, P563, DOI 10.1530/jrf.0.0210563; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Guerquin MJ, 2010, DEV BIOL, V346, P320, DOI 10.1016/j.ydbio.2010.08.002; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hainer SJ, 2019, CELL, V177, P1319, DOI 10.1016/j.cell.2019.03.014; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hebestreit K, 2013, BIOINFORMATICS, V29, P1647, DOI 10.1093/bioinformatics/btt263; Hill PWS, 2018, NATURE, V555, P392, DOI 10.1038/nature25964; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Hyemin, 2012, Immune Netw, V12, P18, DOI 10.4110/in.2012.12.1.18; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li ZG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0685-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Matsumura F, 2003, BIOCHEM PHARMACOL, V66, P527, DOI 10.1016/S0006-2952(03)00157-6; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ohno R, 2013, DEVELOPMENT, V140, P2892, DOI 10.1242/dev.093229; Percharde M, 2017, CELL REP, V19, P1987, DOI 10.1016/j.celrep.2017.05.036; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yamaguchi S, 2013, NATURE, V504, P460, DOI 10.1038/nature12805; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140	53	43	45	2	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					271	+		10.1038/s41586-019-1536-1	http://dx.doi.org/10.1038/s41586-019-1536-1			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31485074	Green Accepted			2022-12-28	WOS:000485415400057
J	Ferry, G				Ferry, Georgina			A woman's place Helen Brooke Taussig: preserver of babies' hearts and limbs	LANCET			English	Editorial Material												mgf@georginaferry.com						Malloy L, 2000, WOMEN SUCCEEDING IN THE SCIENCES, P1; Thomas V, 1985, PARTNERS HEART V THO; Van Robays J, 2016, FACTS VIEWS VIS OBGY, V8, P183	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2019	394	10201					821	821		10.1016/S0140-6736(19)32038-0	http://dx.doi.org/10.1016/S0140-6736(19)32038-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV0US	31498089				2022-12-28	WOS:000483994700011
J	Zhou, L; Sazanov, LA				Zhou, Long; Sazanov, Leonid A.			Structure and conformational plasticity of the intact Thermus thermophilus V/A-type ATPase	SCIENCE			English	Article							BEAM-INDUCED MOTION; CRYSTAL-STRUCTURE; V-ATPASE; CRYO-EM; BOVINE F-1-ATPASE; ATOMIC MODEL; SUBUNIT; COMPLEX; STALK; MECHANISM	V (vacuolar)/A (archaeal)-type adenosine triphosphatases (ATPases), found in archaea and eubacteria, couple ATP hydrolysis or synthesis to proton translocation across the plasma membrane using the rotary-catalysis mechanism. They belong to the V-type ATPase family. which differs from the mitochondrial/chloroplast F-type ATP synthases in overall architecture. We solved cryo-electron microscopy structures of the intact Therm us thermophilus V/A-ATPase, reconstituted into lipid nanodiscs, in three rotational states and two substates. These structures indicate substantial flexibility between V-1 and V-o in a working enzyme. which results from mechanical competition between central shaft rotation and resistance from the peripheral stalks. We also describe details of adenosine diphosphate inhibition release, V-1-V-o torque transmission, and proton translocation, which are relevant for the entire V-type ATPase family.	[Zhou, Long; Sazanov, Leonid A.] IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Sazanov, LA (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	sazanov@ist.ac.at	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bason JV, 2015, P NATL ACAD SCI USA, V112, P6009, DOI 10.1073/pnas.1506465112; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Gruber G, 2014, BBA-BIOENERGETICS, V1837, P940, DOI 10.1016/j.bbabio.2014.03.004; Guo H, 2019, ELIFE, V8, DOI 10.7554/eLife.43128; Guo H, 2018, CURR OPIN STRUC BIOL, V52, P71, DOI 10.1016/j.sbi.2018.08.005; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Hahn A, 2018, SCIENCE, V360, P620, DOI 10.1126/science.aat4318; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; HOCHSTEIN LI, 1992, ARCH BIOCHEM BIOPHYS, V295, P153, DOI 10.1016/0003-9861(92)90501-M; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Keyes M., 2003, METHODS RESULTS CRYS; Kishikawa J, 2014, EUR BIOPHYS J BIOPHY, V43, P415, DOI 10.1007/s00249-014-0973-x; Kishikawa J, 2014, J BIOL CHEM, V289, P403, DOI 10.1074/jbc.M113.523498; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022; Lingl A, 2003, EXTREMOPHILES, V7, P249, DOI 10.1007/s00792-003-0318-7; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Maruyama S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8149; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakanishi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02553-6; Nakanishi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119602; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; NEWMAN MJ, 1980, J BIOL CHEM, V255, P583; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Preiss L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500106; Rees DM, 2012, P NATL ACAD SCI USA, V109, P11139, DOI 10.1073/pnas.1207587109; Roh SH, 2018, MOL CELL, V69, P993, DOI 10.1016/j.molcel.2018.02.006; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Schep DG, 2016, P NATL ACAD SCI USA, V113, P3245, DOI 10.1073/pnas.1521990113; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Singharoy A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00046; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Suzuki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13235; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Vasanthakumar T, 2019, P NATL ACAD SCI USA, V116, P7272, DOI 10.1073/pnas.1814818116; Walker JE, 2012, BBA-BIOENERGETICS, V1817, pS1, DOI 10.1016/j.bbabio.2012.06.013; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; YOKOYAMA K, 1994, J BIOL CHEM, V269, P12248; YOKOYAMA K, 1990, J BIOL CHEM, V265, P21946; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zhao JH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006394; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	76	30	30	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		773	+	eaaw9144	10.1126/science.aaw9144	http://dx.doi.org/10.1126/science.aaw9144			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439765				2022-12-28	WOS:000482464000043
J	Jaeger, K; Bruenle, S; Weinert, T; Guba, W; Muehle, J; Miyazaki, T; Weber, M; Furrer, A; Haenggi, N; Tetaz, T; Huang, CY; Mattle, D; Vonach, JM; Gast, A; Kuglstatter, A; Rudolph, MG; Nogly, P; Benz, J; Dawson, RJP; Standfuss, J				Jaeger, Kathrin; Bruenle, Steffen; Weinert, Tobias; Guba, Wolfgang; Muehle, Jonas; Miyazaki, Takuya; Weber, Martin; Furrer, Antonia; Haenggi, Noemi; Tetaz, Tim; Huang, Chia-Ying; Mattle, Daniel; Vonach, Jean-Marie; Gast, Alain; Kuglstatter, Andreas; Rudolph, Markus G.; Nogly, Przemyslaw; Benz, Joerg; Dawson, Roger J. P.; Standfuss, Joerg			Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7	CELL			English	Article							LYMPH-NODE METASTASIS; CRYSTAL-STRUCTURE; BREAST-CANCER; TARGETS; GPCR; EXPRESSION; CXCR4; CELLS; STABILIZATION; SCH-527123	The CC chemokine receptor 7 (CCR7) balances immunity and tolerance by homeostatic trafficking of immune cells. In cancer, CCR7-mediated trafficking leads to lymph node metastasis, suggesting the receptor as a promising therapeutic target. Here, we present the crystal structure of human CCR7 fused to the protein Sialidase NanA by using data up to 2.1 angstrom resolution. The structure shows the ligand Cmp2105 bound to an intracellular allosteric binding pocket. A sulfonamide group, characteristic for various chemokine receptor ligands, binds to a patch of conserved residues in the Gi protein binding region between transmembrane helix 7 and helix 8. We demonstrate how structural data can be used in combination with a compound repository and automated thermal stability screening to identify and modulate allosteric chemokine receptor antagonists. We detect both novel (CS-1 and CS-2) and clinically relevant (CXCR1-CXCR2 phase-II antagonist Navarixin) CCR7 modulators with implications for multitarget strategies against cancer.	[Jaeger, Kathrin; Bruenle, Steffen; Weinert, Tobias; Muehle, Jonas; Furrer, Antonia; Mattle, Daniel; Nogly, Przemyslaw; Standfuss, Joerg] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, Villigen, Switzerland; [Guba, Wolfgang; Muehle, Jonas; Miyazaki, Takuya; Weber, Martin; Haenggi, Noemi; Tetaz, Tim; Mattle, Daniel; Vonach, Jean-Marie; Gast, Alain; Kuglstatter, Andreas; Rudolph, Markus G.; Benz, Joerg; Dawson, Roger J. P.] F Hoffmann Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Therapeut Modal, CH-4070 Basel, Switzerland; [Miyazaki, Takuya] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Res Div, Kamakura, Kanagawa, Japan; [Huang, Chia-Ying] Paul Scherrer Inst, Swiss Light Source, Macromol Crystallog, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Roche Holding; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Standfuss, J (corresponding author), Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, Villigen, Switzerland.; Dawson, RJP (corresponding author), F Hoffmann Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Therapeut Modal, CH-4070 Basel, Switzerland.	roger.dawson@roche.com; joerg.standfuss@psi.ch	Nogly, Przemyslaw/N-3590-2019; Nogly, Przemyslaw/GQZ-7032-2022; Weinert, Tobias/J-6353-2017	Nogly, Przemyslaw/0000-0002-8040-7753; Nogly, Przemyslaw/0000-0002-8040-7753; Weinert, Tobias/0000-0002-0339-3722; Brunle, Steffen/0000-0002-8057-245X; Rudolph, Markus/0000-0003-0447-1101; Dawson, Roger/0000-0003-2161-5883; Muhle, Jonas/0000-0002-7759-3620	Swiss National Science Foundation [31003A_141235, 31003A_159558]; European Union's Horizon 2020 research and innovation program under the Marie-Sklodowska-Curie grant [701646]; F. Hoffmann-La Roche LTD.	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union's Horizon 2020 research and innovation program under the Marie-Sklodowska-Curie grant; F. Hoffmann-La Roche LTD.(Hoffmann-La Roche)	Christian Bartelmus and Ralf Thoma from F. Hoffmann-La Roche LTD are acknowledged for quality control of screened ligands and fruitful discussions. We thank Laura Vera and May Sharpe from the crystallization facility at the Swiss Light Source for maintaining a productive environment and excellent support during screening and optimization of crystals. We acknowledge Meitian Wang and the team at the beam line X06SA of the Swiss Light Source for support and their continuous efforts in innovating data collection procedures. We further acknowledge the Swiss National Science Foundation for grants 31003A_141235 and 31003A_159558 to J.S. This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie-Sklodowska-Curie grant agreement No 701646 and from F. Hoffmann-La Roche LTD.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cunningham HD, 2010, TRANSL ONCOL, V3, P354, DOI 10.1593/tlo.10178; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Dwyer MP, 2006, J MED CHEM, V49, P7603, DOI 10.1021/jm0609622; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Gunther K, 2005, INT J CANCER, V116, P726, DOI 10.1002/ijc.21123; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Huang CY, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0123-6; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Knepp AM, 2011, BIOCHEMISTRY-US, V50, P502, DOI 10.1021/bi101059w; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Liu XY, 2017, NATURE, V548, P480, DOI 10.1038/nature23652; Mattle D, 2018, P NATL ACAD SCI USA, V115, P3640, DOI 10.1073/pnas.1718084115; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishan MA, 2016, CELL BIOL INT, V40, P955, DOI 10.1002/cbin.10631; Moschovakis GL, 2018, CELL MOL IMMUNOL; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ning Y, 2012, MOL CANCER THER, V11, P1353, DOI 10.1158/1535-7163.MCT-11-0915; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Ramsay RR, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-017-0181-2; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Solari R, 2015, EUR J PHARMACOL, V746, P363, DOI 10.1016/j.ejphar.2014.06.060; Steinberg M, 2010, CLIN THER, V32, P821, DOI 10.1016/j.clinthera.2010.05.007; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Taveras A., 2010, US patent, Patent No. [US7691856B2, 7691856]; Thal DM, 2018, NATURE, V559, P45, DOI 10.1038/s41586-018-0259-z; Tsai CJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7052; Varney ML, 2011, CANCER LETT, V300, P180, DOI 10.1016/j.canlet.2010.10.004; Weinert T, 2015, NAT METHODS, V12, P131, DOI 10.1038/nmeth.3211; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Wojdyla JA, 2018, J SYNCHROTRON RADIAT, V25, P293, DOI 10.1107/S1600577517014503; Wojdyla JA, 2016, J APPL CRYSTALLOGR, V49, P944, DOI 10.1107/S1600576716006233; Woollard SM, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S90580; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	60	53	53	7	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1222	+		10.1016/j.cell.2019.07.028	http://dx.doi.org/10.1016/j.cell.2019.07.028			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442409	Green Published, hybrid			2022-12-28	WOS:000482191000017
J	Suh, J; Romano, DM; Nitschke, L; Herrick, SP; DiMarzio, BA; Dzhala, V; Bae, JS; Oram, MK; Zheng, YJ; Hooli, B; Mullin, K; Gennarino, VA; Wasco, W; Schmahmann, JD; Albers, MW; Zoghbi, HY; Tanzi, RE				Suh, Jaehong; Romano, Donna M.; Nitschke, Larissa; Herrick, Scott P.; DiMarzio, Britt A.; Dzhala, Volodymyr; Bae, Jun-Seok; Oram, Mary K.; Zheng, Yuejiao; Hooli, Basavaraj; Mullin, Kristina; Gennarino, Vincenzo A.; Wasco, Wilma; Schmahmann, Jeremy D.; Albers, Mark W.; Zoghbi, Huda Y.; Tanzi, Rudolph E.			Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription	CELL			English	Article							HIPPOCAMPAL NEUROGENESIS; REGULATES PROLIFERATION; SUSCEPTIBILITY LOCI; LEARNING-DEFICITS; BETA-SECRETASE; CAG REPEAT; DISEASE; MICE; SCA1; EXPANSION	Expansion of CAG trinucleotide repeats in ATXN1 causes spinocerebellar ataxia type 1 (SCA1), a neurodegenerative disease that impairs coordination and cognition. While ATXN1 is associated with increased Alzheimer's disease (AD) risk, CAG repeat number in AD patients is not changed. Here, we investigated the consequences of ataxin-1 loss of function and discovered that knockout of Atxn1 reduced CIC-ETV4/5-mediated inhibition of Bace1 transcription, leading to increased BACE1 levels and enhanced amyloidogenic cleavage of APP, selectively in AD-vulnerable brain regions. Elevated BACE1 expression exacerbated Ab deposition and gliosis in AD mouse models and impaired hippocampal neurogenesis and olfactory axonal targeting. In SCA1 mice, polyglutamine-expanded mutant ataxin-1 led to the increase of BACE1 post-transcriptionally, both in cerebrum and cerebellum, and caused axonal-targeting deficit and neurodegeneration in the hippocampal CA2 region. These findings suggest that loss of ataxin-1 elevates BACE1 expression and A beta pathology, rendering it a potential contributor to AD risk and pathogenesis.	[Suh, Jaehong; Romano, Donna M.; DiMarzio, Britt A.; Bae, Jun-Seok; Oram, Mary K.; Zheng, Yuejiao; Hooli, Basavaraj; Mullin, Kristina; Wasco, Wilma; Tanzi, Rudolph E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit,McCance Ctr Brain Hlth,Mas, Boston, MA 02129 USA; [Nitschke, Larissa; Gennarino, Vincenzo A.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Nitschke, Larissa; Gennarino, Vincenzo A.; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Duncan Neurol Res Inst, Houston, TX 77030 USA; [Nitschke, Larissa; Zoghbi, Huda Y.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Herrick, Scott P.; Dzhala, Volodymyr; Albers, Mark W.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02129 USA; [Schmahmann, Jeremy D.] Harvard Med Sch, Massachusetts Gen Hosp, Lab Neuroanat & Cerebellar Neurobiol, Ataxia Unit,Cognit Behav Neurol Unit,Dept Neurol, Boston, MA 02114 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Gennarino, Vincenzo A.] Columbia Univ, Irving Med Ctr, Dept Genet & Dev, Pediat & Neurol, New York, NY 10032 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Baylor College of Medicine; Howard Hughes Medical Institute; Columbia University; NewYork-Presbyterian Hospital	Suh, J; Tanzi, RE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit,McCance Ctr Brain Hlth,Mas, Boston, MA 02129 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Texas Childrens Hosp, Jan & Duncan Neurol Res Inst, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	suh.jaehong@mgh.harvard.edu; hzoghbi@bcm.edu; tanzi@helix.mgh.harvard.edu	Schmahmann, Jeremy/ABF-1215-2021; Gennarino, Vincenzo A./H-3306-2019; Albers, Mark/AAK-8718-2021; Tanzi, Rudolph/AAE-9622-2019	Schmahmann, Jeremy/0000-0003-0706-5125; Gennarino, Vincenzo A./0000-0002-3312-6991; Albers, Mark/0000-0001-7855-3455; Tanzi, Rudolph/0000-0002-7032-1454; Nitschke, Larissa/0000-0002-8040-2100	NIH [R01 AG056775, R01 MH060009, R01 AG041856, R37 NS027699, U54 HD083092]; Cure Alzheimer's Fund; MINDlink Foundation; Jeffry and Barbara Picower Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056775, R01AG041856] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; MINDlink Foundation; Jeffry and Barbara Picower Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We appreciate Dr. Carla Jodice at the University of Rome Tor Vergata for generously sharing of important information and Dr. Kevin J. Staley for equipment for brain slice culture and electrophysiological recording. We also thank Rachel Souza, Abigail Lebovitz, Nicolas Papele, and Andrea Lesinski for technical assistance. This study was supported by NIH R01 AG056775 (J.S.), R01 MH060009 and R01 AG041856 (R.E.T.), and R37 NS027699 and U54 HD083092 (H.Y.Z.); the Cure Alzheimer's Fund (J.S. and R.E.T.); the MINDlink Foundation (J.D.S.); and the Jeffry and Barbara Picower Foundation (R.E.T. and H.Y.Z). H.Y.Z. is an investigator of the Howard Hughes Medical Institute.	Albers AD, 2016, ANN NEUROL, V80, P846, DOI 10.1002/ana.24792; Asher M, 2016, NEUROSCIENCE, V322, P54, DOI 10.1016/j.neuroscience.2016.02.011; Barao S, 2015, CELL REP, V12, P1367, DOI 10.1016/j.celrep.2015.07.059; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Bettens K, 2010, J ALZHEIMERS DIS, V19, P1169, DOI 10.3233/JAD-2010-1310; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Burk S, 2001, EUR NEUROL, V46, P43, DOI 10.1159/000050755; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao LX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2013; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Chatila ZK, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0067-18.2018; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Culjkovic B, 2000, AM J MED GENET, V96, P884, DOI 10.1002/1096-8628(20001204)96:6<884::AID-AJMG41>3.0.CO;2-M; Cvetanovic M, 2017, CEREBELLUM, V16, P340, DOI 10.1007/s12311-016-0794-9; Demars MP, 2013, NEUROBIOL AGING, V34, P2431, DOI 10.1016/j.neurobiolaging.2013.04.016; Devanand DP, 2015, NEUROLOGY, V84, P182, DOI 10.1212/WNL.0000000000001132; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fancellu R, 2013, J NEUROL, V260, P3134, DOI 10.1007/s00415-013-7138-1; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Fryer JD, 2011, SCIENCE, V334, P690, DOI 10.1126/science.1212673; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hooli BV, 2014, MOL PSYCHIATR, V19, P676, DOI 10.1038/mp.2013.77; Hu XY, 2013, CELL REP, V4, P40, DOI 10.1016/j.celrep.2013.06.005; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; JODICE C, 1994, AM J HUM GENET, V54, P959; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Ju H, 2014, MOL NEUROBIOL, V50, P866, DOI 10.1007/s12035-014-8703-z; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kawai Y, 2009, EUR NEUROL, V61, P257, DOI 10.1159/000206850; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Lee YI, 2016, P NATL ACAD SCI USA, V113, pE479, DOI 10.1073/pnas.1519156113; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lo RY, 2016, PARKINSONISM RELAT D, V22, P87, DOI 10.1016/j.parkreldis.2015.11.021; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma LM, 2014, SCIENCE, V344, P194, DOI 10.1126/science.1248805; Manto Mario, 2015, Cerebellum Ataxias, V2, P2, DOI 10.1186/s40673-015-0023-1; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Moriarty A, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0447-6; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Ou-Yang MH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5620; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Prox J, 2013, J NEUROSCI, V33, P12915, DOI 10.1523/JNEUROSCI.5910-12.2013; Rajapaksha TW, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-88; Rousseaux MWC, 2018, NEURON, V97, P1235, DOI 10.1016/j.neuron.2018.02.013; Rub U, 2012, NEUROPATH APPL NEURO, V38, P665, DOI 10.1111/j.1365-2990.2012.01259.x; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Schafer S, 2007, J NEURAL TRANSM, V114, P387, DOI 10.1007/s00702-006-0580-9; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Smith AS, 2016, MOL PSYCHIATR, V21, P1137, DOI 10.1038/mp.2015.189; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Suh J, 2011, J NEUROCHEM, V119, P377, DOI 10.1111/j.1471-4159.2011.07419.x; Swaminathan S., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/729478; Swaminathan S, 2012, CURR ALZHEIMER RES, V9, P801, DOI 10.2174/156720512802455331; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Wang B, 2017, CELL REP, V18, P1543, DOI 10.1016/j.celrep.2017.01.031; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Xiang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06864; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	78	28	28	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1159	+		10.1016/j.cell.2019.07.043	http://dx.doi.org/10.1016/j.cell.2019.07.043			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442405	Green Accepted, Bronze			2022-12-28	WOS:000482191000013
J	Iorio, A; Stonebraker, JS; Chambost, H; Makris, M; Coffin, D; Herr, C; Germini, F; Stonebraker, JS; Iorio, A; Byams, V; El-Ekiaby, M; Makris, M; O'Hara, J; Pierce, GF; Weill, A				Iorio, Alfonso; Stonebraker, Jeffrey S.; Chambost, Herve; Makris, Michael; Coffin, Donna; Herr, Christine; Germini, Federico; Stonebraker, Jeffrey S.; Iorio, Alfonso; Byams, Vanessa; El-Ekiaby, Magdy; Makris, Michael; O'Hara, Jamie; Pierce, Glenn F.; Weill, Alain		Data Demographics Comm World	Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males A Meta-analytic Approach Using National Registries	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; FACTOR-VIII; DEATH; CARE; MORTALITY; BURDEN; GENE	Background: The large observed variability in hemophilia prevalence prevents robust estimation of burden of disease. Objective: To estimate the prevalence and prevalence at birth of hemophilia and the associated life expectancy disadvantage. Design: Random-effects meta-analysis of registry data. Setting: Australia, Canada, France, Italy, New Zealand, and the United Kingdom. Participants: Male patients with hemophilia A or B. Measurements: Prevalence of hemophilia as a proportion of cases to the male population, prevalence of hemophilia at birth as a proportion of cases to live male births by year of birth, life expectancy disadvantage as a 1 - ratio of prevalence to prevalence at birth, and expected number of patients worldwide based on prevalence in high-income countries and prevalence at birth. Results: Prevalence (per 100 000 males) is 17.1 cases for all severities of hemophilia A, 6.0 cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth (per 100 000 males) is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, 5.0 cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage for high-income countries is 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The expected number of patients with hemophilia worldwide is 1 125 000, of whom 418 000 should have severe hemophilia. Limitation: Details were insufficient to adjust for comorbid conditions and ethnicity. Conclusion: The prevalence of hemophilia is higher than previously estimated. Patients with hemophilia still have a life expectancy disadvantage. Establishing prevalence at birth is a milestone toward assessing years of life lost, years of life with disability, and burden of disease.	[Iorio, Alfonso] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, CRL 140,1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Germini, Federico] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, CRL 125,1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Stonebraker, Jeffrey S.; Stonebraker, Jeffrey S.] North Carolina State Univ, Poole Coll Management, Dept Business Management, Raleigh, NC 27695 USA; [Chambost, Herve] Aix Marseille Univ, La Timone Hosp, AP HM, INSERM, Marseille, France; [Chambost, Herve] INRA, Marseille, France; [Makris, Michael] Univ Sheffield, Sch Med, Dept Infect Immun & Cardiovasc Dis, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England; [Coffin, Donna; Herr, Christine; Pierce, Glenn F.; Weill, Alain] World Federat Hemophilia, 1425 Blvd Rene Levesque Ouest,Bur 1200, Montreal, PQ H3G 1T7, Canada; [Chambost, Herve] Hop La Timone, 278 Rue St Pierre, F-13005 Marseille, France; [Stonebraker, Jeffrey S.] North Carolina State Univ, Poole Coll Management, Raleigh, NC USA; [Iorio, Alfonso] McMaster Univ, Hamilton, ON, Canada; [Byams, Vanessa] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [El-Ekiaby, Magdy] Shabrawishi Hosp Blood Bank, Cairo, Egypt; [Makris, Michael] Univ Sheffield, Sheffield, S Yorkshire, England; [O'Hara, Jamie] Innovat Ctr, Daresbury, Cheshire, England	McMaster University; McMaster University; University of North Carolina; North Carolina State University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE; University of Sheffield; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of North Carolina; North Carolina State University; McMaster University; Centers for Disease Control & Prevention - USA; University of Sheffield	Stonebraker, JS (corresponding author), North Carolina State Univ, Poole Coll Management, Dept Business Management, Raleigh, NC 27695 USA.	jeff_stonebraker@ncsu.edu; germinif@mcmaster.ca; jeff_stonebraker@ncsu.edu	Byams, Vanessa/AAG-8768-2020; Germini, Federico/K-6881-2016	Germini, Federico/0000-0002-0802-3616; Stonebraker, Jeffrey/0000-0002-2856-329X; CHAMBOST, HERVE/0000-0002-5319-1969				[Anonymous], 2017, WORLD POP PROSP 2017; ANTONARAKIS SE, 1995, HUM MUTAT, V5, P1, DOI 10.1002/humu.1380050102; Bolton-Maggs PHB, 2006, BRIT J HAEMATOL, V132, P671, DOI 10.1111/j.1365-2141.2005.05952.x; Calvez T, 2014, BLOOD, V124, P3398, DOI 10.1182/blood-2014-07-586347; Carneiro JDA, 2017, HAEMOPHILIA, V23, P682, DOI 10.1111/hae.13230; Chorba TL, 2001, AM J HEMATOL, V66, P229, DOI 10.1002/ajh.1050; Darby SC, 2007, BLOOD, V110, P815, DOI 10.1182/blood-2006-10-050435; Davidson CJ, 2003, THROMB HAEMOSTASIS, V89, P420, DOI 10.1055/s-0037-1613369; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Doncarli A, 2019, EUR J EPIDEMIOL, V34, P521, DOI 10.1007/s10654-018-0468-7; Gringeri A, 2003, BLOOD, V102, P2358, DOI 10.1182/blood-2003-03-0941; Hill FGH, 2004, AIDS, V18, P525, DOI [10.1097/01.aids.0000104368.21567.3c, 10.1097/00002030-200402200-00020]; Iorio A, 2008, HAEMOPHILIA, V14, P444, DOI 10.1111/j.1365-2516.2008.01679.x; Iorio A, 2017, HAEMOPHILIA, V23, pE1, DOI 10.1111/hae.13127; KemballCook G, 1997, NUCLEIC ACIDS RES, V25, P128, DOI 10.1093/nar/25.1.128; Khosla N, 2018, INTRACTABLE RARE DIS, V7, P213, DOI 10.5582/irdr.2018.01085; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Mannucci PM, 2012, BLOOD, V119, P4108, DOI 10.1182/blood-2012-01-394411; Martinez R, 2019, INT J EPIDEMIOL, V48, P1367, DOI 10.1093/ije/dyy254; Mason JA, 2018, HAEMOPHILIA, V24, P253, DOI 10.1111/hae.13375; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; NATHWANI AC, 1992, BAILLIERE CLIN HAEM, V5, P383, DOI 10.1016/S0950-3536(11)80025-9; O'Hara J, 2018, HAEMOPHILIA, V24, pE301, DOI 10.1111/hae.13546; O'Hara J, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0908-9; ROSENDAAL FR, 1990, THROMB HAEMOSTASIS, V63, P145; Salomon T, 2017, HAEMOPHILIA, V23, P42, DOI 10.1111/hae.13130; SARKAR G, 1990, GENOMICS, V6, P133, DOI 10.1016/0888-7543(90)90458-7; Skinner MW, 2006, HAEMOPHILIA, V12, P169, DOI 10.1111/j.1365-2516.2006.01280.x; Soucie JM, 1998, AM J HEMATOL, V59, P288, DOI 10.1002/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I; Stonebraker JS, 2012, HAEMOPHILIA, V18, pe91, DOI 10.1111/j.1365-2516.2011.02588.x; Stonebraker JS, 2010, HAEMOPHILIA, V16, P20, DOI 10.1111/j.1365-2516.2009.02127.x; Stonebraker JS, 2003, HAEMOPHILIA, V9, P245, DOI 10.1046/j.1365-2516.2003.00758.x; Tagliaferri A, 2010, HAEMOPHILIA, V16, P437, DOI 10.1111/j.1365-2516.2009.02188.x; WALKER I, 1995, TRANSFUSION, V35, P548, DOI 10.1046/j.1537-2995.1995.35795357875.x; World Federation of Hemophilia, 2018, WORLD FED HEM REP AN	36	129	130	7	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2019	171	8					540	+		10.7326/M19-1208	http://dx.doi.org/10.7326/M19-1208			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD4JV	31499529				2022-12-28	WOS:000489944700013
J	Bauer, A; Klemm, M; Rizas, KD; Hamm, W; von Stulpnagel, L; Dommasch, M; Steger, A; Lubinski, A; Flevari, P; Harden, M; Friede, T; Kaab, S; Merkely, B; Sticherling, C; Willems, R; Huikuri, H; Malik, M; Schmidt, G; Zabel, M; Perge, P; Sallo, Z; Szeplaki, G; Luthje, L; Schlogl, S; Haarmann, H; Bergau, L; Seegers, J; Hasenfuss, G; Munoz-Exposito, P; Tichelbacker, T; Kirova, A; Hnatkova, K; Vos, M; Willich, SN; Reinhold, T; Vandenberk, B; Klinika, M; Toplice, K; Flevari, P; Katsimardos, A; Katsaras, D; Hatala, R; Svetlosak, M; Lubinski, A; Kuczejko, T; Hansen, J; Conen, D; Milosrdnice, S; Pavlovic, N; Manola, S; Vinter, O; Benko, I; Tuinenburg, A; Meyer-Zurn, C; Eick, C; Hastrup, J; Brugada, J; Arbelo, E; Kaliska, G; Martinek, J; Sinner, MF; Vdovin, N; Cygankiewicz, I; Ptaszynski, P; Kaczmarek, K; Poddebska, I; Iovev, S; Novotny, T; Kozak, M; Kentta, T; Pelli, A; Kasprzak, JD; Qavoq, D; Brusich, S; Avdovic, E; Klasan, M; Galuszka, J; Taborsky, M; Velchev, V; Dissmann, R; Guzik, P; Bimmel, D; Lieberz, C; Stefanow, S; Rub, N; Wolpert, C; Maier, LS; Behrens, S; Jurisic, Z; Braunschweig, F; Blaschke, F; Pieske, B; Bakotic, Z; Anic, A; Schwinger, RHG; Platonov, P				Bauer, Axel; Klemm, Mathias; Rizas, Konstantinos D.; Hamm, Wolfgang; von Stuelpnagel, Lukas; Dommasch, Michael; Steger, Alexander; Lubinski, Andrezej; Flevari, Panagiota; Harden, Markus; Friede, Tim; Kaeaeb, Stefan; Merkely, Bela; Sticherling, Christian; Willems, Rik; Huikuri, Heikki; Malik, Marek; Schmidt, Georg; Zabel, Markus; Perge, Peter; Sallo, Zoltan; Szeplaki, Gabor; Luthje, Lars; Schlogl, Simon; Haarmann, Helge; Bergau, Leonard; Seegers, Joachim; Hasenfuss, Gerd; Munoz-Exposito, Pascal; Tichelbacker, Tobias; Kirova, Aleksandra; Hnatkova, Katerina; Vos, Marc; Willich, Stefan N.; Reinhold, Thomas; Vandenberk, Bert; Klinika, Magdalena; Toplice, Krapinske; Flevari, Panayota; Katsimardos, Andreas; Katsaras, Dimitrios; Hatala, Robert; Svetlosak, Martin; Lubinski, Andrzej; Kuczejko, Tomasz; Hansen, Jim; Conen, David; Milosrdnice, Sestre; Pavlovic, Nikola; Manola, Sime; Vinter, Ozren; Benko, Ivica; Tuinenburg, Anton; Meyer-Zurn, Christine; Eick, Christian; Hastrup, Jesper; Brugada, Josep; Arbelo, Elena; Kaliska, Gabriela; Martinek, Jozef; Sinner, Moritz F.; Vdovin, Nikolay; Cygankiewicz, Iwona; Ptaszynski, Pawel; Kaczmarek, Krzysztof; Poddebska, Izabela; Iovev, Svetoslav; Novotny, Tomas; Kozak, Milan; Kentta, Tuomas; Pelli, Ari; Kasprzak, Jaroslaw D.; Qavoq, Dariusz; Brusich, Sandro; Avdovic, Ervin; Klasan, Marina; Galuszka, Jan; Taborsky, Milos; Velchev, Vasil; Dissmann, Rudiger; Guzik, Przemyslaw; Bimmel, Dieter; Lieberz, Christiane; Stefanow, Stefan; Rub, Norman; Wolpert, Christian; Maier, Lars S.; Behrens, Steffen; Jurisic, Zrinka; Braunschweig, Frieder; Blaschke, Florian; Pieske, Burkert; Bakotic, Zoran; Anic, Ante; Schwinger, Robert H. G.; Platonov, Pyotr		EU-CERT-ICD Investigators	Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study	LANCET			English	Article							CARDIOVERTER-DEFIBRILLATOR; SUDDEN; PREVENTION; DEATH; RISK	Background A small proportion of patients undergoing primary prophylactic implantation of implantable cardioverter defibrillators (ICDs) experiences malignant arrhythmias. We postulated that periodic repolarisation dynamics, a novel marker of sympathetic-activity-associated repolarisation instability, could be used to identify electrically vulnerable patients who would benefit from prophylactic implantation of ICDs by way of a reduction in mortality. Methods We did a prespecified substudy of EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators (EU-CERT-ICD), a prospective, investigator-initiated, non-randomised, controlled cohort study done at 44 centres in 15 EU countries. Patients aged 18 years or older with ischaemic or non-ischaemic cardiomyopathy and reduced left ventricular ejection fraction (<= 35%) were eligible for inclusion if they met guideline-based criteria for primary prophylactic implantation of ICDs. Periodic repolarisation dynamics from 24-h Holter recordings were assessed blindly in patients the day before ICD implantation or on the day of study enrolment in patients who were conservatively managed. The primary endpoint was all-cause mortality. Propensity scoring and multivariable models were used to assess the interaction between periodic repolarisation dynamics and the treatment effect of ICDs on mortality. Findings Between May 12, 2014, and Sept 7, 2018, 1371 patients were enrolled in our study. 968 of these patients underwent ICD implantation, and 403 were treated conservatively. During follow-up (median 2.7 years [IQR 2.0-3.3] in the ICD group and 1.2 years [0.8-2.7] in the control group), 138 (14%) patients died in the ICD group and 64 (16%) patients died in the control group. We noted a 43% reduction in mortality in the ICD group compared with the control group (adjusted hazard ratio [HR] 0.57 [95% CI 0.41-0.79]; p=0.0008). Periodic repolarisation dynamics significantly predicted the treatment effect of ICDs on mortality (adjusted p=0.0307). The mortality benefits associated with ICD implantation were greater in patients with periodic repolarisation dynamics of 7.5 deg or higher (n=199; adjusted HR 0.25 [95% CI 0.13-0.47] for the ICD group vs the control group; p<0.0001) than in those with periodic repolarisation dynamics less than 7.5 deg (n=1166; adjusted HR 0.69 [95% CI 0.47-1.00]; p=0.0492; P-interaction=0.0056). The number needed to treat was 18.3 (95% CI 10.6-4895.3) in patients with periodic repolarisation dynamics less than 7.5 deg and 3.1 (2.6-4.8) in those with periodic repolarisation dynamics of 7.5 deg or higher. Interpretation Periodic repolarisation dynamics predict mortality reductions associated with prophylactic implantation of ICDs in contemporarily treated patients with ischaemic or non-ischaemic cardiomyopathy. Periodic repolarisation dynamics could help to guide treatment decisions about prophylactic ICD implantation. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Bauer, Axel; Klemm, Mathias; Rizas, Konstantinos D.; Hamm, Wolfgang; von Stuelpnagel, Lukas; Kaeaeb, Stefan] Munich Univ Clin, Med Klin & Poliklin 1, Munich, Germany; [Bauer, Axel] Med Univ Innsbruck, Univ Hosp Internal Med 3, A-6020 Innsbruck, Austria; [Bauer, Axel; Klemm, Mathias; Rizas, Konstantinos D.; Hamm, Wolfgang; von Stuelpnagel, Lukas; Dommasch, Michael; Steger, Alexander; Kaeaeb, Stefan; Schmidt, Georg] German Ctr Cardiovasc Res Partner Site, Munich Heart Alliance, Munich, Germany; [von Stuelpnagel, Lukas] Tech Univ Munich, Dept Elect & Comp Engn, Munich, Germany; [Dommasch, Michael; Steger, Alexander; Schmidt, Georg] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 1, Munich, Germany; [Lubinski, Andrezej; Lubinski, Andrzej] Med Univ Lodz Hosp, Dept Cardiol, Lodz, Poland; [Flevari, Panagiota; Flevari, Panayota] Attikon Univ Hosp, Dept Cardiol 2, Athens, Greece; [Harden, Markus; Friede, Tim] Univ Med Ctr Gottingen, Heart Ctr, Dept Med Stat, Gottingen, Germany; [Zabel, Markus] Univ Med Ctr Gottingen, Heart Ctr, Dept Cardiol & Pneumol, Gottingen, Germany; [Harden, Markus; Friede, Tim; Zabel, Markus] German Ctr Cardiovasc Res Partner Site Gottingen, Gottingen, Germany; [Merkely, Bela] Semmelweis Univ, Heart Ctr, Dept Cardiol, Budapest, Hungary; [Sticherling, Christian] Univ Basel, Univ Hosp, Basel, Switzerland; [Willems, Rik] Univ Hosp Leuven, Leuven, Belgium; [Huikuri, Heikki] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Huikuri, Heikki] Univ Oulu, Oulu, Finland; [Malik, Marek] Imperial Coll London, Heart & Lung Inst, London, England	University of Munich; Medical University of Innsbruck; German Centre for Cardiovascular Research; Munich Heart Alliance; Technical University of Munich; Technical University of Munich; University Hospital Attikon; University of Gottingen; University of Gottingen; Semmelweis University; University of Basel; KU Leuven; University Hospital Leuven; University of Oulu; University of Oulu; Imperial College London	Bauer, A (corresponding author), Med Univ Innsbruck, Univ Hosp Internal Med 3, A-6020 Innsbruck, Austria.	axel.bauer@i-med.ac.at	Novotny, Tomas/ABD-5968-2020; , Milan/AAO-7710-2020; Ptaszynski, Pawel Andrzej/S-9684-2016; Tichelbäcker, Tobias/ADV-9980-2022; Maier, Lars/AAQ-8313-2021; Willems, Rik/AAM-2392-2020; Friede, Tim/ABF-1132-2021; Hatala, Robert/ABV-9334-2022; Arbelo, Elena/GMX-0351-2022; Sticherling, Christian/AAY-4435-2021; Dommasch, Michael/AAL-6188-2021; Arbelo, Elena/GRS-2793-2022; Vinter, Ozren/AAY-4281-2021; Svetlosak, Martin/AGZ-9472-2022; Vandenberk, bert/AAA-9875-2020; Sinner, Moritz/AAW-5043-2020	Ptaszynski, Pawel Andrzej/0000-0001-6084-7324; Tichelbäcker, Tobias/0000-0002-5321-1819; Maier, Lars/0000-0001-9915-4429; Willems, Rik/0000-0002-5469-9609; Friede, Tim/0000-0001-5347-7441; Sticherling, Christian/0000-0001-8428-7050; Svetlosak, Martin/0000-0002-8326-5893; Vandenberk, bert/0000-0001-8296-920X; Malik, Marek/0000-0002-3792-1407; Kentta, Tuomas/0000-0003-2943-7188; Kaczmarek, Krzysztof/0000-0003-1356-5249; Merkely, Bela/0000-0001-6514-0723; Kasprzak, Jaroslaw D/0000-0002-5850-8187; Sappler, Nikolay/0000-0002-4532-5533; Bergau, Leonard/0000-0001-7025-9315; Bauer, Axel/0000-0001-9201-8555; Zuern, Christine/0000-0001-6625-284X; Guzik, Przemyslaw/0000-0001-9052-5027; Braunschweig, Frieder/0000-0002-4966-1315; Cygankiewicz, Iwona/0000-0003-3006-311X; Harden, Markus/0000-0003-2533-9396; Rizas, Konstantinos/0000-0002-5993-0339; Pavlovic, Nikola/0000-0001-9187-7681; ARBELO, ELENA/0000-0003-0424-6393	European Community [HEALTH-F2-2009-602299]	European Community(European Commission)	The study was funded by the European Community's 7th Framework Programme (HEALTH-F2-2009-602299) for 5 years (starting Oct 1, 2013).	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Amer Coll Cardiology, 2018, J AM COLL CARDIOL, V72, P1677, DOI 10.1016/j.jacc.2017.10.053; Banks H, 2018, EUROPACE, V20, P643, DOI 10.1093/europace/eux123; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bilchick KC, 2012, J AM COLL CARDIOL, V60, P1647, DOI 10.1016/j.jacc.2012.07.028; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Hamm W, 2017, INT J CARDIOL, V249, P1, DOI 10.1016/j.ijcard.2017.06.091; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Koneru JN, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007691; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Porter B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00147; Porter B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00328; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Pueyo E, 2016, J MOL CELL CARDIOL, V97, P93, DOI 10.1016/j.yjmcc.2016.05.003; Raatikainen MJP, 2017, EUROPACE, V19, P1, DOI 10.1093/europace/eux258; Rizas KD, 2019, HEART RHYTHM, V16, P1223, DOI 10.1016/j.hrthm.2019.02.024; Rizas KD, 2017, EUR HEART J, V38, P2110, DOI 10.1093/eurheartj/ehx161; Rizas KD, 2016, ARRHYTH ELECTROPHYSI, V5, P31, DOI [10.15420/aer.2015:30:2, 10.15420/AER.2015:30:2]; Rizas KD, 2014, J CLIN INVEST, V124, P1770, DOI 10.1172/JCI70085; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Seegers J, 2016, AM J CARDIOL, V118, P86, DOI 10.1016/j.amjcard.2016.04.016; Shen L, 2017, NEW ENGL J MED, V377, P41, DOI 10.1056/NEJMoa1609758; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Zabel M, 2019, ESC HEART FAIL, V6, P182, DOI 10.1002/ehf2.12367	27	34	35	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1344	1351		10.1016/S0140-6736(19)31996-8	http://dx.doi.org/10.1016/S0140-6736(19)31996-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC9RJ	31488371	Green Submitted			2022-12-28	WOS:000489613700029
J	Santema, BT; Ouwerkerk, W; Tromp, J; Sama, IE; Ravera, A; Regitz-Zagrosek, V; Hillege, H; Samani, NJ; Zannad, F; Dickstein, K; Lang, CC; Cleland, JG; Ter Maaten, JM; Metra, M; Anker, SD; van der Harst, P; Ng, LL; van der Meer, P; van Veldhuisen, DJ; Meyer, S; Lam, CSP; Voors, AA				Santema, Bernadet T.; Ouwerkerk, Wouter; Tromp, Jasper; Sama, Iziah E.; Ravera, Alice; Regitz-Zagrosek, Vera; Hillege, Hans; Samani, Nilesh J.; Zannad, Faiez; Dickstein, Kenneth; Lang, Chim C.; Cleland, John G.; Ter Maaten, Jozine M.; Metra, Marco; Anker, Stefan D.; van der Harst, Pim; Ng, Leong L.; van der Meer, Peter; van Veldhuisen, Dirk J.; Meyer, Sven; Lam, Carolyn S. P.; Voors, Adriaan A.		ASIAN-HF Investigators	Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study	LANCET			English	Article							SEX-BASED DIFFERENCES; MORTALITY; GENDER; MORBIDITY; PHARMACOKINETICS; SUBSETS; THERAPY; DIGOXIN; HEIGHT	Background Guideline-recommended doses of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), and beta blockers are similar for men and women with heart failure with reduced ejection fraction (HFrEF), even though there are known sex differences in pharmacokinetics of these drugs. We hypothesised that there might be sex differences in the optimal dose of ACE inhibitors or ARBs and beta blockers in patients with HFrEF. Methods We did a post-hoc analysis of BIOSTAT-CHF, a prospective study in 11 European countries of patients with heart failure in whom initiation and up-titration of ACE inhibitors or ARBs and beta blockers was encouraged by protocol. We included only patients with left ventricular ejection fraction less than 40%, and excluded those who died within the first 3 months. Primary outcome was a composite of time to all-cause mortality or hospitalisation for heart failure. Findings were validated in ASIAN-HF, an independent cohort of 3539 men and 961 women with HFrEF. Findings Among 1308 men and 402 women with HFrEF from BIOSTAT-CHF, women were older (74 [12] years vs 70 [12] years, p< 0.0001) and had lower bodyweights (72 [16] kg vs 85 [18] kg, p< 0.0001) and heights (162 [7] cm vs 174 [8] cm, p< 0.0001) than did men, although body-mass index did not differ significantly. A similar number of men and women reached guideline-recommended target doses of ACE inhibitors or ARBs (99 [25%] vs 304 [23%], p= 0.61) and beta blockers (57 [14%] vs 168 [13%], p= 0.54). In men, the lowest hazards of death or hospitalisation for heart failure occurred at 100% of the recommended dose of ACE inhibitors or ARBs and beta blockers, but women showed approximately 30% lower risk at only 50% of the recommended doses, with no further decrease in risk at higher dose levels. These sex differences were still present after adjusting for clinical covariates, including age and body surface area. In the ASIAN-HF registry, similar patterns were observed for both ACE inhibitors or ARBs and beta blockers, with women having approximately 30% lower risk at 50% of the recommended doses, with no further benefit at higher dose levels. Interpretation This study suggests that women with HFrEF might need lower doses of ACE inhibitors or ARBs and beta blockers than men, and brings into question what the true optimal medical therapy is for women versus men. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Santema, Bernadet T.; Tromp, Jasper; Sama, Iziah E.; Ravera, Alice; Hillege, Hans; Ter Maaten, Jozine M.; van der Harst, Pim; van der Meer, Peter; van Veldhuisen, Dirk J.; Lam, Carolyn S. P.; Voors, Adriaan A.] Univ Med Ctr Groningen, Dept Cardiol, NL-9713 GZ Groningen, Netherlands; [Ouwerkerk, Wouter; Tromp, Jasper; Lam, Carolyn S. P.] Natl Heart Ctr Singapore, Hosp Dr, Singapore, Singapore; [Ouwerkerk, Wouter] Univ Amsterdam, Amsterdam UMC, Deptartment Dermatol, Amsterdam, Netherlands; [Ouwerkerk, Wouter] Infect & Immun Inst, Amsterdam, Netherlands; [Ravera, Alice; Metra, Marco] Univ Brescia, Inst Cardiol, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Brescia, Italy; [Regitz-Zagrosek, Vera] Charite Univ Med Berlin, Inst Gender Med, Ctr Cardiovasc Res, German Ctr Cardiovasc Res, Berlin, Germany; [Samani, Nilesh J.; Ng, Leong L.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.; Ng, Leong L.] Glenfield Hosp, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Zannad, Faiez] Univ Nancy, French Clin Res, Invest Ctr 1433, Vandoeuvre Les Nancy, France; [Dickstein, Kenneth] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Lang, Chim C.] Univ Dundee, Ninewells Hosp & Med Sch, Div Mol & Clin Med, Ctr Cardiovasc & Lung Biol,Sch Med, Dundee, Scotland; [Cleland, John G.] Imperial Coll, Royal Brompton & Harefield Hosp, Natl Heart & Lung Inst, London, England; [Cleland, John G.] Univ Glasgow, Robertson Inst Biostat, Glasgow, Lanark, Scotland; [Cleland, John G.] Univ Glasgow, Clin Trials Unit, Glasgow, Lanark, Scotland; [Anker, Stefan D.] Charite Univ Med Berlin, German Ctr Cardiovasc Res Partner Site Berlin, Berlin, Germany; [Meyer, Sven] Carl von Ossietzky Univ Oldenburg, European Med Sch Oldenburg Groningen, Dept Cardiol, Heart Ctr Oldenburg, Oldenburg, Germany	University of Groningen; National Heart Centre Singapore; University of Amsterdam; University of Brescia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Universite de Lorraine; Stavanger University Hospital; University of Dundee; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; University of Glasgow; University of Glasgow; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Carl von Ossietzky Universitat Oldenburg	Voors, AA (corresponding author), Univ Med Ctr Groningen, Dept Cardiol, NL-9713 GZ Groningen, Netherlands.	a.a.voors@umcg.nl	Lam, Carolyn SP/ABD-6810-2021; Metra, marco/E-7101-2010; Cleland, John G./AAZ-4185-2020; Ouwerkerk, Wouter/J-1925-2019; Voors, Adriaan/ABE-6784-2020	Lam, Carolyn SP/0000-0003-1903-0018; Cleland, John G./0000-0002-1471-7016; Ouwerkerk, Wouter/0000-0002-2000-9358; Sama, Iziah/0000-0002-9056-7152; Ling, Lieng H./0000-0001-6063-8530; Ng, Leong/0000-0002-6553-5749; Regitz-Zagrosek, Vera/0000-0002-3566-3467	European Commission [FP7-242209-BIOSTAT-CHF]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the European Commission (FP7-242209-BIOSTAT-CHF).	Bonetti M, 2004, BIOSTATISTICS, V5, P465, DOI 10.1093/biostatistics/kxh002; Bonetti M, 2000, STAT MED, V19, P2595, DOI 10.1002/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO;2-M; Du Bois D, 1989, Nutrition, V5, P303; Eugene Andy R, 2016, Med Sci (Basel), V4, DOI 10.3390/medsci4040018; Eugene Andy R, 2016, Int J Clin Pharmacol Toxicol, V5, P209; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Halliday BP, 2019, LANCET, V393, P61, DOI 10.1016/S0140-6736(18)32484-X; Halloran M, 2000, STAT MODELS EPIDEMIO; Hastie T., 1992, GEN ADDITIVE MODELS; Jochmann N, 2005, EUR HEART J, V26, P1585, DOI 10.1093/eurheartj/ehi397; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lam CSP, 2013, EUR J HEART FAIL, V15, P928, DOI 10.1093/eurjhf/hft045; Linde C, 2018, EUR J HEART FAIL, V20, P780, DOI 10.1002/ejhf.1133; Luzier AB, 1999, CLIN PHARMACOL THER, V66, P594, DOI 10.1053/cp.1999.v66.103400001; Mentz RJ, 2018, J AM COLL CARDIOL, V72, P41, DOI 10.1016/j.jacc.2018.04.038; Mizutani T, 2003, DRUG METAB REV, V35, P99, DOI 10.1081/DMR-120023681; Ouwerkerk W, 2017, EUR HEART J, V38, P1883, DOI 10.1093/eurheartj/ehx026; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Perry G, 1997, NEW ENGL J MED, V336, P525; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rathore SS, 2002, NEW ENGL J MED, V347, P1403, DOI 10.1056/NEJMoa021266; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598; Rosano GMC, 2015, EUR HEART J, V36, P2677, DOI 10.1093/eurheartj/ehv161; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van der Wal WM, 2011, J STAT SOFTW, V43, P1; van Veldhuisen DJ, 2018, EUR J HEART FAIL, V20, P1146, DOI 10.1002/ejhf.1200; Voors AA, 2017, EUR J HEART FAIL, V19, P627, DOI 10.1002/ejhf.785; Voors AA, 2016, EUR J HEART FAIL, V18, P716, DOI 10.1002/ejhf.531; Whitley HP, 2009, AM FAM PHYSICIAN, V80, P1254	30	100	99	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1254	1263		10.1016/S0140-6736(19)31792-1	http://dx.doi.org/10.1016/S0140-6736(19)31792-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8XK	31447116	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000488862500030
J	Zhu, YL; Crowley, SC; Latimer, AJ; Lewis, GM; Nash, R; Kucenas, S				Zhu, Yunlu; Crowley, Samantha C.; Latimer, Andrew J.; Lewis, Gwendolyn M.; Nash, Rebecca; Kucenas, Sarah			Migratory Neural Crest Cells Phagocytose Dead Cells in the Developing Nervous System	CELL			English	Article							PHAGOSOME MATURATION; EARLY MACROPHAGES; SPINAL-CORD; ZEBRAFISH; APOPTOSIS; TUBE; INTERLEUKIN-1-BETA; MESENCHYME; PROTEINS; ROLES	During neural tube closure and spinal cord development, many cells die in both the central and peripheral nervous systems (CNS and PNS, respectively). However, myeloid-derived professional phagocytes have not yet colonized the trunk region during early neurogenesis. How apoptotic cells are removed from this region during these stages remains largely unknown. Using live imaging in zebrafish, we demonstrate that neural crest cells (NCCs) respond rapidly to dying cells and phagocytose cellular debris around the neural tube. Additionally, NCCs have the ability to enter the CNS through motor exit point transition zones and clear debris in the spinal cord. Surprisingly, NCCs phagocytosis mechanistically resembles macrophage phagocytosis and their recruitment toward cellular debris is mediated by interleukin-1 beta. Taken together, our results reveal a role for NCCs in phagocytosis of debris in the developing nervous system before the presence of professional phagocytes.	[Zhu, Yunlu; Crowley, Samantha C.; Latimer, Andrew J.; Lewis, Gwendolyn M.; Nash, Rebecca; Kucenas, Sarah] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Kucenas, S (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	sk4ub@virginia.edu	Zhu, Yunlu/AAC-8204-2019	Zhu, Yunlu/0000-0003-2474-2714	NIH [NS072212]; University of Virginia Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Kucenas and Ravichandran laboratories for valuable discussions, Dr. John Lukens for helpful advice, Lori Tocke for zebrafish care, and the following investigators for their generous gifts of fish lines and reagents: Dr. Alvaro Sagasti, Tg(4xUAS:EGFP-2xFYVE)<SUP>la214</SUP> and pME-lamp1-GFP construct; Dr. Georges Lutfalla, il1b: GFP-FTASE construct. This work was funded by NIH (NS072212 to S.K.) and The University of Virginia Brain Institute (to S.K.).	Arya R, 2015, SEMIN CELL DEV BIOL, V39, P12, DOI 10.1016/j.semcdb.2015.02.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; Beattie CE, 2000, BRAIN RES BULL, V53, P489, DOI 10.1016/S0361-9230(00)00382-8; Berardozzi R, 2016, J AM CHEM SOC, V138, P558, DOI 10.1021/jacs.5b09923; Bernut A, 2014, P NATL ACAD SCI USA, V111, pE943, DOI 10.1073/pnas.1321390111; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Binker MG, 2007, CELL MICROBIOL, V9, P2153, DOI 10.1111/j.1462-5822.2007.00946.x; Blakemore W. F, 2008, NEUROPATHOL APPL NEU, V2, P21; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; CANNON GJ, 1992, J CELL SCI, V101, P907; Canton J, 2014, MOL BIOL CELL, V25, P3330, DOI 10.1091/mbc.E14-05-0967; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Chan DW, 1998, CHROMOSOMA, V107, P39, DOI 10.1007/s004120050280; CUADROS MA, 1993, J COMP NEUROL, V330, P113, DOI 10.1002/cne.903300110; Don EK, 2017, ZEBRAFISH, V14, P69, DOI 10.1089/zeb.2016.1321; DUNCAN ID, 1988, GLIA, V1, P233, DOI 10.1002/glia.440010309; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Fogel JL, 2012, JOVE-J VIS EXP, DOI 10.3791/4254; Francisco-Morcillo J, 2014, DEV DYNAM, V243, P1203, DOI [10.1002/dvdy.24174, 10.1002/DVDY.24174]; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gottlieb R. A., 1996, APOPTOSIS, V1, P40, DOI [10.1007/BF00142077, DOI 10.1007/BF00142077]; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Hancock J. M, 2014, DICT BIOINFORMATICS, V25, P25; Hasegawa T, 2017, ELIFE, V6, DOI 10.7554/eLife.22716; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hochgreb-Hagele T, 2013, DEV BIOL, V374, P1, DOI 10.1016/j.ydbio.2012.11.035; Honjo Y, 2005, DEVELOPMENT, V132, P4461, DOI 10.1242/dev.02026; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jao LE, 2012, DEVELOPMENT, V139, P1316, DOI 10.1242/dev.074344; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Johnson K, 2016, GLIA, V64, P1170, DOI 10.1002/glia.22990; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Klumperman J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016857; Kucenas S, 2008, NEURON GLIA BIOL, V4, P71, DOI 10.1017/S1740925X09990123; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Levin R, 2016, IMMUNOL REV, V273, P156, DOI 10.1111/imr.12439; Lewis GM, 2014, J NEUROSCI, V34, P12762, DOI 10.1523/JNEUROSCI.1906-14.2014; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madej MP, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00335; Mai NC, 2014, DIS MODEL MECH, V7, P871, DOI 10.1242/dmm.014498; Massa V, 2009, P NATL ACAD SCI USA, V106, P8233, DOI 10.1073/pnas.0900333106; Masumoto J, 2003, J BIOL CHEM, V278, P4268, DOI 10.1074/jbc.M203944200; Mathiak G, 2000, BRIT J PHARMACOL, V131, P383, DOI 10.1038/sj.bjp.0703629; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; McGrath KE, 2003, BLOOD, V101, P1669, DOI 10.1182/blood-2002-08-2531; McGraw HF, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-23; Mesureur J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006437; Mirkes PE, 2002, TERATOLOGY, V65, P228, DOI 10.1002/tera.10049; Nonomura K, 2013, DEV CELL, V27, P621, DOI 10.1016/j.devcel.2013.11.015; Pages H., 2019, ANNOTATIONDBI MANIPU; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; Prendergast A, 2012, DEVELOPMENT, V139, P1141, DOI 10.1242/dev.072439; Rasmussen JP, 2015, J NEUROSCI, V35, P559, DOI 10.1523/JNEUROSCI.3613-14.2015; Sarvothaman S, 2015, BLOOD RES, V50, P73, DOI 10.5045/br.2015.50.2.73; SCHULTER G, 1973, Z ANAT ENTWICKLUNGS, V141, P251, DOI 10.1007/BF00519046; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Shklover J, 2015, CURR TOP DEV BIOL, V114, P297, DOI 10.1016/bs.ctdb.2015.07.024; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Smith CJ, 2016, GLIA, V64, P1138, DOI 10.1002/glia.22987; Smith CJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001961; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Stachura DL, 2016, METHOD CELL BIOL, V133, P11, DOI 10.1016/bs.mcb.2016.03.022; Stremmel C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02492-2; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Tsarouchas TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07036-w; Turkowyd B, 2017, ANGEW CHEM INT EDIT, V56, P11634, DOI 10.1002/anie.201702870; van Ham TJ, 2010, FASEB J, V24, P4336, DOI 10.1096/fj.10-161018; Varela M, 2014, J VIROL, V88, P12026, DOI 10.1128/JVI.02056-14; Vega-Lopez GA, 2017, INT J DEV BIOL, V61, P5, DOI 10.1387/ijdb.160408gv; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Villani A, 2019, DEV CELL, V49, P77, DOI 10.1016/j.devcel.2019.02.014; Vojtech LN, 2012, INFECT IMMUN, V80, P2878, DOI 10.1128/IAI.00543-12; Wang L, 2014, DEVELOPMENT, V141, P1875, DOI 10.1242/dev.106211; Weil M, 1997, CURR BIOL, V7, P281, DOI 10.1016/S0960-9822(06)00125-4; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	94	16	17	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					74	+		10.1016/j.cell.2019.08.001	http://dx.doi.org/10.1016/j.cell.2019.08.001			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31495570	Bronze, Green Accepted			2022-12-28	WOS:000486618500015
J	DelFattore, J				DelFattore, Joan			Death by Stereotype? Cancer Treatment in Unmarried Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MARITAL-STATUS; SOCIAL SUPPORT; PHYSIOLOGICAL PROCESSES; BREAST-CANCER; LATER LIFE; SURVIVAL; EPIDEMIOLOGY; DIAGNOSIS; MARRIAGE; GENDER		[DelFattore, Joan] Univ Delaware, Coll Arts & Sci, Newark, DE 19716 USA	University of Delaware	DelFattore, J (corresponding author), Univ Delaware, Coll Arts & Sci, Newark, DE 19716 USA.							Aizer AA, 2014, INT J RADIAT ONCOL, V89, P756, DOI 10.1016/j.ijrobp.2014.03.024; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; [Anonymous], 2017, UNM SINGL AM WEEK SE; Chiaramonte GR, 2006, HEALTH PSYCHOL, V25, P255, DOI 10.1037/0278-6133.25.3.255; Costa AS, 2019, EINSTEIN-SAO PAULO, V17, DOI [10.31744/einstein_journal/2019ao4533, 10.31744/einstein_journal/2019AO4533]; Dehon E, 2017, ACAD EMERG MED, V24, P895, DOI 10.1111/acem.13214; Denberg TD, 2005, CANCER-AM CANCER SOC, V103, P1819, DOI 10.1002/cncr.20982; DePaulo, 2007, SINGLED OUT SINGLES; DePaulo B, 2013, PSYCHOL TODAY BLOG; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Frech A, 2007, J HEALTH SOC BEHAV, V48, P149, DOI 10.1177/002214650704800204; Garssen B, 1999, PSYCHIAT RES, V85, P51, DOI 10.1016/S0165-1781(99)00008-6; Greenwald AG, 2015, J PERS SOC PSYCHOL, V108, P553, DOI 10.1037/pspa0000016; Hall AE, 2016, CRIT REV ONCOL HEMAT, V97, P247, DOI 10.1016/j.critrevonc.2015.08.025; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kahneman D., 2011, THINKING FAST SLOW; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Kislev E., 2019, HAPPY SINGLEHOOD RIS; Kroenke CH, 2013, BREAST CANCER RES TR, V137, P261, DOI 10.1007/s10549-012-2253-8; Liu L, 2018, MED SCI MONITOR, V24, P3425, DOI 10.12659/MSM.910811; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Merrill RM, 2017, J CANCER SURVIV, V11, P578, DOI 10.1007/s11764-017-0627-y; Metzl Jonathan M., 2016, Yale Journal of Biology and Medicine, V89, P247; Michalski CW, 2019, J GASTROINTEST SURG, V23, P959, DOI 10.1007/s11605-018-3897-4; Musick K, 2012, J MARRIAGE FAM, V74, P1, DOI 10.1111/j.1741-3737.2011.00873.x; Niu Q, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011378; Phillipson C, 1997, INT J GERIATR PSYCH, V12, P505, DOI 10.1002/(SICI)1099-1166(199705)12:5<505::AID-GPS577>3.0.CO;2-Q; Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187; Sarkisian N, 2016, J SOC PERS RELAT, V33, P361, DOI 10.1177/0265407515597564; Shreders A, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.26_suppl.232; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Tumin D, 2018, SOC SCI QUART, V99, P626, DOI 10.1111/ssqu.12425; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Wang L, 2011, CANCER EPIDEMIOL, V35, P417, DOI 10.1016/j.canep.2011.02.004; Weihs KL, 2005, J PSYCHOSOM RES, V59, P299, DOI 10.1016/j.jpsychores.2004.12.002; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wright MR, 2017, J MARRIAGE FAM, V79, P833, DOI 10.1111/jomf.12375; Wu WR, 2018, CANCER MANAG RES, V10, P23, DOI 10.2147/CMAR.S142019; Zhang WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41695	43	14	14	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					982	985		10.1056/NEJMms1902657	http://dx.doi.org/10.1056/NEJMms1902657			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IW9PR	31483973				2022-12-28	WOS:000485326200016
J	Zhou, HY; Shi, XH; Yuan, WM; Hao, L; Chen, XJ; Ge, J; Ji, T; Jiang, P; Li, G; Liu, BF; Liu, GL; Liu, WJ; Lu, HL; Pan, X; Shen, JT; Shu, XW; Sun, LM; Tian, QG; Wang, HY; Wang, TG; Wu, SM; Yang, CW; Zhang, SH; Zhong, ZH				Zhou, Hongyan; Shi, Xiheng; Yuan, Weimin; Hao, Lei; Chen, Xiangjun; Ge, Jian; Ji, Tuo; Jiang, Peng; Li, Ge; Liu, Bifang; Liu, Guilin; Liu, Wenjuan; Lu, Honglin; Pan, Xiang; Shen, Juntai; Shu, Xinwen; Sun, Luming; Tian, Qiguo; Wang, Huiyuan; Wang, Tinggui; Wu, Shengmiao; Yang, Chenwei; Zhang, Shaohua; Zhong, Zhihao			Fast inflows as the adjacent fuel of supermassive black hole accretion disks in quasars	NATURE			English	Article							BROAD ABSORPTION-LINE; PEAKED EMISSION-LINES; ACTIVE GALAXIES; SPECTRA; ULTRAVIOLET; LUMINOSITY; RELEASE; MASSES	Quasars, which are exceptionally bright objects at the centres (or nuclei) of galaxies, are thought to be produced through the accretion of gas into disks surrounding supermassive black holes(1-3). There is observational evidence at galactic and circumnuclear scales(4) that gas flows inwards towards accretion disks around black holes, and such an inflow has been measured at the scale of the dusty torus that surrounds the central accretion disk(5). At even smaller scales, inflows close to an accretion disk have been suggested to explain the results of recent modelling of the response of gaseous broad emission lines to continuum variations(6,7). However, unambiguous observations of inflows that actually reach accretion disks have been elusive. Here we report the detection of redshifted broad absorption lines of hydrogen and helium atoms in a sample of quasars. The lines show broad ranges of Doppler velocities that extend continuously from zero to redshifts as high as about 5,000 kilometres per second. We interpret this as the inward motion of gases at velocities comparable to freefall speeds close to the black hole, constraining the fastest infalling gas to within 10,000 gravitational radii of the black hole (the gravitational radius being the gravitational constant multiplied by the object mass, divided by the speed of light squared). Extensive photoionization modelling yields a characteristic radial distance of the inflow of approximately 1,000 gravitational radii, possibly overlapping with the outer accretion disk.	[Zhou, Hongyan; Shi, Xiheng; Ji, Tuo; Jiang, Peng; Pan, Xiang; Tian, Qiguo; Wu, Shengmiao; Yang, Chenwei; Zhang, Shaohua] State Ocean Adm, Polar Res Inst China, Key Lab Polar Sci, Antarctic Astron Res Div, Shanghai, Peoples R China; [Zhou, Hongyan; Shi, Xiheng; Chen, Xiangjun; Ji, Tuo; Jiang, Peng; Li, Ge; Liu, Guilin; Lu, Honglin; Pan, Xiang; Sun, Luming; Tian, Qiguo; Wang, Huiyuan; Wang, Tinggui; Wu, Shengmiao; Yang, Chenwei; Zhang, Shaohua; Zhong, Zhihao] Univ Sci & Technol China, Sch Astron & Space Sci, Hefei, Anhui, Peoples R China; [Zhou, Hongyan; Chen, Xiangjun; Li, Ge; Liu, Guilin; Lu, Honglin; Sun, Luming; Wang, Huiyuan; Wang, Tinggui; Zhong, Zhihao] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Res Galaxies & Cosmol, Dept Astron, Hefei, Anhui, Peoples R China; [Yuan, Weimin; Liu, Bifang] Chinese Acad Sci, Natl Astron Observ China, Beijing, Peoples R China; [Yuan, Weimin; Liu, Bifang] Univ Chinese Acad Sci, Sch Astron & Space Sci, Beijing, Peoples R China; [Hao, Lei; Shen, Juntai] Chinese Acad Sci, Shanghai Astron Observ, Shanghai, Peoples R China; [Ge, Jian] Univ Florida, Dept Astron, Bryant Space Sci Ctr, Gainesville, FL 32611 USA; [Liu, Wenjuan] Chinese Acad Sci, Yunnan Observ, Kunming, Yunnan, Peoples R China; [Liu, Wenjuan] Chinese Acad Sci, Key Lab Struct & Evolut Celestial Objects, Kunming, Yunnan, Peoples R China; [Shu, Xinwen] Anhui Normal Univ, Dept Phys, Wuhu, Peoples R China	Polar Research Institute of China; State Oceanic Administration; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; State University System of Florida; University of Florida; Chinese Academy of Sciences; Yunnan Astronomical Observatory, NAOC, CAS; Chinese Academy of Sciences; Anhui Normal University	Zhou, HY (corresponding author), State Ocean Adm, Polar Res Inst China, Key Lab Polar Sci, Antarctic Astron Res Div, Shanghai, Peoples R China.; Zhou, HY; Wang, TG (corresponding author), Univ Sci & Technol China, Sch Astron & Space Sci, Hefei, Anhui, Peoples R China.; Zhou, HY; Wang, TG (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Key Lab Res Galaxies & Cosmol, Dept Astron, Hefei, Anhui, Peoples R China.; Yuan, WM (corresponding author), Chinese Acad Sci, Natl Astron Observ China, Beijing, Peoples R China.; Yuan, WM (corresponding author), Univ Chinese Acad Sci, Sch Astron & Space Sci, Beijing, Peoples R China.	zhouhongyan@pric.org.cn; wmy@nao.cas.cn; twang@ustc.edu.cn	Shu, Xinwen/AAO-5985-2020; Wang, Huiyuan/C-5473-2014; Shu, Xinwen/ABG-3953-2020	Shu, Xinwen/0000-0002-7020-4290; Wang, Huiyuan/0000-0002-4911-6990; Liu, Guilin/0000-0003-4286-5187	Alfred P. Sloan Foundation; US National Science Foundation; US Department of Energy Office of Science; National Natural Science Foundation of China [NSFC11473025]; SOC programme [CHINARE2017-02-03]; Key Research Program of the Chinese Academy of Sciences [XDPB09-02]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Science Foundation(National Science Foundation (NSF)); US Department of Energy Office of Science(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SOC programme; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We acknowledge the use of the Hale 200-inch Telescope at Palomar Observatory through the Telescope Access Program (TAP), which made these observations possible. Funding for the third Sloan Digital Sky Survey (SDSS-III; http://www.sdss3.org) has been provided by the Alfred P. Sloan Foundation, the participating institutions, the US National Science Foundation and the US Department of Energy Office of Science. H.Z., L.S. and X.P. acknowledge support from the National Natural Science Foundation of China (NSFC11473025) and the SOC programme (CHINARE2017-02-03). X.C. and G. Li are grateful for support from the Key Research Program of the Chinese Academy of Sciences (XDPB09-02).	Aalto S, 2019, ASTRON ASTROPHYS, V627, DOI 10.1051/0004-6361/201935480; BARVAINIS R, 1987, ASTROPHYS J, V320, P537, DOI 10.1086/165571; Brandt WN, 2000, ASTROPHYS J, V528, P637, DOI 10.1086/308207; Collin S, 1999, ASTRON ASTROPHYS, V344, P433; Cushing MC, 2004, PUBL ASTRON SOC PAC, V116, P362, DOI 10.1086/382907; Dai XY, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/180; Elvis M, 2017, ASTROPHYS J, V847, DOI 10.3847/1538-4357/aa82b6; Eracleous M, 2004, IAU SYMP P SERIES, P29, DOI 10.1017/S1743921304001383; Eracleous M, 2003, ASTROPHYS J, V599, P886, DOI 10.1086/379540; ERACLEOUS M, 1994, ASTROPHYS J SUPPL S, V90, P1, DOI 10.1086/191856; Ferland GJ, 2017, REV MEX ASTRON ASTR, V53, P385; Gibson RR, 2009, ASTROPHYS J, V692, P758, DOI 10.1088/0004-637X/692/1/758; Glikman E, 2006, ASTROPHYS J, V640, P579, DOI 10.1086/500098; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; Green PJ, 2001, ASTROPHYS J, V558, P109, DOI 10.1086/322311; Greene JE, 2005, ASTROPHYS J, V630, P122, DOI 10.1086/431897; Grier CJ, 2017, ASTROPHYS J, V849, DOI 10.3847/1538-4357/aa901b; Hall PB, 2013, MON NOT R ASTRON SOC, V434, P222, DOI 10.1093/mnras/stt1012; Hall PB, 2007, ASTRON J, V133, P1271, DOI 10.1086/511272; HALPERN JP, 1990, ASTROPHYS J, V365, pL51, DOI 10.1086/185886; Ji T, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/56; Kaspi S, 2005, ASTROPHYS J, V629, P61, DOI 10.1086/431275; Krolik J. H., 1999, ACTIVE GALACTIC NUCL; Leighly KM, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/94; Lewis KT, 2006, ASTROPHYS J, V642, P711, DOI 10.1086/501419; Liu WJ, 2015, ASTROPHYS J SUPPL S, V217, DOI 10.1088/0067-0049/217/1/11; Gaskell CM, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/30; Netzer H., 2013, PHYS EVOLUTION ACTIV; Netzer H, 2015, ANNU REV ASTRON ASTR, V53, P365, DOI 10.1146/annurev-astro-082214-122302; Pancoast A, 2014, MON NOT R ASTRON SOC, V445, P3073, DOI 10.1093/mnras/stu1419; Paris I, 2018, ASTRON ASTROPHYS, V613, DOI 10.1051/0004-6361/201732445; Peterson B. M., 1997, INTRO ACTIVE GALACTI; Rubin KHR, 2017, ASTROPHYS SPACE SC L, V430, P95, DOI 10.1007/978-3-319-52512-9_5; RUDY RJ, 1985, ASTROPHYS J, V288, P531, DOI 10.1086/162818; Runnoe JC, 2012, MON NOT R ASTRON SOC, V422, P478, DOI 10.1111/j.1365-2966.2012.20620.x; Shi XH, 2017, ASTROPHYS J LETT, V843, DOI 10.3847/2041-8213/aa725e; Shi XM, 2016, NANOIMPACT, V3-4, P96, DOI 10.1016/j.impact.2016.09.002; Storchi-Bergmann T, 2019, NAT ASTRON, V3, P48, DOI 10.1038/s41550-018-0611-0; Sun LM, 2017, ASTROPHYS J, V838, DOI 10.3847/1538-4357/aa63eb; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Wang HY, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/2/L23; Wang JM, 2017, NAT ASTRON, V1, P775, DOI 10.1038/s41550-017-0264-4; WEYMANN RJ, 1991, ASTROPHYS J, V373, P23, DOI 10.1086/170020; Wu XB, 2004, ASTROPHYS J, V614, P91, DOI 10.1086/423446; Zhang SH, 2015, ASTROPHYS J, V815, DOI 10.1088/0004-637X/815/2/113; Zhang SH, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/42	47	14	15	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					83	+		10.1038/s41586-019-1510-y	http://dx.doi.org/10.1038/s41586-019-1510-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31485059	Green Submitted			2022-12-28	WOS:000483967700038
J	Oliver, D				Oliver, David			David Oliver: Health policy advice in the new number 10	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Crouch H., 2019, DIGITAL HLTH; Department of Health and Social Care, 2018, M HANC LAUNCH TECH V; Health Foundation, 2018, HLTH EQ ENGL MARM RE; King's Fund, ALT GUID HLTH CAR; McLellan A., 2019, HSJ; Mikkelsen B, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l257; Nuffield Trust, 2018, DOOM REP LESS HIST N; Rhodes D, 2018, BBC; The Health Foundation, 2018, ADD 3 2BN YEAR NEED; Warr W., 2019, TELEGRAPH; Williams R., 2018, BMJ	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l5309	10.1136/bmj.l5309	http://dx.doi.org/10.1136/bmj.l5309			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1FO	31484637	hybrid			2022-12-28	WOS:000485437600008
J	Mills, MC				Mills, Melinda C.			How do genes affect same-sex behavior?	SCIENCE			English	Editorial Material							ORIENTATION; CHROMOSOME; LINKAGE		[Mills, Melinda C.] Univ Oxford, Dept Sociol, 42 Pk End St, Oxford OX1 1JD, England	University of Oxford	Mills, MC (corresponding author), Univ Oxford, Dept Sociol, 42 Pk End St, Oxford OX1 1JD, England.	melinda.mills@nuffield.ox.ac.uk			European Research Council [615603, 835079]; Leverhulme Trust; Leverhulme Centre for Demographic Science; ESRC [ES/N011856/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Leverhulme Trust(Leverhulme Trust); Leverhulme Centre for Demographic Science; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	I thank X. Woltjer and F. C. Tropf for comments. I am supported by European Research Council grants 615603 and 835079 and The Leverhulme Trust, Leverhulme Centre for Demographic Science.	Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Ganna A, 2019, SCIENCE, V365, P882, DOI 10.1126/science.aat7693; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Langstrom N, 2010, ARCH SEX BEHAV, V39, P75, DOI 10.1007/s10508-008-9386-1; Mills MC, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0261-x; Pillard RC, 1998, HUM BIOL, V70, P347; Rahman Q, 2005, NEUROSCI BIOBEHAV R, V29, P1057, DOI 10.1016/j.neubiorev.2005.03.002	11	6	6	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					869	870		10.1126/science.aay2726	http://dx.doi.org/10.1126/science.aay2726			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467212				2022-12-28	WOS:000483975800029
J	Rodriguez-Cruz, LA				Rodriguez-Cruz, Luis Alexis			Between two worlds	SCIENCE			English	Editorial Material									[Rodriguez-Cruz, Luis Alexis] Univ Vermont, Burlington, VT 05405 USA	University of Vermont	Rodriguez-Cruz, LA (corresponding author), Univ Vermont, Burlington, VT 05405 USA.	SciCareerEditor@aaas.org							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					946	946		10.1126/science.365.6456.946	http://dx.doi.org/10.1126/science.365.6456.946			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467224				2022-12-28	WOS:000483975800050
J	Dijk, S; Lok, P				Dijk, Stijntje; Lok, Pat			Stress urinary incontinence: study finds fourfold variation in use of surgery across England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		GORNALL J, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4137; Mamza JB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029878; Medicines and Healthcare Products Regulatory Agency, 2014, SUMM EV BEN RISKS VA; NHS Improvement NHS England, 2019, EXT PAUS US VAG MESH; PIKE H, 2019, BMJ-BRIT MED J, V365, P40645, DOI DOI 10.1136/BMJ.L1537; WISE J, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5523	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l5318	10.1136/bmj.l5318	http://dx.doi.org/10.1136/bmj.l5318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31466997				2022-12-28	WOS:000483892600006
J	Sasson, I; Hayward, MD				Sasson, Isaac; Hayward, Mark D.			Association Between Educational Attainment and Causes of Death Among White and Black US Adults, 2010-2017	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE EXPECTANCY; UNITED-STATES; MORTALITY; TRENDS; GRADIENTS; SMOKING; RACE	IMPORTANCE There are substantial and increasing educational differences in US adult life expectancy. To reduce social inequalities in mortality, it is important to understand how specific causes of death have contributed to increasing educational differences in adult life expectancy in recent years. OBJECTIVE To estimate the relationship of specific causes of death with increasing educational differences in adult life expectancy from 2010 to 2017. DESIGN, SETTING, AND PARTICIPANTS Serial cross-sectional study of 4690729 deaths recorded in the US National Vital Statistics System in 2010 and 2017. EXPOSURES Sex, race/ethnicity, and educational attainment. MAIN OUTCOMES AND MEASURES Life expectancy at age 25 years and years of life lost between ages 25 and 84 years by cause of death. RESULTS The analysis included a total of 2211633 deaths in 2010 and 2479096 deaths in 2017. Between 2010 and 2017, life expectancy at age 25 significantly declined among white and black non-Hispanic US residents from an expected age at death of 79.34 to 79.15 years (difference, -0.18 [95% CI, -0.23 to -0.14]). Greater decreases were observed among persons with a high school degree or less (white men: -1.05 years [95% CI, -1.15 to -0.94], white women: -1.14 years [95% CI, -1.24 to -1.04], and black men: -0.30 years [95% CI, -0.56 to -0.04]). White adults with some college education but no 4-year college degree experienced similar declines in life expectancy (men: -0.89 years [95% CI, -1.07 to -0.73], women: -0.59 years [95% CI, -0.77 to -0.42]). In contrast, life expectancy at age 25 significantly increased among the college-educated (white men: 0.58 years [95% CI, 0.42 to 0.73], white women: 0.78 years [95% CI, 0.57 to 1.00], and black women: 1.70 years [95% CI, 0.91 to 2.53]). The difference between high- and low-education groups increased from 2010 to 2017, largely because life-years lost to drug use increased among those with a high school degree or less (white men: 0.93 years [95% CI, 0.90 to 0.96], white women: 0.50 years [95% CI, 0.47 to 0.52], black men: 0.75 years [95% CI, 0.71 to 0.79], and black women: 0.28 years [95% CI, 0.25 to 0.31]). CONCLUSIONS AND RELEVANCE In this serial cross-sectional study, estimated life expectancy at age 25 years declined overall between 2010 and 2017; however, it declined among persons without a 4-year college degree and increased among college-educated persons. Much of the increasing educational differences in years of life lost may be related to deaths attributed to drug use.	[Sasson, Isaac] Tel Aviv Univ, Dept Sociol & Anthropol, IL-6997801 Tel Aviv, Israel; [Sasson, Isaac] Tel Aviv Univ, Herczeg Inst Aging, IL-6997801 Tel Aviv, Israel; [Hayward, Mark D.] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA; [Hayward, Mark D.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA	Tel Aviv University; Tel Aviv University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Sasson, I (corresponding author), Tel Aviv Univ, Dept Sociol & Anthropol, IL-6997801 Tel Aviv, Israel.; Sasson, I (corresponding author), Tel Aviv Univ, Herczeg Inst Aging, IL-6997801 Tel Aviv, Israel.	isasson@tauex.tau.ac.il	Sasson, Isaac/AAU-6704-2021	Sasson, Isaac/0000-0001-7033-9497	German-Israeli Foundation for Scientific Research and Development (GIF); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P2C HD042849]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD042849] Funding Source: NIH RePORTER	German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a grant from the German-Israeli Foundation for Scientific Research and Development (GIF) awarded to Dr Sasson and an infrastructure grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; P2C HD042849) awarded to the Population Research Center at The University of Texas at Austin.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Alperovitch A, 2009, EUR J EPIDEMIOL, V24, P669, DOI 10.1007/s10654-009-9383-2; Andersen PK, 2013, DEMOGR RES, V29, P1127, DOI 10.4054/DemRes.2013.29.41; Arias Elizabeth, 2008, Vital Health Stat 2, P1; Bound J, 2015, HEALTH AFFAIR, V34, P2167, DOI 10.1377/hlthaff.2015.0481; Brown DC, 2019, POPUL RES POLICY REV, V38, P371, DOI 10.1007/s11113-018-9505-1; Case A, 2017, BROOKINGS PAP ECO AC, P397; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevention, NCHS DEATH RAT LIF E; Centers for Disease Control and Prevention, US STAND CERT DEATH; Centers for Disease Control and Prevention, US CENS POP BRIDG RA; Centers for Disease Control and Prevention, VIT STAT ONL DAT POR; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Dowd JB, 2014, INT J EPIDEMIOL, V43, P983, DOI 10.1093/ije/dyu120; Ho JY, 2017, DEMOGRAPHY, V54, P1175, DOI 10.1007/s13524-017-0565-3; Ho JY, 2015, J HEALTH SOC BEHAV, V56, P307, DOI 10.1177/0022146515592731; Masters RK, 2017, BIODEMOGR SOC BIOL, V63, P31, DOI 10.1080/19485565.2016.1248892; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Montez JK, 2011, RES AGING, V33, P145, DOI 10.1177/0164027510392388; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Rigg KK, 2018, INT J DRUG POLICY, V57, P119, DOI 10.1016/j.drugpo.2018.04.011; Rostron Brian L, 2010, Vital Health Stat 2, P1; Roux AVD, 2017, AM J PUBLIC HEALTH, V107, P1566, DOI [10.2105/AJPH.2017.304041, 10.2105/ajph.2017.304041]; Ruhm CJ, 24188 NBER; Sasson I, 2017, DEMOGRAPHY, V54, P1215, DOI 10.1007/s13524-017-0583-1; Sasson I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163412; Sasson I, 2016, DEMOGRAPHY, V53, P269, DOI 10.1007/s13524-015-0453-7; Stein EM, 2017, AM J PUBLIC HEALTH, V107, P1541, DOI [10.2105/AJPH.2017.303941, 10.2105/ajph.2017.303941]; Tinetti ME, 2012, J AM GERIATR SOC, V60, P1448, DOI 10.1111/j.1532-5415.2012.04077.x; US Census Bureau, 2017, AM COMM SURV ACC DAT; US Census Bureau, AM COMM SURV SAMPL S; Xu J.Q., 2016, MORTALITY US 2015; Xu Jiaquan, 2018, Natl Vital Stat Rep, V67, P1	33	45	45	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					756	763		10.1001/jama.2019.11330	http://dx.doi.org/10.1001/jama.2019.11330			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IU5UJ	31454044	Green Published, Bronze			2022-12-28	WOS:000483652500023
J	Wice, MB				Wice, Martin B.			A Difficult Conversation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a physiatrist recalls his role in telling his wife of her diagnosis of metastatic ovarian cancer, his support during her inexorable decline, and how the experiences of her passing drew his family closer, nurtured his appreciation for relationships, the wonder of nature, and the renewed sense of connection to the world.	[Wice, Martin B.] Washington Univ, Sch Med, Div Neurorehabil, 1 Glen Abbey Dr, St Louis, MO 63131 USA	Washington University (WUSTL)	Wice, MB (corresponding author), Washington Univ, Sch Med, Div Neurorehabil, 1 Glen Abbey Dr, St Louis, MO 63131 USA.	familywice@aol.com						O'Donohue J, 2008, BLESS SPACE US BOOK, P60	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					727	728		10.1001/jama.2019.11757	http://dx.doi.org/10.1001/jama.2019.11757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454049				2022-12-28	WOS:000483652500018
J	Roshandel, G; Khoshnia, M; Poustchi, H; Hemming, K; Kamangar, F; Gharavi, A; Ostovaneh, MR; Nateghi, A; Majed, M; Navabakhsh, B; Merat, S; Pourshams, A; Nalini, M; Malekzadeh, F; Sadeghi, M; Mohammadifard, N; Sarrafzadegan, N; Naemi-Tabiei, M; Fazel, A; Brennan, P; Etemadi, A; Boffetta, P; Thomas, N; Marshall, T; Cheng, KK; Malekzadeh, R				Roshandel, Gholamreza; Khoshnia, Masoud; Poustchi, Hossein; Hemming, Karla; Kamangar, Farin; Gharavi, Abdolsamad; Ostovaneh, Mohammad Reza; Nateghi, Alireza; Majed, Masoud; Navabakhsh, Behrooz; Merat, Shahin; Pourshams, Akram; Nalini, Mahdi; Malekzadeh, Fatemeh; Sadeghi, Masoumeh; Mohammadifard, Noushin; Sarrafzadegan, Nizal; Naemi-Tabiei, Mohammad; Fazel, Abdolreza; Brennan, Paul; Etemadi, Arash; Boffetta, Paolo; Thomas, Neil; Marshall, Tom; Cheng, Kar Keung; Malekzadeh, Reza			Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial	LANCET			English	Article							ADHERENCE; STRATEGY; DESIGN; GOLESTAN; RISK	Background A fixed-dose combination therapy (polypill strategy) has been proposed as an approach to reduce the burden of cardiovascular disease, especially in low-income and middle-income countries (LMICs). The PolyIran study aimed to assess the effectiveness and safety of a four-component polypill including aspirin, atorvastatin, hydrochlorothiazide, and either enalapril or valsartan for primary and secondary prevention of cardiovascular disease. Methods The PolyIran study was a two-group, pragmatic, cluster-randomised trial nested within the Golestan Cohort Study (GCS), a cohort study with 50 045 participants aged 40-75 years from the Golestan province in Iran. Clusters (villages) were randomly allocated (1:1) to either a package of non-pharmacological preventive interventions alone (minimal care group) or together with a once-daily polypill tablet (polypill group). Randomisation was stratified by three districts (Gonbad, Aq-Qala, and Kalaleh), with the village as the unit of randomisation. We used a balanced randomisation algorithm, considering block sizes of 20 and balancing for cluster size or natural log of the cluster size (depending on the skewness within strata). Randomisation was done at a fixed point in time (Jan 18, 2011) by statisticians at the University of Birmingham (Birmingham, UK), independent of the local study team. The non-pharmacological preventive interventions (including educational training about healthy lifestyle-eg, healthy diet with low salt, sugar, and fat content, exercise, weight control, and abstinence from smoking and opium) were delivered by the PolyIran field visit team at months 3 and 6, and then every 6 months thereafter. Two formulations of polypill tablet were used in this study. Participants were first prescribed polypill one (hydrochlorothiazide 12.5 mg, aspirin 81 mg, atorvastatin 20 mg, and enalapril 5 mg). Participants who developed cough during follow-up were switched by a trained study physician to polypill two, which included valsartan 40 mg instead of enalapril 5 mg. Participants were followed up for 60 months. The primary outcome-occurrence of major cardiovascular events (including hospitalisation for acute coronary syndrome, fatal myocardial infarction, sudden death, heart failure, coronary artery revascularisation procedures, and non-fatal and fatal stroke)-was centrally assessed by the GCS follow-up team, who were masked to allocation status. We did intention-to-treat analyses by including all participants who met eligibility criteria in the two study groups. The trial was registered with ClinicalTrials.gov, number NCT01271985. Findings Between Feb 22, 2011, and April 15, 2013, we enrolled 6838 individuals into the study-3417 (in 116 clusters) in the minimal care group and 3421 (in 120 clusters) in the polypill group. 1761 (51.5%) of 3421 participants in the polypill group were women, as were 1679 (49.1%) of 3417 participants in the minimal care group. Median adherence to polypill tablets was 80.5% (IQR 48.5-92.2). During follow-up, 301 (8.8%) of 3417 participants in the minimal care group had major cardiovascular events compared with 202 (5.9%) of 3421 participants in the polypill group (adjusted hazard ratio [HR] 0.66, 95% CI 0.55-0.80). We found no statistically significant interaction with the presence (HR 0.61, 95% CI 0.49-0.75) or absence of pre-existing cardiovascular disease (0.80; 0.51-1.12; p(interaction) = 0.19). When restricted to participants in the polypill group with high adherence, the reduction in the risk of major cardiovascular events was even greater compared with the minimal care group (adjusted HR 0.43, 95% CI 0.33-0.55). The frequency of adverse events was similar between the two study groups. 21 intracranial haemorrhages were reported during the 5 years of follow-up-ten participants in the polypill group and 11 participants in the minimal care group. There were 13 physicianconfirmed diagnoses of upper gastrointestinal bleeding in the polypill group and nine in the minimal care group. Interpretation Use of polypill was effective in preventing major cardiovascular events. Medication adherence was high and adverse event numbers were low. The polypill strategy could be considered as an additional effective component in controlling cardiovascular diseases, especially in LMICs.	[Roshandel, Gholamreza; Khoshnia, Masoud; Poustchi, Hossein; Gharavi, Abdolsamad; Ostovaneh, Mohammad Reza; Nateghi, Alireza; Majed, Masoud; Navabakhsh, Behrooz; Pourshams, Akram; Nalini, Mahdi; Malekzadeh, Fatemeh; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Inst, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Poustchi, Hossein; Pourshams, Akram; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Inst, Shariati Hosp, Digest Oncol Res Ctr, Tehran, Iran; [Merat, Shahin; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Inst, Shariati Hosp, Liver & Pancreaticobiliary Dis Res Ctr, Tehran, Iran; [Roshandel, Gholamreza; Khoshnia, Masoud; Naemi-Tabiei, Mohammad; Fazel, Abdolreza] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Golestan, Iran; [Hemming, Karla; Thomas, Neil; Marshall, Tom; Cheng, Kar Keung] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Kamangar, Farin] Morgan State Univ, Dept Biol Sch Comp Math & Nat Sci, Baltimore, MD 21239 USA; [Sadeghi, Masoumeh] Isfahan Univ Med Sci, Cardiac Rehabil Res Ctr, Esfahan, Iran; [Mohammadifard, Noushin] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Sarrafzadegan, Nizal] Isfahan Univ Med Sci, Cardiovasc Res Inst, Heart Failure Res Ctr, Esfahan, Iran; [Brennan, Paul] WHO, Int Agcy Res Canc, Genet Sect, Lyon, France; [Etemadi, Arash] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Boffetta, Paolo] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Golestan University of Medical Sciences; University of Birmingham; Morgan State University; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai; University of Bologna	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.	malek@tums.ac.ir	Fazel, Abdolreza/GON-4224-2022; Merat, Shahin/A-5478-2009; Hemming, karla/AAB-3391-2021; Mohammadifard, Noushin/M-2244-2018; Sadeghi, Masoumeh/AAU-8493-2021; Nalini/AAY-1099-2020; Cheng, Kar/AAL-8899-2021; Ostovaneh, Mohammad/AAY-5728-2021; Boffetta, Paolo/AAI-7767-2021; Roshandel, Gholamreza/AAJ-9562-2021	Hemming, karla/0000-0002-2226-6550; Mohammadifard, Noushin/0000-0003-1776-1060; Sadeghi, Masoumeh/0000-0001-7179-5558; Nalini/0000-0002-7464-9756; Cheng, Kar/0000-0002-1516-1857; Boffetta, Paolo/0000-0002-3811-2791; Roshandel, Gholamreza/0000-0002-5494-0722; Pourshams, Akram/0000-0002-7950-3983; Thomas, Graham Neil/0000-0002-2777-1847; Marshall, Tom/0000-0001-9277-5214	Barakat Foundation; Digestive Disease Research Institute of Tehran University of Medical Sciences (Tehran, Iran); Golestan University of Medical Sciences (Gorgan, Iran); WHO; US National Institutes of Health or National Cancer Institute; Tehran University of Medical Sciences [81/15]; Cancer Research UK [C20/A5860]; NIHR Collaboration for Leadership in Applied Health Research and Care West Midlands	Barakat Foundation; Digestive Disease Research Institute of Tehran University of Medical Sciences (Tehran, Iran); Golestan University of Medical Sciences (Gorgan, Iran); WHO(World Health Organization); US National Institutes of Health or National Cancer Institute; Tehran University of Medical Sciences(Tehran University of Medical Sciences); Cancer Research UK(Cancer Research UK); NIHR Collaboration for Leadership in Applied Health Research and Care West Midlands	We thank Hamid Reza Jamshidi from the Barakat Foundation, Behrooz Abaie from the Digestive Disease Research Institute of Tehran University of Medical Sciences (Tehran, Iran), Akbar Fotouhi from the Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Golestan Cohort Study (GCS) centre staff, the local health networks and health workers (behvarz) in the study area, the Golestan University of Medical Sciences (Gorgan, Iran), and the chiefs of the Maraveh-Tappeh, Gonbad, Kalaleh, and Aq-Qala health districts for their assistance and support. We also thank the GCS participants who participated in this trial. We thank Kazem Kazempour for independent analysis of the data to verify the findings. The lead authors affirm that the manuscript is an honest, accurate, and transparent account of the study being reported, that no important aspects of the study have been omitted, and that any discrepancies from the study as originally planned have been explained. The authors alone are responsible for the views expressed in this Article and they do not necessarily represent the decisions, policies, or views of the International Agency for Research on Cancer (IARC), WHO, the US National Institutes of Health or National Cancer Institute, the National Institute for Health Research (NIHR), or the UK Department of Health and Social Care. The study was supported by the Barakat Foundation, Alborz Darou, and Tehran University of Medical Sciences. The GCS was supported by Cancer Research UK (grant no C20/A5860), Tehran University of Medical Sciences (grant no 81/15), and the IARC. TM is supported by the NIHR Collaboration for Leadership in Applied Health Research and Care West Midlands.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Bahiru E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009868.pub3; Bramlage P, 2017, EUR J PREV CARDIOL, V24, P297, DOI 10.1177/2047487316674817; Castellano JM, 2014, J AM COLL CARDIOL, V64, P2071, DOI 10.1016/j.jacc.2014.08.021; Chow CK, 2019, NAT REV CARDIOL, V16, P602, DOI 10.1038/s41569-019-0209-y; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Huffman MD, 2017, LANCET, V389, P1055, DOI 10.1016/S0140-6736(17)30553-6; Joseph P, 2018, AM HEART J, V206, P72, DOI 10.1016/j.ahj.2018.07.012; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Lozano R, 2018, LANCET, V392, P2091, DOI [10.1016/S0140-6736(18)32281-5, 10.1016/s0140-6736(18)32281-5]; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Mokdad AH, 2018, INT J PUBLIC HEALTH, V63, P137, DOI 10.1007/s00038-017-1012-3; Nalini M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021479; Nalini M, 2018, ARCH IRAN MED, V21, P86; Ostovaneh MR, 2015, EUR J PREV CARDIOL, V22, P1609, DOI 10.1177/2047487314550803; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Republic of Slovenia, 1995, ZAK NAL BOL COMM DIS; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Sanz G, 2013, NAT REV CARDIOL, V10, P683, DOI 10.1038/nrcardio.2013.157; Selak V, 2011, CONTEMP CLIN TRIALS, V32, P909, DOI 10.1016/j.cct.2011.07.006; Singh K, 2018, INT J CARDIOL, V262, P71, DOI 10.1016/j.ijcard.2018.03.082; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; United Nations Development Program, 2019, SUST DEV GOALS; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Zheng SL, 2019, JAMA-J AM MED ASSOC, V321, P277, DOI 10.1001/jama.2018.20578	28	130	132	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					672	683		10.1016/S0140-6736(19)31791-X	http://dx.doi.org/10.1016/S0140-6736(19)31791-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT6UU	31448738	Green Submitted			2022-12-28	WOS:000483011200031
J	Rugar, D; Giessibl, F				Rugar, Daniel; Giessibl, Franz			Calvin F. Quate (1923-2019)	SCIENCE			English	Biographical-Item									[Rugar, Daniel] Almaden Res Ctr, IBM Res Div, San Jose, CA 95120 USA; [Giessibl, Franz] Univ Regensburg, Inst Expt & Appl Phys, Regensburg, Germany	International Business Machines (IBM); University of Regensburg	Rugar, D (corresponding author), Almaden Res Ctr, IBM Res Div, San Jose, CA 95120 USA.	rugar@us.ibm.com; franz.giessibl@ur.de	Giessibl, Franz J/K-8022-2013	Giessibl, Franz J/0000-0002-5585-1326				QUATE CF, PUBLICATION LIST	1	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		760	760		10.1126/science.aay9386	http://dx.doi.org/10.1126/science.aay9386			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439786				2022-12-28	WOS:000482464000032
J	Brown, KGM; Solomon, MJ; Mahon, K; O'Shannassy, S				Brown, Kilian G. M.; Solomon, Michael J.; Mahon, Kate; O'Shannassy, Sarah			Management of colorectal cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LAPAROSCOPIC-ASSISTED RESECTION; MECHANICAL BOWEL PREPARATION; RANDOMIZED CLINICAL-TRIAL; IRELAND ACPGBI GUIDELINES; SHORT-COURSE RADIOTHERAPY; SURGICAL SITE INFECTION; LOW ANTERIOR RESECTION; QUALITY-OF-LIFE; RECTAL-CANCER; COLON-CANCER		[Brown, Kilian G. M.; Solomon, Michael J.] Surg Outcomes Res Ctr SOuRCe, Sydney, NSW, Australia; [Brown, Kilian G. M.; Solomon, Michael J.; O'Shannassy, Sarah] Royal Prince Alfred Hosp, Inst Acad Surg, Sydney, NSW, Australia; [Brown, Kilian G. M.; Solomon, Michael J.; O'Shannassy, Sarah] Royal Prince Alfred Hosp, Dept Colorectal Surg, Sydney, NSW, Australia; [Solomon, Michael J.; Mahon, Kate] Univ Sydney, Sydney, NSW, Australia; [Mahon, Kate] Chris OBrien Lifehouse, Dept Med Oncol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Solomon, MJ (corresponding author), Surg Outcomes Res Ctr SOuRCe, Sydney, NSW, Australia.; Solomon, MJ (corresponding author), Royal Prince Alfred Hosp, Inst Acad Surg, Sydney, NSW, Australia.; Solomon, MJ (corresponding author), Royal Prince Alfred Hosp, Dept Colorectal Surg, Sydney, NSW, Australia.; Solomon, MJ (corresponding author), Univ Sydney, Sydney, NSW, Australia.	professor.solomon@sydney.edu.au	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913				Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Bagshaw PF, 2012, ANN SURG, V256, P915, DOI 10.1097/SLA.0b013e3182765ff8; Battersby NJ, 2016, DIS COLON RECTUM, V59, P270, DOI 10.1097/DCR.0000000000000552; Bockelman C, 2015, ACTA ONCOL, V54, P5, DOI 10.3109/0284186X.2014.975839; Bregendahl S, 2015, COLORECTAL DIS, V17, P26, DOI 10.1111/codi.12758; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brown H, 2005, J CLIN NURS, V14, P74, DOI 10.1111/j.1365-2702.2004.00945.x; Bucher P, 2005, BRIT J SURG, V92, P409, DOI 10.1002/bjs.4900; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Chaudhri S, 2005, DIS COLON RECTUM, V48, P504, DOI 10.1007/s10350-004-0897-0; Danielsen AK, 2013, COLORECTAL DIS, V15, pE276, DOI 10.1111/codi.12197; Deijen CL, 2017, SURG ENDOSC, V31, P2607, DOI 10.1007/s00464-016-5270-6; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Fleshman J, 2015, JAMA-J AM MED ASSOC, V314, P1346, DOI 10.1001/jama.2015.10529; Fowler JM, 2007, RADIOLOGY, V243, P132, DOI 10.1148/radiol.2431051825; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Glynne-Jones R, 2017, ANN ONCOL, V28, P22, DOI 10.1093/annonc/mdx224; Gollins S, 2017, COLORECTAL DIS, V19, P37, DOI 10.1111/codi.13705; Gray R, 2001, LANCET, V358, P1291; Guenaga KF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001544.pub4; Hellinger Michael D, 2006, Clin Colon Rectal Surg, V19, P228, DOI 10.1055/s-2006-956445; Hendren SK, 2005, ANN SURG, V242, P212, DOI 10.1097/01.sla.0000171299.43954.ce; How P, 2012, DIS COLON RECTUM, V55, P400, DOI 10.1097/DCR.0b013e3182444fd1; Hu WH, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0081-5; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Jayne DG, 2005, BRIT J SURG, V92, P1124, DOI 10.1002/bjs.4989; Keane C, 2017, COLORECTAL DIS, V19, P713, DOI 10.1111/codi.13767; Kiran RP, 2015, ANN SURG, V262, P416, DOI 10.1097/SLA.0000000000001416; Kuhry E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003432.pub2; Lange MM, 2011, NAT REV UROL, V8, P51, DOI 10.1038/nrurol.2010.206; Lassen K, 2009, ARCH SURG-CHICAGO, V144, P961, DOI 10.1001/archsurg.2009.170; Martnez-Perez A, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2016.5665; McDermott FDAS, 2016, ISSUES PROFESSIONAL; Moran B, 2017, COLORECTAL DIS, V19, P18, DOI 10.1111/codi.13704; Morris MS, 2015, ANN SURG, V261, P1034, DOI 10.1097/SLA.0000000000001125; National Health and Medical Research Council, 2017, CLIN PRACT GUID PREV; National Institute for Health and Care Excellence, 2011, COL CANC DIAGN MAN C; Ngan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597; Noblett SE, 2006, COLORECTAL DIS, V8, P563, DOI 10.1111/j.1463-1318.2006.00965.x; Pachler J, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004323.PUB4; Salvadalena G, 2008, J WOUND OSTOMY CONT, V35, P596, DOI 10.1097/01.WON.0000341473.86932.89; Scarborough JE, 2015, ANN SURG, V262, P331, DOI 10.1097/SLA.0000000000001041; Stevenson ARL, 2015, JAMA-J AM MED ASSOC, V314, P1356, DOI 10.1001/jama.2015.12009; Thrumurthy SG, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3590; Tjandra JJ, 2006, COLORECTAL DIS, V8, P375, DOI 10.1111/j.1463-1318.2006.00974.x; Wille-Jorgensen P, 2005, COLORECTAL DIS, V7, P304, DOI 10.1111/j.1463-1318.2005.00804.x; Yamano T, 2016, INT J COLORECTAL DIS, V31, P877, DOI 10.1007/s00384-016-2507-8; Zhuang CL, 2013, DIS COLON RECTUM, V56, P667, DOI 10.1097/DCR.0b013e3182812842; Zmora O, 2003, ANN SURG, V237, P363, DOI 10.1097/00000658-200303000-00010	51	25	26	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2019	366								l4561	10.1136/bmj.l4561	http://dx.doi.org/10.1136/bmj.l4561			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DJ	31439545				2022-12-28	WOS:000482882300002
J	Li, J; Ha, NS; Liu, T; van Dam, RM; Kim, CJ				Li, Jia; Ha, Noel S.; Liu, Tingyi 'Leo'; van Dam, R. Michael; Kim, Chang-Jin 'CJ'			Ionic-surfactant-mediated electro-dewetting for digital microfluidics	NATURE			English	Article							LIQUID DROPLETS; ACTIVE CONTROL; ACTUATION; VOLTAGE; ADSORPTION; CHARGE; WATER; CHIP	The ability to manipulate droplets on a substrate using electric signals(1)-known as digital microfluidics-is used in optical(2,3), biomedical(4,5), thermal(6) and electronic(7) applications and has led to commercially available liquid lenses(8) and diagnostics kits(9,10). Such electrical actuation is mainly achieved by electrowetting, with droplets attracted towards and spreading on a conductive substrate in response to an applied voltage. To ensure strong and practical actuation, the substrate is covered with a dielectric layer and a hydrophobic topcoat for electrowetting-on-dielectric (EWOD)(11-13); this increases the actuation voltage (to about 100 volts) and can compromise reliability owing to dielectric breakdown(14), electric charging(15) and biofouling(16). Here we demonstrate droplet manipulation that uses electrical signals to induce the liquid to dewet, rather than wet, a hydrophilic conductive substrate without the need for added layers. In this electrodewetting mechanism, which is phenomenologically opposite to electrowetting, the liquid-substrate interaction is not controlled directly by electric field but instead by field-induced attachment and detachment of ionic surfactants to the substrate. We show that this actuation mechanism can perform all the basic fluidic operations of digital microfluidics using water on doped silicon wafers in air, with only +/- 2.5 volts of driving voltage, a few microamperes of current and about 0.015 times the critical micelle concentration of an ionic surfactant. The system can also handle common buffers and organic solvents, promising a simple and reliable microfluidic platform for a broad range of applications.	[Li, Jia; Liu, Tingyi 'Leo'; Kim, Chang-Jin 'CJ'] Univ Calif Los Angeles, Mech & Aerosp Engn Dept, Los Angeles, CA 90032 USA; [Ha, Noel S.; van Dam, R. Michael; Kim, Chang-Jin 'CJ'] Univ Calif Los Angeles, Bioengn Dept, Los Angeles, CA 90032 USA; [Ha, Noel S.; van Dam, R. Michael] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Liu, Tingyi 'Leo'] Univ Massachusetts, Mech & Ind Engn Dept, Amherst, MA 01003 USA; [Liu, Tingyi 'Leo'] Univ Massachusetts, Inst Appl Life Sci, Amherst, MA 01003 USA; [van Dam, R. Michael] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [van Dam, R. Michael; Kim, Chang-Jin 'CJ'] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90032 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kim, CJ (corresponding author), Univ Calif Los Angeles, Mech & Aerosp Engn Dept, Los Angeles, CA 90032 USA.; Kim, CJ (corresponding author), Univ Calif Los Angeles, Bioengn Dept, Los Angeles, CA 90032 USA.; Kim, CJ (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90032 USA.	cjkim@ucla.edu	Kim, Chang-Jin/F-6730-2011; Liu, Tingyi/AAB-8492-2020; Liu, Tingyi/O-8127-2014; van Dam, Michael/F-3943-2012	Kim, Chang-Jin/0000-0002-4600-9962; Liu, Tingyi/0000-0002-8928-1560; van Dam, Michael/0000-0003-2316-0173; Ha, Noel/0000-0002-3275-577X	National Science Foundation [1711708, 1720499]; National Institute on Aging [R21 AG049918]; Volgenau Endowed Chair in Engineering; Ralph and Marjorie Crump for the UCLA Crump Institute for Molecular Imaging; Simons Math + X Investigator Award [510776]; University of Massachusetts Amherst	National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Volgenau Endowed Chair in Engineering; Ralph and Marjorie Crump for the UCLA Crump Institute for Molecular Imaging; Simons Math + X Investigator Award; University of Massachusetts Amherst	This work was supported by the National Science Foundation (grants 1711708 and 1720499), by the National Institute on Aging (grant R21 AG049918), by the Volgenau Endowed Chair in Engineering (C.-J.K.), by Ralph and Marjorie Crump for the UCLA Crump Institute for Molecular Imaging (R.M.v.D.), by the Simons Math + X Investigator Award (award 510776) (J.L.) and by the University of Massachusetts Amherst startup package (T.L.). We thank S. Seidlits and W. Xiao for helping with the fluorescence microscopy, S. Sadeghi and M. Balandeh for discussions on electrochemical measurements, J. Wang for help with buffer solutions, and A. L. Bertozzi for discussions on modelling.	ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005; Aguiar J, 2003, J COLLOID INTERF SCI, V258, P116, DOI 10.1016/S0021-9797(02)00082-6; Annapragada SR, 2011, LANGMUIR, V27, P8198, DOI 10.1021/la201322b; [Anonymous], 2019, CORN VAR LENS; [Anonymous], 2019, VOLTRAX; [Anonymous], 2019, EPLEX TRUE SAMPL TO; BENI G, 1981, APPL PHYS LETT, V38, P207, DOI 10.1063/1.92322; BERGE B, 1993, CR ACAD SCI II, V317, P157; Berge B, 2000, EUR PHYS J E, V3, P159, DOI 10.1007/s101890070029; Cheng JT, 2010, EXP FLUIDS, V49, P1349, DOI 10.1007/s00348-010-0882-4; Cho HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9599; Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467; Chokkalingam V, 2013, LAB CHIP, V13, P4740, DOI 10.1039/c3lc50945a; Davanlou A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09531; DICK SG, 1971, J COLLOID INTERF SCI, V37, P595, DOI 10.1016/0021-9797(71)90337-7; ERB RA, 1968, J PHYS CHEM-US, V72, P2412, DOI 10.1021/j100853a023; Fan SK, 2009, LAB CHIP, V9, P1236, DOI 10.1039/b816535a; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; Geng HY, 2017, LAB CHIP, V17, P1060, DOI 10.1039/c7lc00006e; Goloub TP, 1996, LANGMUIR, V12, P3188, DOI 10.1021/la9505475; HARE EF, 1955, J PHYS CHEM-US, V59, P335, DOI 10.1021/j150526a014; Hayes RA, 2003, NATURE, V425, P383, DOI 10.1038/nature01988; He SQ, 2011, TRIBOL LETT, V41, P485, DOI 10.1007/s11249-010-9604-6; Hu GH, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2998845; Jones TB, 2001, J APPL PHYS, V89, P1441, DOI 10.1063/1.1332799; Keng PY, 2012, P NATL ACAD SCI USA, V109, P690, DOI 10.1073/pnas.1117566109; Koo B, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/6/067002; Lapierre F, 2013, LANGMUIR, V29, P13346, DOI 10.1021/la4026848; Latip ENA, 2017, RSC ADV, V7, P49633, DOI 10.1039/c7ra10920b; Lee J, 2002, SENSOR ACTUAT A-PHYS, V95, P259, DOI 10.1016/S0924-4247(01)00734-8; Lomax DJ, 2016, SOFT MATTER, V12, P8798, DOI 10.1039/c6sm01565d; Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509; McHale G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186101; Moon H, 2002, J APPL PHYS, V92, P4080, DOI 10.1063/1.1504171; Mugele F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10519; Nave MI, 2017, FARADAY DISCUSS, V199, P101, DOI 10.1039/c6fd00239k; Nelson WC, 2012, J ADHES SCI TECHNOL, V26, P1747, DOI 10.1163/156856111X599562; Peng L, 2009, COLLOID SURFACE A, V334, P112, DOI 10.1016/j.colsurfa.2008.10.028; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Raj B, 2009, LANGMUIR, V25, P12387, DOI 10.1021/la9016933; Reboud J, 2012, P NATL ACAD SCI USA, V109, P15162, DOI 10.1073/pnas.1206055109; Ruzyllo J., 2016, SEMICONDUCTOR GLOSSA; Sanderson H, 2006, SCI TOTAL ENVIRON, V368, P695, DOI 10.1016/j.scitotenv.2006.04.030; Sen P, 2009, J MICROELECTROMECH S, V18, P990, DOI 10.1109/JMEMS.2009.2029170; Srinivasan V, 2004, LAB CHIP, V4, P310, DOI 10.1039/b403341h; Stalder AF, 2006, COLLOID SURFACE A, V286, P92, DOI 10.1016/j.colsurfa.2006.03.008; Verheijen HJJ, 1999, LANGMUIR, V15, P6616, DOI 10.1021/la990548n; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Xu W, 2016, SOFT MATTER, V12, P6902, DOI 10.1039/c6sm01223j; Zhang Y, 2017, LAB CHIP, V17, P994, DOI 10.1039/c7lc00025a	50	99	101	59	420	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2019	572	7770					507	+		10.1038/s41586-019-1491-x	http://dx.doi.org/10.1038/s41586-019-1491-x			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS5UZ	31435058	Green Submitted			2022-12-28	WOS:000482219600041
J	Van de Weyer, AL; Monteiro, F; Furzer, OJ; Nishimura, MT; Cevik, V; Witek, K; Jones, JDG; Dangl, JL; Weigel, D; Bemm, F				Van de Weyer, Anna-Lena; Monteiro, Freddy; Furzer, Oliver J.; Nishimura, Marc T.; Cevik, Volkan; Witek, Kamil; Jones, Jonathan D. G.; Dangl, Jeffery L.; Weigel, Detlef; Bemm, Felix			A Species-Wide Inventory of NLR Genes and Alleles in Arabidopsis thaliana	CELL			English	Article							DOWNY MILDEW RESISTANCE; INFORMATION RESOURCE TAIR; PLANT IMMUNE RECEPTORS; PATHOGEN EFFECTORS; RECOGNITION SPECIFICITY; ENCODING GENES; LRR GENES; PROTEIN; GENOME; EVOLUTION	Infectious disease is both a major force of selection in nature and a prime cause of yield loss in agriculture. In plants, disease resistance is often conferred by nucleotide-binding leucine-rich repeat (NLR) proteins, intracellular immune receptors that recognize pathogen proteins and their effects on the host. Consistent with extensive balancing and positive selection, NLRs are encoded by one of the most variable gene families in plants, but the true extent of intraspecific NLR diversity has been unclear. Here, we define a nearly complete species-wide pan-NLRome in Arabidopsis thaliana based on sequence enrichment and long-read sequencing. The pan-NLRome largely saturates with approximately 40 well-chosen wild strains, with half of the pan-NLRome being present in most accessions. We chart NLR architectural diversity, identify new architectures, and quantify selective forces that act on specific NLRs and NLR domains. Our study provides a blueprint for defining pan-NLRomes.	[Van de Weyer, Anna-Lena; Weigel, Detlef; Bemm, Felix] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Monteiro, Freddy; Furzer, Oliver J.; Dangl, Jeffery L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Monteiro, Freddy; Furzer, Oliver J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Monteiro, Freddy] CSIC IRTA UAB UB, CRAG, Barcelona 08193, Spain; [Nishimura, Marc T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Furzer, Oliver J.; Cevik, Volkan; Witek, Kamil; Jones, Jonathan D. G.] Univ East Anglia, Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Cevik, Volkan] Univ Bath, Milner Ctr Evolut, Bath BA2 7AY, Avon, England; [Cevik, Volkan] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Max Planck Society; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Colorado State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of Bath; University of Bath	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.; Dangl, JL (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Jones, JDG (corresponding author), Univ East Anglia, Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	jonathan.jones@tsl.ac.uk; dangl@email.unc.edu; weigel@weigelworld.org	Furzer, Oliver/Q-8581-2019; Monteiro, Freddy/E-4043-2019; Jones, Jonathan DG/J-5129-2012; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022	Monteiro, Freddy/0000-0002-9080-6715; Jones, Jonathan DG/0000-0002-4953-261X; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963	Gordon and Betty Moore Foundation [GBMF4725]; Gatsby Charitable Foundation; BBSRC [BB/M003809/1, BB/P021646/1, BB/L009293/1]; NSF [IOS-1758400]; Howard Hughes Medical Institute; European Research Council [IMMUNEMESIS 340602]; Max Planck Society; BBSRC [BB/H019820/1] Funding Source: UKRI	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Florian Jupe for sharing methods before publication, Eunyoung Chae for contributing with alleles for bait design, Burkhard Steuernagel for assistance with demultiplexing, and Johannes Hofberger and Eric Schranz for providing sequences for an early version of the bait library. J.L.D. is an Investigator of the Howard Hughes Medical Institute. We would like to thank three anonymous reviewers, whose comments improved the quality and readability of the manuscript. This work was supported by a grant from the Gordon and Betty Moore Foundation to the 2Blades Foundation (GBMF4725) (J.D.G.J., J.L.D., D.W.); by the Gatsby Charitable Foundation (O.J.F., K.W., J.D.G.J.); by BBSRC grants BB/M003809/1, BB/P021646/1, and BB/L009293/1 (O.J.F., J.D.G.J.); by NSF grant IOS-1758400 (J.L.D.); the Howard Hughes Medical Institute (J.L.D.); the European Research Council (Advanced Grant IMMUNEMESIS 340602); and the Max Planck Society (D.W.). The ORCIDs for authors are as follows: 0000-0002-5180-897X (A.-L.V.d.W.), 0000-0002-9080-6715 (F.M.), 0000-0002-3536-9970 (O.J.F.), 0000-0003-46666-900 (M.T.N.), 0000-0002-3545-3179 (V.C.), 0000-0003-0659-5562 (K.W.), 0000-0002-4953-261X (J.D.G.J.), 0000-0003-3199-8654 (J.L.D.), 0000-0002-2114-7963 (D.W.), and 0000-0001-6557-4898 (F.B.).	Aberer AJ, 2014, MOL BIOL EVOL, V31, P2553, DOI 10.1093/molbev/msu236; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; [Anonymous], 2015, RSTUDIO INT DEV ENV; Asai S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08095-9; Baggs E, 2017, CURR OPIN PLANT BIOL, V38, P59, DOI 10.1016/j.pbi.2017.04.012; Bailey PC, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1392-6; Bakker EG, 2008, GENETICS, V178, P2031, DOI 10.1534/genetics.107.083279; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Bushmanova E, 2016, BIOINFORMATICS, V32, P2210, DOI 10.1093/bioinformatics/btw218; Campbell Michael S, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0411s48; Castel B, 2019, NEW PHYTOL, V222, P966, DOI 10.1111/nph.15659; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cevik V, 2019, P NATL ACAD SCI USA, V116, P2767, DOI 10.1073/pnas.1812911116; Chae E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005452; Chae E, 2014, CELL, V159, P1341, DOI 10.1016/j.cell.2014.10.049; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Durvasula A, 2017, P NATL ACAD SCI USA, V114, P5213, DOI 10.1073/pnas.1616736114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekseth OK, 2014, BIOINFORMATICS, V30, P734, DOI 10.1093/bioinformatics/btt582; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fulgione A, 2018, NEW PHYTOL, V219, P1194, DOI 10.1111/nph.15244; Fulgione A, 2018, MOL BIOL EVOL, V35, P564, DOI 10.1093/molbev/msx300; Gao YX, 2018, PLANT PHYSIOL, V177, P82, DOI 10.1104/pp.18.00185; Goritschnig S, 2016, NEW PHYTOL, V210, P984, DOI 10.1111/nph.13823; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; Lam HM, 2018, MOL BIOL EVOL, V35, P247, DOI 10.1093/molbev/msx263; Haudry A, 2013, NAT GENET, V45, P891, DOI 10.1038/ng.2684; Helm M, 2019, MOL PLANT MICROBE IN, V32, P760, DOI 10.1094/MPMI-12-18-0324-R; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; Hollister JD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003093; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Jehl P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0702-1; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Karasov TL, 2017, PLANT CELL, V29, P666, DOI 10.1105/tpc.16.00931; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Kemmerling B, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00088; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim SH, 2016, SCIENCE, V351, P684, DOI 10.1126/science.aad3436; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Kourelis J, 2016, TRENDS PLANT SCI, V21, P371, DOI 10.1016/j.tplants.2016.04.001; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Leister D, 1998, P NATL ACAD SCI USA, V95, P370, DOI 10.1073/pnas.95.1.370; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li X, 2015, CURR OPIN IMMUNOL, V32, P114, DOI 10.1016/j.coi.2015.01.014; Liu JY, 2015, J GEN PLANT PATHOL, V81, P180, DOI 10.1007/s10327-015-0583-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Y, 2018, P NATL ACAD SCI USA, V115, P10218, DOI 10.1073/pnas.1811858115; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Monteiro F., 2019, DATA FIGURE SCRIPTS; Monteiro F, 2018, ANNU REV PHYTOPATHOL, V56, P243, DOI 10.1146/annurev-phyto-080417-045817; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Neelabh, 2016, PROBIOTICS ANTIMICRO, V8, P85, DOI 10.1007/s12602-016-9212-3; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Novikova PY, 2016, NAT GENET, V48, P1077, DOI 10.1038/ng.3617; Ohno S., 1970, EVOLUTION GENE DUPLI; Peele HM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0298-z; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; Pisupati R, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.184; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prince DC, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0360-z; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Rosenfeld D, 2019, SCIENCE, V364, DOI 10.1126/science.aay4194; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Saucet SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7338; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao ZQ, 2016, PLANT PHYSIOL, V170, P2095, DOI 10.1104/pp.15.01487; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Steuernagel B, 2015, BIOINFORMATICS, V31, P1665, DOI 10.1093/bioinformatics/btv005; Sugio A, 2014, NEW PHYTOL, V202, P838, DOI 10.1111/nph.12721; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; Team RC., 2022, LANG ENV STAT COMP; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Uehling J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006578; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Wang JY, 2011, GENOME, V54, P1029, DOI [10.1139/G11-069, 10.1139/g11-069]; Wang J, 2016, PLANT PHYSIOL, V172, P427, DOI 10.1104/pp.16.01177; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Witek K., 2016, PROTOC EXCHANGE; Witek K, 2016, NAT BIOTECHNOL, V34, P656, DOI 10.1038/nbt.3540; Wright SI, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0133; Wu CH, 2017, P NATL ACAD SCI USA, V114, P8113, DOI 10.1073/pnas.1702041114; Xu F., 2015, SCI REP, V5, P1, DOI DOI 10.1038/SREP08792; Yang L, 2017, CELL HOST MICROBE, V21, P156, DOI 10.1016/j.chom.2017.01.003; Yang RL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00046; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang YM, 2016, J INTEGR PLANT BIOL, V58, P165, DOI 10.1111/jipb.12365; Zhang Y, 2017, NEW PHYTOL, V213, P1330, DOI 10.1111/nph.14216; Zhang Y, 2016, MOL BIOL EVOL, V33, P2692, DOI 10.1093/molbev/msw154; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zou YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1378-9	135	131	130	4	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1260	+		10.1016/j.cell.2019.07.038	http://dx.doi.org/10.1016/j.cell.2019.07.038			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442410	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000482191000020
J	Yusuf, S; Joseph, P; Rangarajan, S; Islam, S; Mente, A; Hystad, P; Brauer, M; Kutty, VR; Gupta, R; Wielgosz, A; AlHabib, KF; Dans, A; Lopez-Jaramillo, P; Avezum, A; Lanas, F; Oguz, A; Kruger, IM; Diaz, R; Yusoff, K; Mony, P; Chifamba, J; Yeates, K; Kelishadi, R; Yusufali, A; Khatib, R; Rahman, O; Zatonska, K; Iqbal, R; Wei, L; Bo, H; Rosengren, A; Kaur, M; Mohan, V; Lear, SA; Teo, KK; Leong, D; O'Donnell, M; McKee, M; Dagenais, G				Yusuf, Salim; Joseph, Philip; Rangarajan, Sumathy; Islam, Shofiqul; Mente, Andrew; Hystad, Perry; Brauer, Michael; Kutty, Vellappillil Raman; Gupta, Rajeev; Wielgosz, Andreas; AlHabib, Khalid F.; Dans, Antonio; Lopez-Jaramillo, Patricio; Avezum, Alvaro; Lanas, Fernando; Oguz, Aytekin; Kruger, Iolanthe M.; Diaz, Rafael; Yusoff, Khalid; Mony, Prem; Chifamba, Jephat; Yeates, Karen; Kelishadi, Roya; Yusufali, Afzalhussein; Khatib, Rasha; Rahman, Omar; Zatonska, Katarzyna; Iqbal, Romaina; Wei, Li; Bo, Hu; Rosengren, Annika; Kaur, Manmeet; Mohan, Viswanathan; Lear, Scott A.; Teo, Koon K.; Leong, Darryl; O'Donnell, Martin; McKee, Martin; Dagenais, Gilles			Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study	LANCET			English	Article							URINARY SODIUM; MYOCARDIAL-INFARCTION; POTASSIUM EXCRETION; BLOOD-PRESSURE	Background Global estimates of the effect of common modifiable risk factors on cardiovascular disease and mortality are largely based on data from separate studies, using different methodologies. The Prospective Urban Rural Epidemiology (PURE) study overcomes these limitations by using similar methods to prospectively measure the effect of modifiable risk factors on cardiovascular disease and mortality across 21 countries (spanning five continents) grouped by different economic levels. Methods In this multinational, prospective cohort study, we examined associations for 14 potentially modifiable risk factors with mortality and cardiovascular disease in 155 722 participants without a prior history of cardiovascular disease from 21 high-income, middle-income, or low-income countries (HICs, MICs, or LICs). The primary outcomes for this paper were composites of cardiovascular disease events (defined as cardiovascular death, myocardial infarction, stroke, and heart failure) and mortality. We describe the prevalence, hazard ratios (HRs), and population-attributable fractions (PAFs) for cardiovascular disease and mortality associated with a cluster of behavioural factors (ie, tobacco use, alcohol, diet, physical activity, and sodium intake), metabolic factors (ie, lipids, blood pressure, diabetes, obesity), socioeconomic and psychosocial factors (ie, education, symptoms of depression), grip strength, and household and ambient pollution. Associations between risk factors and the outcomes were established using multivariable Cox frailty models and using PAFs for the entire cohort, and also by countries grouped by income level. Associations are presented as HRs and PAFs with 95% CIs. Findings Between Jan 6, 2005, and Dec 4, 2016, 155 722 participants were enrolled and followed up for measurement of risk factors. 17 249 (11.1%) participants were from HICs, 102 680 (65.9%) were from MICs, and 35 793 (23.0%) from LICs. Approximately 70% of cardiovascular disease cases and deaths in the overall study population were attributed to modifiable risk factors. Metabolic factors were the predominant risk factors for cardiovascular disease (41.2% of the PAF), with hypertension being the largest (22.3% of the PAF). As a cluster, behavioural risk factors contributed most to deaths (26.3% of the PAF), although the single largest risk factor was a low education level (12.5% of the PAF). Ambient air pollution was associated with 13.9% of the PAF for cardiovascular disease, although different statistical methods were used for this analysis. In MICs and LICs, household air pollution, poor diet, low education, and low grip strength had stronger effects on cardiovascular disease or mortality than in HICs. Interpretation Most cardiovascular disease cases and deaths can be attributed to a small number of common, modifiable risk factors. While some factors have extensive global effects (eg, hypertension and education), others (eg, household air pollution and poor diet) vary by a country's economic level. Health policies should focus on risk factors that have the greatest effects on averting cardiovascular disease and death globally, with additional emphasis on risk factors of greatest importance in specific groups of countries. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Yusuf, Salim; Joseph, Philip; Rangarajan, Sumathy; Islam, Shofiqul; Mente, Andrew; Teo, Koon K.; Leong, Darryl] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Yusuf, Salim; Joseph, Philip; Rangarajan, Sumathy; Islam, Shofiqul; Mente, Andrew; Teo, Koon K.; Leong, Darryl] Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Hystad, Perry] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Brauer, Michael] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Kutty, Vellappillil Raman] Hlth Act People, Trivandrum, Kerala, India; [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India; [Wielgosz, Andreas] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [AlHabib, Khalid F.] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh, Saudi Arabia; [Dans, Antonio] Univ Philippines, Dept Cardiac Sci, Manila, Philippines; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander Clin Carlos Ardila Lulle F, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Escuela Med, Bucaramanga, Colombia; [Avezum, Alvaro] Univ Santo Amaro, Hosp Alemao Oswaldo Cruz, Dept Med, Sao Paulo, Brazil; [Lanas, Fernando] Univ La Frontera, Dept Med, Temuco, Chile; [Oguz, Aytekin] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Kruger, Iolanthe M.] North West Univ, Africa Unit Transdisciplinary Hlth Res AUTHeR, Potchefstroom, South Africa; [Diaz, Rafael] Estudios Clin Latinoamer ECLA, Rosario, Santa Fe, Argentina; [Yusoff, Khalid] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia; [Yusoff, Khalid] UCSI Univ, Kuala Lumpur, Malaysia; [Mony, Prem] St Johns Med Coll, St Johns Res Inst, Bangalore, Karnataka, India; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Physiol Dept, Harare, Zimbabwe; [Yeates, Karen] Queens Univ, Dept Med, Kingston, ON, Canada; [Kelishadi, Roya] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Cardiovasc Res Inst, Esfahan, Iran; [Yusufali, Afzalhussein] Dubai Med Univ, Hatta Hosp, Dept Med, Dubai Hlth Author, Dubai, U Arab Emirates; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Khatib, Rasha] Advocate Hlth Care, Chicago, IL USA; [Rahman, Omar] Independent Univ, Dhaka, Bangladesh; [Zatonska, Katarzyna] Wroclaw Med Univ, Dept Social Med, Wroclaw, Poland; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Wei, Li; Bo, Hu] Chinese Acad Med Sci, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Wei, Li; Bo, Hu] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Kaur, Manmeet] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Chennai, Tamil Nadu, India; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [O'Donnell, Martin] Natl Univ Ireland Galway, Dept Med, Galway, Ireland; [McKee, Martin] London Sch Hyg & Trop Med, Dept Publ Hlth, London, England; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	McMaster University; Population Health Research Institute; McMaster University; Oregon State University; University of British Columbia; Eternal Heart Care Centre & Research Institute; University of Ottawa; King Saud University; University of the Philippines System; University of the Philippines Manila; Universidad Industrial de Santander; Universidade de Santo Amaro (UNISA); Universidad de La Frontera; Istanbul Medeniyet University; North West University - South Africa; Universiti Teknologi MARA; UCSI University; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's Research Institute; University of Zimbabwe; Queens University - Canada; Isfahan University Medical Science; Birzeit University; Independent University Bangladesh (IUB); Wroclaw Medical University; Aga Khan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Gothenburg; Sahlgrenska University Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Madras Diabetes Research Foundation; Simon Fraser University; Ollscoil na Gaillimhe-University of Galway; University of London; London School of Hygiene & Tropical Medicine; Laval University	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.; Yusuf, S (corresponding author), Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Rahman, Omar/E-1329-2019; Brauer, Michael/Y-2810-2019; Qorbani, Mostafa/M-8171-2017; Lanas, Fernando/AAE-8842-2022; Khatib, Rasha/GXV-8883-2022; Avezum, Alvaro/AAP-7687-2020; Oguz, Aytekin/AAJ-2732-2021; Ramli, Anis Safura/K-3322-2014; Kelishadi, Roya/E-6154-2012; Kruger, Iolanthe M/G-8698-2015; Chifamba, Jephat/AHE-4535-2022; O'Donnell, Martin/ABE-7459-2020; Mony, Prem K./GRF-4752-2022; Zatońska, Katarzyna/ABD-4236-2021; Rozanska, Dorota/S-5239-2018	Rahman, Omar/0000-0002-0606-2507; Brauer, Michael/0000-0002-9103-9343; Oguz, Aytekin/0000-0002-2595-5167; Ramli, Anis Safura/0000-0002-9517-1413; Kelishadi, Roya/0000-0001-7455-1495; Kruger, Iolanthe M/0000-0002-8636-7174; Chifamba, Jephat/0000-0001-8166-1182; O'Donnell, Martin/0000-0002-7347-7761; Mony, Prem K./0000-0002-1399-0520; Lanas, Fernando/0000-0003-3595-9759; Rozanska, Dorota/0000-0002-0561-2749; Regulska-Ilow, Bozena/0000-0002-5941-1715; Wolyniec, Maria/0000-0003-2054-1691; Szuba, Andrzej/0000-0002-7555-6201; Yusuf, Salim/0000-0003-4776-5601; AVEZUM, ALVARO/0000-0002-3073-6890; Zatonska, Katarzyna/0000-0002-3772-5588	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research (through the Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit); Heart and Stroke Foundation (ON, Canada); Ontario Ministry of Health and Long-Term Care; Canadian Institutes for Health Research [136893]; Office of the Director, National Institutes of Health [DP500019850]	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research (through the Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (ON, Canada); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Patrick Sheridan for additional statistical support and Matthew McQueen for supervising and standardising the laboratory analyses. The PURE study is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research (including through the Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit), the Heart and Stroke Foundation (ON, Canada), the Ontario Ministry of Health and Long-Term Care. The PURE-AIR study is funded by the Canadian Institutes for Health Research (grant 136893) and by the Office of the Director, National Institutes of Health (award DP500019850). It is also funded by unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier Laboratories, and GlaxoSmithKline, and additional contributions from Novartis, King Pharma, and from several national and local organisations in participating countries. Further details on the funding and participating countries and institutions, and on collaborating staff, are shown in the appendix (pp 24-31).	[Anonymous], 2018, LANCET; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; Ferguson J, 2018, STAT METHODS MED RES, V27, P1141, DOI 10.1177/0962280216655374; Hotchkiss JW, 2013, INT J OBESITY, V37, P732, DOI 10.1038/ijo.2012.102; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Mente A, 2018, LANCET, V392, P496, DOI [10.1016/S0140-6736(18)31376-X, 10.1016/s0140-6736(18)31376-x]; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Shaddick G, 2018, ENVIRON SCI TECHNOL, V52, P9069, DOI 10.1021/acs.est.8b02864; Skalamera J, 2016, PREV MED, V84, P83, DOI 10.1016/j.ypmed.2015.12.011; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Welsh CE, 2019, HYPERTENSION, V73, P1202, DOI 10.1161/HYPERTENSIONAHA.119.12726; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	22	435	442	27	159	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					795	808		10.1016/S0140-6736(19)32008-2	http://dx.doi.org/10.1016/S0140-6736(19)32008-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KH	31492503	Green Accepted			2022-12-28	WOS:000519536900036
J	Shinde, V; Narasimhan, VM; Rohland, N; Mallick, S; Mah, M; Lipson, M; Nakatsuka, N; Adamski, N; Broomandkhoshbacht, N; Ferry, M; Lawson, AM; Michel, M; Oppenheimer, J; Stewardson, K; Jadhav, N; Kim, YJ; Chatterjee, M; Munshi, A; Panyam, A; Waghmare, P; Yadav, Y; Patel, H; Kaushik, A; Thangaraj, K; Meyer, M; Patterson, N; Rai, N; Reich, D				Shinde, Vasant; Narasimhan, Vagheesh M.; Rohland, Nadin; Mallick, Swapan; Mah, Matthew; Lipson, Mark; Nakatsuka, Nathan; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Ferry, Matthew; Lawson, Ann Marie; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Jadhav, Nilesh; Kim, Yong Jun; Chatterjee, Malavika; Munshi, Avradeep; Panyam, Amrithavalli; Waghmare, Pranjali; Yadav, Yogesh; Patel, Himani; Kaushik, Amit; Thangaraj, Kumarasamy; Meyer, Matthias; Patterson, Nick; Rai, Niraj; Reich, David			An Ancient Harappan Genome Lacks Ancestry from Steppe Pastoralists or Iranian Farmers	CELL			English	Article							READ ALIGNMENT; DNA; CONTAMINATION; SEQUENCE; BONES	We report an ancient genome from the Indus Valley Civilization (IVC). The individual we sequenced fits as a mixture of people related to ancient Iranians (the largest component) and Southeast Asian hunter-gatherers, a unique profile that matches ancient DNA from 11 genetic outliers fromsites in Iran and Turkmenistan in cultural communication with the IVC. These individuals had little if any Steppe pastoralist-derived ancestry, showing that it was not ubiquitous in northwest South Asia during the IVC as it is today. The Iranian-related ancestry in the IVC derives froma lineage leading to early Iranian farmers, herders, and hunter-gatherers before their ancestors separated, contradicting the hypothesis that the shared ancestry between early Iranians and South Asians reflects a large-scale spread of western Iranian farmers east. Instead, sampled ancient genomes from the Iranian plateau and IVC descend from different groups of hunter-gatherers who began farming without being connected by substantial movement of people.	[Shinde, Vasant; Jadhav, Nilesh; Kim, Yong Jun; Chatterjee, Malavika; Munshi, Avradeep; Panyam, Amrithavalli; Waghmare, Pranjali; Yadav, Yogesh] Deccan Coll Postgrad & Res Inst, Dept Archaeol, Pune 411006, Maharashtra, India; [Narasimhan, Vagheesh M.; Rohland, Nadin; Mallick, Swapan; Mah, Matthew; Lipson, Mark; Nakatsuka, Nathan; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Ferry, Matthew; Lawson, Ann Marie; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Mallick, Swapan; Mah, Matthew; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Ferry, Matthew; Lawson, Ann Marie; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mallick, Swapan; Mah, Matthew; Patterson, Nick; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Patel, Himani; Rai, Niraj] Birbal Sahni Inst Palaeosci, Lucknow 226007, Uttar Pradesh, India; [Kaushik, Amit] Amity Univ, Amity Inst Biotechnol, Noida 201313, India; [Thangaraj, Kumarasamy; Rai, Niraj] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Meyer, Matthias] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Michel, Megan; Patterson, Nick] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Broomandkhoshbacht, Nasreen] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; [Michel, Megan] Max Planck Harvard Res Ctr Archaeosci Ancient Med, Cambridge, MA 02138 USA; [Oppenheimer, Jonas] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Amity University Noida; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Max Planck Society; Harvard University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Shinde, V (corresponding author), Deccan Coll Postgrad & Res Inst, Dept Archaeol, Pune 411006, Maharashtra, India.; Narasimhan, VM; Reich, D (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Reich, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Reich, D (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Rai, N (corresponding author), Birbal Sahni Inst Palaeosci, Lucknow 226007, Uttar Pradesh, India.; Rai, N (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.	vasant.shinde@dcpune.ac.in; vagheesh@mail.harvard.edu; nirajrai@bsip.res.in; reich@genetics.med.harvard.edu	kaushik, amit/AAD-4457-2022; Rai, Niraj/AAO-7618-2021	Rai, Niraj/0000-0002-1251-9390; Munshi, Avradeep/0000-0002-5890-4542; Lawson, Ann Marie/0000-0003-0990-2329; Michel, Megan/0000-0002-5484-7974; Oppenheimer, Jonas/0000-0001-7973-6173; Kaushik, Amit/0000-0001-9380-7011; Nakatsuka, Nathan/0000-0002-5091-4914; Yadav, Yogesh/0000-0002-0841-4254	FTT project (IndiGen) fund of the Council of Scientific and Industrial Research (CSIR), Government of India [MLP1809]; National Institutes of Health [GM100233, GM007753]; National Science Foundation HOMINID grant [BCS-1032255]; John Templeton Foundation [61220]; Allen Discovery Center grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	FTT project (IndiGen) fund of the Council of Scientific and Industrial Research (CSIR), Government of India; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation HOMINID grant; John Templeton Foundation; Allen Discovery Center grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Meadow for detailed comments on the archaeological context and several anonymous reviewers for critiques of the manuscript and suggestions for improvements. We thank Anna Koutoulas and the Genomics Platform at the Broad Institute for sequencing support. We thank Elena Essel and Sarah Nagel for help in the laboratory. K.T. was supported by the FTT project (IndiGen) fund (MLP1809) of the Council of Scientific and Industrial Research (CSIR), Government of India. N.N. was supported by National Institutes of Health grant GM007753. D.R. is an Investigator of the Howard Hughes Medical Institute, and his ancient DNA laboratory work was supported by National Science Foundation HOMINID grant BCS-1032255, by National Institutes of Health grant GM100233, by an Allen Discovery Center grant, and by grant 61220 from the John Templeton Foundation.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bellwood P.S., 2013, ENCY GLOBAL HUMAN MI, P87; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dales G.F., 1991, MONOGRAPHS WORLD ARC, V3, P61; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Feldman M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09209-7; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Glocke I, 2017, GENOME RES, V27, P1230, DOI 10.1101/gr.219675.116; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Heggarty P., 2019, PREHISTORY LANGUAGE, P616; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipson M, 2018, SCIENCE, V361, P92, DOI 10.1126/science.aat3188; Lipson M, 2017, MOL BIOL EVOL, V34, P889, DOI 10.1093/molbev/msw293; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mughal M. R., 1990, S ASIAN STUDIES, V6, P175; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Possehl G.L., 1982, HARAPPAN CIVILIZATIO, P16; POSSEHL GL, 1990, ANNU REV ANTHROPOL, V19, P261, DOI 10.1146/annurev.an.19.100190.001401; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Rohland N, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0050-5; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Shaffer Jim G., 1989, OLD PROBLEMS NEW PER, P117; Shinde VS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192299; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Vahia MN, 2016, CURR SCI INDIA, V111, P27; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233	42	30	31	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2019	179	3					729	+		10.1016/j.cell.2019.08.048	http://dx.doi.org/10.1016/j.cell.2019.08.048			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JE5PJ	31495572	Green Accepted, Bronze			2022-12-28	WOS:000490744100015
J	Allen, H; Sommers, BD				Allen, Heidi; Sommers, Benjamin D.			Medicaid Expansion and Health Assessing the Evidence After 5 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Allen, Heidi] Columbia Univ, Sch Social Work, New York, NY USA; [Sommers, Benjamin D.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Sommers, Benjamin D.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Sommers, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge Bldg,Room 406, Boston, MA 02115 USA.	bsommers@hsph.harvard.edu			Robert Wood Johnson Foundation's Policies for Action program	Robert Wood Johnson Foundation's Policies for Action program(Robert Wood Johnson Foundation (RWJF))	Support for this article was provided in part by the Robert Wood Johnson Foundation's Policies for Action program.	Allen H, 2017, HEALTH AFFAIR, V36, P1769, DOI 10.1377/hlthaff.2017.0369; Cole MB, 2017, HEALTH AFFAIR, V36, P40, DOI 10.1377/hlthaff.2016.0804; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Gruber J, 2019, J POLICY ANAL MANAG, V38, P1028, DOI 10.1002/pam.22158; Khatana SAM, 2019, JAMA CARDIOL, V4, P671, DOI 10.1001/jamacardio.2019.1651; Loehrer AP, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2017.5568; Miller S, 2019, MED MORTALITY; Sommers BD, 2017, HEALTH AFFAIR, V36, P1119, DOI 10.1377/hlthaff.2017.0293; Swaminathan S, 2018, JAMA-J AM MED ASSOC, V320, P2242, DOI 10.1001/jama.2018.16504; Wadhera RK, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004729	10	30	30	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1253	1254		10.1001/jama.2019.12345	http://dx.doi.org/10.1001/jama.2019.12345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC5OD	31490532				2022-12-28	WOS:000489331900010
J	Wise, J				Wise, Jacqui			No-deal Brexit: U-turn on immigration provides no stability for NHS, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Home Office, 2019, NO DEAL IMM ARR EU C	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5457	10.1136/bmj.l5457	http://dx.doi.org/10.1136/bmj.l5457			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488400				2022-12-28	WOS:000485441400011
J	Xu, M; Xu, HH; Lin, Y; Sun, XN; Wang, LJ; Fang, ZP; Su, XH; Liang, XJ; Hu, Y; Liu, ZM; Cheng, YX; Wei, YY; Li, JB; Li, L; Liu, HJ; Cheng, ZQ; Tang, N; Peng, C; Li, TT; Liu, TF; Qiao, L; Wu, DL; Ding, YQ; Zhou, WJ				Xu, Meng; Xu, Hong-Hai; Lin, Yuan; Sun, Xiangnan; Wang, Li-Jing; Fang, Zhe-Ping; Su, Xue-Han; Liang, Xiang-Jing; Hu, Yang; Liu, Zhi-Min; Cheng, Yuanxiong; Wei, Yuanyuan; Li, Jiabin; Li, Li; Liu, Hong-Juan; Cheng, Zhiqiang; Tang, Na; Peng, Chao; Li, Tingting; Liu, Tengfei; Qiao, Liang; Wu, Dalei; Ding, Yan-Qing; Zhou, Wei-Jie			LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis	CELL			English	Article							RECEPTOR TYROSINE KINASE; HEPATOCELLULAR-CARCINOMA; ANGIOGENESIS; ACTIVATION; CELLS; MORPHOGENESIS; EXPRESSION; PROTEINS; FIBROSIS; CADHERIN	Liver fibrosis is a very common condition seen in millions of patients with various liver diseases, and yet no effective treatments are available owing to poorly characterized molecular pathogenesis. Here, we show that leukocyte cell-derived chemotaxin 2 (LECT2) is a functional ligand of Tie1, a poorly characterized endothelial cell (EC)-specific orphan receptor. Upon binding to Tie1, LECT2 interrupts Tie1/Tie2 heterodimerization, facilitates Tie2/Tie2 homodimerization, activates PPAR signaling, and inhibits the migration and tube formations of EC. In vivo studies showed that LECT2 overexpression inhibits portal angiogenesis, promotes sinusoid capillarization, and worsens fibrosis, whereas these changes were reversed in Lect2-KO mice. Adeno-associated viral vector serotype 9 (AAV9)-LECT2 small hairpin RNA (shRNA) treatment significantly attenuates fibrosis. Upregulation of LECT2 is associated with advanced human liver fibrosis staging. We concluded that targeting LECT2/Tie1 signaling may represent a potential therapeutic target for liver fibrosis, and serum LECT2 level may be a potential biomarker for the screening and diagnosis of liver fibrosis.	[Xu, Meng; Xu, Hong-Hai; Lin, Yuan; Su, Xue-Han; Liang, Xiang-Jing; Hu, Yang; Liu, Zhi-Min; Li, Tingting; Liu, Tengfei; Ding, Yan-Qing; Zhou, Wei-Jie] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Meng; Xu, Hong-Hai; Lin, Yuan; Su, Xue-Han; Liang, Xiang-Jing; Hu, Yang; Liu, Zhi-Min; Li, Tingting; Liu, Tengfei; Ding, Yan-Qing; Zhou, Wei-Jie] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Meng; Xu, Hong-Hai; Lin, Yuan; Su, Xue-Han; Liang, Xiang-Jing; Hu, Yang; Liu, Zhi-Min; Li, Tingting; Liu, Tengfei; Ding, Yan-Qing; Zhou, Wei-Jie] Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Hong-Hai; Wei, Yuanyuan; Li, Jiabin] Anhui Med Univ, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China; [Lin, Yuan; Zhou, Wei-Jie] Southern Med Univ, Shunde Hosp, Peoples Hosp Shunde Foshan 1, Shunde 528333, Guangdong, Peoples R China; [Sun, Xiangnan; Wu, Dalei] Shandong Univ, Helmholtz Int Lab, State Key Lab Microbial Technol, Qingdao 266237, Shandong, Peoples R China; [Wang, Li-Jing; Li, Li] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Sch Life Sci & Biopharmaceut, Guangzhou 510006, Guangdong, Peoples R China; [Fang, Zhe-Ping] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Hepatobiliary Surg, Linhai 317000, Zhejiang, Peoples R China; [Cheng, Yuanxiong] Southern Med Univ, Affiliated Hosp 3, Dept Resp & Crit Care Med, Guangzhou 510630, Guangdong, Peoples R China; [Liu, Hong-Juan] Southern Med Univ, Sch Basic Med Sci, Dept Bioinformat, Guangzhou 510515, Guangdong, Peoples R China; [Cheng, Zhiqiang; Tang, Na] Shenzhen Peoples Hosp, Dept Pathol, Shenzhen 515020, Guangdong, Peoples R China; [Peng, Chao] Natl Facil Prot Sci Shanghai, Zhangjiang Lab, Shanghai 201210, Peoples R China; [Qiao, Liang] Univ Sydney, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW 2145, Australia; [Qiao, Liang] Westmead Hosp, Westmead, NSW 2145, Australia; [Qiao, Liang] Western Clin Sch, Westmead, NSW 2145, Australia; [Zhou, Wei-Jie] Southern Med Univ, Zhujiang Hosp, Microbiome Med Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Zhou, Wei-Jie] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou 510005, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Anhui Medical University; Southern Medical University - China; Shandong University; Guangdong Pharmaceutical University; Wenzhou Medical University; Southern Medical University - China; Southern Medical University - China; Jinan University; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Southern Medical University - China; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Ding, YQ; Zhou, WJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China.; Ding, YQ; Zhou, WJ (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China.; Ding, YQ; Zhou, WJ (corresponding author), Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou 510515, Guangdong, Peoples R China.; Zhou, WJ (corresponding author), Southern Med Univ, Shunde Hosp, Peoples Hosp Shunde Foshan 1, Shunde 528333, Guangdong, Peoples R China.; Zhou, WJ (corresponding author), Southern Med Univ, Zhujiang Hosp, Microbiome Med Ctr, Guangzhou 510515, Guangdong, Peoples R China.; Zhou, WJ (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou 510005, Guangdong, Peoples R China.	dyqgz@126.com; weijiezhouum@163.com	li, jiabin/AHD-4645-2022	Lin, Yuan/0000-0003-3283-9495	National Basic Research Program of China (973 program) [2015CB554002]; National Natural Science Foundation of China [81573015, 81600496, 31700114, 81773101, 31771578]; Guangdong Provincial Natural Science Foundation [2015A030306048]; Guangzhou Science and Technology Collaborative Innovation Major Projects [201704020071]; Guangdong Key Research and Development Plan [2019B020234003]; Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110105002]; Shandong University [86963072]; Natural Science Foundation of Jiangsu Province [BK20170399]; Project of the National Natural Science Foundation of China; NSFC-Guangdong Joint Fund [U1201226]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou Science and Technology Collaborative Innovation Major Projects; Guangdong Key Research and Development Plan; Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; Shandong University; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Joint Fund	We thank Professor Jiong Chen of Ningbo University for providing the Lect2-KO mice. We thank Central Laboratory, Southern Medical University for providing facilities and technical support. This work was supported by the National Basic Research Program of China (973 program, 2015CB554002), the National Natural Science Foundation of China (81573015, 81600496, 31700114, 81773101, 31771578), Guangdong Provincial Natural Science Foundation for Distinguished Young Scientists (2015A030306048), Guangzhou Science and Technology Collaborative Innovation Major Projects (201704020071), Guangdong Key Research and Development Plan (2019B020234003), Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110105002), Qilu Young Scholar of Shandong University (86963072), Natural Science Foundation of Jiangsu Province (BK20170399), and Project of the National Natural Science Foundation of China supported by NSFC-Guangdong Joint Fund (U1201226).	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Chen CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31398; Chen CK, 2014, HEPATOLOGY, V59, P974, DOI 10.1002/hep.26738; Cogger V. C., 2015, JOVE-J VIS EXP, V30; Elpek GO, 2015, WORLD J HEPATOL, V7, P377, DOI 10.4254/wjh.v7.i3.377; Fujii M, 2012, J STEROID BIOCHEM, V129, P145, DOI 10.1016/j.jsbmb.2011.12.014; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Ichikawa Y, 2006, ONCOL REP, V15, P311; Ito M, 2003, PROTEIN EXPRES PURIF, V27, P272, DOI 10.1016/S1046-5928(02)00634-4; Kim KL, 2006, CARDIOVASC RES, V72, P394, DOI 10.1016/j.cardiores.2006.08.002; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Leppanen VM, 2017, P NATL ACAD SCI USA, V114, P4376, DOI 10.1073/pnas.1616166114; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Lin Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01341-6; Lu S, 2015, NAT METHODS, V12, P329, DOI [10.1038/nmeth.3283, 10.1038/NMETH.3283]; Lu XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12719; Lu XJ, 2013, J EXP MED, V210, P5, DOI 10.1084/jem.20121466; Mereuta OM, 2014, BLOOD, V123, P1479, DOI 10.1182/blood-2013-07-517938; Ong HT, 2011, CANCER GENE THER, V18, P399, DOI 10.1038/cgt.2011.5; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Qu XH, 2010, DEVELOPMENT, V137, P1285, DOI 10.1242/dev.043380; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Savant S, 2015, CELL REP, V12, P1761, DOI 10.1016/j.celrep.2015.08.024; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Tyagi N, 2006, CELL MOL BIOL, V52, P21, DOI 10.1170/T730; Yamagoe S, 1996, IMMUNOL LETT, V52, P9, DOI 10.1016/0165-2478(96)02572-2; Yoo HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174717; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17	35	76	81	10	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1478	+		10.1016/j.cell.2019.07.021	http://dx.doi.org/10.1016/j.cell.2019.07.021			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474362	Bronze			2022-12-28	WOS:000483983000020
J	Iacobucci, G				Iacobucci, Gareth			Doctor clashes with Rees-Mogg over risks of no deal Brexit	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci Gareth, 2019, BMJ, V366, pl5343, DOI 10.1136/bmj.l5343; Murray R, 2019, IMPACT DEAL BREXIT H	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5379	10.1136/bmj.l5379	http://dx.doi.org/10.1136/bmj.l5379			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481436				2022-12-28	WOS:000485434400009
J	Mahase, E				Mahase, Elisabeth			MP calls for independent review of benefits and harms of statins	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Godlee F, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4992	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5380	10.1136/bmj.l5380	http://dx.doi.org/10.1136/bmj.l5380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481358				2022-12-28	WOS:000485434400010
J	Stephens, L; Fuller, D; Boivin, N; Rick, T; Gauthier, N; Kay, A; Marwick, B; Armstrong, CGD; Barton, CM; Denham, T; Douglass, K; Driver, J; Janz, L; Roberts, P; Rogers, JD; Thakar, H; Altaweel, M; Johnson, AL; Vattuone, MMS; Aldenderfer, M; Archila, S; Artioli, G; Bale, MT; Beach, T; Borrell, F; Braje, T; Buckland, PI; Cano, NGJ; Capriles, JM; Castillo, AD; Cilingiroglu, C; Cleary, MN; Conolly, J; Coutros, PR; Covey, RA; Cremaschi, M; Crowther, A; Der, L; di Lernia, S; Doershuk, JF; Doolittle, WE; Edwards, KJ; Erlandson, JM; Evans, D; Fairbairn, A; Faulkner, P; Feinman, G; Fernandes, R; Fitzpatrick, SM; Fyfe, R; Garcea, E; Goldstein, S; Goodman, RC; Guedes, JD; Herrmann, J; Hiscock, P; Hommel, P; Horsburgh, KA; Hritz, C; Ives, JW; Junno, A; Kahn, JG; Kaufman, B; Kearns, C; Kidder, TR; Lanoe, F; Lawrence, D; Lee, GA; Levin, MJ; Lindskoug, HB; Lopez-Saez, JA; Macrae, S; Marchant, R; Marston, JM; McClure, S; Mccoy, MD; Miller, AV; Morrison, M; Matuzeviciute, GM; Muller, J; Nayak, A; Noerwidi, S; Peres, TM; Peterson, CE; Proctor, L; Randall, AR; Renette, S; Schug, GR; Ryzewski, K; Saini, R; Scheinsohn, V; Schmidt, P; Sebillaud, P; Seitsonen, O; Simpson, IA; Soltysiak, A; Speakman, RJ; Spengler, RN; Steffen, ML; Storozum, MJ; Strickland, KM; Thompson, J; Thurston, TL; Ulm, S; Ustunkaya, MC; Welker, MH; West, C; Williams, PR; Wright, DK; Wright, N; Zahir, M; Zerboni, A; Beaudoin, E; Garcia, SM; Powell, J; Thornton, A; Kaplan, JO; Gaillard, MJ; Goldewijk, KK; Ellis, E				Stephens, Lucas; Fuller, Dorian; Boivin, Nicole; Rick, Torben; Gauthier, Nicolas; Kay, Andrea; Marwick, Ben; Armstrong, Chelsey Geralda Denise; Barton, C. Michael; Denham, Tim; Douglass, Kristina; Driver, Jonathan; Janz, Lisa; Roberts, Patrick; Rogers, J. Daniel; Thakar, Heather; Altaweel, Mark; Johnson, Amber L.; Sampietro Vattuone, Maria Marta; Aldenderfer, Mark; Archila, Sonia; Artioli, Gilberto; Bale, Martin T.; Beach, Timothy; Borrell, Ferran; Braje, Todd; Buckland, Philip I.; Jimenez Cano, Nayeli Guadalupe; Capriles, Jose M.; Diez Castillo, Agustin; Cilingiroglu, Ciler; Cleary, Michelle Negus; Conolly, James; Coutros, Peter R.; Covey, R. Alan; Cremaschi, Mauro; Crowther, Alison; Der, Lindsay; di Lernia, Savino; Doershuk, John F.; Doolittle, William E.; Edwards, Kevin J.; Erlandson, Jon M.; Evans, Damian; Fairbairn, Andrew; Faulkner, Patrick; Feinman, Gary; Fernandes, Ricardo; Fitzpatrick, Scott M.; Fyfe, Ralph; Garcea, Elena; Goldstein, Steve; Goodman, Reed Charles; Guedes, Jade Dalpoim; Herrmann, Jason; Hiscock, Peter; Hommel, Peter; Horsburgh, K. Ann; Hritz, Carrie; Ives, John W.; Junno, Aripekka; Kahn, Jennifer G.; Kaufman, Brett; Kearns, Catherine; Kidder, Tristram R.; Lanoe, Francois; Lawrence, Dan; Lee, Gyoung-Ah; Levin, Maureece J.; Lindskoug, Henrik B.; Antonio Lopez-Saez, Jose; Macrae, Scott; Marchant, Rob; Marston, John M.; McClure, Sarah; Mccoy, Mark D.; Miller, Alicia Ventresca; Morrison, Michael; Matuzeviciute, Giedre Motuzaite; Mueller, Johannes; Nayak, Ayushi; Noerwidi, Sofwan; Peres, Tanya M.; Peterson, Christian E.; Proctor, Lucas; Randall, Asa R.; Renette, Steve; Schug, Gwen Robbins; Ryzewski, Krysta; Saini, Rakesh; Scheinsohn, Vivian; Schmidt, Peter; Sebillaud, Pauline; Seitsonen, Oula; Simpson, Ian A.; Soltysiak, Arkadiusz; Speakman, Robert J.; Spengler, Robert N.; Steffen, Martina L.; Storozum, Michael J.; Strickland, Keir M.; Thompson, Jessica; Thurston, T. L.; Ulm, Sean; Ustunkaya, M. Cemre; Welker, Martin H.; West, Catherine; Williams, Patrick Ryan; Wright, David K.; Wright, Nathan; Zahir, Muhammad; Zerboni, Andrea; Beaudoin, Ella; Garcia, Santiago Munevar; Powell, Jeremy; Thornton, Alexa; Kaplan, Jed O.; Gaillard, Marie-Jose; Goldewijk, Kees Klein; Ellis, Erle		archaeoGLOBE Project	Archaeological assessment reveals Earth's early transformation through land use	SCIENCE			English	Article							HOLOCENE; COVER; RECONSTRUCTIONS; DOMESTICATION; AGRICULTURE; BIASES; BC	Environmentally transformative human use of land accelerated with the emergence of agriculture, but the extent, trajectory, and implications of these early changes are not well understood. An empirical global assessment of land use from 10,000 years before the present (yr B.P.) to 1850 CE reveals a planet largely transformed by hunter-gatherers, farmers, and pastoralists by 3000 years ago, considerably earlier than the dates in the land-use reconstructions commonly used by Earth scientists. Synthesis of knowledge contributed by more than 250 archaeologists highlighted gaps in archaeological expertise and data quality, which peaked for 2000 yr B.P. and in traditionally studied and wealthier regions. Archaeological reconstruction of global land-use history illuminates the deep roots of Earth's transformation and challenges the emerging Anthropocene paradigm that large-scale anthropogenic global environmental change is mostly a recent phenomenon.	[Stephens, Lucas; Garcia, Santiago Munevar; Powell, Jeremy; Thornton, Alexa; Ellis, Erle] Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA; [Stephens, Lucas] Amer Council Learned Soc, New York, NY 10017 USA; [Stephens, Lucas; Goodman, Reed Charles] Univ Penn, Philadelphia, PA 19104 USA; [Fuller, Dorian] UCL, London, England; [Boivin, Nicole; Kay, Andrea; Crowther, Alison; Fernandes, Ricardo; Miller, Alicia Ventresca; Spengler, Robert N.] Max Planck Inst Sci Human Hist, Jena, Germany; [Rick, Torben; Armstrong, Chelsey Geralda Denise; Rogers, J. Daniel] Smithsonian Inst, Washington, DC 20560 USA; [Gauthier, Nicolas; Barton, C. Michael] Arizona State Univ, Tempe, AZ 85287 USA; [Kay, Andrea; Fairbairn, Andrew] Univ Queensland, Brisbane, Qld, Australia; [Marwick, Ben] Univ Washington, Seattle, WA 98195 USA; [Denham, Tim] Australian Natl Univ, Canberra, ACT, Australia; [Douglass, Kristina] Penn State Univ, University Pk, PA 16802 USA; [Driver, Jonathan] Simon Fraser Univ, Burnaby, BC, Canada; [Janz, Lisa; Conolly, James; Macrae, Scott] Trent Univ, Peterborough, ON, Canada; [Roberts, Patrick; Goldstein, Steve; Nayak, Ayushi; Kaplan, Jed O.] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Thakar, Heather] Texas A&M Univ, College Stn, TX 77843 USA; [Altaweel, Mark] UCL, Inst Archaeol, London, England; [Johnson, Amber L.] Truman State Univ, Kirksville, MO USA; [Sampietro Vattuone, Maria Marta] Natl Univ Tucuman, CONICET, Lab Geoarqueol, San Miguel De Tucuman, Tucuman, Argentina; [Aldenderfer, Mark] Univ Calif, Merced, CA USA; [Archila, Sonia] Univ Los Andes, Dept Anthropol, Bogota, Colombia; [Artioli, Gilberto] Univ Padua, Padua, Italy; [Bale, Martin T.] Yeungnam Univ, Dept Cultural Anthropol, Gyongsan, South Korea; [Beach, Timothy] Univ Texas Austin, Austin, TX 78712 USA; [Borrell, Ferran] CSIC, IMF, Madrid, Spain; [Braje, Todd] Calif Acad Sci, San Francisco, CA 94118 USA; [Buckland, Philip I.] Umea Univ, Environm Archaeol Lab, Umea, Sweden; [Jimenez Cano, Nayeli Guadalupe] Univ Autonoma Yucatan, Merida, Mexico; [Capriles, Jose M.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Diez Castillo, Agustin] Univ Valencia, Valencia, Spain; [Cilingiroglu, Ciler] Ege Univ, Protohist & Near Eastern Arhaeol, Bornova, Turkey; [Cleary, Michelle Negus] Univ Melbourne, Melbourne, Vic, Australia; [Coutros, Peter R.] Univ Puget Sound, Tacoma, WA 98416 USA; [Covey, R. Alan; Doolittle, William E.] Univ Texas Austin, Austin, TX 78712 USA; [Cremaschi, Mauro] Univ Milan, Dipartimento Sci Terra, Milan, Italy; [Crowther, Alison] Univ Queensland, Brisbane, Qld, Australia; [Der, Lindsay] Univ British Columbia, Vancouver, BC, Canada; [di Lernia, Savino] Sapienza Univ Rome, Rome, Italy; [Doershuk, John F.] Univ Iowa, Iowa City, IA 52242 USA; [Edwards, Kevin J.] Univ Aberdeen, Dept Geog & Environm, Aberdeen, Scotland; [Edwards, Kevin J.] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Edwards, Kevin J.] Univ Cambridge, Scott Polar Res Inst, Cambridge, England; [Erlandson, Jon M.] Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA; [Evans, Damian] Ecole Francaise Extreme Orient, Paris, France; [Faulkner, Patrick; Hiscock, Peter] Univ Sydney, Sydney, NSW, Australia; [Feinman, Gary] Field Museum Nat Hist, Chicago, IL 60605 USA; [Fernandes, Ricardo; Hommel, Peter] Univ Oxford, Oxford, England; [Fernandes, Ricardo] Masaryk Univ, Brno, Czech Republic; [Fitzpatrick, Scott M.; Lee, Gyoung-Ah] Univ Oregon, Eugene, OR 97403 USA; [Fyfe, Ralph] Univ Plymouth, Plymouth, Devon, England; [Garcea, Elena] Univ Cassino & Southern Latium, Cassino, Italy; [Guedes, Jade Dalpoim] Univ Calif San Diego, La Jolla, CA 92093 USA; [Herrmann, Jason] Univ Tubingen, Tubingen, Germany; [Horsburgh, K. Ann; Mccoy, Mark D.] Southern Methodist Univ, Dallas, TX USA; [Ives, John W.] Univ Alberta, Edmonton, AB, Canada; [Junno, Aripekka] Univ Groningen, Arctic Ctr, Groningen, Netherlands; [Kahn, Jennifer G.] Coll William & Mary, Dept Anthropol, Williamsburg, VA 23187 USA; [Kaufman, Brett] Univ Illinois, Dept Class, Urbana, IL 61801 USA; [Kearns, Catherine] Univ Chicago, Chicago, IL 60637 USA; [Kidder, Tristram R.] Washington Univ, Dept Anthropol, St Louis, MO 14263 USA; [Lanoe, Francois; Steffen, Martina L.] Univ Arizona, Tucson, AZ 85721 USA; [Lawrence, Dan] Univ Durham, Durham, England; [Levin, Maureece J.] Stanford Univ, Stanford, CA 94305 USA; [Lindskoug, Henrik B.] Univ Catolica Temuco, Fac Ciencias Sociales & Humanidades, Dept Antropol, Temuco, Chile; [Antonio Lopez-Saez, Jose] CSIC, Inst Hist, GI Arqueobiol, Madrid, Spain; [Marchant, Rob] Univ York, KITE, York, N Yorkshire, England; [Marston, John M.] Boston Univ, Boston, MA 02215 USA; [McClure, Sarah] UC Santa Barbara, Santa Barbara, CA USA; [Morrison, Michael] Flinders Univ S Australia, Adelaide, SA, Australia; [Matuzeviciute, Giedre Motuzaite] Vilnius Univ, Vilnius, Lithuania; [Mueller, Johannes] Univ Kiel, Prehist Archaeol, Kiel, Germany; [Noerwidi, Sofwan] Balai Arkeol Yogyakarta, Yogyakarta, Indonesia; [Peres, Tanya M.] Florida State Univ, Tallahassee, FL 32306 USA; [Peterson, Christian E.] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Proctor, Lucas] Univ Connecticut, Storrs, CT USA; [Randall, Asa R.] Univ Oklahoma, Norman, OK 73019 USA; [Renette, Steve] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA; [Schug, Gwen Robbins] Appalachian State Univ, Boone, NC 28608 USA; [Ryzewski, Krysta] Wayne State Univ, Detroit, MI 48202 USA; [Saini, Rakesh] Dr Harsingh Gour Cent Univ, Sagar, MP, India; [Scheinsohn, Vivian] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Schmidt, Peter] Univ Florida, Gainesville, FL 32611 USA; [Schmidt, Peter] Univ Pretoria, Pretoria, South Africa; [Sebillaud, Pauline] Jilin Univ, CNRS East Asian Civilizat Res Ctr, Res Ctr Frontier Archaeol, Changchun, Jilin, Peoples R China; [Seitsonen, Oula] Univ Oulu, Archaeol, Oulu, Finland; [Seitsonen, Oula] Univ Helsinki, Cultural Heritage, Helsinki, Finland; [Simpson, Ian A.] Univ Stirling, Stirling, Scotland; [Soltysiak, Arkadiusz] Univ Warsaw, Warsaw, Poland; [Speakman, Robert J.] Univ Georgia, Athens, GA 30602 USA; [Storozum, Michael J.] Fudan Univ, Inst Archaeol Sci, Shanghai, Peoples R China; [Strickland, Keir M.] La Trobe Univ, Bundoora, Vic, Australia; [Thompson, Jessica] Yale Univ, New Haven, CT 06520 USA; [Thurston, T. L.] SUNY Buffalo, Buffalo, NY USA; [Ulm, Sean] James Cook Univ, ARC Ctr Excellence Australian Biodivers & Heritag, Townsville, Qld, Australia; [Ustunkaya, M. Cemre] McDonald Inst Archaeol Res, Cambridge, England; [Welker, Martin H.] Penn State Univ, University Pk, PA 16802 USA; [West, Catherine] Boston Univ, Boston, MA 02215 USA; [Williams, Patrick Ryan] Field Museum, Chicago, IL USA; [Wright, David K.] Seoul Natl Univ, Seoul, South Korea; [Wright, Nathan] Univ Cambridge, Cambridge, England; [Zahir, Muhammad] Hazara Univ, Dept Archaeol, Mansehra, Pakistan; [Zahir, Muhammad] Hazara Univ, Dept Art & Design, Mansehra, Pakistan; [Zerboni, Andrea] Univ Milan, Dipartimento Sci Terra A Desio, Milan, Italy; [Beaudoin, Ella] Smithsonian Inst, Washington, DC 20560 USA; [Kaplan, Jed O.] Univ Augsburg, Inst Geog, Augsburg, Germany; [Gaillard, Marie-Jose] Linnaeus Univ, Dept Biol & Environm Sci, Vaxjo, Sweden; [Goldewijk, Kees Klein] PBL Netherlands Environm Assessment Agcy, The Hague, Netherlands; [Goldewijk, Kees Klein] Univ Utrecht, Utrecht, Netherlands	University System of Maryland; University of Maryland Baltimore County; University of Pennsylvania; University of London; University College London; Smithsonian Institution; Arizona State University; Arizona State University-Tempe; University of Queensland; University of Washington; University of Washington Seattle; Australian National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Simon Fraser University; Trent University; Texas A&M University System; Texas A&M University College Station; University of London; University College London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; University of California System; University of California Merced; Universidad de los Andes (Colombia); University of Padua; Yeungnam University; University of Texas System; University of Texas Austin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); California Academy of Sciences; Umea University; Universidad Autonoma de Yucatan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Valencia; Ege University; University of Melbourne; University of Texas System; University of Texas Austin; University of Milan; University of Queensland; University of British Columbia; Sapienza University Rome; University of Iowa; University of Aberdeen; University of Aberdeen; University of Cambridge; University of Oregon; UDICE-French Research Universities; PSL Research University Paris; Ecole Francaise d'Extreme-Orient (EFEO); University of Sydney; Field Museum of Natural History (Chicago); University of Oxford; Masaryk University Brno; University of Oregon; University of Plymouth; University of Cassino; University of California System; University of California San Diego; Eberhard Karls University of Tubingen; Southern Methodist University; University of Alberta; University of Groningen; William & Mary; University of Illinois System; University of Illinois Urbana-Champaign; University of Chicago; Washington University (WUSTL); University of Arizona; Durham University; Stanford University; Universidad Catolica de Temuco; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Historia (IH); University of York - UK; Boston University; University of California System; University of California Santa Barbara; Flinders University South Australia; Vilnius University; University of Kiel; State University System of Florida; Florida State University; University of Hawaii System; University of Hawaii Manoa; University of Connecticut; University of Oklahoma System; University of Oklahoma - Norman; University of Pennsylvania; University of North Carolina; Appalachian State University; Wayne State University; Dr. Hari Singh Gour University; University of Buenos Aires; State University System of Florida; University of Florida; University of Pretoria; Jilin University; University of Oulu; University of Helsinki; University of Stirling; University of Warsaw; University System of Georgia; University of Georgia; Fudan University; La Trobe University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; James Cook University; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University; Field Museum of Natural History (Chicago); Seoul National University (SNU); University of Cambridge; Hazara University; Hazara University; University of Milan; Smithsonian Institution; University of Augsburg; Linnaeus University; Utrecht University	Stephens, L; Ellis, E (corresponding author), Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA.; Stephens, L (corresponding author), Amer Council Learned Soc, New York, NY 10017 USA.; Stephens, L (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	lucas.s.stephens@gmail.com; ece@umbc.edu	Ellis, Erle C./B-8264-2008; Thompson, Jessica/X-8734-2019; SCHUG, GWEN ROBBINS/AAN-8980-2020; Motuzaite Matuzeviciute, Giedre/AAK-2928-2021; Strickland, Keir/ABA-9000-2021; Fuller, Dorian/AAF-7400-2019; Seitsonen, Oula/AAM-6028-2021; Thompson, Jessica/GXW-0323-2022; Artioli, Gilberto/F-2149-2015; Levin, Maureece/ABD-4382-2021; Levin, Maureece/AAK-7786-2021; Noerwidi, Sofwan/ABH-2778-2021; Ives, John W./AAK-5238-2020; Klein Goldewijk, Kees/L-5567-2013; Çilingiroğlu, Çiler/A-2355-2019; Gaillard, Marie-José/ABG-2680-2021; Ulm, Sean/A-3854-2010; Renette, Steve/AAR-7926-2020; Horsburgh, K. Ann/B-9369-2016; Marwick, Ben/H-1747-2013; Kaplan, Jed O./P-1796-2015; Lindskoug, Henrik Bernhard/O-2457-2016; Kay, Andrea/X-4373-2019; Peterson, Christian/AAG-9868-2020; Crowther, Alison/AAR-9872-2021; di Lernia, Savino/AAI-4535-2020; Castillo, Agustin Diez/L-6336-2015; Saini, Rakesh/AAK-2584-2020; Buckland, Philip/GYI-8823-2022; Wright, Nathan/Q-2455-2016; CABAH, ARC/T-6419-2019; Capriles, Jose/J-1520-2014; Crowther, Alison/B-7854-2016; Jimenez-Cano, Nayeli G./K-5368-2016	Ellis, Erle C./0000-0002-2006-3362; SCHUG, GWEN ROBBINS/0000-0002-3928-9230; Motuzaite Matuzeviciute, Giedre/0000-0001-9069-1551; Fuller, Dorian/0000-0002-4859-080X; Seitsonen, Oula/0000-0003-3792-0081; Artioli, Gilberto/0000-0002-8693-7392; Levin, Maureece/0000-0002-1833-2084; Noerwidi, Sofwan/0000-0002-2098-8496; Klein Goldewijk, Kees/0000-0003-2714-7507; Çilingiroğlu, Çiler/0000-0002-2936-3732; Ulm, Sean/0000-0001-6653-9963; Horsburgh, K. Ann/0000-0003-0959-8013; Marwick, Ben/0000-0001-7879-4531; Kaplan, Jed O./0000-0001-9919-7613; Lindskoug, Henrik Bernhard/0000-0002-4003-1173; Kay, Andrea/0000-0001-8285-1893; Peterson, Christian/0000-0002-7630-3572; Castillo, Agustin Diez/0000-0001-9122-2941; Saini, Rakesh/0000-0003-4165-7423; Buckland, Philip/0000-0002-2430-0839; Wright, Nathan/0000-0002-2482-2661; Borrell, Ferran/0000-0001-9464-5798; Sebillaud, Pauline/0000-0003-3604-0349; Thompson, Jessica/0000-0003-1627-4949; Herrmann, Jason/0000-0002-8277-5947; Capriles, Jose/0000-0001-6046-0939; Soltysiak, Arkadiusz/0000-0002-9040-5022; Crowther, Alison/0000-0002-2394-1917; Fairbairn, Andrew/0000-0002-4004-6957; Strickland, Keir/0000-0003-1538-2518; Mueller, Johannes/0000-0002-3538-197X; Jimenez-Cano, Nayeli G./0000-0001-9973-2452; Douglass, Kristina/0000-0003-0931-3428; Proctor, Lucas/0000-0001-9769-8211; Nayak, Ayushi/0000-0001-6990-3302; BOIVIN, NICOLE/0000-0002-7783-4199; Speakman, Robert/0000-0003-2063-154X; Gauthier, Nicolas/0000-0002-2225-5827; Roberts, Patrick/0000-0002-4403-7548; Coutros, Peter/0000-0002-4861-6432; Spengler, Robert/0000-0002-5648-6930; Barton, C Michael/0000-0003-2561-1927; Rick, Torben/0000-0002-8254-5885; Morrison, Michael/0000-0003-3971-7829; Lee, Gyoung-Ah/0000-0001-7873-6841; Randall, Asa/0000-0002-5444-0744	National Science Foundation [CNS 1125210]; NERC [NE/G005540/1, NE/K003402/1, NE/N010957/1] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This material is based upon work supported by the National Science Foundation under grant no. CNS 1125210 awarded to E. C. E. in 2011. The full list of author, affiliations, and contributions is in the supplementary materials.	Arbuckle BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099845; ArchaeoGLOBE Project, 2019, ARCHAEOGLOBE PROJECT; Bartling S., 2014, OPENING SCI EVOLVING, V51, DOI [10.5860/choice.51-6715, DOI 10.5860/CHOICE.51-6715]; Bevan A, 2019, HOLOCENE, V29, P703, DOI 10.1177/0959683619826688; Boivin NL, 2016, P NATL ACAD SCI USA, V113, P6388, DOI 10.1073/pnas.1525200113; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Dawson A., 2018, Past Global Changes Magazine, V26, P34, DOI 10.22498/pages.26.1.34; Denham T, 2013, ANTIQUITY, V87, P250, DOI 10.1017/S0003598X00048766; Downey SS, 2016, P NATL ACAD SCI USA, V113, P9751, DOI 10.1073/pnas.1602504113; Ellis E, 2016, NATURE, V540, P192, DOI 10.1038/540192a; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Erlandson JM, 2013, ANTHROPOCENE, V4, P1, DOI 10.1016/j.ancene.2014.05.003; Frey BS., 2013, INT REV EC, V60, P1, DOI DOI 10.1007/S12232-013-0174-4; Fuller D. Q., 2014, GEN ANTHR, V21, P1, DOI [10.1111/gena.01001, DOI 10.1111/GENA.01001]; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; Gaillard MJ, 2010, CLIM PAST, V6, P483, DOI 10.5194/cp-6-483-2010; Gaillard MJ., 2018, GLOBAL CHANGES MAGAZ, V26, P3, DOI [10.22498/pages.26.1.3, DOI 10.22498/PAGES.26.1.3]; Goldewijk KK, 2017, EARTH SYST SCI DATA, V9, P927, DOI 10.5194/essd-9-927-2017; Hames R, 2007, ANNU REV ANTHROPOL, V36, P177, DOI 10.1146/annurev.anthro.35.081705.123321; Hunt CO, 2014, J ARCHAEOL SCI, V51, P22, DOI 10.1016/j.jas.2013.12.011; Kaplan J. O., 2011, PANGEA; Kaplan JO, 2017, LAND-BASEL, V6, DOI 10.3390/land6040091; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Kay AU, 2019, J WORLD PREHIST, V32, P179, DOI 10.1007/s10963-019-09131-2; Kintigh KW, 2015, ADV ARCHAEOL PRACT, V3, P1, DOI 10.7183/2326-3768.3.1.1; Kintigh KW, 2014, AM ANTIQUITY, V79, P5, DOI 10.1073/pnas.1324000111; Kirch PV, 2005, ANNU REV ENV RESOUR, V30, P409, DOI 10.1146/annurev.energy.29.102403.140700; Klein Goldewijk K., 2016, PAGES MAG, V24, P81; Kohler T. A., 2018, PAGES MAG, V26, P68; Kynn M, 2008, J ROY STAT SOC A STA, V171, P239; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Manning K, 2011, J ARCHAEOL SCI, V38, P312, DOI 10.1016/j.jas.2010.09.007; Marshall F, 2018, NATURE, V561, P387, DOI 10.1038/s41586-018-0456-9; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; Marwick B, 2017, J ARCHAEOL METHOD TH, V24, P424, DOI 10.1007/s10816-015-9272-9; McMichael CNH, 2017, P NATL ACAD SCI USA, V114, P522, DOI 10.1073/pnas.1614577114; Morrison K. D., 2018, Past Global Changes Magazine, V26, P8, DOI 10.22498/pages.26.1.8; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; PEDERSEN EJ, 2018, PEERJ PREPRINTS, DOI DOI 10.1002/ECS2.2475; Pfeiffer M, 2013, GEOSCI MODEL DEV, V6, P643, DOI 10.5194/gmd-6-643-2013; Pirzamanbein B, 2014, ECOL COMPLEX, V20, P127, DOI 10.1016/j.ecocom.2014.09.005; RINDOS D, 1980, CURR ANTHROPOL, V21, P751, DOI 10.1086/202569; Roberts N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18646-7; Roberts P, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.93; Ruddiman WF, 2016, REV GEOPHYS, V54, P93, DOI 10.1002/2015RG000503; Ruddiman WF, 2015, SCIENCE, V348, P38, DOI 10.1126/science.aaa7297; Sherratt A., 1980, ENCY ARCHEOLOGY; Smith BD, 2013, ANTHROPOCENE, V4, P8, DOI 10.1016/j.ancene.2013.05.001; Surovell TA, 2017, AM ANTIQUITY, V82, P288, DOI 10.1017/aaq.2016.33; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Trondman AK, 2015, GLOBAL CHANGE BIOL, V21, P676, DOI 10.1111/gcb.12737; Williams JW, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001458; Winchell F, 2017, CURR ANTHROPOL, V58, P673, DOI 10.1086/693898; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn; Zanon M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00253	57	221	226	30	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					897	+		10.1126/science.aax1192	http://dx.doi.org/10.1126/science.aax1192			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467217	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000483975800041
J	Wang, KH; de la Torre, D; Robertson, WE; Chin, JW				Wang, Kaihang; de la Torre, Daniel; Robertson, Wesley E.; Chin, Jason W.			Programmed chromosome fission and fusion enable precise large-scale genome rearrangement and assembly	SCIENCE			English	Article							ESCHERICHIA-COLI	The design and creation of synthetic genomes provide a powerful approach to understanding and engineering biology. However, it is often limited by the paucity of methods for precise genome manipulation. Here, we demonstrate the programmed fission of the Escherichia coli genome into diverse pairs of synthetic chromosomes and the programmed fusion of synthetic chromosomes to generate genomes with user-defined inversions and translocations. We further combine genome fission, chromosome transplant, and chromosome fusion to assemble genomic regions from different strains into a single genome. Thus, we program the scarless assembly of new genomes with nucleotide precision, a key step in the convergent synthesis of genomes from diverse progenitors. This work provides a set of precise, rapid, large-scale (megabase) genome-engineering operations for creating diverse synthetic genomes.	[Wang, Kaihang; de la Torre, Daniel; Robertson, Wesley E.; Chin, Jason W.] MRC, Mol Biol Lab, Francis Crick Ave, Cambridge, England; [Wang, Kaihang] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	MRC Laboratory Molecular Biology; California Institute of Technology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge, England.	chin@mrc-lmb.cam.ac.uk		Robertson, Wesley/0000-0001-9812-8288	Medical Research Council (MRC), UK [MC_U105181009, MC_UP_A024_1008]; ERC Advanced Grant SGCR; MRC [MC_U105181009, MC_UP_A024_1008] Funding Source: UKRI	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC Advanced Grant SGCR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MRC), UK (MC_U105181009 and MC_UP_A024_1008), and an ERC Advanced Grant SGCR, all to I.W.C.	Escudero JA, 2017, INT MICROBIOL, V20, P138, DOI 10.2436/20.1501.01.295; Ausiannikava D, 2018, MOL BIOL EVOL, V35, P1855, DOI 10.1093/molbev/msy075; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Choe D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08888-6; Cooper VS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000732; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Fredens J, 2019, NATURE, V569, P514, DOI 10.1038/s41586-019-1192-5; Giannuzzi G, 2013, GENOME RES, V23, P1763, DOI 10.1101/gr.156240.113; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Itaya M, 1997, P NATL ACAD SCI USA, V94, P5378, DOI 10.1073/pnas.94.10.5378; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Liang XQ, 2013, ACS SYNTH BIOL, V2, P734, DOI 10.1021/sb400079u; Luo JC, 2018, NATURE, V560, P392, DOI 10.1038/s41586-018-0374-x; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Raeside C, 2014, MBIO, V5, DOI 10.1128/mBio.01377-14; Schmied WH, 2018, NATURE, V564, P444, DOI 10.1038/s41586-018-0773-z; Shao YY, 2018, NATURE, V560, P331, DOI 10.1038/s41586-018-0382-x; Ueda Y, 2012, J BIOSCI BIOENG, V113, P675, DOI 10.1016/j.jbiosc.2012.01.013; Wang KH, 2016, NATURE, V539, P59, DOI 10.1038/nature20124; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	27	24	26	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					922	+		10.1126/science.aay0737	http://dx.doi.org/10.1126/science.aay0737			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467221	Green Accepted			2022-12-28	WOS:000483975800047
J	Lucey, CR; Jones, L; Eastburn, A				Lucey, Catherine R.; Jones, Lee; Eastburn, Abigail			A Lethal Hidden Curriculum - Death of a Medical Student from Opioid Use Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lucey, Catherine R.; Eastburn, Abigail] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; [Jones, Lee] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lucey, CR (corresponding author), Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA.			Lucey, Catherine/0000-0002-8345-2795				Jalal H, 2018, SCIENCE, V361, P1218, DOI 10.1126/science.aau1184; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Merlo LJ, 2011, J ADDICT MED, V5, P279, DOI 10.1097/ADM.0b013e31821852a0; Schuckit MA, 2016, NEW ENGL J MED, V375, P357, DOI 10.1056/NEJMra1604339; Warner DO, 2013, JAMA-J AM MED ASSOC, V310, P2289, DOI 10.1001/jama.2013.281954	5	4	4	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					793	795		10.1056/NEJMp1901537	http://dx.doi.org/10.1056/NEJMp1901537			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461592				2022-12-28	WOS:000484431200004
J	Slomski, A				Slomski, Anita			Vitamin D Doesn't Protect Against Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					717	717		10.1001/jama.2019.11564	http://dx.doi.org/10.1001/jama.2019.11564			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454039				2022-12-28	WOS:000483652500007
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			PATHS OUT OF DARKNESS	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		734	735		10.1126/science.365.6455.734	http://dx.doi.org/10.1126/science.365.6455.734			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439774				2022-12-28	WOS:000482464000011
J	Dijk, S; Lok, P				Dijk, Stijntje; Lok, Pat			Polypill cuts major cardiovascular events by a third, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Faridi KF, 2016, JAMA CARDIOL, V1, P147, DOI 10.1001/jamacardio.2016.0001; Roshandel G, 2019, LANCET, V394, P672, DOI 10.1016/S0140-6736(19)31791-X; Torjesen Ingrid, 2014, BMJ, V348, pg2819, DOI 10.1136/bmj.g2819; Viera AJ, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1474; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2019	366								l5268	10.1136/bmj.l5268	http://dx.doi.org/10.1136/bmj.l5268			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DN	31439542				2022-12-28	WOS:000482882800006
J	Horsefield, S; Burdett, H; Zhang, XX; Manik, MK; Shi, Y; Chen, J; Qi, TC; Gilley, J; Lai, JS; Rank, MX; Casey, LW; Gu, WX; Ericsson, DJ; Foley, G; Hughes, RO; Bosanac, T; von Itzstein, M; Rathjen, JP; Nanson, JD; Boden, M; Dry, IB; Williams, SJ; Staskawicz, BJ; Coleman, MP; Ve, T; Dodds, PN; Kobe, B				Horsefield, Shane; Burdett, Hayden; Zhang, Xiaoxiao; Manik, Mohammad K.; Shi, Yun; Chen, Jian; Qi, Tiancong; Gilley, Jonathan; Lai, Jhih-Siang; Rank, Maxwell X.; Casey, Lachlan W.; Gu, Weixi; Ericsson, Daniel J.; Foley, Gabriel; Hughes, Robert O.; Bosanac, Todd; von Itzstein, Mark; Rathjen, John P.; Nanson, Jeffrey D.; Boden, Mikael; Dry, Ian B.; Williams, Simon J.; Staskawicz, Brian J.; Coleman, Michael P.; Ve, Thomas; Dodds, Peter N.; Kobe, Bostjan			NAD(+) cleavage activity by animal an plant TIR domains in cell death pathways	SCIENCE			English	Article							SMALL-ANGLE SCATTERING; PARTICLE MESH EWALD; RESISTANCE PROTEIN; DISEASE RESISTANCE; ASSEMBLY FORMATION; ESCHERICHIA-COLI; ACCURATE DOCKING; SELF-ASSOCIATION; STRUCTURAL BASIS; INNATE IMMUNITY	SARM1 (sterile alpha and TIR motif containing 1) is responsible for depletion of nicotinamide adenine dinucleotide in its oxidized form (NAD(+)) during Wallerian degeneration associated with neuropathies. Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors recognize pathogen effector proteins and trigger localized cell death to restrict pathogen infection. Both processes depend on closely related Toll/interleukin-1 receptor (TIR) domains in these proteins, which, as we show, feature self-association-dependent NAD(+) cleavage activity associated with cell death signaling. We further show that SARM1 SAM (sterile alpha motif) domains form an octamer essential for axon degeneration that contributes to TIR domain enzymatic activity. The crystal structures of ribose and NADP(+) (the oxidized form of nicotinamide adenine dinucleotide phosphate) complexes of SARM1 and plant NLR RUN1 TIR domains, respectively, reveal a conserved substrate binding site. NAD(+) cleavage by TIR domains is therefore a conserved feature of animal and plant cell death signaling pathways.	[Horsefield, Shane; Burdett, Hayden; Manik, Mohammad K.; Lai, Jhih-Siang; Rank, Maxwell X.; Casey, Lachlan W.; Gu, Weixi; Foley, Gabriel; Nanson, Jeffrey D.; Boden, Mikael; Ve, Thomas; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Horsefield, Shane; Burdett, Hayden; Manik, Mohammad K.; Lai, Jhih-Siang; Rank, Maxwell X.; Casey, Lachlan W.; Gu, Weixi; Foley, Gabriel; Nanson, Jeffrey D.; Boden, Mikael; Ve, Thomas; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Zhang, Xiaoxiao; Chen, Jian; Dodds, Peter N.] Agr & Food Commonwealth Sci & Ind Res Org, Canberra, ACT 2601, Australia; [Zhang, Xiaoxiao; Chen, Jian; Rathjen, John P.; Williams, Simon J.] Australian Natl Univ, Res Sch Biol, Plant Sci Div, Canberra, ACT 2601, Australia; [Shi, Yun; von Itzstein, Mark; Ve, Thomas] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia; [Qi, Tiancong] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Gilley, Jonathan; Coleman, Michael P.] Univ Cambridge, Dept Clin Neurosci, John von Geest Ctr Brain Repair, ED Adrian Bldg,Robinson Way, Cambridge CB2 0PY, England; [Gilley, Jonathan; Coleman, Michael P.] Babraham Inst, Cambridge CB22 3AT, England; [Casey, Lachlan W.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Ericsson, Daniel J.] Beamlines Australian Synchrotron, Macromol Crystallog MX, Melbourne, Vic 3168, Australia; [Hughes, Robert O.; Bosanac, Todd] Disarm Therapeut, 400 Technol Sq, Cambridge, MA 02139 USA; [Dry, Ian B.] Agr & Food Commonwealth Sci & Ind Res Org, Urrbrae, SA 5064, Australia	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Griffith University; University of California System; University of California Berkeley; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ve, T; Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld 4072, Australia.; Ve, T; Kobe, B (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.; Dodds, PN (corresponding author), Agr & Food Commonwealth Sci & Ind Res Org, Canberra, ACT 2601, Australia.; Ve, T (corresponding author), Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia.	t.ve@griffith.edu.au; peter.dodds@csiro.au; b.kobe@uq.edu.au	Williams, Simon/F-7447-2011; Shi, Yun/AAG-3890-2020; rathjen, john p/C-9327-2009; Nanson, Jeffrey D/E-6313-2017; Chen, Jian/AAD-2284-2022; Foley, Gabriel/L-6871-2018; Dry, Ian/A-5004-2008; Kobe, Bostjan/D-1292-2009; Casey, Lachlan/N-3396-2015; Ericsson, Daniel/F-7458-2011; Ve, Thomas/AEK-1006-2022; Foley, Gabriel/AAW-8064-2021; Boden, Mikael/A-6030-2010; Zhang, Xiaoxiao/C-6002-2016; Dodds, Peter/D-1181-2009	Williams, Simon/0000-0003-4781-6261; Shi, Yun/0000-0003-3365-4679; rathjen, john p/0000-0003-4073-8088; Nanson, Jeffrey D/0000-0003-1306-1948; Chen, Jian/0000-0001-8670-6984; Foley, Gabriel/0000-0002-0487-2629; Kobe, Bostjan/0000-0001-9413-9166; Casey, Lachlan/0000-0002-4458-0137; Ericsson, Daniel/0000-0001-5101-9244; Ve, Thomas/0000-0002-0113-1905; Foley, Gabriel/0000-0002-0487-2629; Boden, Mikael/0000-0003-3548-268X; Zhang, Xiaoxiao/0000-0002-5417-6963; LAI, JHIH-SIANG/0000-0001-5677-5890; Rank, Maxwell/0000-0001-6962-9235; HORSEFIELD, Shane/0000-0003-0786-3995; Burdett, Hayden/0000-0003-4803-9660; Dodds, Peter/0000-0003-0620-5923; Gu, Weixi/0000-0002-1185-3557	National Health and Medical Research Council (NHMRC) [1107804, 1160570, 1071659, 1108859]; Australian Research Council (ARC) [DP160102244, DP190102526]; NHMRC [1110971]; ARC [FL180100109]; ARC DECRA [DE170100783, DE160100893]; Chinese Scholarship Council (CSC); UK Medical Research Council; John and Lucille van Geest Foundation; Australian Government Research Training Program (RTP); BBSRC [BB/S009582/1, BBS/E/B/000C0433] Funding Source: UKRI	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); ARC DECRA(Australian Research Council); Chinese Scholarship Council (CSC)(China Scholarship Council); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); John and Lucille van Geest Foundation; Australian Government Research Training Program (RTP); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the National Health and Medical Research Council (NHMRC grants 1107804 and 1160570 to B.K. and T.V.. 1071659 to B.K., and 1108859 to T.V.), and the Australian Research Council (ARC grants DP160102244 and DP190102526 to B.K. and P.N.D.). B.K. was an NHMRC Principal Research Fellow (1110971) and ARC Laureate Fellow (FL180100109). T.V. received ARC DECRA (DE170100783) funding and S.J.W. received ARC DECRA DE160100893 funding. J.C. received a Chinese Scholarship Council (CSC) postgraduate scholarship. Y.S. was a Griffith University postdoctoral fellow. J.G. was supported by the UK Medical Research Council and M.P.C. was supported by the John and Lucille van Geest Foundation. M.K.M. was supported by the Australian Government Research Training Program (RTP).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bernoux M, 2016, PLANT CELL, V28, P146, DOI 10.1105/tpc.15.00303; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Buchholz A, 2001, ANAL BIOCHEM, V295, P129, DOI 10.1006/abio.2001.5183; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feechan A, 2013, PLANT J, V76, P661, DOI 10.1111/tpj.12327; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gakiere B, 2018, CRIT REV PLANT SCI, V37, P259, DOI 10.1080/07352689.2018.1505591; Gassner NC, 1999, ACTA CRYSTALLOGR D, V55, P1967, DOI 10.1107/S0907444999013347; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hunt L, 2004, NEW PHYTOL, V163, P31, DOI 10.1111/j.1469-8137.2004.01087.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai J.-S., 2019, BIORXIV, DOI [10.1101/563452, DOI 10.1101/563452]; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Matyszewski M, 2018, J BIOL CHEM, V293, P20240, DOI 10.1074/jbc.RA118.006050; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Nimma S, 2017, CURR OPIN STRUC BIOL, V43, P122, DOI 10.1016/j.sbi.2016.12.014; Nishimura MT, 2017, P NATL ACAD SCI USA, V114, pE2053, DOI 10.1073/pnas.1620973114; Oppenheimer N. J., 1992, ENZYMES, P453; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Pergolizzi G, 2011, CHEM COMMUN, V47, P12655, DOI 10.1039/c1cc15499k; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Schreiber KJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005769; Schultink A, 2017, PLANT J, V92, P787, DOI 10.1111/tpj.13715; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vajjhala PR, 2017, MOL IMMUNOL, V86, P23, DOI 10.1016/j.molimm.2017.02.012; Ve T, 2017, NAT STRUCT MOL BIOL, V24, P743, DOI 10.1038/nsmb.3444; Ve T, 2015, APOPTOSIS, V20, P250, DOI 10.1007/s10495-014-1064-2; Ve T, 2011, ACTA CRYSTALLOGR F, V67, P237, DOI 10.1107/S1744309110051006; Wan L, 2013, ACTA CRYSTALLOGR F, V69, P1275, DOI 10.1107/S1744309113026614; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang JZ, 2019, SCIENCE, V364, P44, DOI 10.1126/science.aav5870; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Williams SJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01850; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013; Zhang XX, 2017, ANNU REV PHYTOPATHOL, V55, P205, DOI 10.1146/annurev-phyto-080516-035250; Zhang XX, 2017, P NATL ACAD SCI USA, V114, pE2046, DOI 10.1073/pnas.1621248114; Zhao ZY, 2019, ISCIENCE, V15, P452, DOI 10.1016/j.isci.2019.05.001	88	206	215	17	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		793	+		10.1126/science.aax1911	http://dx.doi.org/10.1126/science.aax1911			78	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439792	Green Published, Green Submitted			2022-12-28	WOS:000482464000048
J	Underwood, E				Underwood, Emily			READING AN ANGUISHED BRAIN	SCIENCE			English	News Item																			0	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		738	741		10.1126/science.365.6455.738	http://dx.doi.org/10.1126/science.365.6455.738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439776				2022-12-28	WOS:000482464000022
J	von Birgelen, C; Buiten, RA				von Birgelen, Clemens; Buiten, Rosaly Anne			Superiority of biodegradable polymer sirolimus-eluting stents in STEMI	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; BARE-METAL STENTS; DURABLE POLYMER; THIN		[von Birgelen, Clemens; Buiten, Rosaly Anne] Med Spectrum Twente, Thoraxctr Twente, Dept Cardiol, NL-7512 KZ Enschede, Netherlands	Medical Spectrum Twente	von Birgelen, C (corresponding author), Med Spectrum Twente, Thoraxctr Twente, Dept Cardiol, NL-7512 KZ Enschede, Netherlands.	c.vonbirgelen@mst.nl		Buiten, Rosaly Anne/0000-0002-7385-0634				Iglesias JF, 2019, LANCET, V394, P1243, DOI 10.1016/S0140-6736(19)31877-X; Jensen LO, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003610; Kandzari DE, 2017, LANCET, V390, P1843, DOI 10.1016/S0140-6736(17)32249-3; Kok MM, 2018, EUROINTERVENTION, V14, P915, DOI 10.4244/EIJ-D-18-00336; Pilgrim T, 2016, EUROINTERVENTION, V12, pE1343, DOI 10.4244/EIJY15M12_09; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Steg PG, 2009, EUR HEART J, V30, P321, DOI 10.1093/eurheartj/ehn604; van Houwelingen KG, 2016, REV ESP CARDIOL, V69, P1152, DOI 10.1016/j.rec.2016.05.029; von Birgelen C, 2018, LANCET, V392, P1235, DOI 10.1016/S0140-6736(18)32001-4; von Birgelen C, 2016, LANCET, V388, P2607, DOI 10.1016/S0140-6736(16)31920-1; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	14	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1208	1210		10.1016/S0140-6736(19)31955-5	http://dx.doi.org/10.1016/S0140-6736(19)31955-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8XK	31488367				2022-12-28	WOS:000488862500005
J	Rosenbaum, L				Rosenbaum, Lisa			Losing Hahnemann - Real-Life Lessons in "Value-Based" Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The announcement that Hahnemann Hospital would soon close came as a shock to many people. Is the hospital a casualty of the push to optimize the distribution of limited resources - or a cautionary tale about the greed and corruption underlying our health care ills?										Carroll C, 2019, NBER WORKING PAPER; Chandra A, 2016, AM ECON REV, V106, P2110, DOI 10.1257/aer.20151080; DePillis L., CNN BUSINESS 0729; Joynt KE, 2015, HEALTH AFFAIR, V34, P765, DOI 10.1377/hlthaff.2014.1352	4	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1193	1195		10.1056/NEJMp1911307	http://dx.doi.org/10.1056/NEJMp1911307			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC5OT	31461591				2022-12-28	WOS:000489333500002
J	Desai, AS; Solomon, SD; Shah, AM; Claggett, BL; Fang, JC; Izzo, J; McCague, K; Abbas, CA; Rocha, R; Mitchell, GF; Izzo, J; Martinez-Castrillon, M; Beato, J; Shah, V; Pianko, L; Bouza, M; Alhaddad, M; Kashani, A; Sampognaro, G; Stahl, L; Lehman, J; Lebhar, S; Napoli, M; Consuegra, AT; Gonzalez, H; Lloret, R; Ariani, M; Azizad, M; Shah, A; Henderson, D; Covalesky, J; Brabham, D; Chane, M; Sanchez, E; Vega, R; Clay, A; McClure, J; Sogade, F; Ortiz-Munoz, L; Lewis, T; Zequeira, AG; Shah, R; Lepor, N; Gonzalez, M; Tidman, R; Berman, J; Lorenz, D; Nanna, M; Greene, T; Portnay, E; Bernstein, M; Somodevilla, G; Grodman, R; Gaffney, M; Park, H; Dor, I; Aslam, S; Jackson, R; Perez, G; Martinez, L; Gandelman, G; Dy, J; Salacata, A; Abadier, R; Steuter, J; Mahmood, S; Betton, H; Vora, K; Tallaj, J; Weinstein, D; Alhosaini, H; Everett, J; Rosenberg, M; Dunlap, S; Akinboboy, O; Walia, J; Lyandres, Y; Harris, B; Abo-Auda, W; Stearns, Z; Kazemi, N; Bradley, A; Megna, L; Taylor, J; Innasimuthu, A; Waggoner, LD; Moraes, D; Jani, S; Chronos, N; Joshi, N; Radin, M; Suleman, A; Grena, P; Agrawal, S; Holmberg, M				Desai, Akshay S.; Solomon, Scott D.; Shah, Amil M.; Claggett, Brian L.; Fang, James C.; Izzo, Joseph; McCague, Kevin; Abbas, Cheryl A.; Rocha, Ricardo; Mitchell, Gary F.; Izzo, Joseph; Martinez-Castrillon, Melvin; Beato, Jorge; Shah, Vipul; Pianko, Leonard; Bouza, Manuel; Alhaddad, Mohsin; Kashani, Amir; Sampognaro, Gregory; Stahl, Lloyd; Lehman, John; Lebhar, Steve; Napoli, Mark; Consuegra, Aurelio Torres; Gonzalez, Humberto; Lloret, Ramon; Ariani, Mehrdad; Azizad, Masoud; Shah, Anil; Henderson, David; Covalesky, John; Brabham, David; Chane, Majed; Sanchez, Eulogio; Vega, Ramses; Clay, Anthony; McClure, John; Sogade, Felix; Ortiz-Munoz, Luis; Lewis, Todd; Zequeira, Argentina Gonzalez; Shah, Rakesh; Lepor, Norman; Gonzalez, Marisela; Tidman, Raymond; Berman, Jeffrey; Lorenz, David; Nanna, Michele; Greene, Trevor; Portnay, Edward; Bernstein, Marc; Somodevilla, Guillermo; Grodman, Robert; Gaffney, Mary; Park, Hyeun; Dor, Isaac; Aslam, Shamaila; Jackson, Richard; Perez, Guido; Martinez, Luis; Gandelman, Glenn; Dy, Johnny; Salacata, Abraham; Abadier, Rafik; Steuter, John; Mahmood, Sadeem; Betton, Harold; Vora, Kishor; Tallaj, Jose; Weinstein, Debra; Alhosaini, Hassan; Everett, John; Rosenberg, Michael; Dunlap, Stephanie; Akinboboy, Olakunle; Walia, Jasjit; Lyandres, Yuly; Harris, Barry; Abo-Auda, Wael; Stearns, Zebediah; Kazemi, Navid; Bradley, Arden; Megna, Lucien; Taylor, Jeff; Innasimuthu, Anthony; Waggoner, L. Douglas; Moraes, Denzil; Jani, Sandeep; Chronos, Nicolas; Joshi, Nikhil; Radin, Michael; Suleman, Amer; Grena, Paul; Agrawal, Subodh; Holmberg, Mark		EVALUATE-HF Investigators	Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	European-Society-of-Cardiology (ESC) Congress	SEP 02, 2019	Paris, FRANCE	European Soc Cardiol			NEPRILYSIN INHIBITION; SYSTOLIC HYPERTENSION; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; BLOOD-PRESSURE; HEMODYNAMICS; UPDATE; ECHOCARDIOGRAPHY; RECOMMENDATIONS	Key PointsQuestionWhat pathophysiologic mechanisms contribute to the clinical effects of sacubitril-valsartan compared with enalapril in patients with heart failure and reduced ejection fraction (HFrEF)? FindingsIn this randomized clinical trial of 464 participants with HFrEF, there was no significant difference in the change in aortic characteristic impedance (a measure of central aortic stiffness) at 12 weeks among patients treated with sacubitril-valsartan vs enalapril (-2.9 vs -0.7 dynexs/cm(5)). MeaningTreatment of HFrEF with sacubitril-valsartan, compared with enalapril, did not significantly reduce central aortic stiffness. ImportanceCompared with enalapril, sacubitril-valsartan reduces cardiovascular mortality and heart failure hospitalization in patients with heart failure and reduced ejection fraction (HFrEF). These benefits may be related to effects on hemodynamics and cardiac remodeling. ObjectiveTo determine whether treatment of HFrEF with sacubitril-valsartan improves central aortic stiffness and cardiac remodeling compared with enalapril. Design, Setting, and ParticipantsRandomized, double-blind clinical trial of 464 participants with heart failure and ejection fraction of 40% or less enrolled across 85 US sites between August 17, 2016, and June 28, 2018. Follow-up was completed on January 26, 2019. InterventionsRandomization (1:1) to sacubitril-valsartan (n=231; target dosage, 97/103 mg twice daily) vs enalapril (n=233; target dosage, 10 mg twice daily) for 12 weeks. Main Outcomes and MeasuresThe primary outcome was change from baseline to week 12 in aortic characteristic impedance (Zc), a measure of central aortic stiffness. Prespecified secondary outcomes included change from baseline to week 12 in N-terminal pro-B-type natriuretic peptide, ejection fraction, global longitudinal strain, mitral annular relaxation velocity, mitral E/e ratio, left ventricular end-systolic and end-diastolic volume indexes (LVESVI and LVEDVI), left atrial volume index, and ventricular-vascular coupling ratio. ResultsOf 464 validly randomized participants (mean age, 67.3 [SD, 9.1] years; 23.5% women), 427 completed the study. At 12 weeks, Zc decreased from 223.8 to 218.9 dyne x s/cm(5) in the sacubitril-valsartan group and increased from 213.2 to 214.4 dyne x s/cm(5) in the enalapril group (treatment difference, -2.2 [95% CI, -17.6 to 13.2] dyne x s/cm(5); P=.78). Of 9 prespecified secondary end points, no significant between-group difference in change from baseline was seen in 4, including left ventricular ejection fraction (34%-36% with sacubitril-valsartan vs 33 to 35% with enalapril; treatment difference, 0.6% [95% CI, -0.4% to 1.7%]; P=.24). However, greater reductions from baseline were seen with sacubitril-valsartan than with enalapril in all others, including left atrial volume (from 30.4 mL/m(2) to 28.2 mL/m(2) vs from 29.8 mL/m(2) to 30.5 mL/m(2); treatment difference, -2.8 mL/m(2) [95% CI, -4.0 to -1.6 mL/m(2)]; P<.001), LVEDVI (from 75.1 mL/m(2) to 70.3 mL/m(2) vs from 79.1 mL/m(2) to 75.6 mL/m(2); treatment difference, -2.0 mL/m(2) [95% CI, -3.7 to 0.3 mL/m(2)]; P=.02), LVESVI (from 50.8 mL/m(2) to 46.3 mL/m(2) vs from 54.1 to 50.6 mL/m(2); treatment difference, -1.6 mL/m(2) [95% CI, -3.1 to -0.03 mL/m(2)]; P=.045), and mitral E/e ratio (from 13.8 to 12.3 vs from 13.4 to 13.8; treatment difference, -1.8 [95% CI, -2.8 to -0.8]; P=.001). Rates of adverse events including hypotension (1.7% vs 3.9%) were similar in both groups. Conclusions and RelevanceTreatment of HFrEF with sacubitril-valsartan, compared with enalapril, did not significantly reduce central aortic stiffness. The study findings may provide insight into mechanisms underlying the effects of sacubitril-valsartan in HFrEF. Trial RegistrationClinicalTrials.gov Identifier: NCT02874794 This randomized trial compares the effects of sacubitril-valsartan vs enalapril on central aortic stiffness and other physiologic indexes in patients with heart failure and reduced ejection fraction.	[Desai, Akshay S.; Solomon, Scott D.; Shah, Amil M.; Claggett, Brian L.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Fang, James C.] Univ Utah, Cardiovasc Med, Salt Lake City, UT USA; [Izzo, Joseph] SUNY Buffalo, Dept Med, Buffalo, NY USA; [McCague, Kevin; Abbas, Cheryl A.; Rocha, Ricardo] Novartis Pharmaceut, E Hanover, NJ USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA; [Izzo, Joseph] Erie Cty Med Ctr & Labs, Buffalo, NY USA; [Martinez-Castrillon, Melvin] Infinite Clin Res, Doral, FL USA; [Beato, Jorge] Hi Tech & Global Res LLC, Coral Gables, FL USA; [Shah, Vipul] Carolina Heart Specialists, Lancaster, SC USA; [Pianko, Leonard] Aventura Clin Res, Aventura, FL USA; [Bouza, Manuel] Elite Cardiac Res Ctr, Hialeah, FL USA; [Alhaddad, Mohsin] Res Associates Jackson Apex Cardiol, Jackson, TN USA; [Kashani, Amir] Private Practice Leadership LLC, Houston, TX USA; [Sampognaro, Gregory] Clin Trials Amer, Minden, LA USA; [Stahl, Lloyd] Midwest Heart & Vasc Specialists LLC, Overland, KS USA; [Lehman, John] Medicoricium LLC, Fairview Hts, IL USA; [Lebhar, Steve] Pharma Res Int Inc, Naples, FL USA; [Napoli, Mark] Clin Trials Amer LLC, Monroe, LA USA; [Consuegra, Aurelio Torres] Elite Clin Res, Miami, FL USA; [Gonzalez, Humberto] Innovat Med Res Ctr, Miami, FL USA; [Lloret, Ramon] Cardiovasc Res Ctr South Florida, Miami, FL USA; [Ariani, Mehrdad; Azizad, Masoud] Valley Clin Trials Inc, Northridge, CA USA; [Shah, Anil] Coastal Heart Med Grp, Santa Ana, CA USA; [Henderson, David] Cardiol Associates Res Co, Daytona Beach, FL USA; [Covalesky, John] Garden State Hlth Care, Manalapan, NJ USA; [Brabham, David] PharmaTex Res, Amarillo, TX USA; [Chane, Majed] Calif Heart Specialists, Huntington Beach, CA USA; [Sanchez, Eulogio] Cardiovasc & Vein Ctr Florida, Bradenton, FL USA; [Vega, Ramses] Crystal Pharmacol Res, Miami, FL USA; [Clay, Anthony] Cardiol Phys PA, Newark, DE USA; [McClure, John] Mid Michigan Heart & Vasc Ctr, Saginaw, MI USA; [Sogade, Felix] Georgia Arrhythmia Consultants, Macon, GA USA; [Ortiz-Munoz, Luis] SIMA Res Clin, Miami, FL USA; [Lewis, Todd] East Coast Inst Res LLC, St Augustine, FL USA; [Zequeira, Argentina Gonzalez] Celen Med Grp Corp, Miami, FL USA; [Shah, Rakesh] Bay Area Heart, Webster, TX USA; [Lepor, Norman] Westside Med Associates Los Angeles, Beverly Hills, CA USA; [Gonzalez, Marisela] Adv Res Ctr LLC, Miami, FL USA; [Tidman, Raymond] River Birch Res Alliance LLC, Blue Ridge, GA USA; [Berman, Jeffrey] Cardiol Associates Fairfield Cty PC, Trumbull, CT USA; [Lorenz, David] Cardiol Associates Fairfield Cty PC, Norwalk, CT USA; [Nanna, Michele] Cardiac Care & Vasc Med, Bronx, NY USA; [Greene, Trevor] East Coast Inst Res, Jacksonville, FL USA; [Portnay, Edward] Cardiol Associates Fairfield Cty, Stamford, CT USA; [Bernstein, Marc] Louisiana Heart Ctr, Slidell, LA USA; [Somodevilla, Guillermo] Cordova Res Inst LLC, Miami, FL USA; [Grodman, Robert] Detroit Clin Res Ctr, Farmington Hills, MI USA; [Gaffney, Mary] Gaffney Hlth Serv, Charlotte, NC USA; [Park, Hyeun] Lakeland Cardiol Ctr PA, Mt Lakes, NJ USA; [Dor, Isaac] Comprehens Cardiovasc Care, Gurnee, IL USA; [Aslam, Shamaila] Northwest Houston Clin Res PLLC, Tomball, TX USA; [Jackson, Richard] Dominion Med Associates Inc, Richmond, VA USA; [Perez, Guido] Biomed Res Inst, Miami, FL USA; [Martinez, Luis] Universal Axon Clin Res, Doral, FL USA; [Gandelman, Glenn] Gandelman Cardiol, Greenwich, CT USA; [Dy, Johnny] Clin Trials Amer NC LLC, Lenoir, NC USA; [Salacata, Abraham] Endeavor Med Res, Alpena, MI USA; [Abadier, Rafik] Nat Coast Clin Res, Inverness, FL USA; [Steuter, John] Integrated Cardiol Grp LLC Dba Bryan Heart, Lincoln, NE USA; [Mahmood, Sadeem; Betton, Harold] MARC Trials LLC, Little Rock, AR USA; [Vora, Kishor] Res Integr LLC, Owensboro, KY USA; [Tallaj, Jose] Univ Alabama Birmingham, Birmingham, AL USA; [Weinstein, Debra] Atlantic Clin Res Collaborat Cardiol, Boynton Beach, FL USA; [Alhosaini, Hassan] East Carolina Heart Inst, Greenville, NC USA; [Everett, John] Kooental Heart Clin, Coeur Dalene, IL USA; [Rosenberg, Michael] Holy Family Mem Inc, Heart & Vasc Ctr, Manitowoc, WI USA; [Dunlap, Stephanie] Augusta Univ, Clin Trials Off, Augusta, GA USA; [Akinboboy, Olakunle] Laurelton Heart Specialists PC, Rosedale, NY USA; [Walia, Jasjit] NJ Heart, Linden, NJ USA; [Lyandres, Yuly] Premier Cardiol Consultants, Lake Success, NY USA; [Harris, Barry] Integrat Res Associates Inc, Ft Lauderdale, FL USA; [Abo-Auda, Wael] CardioVoyage LLC, Mckinney, TX USA; [Stearns, Zebediah] Opelousas LLC, Horizon Res Grp, Eunice, LA USA; [Kazemi, Navid] Palm Res Ctr Inc, Las Vegas, NV USA; [Bradley, Arden] Adv Clin Res Grp, Stuart, FL USA; [Megna, Lucien] Mid Columbia Res, Richland, WA USA; [Taylor, Jeff] CardioCare, Hillsborough, NJ USA; [Innasimuthu, Anthony] Heart & Vasc Clin PA, Newark, DE USA; [Waggoner, L. Douglas] Kootenai Heart Clin LLC, Spokane, WA USA; [Moraes, Denzil] Our Lady Lake Phys Grp, Res Off, Baton Rouge, LA USA; [Jani, Sandeep] MedStar Heart & Vasc Inst, Baltimore, MD USA; [Chronos, Nicolas] Cardiol Care Clin, Eatonton, GA USA; [Joshi, Nikhil] Sherman Clin Res, Sherman, TX USA; [Radin, Michael] Radin Cardiovasc Med Associates, Newport Beach, CA USA; [Suleman, Amer] Heartbeat Clin PA, Mckinney, TX USA; [Grena, Paul] Cardiol Consultants Philadelphia, Yardley, PA USA; [Agrawal, Subodh] Athena Clin Res LLC, Athens, GA USA; [Holmberg, Mark] Creighton Univ, Med Ctr Bergan, CHI Hlth, Omaha, NE 68178 USA	Harvard University; Brigham & Women's Hospital; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Novartis; Cardiovascular Engineering; University of Alabama System; University of Alabama Birmingham; University System of Georgia; Augusta University; Creighton University	Solomon, SD (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	ssolomon@bwh.harvard.edu	Desai, Akshay/ABE-7250-2020; Lepor, Norman/AAP-2488-2021		Novartis	Novartis(Novartis)	This study was sponsored by Novartis.	Bohm M, 2017, EUR HEART J, V38, P1132, DOI 10.1093/eurheartj/ehw570; Borlaug Barry A, 2008, Heart Fail Clin, V4, P23, DOI 10.1016/j.hfc.2007.10.001; Chirinos JA, 2012, HYPERTENSION, V60, P64, DOI 10.1161/HYPERTENSIONAHA.112.190710; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Kang DH, 2019, CIRCULATION, V139, P1354, DOI 10.1161/CIRCULATIONAHA.118.037077; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lewis EF, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003430; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Mitchell GF, 2006, EUR J HEART FAIL, V8, P191, DOI 10.1016/j.ejheart.2005.07.006; Mitchell GF, 2001, HYPERTENSION, V38, P1433, DOI 10.1161/hy1201.098298; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; Velazquez EJ, 2019, NEW ENGL J MED, V380, P539, DOI 10.1056/NEJMoa1812851; Williams B, 2017, HYPERTENSION, V69, P411, DOI 10.1161/HYPERTENSIONAHA.116.08556; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Zile MR, 2019, J AM COLL CARDIOL, V73, P795, DOI 10.1016/j.jacc.2018.11.042	19	158	168	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1077	1084		10.1001/jama.2019.12843	http://dx.doi.org/10.1001/jama.2019.12843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	JB8LM	31475296	Green Published, Bronze			2022-12-28	WOS:000488821100020
J	Bakkeren, E; Huisman, JS; Fattinger, SA; Hausmann, A; Furter, M; Egli, A; Slack, E; Sellin, ME; Bonhoeffer, S; Regoes, RR; Diard, M; Hardt, WD				Bakkeren, Erik; Huisman, Jana S.; Fattinger, Stefan A.; Hausmann, Annika; Furter, Markus; Egli, Adrian; Slack, Emma; Sellin, Mikael E.; Bonhoeffer, Sebastian; Regoes, Roland R.; Diard, Mederic; Hardt, Wolf-Dietrich			Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut	NATURE			English	Article							ANTIMICROBIAL RESISTANCE; BACTERIAL PERSISTENCE; TOLERANCE; IDENTIFICATION; INFLAMMATION; MACROPHAGES; INFECTIONS; VIRULENCE; DEFENSES; COLITIS	The emergence of antibiotic-resistant bacteria through mutations or the acquisition of genetic material such as resistance plasmids represents a major public health issue(1,2). Persisters are subpopulations of bacteria that survive antibiotics by reversibly adapting their physiology(3-10), and can promote the emergence of antibiotic-resistant mutants(11). We investigated whether persisters can also promote the spread of resistance plasmids. In contrast to mutations, the transfer of resistance plasmids requires the co-occurrence of both a donor and a recipient bacterial strain. For our experiments, we chose the facultative intracellular entero-pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) and Escherichia coli, a common member of the microbiota(12). S. Typhimurium forms persisters that survive antibiotic therapy in several host tissues. Here we show that tissue-associated S. Typhimurium persisters represent long-lived reservoirs of plasmid donors or recipients. The formation of reservoirs of S. Typhimurium persisters requires Salmonella pathogenicity island (SPI)-1 and/or SPI-2 in gut-associated tissues, or SPI-2 at systemic sites. The re-seeding of these persister bacteria into the gut lumen enables the co-occurrence of donors with gut-resident recipients, and thereby favours plasmid transfer between various strains of Enterobacteriaceae. We observe up to 99% transconjugants within two to three days of re-seeding. Mathematical modelling shows that rare re-seeding events may suffice for a high frequency of conjugation. Vaccination reduces the formation of reservoirs of persisters after oral infection with S. Typhimurium, as well as subsequent plasmid transfer. We conclude that-even without selection for plasmid-encoded resistance genes-small reservoirs of pathogen persisters can foster the spread of promiscuous resistance plasmids in the gut.	[Bakkeren, Erik; Fattinger, Stefan A.; Hausmann, Annika; Furter, Markus; Slack, Emma; Diard, Mederic; Hardt, Wolf-Dietrich] Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, Zurich, Switzerland; [Huisman, Jana S.; Bonhoeffer, Sebastian; Regoes, Roland R.] Swiss Fed Inst Technol, Inst Integrat Biol, Dept Environm Syst Sci, Zurich, Switzerland; [Huisman, Jana S.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Fattinger, Stefan A.; Sellin, Mikael E.] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Egli, Adrian] Univ Hosp Basel, Div Clin Microbiol, Basel, Switzerland; [Egli, Adrian] Univ Basel, Dept Biomed, Appl Microbiol Res, Basel, Switzerland; [Slack, Emma] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Dept Hlth Sci & Technol, Zurich, Switzerland; [Diard, Mederic] Univ Basel, Biozentrum, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; Uppsala University; University of Basel; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Diard, M; Hardt, WD (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, Zurich, Switzerland.; Diard, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	mederic.diard@unibas.ch; hardt@micro.biol.ethz.ch	Bonhoeffer, Sebastian/A-2735-2008; Diard, Mederic/AAA-3067-2020; Hausmann, Annika/ABB-5379-2022; Bakkeren, Erik/AAF-4391-2021; Slack, Emma/AAD-5837-2019	Bonhoeffer, Sebastian/0000-0001-8052-3925; Hausmann, Annika/0000-0001-8852-3444; Bakkeren, Erik/0000-0001-7970-7890; Slack, Emma/0000-0002-2473-1145; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Fattinger, Stefan/0000-0003-4899-4414; Huisman, Jana Sanne/0000-0002-1782-8109; Sellin, Mikael/0000-0002-8355-0803	Swiss National Science Foundation (SNF) [310030B-173338]; Promedica Foundation, Chur; Helmut Horten Foundation; SNF NFP 72 [407240-167121]; SNF professorship grant [PP00PP_176954]; Boehringer Ingelheim Fonds PhD fellowship; Swedish Research Council [2015-00635, 2018-02223]; SNF [31003A_179170]; Gebert Ruf Foundation [GRS 073/17]; SNF Bridge Discover Grant [20B2-1 180953]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Promedica Foundation, Chur; Helmut Horten Foundation; SNF NFP 72; SNF professorship grant; Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim); Swedish Research Council(Swedish Research CouncilEuropean Commission); SNF; Gebert Ruf Foundation; SNF Bridge Discover Grant	We thank the members of the Hardt, Slack, Bonhoeffer, Stadler and Ackermann labs for helpful discussion, and the staff at the RCHCI and EPIC animal facilities for their excellent support. This work has been funded, in part, by grants from the Swiss National Science Foundation (SNF; 310030B-173338), the Promedica Foundation, Chur and the Helmut Horten Foundation to W.-D.H., and from the SNF NFP 72 (407240-167121) to W.-D.H., S.B. and A.E.M.D. is funded by an SNF professorship grant (PP00PP_176954), E.B. by a Boehringer Ingelheim Fonds PhD fellowship, and M.E.S. and S.A.F. (in part) by the Swedish Research Council (2015-00635, 2018-02223). R.R.R. is funded by SNF grant number 31003A_179170. E.S. is supported by grant GRS 073/17 from the ` Microbials' programme of the Gebert Ruf Foundation and the SNF Bridge Discover Grant 20B2-1 180953.	APPERLOORENKEMA HZ, 1990, EPIDEMIOL INFECT, V105, P355, DOI 10.1017/S0950268800047944; Balaban NQ, 2019, NAT REV MICROBIOL, V17, P441, DOI 10.1038/s41579-019-0196-3; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Claudi B, 2014, CELL, V158, P722, DOI 10.1016/j.cell.2014.06.045; Coque T M, 2008, Euro Surveill, V13; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Defraine V, 2018, DRUG RESIST UPDATE, V38, P12, DOI 10.1016/j.drup.2018.03.002; Diard M, 2017, SCIENCE, V355, P1211, DOI 10.1126/science.aaf8451; Diard M, 2014, CURR BIOL, V24, P2000, DOI 10.1016/j.cub.2014.07.028; Dolowschiak T, 2016, CELL HOST MICROBE, V20, P238, DOI 10.1016/j.chom.2016.06.008; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Moor K, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00034; Parisi A, 2018, FOODBORNE PATHOG DIS, V15, P428, DOI 10.1089/fpd.2017.2403; Roberts ME, 2005, MICROBIOL-SGM, V151, P75, DOI 10.1099/mic.0.27385-0; Sampei G, 2010, PLASMID, V64, P92, DOI 10.1016/j.plasmid.2010.05.005; San Roman B, 2018, ZOONOSES PUBLIC HLTH, V65, P481, DOI 10.1111/zph.12453; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Stapels DAC, 2018, SCIENCE, V362, P1156, DOI 10.1126/science.aat7148; Stecher B, 2006, INFECT IMMUN, V74, P5047, DOI 10.1128/IAI.00072-06; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; WILCOCK BP, 1976, CAN J COMP MED, V40, P80; Wolzka SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206214; WOOD RL, 1989, AM J VET RES, V50, P1015; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	41	95	95	8	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					276	+		10.1038/s41586-019-1521-8	http://dx.doi.org/10.1038/s41586-019-1521-8			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31485077	Green Accepted			2022-12-28	WOS:000485415400058
J	Gong, JK; Liu, JZ; Ronan, EA; He, FT; Cai, W; Fatima, M; Zhang, WY; Lee, H; Li, ZY; Kim, GH; Pipe, KP; Duan, B; Liu, JF; Xu, XZS				Gong, Jianke; Liu, Jinzhi; Ronan, Elizabeth A.; He, Feiteng; Cai, Wei; Fatima, Mahar; Zhang, Wenyuan; Lee, Hankyu; Li, Zhaoyu; Kim, Gun-Ho; Pipe, Kevin P.; Duan, Bo; Liu, Jianfeng; Xu, X. Z. Shawn			A Cold-Sensing Receptor Encoded by a Glutamate Receptor Gene	CELL			English	Article							C.-ELEGANS; CAENORHABDITIS-ELEGANS; NOCICEPTIVE NEURONS; TRP CHANNEL; KAINATE; EXPRESSION; AMPA; MECHANISMS; SENSATION; SUBUNITS	In search of the molecular identities of cold-sensing receptors, we carried out an unbiased genetic screen for cold-sensing mutants in C. elegans and isolated a mutant allele of glr-3 gene that encodes a kainate-type glutamate receptor. While glutamate receptors are best known to transmit chemical synaptic signals in the CNS, we show that GLR-3 senses cold in the peripheral sensory neuron ASER to trigger cold-avoidance behavior. GLR-3 transmits cold signals via G protein signaling independently of its glutamate-gated channel function, suggesting GLR-3 as a metabotropic cold receptor. The vertebrate GLR-3 homolog GluK2 from zebrafish, mouse, and human can all function as a cold receptor in heterologous systems. Mouse DRG sensory neurons ex- prc GluK2, and GluK2 knockdown in these neurons suppresses their sensitivity to cold but not cool temperatures. Our study identifies an evolutionarily conserved cold receptor, revealing that a central chemical receptor unexpectedly functions as a thermal receptor in the periphery.	[Gong, Jianke; Liu, Jinzhi; He, Feiteng; Zhang, Wenyuan; Liu, Jianfeng] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Coll Life Sci & Technol, MOE, Wuhan 430074, Hubei, Peoples R China; [Gong, Jianke; Liu, Jinzhi; He, Feiteng; Zhang, Wenyuan; Liu, Jianfeng] Huazhong Univ Sci & Technol, Int Res Ctr Sensory Biol & Technol, MOST, Wuhan 430074, Hubei, Peoples R China; [Gong, Jianke; Liu, Jinzhi; Ronan, Elizabeth A.; He, Feiteng; Cai, Wei; Zhang, Wenyuan; Li, Zhaoyu; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gong, Jianke; Liu, Jinzhi; Ronan, Elizabeth A.; He, Feiteng; Cai, Wei; Zhang, Wenyuan; Li, Zhaoyu; Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Fatima, Mahar; Lee, Hankyu; Duan, Bo] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Pipe, Kevin P.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Pipe, Kevin P.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Kim, Gun-Ho] Ulsan Natl Inst Sci & Technol, Dept Mech Engn, 50 UNIST Gil, Ulsan, South Korea; [Li, Zhaoyu] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ulsan National Institute of Science & Technology (UNIST); University of Queensland	Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Coll Life Sci & Technol, MOE, Wuhan 430074, Hubei, Peoples R China.; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Int Res Ctr Sensory Biol & Technol, MOST, Wuhan 430074, Hubei, Peoples R China.; Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Xu, XZS (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	jfliu@mail.hust.edu.cn; shawnxu@umich.edu	Lee, Hankyu/AAB-5542-2020; Fatima, Mahar/GZL-3084-2022; Ronan, Elizabeth/HGA-8412-2022; Lee, Han Kyu/K-8388-2015	Fatima, Mahar/0000-0002-8885-1912; Li, Zhaoyu/0000-0002-5222-6832; Lee, Han Kyu/0000-0002-0949-3345; Ronan, Elizabeth/0000-0001-7400-5718	NIA T32 training grant; MOST [2018YFA0507003, 31420103909, 81872945, 81720108031]; NSFC [2018YFA0507003, 31420103909, 81872945, 81720108031]; 111 project of the MOE [B08029]; National Research Foundation of Korea [NRF-2017R1A4A1015564]; NINDS; NIGMS; NIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM126917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011] Funding Source: NIH RePORTER	NIA T32 training grant; MOST; NSFC(National Natural Science Foundation of China (NSFC)); 111 project of the MOE; National Research Foundation of Korea(National Research Foundation of Korea); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Min Guo, Xi Lan, Jie Liu, Rebekah Ronan, Bonnie Zeng, Seth Kattapong-Graber, and Jonathan Ronan for technical assistance, and Bing Ye for comments. Some strains were obtained from the CGC and Japan knockout consortium. E.A.R. was supported by an NIA T32 training grant. Jianfeng Liu received funding support from the MOST and NSFC (2018YFA0507003, 31420103909, 81872945, and 81720108031) and the 111 project of the MOE (B08029). G.-H.K. received funding support from the National Research Foundation of Korea (NRF-2017R1A4A1015564). B.D. received funding support from the NINDS. X.Z.S.X. received funding support from the NIGMS and NIA.	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bargmann Cornelia I, 2006, WormBook, P1; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Budelli G, 2019, NEURON, V101, P738, DOI 10.1016/j.neuron.2018.12.022; Castillo K, 2018, PHYS BIOL, V15, DOI 10.1088/1478-3975/aa9a6f; Coggeshall RE, 1998, J COMP NEUROL, V391, P78; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Foulkes T, 2007, CHANNELS, V1, P154, DOI 10.4161/chan.4692; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; GIERSCHIK P, 1992, CURR TOP MICROBIOL, V175, P69; Gong JK, 2016, CELL, V167, P1252, DOI 10.1016/j.cell.2016.10.053; Goodman Miriam B, 2006, WormBook, P1; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; McGhee J.D., 2007, C ELEGANS INTESTINE, P1; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Moparthi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28763; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ortiz CO, 2009, CURR BIOL, V19, P996, DOI 10.1016/j.cub.2009.05.043; Pauwels PJ, 2003, J PHARMACOL EXP THER, V307, P608, DOI 10.1124/jpet.103.055871; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Robert A, 2002, NEUROSCIENCE, V115, P1199, DOI 10.1016/S0306-4522(02)00534-1; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Rozas JL, 2003, NEURON, V39, P543, DOI 10.1016/S0896-6273(03)00436-7; Schepers RJ, 2010, NEUROSCI BIOBEHAV R, V34, P177, DOI 10.1016/j.neubiorev.2009.10.003; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valbuena S, 2016, NEURON, V92, P316, DOI 10.1016/j.neuron.2016.10.016; Vandewauw I, 2018, NATURE, V555, P662, DOI 10.1038/nature26137; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang R, 2012, NEURON, V75, P838, DOI 10.1016/j.neuron.2012.06.038; Wang X, 2016, NEURON, V91, P146, DOI 10.1016/j.neuron.2016.05.023; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Winter Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00209; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020	50	34	40	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1375	+		10.1016/j.cell.2019.07.034	http://dx.doi.org/10.1016/j.cell.2019.07.034			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474366	Bronze, Green Accepted			2022-12-28	WOS:000483983000013
J	Tanne, JH				Tanne, Janice Hopkins			US supermarket chain Walmart limits gun and ammunition sales	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Telford T, 2019, FOLLOWING WALMARTS L; Walmart, FIR AMM GUID	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5441	10.1136/bmj.l5441	http://dx.doi.org/10.1136/bmj.l5441			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488426				2022-12-28	WOS:000485441400008
J	Oliver, D				Oliver, David			Exclusive: Government spending on management consultants trebles in three years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hawkes N., 2019, BMJ-BRIT MED J, V364, pI394; LIMB M, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G6849; Limb M, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k893; Lintern S., 2019, HLTH SERV J; OLIVER D, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G7243; Williams D., 2018, HLTH SERV J	6	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l5404	10.1136/bmj.l5404	http://dx.doi.org/10.1136/bmj.l5404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1FO	31488406				2022-12-28	WOS:000485437600011
J	Thayakaran, R; Adderley, NJ; Sainsbury, C; Torlinska, B; Boelaert, K; Sumilo, D; Price, M; Thomas, GN; Toulis, KA; Nirantharakumar, K				Thayakaran, Rasiah; Adderley, Nicola J.; Sainsbury, Christopher; Torlinska, Barbara; Boelaert, Kristien; Sumilo, Dana; Price, Malcolm; Thomas, G. Neil; Toulis, Konstantinos A.; Nirantharakumar, Krishnarajah			Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SUBCLINICAL HYPOTHYROIDISM; INCREASED RISK; NORMAL RANGE; HYPERTHYROIDISM; ASSOCIATION; MORTALITY; FRACTURES; THYROTROPIN; DYSFUNCTION	OBJECTIVE To explore whether thyroid stimulating hormone (TSH) concentration in patients with a diagnosis of hypothyroidism is associated with increased all cause mortality and a higher risk of cardiovascular disease and fractures. DESIGN Retrospective cohort study. SETTING The Health Improvement Network (THIN), a database of electronic patient records from UK primary care. PARTICIPANTS Adult patients with incident hypothyroidism from 1 January 1995 to 31 December 2017. EXPOSURE TSH concentration in patients with hypothyroidism. MAIN OUTCOME MEASURES Ischaemic heart disease, heart failure, stroke/transient ischaemic attack, atrial fibrillation, any fractures, fragility fractures, and mortality. Longitudinal TSH measurements from diagnosis to outcomes, study end, or loss to follow-up were collected. An extended Cox proportional hazards model with TSH considered as a time varying covariate was fitted for each outcome. RESULTS 162 369 patients with hypothyroidism and 863 072 TSH measurements were included in the analysis. Compared with the reference TSH category (2-2.5 mIU/L), risk of ischaemic heart disease and heart failure increased at high TSH concentrations (> 10 mIU/L) (hazard ratio 1.18 (95% confidence interval 1.02 to 1.38; P=0.03) and 1.42 (1.21 to 1.67; P<0.001), respectively). A protective effect for heart failure was seen at low TSH concentrations (hazard ratio 0.79 (0.64 to 0.99; P=0.04) for TSH < 0.1 mIU/L and 0.76 (0.62 to 0.92; P=0.006) for 0.1-0.4 mIU/L). Increased mortality was observed in both the lowest and highest TSH categories (hazard ratio 1.18 (1.08 to 1.28; P<0.001), 1.29 (1.22 to 1.36; P<0.001), and 2.21 (2.07 to 2.36; P<0.001) for TSH < 0.1 mIU/L, 4-10 mIU/L, and > 10 mIU/L. An increase in the risk of fragility fractures was observed in patients in the highest TSH category (> 10 mIU/L) (hazard ratio 1.15 (1.01 to 1.31; P=0.03)). CONCLUSIONS In patients with a diagnosis of hypothyroidism, no evidence was found to suggest a clinically meaningful difference in the pattern of long term health outcomes (all cause mortality, atrial fibrillation, ischaemic heart disease, heart failure, stroke/transient ischaemic attack, fractures) when TSH concentrations were within recommended normal limits. Evidence was found for adverse health outcomes when TSH concentration is outside this range, particularly above the upper reference value.	[Thayakaran, Rasiah; Adderley, Nicola J.; Sainsbury, Christopher; Torlinska, Barbara; Sumilo, Dana; Price, Malcolm; Thomas, G. Neil; Toulis, Konstantinos A.; Nirantharakumar, Krishnarajah] Univ Birmingham, Inst Appl Hlth Res, Birmingham B15 2TT, W Midlands, England; [Sainsbury, Christopher] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [Boelaert, Kristien] Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England; [Boelaert, Kristien] Univ Birmingham, Inst Translat Med, Birmingham B15 2TT, W Midlands, England; [Boelaert, Kristien; Nirantharakumar, Krishnarajah] Ctr Endocrinol Diabet & Metab, Birmingham B15 2TT, W Midlands, England; [Toulis, Konstantinos A.] 424 Gen Army Training Hosp, Dept Endocrinol, Thessaloniki, Greece; [Nirantharakumar, Krishnarajah] Inst Translat Med, Hlth Data Res UK Midlands, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Nirantharakumar, K (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham B15 2TT, W Midlands, England.; Nirantharakumar, K (corresponding author), Ctr Endocrinol Diabet & Metab, Birmingham B15 2TT, W Midlands, England.; Nirantharakumar, K (corresponding author), Inst Translat Med, Hlth Data Res UK Midlands, Birmingham B15 2TH, W Midlands, England.	K.Nirantharan@bham.ac.uk	Torlinska, Barbara/T-6173-2017; Torlinska, Barbara/AAQ-4321-2020; Adderley, Nicola J/ABD-7501-2021	Torlinska, Barbara/0000-0001-8284-1927; Torlinska, Barbara/0000-0001-8284-1927; Sainsbury, Chris/0000-0002-7984-5721; Adderley, Nicola/0000-0003-0543-3254; Price, Malcolm/0000-0002-7352-3027; Thomas, Graham Neil/0000-0002-2777-1847				Adams J, 2005, J PUBLIC HEALTH, V27, P101, DOI 10.1093/pubmed/fdh193; Andersen S, 2003, THYROID, V13, P1069, DOI 10.1089/105072503770867237; Asvold BO, 2015, JAMA INTERN MED, V175, P1037, DOI 10.1001/jamainternmed.2015.0930; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Biondi B, 2018, NEW ENGL J MED, V379, P1485; Biondi B, 2014, ENDOCR REV, V35, P433, DOI 10.1210/er.2013-1083; Blak Betina T, 2011, Inform Prim Care, V19, P251; Boelaert K, 2013, NAT REV ENDOCRINOL, V9, P194, DOI 10.1038/nrendo.2013.30; Cappola AR, 2015, J CLIN ENDOCR METAB, V100, P1088, DOI 10.1210/jc.2014-3586; Chaker L, 2015, J CLIN ENDOCR METAB, V100, P2181, DOI 10.1210/jc.2015-1438; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Favresse J, 2018, ENDOCR REV, V39, P830, DOI 10.1210/er.2018-00119; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; Gammage MD, 2007, ARCH INTERN MED, V167, P928, DOI 10.1001/archinte.167.9.928; Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009; Hall GC, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2229; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Hamer RM, 2009, AM J PSYCHIAT, V166, P639, DOI 10.1176/appi.ajp.2009.09040458; Hoermann R, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00142; Hyland KA, 2013, J CLIN ENDOCR METAB, V98, P533, DOI 10.1210/jc.2012-2180; Ito M, 2012, EUR J ENDOCRINOL, V167, P373, DOI 10.1530/EJE-11-1029; Iverson Jennifer F, 2008, Endocr Pract, V14, P550; Jasim S, 2018, ENDOCR PRACT, V24, P369, DOI 10.4158/EP171796.RA; Jones CM, 2015, GERONTOLOGY, V61, P291, DOI 10.1159/000367692; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Loh TP, 2012, J CLIN ENDOCR METAB, V97, P1823, DOI 10.1210/jc.2011-3490; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Mallinckrodt CH, 2004, PHARM STAT, V3, P161, DOI 10.1002/pst.124; Mitchell AL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-132; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Murphy E, 2010, J CLIN ENDOCR METAB, V95, P3173, DOI 10.1210/jc.2009-2630; Nur U, 2010, INT J EPIDEMIOL, V39, P118, DOI 10.1093/ije/dyp309; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Okosieme OE, 2011, QJM-INT J MED, V104, P395, DOI 10.1093/qjmed/hcq222; Okosieme O, 2016, CLIN ENDOCRINOL, V84, P799, DOI 10.1111/cen.12824; Pearce SHS, 2016, J CLIN ENDOCR METAB, V101, P4385, DOI 10.1210/jc.2016-1935; Razvi S, 2019, THYROID, V29, P174, DOI 10.1089/thy.2018.0251; Razvi S, 2018, J AM COLL CARDIOL, V71, P1781, DOI 10.1016/j.jacc.2018.02.045; Rosario PW, 2017, NEW ENGL J MED, V377, P1404, DOI 10.1056/NEJMc1709853; Rotondi M, 2010, JAMA-J AM MED ASSOC, V304, P2481, DOI 10.1001/jama.2010.1786; Suh S, 2015, ENDOCRINOL METAB, V30, P246, DOI 10.3803/EnM.2015.30.3.246; Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18; Therneau T, 2019, USING TIME DEPENDENT; Tiller D, 2016, THYROID, V26, P1205, DOI 10.1089/thy.2015.0410; Tseng FY, 2012, J AM COLL CARDIOL, V60, P730, DOI 10.1016/j.jacc.2012.03.047; Vestergaard P, 2002, THYROID, V12, P411, DOI 10.1089/105072502760043503; Yang RF, 2018, J BONE MINER METAB, V36, P209, DOI 10.1007/s00774-017-0828-5; Zimmermann MB, 2015, LANCET DIABETES ENDO, V3, P286, DOI 10.1016/S2213-8587(14)70225-6	49	54	57	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l4892	10.1136/bmj.l4892	http://dx.doi.org/10.1136/bmj.l4892			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481394	Green Published, hybrid			2022-12-28	WOS:000485434400001
J	Aral, S; Eckles, D				Aral, Sinan; Eckles, Dean			Protecting elections from social media manipulation	SCIENCE			English	Editorial Material							FAKE NEWS; CONTAGION; DIFFUSION; STRATEGY; VOTER		[Aral, Sinan; Eckles, Dean] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Aral, Sinan; Eckles, Dean] MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Aral, Sinan] Manifest Investment Partners, Tiburon, CA 94920 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Aral, S (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Aral, S (corresponding author), MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Aral, S (corresponding author), Manifest Investment Partners, Tiburon, CA 94920 USA.	sinan@mit.edu		Aral, Sinan/0000-0002-2762-058X	Boston Globe; Amazon; DARPA; Microsoft; Technology Crossover Ventures	Boston Globe; Amazon; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Microsoft(Microsoft); Technology Crossover Ventures	We thank A. J. Berinsky and B. Nyhan for comments. S. A. has financial interest in Alibaba, Google, Amazon, and Twitter. S. A. was a Scholar in Residence at the New York Times in 2013 and visiting researcher at Microsoft in 2016. S. A. has received research funding from The Boston Globe and speaking fees from Microsoft. S. A. is an inventor on a related patent pending. D.E. has financial interest in Facebook, Amazon, Google, and Twitter. D. E. was a consultant at Microsoft in 2018. D. E. was an employee and consultant at Facebook from 2010 to 2017. D. E. has recently received funding from Amazon. D. E.' s attendance at conferences has recently been funded by DARPA, Microsoft, and Technology Crossover Ventures. D. E. is an inventor on a related patent, which is assigned to Facebook. S. A. and D. E. contributed equally to this work.	Allcott Hunt, 2017, J ECON PERSPECT, V31, P211, DOI DOI 10.1257/JEP.31.2.211; Aral S, 2018, SOCIAL MEDIA ONLINE; Aral S, 2017, NATURE COMMUNICATION, V8, P1; Aral S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14753; Aral S, 2014, MANAGE SCI, V60, P1352, DOI 10.1287/mnsc.2014.1936; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Aronow PM, 2017, ANN APPL STAT, V11, P1912, DOI 10.1214/16-AOAS1005; Athey S, 2018, J AM STAT ASSOC, V113, P230, DOI 10.1080/01621459.2016.1241178; Bail CA, 2018, P NATL ACAD SCI USA, V115, P9216, DOI 10.1073/pnas.1804840115; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Bakshy E, 2012, P 13 ACM C EL COMM; Bakshy E, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P283, DOI 10.1145/2566486.2567967; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Barrientos Andres F., 2018, J COMPUTATIONAL GRAP; Bedolla L. Garcia, 2012, MOBILIZING INCLUSION; Belloni A, 2017, ECONOMETRICA, V85, P233, DOI 10.3982/ECTA12723; Blei DM, 2006, INT C MACH LEARN ICM, V148, P113, DOI [10.1145/1143844.1143859, DOI 10.1145/1143844.1143859]; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Brady WJ, 2017, P NATL ACAD SCI USA, V114, P7313, DOI 10.1073/pnas.1618923114; Broockman DE, 2014, POLIT BEHAV, V36, P263, DOI 10.1007/s11109-013-9239-z; Dale A, 2009, AM J POLIT SCI, V53, P787, DOI 10.1111/j.1540-5907.2009.00401.x; Davenport T. C, 2012, UNSUBSCRIBE EF UNPUB; Davenport TC, 2010, POLIT BEHAV, V32, P423, DOI 10.1007/s11109-010-9122-0; De Vries J. V, 2018, NY TIMES; Dwork C., 2008, P INT C THEOR APPL M; Eckles D, 2018, P NATL ACAD SCI USA; Eckles D, 2016, P NATL ACAD SCI USA, V113, P7316, DOI 10.1073/pnas.1511201113; Eckles Dean, 2017, WORKING PAPER; Friggeri A, 2014, P INT C WEB SOC MED; Gerber AS, 2011, AM POLIT SCI REV, V105, P135, DOI 10.1017/S000305541000047X; Gerber AS, 2003, AM J POLIT SCI, V47, P540, DOI 10.2307/3186114; Gordon B.R., 2018, COMP APPROACHES ADVE; Green DP, 2013, J ELECT PUBLIC OPIN, V23, P27, DOI 10.1080/17457289.2012.728223; Grinberg N, 2019, SCIENCE, V363, P374, DOI 10.1126/science.aau2706; Guess A., 2018, AVOIDING ECHO CHAMBE; Guess A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4586; Guo ZJ, 2018, J R STAT SOC B, V80, P793, DOI 10.1111/rssb.12275; Howard P. N, 2018, WORKING PAPER; Howard PN., 2019, IRA SOCIAL MEDIA POL; Huang S, 2019, WORKING PAPER; Huber GA, 2007, AM J POLIT SCI, V51, P957, DOI 10.1111/j.1540-5907.2007.00291.x; Jamieson K.H., 2018, CYBERWAR RUSSIAN HAC; Johnson B, 2018, NEW KNOWLEDGE; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055760; Kalla JL, 2018, AM POLIT SCI REV, V112, P148, DOI 10.1017/S0003055417000363; Kang H, 2016, J AM STAT ASSOC, V111, P132, DOI 10.1080/01621459.2014.994705; Kohavi R, 2017, HARVARD BUS REV, V95, P74; LALONDE RJ, 1986, AM ECON REV, V76, P604; Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998; Malhotra N, 2012, Q J POLIT SCI, V7, P321, DOI 10.1561/100.00011073; Matz SC, 2017, P NATL ACAD SCI USA, V114, P12714, DOI 10.1073/pnas.1710966114; McAfee A, 2012, HARVARD BUS REV, V90, P60; Messing S., 2013, THESIS; Messing S, 2014, COMMUN RES, V41, P1042, DOI 10.1177/0093650212466406; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Nickerson DW, 2008, AM POLIT SCI REV, V102, P49, DOI 10.1017/S0003055408080039; Office of Irish Data Protection Commissioner (OIDPC), 2011, REP AUD; Peysakhovich A, 2018, WEB CONFERENCE 2018: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW2018), P699, DOI 10.1145/3178876.3186151; Plutzer E, 2002, AM POLIT SCI REV, V96, P41, DOI 10.1017/S0003055402004227; Provost F, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P707; Rogers R, 2013, RWP13018 HKS; Rogers T., 2013, RWP13018 HKS; Sen A, 2016, WORKING PAPER, DOI [10.2139/ssrn.2619440, DOI 10.2139/SSRN.2619440]; Shapiro BT, 2018, J POLIT ECON, V126, P381, DOI 10.1086/695475; Sides John, 2018, IDENTITY CRISIS; Sifry M, 2014, MOTHER JONES; Spenkuch JL, 2018, Q J ECON, V133, P1981, DOI 10.1093/qje/qjy010; Varian H, 2016, FINANC DEV, V53, P3; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wang YW, 2018, MARKET SCI, V37, P333, DOI 10.1287/mksc.2017.1079	73	53	53	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					858	+		10.1126/science.aaw8243	http://dx.doi.org/10.1126/science.aaw8243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467206				2022-12-28	WOS:000483975800023
J	Bourgeois, FT; Kesselheim, AS				Bourgeois, Florence T.; Kesselheim, Aaron S.			Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFORMATION		[Bourgeois, Florence T.] Harvard Med Sch, Pediat Therapeut & Regulatory Sci Initiat, Boston, MA 02115 USA; [Bourgeois, Florence T.] Harvard Med Sch, Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA; [Bourgeois, Florence T.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bourgeois, FT (corresponding author), Harvard Med Sch, Pediat Therapeut & Regulatory Sci Initiat, Boston, MA 02115 USA.; Bourgeois, FT (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA.; Bourgeois, FT (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.				Burroughs Wellcome Fund Innovation in Regulatory Science Award; Harvard-MIT Center for Regulatory Science; Arnold Ventures; Engelberg Foundation; Harvard Program in Therapeutic Science at the Harvard-MIT Center for Regulatory Science	Burroughs Wellcome Fund Innovation in Regulatory Science Award; Harvard-MIT Center for Regulatory Science; Arnold Ventures; Engelberg Foundation; Harvard Program in Therapeutic Science at the Harvard-MIT Center for Regulatory Science	Supported by a Burroughs Wellcome Fund Innovation in Regulatory Science Award and by the Harvard-MIT Center for Regulatory Science (to Dr. Bourgeois) and by grants from Arnold Ventures and the Engelberg Foundation and an Ignition Award from the Harvard Program in Therapeutic Science at the Harvard-MIT Center for Regulatory Science (to Dr. Kesselheim).	Adamson PC, 2014, NAT REV CLIN ONCOL, V11, P732, DOI 10.1038/nrclinonc.2014.149; American Academy of Pediatrics Committee on Drugs, 1977, PEDIATRICS, V60, P91; Ballentine C., SULFANILAMIDE DISAST; BARKAN ID, 1985, AM J PUBLIC HEALTH, V75, P18, DOI 10.2105/AJPH.75.1.18; Boots I, 2007, EUR J PEDIATR, V166, P849, DOI 10.1007/s00431-006-0381-z; Eunice Kennedy Shriver National Institute of Child Health and Human Development, PED TRIALS NETW HOM; Eunice Kennedy Shriver National Institute of Child Health and Human Development, BEST PHARM CHILDR AC; FDA Guidance, 2019, RAR PED DIS PRIOR RE; Federal Register, 1998, FED REGISTER, V63, P66632; Food and Drug Administration, 2019, NEW PED LAB INF DAT; Food and Drug Administration, 2018, PED RES EQ ACT PREA; Food and Drug Administration, 2010, RETR REV INF SUBM AC; Food and Drug Administration, CDER PED STUD DEF DE; Food and Drug Administration, 2018, ANN PED LAB CHANG SU; Frattarelli DAC, 2014, PEDIATRICS, V133, P563, DOI 10.1542/peds.2013-4060; Gore L, 2017, J CLIN ONCOL, V35, P3753; Government Accountability Office, 2016, RAR DIS TOO EARL GUA; Government Accountability Office, 2011, PED RES PROD STUD 2; Hudgins JD, 2018, PHARMACOEPIDEM DR S, V27, P161, DOI 10.1002/pds.4351; Hwang TJ, 2019, HEALTH AFFAIR, V38, P313, DOI 10.1377/hlthaff.2018.05330; Hwang TJ, 2018, JAMA PEDIAT; Jong GW, 2001, LANCET, V357, P398, DOI 10.1016/S0140-6736(05)71537-3; Joseph PD, 2015, BRIT J CLIN PHARMACO, V79, P357, DOI 10.1111/bcp.12305; Kimland E, 2012, CLIN PHARMACOL THER, V91, P796, DOI 10.1038/clpt.2012.26; Milstien JB, 2004, J PUBLIC HEALTH POL, V25, P173, DOI 10.1057/palgrave.jphp.3190016; Olson MK, 2018, AM J HEALTH ECON, V4, P321, DOI 10.1162/ajhe_a_00104; Rivera DR, 2014, ANN PHARMACOTHER, V48, P369, DOI 10.1177/1060028013514031; Rodriguez W, 2008, PEDIATRICS, V121, P530, DOI 10.1542/peds.2007-1529; Sachs AN, 2012, JAMA-J AM MED ASSOC, V307, P1914, DOI 10.1001/jama.2012.3435; Shaddy RE, 2010, PEDIATRICS, V125, P850, DOI 10.1542/peds.2010-0082; Sinha MS, 2018, JAMA INTERN MED, V178, P1458, DOI 10.1001/jamainternmed.2018.3933; Wilson JT, 1975, BASIC THERAPEUTIC AS, P411	32	11	12	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					875	881		10.1056/NEJMhle1901265	http://dx.doi.org/10.1056/NEJMhle1901265			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461599				2022-12-28	WOS:000484431200016
J	Ombrato, L; Nolan, E; Kurelac, I; Mavousian, A; Bridgeman, VL; Heinze, I; Chakravarty, P; Horswell, S; Gonzalez-Gualda, E; Matacchione, G; Weston, A; Kirkpatrick, J; Husain, E; Speirs, V; Collinson, L; Ori, A; Lee, JH; Malanchi, I				Ombrato, Luigi; Nolan, Emma; Kurelac, Ivana; Mavousian, Antranik; Bridgeman, Victoria Louise; Heinze, Ivonne; Chakravarty, Probir; Horswell, Stuart; Gonzalez-Gualda, Estela; Matacchione, Giulia; Weston, Anne; Kirkpatrick, Joanna; Husain, Ehab; Speirs, Valerie; Collinson, Lucy; Ori, Alessandro; Lee, Joo-Hyeon; Malanchi, Ilaria			Metastatic-niche labelling reveals parenchymal cells with stem features	NATURE			English	Article							LUNG; NEUTROPHILS; ALVEOLAR; ACTIVATION; EXPRESSION; MODEL; MICE	Direct investigation of the early cellular changes induced by metastatic cells within the surrounding tissue remains a challenge. Here we present a system in which metastatic cancer cells release a cell-penetrating fluorescent protein, which is taken up by neighbouring cells and enables spatial identification of the local metastatic cellular environment. Using this system, tissue cells with low representation in the metastatic niche can be identified and characterized within the bulk tissue. To highlight its potential, we applied this strategy to study the cellular environment of metastatic breast cancer cells in the lung. We report the presence of cancer-associated parenchymal cells, which exhibit stem-cell-like features, expression of lung progenitor markers, multi-lineage differentiation potential and self-renewal activity. In ex vivo assays, lung epithelial cells acquire a cancer-associated parenchymal-cell-like phenotype when co-cultured with cancer cells and support their growth. These results highlight the potential of this method as a platform for new discoveries.	[Ombrato, Luigi; Nolan, Emma; Kurelac, Ivana; Bridgeman, Victoria Louise; Gonzalez-Gualda, Estela; Matacchione, Giulia; Malanchi, Ilaria] Francis Crick Inst, Tumour Host Interact Lab, London, England; [Kurelac, Ivana] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Mavousian, Antranik; Lee, Joo-Hyeon] Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England; [Heinze, Ivonne; Kirkpatrick, Joanna; Ori, Alessandro] Fritz Lipmann Inst, Leibniz Inst Aging, Prote Aging, Jena, Germany; [Chakravarty, Probir; Horswell, Stuart] Francis Crick Inst, Bioinformat & Biostat Unit, London, England; [Weston, Anne; Collinson, Lucy] Francis Crick Inst, Electron Microscopy Unit, London, England; [Husain, Ehab] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland; [Speirs, Valerie] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Lee, Joo-Hyeon] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Francis Crick Institute; University of Bologna; University of Cambridge; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Francis Crick Institute; Francis Crick Institute; University of Aberdeen; University of Aberdeen; University of Cambridge	Malanchi, I (corresponding author), Francis Crick Inst, Tumour Host Interact Lab, London, England.; Lee, JH (corresponding author), Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England.; Lee, JH (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	jhl62@cam.ac.uk; Ilaria.Malanchi@crick.ac.uk	Speirs, Valerie/ABE-7377-2021; Ori, Alessandro/M-8586-2019; Matacchione, Giulia/AAC-2682-2019; Kurelac, Ivana/K-3070-2016; Lee, Joo-Hyeon/AAM-2777-2020	Speirs, Valerie/0000-0002-0602-4666; Ori, Alessandro/0000-0002-3046-0871; Matacchione, Giulia/0000-0002-1840-3903; Kurelac, Ivana/0000-0002-8364-9985; Lee, Joo-Hyeon/0000-0002-7364-6422; Weston, Anne/0000-0001-6701-224X; Nolan, Emma/0000-0001-8093-8733; Ombrato, Luigi/0000-0002-1472-5980; chakravarty, probir/0000-0003-1146-8824; Malanchi, Ilaria/0000-0003-4867-3311; G. Gualda, Estela/0000-0003-1558-4259	FLI Core Facility Proteomics, is a member of the Leibniz Association; Federal Government of Germany; State of Thuringia; Francis Crick Institute from Cancer Research UK [FC001112]; UK Medical Research Council [FC001112]; Wellcome Trust [FC001112]; European Research Council grant (ERC CoG-H2020) [725492]; Wellcome Trust-MRC Stem Cell Institute from the Sir Henry Dale Fellowship from Wellcome; Royal Society [107633/Z/15/Z]; European Research Council [679411]	FLI Core Facility Proteomics, is a member of the Leibniz Association; Federal Government of Germany; State of Thuringia; Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council grant (ERC CoG-H2020)(European Research Council (ERC)); Wellcome Trust-MRC Stem Cell Institute from the Sir Henry Dale Fellowship from Wellcome(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission)	We thank E. Sahai, P. Scaffidi (The Francis Crick Institute) and V. Sanz-Moreno (Barts Cancer Institute) for scientific discussions, critical reading of the manuscript and sharing cell lines and mouse strains; M. Izquierdo (CSIC, Madrid) for sharing the CD63-GFP plasmid; E. Nye and the pathologists G. Stamp and E. Herbert from the Experimental Histopathology Unit at the Francis Crick Institute for histological processing and analysis support; J. Bee from the Biological Resources Unit at the Francis Crick Institute for technical support with mice and mouse tissues; R. Goldstone and A. Edwards from the Advanced Sequencing Facility at the Francis Crick Institute for technical support; M. Llorian-Sopena from the Bioinformatics and Biostatistics Unit at the Francis Crick Institute for helping with the RNA sequencing analysis; the Flow Cytometry Unit at the Francis Crick Institute, particularly S. Purewal and J. Cerveira, for invaluable technical help; the Cell Services Unit at the Francis Crick Institute; C. Moore (The Francis Crick Institute) for intra-tracheal injections; and I. Pshenichnaya, P. Humphreys, S. McCallum and Cambridge Stem Cell Institute core facilities for technical assistance. We acknowledge support from the FLI Core Facility Proteomics, which is a member of the Leibniz Association and is financially supported by the Federal Government of Germany and the State of Thuringia. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001112), the UK Medical Research Council (FC001112), and the Wellcome Trust (FC001112) and the European Research Council grant (ERC CoG-H2020-725492); and by the Wellcome Trust-MRC Stem Cell Institute, which receives funding from the Sir Henry Dale Fellowship from Wellcome, the Royal Society (107633/Z/15/Z) and the European Research Council Starting Grant (679411).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Blomberg OS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036236; Bruderer R, 2017, MOL CELL PROTEOMICS, V16, P2296, DOI 10.1074/mcp.RA117.000314; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Deerink T. J., 2010, NCMIR METHODS 3D EM; Erez N, 2015, NATURE, V522, P41, DOI 10.1038/nature14529; Flinterman M, 2009, MOL THER, V17, P334, DOI 10.1038/mt.2008.256; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heinze I, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0547-y; Hosaka K, 2016, P NATL ACAD SCI USA, V113, pE5618, DOI 10.1073/pnas.1608384113; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lee JW, 2019, NATURE, V567, P249, DOI 10.1038/s41586-019-1004-y; Lee JH, 2017, CELL, V170, P1149, DOI 10.1016/j.cell.2017.07.028; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murgai M, 2017, NAT MED, V23, P1176, DOI 10.1038/nm.4400; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Onnis B, 2013, J CLIN INVEST, V123, P1615, DOI 10.1172/JCI59623; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Singhal S, 2016, CANCER CELL, V30, P120, DOI 10.1016/j.ccell.2016.06.001; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786	47	64	64	4	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					603	+		10.1038/s41586-019-1487-6	http://dx.doi.org/10.1038/s41586-019-1487-6			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31462798	Green Submitted, Green Accepted			2022-12-28	WOS:000483405500043
J	Slomski, A				Slomski, Anita			Antidepressants May Affect Pain Neural Network	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					717	717		10.1001/jama.2019.12354	http://dx.doi.org/10.1001/jama.2019.12354			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454043				2022-12-28	WOS:000483652500011
J	Layden, JE; Ghinai, I; Pray, I; Kimball, A; Layer, M; Tenforde, MW; Navon, L; Hoots, B; Salvatore, PP; Elderbrook, M; Haupt, T; Kanne, J; Patel, MT; Saathoff-Huber, L; King, BA; Schier, JG; Mikosz, CA; Meiman, J				Layden, Jennifer E.; Ghinai, Isaac; Pray, Ian; Kimball, Anne; Layer, Mark; Tenforde, Mark W.; Navon, Livia; Hoots, Brooke; Salvatore, Phillip P.; Elderbrook, Megan; Haupt, Thomas; Kanne, Jeffrey; Patel, Megan T.; Saathoff-Huber, Lori; King, Brian A.; Schier, Josh G.; Mikosz, Christina A.; Meiman, Jonathan			Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BUTANE HASH OIL; LUNG INJURY; UNITED-STATES; ELECTRONIC CIGARETTES; PRODUCT; PNEUMONITIS	Background E-cigarettes are battery-operated devices that heat a liquid and deliver an aerosolized product to the user. Pulmonary illnesses related to e-cigarette use have been reported, but no large series has been described. In July 2019, the Wisconsin Department of Health Services and the Illinois Department of Public Health received reports of lung injury associated with the use of e-cigarettes (also called vaping) and launched a coordinated public health investigation. Methods We defined case patients as persons who reported use of e-cigarette devices and related products in the 90 days before symptom onset and had pulmonary infiltrates on imaging and whose illnesses were not attributed to other causes. Medical record abstraction and case patient interviews were conducted with the use of standardized tools. Results There were 98 case patients, 79% of whom were male; the median age of the patients was 21 years. The majority of patients presented with respiratory symptoms (97%), gastrointestinal symptoms (77%), and constitutional symptoms (100%). All case patients had bilateral infiltrates on chest imaging. A total of 95% of the patients were hospitalized, 26% underwent intubation and mechanical ventilation, and two deaths were reported. A total of 89% of the patients reported having used tetrahydrocannabinol products in e-cigarette devices, although a wide variety of products and devices was reported. Syndromic surveillance data from Illinois showed that the mean monthly rate of visits related to severe respiratory illness in June through August of 2019 was twice the rate that was observed in the same months in 2018. Conclusions Case patients presented with similar clinical characteristics. Although the definitive substance or substances contributing to injury have not been determined, this initial cluster of illnesses represents an emerging clinical syndrome or syndromes. Additional work is needed to characterize the pathophysiology and to identify the definitive causes. Vaping use has rapidly increased. In this final report from the Wisconsin and Illinois departments of public health, a severe respiratory illness in otherwise healthy young people is described. Of the 98 case patients identified in this investigation, 95% were hospitalized, 26% were intubated, and 2 persons died.	[Layden, Jennifer E.; Ghinai, Isaac; Navon, Livia; Patel, Megan T.; Saathoff-Huber, Lori] Illinois Dept Publ Hlth, Springfield, IL 62761 USA; [Ghinai, Isaac; Pray, Ian; Kimball, Anne; Tenforde, Mark W.; Salvatore, Phillip P.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA USA; [Layer, Mark] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Navon, Livia] Ctr Dis Control & Prevent, Div State & Local Readiness, Ctr Preparedness & Response, Atlanta, GA USA; [Hoots, Brooke; Schier, Josh G.; Mikosz, Christina A.] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [King, Brian A.] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Layer, Mark] Emory Univ, Sch Med, Atlanta, GA USA; [Pray, Ian; Elderbrook, Megan; Meiman, Jonathan] Wisconsin Dept Hlth Serv, Madison, WI USA; [Haupt, Thomas] Bur Communicable Dis, Wisconsin Div Publ Hlth, Madison, WI USA; [Kanne, Jeffrey] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Madison, WI USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; University of Wisconsin System; University of Wisconsin Madison	Layden, JE (corresponding author), Illinois Dept Publ Hlth, 69 W Washington St, Chicago, IL 60602 USA.	jennifer.layden@illinois.gov	Ghinai, Isaac/AAI-7985-2021	Ghinai, Isaac/0000-0003-1322-1331; Salvatore, Phillip/0000-0001-8305-9056				Agustin M, 2018, CASE REP PULMONOL, V2018, P9724530; Al-Zouabi I, 2018, SUBST ABUSE REHABIL, V9, P91, DOI 10.2147/SAR.S135252; Allen JG, 2016, ENVIRON HEALTH PERSP, V124, P733, DOI 10.1289/ehp.1510185; Anderson RP, 2019, RESPIR MED CASE REP, V26, P171, DOI 10.1016/j.rmcr.2019.01.002; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], NAT HLTH INT SURV NH; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; [Anonymous], 2018, SURG GEN ADV E CIG U; Arter ZL, 2019, RESPIR MED CASE REP, V27, DOI 10.1016/j.rmcr.2019.100825; Blount BC, 2020, NEW ENGL J MED, V382, P697, DOI 10.1056/NEJMoa1916433; Blount BC, 2019, MMWR-MORBID MORTAL W, V68, P1040, DOI 10.15585/mmwr.mm6845e2; Breitbarth AK, 2018, DRUG ALCOHOL DEPEN, V192, P98, DOI 10.1016/j.drugalcdep.2018.07.031; Burstyn I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-18; Centers for Disease Control and Prevention, 2019, HLTH AL NETW SEV PUL; Centers for Disease Control and Prevention, 2019, OUTBR LUNG INJ ASS E; Centers for Disease Control and Prevention, NAT SYNDR SURV PROGR; Cullen KA, 2018, MMWR-MORBID MORTAL W, V67, P1276, DOI 10.15585/mmwr.mm6745a5; Department of Health and Human Services, 2016, E CIG US YOUTH YOUNG; Ghinai I, 2019, MMWR-MORBID MORTAL W, V68, P865, DOI 10.15585/mmwr.mm6839e2; Gillman IG, 2016, REGUL TOXICOL PHARM, V75, P58, DOI 10.1016/j.yrtph.2015.12.019; Hartnett KP, 2020, NEW ENGL J MED, V382, P766, DOI 10.1056/NEJMsr1915313; He T, 2017, ANN AM THORAC SOC, V14, P468, DOI 10.1513/AnnalsATS.201612-974LE; Jatlaoui TC, 2019, MMWR-MORBID MORTAL W, V68, P1081, DOI 10.15585/mmwr.mm6846e2; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Khan MS, 2018, CLIN RESPIR J, V12, P1295, DOI 10.1111/crj.12775; Lee MS, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/EHP3469, 10.1289/ehp3469]; Lozier MJ, 2019, MMWR-MORBID MORTAL W, V68, P1142, DOI 10.15585/mmwr.mm6849e1; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; McMahon MJ, 2016, ANN AM THORAC SOC, V13, P991, DOI 10.1513/AnnalsATS.201602-101LE; Moore K., 2015, OPEN J EMERG MED, V3, P18, DOI DOI 10.4236/OJEM.2015.33004; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS E CIG; Navon L, 2019, MMWR-MORBID MORTAL W, V68, P1034, DOI 10.15585/mmwr.mm6845e1; Pisinger C, 2014, PREV MED, V69, P248, DOI 10.1016/j.ypmed.2014.10.009; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sommerfeld CG, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2016-3927; Taylor J, 2019, MMWR-MORBID MORTAL W, V68, P1096, DOI 10.15585/mmwr.mm6847e1; Thota D, 2014, J EMERG MED, V47, P15, DOI 10.1016/j.jemermed.2013.09.034; Trivers KF, 2018, JAMA PEDIATR, V172, P1097, DOI 10.1001/jamapediatrics.2018.1920; Yoon PW, 2017, PUBLIC HEALTH REP, V132, p3S, DOI 10.1177/0033354917708995	40	489	499	8	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					903	916		10.1056/NEJMoa1911614	http://dx.doi.org/10.1056/NEJMoa1911614			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KT7TC	31491072	Bronze			2022-12-28	WOS:000519214900006
J	Diver, MM; Cheng, YF; Julius, D				Diver, Melinda M.; Cheng, Yifan; Julius, David			Structural insights into TRPM8 inhibition and desensitization	SCIENCE			English	Article							ION-CHANNEL; CRYSTAL-STRUCTURE; COLD SENSITIVITY; TRPV1 STRUCTURES; VOLTAGE; ACTIVATION; EXPRESSION; MECHANISM; REVEALS; DOMAIN	The transient receptor potential melastatin 8 (TRPM8) ion channel is the primary detector of environmental cold and an important target for treating pathological cold hypersensitivity. Here, we present cryo-electron microscopy structures of TRPM8 in ligand-free, antagonist-bound, or calcium-bound forms, revealing how robust conformational changes give rise to two nonconducting states, closed and desensitized. We describe a malleable ligand-binding pocket that accommodates drugs of diverse chemical structures, and we delineate the ion permeation pathway, including the contribution of lipids to pore architecture. Furthermore. we show that direct calcium binding mediates stimulus-evoked desensitization, clarifying this important mechanism of sensory adaptation. We observe large rearrangements within the S4-S5 linker that reposition the S1-S4 and pore domains relative to the TRP helix, leading us to propose a distinct model for modulation of TRPM8 and possibly other TRP channels.	[Diver, Melinda M.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Cheng, Yifan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	yifan.cheng@ucsf.edu; david.julius@ucsf.edu		Cheng, Yifan/0000-0001-9535-0369; Diver, Melinda/0000-0001-5037-7322	A.P. Giannini Foundation; National Institutes of Health [R35NS105038, R01GM098672, S10OD020054, S10OD021741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R35NS105038] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021741] Funding Source: NIH RePORTER	A.P. Giannini Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by an A.P. Giannini Foundation Postdoctoral Fellowship (M.M.D.) and by grants from the National Institutes of Health (R35NS105038 to D.J and R01GM098672, S10OD020054, and S10OD021741 to Y.C.). Y.C. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baradaran R, 2018, NATURE, V559, P580, DOI 10.1038/s41586-018-0331-8; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bharate SS, 2012, ACS CHEM NEUROSCI, V3, P248, DOI 10.1021/cn300006u; Bonvini SJ, 2017, PULM PHARMACOL THER, V47, P21, DOI 10.1016/j.pupt.2017.06.009; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dosey TL, 2019, NAT STRUCT MOL BIOL, V26, P40, DOI 10.1038/s41594-018-0168-8; Duan JJ, 2018, P NATL ACAD SCI USA, V115, pEB201, DOI 10.1073/pnas.1810719115; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36852; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Hasan R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041256; Huang YH, 2018, NATURE, V562, P145, DOI 10.1038/s41586-018-0558-4; Hughes TET, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06753-6; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Journigan VB, 2013, LIFE SCI, V92, P425, DOI 10.1016/j.lfs.2012.10.032; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Knowlton WM, 2011, CURR PHARM BIOTECHNO, V12, P68; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V295, pF803, DOI 10.1152/ajprenal.90269.2008; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu HP, 2018, ACTA BIOCH BIOPH SIN, V50, P499, DOI 10.1093/abbs/gmy033; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Madej MG, 2018, PFLUG ARCH EUR J PHY, V470, P213, DOI 10.1007/s00424-018-2107-2; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matos-Cruz V, 2017, CELL REP, V21, P3329, DOI 10.1016/j.celrep.2017.11.083; McGoldrick LL, 2018, NATURE, V553, P233, DOI 10.1038/nature25182; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Parks DJ, 2011, J MED CHEM, V54, P233, DOI 10.1021/jm101075v; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pertusa M, 2018, J BIOL CHEM, V293, P12454, DOI 10.1074/jbc.RA118.002256; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sarria I, 2011, J NEUROPHYSIOL, V106, P3056, DOI 10.1152/jn.00544.2011; Schmiege P, 2017, NATURE, V550, P366, DOI 10.1038/nature24036; Singh AK, 2018, NAT STRUCT MOL BIOL, V25, P805, DOI 10.1038/s41594-018-0108-7; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Weyer AD, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020037; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Yin Y, 2019, SCIENCE, V363, P945, DOI 10.1126/science.aav9334; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Z, 2018, ELIFE, V7, DOI 10.7554/eLife.36409; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng W, 2018, CELL REP, V22, P1560, DOI 10.1016/j.celrep.2018.01.042; Zhou XY, 2017, NAT STRUCT MOL BIOL, V24, P1146, DOI 10.1038/nsmb.3502	66	80	80	5	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2019	365	6460					1434	+		10.1126/science.aax6672	http://dx.doi.org/10.1126/science.aax6672			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8QM	31488702	Green Accepted			2022-12-28	WOS:000488838600044
J	Gauthier, M; Wenzel, SE				Gauthier, Marc; Wenzel, Sally E.			As-needed beta agonist-inhaled corticosteroid in mild asthma	LANCET			English	Editorial Material							BUDESONIDE-FORMOTEROL		[Gauthier, Marc; Wenzel, Sally E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Med, Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA; [Wenzel, Sally E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Immunol, Pittsburgh, PA 15261 USA; [Wenzel, Sally E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wenzel, SE (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Med, Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA.; Wenzel, SE (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Immunol, Pittsburgh, PA 15261 USA.; Wenzel, SE (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	swenzel@pitt.edu		Wenzel, Sally/0000-0002-4242-0164				Asthma GIf, 2022, GLOB STRAT ASTHM MAN; Bateman ED, 2018, NEW ENGL J MED, V378, P1877, DOI 10.1056/NEJMoa1715275; Beasley R, 2019, NEW ENGL J MED, V380, P2020, DOI 10.1056/NEJMoa1901963; Bloom CI, 2019, AM J RESP CRIT CARE, V199, P446, DOI 10.1164/rccm.201808-1516OC; Hardy J, 2019, LANCET, V394, P919, DOI 10.1016/S0140-6736(19)31948-8; Lazarus SC, 2019, NEW ENGL J MED, V380, P2009, DOI 10.1056/NEJMoa1814917; O'Byrne PM, 2018, NEW ENGL J MED, V378, P1865, DOI 10.1056/NEJMoa1715274; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861	8	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					897	898		10.1016/S0140-6736(19)31994-4	http://dx.doi.org/10.1016/S0140-6736(19)31994-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31451208				2022-12-28	WOS:000485840600004
J	Horton, R				Horton, Richard			Offline: A canon for global health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2019	394	10201					816	816		10.1016/S0140-6736(19)32084-7	http://dx.doi.org/10.1016/S0140-6736(19)32084-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV0US	31498087				2022-12-28	WOS:000483994700009
J	Liao, MJ; Din, MO; Tsinring, L; Hasty, J				Liao, Michael J.; Din, M. Omar; Tsinring, Lev; Hasty, Jeff			Rock-paper-scissors: Engineered population dynamics increase genetic stability	SCIENCE			English	Article							SYNTHETIC BIOLOGY; CONSTRUCTION; ORGANISMS; PROMOTERS; BACTERIA; GAME	Advances in synthetic biology have led to an arsenal of proof-of-principle bacterial circuits that can be leveraged for applications ranging from therapeutics to bioproduction. A unifying challenge for most applications is the presence of selective pressures that lead to high mutation rates for engineered bacteria. A common strategy is to develop cloning technologies aimed at increasing the fixation time for deleterious mutations in single cells. We adopt a complementary approach that is guided by ecological interactions, whereby cyclical population control is engineered to stabilize the functionality of intracellular gene circuits. Three strains of Escherichia coli were designed such that each strain could kill or be killed by one of the other two strains. The resulting "rock-paper-scissors" dynamic demonstrates rapid cycling of strains in microfluidic devices and leads to an increase in the stability of gene circuit functionality in cell culture.	[Liao, Michael J.; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Liao, Michael J.; Din, M. Omar; Tsinring, Lev; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Tsinring, Lev; Hasty, Jeff] Univ Calif San Diego, San Diego Ctr Syst Biol, San Diego, CA 92103 USA; [Hasty, Jeff] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Hasty, J (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.; Hasty, J (corresponding author), Univ Calif San Diego, San Diego Ctr Syst Biol, San Diego, CA 92103 USA.; Hasty, J (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	hasty@ucsd.edu	Din, Omar/AAK-8962-2020	Liao, Michael/0000-0002-0787-7193	National Institute of General Medical Sciences of the National Institutes of Health [R01GM069811]; National Science Foundation Graduate Research Fellowship [DGE-1650112]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811, P50GM085764] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health (grant no. R01GM069811) and a National Science Foundation Graduate Research Fellowship (grant no. DGE-1650112).	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Boyer AE, 1998, J BACTERIOL, V180, P1662, DOI 10.1128/JB.180.7.1662-1672.1998; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chan CTY, 2016, NAT CHEM BIOL, V12, P82, DOI [10.1038/NCHEMBIO.1979, 10.1038/nchembio.1979]; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Din MO, 2016, NATURE, V536, P81, DOI 10.1038/nature18930; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GERDES K, 1988, BIO-TECHNOL, V6, P1402, DOI 10.1038/nbt1288-1402; Grosskopf T, 2014, CURR OPIN MICROBIOL, V18, P72, DOI 10.1016/j.mib.2014.02.002; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Landry BP, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.BAD-0020-2017; Lee JW, 2018, NAT CHEM BIOL, V14, P530, DOI 10.1038/s41589-018-0056-x; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Ostrov N, 2016, SCIENCE, V353, P819, DOI 10.1126/science.aaf3639; Peredelchuk MY, 1997, GENE, V187, P231, DOI 10.1016/S0378-1119(96)00760-3; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Riglar DT, 2018, NAT REV MICROBIOL, V16, P214, DOI 10.1038/nrmicro.2017.172; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Segall-Shapiro TH, 2018, NAT BIOTECHNOL, V36, P352, DOI 10.1038/nbt.4111; Shong J, 2012, CURR OPIN BIOTECH, V23, P798, DOI 10.1016/j.copbio.2012.02.001; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Teixeira AP, 2017, CURR OPIN BIOTECH, V47, P59, DOI 10.1016/j.copbio.2017.06.004; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zhou K, 2015, NAT BIOTECHNOL, V33, P377, DOI 10.1038/nbt.3095	34	58	59	10	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1045	+		10.1126/science.aaw0542	http://dx.doi.org/10.1126/science.aaw0542			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488693	Green Accepted			2022-12-28	WOS:000484732700051
J	Wyse, R				Wyse, Rosemary			Galactic archaeology with Gaia	SCIENCE			English	Editorial Material							STELLAR HALO; MILKY		[Wyse, Rosemary] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Johns Hopkins University	Wyse, R (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.	wyse@jhu.edu						Belokurov V, 2018, MON NOT R ASTRON SOC, V478, P611, DOI 10.1093/mnras/sty982; Gaia Collaboration, 2018, ASTRON ASTROPHYS, V616, P10; Gallart C., 2019, NAT ASTRON, DOI [10.1038/s4n550-019-0829-5, DOI 10.1038/S4N550-019-0829-5]; GILMORE G, 1989, ANNU REV ASTRON ASTR, V27, P555; Haywood M, 2018, ASTROPHYS J, V863, DOI 10.3847/1538-4357/aad235; Helmi A, 2018, NATURE, V563, P85, DOI 10.1038/s41586-018-0625-x; Ibata RA, 2019, ASTROPHYS J, V872, DOI 10.3847/1538-4357/ab0080; Koppelman H, 2018, ASTROPHYS J LETT, V860, DOI 10.3847/2041-8213/aac882; Laporte CFP, 2019, MON NOT R ASTRON SOC, V485, P3134, DOI 10.1093/mnras/stz583; Mackereth JT, 2019, MON NOT R ASTRON SOC, V482, P3426, DOI 10.1093/mnras/sty2955; Villalobos A, 2008, MON NOT R ASTRON SOC, V391, P1806, DOI 10.1111/j.1365-2966.2008.13979.x; Wyse RFG, 2001, ASTR SOC P, V230, P71	13	2	2	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					979	980		10.1126/science.aay0628	http://dx.doi.org/10.1126/science.aay0628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488672				2022-12-28	WOS:000484732700026
J	Gunduz-Bruce, H; Silber, C; Kaul, I; Rothschild, AJ; Riesenberg, R; Sankoh, AJ; Li, HH; Lasser, R; Zorumski, CF; Rubinow, DR; Paul, SM; Jonas, J; Doherty, JJ; Kanes, SJ				Gunduz-Bruce, Handan; Silber, Christopher; Kaul, Inder; Rothschild, Anthony J.; Riesenberg, Robert; Sankoh, Abdul J.; Li, Haihong; Lasser, Robert; Zorumski, Charles F.; Rubinow, David R.; Paul, Steven M.; Jonas, Jeffrey; Doherty, James J.; Kanes, Stephen J.			Trial of SAGE-217 in Patients with Major Depressive Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA-AMINOBUTYRIC-ACID; PREFRONTAL CORTEX; BRAIN; NEUROSTEROIDS; STRESS; GABA; FLUOXETINE; EXPRESSION; MODEL; SCALE	Background Altered neurotransmission of gamma-aminobutyric acid (GABA) has been implicated in the pathogenesis of depression. Whether SAGE-217, an oral, positive allosteric modulator of GABA type A receptors, is effective and safe for the treatment of major depressive disorder is unknown. Methods In this double-blind, phase 2 trial, we enrolled patients with major depression and randomly assigned them in a 1:1 ratio to receive 30 mg of SAGE-217 or placebo once daily. The primary end point was the change from baseline to day 15 in the score on the 17-item Hamilton Depression Rating Scale (HAM-D; scores range from 0 to 52, with higher scores indicating more severe depression). Secondary efficacy end points, which were assessed on days 2 through 8 and on days 15, 21, 28, 35, and 42, included changes from baseline in scores on additional depression and anxiety scales, a reduction from baseline of more than 50% in the HAM-D score, a HAM-D score of 7 or lower, and a Clinical Global Impression of Improvement score of 1 (very much improved) or 2 (much improved) (on a scale of 1 to 7, with a score of 7 indicating that symptoms are very much worse). Results A total of 89 patients underwent randomization: 45 patients were assigned to the SAGE-217 group, and 44 to the placebo group. The mean baseline HAM-D score was 25.2 in the SAGE-217 group and 25.7 in the placebo group. The least-squares mean (+/- SE) change in the HAM-D score from baseline to day 15 was -17.4 +/- 1.3 points in the SAGE-217 group and -10.3 +/- 1.3 points in the placebo group (least-squares mean difference in change, -7.0 points; 95% confidence interval, -10.2 to -3.9; P<0.001). The differences in secondary end points were generally in the same direction as those of the primary end point. There were no serious adverse events. The most common adverse events in the SAGE-217 group were headache, dizziness, nausea, and somnolence. Conclusions Administration of SAGE-217 daily for 14 days resulted in a reduction in depressive symptoms at day 15. Adverse events were more common in the SAGE-217 group than in the placebo group. Further trials are needed to determine the durability and safety of SAGE-217 in major depressive disorder and to compare SAGE-217 with available treatments.	[Gunduz-Bruce, Handan; Silber, Christopher; Sankoh, Abdul J.; Li, Haihong; Lasser, Robert; Paul, Steven M.; Jonas, Jeffrey; Doherty, James J.; Kanes, Stephen J.] Sage Therapeut, 215 First St, Cambridge, MA 02142 USA; [Kaul, Inder] Kaul Consulting, Concord, MA USA; [Rothschild, Anthony J.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Rothschild, Anthony J.] UMass Mem Healthcare, Worcester, MA USA; [Riesenberg, Robert] Atlanta Ctr Med Res, Atlanta, GA USA; [Zorumski, Charles F.; Paul, Steven M.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Rubinow, David R.] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gunduz-Bruce, H (corresponding author), Sage Therapeut, 215 First St, Cambridge, MA 02142 USA.	handan.gunduz-bruce@sagerx.com	Kanes, Steve/AAX-6132-2021; Kanes, Stephen/AAX-5531-2021; Rothschild, Anthony/AAO-7446-2020; Paul, Steve/ABE-5400-2020	Rothschild, Anthony/0000-0002-0902-5349; 				Althaus AL, 2017, 69 ANN M AM AC NEUR; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2000, Am J Psychiatry, V157, P1; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; Bialer M, 2015, EPILEPSY RES, V111, P85, DOI 10.1016/j.eplepsyres.2015.01.001; Botella GM, 2017, J MED CHEM, V60, P7810, DOI 10.1021/acs.jmedchem.7b00846; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Dong E, 2001, P NATL ACAD SCI USA, V98, P2849, DOI 10.1073/pnas.051628598; Gabbay V, 2012, ARCH GEN PSYCHIAT, V69, P139, DOI 10.1001/archgenpsychiatry.2011.131; GERNER RH, 1981, AM J PSYCHIAT, V138, P1098; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Gunduz-Bruce H, 2017, EUR NEUROPSYCHOPHARM, V27, pS856, DOI 10.1016/S0924-977X(17)31538-9; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; HONIG A, 1988, J PSYCHIAT RES, V22, P159, DOI 10.1016/0022-3956(88)90001-5; Kanes S, 2017, LANCET, V390, P480, DOI 10.1016/S0140-6736(17)31264-3; Kanes S, 2017, BIOL PSYCHIAT, V81, pS347, DOI 10.1016/j.biopsych.2017.02.582; Kanes S, 2017, BIOL PSYCHIAT, V81, pS31, DOI 10.1016/j.biopsych.2017.02.086; Karolewicz B, 2010, INT J NEUROPSYCHOPH, V13, P411, DOI 10.1017/S1461145709990587; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Luscher Bernhard, 2015, Adv Pharmacol, V73, P97, DOI 10.1016/bs.apha.2014.11.003; Mann JJ, 2014, DEPRESS ANXIETY, V31, P814, DOI 10.1002/da.22278; Meltzer-Brody S, 2018, LANCET, V392, P1058, DOI 10.1016/S0140-6736(18)31551-4; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Pibiri F, 2008, P NATL ACAD SCI USA, V105, P5567, DOI 10.1073/pnas.0801853105; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Robichaud AJ, 2014, 68 ANN M AM EP SOC S; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Schur RR, 2016, HUM BRAIN MAPP, V37, P3337, DOI 10.1002/hbm.23244; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Uzunov DP, 1996, P NATL ACAD SCI USA, V93, P12599, DOI 10.1073/pnas.93.22.12599; Uzunova V, 1998, P NATL ACAD SCI USA, V95, P3239, DOI 10.1073/pnas.95.6.3239; Vallee M, 2000, ANAL BIOCHEM, V287, P153, DOI 10.1006/abio.2000.4841; Zorumski CF, 2013, NEUROSCI BIOBEHAV R, V37, P109, DOI 10.1016/j.neubiorev.2012.10.005	38	78	79	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					903	911		10.1056/NEJMoa1815981	http://dx.doi.org/10.1056/NEJMoa1815981			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW9PR	31483961	Green Published			2022-12-28	WOS:000485326200005
J	Hills, G; Lau, C; Wright, A; Fuller, S; Bishop, MD; Srimani, T; Kanhaiya, P; Ho, R; Amer, A; Stein, Y; Murphy, D; Arvind; Chandrakasan, A; Shulaker, MM				Hills, Gage; Lau, Christian; Wright, Andrew; Fuller, Samuel; Bishop, Mindy D.; Srimani, Tathagata; Kanhaiya, Pritpal; Ho, Rebecca; Amer, Aya; Stein, Yosi; Murphy, Denis; Arvind; Chandrakasan, Anantha; Shulaker, Max M.			Modern microprocessor built from complementary carbon nanotube transistors	NATURE			English	Article							DENSITY; DESIGN	Electronics is approaching a major paradigm shift because silicon transistor scaling no longer yields historical energy-efficiency benefits, spurring research towards beyond-silicon nanotechnologies. In particular, carbon nanotube field-effect transistor (CNFET)-based digital circuits promise substantial energy-efficiency benefits, but the inability to perfectly control intrinsic nanoscale defects and variability in carbon nanotubes has precluded the realization of very-large -scale integrated systems. Here we overcome these challenges to demonstrate a beyond-silicon microprocessor built entirely from CNFETs. This 16-bit microprocessor is based on the RISC-V instruction set, runs standard 32-bit instructions on 16 -bit data and addresses, comprises more than 14,000 complementary metal-oxide-semiconductor CNFETs and is designed and fabricated using industry-standard design flows and processes. We propose a manufacturing methodology for carbon nanotubes, a set of combined processing and design techniques for overcoming nanoscale imperfections at macroscopic scales across full wafer substrates. This work experimentally validates a promising path towards practical beyond-silicon electronic systems.	[Hills, Gage; Lau, Christian; Wright, Andrew; Bishop, Mindy D.; Srimani, Tathagata; Kanhaiya, Pritpal; Ho, Rebecca; Amer, Aya; Arvind; Chandrakasan, Anantha; Shulaker, Max M.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Fuller, Samuel; Stein, Yosi; Murphy, Denis] ADI, Wilmington, MA USA	Massachusetts Institute of Technology (MIT)	Shulaker, MM (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	shulaker@mit.edu	Wright, Andrew/HDM-9615-2022	Stein, Yosi/0000-0001-8861-3829	Analog Devices, Inc. (ADI); Defence Advanced Research Projects Agency (DARPA) Three-Dimensional System-on-Chip (3DSoC) program; National Science Foundation; Air Force Research Laboratory	Analog Devices, Inc. (ADI); Defence Advanced Research Projects Agency (DARPA) Three-Dimensional System-on-Chip (3DSoC) program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Air Force Research Laboratory	We acknowledge Analog Devices, Inc. (ADI), the Defence Advanced Research Projects Agency (DARPA) Three-Dimensional System-on-Chip (3DSoC) program, the National Science Foundation and the Air Force Research Laboratory for support. We thank S. Feindt, A. Olney, T. O'Dwyer, S. Gupta and S. Knepper (all at ADI), and Dimitri Antoniadis and Utsav Banerjee (both at MIT) for collaborations.	Aly MMS, 2019, P IEEE, V107, P19, DOI 10.1109/JPROC.2018.2882603; Batude P., 2011, TECH DIG INT ELECT D, P151, DOI [10.1109/IEDM.2011.6131506, DOI 10.1109/IEDM.2011.6131506]; Brady GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601240; Brady GJ, 2014, ACS NANO, V8, P11614, DOI 10.1021/nn5048734; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Celio C., 2015, UCBEECS2015167; Clark LT, 2016, MICROELECTRON J, V53, P105, DOI 10.1016/j.mejo.2016.04.006; Ding L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1682; Ding L, 2009, NANO LETT, V9, P4209, DOI 10.1021/nl9024243; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Geier ML, 2016, NANO LETT, V16, P4329, DOI 10.1021/acs.nanolett.6b01393; Hills G, 2018, IEEE T NANOTECHNOL, V17, P1259, DOI 10.1109/TNANO.2018.2871841; Hills G, 2015, IEEE T COMPUT AID D, V34, P1082, DOI 10.1109/TCAD.2015.2415492; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Kang S.-M., 2003, CMOS DIGITAL INTEGRA; Khan HN, 2018, NAT ELECTRON, V1, P14, DOI 10.1038/s41928-017-0005-9; Lau C, 2018, ACS NANO, V12, P10924, DOI 10.1021/acsnano.8b04208; Lee CS, 2015, IEEE T ELECTRON DEV, V62, P3061, DOI 10.1109/TED.2015.2457453; Lin A, 2009, IEEE T ELECTRON DEV, V56, P2969, DOI 10.1109/TED.2009.2033168; Markov IL, 2015, P IEEE, V103, P1985, DOI 10.1109/JPROC.2015.2478963; Patil N, 2009, P IEEE INT EL DEV M, P1, DOI [DOI 10.1109/IEDM.2009.5424295, 10.1109/IEDM.2009.5424295]; Patterson D, 2018, IEEE INT SOL STAT CI; Shahrjerdi D, 2013, ACS NANO, V7, P8303, DOI 10.1021/nn403935v; Sherazi SMY, 2018, PROC SPIE, V10588, DOI 10.1117/12.2297191; Shulaker M, 2013, IEEE INT SOL STAT CI, DOI [10.1109/ISSCC.2013.6487660, DOI 10.1109/ISSCC.2013.6487660]; Shulaker M. M., 2014, IEDM, DOI [10.1109/IEDM.2014.7047120, DOI 10.1109/IEDM.2014.7047120]; Shulaker M. M., 2015, IEDM, DOI [10.1109/IEDM.2015.7409815, DOI 10.1109/IEDM.2015.7409815]; Shulaker MM, 2014, S VLSI TECH; Shulaker MM, 2014, IEEE J SOLID-ST CIRC, V49, P190, DOI 10.1109/JSSC.2013.2282092; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Shulaker MM, 2011, NANO LETT, V11, P1881, DOI 10.1021/nl200063x; Shulaker MM, 2014, ACS NANO, V8, P3434, DOI 10.1021/nn406301r; Si J, 2018, ACS NANO, V12, P627, DOI 10.1021/acsnano.7b07665; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wang JT, 2018, NAT CATAL, V1, P326, DOI 10.1038/s41929-018-0057-x; Won Y, 2013, P NATL ACAD SCI USA, V110, P20426, DOI 10.1073/pnas.1312253110; Xu JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05967-w; Zhang JL, 2011, ACS NANO, V5, P3284, DOI 10.1021/nn2004298; Zhang J, 2010, DES AUT CON, P889; Zhang ZY, 2007, NANO LETT, V7, P3603, DOI 10.1021/nl0717107	40	295	304	48	373	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					595	+		10.1038/s41586-019-1493-8	http://dx.doi.org/10.1038/s41586-019-1493-8			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31462796				2022-12-28	WOS:000483405500042
J	Mahase, E				Mahase, Elisabeth			NICE lowers treatment threshold for high blood pressure	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.L1105; HAASE CB, 2019, BMJ-BRIT MED J, V365, P502, DOI DOI 10.1136/BMJ.L1657; NICE, 2019, HYPERTENSION ADULTS; Sheppard JP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021827	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l5315	10.1136/bmj.l5315	http://dx.doi.org/10.1136/bmj.l5315			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31466950				2022-12-28	WOS:000483892600005
J	Rimmer, A				Rimmer, Abi			Vaping and lung injuries: five minutes with... Nick Hopkinson	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2019	366								l5314	10.1136/bmj.l5314	http://dx.doi.org/10.1136/bmj.l5314			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HJ	31462442				2022-12-28	WOS:000483891600010
J	Arbour, KC; Riely, GJ				Arbour, Kathryn C.; Riely, Gregory J.			Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PHASE-III TRIAL; OPEN-LABEL; SINGLE-ARM; CLINICAL-PRACTICE; EGFR MUTATION; STAGE IV; CHEMOTHERAPY; CRIZOTINIB; ALK; MULTICENTER	IMPORTANCE Non-small cell lung cancer remains the leading cause of cancer death in the United States. Until the last decade, the 5-year overall survival rate for patients with metastatic non-small cell lung cancer was less than 5%. Improved understanding of the biology of lung cancer has resulted in the development of new biomarker-targeted therapies and led to improvements in overall survival for patients with advanced or metastatic disease. OBSERVATIONS Systemic therapy for metastatic non-small cell lung cancer is selected according to the presence of specific biomarkers. Therefore, all patients with metastatic non-small cell lung cancer should undergo molecular testing for relevant mutations and expression of the protein PD-L1 (programmed death ligand 1). Molecular alterations that predict response to treatment (eg, EGFR mutations, ALK rearrangements, ROS1 rearrangements, and BRAF V600E mutations) are present in approximately 30% of patients with non-small cell lung cancer. Targeted therapy for these alterations improves progression-free survival compared with cytotoxic chemotherapy. For example, somatic activating mutations in the EGFR gene are present in approximately 20% of patients with advanced non-small cell lung cancer. Tyrosine kinase inhibitors such as gefitinib, erlotinib, and afatinib improve progression-free survival in patients with susceptible EGFR mutations. In patients with overexpression of ALK protein, the response rate was significantly better with crizotinib (a tyrosine kinase inhibitor) than with the combination of pemetrexed and either cisplatin or carboplatin (platinum-based chemotherapy) (74% vs 45%, respectively; P < .001) and progression-free survival (median, 10.9 months vs 7.0 months; P < .001). Subsequent generations of tyrosine kinase inhibitors have improved these agents. For patients without biomarkers indicating susceptibility to specific targeted treatments, immune checkpoint inhibitor-containing regimens either as monotherapy or in combination with chemotherapy are superior vs chemotherapy alone. These advances in biomarker-directed therapy have led to improvements in overall survival. For example, the 5-year overall survival rate currently exceeds 25% among patients whose tumors have high PD-L1 expression (tumor proportion score of >= 50%) and 40% among patients with ALK-positive tumors. CONCLUSIONS AND RELEVANCE Improved understanding of the biology and molecular subtypes of non-small cell lung cancer have led to more biomarker-directed therapies for patients with metastatic disease. These biomarker-directed therapies and newer empirical treatment regimens have improved overall survival for patients with metastatic non-small cell lung cancer.	[Arbour, Kathryn C.; Riely, Gregory J.] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv,Div Solid Tumor, New York, NY USA	Cornell University; Memorial Sloan Kettering Cancer Center	Riely, GJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	rielyg@mskcc.org	Riely, Gregory/AAF-4300-2019		National Cancer Institute [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by grant P30 CA008748 from the National Cancer Institute awarded to Memorial Sloan Kettering Cancer Center.	Aggarwal C, 2019, JAMA ONCOL, V5, P173, DOI 10.1001/jamaoncol.2018.4305; Antonia SJ, 2018, NEW ENGL J MED, V379, P2342, DOI 10.1056/NEJMoa1809697; Brahmer JR, 2013, CANCER IMMUNOL RES, V1, P85, DOI 10.1158/2326-6066.CIR-13-0078; Camidge DR, 2018, NEW ENGL J MED, V379, P2027, DOI 10.1056/NEJMoa1810171; Camidge DR, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.TPS9111; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Chen VW, 2014, CANCER-AM CANCER SOC, V120, P3781, DOI 10.1002/cncr.29045; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Davar D, 2019, JAMA ONCOL, V5, P942, DOI 10.1001/jamaoncol.2019.0413; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Drilon A, 2018, J THORAC ONCOL, V13, pS348, DOI 10.1016/j.jtho.2018.08.300; DRILON AE, 2018, J CLIN ONCOL S, V36; Drilon A, 2019, CANCER DISCOV, V9, P384, DOI 10.1158/2159-8290.CD-18-0839; Drilon A, 2018, CANCER DISCOV, V8, P1227, DOI 10.1158/2159-8290.CD-18-0484; Drilon A, 2016, LANCET ONCOL, V17, P1653, DOI 10.1016/S1470-2045(16)30562-9; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Gainor JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/theoncologist.2013-0095; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gautschi O, 2017, J CLIN ONCOL, V35, P1403, DOI 10.1200/JCO.2016.70.9352; Gervais R, 2005, ANN ONCOL, V16, P90, DOI 10.1093/annonc/mdi018; Gettinger SN, 2015, J THORAC ONCOL, V10, pS238; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hellmann Matthew D, 2018, N Engl J Med, V378, P2093, DOI 10.1056/NEJMoa1801946; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Husain H, 2017, JAMA-J AM MED ASSOC, V318, P1272, DOI 10.1001/jama.2017.12131; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Johnson DB, 2018, JAMA-J AM MED ASSOC, V320, P1702, DOI 10.1001/jama.2018.13995; Jordan EJ, 2017, CANCER DISCOV, V7, P596, DOI 10.1158/2159-8290.CD-16-1337; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Lee SH, 2017, ANN ONCOL, V28, P292, DOI 10.1093/annonc/mdw559; Leighl NB, 2019, CLIN CANCER RES, V25, P4691, DOI 10.1158/1078-0432.CCR-19-0624; Li BT, 2018, J CLIN ONCOL, V36, P2532, DOI 10.1200/JCO.2018.77.9777; Lim SM, 2017, J CLIN ONCOL, V35, P2613, DOI 10.1200/JCO.2016.71.3701; Lopes G, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA4; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok Tony S, 2017, N Engl J Med, V376, P629, DOI 10.1056/NEJMoa1612674; Mok TS, 2018, J CLIN ONCOL, V36, P2244, DOI 10.1200/JCO.2018.78.7994; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Naidoo J, 2017, J CLIN ONCOL, V35, P709, DOI 10.1200/JCO.2016.68.2005; National Cancer Institute, SURV EP END RES PROG; Oxnard GR, 2018, JAMA ONCOL, V4, P1527, DOI 10.1001/jamaoncol.2018.2969; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865; Peng J, 2015, CANCER RES, V75, P5034, DOI 10.1158/0008-5472.CAN-14-3098; Pennell NA, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00356; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Reck M, 2019, J CLIN ONCOL, V37, P537, DOI 10.1200/JCO.18.00149; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rizvi NA, 2018, ANN ONCOL, V29; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sabari JK, 2019, JNCI-J NATL CANCER I, V111, P575, DOI 10.1093/jnci/djy156; Santini FC, 2018, CANCER IMMUNOL RES, V6, P1093, DOI 10.1158/2326-6066.CIR-17-0755; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2017, LANCET ONCOL, V18, P1590, DOI 10.1016/S1470-2045(17)30680-0; Shaw AT, 2017, LANCET ONCOL, V18, P874, DOI 10.1016/S1470-2045(17)30339-X; Shaw AT, 2016, LANCET ONCOL, V17, P234, DOI 10.1016/S1470-2045(15)00488-X; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Solomon BJ, 2018, LANCET ONCOL, V19, P1654, DOI 10.1016/S1470-2045(18)30649-1; Solomon BJ, 2018, J CLIN ONCOL, V36, P2251, DOI 10.1200/JCO.2017.77.4794; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Spiro SG, 2007, CHEST, V132, p149S, DOI 10.1378/chest.07-1358; Thompson JA, 2019, J NATL COMPR CANC NE, V17, P255, DOI 10.6004/jnccn.2019.0013; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Wang YC, 2019, JAMA ONCOL, V5, P1008, DOI 10.1001/jamaoncol.2019.0393; Yu HA, 2015, JAMA ONCOL, V1, P981, DOI 10.1001/jamaoncol.2015.1066; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zukin M, 2013, J CLIN ONCOL, V31, P2849, DOI 10.1200/JCO.2012.48.1911	84	469	487	33	173	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					764	774		10.1001/jama.2019.11058	http://dx.doi.org/10.1001/jama.2019.11058			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454018				2022-12-28	WOS:000483652500024
J	Sanders, D; Nandi, S; Labonte, R; Vance, C; Van Damme, W				Sanders, David; Nandi, Sulakshana; Labonte, Ronald; Vance, Carina; Van Damme, Wim			From primary health care to universal health coverage-one step forward and two steps back	LANCET			English	Editorial Material									[Sanders, David; Nandi, Sulakshana] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Nandi, Sulakshana] Publ Hlth Resource Network Chhattisgarh, Raipur, Chhattisgarh, India; [Sanders, David; Nandi, Sulakshana] Peoples Hlth Movement Global, Cape Town, South Africa; [Labonte, Ronald] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Vance, Carina] South Amer Inst Govt Hlth, Rio De Janeiro, Brazil; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium	University of the Western Cape; University of Ottawa; Institute of Tropical Medicine (ITM)	Sanders, D (corresponding author), Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa.; Sanders, D (corresponding author), Peoples Hlth Movement Global, Cape Town, South Africa.	dsanders@phmovement.org	Labonte, Ronald/G-4229-2011; Nandi, Sulakshana/AAX-2698-2020; Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007; Vance, Carina/0000-0001-9400-2493; Nandi, Sulakshana/0000-0002-4366-4566				Brundtland GH, 2018, LANCET, V392, P1174, DOI 10.1016/S0140-6736(18)32387-0; Bryant JH., 2008, INT ENCY PUBLIC HLTH, P152, DOI [10.1016/B978-012373960-5.00001-0, DOI 10.1016/B978-012373960-5.00001-0]; Clark J., 2014, GLOB HLTH ACTION, V7, P10; Freudenberg N., 2014, LETHAL LEGAL CORPORA; Global Justice Now, 2018, 69 RICH 100 ENT PLAN; Labonte RN, 2019, RUCKERT HLTH EQUITY; Pan American Health Organization, 2019, UN HLTH 21 CENT 40 Y; People's Health Movement Medicus Mundi International-Network Health for All Centro Brasileiro de Estudos de Saude, ALT CIV SOC AST STAT; Ranjan A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5431-8; Sengupta, 2013, UNIVERSAL HLTH COVER; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8	11	34	34	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					619	621		10.1016/S0140-6736(19)31831-8	http://dx.doi.org/10.1016/S0140-6736(19)31831-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UU	31448726	Green Published			2022-12-28	WOS:000483011200014
J	Dusetzina, SB; Keating, NL; Huskamp, HA				Dusetzina, Stacie B.; Keating, Nancy L.; Huskamp, Haiden A.			Proposals to Redesign Medicare Part D - Easing the Burden of Rising Drug Prices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Amid concerns about high drug prices, policymakers are considering options for modifying the Medicare Part D prescription-drug benefit to reduce spending by beneficiaries and taxpayers. The redesigns being considered shift spending and benefit phases in various ways.	[Dusetzina, Stacie B.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Keating, Nancy L.; Huskamp, Haiden A.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	Vanderbilt University; Harvard University; Harvard Medical School	Dusetzina, SB (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA.							Medicare Payment Advisory Commission, 2016, C MED HLTH CAR DEL S; Medicare Payment Advisory Commission, 2019, C MED HLTH CAR DEL D; Office of the Inspector General Department of Health and Human Services, 2019, FRAUD AB REM SAF HAR; Senate Finance Committee, PRESCR DRUG PRIC RED; The Board of Trustees Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, 2019, FED HOSP INS FED SUP	5	18	18	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2019	381	15					1401	1404		10.1056/NEJMp1908688	http://dx.doi.org/10.1056/NEJMp1908688			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9YG	31483987				2022-12-28	WOS:000489631900002
J	Valgimigli, M; Manavifar, N				Valgimigli, Marco; Manavifar, Negar			Ticagrelor in patients with diabetes and previous PCI	LANCET			English	Editorial Material							DUAL ANTIPLATELET THERAPY; CLOPIDOGREL; ASPIRIN		[Valgimigli, Marco; Manavifar, Negar] Univ Bern, Bern Univ Hosp, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Valgimigli, M (corresponding author), Univ Bern, Bern Univ Hosp, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland.	marco.valgimigli@insel.ch	Manavifar, Negar/X-9569-2019; Valgimigli, Marco/AAE-9103-2019	Manavifar, Negar/0000-0001-7643-7944; Valgimigli, Marco/0000-0002-4353-7110				Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2019, LANCET; Costa F, 2019, J AM COLL CARDIOL, V73, P741, DOI 10.1016/j.jacc.2018.11.048; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Gargiulo G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5483; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Valgimigli M, 2017, EUR HEART J, V38, P804, DOI 10.1093/eurheartj/ehw525; Valgimigli M, 2009, CIRCULATION, V119, P3215, DOI 10.1161/CIRCULATIONAHA.108.833236	9	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2019	394	10204					1118	1120		10.1016/S0140-6736(19)31957-9	http://dx.doi.org/10.1016/S0140-6736(19)31957-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8TF	31484630				2022-12-28	WOS:000488848800006
J	Manoli, G; Fatichi, S; Schlapfer, M; Yu, KL; Crowther, TW; Meili, N; Burlando, P; Katul, GG; Bou-Zeid, E				Manoli, Gabriele; Fatichi, Simone; Schlapfer, Markus; Yu, Kailiang; Crowther, Thomas W.; Meili, Naika; Burlando, Paolo; Katul, Gabriel G.; Bou-Zeid, Elie			Magnitude of urban heat islands largely explained by climate and population	NATURE			English	Article							GREEN SPACE; PRECIPITATION; VENTILATION; DENSITY; IMPACT; ALBEDO; CITIES; WINTER	Urban heat islands (UHIs) exacerbate the risk of heat-related mortality associated with global climate change. The intensity of UHIs varies with population size and mean annual precipitation, but a unifying explanation for this variation is lacking, and there are no geographically targeted guidelines for heat mitigation. Here we analyse summertime differences between urban and rural surface temperatures (Delta T-s) worldwide and find a nonlinear increase in Delta T-s with precipitation that is controlled by water or energy limitations on evapotranspiration and that modulates the scaling of Delta T-s with city size. We introduce a coarse-grained model that links population, background climate, and UHI intensity, and show that urban-rural differences in evapotranspiration and convection efficiency are the main determinants of warming. The direct implication of these nonlinearities is that mitigation strategies aimed at increasing green cover and albedo are more efficient in dry regions, whereas the challenge of cooling tropical cities will require innovative solutions.	[Manoli, Gabriele; Fatichi, Simone; Meili, Naika; Burlando, Paolo] Swiss Fed Inst Technol, Inst Environm Engn, Zurich, Switzerland; [Schlapfer, Markus; Meili, Naika] Swiss Fed Inst Technol, Singapore ETH Ctr, Future Cities Lab, Singapore, Singapore; [Yu, Kailiang; Crowther, Thomas W.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Katul, Gabriel G.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Bou-Zeid, Elie] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Manoli, Gabriele] UCL, Dept Civil Environm & Geomat Engn, London, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Duke University; Princeton University; University of London; University College London	Manoli, G (corresponding author), Swiss Fed Inst Technol, Inst Environm Engn, Zurich, Switzerland.; Manoli, G (corresponding author), UCL, Dept Civil Environm & Geomat Engn, London, England.	g.manoli@ucl.ac.uk	Meili, Naika/HGB-6735-2022; Katul, Gabriel G/A-7210-2008; Bou-Zeid, Elie/A-9796-2008; Meili, Naika/HGB-6383-2022	Meili, Naika/0000-0001-6283-2134; Katul, Gabriel G/0000-0001-9768-3693; Bou-Zeid, Elie/0000-0002-6137-8109; Crowther, Thomas/0000-0001-5674-8913; Schlapfer, Markus/0000-0001-6393-7501; Manoli, Gabriele/0000-0002-9245-2877; Fatichi, Simone/0000-0003-1361-6659	The Branco Weiss FellowshipSociety in Science; US National Science Foundation [ICER 1664091]; Army Research Office [W911NF-15-1-0003]; Future Cities Laboratory at the Singapore-ETH Centre; Singapore's National Research Foundation [FI 370074016]; SRN [1444758]	The Branco Weiss FellowshipSociety in Science; US National Science Foundation(National Science Foundation (NSF)); Army Research Office; Future Cities Laboratory at the Singapore-ETH Centre; Singapore's National Research Foundation(National Research Foundation, Singapore); SRN	G.M. was supported by the The Branco Weiss FellowshipSociety in Science administered by ETH Zurich. E.B.-Z. acknowledges support by the US National Science Foundation under grant no. ICER 1664091, the SRN under cooperative agreement no. 1444758, and the Army Research Office under contract W911NF-15-1-0003 (program manager J. Barzyk). M. S. was supported by the Future Cities Laboratory at the Singapore-ETH Centre, which was established collaboratively between ETH Zurich and Singapore's National Research Foundation (FI 370074016), under its Campus for Research Excellence and Technological Enterprise programme. We thank P. Edwards, J. Carmeliet, C. Kuffer, and D. Richards for help and discussions at the beginning of this research.	Akbari H., 1990, P AM SOC HEAT REFR A; Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Bai XM, 2018, NATURE, V555, P19, DOI 10.1038/d41586-018-02409-z; Bastin L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210496; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0005; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Chen D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23253-1; Chrysoulakis N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29873-x; CLARKE JF, 1972, ENVIRON RES, V5, P93, DOI 10.1016/0013-9351(72)90023-0; Clinton N, 2013, REMOTE SENS ENVIRON, V134, P294, DOI 10.1016/j.rse.2013.03.008; Emmanuel R, 2007, INT J CLIMATOL, V27, P1995, DOI 10.1002/joc.1609; Endreny TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03622-0; Estrada F, 2017, NAT CLIM CHANGE, V7, P403, DOI [10.1038/nclimate3301, 10.1038/NCLIMATE3301]; European Union, 2016, URB EUR STAT CIT TOW, DOI [10.2785/91120, DOI 10.2785/91120]; Fang Y, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.67; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gelaro R, 2017, J CLIMATE, V30, P5419, DOI 10.1175/JCLI-D-16-0758.1; Georgescu M, 2014, P NATL ACAD SCI USA, V111, P2909, DOI 10.1073/pnas.1322280111; Gill S.E., 2007, BUILT ENV, V33, P115, DOI [10.2148/benv.33.1.115, 10.2148/benv.33.1.115., DOI 10.2148/BENV.33.1.115]; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grimmond CSB, 1999, J APPL METEOROL, V38, P1262, DOI 10.1175/1520-0450(1999)038<1262:APOUAD>2.0.CO;2; Gu YF, 2018, URBAN CLIM, V24, P982, DOI 10.1016/j.uclim.2017.12.001; Gunawardena KR, 2017, SCI TOTAL ENVIRON, V584, P1040, DOI 10.1016/j.scitotenv.2017.01.158; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Imamura I. R., 1970, WIT T ECOL ENV, V1, P395; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Jendritzky G, 2012, INT J BIOMETEOROL, V56, P421, DOI 10.1007/s00484-011-0513-7; Juang JY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031296; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14213-2; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li D, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4299; Li Y, 2016, J GEOPHYS RES-ATMOS, V121, P6178, DOI 10.1002/2016JD024774; Liao WL, 2018, GEOPHYS RES LETT, V45, P11310, DOI 10.1029/2018GL079679; Lim YK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024267; Llaguno-Munitxa M, 2018, URBAN CLIM, V26, P76, DOI 10.1016/j.uclim.2018.08.006; Madani N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21172-9; Manickathan L, 2018, AGR FOREST METEOROL, V248, P259, DOI 10.1016/j.agrformet.2017.10.014; Maxwell RM, 2016, SCIENCE, V353, P377, DOI 10.1126/science.aaf7891; Mayor of London, 2018, LOND ENV STRAT; Miguez-Macho G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017540; Mora C, 2017, NAT CLIM CHANGE, V7, P501, DOI [10.1038/NCLIMATE3322, 10.1038/nclimate3322]; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; OKE TR, 1988, PROG PHYS GEOG, V12, P471, DOI 10.1177/030913338801200401; Oke TR., 2017, AIRFLOW URBAN CLIMAT, DOI [10.1017/9781139016476, DOI 10.1017/, DOI 10.1017/9781139016476.005]; Peng SS, 2012, ENVIRON SCI TECHNOL, V46, P696, DOI 10.1021/es2030438; Richards DR, 2017, LANDSCAPE URBAN PLAN, V157, P553, DOI 10.1016/j.landurbplan.2016.09.005; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Schlapfer M., 2015, URBAN SKYLINES BUILD; Scott AA, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabd6c; Seino N, 2018, URBAN CLIM, V23, P8, DOI 10.1016/j.uclim.2016.11.007; Shashua-Bar L, 2009, LANDSCAPE URBAN PLAN, V92, P179, DOI 10.1016/j.landurbplan.2009.04.005; Shastri H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40178; Shephard JM, 2005, EARTH INTERACT, V9; Sobstyl JM, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.108701; TAHA H, 1988, BUILD ENVIRON, V23, P271, DOI 10.1016/0360-1323(88)90033-9; Taleghani M, 2014, BUILD ENVIRON, V81, P309, DOI 10.1016/j.buildenv.2014.07.010; Willis KJ, 2017, SCIENCE, V356, P374, DOI 10.1126/science.aam9724; Wong MS, 2010, BUILD ENVIRON, V45, P1880, DOI 10.1016/j.buildenv.2010.02.019; Yang JC, 2018, J APPL METEOROL CLIM, V57, P1309, DOI 10.1175/JAMC-D-17-0265.1; Yang XY, 2015, BUILD ENVIRON, V90, P146, DOI 10.1016/j.buildenv.2015.03.037; Zhao L, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9f73; Zhao L, 2014, NATURE, V511, P216, DOI 10.1038/nature13462; Zhou B, 2013, GEOPHYS RES LETT, V40, P5486, DOI 10.1002/2013GL057320; Zhou DC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074009	67	286	298	96	510	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					55	+		10.1038/s41586-019-1512-9	http://dx.doi.org/10.1038/s41586-019-1512-9			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31485056	Green Submitted			2022-12-28	WOS:000483967700034
J	Nil, Z; Millan, RH; Gerbich, T; Leal, P; Yu, ZL; Saraf, A; Sardiu, M; Lange, JJ; Yi, KX; Unruh, J; Slaughter, B; Si, K				Nil, Zelha; Millan, Ruben Hervas; Gerbich, Therese; Leal, Paulo; Yu, Zulin; Saraf, Anita; Sardiu, Mihaela; Lange, Jeffrey J.; Yi, Kexi; Unruh, Jay; Slaughter, Brian; Si, Kausik			Amyloid-like Assembly Activates a Phosphatase in the Developing Drosophila Embryo	CELL			English	Article							PRION-LIKE POLYMERIZATION; PROTEIN-KINASES; FUNCTIONAL AMYLOIDS; NEURONAL ISOFORM; COMMON MECHANISM; GENE ONTOLOGY; APLYSIA CPEB; WINGLESS; IDENTIFICATION; GENOMICS	Prion-like proteins can assume distinct conformational and physical states in the same cell. Sequence analysis suggests that prion-like proteins are prevalent in various species; however, it remains unclear what functional space they occupy in multicellular organisms. Here, we report the identification of a prion-like protein, Herzog (CG5830), through a multimodal screen in Drosophila melanogaster. Herzog functions as a membrane-associated phosphatase and controls embryonic patterning, likely being involved in TGF-beta/BMP and FGF/EGF signaling pathways. Remarkably, monomeric Herzog is enzymatically inactive and becomes active upon amyloid-like assembly. The prion-like domain of Herzog is necessary for both its and membrane targeting. Removal of the prion-like domain impairs activity, while restoring assembly on the membrane using a heterologous prion-like domain and membrane-targeting motif can restore phosphatase activity. This study provides an example of a prion-like domain that allows an enzyme to gain essential functionality via amyloid-like assembly to control animal development.	[Nil, Zelha; Millan, Ruben Hervas; Gerbich, Therese; Leal, Paulo; Yu, Zulin; Saraf, Anita; Sardiu, Mihaela; Lange, Jeffrey J.; Yi, Kexi; Unruh, Jay; Slaughter, Brian; Si, Kausik] Stowers Inst Med Res, 1000E 50th St, Kansas City, MO 64110 USA; [Nil, Zelha; Si, Kausik] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Gerbich, Therese] Univ N Carolina, Biol & Biomed Sci Program, Chapel Hill, NC 27514 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Si, K (corresponding author), Stowers Inst Med Res, 1000E 50th St, Kansas City, MO 64110 USA.; Si, K (corresponding author), Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	ksi@stowers.org		Gerbich, Therese/0000-0003-4232-9536	Stowers Institute for Medical Research	Stowers Institute for Medical Research	We thank Matthew Christenson for in silico screen; Dr. Robb Krumlauf for critical comments; Dr. Joan Conaway for RNAPII CTD assay; Dr. Mark Peifer for review and suggestions; Mark Miller for illustrations; Stephanie Nowatarski for suggestions in embryo count experiments; Takuya Akiyama and Narendra Singh for suggestions in phenotypic characterization; Laurence Florens (Proteomics core) for assistance in data analysis and visualization; and Sunny Sharma, Chaoying Zhang, Fengzhen Ren, Nancy Thomas (Histology Core), and Maria Katt (Tissue Culture) for assistance in experiments. The work is funded by the Stowers Institute for Medical Research. Original data underlying this manuscript can be accessed from the Stowers Original Data Repository at https://www.stowers.org/research/publications/LIBPB-1440.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P813; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASZTALOS Z, 1993, J NEUROSCI, V13, P924; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bakthavachalu B, 2018, NEURON, V98, P754, DOI 10.1016/j.neuron.2018.04.032; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Batlle C, 2017, EXPERT REV PROTEOMIC, V14, P335, DOI 10.1080/14789450.2017.1304214; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benke D., 2011, XPHARM COMPREHENSIVE, P1; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; Bier E, 2018, GENETICS, V208, P1, DOI 10.1534/genetics.117.1113; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Cai X, 2014, TRENDS IMMUNOL, V35, P622, DOI 10.1016/j.it.2014.10.003; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Carpenter K, 2018, DEV CELL, V45, P392, DOI 10.1016/j.devcel.2018.04.001; Cervantes SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38265; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CROWTHER JR, 1990, BIOLOGICALS, V18, P331, DOI 10.1016/1045-1056(90)90038-2; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; DOMBRADI V, 1990, FEBS LETT, V275, P39, DOI 10.1016/0014-5793(90)81434-P; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FERNLEY HN, 1965, BIOCHEM J, V97, P95, DOI 10.1042/bj0970095; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4989; Florens Laurence, 2006, V328, P159; Garvey M, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030067; Gilbert S. F., 2014, DEV BIOL, P69; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Guyonnet B, 2014, MOL CELL BIOL, V34, P2624, DOI 10.1128/MCB.00073-14; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hervas R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002361; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hu Yanhui, 2015, J Genomics, V3, P75, DOI 10.7150/jgen.12863; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jakobson Christopher M, 2018, Curr Opin Syst Biol, V8, P16, DOI 10.1016/j.coisb.2017.11.012; Ji SM, 2019, MOL CELL, V74, P363, DOI 10.1016/j.molcel.2019.02.004; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kiss A, 2019, BBA-MOL CELL RES, V1866, P2, DOI 10.1016/j.bbamcr.2018.07.023; Kopp A, 2009, Q REV BIOL, V84, P201, DOI [10.1086/603491, DOI 10.1086/603491]; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lipke P. N, 2017, MICROBIOL MOL BIOL R, V82, P17; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Lusk JB, 2017, CANCERS, V9, DOI 10.3390/cancers9020016; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Miskei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022218; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Muha V, 2013, INT J MOL SCI, V14, P5920, DOI 10.3390/ijms14035920; Mustelin Tomas, 2007, V365, P9; Narasimha M., 2006, CELL BIOL LAB HDB, P77, DOI DOI 10.1016/B978-012164730-8/50136-2; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Parker L, 2004, PROG MOLEC, V34, P73; Pavelka N, 2008, MOL CELL PROTEOMICS, V7, P631, DOI 10.1074/mcp.M700240-MCP200; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Raveendra BL, 2013, NAT STRUCT MOL BIOL, V20, P495, DOI 10.1038/nsmb.2503; Reynhout S, 2019, BBA-MOL CELL RES, V1866, P31, DOI 10.1016/j.bbamcr.2018.07.010; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Rothwell WF, 1999, J CELL SCI, V112, P2885; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Saupe SJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0029-2016; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; Shenolikar Shirish, 2007, V365, P1; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2015, ANNU REV CELL DEV BI, V31, P149, DOI 10.1146/annurev-cellbio-100913-013409; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Soria MA, 2017, BIOPHYS J, V113, P37, DOI 10.1016/j.bpj.2017.05.039; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Stephan JS, 2015, CELL REP, V11, P1772, DOI 10.1016/j.celrep.2015.04.060; Stroobants K, 2017, BIOCHEMISTRY-US, V56, P3225, DOI 10.1021/acs.biochem.7b00157; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tariq M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-374; Tayeb-Fligelman E, 2017, SCIENCE, V355, P831, DOI 10.1126/science.aaf4901; TREWAVAS A, 1976, ANNU REV PLANT PHYS, V27, P349, DOI 10.1146/annurev.pp.27.060176.002025; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Urban S, 2004, DEVELOPMENT, V131, P1835, DOI 10.1242/dev.01058; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; White-Grindley E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001786; Wickner RB, 2000, CURR BIOL, V10, pR335, DOI 10.1016/S0960-9822(00)00460-7; Wodarz Andreas, 2008, V420, P335, DOI 10.1007/978-1-59745-583-1_21; Wouda RR, 2008, DEVELOPMENT, V135, P2277, DOI 10.1242/dev.017319; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Yang L, 2013, DEVELOPMENT, V140, P413, DOI 10.1242/dev.082578; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang CX, 2000, MOL BIOL CELL, V11, P1011, DOI 10.1091/mbc.11.3.1011; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	121	7	8	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1403	+		10.1016/j.cell.2019.08.019	http://dx.doi.org/10.1016/j.cell.2019.08.019			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491385	Bronze			2022-12-28	WOS:000483983000015
J	Dyer, C				Dyer, Clare			Surgeon who performed wrong knee surgery is suspended for 12 months	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5384	10.1136/bmj.l5384	http://dx.doi.org/10.1136/bmj.l5384			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481590				2022-12-28	WOS:000485434400011
J	Mahase, E				Mahase, Elisabeth			Tell women about long term breast cancer risk with HRT, drug agency tells doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5332; MHRA, 2019, HORM REPL THER HRT F; National Institute for Health and Care Excellence (NICE), 2015, MEN DIAGN MAN	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l5350	10.1136/bmj.l5350	http://dx.doi.org/10.1136/bmj.l5350			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477572				2022-12-28	WOS:000485431800009
J	Smith, P				Smith, Paul			Australian medical college could lose charitable status amid governance concerns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Smith P, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k844; Smith P, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6626	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l5365	10.1136/bmj.l5365	http://dx.doi.org/10.1136/bmj.l5365			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477573				2022-12-28	WOS:000485431800010
J	Longwitz, L; Werner, T				Longwitz, Lars; Werner, Thomas			The Mitsunobu reaction, reimagined	SCIENCE			English	Editorial Material									[Longwitz, Lars; Werner, Thomas] Leibniz Inst Catalysis, Albert Einstein Str 29a, D-18059 Rostock, Germany	Leibniz Institut fur Katalyse e.V. an der Universitat Rostock (LIKAT)	Werner, T (corresponding author), Leibniz Inst Catalysis, Albert Einstein Str 29a, D-18059 Rostock, Germany.	thomas.werner@catalysis.de	Werner, Thomas/A-3177-2015	Werner, Thomas/0000-0001-9025-3244; Longwitz, Lars/0000-0002-2525-4678	Leibniz ScienceCampus Phosphorus Research Rostock	Leibniz ScienceCampus Phosphorus Research Rostock	We are grateful for support from the Leibniz ScienceCampus Phosphorus Research Rostock (www.sciencecampus-rostock.de).	Beddoe RH, 2019, SCIENCE, V365, P910, DOI 10.1126/science.aax3353; Beddoe RH, 2018, ORG BIOMOL CHEM, V16, P7774, DOI 10.1039/c8ob01929k; Buonomo JA, 2015, ANGEW CHEM INT EDIT, V54, P13041, DOI 10.1002/anie.201506263; Fletcher S, 2015, ORG CHEM FRONT, V2, P739, DOI 10.1039/c5qo00016e; Hirose D, 2016, ORG LETT, V18, P4036, DOI 10.1021/acs.orglett.6b01894; Hirose D, 2013, ANGEW CHEM INT EDIT, V52, P4613, DOI 10.1002/anie.201300153; MITSUNOBU O, 1981, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-1981-29317; Oyo M., 1967, B CHEM SOC JPN, V40, P935; Swamy KCK, 2009, CHEM REV, V109, P2551, DOI 10.1021/cr800278z; But TYS, 2006, J AM CHEM SOC, V128, P9636, DOI 10.1021/ja063141v; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206	11	4	4	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					866	867		10.1126/science.aay6635	http://dx.doi.org/10.1126/science.aay6635			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467210				2022-12-28	WOS:000483975800027
J	Crawford, K				Crawford, Kate			Regulate facial-recognition technology	NATURE			English	Editorial Material									[Crawford, Kate] NYU, AI Now Inst, New York, NY 10003 USA; [Crawford, Kate] Microsoft Res, New York, NY 10011 USA	New York University; Microsoft	Crawford, K (corresponding author), NYU, AI Now Inst, New York, NY 10003 USA.; Crawford, K (corresponding author), Microsoft Res, New York, NY 10011 USA.								0	16	16	4	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					565	565		10.1038/d41586-019-02514-7	http://dx.doi.org/10.1038/d41586-019-02514-7			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31455918	Bronze			2022-12-28	WOS:000483405500023
J	Lind, M; Pivodic, A; Svensson, AM; Olafsdottir, AF; Wedel, H; Ludvigsson, J				Lind, Marcus; Pivodic, Aldina; Svensson, Ann-Marie; Olafsdottir, Arndis F.; Wedel, Hans; Ludvigsson, Johnny			HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; RETINAL FUNCTION; COMPLICATIONS; PROGRESSION; CONSENSUS; EFFICACY; HBA1C	OBJECTIVE To evaluate if the lowest target level for glycated haemoglobin (HbA(1c)) of < 6.5% is associated with lower risk for retinopathy and nephropathy than less tight control in children and adults with type 1 diabetes. DESIGN Population based cohort study. SETTING Swedish National Diabetes Registry, 1 January 1998 to 31 December 2017. PARTICIPANTS 10 398 children and adults with type 1 diabetes followed from diagnosis, or close thereafter, until end of 2017. MAIN OUTCOME MEASURES Relative risk (odds ratios) for retinopathy and nephropathy for different mean levels of HbA(1c). RESULTS Mean age of participants was 14.7 years (43.4% female), mean duration of diabetes was 1.3 years, and mean HbA(1c) level was 8.0% (63.4 mmol/mol). After adjustment for age, sex, duration of diabetes, blood pressure, blood lipid levels, body mass index, and smoking, the odds ratio for mean HbA(1c) < 6.5% (< 48 mmol/mol) compared with 6.5-6.9% (48-52 mmol/mol) for any retinopathy (simplex or worse) was 0.77 (95% confidence interval 0.56 to 1.05, P=0.10), for preproliferative diabetic retinopathy or worse was 3.29 (0.99 to 10.96, P=0.05), for proliferative diabetic retinopathy was 2.48 (0.71 to 8.62, P=0.15), for microalbuminuria or worse was 0.98 (0.60 to 1.61, P=0.95), and for macroalbuminuria was 2.47 (0.69 to 8.87, P=0.17). Compared with HbA(1c) levels 6.56.9%, HbA(1c) levels 7.0-7.4% (53-57 mmol/mol) were associated with an increased risk of any retinopathy (1.31, 1.05 to 1.64, P=0.02) and microalbuminuria (1.55, 1.03 to 2.32, P=0.03). The risk for proliferative retinopathy (5.98, 2.10 to 17.06, P<0.001) and macroalbuminuria (3.43, 1.14 to 10.26, P=0.03) increased at HbA(1c) levels > 8.6% (> 70 mmol/mol). The risk for severe hypoglycaemia was increased at mean HbA(1c) < 6.5% compared with 6.5-6.9% (relative risk 1.34, 95% confidence interval 1.09 to 1.64, P=0.005). CONCLUSIONS Risk of retinopathy and nephropathy did not differ at HbA(1c) levels < 6.5% but increased for severe hypoglycaemia compared with HbA(1c) levels 6.5-6.9%. The risk for severe complications mainly occurred at HbA(1c) levels > 8.6%, but for milder complications was increased at HbA(1c) levels > 7.0%.	[Lind, Marcus; Svensson, Ann-Marie; Olafsdottir, Arndis F.] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Lind, Marcus; Olafsdottir, Arndis F.] NU Hosp Grp, Dept Med, Uddevalla, Sweden; [Pivodic, Aldina] Stat Konsultgrp, Gothenburg, Sweden; [Svensson, Ann-Marie] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden; [Wedel, Hans] Univ Gothenburg, Sahlgrenska Acad, Dept Hlth Metr, Gothenburg, Sweden; [Ludvigsson, Johnny] Linkoping Univ, Dept Biomed & Clin Sci, Div Paediat, Linkoping, Sweden; [Ludvigsson, Johnny] Crown Princess Victoria Childrens Hosp, Reg Ostergotland, Linkoping, Sweden	University of Gothenburg; NU Hospital Group; Voestalpine AG; University of Gothenburg; Linkoping University	Lind, M (corresponding author), Uddevalla Cent Hosp, Diabet Outpatient Clin, S-45180 Uddevalla, Sweden.	lind.marcus@telia.com	Lind, Marcus/AAI-6733-2021; Ludvigsson, Johnny/AAI-2051-2020; Lind, Marcus/GRJ-4946-2022	Ludvigsson, Johnny/0000-0003-1695-5234; Lind, Marcus/0000-0002-3796-9283	Swedish government; Novonordisk Foundation	Swedish government; Novonordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by the Swedish government (Agreement for Medical Education and Research) and Novonordisk Foundation. The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; [Anonymous], 1995, DIABETES, V44, P968; Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; DiMeglio LA, 2018, PEDIATR DIABETES, V19, P105, DOI 10.1111/pedi.12737; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032; Forlenza GP, 2019, DIABETES TECHNOL THE, V21, P11, DOI 10.1089/dia.2018.0264; Grauslund J, 2009, DIABETOLOGIA, V52, P1829, DOI 10.1007/s00125-009-1450-4; Gudbjomsdottir S, NDR REPORT 2017; Hanas R, 2010, DIABETES CARE, V33, P1903, DOI 10.2337/dc10-0953; Joubert M, 2012, DIABETES RES CLIN PR, V96, P294, DOI 10.1016/j.diabres.2011.12.010; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Laranjeira FO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194801; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lind M, 2017, JAMA-J AM MED ASSOC, V317, P379, DOI 10.1001/jama.2016.19976; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lind M, 2008, DIABETES METAB SYND, V2, P282, DOI 10.1016/j.dsx.2008.04.006; Lind M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004412; Lindblad B, 2013, CLIN CHEM LAB MED, V51, P2045, DOI 10.1515/cclm-2013-0226; Lindstrom C, 2017, J PEDIATR NURS, V36, P149, DOI 10.1016/j.pedn.2017.06.002; Mathieu C, 2018, DIABETES CARE, V41, P1938, DOI 10.2337/dc18-0623; Mathieu C, 2019, DIABETES CARE, V42, P1081, DOI 10.2337/dc18-1983; Matuleviciene-Anangen V, 2017, HEART, V103, P1687, DOI 10.1136/heartjnl-2016-311050; National Institute for Health and Care Excellence, 2015, TYPE 1 DIABETES IN A; Nordin Gunnar, 2018, J Diabetes Sci Technol, V12, P771, DOI 10.1177/1932296818785622; Nordwall M, 2015, DIABETES CARE, V38, P308, DOI 10.2337/dc14-1203; Samuelsson U, 2018, PEDIATR DIABETES, V19, P150, DOI 10.1111/pedi.12467; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Umino Y, 2012, INVEST OPHTH VIS SCI, V53, P915, DOI 10.1167/iovs.11-8787; Wang SY, 2017, OPHTHALMOLOGY, V124, P424, DOI 10.1016/j.ophtha.2016.10.031; 1996, DIABETES, V45, P1289, DOI DOI 10.2337/DIAB.45.10.1289	36	53	55	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2019	366								l4894	10.1136/bmj.l4894	http://dx.doi.org/10.1136/bmj.l4894			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HJ	31462492	Green Published, hybrid			2022-12-28	WOS:000483891600001
J	Thornton, J				Thornton, Jacqui			Palliative care in Tajikistan	LANCET			English	Editorial Material																			0	0	0	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					624	626		10.1016/S0140-6736(19)31968-3	http://dx.doi.org/10.1016/S0140-6736(19)31968-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UU	31448728				2022-12-28	WOS:000483011200017
J	Dijk, S; Lok, P				Dijk, Stijntje; Lok, Pat			NICE rejects cannabidiol for two types of treatment resistant epilepsy in children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Devinsky O, 2019, EPILEPSIA, V60, P294, DOI 10.1111/epi.14628; Devinsky O, 2018, NEW ENGL J MED, V378, P1888, DOI 10.1056/NEJMoa1714631; European Medicines Agency, M HIGHL COMM MED PRO; National Institute for Health and Care Excellence, 2019, APPR CONS DOC CANN C; Nutt D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2808; US Food and Drug Administration, DRUG APPR PACK EP CA	6	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2019	366								l5280	10.1136/bmj.l5280	http://dx.doi.org/10.1136/bmj.l5280			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DN	31444166				2022-12-28	WOS:000482882800008
J	Siders, AR; Hino, M; Mach, KJ				Siders, A. R.; Hino, Miyuki; Mach, Katharine J.			The case for strategic and managed climate retreat	SCIENCE			English	Editorial Material							RESETTLEMENT		[Siders, A. R.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Siders, A. R.] Univ Delaware, Disaster Res Ctr, Newark, DE USA; [Hino, Miyuki] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA; [Mach, Katharine J.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Mach, Katharine J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	Harvard University; University of Delaware; Stanford University; Stanford University; University of Miami	Siders, AR (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.; Siders, AR (corresponding author), Univ Delaware, Disaster Res Ctr, Newark, DE USA.	siders@udel.edu	Siders, A.R./R-8672-2018	Siders, A.R./0000-0001-6788-8313	Harvard University Center for the Environment; Stanford Woods Institute for the Environment; Sykes Family Fellowship in Stanford University's Emmett Interdisciplinary Program in Environment and Resources	Harvard University Center for the Environment; Stanford Woods Institute for the Environment; Sykes Family Fellowship in Stanford University's Emmett Interdisciplinary Program in Environment and Resources	Research was supported by the Harvard University Center for the Environment, Stanford Woods Institute for the Environment, and the Sykes Family Fellowship in Stanford University's Emmett Interdisciplinary Program in Environment and Resources.	Adger WN, 2016, ANN AM ASSOC GEOGR, V106, P1079; Agyeman J, 2009, ENVIRON PLANN A, V41, P509, DOI 10.1068/a41301; Arnall A, 2014, GEOGR J, V180, P141, DOI 10.1111/geoj.12036; Bansak K, 2018, SCIENCE, V359, P325, DOI 10.1126/science.aao4408; Chetty R, 2018, Q J ECON, V133, P1107, DOI 10.1093/qje/qjy007; Gibbs MT, 2016, OCEAN COAST MANAGE, V130, P107, DOI 10.1016/j.ocecoaman.2016.06.002; Greiving S., 2018, J EXTREM EVENTS, V5, P1, DOI [10.1142/S2345737618500112, DOI 10.1142/S2345737618500112]; Hino M, 2017, NAT CLIM CHANGE, V7, P364, DOI [10.1038/nclimate3252, 10.1038/NCLIMATE3252]; Koslov L, 2016, PUBLIC CULTURE, V28, P359, DOI 10.1215/08992363-3427487; Kousky C, 2014, CLIMATIC CHANGE, V124, P9, DOI 10.1007/s10584-014-1106-3; McAdam J., 2015, FORCED MIGRATION REV, V49, P30; Santiago JSS, 2018, INT J DISAST RISK RE, V27, P480, DOI 10.1016/j.ijdrr.2017.11.012; Siders A., 2013, MANAGED COASTAL RETR; Warnecke A, 2010, CLIMATE CHANGE MIGRA; Weerasinghe Sanjula, 2014, PLANNED RELOCATIONS	15	75	75	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		761	763		10.1126/science.aax8346	http://dx.doi.org/10.1126/science.aax8346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439787				2022-12-28	WOS:000482464000033
J	Schwalm, JD; McCready, T; Lopez-Jaramillo, P; Yusoff, K; Attaran, A; Lamelas, P; Camacho, PA; Majid, F; Bangdiwala, SI; Thabane, L; Islam, S; McKee, M; Yusuf, S				Schwalm, Jon-David; McCready, Tara; Lopez-Jaramillo, Patricio; Yusoff, Khalid; Attaran, Amir; Lamelas, Pablo; Camacho, Paul A.; Majid, Fadhlina; Bangdiwala, Shrikant I.; Thabane, Lehana; Islam, Shofiqul; McKee, Martin; Yusuf, Salim			A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial	LANCET			English	Article							HEALTH-CARE WORKERS; LOW-INCOME; BLOOD-PRESSURE; MIDDLE-INCOME; DISEASE; PREVENTION; MORTALITY; COUNTRIES; MANAGEMENT; TRENDS	Background Hypertension is the leading cause of cardiovascular disease globally. Despite proven benefits, hypertension control is poor. We hypothesised that a comprehensive approach to lowering blood pressure and other risk factors, informed by detailed analysis of local barriers, would be superior to usual care in individuals with poorly controlled or newly diagnosed hypertension. We tested whether a model of care involving non-physician health workers (NPHWs), primary care physicians, family, and the provision of effective medications, could substantially reduce cardiovascular disease risk. Methods HOPE 4 was an open, community-based, cluster-randomised controlled trial involving 1371 individuals with new or poorly controlled hypertension from 30 communities (defined as townships) in Colombia and Malaysia. 16 communities were randomly assigned to control (usual care, n= 727), and 14 (n= 644) to the intervention. After community screening, the intervention included treatment of cardiovascular disease risk factors by NPHWs using tablet computer-based simplified management algorithms and counselling programmes; free antihypertensive and statin medications recommended by NPHWs but supervised by physicians; and support from a family member or friend (treatment supporter) to improve adherence to medications and healthy behaviours. The primary outcome was the change in FraminghamRisk Score 10-year cardiovascular disease risk estimate at 12 months between intervention and control participants. The HOPE 4 trial is registered at ClinicalTrials.gov, NCT01826019. Findings All communities completed 12-month follow-up (data on 97% of living participants, n= 1299). The reduction in Framingham Risk Score for 10-year cardiovascular disease risk was -6.40% (95% CI 8.00 to -4.80) in the control group and -11.17% (-12.88 to -9.47) in the intervention group, with a difference of change of -4.78% (95% CI -7.11 to -2.44, p< 0.0001). There was an absolute 11.45 mm Hg (95% CI -14.94 to -7.97) greater reduction in systolic blood pressure, and a 0.41 mmol/L (95% CI -0.60 to -0.23) reduction in LDL with the intervention group (both p< 0.0001). Change in blood pressure control status (< 140 mm Hg) was 69% in the intervention group versus 30% in the control group (p< 0.0001). There were no safety concerns with the intervention. Interpretation A comprehensive model of care led by NPHWs, involving primary care physicians and family that was informed by local context, substantially improved blood pressure control and cardiovascular disease risk. This strategy is effective, pragmatic, and has the potential to substantially reduce cardiovascular disease compared with current strategies that are typically physician based. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Schwalm, Jon-David; McCready, Tara; Lamelas, Pablo; Bangdiwala, Shrikant I.; Islam, Shofiqul; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Schwalm, Jon-David; McCready, Tara; Lamelas, Pablo; Bangdiwala, Shrikant I.; Islam, Shofiqul; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Lopez-Jaramillo, Patricio; Camacho, Paul A.] Fdn Oftalmol Santander, Res Inst, Floridablanca, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Med Sch, Masira Inst, Bucaramanga, Colombia; [Yusoff, Khalid; Majid, Fadhlina] Univ Teknol MARA, Fac Med, Selayang, Selangor, Malaysia; [Yusoff, Khalid] UCSI, Fac Med & Hlth Sci, Kuala Lumpur, Malaysia; [Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Camacho, Paul A.] Univ Autonoma Bucaramanga, Med Sch, Bucaramanga, Colombia; [Bangdiwala, Shrikant I.; Thabane, Lehana; Yusuf, Salim] McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England	McMaster University; Population Health Research Institute; McMaster University; Universidad Industrial de Santander; UCSI University; University of Ottawa; University of Ottawa; McMaster University; University of London; London School of Hygiene & Tropical Medicine	Schwalm, JD (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.; Schwalm, JD (corresponding author), Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada.	schwalj@mcmaster.ca	Fazli, Ghazal/AAE-8320-2022	Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Camacho, Paul Anthony/0000-0002-6233-9582; Yusuf, Salim/0000-0003-4776-5601	Canadian Institutes of Health Research (CIHR); Grand Challenges Canada (GCC), as part of the Global Alliance for Chronic Disease program (CIHR) [120389, 0069-04, 0070-04]; CIHR's Strategy for Patient Oriented Research (SPOR), through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care; Boehringer Ingelheim; Department of Management of non-communicable diseases, WHO; Santander Departmental Secretary of Health, Bucaramanga, Colombia; Population Health Research Institute	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Grand Challenges Canada (GCC), as part of the Global Alliance for Chronic Disease program (CIHR); CIHR's Strategy for Patient Oriented Research (SPOR), through the Ontario SPOR Support Unit(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Boehringer Ingelheim(Boehringer Ingelheim); Department of Management of non-communicable diseases, WHO; Santander Departmental Secretary of Health, Bucaramanga, Colombia; Population Health Research Institute	We thank our funders and partners at WHO for their collaboration on the NPHW training curriculum at the onset of this project. We acknowledge support from the following physicians in Malaysia and Colombia: Ng Kien Keat, Khairul Shafiq Ibrahim, Adibah Hanim Ismail, Norhaslira Abdul Rahim, Noor Hasliza Hassan, Ruziaton binti Hasim, Nor Anizah bt Muzaid, Sabariah Idris, Johanna Otero, Jose Patricio Lopez-Lopez, Sandra Rueda-Quijano, and Luz Maria Gomez-Pena. This work was supported by the Canadian Institutes of Health Research (CIHR) and Grand Challenges Canada (GCC), as part of the Global Alliance for Chronic Disease program (CIHR grant number 120389; GCC grant numbers 0069-04 and 0070-04); CIHR's Strategy for Patient Oriented Research (SPOR), through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care; an unrestricted grant from Boehringer Ingelheim; the Department of Management of non-communicable diseases, WHO; the Santander Departmental Secretary of Health, Bucaramanga, Colombia; and the Population Health Research Institute. This research programme does not represent the official view of the Global Alliance for Chronic Diseases, WHO, or the governments of Canada, Malaysia, or Colombia. No official support or endorsement of this article by the Global Alliance for Chronic Diseases hypertension programme, WHO, or federal governments of participating countries is intended or should be inferred.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Anand TN, 2019, LANCET GLOB HEALTH, V7, pE761, DOI 10.1016/S2214-109X(19)30077-4; Artigao-Rodenas LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073529; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Chia YC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007324; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Gaziano T, 2015, HEALTH AFFAIR, V34, P1538, DOI 10.1377/hlthaff.2015.0349; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Hoffmann R, 2013, EUR J PUBLIC HEALTH, V23, P852, DOI 10.1093/eurpub/ckt026; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Khan Maheer, 2018, Glob Heart, V13, P93, DOI 10.1016/j.gheart.2017.11.002; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Krogsboll Lasse T, 2012, BMJ, V345, pe7191, DOI 10.1136/bmj.e7191; Legido-Quigley H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122112; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Lopez-Jaramillo P, 2019, J HYPERTENS, V37, P1126, DOI 10.1097/HJH.0000000000002072; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Malaysian Society of Hypertension, 2018, CLIN PRACT GUID MAN; Mamudu HM, 2011, GLOB PUBLIC HEALTH, V6, P347, DOI 10.1080/17441692.2011.574230; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Nachega JB, 2010, AIDS, V24, P1273, DOI 10.1097/QAD.0b013e328339e20e; Ogedegbe G, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002561; Peiris D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213708; Risso-Gill I, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0916-y; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Roshandel G, 2019, SSRN; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schwalm JDR, 2018, AM HEART J, V203, P57, DOI 10.1016/j.ahj.2018.06.004; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Tian MY, 2015, CIRCULATION, V132, P815, DOI 10.1161/CIRCULATIONAHA.115.015373; World Health Organization, 2008, WHO STEPS SURV MAN W; World Health Organization, 2002, WHO CVD RISK MAN PAC; World Health Organization, 2019, WHO MOD LIST ESS MED; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	43	78	82	4	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1231	1242		10.1016/S0140-6736(19)31949-X	http://dx.doi.org/10.1016/S0140-6736(19)31949-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8XK	31488369				2022-12-28	WOS:000488862500028
J	Dong, D; Zheng, LQ; Lin, JQ; Zhang, BL; Zhu, YW; Li, NN; Xie, SY; Wang, YH; Gao, N; Huang, ZW				Dong, De; Zheng, Lvqin; Lin, Jianquan; Zhang, Bailing; Zhu, Yuwei; Li, Ningning; Xie, Shuangyu; Wang, Yuhang; Gao, Ning; Huang, Zhiwei			Structural basis of assembly of the human T cell receptor-CD3 complex	NATURE			English	Article							CRYSTAL-STRUCTURE; PEPTIDE-MHC; TCR; HETERODIMER; RECOGNITION; FEATURES; DIMER	The alpha beta T cell receptor (TCR), in association with the CD3 gamma epsilon-CD3 delta epsilon-CD3 zeta zeta signalling hexamer, is the primary determinant of T cell development and activation, and of immune responses to foreign antigens. The mechanism of assembly of the TCR-CD3 complex remains unknown. Here we report a cryo-electron microscopy structure of human TCR alpha beta in complex with the CD3 hexamer at 3.7 angstrom resolution. The structure contains the complete extracellular domains and all the transmembrane helices of TCR-CD3. The octameric TCR-CD3 complex is assembled with 1:1:1:1 stoichiometry of TCR alpha beta:CD3 gamma epsilon:CD3 zeta zeta:CD3 zeta zeta. Assembly of the extracellular domains of TCR-CD3 is mediated by the constant domains and connecting peptides of TCR alpha beta that pack against CD3 gamma epsilon-CD3 delta epsilon, forming a trimer-like structure proximal to the plasma membrane. The transmembrane segment of the CD3 complex adopts a barrel-like structure formed by interaction of the two transmembrane helices of CD3 zeta zeta with those of CD3 gamma epsilon and CD3 delta epsilon. Insertion of the transmembrane helices of TCR alpha beta into the barrel-like structure via both hydrophobic and ionic interactions results in transmembrane assembly of the TCR-CD3 complex. Together, our data reveal the structural basis for TCR-CD3 complex assembly, providing clues to TCR triggering and a foundation for rational design of immunotherapies that target the complex.	[Dong, De; Lin, Jianquan; Zhang, Bailing; Zhu, Yuwei; Xie, Shuangyu; Wang, Yuhang; Huang, Zhiwei] Harbin Inst Technol, Sch Life Sci & Technol, HIT Ctr Life Sci, Harbin, Heilongjiang, Peoples R China; [Zheng, Lvqin; Li, Ningning; Gao, Ning] Peking Univ, Sch Life Sci, Peking Tsinghua Ctr Life Sci, State Key Lab Membrane Biol, Beijing, Peoples R China; [Zheng, Lvqin] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China	Harbin Institute of Technology; Peking University; Peking University	Huang, ZW (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, HIT Ctr Life Sci, Harbin, Heilongjiang, Peoples R China.; Gao, N (corresponding author), Peking Univ, Sch Life Sci, Peking Tsinghua Ctr Life Sci, State Key Lab Membrane Biol, Beijing, Peoples R China.	gaon@pku.edu.cn; huangzhiwei@hit.edu.cn	Gao, Ning/J-9623-2012; Gao, Ning/AAK-2214-2020; Huang, Zhiwei/AAF-6846-2019; zhang, bailing/GZA-6966-2022	Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Li, Ningning/0000-0001-8601-5171	National Natural Science Foundation of China [31825008, 31422014, 31725007, 31630087, 31800630, 31700655]; Ministry of Science and Technology of China [2016YFA0500700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank the Core Facilities at School of Life Science and Technology of Harbin Institute of Technology and the Core Facilities of Peking University School of Life Sciences for assistance with negative-staining electron microscopy, and the cryo-EM platform of Peking University for help with cryo-EM data collection. The computation was supported by the High-performance Computing Platform of Peking University. We thank J. Chai for critical reading of the manuscript. This research was funded by the National Natural Science Foundation of China grant no. 31825008 and 31422014 to Z.H.; 31725007 and 31630087 to N.G.; 31800630 to Y.Z.; 31700655 to N.L. and the Ministry of Science and Technology of China (2016YFA0500700 to N.G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes RA, 2012, J BIOL CHEM, V287, P13324, DOI 10.1074/jbc.M111.332783; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Hogquist KA, 2016, J IMMUNOL, V197, P3429, DOI 10.4049/jimmunol.1601599; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Nours J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10570; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MEUER SC, 1983, NATURE, V303, P808, DOI 10.1038/303808a0; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395; Samelson L E, 1988, Ann N Y Acad Sci, V540, P1, DOI 10.1111/j.1749-6632.1988.tb27045.x; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	48	109	113	11	109	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					546	+		10.1038/s41586-019-1537-0	http://dx.doi.org/10.1038/s41586-019-1537-0			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31461748				2022-12-28	WOS:000488247600051
J	Bezginov, N; Valdez, T; Horbatsch, M; Marsman, A; Vutha, AC; Hessels, EA				Bezginov, N.; Valdez, T.; Horbatsch, M.; Marsman, A.; Vutha, A. C.; Hessels, E. A.			A measurement of the atomic hydrogen Lamb shift and the proton charge radius	SCIENCE			English	Article							SIZE	The surprising discrepancy between results from different methods for measuring the proton charge radius is referred to as the proton radius puzzle. In particular, measurements using electrons seem to lead to a different radius compared with those using muons. Here, a direct measurement of the n = 2 Lamb shift of atomic hydrogen is presented. Our measurement determines the proton radius to be r(p) = 0.833 femtometers, with an uncertainty of +/- 0.010 femtometers. This electron-based measurement of r(p) agrees with that obtained from the analogous muon-based Lamb shift measurement but is not consistent with the larger radius that was obtained from the averaging of previous electron-based measurements.	[Bezginov, N.; Valdez, T.; Horbatsch, M.; Marsman, A.; Hessels, E. A.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Vutha, A. C.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	York University - Canada; University of Toronto	Hessels, EA (corresponding author), York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada.	hessels@yorku.ca		Vutha, Amar/0000-0002-1250-2927; Horbatsch, Marko/0000-0002-6163-7502; Bezginov, Nikita/0000-0003-3999-464X; Marsman, Alain/0000-0001-8918-7382	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Research Fund; U.S. National Institute for Standards and Technology; York University; Canada Research Chair program; Compute Canada; Compute Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; U.S. National Institute for Standards and Technology; York University; Canada Research Chair program(Canada Research Chairs); Compute Canada; Compute Ontario	Funding for this work was provided by the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation, the Ontario Research Fund, the U.S. National Institute for Standards and Technology, the Canada Research Chair program, Compute Canada, Compute Ontario, and York University.	Antognini A, 2013, SCIENCE, V339, P417, DOI 10.1126/science.1230016; Bernauer JC, 2014, SCI AM, V310, P32, DOI 10.1038/scientificamerican0214-32; BETHE HA, 1947, PHYS REV, V72, P339, DOI 10.1103/PhysRev.72.339; Beyer A, 2017, SCIENCE, V358, P79, DOI 10.1126/science.aah6677; Bezginov N., 2019, HARVARD DATAVERSE, DOI [10.7910/DVN/MJ2RCO, DOI 10.7910/DVN/MJ2RCO]; Dirac PAM, 1928, P R SOC LOND A-CONTA, V117, P610, DOI 10.1098/rspa.1928.0023; Feurbaey H., 2018, PHYS REV LETT, V120; Fleurbaey H, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.183001; Horbatsch M, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.022513; Kato K, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.143002; Kemble EC, 1933, PHYS REV, V44, P1031, DOI 10.1103/PhysRev.44.1031.2; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; LUNDEEN SR, 1981, PHYS REV LETT, V46, P232, DOI 10.1103/PhysRevLett.46.232; Marsman A, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.012509; Marsman A, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.062111; Mohr PJ, 2016, J PHYS CHEM REF DATA, V45, DOI 10.1063/1.4954402; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Pohl R, 2013, ANNU REV NUCL PART S, V63, P175, DOI 10.1146/annurev-nucl-102212-170627; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; RAMSEY NF, 1949, PHYS REV, V76, P996, DOI 10.1103/PhysRev.76.996; Uehling EA, 1935, PHYS REV, V48, P55, DOI 10.1103/PhysRev.48.55; Vutha AC, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.052504	22	145	148	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1007	+		10.1126/science.aau7807	http://dx.doi.org/10.1126/science.aau7807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488684				2022-12-28	WOS:000484732700042
J	Pryor, R; Norvaisas, P; Marinos, G; Best, L; Thingholm, LB; Quintaneiro, LM; De Haes, W; Esser, D; Waschina, S; Lujan, C; Smith, RL; Scott, TA; Martinez-Martinez, D; Woodward, O; Bryson, K; Laudes, M; Lieb, W; Houtkooper, RH; Franke, A; Temmerman, L; Bjedov, I; Cocheme, HM; Kaleta, C; Cabreiro, F				Pryor, Rosina; Norvaisas, Povilas; Marinos, Georgios; Best, Lena; Thingholm, Louise B.; Quintaneiro, Leonor M.; De Haes, Wouter; Esser, Daniela; Waschina, Silvio; Lujan, Celia; Smith, Reuben L.; Scott, Timothy A.; Martinez-Martinez, Daniel; Woodward, Orla; Bryson, Kevin; Laudes, Matthias; Lieb, Wolfgang; Houtkooper, Riekelt H.; Franke, Andre; Temmerman, Liesbet; Bjedov, Ivana; Cocheme, Helena M.; Kaleta, Christoph; Cabreiro, Filipe			Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy	CELL			English	Article							HUMAN GUT MICROBIOME; C. ELEGANS; LIFE-SPAN; METABOLISM; EXPRESSION; COORDINATION; ALTERS; IMPACT	Metformin is the first-line therapy for treating type 2 diabetes and a promising anti-aging drug. We set out to address the fundamental question of how gut microbes and nutrition, key regulators of host physiology, affect the effects of metformin. Combining two tractable genetic models, the bacterium E. coli and the nematode C. elegans, we developed a high-throughput four-way screen to define the underlying host-microbe-drug-nutrient interactions. We show that microbes integrate cues from metformin and the diet through the phosphotransferase signaling pathway that converges on the transcriptional regulator Crp. A detailed experimental characterization of metformin effects downstream of Crp in combination with metabolic modeling of the microbiota in metformin-treated type 2 diabetic patients predicts the production of microbial agmatine, a regulator of metformin effects on host lipid metabolism and lifespan. Our high-throughput screening platform paves the way for identifying exploitable drug-nutrient-microbiome interactions to improve host health and longevity through targeted microbiome therapies.	[Pryor, Rosina; Quintaneiro, Leonor M.; Martinez-Martinez, Daniel; Cocheme, Helena M.; Cabreiro, Filipe] MRC London Inst Med Sci, Du Cane Rd, London W12 0NN, England; [Pryor, Rosina; Quintaneiro, Leonor M.; Martinez-Martinez, Daniel; Cocheme, Helena M.; Cabreiro, Filipe] Imperial Coll London, Inst Clin Sci, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England; [Pryor, Rosina; Norvaisas, Povilas; Quintaneiro, Leonor M.; Scott, Timothy A.; Woodward, Orla; Cabreiro, Filipe] Univ Coll London & Birkbeck, Inst Struct & Mol Biol, London WC1E 6BT, England; [Marinos, Georgios; Best, Lena; Esser, Daniela; Waschina, Silvio; Kaleta, Christoph] Univ Kiel, Inst Expt Med, D-24105 Kiel, Germany; [Thingholm, Louise B.; Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [De Haes, Wouter; Temmerman, Liesbet] Katholieke Univ Leuven, Dept Biol, Mol & Funct Neurobiol, B-3000 Leuven, Belgium; [Lujan, Celia; Bjedov, Ivana] UCL, UCL Canc Inst, London WC1E 6JD, England; [Smith, Reuben L.; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam UMC, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Bryson, Kevin] UCL, Dept Comp Sci, London WC1E 6BT, England; [Laudes, Matthias] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Campus Kiel, Kiel, Germany; [Lieb, Wolfgang] Christian Albrechts Univ Kiel, Inst Epidemiol, D-24105 Kiel, Germany	Imperial College London; University of London; Birkbeck University London; University College London; University of Kiel; University of Kiel; KU Leuven; University of London; University College London; University of Amsterdam; University of London; University College London; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Cabreiro, F (corresponding author), MRC London Inst Med Sci, Du Cane Rd, London W12 0NN, England.; Cabreiro, F (corresponding author), Imperial Coll London, Inst Clin Sci, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.; Cabreiro, F (corresponding author), Univ Coll London & Birkbeck, Inst Struct & Mol Biol, London WC1E 6BT, England.; Kaleta, C (corresponding author), Univ Kiel, Inst Expt Med, D-24105 Kiel, Germany.	c.kaleta@iem.uni-kiel.de; f.cabreiro@lms.mrc.ac.uk	Lieb, Wolfgang/AAC-7650-2022; Esser, Daniela/ABB-9383-2020; Houtkooper, Riekelt/P-5001-2019; Bryson, Kevin/AAZ-8177-2020; Waschina, Silvio/AAE-2908-2021; Franke, Andre/B-2151-2010	Waschina, Silvio/0000-0002-6290-3593; Franke, Andre/0000-0003-1530-5811; MARINOS, GEORGIOS/0000-0002-6443-7696; Houtkooper, Riekelt/0000-0001-9961-0842; Norvaisas, Povilas/0000-0003-4790-9820; Best, Lena/0000-0003-2772-153X; Bryson, Kevin/0000-0002-1163-6368; Bjedov, Ivana/0000-0001-5894-6016; Scott, Timothy/0000-0001-7042-8609; Martinez-Martinez, Daniel/0000-0001-8468-1357; Temmerman, Liesbet/0000-0002-1249-3995; Cocheme, Helena/0000-0001-8637-0042	Wellcome Trust/Royal Society [102531/Z/13/Z, 102531/Z/13/A]; German Research Foundation [CRC 1182, EXC306]; MRC [MC-A654-5QB90]; FWOFlanders; ERC [StG 311331, PoC 842174]; MRC [MC_UP_1605/6, MC_UP_1102/10] Funding Source: UKRI	Wellcome Trust/Royal Society; German Research Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FWOFlanders(FWO); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Worm strains were provided by the Caenorhabditis Genetics Center. F.C. acknowledges funding from the Wellcome Trust/Royal Society (102531/Z/13/Z and 102531/Z/13/A), C.K. from the German Research Foundation (CRC 1182 "Metaorganisms,'' Excellence Cluster "Inflammation at Interfaces [EXC306]), H.M.C. from the MRC (MC-A654-5QB90), W.D.H. and L.T. from FWOFlanders, and I.B. from ERC StG 311331 and ERC PoC 842174. Wethank Clara Essmann, Johannes Zimmermann, Ruwen Bohm, and Guido Laucke for technical advice; Kit-Yi Leung and Nicholas Greene for sharing unpublished data; Athanasios Typas, Jurg Bahler, and Irene Miguel-Aliaga for critical reading of the manuscript; and Andrew Osborne for editing the manuscript.	Ackerman D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002498; Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Bauer PV, 2018, CELL METAB, V27, P101, DOI 10.1016/j.cmet.2017.09.019; Brandstetter BR, 1999, ANN NUTR METAB, V43, P246, DOI 10.1159/000012791; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Cohn JS, 2010, NUTRIENTS, V2, P116, DOI 10.3390/nu2020116; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; DeCorby A, 2007, BBA-BIOENERGETICS, V1767, P1157, DOI 10.1016/j.bbabio.2007.07.003; Elmadfa I., 2015, ERNAHRUNG MENSCHEN, V5; Fischbach MA, 2018, CELL, V174, P785, DOI 10.1016/j.cell.2018.07.038; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Gao AW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02539-w; Garcia-Gonzalez AP, 2017, CELL, V169, P431, DOI 10.1016/j.cell.2017.03.046; Gelius-Dietrich G, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-125; Gonzalez PS, 2018, NATURE, V563, P719, DOI 10.1038/s41586-018-0729-3; Graspeuntner S, 2019, CLIN INFECT DIS, V69, P268, DOI 10.1093/cid/ciy882; Hilbert ZA, 2018, ELIFE, V7, DOI [10.7554/eLife.36547, 10.7554/elife.36547]; Ho CL, 2018, NAT BIOMED ENG, V2, P27, DOI 10.1038/s41551-017-0181-y; Hussey R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006806; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kiela PR, 2016, BEST PRACT RES CL GA, V30, P145, DOI 10.1016/j.bpg.2016.02.007; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kundu P, 2017, CELL, V171, P1481, DOI 10.1016/j.cell.2017.11.024; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma DK, 2012, NEURON, V73, P925, DOI 10.1016/j.neuron.2011.12.037; Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Muller N, 2015, J LIPID RES, V56, P1034, DOI 10.1194/jlr.P052209; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Piper MDW, 2014, NAT METHODS, V11, P100, DOI [10.1038/NMETH.2731, 10.1038/nmeth.2731]; Pryor R, 2015, BIOCHEM J, V471, P307, DOI 10.1042/BJ20150497; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Qi B, 2018, CELL, V175, P571, DOI 10.1016/j.cell.2018.07.032; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; SATISHCHANDRAN C, 1986, J BACTERIOL, V165, P843, DOI 10.1128/jb.165.3.843-848.1986; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scott TA, 2017, CELL, V169, P442, DOI 10.1016/j.cell.2017.03.040; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Sundin OH, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1059-6; Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu LF, 2016, CELL, V167, P1705, DOI 10.1016/j.cell.2016.11.055; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446; Zhang F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00485; Zimmermann J., 2019, BIORXIV, DOI [10.1101/554345, DOI 10.1101/554345]	58	115	122	8	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1299	+		10.1016/j.cell.2019.08.003	http://dx.doi.org/10.1016/j.cell.2019.08.003			43	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474368	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000483983000008
J	Stanley, SY; Borges, AL; Chen, KH; Swaney, DL; Krogan, NJ; Bondy-Denomy, J; Davidson, AR				Stanley, Sabrina Y.; Borges, Adair L.; Chen, Kuei-Ho; Swaney, Danielle L.; Krogan, Nevan J.; Bondy-Denomy, Joseph; Davidson, Alan R.			Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription	CELL			English	Article							STRUCTURAL BASIS; DNA; BACTERIOPHAGE; RNA; INHIBITION; EXPRESSION; GENES; INTERFERENCE; QUANTIFICATION; ACTIVATION	Phages express anti-CRISPR (Acr) proteins to inhibit CRISPR-Cas systems that would otherwise destroy their genomes. Most acr genes are located adjacent-to anti-CRISPR-associated (aca) genes, which encode proteins with a helix- turn- helix DNA- binding motif. The conservation of aca genes has served asa signpost for the identification of acr genes, but the function of the proteins encoded by these genes has not been investigated. Here we reveal that anacr- associated promoter drives high levels of acr transcription immediately after phage DNA injection and that Aca proteins subsequently repress this transcription.Without Aca activity, this strong transcription is lethal to a phage. Our results demonstrate how sufficient levels of Acr proteins accumulate early in the infection process to inhibit existing CRISPR-Cas-complexes in the host cell. They also imply that the conserved role of Aca proteins is to mitigate the deleterious effects of strong constitutive transcription from acr promoters.	[Stanley, Sabrina Y.; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Borges, Adair L.; Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Chen, Kuei-Ho; Swaney, Danielle L.; Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA; [Swaney, Danielle L.; Krogan, Nevan J.; Bondy-Denomy, Joseph] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Swaney, Danielle L.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Davidson, AR (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca	Chen, Kuei-Ho/AAC-8371-2019	Chen, Kuei-Ho/0000-0001-6541-0578; Borges, Adair/0000-0002-1477-7908	NIH [P50GM082250, U01MH115747, DP5-OD021344, R01GM127489]; Canadian Institutes of Health Research [MOP-130482, FDN-15427]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127489, P50GM082250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH115747] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Karen Maxwell, Emma Brownlie, Cayla Burk, and Veronique Taylor for useful comments on the manuscript. The authors would also like to thank Susan Kelso for help with the graphical abstract. This work was supported by NIH grants P50GM082250 and U01MH115747 (to N.J.K.) and DP5-OD021344 and R01GM127489 (to J.B.-D.) and by Canadian Institutes of Health Research grants MOP-130482 and FDN-15427 (to A.R.D.).	Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bair CL, 2007, J MOL BIOL, V366, P779, DOI 10.1016/j.jmb.2006.11.049; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Borges AL, 2018, CELL, V174, P917, DOI 10.1016/j.cell.2018.06.013; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Dong LY, 2019, NAT STRUCT MOL BIOL, V26, P308, DOI 10.1038/s41594-019-0206-1; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Greene AC, 2018, TRENDS BIOTECHNOL, V36, P127, DOI 10.1016/j.tibtech.2017.10.021; Grenha R, 2013, P NATL ACAD SCI USA, V110, P1047, DOI 10.1073/pnas.1213770110; Guo TW, 2017, CELL, V171, P414, DOI 10.1016/j.cell.2017.09.006; Hao N, 2017, TRANSCR-AUSTIN, V8, P120, DOI 10.1080/21541264.2017.1285851; Harrington LB, 2017, CELL, V170, P1224, DOI 10.1016/j.cell.2017.07.037; Hendrix RW, 1998, ADV VIRUS RES, V50, P235, DOI 10.1016/S0065-3527(08)60810-6; Hertveldt K., 2008, PSEUDOMONAS MODEL OR, P255; HONG YR, 1993, VIROLOGY, V194, P481, DOI 10.1006/viro.1993.1287; IIDA S, 1987, VIROLOGY, V157, P156, DOI 10.1016/0042-6822(87)90324-2; Juranek S, 2012, RNA, V18, P783, DOI 10.1261/rna.031468.111; Kamionka A, 2004, NUCLEIC ACIDS RES, V32, P842, DOI 10.1093/nar/gkh200; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Knott GJ, 2019, NAT STRUCT MOL BIOL, V26, P315, DOI 10.1038/s41594-019-0208-z; Landsberger M, 2018, CELL, V174, P908, DOI 10.1016/j.cell.2018.05.058; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LIU YC, 1993, J BIOL CHEM, V268, P23239; Luscombe NM, 2000, GENOME BIOL, V1; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marino ND, 2018, SCIENCE, V362, P240, DOI 10.1126/science.aau5174; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MARRS CF, 1990, VIROLOGY, V174, P192, DOI 10.1016/0042-6822(90)90068-3; NELSON HCM, 1985, CELL, V42, P549, DOI 10.1016/0092-8674(85)90112-6; OROSZ A, 1991, EUR J BIOCHEM, V201, P653, DOI 10.1111/j.1432-1033.1991.tb16326.x; Palmer AC, 2011, TRANSCR-AUSTIN, V2, P9, DOI 10.4161/trns.2.1.13511; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Park C, 2012, GENOME BIOL EVOL, V4, P523, DOI 10.1093/gbe/evs030; Pawluk A, 2017, MBIO, V8, DOI 10.1128/mBio.01751-17; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Piya D, 2017, MOL MICROBIOL, V105, P399, DOI 10.1111/mmi.13705; Pursey E, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006990; Quax TEF, 2013, J VIROL, V87, P8419, DOI 10.1128/JVI.01020-13; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Savalia D, 2010, J MOL BIOL, V402, P118, DOI 10.1016/j.jmb.2010.07.012; Scheirer KE, 2001, BIOCHIMIE, V83, P155, DOI 10.1016/S0300-9084(00)01215-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seo SW, 2013, METAB ENG, V15, P67, DOI 10.1016/j.ymben.2012.10.006; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Solovjev V, 2011, METAGENOMICITAPP, P61; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Young JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038077; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	72	55	58	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1452	+		10.1016/j.cell.2019.07.046	http://dx.doi.org/10.1016/j.cell.2019.07.046			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474367	Bronze, Green Accepted			2022-12-28	WOS:000483983000018
J	Tazawa, R; Ueda, T; Abe, M; Tatsumi, K; Eda, R; Kondoh, S; Morimoto, K; Tanaka, T; Yamaguchi, E; Takahashi, A; Oda, M; Ishii, H; Izumi, S; Sugiyama, H; Nakagawa, A; Tomii, K; Suzuki, M; Konno, S; Ohkouchi, S; Tode, N; Handa, T; Hirai, T; Inoue, Y; Arai, T; Asakawa, K; Sakagami, T; Hashimoto, A; Tanaka, T; Takada, T; Mikami, A; Kitamura, N; Nakata, K				Tazawa, Ryushi; Ueda, Takahiro; Abe, Mitsuhiro; Tatsumi, Koichiro; Eda, Ryosuke; Kondoh, Shotaro; Morimoto, Konosuke; Tanaka, Takeshi; Yamaguchi, Etsuro; Takahashi, Ayumu; Oda, Miku; Ishii, Haruyuki; Izumi, Shinyu; Sugiyama, Haruhito; Nakagawa, Atsushi; Tomii, Keisuke; Suzuki, Masaru; Konno, Satoshi; Ohkouchi, Shinya; Tode, Naoki; Handa, Tomohiro; Hirai, Toyohiro; Inoue, Yoshikazu; Arai, Toru; Asakawa, Katsuaki; Sakagami, Takuro; Hashimoto, Atsushi; Tanaka, Takahiro; Takada, Toshinori; Mikami, Ayako; Kitamura, Nobutaka; Nakata, Koh			Inhaled GM-CSF for Pulmonary Alveolar Proteinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; ANTIBODIES; AUTOANTIBODIES; EFFICACY; THERAPY; MICE	Background Pulmonary alveolar proteinosis is a disease characterized by abnormal accumulation of surfactant in the alveoli. Most cases are autoimmune and are associated with an autoantibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) that prevents clearing of pulmonary surfactant by alveolar macrophages. An open-label, phase 2 study showed some therapeutic efficacy of inhaled recombinant human GM-CSF in patients with severe pulmonary alveolar proteinosis; however, the efficacy in patients with mild-to-moderate disease remains unclear. Methods We conducted a double-blind, placebo-controlled trial of daily inhaled recombinant human GM-CSF (sargramostim), at a dose of 125 mu g twice daily for 7 days, every other week for 24 weeks, or placebo in 64 patients with autoimmune pulmonary alveolar proteinosis who had a partial pressure of arterial oxygen (Pao(2)) while breathing ambient air of less than 70 mm Hg (or <75 mm Hg in symptomatic patients). Patients with severe pulmonary alveolar proteinosis (Pao(2) <50 mm Hg) were excluded to avoid possible exacerbation of the disease in patients who were assigned to receive placebo. The primary end point was the change in the alveolar-arterial oxygen gradient between baseline and week 25. Results The change in the mean (+/- SD) alveolar-arterial oxygen gradient was significantly better in the GM-CSF group (33 patients) than in the placebo group (30 patients) (mean change from baseline, -4.50 +/- 9.03 mm Hg vs. 0.17 +/- 10.50 mm Hg; P=0.02). The change between baseline and week 25 in the density of the lung field on computed tomography was also better in the GM-CSF group (between-group difference, -36.08 Hounsfield units; 95% confidence interval, -61.58 to -6.99, calculated with the use of the Mann-Whitney U test and the Hodges-Lehmann estimate of confidence intervals for pseudo-medians). Serious adverse events developed in 6 patients in the GM-CSF group and in 3 patients in the placebo group. Conclusions In this randomized, controlled trial, inhaled recombinant human GM-CSF was associated with a modest salutary effect on the laboratory outcome of arterial oxygen tension, and no clinical benefits were noted.	[Tazawa, Ryushi; Ueda, Takahiro; Asakawa, Katsuaki; Sakagami, Takuro; Hashimoto, Atsushi; Tanaka, Takahiro; Takada, Toshinori; Kitamura, Nobutaka; Nakata, Koh] Niigata Univ Med & Dent Hosp, Niigata, Japan; [Abe, Mitsuhiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan; [Eda, Ryosuke; Kondoh, Shotaro] Kurashiki Municipal Hosp, Kurashiki, Okayama, Japan; [Morimoto, Konosuke; Tanaka, Takeshi] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan; [Yamaguchi, Etsuro; Takahashi, Ayumu] Aichi Med Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Nagakute, Aichi, Japan; [Oda, Miku; Ishii, Haruyuki] Kyorin Univ, Sch Med, Dept Resp Med, Mitaka, Tokyo, Japan; [Izumi, Shinyu; Sugiyama, Haruhito; Mikami, Ayako] Natl Ctr Global Hlth & Med, Ctr Hosp, Tokyo, Japan; [Nakagawa, Atsushi; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan; [Suzuki, Masaru; Konno, Satoshi] Hokkaido Univ, Fac Med, Dept Resp Med, Sapporo, Hokkaido, Japan; [Suzuki, Masaru; Konno, Satoshi] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ohkouchi, Shinya; Tode, Naoki] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi, Japan; [Ohkouchi, Shinya; Tode, Naoki] Tohoku Univ, Grad Sch Med, Dept Occupat Hlth, Sendai, Miyagi, Japan; [Handa, Tomohiro] Kyoto Univ, Grad Sch Med, Dept Adv Med Resp Failure, Kyoto, Japan; [Handa, Tomohiro; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Inoue, Yoshikazu; Arai, Toru] Natl Hosp Org Kinki Chuo Chest Med Ctr, Osaka, Japan	Niigata University; Chiba University; Nagasaki University; Aichi Medical University; Kyorin University; National Center for Global Health & Medicine - Japan; Kobe City Medical Center General Hospital; Hokkaido University; Hokkaido University; Tohoku University; Tohoku University; Kyoto University; Kyoto University	Nakata, K (corresponding author), Niigata Univ Med & Dent Hosp, Clin & Translat Res Ctr, 1-754 Asahimachi Dori, Niigata 9518520, Japan.	radical@med.niigata-u.ac.jp	Inoue, Yoshikazu/ABE-9772-2020; Suzuki, Masaru/H-2087-2012; Tanaka, Takahiro/GRF-0016-2022; Mikami, Ayako/AAT-2879-2021; Ohkouchi, Shinya/AEV-0334-2022; Yamaguchi, Etsuro/AAB-3923-2020; Tazawa, Ryushi/AAM-6915-2020	Suzuki, Masaru/0000-0002-2124-6793; Mikami, Ayako/0000-0001-8124-8216; Ohkouchi, Shinya/0000-0002-4658-6487; Tazawa, Ryushi/0000-0002-4580-004X; Kitamura, Nobutaka/0000-0001-6257-3144	Japan Agency for Medical Research and Development [#17ek0109079h and #17930161] Funding Source: Medline; Ministry of Health, Labour and Welfare [H24-Rinkensui-Ippan-003] Funding Source: Medline	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)		Beccaria M, 2004, EUR RESPIR J, V23, P526, DOI 10.1183/09031936.04.00102704; Coates AL, 2000, J AEROSOL MED, V13, P169, DOI 10.1089/jam.2000.13.169; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Inoue Y, 2008, AM J RESP CRIT CARE, V177, P752, DOI 10.1164/rccm.200708-1271OC; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; National Cancer Institute, 2006, COMM TERM CRIT ADV E; RAGNHAMMAR P, 1994, BLOOD, V84, P4078, DOI 10.1182/blood.V84.12.4078.bloodjournal84124078; Reed JA, 1999, AM J PHYSIOL-LUNG C, V276, pL556, DOI 10.1152/ajplung.1999.276.4.L556; Robinson TE, 2009, CHEST, V135, P842, DOI 10.1378/chest.08-1317; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Sakagami T, 2009, NEW ENGL J MED, V361, P2679, DOI 10.1056/NEJMc0904077; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Seymour JF, 2001, AM J RESP CRIT CARE, V163, P524, DOI 10.1164/ajrccm.163.2.2003146; Seymour JF, 1996, NEW ENGL J MED, V335, P1924, DOI 10.1056/NEJM199612193352513; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Tazawa R, 2005, AM J RESP CRIT CARE, V171, P1142, DOI 10.1164/rccm.200406-716OC; Tazawa R, 2010, AM J RESP CRIT CARE, V181, P1345, DOI 10.1164/rccm.200906-0978OC; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Uchida K, 2004, BLOOD, V103, P1089, DOI 10.1182/blood-2003-05-1565; Uchida K, 2014, J IMMUNOL METHODS, V402, P57, DOI 10.1016/j.jim.2013.11.011; Venkateshiah SB, 2006, CHEST, V130, P227, DOI 10.1378/chest.130.1.227; Wadhwa M, 1996, CLIN EXP IMMUNOL, V104, P351, DOI 10.1046/j.1365-2249.1996.11704.x; WASSERMA.K, 1968, AM J MED, V44, P611, DOI 10.1016/0002-9343(68)90062-4; Wylam ME, 2006, EUR RESPIR J, V27, P585, DOI 10.1183/09031936.06.00058305; Wylam ME, 2000, AM J RESP CRIT CARE, V161, pA889	28	49	54	6	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					923	932		10.1056/NEJMoa1816216	http://dx.doi.org/10.1056/NEJMoa1816216			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW9PR	31483963	Bronze			2022-12-28	WOS:000485326200007
J	Radonovich, LJ; Simberkoff, MS; Bessesen, MT; Brown, AC; Cummings, DAT; Gaydos, CA; Los, JG; Krosche, AE; Gibert, CL; Gorse, GJ; Nyquist, AC; Reich, NG; Rodriguez-Barradas, MC; Price, CS; Perl, TM; Getka, J; Hoang, T; Kajih, R; Krosche, A; Kubala, M; Los, J; Presser, L; Pulice, K; Spach, M; Simberkoff, MS; Akagbosu, C; Dansky, M; Frederick, BJ; Last, M; Laverie, S; Pike, C; Rikhi, S; Spector, N; Reel-Brander, CA; Price, C; Gorman, K; Irwin, A; O'Malley, S; Silva, K; Perl, TM; Raj, D; Bessesen, M; Adams, JC; Kingery, S; Tuder, S; Fritchman-Palmer, E; Nyquist, AC; Gorski, M; Gibert, C; Chopko, L; Haines, K; Langhorne, C; Silver, D; Southard, C; DeBakey, MC; Rodriguez-Barradas, MC; Kertz, B; Mushtaq, M; Vargas, B; Fisher, E; Shaffer, R; Radonovich, LJ; Eagan, A; Radonovich, LJ; Lipka, M; Tsang, M; Gaydos, C; Holden, J; Valsamakis, A; Gorse, GJ; Mitchell, M; Patel, GB; Yu, YY; Hackman, A; Sherman, M; Borgert, BA; Cummings, DAT; Rattigan, S; Brown, AC; Reich, NG; Lessler, J				Radonovich, Lewis J., Jr.; Simberkoff, Michael S.; Bessesen, Mary T.; Brown, Alexandria C.; Cummings, Derek A. T.; Gaydos, Charlotte A.; Los, Jenna G.; Krosche, Amanda E.; Gibert, Cynthia L.; Gorse, Geoffrey J.; Nyquist, Ann-Christine; Reich, Nicholas G.; Rodriguez-Barradas, Maria C.; Price, Connie Savor; Perl, Trish M.; Getka, Justin; Hoang, Tina; Kajih, Rose; Krosche, Amanda; Kubala, Meghan; Los, Jenna; Presser, Liandra; Pulice, Kathleen; Spach, Margaret; Simberkoff, Michael S.; Akagbosu, Cynthia; Dansky, Madeline; Frederick, Benedict J.; Last, Marilyn; Laverie, Scott; Pike, Courtney; Rikhi, Shefali; Spector, Nicole; Reel-Brander, Christine A.; Price, Connie; Gorman, Katie; Irwin, Amy; O'Malley, Sean; Silva, Kevin; Perl, Trish M.; Raj, Deepa; Bessesen, Mary; Adams, Jill C.; Kingery, Shannon; Tuder, Stefanie; Fritchman-Palmer, Erron; Nyquist, Ann-Christine; Gorski, Megan; Gibert, Cynthia; Chopko, Laura; Haines, Kathy; Langhorne, Caitlin; Silver, Dana; Southard, Courtney; DeBakey, Michael C.; Rodriguez-Barradas, Maria C.; Kertz, Barbara; Mushtaq, Mahwish; Vargas, Blanca; Fisher, Edward; Shaffer, Ronald; Radonovich, Lewis J.; Eagan, Aaron; Radonovich, Lewis J.; Lipka, Melanie; Tsang, Michael; Gaydos, Charlotte; Holden, Jeffrey; Valsamakis, Alexandra; Gorse, Geoffrey J.; Mitchell, Michelle; Patel, Gira B.; Yu, Yinyi; Hackman, Andre; Sherman, Michael; Borgert, Brooke A.; Cummings, Derek A. T.; Rattigan, Susan; Brown, Alexandria C.; Reich, Nicholas G.; Lessler, Justin		ResPECT Investigators	N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGICAL MASKS; WORKERS; INFECTION; VIRUS	IMPORTANCE Clinical studies have been inconclusive about the effectiveness of N95 respirators and medical masks in preventing health care personnel (HCP) from acquiring workplace viral respiratory infections. OBJECTIVE To compare the effect of N95 respirators vs medical masks for prevention of influenza and other viral respiratory infections among HCP. DESIGN, SETTING, AND PARTICIPANTS A cluster randomized pragmatic effectiveness study conducted at 137 outpatient study sites at 7 US medical centers between September 2011 and May 2015, with final follow-up in June 2016. Each year for 4 years, during the 12-week period of peak viral respiratory illness, pairs of outpatient sites (clusters) within each center were matched and randomly assigned to the N95 respirator or medical mask groups. INTERVENTIONS Overall, 1993 participants in 189 clusters were randomly assigned to wear N95 respirators (2512 HCP-seasons of observation) and 2058 in 191 clusters were randomly assigned to wear medical masks (2668 HCP-seasons) when near patients with respiratory illness. MAIN OUTCOMES AND MEASURES The primary outcome was the incidence of laboratory-confirmed influenza. Secondary outcomes included incidence of acute respiratory illness, laboratory-detected respiratory infections, laboratory-confirmed respiratory illness, and influenzalike illness. Adherence to interventions was assessed. RESULTS Among 2862 randomized participants (mean [SD] age, 43 [11.5] years; 2369 [82.8%]) women), 2371 completed the study and accounted for 5180 HCP-seasons. There were 207 laboratory-confirmed influenza infection events (8.2% of HCP-seasons) in the N95 respirator group and 193 (7.2% of HCP-seasons) in the medical mask group (difference, 1.0%, [95% CI,-0.5% to 2.5%]; P=.18) (adjusted odds ratio [OR], 1.18 [95% CI, 0.95-1.45]). There were 1556 acute respiratory illness events in the respirator group vs 1711 in the mask group (difference,-21.9 per 1000 HCP-seasons [95% CI,-48.2 to 4.4]; P=.10); 679 laboratory-detected respiratory infections in the respirator group vs 745 in the mask group (difference,-8.9 per 1000 HCP-seasons, [95% CI,-33.3 to 15.4]; P=.47); 371 laboratory-confirmed respiratory illness events in the respirator group vs 417 in the mask group (difference,-8.6 per 1000 HCP-seasons [95% CI,-28.2 to 10.9]; P=.39); and 128 influenzalike illness events in the respirator group vs 166 in the mask group (difference,-11.3 per 1000 HCP-seasons [95% CI,-23.8 to 1.3]; P=.08). In the respirator group, 89.4% of participants reported "always" or "sometimes" wearing their assigned devices vs 90.2% in the mask group. CONCLUSIONS AND RELEVANCE Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza.	[Radonovich, Lewis J., Jr.] Ctr Dis Control & Prevent, Natl Personal Protect Technol Lab, Natl Inst Occupat Safety & Hlth, Pittsburgh, PA 15236 USA; [Simberkoff, Michael S.] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Simberkoff, Michael S.] NYU, Sch Med, New York, NY USA; [Bessesen, Mary T.] Vet Affairs Eastern Colorado Healthcare Syst, Denver, CO USA; [Bessesen, Mary T.; Nyquist, Ann-Christine; Price, Connie Savor] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Alexandria C.; Reich, Nicholas G.] Univ Massachusetts, Amherst, MA 01003 USA; [Cummings, Derek A. T.] Univ Florida, Gainesville, FL USA; [Cummings, Derek A. T.; Perl, Trish M.] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA; [Gaydos, Charlotte A.; Los, Jenna G.; Krosche, Amanda E.] Johns Hopkins Sch Med, Baltimore, MD USA; [Krosche, Amanda E.] Weill Cornell Med, New York, NY USA; [Gibert, Cynthia L.] Vet Affairs Med Ctr, 50 Irving St NW, Washington, DC 20422 USA; [Gibert, Cynthia L.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Gorse, Geoffrey J.] Vet Affairs St Louis Healthcare Syst, St Louis, MO USA; [Gorse, Geoffrey J.] St Louis Univ, Sch Med, St Louis, MO USA; [Nyquist, Ann-Christine] Childrens Hosp Colorado, Aurora, CO USA; [Rodriguez-Barradas, Maria C.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Houston, TX 77030 USA; [Price, Connie Savor] Denver Hlth Med Ctr, Denver, CO USA; [Perl, Trish M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Perl, Trish M.; Getka, Justin; Hoang, Tina; Kajih, Rose; Krosche, Amanda; Kubala, Meghan; Los, Jenna; Presser, Liandra; Pulice, Kathleen; Spach, Margaret; ResPECT Investigators] Johns Hopkins Univ & Hlth Syst, Baltimore, MD USA; [Simberkoff, Michael S.; Akagbosu, Cynthia; Dansky, Madeline; Frederick, Benedict J.; Last, Marilyn; Laverie, Scott; Pike, Courtney; Rikhi, Shefali; Spector, Nicole; Reel-Brander, Christine A.] VA New York Harbor Healthcare Syst, New York, NY USA; [Price, Connie; Gorman, Katie; Irwin, Amy; O'Malley, Sean; Silva, Kevin] Denver Hlth & Hosp Author, Denver, CO USA; [Perl, Trish M.; Raj, Deepa] UT Southwestern Med Ctr, Dallas, TX USA; [Bessesen, Mary; Adams, Jill C.; Kingery, Shannon; Tuder, Stefanie; Fritchman-Palmer, Erron] VA Eastern Colorado Healthcare Syst, Aurora, CO USA; [Nyquist, Ann-Christine; Gorski, Megan] Childrens Hosp Colorado, Denver, CO USA; [Gibert, Cynthia; Chopko, Laura; Haines, Kathy; Langhorne, Caitlin; Silver, Dana; Southard, Courtney] VAWashington DC Med Ctr, Washington, DC USA; [Rodriguez-Barradas, Maria C.; Kertz, Barbara; Mushtaq, Mahwish; Vargas, Blanca] VA Michael C DeBakey Med Ctr, Houston, TX USA; [Fisher, Edward; Shaffer, Ronald; Radonovich, Lewis J.] Ctr Dis Control & Prevent, Natl Inst Occupat Safety & Hlth, Pittsburgh, PA USA; [Eagan, Aaron; Radonovich, Lewis J.] Vet Hlth Adm Off Publ Hlth, Gainesville, FL USA; [Lipka, Melanie; Tsang, Michael] HandyMetr Corp, Toronto, ON, Canada; [Tsang, Michael] Johns Hopkins Univ, Lab Core, Baltimore, MD USA; [Holden, Jeffrey; Valsamakis, Alexandra] VA St Louis Healthcare Syst, Lab Core, St Louis, MO USA; [Holden, Jeffrey; Valsamakis, Alexandra] St Louis Univ, Sch Med, St Louis, MO USA; [Hackman, Andre; Sherman, Michael] Johns Hopkins Univ, REDCap Core, Baltimore, MD USA; [Borgert, Brooke A.; Cummings, Derek A. T.] Univ Florida, Stat & Epidemiol Core, Gainesville, FL USA; [Brown, Alexandria C.; Reich, Nicholas G.] Univ Massachusetts, Amherst, MA 01003 USA; [Lessler, Justin] Johns Hopkins Univ, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); New York University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Massachusetts System; University of Massachusetts Amherst; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Cornell University; US Department of Veterans Affairs; Veterans Health Administration (VHA); George Washington University; Saint Louis University; Children's Hospital Colorado; Baylor College of Medicine; Baylor College of Medicine; Denver Health Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Medicine; Denver Health Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Colorado; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); US Department of Veterans Affairs; Veterans Health Administration (VHA); Johns Hopkins University; Saint Louis University; Johns Hopkins University; State University System of Florida; University of Florida; University of Massachusetts System; University of Massachusetts Amherst; Johns Hopkins University	Radonovich, LJ (corresponding author), Ctr Dis Control & Prevent, Natl Personal Protect Technol Lab, Natl Inst Occupat Safety & Hlth, Pittsburgh, PA 15236 USA.	mto5@cdc.gov	Gaydos, Charlotte A./E-9937-2010; Shaffer, Ronald/ABI-6508-2020	Shaffer, Ronald/0000-0001-6352-7967; Los, Jennifer/0000-0002-1714-1446	US Centers for Disease Control and Prevention, Veterans Health Administration; Biodefense Advanced Research and Development Agency	US Centers for Disease Control and Prevention, Veterans Health Administration; Biodefense Advanced Research and Development Agency	This trial was funded by the US Centers for Disease Control and Prevention, Veterans Health Administration, and the Biodefense Advanced Research and Development Agency.	[Anonymous], 2016, DET PART FILT EFF LE; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Centers for Disease Control and Prevention, 2009, INT REC FAC RESP US; Centers for Disease Control and Prevention, 2010, UPDATED GUIDANCE PRE; Chiu S, 2017, AM J INFECT CONTROL, V45, P1254, DOI 10.1016/j.ajic.2017.04.008; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Goins WP, 2011, INFECT DIS CLIN N AM, V25, P227, DOI 10.1016/j.idc.2010.11.010; Institute of Medicine, 2008, PREP INFL PAND PERS; Jacobs JL, 2009, AM J INFECT CONTROL, V37, P417, DOI 10.1016/j.ajic.2008.11.002; Janssen Larry, 2013, J Occup Environ Hyg, V10, pD97, DOI 10.1080/15459624.2013.799964; Lipp A, 2016, DISPOSABLE SURG FACE; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MacIntyre CR, 2013, AM J RESP CRIT CARE, V187, P960, DOI 10.1164/rccm.201207-1164OC; MacIntyre CR, 2017, INFLUENZA OTHER RESP, V11, P511, DOI 10.1111/irv.12474; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Offeddu V, 2017, CLIN INFECT DIS, V65, P1934, DOI 10.1093/cid/cix681; de la Tabla VO, 2010, J CLIN MICROBIOL, V48, P3492, DOI 10.1128/JCM.01105-10; Peterson K, 2015, AM J INFECT CONTROL, V43, P63, DOI 10.1016/j.ajic.2014.10.008; Radonovich LJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1494-2; Reich NG, 2015, CLIN INFECT DIS, V60, P499, DOI 10.1093/cid/ciu749; Rupp ME, 2009, LETT FEDERAL PPE GUI; Sartor C, 2002, INFECT CONT HOSP EP, V23, P615, DOI 10.1086/501981; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Smith JD, 2016, CAN MED ASSOC J, V188, P567, DOI 10.1503/cmaj.150835; Tang YW, 2013, J CLIN MICROBIOL, V51, P40, DOI 10.1128/JCM.01978-12; US Department of Labor, 1910, 134 OCC SAF HLTH ADM; World Health Organization, 2010, INF CONTR WEB	30	266	276	3	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					824	833		10.1001/jama.2019.11645	http://dx.doi.org/10.1001/jama.2019.11645			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479137	Green Published, Bronze			2022-12-28	WOS:000486437200012
J	Iacobucci, G				Iacobucci, Gareth			WHO updates guidance on hormonal contraceptive use for women at high HIV risk	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium, 2019, LANCET, V394, P303, DOI DOI 10.1016/S0140-6736(19)31288-7; IACOBUCCI G, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L4888; WHO, CONTR EL WOM HIGH RI	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2019	366								l5335	10.1136/bmj.l5335	http://dx.doi.org/10.1136/bmj.l5335			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9ID	31471284				2022-12-28	WOS:000483893700004
J	Van Meter, KJ; Van Cappellen, P; Basu, NB				Van Meter, K. J.; Van Cappellen, P.; Basu, N. B.			Response to Comment on "Legacy nitrogen may prevent achievement of water quality goals in the Gulf of Mexico"	SCIENCE			English	Editorial Material							MISSISSIPPI; HISTORY; HYPOXIA	Ballard et al. argue that our prediction of a 30-year or longer recovery time for Gulf of Mexico water quality is highly uncertain, and that much shorter time lags are equally likely. We demonstrate that their argument, based on the use of a two-component regression model, does not sufficiently consider fundamental watershed processes or multiple lines of evidence suggesting the existence of decadal-scale lags.	[Van Meter, K. J.] Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA; [Van Cappellen, P.; Basu, N. B.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada; [Van Cappellen, P.; Basu, N. B.] Univ Waterloo, Water Inst, Waterloo, ON N2L 3G1, Canada; [Van Cappellen, P.] Univ Waterloo, Ecohydrol Res Grp, Waterloo, ON N2L 3G1, Canada; [Basu, N. B.] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Waterloo; University of Waterloo; University of Waterloo; University of Waterloo	Basu, NB (corresponding author), Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada.; Basu, NB (corresponding author), Univ Waterloo, Water Inst, Waterloo, ON N2L 3G1, Canada.; Basu, NB (corresponding author), Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada.	nandita.basu@uwaterloo.ca	Van Cappellen, Philippe/A-2906-2013	Van Cappellen, Philippe/0000-0001-5476-0820; B. Basu, Nandidta/0000-0002-8867-8523; Van Meter, Kimberly/0000-0002-3698-7850				Ballard TC, 2019, SCIENCE, V365, DOI 10.1126/science.aau8401; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; Dubrovsky N. M., 2010, US GEOL SURV CIRC, V1350; Kirchner JW, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004362; McIsaac GF, 2016, J ENVIRON QUAL, V45, P1268, DOI 10.2134/jeq2015.10.0531; Murphy J., 2013, NITRATE MISSISSIPPI; Rabalais NN, 2007, ECOL APPL, V17, pS129, DOI 10.1890/06-0644.1; Rabalais NN, 2004, MAR POLLUT BULL, V49, P537, DOI 10.1016/j.marpolbul.2004.03.017; Seibert J, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000978; Turner RE, 2006, MAR POLLUT BULL, V52, P139, DOI 10.1016/j.marpolbul.2005.08.012; Turner RE, 2003, BIOSCIENCE, V53, P563, DOI 10.1641/0006-3568(2003)053[0563:LLAWQI]2.0.CO;2; Van Meter KJ, 2018, SCIENCE, V360, P427, DOI 10.1126/science.aar4462; Van Meter KJ, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7bf4; Van Meter KJ, 2017, GLOBAL BIOGEOCHEM CY, V31, P2, DOI 10.1002/2016GB005498; Van Meter KJ, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035014	15	4	4	4	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI				eaav3851	10.1126/science.aav3851	http://dx.doi.org/10.1126/science.aav3851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439763				2022-12-28	WOS:000482464000002
J	Read, SH; Wild, SH				Read, Stephanie H.; Wild, Sarah H.			Prevention of premature cardiovascular death worldwide	LANCET			English	Editorial Material							RISK-FACTORS; GLOBAL BURDEN; COUNTRIES; DISEASE		[Read, Stephanie H.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Wild, Sarah H.] Univ Edinburgh, Usher Inst, Edinburgh EH8 9AG, Midlothian, Scotland	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Edinburgh	Wild, SH (corresponding author), Univ Edinburgh, Usher Inst, Edinburgh EH8 9AG, Midlothian, Scotland.	sarah.wild@ed.ac.uk		Read, Stephanie H/0000-0002-2087-7358				[Anonymous], 2019, STEPWISE APPR SURV S; Appelman Y, 2015, ATHEROSCLEROSIS, V241, P211, DOI 10.1016/j.atherosclerosis.2015.01.027; Dicker D, 2018, LANCET, V392, P1684, DOI 10.1016/s0140-6736(18)31891-9; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Roth GA, 2014, AMERICAN; World Health Organization, 2017, FACT SHEET; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2020, LANCET, V395, P795, DOI 10.1016/S0140-6736(19)32008-2	9	12	12	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					758	760		10.1016/S0140-6736(19)32034-3	http://dx.doi.org/10.1016/S0140-6736(19)32034-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	31492506	Green Submitted			2022-12-28	WOS:000519536900007
J	Claassens, DMF; Vos, GJA; Bergmeijer, TO; Hermanides, RS; van 't Hof, AWJ; van der Harst, P; Barbato, E; Morisco, C; Gin, RMTJ; Asselbergs, FW; Mosterd, A; Herrman, JPR; Dewilde, WJM; Janssen, PWA; Kelder, JC; Postma, MJ; de Boer, A; Boersma, C; Deneer, VHM; ten Berg, JM				Claassens, Daniel M. F.; Vos, Gerrit J. A.; Bergmeijer, Thomas O.; Hermanides, Renicus S.; van 't Hof, Arnoud W. J.; van der Harst, Pim; Barbato, Emanuele; Morisco, Carmine; Gin, Richard M. Tjon Joe; Asselbergs, Folkert W.; Mosterd, Arend; Herrman, Jean-Paul R.; Dewilde, Willem J. M.; Janssen, Paul W. A.; Kelder, Johannes C.; Postma, Maarten J.; de Boer, Anthonius; Boersma, Cornelis; Deneer, Vera H. M.; ten Berg, Jurrien M.			A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; ST-SEGMENT ELEVATION; CYP2C19 GENOTYPE; STENT THROMBOSIS; OPEN-LABEL; CLOPIDOGREL; OUTCOMES; MULTICENTER	BackgroundIt is unknown whether patients undergoing primary percutaneous coronary intervention (PCI) benefit from genotype-guided selection of oral P2Y(12) inhibitors. MethodsWe conducted a randomized, open-label, assessor-blinded trial in which patients undergoing primary PCI with stent implantation were assigned in a 1:1 ratio to receive either a P2Y(12) inhibitor on the basis of early CYP2C19 genetic testing (genotype-guided group) or standard treatment with either ticagrelor or prasugrel (standard-treatment group) for 12 months. In the genotype-guided group, carriers of CYP2C19*2 or CYP2C19*3 loss-of-function alleles received ticagrelor or prasugrel, and noncarriers received clopidogrel. The two primary outcomes were net adverse clinical events - defined as death from any cause, myocardial infarction, definite stent thrombosis, stroke, or major bleeding defined according to Platelet Inhibition and Patient Outcomes (PLATO) criteria - at 12 months (primary combined outcome; tested for noninferiority, with a noninferiority margin of 2 percentage points for the absolute difference) and PLATO major or minor bleeding at 12 months (primary bleeding outcome). ResultsFor the primary analysis, 2488 patients were included: 1242 in the genotype-guided group and 1246 in the standard-treatment group. The primary combined outcome occurred in 63 patients (5.1%) in the genotype-guided group and in 73 patients (5.9%) in the standard-treatment group (absolute difference, -0.7 percentage points; 95% confidence interval [CI], -2.0 to 0.7; P<0.001 for noninferiority). The primary bleeding outcome occurred in 122 patients (9.8%) in the genotype-guided group and in 156 patients (12.5%) in the standard-treatment group (hazard ratio, 0.78; 95% CI, 0.61 to 0.98; P=0.04). ConclusionsIn patients undergoing primary PCI, a CYP2C19 genotype-guided strategy for selection of oral P2Y(12) inhibitor therapy was noninferior to standard treatment with ticagrelor or prasugrel at 12 months with respect to thrombotic events and resulted in a lower incidence of bleeding. (Funded by the Netherlands Organization for Health Research and Development; POPular Genetics ClinicalTrials.gov number, NCT01761786; Netherlands Trial Register number, NL2872.) Patients undergoing primary PCI were randomly assigned to either a genotype-guided strategy for selecting a P2Y(12) inhibitor or to standard treatment with ticagrelor or prasugrel. At 12 months, genotype-guided therapy was noninferior to standard treatment with respect to thrombotic events and resulted in a lower incidence of bleeding.	[Claassens, Daniel M. F.; Vos, Gerrit J. A.; Bergmeijer, Thomas O.; van der Harst, Pim; Kelder, Johannes C.; ten Berg, Jurrien M.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Hermanides, Renicus S.; van 't Hof, Arnoud W. J.] Isala Hosp, Dept Cardiol, Zwolle, Netherlands; [van 't Hof, Arnoud W. J.] Univ Med Ctr Maastricht, Dept Cardiol, Maastricht, Netherlands; [van 't Hof, Arnoud W. J.] Zuyderland Med Ctr, Dept Cardiol, Heerlen, Netherlands; [van der Harst, Pim; ten Berg, Jurrien M.] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Dept Pharm, Groningen, Netherlands; [Postma, Maarten J.; Boersma, Cornelis] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Unit Global Hlth, Groningen, Netherlands; [Gin, Richard M. Tjon Joe] Rijnstate Hosp, Dept Cardiol, Arnhem, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Deneer, Vera H. M.] Univ Med Ctr Utrecht, Dept Clin Pharm, Div Labs Pharm & Biomed Genet, Utrecht, Netherlands; [de Boer, Anthonius] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Mosterd, Arend] Meander Med Ctr, Dept Cardiol, Amersfoort, Netherlands; [Herrman, Jean-Paul R.] Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands; [Dewilde, Willem J. M.] Amphia Hosp, Dept Cardiol, Breda, Netherlands; [Barbato, Emanuele; Morisco, Carmine] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Barbato, Emanuele] Onze Lieve Vrouw Hosp, Cardiovasc Res Ctr, Aalst, Belgium; [Dewilde, Willem J. M.] Imelda Hosp, Dept Cardiol, Bonheiden, Belgium; [Asselbergs, Folkert W.] UCL, Inst Cardiovasc Sci, Fac Populat Hlth Sci, London, England; [Asselbergs, Folkert W.] UCL, Hlth Data Res UK, London, England; [Asselbergs, Folkert W.] UCL, Inst Hlth Informat, London, England	St. Antonius Hospital Utrecht; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; University of Groningen; University of Groningen; Rijnstate Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Meander Medisch Centrum; Onze Lieve Vrouwe Gasthuis Hospital; Amphia Hospital; University of Naples Federico II; Imeldaziekenhuis; University of London; University College London; University of London; University College London; University of London; University College London	ten Berg, JM (corresponding author), St Antonius Hosp, Koekoekslaan 1, NL-3435 CM Nieuwegein, Netherlands.	jurtenberg@gmail.com	Janssen, Paul/AIC-6947-2022; Asselbergs, Folkert W./ABD-6752-2021	Janssen, Paul/0000-0003-1976-1515; Asselbergs, Folkert W./0000-0002-1692-8669; Boersma, Cornelis/0000-0002-1190-2638; Postma, Maarten/0000-0002-6306-3653; van 't Hof, Arnoud/0000-0002-2344-7564; Bergmeijer, Thomas/0000-0002-7900-9926; Claassens, Daniel/0000-0001-6338-2569	Netherlands Organization for Health Research and Development	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	Funded by the Netherlands Organization for Health Research and Development	Bergmeijer TO, 2018, PHARMACOGENOMICS, V19, P621, DOI 10.2217/pgs-2018-0013; Bergmeijer TO, 2014, AM HEART J, V168, P16, DOI 10.1016/j.ahj.2014.03.006; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Byrne RA, 2015, EUR HEART J, V36, P3320, DOI 10.1093/eurheartj/ehv511; Cavallari LH, 2018, JACC-CARDIOVASC INTE, V11, P181, DOI 10.1016/j.jcin.2017.07.022; Cayla G, 2016, LANCET, V388, P2015, DOI 10.1016/S0140-6736(16)31323-X; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Cutlip DE, 2015, JACC-CARDIOVASC INTE, V8, P404, DOI 10.1016/j.jcin.2014.10.017; Czarny MJ, 2014, CLIN CARDIOL, V37, P505, DOI 10.1002/clc.22289; Genereux P, 2015, J AM COLL CARDIOL, V66, P1036, DOI 10.1016/j.jacc.2015.06.1323; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Harmsze AM, 2010, EUR HEART J, V31, P3046, DOI 10.1093/eurheartj/ehq321; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Janssen PWA, 2019, EUR J CLIN PHARMACOL, V75, P1201, DOI 10.1007/s00228-019-02696-z; Kedhi E, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3793; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394; Notarangelo FM, 2018, J AM COLL CARDIOL, V71, P1869, DOI 10.1016/j.jacc.2018.02.029; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Sanchez-Ramos J, 2016, INT J CARDIOL, V225, P289, DOI 10.1016/j.ijcard.2016.09.088; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2019, JACC CARDIOVASC INTE; Sibbing D, 2017, LANCET, V390, P1747, DOI 10.1016/S0140-6736(17)32155-4; Straub N, 2014, THROMB HAEMOSTASIS, V111, P290, DOI 10.1160/TH13-08-0679; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	33	277	287	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2019	381	17					1621	1631		10.1056/NEJMoa1907096	http://dx.doi.org/10.1056/NEJMoa1907096			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JK2QT	31479209	Green Published, Bronze			2022-12-28	WOS:000494692200006
J	Guo, M; Bottcher, F; Hertkorn, J; Schmidt, JN; Wenzel, M; Buchler, HP; Langen, T; Pfau, T				Guo, Mingyang; Boettcher, Fabian; Hertkorn, Jens; Schmidt, Jan-Niklas; Wenzel, Matthias; Buechler, Hans Peter; Langen, Tim; Pfau, Tilman			The low-energy Goldstone mode in a trapped dipolar supersolid	NATURE			English	Article							EXCITATIONS; HIGGS; BREAKING; PHASE; GAS	A supersolid is a counter-intuitive state of matter that combines the frictionless flow of a superfluid with the crystal-like periodic density modulation of a solid(1,2). Since the first prediction(3) in the 1950s, experimental efforts to realize this state have focused mainly on helium, in which supersolidity remains unobserved(4). Recently, supersolidity has also been studied in ultracold quantum gases, and some of its defining properties have been induced in spin-orbit-coupled Bose-Einstein condensates (BECs)(5,6) and BECs coupled to two crossed optical cavities(7,8). However, no propagating phonon modes have been observed in either system. Recently, two of the three hallmark properties of a supersolid-periodic density modulation and simultaneous global phase coherence-have been observed in arrays of dipolar quantum droplets(9-11), where the crystallization happens in a self-organized manner owing to intrinsic interactions. Here we directly observe the low-energy Goldstone mode, revealing the phase rigidity of the system and thus proving that these droplet arrays are truly supersolid. The dynamics of this mode is reminiscent of the effect of second sound in other superfluid systems(12,13) and features an out-of-phase oscillation of the crystal array and the superfluid density. This mode exists only as a result of the phase rigidity of the experimentally realized state, and therefore confirms the superfluidity of the supersolid.	[Guo, Mingyang; Boettcher, Fabian; Hertkorn, Jens; Schmidt, Jan-Niklas; Wenzel, Matthias; Langen, Tim; Pfau, Tilman] Univ Stuttgart, Phys Inst 5, Stuttgart, Germany; [Guo, Mingyang; Boettcher, Fabian; Schmidt, Jan-Niklas; Wenzel, Matthias; Buechler, Hans Peter; Langen, Tim; Pfau, Tilman] Ctr Integrated Quantum Sci & Technol, Stuttgart, Germany; [Buechler, Hans Peter] Univ Stuttgart, Inst Theoret Phys 3, Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Pfau, T (corresponding author), Univ Stuttgart, Phys Inst 5, Stuttgart, Germany.; Pfau, T (corresponding author), Ctr Integrated Quantum Sci & Technol, Stuttgart, Germany.	t.pfau@physik.uni-stuttgart.de	Langen, Tim/I-6357-2012; Pfau, Tilman/G-1774-2011; Büchler, Hans Peter/M-6543-2018; Guo, Mingyang/AAA-5528-2021	Langen, Tim/0000-0003-2561-0326; Pfau, Tilman/0000-0003-3272-3468; Büchler, Hans Peter/0000-0002-7233-6828; Guo, Mingyang/0000-0001-8800-2876	German Research Foundation (DFG) [FOR2247, Pf381/16-1, Bu2247/1, Pf381/20-1, FUGG INST41/1056-1]; EU within Horizon2020 Marie Sklodowska Curie IF [746525 coolDips]	German Research Foundation (DFG)(German Research Foundation (DFG)); EU within Horizon2020 Marie Sklodowska Curie IF	We acknowledge discussions with the groups of F. Ferlaino, G. Modugno, L. Santos and T. Pohl, as well as with A. Pelster and A. Balaz. This work is supported by the German Research Foundation (DFG) within FOR2247 under Pf381/16-1 and Bu2247/1, Pf381/20-1 and FUGG INST41/1056-1. T.L. acknowledges support from the EU within Horizon2020 Marie Sklodowska Curie IF (grant numbers 746525 coolDips).	ANDERSON PW, 1958, PHYS REV, V112, P1900, DOI 10.1103/PhysRev.112.1900; Atkins K. R., 1959, LIQUID HELIUM; Baillie D, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.195301; Baumann K, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.020701; Behrle A, 2018, NAT PHYS, V14, P781, DOI 10.1038/s41567-018-0128-6; Bersano TM, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.051602; Bissbort U, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.205303; Blakie PB, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033602; Bottcher F, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.011051; Boninsegni M, 2012, REV MOD PHYS, V84, P759, DOI 10.1103/RevModPhys.84.759; Bottcher F., 2019, PREPRINT; Brunello A, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.063614; Chan MHW, 2013, J LOW TEMP PHYS, V172, P317, DOI 10.1007/s10909-013-0882-x; Chomaz L, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021012; Chomaz L, 2018, NAT PHYS, V14, P442, DOI 10.1038/s41567-018-0054-7; Endres M, 2012, NATURE, V487, P454, DOI 10.1038/nature11255; Ferrier-Barbut I, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.011604; Ferrier-Barbut I, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/21/214004; Ferrier-Barbut I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.215301; GOLDSTONE J, 1961, NUOVO CIMENTO, V19, P154, DOI 10.1007/BF02812722; Griffin A., 1993, EXCITATIONS BOSE CON, V4; GROSS EP, 1957, PHYS REV, V106, P161, DOI 10.1103/PhysRev.106.161; HIGGS PW, 1964, PHYS REV LETT, V13, P508, DOI 10.1103/PhysRevLett.13.508; Hoinka S, 2017, NAT PHYS, V13, P943, DOI 10.1038/NPHYS4187; Kadau H, 2016, NATURE, V530, P194, DOI 10.1038/nature16485; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Leonard J, 2017, SCIENCE, V358, P1415, DOI 10.1126/science.aan2608; Leonard J, 2017, NATURE, V543, P87, DOI 10.1038/nature21067; Li JR, 2017, NATURE, V543, P91, DOI 10.1038/nature21431; LITTLEWOOD PB, 1981, PHYS REV LETT, V47, P811, DOI 10.1103/PhysRevLett.47.811; Macri T, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.061602; NAMBU Y, 1961, PHYS REV, V124, P246, DOI 10.1103/PhysRev.124.246; Natale G, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.050402; Petter D, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.183401; Roccuzzo SM, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.041601; Ronen S, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.013623; Ruegg C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205701; Saccani S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.175301; Santos L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.250403; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; SOORYAKUMAR R, 1980, PHYS REV LETT, V45, P660, DOI 10.1103/PhysRevLett.45.660; Stamper-Kurn DM, 1999, PHYS REV LETT, V83, P2876, DOI 10.1103/PhysRevLett.83.2876; Tang Y, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.155301; Tang YJ, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021030; Tang YJ, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.022703; Tanzi L, 2019, NATURE, V574, P382, DOI 10.1038/s41586-019-1568-6; Tanzi L, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.130405; Wenzel M, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.053630; Wilson RM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.094501; YARNELL JL, 1958, PHYS REV LETT, V1, P9, DOI 10.1103/PhysRevLett.1.9	50	87	88	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2019	574	7778					386	+		10.1038/s41586-019-1569-5	http://dx.doi.org/10.1038/s41586-019-1569-5			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JE9DI	31499511	Green Submitted			2022-12-28	WOS:000490988300061
J	Vranckx, P; Valgimigli, M; Eckardt, L; Tijssen, J; Lewalter, T; Gargiulo, G; Batushkin, V; Campo, G; Lysak, Z; Vakaliuk, I; Milewski, K; Laeis, P; Reimitz, PE; Smolnik, R; Zierhut, W; Goette, A				Vranckx, Pascal; Valgimigli, Marco; Eckardt, Lars; Tijssen, Jan; Lewalter, Thorsten; Gargiulo, Giuseppe; Batushkin, Valerii; Campo, Gianluca; Lysak, Zoreslava; Vakaliuk, Igor; Milewski, Krzysztof; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Ruediger; Zierhut, Wolfgang; Goette, Andreas			Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial	LANCET			English	Article							DUAL ANTIPLATELET THERAPY; CLINICAL-TRIALS; 4-PART SERIES; WARFARIN; INTERVENTION; DEFINITIONS; STATISTICS; EFFICACY; ASPIRIN; EVENTS	Background We aimed to assess the safety of edoxaban in combination with P2Y12 inhibition in patients with atrial fibrillation who had percutaneous coronary intervention (PCI). Methods ENTRUST-AF PCI was a randomised, multicentre, open-label, non-inferiority phase 3b trial with masked outcome evaluation, done at 186 sites in 18 countries. Patients had atrial fibrillation requiring oral anticoagulation, were aged at least 18 years, and had a successful PCI for stable coronary artery disease or acute coronary syndrome. Participants were randomly assigned (1:1) from 4 h to 5 days after PCI using concealed, stratified, and blocked web-based central randomisation to either edoxaban (60 mg once daily) plus a P2Y12 inhibitor for 12 months or a vitamin K antagonist (VKA) in combination with a P2Y12 inhibitor and aspirin (100 mg once daily, for 1-12 months). The edoxaban dose was reduced to 30 mg per day if one or more factors (creatinine clearance 15-50 mL/min, bodyweight <= 60 kg, or concomitant use of specified potent P-glycoprotein inhibitors) were present. The primary endpoint was a composite of major or clinically relevant non-major (CRNM) bleeding within 12 months. The primary analysis was done in the intention-to-treat population and safety was assessed in all patients who received at least one dose of their assigned study drug. This trial is registered with ClinicalTrials.gov, NCT02866175, is closed to new participants, and follow-up is completed. Findings From Feb 24, 2017, through May 7, 2018, 1506 patients were enrolled and randomly assigned to the edoxaban regimen (n=751) or VKA regimen (n=755). Median time from PCI to randomisation was 45.1 h (IQR 22.2-76.2). Major or CRNM bleeding events occurred in 128 (17%) of 751 patients (annualised event rate 20.7%) with the edoxaban regimen and 152 (20%) of 755 patients (annualised event rate 25.6%) patients with the VKA regimen; hazard ratio 0.83 (95% CI 0.65-1.05; p=0.0010 for non-inferiority, margin hazard ratio 1.20; p=0.1154 for superiority). Interpretation In patients with atrial fibrillation who had PCI, the edoxaban-based regimen was non-inferior for bleeding compared with the VKA-based regimen, without significant differences in ischaemic events. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Vranckx, Pascal] Hasselt Univ, Fac Med & Life Sci, Dept Cardiol & Intens Care, Jessa Ziekenhuis, Hasselt, Belgium; [Valgimigli, Marco; Gargiulo, Giuseppe] Univ Bern, Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland; [Eckardt, Lars; Lewalter, Thorsten; Goette, Andreas] Atrial Fibrillat Network, Munster, Germany; [Eckardt, Lars] Univ Munster, Div Electrophysiol, Dept Cardiol & Angiol, Munster, Germany; [Tijssen, Jan] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Tijssen, Jan] Cardialysis, Rotterdam, Netherlands; [Lewalter, Thorsten] Hosp Munich South, Dept Cardiol, Munich, Germany; [Lewalter, Thorsten] Univ Bonn, Bonn, Germany; [Gargiulo, Giuseppe] Federico II Univ Naples, Dept Adv Biomed Sci, Naples, Italy; [Batushkin, Valerii] Kyiv City Clin Hosp 5, Dept Cardiol, Kiev, Ukraine; [Campo, Gianluca] Azienda Osped Univ Ferrara, Cardiovasc Inst, Venice, Italy; [Campo, Gianluca] Maria Cecilia Hosp, GVM Care & Res, Cotignola, Italy; [Lysak, Zoreslava] Oleksandrivska Kyiv City Clin Hosp, Dept Cardiac Rehabil, Kiev, Ukraine; [Milewski, Krzysztof] Amer Heart Poland Katowice, Ctr Cardiovascular Res & Dev, Katowice, Poland; [Milewski, Krzysztof] Jerzy Kukuczka Acad Phys Educ, Fac Physiotherapy, Katowice, Poland; [Vakaliuk, Igor] Ivano Frankivsk Natl Med Univ, Dept Internal Med & Nursing 2, Ivano Frankivsk, Ukraine; [Vakaliuk, Igor] Ivano Frankivsk Reg Clin Cardiol Clin, Dept Anesthesiol, Wards Intens Care, Ivano Frankivsk, Ukraine; [Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Ruediger; Zierhut, Wolfgang] Daiichi Sankyo Europe, Munich, Germany; [Goette, Andreas] St Vincenz Hosp, Cardiol & Intens Care Med, Paderborn, Germany; [Goette, Andreas] Univ Hosp Magdeburg, Working Grp Mol Electrophysiol, Magdeburg, Germany	Hasselt University; University of Bern; University Hospital of Bern; University of Munster; University of Amsterdam; Cardialysis; University of Bonn; University of Naples Federico II; University of Ferrara; Arcispedale Sant'Anna; Maria Cecilia Hospital; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; Ivano-Frankivsk National Medical University; Daiichi Sankyo Company Limited; University Hospital Magdeburg	Vranckx, P (corresponding author), Hasselt Univ, Fac Med & Life Sci, Dept Cardiol & Intens Care, Jessa Ziekenhuis, Hasselt, Belgium.; Goette, A (corresponding author), St Vincenz Hosp, Cardiol & Intens Care Med, Paderborn, Germany.	pascal.vranckx@jessazh.be; andreas.goette@vincenz.de	Gargiulo, Giuseppe/AAC-2356-2022; GARGIULO, Giuseppe/AAC-2336-2022; Valgimigli, Marco/AAE-9103-2019	GARGIULO, Giuseppe/0000-0003-4395-6742; Valgimigli, Marco/0000-0002-4353-7110; Campo, Gianluca/0000-0002-5150-188X	Daiichi Sankyo Pharma Development; Daiichi Sankyo Europe; Daiichi Sankyo	Daiichi Sankyo Pharma Development(Daiichi Sankyo Company Limited); Daiichi Sankyo Europe(Daiichi Sankyo Company Limited); Daiichi Sankyo(Daiichi Sankyo Company Limited)	The ENTRUST-AF PCI study was sponsored and funded by Daiichi Sankyo Pharma Development and Daiichi Sankyo Europe. All authors verified the data and vouch for the completeness of the data, the accuracy of the analyses, and the fidelity of the trial to the protocol. Editorial support for linguistic editing was provided by Kathleen Pieper, PhD, of AlphaBioCom, LLC, and funded by Daiichi Sankyo.	BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Capodanno D, 2019, J AM COLL CARDIOL, V74, P83, DOI 10.1016/j.jacc.2019.05.016; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Essebag V, 2019, INT J CARDIOL, V288, P87, DOI 10.1016/j.ijcard.2019.04.066; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Giusti B, 2010, LANCET, V376, P1278, DOI 10.1016/S0140-6736(10)61313-X; Goette A, 2018, EUROPACE, V20, P1936, DOI 10.1093/europace/euy141; Goette A, 2016, LANCET, V388, P1995, DOI 10.1016/S0140-6736(16)31474-X; Hahn JY, 2019, JAMA-J AM MED ASSOC, V321, P2428, DOI 10.1001/jama.2019.8146; Hahn JY, 2018, LANCET, V391, P1274, DOI 10.1016/S0140-6736(18)30493-8; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lemesle G, 2019, CIRCULATION, V139, P617, DOI 10.1161/CIRCULATIONAHA.118.037440; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394; Parasrampuria DA, 2016, CLIN PHARMACOKINET, V55, P641, DOI 10.1007/s40262-015-0342-7; Pocock SJ, 2015, J AM COLL CARDIOL, V66, P2886, DOI 10.1016/j.jacc.2015.10.051; Pocock SJ, 2015, J AM COLL CARDIOL, V66, P2648, DOI 10.1016/j.jacc.2015.10.023; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Vranckx P, 2018, AM HEART J, V196, P105, DOI 10.1016/j.ahj.2017.10.009; Wiviott SD, 2015, LANCET, V386, P292, DOI 10.1016/S0140-6736(15)60213-6	27	337	343	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1335	1343		10.1016/S0140-6736(19)31872-0	http://dx.doi.org/10.1016/S0140-6736(19)31872-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC9RJ	31492505				2022-12-28	WOS:000489613700028
J	Schmidt, E; Kasperkiewicz, M; Joly, P				Schmidt, Enno; Kasperkiewicz, Michael; Joly, Pascal			Pemphigus	LANCET			English	Review							CHRONIC BULLOUS DISEASE; QUALITY-OF-LIFE; PARANEOPLASTIC PEMPHIGUS; ENDEMIC PEMPHIGUS; DESMOGLEIN 3; ANTI-DESMOGLEIN; INTRAVENOUS IMMUNOGLOBULIN; IGG AUTOANTIBODIES; PROGNOSTIC-FACTORS; ADJUVANT THERAPY	Pemphigus consists of a group of rare and severe autoimmune blistering diseases mediated by pathogenic autoantibodies mainly directed against two desmosomal adhesion proteins, desmoglein (Dsg) 1 and Dsg3 (also known as DG1 and DG3), which are present in the skin and surface-close mucosae. The binding of autoantibodies to Dsg proteins induces a separation of neighbouring keratinocytes, in a process known as acantholysis. The two main pemphigus variants are pemphigus vulgaris, which often originates with painful oral erosions, and pemphigus foliaceus, which is characterised by exclusive skin lesions. Pemphigus is diagnosed on the basis of either IgG or complement component 3 deposits (or both) at the keratinocyte cell membrane, detected by direct immunofluorescence microscopy of a perilesional biopsy, with serum anti-Dsg1 or anti-Dsg3 antibodies (or both) detected by ELISA. Corticosteroids are the therapeutic mainstay, which have recently been complemented by the anti-CD20 antibody rituximab in moderate and severe disease. Rituximab induces complete remission off therapy in 90% of patients, despite rapid tapering of corticosteroids, thus allowing for a major corticosteroid-sparing effect and a halved number of adverse events related to corticosteroids.	[Schmidt, Enno] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Schmidt, Enno] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany; [Kasperkiewicz, Michael] Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA USA; [Joly, Pascal] Rouen Univ Hosp, Dept Dermatol, Rouen, France; [Joly, Pascal] Normandy Univ, French Reference Ctr Autoimmune Bullous Dis, INSERM Unit 2345, Rouen, France	University of Lubeck; University of Lubeck; University of Southern California; CHU de Rouen	Schmidt, E (corresponding author), Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	enno.schmidt@uksh.de			German Research Foundation under Germany's Excellence Strategy [EXC 2167]	German Research Foundation under Germany's Excellence Strategy	This Seminar is dedicated to Marcel F Jonkman, Groningen, Netherlands, who contributed enormously to the field of research on pemphigus and who passed away at the height of his career after a short and severe illness. We miss his vast clinical knowledge, sharp intellect, clear concepts, and strong beliefs in scientific discussions. This work was supported by the German Research Foundation under Germany's Excellence Strategy (grant number EXC 2167). We acknowledge researchers who have contributed to this field whose work was not cited directly but through review articles because of space limitation. We thank Stephanie Goletz, Florian Heck, Sabrina Tofern, and Marina Kongsbak-Reim for their help with the immunofluorescence and histopathological photographs, and Carolin Mahlerwein for the graphical design of figure 2.	Abreu-Velez AM, 2003, J AM ACAD DERMATOL, V49, P599, DOI 10.1067/S0190-9622(03)00851-X; Ahmed AR, 2016, EXP DERMATOL, V25, P839, DOI 10.1111/exd.13106; Ahmed AR, 2015, NEW ENGL J MED, V373, P2693, DOI 10.1056/NEJMc1508234; Ahmed AR, 2015, AUTOIMMUN REV, V14, P323, DOI 10.1016/j.autrev.2014.12.002; Ahmed AR, 2006, NEW ENGL J MED, V355, P1772, DOI 10.1056/NEJMoa062930; AHMED AR, 1993, J EXP MED, V177, P419, DOI 10.1084/jem.177.2.419; Almugairen N, 2013, J AM ACAD DERMATOL, V69, P583, DOI 10.1016/j.jaad.2013.05.016; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 2000, J CLIN INVEST, V105, P625, DOI 10.1172/JCI8748; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Amagai M, 2014, J DERMATOL, V41, P471, DOI 10.1111/1346-8138.12486; Amagai M, 2009, J AM ACAD DERMATOL, V60, P595, DOI 10.1016/j.jaad.2008.09.052; Amber KT, 2018, DRUGS, V78, P1527, DOI 10.1007/s40265-018-0976-5; Amber KT, 2018, AUTOIMMUN REV, V17, P1002, DOI 10.1016/j.autrev.2018.04.008; Amber KT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01190; ANHALT GJ, 1990, NEW ENGL J MED, V323, P1729, DOI 10.1056/NEJM199012203232503; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Anstey A, 2015, BRIT J DERMATOL, V173, pE23, DOI 10.1111/bjd.14162; Aoki V, 2015, J DERMATOL, V42, P18, DOI 10.1111/1346-8138.12675; Atzmony L, 2015, J AM ACAD DERMATOL, V73, P264, DOI 10.1016/j.jaad.2015.04.038; Baykal C, 2002, J AM ACAD DERMATOL, V47, P875, DOI 10.1067/mjd.2002.121359; Behzad M, 2012, BRIT J DERMATOL, V166, P844, DOI 10.1111/j.1365-2133.2011.10732.x; Boulard C, 2016, BRIT J DERMATOL, V175, P142, DOI 10.1111/bjd.14405; Brandsen R, 1997, J AM ACAD DERMATOL, V36, P44, DOI 10.1016/S0190-9622(97)70324-4; Bystryn JC, 1996, ARCH DERMATOL, V132, P203, DOI 10.1001/archderm.132.2.203; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chen YM, 2015, J BIOL CHEM, V290, P23826, DOI 10.1074/jbc.M115.668061; Colliou N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005166; Czernik A, 2012, AUTOIMMUNITY, V45, P111, DOI 10.3109/08916934.2011.606452; Daneshpazhooh M, 2016, J AM ACAD DERMATOL, V74, P1160, DOI 10.1016/j.jaad.2015.10.051; Daneshpazhooh M, 2016, J DTSCH DERMATOL GES, V14, P166, DOI 10.1111/ddg.12738; DANIEL BS, 2019, J AM ACAD DERMATOL, DOI DOI 10.1016/J.JAAD.2018.02.021; De D, 2019, BRIT J DERMATOL, V180, P662, DOI 10.1111/bjd.17136; Maehara LDN, 2018, BRIT J DERMATOL, V178, pE212, DOI 10.1111/bjd.16022; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; DIAZ LA, 1989, J INVEST DERMATOL, V92, P4, DOI 10.1111/1523-1747.ep13070394; Diercks GFH, 2009, BRIT J DERMATOL, V160, P460, DOI 10.1111/j.1365-2133.2008.08971.x; Dubash AD, 2011, CURR BIOL, V21, pR529, DOI 10.1016/j.cub.2011.04.035; Ellebrecht CT, 2016, SCIENCE, V353, P179, DOI 10.1126/science.aaf6756; Eming R, 2014, J IMMUNOL, V193, P4391, DOI 10.4049/jimmunol.1401081; EYRE RW, 1987, J EXP MED, V165, P1719, DOI 10.1084/jem.165.6.1719; EYRE RW, 1988, J CLIN INVEST, V81, P807, DOI 10.1172/JCI113387; FARB RM, 1978, P NATL ACAD SCI USA, V75, P459, DOI 10.1073/pnas.75.1.459; Futei Y, 2000, J INVEST DERMATOL, V115, P829, DOI 10.1046/j.1523-1747.2000.00137.x; Gao JP, 2018, J INVEST DERMATOL, V138, P2307, DOI 10.1016/j.jid.2018.05.011; Hahn-Ristic K, 2002, J EUR ACAD DERMATOL, V16, P68, DOI 10.1046/j.1468-3083.2002.00384.x; Harman KE, 2017, BRIT J DERMATOL, V177, P1170, DOI 10.1111/bjd.15930; Harman KE, 2001, BRIT J DERMATOL, V144, P775, DOI 10.1046/j.1365-2133.2001.04132.x; HASHIMOTO T, 1990, J INVEST DERMATOL, V94, P327, DOI 10.1111/1523-1747.ep12874456; Hata T, 2013, J IMMUNOL, V191, P83, DOI 10.4049/jimmunol.1203536; Hebert V, 2019, J INVEST DERMATOL, V139, P31, DOI 10.1016/j.jid.2018.04.042; Herbst A, 2000, J AM ACAD DERMATOL, V42, P422, DOI 10.1016/S0190-9622(00)90213-5; Hertl M, 2006, J CLIN INVEST, V116, P1159, DOI 10.1172/JCI28547; Hertl M, 2015, J EUR ACAD DERMATOL, V29, P405, DOI 10.1111/jdv.12772; Hofrichter M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01935; Hsu DY, 2016, BRIT J DERMATOL, V174, P1290, DOI 10.1111/bjd.14463; Huang YH, 2012, J INVEST DERMATOL, V132, P92, DOI 10.1038/jid.2011.249; Hubner F, 2016, J INVEST DERMATOL, V136, P2495, DOI 10.1016/j.jid.2016.07.013; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Ishii N, 2015, BRIT J DERMATOL, V173, P59, DOI 10.1111/bjd.13711; Jelti L, 2019, J INVEST DERMATOL, V139, P469, DOI 10.1016/j.jid.2018.07.042; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Joly P, 2000, J AM ACAD DERMATOL, V43, P619, DOI 10.1067/mjd.2000.107488; JOLY P, 1994, J INVEST DERMATOL, V103, P65, DOI 10.1111/1523-1747.ep12389680; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Joly P, 2017, LANCET, V389, P2031, DOI 10.1016/S0140-6736(17)30070-3; Kardos M, 2009, OBSTET GYNECOL SURV, V64, P739, DOI 10.1097/OGX.0b013e3181bea089; Kasperkiewicz M, 2012, BRIT J DERMATOL, V166, P154, DOI 10.1111/j.1365-2133.2011.10585.x; Kasperkiewicz M, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.26; KOCH PJ, 1990, EUR J CELL BIOL, V53, P1; KORMAN NJ, 1989, NEW ENGL J MED, V321, P631, DOI 10.1056/NEJM198909073211002; Kridin K, 2018, J AM ACAD DERMATOL, V78, P1084, DOI 10.1016/j.jaad.2017.11.039; Kridin K, 2018, IMMUNOL RES, V66, P255, DOI 10.1007/s12026-018-8986-7; Kridin K, 2017, ACTA DERM-VENEREOL, V97, P607, DOI 10.2340/00015555-2611; Kumar S, 2017, BRIT J DERMATOL, V177, P1583, DOI 10.1111/bjd.15658; Kushner CJ, 2018, AM J CLIN DERMATOL, V19, P391, DOI 10.1007/s40257-018-0342-0; Lai O, 2018, J EUR ACAD DERMATOL, V32, P1256, DOI 10.1111/jdv.14886; Lakshmi MJD, 2017, J AM ACAD DERMATOL, V76, P895, DOI 10.1016/j.jaad.2016.11.039; Langan SM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a180; Langenhan J, 2014, EXP DERMATOL, V23, P253, DOI 10.1111/exd.12355; Leger S, 2012, ARCH DERMATOL, V148, P1165, DOI 10.1001/archdermatol.2012.1830; Leshem YA, 2017, J AM ACAD DERMATOL, V77, P256, DOI 10.1016/j.jaad.2017.01.059; Li N, 2003, J EXP MED, V197, P1501, DOI 10.1084/jem.20022031; Li S, 2018, IMMUNOL INVEST, V47, P101, DOI 10.1080/08820139.2017.1385622; Liu Q, 2008, BRIT J DERMATOL, V158, P587, DOI 10.1111/j.1365-2133.2007.08361.x; Lotti R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00370; Mahmoud A, 2012, J LARYNGOL OTOL, V126, P1041, DOI 10.1017/S0022215112001375; Martin LK, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006263.pub2; Mimouni D, 2002, BRIT J DERMATOL, V147, P725, DOI 10.1046/j.1365-2133.2002.04992.x; Mindorf S, 2017, EXP DERMATOL, V26, P1267, DOI 10.1111/exd.13409; Mintz EM, 2011, DERMATOL CLIN, V29, P699, DOI 10.1016/j.det.2011.08.013; Mintz EM, 2011, DERMATOL CLIN, V29, P459, DOI 10.1016/j.det.2011.03.022; Morell-Dubois S, 2008, DERMATOLOGY, V216, P104, DOI 10.1159/000111506; MORINI JP, 1993, ARCH DERMATOL, V129, P69, DOI 10.1001/archderm.129.1.69; Muller R, 2009, CLIN EXP DERMATOL, V34, P898, DOI 10.1111/j.1365-2230.2009.03241.x; Murrell DE, 2008, J AM ACAD DERMATOL, V58, P1043, DOI 10.1016/j.jaad.2008.01.012; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; Nikolskaia OV, 2003, BRIT J DERMATOL, V149, P1143, DOI 10.1111/j.1365-2133.2003.05659.x; Nousari HC, 1999, NEW ENGL J MED, V340, P1406, DOI 10.1056/NEJM199905063401805; Oktarina DAM, 2012, ARCH DERMATOL, V148, P1173, DOI 10.1001/archdermatol.2012.1896; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Goncalves GAP, 2011, AN BRAS DERMATOL, V86, P1109, DOI 10.1590/S0365-05962011000600007; Pollmann R, 2018, CLIN REV ALLERG IMMU, V54, P1, DOI 10.1007/s12016-017-8662-z; Poot AM, 2013, BRIT J DERMATOL, V169, P1016, DOI 10.1111/bjd.12479; Probst C, 2009, CLIN CHIM ACTA, V410, P13, DOI 10.1016/j.cca.2009.08.022; Qian Y, 2012, J IMMUNOL, V189, P1535, DOI 10.4049/jimmunol.1200842; Rafei D, 2011, AM J PATHOL, V178, P718, DOI 10.1016/j.ajpath.2010.10.016; Rencz F, 2015, BRIT J DERMATOL, V173, P1076, DOI 10.1111/bjd.13848; ROCK B, 1990, J CLIN INVEST, V85, P296, DOI 10.1172/JCI114426; Saha M, 2014, BRIT J DERMATOL, V170, P116, DOI 10.1111/bjd.12630; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Sarig O, 2012, J INVEST DERMATOL, V132, P1798, DOI 10.1038/jid.2012.46; Schmidt E, 2015, BLISTERING DIS, P251; Schmidt E, 2015, J DTSCH DERMATOL GES, V13, P713, DOI [10.1111/ddg.40_12612, 10.1111/ddg.12612]; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Schmidt E, 2010, EXP DERMATOL, V19, P458, DOI 10.1111/j.1600-0625.2010.01069.x; Schmidt E, 2009, ANN NY ACAD SCI, V1173, P683, DOI 10.1111/j.1749-6632.2009.04744.x; Schulze F, 2015, J INVEST DERMATOL, V135, P1445, DOI 10.1038/jid.2014.547; Schulze K, 2012, J INVEST DERMATOL, V132, P346, DOI 10.1038/jid.2011.299; Sebaratnam DF, 2013, JAMA DERMATOL, V149, P1186, DOI 10.1001/jamadermatol.2013.4972; Sokol E, 2015, J INVEST DERMATOL, V135, P1763, DOI 10.1038/jid.2015.109; Spindler V, 2018, J INVEST DERMATOL, V138, P32, DOI 10.1016/j.jid.2017.06.022; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Takahashi H, 2011, J CLIN INVEST, V121, P3677, DOI 10.1172/JCI57379; Tsuchisaka A, 2016, J INVEST DERMATOL, V136, P399, DOI 10.1038/JID.2015.408; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; van Beek N, HARPERS TXB PEDIAT D, P868; van Beek N, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-49; Vodo D, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00226; Wang HH, 2015, ACTA DERM-VENEREOL, V95, P928, DOI 10.2340/00015555-2116; Wang LC, 2004, LANCET, V363, P525, DOI 10.1016/S0140-6736(04)15539-6; Wang R, 2015, BRIT J DERMATOL, V172, P968, DOI 10.1111/bjd.13525; Warren SJP, 2000, NEW ENGL J MED, V343, P23, DOI 10.1056/NEJM200007063430104; Waschke J, 2014, MED RES REV, V34, P1127, DOI 10.1002/med.21310; WOLF R, 1991, DERMATOLOGICA, V182, P207, DOI 10.1159/000247795; Wormser D, 2017, J AM ACAD DERMATOL, V77, P379, DOI 10.1016/j.jaad.2017.04.1116; Wu H, 2000, NEW ENGL J MED, V343, P31, DOI 10.1056/NEJM200007063430105; Yan L, 2012, BRIT J DERMATOL, V167, P768, DOI 10.1111/j.1365-2133.2012.11040.x; Zaraa I, 2011, J EUR ACAD DERMATOL, V25, P1160, DOI 10.1111/j.1468-3083.2010.03939.x; Zhang SY, 2019, BRIT J DERMATOL, V180, P828, DOI 10.1111/bjd.17191; Zhao CY, 2016, PEDIATR DERMATOL, V33, P367, DOI 10.1111/pde.12859; Zimmermann J, 2010, J DTSCH DERMATOL GES, V8, P598, DOI 10.1111/j.1610-0387.2010.07380.x	146	165	171	4	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2019	394	10201					882	894		10.1016/S0140-6736(19)31778-7	http://dx.doi.org/10.1016/S0140-6736(19)31778-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IV0US	31498102				2022-12-28	WOS:000483994700031
J	Tackerman, ME				Tackerman, Mark E.			Machine learning transforms how microstates are sampled	SCIENCE			English	Editorial Material							FREE-ENERGY; MOLECULAR-DYNAMICS; EFFICIENT		[Tackerman, Mark E.] NYU, Dept Chem, New York, NY 10003 USA; [Tackerman, Mark E.] NYU, Courant Inst Math Sci, 251 Mercer St, New York, NY 10003 USA; [Tackerman, Mark E.] NYU Shanghai, NYU ECNU Ctr Computat Chem, Shanghai 200062, Peoples R China	New York University; New York University; NYU Shanghai	Tackerman, ME (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.; Tackerman, ME (corresponding author), NYU, Courant Inst Math Sci, 251 Mercer St, New York, NY 10003 USA.; Tackerman, ME (corresponding author), NYU Shanghai, NYU ECNU Ctr Computat Chem, Shanghai 200062, Peoples R China.	mark.tuckerman@nyu.edu			NSFgrant [CHE-1565980]	NSFgrant(National Science Foundation (NSF))	Supported by NSFgrant CHE-1565980.	Abrams JB, 2008, J PHYS CHEM B, V112, P15742, DOI 10.1021/jp805039u; Chen M, 2015, P NATL ACAD SCI USA, V112, P3235, DOI 10.1073/pnas.1418241112; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Maragliano L, 2006, CHEM PHYS LETT, V426, P168, DOI 10.1016/j.cplett.2006.05.062; Minary P, 2008, SIAM J SCI COMPUT, V30, P2055, DOI 10.1137/070686706; Noe F, 2019, SCIENCE, V365, P1001, DOI 10.1126/science.aaw1147; Rosso L, 2002, J CHEM PHYS, V116, P4389, DOI 10.1063/1.1448491; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Zhang J, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.010601; Zhu ZW, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.100201	13	8	8	9	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					982	983		10.1126/science.aay2568	http://dx.doi.org/10.1126/science.aay2568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488674				2022-12-28	WOS:000484732700028
J	Bhella, D				Bhella, David			Overcoming the Challenges of Symmetry Reveals New Insights into Herpesvirus Biology	CELL			English	Editorial Material							SIMPLEX-VIRUS	The oncogenic gammaherpesvirus Kaposi sarcoma-associated herpesvirus (KSHV) is globally widespread; infection rates are as high as 80% in parts of sub-Saharan Africa. In this issue of Cell, Gong et al. (2019) describe the high-resolution structure of a critical component of the KSHV virion-the portal vertex.	[Bhella, David] Univ Glasgow, MRC, Ctr Virus Res, Sir Michael Stoker Bldg,Garscube Campus, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow	Bhella, D (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Sir Michael Stoker Bldg,Garscube Campus, Glasgow G61 1QH, Lanark, Scotland.	david.bhella@glasgow.ac.uk	Bhella, David/J-8514-2012	Bhella, David/0000-0003-2096-8310	Medical Research Council [MC_ UU_ 12014/7]; MRC [MC_UU_12014/7, MC_UU_12014/6, MC_UP_A550_1029] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.B.'s salary is funded by the Medical Research Council (MC_ UU_ 12014/7).	Cardone G, 2007, VIROLOGY, V361, P426, DOI 10.1016/j.virol.2006.10.047; Dai XH, 2018, SCIENCE, V360, P47, DOI 10.1126/science.aao7298; Gong DY, 2019, CELL, V178, P1329, DOI 10.1016/j.cell.2019.07.035; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; Liu YT, 2019, NATURE, V570, P257, DOI 10.1038/s41586-019-1248-6; McElwee M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006191; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Rochat RH, 2011, J VIROL, V85, P1871, DOI 10.1128/JVI.01663-10; Schmid MF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002961; Yu XK, 2017, SCIENCE, V356, DOI 10.1126/science.aam6892	10	1	1	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1277	1279		10.1016/j.cell.2019.08.017	http://dx.doi.org/10.1016/j.cell.2019.08.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474369	Bronze			2022-12-28	WOS:000483983000003
J	Garrido-Abad, P; Garcia-Martin, L				Garrido-Abad, Pablo; Garcia-Martin, Luis			Vocal Cord Metastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 49-year-old man presented with voice changes and pain with swallowing. Fiberoptic laryngoscopy revealed a laryngeal lesion. Biopsy and imaging were performed, and a diagnosis of metastatic renal-cell carcinoma was made.	[Garrido-Abad, Pablo; Garcia-Martin, Luis] Hosp Univ Henares, Coslada, Spain		Garrido-Abad, P (corresponding author), Hosp Univ Henares, Coslada, Spain.	pgabad@hotmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					E18	E18		10.1056/NEJMicm1815495	http://dx.doi.org/10.1056/NEJMicm1815495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IW9PR	31483968				2022-12-28	WOS:000485326200001
J	Hagan, T; Cortese, M; Rouphael, N; Boudreau, C; Linde, C; Maddur, MS; Das, J; Wang, H; Guthmiller, J; Zheng, NY; Huang, M; Uphadhyay, AA; Gardinassi, L; Petitdemange, C; McCullough, MP; Johnson, SJ; Gill, K; Cervasi, B; Zou, J; Bretin, A; Hahn, M; Gewirtz, AT; Bosinger, SE; Wilson, PC; Li, SZ; Alter, G; Khurana, S; Golding, H; Pulendran, B				Hagan, Thomas; Cortese, Mario; Rouphael, Nadine; Boudreau, Carolyn; Linde, Caitlin; Maddur, Mohan S.; Das, Jishnu; Wang, Hong; Guthmiller, Jenna; Zheng, Nai-Ying; Huang, Min; Uphadhyay, Amit A.; Gardinassi, Luiz; Petitdemange, Caroline; McCullough, Michele Paine; Johnson, Sara Jo; Gill, Kiran; Cervasi, Barbara; Zou, Jun; Bretin, Alexis; Hahn, Megan; Gewirtz, Andrew T.; Bosinger, Steve E.; Wilson, Patrick C.; Li, Shuzhao; Alter, Galit; Khurana, Surender; Golding, Hana; Pulendran, Bali			Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; BILE-ACIDS; MONOCLONAL-ANTIBODIES; SEASONAL INFLUENZA; RECEPTOR; SYSTEMS; VACCINATION; ACTIVATION; INHIBITION; EXPRESSION	Emerging evidence indicates a central role for the microbiome in immunity. However, causal evidence in humans is sparse. Here, we administered broad-spectrum antibiotics to healthy adults prior and subsequent to seasonal influenza vaccination. Despite a 10,000-fold reduction in gut bacterial load and long-lasting diminution in bacterial diversity, antibody responses were not significantly affected. However, in a second trial of subjects with low pre-existing antibody titers, there was significant impairment in H1N1-specific neutralization and binding IgG1 and IgA responses. In addition, in both studies antibiotics treatment resulted in (1) enhanced inflammatory signatures (including AP-1/NR4A expression), observed previously in the elderly, and increased dendritic cell activation; (2) divergent metabolic trajectories, with a 1,000-fold reduction in serum secondary bile acids, which was highly correlated with AP-1/NR4A signaling and inflammasome activation. Multiomics integration revealed significant associations between bacterial species and metabolic phenotypes, highlighting a key role for the microbiome in modulating human immunity.	[Hagan, Thomas; Cortese, Mario; Pulendran, Bali] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Rouphael, Nadine; McCullough, Michele Paine; Johnson, Sara Jo] Emory Vaccine Ctr, Hope Clin, Decatur, GA 30030 USA; [Boudreau, Carolyn; Linde, Caitlin; Das, Jishnu; Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Maddur, Mohan S.; Wang, Hong; Uphadhyay, Amit A.; Petitdemange, Caroline; Gill, Kiran; Cervasi, Barbara; Bosinger, Steve E.] Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Guthmiller, Jenna; Zheng, Nai-Ying; Huang, Min; Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Knapp Ctr Lupus & Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Gardinassi, Luiz; Li, Shuzhao] Emory Univ, Dept Med, Atlanta, GA 30303 USA; [Zou, Jun; Bretin, Alexis; Gewirtz, Andrew T.] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Hahn, Megan; Khurana, Surender; Golding, Hana] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Pulendran, Bali] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Pulendran, Bali] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Maddur, Mohan S.] Pfizer Inc, Pearl River, NY 10965 USA; [Gardinassi, Luiz] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, BR-14040 Ribeirao Preto, SP, Brazil; [Petitdemange, Caroline] Inst Pasteur, HIV Inflammat & Persistence Unit, F-75015 Paris, France	Stanford University; Emory University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Emory University; University of Chicago; Emory University; University System of Georgia; Georgia State University; US Food & Drug Administration (FDA); Stanford University; Stanford University; Pfizer; Universidade de Sao Paulo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pulendran, B (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	bpulend@stanford.edu	Das, Jishnu/AAK-4950-2020; Gardinassi, Luiz/V-2225-2019; Pulendran, Bali/AAW-9550-2021; Upadhyay, Amit/R-5056-2019; Wilson, Patrick/HGC-3157-2022; ZOU, JUN/AAD-3904-2019	Das, Jishnu/0000-0002-5747-064X; Gardinassi, Luiz/0000-0002-9027-2688; Upadhyay, Amit/0000-0002-0952-4164; Pulendran, Bali/0000-0001-6517-4333; Boudreau, Carolyn/0000-0001-5006-3067; Li, Shuzhao/0000-0002-7386-2539	Emory-UGA CEIRS Contract [HHSN272201400004C]; NIH [HIPC U19AI090023, U19AI057266, UH2AI132345, U24AI120134, T32AI07290]; Sean Parker Cancer Institute; Soffer endowment; Violetta Horton endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, U19AI057266, UH2AI132345, R37AI048638, U24AI120134, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER	Emory-UGA CEIRS Contract; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sean Parker Cancer Institute; Soffer endowment; Violetta Horton endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to the Hope Clinic staff who assisted with the clinical work, particularly Mary Bower, Eileen Osinski, and Briyana Domjahn. We would also like to thank Luisa Chan, Kathryn Iverson, and Second Genome for their work in generation and analysis of the microbiome data; Lily Chen and Creative Proteomics for measurement of bile acids by LC-MS; Dmitri Kazmin for data management and curation; Chris Ibegbu and the Emory Immunology/Flow Cytometry Core for technical assistance; Amber N. Wohlabaugh for library preparation and sequencing; Mark Mulligan and Aneesh Mehta for advice about the clinical study design; and Mark Davis, Rafi Ahmed, David Relman, Justin Sonneburg, and Taia Wang for helpful discussion. This work was supported by Emory-UGA CEIRS Contract HHSN272201400004C (to B.P. and principal investigator Walt Orenstein), NIH grants HIPC U19AI090023 (to B.P.), U19AI057266 (to B.P. and principal investigator Rafi Ahmed), UH2AI132345 (to S.L.), U24AI120134 (S.E.B.), T32AI07290 (to T.H.), the Sean Parker Cancer Institute, the Soffer endowment (B.P.), and the Violetta Horton endowment (B.P.).	Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Bakke D, 2018, INFLAMM BOWEL DIS, V24, P1149, DOI 10.1093/ibd/izy092; Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; FRASCA D, 2013, AGEING, V10, DOI DOI 10.1186/1742-4933-10-14; Frommherz L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153959; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gardinassi LG, 2018, REDOX BIOL, V17, P158, DOI 10.1016/j.redox.2018.04.011; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Hagan T, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028894; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Khurana S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11296-5; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Klatt NR, 2017, SCIENCE, V356, P938, DOI 10.1126/science.aai9383; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Levy M, 2017, CURR OPIN MICROBIOL, V35, P8, DOI 10.1016/j.mib.2016.10.003; Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Littman DR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029355; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mitre E, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.0315; Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Pavlidis P, 2015, ALIMENT PHARM THER, V42, P802, DOI 10.1111/apt.13333; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Rampelli S, 2013, AGING-US, V5, P902, DOI 10.18632/aging.100623; Rappuoli R, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029256; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Salazar N, 2017, GUT MICROBES, V8, P82, DOI 10.1080/19490976.2016.1256525; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt N, 2013, IMMUNITY, V39, P629, DOI 10.1016/j.immuni.2013.09.011; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinclair C, 2017, SCIENCE, V357, P1014, DOI 10.1126/science.aaj2155; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Steinhoff U, 2005, IMMUNOL LETT, V99, P12, DOI 10.1016/j.imlet.2004.12.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Voelker T, 2013, BIOANALYSIS, V5, P1229, DOI [10.4155/BIO.13.94, 10.4155/bio.13.94]; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu TW, 2009, BIOINFORMATICS, V25, P1930, DOI 10.1093/bioinformatics/btp291; Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918	81	239	245	16	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1313	+		10.1016/j.cell.2019.08.010	http://dx.doi.org/10.1016/j.cell.2019.08.010			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491384	Green Accepted, Bronze			2022-12-28	WOS:000483983000009
J	Lasso, G; Mayer, SV; Winkelmann, ER; Chu, T; Elliot, O; Patino-Galindo, JA; Park, K; Rabadan, R; Honig, B; Shapira, SD				Lasso, Gorka; Mayer, Sandra V.; Winkelmann, Evandro R.; Chu, Tim; Elliot, Oliver; Patino-Galindo, Juan Angel; Park, Kernyu; Rabadan, Raul; Honig, Barry; Shapira, Sagi D.			A Structure-Informed Atlas of Human-Virus Interactions	CELL			English	Article							CELL NUCLEAR ANTIGEN; EPSTEIN-BARR-VIRUS; PROTEIN-PROTEIN INTERACTIONS; INTEGRATED APPROACH; BINDING-PROTEINS; DNA-REPLICATION; GENE ONTOLOGY; EBOLA-VIRUS; EXPRESSION; E7	While knowledge of protein-protein interactions (PPIs) is critical for understanding virus-host relationships, limitations on the scalability of high-throughput methods have hampered their identification beyond a number of well-studied viruses. Here, we implement an in silico computational framework (pathogen host interactome prediction using structure similarity [P-HIPSTer]) that employs structural information to predict similar to 282,000 pan viral-human PPIs with an experimental validation rate of similar to 76%. In addition to rediscovering known biology, P-HIPSTer has yielded a series of new findings: the discovery of shared and unique machinery employed across human-infecting viruses, a likely role for ZIKV-ESR1 interactions in modulating viral replication, the identification of PPIs that discriminate between human papilloma viruses (HPVs) with high and low oncogenic potential, and a structure-enabled history of evolutionary selective pressure imposed on the human proteome. Further, P-HIPSTer enables discovery of previously unappreciated cellular circuits that act on human-infecting viruses and provides insight into experimentally intractable viruses.	[Lasso, Gorka; Mayer, Sandra V.; Winkelmann, Evandro R.; Chu, Tim; Elliot, Oliver; Patino-Galindo, Juan Angel; Rabadan, Raul; Honig, Barry; Shapira, Sagi D.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Lasso, Gorka; Mayer, Sandra V.; Winkelmann, Evandro R.; Shapira, Sagi D.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA; [Park, Kernyu; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY USA; [Honig, Barry] Columbia Univ, Zuckerman Mind Brain Behav Inst, Med Ctr, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Honig, B; Shapira, SD (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA.; Shapira, SD (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10032 USA.; Honig, B (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.; Honig, B (corresponding author), Columbia Univ, Zuckerman Mind Brain Behav Inst, Med Ctr, New York, NY 10032 USA.; Honig, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, Med Ctr, New York, NY 10032 USA.	bh6@columbia.edu; ss4197@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Cabrera, Gorka Lasso/ABD-1962-2020; Lasso, Gorka/GYV-3393-2022	Cabrera, Gorka Lasso/0000-0001-5355-323X; Honig, Barry/0000-0002-1835-1031; Shapira, Sagi/0000-0002-5425-3682; Rabadan, Raul/0000-0001-7946-9255	NIH [5R01GM109018-05, 5U54CA209997-03, 5R01GM030518-38, 5R01GM117591, S10OD012351, S10OD021764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109018, R01GM030518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Jose Ignacio Garzon and Donald Petrey for their technical support. This work was funded by NIH grants 5R01GM109018-05 and 5U54CA209997-03 to S.D.S., 5R01GM030518-38 to B.H., 5R01GM117591 to R.R., and equipment grants S10OD012351 and S10OD021764 to the Department of Systems Biology.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Artaza-Irigaray C, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0125-x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Batra J, 2018, CELL, V175, P1917, DOI 10.1016/j.cell.2018.08.044; Belinky F, 2015, DATABASE, V2015, DOI [10.1093/database/bav006, DOI 10.1093/DATABASE/BAV006]; Ben-Ari Fuchs S, 2016, OMICS, V20, P139, DOI 10.1089/omi.2015.0168; Berg M, 1997, J VIROL, V71, P3853, DOI 10.1128/JVI.71.5.3853-3863.1997; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Branca M, 2007, EUR J OBSTET GYN R B, V130, P223, DOI 10.1016/j.ejogrb.2006.10.007; Budhu A, 2007, CARCINOGENESIS, V28, P1552, DOI 10.1093/carcin/bgm075; Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Butt AQ, 2014, J BIOL CHEM, V289, P25474, DOI 10.1074/jbc.A112.367490; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Chen G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-249; Chen SJ, 2014, AM J PHYSIOL-GASTR L, V306, pG394, DOI 10.1152/ajpgi.00328.2013; Chen TS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004248; Chen YF, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006762; Chojnacki M, 2018, NUCLEIC ACIDS RES, V46, P229, DOI 10.1093/nar/gkx1103; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Chassey B, 2013, EMBO REP, V14, P938, DOI 10.1038/embor.2013.130; DietrichGoetz W, 1997, P NATL ACAD SCI USA, V94, P163, DOI 10.1073/pnas.94.1.163; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Emmott E, 2017, MOL CELL PROTEOMICS, V16, pS215, DOI 10.1074/mcp.M116.062448; Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frank E., 2016, WEKA WORKBENCH ONLIN, V4th; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Garamszegi S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003778; Garzon JI, 2016, ELIFE, V5, DOI 10.7554/eLife.18715; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Germain MA, 2014, MOL CELL PROTEOMICS, V13, P184, DOI 10.1074/mcp.M113.030155; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Grinstein E, 2002, J EXP MED, V196, P1067, DOI 10.1084/jem.20011053; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halehalli RR, 2015, BIOINFORMATICS, V31, P1025, DOI 10.1093/bioinformatics/btu763; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Hallast P, 2016, GENOME RES, V26, P427, DOI 10.1101/gr.198754.115; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Han XG, 2015, MOL CELLS, V38, P112, DOI [10.14348/molcells.2015.02101, 10.14348/molcells.2015.2101]; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; IARC, 2019, AG CLASS IARC MON, V1-125; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; Kajitani N, 2015, BIOMOLECULES, V5, P758, DOI 10.3390/biom5020758; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kasprzyk A., 2011, DATABASE-OXFORD, V2011, DOI DOI 10.1093/DATABASE/BAR049; Katzenellenbogen RA, 2010, J VIROL, V84, P12934, DOI 10.1128/JVI.01377-10; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XZ, 2013, NUCLEIC ACIDS RES, V41, P10488, DOI 10.1093/nar/gkt803; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Loytynoja A, 2014, METHODS MOL BIOL, V1079, P155, DOI 10.1007/978-1-62703-646-7_10; Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4; Luck K, 2017, TRENDS BIOCHEM SCI, V42, P342, DOI 10.1016/j.tibs.2017.02.006; Ma YJ, 2017, CELL HOST MICROBE, V21, P580, DOI 10.1016/j.chom.2017.04.005; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MELENDY T, 1995, J VIROL, V69, P7857, DOI 10.1128/JVI.69.12.7857-7867.1995; Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066; Mirabello L, 2017, CELL, V170, P1164, DOI 10.1016/j.cell.2017.08.001; MOHR IJ, 1990, SCIENCE, V250, P1694, DOI 10.1126/science.2176744; Muller N, 2006, TRAFFIC, V7, P849, DOI 10.1111/j.1600-0854.2006.00426.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Nicod C, 2017, CURR OPIN MICROBIOL, V39, P7, DOI 10.1016/j.mib.2017.07.005; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0; Pang CL, 2014, ONCOGENE, V33, P4039, DOI 10.1038/onc.2013.426; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pietsch EC, 2008, CANCER BIOL THER, V7, P1916, DOI 10.4161/cbt.7.12.7169; Plaza JJG, 2016, INTRACTABLE RARE DIS, V5, P90, DOI 10.5582/irdr.2016.01008; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028; Raman R, 2016, CURR OPIN STRUC BIOL, V40, P153, DOI 10.1016/j.sbi.2016.10.003; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5; Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HZ, 2017, GENE CHROMOSOME CANC, V56, P598, DOI 10.1002/gcc.22463; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; TANNER J, 1988, J VIROL, V62, P4452, DOI 10.1128/JVI.62.12.4452-4464.1988; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tjalma WA, 2001, EUR J OBSTET GYN R B, V97, P223, DOI 10.1016/S0301-2115(00)00541-8; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tsuchiya N, 1998, J BIOCHEM-TOKYO, V123, P499; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Van den Broeke Celine, 2014, Small GTPases, V5, pe28318, DOI 10.4161/sgtp.28318; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Warnes G.R., 2016, GPLOTS VARIOUS R PRO; White EA, 2017, CELL, V170, P1057, DOI 10.1016/j.cell.2017.08.033; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Yang AS, 2000, J MOL BIOL, V301, P691, DOI 10.1006/jmbi.2000.3975; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	144	63	65	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1526	+		10.1016/j.cell.2019.08.005	http://dx.doi.org/10.1016/j.cell.2019.08.005			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474372	Bronze, Green Accepted			2022-12-28	WOS:000483983000023
J	Scheelbeek, PFD; Cornelsen, L; Marteau, TM; Jebb, SA; Smith, RD				Scheelbeek, Pauline F. D.; Cornelsen, Laura; Marteau, Theresa M.; Jebb, Susan A.; Smith, Richard D.			Potential impact on prevalence of obesity in the UK of a 20% price increase in high sugar snacks: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SWEETENED BEVERAGES; WEIGHT-GAIN; FOOD TAX; PATTERNS; CHILDREN; ADULTS	OBJECTIVE To estimate the potential impact on body mass index (BMI) and prevalence of obesity of a 20% price increase in high sugar snacks. DESIGN Modelling study. SETTING General adult population of the United Kingdom. PARTICIPANTS 36 324 households with data on product level household expenditure from UK Kantar FMCG (fast moving consumer goods) panel for January 2012 to December 2013. Data were used to estimate changes in energy (kcal, 1 kcal=4.18 kJ=0.00418 MJ) purchase associated with a 20% price increase in high sugar snacks. Data for 2544 adults from waves 5 to 8 of the National Diet and Nutrition Survey (2012-16) were used to estimate resulting changes in BMI and prevalence of obesity. MAIN OUTCOME MEASURES The effect on per person take home energy purchases of a 20% price increase for three categories of high sugar snacks: confectionery (including chocolate), biscuits, and cakes. Health outcomes resulting from the price increase were measured as changes in weight, BMI (not overweight (BMI < 25), overweight (BMI >= 25 and < 30), and obese (BMI >= 30)), and prevalence of obesity. Results were stratified by household income and BMI. RESULTS For income groups combined, the average reduction in energy consumption for a 20% price increase in high sugar snacks was estimated to be 8.9x103 kcal (95% confidence interval -13.1x10(3) to -4.2x10(3) kcal). Using a static weight loss model, BMI was estimated to decrease by 0.53 (95% confidence interval -1.01 to -0.06) on average across all categories and income groups. This change could reduce the UK prevalence of obesity by 2.7 percentage points (95% confidence interval -3.7 to -1.7 percentage points) after one year. The impact of a 20% price increase in high sugar snacks on energy purchase was largest in low income households classified as obese and smallest in high income households classified as not overweight. CONCLUSIONS Increasing the price of high sugar snacks by 20% could reduce energy intake, BMI, and prevalence of obesity. This finding was in a UK context and was double that modelled for a similar price increase in sugar sweetened beverages.	[Scheelbeek, Pauline F. D.] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England; [Scheelbeek, Pauline F. D.] London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London, England; [Cornelsen, Laura] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England; [Jebb, Susan A.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Smith, Richard D.] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Oxford; University of Exeter	Scheelbeek, PFD (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England.; Scheelbeek, PFD (corresponding author), London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London, England.	pauline.scheelbeek@lshtm.ac.uk		Cornelsen, Laura/0000-0003-3769-8740; Smith, Richard/0000-0003-3837-6559; Scheelbeek, Pauline/0000-0002-6209-2284; Jebb, Susan/0000-0001-9190-2920	National Institute for Health Research (NIHR) Policy Research Programme (Policy Research Unit in Behaviour and Health) [PR-UN-0409-10109]; Wellcome Trust [205200/Z/16/Z]; MRC [MR/P021999/1]; Oxford NIHR Biomedical Research Centre; Oxford NIHR Collaboration and Leadership in Applied Health Research and Care; MRC [MR/L012324/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Policy Research Programme (Policy Research Unit in Behaviour and Health); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford NIHR Collaboration and Leadership in Applied Health Research and Care; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was independent research funded by the National Institute for Health Research (NIHR) Policy Research Programme (Policy Research Unit in Behaviour and Health (PR-UN-0409-10109 principal investigator TMM)). PS is funded by the Wellcome Trust (205200/Z/16/Z). LC is funded by an MRC fellowship grant (MR/P021999/1). SAJ is funded by the Oxford NIHR Biomedical Research Centre and Oxford NIHR Collaboration and Leadership in Applied Health Research and Care. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health and Social Care or its non-departmental agencies and public bodies and other government departments. The final version of the report and ultimate decision to submit for publication was determined by the authors.	Adriaens MPE, 2003, BRIT J NUTR, V90, P419, DOI 10.1079/BJN2003895; Appelhans BM, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0502-2; Colchero MA, 2017, SALUD PUBLICA MEXICO, V59, P137, DOI 10.21149/7994; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Backholer K, 2016, PUBLIC HEALTH NUTR, V19, P3070, DOI 10.1017/S136898001600104X; Baker C., 2018, 3336 HOUS COMM LIB; Bandy L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210192; Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057; Biro A, 2015, FOOD POLICY, V54, P107, DOI 10.1016/j.foodpol.2015.05.003; Bourke EJ, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000923; Briggs ADM, 2017, LANCET PUBLIC HEALTH, V2, pE15, DOI 10.1016/S2468-2667(16)30037-8; BRIGGS ADM, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6189; Chow CC, 2014, PHYSIOL BEHAV, V134, P60, DOI 10.1016/j.physbeh.2014.02.044; Conolly A, 2017, HLTH SURVEY ENGLAND; Donahoo WT, 2004, CURR OPIN CLIN NUTR, V7, P599, DOI 10.1097/00075197-200411000-00003; Euromonitor International, 2019, PER CAP MARK SIZ FOO; Falbe J, 2015, AM J PUBLIC HEALTH, V105, P2194, DOI 10.2105/AJPH.2015.302881; Fletcher JM, 2015, HEALTH ECON, V24, P566, DOI 10.1002/hec.3045; Flint E, 2016, LANCET PUBLIC HEALTH, V1, pE46, DOI 10.1016/S2468-2667(16)30006-8; Griffith R, 2012, MEASURING QUALITY PE; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hanson S, 2015, BRIT J SPORT MED, V49, P710, DOI 10.1136/bjsports-2014-094157; Harding M, 2017, J HEALTH ECON, V53, P53, DOI 10.1016/j.jhealeco.2017.02.003; Hernandez M, 2019, PREV MED, V118, P16, DOI 10.1016/j.ypmed.2018.09.019; Lal A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002326; Leicester A., 2012, W1201 IFS; Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Nakamura R, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002596; NatCen Social Research UCL, 2017, HLTH SURV ENGL 2016; National Diets and Nutrition Survey (NDNS), 2019, NAT DIET NUTR SURV A; National Health Services Digital, 2017, HLTH SURV ENGL 2016; Organisation for Economic Co- operation and Development, 2017, OB UPD; Pan American Health Organization, 2015, TAX SUG SWEET BEV PU; Public Health England, 2018, SUG RED WID REF PROG; Public Health England, 2018, FOOD STAND AG NAT DI; Public Health England, 2017, SUG RED ACH 20 TECHN; Public Health England, 2018, NCMP CHILD OB PROF; Quirmbach D, 2018, J EPIDEMIOL COMMUN H, V72, P324, DOI 10.1136/jech-2017-209791; Sassi F, 2018, LANCET, V391, P2059, DOI [10.1016/S0140-6736(18)30531-2, 10.1016/s0140-6736(18)30531-2]; Smith RD, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019788; Taillie LS, 2017, PREV MED, V105, pS37, DOI 10.1016/j.ypmed.2017.07.009; The Task Force on Fiscal Policy for Health, 2019, HLTH TAX SAV LIV EMP; Treasury HM, SOFT DRINKS IND LEV; Whybrow S., 2018, Nutrition and Health (Bicester), V24, P29, DOI 10.1177/0260106017745389; World Health Organization, 2016, REP COMM END CHILDH; World Health Organization, OB OV 2018; Wright A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4497-z; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	51	27	27	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l4786	10.1136/bmj.l4786	http://dx.doi.org/10.1136/bmj.l4786			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX1FO	31484641	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000485437600001
J	Banatvala, J; Peachey, M; Munzel, T				Banatvala, Jangu; Peachey, Martin; Muenzel, Thomas			The harms to health caused by aviation noise require urgent action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENVIRONMENTAL NOISE; TRAFFIC NOISE; AIRCRAFT; ROAD		[Banatvala, Jangu] Kings Coll London, Clin Virol, London, England; [Peachey, Martin] Aviat Environm Federat, Bishops Stortford, England; [Muenzel, Thomas] Univ Med Ctr, Dept Cardiol, Mainz, Germany	University of London; King's College London; Johannes Gutenberg University of Mainz	Banatvala, J (corresponding author), Kings Coll London, Clin Virol, London, England.	jangu.banatvala@gmail.com	Munzel, Thomas/A-2912-2014	Munzel, Thomas/0000-0001-5503-4150				[Anonymous], 2018, ENVIRONMENTAL NOISE; [Anonymous], 1999, CHART TRANSP ENV HLT; Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237; Hansell AL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5432; Klatte M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00578; Munzel T, 2018, J AM COLL CARDIOL, V71, P688, DOI 10.1016/j.jacc.2017.12.015; Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030; Seidler A, 2016, INT J HYG ENVIR HEAL, V219, P749, DOI 10.1016/j.ijheh.2016.09.012; Stansfeld SA, 2005, LANCET, V365, P1942, DOI 10.1016/S0140-6736(05)66660-3; Stansfeld S, 2011, NOISE HEALTH, V13, P229, DOI 10.4103/1463-1741.80159; Submission to Uttlesford District Council by Stop Stansted Expansion, 2018, UTTLESFORD DIS UNPUB; Suri Surinderpal, COMMUNICATION; van Kempen E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020379	13	1	1	4	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l5329	10.1136/bmj.l5329	http://dx.doi.org/10.1136/bmj.l5329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477567	Bronze			2022-12-28	WOS:000485431800008
J	Beaglehole, R; Bates, C; Youdan, B; Bonita, R				Beaglehole, Robert; Bates, Clive; Youdan, Ben; Bonita, Ruth			Nicotine without smoke: fighting the tobacco epidemic with harm reduction	LANCET			English	Editorial Material									[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 0624, New Zealand; [Bates, Clive] Counterfactual Consulting Ltd, London, England; [Youdan, Ben] ASH NZ, Heart Fdn, Auckland, New Zealand	University of Auckland	Beaglehole, R (corresponding author), Univ Auckland, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz		Bates, Clive/0000-0002-4106-7119				Abrams DB, 2018, COMMUNICATION   1001; [Anonymous], 2019, REPORT COMMISSIONED; ASH, 2019, FACT SHEET US E CIG; ASH New Zealand, 2018 ASH YEAR 10 SNA; Drope J., 2018, TOBACCO ATLAS; E-cigarette Intelligence, 2019, KEY GLOB CIG MARK DA; European Commission, 2017, EUR SPEC SURV 458 AT; Gentzke AS, 2019, MMWR-MORBID MORTAL W, V68, P157, DOI 10.15585/mmwr.mm6806e1; Ghebreyesus TA, 2019, LANCET, V394, P548, DOI 10.1016/S0140-6736(19)31730-1; Hajek P, 2019, NEW ENGL J MED, V380, P629, DOI 10.1056/NEJMoa1808779; Hammond D, 2019, BMJ-BRIT MED J, V365, P1212; Hartmann-Boyce J, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub5; Jackson SE, 2019, ADDICTION, V114, P1627, DOI 10.1111/add.14656; Japan Tobacco, JAP DOM CIG SAL RES; Kozlowski Lynn T, 2017, Drug Alcohol Depend, V174, P209, DOI 10.1016/j.drugalcdep.2017.01.001; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS E CIG; Notley C, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0237-7; Polosa R, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0187-5; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Tobacco Advisory Group of the Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; US Food and Drug Administration, 2019, PREM TOB PROD MARK O; World Health Organization, 2019, WHO REP GLOB TOB EP; Zhu SH, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3262	23	29	29	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					718	720		10.1016/S0140-6736(19)31884-7	http://dx.doi.org/10.1016/S0140-6736(19)31884-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UW	31478489				2022-12-28	WOS:000483011400012
J	Yee, A				Yee, Amy			The darker side of paradise: heroin addiction in Zanzibar	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					721	722		10.1016/S0140-6736(19)32001-X	http://dx.doi.org/10.1016/S0140-6736(19)32001-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UW	31478490				2022-12-28	WOS:000483011400013
J	Alam, MM; Sanchez-Azqueta, A; Janha, O; Flannery, EL; Mahindra, A; Mapesa, K; Char, AB; Sriranganadane, D; Brancucci, NMB; Antonova-Koch, Y; Crouch, K; Simwela, NV; Millar, SB; Akinwale, J; Mitcheson, D; Solyakov, L; Dudek, K; Jones, C; Zapatero, C; Doerig, C; Nwakanma, DC; Vazquez, MJ; Colmenarejo, G; Lafuente-Monasterio, MJ; Leon, ML; Godoi, PHC; Elkins, JM; Waters, AP; Jamieson, AG; Alvaro, EF; Ranford-Cartwright, LC; Marti, M; Winzeler, EA; Gamo, FJ; Tobin, AB				Alam, Mahmood M.; Sanchez-Azqueta, Ana; Janha, Omar; Flannery, Erika L.; Mahindra, Amit; Mapesa, Kopano; Char, Aditya B.; Sriranganadane, Dev; Brancucci, Nicolas M. B.; Antonova-Koch, Yevgeniya; Crouch, Kathryn; Simwela, Nelson Victor; Millar, Scott B.; Akinwale, Jude; Mitcheson, Deborah; Solyakov, Lev; Dudek, Kate; Jones, Carolyn; Zapatero, Cleofe; Doerig, Christian; Nwakanma, Davis C.; Jesus Vazquez, Maria; Colmenarejo, Gonzalo; Jose Lafuente-Monasterio, Maria; Luisa Leon, Maria; Godoi, Paulo H. C.; Elkins, Jon M.; Waters, Andrew P.; Jamieson, Andrew G.; Fernandez Alvaro, Elena; Ranford-Cartwright, Lisa C.; Marti, Matthias; Winzeler, Elizabeth A.; Javier Gamo, Francisco; Tobin, Andrew B.			Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PRP4 KINASE; TRI-SNRNP; PARASITE; RESISTANCE; REVEALS; DEUBIQUITINASE; ARTEMISININ; PIPERAQUINE; INHIBITORS	The requirement for next-generation antimalarials to be both curative and transmission-blocking necessitates the identification of previously undiscovered druggable molecular pathways. We identified a selective inhibitor of the Plasmodium falciparum protein kinase PfCLK3, which we used in combination with chemogenetics to validate PfCLK3 as a drug target acting at multiple parasite life stages. Consistent with a role for PfCLK3 in RNA splicing, inhibition resulted in the down-regulation of more than 400 essential parasite genes. Inhibition of PfCLK3 mediated rapid killing of asexual liver-and blood-stage P. falciparum and blockade of gametocyte development, thereby preventing transmission, and also showed parasiticidal activity against P. berghei and P. knowlesi. Hence, our data establish PfCLK3 as a target for drugs, with the potential to offer a cure-to be prophylactic and transmission blocking in malaria.	[Alam, Mahmood M.; Crouch, Kathryn; Simwela, Nelson Victor; Millar, Scott B.; Waters, Andrew P.; Marti, Matthias] Univ Glasgow, Wellcome Ctr Integrat Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Sanchez-Azqueta, Ana; Janha, Omar; Tobin, Andrew B.] Univ Glasgow, Ctr Translat Pharmacol, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Flannery, Erika L.] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Mahindra, Amit; Mapesa, Kopano; Jamieson, Andrew G.] Univ Glasgow, Sch Chem, Glasgow G12 8QQ, Lanark, Scotland; [Char, Aditya B.; Ranford-Cartwright, Lisa C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Sriranganadane, Dev; Godoi, Paulo H. C.] Univ Estadual Campinas, Struct Genom Consortium, BR-13083886 Campinas, SP, Brazil; [Brancucci, Nicolas M. B.] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4051 Basel, Switzerland; [Antonova-Koch, Yevgeniya; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, Skaggs Sch Pharmaceut Sci, UC Hlth Sci Ctr Immunol Infect & Inflammat, La Jolla, CA 92093 USA; [Akinwale, Jude; Solyakov, Lev; Dudek, Kate; Jones, Carolyn] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Mitcheson, Deborah] Univ Leicester, Dept Mol Cell Biol, Leicester LE1 9HN, Leics, England; [Zapatero, Cleofe; Jesus Vazquez, Maria; Jose Lafuente-Monasterio, Maria; Luisa Leon, Maria; Fernandez Alvaro, Elena; Javier Gamo, Francisco] GlaxoSmithKline, Dis Dev World, Madrid 28760, Spain; [Doerig, Christian] RMIT Univ, Sch Hlth & Biomed Sci, Biomed Sci Cluster, Melbourne, Vic 3000, Australia; [Nwakanma, Davis C.] MRC Unit Gambia, Banjul, Gambia; [Colmenarejo, Gonzalo] IMDEA Food Inst, Biostat & Bioinformat Unit, Madrid 28049, Spain; [Elkins, Jon M.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England	University of Glasgow; University of Glasgow; Novartis; University of Glasgow; University of Glasgow; Universidade Estadual de Campinas; University of Basel; Swiss Tropical & Public Health Institute; University of California System; University of California San Diego; University of Leicester; University of Leicester; GlaxoSmithKline; Royal Melbourne Institute of Technology (RMIT); University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Tobin, AB (corresponding author), Univ Glasgow, Ctr Translat Pharmacol, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	andrew.tobin@glasgow.ac.uk	Winzeler, Elizabeth/AAP-6752-2020; Millar, Scott/GPX-7987-2022; Sriranganadane, Dev/M-6249-2015; Crouch, Kathryn/HDO-6240-2022; Simwela, Nelson/AAF-3013-2021; Alam, Mahmood/GQQ-9664-2022; Colmenarejo, Gonzalo/Q-6535-2018; Godoi, Paulo HC/B-9847-2012; Ranford-Cartwright, Lisa/H-4701-2013	Winzeler, Elizabeth/0000-0002-4049-2113; Sriranganadane, Dev/0000-0003-1818-1420; Crouch, Kathryn/0000-0001-9310-4762; Simwela, Nelson/0000-0002-4734-0518; Colmenarejo, Gonzalo/0000-0002-8249-4547; Godoi, Paulo HC/0000-0003-1859-3513; MAHINDRA, AMIT/0000-0001-5439-2466; Char, Aditya/0000-0002-9910-1244; Millar, Scott/0000-0003-1718-1947; Brancucci, Nicolas/0000-0003-0655-3266; Ranford-Cartwright, Lisa/0000-0003-1992-3940; Antonova-Koch, Yevgeniya/0000-0003-2862-0407; Janha, Dr Omar/0000-0002-9121-2396	MRC Toxicology Unit program; MRC Developmental Gap Fund; Lord Kelvin Adam Smith Fellowship; GSK Open Lab Foundation Award; MRC Toxicology Unit; MRC Unit the Gambia PhD program; Wellcome Centre for Integrative Parasitology Core [WT104111AIA]; NIH [5R01AI090141, R01AI103058]; Bill & Melinda Gates Foundation [OPP1086217, OPP1141300]; Medicines for Malaria Venture (MMV); WT award [172862-01]; Royal Society; AbbVie; Bayer Pharma AG; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (European Union [EU]/European Federation of Pharmaceutical Industries and Associations [EFPIA]) (ULTRA-DD grant) [115766]; Janssen; Merck Company; Merck KGaA; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation (FAPESP) [2013/50724-5]; Takeda; Wellcome Trust [106169/ZZ14/Z]; Tres Cantos Lab Foundation [TC125]; Scottish Funding Council Global Challenges Research Fund; Boehringer Ingelheim; Daphne Jackson Fellowship; EPSRC [1954365] Funding Source: UKRI; MRC [MC_PC_14117] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090141, R01AI103058] Funding Source: NIH RePORTER	MRC Toxicology Unit program; MRC Developmental Gap Fund; Lord Kelvin Adam Smith Fellowship; GSK Open Lab Foundation Award; MRC Toxicology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Unit the Gambia PhD program; Wellcome Centre for Integrative Parasitology Core; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medicines for Malaria Venture (MMV); WT award; Royal Society(Royal Society of London); AbbVie(AbbVie); Bayer Pharma AG; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (European Union [EU]/European Federation of Pharmaceutical Industries and Associations [EFPIA]) (ULTRA-DD grant); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Company(Merck & Company); Merck KGaA; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome Trust); Tres Cantos Lab Foundation; Scottish Funding Council Global Challenges Research Fund; Boehringer Ingelheim(Boehringer Ingelheim); Daphne Jackson Fellowship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by an MRC Toxicology Unit program grant (A.B.T., M.M.A.), MRC Developmental Gap Fund (A.S.-A.), Lord Kelvin Adam Smith Fellowship (M.M.A.), GSK Open Lab Foundation Award (A. S.-A.), joint MRC Toxicology Unit and MRC Unit the Gambia PhD program (O.J.), and Daphne Jackson Fellowship (D.M.). A.P.W., M.M., M.M. A., K.C., N.V.S., and S.B.M. are supported by Wellcome Centre for Integrative Parasitology Core support award WT104111AIA. E.A.W. is supported by grants from the NIH (5R01AI090141 and R01AI103058) and by grants from the Bill & Melinda Gates Foundation (OPP1086217, OPP1141300) as well as by Medicines for Malaria Venture (MMV). Drug WR99210 for selection of transgenic parasites was a gift from Jacobus Pharmaceuticals. M. M. is supported through WT award 172862-01 and a Wolfson Merit award from the Royal Society. The Structural Genomics Consortium (SGC) is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, the Eshelman Institute for Innovation, Genome Canada, the Innovative Medicines Initiative (European Union [EU]/European Federation of Pharmaceutical Industries and Associations [EFPIA]) (ULTRA-DD grant no. 115766), Janssen, Merck & Company, Merck KGaA, Novartis Pharma AG, the Ontario Ministry of Economic Development and Innovation, Pfizer, the Sao Paulo Research Foundation (FAPESP number 2013/50724-5), Takeda, and the Wellcome Trust (106169/ZZ14/Z). E.F.A. was supported by the Tres Cantos Lab Foundation (grant TC125). A.B.C. was supported by a Scottish Funding Council Global Challenges Research Fund award to L.C.R.-C.	Agarwal S, 2011, J CELL BIOCHEM, V112, P1295, DOI 10.1002/jcb.23034; Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; [Anonymous], 2017, R LANG ENV STAT COMP; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Axel R, 2005, ANGEW CHEM INT EDIT, V44, P6110, DOI 10.1002/anie.200501726; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Brancucci NMB, 2017, CELL, V171, P1532, DOI 10.1016/j.cell.2017.10.020; Brancucci NMB, 2015, NAT PROTOC, V10, P1131, DOI 10.1038/nprot.2015.072; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burrows JN, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1675-x; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Carter R, 1993, Methods Mol Biol, V21, P67; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Doerig C, 2015, NAT REV MICROBIOL, V13, P160, DOI 10.1038/nrmicro3402; Doerig C, 2010, BBA-PROTEINS PROTEOM, V1804, P604, DOI 10.1016/j.bbapap.2009.10.009; Dranchak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057888; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Fraile JM, 2017, J BIOL CHEM, V292, P4164, DOI 10.1074/jbc.M116.762757; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gao Q, 2013, J BIOL CHEM, V288, P30125, DOI 10.1074/jbc.M113.473348; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goodyer ID, 1997, EXP PARASITOL, V86, P158, DOI 10.1006/expr.1997.4156; Gross S, 2015, J CLIN INVEST, V125, P1780, DOI 10.1172/JCI76094; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hadjivassiliou H, 2014, RNA, V20, P656, DOI 10.1261/rna.042838.113; Hui R, 2015, TRENDS PHARMACOL SCI, V36, P452, DOI 10.1016/j.tips.2015.04.011; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Kafsack BFC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-187; Kern S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105732; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Nakagawa S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0213; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Swann J, 2016, ACS INFECT DIS, V2, P281, DOI 10.1021/acsinfecdis.5b00143; Talevich E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-321; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	51	35	35	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					884	+	eaau1682	10.1126/science.aau1682	http://dx.doi.org/10.1126/science.aau1682			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467193	Green Submitted, Green Accepted			2022-12-28	WOS:000483975800038
J	Zeebe, RE; Lourens, LJ				Zeebe, Richard E.; Lourens, Lucas J.			Solar System chaos and the Paleocene-Eocene boundary age constrained by geology and astronomy	SCIENCE			English	Article							PLANETARY EPHEMERIDES; THERMAL MAXIMUM; TIME-SCALE; CARBON; CALIBRATION; TIMESCALE; BEHAVIOR; CLIMATE; RATES	Astronomical calculations reveal the Solar System's dynamical evolution, including its chaoticity, and represent the backbone of cyclostratigraphy and astrochronology. An absolute, fully calibrated astronomical time scale has hitherto been hampered beyond similar to 50 million years before the present (Ma) because orbital calculations disagree before that age. Here, we present geologic data and a new astronomical solution (ZB18a) showing exceptional agreement from similar to 58 to 53 Ma. We provide a new absolute astrochronology up to 58 Ma and a new Paleocene-Eocene boundary age (56.01 +/- 0.05 Ma). We show that the Paleocene-Eocene Thermal Maximum (PETM) onset occurred near a 405-thousand-year (kyr) eccentricity maximum, suggesting an orbital trigger. We also provide an independent PETM duration (170 +/- 30 kyr) from onset to recovery inflection. Our astronomical solution requires a chaotic resonance transition at similar to 50 Ma in the Solar System's fundamental frequencies.	[Zeebe, Richard E.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, 1000 Pope Rd,MSB 629, Honolulu, HI 96822 USA; [Lourens, Lucas J.] Univ Utrecht, Fac Geosci, Dept Earth Sci, Princetonlaan 8a, NL-3584 CB Utrecht, Netherlands	University of Hawaii System; University of Hawaii Manoa; Utrecht University	Zeebe, RE (corresponding author), Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, 1000 Pope Rd,MSB 629, Honolulu, HI 96822 USA.	zeebe@soest.hawaii.edu		Lourens, Lucas/0000-0002-3815-7770	U.S. National Science Foundation [OCE16-58023]; Netherlands Organisation for Scientific Research [NWO-ALW 865.10.001]; Netherlands Earth System Science Centre [NESSC 024.002.001]	U.S. National Science Foundation(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Earth System Science Centre	R.E.Z. acknowledges support from the U.S. National Science Foundation (OCE16-58023). This research was supported by the Netherlands Organisation for Scientific Research(NWO-ALW 865.10.001) and by the Netherlands Earth System Science Centre (NESSC 024.002.001) to L.J.L. We are grateful to the International Ocean Discovery Program for drilling and exploring ODP Site 1262.	Boggs DH, 2014, 42196 IPN; Charles AJ, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003426; Cramer BS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000909; Fienga A, 2015, CELEST MECH DYN ASTR, V123, P325, DOI 10.1007/s10569-015-9639-y; Fienga A, 2011, CELEST MECH DYN ASTR, V111, P363, DOI 10.1007/s10569-011-9377-8; Fienga A, 2009, ASTRON ASTROPHYS, V507, P1675, DOI 10.1051/0004-6361/200911755; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hilgen FJ, 2010, EARTH PLANET SC LETT, V300, P139, DOI 10.1016/j.epsl.2010.09.044; Iorio L, 2005, ASTRON ASTROPHYS, V431, P385, DOI 10.1051/0004-6361:20041646; Jaramillo C, 2010, SCIENCE, V330, P957, DOI 10.1126/science.1193833; Jones TD, 2018, CLIM PAST, V14, P1035, DOI 10.5194/cp-14-1035-2018; LASKAR J, 1989, NATURE, V338, P237, DOI 10.1038/338237a0; Laskar J, 2011, ASTRON ASTROPHYS, V532, DOI [10.1051/0004-6361/201116836, 10.1051/0004-6361/201117504]; Laskar J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117504; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lauretano V, 2016, NEWSL STRATIGR, V49, P383, DOI 10.1127/nos/2016/0077; Lauretano V, 2018, PALEOCEANOGR PALEOCL, V33, P1050, DOI 10.1029/2018PA003422; Lense J., 1918, PHYZ, V19, P156; Li MS, 2018, EARTH PLANET SC LETT, V501, P165, DOI 10.1016/j.epsl.2018.08.041; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Ma C, 2019, EARTH PLANET SC LETT, V513, P1, DOI 10.1016/j.epsl.2019.01.053; Ma C, 2017, NATURE, V542, P468, DOI 10.1038/nature21402; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Mecheri R, 2004, SOL PHYS, V222, P191, DOI 10.1023/B:SOLA.0000043563.96766.21; Meyers SR, 2019, EARTH-SCI REV, V190, P190, DOI 10.1016/j.earscirev.2018.11.015; Meyers SR, 2018, P NATL ACAD SCI USA, V115, P6363, DOI 10.1073/pnas.1717689115; Meyers SR, 2015, PALEOCEANOGRAPHY, V30, P1625, DOI 10.1002/2015PA002850; Milankovic M., 1941, KANON ERDBESTRAHLUNG; Murphy BH, 2010, GEOCHIM COSMOCHIM AC, V74, P5098, DOI 10.1016/j.gca.2010.03.039; Park RS, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa5be2; Pijpers FP, 1998, MON NOT R ASTRON SOC, V297, pL76, DOI 10.1046/j.1365-8711.1998.01801.x; Pitjeva EV, 2014, CELEST MECH DYN ASTR, V119, P237, DOI 10.1007/s10569-014-9569-0; POINCARE H, 1892, METHODES NOUVELLES M, V1; Rauch K.P., 2002, BAAS, V34, P938; Rohl U, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001784; Shipboard Scientific Party, 2004, Proceedings of the Ocean Drilling Program Initial Reports, V208, P1; Soffel M. H, 1989, RELATIVITY ASTROMETR; Spalding C, 2018, ASTROPHYS J LETT, V869, DOI 10.3847/2041-8213/aaf478; Stocker T F, 2013, CLIM CHANG 2013 PHYS; SUSSMAN GJ, 1992, SCIENCE, V257, P56, DOI 10.1126/science.257.5066.56; Varadi F, 2003, ASTROPHYS J, V592, P620, DOI 10.1086/375560; Westerhold T, 2018, PALEOCEANOGR PALEOCL, V33, P626, DOI 10.1029/2017PA003306; Westerhold T, 2008, PALAEOGEOGR PALAEOCL, V257, P377, DOI 10.1016/j.palaeo.2007.09.016; Westerhold T, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001322; Westerhold T, 2017, CLIM PAST, V13, P1129, DOI 10.5194/cp-13-1129-2017; Westerhold T, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004096; Zachos JC, 2010, EARTH PLANET SC LETT, V299, P242, DOI 10.1016/j.epsl.2010.09.004; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zeebe RE, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001395; Zeebe RE, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa8cce; Zeebe RE, 2017, PALEOCEANOGRAPHY, V32, P440, DOI 10.1002/2016PA003054; Zeebe RE, 2016, NAT GEOSCI, V9, P325, DOI 10.1038/NGEO2681; Zeebe RE, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/1/9; Zeebe RE, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/8	59	74	76	6	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					926	+		10.1126/science.aax0612	http://dx.doi.org/10.1126/science.aax0612			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467222	Green Submitted			2022-12-28	WOS:000483975800048
J	Culotta, E				Culotta, Elizabeth			PROBING AN EVOLUTIONARY RIDDLE	SCIENCE			English	News Item																			0	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		748	749		10.1126/science.365.6455.748	http://dx.doi.org/10.1126/science.365.6455.748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439779				2022-12-28	WOS:000482464000025
J	Sinaiko, AD				Sinaiko, Anna D.			What Is the Value of Market-Wide Health Care Price Transparency?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In the wake of a 2019 executive order requiring hospitals to publicly post paid prices and requiring clinicians, insurers, and health plans to provide estimated out-of-pocket costs to patients, this Viewpoint reviews available evidence about the likelihood that price transparency might influence consumer choice, put downward pressure on prices, and influence insurers to incentivize patients to seek lower-cost care.	[Sinaiko, Anna D.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Room 409, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Sinaiko, AD (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Room 409, Boston, MA 02115 USA.	asinaiko@hsph.harvard.edu			Commonwealth Fund	Commonwealth Fund	Funding from the Commonwealth Fund for this work is gratefully acknowledged.	Brown ZY, 2019, REV ECON STAT, V101, P699, DOI 10.1162/rest_a_00765; Cutler D, 2011, NEW ENGL J MED, V364, P894, DOI 10.1056/NEJMp1100540; Desai S, 2016, JAMA-J AM MED ASSOC, V315, P1874, DOI 10.1001/jama.2016.4288; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Pollack Andrew, 2016, NY TIMES; Reinhardt UE, 2013, JAMA-J AM MED ASSOC, V310, P1927, DOI 10.1001/jama.2013.281854; Roberts ET, 2017, HEALTH AFFAIR, V36, P141, DOI 10.1377/hlthaff.2016.0479; Sinaiko AD, 2016, JAMA INTERN MED, V176, P1868, DOI 10.1001/jamainternmed.2016.6622; Trump D., 2019, EXECUTIVE ORDER IMPR	9	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2019	322	15					1449	1450		10.1001/jama.2019.11578	http://dx.doi.org/10.1001/jama.2019.11578			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JI4ST	31486830				2022-12-28	WOS:000493458400009
J	Nikooie, R; Neufeld, KJ; Oh, ES; Wilson, LM; Zhang, A; Robinson, KA; Needham, DM				Nikooie, Roozbeh; Neufeld, Karin J.; Oh, Esther S.; Wilson, Lisa M.; Zhang, Allen; Robinson, Karen A.; Needham, Dale M.			Antipsychotics for Treating Delirium in Hospitalized Adults A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CRITICALLY-ILL PATIENTS; DOUBLE-BLIND; HALOPERIDOL; EFFICACY; CARE; RISPERIDONE; OLANZAPINE; METAANALYSIS; QUETIAPINE; PLACEBO	Background: Delirium is common in hospitalized patients and is associated with worse outcomes. Antipsychotics are commonly used; however, the associated benefits and harms are unclear. Purpose: To conduct a systematic review evaluating the benefits and harms of antipsychotics to treat delirium in adults. Data Sources: PubMed, Embase, CENTRAL, CINAHL, and Psyc-INFO from inception to July 2019 without language restrictions. Study Selection: Randomized controlled trials (RCTs) of antipsychotic versus placebo or another antipsychotic, and prospective observational studies reporting harms. Data Extraction: One reviewer extracted data and assessed strength of evidence (SOE) for critical outcomes, with confirmation by another reviewer. Risk of bias was assessed independently by 2 reviewers. Data Synthesis: Across 16 RCTs and 10 observational studies of hospitalized adults, there was no difference in sedation status (low and moderate SOE), delirium duration, hospital length of stay (moderate SOE), or mortality between haloperidol and second-generation antipsychotics versus placebo. There was no difference in delirium severity (moderate SOE) and cognitive functioning (low SOE) for haloperidol versus second-generation antipsychotics, with insufficient or no evidence for antipsychotics versus placebo. For direct comparisons of different second-generation antipsychotics, there was no difference in mortality and insufficient or no evidence for multiple other outcomes. There was little evidence demonstrating neurologic harms associated with short-term use of antipsychotics for treating delirium in adult inpatients, but potentially harmful cardiac effects tended to occur more frequently. Limitations: Heterogeneity was present in terms of dose and administration route of antipsychotics, outcomes, and measurement instruments. There was insufficient or no evidence regarding multiple clinically important outcomes. Conclusion: Current evidence does not support routine use of haloperidol or second-generation antipsychotics to treat delirium in adult inpatients. Primary Funding Source: Agency for Healthcare Research and Quality. (PROSPERO: CRD42018109552)	[Nikooie, Roozbeh; Neufeld, Karin J.; Oh, Esther S.; Robinson, Karen A.; Needham, Dale M.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Wilson, Lisa M.; Zhang, Allen] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Nikooie, Roozbeh; Needham, Dale M.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, 1830 East Monument St,Fifth Floor, Baltimore, MD 21287 USA; [Neufeld, Karin J.] Johns Hopkins Bayview Med Ctr, Dept Psychiat, A4 Ctr Suite 457,4940 Eastern Ave, Baltimore, MD 21224 USA; [Oh, Esther S.] Johns Hopkins Univ, Sch Med, Dept Med, Mason F Lord Bldg Ctr Tower,5200 Eastern Ave, Baltimore, MD 21224 USA; [Wilson, Lisa M.; Zhang, Allen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 North Broadway,Sixth Floor, Baltimore, MD 21205 USA; [Robinson, Karen A.] Johns Hopkins Univ, Sch Med, Dept Med, 1830 East Monument St,Room 8068, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Needham, DM (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care Med, 1830 East Monument St,5th Floor, Baltimore, MD 21205 USA.	LisaWilson@jhmi.edu; dale.needham@jhmi.edu			Agency for Healthcare Research and Quality [PROSPERO: CRD42018109552]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42018109552)	Agar MR, 2017, JAMA INTERN MED, V177, P34, DOI 10.1001/jamainternmed.2016.7491; [Anonymous], 2014, AHRQ PUBLICATION, V10(12)-EHC063-EF; [Anonymous], 2018, MOB NETW PUBL; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boettger S, 2015, PALLIAT SUPPORT CARE, V13, P1079, DOI 10.1017/S1478951514001059; Boettger S, 2011, EUR J PSYCHIAT, V25, P59; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Burry L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011749.pub2; Burry L, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005594.pub3; Charoenporn Veevarin, 2018, Journal of the Medical Association of Thailand, V101, P361; Collet MO, 2018, INTENS CARE MED, V44, P1081, DOI 10.1007/s00134-018-5204-y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; European Delirium Association, 2014, BMC Med, V12, P141, DOI 10.1186/s12916-014-0141-2; Fick DM, 2017, J AM GERIATR SOC, V65, P2158, DOI 10.1111/jgs.14942; Fox MA, 2019, J INTENSIVE CARE MED, V34, P172, DOI 10.1177/0885066618788018; Girard TD, 2018, NEW ENGL J MED, V379, P2506, DOI 10.1056/NEJMoa1808217; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Gross AL, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0552-4; Grover S, 2016, WORLD J PSYCHIATR, V6, P365, DOI 10.5498/wjp.v6.i3.365; Grover S, 2011, J PSYCHOSOM RES, V71, P277, DOI 10.1016/j.jpsychores.2011.01.019; Han CS, 2004, PSYCHOSOMATICS, V45, P297, DOI 10.1016/S0033-3182(04)70170-X; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Hatta K, 2014, INT J GERIATR PSYCH, V29, P253, DOI 10.1002/gps.3999; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hospital Elder Life Program, 2018, DEL BIBL; Hu H., 2006, CHIN J CLIN REHABIL, V10, P188; Kim JY, 2005, PSYCHIAT CLIN NEUROS, V59, P183, DOI 10.1111/j.1440-1819.2005.01355.x; Kim SW, 2010, HUM PSYCHOPHARM CLIN, V25, P298, DOI 10.1002/hup.1117; Kishi T, 2016, J NEUROL NEUROSUR PS, V87, P767, DOI 10.1136/jnnp-2015-311049; Lee KU, 2005, INT CLIN PSYCHOPHARM, V20, P311, DOI 10.1097/00004850-200511000-00005; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Leslie DL, 2011, J AM GERIATR SOC, V59, pS241, DOI 10.1111/j.1532-5415.2011.03671.x; Lin C-J., 2008, J INTERNAL MED TAIWA, V19, P346; Maneeton B, 2013, DRUG DES DEV THER, V7, P657, DOI 10.2147/DDDT.S45575; Marcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501; Naksuk N, 2017, EUR HEART J-ACUTE CA, V6, P560, DOI 10.1177/2048872615592232; Network for Investigation of Delirium: Unifying Scientists (NIDUS), 2018, DEL MEAS INF CARDS; Network for Investigation of Delirium: Unifying Scientists (NIDUS), 2018, DEL RES CAT; Network for Investigation of Delirium: Unifying Scientists (NIDUS), 2018, CROSSW DEL SEV MEAS; Neufeld KJ, 2016, J AM GERIATR SOC, V64, P705, DOI 10.1111/jgs.14076; Neufeld KJ, 2019, ANTIPSYCHOTICS FOR T; Oh ES, 2019, ANN INTERN MED, V171, P474, DOI 10.7326/M19-1859; Oh ES, 2017, JAMA-J AM MED ASSOC, V318, P1161, DOI 10.1001/jama.2017.12067; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Page VJ, 2013, LANCET RESP MED, V1, P515, DOI 10.1016/S2213-2600(13)70166-8; Rover C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0091-1; Rose L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016371; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Scottish Intercollegiate Guidelines Network, 2019, SIGN PUBL, V157; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Sipahimalani A, 1998, PSYCHOSOMATICS, V39, P422, DOI 10.1016/S0033-3182(98)71301-5; Skrobik YK, 2004, INTENS CARE MED, V30, P444, DOI 10.1007/s00134-003-2117-0; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tahir TA, 2010, J PSYCHOSOM RES, V69, P485, DOI 10.1016/j.jpsychores.2010.05.006; Vasilevskis EE, 2012, BEST PRACT RES-CLIN, V26, P277, DOI 10.1016/j.bpa.2012.07.003; Wu YC, 2019, JAMA PSYCHIAT, V76, P526, DOI 10.1001/jamapsychiatry.2018.4365; Yoon HJ, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-240; Zayed Y, 2019, J CRIT CARE, V50, P280, DOI 10.1016/j.jcrc.2019.01.009; 임현국, 2007, [The Korean Journal of Psychopharmacology, 대한정신약물학회지], V18, P423	66	84	85	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					485	+		10.7326/M19-1860	http://dx.doi.org/10.7326/M19-1860			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB4LK	31476770				2022-12-28	WOS:000488527900006
J	Peretto, G; Di Resta, C; Perversi, J; Forleo, C; Maggi, L; Politano, L; Barison, A; Previtali, SC; Carboni, N; Brun, F; Pegoraro, E; D'Amico, A; Rodolico, C; Magri, F; Manzi, RC; Palladino, A; Isola, F; Gigli, L; Mongini, TE; Semplicini, C; Calore, C; Ricci, G; Comi, GP; Ruggiero, L; Bertini, E; Bonomo, P; Nigro, G; Resta, N; Emdin, M; Favale, S; Siciliano, G; Santoro, L; Sinagra, G; Limongelli, G; Ambrosi, A; Ferrari, M; Golzio, PG; Della Bella, P; Benedetti, S; Sala, S				Peretto, Giovanni; Di Resta, Chiara; Perversi, Jacopo; Forleo, Cinzia; Maggi, Lorenzo; Politano, Luisa; Barison, Andrea; Previtali, Stefano C.; Carboni, Nicola; Brun, Francesca; Pegoraro, Elena; D'Amico, Adele; Rodolico, Carmelo; Magri, Francesca; Manzi, Rosa C.; Palladino, Alberto; Isola, Franco; Gigli, Lorenzo; Mongini, Tiziana E.; Semplicini, Claudio; Calore, Chiara; Ricci, Giulia; Comi, Giacomo P.; Ruggiero, Lucia; Bertini, Enrico; Bonomo, Paolo; Nigro, Gerardo; Resta, Nicoletta; Emdin, Michele; Favale, Stefano; Siciliano, Gabriele; Santoro, Lucio; Sinagra, Gianfranco; Limongelli, Giuseppe; Ambrosi, Alessandro; Ferrari, Maurizio; Golzio, Pier G.; Della Bella, Paolo; Benedetti, Sara; Sala, Simone		Italian Network Laminopathies NIL	Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy	ANNALS OF INTERNAL MEDICINE			English	Article							LAMIN A/C MUTATIONS; VENTRICULAR-ARRHYTHMIAS; DILATED CARDIOMYOPATHY; ESC GUIDELINES; RISK; ASSOCIATION; MANAGEMENT; CARRIERS; SOCIETY; UPDATE	Background: Mutations in the LMNA (lamin A/C) gene have been associated with neuromuscular and cardiac manifestations, but the clinical implications of these signs are not well understood. Objective: To learn more about the natural history of LMNA-related disease. Design: Observational study. Setting: 13 clinical centers in Italy from 2000 through 2018. Patients: 164 carriers of an LMNA mutation. Measurements: Detailed cardiologic and neurologic evaluation at study enrollment and for a median of 10 years of follow-up. Results: The median age at enrollment was 38 years, and 51% of participants were female. Neuromuscular manifestations preceded cardiac signs by a median of 11 years, but by the end of follow-up, 90% of the patients had electrical heart disease followed by structural heart disease. Overall, 10 patients (6%) died, 14 (9%) received a heart transplant, and 32 (20%) had malignant ventricular arrhythmias. Fifteen patients had gait loss, and 6 had respiratory failure. Atrial fibrillation and second- and third-degree atrioventricular block were observed, respectively, in 56% and 51% of patients with combined cardiac and neuromuscular manifestations and 37% and 33% of those with heart disease only. Limitations: Some of the data were collected retrospectively. Neuromuscular manifestations were more frequent in this analysis than in previous studies. Conclusion: Many patients with an LMNA mutation have neurologic symptoms by their 30s and develop progressive cardiac manifestations during the next decade. A substantial proportion of these patients will have life-threatening neurologic or cardiologic conditions. Primary Funding Source: None.	[Peretto, Giovanni; Di Resta, Chiara; Previtali, Stefano C.; Gigli, Lorenzo; Ambrosi, Alessandro; Ferrari, Maurizio; Della Bella, Paolo; Benedetti, Sara; Sala, Simone] IRCCS San Raffaele Hosp, Milan, Italy; [Peretto, Giovanni; Di Resta, Chiara; Previtali, Stefano C.; Gigli, Lorenzo; Ambrosi, Alessandro; Ferrari, Maurizio; Della Bella, Paolo; Benedetti, Sara; Sala, Simone] Univ Vita Salute San Raffaele, Milan, Italy; [Perversi, Jacopo; Mongini, Tiziana E.; Golzio, Pier G.] Azienda Osped Univ Citta Salute & Sci Torino, Corso Bramante 88, I-10126 Turin, Italy; [Forleo, Cinzia; Resta, Nicoletta; Favale, Stefano] Univ Bari Aldo Moro, Piazza Umberto 1, I-70121 Bari, Italy; [Maggi, Lorenzo] Fdn IRCCS Neurol Inst Carlo Besta, Via Giovanni Celoria 11, I-20133 Milan, Italy; [Politano, Luisa; Palladino, Alberto; Nigro, Gerardo; Limongelli, Giuseppe] Univ Campania Luigi Vanvitelli, Via Luciano Armanni 5, I-80138 Naples, Italy; [Barison, Andrea; Ricci, Giulia; Emdin, Michele; Siciliano, Gabriele] Gabriele Monasterio Fdn, Via Giuseppe Moruzzi 1, I-56124 Pisa, Italy; [Peretto, Giovanni; Di Resta, Chiara; Previtali, Stefano C.; Carboni, Nicola; Gigli, Lorenzo; Ferrari, Maurizio; Della Bella, Paolo; Benedetti, Sara; Sala, Simone] IRCCS San Raffaele Hosp, Via Olgettina 60, I-20132 Milan, Italy; [Carboni, Nicola] San Francesco Hosp, Via Salvatore Mannironi, I-08100 Nuoro, Italy; [Brun, Francesca; Siciliano, Gabriele; Sinagra, Gianfranco] Azienda Sanit Univ Integrata Trieste, Via Giovanni Sai 7, I-34128 Trieste, Italy; [Pegoraro, Elena; Semplicini, Claudio; Calore, Chiara] Univ Padua, Via Nicolo Giustiniani 2, I-35128 Padua, Italy; [D'Amico, Adele; Bertini, Enrico] Bambino Gesu Pediat Hosp, Piazza St Onofrio 4, I-00165 Rome, Italy; [Rodolico, Carmelo] Univ Messina, Piazza Pugliatti 1, I-98122 Messina, Italy; [Magri, Francesca; Comi, Giacomo P.] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Via Francesco Sforza 35, I-20122 Milan, Italy; [Manzi, Rosa C.; Isola, Franco; Bonomo, Paolo] Santissima Trinita Hosp, Via Is Mirrionis 92, I-09121 Cagliari, Italy; [Ricci, Giulia; Siciliano, Gabriele] Univ Pisa, Pisa, Italy; [Ruggiero, Lucia; Santoro, Lucio] Univ Naples Federico II, Corso Umberto 1 40, I-80138 Naples, Italy; [Nigro, Gerardo] Monaldi Hosp, Naples, Italy; [Limongelli, Giuseppe] Monaldi Hosp, Naples, Italy; [Limongelli, Giuseppe] UCL, London, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; A.O.U. Citta della Salute e della Scienza di Torino; Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Neurologico Besta; Universita della Campania Vanvitelli; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Trieste; University of Padua; IRCCS Bambino Gesu; University of Messina; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pisa; University of Naples Federico II; University of London; University College London	Peretto, G (corresponding author), Univ Vita Salute San Raffaele, Via Olgettina 60, I-20132 Milan, Italy.; Peretto, G (corresponding author), Osped San Raffaele, Via Olgettina 60, I-20132 Milan, Italy.	peretto.giovanni@hsr.it	Di Resta, Chiara/J-3627-2018; Sala, Simone/AAP-2524-2020; Sinagra, Gianfranco/AAE-3943-2020; Comi, Giacomo P/K-5702-2016; benedetti, sara/AHE-8098-2022; Bertini, Enrico/ABG-1278-2020; Peretto, Giovanni/AAG-5128-2021; POLITANO, LUISA/AAK-6885-2020; ambrosi, alessandro/H-4424-2011; Barison, Andrea/J-3609-2016; Bertini, Enrico/A-2284-2014	Sala, Simone/0000-0003-3303-8892; Comi, Giacomo P/0000-0002-1383-5248; ambrosi, alessandro/0000-0003-1976-5663; Barison, Andrea/0000-0001-9042-340X; Bertini, Enrico/0000-0001-9276-4590; Benedetti, Sara/0000-0003-2826-3040; Golzio, Pier Giorgio/0000-0002-6977-2223; DI RESTA, Chiara/0000-0003-2880-6631; RODOLICO, Carmelo/0000-0003-2543-6356				Al-Khatib SM, 2018, CIRCULATION, V138, pE210, DOI [10.1161/CIR.0000000000000549, 10.1161/CIR.0000000000000548]; Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Benedetti S, 2007, NEUROLOGY, V69, P1285, DOI 10.1212/01.wnl.0000261254.87181.80; Bozkurt B, 2016, CIRCULATION, V134, pE579, DOI 10.1161/CIR.0000000000000455; Carboni Nicola, 2013, Acta Myol, V32, P7; Charron P, 2012, ARRHYTH ELECTROPHYSI, V1, P22, DOI 10.15420/aer.2012.1.22; Hasselberg NE, 2018, EUR HEART J, V39, P853, DOI 10.1093/eurheartj/ehx596; Kumar S, 2016, J AM COLL CARDIOL, V68, P2299, DOI 10.1016/j.jacc.2016.08.058; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LIN F, 1993, J BIOL CHEM, V268, P16321; LOWN B, 1971, CIRCULATION, V44, P130, DOI 10.1161/01.CIR.44.1.130; Maggi L, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030033; Maggi L, 2014, NEUROLOGY, V83, P1634, DOI 10.1212/WNL.0000000000000934; Pasotti M, 2008, J AM COLL CARDIOL, V52, P1250, DOI 10.1016/j.jacc.2008.06.044; Peretto G, 2018, NUCLEUS-PHILA, V9, P380, DOI 10.1080/19491034.2018.1489195; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1; van Rijsingen IAW, 2012, J AM COLL CARDIOL, V59, P493, DOI 10.1016/j.jacc.2011.08.078; Vytopil M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e132; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]	22	24	24	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					458	+		10.7326/M18-2768	http://dx.doi.org/10.7326/M18-2768			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB4LK	31476771				2022-12-28	WOS:000488527900003
J	Li, XN; Liu, SH; Zhang, LD; Issaian, A; Hill, RC; Espinosa, S; Shi, SS; Cui, YX; Kappel, K; Das, R; Hansen, KC; Zhou, ZH; Zhao, R				Li, Xueni; Liu, Shiheng; Zhang, Lingdi; Issaian, Aaron; Hill, Ryan C.; Espinosa, Sara; Shi, Shasha; Cui, Yanxiang; Kappel, Kalli; Das, Rhiju; Hansen, Kirk C.; Zhou, Z. Hong; Zhao, Rui			A unified mechanism for intron and exon definition and back-splicing	NATURE			English	Article							CAP-BINDING COMPLEX; CIRCULAR RNAS; U1 SNRNP; YEAST; SPLICEOSOME; VISUALIZATION; RECOGNITION; MUTATIONS; SYSTEM; REVEAL	The molecular mechanisms of exon definition and back-splicing are fundamental unanswered questions in pre-mRNA splicing. Here we report cryo-electron microscopy structures of the yeast spliceosomal E complex assembled on introns, providing a view of the earliest event in the splicing cycle that commits pre-mRNAs to splicing. The E complex architecture suggests that the same spliceosome can assemble across an exon, and that it either remodels to span an intron for canonical linear splicing (typically on short exons) or catalyses back-splicing to generate circular RNA (on long exons). The model is supported by our experiments, which show that an E complex assembled on the middle exon of yeast EFM5 or HMRA1 can be chased into circular RNA when the exon is sufficiently long. This simple model unifies intron definition, exon definition, and back-splicing through the same spliceosome in all eukaryotes and should inspire experiments in many other systems to understand the mechanism and regulation of these processes.	[Li, Xueni; Zhang, Lingdi; Issaian, Aaron; Hill, Ryan C.; Espinosa, Sara; Shi, Shasha; Hansen, Kirk C.; Zhao, Rui] Univ Colorado Anschutz Med Campus, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Liu, Shiheng; Zhou, Z. Hong] UCLA, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Liu, Shiheng; Cui, Yanxiang; Zhou, Z. Hong] UCLA, Electron Imaging Ctr Nanomachines, Los Angeles, CA 90095 USA; [Kappel, Kalli; Das, Rhiju] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Zhao, Rui] Univ Colorado Anschutz Med Campus, Sch Med, RNA Biosci Initiat, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University; Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhao, R (corresponding author), Univ Colorado Anschutz Med Campus, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.; Zhou, ZH (corresponding author), UCLA, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Zhou, ZH (corresponding author), UCLA, Electron Imaging Ctr Nanomachines, Los Angeles, CA 90095 USA.; Zhao, R (corresponding author), Univ Colorado Anschutz Med Campus, Sch Med, RNA Biosci Initiat, Aurora, CO 80045 USA.	hong.zhou@ucla.edu; rui.zhao@cuanschutz.edu	Zhou, Z Hong/HDN-0747-2022	Kappel, Kalli/0000-0002-2129-199X; Das, Rhiju/0000-0001-7497-0972	NIH [GM126157, GM130673, GM071940, AI094386, GM122579, GM121487, CA219847, 1S10OD018111, 1U24GM116792, R01-GM129325]; NSF GRFP award; Stanford Graduate Fellowship; UCLA; NSF [DBI-1338135, DMR-1548924]; School of Medicine; University of Colorado Cancer Center Support Grant [P30CA046934]; NIGMS [P41-GM103311]; NATIONAL CANCER INSTITUTE [R01CA221282, P30CA046934, R21CA219847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126157, R01GM114178, R01GM130673, R35GM122579, U24GM116792, R01GM071940, R01GM129325, P41GM103311, R01GM121487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF GRFP award; Stanford Graduate Fellowship(Stanford University); UCLA; NSF(National Science Foundation (NSF)); School of Medicine; University of Colorado Cancer Center Support Grant; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM126157 and GM130673 (R.Z.); GM071940 and AI094386 (Z.H.Z.); and GM122579, GM121487, and CA219847 (R.D.). S.E. is a Howard Hughes Medical Institute Gilliam Fellow. K.K. was supported by an NSF GRFP award and a Stanford Graduate Fellowship. We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines (supported by UCLA and by grants from the NIH (1S10OD018111, 1U24GM116792) and NSF (DBI-1338135 and DMR-1548924)) as well as the CU Anschutz School of Medicine Cryo-EM and proteomics core facilities (partially supported by the School of Medicine and the University of Colorado Cancer Center Support Grant P30CA046934). Molecular graphics and analyses were performed with the UCSF Chimera and ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIGMS P41-GM103311 (Chimera, ChimeraX) and NIH R01-GM129325 (ChimeraX). We also thank M. Ares, D. Black, and D. Brow for comments on early versions of the manuscript.	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai R, 2018, SCIENCE, V360, P1423, DOI 10.1126/science.aau0325; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Campodonico E, 2002, GENETICS, V160, P407; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; De Conti L, 2013, WIRES RNA, V4, P49, DOI 10.1002/wrna.1140; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ester C, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-29; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gornemann J, 2011, RNA, V17, P2119, DOI 10.1261/rna.02646811; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Jacewicz A, 2015, RNA, V21, P401, DOI 10.1261/rna.048942.114; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kappel K, 2019, STRUCTURE, V27, P140, DOI 10.1016/j.str.2018.10.001; Kappel K, 2018, NAT METHODS, V15, P947, DOI 10.1038/s41592-018-0172-2; Keating KS, 2012, ACTA CRYSTALLOGR D, V68, P985, DOI 10.1107/S0907444912018549; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LESSER CF, 1993, GENETICS, V133, P851; Lewis JD, 1996, GENE DEV, V10, P1683, DOI 10.1101/gad.10.13.1683; Li XN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01241-9; Li XN, 2013, NUCLEIC ACIDS RES, V41, P3805, DOI 10.1093/nar/gkt062; LI ZR, 1993, NUCLEIC ACIDS RES, V21, P4645, DOI 10.1093/nar/21.19.4645; Liang DM, 2017, MOL CELL, V68, P940, DOI 10.1016/j.molcel.2017.10.034; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Liu JX, 2013, J BIOL CHEM, V288, P10890, DOI 10.1074/jbc.M113.460238; Liu SH, 2017, SCIENCE, V358, P1278, DOI 10.1126/science.aar3462; Lu M, 2009, J MOL BIOL, V393, P397, DOI 10.1016/j.jmb.2009.07.086; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2018, NATURE, V559, P420, DOI 10.1038/s41586-018-0323-8; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Qin DM, 2016, RNA, V22, P237, DOI 10.1261/rna.052829.115; Qiu ZCR, 2012, RNA, V18, P1996, DOI 10.1261/rna.033746.112; Ragan C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37037-0; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; RUBY SW, 1988, SCIENCE, V242, P1028, DOI 10.1126/science.2973660; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schneider M, 2010, MOL CELL, V38, P223, DOI 10.1016/j.molcel.2010.02.027; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Starke S, 2015, CELL REP, V10, P103, DOI 10.1016/j.celrep.2014.12.002; Wan RX, 2019, CELL, V177, P339, DOI 10.1016/j.cell.2019.02.006; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2; Wilusz JE, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1478; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zhang LD, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1523; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	59	67	68	5	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					375	+		10.1038/s41586-019-1523-6	http://dx.doi.org/10.1038/s41586-019-1523-6			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31485080	Green Submitted, Green Accepted			2022-12-28	WOS:000486647800041
J	Drazner, MH				Drazner, Mark H.			Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DYSFUNCTION; ENALAPRIL; FIBROSIS; LCZ696		[Drazner, Mark H.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Drazner, MH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mark.drazner@utsouthwestern.edu			Wooten Chair in Cardiology at the University of Texas Southwestern Medical Center	Wooten Chair in Cardiology at the University of Texas Southwestern Medical Center	Dr Drazner was supported by the JamesM. Wooten Chair in Cardiology at the University of Texas Southwestern Medical Center.	Al-Khatib Sana M, 2018, Circulation, V138, pe272, DOI 10.1161/CIR.0000000000000549; Desai AS, 2019, JAMA-J AM MED ASSOC, V322, P1077, DOI 10.1001/jama.2019.12843; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y; Januzzi JL, 2019, JAMA-J AM MED ASSOC, V322, P1085, DOI 10.1001/jama.2019.12821; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; KRUM H, 1995, CIRCULATION, V92, P1499, DOI 10.1161/01.CIR.92.6.1499; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Suematsu Y, 2016, EUR J HEART FAIL, V18, P386, DOI 10.1002/ejhf.474; Velazquez EJ, 2019, NEW ENGL J MED, V380, P539, DOI 10.1056/NEJMoa1812851; von Lueder TG, 2015, CIRC-HEART FAIL, V8, P71, DOI 10.1161/CIRCHEARTFAILURE.114.001785; Wang YW, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012272; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Zile MR, 2016, J AM COLL CARDIOL, V68, P2425, DOI 10.1016/j.jacc.2016.09.931	14	5	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1051	1053		10.1001/jama.2019.12662	http://dx.doi.org/10.1001/jama.2019.12662			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31475298				2022-12-28	WOS:000488821100017
J	Ducklow, H; Plank, T				Ducklow, Hugh; Plank, Terry			Volcano-stimulated marine photosynthesis	SCIENCE			English	Editorial Material									[Ducklow, Hugh; Plank, Terry] Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA	Columbia University	Ducklow, H (corresponding author), Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA.	hducklow@ldeo.columbia.edu		Plank, Terry/0000-0002-1665-0484				Babin SM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001938; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Duggen S, 2010, BIOGEOSCIENCES, V7, P827, DOI 10.5194/bg-7-827-2010; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GERLACH TM, 1985, NATURE, V313, P273, DOI 10.1038/313273a0; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Li Y, 2014, GEOCHIM COSMOCHIM AC, V129, P13, DOI 10.1016/j.gca.2013.12.031; Manga M, 2018, EARTH PLANET SC LETT, V489, P49, DOI 10.1016/j.epsl.2018.02.025; Neal CA, 2019, SCIENCE, V363, P367, DOI 10.1126/science.aav7046; Sanchez PA, 2003, GEODERMA, V114, P157, DOI 10.1016/S0016-7061(03)00040-5; SANSONE FJ, 1995, J GEOPHYS RES-OCEANS, V100, P13555, DOI 10.1029/95JC01120; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Wilson ST, 2019, SCIENCE, V365, P1040, DOI 10.1126/science.aax4767	14	1	1	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					978	979		10.1126/science.aay8088	http://dx.doi.org/10.1126/science.aay8088			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488671				2022-12-28	WOS:000484732700025
J	Canetta, S; Kellendonk, C				Canetta, Sarah; Kellendonk, Christoph			When Time Matters: An Adolescent Intervention to Prevent Adult Brain Dysfunction	CELL			English	Editorial Material							MOUSE MODEL	Can we one day prevent mental disorders? Mukherjee et al. (2019) use a genetic mouse model of schizophrenia-risk with established abnormalities in adult hippocampal-prefrontal circuit function and cognitive behaviors to identify circuit-specific treatments during adolescence that prevent the onset of the adult deficits.	[Canetta, Sarah; Kellendonk, Christoph] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA; [Kellendonk, Christoph] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Canetta, Sarah; Kellendonk, Christoph] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Kellendonk, C (corresponding author), Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA.; Kellendonk, C (corresponding author), Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY 10032 USA.; Kellendonk, C (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.	ck491@cumc.columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH107760] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Chun S, 2014, SCIENCE, V344, P1178, DOI 10.1126/science.1253895; Dienel S.J., 2018, NEUROBIOL DIS, V18, P30199; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Larsen B, 2018, NEUROSCI BIOBEHAV R, V94, P179, DOI 10.1016/j.neubiorev.2018.09.005; Meechan DW, 2015, CEREB CORTEX, V25, P1143, DOI 10.1093/cercor/bht308; Mukherjee A, 2019, CELL, V178, P1387, DOI 10.1016/j.cell.2019.07.023; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tamura M, 2016, NEURON, V89, P1100, DOI 10.1016/j.neuron.2016.01.025	10	1	1	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1282	1284		10.1016/j.cell.2019.08.015	http://dx.doi.org/10.1016/j.cell.2019.08.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474365	Bronze			2022-12-28	WOS:000483983000005
J	Cramer, P				Cramer, Patrick			Organization and regulation of gene transcription	NATURE			English	Review							RNA-POLYMERASE-II; PRE-INITIATION COMPLEX; BETA-GLOBIN GENE; STRUCTURAL BASIS; PREINITIATION COMPLEX; ELONGATION COMPLEX; C-MYC; PHASE-SEPARATION; P-TEFB; MITOCHONDRIAL TRANSCRIPTION	The regulated transcription of genes determines cell identity and function. Recent structural studies have elucidated mechanisms that govern the regulation of transcription by RNA polymerases during the initiation and elongation phases. Microscopy studies have revealed that transcription involves the condensation of factors in the cell nucleus. A model is emerging for the transcription of protein-coding genes in which distinct transient condensates form at gene promoters and in gene bodies to concentrate the factors required for transcription initiation and elongation, respectively. The transcribing enzyme RNA polymerase II may shuttle between these condensates in a phosphorylation-dependent manner. Molecular principles are being defined that rationalize transcriptional organization and regulation, and that will guide future investigations.	[Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de			Deutsche Forschungsgemeinschaft [SFB860, SPP1935, EXC 2067/1-390729940]; European Research Council (Advanced Investigator Grant TRANSREGULON) [693023]; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (Advanced Investigator Grant TRANSREGULON); Volkswagen Foundation(Volkswagen)	I would like to thank past and present members of the laboratory. I apologize to those colleagues whose work could not be cited owing to space restraints. I am supported by the Deutsche Forschungsgemeinschaft (SFB860, SPP1935 and EXC 2067/1-390729940), the European Research Council (Advanced Investigator Grant TRANSREGULON, grant agreement No 693023), and the Volkswagen Foundation.	Abascal-Palacios G, 2018, NATURE, V553, P301, DOI 10.1038/nature25441; Alekseev S, 2017, MOL CELL, V65, P504, DOI 10.1016/j.molcel.2017.01.012; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Andersen PR, 2017, NATURE, V549, P54, DOI 10.1038/nature23482; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Battaglia S, 2017, ELIFE, V6, DOI 10.7554/eLife.25637; Becker PB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017905; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bernecky C, 2017, NAT STRUCT MOL BIOL, V24, P809, DOI 10.1038/nsmb.3465; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Brown SA, 1998, EMBO J, V17, P3146, DOI 10.1093/emboj/17.11.3146; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Buckley MS, 2014, CURR OPIN GENET DEV, V25, P126, DOI 10.1016/j.gde.2014.01.002; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Castello A, 2016, MOL CELL, V63, P696, DOI 10.1016/j.molcel.2016.06.029; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen F, 2015, GENE DEV, V29, P39, DOI 10.1101/gad.246173.114; Chen FX, 2018, NAT REV MOL CELL BIO, V19, P464, DOI 10.1038/s41580-018-0010-5; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Cisse II, 2013, SCIENCE, V341, P664, DOI 10.1126/science.1239053; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dergai O, 2019, TRENDS GENET, V35, P457, DOI 10.1016/j.tig.2019.04.001; Dienemann C, 2019, MOL CELL, V73, P97, DOI 10.1016/j.molcel.2018.10.014; Ditlev JA, 2018, J MOL BIOL, V430, P4666, DOI 10.1016/j.jmb.2018.08.003; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Ehara H, 2019, SCIENCE, V363, P744, DOI 10.1126/science.aav8912; Ehara H, 2017, SCIENCE, V357, P921, DOI 10.1126/science.aan8552; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Engel C, 2018, ANNU REV BIOPHYS, V47, P425, DOI 10.1146/annurev-biophys-070317-033058; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; Farnung L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07870-y; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Feng Y, 2016, SCIENCE, V352, P1330, DOI 10.1126/science.aaf4417; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Fong YW, 2012, TRENDS CELL BIOL, V22, P292, DOI 10.1016/j.tcb.2012.04.002; French CA, 2016, ADV CANCER RES, V131, P21, DOI 10.1016/bs.acr.2016.04.001; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; GARIGLIO P, 1981, NUCLEIC ACIDS RES, V9, P2589, DOI 10.1093/nar/9.11.2589; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Gibson B. A., 2019, ORG REGULATION CHROM, DOI [10.1101/523662v1, DOI 10.1101/523662V1]; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GOKAL PK, 1990, J BIOL CHEM, V265, P16234; Gressel S, 2017, ELIFE, V6, DOI 10.7554/eLife.29736; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guo XY, 2018, MOL CELL, V69, P816, DOI 10.1016/j.molcel.2018.02.008; Guo YE, 2019, NATURE, V572, P543, DOI 10.1038/s41586-019-1464-0; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Haberle V, 2018, NAT REV MOL CELL BIO, V19, P621, DOI 10.1038/s41580-018-0028-8; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hillen HS, 2018, NAT STRUCT MOL BIOL, V25, P754, DOI 10.1038/s41594-018-0122-9; Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; Iwafuchi-Doi M, 2016, DEVELOPMENT, V143, P1833, DOI 10.1242/dev.133900; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Jeronimo C, 2017, TRENDS CELL BIOL, V27, P765, DOI 10.1016/j.tcb.2017.07.001; Jeronimo C, 2014, NAT STRUCT MOL BIOL, V21, P449, DOI 10.1038/nsmb.2810; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kamieniarz-Gdula K, 2019, TRENDS GENET, V35, P553, DOI 10.1016/j.tig.2019.05.005; Kang JY, 2018, CELL, V173, P1650, DOI 10.1016/j.cell.2018.05.017; KASSAVETIS GA, 1992, J MOL BIOL, V226, P47, DOI 10.1016/0022-2836(92)90123-2; KATO H, 1986, MOL CELL BIOL, V6, P3418, DOI 10.1128/MCB.6.10.3418; Kato M, 2018, ANNU REV BIOCHEM, V87, P351, DOI 10.1146/annurev-biochem-061516-044700; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kornberg RD, 1999, TRENDS BIOCHEM SCI, V24, pM46, DOI 10.1016/S0962-8924(99)01679-7; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kujirai T, 2018, SCIENCE, V362, P595, DOI 10.1126/science.aau9904; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Levens David, 2016, Biophys Rev, V8, P259, DOI 10.1007/s12551-016-0216-8; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Li Y, 2018, TRANSCR-AUSTIN, V9, P88, DOI 10.1080/21541264.2017.1281864; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Logquist A. K., 1993, NUCLEIC ACIDS RES, V21, P3233; Ngoc LV, 2017, GENE DEV, V31, P1289, DOI 10.1101/gad.303149.117; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 2017, Q REV BIOPHYS, V50, DOI 10.1017/S003358351700004X; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Lu FY, 2019, MOL CELL, V73, P1232, DOI 10.1016/j.molcel.2019.01.008; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Martinez-Rucobo FW, 2013, BBA-GENE REGUL MECH, V1829, P9, DOI 10.1016/j.bbagrm.2012.09.002; McDaniel SL, 2017, CELL MOL LIFE SCI, V74, P3317, DOI 10.1007/s00018-017-2517-x; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mortillaro MJ, 1996, P NATL ACAD SCI USA, V93, P8253, DOI 10.1073/pnas.93.16.8253; Muhlbacher W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5310; Muller F, 2014, BBA-GENE REGUL MECH, V1839, P118, DOI 10.1016/j.bbagrm.2013.11.003; MULVIHILL ER, 1982, CELL, V28, P621, DOI 10.1016/0092-8674(82)90217-3; Nair SJ, 2019, NAT STRUCT MOL BIOL, V26, P193, DOI 10.1038/s41594-019-0190-5; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Neyer S, 2016, NATURE, V540, P607, DOI 10.1038/nature20561; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nogales E, 2017, CURR OPIN STRUC BIOL, V47, P60, DOI 10.1016/j.sbi.2017.05.015; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Papantonis A, 2013, CHEM REV, V113, P8683, DOI 10.1021/cr300513p; Parua PK, 2018, NATURE, V558, P460, DOI 10.1038/s41586-018-0214-z; PAYVAR F, 1981, P NATL ACAD SCI-BIOL, V78, P6628, DOI 10.1073/pnas.78.11.6628; Pilsl M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12126; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Porrua O, 2016, TRENDS GENET, V32, P508, DOI 10.1016/j.tig.2016.05.007; Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008; Proudfoot NJ, 2016, SCIENCE, V352, DOI 10.1126/science.aad9926; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Pugh BF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149339; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ray-Soni A, 2016, ANNU REV BIOCHEM, V85, P319, DOI 10.1146/annurev-biochem-060815-014844; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robson MI, 2019, MOL CELL, V74, P1110, DOI 10.1016/j.molcel.2019.05.032; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saba J, 2019, ELIFE, V8, DOI 10.7554/eLife.40981; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sadian Y, 2017, EMBO J, V36, P2698, DOI 10.15252/embj.201796958; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Schilbach S, 2017, NATURE, V551, P204, DOI 10.1038/nature24282; SCHNAPP A, 1991, J BIOL CHEM, V266, P24588; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Sdano MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28723; SENTENAC A, 1985, CRC CR REV BIOCH MOL, V18, P31, DOI 10.3109/10409238509082539; Sentenac A, 2013, BBA-GENE REGUL MECH, V1829, P251, DOI 10.1016/j.bbagrm.2012.10.012; Shao WQ, 2017, NAT GENET, V49, P1045, DOI 10.1038/ng.3867; Sharifi S, 2018, ANNU REV BIOCHEM, V87, P51, DOI 10.1146/annurev-biochem-062917-012612; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Skene PJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02042; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Taatjes DJ, 2017, J MOL BIOL, V429, P2996, DOI 10.1016/j.jmb.2017.07.006; Talbert PB, 2019, NAT REV GENET, V20, P283, DOI 10.1038/s41576-019-0105-7; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tome JM, 2018, NAT GENET, V50, P1533, DOI 10.1038/s41588-018-0234-5; Tsai KL, 2017, NATURE, V544, P196, DOI 10.1038/nature21393; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Van Oss SB, 2017, TRENDS BIOCHEM SCI, V42, P788, DOI 10.1016/j.tibs.2017.08.003; van Steensel B, 2019, NAT REV MOL CELL BIO, V20, P327, DOI 10.1038/s41580-019-0114-6; Van Treeck B, 2018, CELL, V174, P791, DOI 10.1016/j.cell.2018.07.023; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vorlander MK, 2018, NATURE, V553, P295, DOI 10.1038/nature25440; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Wong KH, 2014, MOL CELL, V54, P601, DOI 10.1016/j.molcel.2014.03.024; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Yang Z., 2011, NATURE, V414, P317; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhu FJ, 2018, NATURE, V562, P76, DOI 10.1038/s41586-018-0549-5; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	228	210	212	40	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					45	54		10.1038/s41586-019-1517-4	http://dx.doi.org/10.1038/s41586-019-1517-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31462772				2022-12-28	WOS:000483967700033
J	Lai, AR; Sheu, L; Gensler, LS; McQuaid, K; Dhaliwal, G				Lai, Andrew R.; Sheu, Leslie; Gensler, Lianne S.; McQuaid, Kenneth; Dhaliwal, Gurpreet			A Terminal Event	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLAMMATORY BACK-PAIN; CROHNS-DISEASE; ANKYLOSING-SPONDYLITIS	A 54-year-old man presented with a 2-year history of constant, nonradiating lumbar pain. Over the 6 months before this presentation, severe back pain frequently awakened him from sleep. He reported no fevers, chills, weight loss, or gastrointestinal or urinary symptoms.	[Lai, Andrew R.; Sheu, Leslie; Gensler, Lianne S.; McQuaid, Kenneth; Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Gensler, Lianne S.; McQuaid, Kenneth; Dhaliwal, Gurpreet] San Francisco VA Med Ctr, Med Serv, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lai, AR (corresponding author), Univ Calif San Francisco, 505 Parnassus Ave,Box 0131, San Francisco, CA 94143 USA.	andrew.lai@ucsf.edu						Diekhoff T, 2017, ANN RHEUM DIS, V76, P1502, DOI 10.1136/annrheumdis-2016-210640; El-Kersh K, 2014, RESP CARE, V59, pE190, DOI 10.4187/respcare.03176; Eva Z, 2007, INFLAMM BOWEL DIS, V13, P1058, DOI 10.1002/ibd.20132; Freeman HJ, 2007, CAN J GASTROENTEROL, V21, P583, DOI 10.1155/2007/917649; Freeman HJ, 2014, WORLD J GASTROENTERO, V20, P9990, DOI 10.3748/wjg.v20.i29.9990; Kopylov U, 2018, J RHEUMATOL, V45, P498, DOI 10.3899/jrheum.161216; Lichtenstein GR, 2018, AM J GASTROENTEROL, V113, P481, DOI 10.1038/ajg.2018.27; Menees SB, 2015, AM J GASTROENTEROL, V110, P444, DOI 10.1038/ajg.2015.6; Park YS, 2011, J BONE JOINT SURG BR, V93B, P961, DOI 10.1302/0301-620X.93B7.26337; Rudwaleit M, 2006, ARTHRITIS RHEUM, V54, P569, DOI 10.1002/art.21619; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Sieper J, 2009, ANN RHEUM DIS, V68, P784, DOI 10.1136/ard.2008.101501; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369	15	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					970	976		10.1056/NEJMcps1813698	http://dx.doi.org/10.1056/NEJMcps1813698			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW9PR	31483969				2022-12-28	WOS:000485326200012
J	Shepherd, A				Shepherd, Alison			The naked truth about humans: new gallery opens at Wellcome Collection	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5378	10.1136/bmj.l5378	http://dx.doi.org/10.1136/bmj.l5378			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1EI	31481474				2022-12-28	WOS:000485434400008
J	Carvalho, AF; Heilig, M; Perez, A; Probst, C; Rehm, J				Carvalho, Andre F.; Heilig, Markus; Perez, Augusto; Probst, Charlotte; Rehm, Jurgen			Alcohol use disorders	LANCET			English	Review							SUBSTANCE USE DISORDERS; PRIMARY-HEALTH-CARE; NEUROKININ-1 RECEPTOR; COST-EFFECTIVENESS; BIAS MODIFICATION; HEAVY DRINKERS; DEPENDENCE; ADDICTION; MORTALITY; DRINKING	Alcohol use disorders consist of disorders characterised by compulsive heavy alcohol use and loss of control over alcohol intake. Alcohol use disorders are some of the most prevalent mental disorders globally, especially in high-income and upper-middle-income countries; and are associated with high mortality and burden of disease, mainly due to medical consequences, such as liver cirrhosis or injury. Despite their high prevalence, alcohol use disorders are undertreated partly because of the high stigma associated with them, but also because of insufficient systematic screening in primary health care, although effective and cost-effective psychosocial and pharmacological interventions do exist. Primary health care should be responsible for most treatment, with routine screening for alcohol use, and the provision of a staggered treatment response, from brief advice to pharmacological treatment. Clinical interventions for these disorders should be embedded in a supportive environment, which can be bolstered by the creation of alcohol control policies aimed at reducing the overall level of consumption.	[Carvalho, Andre F.; Probst, Charlotte; Rehm, Jurgen] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON M5S 2S1, Canada; [Carvalho, Andre F.; Rehm, Jurgen] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Rehm, Jurgen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Jurgen] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Heilig, Markus] Linkoping Univ, Dept Clin & Expt Med, Ctr Social & Affect Neurosci, Linkoping, Sweden; [Perez, Augusto] Corp Nuevos Rumbos, Bogota, Colombia; [Rehm, Jurgen] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Rehm, Jurgen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Rehm, Jurgen] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies, Dresden, Germany; [Rehm, Jurgen] Sechenov First Moscow State Med Univ, Inst Leadership & Hlth Management, Dept Int Hlth Projects, Moscow, Russia	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; Linkoping University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Technische Universitat Dresden; Technische Universitat Dresden; Sechenov First Moscow State Medical University	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON M5S 2S1, Canada.	jtrehm@gmail.com	Probst, Charlotte/GRJ-7877-2022		Swedish Research Council [2013-07434]; Canadian Institutes of Health Research, Institute of Neurosciences, Mental Health and Addiction (Canadian Research Initiative in Substance Misuse [CRISM]); Canadian Institutes of Health Research, Institute of Neurosciences, Mental Health and Addiction (Ontario Node grant) [SMN-13950]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes of Health Research, Institute of Neurosciences, Mental Health and Addiction (Canadian Research Initiative in Substance Misuse [CRISM])(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research, Institute of Neurosciences, Mental Health and Addiction (Ontario Node grant)(Canadian Institutes of Health Research (CIHR))	We thank Peter Anderson, Antoni Gual, Robin Room, Reinout Wiers and two other friendly reviewers who wish to remain anonymous. Antoni Gual had an integral role in the creation of figure 2. We would also like to thank Astrid Otto for referencing and thoroughly copy editing the text. MH acknowledges funding from the Swedish Research Council (grant 2013-07434). JR and CP acknowledge funding from the Canadian Institutes of Health Research, Institute of Neurosciences, Mental Health and Addiction (Canadian Research Initiative in Substance Misuse [CRISM]; Ontario Node grant number SMN-13950). None of the funding parties had any role in any aspect of the paper.	AGABIO R, 2018, COCHRANE DB SYST REV, V9, DOI DOI 10.3389/FPSYT.2018.00464; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Society of Clinical Psychopharmacology, 2019, ALC CLIN TRIALS IN A; Anderson P, 2017, NEW GOVERNANCE ADDIC; Anderson Peter, 2017, F1000Res, V6, P311, DOI 10.12688/f1000research.11173.2; Anderson P, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0837-z; Anderson P, 2016, ADDICTION, V111, P1935, DOI 10.1111/add.13476; Babor T.F., 2010, ALCOHOL NO ORDINARY, DOI 10.1093/acprof:oso/9780199551149.001.0001; Barrio P, 2018, ALCOHOL ALCOHOLISM, V53, P762, DOI 10.1093/alcalc/agy064; Boffo M, 2019, NEUROPSYCHOL REV, V29, P52, DOI 10.1007/s11065-018-9386-4; Browne AL, 2013, INJURY, V44, P110, DOI 10.1016/j.injury.2012.01.008; Bruchas MR, 2010, BRAIN RES, V1314, P44, DOI 10.1016/j.brainres.2009.08.062; Casswell S, 2018, DRUG ALCOHOL REV, V37, pS86, DOI 10.1111/dar.12669; Castaldelli-Maia JM, 2014, INT REV PSYCHIATR, V26, P352, DOI 10.3109/09540261.2014.899999; Charlson FJ., 2016, MENTAL NEUROLOGICAL, P41, DOI DOI 10.1596/978-1-4648-0426-7; Chartier KG, 2010, CHILD ADOL PSYCH CL, V19, P493, DOI 10.1016/j.chc.2010.03.004; Chisholm D, 2018, J STUD ALCOHOL DRUGS, V79, P514, DOI 10.15288/jsad.2018.79.514; Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Collins SE, 2016, ALCOHOL RES-CURR REV, V38, P83; Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Cristea IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162226; Degenhardt L, 2019, ADDICTION, V114, P534, DOI 10.1111/add.14482; Domi E, 2018, NEUROPSYCHOPHARMACOL, V43, P1805, DOI 10.1038/s41386-018-0015-y; Erol A, 2015, DRUG ALCOHOL DEPEN, V156, P1, DOI 10.1016/j.drugalcdep.2015.08.023; European Medicines Agency, 2010, GUID DEV MED PROD TR; George DT, 2008, SCIENCE, V319, P1536, DOI 10.1126/science.1153813; Harris AHS, 2010, PSYCHIAT SERV, V61, P392, DOI 10.1176/ps.2010.61.4.392; Hasin DS, 2017, LANCET PSYCHIAT, V4, P469, DOI 10.1016/S2215-0366(17)30130-X; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Heilig M, 2017, GENES BRAIN BEHAV, V16, P86, DOI 10.1111/gbb.12344; Heilig M, 2010, ADDICT BIOL, V15, P169, DOI 10.1111/j.1369-1600.2009.00194.x; HEMSTROM O, 2002, CONTEMP DRUG PROBL, V29, P577; Hesse M, INTEGRATED PSYCHOL T; [Inter-American Drug Abuse Control Commission (CICAD) Organization of American States Observatorio Interamericano de Drogas], 2015, INF US DROG AM; JELLINEK E M, 1960, Can Med Assoc J, V83, P1341; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Jorgenson E, 2017, MOL PSYCHIATR, V22, P1359, DOI 10.1038/mp.2017.101; Kakoschke N, 2017, ADDICT BEHAV, V64, P21, DOI 10.1016/j.addbeh.2016.08.007; Kaner EFS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011479.pub2; King AC, 2016, BIOL PSYCHIAT, V79, P489, DOI 10.1016/j.biopsych.2015.05.007; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Koob George F, 2014, Handb Clin Neurol, V125, P33, DOI 10.1016/B978-0-444-62619-6.00003-3; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Kranzler HR, 2018, JAMA-J AM MED ASSOC, V320, P815, DOI 10.1001/jama.2018.11406; Kranzler HR, 2014, AM J PSYCHIAT, V171, P445, DOI 10.1176/appi.ajp.2013.13081014; Lange S, 2019, ALCOHOL CLIN EXP RES, V43, P2028, DOI 10.1111/acer.14171; Lee MR, 2020, MOL PSYCHIATR, V25, P461, DOI 10.1038/s41380-018-0064-y; Leggio L, 2014, BIOL PSYCHIAT, V76, P734, DOI 10.1016/j.biopsych.2014.03.019; Leucht S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0494-1; Leung RK, 2014, HEALTH PSYCHOL REV, V8, P426, DOI 10.1080/17437199.2011.587961; Lewer D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3265-9; Lewis M, 2018, NEW ENGL J MED, V379, P1551, DOI 10.1056/NEJMra1602872; Li DW, 2012, HUM GENET, V131, P725, DOI 10.1007/s00439-011-1116-4; Li JJ, 2017, J STUD ALCOHOL DRUGS, V78, P442, DOI 10.15288/jsad.2017.78.442; Magill M, 2015, ALCOHOL CLIN EXP RES, V39, P1852, DOI 10.1111/acer.12848; Manthey J, 2019, LANCET, V393, P2493, DOI 10.1016/S0140-6736(18)32744-2; Martin CS, 2014, ADDICTION, V109, P1773, DOI 10.1111/add.12615; Mattick RP, 2018, LANCET PUBLIC HEALTH, V3, pE64, DOI 10.1016/S2468-2667(17)30240-2; MILLER E, 2003, HDB ALCOHOLISM TREAT, P13; Miller WR, 2015, ADDICTION, V110, P401, DOI 10.1111/add.12693; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; Ministerio de Justicia y Ministerio de Salud & Observatorio de Drogas de Colombia, 2016, EST NAC CONS SUST PS; Ministerio de Justicia y Ministerio de Salud & Observatorio de Drogas de Columbia, EST NAC CONS SUST PS; Morgenstern M, 2014, ADDICTION, V109, P2005, DOI 10.1111/add.12667; Naqvi NH, 2015, ALCOHOL RES-CURR REV, V37, P29; National Center for Biotechnology Information, 2018, SCREEN BEH COUNS INT; National Institute for Health and Care Excellence (NICE), 2011, ALCOHOL USE DISORDER; Nutt DJ, 2014, J PSYCHOPHARMACOL, V28, P3, DOI 10.1177/0269881113512038; Pandey SC, 2017, NEUROPHARMACOLOGY, V122, P74, DOI 10.1016/j.neuropharm.2017.02.002; Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X; Perez A, 2015, CONSUMO ESTUDIO ALCO; Polimanti R, 2018, MOL PSYCHIATR, V23, P154, DOI 10.1038/mp.2017.24; Probst C, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1080-0; Probst C, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0028-z; Probst C, 2015, DRUG ALCOHOL REV, V34, P267, DOI 10.1111/dar.12184; Pucci M, 2019, NEUROSCI BIOBEHAV R, V106, P165, DOI 10.1016/j.neubiorev.2018.07.004; Rathod SD, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023421; Ratti E, 2013, J PSYCHOPHARMACOL, V27, P424, DOI 10.1177/0269881113480990; Rehm J, 2018, EXPERT REV PHARM OUT, V18, P43, DOI 10.1080/14737167.2018.1392241; Rehm J, 2015, EUR PSYCHIAT, V30, P885, DOI 10.1016/j.eurpsy.2015.07.012; Rehm J, 2014, ALCOHOL ALCOHOLISM, V49, P118, DOI 10.1093/alcalc/agt171; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P633, DOI 10.1093/alcalc/agt127; Rehm J, 2013, EUR NEUROPSYCHOPHARM, V23, P89, DOI 10.1016/j.euroneuro.2012.08.001; Rehm J, ALCOHOL CLIN EXP RES; Rehm J, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-0997-0; Rehm J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0934-1; Rehm J, 2022, LANCET, V399, pE7, DOI [10.1016/S0140-6736(15)00122-1, 10.1016/S0140-6736(15)00123-3]; Rehm J, 2016, INT J METH PSYCH RES, V25, P79, DOI 10.1002/mpr.1508; Rehm J, 2015, ALCOHOL ALCOHOLISM, V50, P310, DOI 10.1093/alcalc/agv009; Rehm J, 2015, ANN FAM MED, V13, P28, DOI 10.1370/afm.1742; Rehm J, 2014, ALCOHOL CLIN EXP RES, V38, P1068, DOI 10.1111/acer.12331; Rehm J, 2017, NORD STUD ALCOHOL DR, V34, P330, DOI 10.1177/1455072517704795; Rehm J, 2016, ALCOHOL ALCOHOLISM, V51, P422, DOI 10.1093/alcalc/agv127; Riper H, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002714; Roerecke M, 2015, J PSYCHOPHARMACOL, V29, P1152, DOI 10.1177/0269881115602487; Roerecke M, 2013, J CLIN PSYCHIAT, V74, pE1181, DOI 10.4088/JCP.13r08379; Rolland B, 2016, CNS NEUROSCI THER, V22, P25, DOI 10.1111/cns.12489; Room R, 1998, DRUG ALCOHOL REV, V17, P305, DOI 10.1080/09595239800187141; Room R, 2019, ADDICTION, V114, P553, DOI 10.1111/add.14560; Rosenstrom T, 2018, ADDICTION, V113, P15, DOI 10.1111/add.13951; Samokhvalov AV, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1770-3; Samokhvalov AV, 2010, ALCOHOL CLIN EXP RES, V34, P1871, DOI 10.1111/j.1530-0277.2010.01275.x; Sanchez-Roige S, 2019, AM J PSYCHIAT, V176, P107, DOI 10.1176/appi.ajp.2018.18040369; Saunders JB, 2019, ALCOHOL CLIN EXP RES, V43, P1617, DOI 10.1111/acer.14128; Schank JR, 2017, INT REV NEUROBIOL, V136, P151, DOI 10.1016/bs.irn.2017.06.008; Schomerus G, 2014, EUR ADDICT RES, V20, P293, DOI 10.1159/000362407; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Schulte MHJ, 2014, CLIN PSYCHOL REV, V34, P531, DOI 10.1016/j.cpr.2014.08.002; Schumann G, 2016, P NATL ACAD SCI USA, V113, P14372, DOI 10.1073/pnas.1611243113; Schwarzinger M, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4587-y; Sornpaisarn B, 2017, RESOURCE TOOL ALCOHO; Soyka M, 2017, WORLD J BIOL PSYCHIA, V18, P86, DOI 10.1080/15622975.2016.1246752; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Stockwell Tim, 2012, Am J Public Health, V102, pe103, DOI 10.2105/AJPH.2012.301094; Storbjork J., 2006, CONTEMP DRUG PROBL, V33, P611; Summers LH, 2015, LANCET, V386, P2112, DOI 10.1016/S0140-6736(15)00242-1; Tawa EA, 2016, ALCOHOL ALCOHOLISM, V51, P507, DOI 10.1093/alcalc/agw046; Urban NBL, 2010, BIOL PSYCHIAT, V68, P689, DOI 10.1016/j.biopsych.2010.06.005; Urbanoski K, 2018, EMERG MED J, V35, P220, DOI 10.1136/emermed-2015-205554; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018; Vendruscolo LF, 2015, J CLIN INVEST, V125, P3193, DOI 10.1172/JCI79828; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; Viel G, 2012, INT J MOL SCI, V13, P14788, DOI 10.3390/ijms131114788; Vigo DV, 2019, LANCET PSYCHIAT, V6, P350, DOI 10.1016/S2215-0366(18)30434-6; Volkow ND, 2016, NEW ENGL J MED, V374, P363, DOI 10.1056/NEJMra1511480; Walters GD, 2000, AM J DRUG ALCOHOL AB, V26, P443, DOI 10.1081/ADA-100100255; Westman J, 2015, ACTA PSYCHIAT SCAND, V131, P297, DOI 10.1111/acps.12330; Westwood G, 2017, J HEPATOL, V67, P559, DOI 10.1016/j.jhep.2017.04.017; WHO, 2017, BEST BUYS OTH REC IN; WHO, 2018, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; WHO European Region, 2019, ALC CONS HARM POL RE; Wiers RW, 2018, J STUD ALCOHOL DRUGS, V79, P333, DOI 10.15288/jsad.2018.79.333; Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Wurst FM, 2015, ALCOHOL CLIN EXP RES, V39, P2060, DOI 10.1111/acer.12851; Yang P, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00303; Yap MBH, 2017, ADDICTION, V112, P1142, DOI 10.1111/add.13785	139	179	181	11	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					781	792		10.1016/S0140-6736(19)31775-1	http://dx.doi.org/10.1016/S0140-6736(19)31775-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UW	31478502				2022-12-28	WOS:000483011400031
J	Kemet, S				Kemet, Shakkaura			Insight Medicine Lacks - The Continuing Relevance of Henrietta Lacks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kemet, Shakkaura] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kemet, S (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.			Kemet, Shakkaura/0000-0003-0316-2796				Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; Feldman WB, 2018, HEALTH AFFAIR, V37, P1605, DOI 10.1377/hlthaff.2018.0501; Skloot, 2017, IMMORTAL LIFE HENRIE	3	9	9	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					800	801		10.1056/NEJMp1905346	http://dx.doi.org/10.1056/NEJMp1905346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461594	Bronze			2022-12-28	WOS:000484431200007
J	Houston, H				Houston, Heidi			A tale of two trenches	SCIENCE			English	Editorial Material							SLOW EARTHQUAKES; MEGATHRUST; TREMOR		[Houston, Heidi] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of Southern California	Houston, H (corresponding author), Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	heidi.houston@gmail.com			NSF [EAR-1911629]	NSF(National Science Foundation (NSF))	Supported by NSF grant EAR-1911629.	Beroza GC, 2011, ANNU REV EARTH PL SC, V39, P271, DOI 10.1146/annurev-earth-040809-152531; Houston H, 2015, NAT GEOSCI, V8, P409, DOI [10.1038/NGEO2419, 10.1038/ngeo2419]; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Nishikawa T, 2019, SCIENCE, V365, P808, DOI 10.1126/science.aax5618; Obara K, 2016, SCIENCE, V353, P253, DOI 10.1126/science.aaf1512; Ohta K, 2019, GEOPHYS RES LETT, V46, P4591, DOI 10.1029/2019GL082468; Sagiya T, 1999, J GEOPHYS RES-SOL EA, V104, P1111, DOI 10.1029/98JB02644; Tanaka Y, 2019, GEOPHYS RES LETT, V46, P1367, DOI 10.1029/2018GL080741; Uchida N, 2016, SCIENCE, V351, P488, DOI 10.1126/science.aad3108; Warren-Smith E, 2019, NAT GEOSCI, V12, P475, DOI 10.1038/s41561-019-0367-x	11	0	0	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		750	751		10.1126/science.aay5621	http://dx.doi.org/10.1126/science.aay5621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439780				2022-12-28	WOS:000482464000026
J	Penilla, EH; Devia-Cruz, LF; Wieg, AT; Martinez-Torres, P; Cuando-Espitia, N; Sellappan, P; Kodera, Y; Aguilar, G; Garay, JE				Penilla, E. H.; Devia-Cruz, L. F.; Wieg, A. T.; Martinez-Torres, P.; Cuando-Espitia, N.; Sellappan, P.; Kodera, Y.; Aguilar, G.; Garay, J. E.			Ultrafast laser welding of ceramics	SCIENCE			English	Article							YTTRIA-STABILIZED-ZIRCONIA; TRANSPARENT; ALUMINA; PERFORMANCE; SCIENCE; OXIDE	Welding of ceramics is a key missing component in modern manufacturing. Current methods cannot join ceramics in proximity to temperature-sensitive materials like polymers and electronic components. We introduce an ultrafast pulsed laser welding approach that relies on focusing light on interfaces to ensure an optical interaction volume in ceramics to stimulate nonlinear absorption processes, causing localized melting rather than ablation. The key is the interplay between linear and nonlinear optical properties and laser energy-material coupling. The welded ceramic assemblies hold high vacuum and have shear strengths comparable to metal-to-ceramic diffusion bonds. Laser welding can make ceramics integral components in devices for harsh environments as well as in optoelectronic and/or electronic packages needing visible-radio frequency transparency.	[Penilla, E. H.; Devia-Cruz, L. F.; Wieg, A. T.; Sellappan, P.; Kodera, Y.; Garay, J. E.] Univ Calif San Diego, Mat Sci & Engn Program, San Diego, CA 92103 USA; [Penilla, E. H.; Devia-Cruz, L. F.; Wieg, A. T.; Martinez-Torres, P.; Cuando-Espitia, N.; Sellappan, P.; Kodera, Y.; Aguilar, G.; Garay, J. E.] Univ Calif San Diego, Mech & Aerosp Engn Dept, San Diego, CA 92103 USA; [Devia-Cruz, L. F.; Martinez-Torres, P.; Cuando-Espitia, N.; Aguilar, G.] Univ Calif Riverside, Mech Engn Dept, Riverside, CA 92521 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Riverside	Garay, JE (corresponding author), Univ Calif San Diego, Mat Sci & Engn Program, San Diego, CA 92103 USA.; Garay, JE (corresponding author), Univ Calif San Diego, Mech & Aerosp Engn Dept, San Diego, CA 92103 USA.	jegaray@ucsd.edu	Sellappan, Pathikumar/H-9093-2012; Aguilar, Guillermo/M-8353-2017	Sellappan, Pathikumar/0000-0002-7819-6336; Aguilar, Guillermo/0000-0001-7326-1162; Devia-Cruz, Luis Felipe/0000-0002-1987-6120; Kodera, Yasuhiro/0000-0002-6173-7474; Penilla, Elias/0000-0001-5919-7731; Martinez-Torres, Pablo/0000-0002-7581-3693; Cuando, Natanael/0000-0002-2018-8552	Defense Advanced Research Projects Agency (DARPA) [HR0011-16-2-0018]; Office of Naval Research (ONR) [N00014-17-1-2594]; National Science Foundation (NSF) [1545852]; UCR's Office of Research and Economic Development	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); UCR's Office of Research and Economic Development	Funding of this work by Defense Advanced Research Projects Agency (DARPA contract HR0011-16-2-0018) is most gratefully acknowledged. Partial funding from the Office of Naval Research (ONR-N00014-17-1-2594) is also gratefully acknowledged. The National Science Foundation (NSF-PIRE grant contract 1545852) and UCR's Office of Research and Economic Development are also acknowledged for the financial support toward the purchase of the laser system.	AKSELSEN OM, 1992, J MATER SCI, V27, P569, DOI 10.1007/BF02403862; Alaniz JE, 2009, OPT MATER, V32, P62, DOI 10.1016/j.optmat.2009.06.004; Buban JP, 2006, SCIENCE, V311, P212, DOI 10.1126/science.1119839; Casolco SR, 2008, SCRIPTA MATER, V58, P516, DOI 10.1016/j.scriptamat.2007.11.014; Castillo-Vega GR, 2012, OPT MATER EXPRESS, V2, P1416, DOI 10.1364/OME.2.001416; Chen F, 2014, LASER PHOTONICS REV, V8, P251, DOI 10.1002/lpor.201300025; Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250; Christel P. S., 1992, CLIN ORTHOP RELAT R, V282, P8; Damestani Y, 2013, NANOMED-NANOTECHNOL, V9, P1135, DOI 10.1016/j.nano.2013.08.002; DEPARIS A, 1991, J PHYS IV, V1, P127, DOI 10.1051/jp4:1991726; du Merac MR, 2013, J AM CERAM SOC, V96, P3341, DOI 10.1111/jace.12637; Dupuy AD, 2016, ADV MATER, V28, P7970, DOI 10.1002/adma.201600947; Eckel ZC, 2016, SCIENCE, V351, P58, DOI 10.1126/science.aad2688; Exner H., 1999, P SPIE LASER APPL MI, P262; Fernie JA, 2009, INT MATER REV, V54, P283, DOI 10.1179/174328009X461078; Garay JE, 2010, ANNU REV MATER RES, V40, P445, DOI [10.1146/annurev-matsci-070909-104433, 10.1146/annurev-matsci-070909-10443]; Gutierrez MI, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700214; Hardin CL, 2013, OPT MATER EXPRESS, V3, P893, DOI 10.1364/OME.3.000893; Hu A., 2011, OPEN SURF SCI J, V3, P42, DOI [10.2174/1876531901103010042, DOI 10.2174/1876531901103010042]; Ikesue A, 2008, NAT PHOTONICS, V2, P721, DOI 10.1038/nphoton.2008.243; Itoh K, 2006, MRS BULL, V31, P620, DOI 10.1557/mrs2006.159; Kim MG, 2011, NAT MATER, V10, P382, DOI [10.1038/nmat3011, 10.1038/NMAT3011]; Kodera Y, 2013, SCRIPTA MATER, V69, P149, DOI 10.1016/j.scriptamat.2013.02.013; Lee SH, 2006, J AM CERAM SOC, V89, P1945, DOI 10.1111/j.1551-2916.2006.01051.x; Li YZ, 2017, CERAM INT, V43, P7768, DOI 10.1016/j.ceramint.2017.03.085; Malinauskas M, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.133; Martin JH, 2017, NATURE, V549, P365, DOI 10.1038/nature23894; Padture NP, 2002, SCIENCE, V296, P280, DOI 10.1126/science.1068609; Penilla EH, 2016, J APPL PHYS, V119, DOI 10.1063/1.4939090; Penilla EH, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/s41377-018-0023-z; RIVIERE C, 1994, J PHYS IV, V4, P135, DOI 10.1051/jp4:1994429; Sellappan P, 2017, MATER RES LETT, V5, P41, DOI 10.1080/21663831.2016.1195779; Shishkovsky I, 2007, APPL SURF SCI, V254, P966, DOI 10.1016/j.apsusc.2007.09.001; Steele BCH, 2001, J MATER SCI, V36, P1053, DOI 10.1023/A:1004853019349; Tamaki T, 2005, JPN J APPL PHYS 2, V44, pL687, DOI 10.1143/JJAP.44.L687; Travessa D, 2002, MAT SCI ENG A-STRUCT, V337, P287, DOI 10.1016/S0921-5093(02)00046-1; U. S. Department of Defense (DOD), 2004, MIL883TM10141 DOD; U. S. Department of Defense (DOD), 2004, MIL883TM101412 DOD, V12; Wieg AT, 2016, APL MATER, V4, DOI 10.1063/1.4971846; Yap CY, 2015, APPL PHYS REV, V2, DOI 10.1063/1.4935926	40	68	68	21	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		803	+		10.1126/science.aaw6699	http://dx.doi.org/10.1126/science.aaw6699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439794	Green Submitted			2022-12-28	WOS:000482464000050
J	Zastrow, M				Zastrow, Mark			THE CRYSTAL KINGS	NATURE			English	News Item																		Caldwell JD, 2019, NAT REV MATER, V4, P552, DOI 10.1038/s41578-019-0124-1; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Rhodes D, 2019, NAT MATER, V18, P541, DOI 10.1038/s41563-019-0366-8; Serlin M., 2019, PREPRINT; Sharpe A. L., 2019, PREPRINT; Taniguchi T, 2002, JPN J APPL PHYS 2, V41, pL109, DOI 10.1143/JJAP.41.L109; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134	10	16	16	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2019	572	7770					429	432		10.1038/d41586-019-02472-0	http://dx.doi.org/10.1038/d41586-019-02472-0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS5UZ	31435060				2022-12-28	WOS:000482219600018
J	Legoux, F; Bellet, D; Daviaud, C; El Morr, Y; Darbois, A; Niort, K; Procopio, E; Salou, M; Gilet, J; Ryffel, B; Balvay, A; Foussier, A; Sarkis, M; El Marjou, A; Schmidt, F; Rabot, S; Lantz, O				Legoux, Francois; Bellet, Deborah; Daviaud, Celine; El Morr, Yara; Darbois, Aurelie; Niort, Kristina; Procopio, Emanuele; Salou, Marion; Gilet, Jules; Ryffel, Bernhard; Balvay, Aurelie; Foussier, Anne; Sarkis, Manal; El Marjou, Ahmed; Schmidt, Frederic; Rabot, Sylvie; Lantz, Olivier			Microbial metabolites control the thymic development of mucosal-associated invariant T cells	SCIENCE			English	Article							MOUSE; MAIT; RIBOFLAVIN; SELECTION; MR1	How the microbiota modulate immune functions remains poorly understood. Mucosal-associated invariant T (MAIT) cells are implicated in mucosal homeostasis and absent in germ-free mice. Here, we show that commensal bacteria govern murine MAIT intrathymic development, as MAIT cells did not recirculate to the thymus. MAIT development required RibD expression in bacteria, indicating that production of the MAIT antigen 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU) was necessary. 5-OP-RU rapidly traveled from mucosal surfaces to the thymus, where it was captured by the major histocompatibility complex class Ib molecule MR1. This led to increased numbers of the earliest MAIT precursors and the expansion of more mature receptor-related, orphan receptor gamma t-positive MAIT cells. Thus, a microbiota-derived metabolite controls the development of mucosally targeted T cells in a process blurring the distinction between exogenous antigens and self-antigens.	[Legoux, Francois; Daviaud, Celine; El Morr, Yara; Darbois, Aurelie; Procopio, Emanuele; Salou, Marion; Gilet, Jules; Sarkis, Manal; Lantz, Olivier] PSL Univ, Inst Curie, INSERM, U932, F-75005 Paris, France; [Bellet, Deborah; Balvay, Aurelie; Foussier, Anne; Rabot, Sylvie] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France; [Daviaud, Celine] Inst Curie, Anim Facil, F-75005 Paris, France; [Niort, Kristina; El Marjou, Ahmed] Inst Curie, Recombinant Prot Facil, F-75005 Paris, France; [Ryffel, Bernhard] Univ Orleans, CNRS, UMR7355, F-45060 Orleans, France; [Sarkis, Manal; Schmidt, Frederic] PSL Univ, Inst Curie, INSERM, U1143,CNRS,UMR3666, F-75005 Paris, France; [Lantz, Olivier] Inst Curie, Lab Immunol Clin, F-75005 Paris, France; [Lantz, Olivier] Inst Curie, Ctr Invest Clin Biotherapie, Gustave Roussy Inst Curie CIC BT1428, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Legoux, F; Lantz, O (corresponding author), PSL Univ, Inst Curie, INSERM, U932, F-75005 Paris, France.; Lantz, O (corresponding author), Inst Curie, Lab Immunol Clin, F-75005 Paris, France.; Lantz, O (corresponding author), Inst Curie, Ctr Invest Clin Biotherapie, Gustave Roussy Inst Curie CIC BT1428, F-75005 Paris, France.	francois.legoux@curie.fr; olivier.lantz@curie.fr	Schmidt, Frederic/F-8946-2016	Schmidt, Frederic/0000-0002-1537-3585; GILET, Jules/0000-0002-1132-9608; , BELLET/0000-0002-5571-2668; Salou, Marion/0000-0003-3546-0886; Lantz, olivier/0000-0003-3161-7719	Marie-Sklodowska Curie individual fellowship from the European Commission (H2020) [706353]; Institut National de la Sante et de la Recherche Medicale; Institut Curie; Agence Nationale de la Recherche (ANR); Equipe Labellisee de la Ligue Contre le Cancer	Marie-Sklodowska Curie individual fellowship from the European Commission (H2020); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Equipe Labellisee de la Ligue Contre le Cancer	F.L. was supported by a Marie-Sklodowska Curie individual fellowship (706353) from the European Commission (H2020). This work was supported by the Institut National de la Sante et de la Recherche Medicale, Institut Curie, and Agence Nationale de la Recherche (ANR) [Blanc (neoMAIT, MAIT, and diabMAIT) and Labex DCBIOL]. O.L.'s group is supported by the Equipe Labellisee de la Ligue Contre le Cancer.	Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Legoux F, 2019, NAT IMMUNOL, V20, P1244, DOI 10.1038/s41590-019-0465-3; Legoux FP, 2012, JOVE-J VIS EXP, DOI 10.3791/4420; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Miyazaki Y, 2011, INT IMMUNOL, V23, P529, DOI 10.1093/intimm/dxr047; Mondot S, 2016, IMMUNOGENETICS, V68, P537, DOI 10.1007/s00251-016-0927-9; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Rouxel O, 2017, NAT IMMUNOL, V18, P1321, DOI 10.1038/ni.3854; Salou M, 2019, J EXP MED, V216, P133, DOI 10.1084/jem.20181483; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Soudais C, 2015, J IMMUNOL, V194, P4641, DOI 10.4049/jimmunol.1403224; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; Varelias A, 2018, J CLIN INVEST, V128, P1919, DOI 10.1172/JCI91646; Xing LY, 2014, JOVE-J VIS EXP, DOI 10.3791/51138	31	138	140	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2019	366	6464					494	+		10.1126/science.aaw2719	http://dx.doi.org/10.1126/science.aaw2719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JI0SR	31467190				2022-12-28	WOS:000493177900048
J	Silbermann, E; Bourdette, D				Silbermann, Elizabeth; Bourdette, Dennis			A new era for neuromyelitis optica spectrum disorder	LANCET			English	Editorial Material									[Silbermann, Elizabeth; Bourdette, Dennis] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA	Oregon Health & Science University	Bourdette, D (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA.	bourdett@ohsu.edu						Chen D, 2016, J CLIN MED, V5, DOI 10.3390/jcm5120107; Cree BAC, 2019, LANCET, V394, P1352, DOI 10.1016/S0140-6736(19)31817-3; Damato V, 2016, JAMA NEUROL, V73, P1342, DOI 10.1001/jamaneurol.2016.1637; Forsthuber TG, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418761697; Jarius S, 2012, J NEUROL, V259, P1354, DOI 10.1007/s00415-011-6355-8; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Pittock SJ, 2019, NEW ENGL J MED, V381, P614, DOI 10.1056/NEJMoa1900866; Yamamura T, 2019, NEUROLOGY, V92	8	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1304	1305		10.1016/S0140-6736(19)31878-1	http://dx.doi.org/10.1016/S0140-6736(19)31878-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9RJ	31495499				2022-12-28	WOS:000489613700007
J	Staff, AC				Staff, Anne Cathrine			Long-term cardiovascular health after stopping pre-eclampsia	LANCET			English	Editorial Material									[Staff, Anne Cathrine] Univ Oslo, Fac Med, N-0381 Oslo, Norway; [Staff, Anne Cathrine] Oslo Univ Hosp, Div Obstet & Gynaecol, Oslo, Norway	University of Oslo; University of Oslo	Staff, AC (corresponding author), Univ Oslo, Fac Med, N-0381 Oslo, Norway.; Staff, AC (corresponding author), Oslo Univ Hosp, Div Obstet & Gynaecol, Oslo, Norway.	a.c.staff@medisin.uio.no						Bernardes TP, 2019, ULTRASOUND OBST GYN, V53, P443, DOI 10.1002/uog.20224; Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Chappell LC, 2019, LANCET, V394, P1181, DOI 10.1016/S0140-6736(19)31963-4; Chappell LC, 2019, TRIALS, V20, DOI 10.1186/s13063-018-3150-1; Churchill D, 2018, COCHRANE DB SYST REV, V10; Poon LC, 2019, INT J GYNECOL OBSTET, V145, P1, DOI 10.1002/ijgo.12802; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Rolnik DL, 2017, NEW ENGL J MED, V377, P613, DOI 10.1056/NEJMoa1704559; Staff AC, 2019, J REPROD IMMUNOL, V134, P1, DOI 10.1016/j.jri.2019.07.004; Staff AC, 2016, HYPERTENSION, V67, P251, DOI 10.1161/HYPERTENSIONAHA.115.06357; The National Institute for Health and Care Excellence, 2019, 133 NICE	12	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2019	394	10204					1120	1121		10.1016/S0140-6736(19)31993-2	http://dx.doi.org/10.1016/S0140-6736(19)31993-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8TF	31472929	hybrid			2022-12-28	WOS:000488848800007
J	Fan, HT; Walker, AP; Carrique, L; Keown, JR; Martin, IS; Karia, D; Sharps, J; Hengrung, N; Pardon, E; Steyaert, J; Grimes, JM; Fodor, E				Fan, Haitian; Walker, Alexander P.; Carrique, Loic; Keown, Jeremy R.; Martin, Itziar Serna; Karia, Dimple; Sharps, Jane; Hengrung, Narin; Pardon, Els; Steyaert, Jan; Grimes, Jonathan M.; Fodor, Ervin			Structures of influenza A virus RNA polymerase offer insight into viral genome replication	NATURE			English	Article							CRYO-EM STRUCTURE; PA SUBUNIT; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; PROTEIN; MUTATION; VIRULENCE; MODEL; TRANSCRIPTION; INITIATION	Influenza A viruses are responsible for seasonal epidemics, and pandemics can arise from the transmission of novel zoonotic influenza A viruses to humans(1,2). Influenza A viruses contain a segmented negative-sense RNA genome, which is transcribed and replicated by the viral-RNA-dependent RNA polymerase (FluPol(A)) composed of PB1, PB2 and PA subunits(3-5). Although the high-resolution crystal structure of FluPolA of bat influenza A virus has previously been reported(6), there are no complete structures available for human and avian FluPolA. Furthermore, the molecular mechanisms of genomic viral RNA (vRNA) replication-which proceeds through a complementary RNA (cRNA) replicative intermediate, and requires oligomerization of the polymerase(7-10)-remain largely unknown. Here, using crystallography and cryo-electron microscopy, we determine the structures of FluPolA from human influenza A/NT/60/1968 (H3N2) and avian influenza A/duck/Fujian/01/2002 (H5N1) viruses at a resolution of 3.0-4.3 angstrom, in the presence or absence of a cRNA or vRNA template. In solution, FluPolA forms dimers of heterotrimers through the C-terminal domain of the PA subunit, the thumb subdomain of PB1 and the N1 subdomain of PB2. The cryo-electron microscopy structure of monomeric FluPolA bound to the cRNA template reveals a binding site for the 3' cRNA at the dimer interface. We use a combination of cell-based and in vitro assays to show that the interface of the FluPolA dimer is required for vRNA synthesis during replication of the viral genome. We also show that a nanobody (a single-domain antibody) that interferes with FluPolA dimerization inhibits the synthesis of vRNA and, consequently, inhibits virus replication in infected cells. Our study provides high-resolution structures of medically relevant FluPolA, as well as insights into the replication mechanisms of the viral RNA genome. In addition, our work identifies sites in FluPolA that could be targeted in the development of antiviral drugs.	[Fan, Haitian; Walker, Alexander P.; Martin, Itziar Serna; Sharps, Jane; Hengrung, Narin; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Carrique, Loic; Keown, Jeremy R.; Martin, Itziar Serna; Karia, Dimple; Hengrung, Narin; Grimes, Jonathan M.] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford, England; [Pardon, Els] VIB, VIB VUB Ctr Struct Biol, Brussels, Belgium; [Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Grimes, Jonathan M.] Diamond Light Source, Didcot, Oxon, England; [Martin, Itziar Serna] Univ Utrecht, Crystal & Struct Chem, Bijvoet Ctr Biomol Res, Dept Chem,Fac Sci, Utrecht, Netherlands; [Hengrung, Narin] Francis Crick Inst, London, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Diamond Light Source; Utrecht University; Francis Crick Institute	Fodor, E (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.; Grimes, JM (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford, England.; Grimes, JM (corresponding author), Diamond Light Source, Didcot, Oxon, England.	jonathan@strubi.ox.ac.uk; ervin.fodor@path.ox.ac.uk	Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022; Keown, Jeremy/AAH-4361-2021	Steyaert, Jan/0000-0002-3825-874X; Keown, Jeremy/0000-0003-0159-9257; Pardon, Els/0000-0002-2466-0172; Serna Martin, Itziar/0000-0003-0305-0057; Hengrung, Narin/0000-0003-0354-0507; Carrique, Loic/0000-0001-5332-8593; Grimes, Jonathan Mark/0000-0001-9698-0389; Fan, Haitian/0000-0003-4337-665X; Fodor, Ervin/0000-0003-3249-196X; Walker, Alexander P/0000-0002-9650-382X	Instruct-ULTRA (EU H2020 Grant) [731005]; Medical Research Council (MRC) programme [MR/K000241/1, MR/R009945/1]; Wellcome Investigator Award [200835/Z/16/Z]; MRC Studentships; Wellcome Studentship [092931/Z/10/Z]; Wellcome [EM14856, EM20233, 203141/Z/16/Z, MX10627, MX14744, MX19946]; MRC [EM14856, EM20233, MX10627, MX14744, MX19946]; BBSRC [EM14856, EM20233, MX10627, MX14744, MX19946]; Wellcome JIF award [060208/Z/00/Z]; Wellcome equipment grant [093305/Z/10/Z]; Health Data Research UK; NIHR Oxford Biomedical Research Centre; Wellcome Trust [203141/Z/16/Z]; MRC [MC_PC_17137, MR/R009945/1, 1960073, MR/K000241/1] Funding Source: UKRI	Instruct-ULTRA (EU H2020 Grant); Medical Research Council (MRC) programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Investigator Award; MRC Studentships(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Studentship; Wellcome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome JIF award; Wellcome equipment grant; Health Data Research UK; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. G. Brownlee and F. Vreede for plasmids; I. Berger for the MultiBac system; S. Cusack for sharing and discussing unpublished data on the 3' promoter binding site; K. Harlos and T. Walter for assistance with crystallization; K. Dent and D. Clare for cryo-EM assistance; G. G. Brownlee, D. Stuart and A. te Velthuis, as well as members of the Fodor and Grimes laboratories, for helpful comments and discussions; and InstructERIC, part of the European Strategy Forum on Research Infrastructures (ESFRI), Instruct-ULTRA (EU H2020 Grant 731005), and the Research Foundation Flanders (FWO) for support with nanobody discovery. This work was supported by Medical Research Council (MRC) programme grants MR/K000241/1 and MR/R009945/1 (to E.F.), Wellcome Investigator Award 200835/Z/16/Z (to J.M.G.), MRC Studentships (to A.P.W. and I.S.M.) and Wellcome Studentship 092931/Z/10/Z (to N.H.). We thank Diamond Light source for beamtime (proposals MX10627, MX14744, and MX19946), and for access and support of the cryo-EM facilities at the UK National Electron Bio-Imaging Centre (eBIC) (proposals EM14856 and EM20233), funded by the Wellcome, MRC and BBSRC. Further electron microscopy provision was provided through the OPIC electron microscopy facility, which was funded by a Wellcome JIF award (060208/Z/00/Z) and is supported by a Wellcome equipment grant (093305/Z/10/Z). Computation used the Oxford Biomedical Research Computing (BMRC) facility, a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute, supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre. Financial support was provided by a Wellcome Trust Core Award (203141/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Part of this work was supported by Wellcome administrative support grant 203141/Z/16/Z.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bussey KA, 2011, J VIROL, V85, P7020, DOI 10.1128/JVI.00522-11; Chang SH, 2015, MOL CELL, V57, P925, DOI 10.1016/j.molcel.2014.12.031; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Hu J, 2013, J VIROL, V87, P2660, DOI 10.1128/JVI.02891-12; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiki H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110653; Killip MJ, 2015, VIRUS RES, V209, P11, DOI 10.1016/j.virusres.2015.02.003; Lee CY, 2018, VET MICROBIOL, V221, P114, DOI 10.1016/j.vetmic.2018.05.026; Liedmann S, 2014, J INFECT DIS, V209, P532, DOI 10.1093/infdis/jit463; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Martin IS, 2018, MOL CELL, V70, P1101, DOI 10.1016/j.molcel.2018.05.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Mostafa A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090497; Naydenova K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00782-3; Neumann G, 2014, J VIROL, V88, P4877, DOI 10.1128/JVI.00107-14; Nilsson-Payant BE, 2018, J VIROL, V92, DOI 10.1128/JVI.00687-18; Oymans J, 2018, J VIROL, V92, DOI 10.1128/JVI.01773-17; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Peng XM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00453; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A, 2017, VIRUS RES, V234, P103, DOI 10.1016/j.virusres.2017.01.013; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reich S, 2017, NUCLEIC ACIDS RES, V45, P3353, DOI 10.1093/nar/gkx043; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shkumatov AV, 2015, ACTA CRYSTALLOGR D, V71, P1347, DOI 10.1107/S1399004715007154; Slaine PD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050272; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; te Velthuis AJW, 2018, NAT MICROBIOL, V3, P1234, DOI 10.1038/s41564-018-0240-5; te Velthuis AJW, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.29, 10.1038/NMICROBIOL.2016.29]; te Velthuis AJW, 2016, NAT REV MICROBIOL, V14, P479, DOI 10.1038/nrmicro.2016.87; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Walker AP, 2019, TRENDS MICROBIOL, V27, P398, DOI 10.1016/j.tim.2018.12.013; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Weissmann F, 2016, P NATL ACAD SCI USA, V113, pE2564, DOI 10.1073/pnas.1604935113; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Xu GL, 2016, J VIROL, V90, P8105, DOI 10.1128/JVI.00883-16; Yamaji R, 2015, J VIROL, V89, P4117, DOI 10.1128/JVI.03532-14; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZD, 2011, INFECT GENET EVOL, V11, P1790, DOI 10.1016/j.meegid.2011.07.025; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhong GX, 2018, J VIROL, V92, DOI 10.1128/JVI.01557-17	67	75	75	2	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					287	+		10.1038/s41586-019-1530-7	http://dx.doi.org/10.1038/s41586-019-1530-7			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31485076	Green Accepted, Green Submitted			2022-12-28	WOS:000485415400060
J	Wagner, B; Vogel, H; Francke, A; Friedrich, T; Donders, T; Lacey, JH; Leng, MJ; Regattieri, E; Sadori, L; Wilke, T; Zanchetta, G; Albrecht, C; Bertini, A; Combourieu-Nebout, N; Cvetkoska, A; Giaccio, B; Grazhdani, A; Hauffe, T; Holtvoeth, J; Joannin, S; Jovanovska, E; Just, J; Kouli, K; Kousis, I; Koutsodendris, A; Krastel, S; Lagos, M; Leicher, N; Levkov, Z; Lindhorst, K; Masi, A; Melles, M; Mercuri, AM; Nomade, S; Nowaczyk, N; Panagiotopoulos, K; Peyron, O; Reed, JM; Sagnotti, L; Sinopoli, G; Stelbrink, B; Sulpizio, R; Timmermann, A; Tofilovska, S; Torri, P; Wagner-Cremer, F; Wonik, T; Zhang, XS				Wagner, Bernd; Vogel, Hendrik; Francke, Alexander; Friedrich, Tobias; Donders, Timme; Lacey, Jack H.; Leng, Melanie J.; Regattieri, Eleonora; Sadori, Laura; Wilke, Thomas; Zanchetta, Giovanni; Albrecht, Christian; Bertini, Adele; Combourieu-Nebout, Nathalie; Cvetkoska, Aleksandra; Giaccio, Biagio; Grazhdani, Andon; Hauffe, Torsten; Holtvoeth, Jens; Joannin, Sebastien; Jovanovska, Elena; Just, Janna; Kouli, Katerina; Kousis, Ilias; Koutsodendris, Andreas; Krastel, Sebastian; Lagos, Markus; Leicher, Niklas; Levkov, Zlatko; Lindhorst, Katja; Masi, Alessia; Melles, Martin; Mercuri, Anna M.; Nomade, Sebastien; Nowaczyk, Norbert; Panagiotopoulos, Konstantinos; Peyron, Odile; Reed, Jane M.; Sagnotti, Leonardo; Sinopoli, Gaia; Stelbrink, Bjoern; Sulpizio, Roberto; Timmermann, Axel; Tofilovska, Slavica; Torri, Paola; Wagner-Cremer, Friederike; Wonik, Thomas; Zhang, Xiaosen			Mediterranean winter rainfall in phase with African monsoons during the past 1.36 million years	NATURE			English	Article							LAKE OHRID MACEDONIA; MIDDLE PLEISTOCENE; TEPHROCHRONOLOGICAL RECORD; LACUSTRINE SUCCESSION; VEGETATION DYNAMICS; SEDIMENT SEQUENCE; ISOTOPE RECORDS; CLIMATE CHANGES; CARBON-DIOXIDE; SULMONA BASIN	Mediterranean climates are characterized by strong seasonal contrasts between dry summers and wet winters. Changes in winter rainfall are critical for regional socioeconomic development, but are difficult to simulate accurately(1) and reconstruct on Quaternary timescales. This is partly because regional hydroclimate records that cover multiple glacial-interglacial cycles(2,3) with different orbital geometries, global ice volume and atmospheric greenhouse gas concentrations are scarce. Moreover, the underlying mechanisms of change and their persistence remain unexplored. Here we show that, over the past 1.36 million years, wet winters in the northcentral Mediterranean tend to occur with high contrasts in local, seasonal insolation and a vigorous African summer monsoon. Our proxy time series from Lake Ohrid on the Balkan Peninsula, together with a 784,000-year transient climate model hindcast, suggest that increased sea surface temperatures amplify local cyclone development and refuel North Atlantic low-pressure systems that enter the Mediterranean during phases of low continental ice volume and high concentrations of atmospheric greenhouse gases. A comparison with modern reanalysis data shows that current drivers of the amount of rainfall in the Mediterranean share some similarities to those that drive the reconstructed increases in precipitation. Our data cover multiple insolation maxima and are therefore an important benchmark for testing climate model performance.	[Wagner, Bernd; Francke, Alexander; Just, Janna; Leicher, Niklas; Melles, Martin; Panagiotopoulos, Konstantinos] Univ Cologne, Inst Geol & Mineral, Cologne, Germany; [Vogel, Hendrik] Univ Bern, Inst Geol Sci, Bern, Switzerland; [Vogel, Hendrik] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Francke, Alexander] Univ Wollongong, Sch Earth Atmospher & Life Sci, Wollongong, NSW, Australia; [Friedrich, Tobias] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Donders, Timme; Cvetkoska, Aleksandra; Wagner-Cremer, Friederike] Univ Utrecht, Dept Phys Geog, Palaeoecol, Utrecht, Netherlands; [Lacey, Jack H.; Leng, Melanie J.] British Geol Survey, Natl Environm Isotope Facil, Nottingham, England; [Leng, Melanie J.] Univ Nottingham, Sch Biosci, Ctr Environm Geochem, Nottingham, England; [Regattieri, Eleonora; Zanchetta, Giovanni] Univ Pisa, Dipartimento Sci Terra, Pisa, Italy; [Regattieri, Eleonora] Italian Natl Res Council IGG CNR, Inst Earth Sci & Earth Resources, Pisa, Italy; [Sadori, Laura; Masi, Alessia; Sinopoli, Gaia] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Wilke, Thomas; Albrecht, Christian; Cvetkoska, Aleksandra; Hauffe, Torsten; Jovanovska, Elena; Stelbrink, Bjoern] Justus Liebig Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany; [Bertini, Adele] Univ Firenze, Dipartimento Sci Terra, Florence, Italy; [Combourieu-Nebout, Nathalie] Museum Natl Hist Nat, Inst Paleontol Humaine, CNRS, UMR 7194, Paris, France; [Giaccio, Biagio] CNR, Ist Geol Ambientale & Geoingn, Rome, Italy; [Grazhdani, Andon] Univ Tirana, Fac Geol & Mineral, Tirana, Albania; [Holtvoeth, Jens] Univ Bristol, Sch Chem, Bristol, Avon, England; [Joannin, Sebastien; Peyron, Odile] Univ Montpellier, Inst Sci Evolut Montpellier, CNRS, UMR 5554, Montpellier, France; [Just, Janna] Univ Bremen, Fachbereich Geowissensch, Bremen, Germany; [Kouli, Katerina] Univ Athens, Fac Geol & Geoenvironm, Athens, Greece; [Kousis, Ilias; Koutsodendris, Andreas] Heidelberg Univ, Paleoenvironm Dynam Grp, Inst Earth Sci, Heidelberg, Germany; [Krastel, Sebastian; Lindhorst, Katja] Christian Albrechts Univ Kiel, Inst Geosci, Kiel, Germany; [Lagos, Markus; Tofilovska, Slavica] Univ Bonn, Inst Geosci & Meteorol, Bonn, Germany; [Levkov, Zlatko] Univ Ss Cyril & Methodius, Inst Biol, Skopje, Macedonia; [Mercuri, Anna M.; Torri, Paola] Univ Modena & Reggio Emilia, Lab Palinol & Paleobot, Dipartimento Sci Vita, Modena, Italy; [Nomade, Sebastien] Univ Paris Saclay, Lab Sci Climat & Environm, CEA, CNRS,UMR 8212,UVSQ, Gif Sur Yvette, France; [Nowaczyk, Norbert] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, Potsdam, Germany; [Reed, Jane M.] Univ Hull, Dept Geog Geol & Environm, Kingston Upon Hull, N Humberside, England; [Sagnotti, Leonardo] Ist Nazl Geofis & Vulcanol, Rome, Italy; [Sulpizio, Roberto] Univ Bari, Dipartimento Sci Terra & Geoambientali, Bari, Italy; [Sulpizio, Roberto] IDPA CNR, Milan, Italy; [Timmermann, Axel] Inst Basic Sci, Ctr Climate Phys, Busan, South Korea; [Timmermann, Axel] Pusan Natl Univ, Busan, South Korea; [Wonik, Thomas] LIAG, Hannover, Germany; [Zhang, Xiaosen] Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi, Peoples R China	University of Cologne; University of Bern; University of Bern; University of Wollongong; University of Hawaii System; University of Hawaii Manoa; Utrecht University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham; University of Pisa; Sapienza University Rome; Justus Liebig University Giessen; University of Florence; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Geologia Ambientale e Geoingegneria (IGAG-CNR); University of Tirana (UT); University of Bristol; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Bremen; National & Kapodistrian University of Athens; Ruprecht Karls University Heidelberg; University of Kiel; University of Bonn; Saints Cyril & Methodius University of Skopje; Universita di Modena e Reggio Emilia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Hull; Istituto Nazionale Geofisica e Vulcanologia (INGV); Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Institute for Basic Science - Korea (IBS); Pusan National University; Leibniz Institut fur Angewandte Geophysik (LIAG); Shanxi University	Wagner, B (corresponding author), Univ Cologne, Inst Geol & Mineral, Cologne, Germany.	wagnerb@uni-koeln.de	Wilke, Thomas/G-1517-2012; Melles, Martin/J-4070-2012; Albrecht, Christian/AFV-5313-2022; Wagner-Cremer, Friederike/B-4225-2009; Albrecht, Christian/AAJ-5484-2020; Francke, Alexander/N-9761-2013; Sagnotti, Leonardo/AFM-3916-2022; Wagner, Bernd/J-4682-2012; Kouli, Katerina/M-8243-2013; Timmermann, Axel/Y-2799-2019; Stelbrink, Björn/Y-5023-2019; Giaccio, Biagio/B-2561-2017; Mercuri, Anna Maria/G-2085-2011; Timmermann, Axel/F-4977-2011; Krastel, Sebastian/C-2001-2017; Just, Janna/I-1874-2015; Vogel, Hendrik/C-6148-2014; Cvetkoska, Aleksandra/AAJ-2225-2020; Cvetkoska, Aleksandra/AAE-3972-2021; Sadori, Laura/E-4774-2015; Joannin, Sebastien/C-8324-2012; Panagiotopoulos, Konstantinos/P-3823-2019; Koutsodendris, Andreas/G-8966-2013; Masi, Alessia/N-1302-2013; Lacey, Jack H./AAL-3601-2020	Wilke, Thomas/0000-0001-8263-7758; Melles, Martin/0000-0003-0977-9463; Wagner-Cremer, Friederike/0000-0002-8119-3558; Francke, Alexander/0000-0002-0370-5802; Sagnotti, Leonardo/0000-0003-3944-201X; Wagner, Bernd/0000-0002-1369-7893; Kouli, Katerina/0000-0003-1656-1091; Timmermann, Axel/0000-0003-0657-2969; Stelbrink, Björn/0000-0002-7471-4992; Giaccio, Biagio/0000-0002-7007-9127; Mercuri, Anna Maria/0000-0001-6138-4165; Timmermann, Axel/0000-0003-0657-2969; Krastel, Sebastian/0000-0002-5899-9748; Just, Janna/0000-0002-5257-604X; Vogel, Hendrik/0000-0002-9902-8120; Sadori, Laura/0000-0002-2774-6705; Joannin, Sebastien/0000-0001-8345-9252; Panagiotopoulos, Konstantinos/0000-0002-3158-7962; Koutsodendris, Andreas/0000-0003-4236-7508; Masi, Alessia/0000-0001-9822-9767; Lacey, Jack H./0000-0002-6329-2149; Regattieri, Eleonora/0000-0003-0089-4027; Hauffe, Torsten/0000-0001-5711-9457; Zhang, Xiaosen/0000-0002-8069-8095; Levkov, Zlatko/0000-0002-1184-2356; Holtvoeth, Jens/0000-0002-9259-4728; BERTINI, Adele/0000-0002-9332-6725; Tofilovska, Slavica/0000-0002-0092-4487; Sulpizio, Roberto/0000-0002-3930-5421; Donders, Timme/0000-0003-4698-3463; nomade, sebastien/0000-0001-7373-0571; Combourieu-Nebout, Nathalie/0000-0002-3604-5986; Leicher, Niklas/0000-0002-3367-5982	International Continental Scientific Drilling Program (ICDP); German Ministry of Higher Education and Research; University of Cologne; British Geological Survey; INGV, Italy; CNR, Italy; German Research Foundation; government of the republic of Albania; LEFE ` INTERMED' grant (CNRS-INSU); government of the republic of North Macedonia	International Continental Scientific Drilling Program (ICDP); German Ministry of Higher Education and Research; University of Cologne; British Geological Survey; INGV, Italy(Istituto Nazionale Geofisica e Vulcanologia (INGV)); CNR, Italy(Consiglio Nazionale delle Ricerche (CNR)); German Research Foundation(German Research Foundation (DFG)); government of the republic of Albania; LEFE ` INTERMED' grant (CNRS-INSU); government of the republic of North Macedonia	The Hydrobiological Institute in Ohrid (S. Trajanovski and G. Kostoski) and the Hydrometeorological Institute in Tirana (M. Sanxhaku and B. Lushaj) provided logistic support for site surveys and the scientific drilling campaign. Drilling was carried out by Drilling, Observation and Sampling of the Earth's Continental Crust (DOSECC). A. Skinner provided logistic and technical advice before and during the drilling operation. The Scientific Collaboration on Past Speciation Conditions in Lake Ohrid (SCOPSCO) drilling project was funded by the International Continental Scientific Drilling Program (ICDP), the German Ministry of Higher Education and Research, the German Research Foundation, the University of Cologne, the British Geological Survey, the INGV and CNR (both Italy), and the governments of the republics of North Macedonia and Albania. V. Scao collected the V5 tephra, which was 40Ar/39Ar dated with funding from the LEFE 'INTERMED' grant (CNRS-INSU) to S. N.	Albert PG, 2015, QUATERNARY SCI REV, V118, P105, DOI 10.1016/j.quascirev.2014.04.002; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Beug H.J, 2004, LEITFADEN POLLENBEST; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Bosmans JHC, 2015, QUATERNARY SCI REV, V123, P16, DOI 10.1016/j.quascirev.2015.06.008; Brovkin V, 1997, ECOL MODEL, V101, P251, DOI 10.1016/S0304-3800(97)00049-5; Capraro L, 2005, GEOL SOC SPEC PUBL, V247, P159, DOI 10.1144/GSL.SP.2005.247.01.09; Capraro L, 2011, QUATERNARY SCI REV, V30, P1185, DOI 10.1016/j.quascirev.2011.02.008; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; Cheng H, 2016, NATURE, V534, P640, DOI 10.1038/nature18591; Chukanov N.V., 2014, INFRARED SPECTRA MIN, DOI [10.1007/978-94-007-7128-4, DOI 10.1007/978-94-007-7128-4]; Ciaranfi N, 2010, QUATERN INT, V219, P109, DOI 10.1016/j.quaint.2009.10.027; Colleoni F, 2012, EARTH PLANET SC LETT, V319, P35, DOI 10.1016/j.epsl.2011.12.020; Combourieu-Nebout N, 2015, REV PALAEOBOT PALYNO, V218, P127, DOI 10.1016/j.revpalbo.2015.03.001; EMEIS KC, 1991, MAR GEOL, V100, P155, DOI 10.1016/0025-3227(91)90231-R; Farmer V. C., 1974, INFRARED SPECTRA MIN; Forner A, 2018, TREE PHYSIOL, V38, P1127, DOI 10.1093/treephys/tpy022; Francke A, 2019, GLOBAL PLANET CHANGE, V177, P186, DOI 10.1016/j.gloplacha.2019.04.005; Francke A, 2016, BIOGEOSCIENCES, V13, P1179, DOI 10.5194/bg-13-1179-2016; Friedrich T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501923; Ganopolski A, 2011, CLIM PAST, V7, P1415, DOI 10.5194/cp-7-1415-2011; Giaccio B, 2009, QUATERNARY SCI REV, V28, P2710, DOI 10.1016/j.quascirev.2009.06.009; Giaccio B, 2017, SCI REP-UK, V7, DOI 10.1038/srep45940; Giaccio B, 2017, QUATERNARY SCI REV, V158, P211, DOI 10.1016/j.quascirev.2017.01.004; Giaccio B, 2015, GEOLOGY, V43, P603, DOI 10.1130/G36677.1; Giaccio B, 2013, J QUATERNARY SCI, V28, P545, DOI 10.1002/jqs.2647; Giaccio B, 2013, QUATERNARY SCI REV, V67, P190, DOI 10.1016/j.quascirev.2013.01.028; Goosse H, 2010, GEOSCI MODEL DEV, V3, P603, DOI 10.5194/gmd-3-603-2010; Goosse H, 1999, J GEOPHYS RES-OCEANS, V104, P23337, DOI 10.1029/1999JC900215; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Hammer O, 2018, PALEONTOLOGICAL STAT; Hoerling M, 2012, J CLIMATE, V25, P2146, DOI 10.1175/JCLI-D-11-00296.1; Just J, 2016, BIOGEOSCIENCES, V13, P2093, DOI 10.5194/bg-13-2093-2016; Karner DB, 2001, J VOLCANOL GEOTH RES, V107, P185, DOI 10.1016/S0377-0273(00)00258-4; Konijnendijk TYM, 2014, NEWSL STRATIGR, V47, P263, DOI 10.1127/0078-0421/2014/0047; Kousis I, 2018, QUATERNARY SCI REV, V190, P20, DOI 10.1016/j.quascirev.2018.04.014; Kroon D., 1998, ARCTIC, V160, P181, DOI DOI 10.2973/ODP.PROC.SR.160.071.1998(CHAPTER14)160; Kutzbach JE, 2014, CLIM DYNAM, V42, P1079, DOI 10.1007/s00382-013-1692-1; Lacey JH, 2016, BIOGEOSCIENCES, V13, P1801, DOI 10.5194/bg-13-1801-2016; Langgut D, 2011, QUATERNARY SCI REV, V30, P3960, DOI 10.1016/j.quascirev.2011.10.016; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Laurenzi M.A., 1987, PERIOD MINERAL, V56, P285; LEBAS MJ, 1986, J PETROL, V27, P745, DOI 10.1093/petrology/27.3.745; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; Leicher N, 2016, BIOGEOSCIENCES, V13, P2151, DOI 10.5194/bg-13-2151-2016; Lindhorst K, 2015, BASIN RES, V27, P84, DOI 10.1111/bre.12063; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Macri P, 2018, PHYS EARTH PLANET IN, V278, P1, DOI 10.1016/j.pepi.2018.02.005; Magny M, 2013, CLIM PAST, V9, P2043, DOI 10.5194/cp-9-2043-2013; Marra F, 2009, J VOLCANOL GEOTH RES, V179, P217, DOI 10.1016/j.jvolgeores.2008.11.009; Martrat B, 2014, QUATERNARY SCI REV, V99, P122, DOI 10.1016/j.quascirev.2014.06.016; Massari F, 2002, GEOL SOC AM BULL, V114, P1183, DOI 10.1130/0016-7606(2002)114<1183:IBTAGE>2.0.CO;2; Matzinger A, 2006, J GREAT LAKES RES, V32, P158, DOI 10.3394/0380-1330(2006)32[158:SOALOT]2.0.CO;2; MELARD G, 1984, J R STAT SOC C-APPL, V33, P104; Mercer CM, 2016, CHEM GEOL, V440, P148, DOI 10.1016/j.chemgeo.2016.06.020; Milner AM, 2012, GEOLOGY, V40, P919, DOI 10.1130/G33204.1; Niespolo EM, 2017, QUAT GEOCHRONOL, V39, P205, DOI 10.1016/j.quageo.2016.09.004; Opsteegh JD, 1998, TELLUS A, V50, P348, DOI 10.1034/j.1600-0870.1998.t01-1-00007.x; Petrosino P, 2015, QUATERN INT, V383, P89, DOI 10.1016/j.quaint.2014.10.049; Petrosino P, 2014, J VOLCANOL GEOTH RES, V274, P34, DOI 10.1016/j.jvolgeores.2014.01.014; Popovska C, 2007, HYDROL PROCESS, V21, P658, DOI 10.1002/hyp.6252; Regattieri E, 2017, PALAEOGEOGR PALAEOCL, V472, P51, DOI 10.1016/j.palaeo.2017.02.013; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Rio D, 1996, GEOLOGY, V24, P743, DOI 10.1130/0091-7613(1996)024<0743:RPEIAT>2.3.CO;2; Roberts N, 2008, QUATERNARY SCI REV, V27, P2426, DOI 10.1016/j.quascirev.2008.09.005; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; Rossignol-Strick M, 1999, QUATERNARY SCI REV, V18, P515, DOI 10.1016/S0277-3791(98)00093-6; ROSSIGNOLSTRICK M, 1985, PALAEOGEOGR PALAEOCL, V49, P237, DOI 10.1016/0031-0182(85)90056-2; Sadori L, 2016, BIOGEOSCIENCES, V13, P1423, DOI 10.5194/bg-13-1423-2016; Sagnotti L, 2016, GEOPHYS J INT, V204, P798, DOI 10.1093/gji/ggv486; Sagnotti L, 2014, GEOPHYS J INT, V199, P1110, DOI 10.1093/gji/ggu287; Satow C, 2015, QUATERNARY SCI REV, V117, P96, DOI 10.1016/j.quascirev.2015.04.005; Siani G, 2004, QUATERNARY SCI REV, V23, P2485, DOI 10.1016/j.quascirev.2004.06.004; Simon Q, 2017, EARTH PLANET SC LETT, V460, P255, DOI 10.1016/j.epsl.2016.11.052; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Stockhecke M, 2016, QUATERNARY SCI REV, V133, P77, DOI 10.1016/j.quascirev.2015.12.016; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Timmermann A, 2014, J CLIMATE, V27, P1863, DOI 10.1175/JCLI-D-13-00311.1; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Totz S, 2017, GEOPHYS RES LETT, V44, P12418, DOI 10.1002/2017GL075674; Toucanne S, 2015, QUATERNARY SCI REV, V129, P178, DOI 10.1016/j.quascirev.2015.10.016; Trigo RM, 2002, CLIMATE RES, V20, P9, DOI 10.3354/cr020009; Tzedakis PC, 2007, QUATERNARY SCI REV, V26, P2042, DOI 10.1016/j.quascirev.2007.03.014; Tzedakis PC, 2006, QUATERNARY SCI REV, V25, P3416, DOI 10.1016/j.quascirev.2006.09.002; Vogel H, 2010, J PALEOLIMNOL, V44, P295, DOI 10.1007/s10933-009-9404-x; Wagner B, 2008, J VOLCANOL GEOTH RES, V177, P71, DOI 10.1016/j.jvolgeores.2007.08.018; Wagner B, 2014, SCI DRILL, V17, P19, DOI 10.5194/sd-17-19-2014; Wagner B, 2017, BIOGEOSCIENCES, V14, P2033, DOI 10.5194/bg-14-2033-2017; Weisheimer A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1162; Zanchetta G, 2016, BIOGEOSCIENCES, V13, P2757, DOI 10.5194/bg-13-2757-2016; Zanchetta G, 2011, HOLOCENE, V21, P33, DOI 10.1177/0959683610377531	94	77	79	8	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					256	+		10.1038/s41586-019-1529-0	http://dx.doi.org/10.1038/s41586-019-1529-0			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31477908	Green Submitted, Green Accepted			2022-12-28	WOS:000485415400054
J	McDonald, B; McCoy, KD				McDonald, Braedon; McCoy, Kathy D.			Maternal microbiota in pregnancy and early life	SCIENCE			English	Editorial Material							GUT MICROBIOTA; MODE; MOTHER		[McDonald, Braedon] Univ Calgary, Dept Crit Care Med, Cumming Sch Med, Calgary, AB, Canada; [McCoy, Kathy D.] Univ Calgary, Dept Physiol & Pharmacol, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary	McDonald, B (corresponding author), Univ Calgary, Dept Crit Care Med, Cumming Sch Med, Calgary, AB, Canada.	bamcdona@ucalgary.ca; kathy.mccoy@ucalgary.ca	McCoy, Kathy/ABD-5814-2021					Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Haahr T, 2018, BJOG-INT J OBSTET GY, V125, P533, DOI 10.1111/1471-0528.14792; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pronovost GN, 2019, IMMUNITY, V50, P18, DOI 10.1016/j.immuni.2018.11.016; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Tormo-Badia N, 2014, SCAND J IMMUNOL, V80, P250, DOI 10.1111/sji.12205; Tun HM, 2018, JAMA PEDIATR, V172, P368, DOI 10.1001/jamapediatrics.2017.5535; van den Elsen LWJ, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00047	16	29	29	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					984	985		10.1126/science.aay0618	http://dx.doi.org/10.1126/science.aay0618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488675				2022-12-28	WOS:000484732700029
J	Bloeschl, G; Hall, J; Viglione, A; Perdigao, RAP; Parajka, J; Merz, B; Lun, D; Arheimer, B; Aronica, GT; Bilibashi, A; Bohac, M; Bonacci, O; Borga, M; Canjevac, I; Castellarin, A; Chirico, GB; Claps, P; Frolova, N; Ganora, D; Gorbachova, L; Gul, A; Hannaford, J; Harrigan, S; Kireeva, M; Kiss, A; Kjeldsen, TR; Kohnova, S; Koskela, JJ; Ledvinka, O; Macdonald, N; Mavrova-Guirguinova, M; Mediero, L; Merz, R; Molnar, P; Montanari, A; Murphy, C; Osuch, M; Ovcharuk, V; Radevski, I; Salinas, JL; Sauquet, E; Sraj, M; Szolgay, J; Volpi, E; Wilson, D; Zaimi, K; Zivkovic, N				Bloeschl, Guenter; Hall, Julia; Viglione, Alberto; Perdigao, Rui A. P.; Parajka, Juraj; Merz, Bruno; Lun, David; Arheimer, Berit; Aronica, Giuseppe T.; Bilibashi, Ardian; Bohac, Milon; Bonacci, Ognjen; Borga, Marco; Canjevac, Ivan; Castellarin, Attilio; Chirico, Giovanni B.; Claps, Pierluigi; Frolova, Natalia; Ganora, Daniele; Gorbachova, Liudmyla; Gul, Ali; Hannaford, Jamie; Harrigan, Shaun; Kireeva, Maria; Kiss, Andrea; Kjeldsen, Thomas R.; Kohnova, Silvia; Koskela, Jarkko J.; Ledvinka, Ondrej; Macdonald, Neil; Mavrova-Guirguinova, Maria; Mediero, Luis; Merz, Ralf; Molnar, Peter; Montanari, Alberto; Murphy, Conor; Osuch, Marzena; Ovcharuk, Valeryia; Radevski, Ivan; Salinas, Jose L.; Sauquet, Eric; Sraj, Mojca; Szolgay, Jan; Volpi, Elena; Wilson, Donna; Zaimi, Klodian; Zivkovic, Nenad			Changing climate both increases and decreases European river floods	NATURE			English	Article							FREQUENCY; TERM; SEASONALITY; VARIABILITY	Climate change has led to concerns about increasing river floods resulting from the greater water-holding capacity of a warmer atmosphere(1). These concerns are reinforced by evidence of increasing economic losses associated with flooding in many parts of the world, including Europe(2). Any changes in river floods would have lasting implications for the design of flood protection measures and flood risk zoning. However, existing studies have been unable to identify a consistent continental-scale climatic-change signal in flood discharge observations in Europe(3), because of the limited spatial coverage and number of hydrometric stations. Here we demonstrate clear regional patterns of both increases and decreases in observed river flood discharges in the past five decades in Europe, which are manifestations of a changing climate. Our results-arising from the most complete database of European flooding so far-suggest that: increasing autumn and winter rainfall has resulted in increasing floods in northwestern Europe; decreasing precipitation and increasing evaporation have led to decreasing floods in medium and large catchments in southern Europe; and decreasing snow cover and snowmelt, resulting from warmer temperatures, have led to decreasing floods in eastern Europe. Regional flood discharge trends in Europe range from an increase of about 11 per cent per decade to a decrease of 23 per cent. Notwithstanding the spatial and temporal heterogeneity of the observational record, the flood changes identified here are broadly consistent with climate model projections for the next century(4,5), suggesting that climate-driven changes are already happening and supporting calls for the consideration of climate change in flood risk management.	[Bloeschl, Guenter; Hall, Julia; Viglione, Alberto; Perdigao, Rui A. P.; Parajka, Juraj; Lun, David; Kiss, Andrea; Salinas, Jose L.] Tech Univ Wien, Inst Hydraul Engn & Water Resources Management, Vienna, Austria; [Viglione, Alberto; Claps, Pierluigi; Ganora, Daniele] Politecn Torino, Dept Environm Land & Infrastruct Engn DIATI, Turin, Italy; [Merz, Bruno] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, Potsdam, Germany; [Arheimer, Berit] Swedish Meteorol & Hydrol Inst, Norrkoping, Sweden; [Aronica, Giuseppe T.] Univ Messina, Dept Engn, Messina, Italy; [Bilibashi, Ardian] Renewable Energy Syst & Technol, Tirana, Albania; [Bohac, Milon; Ledvinka, Ondrej] Czech Hydrometeorol Inst, Prague, Czech Republic; [Bonacci, Ognjen] Split Univ, Fac Civil Engn Architecture & Geodesy, Split, Croatia; [Borga, Marco] Univ Padua, Dept Land Environm Agr & Forestry, Padua, Italy; [Canjevac, Ivan] Univ Zagreb, Dept Geog, Fac Sci, Zagreb, Croatia; [Castellarin, Attilio; Montanari, Alberto] Univ Bologna, Dept Civil Chem Environm & Mat Engn DICAM, Bologna, Italy; [Chirico, Giovanni B.] Univ Naples Federico II, Dept Agr Sci, Naples, Italy; [Frolova, Natalia; Kireeva, Maria] Lomonosov Moscow State Univ, Dept Land Hydrol, Moscow, Russia; [Gorbachova, Liudmyla] Ukrainian Hydrometeorol Inst, Dept Hydrol Res, Kiev, Ukraine; [Gul, Ali] Dokuz Eylul Univ, Dept Civil Engn, Izmir, Turkey; [Hannaford, Jamie] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Harrigan, Shaun] European Ctr Medium Range Weather Forecasts ECMWF, Forecast Dept, Reading, Berks, England; [Kjeldsen, Thomas R.] Univ Bath, Dept Architecture & Civil Engn, Bath, Avon, England; [Kohnova, Silvia; Szolgay, Jan] Slovak Univ Technol Bratislava, Dept Land & Water Resources Management, Fac Civil Engn, Bratislava, Slovakia; [Koskela, Jarkko J.] Finnish Environm Inst, Helsinki, Finland; [Macdonald, Neil] Univ Liverpool, Dept Geog & Planning, Liverpool, Merseyside, England; [Macdonald, Neil] Univ Liverpool, Inst Risk & Uncertainty, Liverpool, Merseyside, England; [Mavrova-Guirguinova, Maria] Univ Architecture Civil Engn & Geodesy, Sofia, Bulgaria; [Mediero, Luis] Univ Politecn Madrid, Dept Civil Engn Hydraul Energy & Environm, Madrid, Spain; [Merz, Ralf] UFZ Helmholtz Ctr Environm Res, Dept Catchment Hydrol, Halle, Germany; [Molnar, Peter] Swiss Fed Inst Technol, Inst Environm Engn, Zurich, Switzerland; [Murphy, Conor] Maynooth Univ, Dept Geog, Irish Climate Anal & Res Units ICARUS, Maynooth, Kildare, Ireland; [Osuch, Marzena] Polish Acad Sci, Dept Hydrol & Hydrodynam, Inst Geophys, Warsaw, Poland; [Ovcharuk, Valeryia] Odessa State Environm Univ, Hydrometeorol Inst, Odessa, Ukraine; [Radevski, Ivan] Ss Cyril & Methodius Univ, Fac Nat Sci & Math, Inst Geog, Skopje, North Macedonia; [Sauquet, Eric] Irstea, UR RiverLy, Lyon, France; [Sraj, Mojca] Univ Ljubljana, Fac Civil & Geodet Engn, Ljubljana, Slovenia; [Volpi, Elena] Univ Roma Tre, Dept Engn, Rome, Italy; [Wilson, Donna] Norwegian Water Resources & Energy Directorate, Oslo, Norway; [Zaimi, Klodian] Polytech Univ Tirana, IGEWE, Tirana, Albania; [Zivkovic, Nenad] Univ Belgrade, Fac Geog, Belgrade, Serbia	Technische Universitat Wien; Polytechnic University of Turin; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Swedish Meteorological & Hydrological Institute; University of Messina; Czech Hydrometeorological Institute; University of Split; University of Padua; University of Zagreb; University of Bologna; University of Naples Federico II; Lomonosov Moscow State University; National Academy of Sciences Ukraine; Ukrainian Hydrometeorological Institute of the State Emergency Service of Ukraine & National Academy of Sciences of Ukraine; Dokuz Eylul University; UK Centre for Ecology & Hydrology (UKCEH); European Centre for Medium-Range Weather Forecasts (ECMWF); University of Bath; Slovak University of Technology Bratislava; Finnish Environment Institute; University of Liverpool; University of Liverpool; University of Architecture & Civil Engineering - Bulgaria; Universidad Politecnica de Madrid; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Swiss Federal Institutes of Technology Domain; ETH Zurich; Maynooth University; Polish Academy of Sciences; Institute of Geophysics of the Polish Academy of Sciences; Ministry of Education & Science of Ukraine; Odessa State Environmental University; Saints Cyril & Methodius University of Skopje; INRAE; University of Ljubljana; Roma Tre University; Norwegian Water Resources & Energy Directorate; Polytechnic University of Tirana (UPT); University of Belgrade	Bloeschl, G (corresponding author), Tech Univ Wien, Inst Hydraul Engn & Water Resources Management, Vienna, Austria.	bloeschl@hydro.tuwien.ac.at	Frolova, Natalia/AAT-2671-2020; Szolgay, Jan/AAC-5336-2019; Mediero, Luis/K-6430-2014; Ovcharuk, Valeriya A/B-6240-2016; Ledvinka, Ondrej/M-4579-2016; Molnar, Peter/F-3066-2013; Gorbachova, Liudmyla/AAB-9162-2020; Montanari, Alberto/B-5427-2009; Kohnova, Silvia/AAC-4930-2019; Hall, Julia/F-2651-2015; Zaimi, Klodian/GVS-3765-2022; Gül, Ali/Q-1054-2019; Radevski, Ivan/C-9154-2014; Perdigão, Rui A. P./K-9896-2015; Macdonald, Neil/ABD-6120-2021; Kohnova, Silvia/GLT-0065-2022; Ovcharuk, Valeriya A/H-3953-2018; Sraj, Mojca/I-3502-2019; Radevski, Ivan/HGE-4913-2022; Frolova, Natalia L./E-2775-2012; Merz, Ralf/N-7614-2014; Čanjevac, Ivan/AAA-6432-2022; Claps, Pierluigi/F-5081-2012; Kireeva, Maria/B-2482-2014; Viglione, Alberto/M-4860-2017; Castellarin, Attilio/B-2508-2009; Zaimi, Klodian/GWU-9487-2022; borga, marco/C-6697-2014; Harrigan, Shaun/C-9370-2014	Frolova, Natalia/0000-0003-3576-285X; Szolgay, Jan/0000-0003-4348-3332; Mediero, Luis/0000-0002-9346-6592; Ovcharuk, Valeriya A/0000-0001-5654-3731; Ledvinka, Ondrej/0000-0002-0203-7064; Molnar, Peter/0000-0001-6437-4931; Gorbachova, Liudmyla/0000-0003-1033-9385; Montanari, Alberto/0000-0001-7428-0410; Hall, Julia/0000-0002-4242-2020; Gül, Ali/0000-0001-8137-8950; Radevski, Ivan/0000-0003-4408-4691; Perdigão, Rui A. P./0000-0001-5543-1754; Macdonald, Neil/0000-0003-0350-7096; Ovcharuk, Valeriya A/0000-0003-1638-841X; Sraj, Mojca/0000-0001-7796-5618; Merz, Ralf/0000-0002-3698-2339; Claps, Pierluigi/0000-0002-9624-7408; Kireeva, Maria/0000-0002-8285-9761; Kiss, Andrea/0000-0003-4254-2759; Viglione, Alberto/0000-0002-7587-4832; Kjeldsen, Thomas Rodding/0000-0001-9423-5203; Castellarin, Attilio/0000-0002-6111-0612; Chirico, Giovanni Battista/0000-0002-9536-4741; Arheimer, Berit/0000-0001-8314-0735; Zivkovic, Nenad/0000-0002-2731-2835; Zaimi, Klodian/0000-0003-0495-586X; borga, marco/0000-0003-3435-2779; GANORA, DANIELE/0000-0003-0605-6200; Harrigan, Shaun/0000-0002-0992-3667; Sauquet, Eric/0000-0001-9539-7730	ERC Advanced Grant 'FloodChange' project [291152]; Horizon 2020 ETN 'System Risk' project [676027]; DFG 'SPATE' project [FOR 2416]; FWF 'SPATE' project [I 3174]; Russian Foundation for Basic Research (RFBR) project [17-05-41030 rgo_a]	ERC Advanced Grant 'FloodChange' project; Horizon 2020 ETN 'System Risk' project; DFG 'SPATE' project(German Research Foundation (DFG)); FWF 'SPATE' project; Russian Foundation for Basic Research (RFBR) project(Russian Foundation for Basic Research (RFBR))	This work was supported by the ERC Advanced Grant 'FloodChange' project (number 291152), the Horizon 2020 ETN 'System Risk' project (number 676027), the DFG 'SPATE' project (FOR 2416), the FWF 'SPATE' project (I 3174) and a Russian Foundation for Basic Research (RFBR) project (number 17-05-41030 rgo_a). The data analysis was performed in R using the supporting packages automap, boot, lattice, maptools, ncdf4, plyr, raster, RColorBrewer, rgdal and rworldmap. The authors acknowledge the involvement in the data screening process of C. Alvaro Diaz, I. Borzi, E. Diamantini, K. Jeneiova, M. Kupfersberger, S. Mallucci and S. Persiano during their stays at the Vienna University of Technology. We thank L. Gaal and D. Rosbjerg for contacting Finnish and Danish data holders, respectively; B. Renard (France), W. Rigott (South Tyrol, Italy), G. Lindstrom (Sweden) and P. Burlando (Switzerland) for assistance in preparing and/or providing data or metadata from their respective regions. We acknowledge all flood data providers listed in Extended Data Table 1.	Amponsah W, 2018, EARTH SYST SCI DATA, V10, P1783, DOI 10.5194/essd-10-1783-2018; Archer CL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033614; Ban N, 2015, GEOPHYS RES LETT, V42, P1165, DOI 10.1002/2014GL062588; Bayliss A.C., 1993, 121 IH; Berghuijs WR, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8847; Bloschl G, 2017, SCIENCE, V357, P588, DOI 10.1126/science.aan2506; Brooks HE, 2013, ATMOS RES, V123, P129, DOI 10.1016/j.atmosres.2012.04.002; Desai B., 2015, GLOB ASS REP DIS RIS; Estilow TW, 2015, EARTH SYST SCI DATA, V7, P137, DOI 10.5194/essd-7-137-2015; European Academies' Science Advisory Council, 2018, 22 EUR AC SCI ADV CO; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Frolova NL, 2017, NAT HAZARDS, V88, P103, DOI 10.1007/s11069-016-2632-2; Hall J, 2015, P INT ASS HYDROL SCI, V370, P89, DOI 10.5194/piahs-370-89-2015; Hall J, 2014, HYDROL EARTH SYST SC, V18, P2735, DOI 10.5194/hess-18-2735-2014; Hall J, 2018, HYDROL EARTH SYST SC, V22, P3883, DOI 10.5194/hess-22-3883-2018; Hensel DR, 2006, ENVIRON SCI TECHNOL, V40, P4066, DOI 10.1021/es051650b; Hiemstra PH, 2009, COMPUT GEOSCI-UK, V35, P1711, DOI 10.1016/j.cageo.2008.10.011; Hodgkins GA, 2017, J HYDROL, V552, P704, DOI 10.1016/j.jhydrol.2017.07.027; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kang SM, 2012, J CLIMATE, V25, P8387, DOI 10.1175/JCLI-D-12-00323.1; Kundzewicz ZW, 2017, HYDROLOG SCI J, V62, P1, DOI 10.1080/02626667.2016.1241398; Mangini W, 2018, HYDROLOG SCI J, V63, P493, DOI 10.1080/02626667.2018.1444766; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Martins ES, 2000, WATER RESOUR RES, V36, P737, DOI 10.1029/1999WR900330; Mediero L, 2015, J HYDROL, V528, P341, DOI 10.1016/j.jhydrol.2015.06.016; Mediero L, 2014, J HYDROL, V517, P1072, DOI 10.1016/j.jhydrol.2014.06.040; Perdigao R. A. P., 2016, ARXIV161103403; Renard B, 2006, STOCH ENV RES RISK A, V21, P97, DOI 10.1007/s00477-006-0047-4; Rogger M, 2017, WATER RESOUR RES, V53, P5209, DOI 10.1002/2017WR020723; Salinas JL, 2014, HYDROL EARTH SYST SC, V18, P4391, DOI 10.5194/hess-18-4391-2014; Schroter K, 2015, HYDROL EARTH SYST SC, V19, P309, DOI 10.5194/hess-19-309-2015; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sivapalan M, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003439; Stephenson TS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009127; Theil H., 1950, RANK INVARIANT METHO, V53, P386, DOI DOI 10.1007/978-94-011-2546-8_20; Thober S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9e35; van den Dool H, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003114; Vogt J., 2007, PAN EUROPEAN RIVER C, DOI [10.2788/35907, DOI 10.2788/35907]; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Wilcox RR, 1998, BIOMETRICAL J, V40, P261, DOI 10.1002/(SICI)1521-4036(199807)40:3<261::AID-BIMJ261>3.0.CO;2-V; Winsemius HC, 2016, NAT CLIM CHANGE, V6, P381, DOI [10.1038/nclimate2893, 10.1038/NCLIMATE2893]; Xoplaki E, 2004, CLIM DYNAM, V23, P63, DOI 10.1007/s00382-004-0422-0	42	377	387	71	486	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					108	+		10.1038/s41586-019-1495-6	http://dx.doi.org/10.1038/s41586-019-1495-6			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31462777	Green Submitted, Green Accepted			2022-12-28	WOS:000483967700043
J	Yoeli, E; Rathauser, J; Kimenye, MK				Yoeli, Erez; Rathauser, Jon; Kimenye, Maureen K.			Digital Health Support in Treatment for Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Yoeli, Erez] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rathauser, Jon] Keheala, Belle Mead, NJ USA; [Kimenye, Maureen K.] Kenya Minist Hlth, Nairobi, Kenya	Massachusetts Institute of Technology (MIT)	Yoeli, E (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	eyoeli@mit.edu			United States Agency for International Development [AID-OAA-F-15-00045] Funding Source: Medline; World Health Organization [001] Funding Source: Medline	United States Agency for International Development(United States Agency for International Development (USAID)); World Health Organization(World Health Organization)		Metcalfe JZ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001877; NBS, 2018, LAB FORC STAT EMPL S, V2; Rand D.G., 2014, POL INS BEH BRAIN SC, V1, P263, DOI [10.1177/2372732214548426, DOI 10.1177/2372732214548426]; Wald DS, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.05.035; WHO, 2015, WORLD HEAL ORGAN, V58, P7250	5	19	19	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					986	987		10.1056/NEJMc1806550	http://dx.doi.org/10.1056/NEJMc1806550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW9PR	31483974	Green Published, Bronze			2022-12-28	WOS:000485326200023
J	Smith-Bindman, R; Kwan, ML; Marlow, EC; Theis, MK; Bolch, W; Cheng, SY; Bowles, EJA; Duncan, JR; Greenlee, RT; Kushi, LH; Pole, JD; Rahm, AK; Stout, NK; Weinmann, S; Miglioretti, DL				Smith-Bindman, Rebecca; Kwan, Marilyn L.; Marlow, Emily C.; Theis, Mary Kay; Bolch, Wesley; Cheng, Stephanie Y.; Bowles, Erin J. A.; Duncan, James R.; Greenlee, Robert T.; Kushi, Lawrence H.; Pole, Jason D.; Rahm, Alanna K.; Stout, Natasha K.; Weinmann, Sheila; Miglioretti, Diana L.			Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADIATION-EXPOSURE	IMPORTANCE Medical imaging increased rapidly from 2000 to 2006, but trends in recent years have not been analyzed. OBJECTIVE To evaluate recent trends in medical imaging. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of patterns of medical imaging between 2000 and 2016 among 16 million to 21 million patients enrolled annually in 7 US integrated and mixed-model insurance health care systems and for individuals receiving care in Ontario, Canada. EXPOSURES Calendar year and country (United States vs Canada). MAIN OUTCOMES AND MEASURES Use of computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine imaging. Annual and relative imaging rates by imaging modality, country, and age (children [< 18 years], adults [18-64 years], and older adults [similar to 65 years]). RESULTS Overall, 135 774 532 imaging examinations were included; 5 439 874 (4%) in children, 89 635 312 (66%) in adults, and 40 699 346 (30%) in older adults. Among adults and older adults, imaging rates were significantly higher in 2016 vs 2000 for all imaging modalities other than nuclear medicine. For example, among older adults, CT imaging rates were 428 per 1000 person-years in 2016 vs 204 per 1000 in 2000 in US health care systems and 409 per 1000 vs 161 per 1000 in Ontario; for MRI, 139 per 1000 vs 62 per 1000 in the United States and 89 per 1000 vs 13 per 1000 in Ontario; and for ultrasound, 495 per 1000 vs 324 per 1000 in the United States and 580 per 1000 vs 332 per 1000 in Ontario. Annual growth in imaging rates among US adults and older adults slowed over time for CT (from an 11.6% annual percentage increase among adults and 9.5% among older adults in 2000-2006 to 3.7% among adults in 2013-2016 and 5.2% among older adults in 2014-2016) and for MRI (from 11.4% in 2000-2004 in adults and 11.3% in 2000-2005 in older adults to 1.3% in 2007-2016 in adults and 2.2% in 2005-2016 in older adults). Patterns in Ontario were similar. Among children, annual growth for CT stabilized or declined (United States: from 10.1% in 2000-2005 to 0.8% in 2013-2016; Ontario: from 3.3% in 2000-2006 to -5.3% in 2006-2016), but patterns for MRI were similar to adults. Changes in annual growth in ultrasound were smaller among adults and children in the United States and Ontario compared with CT and MRI. Nuclear medicine imaging declined in adults and children after 2006. CONCLUSIONS AND RELEVANCE From 2000 to 2016 in 7 US integrated and mixed-model health care systems and in Ontario, rates of CT and MRI use continued to increase among adults, but at a slower pace in more recent years. In children, imaging rates continued to increase except for CT, which stabilized or declined in more recent periods. Whether the observed imaging utilization was appropriate or was associated with improved patient outcomes is unknown.	[Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Radiol & Biomed Imaging Epidemiol & Biostat, Parnassus Ave,Ste 307A, San Francisco, CA 94143 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Kwan, Marilyn L.; Kushi, Lawrence H.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Marlow, Emily C.; Miglioretti, Diana L.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Marlow, Emily C.] Univ Calif Davis, Grad Grp Epidemiol, Davis, CA 95616 USA; [Theis, Mary Kay; Bowles, Erin J. A.; Miglioretti, Diana L.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA USA; [Bolch, Wesley] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA; [Cheng, Stephanie Y.; Pole, Jason D.] ICES, Toronto, ON, Canada; [Duncan, James R.] Washington Univ, Intervent Radiol Sect, St Louis, MO 63110 USA; [Greenlee, Robert T.] Marshfield Clin Res Inst, Marshfield, WI USA; [Pole, Jason D.] Univ Toronto, Pediat Oncol Grp Ontario, Toronto, ON, Canada; [Pole, Jason D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rahm, Alanna K.] Genom Med Inst, Ctr Hlth Res, Danville, PA USA; [Stout, Natasha K.] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Weinmann, Sheila] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; University of California System; University of California Davis; University of California System; University of California Davis; Kaiser Permanente; State University System of Florida; University of Florida; University of Toronto; Washington University (WUSTL); University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Kaiser Permanente	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging Epidemiol & Biostat, Parnassus Ave,Ste 307A, San Francisco, CA 94143 USA.	rebecca.smith-bindman@ucsf.edu	Pole, Jason D./AAD-9148-2020; Kwan, Marilyn/AAH-4850-2021; Rahm, Alanna Kulchak/AAG-1967-2021	Pole, Jason D./0000-0002-0413-5434; Rahm, Alanna Kulchak/0000-0003-2513-9298; Marlow, Emily/0000-0001-8594-6927	National Cancer Institute at the National Institutes of Health [R01CA185687, R50CA211115]; ICES; Ontario Ministry of Health, Long-Term Care; NATIONAL CANCER INSTITUTE [R01CA185687, R50CA211115] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICES(University of Toronto); Ontario Ministry of Health, Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute at the National Institutes of Health (grants R01CA185687 and R50CA211115). The Ontario portion of the study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health, Long-Term Care. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information.	American Medical Association, 2018, HCPCS LEV 2 2018 PRO; American Medical Association, 2017, ICD 10 CM 2018 COMPL; [Anonymous], GAO08452; [Anonymous], 2012, CAN CLASS HLTH INT, V3; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Centers for Medicare & Medicaid Services, 2014, MED IM DEM EV REP C; Chubak J, 2016, CANCER CAUSE CONTROL, V27, P1315, DOI 10.1007/s10552-016-0808-4; Horny M, 2014, J AM COLL RADIOL, V11, P692, DOI 10.1016/j.jacr.2014.01.019; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; IMV Medical Information Division, 2017, 2018 CT BENCHM REP; Institute of Medicine Report, 2012, BEST CARE LOWER COST; Kim HJ, 2014, STAT MED, V33, P4087, DOI 10.1002/sim.6221; Kirschner CG, 1993, CPT 1993 PHYS CURREN; Levin DC, 2017, J AM COLL RADIOL, V14, P1007, DOI 10.1016/j.jacr.2017.02.044; Levin DC, 2017, HEALTH AFFAIR, V36, P663, DOI 10.1377/hlthaff.2016.0836; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Qadri SB, 2000, J MATER RES, V15, P21, DOI 10.1557/JMR.2000.0007; Raja AS, 2014, AM J ROENTGENOL, V203, P355, DOI 10.2214/AJR.13.11892; Ross Tyler R, 2014, EGEMS (Wash DC), V2, P1049, DOI 10.13063/2327-9214.1049; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; Smith-Bindman R, 2016, JAMA INTERN MED, V176, P870, DOI 10.1001/jamainternmed.2016.2075; Smith-Bindman R, 2016, JAMA INTERN MED, V176, P168, DOI 10.1001/jamainternmed.2015.7113; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wagner Edward H, 2005, J Natl Cancer Inst Monogr, P3, DOI 10.1093/jncimonographs/lgi032; Winter A, 2008, INTRO EXPERT PANEL N; World Health Organization, 1997, INT CLASS DIS 9 REV	30	168	168	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					843	856		10.1001/jama.2019.11456	http://dx.doi.org/10.1001/jama.2019.11456			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479136	Bronze, Green Published			2022-12-28	WOS:000486437200014
J	Benson, R; McGregor, G; Shehata, M; Imray, C				Benson, Ruth; McGregor, Gordon; Shehata, Mishkat; Imray, Christopher			Optimising fitness for major vascular surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ABDOMINAL AORTIC-ANEURYSM; PERIPHERAL ARTERY-DISEASE; SMOKING-CESSATION; RANDOMIZED-TRIALS; ADVERSE OUTCOMES; MORTALITY; RISK; REPAIR; COMPLICATIONS; SURVIVAL		[Benson, Ruth] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [McGregor, Gordon] Coventry Univ, Ctr Sport Exercise & Life Sci, Coventry, W Midlands, England; [Shehata, Mishkat] Univ Warwick, Unit Acad Primary Care, Coventry, W Midlands, England; [Imray, Christopher] Coventry Univ, Warwick Med Sch, Coventry, W Midlands, England; [Imray, Christopher] Exeter Univ, Exeter, Devon, England	University of Birmingham; Coventry University; University of Warwick; Coventry University; University of Warwick; University of Exeter	Benson, R (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England.	ruth.benson@gmail.com	McGregor, Gordon/AAP-1917-2020; Shehata, Mishkat/AAQ-2080-2020	McGregor, Gordon/0000-0001-8963-9107; Benson, Ruth A/0000-0001-5889-4391; imray, chris/0000-0001-8451-4102				Aboyans V, 2018, EUR J VASC ENDOVASC, V55, P305, DOI 10.1016/j.ejvs.2017.07.018; Ali TZ, 2018, ANN VASC SURG, V46, P168, DOI 10.1016/j.avsg.2017.07.007; Armstrong EJ, 2014, J VASC SURG, V60, P1565, DOI 10.1016/j.jvs.2014.08.064; Arya S, 2015, J VASC SURG, V61, P324, DOI 10.1016/j.jvs.2014.08.115; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barakat HM, 2015, ANAESTHESIA, V70, P679, DOI 10.1111/anae.12986; Barakat HM, 2016, ANN SURG, V264, P47, DOI 10.1097/SLA.0000000000001609; Barrett KM, 2017, CIRC RES, V120, P496, DOI 10.1161/CIRCRESAHA.117.310138; Benson RA, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170306; Bhak RH, 2015, JAMA SURG, V150, P44, DOI 10.1001/jamasurg.2014.2025; Brown LC, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16090; Carlisle J, 2007, BRIT J SURG, V94, P966, DOI 10.1002/bjs.5734; De Martino RR, 2014, J VASC SURG, V59, P1615, DOI 10.1016/j.jvs.2013.12.013; Dresler CM, 2006, LANCET, V368, P348, DOI 10.1016/S0140-6736(06)69086-7; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Ferraris VA, 2012, ARCH SURG-CHICAGO, V147, P49, DOI 10.1001/archsurg.2011.790; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fowler AJ, 2015, BRIT J SURG, V102, P1314, DOI 10.1002/bjs.9861; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Grant SW, 2015, BRIT J ANAESTH, V114, P430, DOI 10.1093/bja/aeu383; Harris DG, 2017, J VASC SURG, V66, P743, DOI 10.1016/j.jvs.2017.01.028; Hartley RA, 2012, BRIT J SURG, V99, P1539, DOI 10.1002/bjs.8896; Hasvold P, 2018, EUR HEART J-QUAL CAR, V4, P10, DOI 10.1093/ehjqcco/qcx028; Jack S, 2011, BEST PRAC RES-CL ANA, V25, P461, DOI 10.1016/j.bpa.2011.07.003; Kotze A, 2015, BRIT J HAEMATOL, V171, P322, DOI 10.1111/bjh.13623; Lane DA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003075.pub3; Liao KM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015806; Melin AA, 2015, J VASC SURG, V61, P683, DOI 10.1016/j.jvs.2014.10.009; Mills E, 2011, AM J MED, V124, P144, DOI 10.1016/j.amjmed.2010.09.013; National Institute for Health and Care Excellence, 2010, CLOP MOD REL DIP PRE; National Institute for Health and Care Excellence, 2018, DRAFT CONS ABD AORT; National Institute for Health and Care Excellence, 2019, CHRON OBSTR PULM DIS; National Institute for Health and Care Excellence, 2015, LIP MOD CVD PREV CLI; National Institute for Health and Care Excellence Clinical Guideline (CG147), 2018, PER ART DIS DIAGN MA; Obi AT, 2015, J VASC SURG, V61, P1000, DOI 10.1016/j.jvs.2014.10.106; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Pouwels S, 2015, EUR J VASC ENDOVASC, V49, P66, DOI 10.1016/j.ejvs.2014.10.008; Quinn TJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l13; Sacks GD, 2015, J AM COLL SURGEONS, V220, P1113, DOI 10.1016/j.jamcollsurg.2015.02.029; Schouten O, 2009, NEW ENGL J MED, V361, P980, DOI 10.1056/NEJMoa0808207; Snowden CP, 2013, ANN SURG, V257, P999, DOI 10.1097/SLA.0b013e31828dbac2; Stone DH, 2013, J VASC SURG, V57, P1531, DOI 10.1016/j.jvs.2012.11.132; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; Taylor GMJ, 2017, INT J EPIDEMIOL, V46, P1948, DOI 10.1093/ije/dyx109; Tew GA, 2017, BRIT J SURG, V104, P1791, DOI 10.1002/bjs.10669; Vascular Society Quality Improvement Programme, 2018, NAT VASC REG 2018 AN; Wilkes Scott, 2008, Int J Chron Obstruct Pulmon Dis, V3, P45; Wilson RJT, 2010, BRIT J ANAESTH, V105, P297, DOI 10.1093/bja/aeq128	48	3	3	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l5002	10.1136/bmj.l5002	http://dx.doi.org/10.1136/bmj.l5002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477574	Green Submitted			2022-12-28	WOS:000485431800004
J	Christie, B				Christie, Bryan			GP recruitment in Scotland is "challenging," warns auditor	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Audit Scotland, 2019, NHS WORKF PLANN 2; Christie B, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/sbmj.k297	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l5323	10.1136/bmj.l5323	http://dx.doi.org/10.1136/bmj.l5323			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31466951				2022-12-28	WOS:000483892600010
J	Iacobucci, G				Iacobucci, Gareth			GPs earned 94 pound 800 on average last year, but expenses continue to rise	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Digital, GP EARN EXP EST 2017	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l5331	10.1136/bmj.l5331	http://dx.doi.org/10.1136/bmj.l5331			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31466946				2022-12-28	WOS:000483892600012
J	Howick, VM; Russell, AJC; Andrews, T; Heaton, H; Reid, AJ; Natarajan, K; Butungi, H; Metcalf, T; Verzier, LH; Rayner, JC; Berriman, M; Herren, JK; Billker, O; Hemberg, M; Talman, AM; Lawniczak, MKN				Howick, Virginia M.; Russell, Andrew J. C.; Andrews, Tallulah; Heaton, Haynes; Reid, Adam J.; Natarajan, Kedar; Butungi, Hellen; Metcalf, Tom; Verzier, Lisa H.; Rayner, Julian C.; Berriman, Matthew; Herren, Jeremy K.; Billker, Oliver; Hemberg, Martin; Talman, Arthur M.; Lawniczak, Mara K. N.			The Malaria Cell Atlas: Single parasite transcriptomes across the complete Plasmodium life cycle	SCIENCE			English	Article							RNA-SEQ DATA; PROTEIN; REVEALS; MOSQUITO; EGRESS; VISUALIZATION; TRANSMISSION; REGULATORS; INVASION	Malaria parasites adopt a remarkable variety of morphological life stages as they transition through multiple mammalian host and mosquito vector environments. We profiled the single-cell transcriptomes of thousands of individual parasites, deriving the first high-resolution transcriptional atlas of the entire Plasmodium berghei life cycle. We then used our atlas to precisely define developmental stages of single cells from three different human malaria parasite species, including parasites isolated directly from infected individuals. The Malaria Cell Atlas provides both a comprehensive view of gene usage in a eukaryotic parasite and an open-access reference dataset for the study of malaria parasites.	[Howick, Virginia M.; Russell, Andrew J. C.; Andrews, Tallulah; Heaton, Haynes; Reid, Adam J.; Metcalf, Tom; Verzier, Lisa H.; Rayner, Julian C.; Berriman, Matthew; Billker, Oliver; Hemberg, Martin; Talman, Arthur M.; Lawniczak, Mara K. N.] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Natarajan, Kedar] Univ Southern Denmark, Dept Biochem & Mol Biol, D IAS, Odense, Denmark; [Butungi, Hellen] Icipe, Nairobi, Kenya; [Butungi, Hellen; Herren, Jeremy K.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria,MRC Collaborating Ctr Multi, Johannesburg, South Africa; [Verzier, Lisa H.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Herren, Jeremy K.] MRC Univ Glasgow, Ctr Virus Res, Glasgow, Lanark, Scotland; [Billker, Oliver] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea, Sweden; [Talman, Arthur M.] Univ Montpellier, CNRS, MIVEGEC, IRD, Montpellier, France	Wellcome Trust Sanger Institute; University of Southern Denmark; International Centre of Insect Physiology & Ecology (ICIPE); University of Witwatersrand; Walter & Eliza Hall Institute; University of Glasgow; Umea University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lawniczak, MKN (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.	mara@sanger.ac.uk	Berriman, Matthew/A-7618-2011; Andrews, Tallulah/L-8307-2019; Talman, Arthur/GMW-9116-2022	Berriman, Matthew/0000-0002-9581-0377; Andrews, Tallulah/0000-0003-1120-2196; Talman, Arthur/0000-0003-2584-3672; Reid, Adam/0000-0002-5926-7768; Heaton, Haynes/0000-0002-9649-525X; Russell, Andrew/0000-0001-5411-2807; Verzier, Lisa H./0000-0002-5518-8157; Rayner, Julian/0000-0002-9835-1014; Natarajan, Kedar Nath/0000-0002-9264-1280	Wellcome Trust [206194/Z/17/Z, 107372]; MRC Career Development Award [G1100339]; Danish Institute of Advanced Study (D-IAS); University of Southern Denmark (SDU); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); German Academic Exchange Service (DAAD); Kenyan government; NIH/NIAID [R01AI137154]; Chan Zuckerberg Initiative [183501]; MRC [G1100339] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Institute of Advanced Study (D-IAS); University of Southern Denmark (SDU); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Kenyan government; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chan Zuckerberg Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Sanger Institute is funded by the Wellcome Trust (grant 206194/Z/17/Z), which supports M.K.N.L., M.H., O.B., M.B., and J.C.R. Also supported by MRC Career Development Award G1100339 (M.K.N.L.); the Danish Institute of Advanced Study (D-IAS) and the University of Southern Denmark (SDU) (K.N.); Wellcome Trust grant 107372, the UK Department for International Development (DFID), the Swedish International Development Cooperation Agency (Sida), the Swiss Agency for Development and Cooperation (SDC), the German Academic Exchange Service (DAAD), and the Kenyan government (J.K.H. and H.B.); NIH/NIAID grant R01AI137154 (J.R. and L.V.); and Chan Zuckerberg Initiative grant reference 183501 (T.A.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andreadaki M, 2014, CELL MICROBIOL, V16, P751, DOI 10.1111/cmi.12274; Andrews TS, 2019, BIOINFORMATICS, V35, P2865, DOI 10.1093/bioinformatics/bty1044; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Bastian M, 2009, INT AAAI C WEBL SOC; Bohme U, 2018, GENOME RES, V28, P547, DOI 10.1101/gr.218123.116; Brugat T, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.276; Burda PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004760; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; CARTER R, 1976, NATURE, V263, P57, DOI 10.1038/263057a0; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fincher CT, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1736; Gomes AR, 2015, CELL HOST MICROBE, V17, P404, DOI 10.1016/j.chom.2015.01.014; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hanson KK, 2015, EUKARYOT CELL, V14, P96, DOI 10.1128/EC.00166-14; Hoo R, 2016, EBIOMEDICINE, V7, P255, DOI 10.1016/j.ebiom.2016.04.011; Howick V. M., 2019, VHOWICK MALARIACELLA, DOI [10.5281/zenodo.2843883, DOI 10.5281/ZENODO.2843883]; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kaneko I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004905; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kiselev VY, 2018, NAT METHODS, V15, P359, DOI 10.1038/nmeth.4644; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lapp SA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0612-8; Lasonder E, 2016, NUCLEIC ACIDS RES, V44, P6087, DOI 10.1093/nar/gkw536; Lee HJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3619; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; Lun Aaron T L, 2016, F1000Res, V5, P2122; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; MARTIN WJ, 1971, NATURE-NEW BIOL, V233, P260, DOI 10.1038/newbio233260a0; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Modrzynska K, 2017, CELL HOST MICROBE, V21, P11, DOI 10.1016/j.chom.2016.12.003; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Painter HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04966-3; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ponzi M, 2009, CELL MICROBIOL, V11, P1272, DOI 10.1111/j.1462-5822.2009.01331.x; Poran A, 2017, NATURE, V551, P95, DOI 10.1038/nature24280; Rathnapala UL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006396; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez MD, 2000, MOL BIOCHEM PARASIT, V110, P147, DOI 10.1016/S0166-6851(00)00265-6; Roques M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005273; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Saelens W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03424-4; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; Talman AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-315; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Welch JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0975-3; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yeoh LM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4100-0; Young JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-70; ZHENG GX, 2017, NATURE, V0008	77	91	92	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		774	+	eaaw2619	10.1126/science.aaw2619	http://dx.doi.org/10.1126/science.aaw2619			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439762	Green Submitted, Green Accepted			2022-12-28	WOS:000482464000044
J	Cheng, CW; Biton, M; Haber, AL; Gunduz, N; Eng, G; Gaynor, LT; Tripathi, S; Calibasi-Koca, G; Rickelt, S; Butty, VL; Moreno-Serrano, M; Iqbal, AM; Bauer-Rowe, KE; Imada, S; Ulutas, MS; Mylonas, C; Whary, MT; Levine, SS; Basbinar, Y; Hynes, RO; Mino-Kenudson, M; Deshpande, V; Boyer, LA; Fox, JG; Terranova, C; Rai, K; Piwnica-Worms, H; Mihaylova, MM; Regev, A; Yilmaz, OH				Cheng, Chia-Wei; Biton, Moshe; Haber, Adam L.; Gunduz, Nuray; Eng, George; Gaynor, Liam T.; Tripathi, Surya; Calibasi-Koca, Gizem; Rickelt, Steffen; Butty, Vincent L.; Moreno-Serrano, Marta; Iqbal, Ameena M.; Bauer-Rowe, Khristian E.; Imada, Shinya; Ulutas, Mehmet Sefa; Mylonas, Constantine; Whary, Mark T.; Levine, Stuart S.; Basbinar, Yasemin; Hynes, Richard O.; Mino-Kenudson, Mari; Deshpande, Vikram; Boyer, Laurie A.; Fox, James G.; Terranova, Christopher; Rai, Kunal; Piwnica-Worms, Helen; Mihaylova, Maria M.; Regev, Aviv; Yilmaz, Omer H.			Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet	CELL			English	Article							THROUGHPUT CHROMATIN IMMUNOPRECIPITATION; FATTY-ACID OXIDATION; GENOME-WIDE; PPAR-DELTA; BETA-HYDROXYBUTYRATE; LATERAL INHIBITION; IN-VITRO; NOTCH; DIFFERENTIATION; EXPRESSION	Little is known about how metabolites couple tissuespecific stem cell function with physiology. Here we show that, in the mammalian small intestine, the expression of Hmgcs2 (3-hydroxy-3-methylglutarylCoA synthetase 2), the gene encoding the ratelimiting enzyme in the production of ketone bodies, including beta-hydroxybutyrate (beta OHB), distinguishes self-renewing Lgr5(+) stem cells (ISCs) from differentiated cell types. Hmgcs2 loss depletes beta OHB levels in Lgr5(+) ISCs and skews their differentiation toward secretory cell fates, which can be rescued by exogenous beta OHB and class I histone deacetylase (HDAC) inhibitor treatment. Mechanistically, beta OHB acts by inhibiting HDACs to reinforce Notch signaling, instructing ISC self-renewal and lineage decisions. Notably, although a high-fat ketogenic diet elevates ISC function and postinjury regeneration through beta OHB-mediated Notch signaling, a glucose-supplemented diet has the opposite effects. These findings reveal how control of beta OHB-activated signaling in ISCs by diet helps to fine-tune stem cell adaptation in homeostasis and injury.	[Cheng, Chia-Wei; Gunduz, Nuray; Eng, George; Tripathi, Surya; Calibasi-Koca, Gizem; Rickelt, Steffen; Moreno-Serrano, Marta; Iqbal, Ameena M.; Bauer-Rowe, Khristian E.; Imada, Shinya; Ulutas, Mehmet Sefa; Hynes, Richard O.; Regev, Aviv; Yilmaz, Omer H.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Mylonas, Constantine; Boyer, Laurie A.; Yilmaz, Omer H.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Whary, Mark T.; Fox, James G.] MIT, Dept Biol Engn, Div Comparat Med, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Eng, George; Mino-Kenudson, Mari; Deshpande, Vikram; Yilmaz, Omer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Eng, George; Mino-Kenudson, Mari; Deshpande, Vikram; Yilmaz, Omer H.] Harvard Med Sch, Boston, MA 02114 USA; [Biton, Moshe] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Biton, Moshe; Haber, Adam L.; Regev, Aviv; Yilmaz, Omer H.] Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA 02142 USA; [Hynes, Richard O.; Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gaynor, Liam T.] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA; [Mihaylova, Maria M.] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Butty, Vincent L.; Levine, Stuart S.] MIT, Dept Biol, BioMicro Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Terranova, Christopher; Rai, Kunal] Univ Texas MD Anderson Canc Ctr, Genom Med Dept, Houston, TX 77030 USA; [Piwnica-Worms, Helen] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Gunduz, Nuray] Bilkent Univ, Natl Nanotechnol Res Ctr UNAM, Inst Mat Sci & Nanotechnol, TR-06800 Ankara, Turkey; [Calibasi-Koca, Gizem; Basbinar, Yasemin] Dokuz Eylul Univ, Inst Oncol, Dept Translat Oncol, Izmir, Turkey; [Imada, Shinya] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan; [Ulutas, Mehmet Sefa] Siirt Univ, Sci & Arts Fac, Dept Biol, TR-56100 Siirt, Turkey	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Ihsan Dogramaci Bilkent University; Dokuz Eylul University; Hiroshima University; Siirt University	Yilmaz, OH (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Yilmaz, OH (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Yilmaz, OH (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Yilmaz, OH (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Yilmaz, OH (corresponding author), Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA 02142 USA.	ohyilmaz@mit.edu	Ulutas, Mehmet Sefa/AAA-6055-2022; Calibasi, Gizem/G-1761-2014; Imada, Shinya/GQY-7056-2022; Mihaylova, Maria M./ACZ-4949-2022; Ulutas, Mehmet Sefa/AAD-4664-2021	Calibasi, Gizem/0000-0002-3201-4752; Mihaylova, Maria M./0000-0002-2725-767X; Gunduz, Nuray/0000-0003-3477-2888; Rickelt, Steffen/0000-0002-5224-7764; /0000-0003-1088-923X; Levine, Stuart/0000-0001-7363-562X; Rai, Kunal/0000-0003-2321-6894; Basbinar, Yasemin/0000-0001-9439-2217; Biton, Moshe/0000-0001-8330-1674; Butty, Vincent/0000-0003-1173-2429	NIH [R00 AG054760, R00 AG045144, R01CA211184, R01CA034992, U54CA224068]; V Foundation V scholar award; Sidney Kimmel scholar award; Pew-Stewart Trust scholar award; Kathy and Curt Marble Cancer Research Fund; Bridge grant; American Federation of Aging Research (AFAR); MIT Stem Cell Initiative through Fondation MIT; Ludwig postdoctoral fellowship; Helen Hay Whitney postdoctoral fellowship; TUBITAK-BIDEB 2214-A fellowship; TUBITAK 2219 international postdoctoral research fellowship; MIT Ludwig Center for Molecular Oncology Research, NIH [U54CA163109]; Howard Hughes Medical Institute; Klarman Cell Observatory; HHMI; NATIONAL CANCER INSTITUTE [R01CA207236, R01CA034992, R01CA211184, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG054760, K99AG054760, R00AG045144] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation V scholar award; Sidney Kimmel scholar award; Pew-Stewart Trust scholar award; Kathy and Curt Marble Cancer Research Fund; Bridge grant; American Federation of Aging Research (AFAR); MIT Stem Cell Initiative through Fondation MIT; Ludwig postdoctoral fellowship; Helen Hay Whitney postdoctoral fellowship; TUBITAK-BIDEB 2214-A fellowship; TUBITAK 2219 international postdoctoral research fellowship(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); MIT Ludwig Center for Molecular Oncology Research, NIH; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Fang Wang for providing beta OHB oligomers. We thank Dr. Julien Sage and Dr. Spyros Artavanis-Tsakonas for the generous gift of Hes1-GFP reporter mice. We thank Sven Holder for histology support, the Whitehead Institute Metabolite profiling core facility, and the Koch Institute Flow Cytometry, Histology, and ES Cell and Transgenics core facilities. We thank Leah Bury for illustration assistance, members of the Yilmaz laboratory for discussions, and Kerry Kelley for laboratory management. O.H.Y. is supported by NIH R00 AG045144, R01CA211184, R01CA034992, and U54CA224068; a V Foundation V scholar award; a Sidney Kimmel scholar award; a Pew-Stewart Trust scholar award; the Kathy and Curt Marble Cancer Research Fund; a Bridge grant; the American Federation of Aging Research (AFAR); and the MIT Stem Cell Initiative through Fondation MIT. C.W.C. is supported by a Ludwig postdoctoral fellowship and a Helen Hay Whitney postdoctoral fellowship. N.G is supported by a TUBITAK-BIDEB 2214-A fellowship. G. C.-K. is supported by a TUBITAK 2219 international postdoctoral research fellowship. We thank the members of The Hope Babette Tang (1983) Histology Facility at the Koch Institute. S. R. was supported by a postdoctoral fellowship from the MIT Ludwig Center for Molecular Oncology Research, NIH grant U54CA163109, and the Howard Hughes Medical Institute (to R. O. H.). A. R. is supported by the Klarman Cell Observatory and HHMI. M. M. M. is supported by NIH R00 AG054760. A. R. is a SAB member of Thermo Fisher Scientific, Driver Group, and Syros Pharmaceuticals and a co-founder of Celsius Therapeutics. We would like to thank Kerry Kelly for excellent lab management.	Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; Arts J, 2009, CLIN CANCER RES, V15, P6841, DOI 10.1158/1078-0432.CCR-09-0547; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beumer J, 2016, DEVELOPMENT, V143, P3639, DOI 10.1242/dev.133132; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bonilla MD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33747-7; Chen YW, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r11; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Degirmenci B, 2018, NATURE, V558, P449, DOI 10.1038/s41586-018-0190-3; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gonneaud A, 2015, FEBS LETT, V589, P2776, DOI 10.1016/j.febslet.2015.08.009; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Igarashi M, 2016, CELL, V166, P436, DOI 10.1016/j.cell.2016.05.044; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kim TH, 2016, CELL REP, V16, P2053, DOI 10.1016/j.celrep.2016.07.056; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2009, BRIT J CANCER, V101, P691, DOI 10.1038/sj.bjc.6605202; Lim JS, 2017, NATURE, V545, P360, DOI 10.1038/nature22323; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Mihaylova MM, 2018, CELL STEM CELL, V22, P769, DOI 10.1016/j.stem.2018.04.001; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Newman JC, 2017, CELL METAB, V26, P547, DOI 10.1016/j.cmet.2017.08.004; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Peregrina K, 2015, CARCINOGENESIS, V36, P25, DOI 10.1093/carcin/bgu221; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Qi Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13824; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rickelt S, 2018, MATRIX BIOL, V71-72, P10, DOI 10.1016/j.matbio.2018.04.011; Rodriguez-Colman MJ, 2017, NATURE, V543, P424, DOI 10.1038/nature21673; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Sancho R, 2015, EMBO REP, V16, P571, DOI 10.15252/embr.201540188; Sasaki N, 2016, P NATL ACAD SCI USA, V113, pE5399, DOI 10.1073/pnas.1607327113; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shoshkes-Carmel M, 2018, NATURE, V560, pE29, DOI 10.1038/s41586-018-0286-9; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian H, 2015, CELL REP, V11, P33, DOI 10.1016/j.celrep.2015.03.007; Tinkum KL, 2015, P NATL ACAD SCI USA, V112, pE7148, DOI 10.1073/pnas.1509249112; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Vooijs M, 2011, GASTROENTEROLOGY, V141, P448, DOI 10.1053/j.gastro.2011.06.003; Wang B, 2018, CELL STEM CELL, V22, P206, DOI 10.1016/j.stem.2017.12.017; Wang QD, 2017, CELL DEATH DIFFER, V24, P458, DOI 10.1038/cdd.2016.142; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhao M, 2009, CELL RES, V19, P793, DOI 10.1038/cr.2009.61; Zimberlin CD, 2015, FASEB J, V29, P2070, DOI 10.1096/fj.14-257931	86	113	117	10	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1115	+		10.1016/j.cell.2019.07.048	http://dx.doi.org/10.1016/j.cell.2019.07.048			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442404	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000482191000010
J	Bradley, SF				Bradley, Suzanne F.			What Is Known About Candida auris	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Insights Clinical Update reviews infection control and treatment strategies to manage Candida auris, a new drug-resistant fungal species that can cause severe invasive infection with high morbidity and mortality in patients with underlying comorbid illnesses.	[Bradley, Suzanne F.] Univ Michigan, Med Sch, Dept Internal Med, Infect Dis Div, Ann Arbor, MI USA; [Bradley, Suzanne F.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Bradley, SF (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Infect Dis Sect 111i, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	sbradley@umich.edu						Adams E, 2018, EMERG INFECT DIS, V24, P1816, DOI 10.3201/eid2410.180649; Bougnoux ME, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0338-9; Centers for Disease Control and Prevention, CAND AUR; Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373; Jeffery-Smith A, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00029-17; Ku TSN, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00726; Lamoth F, 2018, J INFECT DIS, V217, P516, DOI 10.1093/infdis/jix597; Spivak ES, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01588-17	8	6	6	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2019	322	15					1510	1511		10.1001/jama.2019.13843	http://dx.doi.org/10.1001/jama.2019.13843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI4ST	31490531				2022-12-28	WOS:000493458400021
J	Al-Khatib, SM				Al-Khatib, Sana M.			Improved patient selection for implantable defibrillators	LANCET			English	Editorial Material							CARDIOVERTER-DEFIBRILLATOR; CARDIAC DEATH; SUDDEN; DISPARITIES; PREVENTION		[Al-Khatib, Sana M.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University	Al-Khatib, SM (corresponding author), Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA.	alkha001@mc.duke.edu						Al-Khatib SM, 2007, AM HEART J, V153, P941, DOI 10.1016/j.ahj.2007.03.003; Al-Khatib Sana M, 2018, Circulation, V138, pe272, DOI 10.1161/CIR.0000000000000549; Al-Khatib SM, 2012, CIRCULATION, V125, P1094, DOI 10.1161/CIRCULATIONAHA.111.066605; Bardy G, 2012, HEART RHYTHM, V9, P1579, DOI [10.1016/j.hrthm.2012.06.018, DOI 10.1016/J.HRTHM.2012.06.018]; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bauer A, 2019, LANCET, V394, P1344, DOI 10.1016/S0140-6736(19)31996-8; Costantini O, 2009, J AM COLL CARDIOL, V53, P471, DOI 10.1016/j.jacc.2008.08.077; Goldenberg I, 2010, CIRCULATION, V122, P1265, DOI 10.1161/CIRCULATIONAHA.110.940148; Kong MH, 2010, AM HEART J, V160, P605, DOI 10.1016/j.ahj.2010.07.011; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Rizas KD, 2017, EUR HEART J, V38, P2110, DOI 10.1093/eurheartj/ehx161	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1302	1304		10.1016/S0140-6736(19)31956-7	http://dx.doi.org/10.1016/S0140-6736(19)31956-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9RJ	31488368				2022-12-28	WOS:000489613700006
J	Steg, PG; Bhatt, DL; Simon, T; Fox, K; Mehta, SR; Harrington, RA; Held, C; Andersson, M; Himmelmann, A; Ridderstrale, W; Leonsson-Zachrisson, M; Liu, YY; Opolski, G; Zateyshchikov, D; Ge, JB; Nicolau, JC; Corbalan, R; Cornel, JH; Widimsky, P; Leiter, LA				Steg, P. Gabriel; Bhatt, Deepak L.; Simon, Tabassome; Fox, Kim; Mehta, Shamir R.; Harrington, Robert A.; Held, Claes; Andersson, Marielle; Himmelmann, Anders; Ridderstrale, Wilhelm; Leonsson-Zachrisson, Maria; Liu, Yuyin; Opolski, Grzegorz; Zateyshchikov, Dmitry; Ge, Junbo; Nicolau, Jose C.; Corbalan, Ramon; Cornel, Jan H.; Widimsky, Petr; Leiter, Lawrence A.		THEMIS Steering Comm Investigators	Ticagrelor in Patients with Stable Coronary Disease and Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DUAL ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; PLATELET INHIBITION; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; CLINICAL BENEFIT; 60 MG; CLOPIDOGREL; PRASUGREL	Patients with stable coronary artery disease and diabetes were randomly assigned to receive either ticagrelor plus aspirin or placebo plus aspirin. At 40 months, the incidence of the composite efficacy outcome of cardiovascular death, myocardial infarction, or stroke was lower with ticagrelor than with placebo; the frequency of major bleeding was higher with ticagrelor. Background Patients with stable coronary artery disease and diabetes mellitus who have not had a myocardial infarction or stroke are at high risk for cardiovascular events. Whether adding ticagrelor to aspirin improves outcomes in this population is unclear. Methods In this randomized, double-blind trial, we assigned patients who were 50 years of age or older and who had stable coronary artery disease and type 2 diabetes mellitus to receive either ticagrelor plus aspirin or placebo plus aspirin. Patients with previous myocardial infarction or stroke were excluded. The primary efficacy outcome was a composite of cardiovascular death, myocardial infarction, or stroke. The primary safety outcome was major bleeding as defined by the Thrombolysis in Myocardial Infarction (TIMI) criteria. Results A total of 19,220 patients underwent randomization. The median follow-up was 39.9 months. Permanent treatment discontinuation was more frequent with ticagrelor than placebo (34.5% vs. 25.4%). The incidence of ischemic cardiovascular events (the primary efficacy outcome) was lower in the ticagrelor group than in the placebo group (7.7% vs. 8.5%; hazard ratio, 0.90; 95% confidence interval [CI], 0.81 to 0.99; P=0.04), whereas the incidence of TIMI major bleeding was higher (2.2% vs. 1.0%; hazard ratio, 2.32; 95% CI, 1.82 to 2.94; P<0.001), as was the incidence of intracranial hemorrhage (0.7% vs. 0.5%; hazard ratio, 1.71; 95% CI, 1.18 to 2.48; P=0.005). There was no significant difference in the incidence of fatal bleeding (0.2% vs. 0.1%; hazard ratio, 1.90; 95% CI, 0.87 to 4.15; P=0.11). The incidence of an exploratory composite outcome of irreversible harm (death from any cause, myocardial infarction, stroke, fatal bleeding, or intracranial hemorrhage) was similar in the ticagrelor group and the placebo group (10.1% vs. 10.8%; hazard ratio, 0.93; 95% CI, 0.86 to 1.02). Conclusions In patients with stable coronary artery disease and diabetes without a history of myocardial infarction or stroke, those who received ticagrelor plus aspirin had a lower incidence of ischemic cardiovascular events but a higher incidence of major bleeding than those who received placebo plus aspirin. (Funded by AstraZeneca; THEMIS ClinicalTrials.gov number, NCT01991795.).	[Steg, P. Gabriel] Univ Paris, French Alliance Cardiovasc Trials, Dept Hosp Univ FIRE, Hop Bichat,INSERM,U1148, Paris, France; [Steg, P. Gabriel; Simon, Tabassome] Hop St Antoine, AP HP, Paris, France; [Simon, Tabassome] Dept Clin Pharmacol, Unite Rech Clin, Paris, France; [Simon, Tabassome] Sorbonne Univ, Paris, France; [Steg, P. Gabriel; Fox, Kim] Imperial Coll, Natl Heart & Lung Inst, London, England; [Steg, P. Gabriel; Fox, Kim] Royal Brompton Hosp, London, England; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA 02115 USA; [Liu, Yuyin] Baim Inst Clin Res, Boston, MA USA; [Mehta, Shamir R.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Mehta, Shamir R.] McMaster Univ, Hamilton, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada; [Harrington, Robert A.] Stanford Univ, Stanford, CA 94305 USA; [Held, Claes] Uppsala Univ, Uppsala Clin Res Ctr, Dept Med Sci, Cardiol, Uppsala, Sweden; [Andersson, Marielle; Himmelmann, Anders; Ridderstrale, Wilhelm; Leonsson-Zachrisson, Maria] AstraZeneca BioPharmaceut Res & Dev, Molndal, Sweden; [Opolski, Grzegorz] Med Univ Warsaw, Dept Cardiol, Warsaw, Poland; [Zateyshchikov, Dmitry] City Clin Hosp 51, State Hlth Care Agcy, Moscow, Russia; [Ge, Junbo] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai, Peoples R China; [Nicolau, Jose C.] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Coracao, Sao Paulo, Brazil; [Corbalan, Ramon] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Cornel, Jan H.] Alkmaar, Dutch Network Cardiovasc Res, Northwest Clin, Utrecht, Netherlands; [Cornel, Jan H.] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, Nijmegen, Netherlands; [Widimsky, Petr] Charles Univ Prague, Cardioctr, Fac Med 3, Univ Hosp Kralovske Vinohrady, Prague, Czech Republic	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Royal Brompton Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; McMaster University; Population Health Research Institute; McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Stanford University; Uppsala University; Medical University of Warsaw; Fudan University; Universidade de Sao Paulo; Pontificia Universidad Catolica de Chile; Radboud University Nijmegen; Charles University Prague; University Hospital Vinohrady	Steg, PG (corresponding author), Hop Bichat Claude Bernard, Dept Cardiol, 46 Rue Henri Huchard, F-75018 Paris, France.; Bhatt, DL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA.	gabriel.steg@aphp.fr; dlbhattmd@post.harvard.edu	Widimsky, Petr/P-8088-2016; Rasputina, Lesia/AAE-5764-2019; Khasanov, Niiaz/W-7678-2019; Maslovskyi, Valentyn/V-3896-2019; Bhatt, Deepak L./Y-3070-2019; Leiter, Lawrence/AAG-4059-2020; Zateyshchikov, Dmitry A/D-6575-2012; Gonzalez, Arnulfo/AAD-9873-2019; Bueno, Hector/I-3910-2015; Maslovskyi, Valentyn/GQO-9125-2022; Nicolau, Jose C/E-1487-2012; Magnitskaya, Olga/B-1111-2016; Alshehri, Abdullah/AAS-9771-2020; Ma, Ronald/C-2788-2009; Held, Claes/AAA-3973-2021; GUERRERO, DIEGO BELLIDO/C-9446-2017; Boldueva, Svetlana/AAH-3862-2019; Liu, Yuyin/AAG-9794-2019; cornel, jan hein/Y-7065-2019; Reznik, Elena Vladimirovna/N-6856-2016; Martin-Asenjo, Roberto/D-6447-2017	Widimsky, Petr/0000-0001-5686-7752; Rasputina, Lesia/0000-0003-1230-4039; Khasanov, Niiaz/0000-0002-7760-0763; Maslovskyi, Valentyn/0000-0001-5184-1799; Bhatt, Deepak L./0000-0002-1278-6245; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Bueno, Hector/0000-0003-0277-7596; Maslovskyi, Valentyn/0000-0001-5184-1799; Nicolau, Jose C/0000-0002-9680-3689; Magnitskaya, Olga/0000-0001-6670-9029; Alshehri, Abdullah/0000-0002-0795-1760; Ma, Ronald/0000-0002-1227-803X; Held, Claes/0000-0001-9402-7404; GUERRERO, DIEGO BELLIDO/0000-0003-0631-2710; Boldueva, Svetlana/0000-0002-1898-084X; cornel, jan hein/0000-0002-1006-2112; Reznik, Elena Vladimirovna/0000-0001-7479-418X; Kietselaer, Bas/0000-0002-0096-8594; Opolski, Grzegorz/0000-0003-4744-2554; Garcia-Lledo, Alberto/0000-0002-8986-2584; Basiak, Marcin/0000-0003-0674-5612; Merkely, Bela/0000-0001-6514-0723; ELBAZ, Meyer/0000-0002-3520-7883; DE ARRUDA, JOSE AIRTON/0000-0002-2129-4947; Sztembis, Rafal/0000-0003-3188-6214; Garcia del Blanco, Bruno/0000-0002-4527-1600; Gonzalez-Cantu, Arnulfo/0000-0003-0103-0079; Rha, Seung-Woon/0000-0001-9456-9852; Liu, Yuyin/0000-0002-4995-832X; Martin-Asenjo, Roberto/0000-0001-6776-6922; Koranyi, Laszlo/0000-0002-5733-9350	AstraZeneca	AstraZeneca(AstraZeneca)	Supported by AstraZeneca.	Baber U, 2016, AM HEART J, V182, P125, DOI 10.1016/j.ahj.2016.09.006; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2019, NEW ENGL J MED, V380, P1825, DOI 10.1056/NEJMoa1901778; Bhatt DL, 2019, CLIN CARDIOL, V42, P498, DOI 10.1002/clc.23164; Bhatt DL, 2018, LANCET, V392, P896, DOI 10.1016/S0140-6736(18)31884-1; Bhatt DL, 2017, J AM COLL CARDIOL, V69, P603, DOI 10.1016/j.jacc.2016.11.050; Bhatt DL, 2016, J AM COLL CARDIOL, V67, P2732, DOI 10.1016/j.jacc.2016.03.529; Bhatt DL, 2009, NAT REV CARDIOL, V6, P737, DOI 10.1038/nrcardio.2009.192; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Capodanno D, 2018, NAT REV CARDIOL, V15, P480, DOI 10.1038/s41569-018-0049-1; Cavender MA, 2015, CIRCULATION, V132, P923, DOI 10.1161/CIRCULATIONAHA.114.014796; Elmariah S, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.005795; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; James S, 2010, EUR HEART J, V31, P3006, DOI 10.1093/eurheartj/ehq325; Krempf M, 2010, AM J CARDIOL, V105, P667, DOI 10.1016/j.amjcard.2009.10.048; Ferreiro JL, 2011, CIRCULATION, V123, P798, DOI 10.1161/CIRCULATIONAHA.109.913376; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Meredith IT, 2016, CIRCULATION, V133, P1772, DOI 10.1161/CIRCULATIONAHA.115.016783; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Steg PG, 2018, CIRCULATION, V137, P1429, DOI 10.1161/CIRCULATIONAHA.117.033442; Storey RF, 2016, J AM COLL CARDIOL, V67, P1145, DOI 10.1016/j.jacc.2015.12.062; Thomas MR, 2017, THROMB HAEMOSTASIS, V117, P940, DOI 10.1160/TH16-09-0703; Udell JA, 2016, EUR HEART J, V37, P390, DOI 10.1093/eurheartj/ehv443; Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Welsh RC, 2016, AM HEART J, V181, P92, DOI 10.1016/j.ahj.2016.08.008; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2013, LANCET, V382, P605, DOI 10.1016/S0140-6736(13)61451-8	32	174	179	3	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2019	381	14					1309	1320		10.1056/NEJMoa1908077	http://dx.doi.org/10.1056/NEJMoa1908077			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8MC	31475798	Green Published, Bronze			2022-12-28	WOS:000488823400005
J	Gilman, MSA; Liu, C; Fung, A; Behera, I; Jordan, P; Rigaux, P; Ysebaert, N; Tcherniuk, S; Sourimant, J; Eleouet, JF; Sutto-Ortiz, P; Decroly, E; Roymans, D; Jin, ZN; McLellan, JS				Gilman, Morgan S. A.; Liu, Cheng; Fung, Amy; Behera, Ishani; Jordan, Paul; Rigaux, Peter; Ysebaert, Nina; Tcherniuk, Sergey; Sourimant, Julien; Eleouet, Jean-Francois; Sutto-Ortiz, Priscila; Decroly, Etienne; Roymans, Dirk; Jin, Zhinan; McLellan, Jason S.			Structure of the Respiratory Syncytial Virus Polymerase Complex	CELL			English	Article							DEPENDENT RNA-POLYMERASE; VESICULAR STOMATITIS-VIRUS; P-PROTEIN; N-PROTEIN; CRYO-EM; VACCINE CANDIDATE; ESCHERICHIA-COLI; ACTIVE-SITE; PHOSPHOPROTEIN; REPLICATION	Numerous interventions are in clinical development for respiratory syncytial virus (RSV) infection, including small molecules that target viral transcription and replication. These processes are catalyzed by a complex comprising the RNA-dependent RNA polymerase (L) and the tetrameric phosphoprotein (P). RSV P recruits multiple proteins to the polymerase complex and, with the exception of its oligomerization domain, is thought to be intrinsically disordered. Despite their critical roles in RSV transcription and replication, structures of L and P have remained elusive. Here, we describe the 3.2-angstrom cryo-EM structure of RSV L bound to tetrameric P. The structure reveals a striking tentacular arrangement of P, with each of the four monomers adopting a distinct conformation. The structure also rationalizes inhibitor escape mutants and mutations observed in live-attenuated vaccine candidates. These results provide a framework for determining the molecular underpinnings of RSV replication and transcription and should facilitate the design of effective RSV inhibitors.	[Gilman, Morgan S. A.; McLellan, Jason S.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Liu, Cheng; Fung, Amy; Behera, Ishani; Jordan, Paul; Jin, Zhinan] Janssen Pharmaceut Co, Janssen BioPharma Inc, San Francisco, CA 94080 USA; [Rigaux, Peter; Ysebaert, Nina; Roymans, Dirk] Janssen Infect Dis & Vaccines, B-2340 Beerse, Belgium; [Tcherniuk, Sergey; Sourimant, Julien; Eleouet, Jean-Francois] Univ Paris Saclay, Unite Virol & Immunol Mol, INRA, F-78350 Jouy En Josas, France; [Sutto-Ortiz, Priscila; Decroly, Etienne] Aix Marseille Univ, CNRS, UMR 7257, AFMB, Marseille, France	University of Texas System; University of Texas Austin; Johnson & Johnson; Janssen Pharmaceuticals; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	McLellan, JS (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	jmclellan@austin.utexas.edu	Roymans, Dirk/AFQ-3892-2022; Eléouët, Jean-François/AAD-1994-2019	McLellan, Jason/0000-0003-3991-542X; DECROLY, Etienne/0000-0002-6046-024X; Sourimant, Julien/0000-0002-1660-1666	Cancer Prevention and Research Institute of Texas [RR160023]; Janssen Pharmaceutical Companies of Johnson Johnson; University of Texas College of Natural Sciences	Cancer Prevention and Research Institute of Texas; Janssen Pharmaceutical Companies of Johnson Johnson; University of Texas College of Natural Sciences	We would like to thank Dr. Aguang Dai at the Sauer Structural Biology Laboratory at UT Austin for assistance with cryo-EM data collection. We acknowledge the University of Texas College of Natural Sciences and award RR160023 of the Cancer Prevention and Research Institute of Texas for support of the EM facility at the University of Texas at Austin. We acknowledge Dr. Jerome Deval for initial contributions to this project. We thank Francoise Debart and JeanJacques Vasseur for preparation of RNA molecules used in the methyltransferase assay. We also thank Johannes Langedijk, George Kukolj, and members of the McLellan Laboratory for providing helpful comments on the manuscript. Support for this work was provided by Janssen Pharmaceutical Companies of Johnson & Johnson.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Arbesu M, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00039; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Blondot ML, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002734; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Braun MR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006803; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; Clarke MO, 2015, BIOORG MED CHEM LETT, V25, P2484, DOI 10.1016/j.bmcl.2015.04.073; Cockerill GS, 2019, J MED CHEM, V62, P3206, DOI 10.1021/acs.jmedchem.8b01361; Collins PL, 1996, P NATL ACAD SCI USA, V93, P81, DOI 10.1073/pnas.93.1.81; Cox R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00459; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Deval J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154097; Deval J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004995; DeVincenzo JP, 2015, NEW ENGL J MED, V373, P2048, DOI 10.1056/NEJMoa1413275; Duvall JR, 2016, ANTIVIR RES, V131, P19, DOI 10.1016/j.antiviral.2016.03.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esneau C, 2019, J BIOL CHEM, V294, P3647, DOI 10.1074/jbc.RA118.006453; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fearns R, 2016, ANTIVIR RES, V134, P63, DOI 10.1016/j.antiviral.2016.08.006; Fix Jenna, 2011, Open Virol J, V5, P103, DOI 10.2174/1874357901105010103; Galloux M, 2015, J VIROL, V89, P3484, DOI 10.1128/JVI.03666-14; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; GROSFELD H, 1995, J VIROL, V69, P5677, DOI 10.1128/JVI.69.9.5677-5686.1995; Gytz H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1212; Hardy RW, 1998, J VIROL, V72, P520, DOI 10.1128/JVI.72.1.520-526.1998; Homaira Nusrat, 2014, Int J Pediatr, V2014, P571609, DOI 10.1155/2014/571609; Jacome R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139001; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Knauer SH, 2012, CELL CYCLE, V11, P4289, DOI 10.4161/cc.22468; Leyrat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080371; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; Liuzzi M, 2005, J VIROL, V79, P13105, DOI 10.1128/JVI.79.20.13105-13115.2005; Llorente MT, 2008, PROTEINS, V72, P946, DOI 10.1002/prot.21988; Llorente MT, 2006, J GEN VIROL, V87, P159, DOI 10.1099/vir.0.81430-0; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Longhi S, 2017, CELL MOL LIFE SCI, V74, P3091, DOI 10.1007/s00018-017-2556-3; Lu B, 2002, J VIROL, V76, P2871, DOI 10.1128/JVI.76.6.2871-2880.2002; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Vilas JL, 2018, STRUCTURE, V26, P337, DOI 10.1016/j.str.2017.12.018; Luongo C, 2012, J VIROL, V86, P10792, DOI 10.1128/JVI.01227-12; Mason SW, 2003, J VIROL, V77, P10670, DOI 10.1128/JVI.77.19.10670-10676.2003; McCutcheon KM, 2016, J VIROL, V90, P1705, DOI 10.1128/JVI.02417-15; Neubauer J, 2016, NUCLEIC ACIDS RES, V44, P330, DOI 10.1093/nar/gkv1286; Noton SL, 2014, VIROLOGY, V462, P318, DOI 10.1016/j.virol.2014.05.032; Noval MG, 2016, BIOCHEMISTRY-US, V55, P1441, DOI 10.1021/acs.biochem.5b01332; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Paesen GC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9749; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rahmeh AA, 2012, P NATL ACAD SCI USA, V109, P14628, DOI 10.1073/pnas.1209147109; Rahmeh AA, 2010, P NATL ACAD SCI USA, V107, P20075, DOI 10.1073/pnas.1013559107; Richard CA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006920; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; SANKAR S, 1992, J BIOL CHEM, V267, P10168; Selvaraj M, 2018, MBIO, V9, DOI 10.1128/mBio.01554-18; Shahabi A, 2018, PHARMACOECON-OPEN, V2, P53, DOI 10.1007/s41669-017-0042-3; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Simabuco FM, 2011, BRAZ J MICROBIOL, V42, P340, DOI 10.1590/S1517-83822011000100043; Sourimant J, 2015, J VIROL, V89, P4421, DOI 10.1128/JVI.03619-14; Takeshita D, 2014, NUCLEIC ACIDS RES, V42, P10809, DOI 10.1093/nar/gku745; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; WAHBA AJ, 1974, J BIOL CHEM, V249, P3314; Wang GY, 2015, J MED CHEM, V58, P1862, DOI 10.1021/jm5017279; Whitehead SS, 1999, J VIROL, V73, P871, DOI 10.1128/JVI.73.2.871-877.1999; YU QZ, 1995, J VIROL, V69, P2412, DOI 10.1128/JVI.69.4.2412-2419.1995	82	67	68	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					193	+		10.1016/j.cell.2019.08.014	http://dx.doi.org/10.1016/j.cell.2019.08.014			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31495574	Green Published, Bronze			2022-12-28	WOS:000486618500023
J	Loeffler, D; Wehling, A; Schneiter, F; Zhang, Y; Muller-Botticher, N; Hoppe, PS; Hilsenbeck, O; Kokkaliaris, KD; Endele, M; Schroeder, T				Loeffler, Dirk; Wehling, Arne; Schneiter, Florin; Zhang, Yang; Muller-Botticher, Niklas; Hoppe, Philipp S.; Hilsenbeck, Oliver; Kokkaliaris, Konstantinos D.; Endele, Max; Schroeder, Timm			Asymmetric lysosome inheritance predicts activation of haematopoietic stem cells	NATURE			English	Article							SELF-RENEWAL; DIVISION; PROTEIN; MOUSE; QUANTIFICATION; EXPRESSION	Haematopoietic stem cells self-renew and differentiate into all blood lineages throughout life, and can repair damaged blood systems upon transplantation. Asymmetric cell division has previously been suspected to be a regulator of haematopoietic-stem-cell fate, but its existence has not directly been shown(1). In asymmetric cell division, asymmetric fates of future daughter cells are prospectively determined by a mechanism that is linked to mitosis. This can be mediated by asymmetric inheritance of cell-extrinsic niche signals by, for example, orienting the divisional plane, or by the asymmetric inheritance of cell-intrinsic fate determinants. Observations of asymmetric inheritance or of asymmetric daughter-cell fates alone are not sufficient to demonstrate asymmetric cell division(2). In both cases, sister-cell fates could be controlled by mechanisms that are independent of division. Here we demonstrate that the cellular degradative machinery-including lysosomes, autophagosomes, mitophagosomes and the protein NUMB-can be asymmetrically inherited into haematopoietic-stem-cell daughter cells. This asymmetric inheritance predicts the asymmetric future metabolic and translational activation and fates of haematopoietic-stem-cell daughter cells and their offspring. Therefore, our studies provide evidence for the existence of asymmetric cell division in haematopoietic stem cells.	[Loeffler, Dirk; Wehling, Arne; Schneiter, Florin; Zhang, Yang; Muller-Botticher, Niklas; Hoppe, Philipp S.; Hilsenbeck, Oliver; Kokkaliaris, Konstantinos D.; Endele, Max; Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Loeffler, Dirk; Hoppe, Philipp S.; Hilsenbeck, Oliver; Kokkaliaris, Konstantinos D.; Endele, Max; Schroeder, Timm] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Stem Cell Dynam, Neuherberg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schroeder, T (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.; Schroeder, T (corresponding author), German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Stem Cell Dynam, Neuherberg, Germany.	timm.schroeder@bsse.ethz.ch	Kokkaliaris, Konstantinos/GWQ-3400-2022	Loeffler, Dirk/0000-0001-9870-0088; Muller-Botticher, Niklas/0000-0001-5103-7282; Schroeder, Timm/0000-0001-9320-0252; KOKKALIARIS, KONSTANTINOS/0000-0002-9952-3463; Wehling, Arne/0000-0002-0845-626X; /0000-0002-4242-4544	DFG [SFB 684]; SNF; SystemsX.ch	DFG(German Research Foundation (DFG)); SNF; SystemsX.ch	We thank S. Ammersdoerfer, G. Camenisch, M. D. Hussherr, V. Jaggin, T. Lopes, H. Oller, C. Raithel, B. Vogel and A. Ziegler for technical support. This work was supported by DFG SFB 684 and the SNF to T.S. T.S. and O.H. acknowledge financial support from SystemsX.ch. We thank J. Arias for providing the cDNA for pHLuorin-DsRed-LC3 beta.	Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018; Eilken H., 2014, PROTOCOL EXCHANGE, DOI [10.1038/protex.2011.205, DOI 10.1038/PROTEX.2011.205, 10.1038/ protex.2011.205]; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Hilsenbeck O, 2017, BIOINFORMATICS, V33, P2020, DOI 10.1093/bioinformatics/btx107; Hilsenbeck O, 2016, NAT BIOTECHNOL, V34, P703, DOI 10.1038/nbt.3626; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Loeffler D, 2019, BLOOD, V133, P1406, DOI 10.1182/blood-2018-09-835397; Loeffler D, 2018, BLOOD, V131, P1425, DOI 10.1182/blood-2017-07-794131; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Motamedi M, 2016, J IMMUNOL METHODS, V437, P43, DOI 10.1016/j.jim.2016.08.002; Pham K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00026; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Schroeder T, 2007, CELL STEM CELL, V1, P479, DOI 10.1016/j.stem.2007.10.016; Shao XM, 2017, J BIOL CHEM, V292, P20628, DOI 10.1074/jbc.M117.800946; Skylaki S, 2016, NAT BIOTECHNOL, V34, P1137, DOI 10.1038/nbt.3713; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Vannini N, 2019, CELL STEM CELL, V24, P405, DOI 10.1016/j.stem.2019.02.012; Vannini N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13125; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zimdahl B, 2014, NAT GENET, V46, P245, DOI 10.1038/ng.2889	35	77	77	3	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					426	+		10.1038/s41586-019-1531-6	http://dx.doi.org/10.1038/s41586-019-1531-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31485073	Green Submitted			2022-12-28	WOS:000486647800052
J	Iwamoto, N; Mason, RD; Song, KM; Gorman, J; Welles, HC; Arthos, J; Cicala, C; Min, S; King, HAD; Belli, AJ; Reimann, KA; Foulds, KE; Kwong, PD; Lifson, JD; Keele, BF; Roederer, M				Iwamoto, Nami; Mason, Rosemarie D.; Song, Kaimei; Gorman, Jason; Welles, Hugh C.; Arthos, James; Cicala, Claudia; Min, Susie; King, Hannah A. D.; Belli, Aaron J.; Reimann, Keith A.; Foulds, Kathryn E.; Kwong, Peter D.; Lifson, Jeffrey D.; Keele, Brandon F.; Roederer, Mario			Blocling alpha(4)beta(7) integrin binding to SIV does not improve virologic control	SCIENCE			English	Article							CD4 BINDING; ANTIBODY; MACAQUES; EPITOPES; TISSUES; HUMANS; VRC01	A study in nonhuman primates reported that infusions of an antibody against alpha(4)beta(7) integrin, in combination with antiretroviral therapy, showed consistent, durable control of simian immunodeficiency virus (SIV) in rhesus macaques. The antibody used has pleiotropic effects, so we set out to gain insight into the underlying mechanism by comparing this treatment to treatment with non-neutralizing monoclonal antibodies against the SIV envelope glycoprotein that only block alpha(4)beta(7) binding to SIV Env but have no other host-directed effects. Similar to the initial study, we used an attenuated strain of SIV containing a stop codon in nef. The study used 30 macaques that all began antiretroviral therapy and then were divided into five groups to receive different antibody treatments. Unlike the published report, we found no sustained virologic control by these treatments in vivo.	[Iwamoto, Nami; Mason, Rosemarie D.; Song, Kaimei; Gorman, Jason; Welles, Hugh C.; King, Hannah A. D.; Foulds, Kathryn E.; Kwong, Peter D.; Roederer, Mario] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Arthos, James; Cicala, Claudia; Min, Susie] NIAID, Lab Immunoregulat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lifson, Jeffrey D.; Keele, Brandon F.] Frederick Natl Lab, AIDS Canc Virus Program, Frederick, MD USA; [Belli, Aaron J.; Reimann, Keith A.] Univ Massachusetts, Med Sch, MassBiol, Boston, MA 02125 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Boston	Roederer, M (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	roederer@nih.gov	Gorman, Jason/AGG-9417-2022; Roederer, Mario/G-1887-2011	Mason, Rosemarie/0000-0001-7123-4902; Cicala, Claudia/0000-0002-1181-8997; Iwamoto, Nami/0000-0002-5442-1500; Welles, Hugh/0000-0002-3336-1203	Intramural Research Program of the Vaccine Research Center, National Institutes of Health; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Cancer Institute, National Institutes of Health [HSN261200800001E]; NHP Reagent Resource grants [OD010976, AI126683T]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005126, ZICAI005103, ZIAAI005021, ZIAAI005022, U24AI126683] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHP Reagent Resource grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Intramural Research Programs of the Vaccine Research Center and the National Institute of Allergy and Infectious Diseases, National Institutes of Health; in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HSN261200800001E; and by the NHP Reagent Resource grants OD010976 and AI126683T. he content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of any trade names, commercial products, or organizations imply endorsement by the U.S. government.	Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Calenda G, 2018, J IMMUNOL, V200, P810, DOI 10.4049/jimmunol.1701150; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Cihlar T, 2016, CURR OPIN VIROL, V18, P50, DOI 10.1016/j.coviro.2016.03.004; Fennessey CM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0175-3; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Lertjuthaporn S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007278; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Mason RD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005537; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Santangelo PJ, 2018, MUCOSAL IMMUNOL, V11, P932, DOI 10.1038/mi.2017.112; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Tassaneetrithep B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108446; Welles HC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007395	22	22	22	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1033	+		10.1126/science.aaw7765	http://dx.doi.org/10.1126/science.aaw7765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488690	Green Accepted			2022-12-28	WOS:000484732700048
J	Mahase, E				Mahase, Elisabeth			Trainees and locums will get "NHS passports" to cut admin when they work between sites	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2019	366								l5473	10.1136/bmj.l5473	http://dx.doi.org/10.1136/bmj.l5473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1JQ	31492685				2022-12-28	WOS:000485448300009
J	Muller-Parker, G				Muller-Parker, Gisele			The rewards of government work	SCIENCE			English	Editorial Material									[Muller-Parker, Gisele] NSF, Grad Res Fellowship Program, Alexandria, VA 22314 USA	National Science Foundation (NSF)	Muller-Parker, G (corresponding author), NSF, Grad Res Fellowship Program, Alexandria, VA 22314 USA.			Muller-Parker, Gisele/0000-0001-5900-3722					0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1054	1054		10.1126/science.365.6457.1054	http://dx.doi.org/10.1126/science.365.6457.1054			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488694				2022-12-28	WOS:000484732700052
J	Yang, Y; Peng, C; Zhu, D; Buljan, H; Joanmopoulos, JD; Zhen, B; Soljacic, M				Yang, Yi; Peng, Chao; Zhu, Di; Buljan, Hrvoje; Joanmopoulos, John D.; Zhen, Bo; Soljacic, Matin			Synthesis and observation of non-Abelian gauge fields in real space	SCIENCE			English	Article							PHASE-FACTORS; REALIZATION; PHOTONS	Particles placed inside an Abelian (commutative) gauge field can acquire different phases when traveling along the same path in opposite directions, as is evident from the Aharonov-Bohm effect. Such behaviors can get significantly enriched for a non-Abelian gauge field, where even the ordering of different paths cannot be switched. So far, real-space realizations of gauge fields have been limited to Abelian ones. We report an experimental synthesis of non-Abelian gauge fields in real space and the observation of the non-Abelian Aharonov-Bohm effect with classical waves and classical fluxes. On the basis of optical mode degeneracy, we break time-reversal symmetry in different manners, via temporal modulation and the Faraday effect, to synthesize tunable non-Abelian gauge fields. The Sagnac interference of two final states, obtained by reversely ordered path integrals, demonstrates the noncommutativity of the gauge fields. Our work introduces real-space building blocks for non-Abelian gauge fields, relevant for classical and quantum exotic topological phenomena.	[Yang, Yi; Zhu, Di; Joanmopoulos, John D.; Soljacic, Matin] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Peng, Chao] Peking Univ, Dept Elect, State Key Lab Adv Opt Commun Syst & Networks, Beijing 100871, Peoples R China; [Peng, Chao] Minist Educ, Nano Optoelect Frontier Ctr, Beijing 100871, Peoples R China; [Buljan, Hrvoje] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 10000, Croatia; [Buljan, Hrvoje] Nankai Univ, TEDA Appl Phys Inst, MOE Key Lab Weak Light Nonlinear Photon, Tianjin 300457, Peoples R China; [Buljan, Hrvoje] Nankai Univ, Sch Phys, Tianjin 300457, Peoples R China; [Zhen, Bo] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	Massachusetts Institute of Technology (MIT); Peking University; University of Zagreb; Nankai University; Nankai University; University of Pennsylvania	Yang, Y (corresponding author), MIT, Res Lab Elect, Cambridge, MA 02139 USA.; Zhen, B (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	yiy@mit.edu; bozhen@sas.upenn.edu	Zhu, Di/GYA-3197-2022; Buljan, Hrvoje/L-9155-2013	Zhu, Di/0000-0003-0210-1860; /0000-0003-2879-4968; Buljan, Hrvoje/0000-0002-9808-6628	Army Research Office [W911NF-18-2-0048]; NSF [DMR-1838412, CCF-1640012]; AFRL [FA8650-16-D-5403]; MRSEC Program of NSF [DMR-1419807]; National Natural Science Foundation of China [61575002]; National Science Scholarship from A*STAR, Singapore; QuantiXLie Centre of Excellence - European Regional Development Fund [KK.01.11.01.0004]; Croatian Science Foundation [IP-2016-06-5885 SynthMagIA]; Charles E. Kaufman Foundation	Army Research Office; NSF(National Science Foundation (NSF)); AFRL(United States Department of DefenseUS Air Force Research Laboratory); MRSEC Program of NSF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Scholarship from A*STAR, Singapore; QuantiXLie Centre of Excellence - European Regional Development Fund; Croatian Science Foundation; Charles E. Kaufman Foundation	Supported by the Army Research Office under Cooperative Agreement W911NF-18-2-0048, NSF grant CCF-1640012, AFRL contract FA8650-16-D-5403, and the MRSEC Program of NSF under award DMR-1419807; National Natural Science Foundation of China grant 61575002 (C.P.); a National Science Scholarship from A*STAR, Singapore (D.Z.); the QuantiXLie Centre of Excellence, funded by the European Regional Development Fund (grant KK.01.11.01.0004) and Croatian Science Foundation grant IP-2016-06-5885 SynthMagIA (H.B.); and the Charles E. Kaufman Foundation, a supporting organization of the Pittsburgh Foundation, and NSF grant DMR-1838412 (B.Z.).	Abdumalikov AA, 2013, NATURE, V496, P482, DOI 10.1038/nature12010; AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Aidelsburger M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255301; Bermudez A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033041; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Chen YT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10974-8; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Fang KJ, 2012, NAT PHOTONICS, V6, P782, DOI [10.1038/NPHOTON.2012.236, 10.1038/nphoton.2012.236]; Goldman N, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/126401; Goldman N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.035301; Goldman N, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023624; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hauke P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.145301; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Huang LH, 2016, NAT PHYS, V12, P540, DOI [10.1038/NPHYS3672, 10.1038/nphys3672]; Iadecola T, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.073901; Jacob A, 2007, APPL PHYS B-LASERS O, V89, P439, DOI 10.1007/s00340-007-2865-6; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Kremer M., 2019, ARXIV190202559PHYSIC; Lim HT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14540; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Mazza L, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/015007; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Nielsen, 2010, QUANTUM COMPUTATION; Osterloh K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010403; Roushan P, 2017, NAT PHYS, V13, P146, DOI [10.1038/NPHYS3930, 10.1038/nphys3930]; Ruseckas J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010404; Saleh B. E., 2007, FUNDAMENTALS PHOTONI, P200; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; Sugawa S, 2018, SCIENCE, V360, P1429, DOI 10.1126/science.aam9031; Tzuang LD, 2014, NAT PHOTONICS, V8, P701, DOI [10.1038/NPHOTON.2014.177, 10.1038/nphoton.2014.177]; Umucalilar RO, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043804; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; WU TT, 1975, PHYS REV D, V12, P3845, DOI 10.1103/PhysRevD.12.3845; Wu Z, 2016, SCIENCE, V354, P83, DOI 10.1126/science.aaf6689; Yakaboylu E, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.235301; ZWANZIGER JW, 1990, PHYS REV A, V42, P3107, DOI 10.1103/PhysRevA.42.3107	38	40	40	6	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1021	+		10.1126/science.aay3183	http://dx.doi.org/10.1126/science.aay3183			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488687	Green Submitted			2022-12-28	WOS:000484732700045
J	Demircioglu, D; Cukuroglu, E; Kindermans, M; Nandi, T; Calabrese, C; Fonseca, NA; Kahles, A; Kjong-Van Lehmann; Stegle, O; Brazma, A; Brooks, AN; Ratsch, G; Tan, P; Goke, J				Demircioglu, Deniz; Cukuroglu, Engin; Kindermans, Martin; Nandi, Tannistha; Calabrese, Claudia; Fonseca, Nuno A.; Kahles, Andre; Kjong-Van Lehmann; Stegle, Oliver; Brazma, Alvis; Brooks, Angela N.; Ratsch, Gunnar; Tan, Patrick; Goke, Jonathan			A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters	CELL			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; BREAST-CANCER; DNA ELEMENTS; CAP ANALYSIS; MUTATIONS; SURVIVAL; ISOFORM; TUMORS; CAGE	Most human protein-coding genes are regulated by multiple, distinct promoters, suggesting that the choice of promoter is as important as its level of transcriptional activity. However, while a global change in transcription is recognized as a defining feature of cancer, the contribution of alternative promoters still remains largely unexplored. Here, we infer active promoters using RNA-seq data from 18,468 cancer and normal samples, demonstrating that alternative promoters are a major contributor to context-specific regulation of transcription. We find that promoters are deregulated across tissues, cancer types, and patients, affecting known cancer genes and novel candidates. For genes with independently regulated promoters, we demonstrate that promoter activity provides a more accurate predictor of patient survival than gene expression. Our study suggests that a dynamic landscape of active promoters shapes the cancer transcriptome, opening new diagnostic avenues and opportunities to further explore the interplay of regulatory mechanisms with transcriptional aberrations in cancer.	[Demircioglu, Deniz; Cukuroglu, Engin; Kindermans, Martin; Nandi, Tannistha; Goke, Jonathan] Genome Inst Singapore, Computat & Syst Biol, Singapore 138672, Singapore; [Demircioglu, Deniz] Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore; [Calabrese, Claudia; Fonseca, Nuno A.; Stegle, Oliver; Brazma, Alvis] EMBL, EBI, Wellcome Genome Campus, Hinxton CB10 1SD, Cambs, England; [Calabrese, Claudia; Stegle, Oliver] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Fonseca, Nuno A.] Univ Porto, CIBIO InBIO Res Ctr Biodivers & Genet Resources, P-4485601 Vairao, Portugal; [Kahles, Andre; Kjong-Van Lehmann; Ratsch, Gunnar] Swiss Fed Inst Technol, Dept Comp Sci, CH-8092 Zurich, Switzerland; [Kahles, Andre; Ratsch, Gunnar] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Kahles, Andre; Kjong-Van Lehmann; Ratsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Kahles, Andre; Kjong-Van Lehmann; Ratsch, Gunnar] SIB, CH-1015 Lausanne, Switzerland; [Kahles, Andre; Kjong-Van Lehmann; Ratsch, Gunnar] Univ Hosp Zurich, Biomed Informat Res, CH-8091 Zurich, Switzerland; [Stegle, Oliver] German Canc Res Ctr, Div Computat Genom & Syst Genet, D-69120 Heidelberg, Germany; [Brooks, Angela N.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Ratsch, Gunnar] Weill Cornell Med Coll, New York, NY 10065 USA; [Tan, Patrick] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Tan, Patrick] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Tan, Patrick] Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Singapore 138672, Singapore; [Tan, Patrick] Natl Heart Ctr Singapore, SingHlth Duke NUS Inst Precis Med, Singapore 169856, Singapore; [Tan, Patrick; Goke, Jonathan] Natl Canc Ctr, Cellular & Mol Res, Singapore 169610, Singapore; [Tan, Patrick] Singapore Gastr Canc Consortium, Singapore 119074, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Universidade do Porto; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Memorial Sloan Kettering Cancer Center; Swiss Institute of Bioinformatics; University of Zurich; University Zurich Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California Santa Cruz; Cornell University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National Heart Centre Singapore; National Cancer Centre Singapore (NCCS)	Goke, J (corresponding author), Genome Inst Singapore, Computat & Syst Biol, Singapore 138672, Singapore.; Goke, J (corresponding author), Natl Canc Ctr, Cellular & Mol Res, Singapore 169610, Singapore.	gokej@gis.a-star.edu.sg	Kahles, Andre/ABB-8343-2020; Fonseca, Nuno A./B-7801-2009; Stegle, Oliver/AAU-9177-2020	Kahles, Andre/0000-0002-3411-0692; Fonseca, Nuno A./0000-0003-4832-578X; Stegle, Oliver/0000-0002-8818-7193; Goke, Jonathan/0000-0002-0825-4991; Calabrese, Claudia/0000-0002-8941-2620; Demircioglu, Deniz/0000-0001-7857-0407; Lehmann, Kjong-Van/0000-0002-1936-298X; Brazma, Alvis/0000-0001-5988-7409	Agency for Science, Technology and Research (A*STAR), Singapore; Singapore Ministry of Health's National Medical Research Council [OFIRG16nov019]; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centres of Excellence initiative; National Medical Research Council [TCR/009-NUHS/2013, NMRC/STaR/0026/2015]; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centres of Excellence initiative(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is funded by the Agency for Science, Technology and Research (A*STAR), Singapore, and supported by the Singapore Ministry of Health's National Medical Research Council under its Individual Research Grant funding scheme (OFIRG16nov019). A portion of this research is supported by the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence initiative. P.T. is supported by National Medical Research Council grants TCR/009-NUHS/2013 and NMRC/STaR/0026/2015. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The GTEx data used for the analyses described in this manuscript were obtained from the dbGaP accession number phs000424.v6.p1 on September 4, 2015. The TCGA data used in this manuscript were obtained from the dbGaP accession number phs000178.v10.p8. The results published here are in whole or part based upon data generated by TCGA managed by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov. We acknowledge the ENCODE Consortium and the ENCODE production laboratories for generating the datasets used in this study.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; [Anonymous], 2019, GPLOTS STAT PACKAGE; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Calabrese C., 2018, BIORXIV, DOI [10.1101/183889, DOI 10.1101/183889]; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donaldson J., 2016, T DISTRIBUTED STOCHA; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fay Michael J, 2003, Mol Cancer, V2, P40, DOI 10.1186/1476-4598-2-40; Feng GH, 2016, EMBO REP, V17, P1304, DOI 10.15252/embr.201541476; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerstung M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6901; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gross AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142618; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hashimoto K, 2015, GENOME RES, V25, P1812, DOI 10.1101/gr.191031.115; Heber Steffen, 2002, Bioinformatics, V18 Suppl 1, pS181; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hippo Y, 2002, CANCER RES, V62, P233; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Kaczkowski B, 2016, CANCER RES, V76, P216, DOI 10.1158/0008-5472.CAN-15-0484; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kassambara A., 2018, GGPUBR GGPLOT2 BASED; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lazar AJF, 2008, AM J PATHOL, V173, P1518, DOI 10.2353/ajpath.2008.080475; Lee JH, 2004, J PATHOL, V202, P439, DOI 10.1002/path.1532; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marx V, 2017, NAT METHODS, V14, P343, DOI 10.1038/nmeth.4232; Moody SE, 2015, ONCOGENE, V34, P2061, DOI 10.1038/onc.2014.153; Muratani M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5361; Nissim L, 2017, CELL, V171, P1138, DOI 10.1016/j.cell.2017.09.049; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Perlman EJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10013; Qamra A, 2017, CANCER DISCOV, V7, P630, DOI 10.1158/2159-8290.CD-16-1022; R Core Team, 2018, R A LANGUAGE AND ENV; Rapin N, 2014, BLOOD, V123, P894, DOI 10.1182/blood-2013-02-485771; Reyes A, 2018, NUCLEIC ACIDS RES, V46, P582, DOI 10.1093/nar/gkx1165; Rheinbay E., 2017, DISCOVERY CHARACTERI, DOI [10.1101/237313, DOI 10.1101/237313]; Rheinbay E, 2017, NATURE, V547, P55, DOI 10.1038/nature22992; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Soneson C, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800175; Takahashi H, 2012, METHODS MOL BIOL, V786, P181, DOI 10.1007/978-1-61779-292-2_11; Teng MX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0940-1; Therneau TM, 2000, MODELING SURVIVAL DA; Thomas-Chollier M, 2012, NAT PROTOC, V7, P1551, DOI 10.1038/nprot.2012.088; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Ulz P, 2016, NAT GENET, V48, P1273, DOI 10.1038/ng.3648; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiesner T, 2015, NATURE, V526, P453, DOI 10.1038/nature15258	87	65	67	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1465	+		10.1016/j.cell.2019.08.018	http://dx.doi.org/10.1016/j.cell.2019.08.018			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491388	Bronze			2022-12-28	WOS:000483983000019
J	Perkel, JM				Perkel, Jeffrey M.			THAT'S THE WAY WE FLOW	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008				Baichoo S, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2446-1	1	22	22	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					149	150		10.1038/d41586-019-02619-z	http://dx.doi.org/10.1038/d41586-019-02619-z			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0KI	31477884	Bronze			2022-12-28	WOS:000483967700052
J	Thow, AM; Nisbett, N				Thow, Anne Marie; Nisbett, Nicholas			Trade, nutrition, and sustainable food systems	LANCET			English	Editorial Material							HEALTH		[Thow, Anne Marie] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Thow, Anne Marie] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Nisbett, Nicholas] Inst Dev Studies, Brighton, E Sussex, England	University of Sydney; University of Sydney	Thow, AM (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.; Thow, AM (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	annemarie.thow@sydney.edu.au		Nisbett, Nicholas/0000-0002-9558-2263				[Anonymous], 2018, J INT BUS POLICY, DOI DOI 10.1057/S42214-018-0001-4; Drope J, 2014, J HEALTH POLIT POLIC, V39, P591, DOI 10.1215/03616878-2682621; Friel S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-46; Hawkes C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0383-7; HM Treasury, 2018, SOFT DRINKS IND LEV; Kevany S., 2018, GUARDIAN; Ostry J.D., 2016, FINANCE DEV IMF, V53, P38; Puig S, 2018, AM J INT LAW, V112, P361, DOI 10.1017/ajil.2018.70; Raworth K., 2017, DOUGHNUT EC 7 WAYS T; Rodrik D, 2018, J ECON PERSPECT, V32, P73, DOI 10.1257/jep.32.2.73; Scottish Government, 2019, MIN UN PRIC; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Thow AM, 2018, HEALTH PROMOT INT, V33, P561, DOI 10.1093/heapro/daw109; Thow AM, 2017, B WORLD HEALTH ORGAN, V95, P723, DOI [10.2471/BLT.17.192468, 10.2471/blt.17.192468]; Thow AM, 2014, B WORLD HEALTH ORGAN, V92, P139, DOI 10.2471/BLT.13.120543; Voon T, 2016, ICSID REV, V31, P413, DOI 10.1093/icsidreview/siw010; Wilkinson R, 2016, GLOB POLICY, V7, P247, DOI 10.1111/1758-5899.12339; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4	18	7	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					716	718		10.1016/S0140-6736(19)31292-9	http://dx.doi.org/10.1016/S0140-6736(19)31292-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UW	31478488				2022-12-28	WOS:000483011400011
J	Ganna, A; Verweij, KJH; Nivard, MG; Maier, R; Wedow, R; Busch, AS; Abdellaoui, A; Guo, S; Sathirapongsasuti, JF; Lichtenstein, P; Lundstrom, S; Langstrom, N; Auton, A; Harris, KM; Beecham, GW; Martin, ER; Sanders, AR; Perry, JRB; Neale, BM; Zietsch, BP; Agee, M; Alipanahi, B; Auton, A; Bell, RK; Bryc, K; Elson, SL; Fontanillas, P; Furlotte, NA; Hicks, B; Huber, KE; Jewett, EM; Jiang, Y; Kleinman, A; Lin, KH; Litterman, NK; McCreight, JC; McIntyre, MH; McManus, KF; Mountain, JL; Noblin, ES; Northover, CAM; Pitts, SJ; Poznik, GD; Shastri, AJ; Shelton, JF; Shringarpure, S; Tian, C; Tung, JY; Vacic, V; Wang, X; Wilson, CH				Ganna, Andrea; Verweij, Karin J. H.; Nivard, Michel G.; Maier, Robert; Wedow, Robbee; Busch, Alexander S.; Abdellaoui, Abdel; Guo, Shengru; Sathirapongsasuti, J. Fah; Lichtenstein, Paul; Lundstrom, Sebastian; Langstrom, Niklas; Auton, Adam; Harris, Kathleen Mullan; Beecham, Gary W.; Martin, Eden R.; Sanders, Alan R.; Perry, John R. B.; Neale, Benjamin M.; Zietsch, Brendan P.; Agee, M.; Alipanahi, B.; Auton, A.; Bell, R. K.; Bryc, K.; Elson, S. L.; Fontanillas, P.; Furlotte, N. A.; Hicks, B.; Huber, K. E.; Jewett, E. M.; Jiang, Y.; Kleinman, A.; Lin, K. -H.; Litterman, N. K.; McCreight, J. C.; McIntyre, M. H.; McManus, K. F.; Mountain, J. L.; Noblin, E. S.; Northover, C. A. M.; Pitts, S. J.; Poznik, G. D.; Shastri, A. J.; Shelton, J. F.; Shringarpure, S.; Tian, C.; Tung, J. Y.; Vacic, V.; Wang, X.; Wilson, C. H.		23AndMe Res Team	Large-scale GWAS reveals insights into the genetic architecture of same-sex sexual behavior	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; PSYCHIATRIC-DISORDERS; GENERAL-POPULATION; ORIENTATION; LINKAGE; DISEASE; LOCI; SCHIZOPHRENIA; TRAIT; HOMOSEXUALITY	Twin and family studies have shown that same-sex sexual behavior is partly genetically influenced, but previous searches for specific genes involved have been underpowered. We performed a genome-wide association study (GWAS) on 477,522 individuals, revealing five loci significantly associated with same-sex sexual behavior. In aggregate, all tested genetic variants accounted for 8 to 25% of variation in same-sex sexual behavior, only partially overlapped between males and females, and do not allow meaningful prediction of an individual's sexual behavior. Comparing these GWAS results with those for the proportion of same-sex to total number of sexual partners among nonheterosexuals suggests that there is no single continuum from opposite-sex to same-sex sexual behavior. Overall, our findings provide insights into the genetics underlying same-sex sexual behavior and underscore the complexity of sexuality.	[Ganna, Andrea; Maier, Robert; Wedow, Robbee; Neale, Benjamin M.] Massachusetts Gen Hosp, Ctr Genom Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ganna, Andrea; Maier, Robert; Neale, Benjamin M.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ganna, Andrea; Maier, Robert; Wedow, Robbee; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Ganna, Andrea; Lichtenstein, Paul; Langstrom, Niklas] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Verweij, Karin J. H.; Abdellaoui, Abdel] Univ Amsterdam, AMC, Amsterdam Univ Med Ctr UMC, Dept Psychiat, Meibergdreef 5, NL-1105 AZ Amsterdam, Netherlands; [Nivard, Michel G.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Wedow, Robbee] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Wedow, Robbee] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wedow, Robbee] Univ Colorado, Dept Sociol, Boulder, CO 80309 USA; [Wedow, Robbee] Univ Colorado, Inst Behav Sci, Hlth & Soc Program & Populat Program, Boulder, CO 80309 USA; [Wedow, Robbee] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Busch, Alexander S.; Perry, John R. B.] Univ Cambridge, Inst Metab Sci, Sch Clin Med, MRC,Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England; [Busch, Alexander S.] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark; [Busch, Alexander S.] Rigshosp, Int Ctr Res & Res Training Endocrine Disrupt Male, Copenhagen, Denmark; [Guo, Shengru; Beecham, Gary W.; Martin, Eden R.] Univ Miami, Dept Human Genet, Miami, FL 33136 USA; [Sathirapongsasuti, J. Fah; Auton, Adam; 23AndMe Res Team] 23andMe, Mountain View, CA 94041 USA; [Lundstrom, Sebastian] Univ Gothenburg, Gillberg Neuropsychiat Ctr, Ctr Eth Law & Mental Hlth, Gothenburg, Sweden; [Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA; [Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27599 USA; [Sanders, Alan R.] NorthShore Univ HealthSyst Res Inst, Dept Psychiat & Behav Sci, Evanston, IL 60201 USA; [Sanders, Alan R.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Zietsch, Brendan P.] Univ Queensland, Sch Psychol, Ctr Psychol & Evolut, Brisbane, Qld 4072, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Cambridge; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Miami; University of Gothenburg; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; NorthShore University Health System; University of Chicago; University of Queensland	Zietsch, BP (corresponding author), Univ Queensland, Sch Psychol, Ctr Psychol & Evolut, Brisbane, Qld 4072, Australia.	zietsch@psy.uq.edu.au	Langstrom, Niklas/C-5615-2009	Langstrom, Niklas/0000-0002-2686-6799; Busch, Alexander Siegfried/0000-0003-4417-569X; Ganna, Andrea/0000-0002-8147-240X; Nivard, Michel/0000-0003-2015-1888; lichtenstein, paul/0000-0003-3037-5287; Wedow, Robbee/0000-0002-3108-7087; Zietsch, Brendan/0000-0003-0274-6140	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD041563, R21HD080410, P01-HD031921]; Australian Research Council [FT160100298]; Knut and Alice Wallenberg Foundation [2015.0327]; Swedish Research Council [2016-00250]; National Institutes of Health (NIH) [1R01MH107649-03]; National Science Foundation's Graduate Research Fellowship Program [DGE 1144083]; ZonMw grants from the Netherlands Organisation for Health Research and Development [849200011, 531003014]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD073342, R01 HD060726]; Swedish Council for Working Life and Social Research [2014-0834]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080410, P01HD031921, P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107649] Funding Source: NIH RePORTER; MRC [MC_UU_12015/2] Funding Source: UKRI	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Australian Research Council(Australian Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation's Graduate Research Fellowship Program(National Science Foundation (NSF)); ZonMw grants from the Netherlands Organisation for Health Research and Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A. R. S. received funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development specifically to investigate the genetics of sexual orientation: R01HD041563 (A. R. S., principal investigator) and R21HD080410 (A. R. S. and E. R. M., multiple principal investigators). E. R. M., G. W. B., and S. G. are also supported by R21HD080410. No other member of the group received funding specifically for this study, but members of our team received salary funding from organizations as well as our own universities. B. P. Z. received funding from The Australian Research Council (FT160100298). A. G. was supported by the Knut and Alice Wallenberg Foundation (2015.0327) and the Swedish Research Council (2016-00250). A. G., R. M., and B. M. N. were supported by National Institutes of Health (NIH) grant 1R01MH107649-03 (to B. M. N.). R. W. was supported by the National Science Foundation's Graduate Research Fellowship Program (DGE 1144083). Any opinion, findings, conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. M. G. N. is supported by ZonMw grants 849200011 and 531003014 from the Netherlands Organisation for Health Research and Development. This research used data from Add Health, a program project directed by K. M. H. (principal investigator) and designed by J. R. Udry, P. S. Bearman, and K. M. H. at the University of North Carolina at Chapel Hill, and funded by grant P01-HD031921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Information on how to obtain the Add Health data files is available on the Add Health website (www.cpc.unc.edu/addhealth). This research used Add Health GWAS data funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grants R01 HD073342 to K. M. H. (principal investigator) and R01 HD060726 to K. M. H., J. D. Boardman, and M. B. McQueen (multiple principal investigators). The genetic part of the CATSS study was supported by grant 2014-0834 from the Swedish Council for Working Life and Social Research. We thank the research participants of 23andMe and the other contributing cohorts for making this study possible. Collaborators for the 23andMe Research Team are M. Agee, B. Alipanahi, A. Auton, R. K. Bell, K. Bryc, S. L. Elson, P. Fontanillas, N. A. Furlotte, B. Hicks, K. E. Huber, E. M. Jewett, Y. Jiang, A. Kleinman, K.-H. Lin, N. K. Litterman, J. C. McCreight, M. H. McIntyre, K. F. McManus, J. L. Mountain, E. S. Noblin, C. A. M. Northover, S. J. Pitts, G. D. Poznik, A. J. Shastri, J. F. Shelton, S. Shringarpure, C. Tian, J. Y. Tung, V. Vacic, X. Wang, and C. H. Wilson.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bailey JM, 2016, PSYCHOL SCI PUBL INT, V17, P45, DOI 10.1177/1529100616637616; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Bhandari RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019935; Bialer P., 2013, POSITION STATEMENT I; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; BURKE CW, 1972, NATURE, V240, P38, DOI 10.1038/240038a0; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; Cui SY, 2004, DEVELOPMENT, V131, P4095, DOI 10.1242/dev.01266; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Eastwood SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162388; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; GALLUP In U. S, 2018, EST LGBT POP RIS 4 5; Ganna A, 2018, AM J HUM GENET, V102, P1204, DOI 10.1016/j.ajhg.2018.05.002; Goddard ME, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0569; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; Harris KM, 2019, INT J EPIDEMIOL, V48, P1415, DOI 10.1093/ije/dyz115; Harris SE, 2017, INT J EPIDEMIOL, V46, P994, DOI 10.1093/ije/dyw219; Herek GM, 2010, SEX RES SOC POLICY, V7, P176, DOI 10.1007/s13178-010-0017-y; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kische H, 2017, JAMA DERMATOL, V153, P935, DOI 10.1001/jamadermatol.2017.0297; Klein F., 1993, THE BISEXUAL OPTION; Langstrom N, 2010, ARCH SEX BEHAV, V39, P75, DOI 10.1007/s10508-008-9386-1; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levinson DF, 2012, AM J PSYCHIAT, V169, P963, DOI 10.1176/appi.ajp.2012.11091423; Linner RK, 2019, NAT GENET, V51, P245, DOI 10.1038/s41588-018-0309-3; Lippa RA, 2008, ARCH SEX BEHAV, V37, P173, DOI 10.1007/s10508-007-9267-z; Lloyd-Jones LR, 2018, GENETICS, V208, P1397, DOI 10.1534/genetics.117.300360; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lowe GM, 2009, FREE RADICAL RES, V43, P280, DOI 10.1080/10715760802691497; Lynch M., 1998, GENETICS ANAL QUANTI, V1; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Martin J, 2018, BIOL PSYCHIAT, V83, P1044, DOI 10.1016/j.biopsych.2017.11.026; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McQueen MB, 2015, BEHAV GENET, V45, P12, DOI 10.1007/s10519-014-9692-4; McRae JF, 2013, CURR BIOL, V23, P1596, DOI 10.1016/j.cub.2013.07.031; MELBYE M, 1992, AM J EPIDEMIOL, V135, P593, DOI 10.1093/oxfordjournals.aje.a116338; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Norris AL, 2015, PSYCHOL SCI, V26, P1843, DOI 10.1177/0956797615598617; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Pasman JA, 2018, NAT NEUROSCI, V21, P1161, DOI 10.1038/s41593-018-0206-1; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Peyrot WJ, 2016, AM J HUM GENET, V98, P382, DOI 10.1016/j.ajhg.2015.12.017; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pillard RC, 1998, HUM BIOL, V70, P347; Power RA, 2013, JAMA PSYCHIAT, V70, P22, DOI 10.1001/jamapsychiatry.2013.268; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rawlik K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1025-x; Rice G, 1999, SCIENCE, V284, P665, DOI 10.1126/science.284.5414.665; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders AR, 2015, PSYCHOL MED, V45, P1379, DOI 10.1017/S0033291714002451; Sanders AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15736-4; Sanders AR, 2010, AM J PSYCHIAT, V167, P854, DOI 10.1176/appi.ajp.2010.09071050; Sandfort TGM, 2001, ARCH GEN PSYCHIAT, V58, P85, DOI 10.1001/archpsyc.58.1.85; Sell RL, 1997, ARCH SEX BEHAV, V26, P643, DOI 10.1023/A:1024528427013; Semenyna SW, 2017, J SEX RES, V54, P1077, DOI 10.1080/00224499.2016.1218416; Semlyen J, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0767-z; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Turley P, 2018, NAT GENET, V50, P229, DOI 10.1038/s41588-017-0009-4; Uehara DT, 2016, J HUM GENET, V61, P335, DOI 10.1038/jhg.2015.154; Valdes-Socin H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00109; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Warrington NM, 2018, HUM MOL GENET, V27, P2025, DOI 10.1093/hmg/ddy121; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Xu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034327; Zhan XW, 2016, BIOINFORMATICS, V32, P1423, DOI 10.1093/bioinformatics/btw079; Zietsch B.P., 2011, PSYCHIAT DISORDERS W, P277; 1992, NATURE, V360, P407, DOI DOI 10.1038/360407A0	106	123	124	14	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					882	+	eaat7693	10.1126/science.aat7693	http://dx.doi.org/10.1126/science.aat7693			95	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467194	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000483975800036
J	Owens, B				Owens, Brian			HORTICULTURE A serious effort	NATURE			English	Editorial Material																			0	4	4	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					S10	S11		10.1038/d41586-019-02527-2	http://dx.doi.org/10.1038/d41586-019-02527-2			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31462785	Bronze			2022-12-28	WOS:000483405500016
J	Kleinman, A				Kleinman, Arthur			The art of medicine The soul in medicine	LANCET			English	Editorial Material									[Kleinman, Arthur] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Kleinman, Arthur] Harvard Univ, Fac Med, Cambridge, MA 02138 USA	Harvard University; Harvard University	Kleinman, A (corresponding author), Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA.; Kleinman, A (corresponding author), Harvard Univ, Fac Med, Cambridge, MA 02138 USA.	kleinman@fas.harvard.edu							0	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					630	631		10.1016/S0140-6736(19)31961-0	http://dx.doi.org/10.1016/S0140-6736(19)31961-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UU	31448729				2022-12-28	WOS:000483011200018
J	Munday, D; Boyd, K; Jeba, J; Kimani, K; Moine, S; Grant, L; Murray, S				Munday, Daniel; Boyd, Kirsty; Jeba, Jenifer; Kimani, Kellen; Moine, Sebastien; Grant, Liz; Murray, Scott			Defining primary palliative care for universal health coverage	LANCET			English	Editorial Material									[Munday, Daniel; Boyd, Kirsty; Moine, Sebastien; Grant, Liz; Murray, Scott] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Primary Palliat Care Grp, Edinburgh EH8 9AG, Midlothian, Scotland; [Jeba, Jenifer] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Kimani, Kellen] Hlth Serv Dept, Kiambu, Kiambu County, Kenya	University of Edinburgh; Christian Medical College & Hospital (CMCH) Vellore	Munday, D (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Primary Palliat Care Grp, Edinburgh EH8 9AG, Midlothian, Scotland.	daniel.munday@ed.ac.uk		MOINE, Sebastien/0000-0003-3960-9422				Bloom G, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2107; CHARLTON R, 2002, PRIMARY PALLIATIVE C; Das J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1716; European Association For Palliative Care, 2019, TOOLK DEV PALL CAR P; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; Munday D, 2019, BMJ SUPPORT PALLIAT, V9, DOI 10.1136/bmjspcare-2018-001579; Murray SA, 2004, BMJ-BRIT MED J, V329, P1056, DOI 10.1136/bmj.329.7474.1056; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Sleeman KE, 2019, LANCET GLOB HEALTH, V7, pE883, DOI 10.1016/S2214-109X(19)30172-X; Stjernsward J, 2007, J PAIN SYMPTOM MANAG, V33, P486, DOI 10.1016/j.jpainsymman.2007.02.016; Weissman D. E, 2010, J PALLIAT MED, V14, P17; WHO, 2017, UN HLTH COV FACTSH; World Health Organization, 2018, INT PALL CAR SYMPT R	13	6	6	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					621	622		10.1016/S0140-6736(19)31830-6	http://dx.doi.org/10.1016/S0140-6736(19)31830-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UU	31448727	Green Accepted			2022-12-28	WOS:000483011200015
J	Miller, G				Miller, Greg			PATHWAYS TO PREVENTION	SCIENCE			English	News Item																			0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		745	747		10.1126/science.365.6455.745	http://dx.doi.org/10.1126/science.365.6455.745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439778				2022-12-28	WOS:000482464000024
J	Dagenais, GR; Leong, DP; Rangarajan, S; Lanas, F; Lopez-Jaramillo, P; Gupta, R; Diaz, R; Avezum, A; Oliveira, GBF; Wielgosz, A; Parambath, SR; Mony, P; Alhabib, KF; Temizhan, A; Ismail, N; Chifamba, J; Yeates, K; Khatib, R; Rahman, O; Zatonska, K; Kazmi, K; Wei, L; Zhu, J; Rosengren, A; Vijayakumar, K; Kaur, M; Mohan, V; Yusufali, A; Kelishadi, R; Teo, KK; Joseph, P; Yusuf, S				Dagenais, Gilles R.; Leong, Darryl P.; Rangarajan, Sumathy; Lanas, Fernando; Lopez-Jaramillo, Patricio; Gupta, Rajeev; Diaz, Rafael; Avezum, Alvaro; Oliveira, Gustavo B. F.; Wielgosz, Andreas; Parambath, Shameena R.; Mony, Prem; Alhabib, Khalid F.; Temizhan, Ahmet; Ismail, Noorhassim; Chifamba, Jephat; Yeates, Karen; Khatib, Rasha; Rahman, Omar; Zatonska, Katarzyna; Kazmi, Khawar; Wei, Li; Zhu, Jun; Rosengren, Annika; Vijayakumar, K.; Kaur, Manmeet; Mohan, Viswanathan; Yusufali, AfzalHussein; Kelishadi, Roya; Teo, Koon K.; Joseph, Philip; Yusuf, Salim			Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study	LANCET			English	Article							GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; HIGH-INCOME; NONCOMMUNICABLE DISEASES; RISK-FACTORS; MORTALITY; EPIDEMIOLOGY; PREVENTION; PREVALENCE; INTERHEART	Background To our knowledge, no previous study has prospectively documented the incidence of common diseases and related mortality in high-income countries (HICs), middle-income countries (MICs), and low-income countries (LICs) with standardised approaches. Such information is key to developing global and context-specific health strategies. In our analysis of the Prospective Urban Rural Epidemiology (PURE) study, we aimed to evaluate differences in the incidence of common diseases, related hospital admissions, and related mortality in a large contemporary cohort of adults from 21 HICs, MICs, and LICs across five continents by use of standardised approaches. Methods The PURE study is a prospective, population-based cohort study of individuals aged 35-70 years who have been enrolled from 21 countries across five continents. The key outcomes were the incidence of fatal and non-fatal cardiovascular diseases, cancers, injuries, respiratory diseases, and hospital admissions, and we calculated the age-standardised and sex-standardised incidence of these events per 1000 person-years. Findings This analysis assesses the incidence of events in 162534 participants who were enrolled in the first two phases of the PURE core study, between Jan 6, 2005, and Dec 4, 2016, and who were assessed for a median of 9.5 years (IQR 8.5-10.9). During follow-up, 11307 (7.0%) participants died, 9329 (5.7%) participants had cardiovascular disease, 5151 (3.2%) participants had a cancer, 4386 (2.7%) participants had injuries requiring hospital admission, 2911 (1.8%) participants had pneumonia, and 1830 (1.1%) participants had chronic obstructive pulmonary disease (COPD). Cardiovascular disease occurred more often in LICs (7.1 cases per 1000 person-years) and in MICs (6.8 cases per 1000 person-years) than in HICs (4.3 cases per 1000 person-years). However, incident cancers, injuries, COPD, and pneumonia were most common in HICs and least common in LICs. Overall mortality rates in LICs (13.3 deaths per 1000 person-years) were double those in MICs (6.9 deaths per 1000 person-years) and four times higher than in HICs (3.4 deaths per 1000 person-years). This pattern of the highest mortality in LICs and the lowest in HICs was observed for all causes of death except cancer, where mortality was similar across country income levels. Cardiovascular disease was the most common cause of deaths overall (40%) but accounted for only 23% of deaths in HICs (vs 41% in MICs and 43% in LICs), despite more cardiovascular disease risk factors (as judged by INTERHEART risk scores) in HICs and the fewest such risk factors in LICs. The ratio of deaths from cardiovascular disease to those from cancer was 0.4 in HICs, 1.3 in MICs, and 3.0 in LICs, and four upper-MICs (Argentina, Chile, Turkey, and Poland) showed ratios similar to the HICs. Rates of first hospital admission and cardiovascular disease medication use were lowest in LICs and highest in HICs. Interpretation Among adults aged 35-70 years, cardiovascular disease is the major cause of mortality globally. However, in HICs and some upper-MICs, deaths from cancer are now more common than those from cardiovascular disease, indicating a transition in the predominant causes of deaths in middle-age. As cardiovascular disease decreases in many countries, mortality from cancer will probably become the leading cause of death. The high mortality in poorer countries is not related to risk factors, but it might be related to poorer access to health care. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Dagenais, Gilles R.] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Dept Cardiol, Quebec City, PQ, Canada; [Leong, Darryl P.; Rangarajan, Sumathy; Parambath, Shameena R.; Teo, Koon K.; Joseph, Philip; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Lanas, Fernando] Univ La Frontera, Dept Med, Temuco, Chile; [Lopez-Jaramillo, Patricio] Univ Santander, Fdn Oftalmol Santander, Med Sch, Bucaramanga, Colombia; [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India; [Gupta, Rajeev] Rajasthan Univ Hlth Sci, Dept Med, Jaipur, Rajasthan, India; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Avezum, Alvaro] Univ Santo Amaro, Hosp Alemao Oswaldo Cruz, Dept Med, Sao Paulo, Brazil; [Oliveira, Gustavo B. F.] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Wielgosz, Andreas] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Mony, Prem] St Johns Med Coll, St Johns Res Inst, Bangalore, Karnataka, India; [Alhabib, Khalid F.] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh, Saudi Arabia; [Temizhan, Ahmet] Saglik Bilimleri Univ, Fac Med, Dept Cardiol, Ankara, Turkey; [Ismail, Noorhassim] Univ Kebangsaan Malaysia, Fac Med, Dept Community Hlth, Kuala Lumpur, Malaysia; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Yeates, Karen] Pamoja Tunaweza Womens Ctr, Moshi, Tanzania; [Yeates, Karen] Queens Univ, Dept Med, Div Nephrol, Kingston, ON, Canada; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Khatib, Rasha] Advocate Res Inst, Advocate Hlth Care, Chicago, IL USA; [Rahman, Omar] Independent Univ, Dhaka, Bangladesh; [Zatonska, Katarzyna] Wroclaw Med Univ, Dept Social Med, Wroclaw, Poland; [Kazmi, Khawar] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Wei, Li] Chinese Acad Med Sci, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Wei, Li; Zhu, Jun] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Vijayakumar, K.] Hlth Act People, Trivandrum, Kerala, India; [Vijayakumar, K.] Amrita Inst Med Sci, Kochi, Kerala, India; [Kaur, Manmeet] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Chennai, Tamil Nadu, India; [Yusufali, AfzalHussein] Dubai Med Univ, Hatta Hosp, Dept Med, Dubai Hlth Author, Dubai, U Arab Emirates; [Kelishadi, Roya] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Esfahan, Iran	Laval University; McMaster University; Population Health Research Institute; Universidad de La Frontera; Universidad Industrial de Santander; Eternal Heart Care Centre & Research Institute; Universidade de Santo Amaro (UNISA); Instituto Dante Pazzanese de Cardiologia; University of Ottawa; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's Research Institute; King Saud University; University of Health Sciences Turkey; Universiti Kebangsaan Malaysia; University of Zimbabwe; Queens University - Canada; Birzeit University; Independent University Bangladesh (IUB); Wroclaw Medical University; Aga Khan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Gothenburg; Sahlgrenska University Hospital; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Madras Diabetes Research Foundation; Isfahan University Medical Science	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada.	salim.yusuf@phri.ca	Kelishadi, Roya/E-6154-2012; Mony, Prem K./GRF-4752-2022; Khatib, Rasha/GXV-8883-2022; Zatońska, Katarzyna/ABD-4236-2021; Avezum, Alvaro/AAP-7687-2020; Rahman, Omar/E-1329-2019; Qorbani, Mostafa/M-8171-2017; Lanas, Fernando/AAE-8842-2022; Chifamba, Jephat/AHE-4535-2022; Mohamed Noor Khan, Nor Ashikin/AAG-3988-2020; Nor-Ashikin, Mohamed Noor Khan/P-2055-2015; Rozanska, Dorota/S-5239-2018	Kelishadi, Roya/0000-0001-7455-1495; Mony, Prem K./0000-0002-1399-0520; Rahman, Omar/0000-0002-0606-2507; Chifamba, Jephat/0000-0001-8166-1182; Mohamed Noor Khan, Nor Ashikin/0000-0002-1325-9236; Nor-Ashikin, Mohamed Noor Khan/0000-0002-1325-9236; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Zatonska, Katarzyna/0000-0002-3772-5588; Regulska-Ilow, Bozena/0000-0002-5941-1715; Lanas, Fernando/0000-0003-3595-9759; AVEZUM, ALVARO/0000-0002-3073-6890; Wolyniec, Maria/0000-0003-2054-1691; Rozanska, Dorota/0000-0002-0561-2749; Szuba, Andrzej/0000-0002-7555-6201; Ismail, Noor Hassim/0000-0003-1547-7904; Yusuf, Salim/0000-0003-4776-5601	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research (through the Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit); Heart and Stroke Foundation (ON, Canada); Ontario Ministry of Health and Long-Term Care	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research (through the Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (ON, Canada); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	We would like to thank Leanne Dyal, Chinthanie Ramasundarahettige, and Dawn Agapay for their help throughout the preparation of the manuscript. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research (including through the Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit), the Heart and Stroke Foundation (ON, Canada), the Ontario Ministry of Health and Long-Term Care, and by unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier Laboratories, and GlaxoSmithKline, and additional contributions from Novartis, King Pharma, and from several national and local organisations in participating countries. Details on the funding and participating countries and institutions, and on collaborating staff, are shown in the appendix (pp 20-25).	[Anonymous], 2016, ICD 10 VERS 2016; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao B, 2018, LANCET GLOB HEALTH, V6, pE1288, DOI [10.1016/S2214-109X(18)30411-X, 10.1016/s2214-109x(18)30411-x]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Deutscher M, 2012, J EPIDEMIOL GLOB HEA, V2, P73, DOI 10.1016/j.jegh.2012.03.001; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hastings KG, 2018, ANN INTERN MED, V169, P836, DOI 10.7326/M17-0796; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Joseph P, 2018, HEART, V104, P581, DOI 10.1136/heartjnl-2017-311609; Joseph P, 2017, CIRC RES, V121, P677, DOI 10.1161/CIRCRESAHA.117.308903; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Leong DP, 2017, CIRC RES, V121, P695, DOI 10.1161/CIRCRESAHA.117.311849; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Melaku YA, 2018, CANCER EPIDEMIOL, V52, P43, DOI 10.1016/j.canep.2017.11.007; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Santosa A, 2014, GLOBAL HEALTH ACTION, V7, P56, DOI 10.3402/gha.v7.23574; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2020, LANCET, V395, P795, DOI 10.1016/S0140-6736(19)32008-2; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	25	265	277	11	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					785	794		10.1016/S0140-6736(19)32007-0	http://dx.doi.org/10.1016/S0140-6736(19)32007-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KH	31492501				2022-12-28	WOS:000519536900035
J	Spiegel, P; Kass, N; Rubenstein, L				Spiegel, Paul; Kass, Nancy; Rubenstein, Leonard			Can Physicians Work in US Immigration Detention Facilities While Upholding Their Hippocratic Oath?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint proposes conditions under which physicians might sign on to deliver humane and ethical medical treatment of immigrants in US detention facilities while managing dual loyalty conflicts with immigration enforcement agencies, including exemption from nondisclosure agreements, use of 3rd-party hiring agencies, and establishment of independent health oversight committees.	[Spiegel, Paul; Kass, Nancy; Rubenstein, Leonard] Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21215 USA; [Spiegel, Paul; Rubenstein, Leonard] Johns Hopkins Ctr Humanitarian Hlth, Baltimore, MD USA; [Kass, Nancy; Rubenstein, Leonard] Johns Hopkins Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Spiegel, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21215 USA.	pbspiegel@jhu.edu	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Homeland Security Digital Library, DEP HOM SEC NOND AGR; Linton JM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0483; Lorek A, 2009, CHILD ABUSE NEGLECT, V33, P573, DOI 10.1016/j.chiabu.2008.10.005; Physicians for Human Rights, 2011, DUAL LOYALT CHALL PR; Sriraman NK, 2019, CURR PROB PEDIATR AD, V49, P50, DOI 10.1016/j.cppeds.2019.01.005; UN Refugee Agency, 2014, UN REF AG CALLS STAT; United Nations Convention on the Rights of the Child, 2005, CRCGC20056; Wood LCN, 2018, BMJ PAEDIATR OPEN, V2, DOI 10.1136/bmjpo-2018-000338	8	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2019	322	15					1445	1446		10.1001/jama.2019.12567	http://dx.doi.org/10.1001/jama.2019.12567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI4ST	31469388				2022-12-28	WOS:000493458400007
J	Stravitz, RT; Lee, WM				Stravitz, R. Todd; Lee, William M.			Acute liver failure	LANCET			English	Review							INFLAMMATORY RESPONSE SYNDROME; ACETAMINOPHEN-PROTEIN ADDUCTS; INTRAVENOUS N-ACETYLCYSTEINE; RANDOMIZED CONTROLLED-TRIAL; RENAL REPLACEMENT THERAPY; TRANSPLANT-FREE SURVIVAL; INTRACRANIAL-PRESSURE; HEPATIC-ENCEPHALOPATHY; MODERATE HYPOTHERMIA; ARTERIAL AMMONIA	Acute liver failure is a rare and severe consequence of abrupt hepatocyte injury, and can evolve over days or weeks to a lethal outcome. A variety of insults to liver cells result in a consistent pattern of rapid-onset elevation of aminotransferases, altered mentation, and disturbed coagulation. The absence of existing liver disease distinguishes acute liver failure from decompensated cirrhosis or acute-on-chronic liver failure. Causes of acute liver failure include paracetamol toxicity, hepatic ischaemia, viral and autoimmune hepatitis, and drug-induced liver injury from prescription drugs, and herbal and dietary supplements. Diagnosis requires careful review of medications taken, and serological testing for possible viral exposure. Because of its rarity, acute liver failure has not been studied in large, randomised trials, and most treatment recommendations represent expert opinion. Improvements in management have resulted in lower mortality, although liver transplantation, used in nearly 30% of patients with acute liver failure, still provides a life-saving alternative to medical management.	[Stravitz, R. Todd] Virginia Commonwealth Univ, Hume Lee Transplant Ctr, Richmond, VA USA; [Lee, William M.] Univ Texas Southwestern Med Ctr Dallas, Digest & Liver Dis Div, 5959 Harry Hines Blvd, Dallas, TX 75390 USA	Virginia Commonwealth University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lee, WM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Digest & Liver Dis Div, 5959 Harry Hines Blvd, Dallas, TX 75390 USA.	william.lee@utsouthwestern.edu			National Institute of Diabetes, Digestive and Kidney Diseases; United States Food and Drug Administration; Southwestern Medical Foundation, Dallas, TX, USA	National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Food and Drug Administration; Southwestern Medical Foundation, Dallas, TX, USA	Many of the insights gained from writing this Seminar derived from the experience the authors have had with the site investigators, coordinators, and patients and their families who participated in the Acute Liver Failure Study Group (ALFSG) Registry over the past 22 years. We thank David Kleiner (National Cancer Institute, Bethesda, MD, USA) for providing the photomicrographs (figure 2), Michelle Gottfried (Medical University of South Carolina Data Coordinating Unit, Charleston, SC, USA) for managing tables and figures, and the entire ALFSG administrative team. The ALFSG has been supported since 1997 by the National Institute of Diabetes, Digestive and Kidney Diseases, the United States Food and Drug Administration, and the Southwestern Medical Foundation, Dallas, TX, USA.	Agarwal B, 2012, J HEPATOL, V57, P780, DOI 10.1016/j.jhep.2012.06.020; Anastasiou OE, 2019, HEPATOLOGY, V69, P993, DOI 10.1002/hep.30279; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bernal W, 2016, J HEPATOL, V65, P273, DOI 10.1016/j.jhep.2016.03.003; Bernal W, 2015, LANCET, V386, P1576, DOI 10.1016/S0140-6736(15)00309-8; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; BERNUAU J, 1993, LANCET, V342, P252, DOI 10.1016/0140-6736(93)91809-Z; BERNUAU J, 1991, HEPATOLOGY, V14, pA49; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; Broussard CN, 2001, AM J GASTROENTEROL, V96, P3193; Butterworth RF, 2015, J CLIN EXP HEPATOL, V5, pS96, DOI 10.1016/j.jceh.2014.02.004; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Cardoso FS, 2018, HEPATOLOGY, V67, P711, DOI 10.1002/hep.29488; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7118, DOI 10.1073/pnas.1521644112; Centers for Disease Control and Prevention, WID OUTBR HEP A US; Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006; Chauhan A, 2019, CLIN RES HEPATOL GAS, V43, P649, DOI 10.1016/j.clinre.2019.01.005; Chen L, 2018, DECIS SUPPORT SYST, V115, P78, DOI 10.1016/j.dss.2018.09.006; Chiew AL, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003328.pub3; Chung Raymond T, 2012, Gastroenterology, V143, pe1, DOI 10.1053/j.gastro.2012.07.011; Cirulli ET, 2019, GASTROENTEROLOGY, V156, P1707, DOI 10.1053/j.gastro.2019.01.034; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Dao DY, 2012, DIGEST DIS SCI, V57, P1349, DOI 10.1007/s10620-011-2013-3; Dao DY, 2012, HEPATOLOGY, V55, P676, DOI 10.1002/hep.24732; Darweesh SK, 2017, CLIN DRUG INVEST, V37, P473, DOI 10.1007/s40261-017-0505-4; DAVENPORT A, 1993, CRIT CARE MED, V21, P328, DOI 10.1097/00003246-199303000-00007; Davern TJ, 2006, GASTROENTEROLOGY, V130, P687, DOI 10.1053/j.gastro.2006.01.033; Davis BC, 2017, LIVER INT, V37, P509, DOI 10.1111/liv.13373; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; DONALDSON BW, 1993, HEPATOLOGY, V18, P1370, DOI 10.1016/0270-9139(93)90226-D; Donnelly MC, 2017, ALIMENT PHARM THER, V45, P833, DOI 10.1111/apt.13943; Eefsen M, 2007, J HEPATOL, V47, P381, DOI 10.1016/j.jhep.2007.04.015; European Assoc Study Liver, 2017, J HEPATOL, V66, P1047, DOI 10.1016/j.jhep.2016.12.003; Figorilli F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188151; Fix OK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155500; Fontana RJ, 2015, LIVER INT, V35, P370, DOI 10.1111/liv.12632; Fontana RJ, 2016, HEPATOLOGY, V64, P1870, DOI 10.1002/hep.28649; FORBES A, 1989, HEPATOLOGY, V10, P306, DOI 10.1002/hep.1840100309; Ganger DR, 2018, AM J GASTROENTEROL, V113, P1319, DOI 10.1038/s41395-018-0160-2; Hadem J, 2008, CLIN GASTROENTEROL H, V6, P339, DOI 10.1016/j.cgh.2007.12.039; HANID MA, 1980, GUT, V21, P866, DOI 10.1136/gut.21.10.866; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; Harry R, 2002, HEPATOLOGY, V36, P395, DOI 10.1053/jhep.2002.34514; Ichai P, 2005, LIVER TRANSPLANT, V11, P1550, DOI 10.1002/lt.20545; Ichai P, 2007, LIVER TRANSPLANT, V13, P996, DOI 10.1002/lt.21036; Ichai P, 2019, J HEPATOL, V70, P431, DOI 10.1016/j.jhep.2018.11.024; Jackson EW, 2002, LIVER TRANSPLANT, V8, P932, DOI 10.1053/jlts.2002.35550; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Jalan R, 2002, J HEPATOL, V37, P536, DOI 10.1016/S0168-8278(02)00240-4; Jalan R, 2001, HEPATOLOGY, V34, P50, DOI 10.1053/jhep.2001.25386; Karkhanis J, 2014, HEPATOLOGY, V59, P612, DOI 10.1002/hep.26678; Karvellas CJ, 2017, CLIN GASTROENTEROL H, V15, P113, DOI 10.1016/j.cgh.2016.06.008; Karvellas CJ, 2016, LIVER INT, V36, P1043, DOI 10.1111/liv.13080; Karvellas CJ, 2014, CLIN GASTROENTEROL H, V12, P1942, DOI 10.1016/j.cgh.2014.03.011; Karvellas CJ, 2014, CRIT CARE MED, V42, P1157, DOI 10.1097/CCM.0000000000000144; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; Khandelwal N, 2011, HEPATOLOGY, V53, P567, DOI 10.1002/hep.24060; Koch DG, 2016, CLIN GASTROENTEROL H, V14, P1199, DOI 10.1016/j.cgh.2016.03.046; Korman JD, 2008, HEPATOLOGY, V48, P1167, DOI 10.1002/hep.22446; Kumar M, 2007, HEPATOLOGY, V45, P97, DOI 10.1002/hep.21486; Lammert C, 2008, HEPATOLOGY, V47, P2003, DOI 10.1002/hep.22272; Larsen FS, 2016, J HEPATOL, V64, P69, DOI 10.1016/j.jhep.2015.08.018; Lee KCL, 2016, LIVER TRANSPLANT, V22, P839, DOI 10.1002/lt.24396; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Lee WM, 2012, HEPATOLOGY, V55, P965, DOI 10.1002/hep.25551; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Leithead JA, 2009, GUT, V58, P443, DOI 10.1136/gut.2008.154120; Leventhal TM, 2019, CLIN GASTROENTEROL H, V17, P2110, DOI 10.1016/j.cgh.2019.01.040; Levitsky J, 2008, LIVER TRANSPLANT, V14, P1498, DOI 10.1002/lt.21567; LIDOFSKY SD, 1992, HEPATOLOGY, V16, P1, DOI 10.1002/hep.1840160102; Lisman T, 2012, J THROMB HAEMOST, V10, P1312, DOI 10.1111/j.1538-7836.2012.04770.x; Little L, 2019, HEPATOLOGY, V69, P917, DOI 10.1002/hep.30236; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; McPhail MJW, 2016, CLIN GASTROENTEROL H, V14, P516, DOI 10.1016/j.cgh.2015.10.007; Mitchell I, 1998, CRIT CARE MED, V26, P279, DOI 10.1097/00003246-199802000-00026; MITCHELL JR, 1974, CLIN PHARMACOL THER, V16, P676; Montanini S, 1999, ARZNEIMITTEL-FORSCH, V49, P1044; Mumtaz K, 2009, HEPATOL INT, V3, P563, DOI 10.1007/s12072-009-9151-0; MUNOZ SJ, 1991, HEPATOLOGY, V13, P209, DOI 10.1002/hep.1840130202; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Nabi T, 2017, SAUDI J GASTROENTERO, V23, P169, DOI 10.4103/1319-3767.207711; Nelson DB, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.006; Nicoletti P, 2017, GASTROENTEROLOGY, V152, P1078, DOI 10.1053/j.gastro.2016.12.016; Nourjah P, 2006, PHARMACOEPIDEM DR S, V15, P398, DOI 10.1002/pds.1191; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Parekh J, 2017, LIVER TRANSPLANT, V23, P135, DOI 10.1002/lt.24643; PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097; Putignano A, 2018, LIVER INT, V38, P2228, DOI 10.1111/liv.13914; Reddy KR, 2016, LIVER TRANSPLANT, V22, P505, DOI 10.1002/lt.24347; Reddy KR, 2015, GASTROENTEROLOGY, V148, P215, DOI 10.1053/j.gastro.2014.10.039; Reuben A, 2016, ANN INTERN MED, V164, P724, DOI 10.7326/M15-2211; Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937; Rich NE, 2015, CLIN GASTROENTEROL H, V13, P1025, DOI 10.1016/j.cgh.2014.09.040; Roberts DW, 2017, CLIN GASTROENTEROL H, V15, P555, DOI 10.1016/j.cgh.2016.09.007; Rockey DC, 2010, HEPATOLOGY, V51, P2117, DOI 10.1002/hep.23577; Rolando N, 1996, Liver Transpl Surg, V2, P8, DOI 10.1002/lt.500020103; ROLANDO N, 1991, J HEPATOL, V12, P1, DOI 10.1016/0168-8278(91)90900-V; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; ROLANDO N, 1993, HEPATOLOGY, V17, P196, DOI 10.1016/0270-9139(93)90076-Y; Rumack BH, 2002, J TOXICOL-CLIN TOXIC, V40, P3, DOI 10.1081/CLT-120002882; Schiodt FV, 1997, NEW ENGL J MED, V337, P1112, DOI 10.1056/NEJM199710163371602; Schmidt LE, 2007, HEPATOLOGY, V45, P789, DOI 10.1002/hep.21503; Schmidt LE, 2002, HEPATOLOGY, V36, P659, DOI 10.1053/jhep.2002.35069; Singhal A, 2012, TRANSPL INT, V25, P658, DOI 10.1111/j.1432-2277.2012.01470.x; Somasekar S, 2017, CLIN INFECT DIS, V65, P1477, DOI 10.1093/cid/cix596; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Stravitz RT, 2018, HEPATOLOGY, V67, P1931, DOI 10.1002/hep.29694; Stravitz RT, 2018, HEPATOLOGY, V67, P1003, DOI 10.1002/hep.29621; Stravitz RT, 2016, CLIN GASTROENTEROL H, V14, P613, DOI 10.1016/j.cgh.2015.09.029; Stravitz RT, 2013, HEPATOLOGY, V58, P304, DOI 10.1002/hep.26307; Stravitz RT, 2012, J HEPATOL, V56, P129, DOI 10.1016/j.jhep.2011.04.020; Stravitz RT, 2011, HEPATOLOGY, V53, P517, DOI 10.1002/hep.24080; Stravitz RT, 2009, CRIT CARE MED, V37, pS258, DOI 10.1097/CCM.0b013e3181aa5fb8; Tapper EB, 2015, AM J MED, V128, P1314, DOI 10.1016/j.amjmed.2015.07.033; Taylor RM, 2006, HEPATOLOGY, V44, P1589, DOI 10.1002/hep.21439; Taylor RM, 2012, DIGEST DIS SCI, V57, P777, DOI 10.1007/s10620-011-1918-1; Trey C, 1970, Prog Liver Dis, V3, P282; Tujios SR, 2015, CLIN GASTROENTEROL H, V13, P352, DOI 10.1016/j.cgh.2014.07.011; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; WENDON JA, 1992, HEPATOLOGY, V15, P1067, DOI 10.1002/hep.1840150616; Wendon J, 2008, NEUROCRIT CARE, V9, P97, DOI 10.1007/s12028-008-9123-6; Westbrook RH, 2010, AM J TRANSPLANT, V10, P2520, DOI 10.1111/j.1600-6143.2010.03301.x; Wijdicks EFM, 2017, NEW ENGL J MED, V376, P186, DOI 10.1056/NEJMc1614962; Wijdicks EFM, 2002, TRANSPLANT P, V34, P1220, DOI 10.1016/S0041-1345(02)02804-X; Zabron A, 2018, LIVER INT, V38, P1592, DOI 10.1111/liv.13725; Zarrinpar A, 2007, AM SURGEON, V73, P1013	133	234	244	30	124	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2019	394	10201					869	881		10.1016/S0140-6736(19)31894-X	http://dx.doi.org/10.1016/S0140-6736(19)31894-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IV0US	31498101				2022-12-28	WOS:000483994700030
J	Iacobucci, G				Iacobucci, Gareth			NHS to step up efforts to tackle "health emergency" of climate change	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5458	10.1136/bmj.l5458	http://dx.doi.org/10.1136/bmj.l5458			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488398				2022-12-28	WOS:000485441400012
J	Paterlini, M				Paterlini, Marta			From a refugee health centre to Brussels: Pietro Bartolo now has two constituencies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												martapaterlini@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l5306	10.1136/bmj.l5306	http://dx.doi.org/10.1136/bmj.l5306			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1FO	31484639				2022-12-28	WOS:000485437600007
J	Voelker, R				Voelker, Rebecca			Nasal Glucagon Approved for Severe Hypoglycemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					807	807		10.1001/jama.2019.12938	http://dx.doi.org/10.1001/jama.2019.12938			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479125				2022-12-28	WOS:000486437200004
J	Armstrong, K; Frost, DJ; McCammon, CA; Rubie, DC; Ballaran, TB				Armstrong, Katherine; Frost, Daniel J.; McCammon, Catherine A.; Rubie, David C.; Ballaran, Tiziana Boffa			Deep magma ocean formation set the oxidation state of Earth's mantle	SCIENCE			English	Article							EQUATION-OF-STATE; OXYGEN FUGACITY; SILICATE MELT; HIGH-PRESSURE; FE3+/SIGMA-FE RATIO; HIGH-TEMPERATURES; ATMOSPHERIC LOSS; REDOX STATE; CARBON; METAL	The composition of Earth's atmosphere depends on the redox state of the mantle, which became more oxidizing at some stage after Earth's core started to form. Through high-pressure experiments, we found that Fe2+ in a deep magma ocean would disproportionate to Fe3+ plus metallic iron at high pressures. The separation of this metallic iron to the core raised the oxidation state of the upper mantle, changing the chemistry of degassing volatiles that formed the atmosphere to more oxidized species. Additionally, the resulting gradient in redox state of the magma ocean allowed dissolved CO2 from the atmosphere to precipitate as diamond at depth. This explains Earth's carbon-rich interior and suggests that redox evolution during accretion was an important variable in determining the composition of the terrestrial atmosphere.	[Armstrong, Katherine; Frost, Daniel J.; McCammon, Catherine A.; Rubie, David C.; Ballaran, Tiziana Boffa] Univ Bayreuth, Bayer Geoinst, D-95447 Bayreuth, Germany; [Armstrong, Katherine] Univ Calif Davis, Peter A Rock Thermochem Lab, Davis, CA 95616 USA	University of Bayreuth; University of California System; University of California Davis	Frost, DJ (corresponding author), Univ Bayreuth, Bayer Geoinst, D-95447 Bayreuth, Germany.	dan.frost@uni-bayreuth.de		Armstrong, Katherine/0000-0001-6970-4573	DFG-SPP program 1833 "Building a Habitable Earth" [FR 1555/10-1]; DFG international research and training group "Deep Volatile Cycles" [GRK 2156/1]	DFG-SPP program 1833 "Building a Habitable Earth"; DFG international research and training group "Deep Volatile Cycles"	Supported by the DFG-SPP program 1833 "Building a Habitable Earth" through grant FR 1555/10-1 and through the DFG international research and training group "Deep Volatile Cycles," GRK 2156/1.	Andrault D, 2018, GEOCHEM PERSPECT LET, V6, P5, DOI 10.7185/geochemlet.1801; Armstrong K., 2018, THESIS; Aulbach S, 2016, GEOLOGY, V44, P751, DOI 10.1130/G38070.1; BELONOSHKO AB, 1992, GEOCHIM COSMOCHIM AC, V56, P3611, DOI 10.1016/0016-7037(92)90157-E; Berry AJ, 2004, AM MINERAL, V89, P790; Borisov A., 1998, 29 LUN PLAN SCI C, P1320; Campbell AJ, 2009, EARTH PLANET SC LETT, V286, P556, DOI 10.1016/j.epsl.2009.07.022; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Dalou C, 2017, EARTH PLANET SC LETT, V458, P141, DOI 10.1016/j.epsl.2016.10.026; de Vries J, 2016, PROG EARTH PLANET SC, V3, DOI 10.1186/s40645-016-0083-8; Delano JW, 2001, ORIGINS LIFE EVOL B, V31, P311, DOI 10.1023/A:1011895600380; DREIBUS G, 1987, ICARUS, V71, P225, DOI 10.1016/0019-1035(87)90148-5; Duncan MS, 2017, EARTH PLANET SC LETT, V466, P115, DOI 10.1016/j.epsl.2017.03.008; Ertel W, 1999, GEOCHIM COSMOCHIM AC, V63, P2439, DOI 10.1016/S0016-7037(99)00136-2; Franke P., 2006, THERMODYNAMIC PROP 4; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Frost DJ, 2004, PHYS EARTH PLANET IN, V143, P507, DOI 10.1016/j.pepi.2004.03.003; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; GUILLERMET AF, 1989, CALPHAD, V13, P1, DOI 10.1016/0364-5916(89)90034-5; Guillot B, 2011, GEOCHIM COSMOCHIM AC, V75, P1829, DOI 10.1016/j.gca.2011.01.004; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; Hirschmann MM, 2018, EARTH PLANET SC LETT, V502, P262, DOI 10.1016/j.epsl.2018.08.023; Hirschmann MM, 2012, EARTH PLANET SC LETT, V341, P48, DOI 10.1016/j.epsl.2012.06.015; Holland TJB, 2011, J METAMORPH GEOL, V29, P333, DOI 10.1111/j.1525-1314.2010.00923.x; Huang Y. K., 2002, J PHYS D, V7, P2021; HUANG YK, 1974, J PHYS D APPL PHYS, V7, P2021, DOI 10.1088/0022-3727/7/15/305; Jacobson SA, 2017, EARTH PLANET SC LETT, V474, P375, DOI 10.1016/j.epsl.2017.06.023; Jayasuriya KD, 2004, AM MINERAL, V89, P1597, DOI 10.2138/am-2004-11-1203; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; Keppler H., 2005, EMU NOTES MINERALOGY, V7, P1; Komabayashi T, 2014, J GEOPHYS RES-SOL EA, V119, P4164, DOI 10.1002/2014JB010980; KOWALSKI M, 1995, CALPHAD, V19, P229, DOI 10.1016/0364-5916(95)00024-9; KRESS VC, 1991, CONTRIB MINERAL PETR, V108, P82, DOI 10.1007/BF00307328; Kump LR, 2001, GEOCHEM GEOPHY GEOSY, V2; Lammer H, 2018, ASTRON ASTROPHYS REV, V26, DOI 10.1007/s00159-018-0108-y; LANGE RA, 1987, GEOCHIM COSMOCHIM AC, V51, P2931, DOI 10.1016/0016-7037(87)90368-1; LANGE RL, 1990, REV MINERAL, V24, P25; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Li Y, 2015, EARTH PLANET SC LETT, V415, P54, DOI 10.1016/j.epsl.2015.01.017; Liu Q, 2006, AM MINERAL, V91, P385, DOI 10.2138/am.2006.1902; Mann U, 2012, GEOCHIM COSMOCHIM AC, V84, P593, DOI 10.1016/j.gca.2012.01.026; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; Nakajima Y, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009151; Nicklas RW, 2019, GEOCHIM COSMOCHIM AC, V250, P49, DOI 10.1016/j.gca.2019.01.037; O'Neill HSC, 2006, AM MINERAL, V91, P404, DOI 10.2138/am.2005.1929; O'Neill HSC, 2002, CHEM GEOL, V186, P151, DOI 10.1016/S0009-2541(01)00414-4; Ohtani E, 2001, EARTH PLANET SC LETT, V193, P69, DOI 10.1016/S0012-821X(01)00505-2; Prescher C, 2012, J APPL CRYSTALLOGR, V45, P329, DOI 10.1107/S0021889812004979; Pringle EA, 2013, EARTH PLANET SC LETT, V373, P75, DOI 10.1016/j.epsl.2013.04.012; Ringwood A. E., 1966, CHEM COMPOSITION ORI; Rohrbach A, 2007, NATURE, V449, P456, DOI 10.1038/nature06183; Roskosz M, 2013, GEOCHIM COSMOCHIM AC, V121, P15, DOI 10.1016/j.gca.2013.07.007; Rubie DC, 2016, SCIENCE, V353, P1141, DOI 10.1126/science.aaf6919; Rubie DC, 2003, EARTH PLANET SC LETT, V205, P239, DOI 10.1016/S0012-821X(02)01044-0; Schaefer L, 2007, ICARUS, V186, P462, DOI 10.1016/j.icarus.2006.09.002; Schaefer L, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2018.0109; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Sharp ZD, 2013, EARTH PLANET SC LETT, V380, P88, DOI 10.1016/j.epsl.2013.08.015; Shim SH, 2017, P NATL ACAD SCI USA, V114, P6468, DOI 10.1073/pnas.1614036114; Smith EM, 2016, SCIENCE, V354, P1403, DOI 10.1126/science.aal1303; Solomatov Y. S., 2000, ORIGIN EARTH MOON, P323; SUZUKI A, 1995, SCIENCE, V269, P216, DOI 10.1126/science.269.5221.216; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726; Trail D, 2011, NATURE, V480, P79, DOI 10.1038/nature10655; Tronnes RG, 2002, EARTH PLANET SC LETT, V197, P117, DOI 10.1016/S0012-821X(02)00466-1; Tucker JM, 2014, EARTH PLANET SC LETT, V393, P254, DOI 10.1016/j.epsl.2014.02.050; Wadhwa M, 2008, REV MINERAL GEOCHEM, V68, P493, DOI 10.2138/rmg.2008.68.17; Woodland AB, 2006, LITHOS, V89, P222, DOI 10.1016/j.lithos.2005.12.014; Zhang HL, 2017, GEOCHIM COSMOCHIM AC, V204, P83, DOI 10.1016/j.gca.2017.01.023	75	57	62	9	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					903	+		10.1126/science.aax8376	http://dx.doi.org/10.1126/science.aax8376			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467218				2022-12-28	WOS:000483975800042
J	Marcu, J				Marcu, Jahan			PERSPECTIVE Policy with a dab of science	NATURE			English	Editorial Material									[Marcu, Jahan] Int Res Ctr Cannabis & Mental Hlth, Expt Pharmacol & Behav Res, New York, NY 10010 USA		Marcu, J (corresponding author), Int Res Ctr Cannabis & Mental Hlth, Expt Pharmacol & Behav Res, New York, NY 10010 USA.	jmarcu@irccmh.org						Lewis MA, 2018, PLANTA MED, V84, P225, DOI 10.1055/s-0043-122240	1	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					S19	S19		10.1038/d41586-019-02531-6	http://dx.doi.org/10.1038/d41586-019-02531-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IU2JG	31462790	Bronze			2022-12-28	WOS:000483405500020
J	Pasternak, B; Ueda, P; Eliasson, B; Svensson, AM; Franzen, S; Gudbjornsdottir, S; Hveem, K; Jonasson, C; Wintzell, V; Melbye, M; Svanstrom, H				Pasternak, Bjorn; Ueda, Peter; Eliasson, Bjorn; Svensson, Ann-Marie; Franzen, Stefan; Gudbjornsdottir, Soffia; Hveem, Kristian; Jonasson, Christian; Wintzell, Viktor; Melbye, Mads; Svanstrom, Henrik			Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOWERING DRUGS; CVD-REAL; MORTALITY; OUTCOMES; MULTICENTER; INITIATION; DEATH	OBJECTIVE To investigate the cardiovascular effectiveness of sodium glucose cotransporter 2 (SGLT2) inhibitors in routine clinical practice. DESIGN Cohort study using data from nationwide registers and an active-comparator new-user design. SETTING Denmark, Norway, and Sweden, from April 2013 to December 2016. PARTICIPANTS 20 983 new users of SGLT2 inhibitors and 20 983 new users of dipeptidyl peptidase 4 (DPP4) inhibitors, aged 35-84, matched by age, sex, history of major cardiovascular disease, and propensity score. MAIN OUTCOME MEASURES Primary outcomes were major cardiovascular events (composite of myocardial infarction, stroke, and cardiovascular death) and heart failure (hospital admission for heart failure or death due to heart failure). Secondary outcomes were the individual components of the cardiovascular composite and any cause death. In the primary analyses, patients were defined as exposed from treatment start throughout follow-up (analogous to intention to treat); additional analyses were conducted with an as-treated exposure definition. Cox regression was used to estimate hazard ratios. RESULTS Mean age of the study cohort was 61 years, 60% were men, and 19% had a history of major cardiovascular disease. Of the total 27 416 person years of follow-up in the SGLT2 inhibitor group, 22 627 (83%) was among patients who initiated dapagliflozin, 4521 (16%) among those who initiated empagliflozin, and 268 (1%) among those who initiated canagliflozin. During follow-up, 467 SGLT2 inhibitor users (incidence rate 17.0 events per 1000 person years) and 662 DPP4 inhibitor users (18.0) had a major cardiovascular event, whereas 130 (4.7) and 265 (7.1) had a heart failure event, respectively. Hazard ratios were 0.94 (95% confidence interval 0.84 to 1.06) for major cardiovascular events and 0.66 (0.53 to 0.81) for heart failure. Hazard ratios were consistent among subgroups of patients with and without history of major cardiovascular disease and with and without history of heart failure. Hazard ratios for secondary outcomes, comparing SGLT2 inhibitors with DPP4 inhibitors, were 0.99 (0.85 to 1.17) for myocardial infarction, 0.94 (0.77 to 1.15) for stroke, 0.84 (0.65 to 1.08) for cardiovascular death, and 0.80 (0.69 to 0.92) for any cause death. In the as-treated analyses, hazard ratios were 0.84 (0.72 to 0.98) for major cardiovascular events, 0.55 (0.42 to 0.73) for heart failure, 0.93 (0.76 to 1.14) for myocardial infarction, 0.83 (0.64 to 1.07) for stroke, 0.67 (0.49 to 0.93) for cardiovascular death, and 0.75 (0.61 to 0.91) for any cause death. CONCLUSIONS In this large Scandinavian cohort, SGLT2 inhibitor use compared with DPP4 inhibitor use was associated with reduced risk of heart failure and any cause death, but not with major cardiovascular events in the primary intention-to-treat analysis. In the additional as-treated analyses, the magnitude of the association with heart failure and any cause death became larger, and a reduced risk of major cardiovascular events that was largely driven by the cardiovascular death component was observed. These data help inform patients, practitioners, and authorities regarding the cardiovascular effectiveness of SGLT2 inhibitors in routine clinical practice.	[Pasternak, Bjorn; Ueda, Peter; Wintzell, Viktor; Svanstrom, Henrik] Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, S-17176 Stockholm, Sweden; [Pasternak, Bjorn; Melbye, Mads; Svanstrom, Henrik] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Eliasson, Bjorn; Svensson, Ann-Marie; Gudbjornsdottir, Soffia] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Svensson, Ann-Marie; Franzen, Stefan; Gudbjornsdottir, Soffia] Vastra Gotalandsregionen, Swedish Natl Diabet Register, Gothenburg, Sweden; [Franzen, Stefan] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Hlth Metr, Gothenburg, Sweden; [Hveem, Kristian; Jonasson, Christian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, KG Jebsen Ctr Genet Epidemiol, Fac Med & Hlth Sci, Trondheim, Norway; [Hveem, Kristian; Jonasson, Christian] Norwegian Univ Sci & Technol, HUNT Res Ctr, Fac Med, Levanger, Norway; [Melbye, Mads] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Karolinska Institutet; Statens Serum Institut; University of Gothenburg; University of Gothenburg; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Copenhagen; Stanford University	Pasternak, B (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, S-17176 Stockholm, Sweden.; Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.	bjorn.pasternak@ki.se	Hveem, Kristian/AFV-4683-2022; Ueda, Peter/AAB-8961-2020; Wintzell, Viktor/AAF-1282-2020; Ueda, Peter/AGH-9915-2022; Pasternak, Bjorn/H-5739-2012	Ueda, Peter/0000-0002-3275-8743; Ueda, Peter/0000-0002-3275-8743; Pasternak, Bjorn/0000-0002-2097-8466; Jonasson, Christian/0000-0002-7694-6025; melbye, mads/0000-0001-8264-6785	Swedish Heart-Lung Foundation; Novo Nordisk Foundation; Swedish Society for Medical Research; Strategic Research Area Epidemiology programme at the Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Society for Medical Research; Strategic Research Area Epidemiology programme at the Karolinska Institutet	The study was conducted with unrestricted research grant support from the Swedish Heart-Lung Foundation, Novo Nordisk Foundation, and Swedish Society for Medical Research. BP was supported by an investigator grant from the Strategic Research Area Epidemiology programme at the Karolinska Institutet. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Birkeland KI, 2017, LANCET DIABETES ENDO, V5, P709, DOI 10.1016/S2213-8587(17)30258-9; Blau JE, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2924; Chang HY, 2018, JAMA INTERN MED, V178, P1190, DOI 10.1001/jamainternmed.2018.3034; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; Filion KB, 2016, NEW ENGL J MED, V374, P1145, DOI 10.1056/NEJMoa1506115; Fralick M, 2017, NEW ENGL J MED, V376, P2300, DOI 10.1056/NEJMc1701990; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Harel O, 2007, STAT MED, V26, P3057, DOI 10.1002/sim.2787; Kim YG, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0737-5; Kosiborod M, 2018, J AM COLL CARDIOL, V71, P2628, DOI 10.1016/j.jacc.2018.03.009; Kosiborod M, 2017, CIRCULATION, V136, P249, DOI 10.1161/CIRCULATIONAHA.117.029190; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lund Jennifer L, 2015, Curr Epidemiol Rep, V2, P221; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Patorno E, 2019, CIRCULATION, V139, P2822, DOI 10.1161/CIRCULATIONAHA.118.039177; Patorno E, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k119; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Persson F, 2018, DIABETES OBES METAB, V20, P344, DOI 10.1111/dom.13077; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V321, P69, DOI 10.1001/jama.2018.18269; Ryan PB, 2018, DIABETES OBES METAB, V20, P2585, DOI 10.1111/dom.13424; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Suissa S, 2018, CIRCULATION, V137, P1432, DOI 10.1161/CIRCULATIONAHA.117.032799; Suissa S, 2018, DIABETES CARE, V41, P6, DOI 10.2337/dc17-1223; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Svanstrom H, 2019, LANCET DIABETES ENDO, V7, P106, DOI 10.1016/S2213-8587(18)30320-6; Toh S, 2016, ANN INTERN MED, V164, P705, DOI 10.7326/M15-2568; Udell JA, 2018, CIRCULATION, V137, P1450, DOI 10.1161/CIRCULATIONAHA.117.031227; Ueda P, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4365; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Yang JY, 2019, DIABETES OBES METAB, V21, P1223, DOI 10.1111/dom.13647; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X; Zhang XL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007165; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	35	55	56	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l4772	10.1136/bmj.l4772	http://dx.doi.org/10.1136/bmj.l4772			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31467044	Green Published, hybrid			2022-12-28	WOS:000483892600002
J	Kuehn, B				Kuehn, Bridget			Rising PrEP Awareness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					718	718		10.1001/jama.2019.11853	http://dx.doi.org/10.1001/jama.2019.11853			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454021				2022-12-28	WOS:000483652500013
J	Ray, KK; Corral, P; Morales, E; Nicholls, SJ				Ray, Kausik K.; Corral, Pablo; Morales, Enrique; Nicholls, Stephen J.			Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options	LANCET			English	Review							HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; DENSITY-LIPOPROTEIN CHOLESTEROL; POLYUNSATURATED FATTY-ACIDS; LOWERING LDL CHOLESTEROL; CARDIOVASCULAR OUTCOMES; STATIN THERAPY; DOUBLE-BLIND; HIGH-RISK; TARGETING APOLIPOPROTEIN(A); ATHEROGENIC DYSLIPIDEMIA	Atherosclerosis and its clinical manifestation as ischaemic heart disease remains a considerable health burden. Given that many factors contribute to ischaemic heart disease, a multifactorial approach to prevention is recommended, starting with lifestyle advice, smoking cessation, and control of known cardiovascular risk factors, such as blood pressure and lipids. Within the lipid profile, the principal target is lowering LDL cholesterol, firstly with lifestyle interventions and subsequently with pharmacological therapy. Statins are the recommended first-line pharmacological treatment. Some individuals might require further lowering of LDL cholesterol or be unable to tolerate statins. Additional therapies targeting different pathways in cholesterol metabolism are now available, ranging from small molecules taken orally, to injectable therapies. Examples include ezetimibe, which targets Niemann-Pick C1-like protein, and monoclonal antibodies that target PCSK9. Phase 3 trials have also been completed for bempedoic acid (targeting ATP-citrate lyase) and inclisiran (an interference RNA-based therapeutic targeting hepatic PCSK9 synthesis). In addition to LDL cholesterol, mendelian randomisation studies support a causal role for lipoprotein(a) and triglycerides in ischaemic heart disease. In this Series paper, we appraise currently available and emerging therapies for lowering LDL cholesterol, lipoprotein(a), and triglycerides for prevention of ischaemic heart disease.	[Ray, Kausik K.] Imperial Coll London, Sch Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London W6 8RP, England; [Corral, Pablo] FASTA Univ, Sch Med, Dept Pharmacol, Mar Del Plata, Buenos Aires, Argentina; [Morales, Enrique] MAC Hosp, Cardiometab Res Ctr, Aguascalientes, Mexico; [Nicholls, Stephen J.] Monash Univ, Monash Cardiovasc Res Ctr, Melbourne, Vic, Australia	Imperial College London; Monash University	Ray, KK (corresponding author), Imperial Coll London, Sch Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London W6 8RP, England.	k.ray@imperial.ac.uk	Keskin, Kudret/AAB-8198-2019; Ray, Kausik/Z-2055-2019	Keskin, Kudret/0000-0002-9049-1530; Corral, Pablo/0000-0003-0017-8725	National Institute for Health Research Imperial Biomedical Research Centre	National Institute for Health Research Imperial Biomedical Research Centre	KKR acknowledges support from the National Institute for Health Research Imperial Biomedical Research Centre.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; [Anonymous], 1992, Arch Intern Med, V152, P1399; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Ballantyne CM, 2018, ATHEROSCLEROSIS, V277, P195, DOI 10.1016/j.atherosclerosis.2018.06.002; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berberich AJ, 2017, EXPERT OPIN PHARMACO, V18, P1261, DOI 10.1080/14656566.2017.1340941; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Blom D, 2015, CIRCULATION, V132; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boffa MB, 2016, J LIPID RES, V57, P745, DOI 10.1194/jlr.R060582; Bonaca MP, 2018, CIRCULATION, V137, P338, DOI 10.1161/CIRCULATIONAHA.117.032235; Bowman L, 2018, NEW ENGL J MED, V379, P1540, DOI 10.1056/NEJMoa1804989; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; DOLECEK TA, 1992, P SOC EXP BIOL MED, V200, P177, DOI 10.3181/00379727-200-43413; Duell PB, 2016, J CLIN LIPIDOL, V10, P1011, DOI 10.1016/j.jacl.2016.04.013; Eisen A, 2016, EUR HEART J, V37, P3576, DOI 10.1093/eurheartj/ehw377; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Ference BA, 2017, EUR HEART J, DOI [10.1093/eurheartj/ehx450, DOI 10.1093/eurheartj/ehx450]; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Gaudet D, 2017, NEW ENGL J MED, V377, P296, DOI 10.1056/NEJMc1705994; Gaudet D, 2014, NEW ENGL J MED, V371, P2200, DOI 10.1056/NEJMoa1400284; Gibson CM, 2016, AM HEART J, V180, P22, DOI 10.1016/j.ahj.2016.06.017; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444; Ida S, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0845-x; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99, DOI 10.5551/jat.5876; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Kamstrup PR, 2014, J AM COLL CARDIOL, V63, P470, DOI 10.1016/j.jacc.2013.09.038; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Khvorova A, 2017, NAT BIOTECHNOL, V35, P238, DOI 10.1038/nbt.3765; Kosoglou T, 2002, BRIT J CLIN PHARMACO, V54, P309, DOI 10.1046/j.1365-2125.2002.01633.x; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Lee M, 2011, ATHEROSCLEROSIS, V217, P492, DOI 10.1016/j.atherosclerosis.2011.04.020; Lincoff AM, 2017, NEW ENGL J MED, V376, P1933, DOI 10.1056/NEJMoa1609581; Luo MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02601-7; MABUCHI H, 1981, NEW ENGL J MED, V305, P478, DOI 10.1056/NEJM198108273050902; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Mansouri RM, 2008, CIRC RES, V103, P450, DOI 10.1161/CIRCRESAHA.108.179861; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Nicholls SJ, 2018, CLIN CARDIOL, V41, P1281, DOI 10.1002/clc.23055; Nicholls SJ, 2018, JAMA CARDIOL, V3, P806, DOI 10.1001/jamacardio.2018.2112; Nicholls SJ, 2018, JAMA CARDIOL, V3, P815, DOI 10.1001/jamacardio.2018.2121; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, JAMA-J AM MED ASSOC, V297, P1362, DOI 10.1001/jama.297.12.1362; O'Donoghue ML, 2019, CIRCULATION, V139, P1483, DOI 10.1161/CIRCULATIONAHA.118.037184; PEDERSEN TR, 1994, LANCET, V344, P1383; Pradhan AD, 2018, AM HEART J, V206, P80, DOI 10.1016/j.ahj.2018.09.011; Puri R, 2016, ARTERIOSCL THROM VAS, V36, P2220, DOI 10.1161/ATVBAHA.116.307601; Raal FJ, 2018, ATHEROSCLEROSIS, V277, P483, DOI 10.1016/j.atherosclerosis.2018.06.859; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Ray KK, 2019, LANCET DIABETES ENDO, V7, P618, DOI 10.1016/S2213-8587(19)30158-5; Ray KK, 2019, NEW ENGL J MED, V380, P1022, DOI 10.1056/NEJMoa1803917; Ray KK, 2018, CIRCULATION, V138, P1304, DOI 10.1161/CIRCULATIONAHA.118.034710; Ray KK, 2017, NEW ENGL J MED, V376, P1430, DOI 10.1056/NEJMoa1615758; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Sabatine MS, 2018, CIRCULATION, V138, P756, DOI 10.1161/CIRCULATIONAHA.118.034309; Sabatine MS, 2017, LANCET DIABETES ENDO, V5, P941, DOI 10.1016/S2213-8587(17)30313-3; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Saito Y, 2008, ATHEROSCLEROSIS, V200, P135, DOI 10.1016/j.atherosclerosis.2008.06.003; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Aung T, 2018, JAMA CARDIOL, V3, P225, DOI 10.1001/jamacardio.2017.5205; Thompson PD, 2016, J CLIN LIPIDOL, V10, P556, DOI 10.1016/j.jacl.2015.12.025; Tsimikas S, 2018, J AM COLL CARDIOL, V71, P177, DOI 10.1016/j.jacc.2017.11.014; Tsimikas S, 2017, J AM COLL CARDIOL, V69, P692, DOI 10.1016/j.jacc.2016.11.042; Tsimikas S, 2015, LANCET, V386, P1472, DOI 10.1016/S0140-6736(15)61252-1; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Viney NJ, 2016, LANCET, V388, P2239, DOI 10.1016/S0140-6736(16)31009-1; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang Y, 2015, J LIPID RES, V56, P1296, DOI 10.1194/jlr.M054882; Zheng CY, 2013, EUR HEART J, V34, P615, DOI 10.1093/eurheartj/ehs271	100	44	44	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					697	708		10.1016/S0140-6736(19)31950-6	http://dx.doi.org/10.1016/S0140-6736(19)31950-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT6UU	31448741	Green Submitted			2022-12-28	WOS:000483011200034
J	[Anonymous]				[Anonymous]			Is the concept of hypertension as a disease unhelpful?	LANCET			English	Editorial Material													Fox, Nick C/AAE-1849-2021	Fox, Nick C/0000-0002-6660-657X					0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					611	611		10.1016/S0140-6736(19)31964-6	http://dx.doi.org/10.1016/S0140-6736(19)31964-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UU	31448722				2022-12-28	WOS:000483011200008
J	Rimmer, A				Rimmer, Abi			Opioid policies: scientists advising US government had commercial ties, BMJ investigation finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Academy of Sciences National Academy of Engineering Institute of Medicine National Research Council., 2003, POL COMM COMP BAL CO; Schwab T, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5167	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2019	366								l5273	10.1136/bmj.l5273	http://dx.doi.org/10.1136/bmj.l5273			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DJ	31439576				2022-12-28	WOS:000482882300010
J	Solomon, SD; McMurray, JJV; Anand, IS; Ge, J; Lam, CSP; Maggioni, AP; Martinez, F; Packer, M; Pfeffer, MA; Pieske, B; Redfield, MM; Rouleau, JL; van Veldhuisen, DJ; Zannad, F; Zile, MR; Desai, AS; Claggett, B; Jhund, PS; Boytsov, SA; Comin-Colet, J; Cleland, J; Dungen, HD; Goncalvesova, E; Katova, T; Kerr Saraiva, JF; Lelonek, M; Merkely, B; Senni, M; Shah, SJ; Zhou, J; Rizkala, AR; Gong, J; Shi, VC; Lefkowitz, MP				Solomon, S. D.; McMurray, J. J. V.; Anand, I. S.; Ge, J.; Lam, C. S. P.; Maggioni, A. P.; Martinez, F.; Packer, M.; Pfeffer, M. A.; Pieske, B.; Redfield, M. M.; Rouleau, J. L.; van Veldhuisen, D. J.; Zannad, F.; Zile, M. R.; Desai, A. S.; Claggett, B.; Jhund, P. S.; Boytsov, S. A.; Comin-Colet, J.; Cleland, J.; Dungen, H. -D.; Goncalvesova, E.; Katova, T.; Kerr Saraiva, J. F.; Lelonek, M.; Merkely, B.; Senni, M.; Shah, S. J.; Zhou, J.; Rizkala, A. R.; Gong, J.; Shi, V. C.; Lefkowitz, M. P.		PARAGON-HF Investigators Comm	Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED SYSTOLIC FUNCTION; MIDDLE CHILD; MIDRANGE; SPIRONOLACTONE	Background The angiotensin receptor-neprilysin inhibitor sacubitril-valsartan led to a reduced risk of hospitalization for heart failure or death from cardiovascular causes among patients with heart failure and reduced ejection fraction. The effect of angiotensin receptor-neprilysin inhibition in patients with heart failure with preserved ejection fraction is unclear. Methods We randomly assigned 4822 patients with New York Heart Association (NYHA) class II to IV heart failure, ejection fraction of 45% or higher, elevated level of natriuretic peptides, and structural heart disease to receive sacubitril-valsartan (target dose, 97 mg of sacubitril with 103 mg of valsartan twice daily) or valsartan (target dose, 160 mg twice daily). The primary outcome was a composite of total hospitalizations for heart failure and death from cardiovascular causes. Primary outcome components, secondary outcomes (including NYHA class change, worsening renal function, and change in Kansas City Cardiomyopathy Questionnaire [KCCQ] clinical summary score [scale, 0 to 100, with higher scores indicating fewer symptoms and physical limitations]), and safety were also assessed. Results There were 894 primary events in 526 patients in the sacubitril-valsartan group and 1009 primary events in 557 patients in the valsartan group (rate ratio, 0.87; 95% confidence interval [CI], 0.75 to 1.01; P=0.06). The incidence of death from cardiovascular causes was 8.5% in the sacubitril-valsartan group and 8.9% in the valsartan group (hazard ratio, 0.95; 95% CI, 0.79 to 1.16); there were 690 and 797 total hospitalizations for heart failure, respectively (rate ratio, 0.85; 95% CI, 0.72 to 1.00). NYHA class improved in 15.0% of the patients in the sacubitril-valsartan group and in 12.6% of those in the valsartan group (odds ratio, 1.45; 95% CI, 1.13 to 1.86); renal function worsened in 1.4% and 2.7%, respectively (hazard ratio, 0.50; 95% CI, 0.33 to 0.77). The mean change in the KCCQ clinical summary score at 8 months was 1.0 point (95% CI, 0.0 to 2.1) higher in the sacubitril-valsartan group. Patients in the sacubitril-valsartan group had a higher incidence of hypotension and angioedema and a lower incidence of hyperkalemia. Among 12 prespecified subgroups, there was suggestion of heterogeneity with possible benefit with sacubitril-valsartan in patients with lower ejection fraction and in women. Conclusions Sacubitril-valsartan did not result in a significantly lower rate of total hospitalizations for heart failure and death from cardiovascular causes among patients with heart failure and an ejection fraction of 45% or higher. (Funded by Novartis; PARAGON-HF ClinicalTrials.gov number, NCT01920711.)	[Solomon, S. D.; Pfeffer, M. A.; Desai, A. S.; Claggett, B.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA; [McMurray, J. J. V.; Jhund, P. S.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Cleland, J.] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat & Clin Trials, Glasgow, Lanark, Scotland; [Cleland, J.] Imperial Coll, Royal Brompton & Harefield Hosp, Natl Heart & Lung Inst, London, England; [Anand, I. S.] Univ Minnesota, Minneapolis, MN USA; [Redfield, M. M.] Mayo Clin, Rochester, MN USA; [Ge, J.] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai, Peoples R China; [Zhou, J.] Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai, Peoples R China; [Lam, C. S. P.] Natl Heart Ctr Singapore, Singapore, Singapore; [Lam, C. S. P.] Duke Natl Univ Singapore, Singapore, Singapore; [Maggioni, A. P.] Natl Assoc Hosp, Cardiologists Res Ctr, Florence, Italy; [Senni, M.] Hosp Papa Giovanni XXIII, Cardiovasc Dept, Cardiol Div, Bergamo, Italy; [Martinez, F.] Natl Univ Cordoba, Cordoba, Argentina; [Packer, M.] Baylor Univ, Med Ctr, Dallas, TX USA; [Pieske, B.] German Ctr Cardiovasc Res Partner Site Berlin, Dept Internal Med & Cardiol, Berlin, Germany; [Dungen, H. -D.] Charite, Dept Cardiol, Campus Virchow Klinikum, Berlin, Germany; [Rouleau, J. L.] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada; [Rouleau, J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Zannad, F.] INSERM, Ctr Invest Clin 1433, Nancy, France; [Zannad, F.] Univ Lorraine, CHRU Nancy, Nancy, France; [Zile, M. R.] Med Univ South Carolina, Charleston, SC 29425 USA; [Zile, M. R.] Vet Affairs Med Ctr, Ralph H Johnson Dept, Charleston, SC 29403 USA; [Boytsov, S. A.] Minist Hlth Russian Federat, Natl Res Ctr Cardiol, Moscow, Russia; [Comin-Colet, J.] Univ Barcelona, Bellvitge Univ Hosp, Dept Cardiol, Community Heart Failure Program, Barcelona, Spain; [Comin-Colet, J.] Univ Barcelona, Bellvitge Inst Biomed Res, Barcelona, Spain; [Goncalvesova, E.] Natl Cardiovasc Inst, Dept Heart Failure Transplantat, Bratislava, Slovakia; [Katova, T.] Natl Cardiol Hosp, Clin Cardiol, Sofia, Bulgaria; [Kerr Saraiva, J. F.] Pontificia Univ Catolica Campinas, Fac Med, Disciplina Cardiol, Sao Paulo, Brazil; [Lelonek, M.] Med Univ Lodz, Dept Noninvas Cardiol, Lodz, Poland; [Merkely, B.] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary; [Shah, S. J.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Rizkala, A. R.; Gong, J.; Shi, V. C.; Lefkowitz, M. P.] Novartis Pharmaceut, E Hanover, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Glasgow; University of Glasgow; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Fudan University; Fudan University; National Heart Centre Singapore; National University of Singapore; ASST Papa Giovanni XXIII; National University of Cordoba; Baylor University; Baylor University Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite de Montreal; Institut de Cardiologie de Montreal; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; Universite de Lorraine; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Ministry of Health of the Russian Federation; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Medical University Sofia; Pontificia Universidade Catolica de Campinas; Medical University Lodz; Semmelweis University; Northwestern University; Feinberg School of Medicine; Novartis	McMurray, JJV (corresponding author), Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.; Solomon, SD (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.	ssolomon@bwh.harvard.edu; john.mcmurray@glasgow.ac.uk	Desai, Akshay/ABE-7250-2020; Boytsov, Sergey A/M-4486-2014; Espinosa, Luis Manzano/AAB-1702-2020; Urina-Triana, Miguel A/H-2605-2016; Jhund, Pardeep/GLS-9508-2022; Bayes-Genis, Antonio/AAV-9422-2021; Comin-Colet, Josep/AAM-3000-2021; Zaruba, Marc-Michael/AAI-8571-2020; Cleland, John G./AAZ-4185-2020; Shah, Sanjiv J./AFQ-9480-2022; Khromtsova, Oksana M./F-4530-2018; Rafalskiy, Vladimir V/G-3172-2013; Pfister, Otmar/AAB-4752-2022; Beyer-Westendorf, Jan/K-7569-2019; Carluccio, Erberto/AAA-4426-2019; Lam, Carolyn SP/ABD-6810-2021; Maggioni, Aldo Pietro/AAL-5334-2020; Pieske, Burkert/M-8089-2016	Boytsov, Sergey A/0000-0001-6998-8406; Espinosa, Luis Manzano/0000-0002-0472-1820; Urina-Triana, Miguel A/0000-0001-6003-4622; Jhund, Pardeep/0000-0003-4306-5317; Bayes-Genis, Antonio/0000-0002-3044-197X; Comin-Colet, Josep/0000-0001-8780-720X; Zaruba, Marc-Michael/0000-0003-1074-5463; Cleland, John G./0000-0002-1471-7016; Khromtsova, Oksana M./0000-0003-0763-0542; Rafalskiy, Vladimir V/0000-0002-2503-9580; Beyer-Westendorf, Jan/0000-0002-6983-9993; Lam, Carolyn SP/0000-0003-1903-0018; Maggioni, Aldo Pietro/0000-0003-2764-6779; Vazir, Ali/0000-0002-6706-7862; mcmurray, john/0000-0002-6317-3975; Westermann, Dirk/0000-0002-7542-1956; Pieske, Burkert/0000-0002-6466-5306; Merkely, Bela/0000-0001-6514-0723; GALINIER, Michel/0000-0003-1735-3390; Giamouzis, Grigorios/0000-0002-7406-5427; Kober, Lars/0000-0002-6635-1466; Hove, Jens/0000-0002-5600-5623; Yehya, Amin/0000-0001-5947-4778; jourdain, patrick/0000-0002-5202-6902; Girerd, Nicolas/0000-0002-3278-2057; gosse, philippe/0000-0002-5840-7749; Howes, Laurence/0000-0002-1507-8260; Zile, Michael/0000-0001-7076-221X; Car, Sinisa/0000-0001-6439-123X; Lelonek, Malgorzata/0000-0003-0756-5541; Shah, Sanjiv/0000-0002-5655-8201; Hollingdal, Malene/0000-0002-5891-0723; Kostis, William/0000-0002-0543-9798; Foley, Paul/0000-0002-4856-832X	Novartis	Novartis(Novartis)	Funded by Novartis	Abdul-Rahim AH, 2018, EUR J HEART FAIL, V20, P1139, DOI 10.1002/ejhf.1160; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Cleland JGF, 2018, EUR HEART J, V39, P26, DOI 10.1093/eurheartj/ehx564; Cowling BJ, 2006, J ROY STAT SOC C-APP, V55, P31, DOI 10.1111/j.1467-9876.2005.00529.x; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Kraigher-Krainer E, 2014, J AM COLL CARDIOL, V63, P447, DOI 10.1016/j.jacc.2013.09.052; Lam CSP, 2017, CIRCULATION, V135, P1279, DOI 10.1161/CIRCULATIONAHA.117.027324; Lam CSP, 2014, EUR J HEART FAIL, V16, P1049, DOI 10.1002/ejhf.159; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Lund LH, 2018, EUR J HEART FAIL, V20, P1230, DOI 10.1002/ejhf.1149; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Mohammed SF, 2014, JACC-HEART FAIL, V2, P113, DOI 10.1016/j.jchf.2013.11.004; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Redfield MM, 2017, NEW ENGL J MED, V376, P897, DOI 10.1056/NEJMc1615918; Shah AM, 2015, CIRCULATION, V132, P402, DOI 10.1161/CIRCULATIONAHA.115.015884; Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637; Solomon SD, 2017, JACC-HEART FAIL, V5, P471, DOI 10.1016/j.jchf.2017.04.013; Solomon SD, 2016, EUR HEART J, V37, P455, DOI 10.1093/eurheartj/ehv464; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	23	908	945	16	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2019	381	17					1609	1620		10.1056/NEJMoa1908655	http://dx.doi.org/10.1056/NEJMoa1908655			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JK2QT	31475794	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000494692200005
J	Oberst, P; Fievre, S; Baumann, N; Concetti, C; Bartolini, G; Jabaudon, D				Oberst, Polina; Fievre, Sabine; Baumann, Natalia; Concetti, Cristina; Bartolini, Giorgia; Jabaudon, Denis			Temporal plasticity of apical progenitors in the developing mouse neocortex	NATURE			English	Article							EMBRYONIC-STEM-CELLS; NEURONS; CYCLE; DIFFERENTIATION; SPECIFICATION; RESTRICTION; ACQUISITION; DECISIONS; FEEDBACK; LAYERS	The diverse subtypes of excitatory neurons that populate the neocortex are born from apical progenitors located in the ventricular zone. During corticogenesis, apical progenitors sequentially generate deep-layer neurons followed by superficial-layer neurons directly or via the generation of intermediate progenitors. Whether neurogenic fate progression necessarily implies fate restriction in single progenitor types is unknown. Here we specifically isolated apical progenitors and intermediate progenitors, and fate-mapped their respective neuronal progeny following heterochronic transplantation into younger embryos. We find that apical progenitors are temporally plastic and can re-enter past molecular, electrophysiological and neurogenic states when exposed to an earlier-stage environment by sensing dynamic changes in extracellular Wnt. By contrast, intermediate progenitors are committed progenitors that lack such retrograde fate plasticity. These findings identify a diversity in the temporal plasticity of neocortical progenitors, revealing that some subtypes of cells can be untethered from their normal temporal progression to re-enter past developmental states.	[Oberst, Polina; Fievre, Sabine; Baumann, Natalia; Concetti, Cristina; Bartolini, Giorgia; Jabaudon, Denis] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Jabaudon, Denis] Geneva Univ Hosp, Clin Neurol, Geneva, Switzerland; [Oberst, Polina] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, 1275 York Ave, New York, NY 10021 USA; [Concetti, Cristina] Swiss Fed Inst Technol, Inst Neurosci, Schwerzenbach, Switzerland	University of Geneva; University of Geneva; Memorial Sloan Kettering Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jabaudon, D (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.; Jabaudon, D (corresponding author), Geneva Univ Hosp, Clin Neurol, Geneva, Switzerland.	denis.jabaudon@unige.ch	Fièvre, Sabine/AAC-6879-2019; Jabaudon, Denis/B-8802-2014	Fièvre, Sabine/0000-0001-6690-2283; Jabaudon, Denis/0000-0003-2438-4769	Swiss National Science Foundation; Fondation des HUG; Carigest Foundation; iGE3	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation des HUG; Carigest Foundation; iGE3	We thank members of the Jabaudon laboratory and E. Azim for comments on the manuscript. We thank O. Raineteau for providing plasmids. We thank A. S. Lopes, A. Benoit, the FACS facility, the Genomics Platform and the Bioimaging Facility of the University of Geneva for technical assistance. Work in the Jabaudon laboratory is supported by the Swiss National Science Foundation, the Fondation des HUG, and the Carigest Foundation. P.O. is supported by a fellowship from iGE3.	Aldiri I, 2013, DEVELOPMENT, V140, P2867, DOI 10.1242/dev.088096; Bocchi R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01046-w; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Cadwell CR, 2016, NAT BIOTECHNOL, V34, P199, DOI 10.1038/nbt.3445; Chen FY, 2012, J NEUROSCI METH, V207, P172, DOI 10.1016/j.jneumeth.2012.03.016; Desai AR, 2000, DEVELOPMENT, V127, P2863; FISHELL G, 1995, DEVELOPMENT, V121, P803; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Fuzik J, 2016, NAT BIOTECHNOL, V34, P175, DOI 10.1038/nbt.3443; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Govindan S, 2018, NAT PROTOC, V13, P2297, DOI 10.1038/s41596-018-0038-1; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Jabaudon D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16042; Knobloch M, 2017, CELL REP, V20, P2144, DOI 10.1016/j.celrep.2017.08.029; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kuwahara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094408; Llorca A, 2018, PREPRINT, DOI [10.1101/494088v1, DOI 10.1101/494088V1]; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; Mihalas AB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164335; Mihalas AB, 2016, CELL REP, V16, P92, DOI 10.1016/j.celrep.2016.05.072; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Mutch CA, 2009, J NEUROSCI, V29, P13710, DOI 10.1523/JNEUROSCI.3022-09.2009; Nagashima F, 2014, STEM CELLS DEV, V23, P2129, DOI 10.1089/scd.2013.0251; Naujok Ortwin, 2014, BMC Res Notes, V7, P273, DOI 10.1186/1756-0500-7-273; Okamoto M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11349; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Reillo I, 2012, CEREB CORTEX, V22, P2039, DOI 10.1093/cercor/bhr284; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Soufi A, 2016, DEVELOPMENT, V143, P4301, DOI 10.1242/dev.142075; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Telley L, 2019, SCIENCE, V364, P547, DOI 10.1126/science.aav2522; Telley L, 2016, SCIENCE, V351, P1443, DOI 10.1126/science.aad8361; Teo CH, 2010, J MACH LEARN RES, V11, P311; Toma K, 2014, J NEUROSCI, V34, P13259, DOI 10.1523/JNEUROSCI.2334-14.2014; Vasistha NA, 2015, CEREB CORTEX, V25, P3290, DOI 10.1093/cercor/bhu125; Vitali I, 2018, CELL, V174, P1264, DOI 10.1016/j.cell.2018.06.036; Yuzwa SA, 2017, CELL REP, V21, P3970, DOI 10.1016/j.celrep.2017.12.017	43	54	55	1	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					370	+		10.1038/s41586-019-1515-6	http://dx.doi.org/10.1038/s41586-019-1515-6			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31462778				2022-12-28	WOS:000486647800040
J	Grummon, AH; Lockwood, BB; Taubinsky, D; Allcott, H				Grummon, Anna H.; Lockwood, Benjamin B.; Taubinsky, Dmitry; Allcott, Hunt			Designing better sugary drink taxes	SCIENCE			English	Editorial Material							SWEETENED BEVERAGES; COST-EFFECTIVENESS; PUBLIC-HEALTH; EXCISE TAX; OBESITY; PRICES; CONSUMPTION; SUBSIDIES; CHILDREN; ADULTS		[Grummon, Anna H.] Harvard TH Chan Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Lockwood, Benjamin B.] Univ Penn, Wharton Sch Business, Dept Business Econ & Publ Policy, Philadelphia, PA 19104 USA; [Lockwood, Benjamin B.; Taubinsky, Dmitry; Allcott, Hunt] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Taubinsky, Dmitry] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA; [Allcott, Hunt] Microsoft Res, Cambridge, MA 02142 USA; [Allcott, Hunt] NYU, Dept Econ, New York, NY 10003 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; National Bureau of Economic Research; University of California System; University of California Berkeley; Microsoft; New York University	Allcott, H (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.; Allcott, H (corresponding author), Microsoft Res, Cambridge, MA 02142 USA.; Allcott, H (corresponding author), NYU, Dept Econ, New York, NY 10003 USA.	hunt.allcott@nyu.edu		Grummon, Anna/0000-0002-8705-038X	Sloan Foundation; National Institutes of Health [CPC P2C HD050924, T32 HD007168]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, T32HD007168] Funding Source: NIH RePORTER	Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Bhargava for research assistance. We thank the Sloan Foundation for financial support. A.H.G. received general and training support from the National Institutes of Health (CPC P2C HD050924 and T32 HD007168).	Allcott H, 2019, Q J ECON, V134, P1557, DOI [10.1093/qje/qjz017, 10.3386/w25841]; Allcott H, 2019, J ECON PERSPECT, V33, P202, DOI 10.1257/jep.33.3.202; [Anonymous], [No title captured]; Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231; Colchero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144408; Basu S, 2014, HEALTH AFFAIR, V33, P1032, DOI 10.1377/hlthaff.2013.1246; Basu S, 2013, MED DECIS MAKING, V33, P937, DOI 10.1177/0272989X13493971; BERRY S, 1995, ECONOMETRICA, V63, P841, DOI 10.2307/2171802; Bleich SN, 2018, OBESITY, V26, P432, DOI 10.1002/oby.22056; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Caro JC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002597; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Centers for Disease Control, 2017, NAT DIAB STAT REP 20; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362; FRANCIS NORTON, 2016, PROS CONS TAXING SWE; Global Food Research Program (GFRP), 2019, SUG DRINK TAX WORLD; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Jacobsen Mark R, 2018, WORKING PAPER; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Powell LI, 2014, SUGAR SWEETENED BEVE; Reid M, 2007, BRIT J NUTR, V97, P193, DOI 10.1017/S0007114507252705; Roberto CA, 2019, JAMA-J AM MED ASSOC, V321, P1799, DOI 10.1001/jama.2019.4249; Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; Van Wymelbeke V, 2004, EUR J CLIN NUTR, V58, P154, DOI 10.1038/sj.ejcn.1601762; Vargas-Garcia EJ, 2017, OBES REV, V18, P1350, DOI 10.1111/obr.12580; Wang YC, 2012, HEALTH AFFAIR, V31, P199, DOI 10.1377/hlthaff.2011.0410; Yong Pierre L, 2011, ASPE RES BRIEF; Zhen C, 2014, AM J AGR ECON, V96, P1070, DOI 10.1093/ajae/aau052; Zhong YC, 2018, AM J PREV MED, V55, P26, DOI 10.1016/j.amepre.2018.02.017	37	28	29	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					989	+		10.1126/science.aav5199	http://dx.doi.org/10.1126/science.aav5199			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488678	Green Accepted			2022-12-28	WOS:000484732700032
J	Exposito-Alonso, M; Burbano, HA; Bossdorf, O; Nielsen, R; Weigel, D; Exposito-Alonso, M; Rodriguez, RG; Barragan, C; Capovilla, G; Chae, E; Devos, J; Dogan, ES; Friedemann, C; Gross, C; Lang, P; Lundberg, D; Middendorf, V; Kageyama, J; Karasov, T; Kersten, S; Petersen, S; Rabbani, L; Regalado, J; Reinelt, L; Rowan, B; Seymour, DK; Symeonidi, E; Schwab, R; Tran, DTN; Venkataramani, K; Van de Weyer, AL; Vasseur, F; Wang, G; Wedegartner, R; Weiss, F; Wu, R; Xi, WY; Zaidem, M; Zhu, WS; Garcia-Arenal, F; Burbano, HA; Bossdorf, O; Weigel, D				Exposito-Alonso, Moises; Burbano, Hernan A.; Bossdorf, Oliver; Nielsen, Rasmus; Weigel, Detlef; Exposito-Alonso, Moises; Gomez Rodriguez, Rociprimeo; Barragan, Cristina; Capovilla, Giovanna; Chae, Eunyoung; Devos, Jane; Dogan, Ezgi S.; Friedemann, Claudia; Gross, Caspar; Lang, Patricia; Lundberg, Derek; Middendorf, Vera; Kageyama, Jorge; Karasov, Talia; Kersten, Sonja; Petersen, Sebastian; Rabbani, Leily; Regalado, Julian; Reinelt, Lukas; Rowan, Beth; Seymour, Danelle K.; Symeonidi, Efthymia; Schwab, Rebecca; Diep Thi Ngoc Tran; Venkataramani, Kavita; Van de Weyer, Anna-Lena; Vasseur, Francois; Wang, George; Wedegartner, Ronja; Weiss, Frank; Wu, Rui; Xi, Wanyan; Zaidem, Maricris; Zhu, Wangsheng; Garcia-Arenal, Fernando; Burbano, Hernan A.; Bossdorf, Oliver; Weigel, Detlef		500 Genomes Field Expt Team	Natural selection on the Arabidopsis thaliana genome in present and future climates	NATURE			English	Article							ADAPTATION; EVOLUTION	Through the lens of evolution, climate change is an agent of natural selection that forces populations to change and adapt, or face extinction. However, current assessments of the risk of biodiversity associated with climate change(1) do not typically take into account how natural selection influences populations differently depending on their genetic makeup(2). Here we make use of the extensive genome information that is available for Arabidopsis thaliana and measure how manipulation of the amount of rainfall affected the fitness of 517 natural Arabidopsis lines that were grown in Spain and Germany. This allowed us to directly infer selection along the genome(3). Natural selection was particularly strong in the hot-dry location in Spain, where 63% of lines were killed and where natural selection substantially changed the frequency of approximately 5% of all genome-wide variants. A significant portion of this climate-driven natural selection of variants was predictable from signatures of local adaptation (R-2 = 29-52%), as genetic variants that were found in geographical areas with climates more similar to the experimental sites were positively selected. Field-validated predictions across the species range indicated that Mediterranean and western Siberian populations-at the edges of the environmental limits of this species-currently experience the strongest climate-driven selection. With more frequent droughts and rising temperatures in Europe(4), we forecast an increase in directional natural selection moving northwards from the southern end of Europe, putting many native A. thaliana populations at evolutionary risk.	[Exposito-Alonso, Moises; Weigel, Detlef; Exposito-Alonso, Moises; Barragan, Cristina; Capovilla, Giovanna; Chae, Eunyoung; Devos, Jane; Dogan, Ezgi S.; Friedemann, Claudia; Gross, Caspar; Lang, Patricia; Lundberg, Derek; Middendorf, Vera; Kageyama, Jorge; Karasov, Talia; Kersten, Sonja; Petersen, Sebastian; Rabbani, Leily; Regalado, Julian; Reinelt, Lukas; Rowan, Beth; Seymour, Danelle K.; Symeonidi, Efthymia; Schwab, Rebecca; Diep Thi Ngoc Tran; Venkataramani, Kavita; Van de Weyer, Anna-Lena; Vasseur, Francois; Wang, George; Wedegartner, Ronja; Weiss, Frank; Wu, Rui; Xi, Wanyan; Zaidem, Maricris; Zhu, Wangsheng; Burbano, Hernan A.; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Burbano, Hernan A.] Max Planck Inst Dev Biol, Res Grp Ancient Genom & Evolut, Tubingen, Germany; [Bossdorf, Oliver; Bossdorf, Oliver] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Exposito-Alonso, Moises; Nielsen, Rasmus] Univ Copenhagen, Globe Inst, Copenhagen, Denmark; [Exposito-Alonso, Moises] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Burbano, Hernan A.] UCL, Dept Genet Evolut & Environm, Ctr Lifes Origins & Evolut, London, England; [Gomez Rodriguez, Rociprimeo; Garcia-Arenal, Fernando] Tech Univ Madrid, Ctr Plant Biotechnol & Genom, Pozuelo De Alarcon, Spain	Max Planck Society; Max Planck Society; Eberhard Karls University of Tubingen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen; Carnegie Institution for Science; University of London; University College London; Universidad Politecnica de Madrid	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	weigel@weigelworld.org; weigel@weigelworld.org	Weigel, Detlef/AAR-3312-2021; Chae, Eunyoung/AAA-6997-2021; Weigel, Detlef/C-1418-2008; Schwab, Rebecca/I-9352-2012; Bossdorf, Oliver/A-8328-2008; Weigel, Detlef/GSJ-0799-2022; Capovilla, Giovanna/AAV-4033-2020	Chae, Eunyoung/0000-0002-0889-9837; Weigel, Detlef/0000-0002-2114-7963; Schwab, Rebecca/0000-0001-9933-9669; Bossdorf, Oliver/0000-0001-7504-6511; Weigel, Detlef/0000-0002-2114-7963; Capovilla, Giovanna/0000-0002-2399-2386; Lang, Patricia/0000-0001-6648-8721; Barragan, A. Cristina/0000-0003-1656-9261; Symeonidi, Efthymia/0000-0002-4412-4596; Exposito-Alonso, Moises/0000-0001-5711-0700; Lundberg, Derek/0000-0001-7970-1595	EMBO Short Term Fellowship; ERC Advanced Grant IMMUNEMESIS; Max Planck Society	EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); ERC Advanced Grant IMMUNEMESIS; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank P. Lang, A. Hancock and T. Karasov for comments on the manuscript, and members of the Weigel and Burbano laboratories for discussions; X. Pico for advice on experimental design, I. Bezrukov for advice on image-processing replicability; and B. Mendez-Vigo, C. Alonso-Blanco, A. Lopez Quiros, M. Lopez Herranz and M. Angel Mora Plaza for assistance during sowing in Madrid. This work was funded by an EMBO Short Term Fellowship (M. E.-A.), ERC Advanced Grant IMMUNEMESIS and the Max Planck Society (D.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2018, SCI DATA, V5, DOI 10.1038/sdata.2017.191; Aitken SN, 2016, EVOL APPL, V9, P271, DOI 10.1111/eva.12293; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Anderson JT, 2014, EVOLUTION, V68, P16, DOI 10.1111/evo.12259; Asner GP, 2004, P NATL ACAD SCI USA, V101, P6039, DOI 10.1073/pnas.0400168101; Bay RA, 2018, SCIENCE, V359, P83, DOI 10.1126/science.aan4380; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Charlesworth B, 2012, GENETICS, V190, P5, DOI 10.1534/genetics.111.134288; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Exposito-Alonso M, 2018, NAT ECOL EVOL, V2, P352, DOI 10.1038/s41559-017-0423-0; Fitzpatrick MC, 2015, ECOL LETT, V18, P1, DOI 10.1111/ele.12376; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Gompert Z, 2017, MOL ECOL, V26, P365, DOI 10.1111/mec.13867; Gompert Z, 2014, ECOL LETT, V17, P369, DOI 10.1111/ele.12238; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; IPCC, 2014, CLIM CHANG 2014 PHYS; Jezkova T, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.2104; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kojima K., 1970, MATH TOPICS POPULATI, P367; Manzano-Piedras E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087836; Neher RA, 2013, ANNU REV ECOL EVOL S, V44, P195, DOI 10.1146/annurev-ecolsys-110512-135920; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nosil P, 2018, SCIENCE, V359, P765, DOI 10.1126/science.aap9125; Samaniego L, 2018, NAT CLIM CHANGE, V8, P421, DOI 10.1038/s41558-018-0138-5; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Thurman TJ, 2016, MOL ECOL, V25, P1429, DOI 10.1111/mec.13559; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	30	73	72	6	107	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					126	+		10.1038/s41586-019-1520-9	http://dx.doi.org/10.1038/s41586-019-1520-9			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31462776				2022-12-28	WOS:000483967700047
J	Mukherjee, A; Carvalho, F; Eliez, S; Caroni, P				Mukherjee, Arghya; Carvalho, Fernando; Eliez, Stephan; Caroni, Pico			Long-Lasting Rescue of Network and Cognitive Dysfunction in a Genetic Schizophrenia Model	CELL			English	Article							VENTRAL HIPPOCAMPAL LESION; MOUSE MODEL; DOPAMINE MODULATION; NEURODEVELOPMENTAL MODEL; GAMMA OSCILLATIONS; NEURAL SYNCHRONY; ANIMAL-MODEL; PARVALBUMIN; DEFICITS; INTERNEURONS	Although sensitizing processes occur earlier, schizophrenia is diagnosed in young adulthood, which suggests that it might involve a pathological transition during late brain development in predisposed individuals. Parvalbumin (PV) interneuron alterations have been noticed, but their role in the disease is unclear. Here we demonstrate that adult LgDel(+/-) mice, a genetic model of schizophrenia, exhibit PV neuron hypo-recruitment and associated chronic PV neuron plasticity together with network and cognitive deficits. All these deficits can be permanently rescued by chemogenetic activation of PV neurons or D2R antagonist treatments, specifically in the ventral hippocampus (vH) or medial-prefrontal cortex during a late-adolescence-sensitive time window. PV neuron alterations were initially restricted to the hippocampal CA1/subiculum, where they became responsive to treatment in late adolescence. Therefore, progression to disease in schizophrenia-model mice can be prevented by treatments supporting vH-mPFC PV network function during a sensitive time window late in adolescence, suggesting therapeutic strategies to prevent the outbreak of schizophrenia.	[Mukherjee, Arghya; Carvalho, Fernando; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Eliez, Stephan] Univ Geneva, Sch Med, Dept Psychiat, CH-1201 Geneva, Switzerland; [Eliez, Stephan] Univ Geneva, Sch Med, Dept Med Genet, CH-1201 Geneva, Switzerland; [Carvalho, Fernando] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA	Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of Geneva; Yale University	Caroni, P (corresponding author), Friedrich Miescher Inst, CH-4058 Basel, Switzerland.	caroni@fmi.ch		Mukherjee, Arghya/0000-0002-3341-4408	Swiss National Center for Competence in Research Synapsy (Synaptic Bases of Mental Health); Friedrich Miescher Institut for Biomedical Research, Basel, Switzerland; European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (MemoryDynamics grant) [694086]	Swiss National Center for Competence in Research Synapsy (Synaptic Bases of Mental Health); Friedrich Miescher Institut for Biomedical Research, Basel, Switzerland; European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (MemoryDynamics grant)(European Research Council (ERC))	This work was supported by the Swiss National Center for Competence in Research Synapsy (Synaptic Bases of Mental Health) to A.M., F.C., S.E., and P.C., and by the Friedrich Miescher Institut for Biomedical Research, Basel, Switzerland to A.M., F.C., and P.C. This project also received funding from the European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (MemoryDynamics grant agreement 694086). We thank Julien Courtin (FMI) for help with the LFP measurements and single-unit recordings and Silvia Arber (FMI and Biozentrum University of Basel) for valuable comments on the manuscript.	Abbas AI, 2018, NEURON, V100, P926, DOI 10.1016/j.neuron.2018.09.029; Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; Arguello PA, 2010, SCHIZOPHRENIA BULL, V36, P289, DOI 10.1093/schbul/sbp153; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Birnbaum R, 2017, NAT REV NEUROSCI, V18, P727, DOI 10.1038/nrn.2017.125; Boley AM, 2014, SCHIZOPHR RES, V157, P238, DOI 10.1016/j.schres.2014.05.005; Borkowska M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156082; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Caballero A, 2016, NEUROSCI BIOBEHAV R, V70, P4, DOI 10.1016/j.neubiorev.2016.05.013; Caballero A, 2016, TRENDS NEUROSCI, V39, P441, DOI 10.1016/j.tins.2016.04.010; Cardarelli Ross A, 2018, Mol Neuropsychiatry, V4, P20, DOI 10.1159/000488030; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Chung DW, 2016, AM J PSYCHIAT, V173, P1131, DOI 10.1176/appi.ajp.2016.16010025; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dejean C, 2016, NATURE, V535, P420, DOI 10.1038/nature18630; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Dienel SJ, 2019, NEUROBIOL DIS, V131, DOI 10.1016/j.nbd.2018.06.020; Donato F, 2015, NEURON, V85, P770, DOI 10.1016/j.neuron.2015.01.011; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Du YJ, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw065; Duvarci S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05214-4; Enomoto T, 2011, BIOL PSYCHIAT, V69, P432, DOI 10.1016/j.biopsych.2010.09.038; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Garner JP, 2006, BEHAV BRAIN RES, V173, P53, DOI 10.1016/j.bbr.2006.06.002; Glausier JR, 2018, HAND CLINIC, V150, P389, DOI 10.1016/B978-0-444-63639-3.00025-6; Gomes FV, 2019, SCHIZOPHR RES, V213, P107, DOI 10.1016/j.schres.2019.01.030; Gomes FV, 2016, NEUROSCI BIOBEHAV R, V70, P260, DOI 10.1016/j.neubiorev.2016.05.030; Gonzalez-Burgos G, 2015, BIOL PSYCHIAT, V77, P1031, DOI 10.1016/j.biopsych.2015.03.010; Grace AA, 2019, SCHIZOPHRENIA BULL, V45, P148, DOI 10.1093/schbul/sbx199; Hadar R, 2018, MOL PSYCHIATR, V23, P943, DOI 10.1038/mp.2017.52; Hamm JP, 2017, NEURON, V94, P153, DOI 10.1016/j.neuron.2017.03.019; Heckers S, 2015, SCHIZOPHR RES, V167, P4, DOI 10.1016/j.schres.2014.09.041; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Karunakaran S, 2016, NAT NEUROSCI, V19, P454, DOI 10.1038/nn.4231; Larsen B, 2018, NEUROSCI BIOBEHAV R, V94, P179, DOI 10.1016/j.neubiorev.2018.09.005; Larsen KM, 2018, SCHIZOPHRENIA BULL, V44, P388, DOI 10.1093/schbul/sbx058; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lodge DJ, 2008, NEUROTOX RES, V14, P97, DOI 10.1007/BF03033801; Lohani S, 2019, CELL REP, V27, P99, DOI 10.1016/j.celrep.2019.03.012; Marissal T, 2018, NAT NEUROSCI, V21, P1412, DOI 10.1038/s41593-018-0225-y; Meechan DW, 2015, CEREB CORTEX, V25, P1143, DOI 10.1093/cercor/bht308; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Millan MJ, 2016, NAT REV DRUG DISCOV, V15, P485, DOI 10.1038/nrd.2016.28; Mukherjee A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05318-x; Nguyen R, 2014, J NEUROSCI, V34, P14948, DOI 10.1523/JNEUROSCI.2204-14.2014; Petrie KA, 2005, J NEUROSCI, V25, P1629, DOI 10.1523/JNEUROSCI.3579-04.2005; Phillips KG, 2012, NEURON, V76, P526, DOI 10.1016/j.neuron.2012.09.016; Piskorowski RA, 2016, NEURON, V89, P163, DOI 10.1016/j.neuron.2015.11.036; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Spellman TJ, 2015, CURR OPIN NEUROBIOL, V30, P17, DOI 10.1016/j.conb.2014.08.009; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Tamura M, 2016, NEURON, V89, P1100, DOI 10.1016/j.neuron.2016.01.025; Thomases DR, 2013, J NEUROSCI, V33, P26, DOI 10.1523/JNEUROSCI.4147-12.2013; Tomasella E, 2018, P NATL ACAD SCI USA, V115, P3476, DOI 10.1073/pnas.1719897115; Tseng KY, 2009, BEHAV BRAIN RES, V204, P295, DOI 10.1016/j.bbr.2008.11.039; Tseng KY, 2008, J NEUROSCI, V28, P12691, DOI 10.1523/JNEUROSCI.4166-08.2008; Tseng KY, 2007, BIOL PSYCHIAT, V62, P730, DOI 10.1016/j.biopsych.2006.10.012; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Uhlhaas PJ, 2015, BIOL PSYCHIAT, V77, P1001, DOI 10.1016/j.biopsych.2014.11.019; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Volman V, 2011, J NEUROSCI, V31, P18137, DOI 10.1523/JNEUROSCI.3041-11.2011; Woo TUW, 2010, HARVARD REV PSYCHIAT, V18, P173, DOI 10.3109/10673221003747609; Zimmerman EC, 2016, J NEUROSCI, V36, P8977, DOI 10.1523/JNEUROSCI.1402-16.2016	69	66	68	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1387	+		10.1016/j.cell.2019.07.023	http://dx.doi.org/10.1016/j.cell.2019.07.023			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474363	Bronze			2022-12-28	WOS:000483983000014
J	Niu, JX; Sun, Y; Chen, BE; Zheng, BH; Jarugumilli, GK; Walker, SR; Hata, AN; Mino-Kenudson, M; Frank, DA; Wu, X				Niu, Jixiao; Sun, Yang; Chen, Baoen; Zheng, Baohui; Jarugumilli, Gopala K.; Walker, Sarah R.; Hata, Aaron N.; Mino-Kenudson, Mari; Frank, David A.; Wu, Xu			Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation	NATURE			English	Article							PROTEIN PALMITOYLATION; CELLS; SPECIFICITY; METASTASIS; DIETARY; OBESITY; IL-6; SH2; RAS	Signal transducer and activator of transcription 3 (STAT3) has a critical role in regulating cell fate, inflammation and immunity(1,2). Cytokines and growth factors activate STAT3 through kinase-mediated tyrosine phosphorylation and dimerization(3,4). It remains unknown whether other factors promote STAT3 activation through different mechanisms. Here we show that STAT3 is post-translationally S-palmitoylated at the SRC homology 2 (SH2) domain, which promotes the dimerization and transcriptional activation of STAT3. Fatty acids can directly activate STAT3 by enhancing its palmitoylation, in synergy with cytokine stimulation. We further identified ZDHHC19 as a palmitoyl acyltransferase that regulates STAT3. Cytokine stimulation increases STAT3 palmitoylation by promoting the association between ZDHHC19 and STAT3, which is mediated by the SH3 domain of GRB2. Silencing ZDHHC19 blocks STAT3 palmitoylation and dimerization, and impairs the cytokine-and fatty-acid-induced activation of STAT3. ZDHHC19 is frequently amplified in multiple human cancers, including in 39% of lung squamous cell carcinomas. High levels of ZDHHC19 correlate with high levels of nuclear STAT3 in patient samples. In addition, knockout of ZDHHC19 in lung squamous cell carcinoma cells significantly blocks STAT3 activity, and inhibits the fatty-acid-induced formation of tumour spheres as well as tumorigenesis induced by high-fat diets in an in vivo mouse model. Our studies reveal that fatty-acid-and ZDHHC19-mediated palmitoylation are signals that regulate STAT3, which provides evidence linking the deregulation of palmitoylation to inflammation and cancer.	[Niu, Jixiao; Sun, Yang; Chen, Baoen; Zheng, Baohui; Jarugumilli, Gopala K.; Wu, Xu] Harvard Med Sch, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Walker, Sarah R.; Frank, David A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Walker, Sarah R.; Hata, Aaron N.; Frank, David A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Hata, Aaron N.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Mino-Kenudson, Mari] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Walker, Sarah R.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University System Of New Hampshire; University of New Hampshire	Wu, X (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	xwu@cbrc2.mgh.harvard.edu			Samuel M. Fisher Memorial-Melanoma Research Alliance (MRA) Established Investigator Award; Idea Award from Prostate Cancer Research Program, US Department of Defense [W81XWH-17-1-0361]; National Institutes of Health [R01CA181537, R01DK107651-01, R01CA238270-01, R01CA160979]; Confocal Imaging Core at Cutaneous Biology Research Center of Massachusetts General Hospital [1S10RR027673-01]; NATIONAL CANCER INSTITUTE [R01CA160979, R01CA238270, R01CA181537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107651] Funding Source: NIH RePORTER	Samuel M. Fisher Memorial-Melanoma Research Alliance (MRA) Established Investigator Award; Idea Award from Prostate Cancer Research Program, US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Confocal Imaging Core at Cutaneous Biology Research Center of Massachusetts General Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Samuel M. Fisher Memorial-Melanoma Research Alliance (MRA) Established Investigator Award, the Idea Award from Prostate Cancer Research Program, US Department of Defense (W81XWH-17-1-0361) and grants from National Institutes of Health (R01CA181537, R01DK107651-01 and R01CA238270-01 to X.W., and R01CA160979 to D. A. F.). We thank T. Maniatis for the expression vector of STAT2, M. Fukata for the expression vectors of the ZDHHC proteins, J. Hersch for commenting and editing of the manuscript, the Confocal Imaging Core at Cutaneous Biology Research Center of Massachusetts General Hospital with the Shared Instrumentation Grant (1S10RR027673-01), and the Taplin Mass Spectrometry Core at Harvard Medical School for proteomic studies.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Braakman I., 2017, CURR PROTOC PROTEIN, V90; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Chen BE, 2018, CELL CHEM BIOL, V25, P817, DOI 10.1016/j.chembiol.2018.05.003; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Giordano V, 1997, J IMMUNOL, V158, P4097; Hayashi T, 2018, CLIN CANCER RES, V24, P4309, DOI 10.1158/1078-0432.CCR-18-0106; Herbert D, 2018, J INVEST DERMATOL, V138, P1999, DOI 10.1016/j.jid.2018.03.1522; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1499, DOI 10.1016/j.bbalip.2013.02.008; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Niu J, 2016, ONCOGENE, V35, P1302, DOI 10.1038/onc.2015.189; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park MJ, 2016, MOL CELL, V62, P7, DOI 10.1016/j.molcel.2016.01.027; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Rana MS, 2018, SCIENCE, V359, P176, DOI 10.1126/science.aao6326; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2017, BIOCHEM SOC T, V45, P409, DOI 10.1042/BST20160233; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Tian H, 2015, MOL CANCER RES, V13, P784, DOI 10.1158/1541-7786.MCR-14-0608; Wang J, 2013, CLIN CANCER RES, V19, P5580, DOI 10.1158/1078-0432.CCR-13-0594; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang JJ, 2017, J CLIN ONCOL, V35, P3055, DOI [10.1200/jco.2017.73.3329, 10.1200/JCO.2017.73.3329]; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zheng BH, 2013, J AM CHEM SOC, V135, P7082, DOI 10.1021/ja311416v	38	30	32	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					139	+		10.1038/s41586-019-1511-x	http://dx.doi.org/10.1038/s41586-019-1511-x			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31462771	Green Accepted			2022-12-28	WOS:000483967700050
J	Rimmer, A; Iacobucci, G				Rimmer, Abi; Iacobucci, Gareth			Vaping: CDC investigation continues after patient dies from severe lung injuries	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ASH, 2019, FACT SHEET US E CIG; CDC, 2019, TRANSCR AUG 23 2019; Cullen KA, 2018, MMWR-MORBID MORTAL W, V67, P1276, DOI 10.15585/mmwr.mm6745a5; FDA, 2019, MAN; Public Health England, 2019, VAP ENGL EV UPD; Wisconsin Department of Health Services, OUTBR WISC	6	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l5320	10.1136/bmj.l5320	http://dx.doi.org/10.1136/bmj.l5320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31467143				2022-12-28	WOS:000483892600008
J	Dyer, C				Dyer, Clare			Cardiologist who fitted wrong pacemaker and destroyed patient notes is struck off	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2019	366								l5282	10.1136/bmj.l5282	http://dx.doi.org/10.1136/bmj.l5282			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DN	31444164				2022-12-28	WOS:000482882800009
J	Jaumann, R; Schmitz, N; Ho, TM; Schroder, SE; Otto, KA; Stephan, K; Elgner, S; Krohn, K; Preusker, F; Scholten, F; Biele, J; Ulamec, S; Krause, C; Sugita, S; Matz, KD; Roatsch, T; Parekh, R; Mottola, S; Grott, M; Michel, P; Trauthan, F; Koncz, A; Michaelis, H; Lange, C; Grundmann, JT; Maibaum, M; Sasaki, K; Wolff, F; Reill, J; Moussi-Soffys, A; Lorda, L; Neumann, W; Vincent, JB; Wagner, R; Bibring, JP; Kameda, S; Yano, H; Watanabe, S; Yoshikawa, M; Tsuda, Y; Okada, T; Yoshimitsu, T; Mimasu, Y; Saiki, T; Yabuta, H; Rauer, H; Honda, R; Morota, T; Yokota, Y; Kouyama, T				Jaumann, R.; Schmitz, N.; Ho, T. -M.; Schroder, S. E.; Otto, K. A.; Stephan, K.; Elgner, S.; Krohn, K.; Preusker, F.; Scholten, F.; Biele, J.; Ulamec, S.; Krause, C.; Sugita, S.; Matz, K. -D.; Roatsch, T.; Parekh, R.; Mottola, S.; Grott, M.; Michel, P.; Trauthan, F.; Koncz, A.; Michaelis, H.; Lange, C.; Grundmann, J. T.; Maibaum, M.; Sasaki, K.; Wolff, F.; Reill, J.; Moussi-Soffys, A.; Lorda, L.; Neumann, W.; Vincent, J. -B.; Wagner, R.; Bibring, J. -P.; Kameda, S.; Yano, H.; Watanabe, S.; Yoshikawa, M.; Tsuda, Y.; Okada, T.; Yoshimitsu, T.; Mimasu, Y.; Saiki, T.; Yabuta, H.; Rauer, H.; Honda, R.; Morota, T.; Yokota, Y.; Kouyama, T.			Images from the surface of asteroid Ryugu show rocks similar to carbonaceous chondrite meteorites	SCIENCE			English	Article							SPECTRAL REFLECTANCE PROPERTIES; MARS-EXPRESS; TAGISH LAKE; CAMERA; FORCES	The near-Earth asteroid (162173) Ryugu is a 900-m-diameter dark object expected to contain primordial material from the solar nebula. The Mobile Asteroid Surface Scout (MASCOT) landed on Ryugu's surface on 3 October 2018. We present images from the MASCOT camera (MASCam) taken during the descent and while on the surface. The surface is covered by decimeter- to meter-sized rocks, with no deposits of fine-grained material. Rocks appear either bright, with smooth faces and sharp edges, or dark, with a cauliflower-like, crumbly surface. Close-up images of a rock of the latter type reveal a dark matrix with small, bright, spectrally different inclusions, implying that it did not experience extensive aqueous alteration. The inclusions appear similar to those in carbonaceous chondrite meteorites.	[Jaumann, R.; Schmitz, N.; Schroder, S. E.; Otto, K. A.; Stephan, K.; Elgner, S.; Krohn, K.; Preusker, F.; Scholten, F.; Matz, K. -D.; Roatsch, T.; Parekh, R.; Mottola, S.; Grott, M.; Trauthan, F.; Koncz, A.; Michaelis, H.; Neumann, W.; Vincent, J. -B.; Wagner, R.; Rauer, H.] German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany; [Jaumann, R.; Rauer, H.] Free Univ Berlin, Inst Geosci, Berlin, Germany; [Ho, T. -M.; Lange, C.] DLR, Inst Space Syst, Bremen, Germany; [Biele, J.; Ulamec, S.; Krause, C.; Maibaum, M.] DLR, Micrograv User Support Ctr, Cologne, Germany; [Sugita, S.] Univ Tokyo, Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Michel, P.] Univ Cote Azur, Observ Cote Azur, CNRS, Lab Lagrange, Nice, France; [Grundmann, J. T.; Sasaki, K.; Wolff, F.] DLR, Inst Syst Dynam & Control, Oberpfaffenhofen, Germany; [Reill, J.] DLR, Inst Robot & Mechatron, Oberpfaffenhofen, Germany; [Moussi-Soffys, A.; Lorda, L.] Ctr Natl Etud Spati, 18 Ave E Belin, F-31401 Toulouse, France; [Bibring, J. -P.] Univ Paris Sud, Inst Astrophys Spatiale, Orsay, France; [Kameda, S.] Rikkyo Univ, Dept Phys, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan; [Yano, H.; Watanabe, S.; Yoshikawa, M.; Tsuda, Y.; Okada, T.; Yoshimitsu, T.; Mimasu, Y.; Saiki, T.; Yokota, Y.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan; [Watanabe, S.] Nagoya Univ, Dept Earth & Planetary Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan; [Yabuta, H.] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Hiroshima, Japan; [Honda, R.] Kochi Univ, Dept Informat Sci, Kochi, Japan; [Morota, T.] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo, Japan; [Kouyama, T.] Natl Inst Adv Ind Sci & Technol, Koto Ku, Tokyo, Japan	Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Helmholtz Association; German Aerospace Centre (DLR); University of Tokyo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Helmholtz Association; German Aerospace Centre (DLR); Helmholtz Association; German Aerospace Centre (DLR); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Rikkyo University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Nagoya University; Hiroshima University; Kochi University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Jaumann, R (corresponding author), German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany.; Jaumann, R (corresponding author), Free Univ Berlin, Inst Geosci, Berlin, Germany.	ralf.jaumann@dlr.de	Neumann, Wladimir/Q-2107-2018; Biele, Jens/ABI-1218-2020; Sugita, Seiji/GQI-1142-2022; Schröder, Stefan/D-9709-2013; Michel, Patrick/AGX-0167-2022; Kouyama, Toru/B-1155-2017	Neumann, Wladimir/0000-0003-1932-602X; Biele, Jens/0000-0002-7414-829X; Sugita, Seiji/0000-0001-6076-3614; Schröder, Stefan/0000-0003-0323-8324; Michel, Patrick/0000-0002-0884-1993; Reill, Josef/0000-0003-4092-063X; Sasaki, Kaname/0000-0003-0365-4539; Parekh, Rutu/0000-0002-9446-146X; YOSHIMITSU, Tetsuo/0000-0002-2626-0578; Kouyama, Toru/0000-0002-1060-3986	DLR; CNES	DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); CNES(Centre National D'etudes Spatiales)	The team acknowledges funding by DLR and CNES.	ASADA N, 1985, J GEOPHYS RES-SOLID, V90, P2445, DOI 10.1029/JB090iB14p12445; Brearley AJ, 1998, REV MINERAL, V36, pC1; Cloutis EA, 2012, ICARUS, V220, P466, DOI 10.1016/j.icarus.2012.05.019; Cloutis EA, 2011, ICARUS, V216, P309, DOI 10.1016/j.icarus.2011.09.009; Cloutis EA, 2011, ICARUS, V212, P180, DOI 10.1016/j.icarus.2010.12.009; Delbo M, 2014, NATURE, V508, P233, DOI 10.1038/nature13153; Flynn GJ, 2004, PLANET SPACE SCI, V52, P1129, DOI 10.1016/j.pss.2004.07.010; FREDRIKSSON K, 1988, METEORITICS, V23, P35, DOI 10.1111/j.1945-5100.1988.tb00894.x; Fuchs L.H., 1973, SMITHSONIAN CONTRIBS, V10, P1, DOI [DOI 10.5479/SI.00810274.10.1, 10.5479/si.00810274.10.1]; Green R. O., 2015, 46 LUN PLAN SCI C; Green R. O., 2015, 47 LUN PLAN SCI C; Grott M., 2019, NATURE ASTRONOMY; Gwinner K, 2009, PHOTOGRAMM ENG REM S, V75, P1127, DOI 10.14358/PERS.75.9.1127; Hartzell CM, 2011, PLANET SPACE SCI, V59, P1758, DOI 10.1016/j.pss.2011.04.017; Hercik D, 2017, SPACE SCI REV, V208, P433, DOI 10.1007/s11214-016-0236-5; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; Ho TM, 2017, SPACE SCI REV, V208, P339, DOI 10.1007/s11214-016-0251-6; Jaumann R, 2007, PLANET SPACE SCI, V55, P928, DOI 10.1016/j.pss.2006.12.003; Jaumann R, 2017, SPACE SCI REV, V208, P375, DOI 10.1007/s11214-016-0263-2; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Kameda S, 2017, SPACE SCI REV, V208, P17, DOI 10.1007/s11214-015-0227-y; Kitazato K, 2019, SCIENCE, V364, P272, DOI 10.1126/science.aav7432; Lazzaro D, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220629; MCSWEEN HY, 1977, GEOCHIM COSMOCHIM AC, V41, P477, DOI 10.1016/0016-7037(77)90286-1; MCSWEEN HY, 1979, GEOCHIM COSMOCHIM AC, V43, P1761, DOI 10.1016/0016-7037(79)90024-3; Molaro JL, 2017, ICARUS, V294, P247, DOI 10.1016/j.icarus.2017.03.008; Moskovitz NA, 2013, ICARUS, V224, P24, DOI 10.1016/j.icarus.2013.02.009; Perna D, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201630346; Preusker F, 2011, PLANET SPACE SCI, V59, P1910, DOI 10.1016/j.pss.2011.07.005; Raymond CA, 2011, SPACE SCI REV, V163, P487, DOI 10.1007/s11214-011-9863-z; Robinson MS, 2001, NATURE, V413, P396, DOI 10.1038/35096518; Scheeres DJ, 2010, ICARUS, V210, P968, DOI 10.1016/j.icarus.2010.07.009; Simon JI, 2018, EARTH PLANET SC LETT, V494, P69, DOI 10.1016/j.epsl.2018.04.021; Sugita S, 2019, SCIENCE, V364, P252, DOI 10.1126/science.aaw0422; TOMEOKA K, 1985, GEOCHIM COSMOCHIM AC, V49, P2149, DOI 10.1016/0016-7037(85)90073-0; Watanabe S, 2019, SCIENCE, V364, P268, DOI 10.1126/science.aav8032; Watanabe S, 2017, SPACE SCI REV, V208, P3, DOI 10.1007/s11214-017-0377-1; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164; Zolensky ME, 2002, METEORIT PLANET SCI, V37, P737, DOI 10.1111/j.1945-5100.2002.tb00852.x	39	73	73	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		817	+		10.1126/science.aaw8627	http://dx.doi.org/10.1126/science.aaw8627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439797	Green Submitted			2022-12-28	WOS:000482464000053
J	Servick, K				Servick, Kelly			WARNING SIGNS	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		742	744		10.1126/science.365.6455.742	http://dx.doi.org/10.1126/science.365.6455.742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439777				2022-12-28	WOS:000482464000023
J	Chappell, LC; Brocklehurst, P; Green, ME; Hunter, R; Hardy, P; Juszczak, E; Linsell, L; Chiocchia, V; Greenland, M; Placzek, A; Townend, J; Marlow, N; Sandall, J; Shennan, A				Chappell, Lucy C.; Brocklehurst, Peter; Green, Marcus E.; Hunter, Rachael; Hardy, Pollyanna; Juszczak, Edmund; Linsell, Louise; Chiocchia, Virginia; Greenland, Melanie; Placzek, Anna; Townend, John; Marlow, Neil; Sandall, Jane; Shennan, Andrew		PHOENIX Study Grp	Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial	LANCET			English	Article								Background In women with late preterm pre-eclampsia, the optimal time to initiate delivery is unclear because limitation of maternal disease progression needs to be balanced against infant complications. The aim of this trial was to determine whether planned earlier initiation of delivery reduces maternal adverse outcomes without substantial worsening of neonatal or infant outcomes, compared with expectant management (usual care) in women with late preterm pre-eclampsia. Methods In this parallel-group, non-masked, multicentre, randomised controlled trial done in 46 maternity units across England and Wales, we compared planned delivery versus expectant management (usual care) with individual randomisation in women with late preterm pre-eclampsia from 34 to less than 37 weeks' gestation and a singleton or dichorionic diamniotic twin pregnancy. The co-primary maternal outcome was a composite of maternal morbidity or recorded systolic blood pressure of at least 160 mm Hg with a superiority hypothesis. The co-primary perinatal outcome was a composite of perinatal deaths or neonatal unit admission up to infant hospital discharge with a non-inferiority hypothesis (non-inferiority margin of 10% difference in incidence). Analyses were by intention to treat, together with a per-protocol analysis for the perinatal outcome. The trial was prospectively registered with the ISRCTN registry, ISRCTN01879376. The trial is closed to recruitment but follow-up is ongoing. Findings Between Sept 29, 2014, and Dec 10, 2018, 901 women were recruited. 450 women (448 women and 471 infants analysed) were allocated to planned delivery and 451 women (451 women and 475 infants analysed) to expectant management. The incidence of the co-primary maternal outcome was significantly lower in the planned delivery group (289 [65%] women) compared with the expectant management group (338 [75%] women; adjusted relative risk 0.86, 95% CI 0.79-0.94; p=0.0005). The incidence of the co-primary perinatal outcome by intention to treat was significantly higher in the planned delivery group (196 [42%] infants) compared with the expectant management group (159 [34%] infants; 1.26, 1.08-1.47; p=0.0034). The results from the per-protocol analysis were similar. There were nine serious adverse events in the planned delivery group and 12 in the expectant management group. Interpretation There is strong evidence to suggest that planned delivery reduces maternal morbidity and severe hypertension compared with expectant management, with more neonatal unit admissions related to prematurity but no indicators of greater neonatal morbidity. This trade-off should be discussed with women with late preterm pre-eclampsia to allow shared decision making on timing of delivery. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.	[Chappell, Lucy C.; Sandall, Jane; Shennan, Andrew] Kings Coll London, Sch Life Course Sci, Dept Women & Childrens Hlth, London SE1 7EH, England; [Brocklehurst, Peter; Hardy, Pollyanna] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Green, Marcus E.] Act Preeclampsia, Evesham, England; [Hunter, Rachael] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Marlow, Neil] UCL, UCL EGA Inst Womens Hlth, London, England; [Juszczak, Edmund; Linsell, Louise; Chiocchia, Virginia; Greenland, Melanie; Placzek, Anna; Townend, John] Univ Oxford, Natl Perinatal Epidemiol Unit, Clin Trials Unit, Nuffield Dept Populat Hlth, Oxford, England	University of London; King's College London; University of Birmingham; University of London; University College London; University of London; University College London; University of Oxford	Chappell, LC (corresponding author), Kings Coll London, Sch Life Course Sci, Dept Women & Childrens Hlth, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk	Hunter, Rachael Maree/H-7846-2019; Wu, Pensée/ABD-2931-2020; Chiocchia, Virginia/H-8885-2019; Chappell, Lucy/U-4778-2018; Sandall, Jane/D-4146-2009; Marlow, Neil/D-2918-2009	Hunter, Rachael Maree/0000-0002-7447-8934; Wu, Pensée/0000-0003-0011-5636; Chiocchia, Virginia/0000-0002-6196-3308; Townend, Jonathan/0000-0002-5881-5806; Myers, Jenny/0000-0003-0913-2096; Chappell, Lucy/0000-0001-6219-3379; Shennan, Andrew/0000-0001-5273-3132; Sandall, Jane/0000-0003-2000-743X; Greenland, Melanie/0000-0001-9363-8844; Marlow, Neil/0000-0001-5890-2953	National Institute for Health Research Health Technology Assessment Programme	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR))	National Institute for Health Research Health Technology Assessment Programme.	[Anonymous], 2019, Obstet Gynecol, V133, pe151, DOI 10.1097/AOG.0000000000003083; Bernardes TP, 2019, ULTRASOUND OBST GYN, V53, P443, DOI 10.1002/uog.20224; British Association of Perinatal Medicine, 2010, SERV STAND HOSP PROV; Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Chappell LC, 2019, TRIALS, V20, DOI 10.1186/s13063-018-3150-1; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Cluver C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009273.pub2; Coviello EM, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.09.027; Kahan BC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5840; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Nathan HL, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020401; National Institute for Health and Clinical Excellence, 2010, HYP PREGN MAN HYP DI; NHS Improvement, 2018, REF COSTS NHS IMPR H; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; Wang YH, 2017, ARCH GYNECOL OBSTET, V295, P607, DOI 10.1007/s00404-016-4281-9; Zwertbroek EF, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.03.024	21	68	68	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2019	394	10204					1181	1190		10.1016/S0140-6736(19)31963-4	http://dx.doi.org/10.1016/S0140-6736(19)31963-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8TF	31472930	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000488848800029
J	Kotsopoulos, J				Kotsopoulos, Joanne			Menopausal hormones: definitive evidence for breast cancer	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; ESTROGEN		[Kotsopoulos, Joanne] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Kotsopoulos, Joanne] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1B2, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Kotsopoulos, J (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.; Kotsopoulos, J (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1B2, Canada.	joanne.kotsopoulos@wchospital.ca						Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Collaborative Grp Hormonal Factors, 2019, LANCET, V394, P1159, DOI 10.1016/S0140-6736(19)31709-X; Kumle M, 2008, LANCET, V372, P608, DOI 10.1016/S0140-6736(08)61255-6; Manson JE, 2014, FERTIL STERIL, V101, P916, DOI 10.1016/j.fertnstert.2014.02.043; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	6	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2019	394	10204					1116	1118		10.1016/S0140-6736(19)31901-4	http://dx.doi.org/10.1016/S0140-6736(19)31901-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB8TF	31474333	hybrid			2022-12-28	WOS:000488848800005
J	Finn, EH; Misteli, T				Finn, Elizabeth H.; Misteli, Tom			Molecular basis and biological function of variability in spatial genome organization	SCIENCE			English	Review							IMPRINTING CONTROL REGION; CHROMATIN DECONDENSATION; GENE-EXPRESSION; NUCLEAR REORGANIZATION; PHASE-SEPARATION; TRANSCRIPTION; CHROMOSOME; FLUCTUATIONS; COMPARTMENTS; CELLS	The complex three-dimensional organization of genomes in the cell nucleus arises from a wide range of architectural features including DNA loops, chromatin domains, and higher-order compartments. Although these features are universally present in most cell types and tissues, recent single-cell biochemistry and imaging approaches have demonstrated stochasticity in transcription and high variability of chromatin architecture in individual cells. We review the occurrence, mechanistic basis, and functional implications of stochasticity in genome organization. We summarize recent observations on cell-and allele-specific variability of genome architecture, discuss the nature of extrinsic and intrinsic sources of variability in genome organization, and highlight potential implications of structural heterogeneity for genome function.	[Finn, Elizabeth H.; Misteli, Tom] NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Finn, EH; Misteli, T (corresponding author), NCI, Bethesda, MD 20892 USA.	elizabeth.finn@nih.gov; mistelit@mail.nih.gov		Finn, Elizabeth/0000-0001-8320-2190; Misteli, Tom/0000-0003-3530-3020	Center for Cancer Research; 4D Nucleome Common Fund [U54 DK107980]; Intramural Research Program of National Institutes of Health (NIH), National Cancer Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107980] Funding Source: NIH RePORTER	Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); 4D Nucleome Common Fund; Intramural Research Program of National Institutes of Health (NIH), National Cancer Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by funding from the Intramural Research Program of National Institutes of Health (NIH), National Cancer Institute, and Center for Cancer Research and by the 4D Nucleome Common Fund (U54 DK107980).	Alexander JM, 2019, ELIFE, V8, DOI 10.7554/eLife.41769; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bintu B, 2018, SCIENCE, V362, P419, DOI 10.1126/science.aau1783; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Branciamore S, 2018, P NATL ACAD SCI USA, V115, pE10379, DOI 10.1073/pnas.1808652115; Cattoni DI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01962-x; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen CK, 2016, SCIENCE, V354, P468, DOI 10.1126/science.aae0047; Chen HT, 2018, NAT GENET, V50, P1296, DOI 10.1038/s41588-018-0175-z; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Courchaine EM, 2016, EMBO J, V35, P1603, DOI 10.15252/embj.201593517; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Deng XX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0728-8; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Drubin DA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-19; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; Finn EH, 2019, CELL, V176, P1502, DOI 10.1016/j.cell.2019.01.020; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; Ghavi-Helm Y, 2019, NAT GENET, V51, P1272, DOI 10.1038/s41588-019-0462-3; Gibcus JH, 2018, SCIENCE, V359, P652, DOI 10.1126/science.aao6135; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Goes ACS, 2011, J CELL BIOCHEM, V112, P2072, DOI 10.1002/jcb.23129; Gu B, 2018, SCIENCE, V359, P1050, DOI 10.1126/science.aao3136; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Heinz S, 2018, CELL, V174, P1522, DOI 10.1016/j.cell.2018.07.047; Khanna N, 2014, CURR BIOL, V24, P1138, DOI 10.1016/j.cub.2014.03.053; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lenstra TL, 2016, ANNU REV BIOPHYS, V45, P25, DOI 10.1146/annurev-biophys-062215-010838; Lim B, 2018, MOL CELL, V70, P287, DOI 10.1016/j.molcel.2018.02.029; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Lyons DB, 2014, CELL REP, V9, P884, DOI 10.1016/j.celrep.2014.10.001; Marcello A, 2004, GENE, V326, P1, DOI 10.1016/j.gene.2003.10.018; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; Marshall AD, 2017, ONCOGENE, V36, P4100, DOI 10.1038/onc.2017.25; Mateo LJ, 2019, NATURE, V568, P49, DOI 10.1038/s41586-019-1035-4; Meaburn KJ, 2016, FUNCTIONAL NUCLEUS, P101, DOI 10.1007/978-3-319-38882-3_5; Meaburn KJ, 2016, HISTOCHEM CELL BIOL, V145, P433, DOI 10.1007/s00418-015-1401-8; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Monahan K, 2019, NATURE, V565, P448, DOI 10.1038/s41586-018-0845-0; Monahan K, 2017, ELIFE, V6, DOI 10.7554/elife.28620.001; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Parada LA, 2003, TRENDS CELL BIOL, V13, P393, DOI 10.1016/S0962-8924(03)00149-1; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rodriguez J, 2019, CELL, V176, P213, DOI 10.1016/j.cell.2018.11.026; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shi G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05606-6; Shin Y, 2018, CELL, V175, P1481, DOI 10.1016/j.cell.2018.10.057; Sinha DK, 2008, BIOPHYS J, V95, P5432, DOI 10.1529/biophysj.108.135921; Soutoglou Evi, 2008, J Natl Cancer Inst Monogr, P16, DOI 10.1093/jncimonographs/lgn017; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Stapel LC, 2017, GENE DEV, V31, P1635, DOI 10.1101/gad.302935.117; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Symmons O, 2016, MOL CELL, V62, P788, DOI 10.1016/j.molcel.2016.05.023; Szabo Q, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8082; Tan LZ, 2018, SCIENCE, V361, P924, DOI 10.1126/science.aat5641; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Terrier O, 2014, VIROLOGY, V456, P39, DOI 10.1016/j.virol.2014.03.013; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Tiana G, 2016, BIOPHYS J, V110, P1234, DOI 10.1016/j.bpj.2016.02.003; Torres CM, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1644; Vivante A, 2017, METHODS, V123, P128, DOI 10.1016/j.ymeth.2017.01.008; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Yang S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5761; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	90	74	74	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					998	+	eaaw9498	10.1126/science.aaw9498	http://dx.doi.org/10.1126/science.aaw9498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488662	Green Accepted			2022-12-28	WOS:000484732700037
J	Yang, ZY; Albrow-Owen, T; Cui, HX; Alexander-Webber, J; Gu, FX; Wang, XM; Wu, TC; Zhuge, MH; Williams, C; Wang, P; Zayats, AV; Cai, WW; Dais, L; Hofmann, S; Overend, M; Tong, LM; Yang, Q; Sun, ZP; Hasan, T				Yang, Zongyin; Albrow-Owen, Tom; Cui, Hanxiao; Alexander-Webber, Jack; Gu, Fuxing; Wang, Xiaomu; Wu, Tien-Chun; Zhuge, Minghua; Williams, Calun; Wang, Pan; Zayats, Anatoly V.; Cai, Weiwei; Dais, Lun; Hofmann, Stephan; Overend, Mauro; Tong, Limin; Yang, Qing; Sun, Zhipei; Hasan, Tawfique			Single-nanowire spectrometers	SCIENCE			English	Article							PHOTODETECTORS; TRANSMISSION; DESIGN; ARRAYS	Spectrometers with ever-smaller footprints are sought after for a wide range of applications in which minimized size and weight are paramount, including emerging in situ characterization techniques. We report on an ultracompact microspectrometer design based on a single compositionally engineered nanowire. This platform is independent of the complex optical components or cavities that tend to constrain further miniaturization of current systems. We show that incident spectra can be computationally reconstructed from the different spectral response functions and measured photocurrents along the length of the nanowire. Our devices are capable of accurate, visible-range monochromatic and broadband light reconstruction, as well as spectral imaging from centimeter-scale focal planes down to lensless, single-cell-scale in situ mapping.	[Yang, Zongyin; Albrow-Owen, Tom; Wu, Tien-Chun; Hasan, Tawfique] Univ Cambridge, Cambridge Graphene Ctr, Cambridge CB3 0FA, England; [Cui, Hanxiao; Alexander-Webber, Jack; Williams, Calun; Hofmann, Stephan; Overend, Mauro] Univ Cambridge, Dept Engn, Cambridge CB3 0FA, England; [Gu, Fuxing] Univ Shanghai Sci & Technol, Shanghai Key Lab Modern Opt Syst, Shanghai 200093, Peoples R China; [Wang, Xiaomu] Nanjing Univ, Sch Elect Sci & Engn, Nanjing 210023, Jiangsu, Peoples R China; [Zhuge, Minghua; Tong, Limin; Yang, Qing] Zhejiang Univ, Coll Opt Sci & Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310027, Zhejiang, Peoples R China; [Wang, Pan; Zayats, Anatoly V.] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Wang, Pan; Zayats, Anatoly V.] Kings Coll London, London Ctr Nanotechnol, London WC2R 2LS, England; [Cai, Weiwei] Shanghai Jiao Tong Univ, Sch Mech Engn, Educ Minist Power Machinery & Engn, Key Lab, Shanghai 200240, Peoples R China; [Dais, Lun] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China; [Sun, Zhipei] Aalto Univ, Dept Elect & Nanoengn, Tietotie 3, FI-00076 Espoo, Finland; [Sun, Zhipei] Aalto Univ, Dept Appl Phys, QTF Ctr Excellence, FI-00076 Espoo, Finland	University of Cambridge; University of Cambridge; University of Shanghai for Science & Technology; Nanjing University; Zhejiang University; University of London; King's College London; University of London; King's College London; University College London; Shanghai Jiao Tong University; Peking University; Aalto University; Aalto University	Hasan, T (corresponding author), Univ Cambridge, Cambridge Graphene Ctr, Cambridge CB3 0FA, England.	th270@cam.ac.uk	Hofmann, Stephan/D-3906-2012; Sun, Zhipei/G-2442-2013; Hasan, Tawfique/C-8605-2009; cai, weiwei/Q-5932-2016; Williams, Calum/Y-8200-2019	Hofmann, Stephan/0000-0001-6375-1459; Hasan, Tawfique/0000-0002-6250-7582; cai, weiwei/0000-0003-3589-7500; Williams, Calum/0000-0002-6432-6515; Alexander-Webber, Jack/0000-0002-9374-7423; Cui, Hanxiao/0000-0001-8423-3028; Yang, Zongyin/0000-0003-2869-406X; Wu, Tien-Chun/0000-0002-6185-3256; Albrow-Owen, Tom/0000-0003-0443-014X; Gu, Fuxing/0000-0001-5442-8043	Cambridge Trust; EPSRC [EP/M013812/1, EP/L016087/1]; Royal Commission for the Exhibition of 1851; CRUK Pioneer Award [C55962/A24669]; Business Finland (A-Photonics); Academy of Finland; ERC [834742]; EU [820423]; Royal Academy of Engineering; Royal Society	Cambridge Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Commission for the Exhibition of 1851; CRUK Pioneer Award; Business Finland (A-Photonics); Academy of Finland(Academy of Finland); ERC(European Research Council (ERC)European Commission); EU(European Commission); Royal Academy of Engineering(Royal Academy of Engineering - UK); Royal Society(Royal Society of London)	Z.Y. acknowledges support from Cambridge Trust; T.A.-O. from EPSRC(EP/L016087/1); J.A.-W. from the Royal Commission for the Exhibition of 1851; C.W. from the CRUK Pioneer Award (C55962/A24669); A.V.Z from EPSRC (EP/M013812/1); Z.S. from Business Finland (A-Photonics), Academy of Finland, the ERC (834742), and the EU Horizon 2020 (820423) T.H. from the Royal Academy of Engineering: and Q.Y. and T.H. from the Royal Society.	Alexander-Webber JA, 2017, ACS APPL MATER INTER, V9, P43993, DOI 10.1021/acsami.7b14415; Bao J, 2015, NATURE, V523, P67, DOI 10.1038/nature14576; Blind N, 2017, OPT EXPRESS, V25, P27341, DOI 10.1364/OE.25.027341; Bouillard JS, 2010, OPT EXPRESS, V18, P16513, DOI 10.1364/OE.18.016513; Bryan KM, 2013, OPT EXPRESS, V21, P4411, DOI 10.1364/OE.21.004411; Calafiore G, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.84; Cerjan B, 2019, ACS PHOTONICS, V6, P79, DOI 10.1021/acsphotonics.8b01503; Chang CC, 2008, OPT EXPRESS, V16, P1056, DOI 10.1364/OE.16.001056; Chang CC, 2011, OPT ENG, V50, DOI 10.1117/1.3645086; DENTON AR, 1991, PHYS REV A, V43, P3161, DOI 10.1103/PhysRevA.43.3161; Faraji-Dana M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06495-5; Flagello D, 2005, J MICROLITH MICROFAB, V4, DOI 10.1117/1.2039081; Gao T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1915514; Geelen B, 2014, PROC SPIE, V8974, DOI 10.1117/12.2037607; Gu FX, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3657523; Gu FX, 2011, J AM CHEM SOC, V133, P2037, DOI 10.1021/ja110092a; Hagen N, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.9.090901; Hansen P. C., 2010, DISCRETE INVERSE PRO, V7; HANSEN PC, 1992, SIAM REV, V34, P561, DOI 10.1137/1034115; Harris AT, 2006, CYTOM PART A, V69A, P872, DOI 10.1002/cyto.a.20309; Hu XL, 2018, ADV OPT MATER, V6, DOI 10.1002/adom.201800293; Jie JS, 2006, NANO LETT, V6, P1887, DOI 10.1021/nl060867g; Kim CJ, 2011, ADV MATER, V23, P1025, DOI 10.1002/adma.201004034; Kind H, 2002, ADV MATER, V14, P158, DOI 10.1002/1521-4095(20020116)14:2<158::AID-ADMA158>3.0.CO;2-W; Kita DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06773-2; Kurokawa U, 2011, IEEE SENS J, V11, P1556, DOI 10.1109/JSEN.2010.2103054; Kuykendall T, 2007, NAT MATER, V6, P951, DOI 10.1038/nmat2037; Lapray PJ, 2014, SENSORS-BASEL, V14, P21626, DOI 10.3390/s141121626; Long YZ, 2012, CHEM SOC REV, V41, P4560, DOI 10.1039/c2cs15335a; Lu GL, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.010901; Manzardo O, 1999, OPT LETT, V24, P1705, DOI 10.1364/OL.24.001705; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Ning CZ, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.70; Oliver J, 2012, OPT EXPRESS, V20, P2613, DOI 10.1364/OE.20.002613; Pan J, 2012, ADV MATER, V24, P4151, DOI 10.1002/adma.201104996; Ren PY, 2014, ADV MATER, V26, P7444, DOI 10.1002/adma.201402945; Sander D, 2001, SENSOR ACTUAT A-PHYS, V88, P1, DOI 10.1016/S0924-4247(00)00499-4; Savage N, 2009, NAT PHOTONICS, V3, P601, DOI 10.1038/nphoton.2009.185; Stender AS, 2013, CHEM REV, V113, P2469, DOI 10.1021/cr300336e; Tian B, 2009, CHEM SOC REV, V38, P16, DOI 10.1039/b718703n; Tittl A, 2018, SCIENCE, V360, P1105, DOI 10.1126/science.aas9768; Tsivion D, 2011, SCIENCE, V333, P1003, DOI 10.1126/science.1208455; WAHBA G, 1977, SIAM J NUMER ANAL, V14, P651, DOI 10.1137/0714044; Wang Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08994-5; Wolffenbuttel RF, 2004, IEEE T INSTRUM MEAS, V53, P197, DOI 10.1109/TIM.2003.821490; Yang T, 2013, OPTIK, V124, P1377, DOI 10.1016/j.ijleo.2012.03.036; Yang Z., 2019, DATA SINGLE NANOWIRE, DOI [10.17863/CAM.43168, DOI 10.17863/CAM.43168]; Yang Z., 2019, DATA SINGLE NANOWIRE; Yang ZY, 2014, NANO LETT, V14, P3153, DOI 10.1021/nl500432m; Yang ZY, 2011, NANO LETT, V11, P5085, DOI 10.1021/nl203529h; Yesilkoy F, 2019, NAT PHOTONICS, V13, P390, DOI 10.1038/s41566-019-0394-6; ZHANG HY, 1995, P SOC PHOTO-OPT INS, V2475, P376, DOI 10.1117/12.211276; Zhang S, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020644; Zhuang XJ, 2012, ADV MATER, V24, P13, DOI 10.1002/adma.201103191	55	158	163	66	419	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1017	+		10.1126/science.aax8814	http://dx.doi.org/10.1126/science.aax8814			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488686	Green Submitted, Green Accepted			2022-12-28	WOS:000484732700044
J	Green, D; Dong, XZ				Green, Dustin; Dong, Xinzhong			A Pungent and Painful Toxin	CELL			English	Editorial Material							ION CHANNELS	In this issue of Cell, King et al. (2019) have discovered a cell penetrating peptide isolated from the venom of the Australian Black Rock scorpion that activates the TRPA1 receptor in a unique way to induce pain. Their findings offer new insights into how animals evolved venoms to target specific ion channel functions.	[Green, Dustin; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Dept Neurosurg,Dept Dermatol,Ctr Sensory Biol, Baltimore, MD 21205 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Green, D; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Dept Neurosurg,Dept Dermatol,Ctr Sensory Biol, Baltimore, MD 21205 USA.; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	dgreen89@jhmi.edu; xdong2@jhmi.edu			NIH [R01NS054791]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R01NS054791.	Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; King JVL, 2019, CELL, V178, P1362, DOI 10.1016/j.cell.2019.07.014; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544	9	2	2	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1279	1281		10.1016/j.cell.2019.08.016	http://dx.doi.org/10.1016/j.cell.2019.08.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31474364	Bronze			2022-12-28	WOS:000483983000004
J	Stewart, AJ; Mosleh, M; Diakonova, M; Arechar, AA; Rand, DG; Plotkin, JB				Stewart, Alexander J.; Mosleh, Mohsen; Diakonova, Marina; Arechar, Antonio A.; Rand, David G.; Plotkin, Joshua B.			Information gerrymandering and undemocratic decisions	NATURE			English	Article							NEWS	People must integrate disparate sources of information when making decisions, especially in social contexts. But information does not always flow freely. It can be constrained by social networks(1-3) and distorted by zealots and automated bots(4). Here we develop a voter game as a model system to study information flow in collective decisions. Players are assigned to competing groups (parties) and placed on an 'influence network' that determines whose voting intentions each player can observe. Players are incentivized to vote according to partisan interest, but also to coordinate their vote with the entire group. Our mathematical analysis uncovers a phenomenon that we call information gerrymandering: the structure of the influence network can sway the vote outcome towards one party, even when both parties have equal sizes and each player has the same influence. A small number of zealots, when strategically placed on the influence network, can also induce information gerrymandering and thereby bias vote outcomes. We confirm the predicted effects of information gerrymandering in social network experiments with n = 2,520 human subjects. Furthermore, we identify extensive information gerrymandering in real-world influence networks, including online political discussions leading up to the US federal elections, and in historical patterns of bill co-sponsorship in the US Congress and European legislatures. Our analysis provides an account of the vulnerabilities of collective decision-making to systematic distortion by restricted information flow. Our analysis also highlights a group-level social dilemma: information gerrymandering can enable one party to sway decisions in its favour, but when multiple parties engage in gerrymandering the group loses its ability to reach consensus and remains trapped in deadlock.	[Stewart, Alexander J.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Mosleh, Mohsen; Arechar, Antonio A.; Rand, David G.] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Diakonova, Marina] Univ Oxford, Environm Change Inst, Oxford, England; [Arechar, Antonio A.] Ctr Res & Teaching Econ CIDE, Aguascalientes, Mexico; [Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Houston System; University of Houston; Massachusetts Institute of Technology (MIT); University of Oxford; University of Pennsylvania	Stewart, AJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	astewar6@central.uh.edu		Stewart, Alexander/0000-0001-5234-3871	Defense Advanced Research Projects Agency NGS2 program [D17AC00005]; Ethics and Governance of Artificial Intelligence Initiative of the Miami Foundation; Templeton World Charity Foundation; John Templeton Foundation; Army Research Office [W911NF-17-1-0083]; David & Lucile Packard Foundation	Defense Advanced Research Projects Agency NGS2 program; Ethics and Governance of Artificial Intelligence Initiative of the Miami Foundation; Templeton World Charity Foundation(Templeton World Charity Foundation); John Templeton Foundation; Army Research Office; David & Lucile Packard Foundation(The David & Lucile Packard Foundation)	We acknowledge funding from the Defense Advanced Research Projects Agency NGS2 program (grant D17AC00005; to A. J. S., J. B. P., M. M., A. A. A. and D. G. R.), the Ethics and Governance of Artificial Intelligence Initiative of the Miami Foundation (to D. G. R.), the Templeton World Charity Foundation and the John Templeton Foundation (to D. G. R.), the Army Research Office (grant W911NF-17-1-0083; to J. B. P.) and the David & Lucile Packard Foundation (to J. B. P.). The views, opinions, and findings expressed are those of the authors and should not be interpreted as representing the official views or policies of the Department of Defense or the US Government.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Bail CA, 2018, P NATL ACAD SCI USA, V115, P9216, DOI 10.1073/pnas.1804840115; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Barbera P, 2015, PSYCHOL SCI, V26, P1531, DOI 10.1177/0956797615594620; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Briatte F, 2016, NETW SCI, V4, P266, DOI 10.1017/nws.2015.31; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Crockett MJ, 2017, NAT HUM BEHAV, V1, P769, DOI 10.1038/s41562-017-0213-3; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Faris R., 2017, PARTISANSHIP PROPAGA; Fowler JH, 2006, SOC NETWORKS, V28, P454, DOI 10.1016/j.socnet.2005.11.003; Gavrilets S, 2017, P NATL ACAD SCI USA, V114, P6068, DOI 10.1073/pnas.1703857114; Guilbeault D, 2018, P NATL ACAD SCI USA, V115, P9714, DOI 10.1073/pnas.1722664115; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998; Lewis JB, 2004, POLIT ANAL, V12, P105, DOI 10.1093/pan/mph015; Matz SC, 2017, P NATL ACAD SCI USA, V114, P12714, DOI 10.1073/pnas.1710966114; Newport F., 2017, GALLUP; Pennycook G, 2019, P NATL ACAD SCI USA, V116, P2521, DOI 10.1073/pnas.1806781116; Pennycook G, 2019, COGNITION, V188, P39, DOI 10.1016/j.cognition.2018.06.011; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Shirado H, 2017, NATURE, V545, P370, DOI 10.1038/nature22332; Stephanopoulos NO, 2015, U CHICAGO LAW REV, V82, P831; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Weber EU, 2011, AM PSYCHOL, V66, P315, DOI 10.1037/a0023253	29	30	30	4	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					117	+		10.1038/s41586-019-1507-6	http://dx.doi.org/10.1038/s41586-019-1507-6			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0KI	31485058				2022-12-28	WOS:000483967700045
J	Dyer, C				Dyer, Clare			Judge rules that doctors can perform caesarean section if woman loses mental capacity	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2019	366								l5370	10.1136/bmj.l5370	http://dx.doi.org/10.1136/bmj.l5370			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX1EI	31481395				2022-12-28	WOS:000485434400007
J	Mahase, E				Mahase, Elisabeth			Medical cannabis: patients turn to private clinics because of NHS void	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												emahase@bmj.com						Barnes M., MED CANNABIS; British Paediatric Neurology Association, 2018, GUID US CANN BAS PRO; DIJK S, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5280; DYER C, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4833; HURLEY R, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4654; National Institute for Health and Care Excellence, 2019, CANN BAS MED PROD DR; NHS, 2018, MED CANN CANN OILS; NHS England, 2018, CANN BAS PROD MED US; NHS England, 2019, BARR ACC CANN BAS PR; Royal College of Physicians, 2018, REC CANN BAS PROD ME; The Medical Cannabis Clinics, 2019, COND SYMPT	11	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2019	366								l5290	10.1136/bmj.l5290	http://dx.doi.org/10.1136/bmj.l5290			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1DI	31477576				2022-12-28	WOS:000485431800005
J	Chau, CH; Steeg, PS; Figg, WD				Chau, Cindy H.; Steeg, Patricia S.; Figg, William D.			Antibody-drug conjugates for cancer	LANCET			English	Review							METASTATIC BREAST-CANCER; ACUTE MYELOID-LEUKEMIA; RELAPSED HODGKIN LYMPHOMA; BRENTUXIMAB VEDOTIN; TRASTUZUMAB EMTANSINE; GEMTUZUMAB OZOGAMICIN; OPEN-LABEL; ADULT PATIENTS; FDA APPROVAL; INTRACELLULAR TRAFFICKING	Antibody-drug conjugates (ADCs) are immunoconjugates comprised of a monoclonal antibody tethered to a cytotoxic drug (known as the payload) via a chemical linker. The ADC is designed to selectively deliver the ultratoxic payload directly to the target cancer cells. To date, five ADCs have received market approval and over 100 are being investigated in various stages of clinical development. In this Therapeutics paper, we review recent clinical experience with the approved ADCs and other promising late-stage candidates on the horizon, following an overview of the biology and chemistry of ADCs and how the individual components of an ADC (antibody [or target], linker and conjugation chemistry, and cytotoxic payload) influence its activity. We briefly discuss opportunities for enhancing ADC efficacy, drug resistance, and future perspectives for this novel antibody-based molecular platform, which has great potential to make a paradigm shift in cancer chemotherapy.	[Chau, Cindy H.; Figg, William D.] NCI, Mol Pharmacol Sect, Genitourinary Malignancies Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Steeg, Patricia S.] NCI, Womens Malignancies Branch, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Steeg, Patricia S.] NCI, Nat Prod Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Figg, WD (corresponding author), NCI, Mol Pharmacol Sect, Genitourinary Malignancies Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	figgw@mail.nih.gov		Figg, William/0000-0003-2428-5613	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA	We thank the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA, for providing research support. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organisations imply endorsement by the US Government.	Amadori S, 2016, J CLIN ONCOL, V34, P972, DOI 10.1200/JCO.2015.64.0060; Amiri-Kordestani L, 2014, CLIN CANCER RES, V20, P4436, DOI 10.1158/1078-0432.CCR-14-0012; Andreev J, 2017, MOL CANCER THER, V16, P681, DOI 10.1158/1535-7163.MCT-16-0658; Bauzon M, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1565859; Beck A, 2017, NAT REV DRUG DISCOV, V16, P315, DOI 10.1038/nrd.2016.268; Behrens CR, 2014, MABS-AUSTIN, V6, P46, DOI 10.4161/mabs.26632; Blumenthal GM, 2013, CLIN CANCER RES, V19, P4911, DOI 10.1158/1078-0432.CCR-13-1212; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Carter PJ, 2018, NAT REV DRUG DISCOV, V17, P197, DOI 10.1038/nrd.2017.227; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Connors JM, 2018, NEW ENGL J MED, V378, P331, DOI 10.1056/NEJMoa1708984; Convention on Pharmaceutical Ingredients, 2018, ANN IND REP 2018; Corbacioglu S, 2019, BIOL BLOOD MARROW TR, V25, P1271, DOI 10.1016/j.bbmt.2019.02.018; Criscitiello C, 2019, EUR J CANCER, V117, P1, DOI 10.1016/j.ejca.2019.04.028; D'Amico L, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-018-0464-1; Damelin M, 2015, PHARM RES-DORDR, V32, P3494, DOI 10.1007/s11095-015-1624-3; Damle NK, 2003, CURR OPIN PHARMACOL, V3, P386, DOI 10.1016/S1471-4892(03)00083-3; Dan N, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020032; de Claro RA, 2012, CLIN CANCER RES, V18, P5845, DOI 10.1158/1078-0432.CCR-12-1803; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Dieras V, 2017, LANCET ONCOL, V18, P732, DOI 10.1016/S1470-2045(17)30312-1; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Frigerio M, 2017, CURR TOP MED CHEM, V17, P3393, DOI 10.2174/1568026618666180118155847; Garg AD, 2017, IMMUNOL REV, V280, P126, DOI 10.1111/imr.12574; Gerber HP, 2016, BIOCHEM PHARMACOL, V102, P1, DOI 10.1016/j.bcp.2015.12.008; Gorovits B, 2013, CANCER IMMUNOL IMMUN, V62, P217, DOI 10.1007/s00262-012-1369-3; Gravanis I, 2016, ONCOLOGIST, V21, P102, DOI 10.1634/theoncologist.2015-0276; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Herrera AF, 2018, BLOOD, V131, P1183, DOI 10.1182/blood-2017-10-811224; Hills RK, 2014, LANCET ONCOL, V15, P986, DOI 10.1016/S1470-2045(14)70281-5; Hoffmann RM, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1395127; Horwitz S, 2019, LANCET, V393, P229, DOI 10.1016/S0140-6736(18)32984-2; Hurvitz SA, 2018, LANCET ONCOL, V19, P115, DOI 10.1016/S1470-2045(17)30716-7; Jain N, 2015, PHARM RES-DORDR, V32, P3526, DOI 10.1007/s11095-015-1657-7; Jen EY, 2018, CLIN CANCER RES, V24, P3242, DOI 10.1158/1078-0432.CCR-17-3179; Kalim M, 2017, DRUG DES DEV THER, V11, P2265, DOI 10.2147/DDDT.S135571; Kantarjian H, 2018, LANCET ONCOL, V19, P240, DOI 10.1016/S1470-2045(18)30011-1; Kantarjian HM, 2019, CANCER-AM CANCER SOC, V125, P2474, DOI 10.1002/cncr.32116; Kantarjian HM, 2017, LANCET HAEMATOL, V4, pE387, DOI 10.1016/S2352-3026(17)30103-5; Kantarjian HM, 2016, NEW ENGL J MED, V375, P740, DOI 10.1056/NEJMoa1509277; Kaplon H, 2019, MABS-AUSTIN, V11, P219, DOI 10.1080/19420862.2018.1556465; Kebriaei P, 2018, BONE MARROW TRANSPL, V53, P449, DOI 10.1038/s41409-017-0019-y; Khera E, 2018, BIODRUGS, V32, P465, DOI 10.1007/s40259-018-0302-5; Krop IE, 2017, LANCET ONCOL, V18, P743, DOI 10.1016/S1470-2045(17)30313-3; Lambert J, 2019, HAEMATOLOGICA, V104, P113, DOI 10.3324/haematol.2018.188888; Li F, 2016, CANCER RES, V76, P2710, DOI 10.1158/0008-5472.CAN-15-1795; Li JY, 2016, CANCER CELL, V29, P117, DOI 10.1016/j.ccell.2015.12.008; Lu J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040561; MacMillan KS, 2009, J MED CHEM, V52, P5771, DOI 10.1021/jm9006214; McCombs JR, 2015, AAPS J, V17, P339, DOI 10.1208/s12248-014-9710-8; Nagayama A, 2017, TARGET ONCOL, V12, P719, DOI 10.1007/s11523-017-0535-0; Norsworthy KJ, 2018, ONCOLOGIST, V23, P1103, DOI 10.1634/theoncologist.2017-0604; Perez EA, 2017, J CLIN ONCOL, V35, P141, DOI 10.1200/JCO.2016.67.4887; Peters C, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150089; Petersdorf SH, 2013, BLOOD, V121, P4854, DOI 10.1182/blood-2013-01-466706; Pfeifer M, 2015, LEUKEMIA, V29, P1578, DOI 10.1038/leu.2015.48; Prince HM, 2017, LANCET, V390, P555, DOI 10.1016/S0140-6736(17)31266-7; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Ramchandren R, 2019, CLIN CANCER RES, V25, P1718, DOI 10.1158/1078-0432.CCR-18-2435; Rios-Doria J, 2017, CANCER RES, V77, P2686, DOI 10.1158/0008-5472.CAN-16-2854; Ritchie M, 2013, MABS-AUSTIN, V5, P13, DOI 10.4161/mabs.22854; Ryan Q, 2008, ONCOLOGIST, V13, P1114, DOI 10.1634/theoncologist.2008-0816; Sau S, 2019, CANCERS, V11, DOI 10.3390/cancers11020232; Senter PD, 2012, NAT BIOTECHNOL, V30, P631, DOI 10.1038/nbt.2289; Sharma V., 2018, CPHI ANN REPORT 2018; Sjogren S, 1998, J CLIN ONCOL, V16, P462; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Staudacher AH, 2019, MOL CANCER THER, V18, P335, DOI 10.1158/1535-7163.MCT-18-0842; Staudacher AH, 2017, BRIT J CANCER, V117, P1736, DOI 10.1038/bjc.2017.367; Storz U, 2015, MABS-AUSTIN, V7, P989, DOI 10.1080/19420862.2015.1082019; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Szot C, 2018, J CLIN INVEST, V128, P2927, DOI 10.1172/JCI120481; Tai YT, 2014, BLOOD, V123, P3128, DOI 10.1182/blood-2013-10-535088; Taksin AL, 2007, LEUKEMIA, V21, P66, DOI 10.1038/sj.leu.2404434; Thomas A, 2016, LANCET ONCOL, V17, pE254, DOI 10.1016/S1470-2045(16)30030-4; Thorson JS, 2000, CURR PHARM DESIGN, V6, P1841, DOI 10.2174/1381612003398564; Thuss-Patience PC, 2017, LANCET ONCOL, V18, P640, DOI 10.1016/S1470-2045(17)30111-0; Tian F, 2014, P NATL ACAD SCI USA, V111, P1766, DOI 10.1073/pnas.1321237111; Tsuchikama K, 2018, PROTEIN CELL, V9, P33, DOI 10.1007/s13238-016-0323-0; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Vernieri C, 2019, CRIT REV ONCOL HEMAT, V139, P53, DOI 10.1016/j.critrevonc.2019.05.001; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Wynne J, 2019, BLOOD ADV, V3, P96, DOI 10.1182/bloodadvances.2018026211; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410	87	228	234	45	252	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					793	804		10.1016/S0140-6736(19)31774-X	http://dx.doi.org/10.1016/S0140-6736(19)31774-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT6UW	31478503				2022-12-28	WOS:000483011400032
J	Baldrich, P; Meyers, BC				Baldrich, Patricia; Meyers, Blake C.			Bacteria send messages to colonize plant roots	SCIENCE			English	Editorial Material									[Baldrich, Patricia; Meyers, Blake C.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Meyers, Blake C.] Univ Missouri Columbia, Div Plant Sci, Columbia, MO 65211 USA	Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Columbia	Baldrich, P (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	pbaldrich@danforthcenter.org; bmeyers@danforthcenter.org	Baldrich, Patricia/AAD-9833-2019; Meyers, Blake/B-6535-2012	Baldrich, Patricia/0000-0003-4669-6632; Meyers, Blake/0000-0003-3436-6097	National Science Foundation (IOS award) [1842698]	National Science Foundation (IOS award)(National Science Foundation (NSF))	We acknowledge the support of the National Science Foundation (IOS award 1842698).	Baldrich P, 2019, PLANT CELL, V31, P315, DOI 10.1105/tpc.18.00872; Cai Q, 2018, SCIENCE, V360, P1126, DOI 10.1126/science.aar4142; Lawes J. B., 1889, PHILOS T R SOC BIOL, V180, P1; Loss-Morais G, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-6; Martinez German, 2017, Mob Genet Elements, V7, P1, DOI 10.1080/2159256X.2017.1393490; Martinez G, 2017, NUCLEIC ACIDS RES, V45, P5142, DOI 10.1093/nar/gkx103; QUISPEL A, 1954, ACTA BOT NEERL, V3, P495; Ren B, 2019, SCIENCE, V365, P919, DOI 10.1126/science.aav8907; Tsikou D, 2018, SCIENCE, V362, P233, DOI 10.1126/science.aat6907	9	4	4	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					868	869		10.1126/science.aay7101	http://dx.doi.org/10.1126/science.aay7101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467211				2022-12-28	WOS:000483975800028
J	Zhou, RB; Han, BR; Xia, CL; Zhuang, XW				Zhou, Ruobo; Han, Boran; Xia, Chenglong; Zhuang, Xiaowei			Membrane-associated periodic skeleton is a signaling platform for RTK transactivation in neurons	SCIENCE			English	Article							RECEPTOR; SPECTRIN; PROTEIN; KINASE; ACTIN; CYTOSKELETON; ORGANIZATION; ENDOCYTOSIS; ACTIVATION; MICROSCOPY	Actin, spectrin, and related molecules form a membrane-associated periodic skeleton (MPS) in neurons. The function of the MPS, however, remains poorly understood. Using super-resolution imaging, we observed that G protein-coupled receptors (GPCRs), cell adhesion molecules (CAMs), receptor tyrosine kinases (RTKs), and related signaling molecules were recruited to the MPS in response to extracellular stimuli, resulting in colocalization of these molecules and RTK transactivation by GPCRs and CAMs, giving rise to extracellular signal-regulated kinase (ERK) signaling. Disruption of the MPS prevented such molecular colocalizations and downstream ERK signaling. ERK signaling in turn caused calpain-dependent MPS degradation, providing a negative feedback that modulates signaling strength. These results reveal an important functional role of the MPS and establish it as a dynamically regulated platform for GPCR-and CAM-mediated RTK signaling.	[Zhou, Ruobo; Han, Boran; Xia, Chenglong; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhou, Ruobo; Han, Boran; Xia, Chenglong; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhou, Ruobo; Han, Boran; Xia, Chenglong; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Xia, Chenglong/AAD-4704-2019	Xia, Chenglong/0000-0002-5895-6342; Zhou, Ruobo/0000-0001-8628-0282; Han, Boran/0000-0001-9567-7062	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by the National Institutes of Health. R.Z. is an HHMI Fellow of the Life Sciences Research Foundation. X.Z. is a Howard Hughes Medical Institute investigator.	Albrecht D, 2016, J CELL BIOL, V215, P37, DOI 10.1083/jcb.201603108; Asimaki O, 2011, J NEUROCHEM, V116, P866, DOI 10.1111/j.1471-4159.2010.07030.x; Bennett V, 2016, CURR TOP MEMBR, V77, P143, DOI 10.1016/bs.ctm.2015.10.001; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; Bossi M, 2008, NANO LETT, V8, P2463, DOI 10.1021/nl801471d; Bugaj LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7898; Cattaneo F, 2014, INT J MOL SCI, V15, P19700, DOI 10.3390/ijms151119700; Chao HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072032; Coutts AA, 2001, J NEUROSCI, V21, P2425; D'Este E, 2017, P NATL ACAD SCI USA, V114, pE191, DOI 10.1073/pnas.1619553114; D'Este E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22741; D'Este E, 2015, CELL REP, V10, P1246, DOI 10.1016/j.celrep.2015.02.007; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Han BR, 2017, P NATL ACAD SCI USA, V114, pE6678, DOI 10.1073/pnas.1705043114; Hauser M, 2018, CELL REP, V24, P1512, DOI 10.1016/j.celrep.2018.07.005; He J, 2016, P NATL ACAD SCI USA, V113, P6029, DOI 10.1073/pnas.1605707113; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang CYM, 2018, ANN NY ACAD SCI, V1420, P46, DOI 10.1111/nyas.13718; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Krishnamurty R, 2013, NAT CHEM BIOL, V9, P43, DOI [10.1038/NCHEMBIO.1118, 10.1038/nchembio.1118]; Latham V., 2003, HDB CELL SIGNALING, V3, P293; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Nedrelow JH, 2003, J BIOL CHEM, V278, P7735, DOI 10.1074/jbc.M210988200; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Richter KN, 2018, EMBO J, V37, P139, DOI 10.15252/embj.201695709; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Robinson RH, 2013, J NEUROIMMUNE PHARM, V8, P1239, DOI 10.1007/s11481-013-9485-1; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Son H, 2002, BIOCHEM BIOPH RES CO, V298, P262, DOI 10.1016/S0006-291X(02)02453-1; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; WANG DS, 1994, BIOCHEM BIOPH RES CO, V203, P29, DOI 10.1006/bbrc.1994.2144; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Winterflood CM, 2015, BIOPHYS J, V109, P3, DOI 10.1016/j.bpj.2015.05.026; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010; Zhong GS, 2014, ELIFE, V3, DOI 10.7554/eLife.04581	48	54	54	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					929	+		10.1126/science.aaw5937	http://dx.doi.org/10.1126/science.aaw5937			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0NL	31467223	Green Accepted			2022-12-28	WOS:000483975800049
J	Iaccarino, MA; Zafonte, RD; Roy, ED; Wojtowicz, M				Iaccarino, Mary A.; Zafonte, Ross D.; Roy, Emily D.; Wojtowicz, Magdalena			Case 27-2019: A 16-Year-Old Girl with Head Trauma during a Sailboat Race	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPORTS-RELATED CONCUSSION; BRAIN-INJURY; RECOMMENDATIONS; REHABILITATION; EDUCATION; PREDICTORS; MANAGEMENT; DIZZINESS; SYMPTOMS; CHILDREN	A 16-year-old girl was seen in the sports concussion clinic because of headache, dizziness, balance problems, fatigue, irritability, and difficulties with sleep and concentration after she had head trauma during a sailboat race. A diagnosis and management decisions were made.	[Iaccarino, Mary A.; Zafonte, Ross D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Roy, Emily D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Phys Therapy, Boston, MA 02115 USA; [Iaccarino, Mary A.; Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Iaccarino, Mary A.; Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Brigham & Womens Hosp, Boston, MA 02115 USA; [Iaccarino, Mary A.; Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Wojtowicz, Magdalena] York Univ, Dept Psychol, Toronto, ON, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; York University - Canada	Iaccarino, MA (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iaccarino, MA (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA.; Iaccarino, MA (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Brigham & Womens Hosp, Boston, MA 02115 USA.; Iaccarino, MA (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.							American College of Rehabilitative Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bernstein JPK, 2019, APPL NEUROPSYCH-ADUL, V26, P275, DOI 10.1080/23279095.2017.1416471; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dispenza F, 2011, AM J OTOLARYNG, V32, P376, DOI 10.1016/j.amjoto.2010.07.009; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Hansson EE, 2004, CLIN REHABIL, V18, P558, DOI 10.1191/0269215504cr771oa; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kim JS, 2014, NEW ENGL J MED, V370, P1138, DOI 10.1056/NEJMcp1309481; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leddy JJ, 2019, JAMA PEDIAT; LumbaBrown A., 2018, JAMA PEDIAT, V172; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Morris Saint-Aaron, 2014, Neurosurgery, V75 Suppl 4, pS96, DOI 10.1227/NEU.0000000000000465; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM, V3rd; Quinn PO, 2014, PRIM CARE COMPANION, V16; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	40	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2019	381	9					863	871		10.1056/NEJMcpc1900590	http://dx.doi.org/10.1056/NEJMcpc1900590			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IV7FE	31461598				2022-12-28	WOS:000484431200014
J	Li, DF; Lee, K; Wang, BY; Osada, M; Crossley, S; Lee, HR; Cui, Y; Hikita, Y; Hwang, HY				Li, Danfeng; Lee, Kyuho; Wang, Bai Yang; Osada, Motoki; Crossley, Samuel; Lee, Hye Ryoung; Cui, Yi; Hikita, Yasuyuki; Hwang, Harold Y.			Superconductivity in an infinite-layer nickelate	NATURE			English	Article							METAL-INSULATOR-TRANSITION; PEROVSKITE; NDNIO3; FILMS; PR; LA	The discovery of unconventional superconductivity in (La,Ba)(2)CuO4 (ref.(1)) has motivated the study of compounds with similar crystal and electronic structure, with the aim of finding additional superconductors and understanding the origins of copper oxide superconductivity. Isostructural examples include bulk superconducting Sr2RuO4 (ref.(2)) and surface-electron-doped Sr2IrO4, which exhibits spectroscopic signatures consistent with a superconducting gap(3,4), although a zero-resistance state has not yet been observed. This approach has also led to the theoretical investigation of nickelates(5,6), as well as thin-film heterostructures designed to host superconductivity. One such structure is the LaAlO3/LaNiO3 superlattice(7-9), which has been recently proposed for the creation of an artificially layered nickelate heterostructure with a singly occupied d(x2-y2) band. The absence of superconductivity observed in previous related experiments has been attributed, at least in part, to incomplete polarization of the e(g) orbitals(10). Here we report the observation of superconductivity in an infinite-layer nickelate that is isostructural to infinite-layer copper oxides(11-13). Using soft-chemistry topotactic reduction(14-20), NdNiO2 and Nd0.8Sr0.2NiO2 single-crystal thin films are synthesized by reducing the perovskite precursor phase. Whereas NdNiO2 exhibits a resistive upturn at low temperature, measurements of the resistivity, critical current density and magnetic-field response of Nd0.8Sr0.2NiO2 indicate a superconducting transition temperature of about 9 to 15 kelvin. Because this compound is a member of a series of reduced layered nickelate crystal structures(21-23), these results suggest the possibility of a family of nickelate superconductors analogous to copper oxides(24) and pnictides(25).	[Li, Danfeng; Lee, Kyuho; Wang, Bai Yang; Osada, Motoki; Crossley, Samuel; Lee, Hye Ryoung; Cui, Yi; Hikita, Yasuyuki; Hwang, Harold Y.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Li, Danfeng; Crossley, Samuel; Hwang, Harold Y.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Lee, Kyuho; Wang, Bai Yang] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Osada, Motoki; Lee, Hye Ryoung; Cui, Yi] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; Stanford University	Li, DF; Hwang, HY (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.; Li, DF; Hwang, HY (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	denverli@stanford.edu; hyhwang@stanford.edu	Li, Denver/GQI-4096-2022; Hikita, Yasuyuki/N-5969-2019; Osada, Motoki/AAB-9020-2022; Li, Danfeng/U-6507-2017	Hikita, Yasuyuki/0000-0002-7748-8329; Osada, Motoki/0000-0002-7947-8730; Li, Danfeng/0000-0001-6894-6765	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; Swiss National Science Foundation; Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems Initiative [GBMF4415]; Takenaka Scholarship Foundation	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems Initiative; Takenaka Scholarship Foundation	We thank A. Kapitulnik, S. A. Kivelson, W.-S. Lee, Y. Z. Li, S. Raghu and Z. X. Shen for discussions. This work was supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under contract number DE-AC02-76SF00515. D. L. acknowledges partial support by the Swiss National Science Foundation, and the Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems Initiative through grant number GBMF4415, which also supported S.C. and provided synthesis equipment. M.O. acknowledges partial financial support from the Takenaka Scholarship Foundation.	Anisimov VI, 1999, PHYS REV B, V59, P7901, DOI 10.1103/PhysRevB.59.7901; AZUMA M, 1992, NATURE, V356, P775, DOI 10.1038/356775a0; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Chaloupka J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016404; CHEONG SW, 1994, PHYSICA B, V194, P1087, DOI 10.1016/0921-4526(94)90873-7; CRESPIN M, 1983, J CHEM SOC FARAD T 2, V79, P1181, DOI 10.1039/f29837901181; Disa AS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.026801; Fruchter L, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144529; GARCIAMUNOZ JL, 1995, PHYS REV B, V52, P13563, DOI 10.1103/PhysRevB.52.13563; Han MJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.206804; Hansmann P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.016401; Hayward MA, 2003, SOLID STATE SCI, V5, P839, DOI 10.1016/S1293-2558(03)00111-0; Hayward MA, 1999, J AM CHEM SOC, V121, P8843, DOI 10.1021/ja991573i; He X, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4967004; Hosono H, 2015, PHYSICA C, V514, P399, DOI 10.1016/j.physc.2015.02.020; Ikeda A, 2016, APPL PHYS EXPRESS, V9, DOI 10.7567/APEX.9.061101; Kaneko D, 2009, PHYSICA C, V469, P936, DOI 10.1016/j.physc.2009.05.104; Kawai M, 2010, CRYST GROWTH DES, V10, P2044, DOI 10.1021/cg100178y; Kawai M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3078276; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kim YK, 2016, NAT PHYS, V12, P37, DOI [10.1038/nphys3503, 10.1038/NPHYS3503]; LACORRE P, 1992, J SOLID STATE CHEM, V97, P495, DOI 10.1016/0022-4596(92)90061-Y; Lee KW, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.045104; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Onozuka T, 2016, DALTON T, V45, P12114, DOI 10.1039/c6dt01737a; Poltavets VV, 2006, J AM CHEM SOC, V128, P9050, DOI 10.1021/ja063031o; SIEGRIST T, 1988, NATURE, V334, P231, DOI 10.1038/334231a0; SMITH MG, 1991, NATURE, V351, P549, DOI 10.1038/351549a0; TORRANCE JB, 1992, PHYS REV B, V45, P8209, DOI 10.1103/PhysRevB.45.8209; Yan YJ, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041018; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759; Zhang JJ, 2017, NAT PHYS, V13, P864, DOI [10.1038/NPHYS4149, 10.1038/nphys4149]	33	400	402	66	664	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					624	+		10.1038/s41586-019-1496-5	http://dx.doi.org/10.1038/s41586-019-1496-5			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31462797	Green Submitted			2022-12-28	WOS:000483405500047
J	Crowther, TW; van den Hoogen, J; Wan, J; Mayes, MA; Keiser, AD; Mo, L; Averill, C; Maynard, DS				Crowther, T. W.; van den Hoogen, J.; Wan, J.; Mayes, M. A.; Keiser, A. D.; Mo, L.; Averill, C.; Maynard, D. S.			The global soil community and its influence on biogeochemistry	SCIENCE			English	Review							CARBON-USE EFFICIENCY; MICROBIAL COMMUNITIES; MACROECOLOGICAL PATTERNS; ECTOMYCORRHIZAL FUNGI; NITROGEN; DIVERSITY; DECOMPOSITION; DYNAMICS; RESPIRATION; MODEL	Soil organisms represent the most biologically diverse community on land and govern the turnover of the largest organic matter pool in the terrestrial biosphere. The highly complex nature of these communities at local scales has traditionally obscured efforts to identify unifying patterns in global soil biodiversity and biogeochemistry. As a result, environmental covariates have generally been used as a proxy to represent the variation in soil community activity in global biogeochemical models. Yet over the past decade, broad-scale studies have begun to see past this local heterogeneity to identify unifying patterns in the biomass, diversity, and composition of certain soil groups across the globe. These unifying patterns provide new insights into the fundamental distribution and dynamics of organic matter on land.	[Crowther, T. W.; van den Hoogen, J.; Wan, J.; Mo, L.; Averill, C.; Maynard, D. S.] Swiss Fed Inst Technol, Inst Integrat Biol, Dept Environm Syst Sci, Crowther Lab, Zurich, Switzerland; [Mayes, M. A.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Mayes, M. A.] Oak Ridge Natl Lab, Environm Sci Div, POB 2008, Oak Ridge, TN 37831 USA; [Mayes, M. A.] Oak Ridge Natl Lab, Climate Change Sci Inst, POB 2008, Oak Ridge, TN 37831 USA; [Keiser, A. D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Keiser, A. D.] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Averill, C.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Boston University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Amherst; Boston University	Crowther, TW (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Dept Environm Syst Sci, Crowther Lab, Zurich, Switzerland.	tom.crowther@usys.ethz.ch	Keiser, Ashley/ABG-5969-2021	Keiser, Ashley/0000-0002-4381-4974; van den Hoogen, Johan/0000-0001-6624-8461; Crowther, Thomas/0000-0001-5674-8913; mayes, melanie/0000-0001-6368-9210; Wan, Joe/0000-0001-5950-2353; Maynard, Daniel/0000-0003-0142-9100	DOB Ecology; German Ministry for Economic Cooperation and Development; U.S. Department of Energy (DOE) grant from the Office of Biological and Environmental Research through the Terrestrial Ecosystem Science Scientific Focus Area (TES-SFA) at Oak Ridge National Laboratory (ORNL); DOE Early Career grant; Ambizione Grant from the Swiss National Science Foundation [PZ00P3_179900]	DOB Ecology; German Ministry for Economic Cooperation and Development; U.S. Department of Energy (DOE) grant from the Office of Biological and Environmental Research through the Terrestrial Ecosystem Science Scientific Focus Area (TES-SFA) at Oak Ridge National Laboratory (ORNL)(United States Department of Energy (DOE)); DOE Early Career grant(United States Department of Energy (DOE)); Ambizione Grant from the Swiss National Science Foundation	This research was funded by grants to T.W.C. from DOB Ecology and from the German Ministry for Economic Cooperation and Development. M.A.M. was funded by a U.S. Department of Energy (DOE) grant from the Office of Biological and Environmental Research through the Terrestrial Ecosystem Science Scientific Focus Area (TES-SFA) at Oak Ridge National Laboratory (ORNL) and a DOE Early Career grant. C. A. was supported by Ambizione Grant PZ00P3_179900 from the Swiss National Science Foundation.	Allison SD, 2018, GLOBAL CHANGE BIOL, V24, P2884, DOI 10.1111/gcb.14045; Allison SD, 2017, SOIL BIOL BIOCHEM, V107, P104, DOI 10.1016/j.soilbio.2017.01.001; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Averill C, 2018, GLOBAL CHANGE BIOL, V24, P4544, DOI 10.1111/gcb.14368; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Bahram M, 2018, NATURE, V560, P233, DOI 10.1038/s41586-018-0386-6; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Bastida F, 2018, SCI TOTAL ENVIRON, V640, P18, DOI 10.1016/j.scitotenv.2018.05.288; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Bouskill NJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00364; Bradford MA, 2019, NAT ECOL EVOL, V3, P223, DOI 10.1038/s41559-018-0771-4; Bradford MA, 2017, NAT ECOL EVOL, V1, P1836, DOI 10.1038/s41559-017-0367-4; Bradford MA, 2014, NAT CLIM CHANGE, V4, P625, DOI [10.1038/NCLIMATE2251, 10.1038/nclimate2251]; Cavicchioli R, 2019, NAT REV MICROBIOL, V17, P569, DOI 10.1038/s41579-019-0222-5; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; Crowther TW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00579; Crowther TW, 2014, GLOBAL CHANGE BIOL, V20, P2983, DOI 10.1111/gcb.12565; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; Delgado-Baquerizo M, 2018, SCIENCE, V359, P320, DOI 10.1126/science.aap9516; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; Elgersma KJ, 2011, OECOLOGIA, V167, P733, DOI 10.1007/s00442-011-2022-0; Feinstein LM, 2013, MOL ECOL, V22, P1171, DOI 10.1111/mec.12160; Fichtner A, 2014, SOIL BIOL BIOCHEM, V70, P79, DOI 10.1016/j.soilbio.2013.12.015; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fujita Y, 2014, GLOBAL BIOGEOCHEM CY, V28, P223, DOI 10.1002/2013GB004595; Grant R. F., 2003, GLOBAL BIOGEOCHEM CY, V16, P2; Hararuk O, 2015, GLOBAL CHANGE BIOL, V21, P2439, DOI 10.1111/gcb.12827; Hashimoto S, 2015, BIOGEOSCIENCES, V12, P4121, DOI 10.5194/bg-12-4121-2015; Hawkes CV, 2017, P NATL ACAD SCI USA, V114, P6322, DOI 10.1073/pnas.1620811114; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Kaiser C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9960; Kallenbach CM, 2015, GCB BIOENERGY, V7, P1232, DOI 10.1111/gcbb.12218; Kaminsky LM, 2019, TRENDS BIOTECHNOL, V37, P140, DOI 10.1016/j.tibtech.2018.11.011; Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Lajtha K, 2018, SCI TOTAL ENVIRON, V640, P1112, DOI 10.1016/j.scitotenv.2018.05.388; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li ZL, 2019, GLOBAL CHANGE BIOL, V25, P1078, DOI 10.1111/gcb.14557; Lindahl BD, 2015, NEW PHYTOL, V205, P1443, DOI 10.1111/nph.13201; Luo YQ, 2016, GLOBAL BIOGEOCHEM CY, V30, P40, DOI 10.1002/2015GB005239; Maestre FT, 2015, P NATL ACAD SCI USA, V112, P15684, DOI 10.1073/pnas.1516684112; Mahecha MD, 2010, PATTERN RECOGN LETT, V31, P2309, DOI 10.1016/j.patrec.2010.06.021; Malik AA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01247; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Maynard DS, 2019, NAT MICROBIOL, V4, P846, DOI 10.1038/s41564-019-0361-5; Meiser A, 2014, NEW PHYTOL, V201, P623, DOI 10.1111/nph.12532; Meisner A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00294; Michaelis L, 1913, BIOCHEM Z, V49, P333; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Moorhead DL, 2018, SOIL BIOL BIOCHEM, V125, P261, DOI 10.1016/j.soilbio.2018.07.021; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Noronha MF, 2017, SCI TOTAL ENVIRON, V609, P1064, DOI 10.1016/j.scitotenv.2017.07.159; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Ramirez KS, 2018, NAT MICROBIOL, V3, P189, DOI 10.1038/s41564-017-0062-x; Ramirez KS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1988; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Rubenstein MA, 2017, SOIL BIOL BIOCHEM, V112, P110, DOI 10.1016/j.soilbio.2017.05.005; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Saunois M, 2016, EARTH SYST SCI DATA, V8, P697, DOI 10.5194/essd-8-697-2016; Scheibe TD, 2009, MICROB BIOTECHNOL, V2, P274, DOI 10.1111/j.1751-7915.2009.00087.x; Schlesinger William H., 2013, BIOGEOCHEMISTRY ANAL, DOI [10.1016/C2010-0-66291-2, DOI 10.1016/C2010-0-66291-2, 10.1016/C2010-0-66291-2.]; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Serna-Chavez HM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1162, DOI 10.1111/geb.12070; Shah F, 2016, NEW PHYTOL, V209, P1705, DOI 10.1111/nph.13722; Shi Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04526-9; Sinsabaugh RL, 2013, ECOL LETT, V16, P930, DOI 10.1111/ele.12113; Steidinger BS, 2019, NATURE, V569, P404, DOI 10.1038/s41586-019-1128-0; Strickland MS, 2015, BIOGEOCHEMISTRY, V122, P165, DOI 10.1007/s10533-014-0065-0; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Sulman BN, 2018, BIOGEOCHEMISTRY, V141, P109, DOI 10.1007/s10533-018-0509-z; Sulman BN, 2017, ECOL LETT, V20, P1043, DOI 10.1111/ele.12802; Sulman BN, 2014, NAT CLIM CHANGE, V4, P1099, DOI [10.1038/nclimate2436, 10.1038/NCLIMATE2436]; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Terrer C, 2016, SCIENCE, V353, P72, DOI 10.1126/science.aaf4610; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Todd-Brown K, 2018, BIOGEOSCIENCES, V15, P3659, DOI 10.5194/bg-15-3659-2018; Treseder KK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206441; Treseder KK, 2015, MICROBIOL MOL BIOL R, V79, P243, DOI 10.1128/MMBR.00001-15; Tuomi M, 2009, ECOL MODEL, V220, P3362, DOI 10.1016/j.ecolmodel.2009.05.016; van den Hoogen J, 2019, NATURE, V572, P194, DOI 10.1038/s41586-019-1418-6; van der Wal A, 2015, ECOLOGY, V96, P124, DOI 10.1890/14-0242.1; Waldrop MP, 2006, MICROB ECOL, V52, P470, DOI 10.1007/s00248-006-9100-6; Wang GS, 2015, ISME J, V9, P226, DOI 10.1038/ismej.2014.120; Wang KF, 2017, J ADV MODEL EARTH SY, V9, P2368, DOI 10.1002/2017MS000920; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Waring BG, 2013, ECOL LETT, V16, P887, DOI 10.1111/ele.12125; Wieder WR, 2014, BIOGEOSCIENCES, V11, P3899, DOI 10.5194/bg-11-3899-2014; Wieder WR, 2018, GLOBAL CHANGE BIOL, V24, P1563, DOI 10.1111/gcb.13979; Wieder WR, 2015, NAT GEOSCI, V8, P441, DOI 10.1038/NGEO2413; Wieder WR, 2014, GLOBAL BIOGEOCHEM CY, V28, P211, DOI 10.1002/2013GB004665; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Wubs ERJ, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.107, 10.1038/nplants.2016.107]; Xu XF, 2015, J GEOPHYS RES-BIOGEO, V120, P1315, DOI 10.1002/2015JG002935; Xu XF, 2013, GLOBAL ECOL BIOGEOGR, V22, P737, DOI 10.1111/geb.12029; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Zhao ZY, 2017, EARTHS FUTURE, V5, P715, DOI 10.1002/2016EF000480; Zheng JQ, 2015, ENVIRON SCI TECHNOL, V49, P2132, DOI 10.1021/es504513v; Zhou JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12083; Zhu K, 2018, J ECOL, V106, P524, DOI 10.1111/1365-2745.12918; Zhu Q, 2015, NAT CLIM CHANGE, V5, P705, DOI 10.1038/nclimate2696	114	300	316	193	1026	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		772	+	eaav0550	10.1126/science.aav0550	http://dx.doi.org/10.1126/science.aav0550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS9JH	31439761	Green Submitted			2022-12-28	WOS:000482464000042
J	Sibley, CH				Sibley, Carol Hopkins			Genomic analysis informs malaria evolution	SCIENCE			English	Editorial Material							PLASMODIUM-FALCIPARUM; DIVERSITY; SEQUENCE; AFRICA		[Sibley, Carol Hopkins] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sibley, CH (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	sibley@uw.edu						Amambua-Ngwa A, 2019, SCIENCE, V365, P813, DOI 10.1126/science.aav5427; Bohme Ulrike, 2019, Wellcome Open Res, V4, P58, DOI [10.12688/wellcomeopenres.15194.1, 10.12688/wellcomeopenres.15194.2]; Caye K, 2016, MOL ECOL RESOUR, V16, P540, DOI 10.1111/1755-0998.12471; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghansah A, 2014, SCIENCE, V345, P1297, DOI 10.1126/science.1259423; Henn BM, 2018, CURR OPIN GENET DEV, V53, pIII, DOI 10.1016/j.gde.2018.11.004; Lahr M. M, 1994, EVOL ANTHROPOL, V3, P48, DOI DOI 10.1002/EVAN.1360030206; Li WT, 2017, J BIOINF COMPUT BIOL, V15, DOI 10.1142/S0219720017500172; Loy DE, 2017, INT J PARASITOL, V47, P87, DOI 10.1016/j.ijpara.2016.05.008; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Patin E, 2017, SCIENCE, V356, P543, DOI 10.1126/science.aal1988; Rosenbom S, 2015, MOL PHYLOGENET EVOL, V85, P88, DOI 10.1016/j.ympev.2015.01.005; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	14	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI		752	753		10.1126/science.aay0988	http://dx.doi.org/10.1126/science.aay0988			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439781				2022-12-28	WOS:000482464000027
J	Grubaugh, ND; Saraf, S; Gangavarapu, K; Watts, A; Tan, AL; Oidtman, RJ; Ladner, JT; Oliveira, G; Matteson, NL; Kraemer, MUG; Vogels, CBF; Hentoff, A; Bhatia, D; Stanek, D; Scott, B; Landis, V; Stryker, I; Cone, MR; Kopp, EW; Cannons, AC; Heberlein-Larson, L; White, S; Gillis, LD; Ricciardi, MJ; Kwal, J; Lichtenberger, PK; Magnani, DM; Watkins, DI; Palacios, G; Hamer, DH; Gardner, LM; Perkins, TA; Baele, G; Khan, K; Morrison, A; Isern, S; Michael, SF; Andersen, KG				Grubaugh, Nathan D.; Saraf, Sharada; Gangavarapu, Karthik; Watts, Alexander; Tan, Amanda L.; Oidtman, Rachel J.; Ladner, Jason T.; Oliveira, Glenn; Matteson, Nathaniel L.; Kraemer, Moritz U. G.; Vogels, Chantal B. F.; Hentoff, Aaron; Bhatia, Deepit; Stanek, Danielle; Scott, Blake; Landis, Vanessa; Stryker, Ian; Cone, Marshall R.; Kopp, Edgar W.; Cannons, Andrew C.; Heberlein-Larson, Lea; White, Stephen; Gillis, Leah D.; Ricciardi, Michael J.; Kwal, Jaclyn; Lichtenberger, Paola K.; Magnani, Diogo M.; Watkins, David, I; Palacios, Gustavo; Hamer, Davidson H.; Gardner, Lauren M.; Perkins, T. Alex; Baele, Guy; Khan, Kamran; Morrison, Andrea; Isern, Sharon; Michael, Scott F.; Andersen, Kristian G.		GeoSentinel Surveillance Network	Travel Surveillance and Genomics Uncover a Hidden Zika Outbreak during the Waning Epidemic	CELL			English	Article							ACTIVE COMMUNITY PARTICIPATION; GEOSENTINEL SURVEILLANCE; RETURNED TRAVELERS; AEDES-AEGYPTI; VIRUS-DISEASE; TRANSMISSION; DENGUE; CUBA; CHIKUNGUNYA; PERFORMANCE	The Zika epidemic in the Americas has challenged surveillance and control. As the epidemic appears to be waning, it is unclear whether transmission is still ongoing, which is exacerbated by discrepancies in reporting. To uncover locations with lingering outbreaks, we investigated travel-associated Zika cases to identify transmission not captured by reporting. We uncovered an unreported outbreak in Cuba during 2017, a year after peak transmission in neigh-boring islands. By sequencing Zika virus, we show that the establishment of the virus was delayed by a year and that the ensuing outbreak was sparked by long-lived lineages of Zika virus from other Caribbean islands. Our data suggest that, although mosquito control in Cuba may initially have been effective at mitigating Zika virus transmission, such measures need to be maintained to be effective. Our study highlights how Zika virus may still be ''silently'' spreading and provides a framework for understanding outbreak dynamics.	[Grubaugh, Nathan D.; Vogels, Chantal B. F.; Hentoff, Aaron] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Grubaugh, Nathan D.; Saraf, Sharada; Gangavarapu, Karthik; Oliveira, Glenn; Matteson, Nathaniel L.; Michael, Scott F.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Watts, Alexander; Bhatia, Deepit; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada; [Tan, Amanda L.; Isern, Sharon] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA; [Tan, Amanda L.; Stryker, Ian; Cone, Marshall R.; Kopp, Edgar W.; Cannons, Andrew C.; Heberlein-Larson, Lea] Florida Dept Hlth, Div Dis Control & Hlth Protect, Bur Publ Hlth Labs, Tampa, FL 33612 USA; [Oidtman, Rachel J.; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Oidtman, Rachel J.; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Ladner, Jason T.; Palacios, Gustavo] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA; [Ladner, Jason T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA; [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA 02115 USA; [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA 02115 USA; [Stanek, Danielle; Scott, Blake; Landis, Vanessa; Morrison, Andrea] Florida Dept Hlth, Div Dis Control & Hlth Protect, Bur Epidemiol, Tallahassee, FL 32399 USA; [White, Stephen; Gillis, Leah D.] Florida Dept Hlth, Div Dis Control & Hlth Protect, Bur Publ Hlth Labs, Miami, FL 33125 USA; [Ricciardi, Michael J.; Kwal, Jaclyn; Lichtenberger, Paola K.; Magnani, Diogo M.; Watkins, David, I] Univ Miami, Dept Pathol, Miller Sch Med, Miami, FL 33136 USA; [Magnani, Diogo M.] Univ Massachusetts, MassBiol, Med Sch, Boston, MA 02126 USA; [Hamer, Davidson H.] Boston Univ, Dept Global Hlth, Sch Publ Hlth, Boston, MA 02118 USA; [Hamer, Davidson H.] Boston Med Ctr, Dept Med, Sect Infect Dis, Boston, MA 02118 USA; [Gardner, Lauren M.] UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW 2052, Australia; [Gardner, Lauren M.] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21287 USA; [Baele, Guy] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium; [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON M5B 1T8, Canada; [Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA 92037 USA	Yale University; Scripps Research Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; State University System of Florida; Florida Gulf Coast University; Florida Department of Health; University of Notre Dame; University of Notre Dame; Northern Arizona University; University of Oxford; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Florida Department of Health; Florida Department of Health; University of Miami; University of Massachusetts System; University of Massachusetts Boston; Boston University; Boston Medical Center; University of New South Wales Sydney; Johns Hopkins University; KU Leuven; University of Toronto	Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Grubaugh, ND; Michael, SF; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.	nathan.grubaugh@yale.edu; smichael@fgcu.edu; andersen@scripps.edu	Bhatia, Deepit/AAC-1444-2020; Bhatia, Deepit/ABB-7533-2021; Ladner, Jason/G-3486-2011; Palacios, Gustavo/I-7773-2015; Hamer, Davidson Howes/J-2020-2019; Baele, Guy/R-8157-2017	Bhatia, Deepit/0000-0001-8168-6873; Ladner, Jason/0000-0001-7751-4366; Palacios, Gustavo/0000-0001-5062-1938; Hamer, Davidson Howes/0000-0002-4700-1495; Baele, Guy/0000-0002-1915-7732; Asgeirsson, Hilmir/0000-0003-3869-8021; Grubaugh, Nathan/0000-0003-2031-1933; Magnani, Diogo/0000-0002-1773-2406; Vogels, Chantal/0000-0003-0027-6480; White, Stephen/0000-0002-2112-1560	Arthur J. Schmitt Leadership Fellowship in Science and Engineering; Eck Institute for Global Health Graduate Fellowship; Branco Weiss Fellowship-Society in Science; National Institute of Child Health and Human Development [T32HD040128]; Centers for Disease Control and Prevention [U50CK00189]; Public Health Agency of Canada; Interne Fondsen KU Leuven/Internal Funds KU Leuven [C14/18/094]; RAPID award from the National Science Foundation [DEB 1641130]; Defense Advanced Research Projects Agency [D16AP0014]; NIH NIAID [R01AI099210]; NIH NCATS CTSA [UL1TR002550]; NIAID [U19AI135995, HHSN272201400048C, R21AI137690]; Ray Thomas Foundation; International Society of Travel Medicine; NWO Rubicon [019.181EN. 004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099210, U19AI135995, R21AI137690] Funding Source: NIH RePORTER	Arthur J. Schmitt Leadership Fellowship in Science and Engineering; Eck Institute for Global Health Graduate Fellowship; Branco Weiss Fellowship-Society in Science; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Public Health Agency of Canada; Interne Fondsen KU Leuven/Internal Funds KU Leuven; RAPID award from the National Science Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NCATS CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ray Thomas Foundation; International Society of Travel Medicine; NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Robles-Sikisaka, M. Pauthner, E. Spencer, M. R. Wiley, K. Prieto, S. Taylor, and P. Jack for laboratory support and the ECDC for graciously providing data regarding travel-associated Zika virus infections. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Army, CDC, ECDC, or the FL-DOH. R. J. O. received support from the Arthur J. Schmitt Leadership Fellowship in Science and Engineering and from an Eck Institute for Global Health Graduate Fellowship. M. U. G. K. is supported by The Branco Weiss Fellowship-Society in Science, administered by the ETH Zurich, and acknowledges funding from a training grant from the National Institute of Child Health and Human Development (T32HD040128). C. B. F. V. is supported by NWO Rubicon 019.181EN. 004. GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine, is supported by a cooperative agreement (U50CK00189) from the Centers for Disease Control and Prevention as well as the International Society of Travel Medicine and the Public Health Agency of Canada. G. B. acknowledges support from the Interne Fondsen KU Leuven/Internal Funds KU Leuven under grant agreement C14/18/094. T. A. P. received support from a RAPID award from the National Science Foundation (DEB 1641130) and a Young Faculty Award from the Defense Advanced Research Projects Agency (D16AP0014). S. I. and S. F. M. are supported by NIH NIAID R01AI099210. K. G. A. is a Pew Biomedical Scholar and is supported by NIH NCATS CTSA UL1TR002550, NIAID contract HHSN272201400048C, NIAID R21AI137690, NIAID U19AI135995, and The Ray Thomas Foundation.	Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157; [Anonymous], 2017, REG ZIK EP UPD AM; [Anonymous], 2018, PLOS CURR, DOI DOI 10.3390/V10060327; [Anonymous], 2014, PLOS CURR, DOI DOI 10.3389/FNHUM.2014.00847; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725; Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114; Serrate PCF, 2016, MEDICC REV, V18, P48, DOI 10.37757/MR2016.V18.N4.10; Castro M, 2017, AM J TROP MED HYG, V97, P311, DOI 10.4269/ajtmh.16-0906; Cauchemez S., 2004, EUROSURVEILLANCE, V19; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; CDC, 2018, ZIK TRAV INF; da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; FL DOH, 2017, SINGL CAS LOC TRANSM; FL DOH, 2018, MOSQ BORN DIS SURV; FL DOH, 2017, SEX TRANSM CAS ZIK I; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726; Gorry C, 2016, MEDICC REV, V18, P6, DOI 10.37757/MR2016.V18.N1-2.2; Grubaugh ND, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1618-7; Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2; Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guzman MG, 2009, LANCET, V374, P1660, DOI 10.1016/S0140-6736(09)61975-9; Guzman MG, 2005, SCIENCE, V309, P1495, DOI 10.1126/science.1115177; Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842; Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1; Hill S. C., 2019, BIORXIV, DOI [10.1101/520437, DOI 10.1101/520437]; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004648; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247; Ladner JT, 2019, NAT MED, V25, P206, DOI 10.1038/s41591-019-0345-2; Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91; Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480; Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402; Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568; Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383; Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]; Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769; O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8; PAHO, 2017, COUNTR TERR AUT TRAN; Pan American Health Organization (PAHO), 2017, ZIK EP REP CUB; Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904; Penton M. J., 2018, YOU PLAN TRAVEL CUBA; Phumee A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010030; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Reardon S, 2016, NATURE, V536, P257, DOI 10.1038/536257a; Reuters, 2017, REUTERS; Robles Frances, 2016, NY TIMES; Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618; Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7; Rund SSC, 2018, BIORXIV, DOI [10. 1101/096875, DOI 10.1101/096875]; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Talevich E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-209; Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448; Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115; Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130; Vora S, 2016, NY TIMES; Watts Alexander G, 2018, J Travel Med, V25, DOI 10.1093/jtm/tay132; Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122; Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044; Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273; World Health Organization (WHO), 2016, 5 M EM COMM INT HLTH; Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	94	41	41	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1057	+		10.1016/j.cell.2019.07.018	http://dx.doi.org/10.1016/j.cell.2019.07.018			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442400	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000482191000006
J	Mittelman, K; Burstein, D				Mittelman, Karin; Burstein, David			Tiny Hidden Genes within Our Microbiome	CELL			English	Editorial Material								Exploration of tiny protein-coding sequences within the human microbiome reveals thousands of conserved gene families that have been overlooked by traditional analyses. These small proteins may play key roles in the crosstalk among bacteria within the microbiome and in interactions with their human hosts.	[Mittelman, Karin; Burstein, David] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Mol Cell Biol & Biotechnol, IL-6997801 Tel Aviv, Israel	Tel Aviv University	Burstein, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Sch Mol Cell Biol & Biotechnol, IL-6997801 Tel Aviv, Israel.	davidbur@tauex.tau.ac.il	Burstein, David/Y-7993-2019	Burstein, David/0000-0002-6219-1880				Baumgartner D, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0896-z; Herberg S, 2018, SCIENCE, V361, P1029, DOI 10.1126/science.aat7113; Housman G, 2016, BBA-GENE REGUL MECH, V1859, P31, DOI 10.1016/j.bbagrm.2015.07.017; Makarewich CA, 2017, TRENDS CELL BIOL, V27, P685, DOI 10.1016/j.tcb.2017.04.006; Miravet-Verde S, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188290; Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964; Sberro H, 2019, CELL, V178, P1245, DOI 10.1016/j.cell.2019.07.016; van Heesch S, 2019, CELL, V178, P242, DOI 10.1016/j.cell.2019.05.010; Weaver J, 2019, MBIO, V10, DOI 10.1128/mBio.02819-18; Zhang L, 2019, NAT ECOL EVOL, V3, P679, DOI 10.1038/s41559-019-0822-5	10	1	1	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1034	1035		10.1016/j.cell.2019.07.039	http://dx.doi.org/10.1016/j.cell.2019.07.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442396	Bronze			2022-12-28	WOS:000482191000002
J	Hausenloy, DJ; Kharbanda, RK; Moller, UK; Ramlall, M; Aaroe, J; Butler, R; Bulluck, H; Clayton, T; Dana, A; Dodd, M; Engstrom, T; Evans, R; Lassen, JF; Christensen, EF; Garcia-Ruiz, JM; Gorog, DA; Hjort, J; Houghton, RF; Ibanez, B; Knight, R; Lippert, FK; Lonborg, JT; Maeng, M; Milasinovic, D; More, R; Nicholas, JM; Jensen, LO; Perkins, A; Radovanovic, N; Rakhit, RD; Ravkilde, J; Ryding, AD; Schmidt, MR; Riddervold, IS; Sorensen, HT; Stankovic, G; Varma, M; Webb, I; Terkelsen, CJ; Greenwood, JP; Yellon, DM; Botker, HE				Hausenloy, Derek J.; Kharbanda, Rajesh K.; Moller, Ulla Kristine; Ramlall, Manish; Aaroe, Jens; Butler, Robert; Bulluck, Heerajnarain; Clayton, Tim; Dana, Ali; Dodd, Matthew; Engstrom, Thomas; Evans, Richard; Lassen, Jens Flensted; Christensen, Erika Frischknecht; Manuel Garcia-Ruiz, Jose; Gorog, Diana A.; Hjort, Jakob; Houghton, Richard F.; Ibanez, Borja; Knight, Rosemary; Lippert, Freddy K.; Lonborg, Jacob T.; Maeng, Michael; Milasinovic, Dejan; More, Ranjit; Nicholas, Jennifer M.; Jensen, Lisette Okkels; Perkins, Alexander; Radovanovic, Nebojsa; Rakhit, Roby D.; Ravkilde, Jan; Ryding, Alisdair D.; Schmidt, Michael R.; Riddervold, Ingunn Skogstad; Sorensen, Henrik Toft; Stankovic, Goran; Varma, Madhusudhan; Webb, Ian; Terkelsen, Christian Juhl; Greenwood, John P.; Yellon, Derek M.; Botker, Hans Erik		CONDI-2 ERIC-PPCI Investigators	Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; ISCHEMIA/REPERFUSION INJURY; TASK-FORCE; SIZE; CARDIOPROTECTION; ADJUNCT; LIMB	Background Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote ischaemic conditioning could reduce the incidence of cardiac death and hospitalisation for heart failure at 12 months. Methods We did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia. Patients (age >18 years) with suspected STEMI and who were eligible for PPCI were randomly allocated (1:1, stratified by centre with a permuted block method) to receive standard treatment (including a sham simulated remote ischaemic conditioning intervention at UK sites only) or remote ischaemic conditioning treatment (intermittent ischaemia and reperfusion applied to the arm through four cycles of 5-min inflation and 5-min deflation of an automated cuff device) before PPCI. Investigators responsible for data collection and outcome assessment were masked to treatment allocation. The primary combined endpoint was cardiac death or hospitalisation for heart failure at 12 months in the intention-to-treat population. This trial is registered with ClinicalTrials.gov (NCT02342522) and is completed. Findings Between Nov 6, 2013, and March 31, 2018, 5401 patients were randomly allocated to either the control group (n=2701) or the remote ischaemic conditioning group (n=2700). After exclusion of patients upon hospital arrival or loss to follow-up, 2569 patients in the control group and 2546 in the intervention group were included in the intention-to-treat analysis. At 12 months post-PPCI, the Kaplan-Meier-estimated frequencies of cardiac death or hospitalisation for heart failure (the primary endpoint) were 220 (8.6%) patients in the control group and 239 (9.4%) in the remote ischaemic conditioning group (hazard ratio 1.10 [95% CI 0.91-1.32], p=0.32 for intervention versus control). No important unexpected adverse events or side effects of remote ischaemic conditioning were observed. Interpretation Remote ischaemic conditioning does not improve clinical outcomes (cardiac death or hospitalisation for heart failure) at 12 months in patients with STEMI undergoing PPCI. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.	[Hausenloy, Derek J.; Ramlall, Manish; Yellon, Derek M.] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Rakhit, Roby D.] UCL, Royal Free Hosp London, London, England; [Rakhit, Roby D.] UCL, Inst Cardiovasc Sci, London, England; [Hausenloy, Derek J.] Univ Coll London Hosp, Natl Inst Hlth Res Biomed Res Ctr, Res & Dev, London, England; [Hausenloy, Derek J.] Duke Natl Univ Singapore Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Hausenloy, Derek J.] Natl Heart Ctr, Natl Heart Res Inst Singapore, Singapore, Singapore; [Hausenloy, Derek J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Hausenloy, Derek J.] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Mexico; [Kharbanda, Rajesh K.] Oxford Univ Hosp Natl Hlth Serv Trust, Oxford Heart Ctr, Oxford, England; [Kharbanda, Rajesh K.] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Moller, Ulla Kristine; Lassen, Jens Flensted; Maeng, Michael; Schmidt, Michael R.; Terkelsen, Christian Juhl; Botker, Hans Erik] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Ramlall, Manish] Univ Hosp Southampton Natl Hlth Serv Fdn Trust, Southampton, Hants, England; [Aaroe, Jens; Ravkilde, Jan] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Butler, Robert] Royal Stoke Univ Hosp, Dept Cardiol, Univ Hosp North Midlands, Stoke On Trent, Staffs, England; [Bulluck, Heerajnarain; Ryding, Alisdair D.] Norfolk & Norwich Univ Hosp, Dept Cardiol, Norwich, Norfolk, England; [Clayton, Tim; Dodd, Matthew; Evans, Richard; Knight, Rosemary; Nicholas, Jennifer M.; Perkins, Alexander] London Sch Hyg & Trop Med, Clin Trials Unit, London, England; [Clayton, Tim; Dodd, Matthew; Evans, Richard; Knight, Rosemary; Nicholas, Jennifer M.; Perkins, Alexander] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Dana, Ali] Portsmouth Hosp Natl Hlth Serv Trust, Portsmouth, Hants, England; [Engstrom, Thomas; Lonborg, Jacob T.] Univ Copenhagen, Dept Cardiol, Rigshosp, Copenhagen, Denmark; [Christensen, Erika Frischknecht; Riddervold, Ingunn Skogstad] Cent Denmark Reg, Prehosp Emergency Med Serv, Aarhus, Denmark; [Manuel Garcia-Ruiz, Jose] Hosp Univ Cabuenes, Inst Invest Sanitaria Principado Asturias, Oviedo, Spain; [Manuel Garcia-Ruiz, Jose; Ibanez, Borja] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Manuel Garcia-Ruiz, Jose] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain; [Gorog, Diana A.] East & North Hertfordshire Natl Hlth Serv Trust, Dept Cardiol, Lister Hosp, Stevenage, Herts, England; [Gorog, Diana A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Hjort, Jakob] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Houghton, Richard F.] Serv Atenc Med Urgencia Asturias, Oviedo, Spain; [Ibanez, Borja] Ctr Invest Biomed Red Cardiovasc, Madrid, Spain; [Ibanez, Borja] IIS Fdn Jimenez Diaz Univ Hosp, Madrid, Spain; [Lippert, Freddy K.] Capital Reg Denmark, Prehosp Emergency Med Serv, Copenhagen, Denmark; [Milasinovic, Dejan] Univ Belgrade, Dept Cardiol, Clin Ctr Serbia, Fac Med, Belgrade, Serbia; [Radovanovic, Nebojsa; Stankovic, Goran] Univ Belgrade, Cardiol Clin, Clin Ctr Serbia, Fac Med, Belgrade, Serbia; [Radovanovic, Nebojsa] Univ Belgrade, Emergency Ctr, Clin Ctr Serbia, Fac Med, Belgrade, Serbia; [Stankovic, Goran] Univ Belgrade, Dept Diagnost, Clin Ctr Serbia, Fac Med, Belgrade, Serbia; [Stankovic, Goran] Univ Belgrade, Catheterizat Labs, Clin Ctr Serbia, Fac Med, Belgrade, Serbia; [More, Ranjit] Blackpool Teaching Hosp Natl Hlth Serv Fdn Trust, Lancashire Cardiac Ctr, Blackpool, England; [Jensen, Lisette Okkels] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Varma, Madhusudhan] North Cumbria Univ Hosp Natl Hlth Serv Trust, Ctr Heart, Carlisle, PA USA; [Webb, Ian] Kings Coll Hosp London, Kings Hlth Partnership, London, England; [Greenwood, John P.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Greenwood, John P.] Leeds Teaching Hosp Natl Hlth Serv Trust, Leeds, W Yorkshire, England	University of London; University College London; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; National Heart Centre Singapore; National University of Singapore; Tecnologico de Monterrey; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Royal Stoke University Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Portsmouth Hospitals NHS Trust; Rigshospitalet; University of Copenhagen; Hospital de Cabuenes; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Lister Hospital; Imperial College London; Aarhus University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Fundacion Jimenez Diaz; Clinical Centre of Serbia; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Southern Denmark; Odense University Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; King's Health Partners; University of Leeds	Hausenloy, DJ (corresponding author), UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England.; Botker, HE (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark.	d.hausenloy@ucl.ac.uk; haboet@rm.dk	Farag, Mohamed/X-1076-2019; Wittrock, Daniel/ABA-7511-2021; Bueno, Hector/I-3910-2015; Ibáñez, Borja/J-6993-2014; Lassen, Jens Flensted/AAY-2127-2021; Yellon, Derek M/ABD-5110-2021; terkelsen, christian/ABD-6294-2021; Bulluck, Heeraj/AAB-7669-2022; Christensen, Erika Frischknecht/H-8753-2017; DEL VALLE, RAQUEL/AFM-9143-2022; Sorensen, Henrik Toft/Z-6181-2019; Stankovic, Goran/Q-8507-2019; Maeng, Michael/AAY-2135-2021; DEL VALLE FERNANDEZ, RAQUEL/GMW-9829-2022; Avanzas, Pablo/B-6811-2008; Bulluck, Heeraj/H-7425-2019	Farag, Mohamed/0000-0003-0811-7679; Wittrock, Daniel/0000-0003-0034-0876; Bueno, Hector/0000-0003-0277-7596; Ibáñez, Borja/0000-0002-5036-254X; Lassen, Jens Flensted/0000-0001-7972-9192; Christensen, Erika Frischknecht/0000-0003-3673-9694; DEL VALLE, RAQUEL/0000-0001-7891-2913; Sorensen, Henrik Toft/0000-0003-4299-7040; Stankovic, Goran/0000-0002-9414-0885; Maeng, Michael/0000-0002-4310-6433; DEL VALLE FERNANDEZ, RAQUEL/0000-0001-7891-2913; Avanzas, Pablo/0000-0002-4958-6108; Bulluck, Heeraj/0000-0002-1985-1783; MAthur, Anthony/0000-0001-7941-9653; Sorensen, Rikke/0000-0001-9238-6681; Clayton, Tim/0000-0002-1266-3288; Gomes de Oliveira, Joana Maria/0000-0001-8723-670X; Perkins, Alexander/0000-0002-9817-2390; Yellon, Derek/0000-0001-7791-9320; terkelsen, christian juhl/0000-0003-0205-9551; Spinthakis, Nikolaos/0000-0002-1146-3655; Jamal, Zahra/0000-0002-3817-6795; Andersen, Grethe/0000-0001-6807-2500; Brogan, Richard/0000-0003-2265-0488; Gorog, Diana/0000-0002-9286-1451; Greenwood, John/0000-0002-2861-0914; Dodd, Matthew/0000-0002-6207-6604; Riddervold, Ingunn Skogstad/0000-0002-2335-9134; Bijsterveld, Petra/0000-0002-9257-5850; Mehmedbegovic, Zlatko/0000-0001-6400-1828; Bidle, Amanda/0000-0002-3292-0763; Copas, Andrew/0000-0001-8968-5963; Neubauer, Stefan/0000-0001-9017-5645; Botker, Hans Erik/0000-0001-6358-8962; Hausenloy, Derek/0000-0003-0729-4956; Lasica, Ratko/0000-0001-9033-5995; Jensen, Lisette Okkels/0000-0002-4838-2429; Cotton, James/0000-0001-6548-2723	British Heart Foundation [CS/14/3/31002, FS/10/039/28270]; University College London Hospitals/University College London Biomedical Research Centre clinical research grant; Danish Innovation Foundation [11-108354, 11-115818]; Novo Nordisk Foundation [NNF13OC0007447, NNF14OC0013337, NNF15OC0016674]; TrygFonden [109624]; National Institute for Health Research (NIHR) Biomedical Research Centre at University College London Hospitals; Duke-National University Singapore Medical School; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist-Senior Investigator scheme [NMRC/CSA-SI/0011/2017]; Singapore Ministry of Health's National Medical Research Council under its Collaborative Centre Grant scheme [NMRC/CGAug16C006]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2016-T2-2-021]; Oxford NIHR Biomedical Centre; NIHR infrastructure at Leeds; COST Action EU-CARDIOPROTECTION [CA16225]; COST (European Cooperation in Science and Technology); MRC [MC_G1002673] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); University College London Hospitals/University College London Biomedical Research Centre clinical research grant; Danish Innovation Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); TrygFonden; National Institute for Health Research (NIHR) Biomedical Research Centre at University College London Hospitals(National Institute for Health Research (NIHR)); Duke-National University Singapore Medical School; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist-Senior Investigator scheme(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Health's National Medical Research Council under its Collaborative Centre Grant scheme(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); Oxford NIHR Biomedical Centre; NIHR infrastructure at Leeds; COST Action EU-CARDIOPROTECTION(European Cooperation in Science and Technology (COST)); COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The ERIC-PPCI trial was funded by a British Heart Foundation clinical study grant (grant number CS/14/3/31002) and a University College London Hospitals/University College London Biomedical Research Centre clinical research grant. The CONDI-2 trial was funded by Danish Innovation Foundation grants (grant numbers 11-108354 and 11-115818), Novo Nordisk Foundation (grant number NNF13OC0007447), and TrygFonden (grant number 109624). DJH was supported by the British Heart Foundation (grant number FS/10/039/28270), the National Institute for Health Research (NIHR) Biomedical Research Centre at University College London Hospitals, the Duke-National University Singapore Medical School, the Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist-Senior Investigator scheme (grant number NMRC/CSA-SI/0011/2017) and its Collaborative Centre Grant scheme (grant number NMRC/CGAug16C006), and the Singapore Ministry of Education Academic Research Fund Tier 2 (grant number MOE2016-T2-2-021). HEB was supported by the Novo Nordisk Foundation (grant numbers NNF14OC0013337, NNF15OC0016674). RKK is supported by the Oxford NIHR Biomedical Centre. The research was also supported by the NIHR infrastructure at Leeds. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health. This article is based on the work of COST Action EU-CARDIOPROTECTION (CA16225) and supported by COST (European Cooperation in Science and Technology). We thank all study personnel for their invaluable assistance.; British Heart Foundation, University College London Hospitals/University College London Biomedical Research Centre, Danish Innovation Foundation, Novo Nordisk Foundation, TrygFonden.	Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Cohen MV, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0653-y; Crimi G, 2013, JACC-CARDIOVASC INTE, V6, P1055, DOI 10.1016/j.jcin.2013.05.011; Davidson SM, 2019, J AM COLL CARDIOL, V73, P89, DOI 10.1016/j.jacc.2018.09.086; Davies WR, 2013, CIRC-CARDIOVASC INTE, V6, P246, DOI 10.1161/CIRCINTERVENTIONS.112.000184; Eitel I, 2015, EUR HEART J, V36, P3049, DOI 10.1093/eurheartj/ehv463; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Gaspar A, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0672-3; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Hausenloy DJ, 2015, EUR HEART J, V36, P1846; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI 10.1016/j.jacc.2014.12.018; Hong DM, 2014, EUR HEART J, V35, P176, DOI 10.1093/eurheartj/eht346; Hougaard KD, 2014, STROKE, V45, P159, DOI 10.1161/STROKEAHA.113.001346; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Johnsen J, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0529-6; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; MacAllister R, 2015, EFFICACY MECH EVALUA; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Prunier F, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0400-y; Rentoukas I, 2010, JACC-CARDIOVASC INTE, V3, P49, DOI 10.1016/j.jcin.2009.10.015; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Sloth AD, 2014, EUR HEART J, V35, P168, DOI 10.1093/eurheartj/eht369; Stiermaier T, 2019, CIRC RES, V124, P1482, DOI 10.1161/CIRCRESAHA.118.314500; Szummer K, 2017, EUR HEART J, V38, P3056, DOI 10.1093/eurheartj/ehx515; Traverse JH, 2019, CIRC RES, V124, P769, DOI 10.1161/CIRCRESAHA.118.314060; Vanezis AP, 2018, HEART, V104, P1955, DOI 10.1136/heartjnl-2018-313091; Verouhis D, 2016, AM HEART J, V181, P66, DOI 10.1016/j.ahj.2016.08.004; White SK, 2015, JACC-CARDIOVASC INTE, V8, P178, DOI 10.1016/j.jcin.2014.05.015; Yang XM, 2013, J CARDIOVASC PHARM T, V18, P251, DOI 10.1177/1074248412467692; Yellon DM, 2015, J AM COLL CARDIOL, V65, P2764, DOI 10.1016/j.jacc.2015.02.082	31	161	163	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2019	394	10207					1415	1424		10.1016/S0140-6736(19)32039-2	http://dx.doi.org/10.1016/S0140-6736(19)32039-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JE5IX	31500849	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000490727200026
J	Tanzi, L; Roccuzzo, SM; Lucioni, E; Fama, F; Fioretti, A; Gabbanini, C; Modugno, G; Recati, A; Stringari, S				Tanzi, L.; Roccuzzo, S. M.; Lucioni, E.; Fama, F.; Fioretti, A.; Gabbanini, C.; Modugno, G.; Recati, A.; Stringari, S.			Supersolid symmetry breaking from compressional oscillations in a dipolar quantum gas	NATURE			English	Article							BOSE-EINSTEIN CONDENSATE; COLLECTIVE EXCITATIONS	Supersolids are exotic materials combining the frictionless flow of a superfluid with the crystal-like periodic density modulation of a solid. The supersolid phase of matter was predicted 50 years ago(1-3) for solid helium(4-8). Ultracold quantum gases have recently been made to exhibit periodic order typical of a crystal, owing to various types of controllable interaction(9-13). A crucial feature of a D-dimensional supersolid is the occurrence of D + 1 gapless excitations, reflecting the Goldstone modes associated with the spontaneous breaking of two continuous symmetries: the breaking of phase invariance, corresponding to the locking of the phase of the atomic wave functions at the origin of superfluid phenomena, and the breaking of translational invariance due to the lattice structure of the system. Such modes have been the object of intense theoretical investigations(1,14-18), but they have not yet been observed experimentally. Here we demonstrate supersolid symmetry breaking through the appearance of two distinct compressional oscillation modes in a harmonically trapped dipolar Bose-Einstein condensate, reflecting the gapless Goldstone excitations of the homogeneous system. We observe that the higher-frequency mode is associated with an oscillation of the periodicity of the emergent lattice and the lower-frequency mode characterizes the superfluid oscillations. This work also suggests the presence of two separate quantum phase transitions between the superfluid, supersolid and solid-like configurations.	[Tanzi, L.; Lucioni, E.; Fama, F.; Fioretti, A.; Gabbanini, C.; Modugno, G.] Sede Secondaria Pisa, INO, CNR, Pisa, Italy; [Tanzi, L.; Lucioni, E.; Modugno, G.] Univ Firenze, LENS, Florence, Italy; [Tanzi, L.; Lucioni, E.; Modugno, G.] Univ Firenze, Dipartimento Fis & Astron, Florence, Italy; [Roccuzzo, S. M.; Recati, A.; Stringari, S.] CNR, INO, BEC Ctr, Trento, Italy; [Roccuzzo, S. M.; Recati, A.; Stringari, S.] Univ Trento, Dipartimento Fis, Trento, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Trento	Modugno, G (corresponding author), Sede Secondaria Pisa, INO, CNR, Pisa, Italy.; Modugno, G (corresponding author), Univ Firenze, LENS, Florence, Italy.; Modugno, G (corresponding author), Univ Firenze, Dipartimento Fis & Astron, Florence, Italy.; Recati, A (corresponding author), CNR, INO, BEC Ctr, Trento, Italy.; Recati, A (corresponding author), Univ Trento, Dipartimento Fis, Trento, Italy.	modugno@lens.unifi.it; alessio.recati@unitn.it	Tanzi, Luca/M-1809-2014; RECATI, ALESSIO/AAE-4794-2021; Recati, Alessio/AAK-2486-2021; Modugno, Giovanni/AAT-9718-2021; Recati, Alessio/J-7566-2015; Modugno, Giovanni/C-3179-2009	Tanzi, Luca/0000-0002-1933-5092; Modugno, Giovanni/0000-0002-4394-8593; Modugno, Giovanni/0000-0002-4394-8593; Gabbanini, Carlo/0000-0002-8348-4041; RECATI, ALESSIO/0000-0002-8682-2034	EC-H2020 research and innovation program [641122-QUIC]; Provincia Autonoma di Trento	EC-H2020 research and innovation program; Provincia Autonoma di Trento(Autonomous Province of Trento)	This work received funding from the EC-H2020 research and innovation program (grant number 641122-QUIC). We acknowledge discussions with R. Citro and J. G. Maloberti and technical assistance from A. Barbini, F. Pardini, M. Tagliaferri and M. Voliani. S.M.R., A.R. and S.S. acknowledge funding from Provincia Autonoma di Trento and the Q@TNinitiative.We acknowledge discussions with the participants of the Stuttgart meeting on 'Perspectives for supersolidity in dipolar droplet arrays'.	Ancilotto F, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033618; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Balibar S, 2010, NATURE, V464, P176, DOI 10.1038/nature08913; Blakie PB, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.021604; Bottcher F, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.011051; Boninsegni M, 2012, REV MOD PHYS, V84, P759, DOI 10.1103/RevModPhys.84.759; Bottcher F., 2019, PREPRINT; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; Chomaz L, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021012; Chomaz L, 2018, NAT PHYS, V14, P442, DOI 10.1038/s41567-018-0054-7; Giorgini S, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063615; Giovanazzi S, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.013621; Guo M, 2019, NATURE, V574, P386, DOI 10.1038/s41586-019-1569-5; Jin DS, 1996, PHYS REV LETT, V77, P420, DOI 10.1103/PhysRevLett.77.420; Josserand C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195301; Kadau H, 2016, NATURE, V530, P194, DOI 10.1038/nature16485; Kim DY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.155301; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kunimi M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060510; Lang J, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa9b4a; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Leonard J, 2017, SCIENCE, V358, P1415, DOI 10.1126/science.aan2608; Leonard J, 2017, NATURE, V543, P87, DOI 10.1038/nature21067; Li JR, 2017, NATURE, V543, P91, DOI 10.1038/nature21431; Li YH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195504; Lima ARP, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.063609; Lu ZK, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.075303; Lucioni E, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.060701; Macri T, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.061602; Matveeva N, 2011, EUR PHYS J D, V65, P219, DOI 10.1140/epjd/e2011-20253-6; Menotti C, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043610; Mewes MO, 1996, PHYS REV LETT, V77, P988, DOI 10.1103/PhysRevLett.77.988; Natale G, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.050402; Nyeki J, 2017, NAT PHYS, V13, P455, DOI [10.1038/nphys4023, 10.1038/NPHYS4023]; Petter D, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.183401; Pitaevskii L., 2011, BOSE EINSTEIN CONDEN; Pupillo G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.223002; Roccuzzo SM, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.041601; Ronen S, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.013623; Saccani S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.175301; Stringari S, 1996, PHYS REV LETT, V77, P2360, DOI 10.1103/PhysRevLett.77.2360; Tanzi L, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.130405; van Bijnen RMW, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.033612; Watanabe H, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.085010; Wenzel M, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.053630	45	91	92	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2019	574	7778					382	+		10.1038/s41586-019-1568-6	http://dx.doi.org/10.1038/s41586-019-1568-6			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JE9DI	31499510	Green Submitted			2022-12-28	WOS:000490988300060
J	Strongman, H; Gadd, S; Matthews, A; Mansfield, KE; Stanway, S; Lyon, AR; dos-Santos-Silva, I; Smeeth, L; Bhaskaran, K				Strongman, Helen; Gadd, Sarah; Matthews, Anthony; Mansfield, Kathryn E.; Stanway, Susannah; Lyon, Alexander R.; dos-Santos-Silva, Isabel; Smeeth, Liam; Bhaskaran, Krishnan			Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases	LANCET			English	Article							BREAST-CANCER; VENOUS THROMBOEMBOLISM; 5-YEAR SURVIVORS; COMPLICATIONS; MANAGEMENT; PREVENTION; GUIDELINES; DIAGNOSIS; MORTALITY; THERAPY	Background The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is scarce on the risks of specific cardiovascular diseases in survivors of a wide range of cancers to inform prevention and management. In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps. Methods For this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to investigate effect modification, and flexible parametric survival models to estimate absolute excess risks over time. Findings Between Jan 1, 1990, and Dec 31, 2015, 126 120 individuals with a diagnosis of a cancer of interest still being followed up at least 1 year later were identified and matched to 630 144 controls. After exclusions, 108 215 cancer survivors and 523 541 controls were included in the main analyses. Venous thromboembolism risk was elevated in survivors of 18 of 20 site-specific cancers compared with that of controls; adjusted hazard ratios (HRs) ranged from 1.72 (95% CI 1.57-1.89) in patients after prostate cancer to 9.72 (5.50-17.18) after pancreatic cancer. HRs decreased over time, but remained elevated more than 5 years after diagnosis. We observed increased risks of heart failure or cardiomyopathy in patients after ten of 20 cancers, including haematological (adjusted HR 1.94, 1.66-2.25, with non-Hodgkin lymphoma; 1.77, 1.50-2.09, with leukaemia; and 3.29, 2.59-4.18, with multiple myeloma), oesophageal (1.96, 1.46-2.64), lung (1.82, 1.52-2.17) kidney (1.73, 1.38-2.17) and ovarian (1.59, 1.19-2.12). Elevated risks of arrhythmia, pericarditis, coronary artery disease, stroke, and valvular heart disease were also observed for multiple cancers, including haematological malignancies. HRs for heart failure or cardiomyopathy and venous thromboembolism were greater in patients without previous cardiovascular disease and in younger patients. However, absolute excess risks were generally greater with increasing age. Increased risks of these outcomes seemed most pronounced in patients who had received chemotherapy. Interpretation Survivors of most site-specific cancers had increased medium-term to long-term risk for one or more cardiovascular diseases compared with that for the general population, with substantial variations between cancer sites. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Strongman, Helen; Gadd, Sarah; Matthews, Anthony; Mansfield, Kathryn E.; dos-Santos-Silva, Isabel; Smeeth, Liam; Bhaskaran, Krishnan] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Gadd, Sarah] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Matthews, Anthony] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Stanway, Susannah] Royal Marsden Hosp, Breast Unit, London, England; [Lyon, Alexander R.] Imperial Coll London, Royal Brompton Hosp, London, England; [Lyon, Alexander R.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Smeeth, Liam] Hlth Data Res UK, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Leeds; Karolinska Institutet; Royal Marsden NHS Foundation Trust; Imperial College London; Royal Brompton Hospital; Imperial College London	Bhaskaran, K (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	Matthews, Anthony/H-9441-2019; Smeeth, Liam/X-5862-2018	Matthews, Anthony/0000-0002-1290-271X; Smeeth, Liam/0000-0002-9168-6022; Bhaskaran, Krishnan/0000-0001-5364-8757; Strongman, Helen/0000-0001-8739-4601; Lawson, Claire/0000-0003-0127-5236	Wellcome Trust; Royal Society	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	Wellcome Trust and Royal Society.	Abdel-Qadir H, 2019, JNCI-J NATL CANCER I, V111, P854, DOI 10.1093/jnci/djy218; Ameijide A, 2019, CLIN TRANSL ONCOL, V21, P1014, DOI 10.1007/s12094-018-02015-5; Arhi CS, 2018, CANCER EPIDEMIOL, V57, P148, DOI 10.1016/j.canep.2018.08.009; Armenian SH, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.3920; Armenian SH, 2016, J CLIN ONCOL, V34, P1122, DOI 10.1200/JCO.2015.64.0409; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Boekel NB, 2016, INT J RADIAT ONCOL, V94, P1061, DOI 10.1016/j.ijrobp.2015.11.040; Bowles EJA, 2012, JNCI-J NATL CANCER I, V104, P1293, DOI 10.1093/jnci/djs317; Brand JS, 2017, CANCER-AM CANCER SOC, V123, P468, DOI 10.1002/cncr.30364; Cancer Research UK, 2019, CANC STAT UK; Chang HM, 2017, J AM COLL CARDIOL, V70, P2552, DOI 10.1016/j.jacc.2017.09.1095; Chidwick K, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4947-8; Cronin-Fenton DP, 2010, BRIT J CANCER, V103, P947, DOI 10.1038/sj.bjc.6605883; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Henson KE, 2016, CIRCULATION, V134, P1519, DOI 10.1161/CIRCULATIONAHA.116.022514; HERRETT E, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2350; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, P2099, DOI DOI 10.1136/BMJ.J2099; Jordan JH, 2014, BREAST CANCER RES TR, V146, P401, DOI 10.1007/s10549-014-3021-8; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Lenneman CG, 2016, CIRC RES, V118, P1008, DOI 10.1161/CIRCRESAHA.115.303633; Mehta LS, 2018, CIRCULATION, V137, pE30, DOI 10.1161/CIR.0000000000000556; Natalis A, 2019, EUR HEART J, V40, P562, DOI 10.1093/eurheartj/ehy858; NHS Digital, 2018, READ COD; Padmanabhan S, 2019, EUR J EPIDEMIOL, V34, P91, DOI 10.1007/s10654-018-0442-4; Pareek N, 2018, EUR J HEART FAIL, V20, P1721, DOI 10.1002/ejhf.1292; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Power NE, 2016, BLADDER CANCER, V2, P27, DOI 10.3233/BLC-150034; Riihimaki M, 2012, ANN ONCOL, V23, P604, DOI 10.1093/annonc/mdr160; Rugbjerg K, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju110; Schoormans D, 2018, CANCER MED-US, V7, P4952, DOI 10.1002/cam4.1754; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Tweed EJ, 2018, PUBLIC HEALTH, V154, P1, DOI 10.1016/j.puhe.2017.10.005; UK Data Service Census Support, 2019, DEPR DAT; Virani SA, 2016, CAN J CARDIOL, V32, P831, DOI 10.1016/j.cjca.2016.02.078; Walker AJ, 2016, BLOOD, V127, P849, DOI 10.1182/blood-2015-01-625582; Walter FM, 2015, BRIT J GEN PRACT, V65, pE761, DOI 10.3399/bjgp15X687409; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Zamorano J, 2016, EUR HEART J-CARD IMG, V17, P9, DOI 10.1093/ehjci/jev282	42	166	169	3	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					1041	1054		10.1016/S0140-6736(19)31674-5	http://dx.doi.org/10.1016/S0140-6736(19)31674-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ4FC	31443926	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000487038700031
J	Chou, R; Ballantyne, J; Lembke, A				Chou, Roger; Ballantyne, Jane; Lembke, Anna			Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHRONIC PAIN; THERAPY		[Chou, Roger] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Ballantyne, Jane] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,Mail Code BB 1421, Seattle, WA 98195 USA; [Lembke, Anna] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; Stanford University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu						Busse JW, 2018, JAMA-J AM MED ASSOC, V320, P2448, DOI 10.1001/jama.2018.18472; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Darnall BD, 2018, JAMA INTERN MED, V178, P707, DOI 10.1001/jamainternmed.2017.8709; Dowell D, 2017, ANN INTERN MED, V167, P208, DOI 10.7326/M17-1402; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Frank JW, 2017, ANN INTERN MED, V167, P181, DOI 10.7326/M17-0598; Oregon Pain Guidance Clinical Advisory Group Tapering Workgroup, 2019, TAP GUID TOOLS CLIN; Stanford Center for Continuing Medical Education, 2019, TAP PAT CHRON OP THE; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; White JM, 2004, ADDICT BEHAV, V29, P1311, DOI 10.1016/j.addbeh.2004.06.007	10	23	23	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					427	+		10.7326/M19-1488	http://dx.doi.org/10.7326/M19-1488			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31450240				2022-12-28	WOS:000486101400017
J	Izzo, MC; Bronner, G; Shields, CL				Izzo, Michael C.; Bronner, Guri; Shields, Carol L.			Rapidly Progressive Vision Loss in a Patient With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTASIS	A 67-year-old white female patient with metastatic breast cancer presented with 2 weeks of painless reduced vision in her right eye (OD), without headache, photophobia, diplopia, or eye pain, with placoid yellow choroidal lesions with ill-defined borders and subretinal fluid in each eye (OU). What is the diagnosis and what would you do next?	[Izzo, Michael C.; Shields, Carol L.] Thomas Jefferson Univ, Wills Eye Hosp, Ocular Oncol Serv, Philadelphia, PA 19107 USA; [Izzo, Michael C.] Reading Hosp Med Ctr, Dept Med, W Reading, PA USA; [Bronner, Guri] Berks Eye Phys & Surg Ltd, Reading, PA USA	Jefferson University	Shields, CL (corresponding author), Wills Eye Hosp & Res Inst, Ocular Oncol Serv, 840 Walnut St,Ste 1440, Philadelphia, PA 19107 USA.	carolshields@gmail.com			Eye Tumor Research Foundation	Eye Tumor Research Foundation	Support provided, in part, by the Eye Tumor Research Foundation (Dr Shields).	Augustine H, 2014, CAN J OPHTHALMOL, V49, P458, DOI 10.1016/j.jcjo.2014.06.008; Esmaeli B, 2003, CANCER, V98, P504, DOI 10.1002/cncr.11527; Horgan N, 2010, CURR OPIN OPHTHALMOL, V21, P233, DOI 10.1097/ICU.0b013e3283386687; Maudgil A, 2015, EYE, V29, P707, DOI 10.1038/eye.2015.21; NELSON CC, 1983, AM J OPHTHALMOL, V95, P788, DOI 10.1016/0002-9394(83)90066-1; Rudoler SB, 1997, J CLIN ONCOL, V15, P1244, DOI 10.1200/JCO.1997.15.3.1244; Shields CL, 2018, MIDDLE EAST AFR J OP, V25, P81, DOI 10.4103/meajo.MEAJO_6_18; Shields CL, 2012, RETINA-J RET VIT DIS, V32, P1363, DOI 10.1097/IAE.0b013e31824d09a8; Tang R, 1997, EYE, V11, P295, DOI 10.1038/eye.1997.64; Walkhom B, 2000, NEW ENGL J MED, V343, P740, DOI 10.1056/NEJM200009073431015	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1098	1099		10.1001/jama.2019.12691	http://dx.doi.org/10.1001/jama.2019.12691			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31436796				2022-12-28	WOS:000488821100023
J	Weinberg, DN; Papillon-Cavanagh, S; Chen, HF; Yue, Y; Chen, X; Rajagopalan, KN; Horth, C; McGuire, JT; Xu, XJ; Nikbakht, H; Lemiesz, AE; Marchione, DM; Marunde, MR; Meiners, MJ; Cheek, MA; Keogh, MC; Bareke, E; Djedid, A; Harutyunyan, AS; Jabado, N; Garcia, BA; Li, HT; Allis, CD; Majewski, J; Lu, C				Weinberg, Daniel N.; Papillon-Cavanagh, Simon; Chen, Haifen; Yue, Yuan; Chen, Xiao; Rajagopalan, Kartik N.; Horth, Cynthia; McGuire, John T.; Xu, Xinjing; Nikbakht, Hamid; Lemiesz, Agata E.; Marchione, Dylan M.; Marunde, Matthew R.; Meiners, Matthew J.; Cheek, Marcus A.; Keogh, Michael-Christopher; Bareke, Eric; Djedid, Anissa; Harutyunyan, Ashot S.; Jabado, Nada; Garcia, Benjamin A.; Li, Haitao; Allis, C. David; Majewski, Jacek; Lu, Chao			The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape	NATURE			English	Article							DE-NOVO METHYLATION; LYSINE 36; MUTATIONS; H3; NSD1; GENE; DIMETHYLATION; TRANSCRIPTION; OVERGROWTH; GENOME	Enzymes that catalyse CpG methylation in DNA, including the DNA methyltransferases 1 (DNMT1), 3A (DNMT3A) and 3B (DNMT3B), are indispensable for mammalian tissue development and homeostasis(1-4). They are also implicated in human developmental disorders and cancers(5-8), supporting the critical role of DNA methylation in the specification and maintenance of cell fate. Previous studies have suggested that post-translational modifications of histones are involved in specifying patterns of DNA methyltransferase localization and DNA methylation at promoters and actively transcribed gene bodies(9-11). However, the mechanisms that control the establishment and maintenance of intergenic DNA methylation remain poorly understood. Tatton-Brown-Rahman syndrome (TBRS) is a childhood overgrowth disorder that is defined by germline mutations in DNMT3A. TBRS shares clinical features with Sotos syndrome (which is caused by haploinsufficiency of NSD1, a histone methyltransferase that catalyses the dimethylation of histone H3 at K36 (H3K36me2)(8,12,13)), which suggests that there is a mechanistic link between these two diseases. Here we report that NSD1-mediated H3K36me2 is required for the recruitment of DNMT3A and maintenance of DNA methylation at intergenic regions. Genome-wide analysis shows that the binding and activity of DNMT3A colocalize with H3K36me2 at non-coding regions of euchromatin. Genetic ablation of Nsd1 and its paralogue Nsd2 in mouse cells results in a redistribution of DNMT3A to H3K36me3-modified gene bodies and a reduction in the methylation of intergenic DNA. Blood samples from patients with Sotos syndrome and NSD1-mutant tumours also exhibit hypomethylation of intergenic DNA. The PWWP domain of DNMT3A shows dual recognition of H3K36me2 and H3K36me3 in vitro, with a higher binding affinity towards H3K36me2 that is abrogated by TBRS-derived missense mutations. Together, our study reveals a trans-chromatin regulatory pathway that connects aberrant intergenic CpG methylation to human neoplastic and developmental overgrowth.	[Weinberg, Daniel N.; Lemiesz, Agata E.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA; [Papillon-Cavanagh, Simon; Chen, Haifen; Horth, Cynthia; Nikbakht, Hamid; Bareke, Eric; Djedid, Anissa; Harutyunyan, Ashot S.; Jabado, Nada; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Yue, Yuan; Li, Haitao] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol,Sch Med, Beijing Frontier Res Ctr Biol Struct,MOE Key Lab, Tsinghua Peking Joint Ctr Life Sci,Dept Basic Med, Beijing, Peoples R China; [Chen, Xiao; McGuire, John T.; Xu, Xinjing; Lu, Chao] Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY 10027 USA; [Chen, Xiao; McGuire, John T.; Xu, Xinjing; Lu, Chao] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY 10027 USA; [Rajagopalan, Kartik N.] Columbia Univ, Div Pulm Allergy & Crit Care Med, Irving Med Ctr, New York, NY USA; [Marchione, Dylan M.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marchione, Dylan M.; Garcia, Benjamin A.] Univ Penn, Penn Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marunde, Matthew R.; Meiners, Matthew J.; Cheek, Marcus A.; Keogh, Michael-Christopher] EpiCypher Inc, Durham, NC USA; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	Rockefeller University; McGill University; Tsinghua University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; McGill University; McGill University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA.; Majewski, J (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Lu, C (corresponding author), Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY 10027 USA.; Lu, C (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY 10027 USA.	alliscd@rockefeller.edu; jacek.majewski@mcgill.ca; cl3684@cumc.columbia.edu	Chen, Xiao/ABG-4082-2021; Jabado, Nada/AAN-4026-2020; Papillon-Cavanagh, Simon/AAS-8749-2020; Li, Haitao/B-2668-2012; Harutyunyan, Ashot/M-3528-2014	Chen, Xiao/0000-0001-5059-8846; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Lu, Chao/0000-0003-0982-8122; Patriotis, Agata Lemiesz/0000-0002-8237-975X; Weinberg, Daniel/0000-0002-6718-3724; Li, Haitao/0000-0001-6741-293X; Bareke, Eric/0000-0003-3928-7160; Harutyunyan, Ashot/0000-0002-9050-9315; Nikbakht, Hamid/0000-0003-0209-5667	US National Institutes of Health (NIH) [P01CA196539, R00CA212257, T32GM007739, F30CA224971, T32GM008275, R44GM116584, R44GM117683]; Rockefeller University; Cedars Cancer Foundation; NIH/NCI Cancer Center Support Grant [P30CA013696]; Genome Canada; Genome Quebec; Institute for Cancer Research of the CIHR, McGill University; Montreal Children's Hospital Foundation; National Natural Science Foundation of China [31725014, 91753203]; Damon Runyon Foundation [DFS-28-18]; AACR Gertrude B. Elion Cancer Research Grant; Fond de la Recherche du Quebec en Sante; Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award; NATIONAL CANCER INSTITUTE [F30CA224971, P01CA196539, P30CA013696, R00CA212257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM117683, R44GM116584, T32GM008275, T32GM007739] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Cedars Cancer Foundation; NIH/NCI Cancer Center Support Grant; Genome Canada(Genome Canada); Genome Quebec; Institute for Cancer Research of the CIHR, McGill University; Montreal Children's Hospital Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Damon Runyon Foundation; AACR Gertrude B. Elion Cancer Research Grant; Fond de la Recherche du Quebec en Sante; Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Bestor and members of the Lu, Majewski and Allis laboratories for critical reading of the manuscript. This research was supported by US National Institutes of Health (NIH) grants (P01CA196539 to N.J., B.A.G., C.D.A. and J.M.; R00CA212257 to C.L.; T32GM007739 and F30CA224971 to D.N.W.; T32GM008275 to D.M.M.; and R44GM116584 and R44GM117683 to M.-C.K.), the Rockefeller University (C.D.A.) and the Cedars Cancer Foundation (N. J.). The research was funded in part through the NIH/NCI Cancer Center Support Grant P30CA013696 and used the HICCC Flow Cytometry Shared Resource. This work was performed within the context of the I-CHANGE consortium and was supported by funding from Genome Canada, Genome Quebec, the Institute for Cancer Research of the CIHR, McGill University and the Montreal Children's Hospital Foundation. B.A.G. is funded by a Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award; H.L. is funded by the National Natural Science Foundation of China (31725014 and 91753203); C.L. is the Giannandrea Family Dale F. Frey Breakthrough Scientist of the Damon Runyon Foundation (DFS-28-18), a Pew-Stewart Scholar for Cancer Research and supported by an AACR Gertrude B. Elion Cancer Research Grant; N.J. is a member of the Penny Cole Laboratory and the recipient of a Chercheur Boursier, Chaire de Recherche Award from the Fond de la Recherche du Quebec en Sante; and S.P.-C. and A.S.H. are supported by a studentship and postdoctoral fellowship from the Fond de la Recherche du Quebec en Sante, respectively.	Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Boulard M, 2015, NAT GENET, V47, P479, DOI 10.1038/ng.3272; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorcas W. G., 2015, AM J THEORETICAL APP, V4, P581, DOI [10.11648/j.ajtas.20150406.30, DOI 10.11648/J.AJTAS.20150406.30]; Doynova MD, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0122-1; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Heyn P, 2019, NAT GENET, V51, P96, DOI 10.1038/s41588-018-0274-x; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Jeffries AR, 2019, GENOME RES, V29, P1057, DOI 10.1101/gr.243584.118; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Papillon-Cavanagh S, 2017, NAT GENET, V49, P180, DOI 10.1038/ng.3757; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quintana RM, 2013, J INVEST DERMATOL, V133, P239, DOI 10.1038/jid.2012.245; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rinaldi L, 2017, ELIFE, V6, DOI [10.7554/elife.21697, 10.7554/eLife.21697]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sendzikaite G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09713-w; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Sidoli S., 2016, JOVE-J VIS EXP, V111, P54112, DOI DOI 10.3791/54112.HTTPS://WWW.NCBI.NLM.NIH.G0V/PUBMED/27286567; Tatton-Brown K, 2017, AM J HUM GENET, V100, P725, DOI 10.1016/j.ajhg.2017.03.010; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yuan ZF, 2018, J PROTEOME RES, V17, P2533, DOI 10.1021/acs.jproteome.8b00133	44	188	189	13	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					281	+		10.1038/s41586-019-1534-3	http://dx.doi.org/10.1038/s41586-019-1534-3			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31485078	Green Accepted			2022-12-28	WOS:000485415400059
J	Flaus, A; Owen-Hughes, T				Flaus, Andrew; Owen-Hughes, Tom			The Face of Chromatin Variants	CELL			English	Editorial Material							SRCAP	A developmental program affecting human face shape is shown by Greenberg et al. (2019) to hinge on the ability to distinguish a single methyl group between two histone variant isoforms and the action of the chromatin-remodeling enzyme SRCAP. This challenges researchers to link atomic structure to a morphological defect.	[Flaus, Andrew] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Biochem, Galway, Ireland; [Owen-Hughes, Tom] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	Ollscoil na Gaillimhe-University of Galway; University of Dundee	Owen-Hughes, T (corresponding author), Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	t.a.owenhughes@dundee.ac.uk		Owen-Hughes, Tom/0000-0002-0618-8185	MRC [MR/S021647/1]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	T.O.-H. is funded by MRC grant MR/S021647/1.	Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Friedmann HC, 2004, PERSPECT BIOL MED, V47, P47, DOI 10.1353/pbm.2004.0007; Giaimo BD, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0274-9; Greenberg RS, 2019, CELL, V178, P1421, DOI 10.1016/j.cell.2019.08.002; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Horikoshi N, 2013, ACTA CRYSTALLOGR D, V69, P2431, DOI 10.1107/S090744491302252X; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Nacev BA, 2019, NATURE, V567, P473, DOI 10.1038/s41586-019-1038-1; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Willhoft O, 2018, SCIENCE, V362, P199, DOI 10.1126/science.aat7716	10	0	0	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1284	1286		10.1016/j.cell.2019.08.024	http://dx.doi.org/10.1016/j.cell.2019.08.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491382	Bronze, Green Published			2022-12-28	WOS:000483983000006
J	Gong, DY; Dai, XH; Jih, J; Liu, YT; Bi, GQ; Sun, R; Zhou, ZH				Gong, Danyang; Dai, Xinghong; Jih, Jonathan; Liu, Yun-Tao; Bi, Guo-Qiang; Sun, Ren; Zhou, Z. Hong			DNA-Packing Portal and Capsid-Associated Tegument Complexes in the Tumor Herpesvirus KSHV	CELL			English	Article							SIMPLEX-VIRUS TYPE-1; SARCOMA-ASSOCIATED HERPESVIRUS; PROTEIN INTERACTIONS; PACKAGING PROTEIN; ANTIVIRAL DRUGS; UL25 GENE; RESISTANCE; CLEAVAGE; IDENTIFICATION; VISUALIZATION	Assembly of Kaposi's sarcoma-associated herpesvirus (KSHV) begins at a bacteriophage-like portal complex that nucleates formation of an icosahedral capsid with capsid-associated tegument complexes (CATCs) and facilitates translocation of an similar to 150-kb dsDNA genome, followed by acquisition of a pleomorphic tegument and envelope. Because of deviation from icosahedral symmetry, KSHV portal and tegument structures have largely been obscured in previous studies. Using symmetry-relaxed cryo-EM, we determined the in situ structure of the KSHV portal and its interactions with surrounding capsid proteins, CATCs, and the terminal end of KSHV's dsDNA genome. Our atomic models of the portal and capsid/CATC, together with visualization of CATCs' variable occupancy and alternate orientation of CATC-interacting vertex triplexes, suggest a mechanism whereby the portal orchestrates procapsid formation and asymmetric long-range determination of CATC attachment during DNA packaging prior to pleomorphic tegumentation/envelopment. Structure-based mutageneses confirm that a triplex deep binding groove for CATCs is a hotspot that holds promise for antiviral development.	[Gong, Danyang; Dai, Xinghong; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Dai, Xinghong; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Jih, Jonathan; Liu, Yun-Tao; Sun, Ren; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90095 USA; [Liu, Yun-Tao; Bi, Guo-Qiang] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Ctr Integrat Imaging, Hefei 230026, Anhui, Peoples R China; [Liu, Yun-Tao; Bi, Guo-Qiang] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Sun, R; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90095 USA.	rsun@mednet.ucla.edu; hong.zhou@ucla.edu	Zhou, Z Hong/HDN-0747-2022; 刘, 云涛/GQQ-5223-2022; Liu, Yun-Tao/AAI-2288-2019; Bi, Guo-Qiang/E-5075-2013	Liu, Yun-Tao/0000-0003-2577-1859; Dai, Xinghong/0000-0002-4102-3175; Jih, Jonathan/0000-0001-5169-0919; Bi, Guo-Qiang/0000-0001-8735-3818	National Key R&D Program of China [2017YFA0505300, 2016YFA0400900]; NIH [GM071940, DE025567, DE028583, DE027901, AI094386, CA177322, CA091791, DE023591, 1S10RR23057, 1U24GM116792]; NSF [DBI-1338135, DMR-1548924]; UCLA; NATIONAL CANCER INSTITUTE [P01CA177322, R01CA091791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE028583, R01DE027901, R01DE025567, R01DE023591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U24GM116792, R01GM071940] Funding Source: NIH RePORTER	National Key R&D Program of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bioinformatics Center of the University of Science and Technology of China, School of Life Science, for providing supercomputing resources for this project. This research has been supported in part by grants from the National Key R&D Program of China (2017YFA0505300 and 2016YFA0400900 and NIH (GM071940, DE025567, DE028583, DE027901, and AI094386 to Z.H.Z and CA177322, CA091791, and DE023591 to R.S.). We acknowledge the use of resources at the Electron Imaging Center for Nanomachines supported by UCLA and by instrumentation grants from the NIH (1S10RR23057 and 1U24GM116792) and NSF (DBI-1338135 and DMR-1548924).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adelman K, 2001, P NATL ACAD SCI USA, V98, P3086, DOI 10.1073/pnas.061555698; Beard PM, 2002, J VIROL, V76, P4785, DOI 10.1128/JVI.76.10.4785-4791.2002; Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196; Bowman BR, 2006, J VIROL, V80, P2309, DOI 10.1128/JVI.80.5.2309-2317.2006; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Cardone G, 2007, VIROLOGY, V361, P426, DOI 10.1016/j.virol.2006.10.047; Cardone G, 2012, ADV EXP MED BIOL, V726, P423, DOI 10.1007/978-1-4614-0980-9_19; Chang JT, 2007, J VIROL, V81, P2065, DOI 10.1128/JVI.02053-06; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Dai XH, 2018, SCIENCE, V360, P47, DOI 10.1126/science.aao7298; Dai XH, 2018, NATURE, V553, P521, DOI 10.1038/nature25438; Dai XH, 2014, J VIROL, V88, P12694, DOI 10.1128/JVI.01509-14; Deng BB, 2008, J STRUCT BIOL, V161, P419, DOI 10.1016/j.jsb.2007.10.016; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Giffin L, 2014, ADV VIRUS RES, V88, P111, DOI 10.1016/B978-0-12-800098-4.00002-7; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Goldsmith CS, 2004, EMERG INFECT DIS, V10, P320, DOI 10.3201/eid1002.030913; Gong DY, 2017, J VIROL, V91, DOI 10.1128/JVI.00362-17; Gong DY, 2016, CELL HOST MICROBE, V20, P642, DOI 10.1016/j.chom.2016.10.004; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Heming JD, 2017, ADV ANAT EMBRYOL CEL, V223, P119, DOI 10.1007/978-3-319-53168-7_6; Huffman JB, 2017, J VIROL, V91, DOI 10.1128/JVI.00641-17; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu W., 2018, BIORXIV, DOI [10.1101/420604, DOI 10.1101/420604]; Liu YT, 2017, J GEN VIROL, V98, P2837, DOI 10.1099/jgv.0.000903; Lokareddy RK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14310; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; McElwee M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006191; McNab AR, 1998, J VIROL, V72, P1060, DOI 10.1128/JVI.72.2.1060-1070.1998; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Motwani T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700423; Newcomb WW, 2005, J VIROL, V79, P10540, DOI 10.1128/JVI.79.16.10540-10546.2005; NEWCOMB WW, 1994, J VIROL, V68, P6059, DOI 10.1128/JVI.68.9.6059-6063.1994; Ogasawara M, 2001, J VIROL, V75, P1427, DOI 10.1128/JVI.75.3.1427-1436.2001; Owen DJ, 2015, VIRUSES-BASEL, V7, P5084, DOI 10.3390/v7092861; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reusser P, 1996, J HOSP INFECT, V33, P235, DOI 10.1016/S0195-6701(96)90010-9; Rochat RH, 2011, J VIROL, V85, P1871, DOI 10.1128/JVI.01663-10; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Sathish N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00098; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sun L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8548; TATMAN JD, 1994, J GEN VIROL, V75, P1101, DOI 10.1099/0022-1317-75-5-1101; Thurlow JK, 2006, J VIROL, V80, P2118, DOI 10.1128/JVI.80.5.2118-2126.2006; Trus BL, 2001, J VIROL, V75, P2879, DOI 10.1128/JVI.75.6.2879-2890.2001; Vahey MD, 2019, CELL, V176, P281, DOI 10.1016/j.cell.2018.10.056; Walling DM, 2003, J INFECT DIS, V188, P883, DOI 10.1086/378072; Wang JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06078-4; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Wu LJ, 2000, J VIROL, V74, P9646, DOI 10.1128/JVI.74.20.9646-9654.2000; Yang K, 2007, J VIROL, V81, P6419, DOI 10.1128/JVI.00047-07; Yu I, 2018, J STRUCT BIOL, V204, P313, DOI 10.1016/j.jsb.2018.08.004; Yu XK, 2017, SCIENCE, V356, DOI 10.1126/science.aam6892; Zhang X, 2011, J STRUCT BIOL, V175, P253, DOI 10.1016/j.jsb.2011.05.004; Zhou ZH, 2014, STRUCTURE, V22, P1385, DOI 10.1016/j.str.2014.05.019; Zhou ZH, 1998, P NATL ACAD SCI USA, V95, P2778, DOI 10.1073/pnas.95.6.2778	66	27	27	4	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1329	+		10.1016/j.cell.2019.07.035	http://dx.doi.org/10.1016/j.cell.2019.07.035			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31447177	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000483983000010
J	Liu, ZY; Gu, YQ; Chakarov, S; Bleriot, C; Kwok, I; Chen, X; Shin, A; Huang, WJ; Dress, RJ; Dutertre, CA; Schlitzer, A; Chen, JM; Ng, LG; Wang, HL; Liu, ZD; Su, B; Ginhoux, F				Liu, Zhaoyuan; Gu, Yaqi; Chakarov, Svetoslav; Bleriot, Camille; Kwok, Immanuel; Chen, Xin; Shin, Amanda; Huang, Weijie; Dress, Regine J.; Dutertre, Charles-Antoine; Schlitzer, Andreas; Chen, Jinmiao; Ng, Lai Guan; Wang, Honglin; Liu, Zhiduo; Su, Bing; Ginhoux, Florent			Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells	CELL			English	Article							PLASMACYTOID DENDRITIC CELLS; GENE-EXPRESSION; MACROPHAGES; TISSUE; PROGENITORS; REVEALS; LINEAGE; HETEROGENEITY; PRECURSORS; CX(3)CR1	Most tissue-resident macrophage (RTM) populations are seeded by waves of embryonic hematopoiesis and are self-maintained independently of a bone marrow contribution during adulthood. A proportion of RTMs, however, is constantly replaced by blood monocytes, and their functions compared to embryonic RTMs remain unclear. The kinetics and extent of the contribution of circulating monocytes to RTM replacement during homeostasis, inflammation, and disease are highly debated. Here, we identified Ms4a3 as a specific gene expressed by granulocyte-monocyte progenitors (GMPs) and subsequently generated Ms4a3(TdT) reporter, Ms4a3(Cre), and Ms4a3(CreERT2) fate-mapping models. These models traced efficiently monocytes and granulocytes, but no lymphocytes or tissue dendritic cells. Using these models, we precisely quantified the contribution of monocytes to the RTM pool during homeostasis and inflammation. The unambiguous idenification of monocyte-derived cells will permit future studies of their function under any condition.	[Liu, Zhaoyuan; Gu, Yaqi; Chen, Xin; Shin, Amanda; Huang, Weijie; Wang, Honglin; Liu, Zhiduo; Su, Bing; Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China; [Chakarov, Svetoslav; Bleriot, Camille; Kwok, Immanuel; Dress, Regine J.; Dutertre, Charles-Antoine; Chen, Jinmiao; Ng, Lai Guan; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore; [Schlitzer, Andreas] Univ Bonn, LIMES Inst, Myeloid Cell Biol, D-53115 Bonn, Germany; [Su, Bing] Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Sch Med, Shanghai 200025, Peoples R China; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore	Chinese Academy of Sciences; Shanghai Jiao Tong University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Bonn; Shanghai Jiao Tong University	Su, B; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China.; Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.; Su, B (corresponding author), Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Sch Med, Shanghai 200025, Peoples R China.; Ginhoux, F (corresponding author), SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore.	bingsu@sjtu.edu.cn; florent_ginhoux@immunol.a-star.edu.sg	WANG, Honglin/AAJ-2708-2020; Kwok, Immanuel/GXH-0537-2022; Chen, Jinmiao/ABE-5601-2021; Ng, Lai Guan/E-5673-2011; Chakarov, Svetoslav/AAC-9283-2019	WANG, Honglin/0000-0001-6302-6927; Kwok, Immanuel/0000-0003-1523-1621; Ng, Lai Guan/0000-0003-1905-3586; Chakarov, Svetoslav/0000-0002-0665-5417; BLERIOT, Camille/0000-0002-4298-2888; Dress, Regine J./0000-0001-8785-5471; Dutertre, Charles-Antoine/0000-0001-7950-3652	Singapore Immunology Network (SIgN); Singapore National Research Foundation Senior Investigatorship (NRFI) [NRF2016NRF-NRFI001-02]; BMRC [IAF 311006]; BMRC transition funds [H16/99/b0/011]; National Natural Science Foundation of China (NSFC) [31470845, 81430033, 31670896]; Shanghai Science and Technology Commission (SSTC) [13JC1404700]; NSFC [31870871]; SSTC [17PJ1408300, 17ZR1425000]	Singapore Immunology Network (SIgN)(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation Senior Investigatorship (NRFI)(National Research Foundation, Singapore); BMRC(Agency for Science Technology & Research (A*STAR)); BMRC transition funds(Agency for Science Technology & Research (A*STAR)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission (SSTC); NSFC(National Natural Science Foundation of China (NSFC)); SSTC	F.G. is an EMBO YIP awardee and is supported by Singapore Immunology Network (SIgN) core funding as well as a Singapore National Research Foundation Senior Investigatorship (NRFI) NRF2016NRF-NRFI001-02. Some experiments were done with the help of the SIgN Immunomonitoring platform (bioinformatics and immunogenomics platforms supported by a BMRC IAF 311006 grant and BMRC transition funds #H16/99/b0/011). This work was supported by the National Natural Science Foundation of China (NSFC) (31470845, 81430033, and 31670896 to B.S.) and Shanghai Science and Technology Commission (SSTC) (13JC1404700 to B.S.). Zhiduo L. was supported by NSFC (31870871) and SSTC (17PJ1408300 and 17ZR1425000). The authors would like to thank the flow core, sequencing core, and imaging core of Shanghai Institute of Immunology for their support. The authors would also like to thank Insight Editing London for editing the manuscript prior to submission.	Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Donato JL, 2002, J CLIN INVEST, V109, P51, DOI 10.1172/JCI200214025; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hulett MD, 2001, IMMUNOL CELL BIOL, V79, P345, DOI 10.1046/j.1440-1711.2001.01017.x; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Terry RL, 2014, CELL IMMUNOL, V291, P16, DOI 10.1016/j.cellimm.2014.02.008; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	41	194	201	15	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1509	+		10.1016/j.cell.2019.08.009	http://dx.doi.org/10.1016/j.cell.2019.08.009			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491389	Green Submitted, Bronze			2022-12-28	WOS:000483983000022
J	Scattolin, T; Bouayad-Gervais, S; Schoenebeck, F				Scattolin, Thomas; Bouayad-Gervais, Samir; Schoenebeck, Franziska			Straightforward access to N-trifluoromethyl amides, carbamates, thiocarbamates and ureas	NATURE			English	Article							FLUORINE; ACID	Amides and related carbonyl derivatives are of central importance across the physical and life sciences(1,2). As a key biological building block, the stability and conformation of amides affect the structures of peptides and proteins as well as their biological function. In addition, amide-bond formation is one of the most frequently used chemical transformations(3,4). Given their ubiquity, a technology that is capable of modifying the fundamental properties of amides without compromising on stability may have considerable potential in pharmaceutical, agrochemical and materials science. In order to influence the physical properties of organic molecules-such as solubility, lipophilicity, conformation, pK(a) and (metabolic) stability-fluorination approaches have been widely adopted(5-7). Similarly, site-specific modification with isosteres and peptidomimetics(8), or in particular by N-methylation(9), has been used to improve the stability, physical properties, bioactivities and cellular permeabilities of compounds. However, the N-trifluoromethyl carbonyl motif-which combines both N-methylation and fluorination approaches-has not yet been explored, owing to a lack of efficient methodology to synthesize it. Here we report a straightforward method to access N-trifluoromethyl analogues of amides and related carbonyl compounds. The strategy relies on the operationally simple preparation of bench-stable carbamoyl fluoride building blocks, which can be readily diversified to the corresponding N-CF3 amides, carbamates, thiocarbamates and ureas. This method tolerates rich functionality and stereochemistry, and we present numerous examples of highly functionalized compounds-including analogues of widely used drugs, antibiotics, hormones and polymer units.	[Scattolin, Thomas; Bouayad-Gervais, Samir; Schoenebeck, Franziska] Rhein Westfal TH Aachen, Inst Organ Chem, Aachen, Germany	RWTH Aachen University	Schoenebeck, F (corresponding author), Rhein Westfal TH Aachen, Inst Organ Chem, Aachen, Germany.	franziska.schoenebeck@rwth-aachen.de	Schoenebeck, Franziska/D-2463-2014	Schoenebeck, Franziska/0000-0003-0047-0929; Scattolin, Thomas/0000-0002-2950-2456	RWTH Aachen University	RWTH Aachen University	We acknowledge RWTH Aachen University for financial support, and K. Deckers and T. Sperger for assistance and discussions.	Brow DG, 2016, J MED CHEM, V59, P4443, DOI 10.1021/acs.jmedchem.5b01409; Chatterjee J, 2008, ACCOUNTS CHEM RES, V41, P1331, DOI 10.1021/ar8000603; CLARK RD, 1981, J MED CHEM, V24, P1250, DOI 10.1021/jm00142a024; Greenberg A., 2000, AMIDE LINKAGE STRUCT; Hagooly Y, 2009, J ORG CHEM, V74, P8578, DOI 10.1021/jo901560b; Handa M., 2010, Japanese patent, Patent No. [JP2012062284A, 20120622874]; HOLLAND JF, 1966, BLOOD-J HEMATOL, V27, P328, DOI 10.1182/blood.V27.3.328.328; Isanbor C, 2006, J FLUORINE CHEM, V127, P303, DOI 10.1016/j.jfluchem.2006.01.011; KLOTER G, 1979, J AM CHEM SOC, V101, P347; Metcalf L. R., 2000, ULLMANNS ENCY IND CH; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Pajtas D, 2017, J ORG CHEM, V82, P4578, DOI 10.1021/acs.joc.7b00124; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Pharmaceutical Products and Market, STAT; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; RUPPERT I, 1980, TETRAHEDRON LETT, V21, P4893, DOI 10.1016/S0040-4039(00)71148-8; Scattolin T, 2017, ANGEW CHEM INT EDIT, V56, P221, DOI 10.1002/anie.201609480; Schindler CS, 2010, ORG LETT, V12, P4102, DOI 10.1021/ol1016977; Schneider N, 2016, J MED CHEM, V59, P4385, DOI 10.1021/acs.jmedchem.6b00153; SHEPPARD WA, 1965, J AM CHEM SOC, V87, P4338, DOI 10.1021/ja00947a021; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; van der Werf A, 2017, ORG LETT, V19, P2374, DOI 10.1021/acs.orglett.7b00908	24	51	51	7	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					102	+		10.1038/s41586-019-1518-3	http://dx.doi.org/10.1038/s41586-019-1518-3			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31485055				2022-12-28	WOS:000483967700042
J	Pisani, E				Pisani, Elizabeth			How moves towards universal health coverage could encourage poor quality drugs: an essay by Elizabeth Pisani	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pisani, Elizabeth] Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Pisani, Elizabeth] Kings Coll London, London, England	Erasmus University Rotterdam; University of London; King's College London	Pisani, E (corresponding author), Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands.; Pisani, E (corresponding author), Kings Coll London, London, England.	pisani@ternyata.org		Pisani, Elizabeth/0000-0002-3674-631X				AfRx Consulting, 2018, BACKGR RES LANDSC AN; Bate R, 2015, J ECON MANAGE STRAT, V24, P687, DOI 10.1111/jems.12114; Eban Katherine, 2019, BOTTLE LIES INSIDE S; Havel BF, 2014, PRINCIPLES PRACTICE; Hill AM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000571; Karmini N, 2016, VACCINE SCANDAL HIGH; Kesehatan BPJS, 2018, LAP PENG PROGR TAH 2; Kesehatan BPJS, 2019, JUML PES PROGR JKN; Lahore High Court, 2012, PATH NEGL REP JUD IN; Pisani E, 2015, ANTIMICROBIAL REV; Pisani Elizabeth, 2019, Wellcome Open Res, V4, P70, DOI 10.12688/wellcomeopenres.15236.1; Silverman R, 2019, TACKLING TRIPLE TRAN; StatisticsIndonesia, 2019, SURV SOS EK NAS 2018; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization (WHO), 2017, 1 10 MED PROD DEV CO	15	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l5327	10.1136/bmj.l5327	http://dx.doi.org/10.1136/bmj.l5327			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1FO	31484643	Green Published, hybrid			2022-12-28	WOS:000485437600009
J	Gage, BF; Bass, AR; Lin, H; Woller, SC; Stevens, SM; Al-Hammadi, N; Anderson, JL; Li, J; Rodriguez, T; Miller, JP; McMillin, GA; Pendleton, RC; Jaffer, AK; King, CR; Whipple, B; Porche-Sorbet, R; Napoli, L; Merritt, K; Thompson, AM; Hyun, G; Hollomon, W; Barrack, RL; Nunley, RM; Moskowitz, G; Davila-Roman, V; Eby, CS				Gage, Brian F.; Bass, Anne R.; Hannah Lin; Woller, Scott C.; Stevens, Scott M.; Al-Hammadi, Noor; Anderson, Jeffrey L.; Li, Juan; Rodriguez, Tomas, Jr.; Miller, J. Philip; McMillin, Gwendolyn A.; Pendleton, Robert C.; Jaffer, Amir K.; King, Cristi R.; Whipple, Brandi; Porche-Sorbet, Rhonda; Napoli, Lynnae; Merritt, Kerri; Thompson, Anna M.; Hyun, Gina; Hollomon, Wesley; Barrack, Robert L.; Nunley, Ryan M.; Moskowitz, Gerard; Davila-Roman, Victor; Eby, Charles S.			Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; ANTITHROMBOTIC THERAPY; ATRIAL-FIBRILLATION; LONG-TERM; ANTICOAGULATION; PREVENTION; THROMBOPROPHYLAXIS; OUTCOMES; RIVAROXABAN	IMPORTANCE The optimal international normalized ratio (INR) to prevent venous thromboembolism (VTE) in warfarin-treated patients with recent arthroplasty is unknown. OBJECTIVE To determine the safety and efficacy of a target INR of 1.8 vs 2.5 for VTE prophylaxis after orthopedic surgery. DESIGN, SETTING, AND PARTICIPANTS The randomized Genetic Informatics Trial (GIFT) of Warfarin to Prevent Deep Vein Thrombosis enrolled 1650 patients aged 65 years or older initiating warfarin for elective hip or knee arthroplasty at 6 US medical centers. Enrollment began in April 2011 and follow-up concluded in October 2016. INTERVENTIONS In a 2 x 2 factorial design, participantswere randomized to a target INR of 1.8 (n= 823) or 2.5 (n= 827) and to either genotype-guided or clinically guidedwarfarin dosing. For the first 11 days of therapy, open-labelwarfarin dosingwas guided by aweb application. MAIN OUTCOMES AND MEASURES The primary outcomewas the composite of VTE (within 60 days) or death (within 30 days). Participants underwent screening duplex ultrasound postoperatively. The hypothesis was that an INR target of 1.8 would be noninferior to an INR target of 2.5, using a noninferiority margin of 3% for the absolute risk of VTE. Secondary end points were bleeding and INR values of 4 or more. RESULTS Among 1650 patients who were randomized (mean age, 72.1 years; 1049 women [63.6%]; 1502 white [91.0%]), 1597 (96.8%) received at least 1 dose of warfarin and were included in the primary analysis. The rate of the primary composite outcome of VTE or death was 5.1%(41 of 804) in the low-intensity-warfarin group (INR target, 1.8) vs 3.8% (30 of 793) in the standard-treatment-warfarin group (INR target, 2.5), for a difference of 1.3%(1-sided 95% CI, -infinity to 3.05%, P=.06 for noninferiority). Major bleeding occurred in 0.4% of patients in the low-intensity group and 0.9% of patients in the standard-intensity group, for a difference of -0.5%(95% CI, -1.6% to 0.4%). The INR values of 4 or more occurred in 4.5% of patients in the low-intensity group and 12.2% of the standard-intensity group, for a difference of -7.8%(95% CI, -10.5% to -5.1%). CONCLUSIONS AND RELEVANCE Among older patients undergoing hip or knee arthroplasty and receiving warfarin prophylaxis, an international normalized ratio goal of 1.8 compared with 2.5 did not meet the criterion for noninferiority for risk of the composite outcome of VTE or death. However, the trial may have been underpowered to meet this criterion and further research may be warranted.	[Gage, Brian F.; Hannah Lin; Al-Hammadi, Noor; Li, Juan; Rodriguez, Tomas, Jr.; Miller, J. Philip; King, Cristi R.; Whipple, Brandi; Porche-Sorbet, Rhonda; Thompson, Anna M.; Hyun, Gina; Moskowitz, Gerard; Davila-Roman, Victor; Eby, Charles S.] Washington Univ, Dept Med, St Louis, MO USA; [Bass, Anne R.; Merritt, Kerri] Hosp Special Surg, Dept Med, 535 E 70th St, New York, NY 10021 USA; [Hannah Lin] Univ Massachusetts, Dept Med Educ, Worcester, MA 01605 USA; [Woller, Scott C.; Stevens, Scott M.] Intermt Med Ctr, Dept Med, Salt Lake City, UT USA; [Woller, Scott C.; Stevens, Scott M.; Anderson, Jeffrey L.; Pendleton, Robert C.; Napoli, Lynnae] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Anderson, Jeffrey L.] Intermt Med Ctr, Dept Cardiol, Salt Lake City, UT USA; [McMillin, Gwendolyn A.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Jaffer, Amir K.] New York Presbyterian Queens Hosp, Dept Med, New York, NY USA; [Thompson, Anna M.] Univ Cent Florida, Coll Med, Dept Med Educ, Orlando, FL 32816 USA; [Hyun, Gina] Walter Reed Natl Mil Med Ctr, Dept Radiol, Bethesda, MD USA; [Hollomon, Wesley] Hosp Special Surg, Dept Orthoped Surg, 535 E 70th St, New York, NY 10021 USA; [Barrack, Robert L.; Nunley, Ryan M.] Washington Univ St Louis, Dept Orthoped Surg, St Louis, MO USA; [Eby, Charles S.] Washington Univ St Louis, Dept Pathol & Immunol, St Louis, MO USA	Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Worcester; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; State University System of Florida; University of Central Florida; Walter Reed National Military Medical Center; Washington University (WUSTL); Washington University (WUSTL)	Gage, BF (corresponding author), Washington Univ, Gen Med Sci, Campus Box 8005,4523 Clayton Ave, St Louis, MO 63110 USA.	bgage@dom.wustl.edu	Woller, Scott C./AAV-6187-2021; Miller, John J/GZG-5663-2022; Al-Hammadi, Noor/E-5866-2019	Woller, Scott C./0000-0002-2522-2705; Gage, Brian/0000-0002-4727-8742; Al-Hammadi, Noor/0000-0003-1742-6609	NHLBI [R01 HL097036]; National Center for Advancing Translational Sciences through the Washington University Institute of Clinical and Translational Sciences [UL1 TR000448]; Centers for Medicare & Medicaid Services (CMS) [CAG-00400N]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences through the Washington University Institute of Clinical and Translational Sciences; Centers for Medicare & Medicaid Services (CMS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported by grant R01 HL097036 from the NHLBI. Statistical analyses were supported by the grant UL1 TR000448 from the National Center for Advancing Translational Sciences through the Washington University Institute of Clinical and Translational Sciences. Genotyping was supported by grant CAG-00400N from the Centers for Medicare & Medicaid Services (CMS). GenMarkDx loaned the eSensor genotyping platform to the Central Genotyping Laboratory.	Amerongen AV, 2007, ANN NY ACAD SCI, V1098, P1, DOI 10.1196/annals.1384.033; Aynardi M, 2013, J ARTHROPLASTY, V28, P1251, DOI 10.1016/j.arth.2012.12.007; Bern MM, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0062-0; Cieri NE, 2017, PHARMACOTHERAPY, V37, P170, DOI 10.1002/phar.1888; Clark NP, 2013, THROMB RES, V131, P390, DOI 10.1016/j.thromres.2013.02.017; Do EJ, 2012, PHARMACOGENOMICS J, V12, P417, DOI 10.1038/tpj.2011.18; Eckman MH, 2015, THROMB RES, V136, P341, DOI 10.1016/j.thromres.2015.05.020; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 2017, JAMA-J AM MED ASSOC, V318, P1115, DOI 10.1001/jama.2017.11469; Horne BD, 2012, THROMB HAEMOSTASIS, V107, P232, DOI 10.1160/TH11-06-0388; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Jensen CD, 2011, J BONE JOINT SURG BR, V93B, P91, DOI 10.1302/0301-620X.93B1.24987; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Lenzini PA, 2008, J THROMB HAEMOST, V6, P1655, DOI 10.1111/j.1538-7836.2008.03095.x; Lenzini PA, 2007, ANN PHARMACOTHER, V41, P1798, DOI 10.1345/aph.1K197; Man-Son-Hing M, 2005, MED DECIS MAKING, V25, P548, DOI 10.1177/0272989X05280558; Markel DC, 2010, J ARTHROPLASTY, V25, P3, DOI 10.1016/j.arth.2009.07.021; Nam D, 2016, J ARTHROPLASTY, V31, P1299, DOI 10.1016/j.arth.2015.12.007; Nassif ME, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002680; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nordstrom BL, 2011, CURR MED RES OPIN, V27, P1973, DOI 10.1185/03007995.2011.614938; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171; Parvizi J, 2007, J ARTHROPLASTY, V22, P24, DOI 10.1016/j.arth.2007.03.007; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Shehab N, 2016, JAMA-J AM MED ASSOC, V316, P2115, DOI 10.1001/jama.2016.16201; Venker BT, 2017, J ARTHROPLASTY, V32, P645, DOI 10.1016/j.arth.2016.09.033; Wigle P, 2013, AM FAM PHYSICIAN, V87, P556	33	5	5	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2019	322	9					834	842		10.1001/jama.2019.12085	http://dx.doi.org/10.1001/jama.2019.12085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY5MW	31479138	Green Published, Bronze			2022-12-28	WOS:000486437200013
J	Li, S; Wu, LM				Li, Sheng; Wu, Liming			Hair loss and lymphadenopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALOPECIA		[Li, Sheng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [Wu, Liming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, LM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou, Zhejiang, Peoples R China.	wlm@zju.edu.cn	Wu, liming/AAH-5415-2019					Atzori L, 2017, GIORN ITAL DERMAT V, V152, P520, DOI 10.23736/S0392-0488.17.04911-2; Barnett R, 2018, LANCET, V391, P1471, DOI 10.1016/S0140-6736(18)30833-X; Costa MC, 2018, INT J DERMATOL, V57, P593, DOI 10.1111/ijd.13892; Doche I, 2017, SKIN APPENDAGE DISOR, V3, P222, DOI 10.1159/000477415; French P, 2007, BMJ-BRIT MED J, V334, P143, DOI 10.1136/bmj.39085.518148.BE	5	3	3	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l4555	10.1136/bmj.l4555	http://dx.doi.org/10.1136/bmj.l4555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31467132				2022-12-28	WOS:000483892600001
J	Buono, R; Longo, VD				Buono, Roberta; Longo, Valter D.			When Fasting Gets Tough, the Tough Immune Cells Get Going-or Die	CELL			English	Editorial Material							REGENERATION; AUTOIMMUNITY	Cycles of fasting reduce autoimmunity and activate lymphocyte-dependent killing of cancer cells, but the mechanisms remain poorly understood. Three studies in this issue of Cell begin to reveal the drastic and complex effects of fasting and severe calorie restriction on the levels and localization of different immune cells and the mechanisms responsible for them.	[Buono, Roberta; Longo, Valter D.] Univ Southern Calif, Sch Gerontol, Longev Inst, Dept Biol Sci, 3715 McClintock Ave, Los Angeles, CA 90089 USA; [Longo, Valter D.] IFOM FIRC, Inst Mol Oncol, Via Adamello 16, I-20139 Milan, Italy; [Longo, Valter D.] Univ Southern Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California; IFOM - FIRC Institute of Molecular Oncology; University of Southern California	Longo, VD (corresponding author), Univ Southern Calif, Sch Gerontol, Longev Inst, Dept Biol Sci, 3715 McClintock Ave, Los Angeles, CA 90089 USA.; Longo, VD (corresponding author), IFOM FIRC, Inst Mol Oncol, Via Adamello 16, I-20139 Milan, Italy.; Longo, VD (corresponding author), Univ Southern Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	vlongo@usc.edu			NCI NIH HHS [P30 CA014089] Funding Source: Medline; NIA NIH HHS [P01 AG055369] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Cignarella F, 2018, CELL METAB, V27, P1222, DOI 10.1016/j.cmet.2018.05.006; Collins N, 2019, CELL, V178, P1088, DOI 10.1016/j.cell.2019.07.049; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Nagai M, 2019, CELL, V178, P1072, DOI 10.1016/j.cell.2019.07.047; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Rangan P, 2019, CELL REP, V26, P2704, DOI 10.1016/j.celrep.2019.02.019	11	18	20	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1038	1040		10.1016/j.cell.2019.07.052	http://dx.doi.org/10.1016/j.cell.2019.07.052			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442398	Green Accepted, Bronze			2022-12-28	WOS:000482191000004
J	Collins, N; Han, SJ; Enamorado, M; Link, VM; Huang, B; Moseman, EA; Kishton, RJ; Shannon, JP; Dixit, D; Schwab, SR; Hickman, HD; Restifo, NP; McGavern, DB; Schwartzberg, PL; Belkaid, Y				Collins, Nicholas; Han, Seong-Ji; Enamorado, Michel; Link, Verena M.; Huang, Bonnie; Moseman, E. Ashley; Kishton, Rigel J.; Shannon, John P.; Dixit, Dhaval; Schwab, Susan R.; Hickman, Heather D.; Restifo, Nicholas P.; McGavern, Dorian B.; Schwartzberg, Pamela L.; Belkaid, Yasmine			The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction	CELL			English	Article							T-CELL MEMORY; LYMPHOCYTE EGRESS; ADIPOSE-TISSUE; SELF-RENEWAL; METABOLISM; RESERVOIR; EFFECTOR; SUBSETS; BLOOD; MICE	Mammals evolved in the face of fluctuating food availability. How the immune system adapts to transient nutritional stress remains poorly understood. Here, we show that memory T cells collapsed in secondary lymphoid organs in the context of dietary restriction (DR) but dramatically accumulated within the bone marrow (BM), where they adopted a state associated with energy conservation. This response was coordinated by glucocorticoids and associated with a profound remodeling of the BM compartment, which included an increase in T cell homing factors, erythropoiesis, and adipogenesis. Adipocytes, as well as CXCR4-CXCL12 and S1P-S1P(1)R interactions, contributed to enhanced T cell accumulation in BM during DR. Memory T cell homing to BM during DR was associated with enhanced protection against infections and tumors. Together, this work uncovers a fundamental host strategy to sustain and optimize immunological memory during nutritional challenges that involved a temporal and spatial reorganization of the memory pool within ''safe haven'' compartments.	[Collins, Nicholas; Han, Seong-Ji; Enamorado, Michel; Link, Verena M.; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Huang, Bonnie; Schwartzberg, Pamela L.] NIH, Cell Signaling Sect, Lab Immune Syst Biol, Bethesda, MD 20892 USA; [Moseman, E. Ashley; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Kishton, Rigel J.; Restifo, Nicholas P.] NCI, Surg Branch, NIH, Bethesda, MD 20814 USA; [Shannon, John P.; Hickman, Heather D.] NIAID, Viral Immun & Pathogenesis Unit, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dixit, Dhaval; Schwab, Susan R.] NYU, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University	Belkaid, Y (corresponding author), NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Shannon, John/AAY-2423-2020; Restifo, Nicholas Phillip/Z-1614-2019; McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X; Shannon, John/0000-0002-8722-2209; Restifo, Nicholas P./0000-0003-4229-4580; Hickman, Heather/0000-0003-4168-4894; Enamorado Escalona, Neris Michel/0000-0001-7748-454X	Division of Intramural Research of NIAID, NIH [ZIAAI001132, ZIA-AI001133]; NIH [R01AI085166, R01AI123308]; Office of Dietary Supplements Research Scholar program, NIH; Vilcek Scholar Award; Belkaid lab; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123308, R01AI085166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003111] Funding Source: NIH RePORTER	Division of Intramural Research of NIAID, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements Research Scholar program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Scholar Award; Belkaid lab; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Y. B. is supported by the Division of Intramural Research of NIAID (NIAID; ZIAAI001132, ZIA-AI001133), NIH. N. C. and Y. B. were supported by the Office of Dietary Supplements Research Scholar program, NIH. Work in the Schwab lab was supported by NIH grants R01AI085166 and R01AI123308, and a Vilcek Scholar Award to D. D. We thank the Belkaid lab for their suggestions, support, and critical reading of the manuscript and J. Kehr and N. Bouladoux for managing the program of the laboratory. We thank K. Beacht, E. Lewis, and J. LeGrand for technical assistance; the NIAID animal facility staff; T. Hawley (NIAID flow cytometry facility); O. Schwartz (NIAID biological imaging facility); and B. Tran and J. Sheti (NCI sequencing core facility).	Abhyankar MM., 2021, FRONT IMMUNOL, V12, P683157, DOI [DOI 10.3389/FIMMU.2016.00051, 10.3389/fimmu.2021.683157, DOI 10.3389/FIMMU.2021.683157]; Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Aramburu J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005326; Arojo OA, 2018, J IMMUNOL, V201, P908, DOI 10.4049/jimmunol.1800529; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Besedovsky L, 2014, AM J PHYSIOL-ENDOC M, V306, pE1322, DOI 10.1152/ajpendo.00678.2013; Besedovsky L, 2014, FASEB J, V28, P67, DOI 10.1096/fj.13-237958; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; Chaix J, 2014, J IMMUNOL, V193, P1013, DOI 10.4049/jimmunol.1400488; Chongsathidkiet P, 2018, NAT MED, V24, P1459, DOI 10.1038/s41591-018-0135-2; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Contreras NA, 2018, GEROSCIENCE, V40, P279, DOI 10.1007/s11357-018-0022-2; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Ghosh MC, 2009, BLOOD, V113, P575, DOI 10.1182/blood-2008-04-151803; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Harp JR, 2010, J IMMUNOL, V185, P5751, DOI 10.4049/jimmunol.1001878; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karsten E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21387-w; Karsten E, 2018, CYTOKINE, V102, P34, DOI 10.1016/j.cyto.2017.12.005; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Manglani M, 2018, CURR PROTOC IMMUNOL, V120, P2421; Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mendoza A, 2017, NATURE, V546, P158, DOI 10.1038/nature22352; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nikolich-Zugich J, 2005, EXP GERONTOL, V40, P884, DOI 10.1016/j.exger.2005.06.007; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; PABST R, 1986, IMMUNOLOGY, V59, P217; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Parretta E, 2005, J IMMUNOL, V174, P7654, DOI 10.4049/jimmunol.174.12.7654; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Raud B, 2018, IMMUNOL REV, V283, P213, DOI 10.1111/imr.12655; Redman LM, 2018, CELL METAB, V27, P805, DOI 10.1016/j.cmet.2018.02.019; Robertson LT, 2013, EXP GERONTOL, V48, P1043, DOI 10.1016/j.exger.2013.01.009; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheller EL, 2019, BONE, V118, P32, DOI 10.1016/j.bone.2018.01.016; Scheller EL, 2016, TRENDS ENDOCRIN MET, V27, P392, DOI 10.1016/j.tem.2016.03.016; Scheller EL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8808; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; WING EJ, 1988, IMMUNOLOGY, V63, P677; Xiao HY, 2011, J IMMUNOL, V187, P1788, DOI 10.4049/jimmunol.1101138; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570	72	78	79	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1088	+		10.1016/j.cell.2019.07.049	http://dx.doi.org/10.1016/j.cell.2019.07.049			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442402	Green Accepted, Bronze			2022-12-28	WOS:000482191000008
J	Javaux, EJ				Javaux, Emmanuelle J.			Challenges in evidencing the earliest traces of life	NATURE			English	Review							BARBERTON MOUNTAIN LAND; STRELLEY POOL FORMATION; GA DRESSER FORMATION; MICROBIAL SULFATE REDUCTION; CARBON ISOTOPIC SIGNATURES; PILBARA CRATON; WESTERN-AUSTRALIA; ORGANIC-MATTER; GREENSTONE-BELT; EARLY EARTH	Earth has been habitable for 4.3 billion years, and the earliest rock record indicates the presence of a microbial biosphere by at least 3.4 billion years ago-and disputably earlier. Possible traces of life can be morphological or chemical but abiotic processes that mimic or alter them, or subsequent contamination, may challenge their interpretation. Advances in micro-and nanoscale analyses, as well as experimental approaches, are improving the characterization of these biosignatures and constraining abiotic processes, when combined with the geological context. Reassessing the evidence of early life is challenging, but essential and timely in the quest to understand the origin and evolution of life, both on Earth and beyond.	[Javaux, Emmanuelle J.] Univ Liege, Dept Geol, UR Astrobiol, Early Life Traces & Evolut Astrobiol, Liege, Belgium	University of Liege	Javaux, EJ (corresponding author), Univ Liege, Dept Geol, UR Astrobiol, Early Life Traces & Evolut Astrobiol, Liege, Belgium.	ej.javaux@uliege.be			European Research Council StG ELiTE [FP7/308074]; Belgian FRS-FNRS-FWO Excellence of Science project ET-HOME	European Research Council StG ELiTE(European Research Council (ERC)); Belgian FRS-FNRS-FWO Excellence of Science project ET-HOME(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the European Research Council StG ELiTE FP7/308074 and the Belgian FRS-FNRS-FWO Excellence of Science project ET-HOME. N. Butterfield, J. Cosmidis, C. Demoulin, A. H. Knoll and K. Lepot are acknowledged for providing some of the images. I thank many colleagues for fruitful discussions over the years, and I apologize for all the work that could not be cited, owing to limitations of space.	Alleon J, 2019, FREE RADICAL BIO MED, V140, P103, DOI 10.1016/j.freeradbiomed.2019.03.005; Alleon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01612-8; Alleon J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11977; Allwood AC, 2007, PRECAMBRIAN RES, V158, P198, DOI 10.1016/j.precamres.2007.04.013; Allwood AC, 2018, NATURE, V563, P241, DOI 10.1038/s41586-018-0610-4; Allwood AC, 2010, CHEM GEOL, V270, P148, DOI 10.1016/j.chemgeo.2009.11.013; Allwood AC, 2009, P NATL ACAD SCI USA, V106, P9548, DOI 10.1073/pnas.0903323106; Awramik SM, 2006, NATURE, V441, P700, DOI 10.1038/441700a; Bernard S, 2014, ELEMENTS, V10, P435, DOI 10.2113/gselements.10.6.435; Bontognali TRR, 2012, P NATL ACAD SCI USA, V109, P15146, DOI 10.1073/pnas.1207491109; Bosak T, 2013, ANNU REV EARTH PL SC, V41, P21, DOI 10.1146/annurev-earth-042711-105327; Brasier M, 2006, PHILOS T R SOC B, V361, P887, DOI 10.1098/rstb.2006.1835; Brasier MD, 2005, PRECAMBRIAN RES, V140, P55, DOI 10.1016/j.precamres.2005.06.008; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; BRIDGWATER D, 1981, NATURE, V289, P51, DOI 10.1038/289051a0; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; BUICK R, 1995, GEOLOGY, V23, P191, DOI 10.1130/0091-7613(1995)023<0191:AOODSO>2.3.CO;2; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Buick R, 2010, NATURE, V463, P885, DOI 10.1038/463885a; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; Cady SL, 2003, ASTROBIOLOGY, V3, P351, DOI 10.1089/153110703769016442; Cosmidis J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12812; Craddock PR, 2011, EARTH PLANET SC LETT, V303, P121, DOI 10.1016/j.epsl.2010.12.045; Crosby CH, 2018, GEOBIOLOGY, V16, P80, DOI 10.1111/gbi.12264; Czaja AD, 2013, EARTH PLANET SC LETT, V363, P192, DOI 10.1016/j.epsl.2012.12.025; Dauphas N, 2017, REV MINERAL GEOCHEM, V82, P415, DOI 10.2138/rmg.2017.82.11; Delarue F, 2018, GEOCHEM PERSPECT LET, V7, P32, DOI 10.7185/geochemlet.1816; Delarue F, 2017, ASTROBIOLOGY, V17, P1192, DOI 10.1089/ast.2016.1531; Demoulin CF, 2019, FREE RADICAL BIO MED, V140, P206, DOI 10.1016/j.freeradbiomed.2019.05.007; Djokic T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15263; Dodd MS, 2017, NATURE, V543, P60, DOI 10.1038/nature21377; Fedo CM, 2002, SCIENCE, V296, P1448, DOI 10.1126/science.1070336; Flannery DT, 2018, GEOCHIM COSMOCHIM AC, V223, P21, DOI 10.1016/j.gca.2017.11.028; French KL, 2015, P NATL ACAD SCI USA, V112, P5915, DOI 10.1073/pnas.1419563112; Furnes H, 2004, SCIENCE, V304, P578, DOI 10.1126/science.1095858; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Grosch EG, 2014, P NATL ACAD SCI USA, V111, P8380, DOI 10.1073/pnas.1402565111; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Harrison TM, 2017, REV MINERAL GEOCHEM, V83, P329, DOI 10.2138/rmg.2017.83.11; Hassenkam T, 2017, NATURE, V548, P78, DOI 10.1038/nature23261; Heubeck C, 2009, GEOLOGY, V37, P931, DOI 10.1130/G30101A.1; Hickman AH., 2008, W AUSTR GEOL SURV RE, V2008, P15; Hickman-Lewis K, 2018, PRECAMBRIAN RES, V312, P45, DOI 10.1016/j.precamres.2018.04.007; Hickman-Lewis K, 2016, PRECAMBRIAN RES, V278, P161, DOI 10.1016/j.precamres.2016.03.013; Hofmann HJ, 1999, GEOL SOC AM BULL, V111, P1256, DOI 10.1130/0016-7606(1999)111<1256:OOGCSI>2.3.CO;2; Homann M, 2018, NAT GEOSCI, V11, P665, DOI 10.1038/s41561-018-0190-9; House CH, 2013, GEOLOGY, V41, P651, DOI 10.1130/G34055.1; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Igisu M, 2018, GEOBIOLOGY, V16, P412, DOI 10.1111/gbi.12294; Javaux EJ, 2003, ORIGINS LIFE EVOL B, V33, P75, DOI 10.1023/A:1023992712071; Javaux EJ, 2004, GEOBIOLOGY, V2, P121, DOI 10.1111/j.1472-4677.2004.00027.x; Javaux EJ, 2018, EARTH-SCI REV, V176, P68, DOI 10.1016/j.earscirev.2017.10.001; Javaux EJ, 2010, NATURE, V463, P934, DOI 10.1038/nature08793; Kamyshny A, 2014, GEOCHEM T, V15, DOI 10.1186/1467-4866-15-7; KNOLL AH, 1975, SCIENCE, V190, P52, DOI 10.1126/science.190.4209.52; KNOLL AH, 1974, P NATL ACAD SCI USA, V71, P2329, DOI 10.1073/pnas.71.6.2329; KNOLL AH, 1977, SCIENCE, V198, P396, DOI 10.1126/science.198.4315.396; Knoll AH, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0493; Lepland A, 2005, GEOLOGY, V33, P77, DOI 10.1130/G20890.1; Lepot K, 2019, GEOCHIM COSMOCHIM AC, V244, P522, DOI 10.1016/j.gca.2018.10.014; Lepot K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14890; Lepot K, 2013, GEOCHIM COSMOCHIM AC, V112, P66, DOI 10.1016/j.gca.2013.03.004; Lepot K, 2011, EARTH PLANET SC LETT, V312, P37, DOI 10.1016/j.epsl.2011.10.016; Lepot K, 2009, GEOCHIM COSMOCHIM AC, V73, P6579, DOI 10.1016/j.gca.2009.08.014; Livage J, 2009, CR PALEVOL, V8, P629, DOI 10.1016/j.crpv.2008.11.009; Lollar BS, 2006, NATURE, V444, pE18, DOI 10.1038/nature05499; Loron CC, 2019, NATURE, V570, P232, DOI 10.1038/s41586-019-1217-0; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; Marshall AO, 2013, GONDWANA RES, V23, P1654, DOI 10.1016/j.gr.2012.12.006; MATHEZ EA, 1987, GEOCHIM COSMOCHIM AC, V51, P2339, DOI 10.1016/0016-7037(87)90288-2; McCollom TM, 2006, EARTH PLANET SC LETT, V243, P74, DOI 10.1016/j.epsl.2006.01.027; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Mcloughlin N, 2008, GEOBIOLOGY, V6, P95, DOI 10.1111/j.1472-4669.2007.00141.x; McMahon S, 2018, J GEOPHYS RES-PLANET, V123, P1012, DOI 10.1029/2017JE005478; Miao LY, 2019, PRECAMBRIAN RES, V321, P172, DOI 10.1016/j.precamres.2018.11.019; Miot J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17111-9; Missbach H, 2018, ORG GEOCHEM, V119, P110, DOI 10.1016/j.orggeochem.2018.02.012; Mitchell AJ, 1997, J APPL MICROBIOL, V83, P76, DOI 10.1046/j.1365-2672.1997.00192.x; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Morag N, 2016, PRECAMBRIAN RES, V275, P429, DOI 10.1016/j.precamres.2016.01.014; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Nabhan S, 2016, GEOLOGY, V44, P763, DOI 10.1130/G38090.1; Naraoka H, 1996, CHEM GEOL, V133, P251, DOI 10.1016/S0009-2541(96)00076-9; Nie NX, 2017, EARTH PLANET SC LETT, V458, P179, DOI 10.1016/j.epsl.2016.10.035; Noffke N, 2010, GEOBIOLOGY: MICROBIAL MATS IN SANDY DEPOSITS FROM THE ARCHEAN ERA TO TODAY, P1, DOI 10.1007/978-3-642-12772-4; Oehler DZ, 2017, PRECAMBRIAN RES, V296, P112, DOI 10.1016/j.precamres.2017.04.031; Oehler DZ, 2010, ASTROBIOLOGY, V10, P413, DOI 10.1089/ast.2009.0426; OEHLER JH, 1971, SCIENCE, V174, P1229, DOI 10.1126/science.174.4015.1229; Orange F, 2013, ASTROBIOLOGY, V13, P163, DOI 10.1089/ast.2012.0887; Otalora F, 2018, J APPL CRYSTALLOGR, V51, P1050, DOI 10.1107/S1600576718007343; Pasteris JD, 2003, ASTROBIOLOGY, V3, P727, DOI 10.1089/153110703322736051; PFLUG HD, 1979, NATURE, V280, P483, DOI 10.1038/280483a0; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Picard A, 2016, GEOBIOLOGY, V14, P276, DOI 10.1111/gbi.12171; Pinti DL, 2009, NAT GEOSCI, V2, P640, DOI 10.1038/NGEO601; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Rosing MT, 1996, GEOLOGY, V24, P43, DOI 10.1130/0091-7613(1996)024<0043:EPOESS>2.3.CO;2; ROSS CS, 1962, AM MINERAL, V47, P723; Rouillard J, 2018, GEOBIOLOGY, V16, P279, DOI 10.1111/gbi.12278; Schidlowski M, 2001, PRECAMBRIAN RES, V106, P117, DOI 10.1016/S0301-9268(00)00128-5; Schopf JW, 2017, PRECAMBRIAN RES, V299, P309, DOI 10.1016/j.precamres.2017.07.021; Schopf JW, 2012, GONDWANA RES, V22, P761, DOI 10.1016/j.gr.2012.07.003; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Sephton MA, 2002, NAT PROD REP, V19, P292, DOI 10.1039/b103775g; Sforna MC, 2014, GEOCHIM COSMOCHIM AC, V124, P18, DOI 10.1016/j.gca.2013.09.031; Sforna MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07385-6; Sforna MC, 2014, NAT GEOSCI, V7, P811, DOI 10.1038/NGEO2276; Shen YN, 2009, EARTH PLANET SC LETT, V279, P383, DOI 10.1016/j.epsl.2009.01.018; Spang A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.56, 10.1038/nmicrobiol.2016.56]; Stueken EE, 2015, NATURE, V520, P666, DOI 10.1038/nature14180; Stueken EE, 2017, GEOBIOLOGY, V15, P767, DOI 10.1111/gbi.12251; Stueken EE, 2017, GEOCHIM COSMOCHIM AC, V217, P80, DOI 10.1016/j.gca.2017.08.019; Su PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048098; Sugitani K, 2015, GEOBIOLOGY, V13, P507, DOI 10.1111/gbi.12148; Sugitani K, 2007, PRECAMBRIAN RES, V158, P228, DOI 10.1016/j.precamres.2007.03.006; Tashiro T, 2017, NATURE, V549, P516, DOI 10.1038/nature24019; Thomazo C, 2009, CR PALEVOL, V8, P665, DOI 10.1016/j.crpv.2009.02.003; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; Ueno Y, 2006, NATURE, V440, P516, DOI 10.1038/nature04584; Ueno Y, 2008, GEOCHIM COSMOCHIM AC, V72, P5675, DOI 10.1016/j.gca.2008.08.026; Vago JL, 2017, ASTROBIOLOGY, V17, P471, DOI 10.1089/ast.2016.1533; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; van Zuilen MA, 2007, GEOCHIM COSMOCHIM AC, V71, P655, DOI 10.1016/j.gca.2006.09.029; van Zuilen MA, 2018, NATURE, V563, P190, DOI 10.1038/d41586-018-06994-x; Wacey D., 2009, EARLY LIFE EARTH PRA; Wacey D, 2018, ASTROBIOLOGY, V18, P539, DOI 10.1089/ast.2017.1734; Wacey D, 2018, EARTH PLANET SC LETT, V487, P33, DOI 10.1016/j.epsl.2018.01.021; Wacey D, 2016, GONDWANA RES, V36, P296, DOI 10.1016/j.gr.2015.07.010; Wacey D, 2015, PRECAMBRIAN RES, V258, P24, DOI 10.1016/j.precamres.2014.12.012; Wacey D, 2010, ASTROBIOLOGY, V10, P381, DOI 10.1089/ast.2009.0423; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; WALTER MR, 1980, NATURE, V284, P443, DOI 10.1038/284443a0; Westall F, 2005, SCIENCE, V308, P366, DOI 10.1126/science.1107227; Westall F, 2003, PRECAMBRIAN RES, V126, P313, DOI 10.1016/S0301-9268(03)00102-5; Westall F, 2015, GEOLOGY, V43, P615, DOI 10.1130/G36646.1	145	64	64	10	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2019	572	7770					451	460		10.1038/s41586-019-1436-4	http://dx.doi.org/10.1038/s41586-019-1436-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS5UZ	31435057				2022-12-28	WOS:000482219600032
J	Walker, XJ; Baltzer, JL; Cumming, SG; Day, NJ; Ebert, C; Goetz, S; Johnstone, JF; Potter, S; Rogers, BM; Schuur, EAG; Turetsky, MR; Mack, MC				Walker, Xanthe J.; Baltzer, Jennifer L.; Cumming, Steven G.; Day, Nicola J.; Ebert, Christopher; Goetz, Scott; Johnstone, Jill F.; Potter, Stefano; Rogers, Brendan M.; Schuur, Edward A. G.; Turetsky, Merritt R.; Mack, Michelle C.			Increasing wildfires threaten historic carbon sink of boreal forest soils	NATURE			English	Article							CLIMATE-CHANGE; FIRE; EMISSIONS; ACCUMULATION; ECOSYSTEMS; NITROGEN	Boreal forest fires emit large amounts of carbon into the atmosphere primarily through the combustion of soil organic matter(1-3). During each fire, a portion of this soil beneath the burned layer can escape combustion, leading to a net accumulation of carbon in forests over multiple fire events(4). Climate warming and drying has led to more severe and frequent forest fires(5-7), which threaten to shift the carbon balance of the boreal ecosystem from net accumulation to net loss(1), resulting in a positive climate feedback(8). This feedback will occur if organic-soil carbon that escaped burning in previous fires, termed 'legacy carbon', combusts. Here we use soil radiocarbon dating to quantitatively assess legacy carbon loss in the 2014 wildfires in the Northwest Territories of Canada(2). We found no evidence for the combustion of legacy carbon in forests that were older than the historic fire-return interval of northwestern boreal forests(9). In forests that were in dry landscapes and less than 60 years old at the time of the fire, legacy carbon that had escaped burning in the previous fire cycle was combusted. We estimate that 0.34 million hectares of young forests (<60 years) that burned in the 2014 fires could have experienced legacy carbon combustion. This implies a shift to a domain of carbon cycling in which these forests become a net source-instead of a sink-of carbon to the atmosphere over consecutive fires. As boreal wildfires continue to increase in size, frequency and intensity(7), the area of young forests that experience legacy carbon combustion will probably increase and have a key role in shifting the boreal carbon balance.	[Walker, Xanthe J.; Ebert, Christopher; Schuur, Edward A. G.; Mack, Michelle C.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86001 USA; [Baltzer, Jennifer L.; Day, Nicola J.] Wilfrid Laurier Univ, Biol Dept, Waterloo, ON, Canada; [Cumming, Steven G.] Laval Univ, Dept Wood & Forest Sci, Quebec City, PQ, Canada; [Goetz, Scott] No Arizona Univ, SICCS, Flagstaff, AZ USA; [Goetz, Scott; Potter, Stefano; Rogers, Brendan M.] Woods Hole Res Ctr, Falmouth, MA USA; [Johnstone, Jill F.] Univ Saskatchewan, Dept Biol, Saskatoon, SK, Canada; [Johnstone, Jill F.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Schuur, Edward A. G.; Mack, Michelle C.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ USA; [Turetsky, Merritt R.] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Turetsky, Merritt R.] Univ Colorado Boulder, Dept Ecol & Evolutionary, Inst Arctic & Alpine Res, Boulder, CO USA	Northern Arizona University; Wilfrid Laurier University; Laval University; Northern Arizona University; Woods Hole Research Center; University of Saskatchewan; University of Alaska System; University of Alaska Fairbanks; Northern Arizona University; University of Guelph; University of Colorado System; University of Colorado Boulder	Walker, XJ (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86001 USA.	xanthe.walker@gmail.com	Johnstone, Jill F./C-9204-2009; Goetz, Scott J/A-3393-2015	Johnstone, Jill F./0000-0001-6131-9339; Goetz, Scott J/0000-0002-6326-4308; Day, Nicola/0000-0002-3135-7585	NSF DEB RAPID grant [1542150]; NASA Arctic Boreal and Vulnerability Experiment (ABoVE) Legacy Carbon grant [NNX15AT71A]; NSERC; Government of the Northwest Territories Cumulative Impacts Monitoring Program [170]; NSERC-PDF; Polar Knowledge Canada's Northern Science Training Program; Government of the Northwest Territories-Wilfrid Laurier University Partnership Agreement	NSF DEB RAPID grant; NASA Arctic Boreal and Vulnerability Experiment (ABoVE) Legacy Carbon grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of the Northwest Territories Cumulative Impacts Monitoring Program; NSERC-PDF(Natural Sciences and Engineering Research Council of Canada (NSERC)); Polar Knowledge Canada's Northern Science Training Program; Government of the Northwest Territories-Wilfrid Laurier University Partnership Agreement	This project was supported by funding awarded to M.C.M. from NSF DEB RAPID grant number 1542150, and from the NASA Arctic Boreal and Vulnerability Experiment (ABoVE) Legacy Carbon grant NNX15AT71A; by NSERC Discovery Grants to J.F.J. and M.R.T.; by Government of the Northwest Territories Cumulative Impacts Monitoring Program Funding project number 170 to J.L.B.; by an NSERC-PDF to N.J.D.; and by Polar Knowledge Canada's Northern Science Training Program funding awarded to Canadian field assistants. Logistical and financial support was provided through the Government of the Northwest Territories-Wilfrid Laurier University Partnership Agreement.	Amiro BD, 2001, CAN J FOREST RES, V31, P512, DOI 10.1139/cjfr-31-3-512; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P578, DOI 10.1111/j.1365-2486.2008.01679.x; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Burnham K P, 2003, MODEL SELECT MULTIMO; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burton PJ, 2008, INT J WILDLAND FIRE, V17, P754, DOI 10.1071/WF07149; Chapin F. S, 2008, PNWGTR767 USDA; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Cook E.R., 2013, METHODS DENDROCHRONO; de Groot WJ, 2007, INT J WILDLAND FIRE, V16, P593, DOI 10.1071/WF06150; de Groot WJ, 2013, FOREST ECOL MANAG, V294, P35, DOI 10.1016/j.foreco.2012.09.027; Fraser RH, 2000, REMOTE SENS ENVIRON, V74, P362, DOI 10.1016/S0034-4257(00)00078-X; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Hayes DJ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003813; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2016, LOGISTF FIRTHS BIAS; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hoy EE, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/095001; Johnson E.A., 1992, FIRE VEGETATION DYNA; Johnstone JF, 2010, CAN J FOREST RES, V40, P1302, DOI 10.1139/X10-061; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Kelly R, 2013, P NATL ACAD SCI USA, V110, P13055, DOI 10.1073/pnas.1305069110; Levin I, 2000, RADIOCARBON, V42, P69, DOI 10.1017/S0033822200053066; Li F, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6685; Little D, 1997, CATENA, V30, P83, DOI 10.1016/S0341-8162(97)00003-9; Lorenz K, 2010, CARBON SEQUESTRATION IN FOREST ECOSYSTEMS, P159, DOI 10.1007/978-90-481-3266-9_4; Mack MC, 2011, NATURE, V475, P489, DOI 10.1038/nature10283; Melvin AM, 2015, ECOSYSTEMS, V18, P1472, DOI 10.1007/s10021-015-9912-7; Minayeva TY, 2008, BIOL BULL+, V35, P524, DOI 10.1134/S1062359008050142; Parisien MA, 2006, INT J WILDLAND FIRE, V15, P361, DOI 10.1071/WF06009; Pellegrini AFA, 2018, NATURE, V553, P194, DOI 10.1038/nature24668; Rogers BM, 2015, NAT GEOSCI, V8, P228, DOI [10.1038/ngeo2352, 10.1038/NGEO2352]; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Schuur EAG, 2016, RADIOCARBON AND CLIMATE CHANGE: MECHANISMS, APPLICATIONS AND LABORATORY TECHNIQUES, P1, DOI 10.1007/978-3-319-25643-6; Stocks B. J., 2003, Journal of Geophysical Research, V108, pFFR5, DOI 10.1029/2001JD000484; Team RC., 2013, R LANG ENV STAT COMP; Trumbore SE, 2016, RADIOCARBON AND CLIMATE CHANGE: MECHANISMS, APPLICATIONS AND LABORATORY TECHNIQUES, P279, DOI 10.1007/978-3-319-25643-6_9; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; van der Werf GR, 2017, EARTH SYST SCI DATA, V9, P697, DOI 10.5194/essd-9-697-2017; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; Walker XJ, 2018, GLOBAL CHANGE BIOL, V24, P4251, DOI 10.1111/gcb.14287; Walker XJ, 2018, INT J WILDLAND FIRE, V27, P125, DOI 10.1071/WF17095; Young AM, 2017, ECOGRAPHY, V40, P606, DOI 10.1111/ecog.02205; Yue X, 2015, ATMOS CHEM PHYS, V15, P10033, DOI 10.5194/acp-15-10033-2015	46	176	180	55	350	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 22	2019	572	7770					520	+		10.1038/s41586-019-1474-y	http://dx.doi.org/10.1038/s41586-019-1474-y			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS5UZ	31435055				2022-12-28	WOS:000482219600044
J	[Anonymous]				[Anonymous]			Seven days in medicine: 14-20 August 2019	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA Scotland, 2019, SEC CAR MATT SHAP FU; DYER C, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4909; Statistics Canada, 2019, NATL CANNABIS SURVEY	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2019	366								l5206	10.1136/bmj.l5206	http://dx.doi.org/10.1136/bmj.l5206			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DJ	31439590				2022-12-28	WOS:000482882300007
J	Packer, JS; Zhu, Q; Huynh, C; Sivaramakrishnan, P; Preston, E; Dueck, H; Stefanik, D; Tan, K; Trapnell, C; Kim, J; Waterston, RH; Murray, JI				Packer, Jonathan S.; Zhu, Qin; Huynh, Chau; Sivaramakrishnan, Priya; Preston, Elicia; Dueck, Hannah; Stefanik, Derek; Tan, Kai; Trapnell, Cole; Kim, Junhyong; Waterston, Robert H.; Murray, John I.			A lineage-resolved molecular atlas of C. elegans embryogenesis at single-cell resolution	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; RNA-SEQ; DIVERSITY; INFERENCE; NEMATODE; EMBRYO; GENOME; LIM-6	Caenorhabditis elegans is an animal with few cells but a wide diversity of cell types. In this study, we characterize the molecular basis for their specification by profiling the transcriptomes of 86,024 single embryonic cells. We identify 502 terminal and preterminal cell types, mapping most single-cell transcriptomes to their exact position in C. elegans' invariant lineage. Using these annotations, we find that (i) the correlation between a cell's lineage and its transcriptome increases from middle to late gastrulation, then falls substantially as cells in the nervous system and pharynx adopt their terminal fates; (ii) multilineage priming contributes to the differentiation of sister cells at dozens of lineage branches; and (iii) most distinct lineages that produce the same anatomical cell type converge to a homogenous transcriptomic state.	[Packer, Jonathan S.; Huynh, Chau; Trapnell, Cole; Waterston, Robert H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Zhu, Qin] Univ Penn, Genom & Computat Biol Grad Grp, Philadelphia, PA 19104 USA; [Sivaramakrishnan, Priya; Preston, Elicia; Dueck, Hannah; Tan, Kai; Murray, John I.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stefanik, Derek; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Tan, Kai] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Tan, Kai] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Tan, Kai] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tan, Kai] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dueck, Hannah] NCI, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waterston, RH (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Murray, JI (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.; Kim, J (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	junhyong@sas.upenn.edu; watersto@uw.edu; jmurr@pennmedicine.upenn.edu	Horwitz, Marshall/AAE-8376-2021; Zhu, Qin/AAX-6363-2021	Zhu, Qin/0000-0001-5539-6071; STEFANIK, DEREK/0000-0001-9351-6804; Sivaramakrishnan, Priya/0000-0002-8717-8287; Trapnell, Cole/0000-0002-8105-4347; Dueck, Hannah/0000-0002-3324-4357; Packer, Jonathan/0000-0003-4025-0007; Tan, Kai/0000-0002-9104-5567	NIH [U41HG007355, R01GM072675, R35GM127093, R21HD085201]; Commonwealth of Pennsylvania Health Research Formula Funds; William H. Gates Chair of Biomedical Sciences; Allen Discovery Center for Lineage Tracing;  [RM1HG010023];  [U2C CA233285]; NATIONAL CANCER INSTITUTE [U2CCA233285] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007355, RM1HG010023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072675, R35GM127093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania Health Research Formula Funds; William H. Gates Chair of Biomedical Sciences; Allen Discovery Center for Lineage Tracing; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grants U41HG007355 and R01GM072675 (R.H.W.) and R35GM127093 and R21HD085201 (J.I.M.). This work was also funded in part by Commonwealth of Pennsylvania Health Research Formula Funds and RM1HG010023 (J.K.), U2C CA233285 (K.T.), the William H. Gates Chair of Biomedical Sciences (R.H.W.), and the Allen Discovery Center for Lineage Tracing (J.S.P. and C.T.). The opinions expressed in this article are the authors' own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the U.S. government.	Abdus-Saboor I, 2012, DEV BIOL, V366, P298, DOI 10.1016/j.ydbio.2012.03.015; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Araya CL, 2014, NATURE, V512, P400, DOI 10.1038/nature13497; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Blondel V. D., 2008, ARXIV08030476PHYSICS; Boeck ME, 2016, GENOME RES, V26, P1441, DOI 10.1101/gr.202663.115; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Broitman-Maduro G, 2009, DEVELOPMENT, V136, P2735, DOI 10.1242/dev.038307; Brunschwig K, 1999, DEVELOPMENT, V126, P1537; Brunskill EW, 2014, DEVELOPMENT, V141, P3093, DOI 10.1242/dev.110601; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Deltas G, 2003, REV ECON STAT, V85, P226, DOI 10.1162/rest.2003.85.1.226; Ebbing A, 2018, DEV CELL, V47, P801, DOI 10.1016/j.devcel.2018.10.016; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Fincher CT, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1736; Harterink M, 2011, DEVELOPMENT, V138, P2915, DOI 10.1242/dev.064733; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Hirose T, 2010, P NATL ACAD SCI USA, V107, P15479, DOI 10.1073/pnas.1010023107; Hobert O, 1999, DEVELOPMENT, V126, P1547; Hobert O, 2016, WIRES DEV BIOL, V5, P474, DOI 10.1002/wdev.233; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Karaiskos N, 2017, SCIENCE, V358, P194, DOI 10.1126/science.aan3235; Kester L, 2018, CELL STEM CELL, V23, P166, DOI 10.1016/j.stem.2018.04.014; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lee RYN, 2018, NUCLEIC ACIDS RES, V46, pD869, DOI 10.1093/nar/gkx998; Lesch BJ, 2010, GENE DEV, V24, P1802, DOI 10.1101/gad.1932610; McInnes L., 2018, ARXIV180203426STATML; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Packer J, 2018, TRENDS GENET, V34, P653, DOI 10.1016/j.tig.2018.06.001; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Plass M, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1723; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Richards JL, 2013, DEV BIOL, V374, P12, DOI 10.1016/j.ydbio.2012.11.034; Sarafi-Reinach TR, 2000, GENE DEV, V14, P2472, DOI 10.1101/gad.832300; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Sebe-Pedros A, 2018, CELL, V173, P1520, DOI 10.1016/j.cell.2018.05.019; Sommermann EM, 2010, DEV BIOL, V347, P154, DOI 10.1016/j.ydbio.2010.08.020; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tintori SC, 2016, DEV CELL, V38, P430, DOI 10.1016/j.devcel.2016.07.025; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Waddington C., 1957, STRATEGY GENES; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362; Wang W, 2019, NAT CELL BIOL, V21, P674, DOI 10.1038/s41556-019-0336-z; Warner AD, 2019, GENOME RES, V29, P1036, DOI 10.1101/gr.243394.118; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weisdepp P., 2019, DRYAD; Young Matthew D, 2020, Gigascience, V9, DOI 10.1093/gigascience/giaa151; Yu DN, 2013, BIOINFORMATICS, V29, P1275, DOI 10.1093/bioinformatics/btt143; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	62	138	138	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2019	365	6459					1265	+	eaax1971	10.1126/science.aax1971	http://dx.doi.org/10.1126/science.aax1971			103	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JA1AC	31488706	Green Submitted, Green Accepted			2022-12-28	WOS:000487547400036
J	Windham, BG; Griswold, ME; Wilkening, SR; Su, D; Tingle, J; Coker, LH; Knopman, D; Gottesman, RF; Shibata, D; Mosley, TH				Windham, B. Gwen; Griswold, Michael E.; Wilkening, Steven R.; Su, Dan; Tingle, Jonathan; Coker, Laura H.; Knopman, David; Gottesman, Rebecca F.; Shibata, Dean; Mosley, Thomas H.			Midlife Smaller and Larger Infarctions, White Matter Hyperintensities, and 20-Year Cognitive Decline A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SMALL-VESSEL DISEASE; STRUCTURAL NETWORK EFFICIENCY; MIDDLE-AGED ADULTS; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; PERIVASCULAR SPACES; BRAIN INFARCTION; MRI FINDINGS; DEMENTIA; LESIONS	Background: Smaller (<3-mm) infarctions are associated with stroke and stroke mortality, but relationships with cognitive decline are unknown. Objective: To characterize the relationships of smaller, larger, and both smaller and larger infarctions in middle age with 20-year cognitive decline. Design: Longitudinal cohort study. Setting: Two ARIC (Atherosclerosis Risk in Communities) study sites with magnetic resonance imaging data (1993 to 1995) and up to 5 cognitive assessments over 20 years. Participants: Stroke-free participants aged 50 years or older. Measurements: Infarctions were categorized as none, smaller only, larger only (3 to 20 mm), or both smaller and larger. Global cognitive Z scores were derived from 3 cognitive tests administered up to 5 times. Mixed-effects models estimated adjusted associations between infarctions and cognitive decline. Results are the average difference in standardized cognitive decline associated with infarctions versus no infarctions. Results: Among 1884 participants (mean age, 62 years; 60% women; 50% black), 1611 (86%) had no infarctions, 50 (3%) had smaller infarctions only, 185 (10%) had larger infarctions only, and 35 (2%) had both. Participants with both smaller and larger infarctions had steeper cognitive decline by more than half an SD (difference, -0.57 SD [95% CI, -0.89 to -0.26 SD]) compared with those who had no infarctions. Amounts of cognitive decline associated with only smaller infarctions and only larger infarctions were similar and were not statistically different from that associated with no infarctions. Limitation: Few participants had only smaller infarctions or both smaller and larger infarctions, and the data lacked counts of smaller infarctions and volumes of white matter hyperintensities. Conclusion: The substantial cognitive decline from middle age associated with having both smaller and larger infarctions, but not larger infarctions alone, suggests that the combination of smaller and larger infarctions may escalate risk for cognitive decline later in life in stroke-free persons.	[Windham, B. Gwen; Griswold, Michael E.; Wilkening, Steven R.; Su, Dan; Tingle, Jonathan; Mosley, Thomas H.] Univ Mississippi, Med Ctr, 2500 North State St, Jackson, MS 39216 USA; [Coker, Laura H.] Wake Forest Univ, Bowman Gray Sch Med, Med Ctr Blvd, Winston Salem, NC 27103 USA; [Knopman, David] Mayo Clin, 200 First St SW, Rochester, MN 55905 USA; [Gottesman, Rebecca F.] Johns Hopkins Med, Phipps 446D,600 North Wolfe St, Baltimore, MD 21287 USA; [Shibata, Dean] Univ Washington, 1959 NE Pacific St, Seattle, WA 98195 USA	University of Mississippi; University of Mississippi Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle	Windham, BG (corresponding author), Univ Mississippi, Med Ctr, 2500 North State St, Jackson, MS 39216 USA.	gwindham@umc.edu	Gottesman, Rebecca/ABA-8468-2020		National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health.	Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Bryan RN, 1999, AM J NEURORADIOL, V20, P1273; BRYAN RN, 1994, AM J NEURORADIOL, V15, P1625; Buratti L, 2016, J CEREBR BLOOD F MET, V36, P1804, DOI 10.1177/0271678X15613526; Carmichael O, 2010, ARCH NEUROL-CHICAGO, V67, P1370, DOI 10.1001/archneurol.2010.284; Corriveau RA, 2017, NEUROLOGY, V89, P2381, DOI 10.1212/WNL.0000000000004717; Debette S, 2007, STROKE, V38, P2924, DOI 10.1161/STROKEAHA.107.488403; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Hurford R, 2014, J NEUROL NEUROSUR PS, V85, P522, DOI 10.1136/jnnp-2013-305815; Jokinen H, 2011, NEUROLOGY, V76, P1872, DOI 10.1212/WNL.0b013e31821d752f; Jokinen H, 2009, CEREBROVASC DIS, V27, P384, DOI 10.1159/000207442; KNOPMAN DS, 1989, ARCH NEUROL-CHICAGO, V46, P141, DOI 10.1001/archneur.1989.00520380041011; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Kuller LH, 2003, NEUROEPIDEMIOLOGY, V22, P13, DOI 10.1159/000067109; Lawrence AJ, 2014, NEUROLOGY, V83, P304, DOI 10.1212/WNL.0000000000000612; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Liao DP, 1997, NEUROEPIDEMIOLOGY, V16, P149, DOI 10.1159/000368814; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Massaro JM, 2004, STAT MED, V23, P351, DOI 10.1002/sim.1743; Mosley TH, 2005, NEUROLOGY, V64, P2056, DOI 10.1212/01.WNL.0000165985.97397.88; Prabhakaran S, 2008, NEUROLOGY, V70, P425, DOI 10.1212/01.wnl.0000277521.66947.e5; Price TR, 1997, STROKE, V28, P1158, DOI 10.1161/01.STR.28.6.1158; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosano C, 2005, J AM GERIATR SOC, V53, P649, DOI 10.1111/j.1532-5415.2005.53214.x; Schmidt R, 2005, ANN NEUROL, V58, P610, DOI 10.1002/ana.20630; Schneider JA, 2004, NEUROLOGY, V62, P1148, DOI 10.1212/01.WNL.0000118211.78503.F5; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Tuladhar AM, 2016, NEUROLOGY, V86, P1112, DOI 10.1212/WNL.0000000000002502; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wechsler D., 1945, WECHSLER MEMORY SCAL; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179; Windham BG, 2015, ANN INTERN MED, V163, P22, DOI 10.7326/M14-2057; Yao M, 2014, NEUROBIOL AGING, V35, P2118, DOI 10.1016/j.neurobiolaging.2014.03.021	43	10	10	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					389	+		10.7326/M18-0295	http://dx.doi.org/10.7326/M18-0295			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31450238	Green Accepted			2022-12-28	WOS:000486101400012
J	Desvignes, G; Kramer, M; Lee, K; van Leeuwen, J; Stairs, I; Jessner, A; Cognard, I; Kasian, L; Lyne, A; Stappers, B				Desvignes, Gregory; Kramer, Michael; Lee, Kejia; van Leeuwen, Joeri; Stairs, Ingrid; Jessner, Axel; Cognard, Ismaei; Kasian, Laura; Lyne, Andrew; Stappers, Ben W.			Radio emission from a pulsar's magnetic pole revealed by general relativity	SCIENCE			English	Article							SPIN PRECESSION; PAIR CREATION; POLARIZATION; DISCOVERY; PROFILES; GEOMETRY; ALTITUDE; SYSTEMS; MODEL	Binary pulsars are affected by general relativity (GR), causing the spin axis of each pulsar to precess. We present polarimetric radio observations of the pulsar PSR J1906+ 0746 that demonstrate the validity of the geometrical model of pulsar polarization. We reconstruct the (sky-projected) polarization emission map over the pulsar's magnetic pole and predict the disappearance of the detectable emission by 2028. Two tests of GR are performed using this system, including the spin precession for strongly self-gravitating bodies. We constrain the relativistic treatment of the pulsar polarization model and measure the pulsar beaming fraction, with implications for the population of neutron stars and the expected rate of neutron star mergers.	[Desvignes, Gregory; Kramer, Michael; Jessner, Axel] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany; [Desvignes, Gregory] Univ Paris, Sorbonne Univ, Univ Paris Sci & Lettres,Observ Paris, Lab Etud Spatiales & Instrumentat Astrophys,CNRS, 5 Pl Jules Janssen, F-92195 Meudon, France; [Kramer, Michael; Lyne, Andrew; Stappers, Ben W.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Lee, Kejia] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [van Leeuwen, Joeri] Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands; [van Leeuwen, Joeri] Univ Amsterdam, Astron Inst Anton Pannekoek, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Stairs, Ingrid; Kasian, Laura] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Cognard, Ismaei] Univ Orleans, CNRS, Lab Phys & Chim Environm & Espace, F-45071 Orleans, France; [Cognard, Ismaei] Inst Natl Sci Univers, CNRS, Observ Paris, Stn Radioastron Nancay, F-18330 Nancay, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Manchester; Jodrell Bank Centre for Astrophysics; Peking University; University of Amsterdam; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Desvignes, G (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.; Desvignes, G (corresponding author), Univ Paris, Sorbonne Univ, Univ Paris Sci & Lettres,Observ Paris, Lab Etud Spatiales & Instrumentat Astrophys,CNRS, 5 Pl Jules Janssen, F-92195 Meudon, France.	gdesvignes@mpifr-bonn.mpg.de		Desvignes, Gregory/0000-0003-3922-4055; lee, kejia/0000-0002-1435-0883; Lyne, Andrew/0000-0002-4799-1281; van Leeuwen, Joeri/0000-0001-8503-6958; Stappers, Benjamin/0000-0001-9242-7041; Kramer, Michael/0000-0002-4175-2271; Cognard, Ismael/0000-0002-1775-9692; Jessner, Axel/0000-0001-6152-9504	European Research Council (ERC) Synergy Grant "BlackHoleCam" Grant [610058]; 973 program [2015CB857101]; Max-Planck Partner Group; Netherlands Organisation for Scientific Research(NWO) [614.001.301]; ERC under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant [617199]; NSERC Discovery Grant; Canadian Institute for Advanced Research; NSF [AST-1100968]; NSFC [U15311243, XDB23010200, 11690024]; STFC [ST/P000649/1] Funding Source: UKRI	European Research Council (ERC) Synergy Grant "BlackHoleCam" Grant(European Research Council (ERC)); 973 program(National Basic Research Program of China); Max-Planck Partner Group; Netherlands Organisation for Scientific Research(NWO)(Netherlands Organization for Scientific Research (NWO)); ERC under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NSF(National Science Foundation (NSF)); NSFC(National Natural Science Foundation of China (NSFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	G.D. and M.K. gratefully acknowledge support from European Research Council (ERC) Synergy Grant "BlackHoleCam" Grant Agreement Number 610058. K.L. received support from 973 program 2015CB857101, NSFC U15311243, XDB23010200, 11690024, and funding from Max-Planck Partner Group. J.v.L acknowledges funding from the Netherlands Organisation for Scientific Research(NWO) under project "CleanMachne" (614.001.301) and from the ERC under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement 617199. Pulsar research at UBC is supported by an NSERC Discovery Grant and by the Canadian Institute for Advanced Research. The Arecibo Observatory is operated by SRI International under a cooperative agreement with the NSF(AST-1100968), and in alliance with Ana G. Mendez-Universidad Metropolitana, and the Universities Space Research Association. The Nangay Radio Observatory is operated by the Paris Observatory, associated with the French Centre National de la Recherche Scientifique (CNRS) and the Universite d'Orleans.	Arendt Jr P. N., 1998, ARXIVASTROPH9801257; ARONS J, 1983, ASTROPHYS J, V266, P215, DOI 10.1086/160771; Bassa CG, 2016, MON NOT R ASTRON SOC, V456, P2196, DOI 10.1093/mnras/stv2755; Beskin VS, 2012, MON NOT R ASTRON SOC, V425, P814, DOI 10.1111/j.1365-2966.2012.20988.x; BLASKIEWICZ M, 1991, ASTROPHYS J, V370, P643, DOI 10.1086/169850; Breton RP, 2008, SCIENCE, V321, P104, DOI 10.1126/science.1159295; Brun R, 1997, NUCL INSTRUM METH A, V389, P81, DOI 10.1016/S0168-9002(97)00048-X; DAMOUR T, 1992, PHYS REV D, V45, P1840, DOI 10.1103/PhysRevD.45.1840; DAMOUR T, 1974, CR ACAD SCI A MATH, V279, P971; Desvignes G., 2019, ZENODO, DOI [10.5281/zenodo3358819, DOI 10.5281/ZENODO.3358819]; Desvignes G., 2019, ZENODO, DOI [10.5281/zenodo.3358819, DOI 10.5281/ZEN0D0.3358819]; Desvignes G., 2019, ZENODO, DOI [10.5281/zonodo.3265755, DOI 10.5281/ZENODO.3265755]; Dyks J, 2003, ASTROPHYS J, V598, P1201, DOI 10.1086/379052; Dyks J, 2008, MON NOT R ASTRON SOC, V391, P859, DOI 10.1111/j.1365-2966.2008.13923.x; Eilek J. A., 1998, ARXIVASTROPH9801257A; Fonseca E, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/82; Gralla SE, 2017, ASTROPHYS J, V851, DOI 10.3847/1538-4357/aa978d; Handley WJ, 2015, MON NOT R ASTRON SOC, V453, P4384, DOI 10.1093/mnras/stv1911; Hibschman JA, 2001, ASTROPHYS J, V546, P382, DOI 10.1086/318224; Ilie CD, 2019, MON NOT R ASTRON SOC, V483, P2778, DOI 10.1093/mnras/sty3315; Janka HT, 2017, ASTROPHYS J, V837, DOI 10.3847/1538-4357/aa618e; Jones RC, 1941, J OPT SOC AM, V31, P488, DOI 10.1364/JOSA.31.000488; Kasian L., 2012, THESIS; KOMESAROFF MM, 1970, NATURE, V225, P612, DOI 10.1038/225612a0; Kramer M, 1998, ASTROPHYS J, V509, P856, DOI 10.1086/306535; Kramer M, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/7/073001; KRAMER M, 1994, ASTRON ASTROPHYS SUP, V107, P515; Kramer M, 2008, MON NOT R ASTRON SOC, V390, P87, DOI 10.1111/j.1365-2966.2008.13780.x; Lorimer D. R., 2012, HDB PULSAR ASTRONOMY; Lorimer DR, 2006, ASTROPHYS J, V640, P428, DOI 10.1086/499918; Lorimer DR, 2005, HDB PULSAR ASTRONOMY; Lyne A., 2012, CSIRO, DOI [10.4225/08/5850b61f44170, DOI 10.4225/08/5850B61F44170]; Lyne A, 2012, CSIRO, DOI [10.4225/08/5850b61f44170, DOI 10.4225/08/5850B61144170]; Manchester RN, 2010, ASTROPHYS J, V710, P1694, DOI 10.1088/0004-637X/710/2/1694; Manchester RN, 2001, MON NOT R ASTRON SOC, V328, P17, DOI 10.1046/j.1365-8711.2001.04751.x; O'Shaughnessy R, 2010, ASTROPHYS J, V715, P230, DOI 10.1088/0004-637X/715/1/230; RADHAKRISHNAN V, 1990, ASTROPHYS J, V352, P258, DOI 10.1086/168531; RADHAKRISHNAN V, 1969, ASTROPHYS LETT, V3, P225; Ransom S. M., 2001, THESIS; Stairs IH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.141101; van Leeuwen J, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/118; van Straten W, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/1/13; van Straten W., 2012, AR T, V9, P237; WEISBERG JM, 1989, ASTROPHYS J, V347, P1030, DOI 10.1086/168193; Wex N, 2000, ASTROPHYS J, V528, P401, DOI 10.1086/308148; Yan WM, 2011, MON NOT R ASTRON SOC, V414, P2087, DOI 10.1111/j.1365-2966.2011.18522.x; Yuen R, 2014, PUBL ASTRON SOC AUST, V31, DOI 10.1017/pasa.2014.35	49	29	30	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					1013	+		10.1126/science.aav7272	http://dx.doi.org/10.1126/science.aav7272			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW1MK	31488685	Green Submitted			2022-12-28	WOS:000484732700043
J	Johnston, CW; Collins, JJ				Johnston, Chad W.; Collins, James J.			Engineering microbial peer pressure	SCIENCE			English	Editorial Material									[Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jimjc@mit.edu		Johnston, Chad/0000-0002-1988-709X				Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Chan CTY, 2016, NAT CHEM BIOL, V12, P82, DOI [10.1038/NCHEMBIO.1979, 10.1038/nchembio.1979]; Din MO, 2016, NATURE, V536, P81, DOI 10.1038/nature18930; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fischbach MA, 2018, CELL, V174, P785, DOI 10.1016/j.cell.2018.07.038; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Green AA, 2017, NATURE, V548, P117, DOI 10.1038/nature23271; Isabella VM, 2018, NAT BIOTECHNOL, V36, P857, DOI 10.1038/nbt.4222; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Liao MJ, 2019, SCIENCE, V365, P1045, DOI 10.1126/science.aaw0542; Mao N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2586; Moratorio G, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.88; Ostrov N, 2016, SCIENCE, V353, P819, DOI 10.1126/science.aaf3639	14	0	0	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2019	365	6457					986	987		10.1126/science.aay3157	http://dx.doi.org/10.1126/science.aay3157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW1MK	31488676	Green Published			2022-12-28	WOS:000484732700030
J	De Rosa, MJ; Veuthey, T; Florman, J; Grant, J; Blanco, MG; Andersen, N; Donnelly, J; Rayes, D; Alkema, MJ				Jose De Rosa, Maria; Veuthey, Tania; Florman, Jeremy; Grant, Jeff; Gabriela Blanco, Maria; Andersen, Natalia; Donnelly, Jamie; Rayes, Diego; Alkema, Mark J.			The flight response impairs cytoprotective mechanisms by activating the insulin pathway	NATURE			English	Article							BIOGENIC-AMINE RECEPTORS; CAENORHABDITIS-ELEGANS; LIFE-SPAN; OXIDATIVE STRESS; TYRAMINE; INTEGRATION; EXPRESSION; OCTOPAMINE; HORMESIS; NEURONS	An animal's stress response requires different adaptive strategies depending on the nature and duration of the stressor. Whereas acute stressors, such as predation, induce a rapid and energy-demanding fight-or-flight response, long-term environmental stressors induce the gradual and long-lasting activation of highly conserved cytoprotective processes(1-3). In animals across the evolutionary spectrum, continued activation of the fight-or-flight response weakens the animal's resistance to environmental challenges(4,5). However, the molecular and cellular mechanisms that regulate the trade-off between the flight response and long-term stressors are poorly understood. Here we show that repeated induction of the flight response in Caenorhabditis elegans shortens lifespan and inhibits conserved cytoprotective mechanisms. The flight response activates neurons that release tyramine, an invertebrate analogue of adrenaline and noradrenaline. Tyramine stimulates the insulin-IGF-1 signalling (IIS) pathway and precludes the induction of stress response genes by activating an adrenergic-like receptor in the intestine. By contrast, long-term environmental stressors, such as heat or oxidative stress, reduce tyramine release and thereby allow the induction of cytoprotective genes. These findings demonstrate that a neural stress hormone supplies a state-dependent neural switch between acute flight and long-term environmental stress responses and provides mechanistic insights into how the flight response impairs cellular defence systems and accelerates ageing.	[Jose De Rosa, Maria; Veuthey, Tania; Gabriela Blanco, Maria; Andersen, Natalia; Rayes, Diego] Univ Nacl Sur, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca CONICET, Bahia Blanca, Buenos Aires, Argentina; [Florman, Jeremy; Grant, Jeff; Donnelly, Jamie; Rayes, Diego; Alkema, Mark J.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	National University of the South; University of Massachusetts System; University of Massachusetts Worcester	Rayes, D (corresponding author), Univ Nacl Sur, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca CONICET, Bahia Blanca, Buenos Aires, Argentina.; Rayes, D; Alkema, MJ (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA.	drayes@criba.edu.ar; mark.alkema@umassmed.edu	, Diego/AAH-4523-2020	DE ROSA, MARIA JOSE/0000-0002-2149-6127; Florman, Jeremy/0000-0001-7578-3511; Blanco, Maria Gabriela/0000-0001-9611-1482	NIH Office of Research Infrastructure Programs [P40 OD010440]; UNS [PGI 24/B216, PGI 24/ZB62]; ANPCYT [PICT 2014 3118]; CONICET [PIP11220150100182CO]; National Institutes of Health [GM084491]	NIH Office of Research Infrastructure Programs; UNS; ANPCYT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank C. Bargmann, M. Nonet, A. Dillin, H. Tissenbaum, D. Albrecht, J. Hawk, C. Weist, M. Madhav, A. Thackeray, C. Benard, M. Gorczyca, A. Bizet and W. Joyce for strains and technical support; and A. Garelli, G. Spitzmaul, A. Byrne, V. Budnik, M. Walhout, M. Belew, M. Ailion and T. Shpilka for discussions. This work was supported by grants from UNS (PGI 24/B216 to D. R., PGI 24/ZB62 to M. J. D. R.), ANPCYT (PICT 2014 3118 to D. R.) and CONICET (PIP11220150100182CO to D. R. and M. J. D. R.), and grant GM084491 from the National Institutes of Health to M. J. A.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; [Anonymous], 1915, BODILY CHANGES PAIN; Arantes-Oliveira N, 2003, SCIENCE, V302, P611, DOI 10.1126/science.1089169; Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x; BRENNER S, 1974, GENETICS, V77, P71; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P453, DOI 10.1080/10408440802004007; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Chun L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9828; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; DORMAN JB, 1995, GENETICS, V141, P1399; Du W, 2016, ELIFE, V5, DOI 10.7554/eLife.18134; Edelstein Arthur D, 2014, J Biol Methods, V1; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Hawk JD, 2018, NEURON, V97, P356, DOI 10.1016/j.neuron.2017.12.027; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Jin X, 2016, CELL, V164, P632, DOI 10.1016/j.cell.2016.01.007; Kagawa-Nagamura Y, 2018, ZOOL LETT, V4, DOI 10.1186/s40851-018-0103-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Komuniecki RW, 2004, MOL BIOCHEM PARASIT, V137, P1, DOI 10.1016/j.molbiopara.2004.05.010; Kumsta C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14337; Lee IR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032585; Lionaki Eirini, 2013, Methods Mol Biol, V965, P473, DOI 10.1007/978-1-62703-239-1_31; Maguire SM, 2011, CURR BIOL, V21, P1326, DOI 10.1016/j.cub.2011.06.063; Mesa R, 2011, GENETICS, V187, P467, DOI 10.1534/genetics.110.121996; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Rabasa C, 2016, CURR OPIN BEHAV SCI, V9, P71, DOI 10.1016/j.cobeha.2016.01.011; Rattan SIS, 2007, ANN NY ACAD SCI, V1100, P424, DOI 10.1196/annals.1395.047; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Stiernagle Theresa, 2006, WormBook, P1; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yemini Eviatar, 2011, Cold Spring Harb Protoc, V2011, P1483, DOI 10.1101/pdb.prot067025; Zheng MH, 2012, J NEUROSCI METH, V206, P78, DOI 10.1016/j.jneumeth.2012.01.002	43	17	17	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					135	+		10.1038/s41586-019-1524-5	http://dx.doi.org/10.1038/s41586-019-1524-5			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV0KI	31462774	Green Published, Green Accepted			2022-12-28	WOS:000483967700049
J	Kaaij, LJT; Mohn, F; van der Weide, RH; de Wit, E; Buhler, M				Kaaij, Lucas J. T.; Mohn, Fabio; van der Weide, Robin H.; de Wit, Elzo; Buhler, Marc			The ChAHP Complex Counteracts Chromatin Looping at CTCF Sites that Emerged from SINE Expansions in Mouse	CELL			English	Article							HI-C REVEALS; TRANSPOSABLE ELEMENTS; MAMMALIAN GENOMES; 3D GENOME; DOMAINS; COHESIN; ORGANIZATION; BINDING; PRINCIPLES; ARCHITECTURE	CCCTC-binding factor (CTCF) and cohesin are key players in three-dimensional chromatin organization. The topologically associating domains (TADs) demarcated by CTCF are remarkably well conserved between species, although genome-wide CTCF binding has diverged substantially following transposon-mediated motif expansions. Therefore, the CTCF consensus motif poorly predicts TADs, and additional factors must modulate CTCF binding and subsequent TAD formation. Here, we demonstrate that the ChAHP complex (CHD4, ADNP, HP1) competes with CTCF for a common set of binding motifs. In Adnp knockout cells, novel insulated regions are formed at sites normally bound by ChAHP, whereas proximal canonical boundaries are weakened. These data reveal that CTCF-mediated loop formation is modulated by a distinct zinc-finger protein complex. Strikingly, ChAHP-bound loci are mainly situated within less diverged SINE B2 transposable elements. This implicates ChAHP in maintenance of evolutionarily conserved spatial chromatin organization by buffering novel CTCF binding sites that emerged through SINE expansions.	[Kaaij, Lucas J. T.; Mohn, Fabio; Buhler, Marc] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [van der Weide, Robin H.; de Wit, Elzo] Netherlands Canc Inst, Oncode Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Buhler, Marc] Univ Basel, Peterspl 10, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Netherlands Cancer Institute; University of Basel	Kaaij, LJT; Mohn, F; Buhler, M (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.; Buhler, M (corresponding author), Univ Basel, Peterspl 10, CH-4003 Basel, Switzerland.	lucas.kaaij@fmi.ch; fabio.mohn@fmi.ch; marc.buehler@fmi.ch	Buehler, Marc/S-5866-2019; van der Weide, Robin H./GLV-1335-2022	Buehler, Marc/0000-0001-6661-9795; van der Weide, Robin Harm/0000-0002-6466-7280; de Wit, Elzo/0000-0003-2883-1415; Mohn, Fabio/0000-0001-9889-5225	Novartis Research Foundation	Novartis Research Foundation	We thank L. Giorgetti, D. Schubeler, and A. Tuck for discussions and feedback on the manuscript. We thank Y. Shimada and N. Laschet for technical support and all the members of the Buhler lab for critical discussions. We thank S. Smallwood and the FMI Functional Genomics team for next-generation sequencing, Yinxiu Zhan for advice on TAD calling and sharing software, and M. Stadler for help with implementing Z score normalization. This work received funding from the Novartis Research Foundation.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beischlag TV, 2018, METHODS MOL BIOL, V1689, P103, DOI 10.1007/978-1-4939-7380-4_9; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bohne A, 2008, CHROMOSOME RES, V16, P203, DOI 10.1007/s10577-007-1202-6; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Geeven G, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky443; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Heger P, 2012, P NATL ACAD SCI USA, V109, P17507, DOI 10.1073/pnas.1111941109; Heinz S, 2018, CELL, V174, P1522, DOI 10.1016/j.cell.2018.07.047; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Kaaij LJT, 2018, CELL REP, V24, P1, DOI 10.1016/j.celrep.2018.06.003; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Nagano T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0753-7; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nuebler J, 2018, P NATL ACAD SCI USA, V115, pE6697, DOI 10.1073/pnas.1717730115; Ostapcuk V, 2018, NATURE, V557, P739, DOI 10.1038/s41586-018-0153-8; Pekowska A, 2018, CELL SYST, V7, P482, DOI 10.1016/j.cels.2018.09.003; Phanstiel DH, 2017, MOL CELL, V67, P1037, DOI 10.1016/j.molcel.2017.08.006; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; R Development Core Team, 2014, R LANG ENV STAT COMP; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramirez F., 2016, NUCLEIC ACIDS RES, V44, P195; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rowley MJ, 2017, MOL CELL, V67, P837, DOI 10.1016/j.molcel.2017.07.022; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sotero-Caio CG, 2017, GENOME BIOL EVOL, V9, P161, DOI 10.1093/gbe/evw264; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sundaram V, 2014, GENOME RES, V24, P1963, DOI 10.1101/gr.168872.113; Thybert D, 2018, GENOME RES, V28, P448, DOI 10.1101/gr.234096.117; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Van Dijck A, 2019, BIOL PSYCHIAT, V85, P287, DOI 10.1016/j.biopsych.2018.02.1173; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Zhan YX, 2017, GENOME RES, V27, P479, DOI 10.1101/gr.212803.116; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	71	52	52	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1437	+		10.1016/j.cell.2019.08.007	http://dx.doi.org/10.1016/j.cell.2019.08.007			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491387	Bronze			2022-12-28	WOS:000483983000017
J	King, JVL; Emrick, JJ; Kelly, MJS; Herzig, V; King, GF; Medzihradszky, KF; Julius, D				King, John V. Lin; Emrick, Joshua J.; Kelly, Mark J. S.; Herzig, Volker; King, Glenn F.; Medzihradszky, Katalin F.; Julius, David			A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain	CELL			English	Article							RECEPTOR POTENTIAL A1; ION-CHANNEL TRPA1; CAPSAICIN RECEPTOR; MOLECULAR-MECHANISMS; TRPV1 STRUCTURES; PLASMA-MEMBRANE; TAT PROTEIN; PEPTIDES; ACTIVATION; NOCICEPTOR	TRPA1 is a chemosensory ion channel that functions as a sentinel for structurally diverse electrophilic irritants. Channel activation occurs through an unusual mechanism involving covalent modification of cysteine residues clustered within an amino-terminal cytoplasmic domain. Here, we describe a peptidergic scorpion toxin (WaTx) that activates TRPA1 by penetrating the plasma membrane to access the same intracellular site modified by reactive electrophiles. WaTx stabilizes TRPA1 in a biophysically distinct active state characterized by prolonged channel openings and low Ca2+ permeability. Consequently, WaTx elicits acute pain and pain hypersensitivity but fails to trigger efferent release of neuropeptides and neurogenic inflammation typically produced by noxious electrophiles. These findings provide a striking example of convergent evolution whereby chemically disparate animal- and plant-derived irritants target the same key allosteric regulatory site to differentially modulate channel activity. WaTx is a unique pharmacological probe for dissecting TRPA1 function and its contribution to acute and persistent pain.	[King, John V. Lin; Emrick, Joshua J.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [King, John V. Lin] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Emrick, Joshua J.] Univ Calif San Francisco, Sch Dent, Oral & Craniofacial Sci Program, San Francisco, CA 94143 USA; [Kelly, Mark J. S.; Medzihradszky, Katalin F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Herzig, Volker; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Emrick, Joshua J.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Medzihradszky, Katalin F.] Hungarian Acad Sci, Biol Res Ctr, Lab Prote Res, H-6727 Szeged, Hungary	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	david.julius@ucsf.edu	Emrick, Joshua/AAD-6816-2019	Emrick, Joshua/0000-0001-5619-1078; Lin King, John/0000-0001-5194-4798; King, Glenn/0000-0002-2308-2200; Herzig, Volker/0000-0003-2514-3983	NSF [1650113]; UCSF Chuan-Lyu Discovery Fellowship; NIH [R37 NS065071, R35 NS105038, T32 GM007449, DE023476, S10OD023455, P41GM103481]; Australian National Health & Medical Research Council [APP1136889, APP1072113]; UCSF Program for Breakthrough Biomedical Research TMC grant; UCSF Research Resource Program; UCSF Chancellor Funds; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS105038, R37NS065071] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); UCSF Chuan-Lyu Discovery Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); UCSF Program for Breakthrough Biomedical Research TMC grant; UCSF Research Resource Program; UCSF Chancellor Funds; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Julius lab for provocative discussions, especially N. Bellono for guidance and advice with patch-clamp electrophysiology and D. Leitch for guidance with interpretation of transcriptomic data. We also recognize J. Poblete and J. Braz for expert technical assistance with mouse experiments. Finally, we are grateful to L.Y. Jan, R.A. Nicoll, D. Cohn, and W.J. Tang for their critical reading of the manuscript. This work was supported by an NSF Graduate Research Fellowship (1650113 to J.V.L.K), a UCSF Chuan-Lyu Discovery Fellowship (J.V.L.K), and grants from the NIH (R37 NS065071 and R35 NS105038 to D.J. and T32 GM007449 to J.V.L.K). Additional funding was provided by the NIH (Predoctoral Fellowship DE023476 to J.J.E) and the Australian National Health & Medical Research Council (Principal Research Fellowship APP1136889 and Program Grant APP1072113 to G.F.K). NMR and MS resources were funded by the NIH (S10OD023455 and P41GM103481), the UCSF Program for Breakthrough Biomedical Research TMC grant, UCSF Research Resource Program, UCSF Chancellor Funds, and the Howard Hughes Medical Institute.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bahia PK, 2016, J GEN PHYSIOL, V147, P451, DOI 10.1085/jgp.201611581; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Banzawa N, 2014, J BIOL CHEM, V289, P31927, DOI 10.1074/jbc.M114.586891; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bobkov YV, 2011, BBA-BIOMEMBRANES, V1808, P1120, DOI 10.1016/j.bbamem.2010.12.024; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2011, PAIN, V152, P1165, DOI 10.1016/j.pain.2011.01.049; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Emrick JJ, 2018, P NATL ACAD SCI USA, V115, pE12091, DOI 10.1073/pnas.1814132115; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HORN R, 1991, BIOPHYS J, V60, P329, DOI 10.1016/S0006-3495(91)82057-4; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Kalia J, 2015, J MOL BIOL, V427, P158, DOI 10.1016/j.jmb.2014.07.027; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Kauffman WB, 2015, TRENDS BIOCHEM SCI, V40, P749, DOI 10.1016/j.tibs.2015.10.004; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mihailescu M, 2014, P NATL ACAD SCI USA, V111, pE5463, DOI 10.1073/pnas.1415324111; Miles AJ, 2018, PROTEIN SCI, V27, P1717, DOI 10.1002/pro.3474; Moran MM, 2018, ANNU REV PHARMACOL, V58, P309, DOI 10.1146/annurev-pharmtox-010617-052832; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; NICOLL RA, 1975, NATURE, V258, P625, DOI 10.1038/258625a0; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Palovcak E, 2015, J GEN PHYSIOL, V146, P37, DOI 10.1085/jgp.201411329; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Sakmann B, 2009, SINGLE CHANNEL RECOR; SHI GY, 1994, J BIOL CHEM, V269, P23204; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sunagar K, 2013, TOXINS, V5, P2456, DOI 10.3390/toxins5122456; Thorell T., 1876, Annals of Natural History, V(4), P1; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang CC, 2017, P NATL ACAD SCI USA, V114, pE2524, DOI 10.1073/pnas.1615484114	89	46	47	4	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1362	+		10.1016/j.cell.2019.07.014	http://dx.doi.org/10.1016/j.cell.2019.07.014			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31447178	Green Accepted, Bronze			2022-12-28	WOS:000483983000012
J	Yamashita, Y; Tsurumi, J; Ohno, M; Fujimoto, R; Kumagai, S; Kurosawa, T; Okamoto, T; Takeya, J; Watanabe, S				Yamashita, Yu; Tsurumi, Junto; Ohno, Masahiro; Fujimoto, Ryo; Kumagai, Shohei; Kurosawa, Tadanori; Okamoto, Toshihiro; Takeya, Jun; Watanabe, Shun			Efficient molecular doping of polymeric semiconductors driven by anion exchange	NATURE			English	Article							TRANSPORT; BAND	The efficiency with which polymeric semiconductors can be chemically doped-and the charge carrier densities that can thereby be achieved-is determined primarily by the electrochemical redox potential between the pi-conjugated polymer and the dopant species(1,2). Thus, matching the electron affinity of one with the ionization potential of the other can allow effective doping(3,4). Here we describe a different process-which we term 'anion exchange'- that might offer improved doping levels. This process is mediated by an ionic liquid solvent and can be pictured as the effective instantaneous exchange of a conventional small p-type dopant anion with a second anion provided by an ionic liquid. The introduction of optimized ionic salt (the ionic liquid solvent) into a conventional binary donor-acceptor system can overcome the redox potential limitations described by Marcus theory(5), and allows an anion-exchange efficiency of nearly 100 per cent. As a result, doping levels of up to almost one charge per monomer unit can be achieved. This demonstration of increased doping levels, increased stability and excellent transport properties shows that anion-exchange doping, which can use an almost infinite selection of ionic salts, could be a powerful tool for the realization of advanced molecular electronics.	[Yamashita, Yu; Tsurumi, Junto; Ohno, Masahiro; Fujimoto, Ryo; Kumagai, Shohei; Kurosawa, Tadanori; Okamoto, Toshihiro; Takeya, Jun; Watanabe, Shun] Univ Tokyo, MIRC, Kashiwa, Chiba, Japan; [Yamashita, Yu; Tsurumi, Junto; Ohno, Masahiro; Fujimoto, Ryo; Kumagai, Shohei; Kurosawa, Tadanori; Okamoto, Toshihiro; Takeya, Jun; Watanabe, Shun] Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Yamashita, Yu; Tsurumi, Junto; Takeya, Jun] NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki, Japan; [Okamoto, Toshihiro; Takeya, Jun; Watanabe, Shun] Natl Inst Adv Ind Sci & Technol, AIST UTokyo Adv Operandomeasurement Technol Open, Kashiwa, Chiba, Japan; [Okamoto, Toshihiro; Watanabe, Shun] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; University of Tokyo; National Institute for Materials Science; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Watanabe, S (corresponding author), Univ Tokyo, MIRC, Kashiwa, Chiba, Japan.; Watanabe, S (corresponding author), Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.; Watanabe, S (corresponding author), Natl Inst Adv Ind Sci & Technol, AIST UTokyo Adv Operandomeasurement Technol Open, Kashiwa, Chiba, Japan.; Watanabe, S (corresponding author), Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan.	swatanabe@edu.k.u-tokyo.ac.jp	Yu, Yamashita/AGK-2511-2022; Okamoto, Toshihiro/N-3303-2013; Kumagai, Shohei/C-4917-2018	Okamoto, Toshihiro/0000-0002-4783-0621; Kumagai, Shohei/0000-0002-1554-054X; Yamashita, Yu/0000-0001-7966-3197	Japan Society for the Promotion of Science (JSPS) Research Fellowship; PRESTO-JST through the Hyper-nanospace Design Toward Innovative Functionality project [JPMJPR151E]; Leading Initiative for Excellent Young Researchers of JSPS; JSPS KAKENHI [JP17H06123, JP17H06200]	Japan Society for the Promotion of Science (JSPS) Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO-JST through the Hyper-nanospace Design Toward Innovative Functionality project; Leading Initiative for Excellent Young Researchers of JSPS; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Y.Y. was supported by a Grant-in-Aid via a Japan Society for the Promotion of Science (JSPS) Research Fellowship. S. W. acknowledges support from PRESTO-JST through the Hyper-nanospace Design Toward Innovative Functionality project (JPMJPR151E) and from the Leading Initiative for Excellent Young Researchers of JSPS. This work was also supported in part by JSPS KAKENHI grants (JP17H06123 and JP17H06200).	ARNOLD E, 1976, SOLID STATE COMMUN, V18, P1153, DOI 10.1016/0038-1098(76)90927-3; Chia PJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096602; CHIANG CK, 1977, PHYS REV LETT, V39, P1098, DOI 10.1103/PhysRevLett.39.1098; Farka D, 2017, ADV ELECTRON MATER, V3, DOI 10.1002/aelm.201700050; Fujimoto R, 2017, J MATER CHEM C, V5, P12023, DOI 10.1039/c7tc03905k; FUKUYAMA H, 1969, PROG THEOR PHYS, V42, P494, DOI 10.1143/PTP.42.494; Guardado JO, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201701791; HIKAMI S, 1980, PROG THEOR PHYS, V63, P707, DOI 10.1143/PTP.63.707; Holomb R, 2006, J PHYS CHEM A, V110, P11467, DOI 10.1021/jp0626824; Ito H, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.03DC08; Jacobs IE, 2017, ADV MATER, V29, DOI 10.1002/adma.201703063; Kang K, 2016, NAT MATER, V15, P896, DOI [10.1038/nmat4634, 10.1038/NMAT4634]; Karpov Y, 2017, MACROMOLECULES, V50, P914, DOI 10.1021/acs.macromol.6b02452; Lin X, 2017, NAT MATER, V16, P1209, DOI [10.1038/nmat5027, 10.1038/NMAT5027]; Lussem B, 2016, CHEM REV, V116, P13714, DOI 10.1021/acs.chemrev.6b00329; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; Mcculloch I, 2006, NAT MATER, V5, P328, DOI 10.1038/nmat1612; Muller L, 2017, ADV MATER, V29, DOI 10.1002/adma.201701466; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; Png RQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11948; Salzmann I, 2016, ACCOUNTS CHEM RES, V49, P370, DOI 10.1021/acs.accounts.5b00438; Tang CC, 2016, NATURE, V539, P536, DOI 10.1038/nature20133; Le TH, 2013, INORG CHIM ACTA, V395, P252, DOI 10.1016/j.ica.2012.10.019; Yamashita Y, 2014, ADV MATER, V26, P8169, DOI 10.1002/adma.201403767; Zhao LH, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4734502	25	122	124	23	192	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					634	+		10.1038/s41586-019-1504-9	http://dx.doi.org/10.1038/s41586-019-1504-9			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31462795				2022-12-28	WOS:000483405500049
J	Jordan, S; Tung, N; Casanova-Acebes, M; Chang, C; Cantoni, C; Zhang, DC; Wirtz, TH; Naik, S; Rose, SA; Brocker, CN; Gainullina, A; Hornburg, D; Horng, S; Maier, BB; Cravedi, P; LeRoith, D; Gonzalez, FJ; Meissner, F; Ochando, J; Rahman, A; Chipuk, JE; Artyomov, MN; Frenette, PS; Piccio, L; Berres, ML; Gallagher, EJ; Merad, M				Jordan, Stefan; Tung, Navpreet; Casanova-Acebes, Maria; Chang, Christie; Cantoni, Claudia; Zhang, Dachuan; Wirtz, Theresa H.; Naik, Shruti; Rose, Samuel A.; Brocker, Chad N.; Gainullina, Anastasiia; Hornburg, Daniel; Horng, Sam; Maier, Barbara B.; Cravedi, Paolo; LeRoith, Derek; Gonzalez, Frank J.; Meissner, Felix; Ochando, Jordi; Rahman, Adeeb; Chipuk, Jerry E.; Artyomov, Maxim N.; Frenette, Paul S.; Piccio, Laura; Berres, Marie-Luise; Gallagher, Emily J.; Merad, Miriam			Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool	CELL			English	Article							WEIGHT-LOSS; BONE-MARROW; VEGETARIAN DIET; LOW-CALORIE; OVERWEIGHT; AUTOIMMUNITY; PROTEIN; STEM; PARAMETERS; EMIGRATION	Caloric restriction is known to improve inflammatory and autoimmune diseases. However, the mechanisms by which reduced caloric intake modulates inflammation are poorly understood. Here we show that short-term fasting reduced monocyte metabolic and inflammatory activity and drastically reduced the number of circulating monocytes. Regulation of peripheral monocyte numbers was dependent on dietary glucose and protein levels. Specifically, we found that activation of the low-energy sensor 5'-AMP-activated protein kinase (AMPK) in hepato-cytes and suppression of systemic CCL2 production by peroxisome proliferator-activator receptor alpha (PPAR alpha) reduced monocyte mobilization from the bone marrow. Importantly, we show that fasting improves chronic inflammatory diseases without compromising monocyte emergency mobilization during acute infectious inflammation and tissue repair. These results reveal that caloric intake and liver energy sensors dictate the blood and tissue immune tone and link dietary habits to inflammatory disease outcome.	[Jordan, Stefan; Tung, Navpreet; Casanova-Acebes, Maria; Chang, Christie; Maier, Barbara B.; Ochando, Jordi; Chipuk, Jerry E.; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Ontol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Jordan, Stefan; Tung, Navpreet; Casanova-Acebes, Maria; Chang, Christie; Maier, Barbara B.; Cravedi, Paolo; Merad, Miriam] Icahn Sch Med Mt Sinai, Precis Immunol Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Jordan, Stefan; Tung, Navpreet; Casanova-Acebes, Maria; Chang, Christie; Maier, Barbara B.; Rahman, Adeeb; Chipuk, Jerry E.; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Rose, Samuel A.; Rahman, Adeeb] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA; [LeRoith, Derek; Gallagher, Emily J.] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Horng, Sam] Icahn Sch Med Mt Sinai, Dept Neurol & Neurosci, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Rahman, Adeeb] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Zhang, Dachuan; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Dept Cell Biol, 1301 Morris Pk Ave, Bronx, NY 10461 USA; [Wirtz, Theresa H.; Berres, Marie-Luise] Rhein Westfal TH Aachen, Dept Internal Med 3, Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany; [Naik, Shruti] NYU, Dept Pathol, Sch Med, 240 East 38th St, New York, NY 10016 USA; [Naik, Shruti] NYU, Ronald O Perelman Dept Dermatol, Sch Med, 240 East 38th St, New York, NY 10016 USA; [Brocker, Chad N.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA; [Gainullina, Anastasiia; Artyomov, Maxim N.] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA; [Cantoni, Claudia; Piccio, Laura] Washington Univ, Dept Neurol, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA; [Gainullina, Anastasiia] ITMO Univ, Comp Technol Dept, Kronverksky 49, St Petersburg, Russia; [Hornburg, Daniel; Meissner, Felix] Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany; [Piccio, Laura] Univ Sydney, Brain & Mind Ctr, 94 Mallett St, Camperdown, NSW 2050, Australia	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; RWTH Aachen University; RWTH Aachen University Hospital; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Washington University (WUSTL); ITMO University; Max Planck Society; University of Sydney	Jordan, S; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Ontol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA.; Jordan, S; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA.; Jordan, S; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA.	stefan.jordan@mssm.edu; miriam.merad@mssm.edu	Jordan, Stefan/AAH-8261-2021; Jordan, Stefan/AAI-1073-2021; Gainullina, Anastasiia/O-4727-2019; Berres, Marie-Luise/AAN-5351-2021; Zhang, Dachuan/GZA-8781-2022; Acebes, Maria Casanova/AAH-1929-2019; Ochando, jordi/ABE-2358-2020; Meissner, Felix/C-8767-2015	Jordan, Stefan/0000-0001-9330-1715; Jordan, Stefan/0000-0001-9330-1715; Gainullina, Anastasiia/0000-0003-3796-2337; Acebes, Maria Casanova/0000-0002-5790-1163; Ochando, jordi/0000-0001-7037-1681; Brocker, Chad/0000-0003-4262-3567; Chang, Christie/0000-0002-7651-7220; Meissner, Felix/0000-0003-1000-7989; Maier, Barbara/0000-0002-7359-6576; Zhang, Dachuan/0000-0002-1746-275X; Piccio, Laura/0000-0002-8760-109X; Cravedi, Paolo/0000-0001-7837-0923	NIH [R01 CA154947, U24 AI118644, U19 AI128949, K08CA190770]; Tisch Cancer Institute; German Research Council (DFG) [SFB-TRR57 P07, JO 1216/1-1]; NATIONAL CANCER INSTITUTE [K08CA190770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tisch Cancer Institute; German Research Council (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Agudo, S. Offermanns, C. Buettner, S. Fried, T. E. McGraw, A. W. Ferrante and the Merad laboratory for helpful discussions. We thank J. LeBerichel for technical assistance, A. Lansky for submission of the IRB application, the Flow Cytometry facility for technical support, the Human immune monitoring core for assistance with the multiplex assay, M. Davila for processing CyTOF data, M. Serasinghe for help with metabolic measurements in monocytes, the Stable Isotope & Metabolomics core at Albert Einstein College of Medicine for assistance with blood metabolite measurements, S. Hatem for assistance with phlebotomy and all participants of the human fasting experiment. We are grateful to Y. Belkaid for giving us the opportunity to use her laboratory at NIH and N. Bouladoux for assistance. We thank Wiegand von Hartmann GBR for designing the graphical abstract. Supported by the NIH (R01 CA154947, U24 AI118644, U19 AI128949 to M. M. and K08CA190770 to E.J.G),The Tisch Cancer Institute (Junior Scientist Award to E. J. G), and the German Research Council (DFG) (SFB-TRR57 P07 to M.-L. B, JO 1216/1-1 to S. J.).	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Aksungar FB, 2007, ANN NUTR METAB, V51, P88, DOI 10.1159/000100954; Boniakowski AE, 2018, EUR J IMMUNOL, V48, P1445, DOI 10.1002/eji.201747400; Brandhorst S, 2013, EXP GERONTOL, V48, P1120, DOI 10.1016/j.exger.2013.02.016; Brocker CN, 2017, AM J PHYSIOL-GASTR L, V312, pG283, DOI 10.1152/ajpgi.00205.2016; Choi IY, 2017, MOL CELL ENDOCRINOL, V455, P4, DOI 10.1016/j.mce.2017.01.042; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Cignarella F, 2018, CELL METAB, V27, P1222, DOI 10.1016/j.cmet.2018.05.006; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DARLINGTON LG, 1986, LANCET, V1, P236; Decker M, 2018, SCIENCE, V360, P106, DOI 10.1126/science.aap8861; Faris E, 2012, NUTR RES, V32, P947, DOI 10.1016/j.nutres.2012.06.021; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Ho TP, 2015, HORM METAB RES, V47, P289, DOI 10.1055/s-0034-1382011; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Imayama I, 2012, CANCER RES, V72, P2314, DOI 10.1158/0008-5472.CAN-11-3092; Jensen P, 2016, AM J CLIN NUTR, V104, P259, DOI 10.3945/ajcn.115.125849; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kani AH, 2017, HORM METAB RES, V49, P687, DOI 10.1055/s-0042-118707; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; KJELDSENKRAGH J, 1991, LANCET, V338, P899, DOI 10.1016/0140-6736(91)91770-U; Lips MA, 2016, METABOLISM, V65, P1614, DOI 10.1016/j.metabol.2016.07.013; Loria-Kohen V, 2013, CLIN NUTR, V32, P511, DOI 10.1016/j.clnu.2012.10.015; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma EH, 2017, CELL METAB, V25, P482, DOI 10.1016/j.cmet.2017.01.014; Manzel A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0404-6; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Moro T, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1044-0; Oh EG, 2013, BIOL RES NURS, V15, P48, DOI 10.1177/1099800411416637; Orr JS, 2013, JOVE-J VIS EXP, DOI 10.3791/50707; Ott B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12109-9; Picca A, 2017, CLIN INTERV AGING, V12, P1887, DOI 10.2147/CIA.S126458; Piccio L, 2008, J LEUKOCYTE BIOL, V84, P940, DOI 10.1189/jlb.0208133; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Ramel A, 2010, EUR J CLIN NUTR, V64, P987, DOI 10.1038/ejcn.2010.99; Serbina NV, 2012, ADV IMMUNOL, V113, P119, DOI 10.1016/B978-0-12-394590-7.00003-8; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sergushichev AA, 2016, NUCLEIC ACIDS RES, V44, pW194, DOI 10.1093/nar/gkw266; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; SKOLDSTAM L, 1979, SCAND J RHEUMATOL, V8, P249, DOI 10.3109/03009747909114631; Tajik N, 2013, J ENDOCRINOL INVEST, V36, P211, DOI 10.3275/8465; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700; Yamanashi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08055-1; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zubrzycki A, 2018, J PHYSIOL PHARMACOL, V69, P663, DOI 10.26402/jpp.2018.5.02	54	153	158	4	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2019	178	5					1102	+		10.1016/j.cell.2019.07.050	http://dx.doi.org/10.1016/j.cell.2019.07.050			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IS5KJ	31442403	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000482191000009
J	Harel, M; Ortenberg, R; Varanasi, SK; Mangalhara, KC; Mardamshina, M; Markovits, E; Baruch, EN; Tripple, V; Arama-Chayoth, M; Greenberg, E; Shenoy, A; Ayasun, R; Knafo, N; Xu, SH; Anafi, L; Yanovich-Arad, G; Barnabas, GD; Ashkenazi, S; Besser, MJ; Schachter, J; Bosenberg, M; Shadel, GS; Barshack, I; Kaech, SM; Markel, G; Geiger, T				Harel, Michal; Ortenberg, Rona; Varanasi, Siva Karthik; Mangalhara, Kailash Chandra; Mardamshina, Mariya; Markovits, Ettai; Baruch, Erez N.; Tripple, Victoria; Arama-Chayoth, May; Greenberg, Eyal; Shenoy, Anjana; Ayasun, Ruveyda; Knafo, Naama; Xu, Shihao; Anafi, Liat; Yanovich-Arad, Gali; Barnabas, Georgina D.; Ashkenazi, Shira; Besser, Michal J.; Schachter, Jacob; Bosenberg, Marcus; Shadel, Gerald S.; Barshack, Iris; Kaech, Susan M.; Markel, Gal; Geiger, Tamar			Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence	CELL			English	Article							MHC CLASS-I; TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; SOMATIC MUTATIONS; ADOPTIVE TRANSFER; CD4+T CELLS; IFN-GAMMA; PHASE-II; CHECKPOINT; MICROENVIRONMENT	Immunotherapy has revolutionized cancer treatment, yet most patients do not respond. Here, we investigated mechanisms of response by profiling the proteome of clinical samples from advanced stage melanoma patients undergoing either tumor infiltrating lymphocyte (TIL)-based or anti- programmed death 1 (PD1) immunotherapy. Using high-resolution mass spectrometry, we quantified over 10,300 proteins in total and similar to 4,500 proteins across most samples in each dataset. Statistical analyses revealed higher oxidative phosphorylation and lipid metabolism in responders than in non-responders in both treatments. To elucidate the effects of the metabolic state on the immune response, we examined melanoma cells upon metabolic perturbations or CRISPR-Cas9 knockouts. These experiments indicated lipid metabolism as a regulatory mechanism that increases melanoma immunogenicity by elevating antigen presentation, thereby increasing sensitivity to T cell mediated killing both in vitro and in vivo. Altogether, our proteomic analyses revealed association between the melanoma metabolic state and the response to immunotherapy, which can be the basis for future improvement of therapeutic response.	[Harel, Michal; Mardamshina, Mariya; Arama-Chayoth, May; Shenoy, Anjana; Knafo, Naama; Yanovich-Arad, Gali; Barnabas, Georgina D.; Geiger, Tamar] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-6997801 Tel Aviv, Israel; [Ortenberg, Rona; Markovits, Ettai; Baruch, Erez N.; Greenberg, Eyal; Ashkenazi, Shira; Besser, Michal J.; Schachter, Jacob; Markel, Gal] Sheba Med Ctr, Ella Lemelbaum Inst Immunooncol, IL-5265601 Tel Hashomer, Israel; [Ortenberg, Rona; Markovits, Ettai; Baruch, Erez N.; Ashkenazi, Shira; Besser, Michal J.; Markel, Gal] Tel Aviv Univ, Sackler Sch Med, Dept Clin Immunol & Microbiol, IL-6997801 Tel Aviv, Israel; [Varanasi, Siva Karthik; Tripple, Victoria; Ayasun, Ruveyda; Xu, Shihao; Kaech, Susan M.] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Mangalhara, Kailash Chandra; Shadel, Gerald S.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Anafi, Liat; Barshack, Iris] Sheba Med Ctr, Inst Pathol, IL-5265601 Tel Hashomer, Israel; [Schachter, Jacob; Barshack, Iris] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Bosenberg, Marcus] Yale Comprehens Canc Ctr, New Haven, CT 06510 USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Salk Institute; Salk Institute; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Yale University; Yale University; Yale University	Geiger, T (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-6997801 Tel Aviv, Israel.; Markel, G (corresponding author), Sheba Med Ctr, Ella Lemelbaum Inst Immunooncol, IL-5265601 Tel Hashomer, Israel.; Markel, G (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Immunol & Microbiol, IL-6997801 Tel Aviv, Israel.	markel@post.tau.ac.il; geiger@tauex.tau.ac.il		Arad, Gali/0000-0003-1415-5997; Geiger, Tamar/0000-0002-9526-197X; Mardamshina, Mariya/0000-0003-0066-0861; Baruch, Erez Nissim/0000-0001-6001-6598	Melanoma Research Alliance Saban Family Team Science Award; Kamin grant of the Israel Innovation Authority; Samueli Foundation Grant for Integrative Immuno-Oncology; NIH [R01 CA216102]; Salkexcellerators Postdoctoral fellowship; NOMIS Center Postdoctoral Foundation; National Cancer Center; NATIONAL CANCER INSTITUTE [P01CA128814] Funding Source: NIH RePORTER	Melanoma Research Alliance Saban Family Team Science Award; Kamin grant of the Israel Innovation Authority; Samueli Foundation Grant for Integrative Immuno-Oncology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salkexcellerators Postdoctoral fellowship; NOMIS Center Postdoctoral Foundation; National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Prof. Juergen Cox, Dr. Livnat Jerby-Arnon, and Dr. Yael Elbaz-Alon for fruitful discussions and Dr. Keren Yizhak for her assistance in computational analyses. We thank Diana Nemichenitzer for technical assistance in sample preparation. We thank the Lemelbaum family for the generous continuous support. This work was funded by the Melanoma Research Alliance Saban Family Team Science Award and Kamin grant of the Israel Innovation Authority to G.M. and T.G., Samueli Foundation Grant for Integrative Immuno-Oncology to G.M., NIH R01 CA216102 to G.S.S. and S.M.K., the Salkexcellerators Postdoctoral fellowship to K.C.M., and NOMIS Center Postdoctoral Foundation and the National Cancer Center to S.K.V.	Ahmed D, 2017, CANCER LETT, V409, P20, DOI 10.1016/j.canlet.2017.08.037; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Ardiani A, 2014, CANCER RES, V74, P1945, DOI 10.1158/0008-5472.CAN-13-2045; Auslander N, 2018, NAT MED, V24, P1545, DOI 10.1038/s41591-018-0157-9; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Charni S, 2010, J IMMUNOL, V185, P3498, DOI 10.4049/jimmunol.1001250; Charni S, 2009, J IMMUNOL, V182, P3398, DOI 10.4049/jimmunol.0803006; Conforti F, 2018, LANCET ONCOL, V19, P737, DOI 10.1016/S1470-2045(18)30261-4; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Goto Y, 2010, J INVEST DERMATOL, V130, P221, DOI 10.1038/jid.2009.195; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Ho PC, 2017, CURR OPIN IMMUNOL, V46, P38, DOI 10.1016/j.coi.2017.04.003; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Jongsma MLM, 2017, MOL IMMUNOL, V17, P30598; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Lauss M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01460-0; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Liebermeister W, 2014, P NATL ACAD SCI USA, V111, P8488, DOI 10.1073/pnas.1314810111; Lim S, 2017, CANCER RES, V77, P1245, DOI 10.1158/0008-5472.CAN-16-1647; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Montoya M, 1999, J IMMUNOL, V163, P1914; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Perry CJ, 2018, J EXP MED, V215, P877, DOI 10.1084/jem.20171435; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Rudolph JD, 2019, J PROTEOME RES, V18, P2052, DOI 10.1021/acs.jproteome.8b00927; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Scheltema RA, 2014, MOL CELL PROTEOMICS, V13, P3698, DOI 10.1074/mcp.M114.043489; Seliger B, 2014, J IMMUNOTOXICOL, V11, P308, DOI 10.3109/1547691X.2013.875084; Sethumadhavan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187314; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Sisler JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144444; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang J, 2017, PIGM CELL MELANOMA R, V30, P428, DOI 10.1111/pcmr.12591; Wang J, 2017, MOL CELL PROTEOMICS, V16, P121, DOI 10.1074/mcp.M116.060301; Weide B, 2016, CLIN CANCER RES, V22, P5487, DOI 10.1158/1078-0432.CCR-16-0127; Wellenstein MD, 2018, IMMUNITY, V48, P399, DOI 10.1016/j.immuni.2018.03.004; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yanovich G, 2018, CANCER RES, V78, P6001, DOI 10.1158/0008-5472.CAN-18-1079; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhang Y, 2017, CANCER CELL, V32, P377, DOI 10.1016/j.ccell.2017.08.004; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120; Zikich D, 2016, IMMUNOTHERAPY-UK, V8, P35, DOI 10.2217/imt.15.99	84	120	122	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					236	+		10.1016/j.cell.2019.08.012	http://dx.doi.org/10.1016/j.cell.2019.08.012			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31495571	Green Accepted, Bronze			2022-12-28	WOS:000486618500026
J	Haile-Selassie, Y; Melillo, SM; Vazzana, A; Benazzi, S; Ryan, TM				Haile-Selassie, Yohannes; Melillo, Stephanie M.; Vazzana, Antonino; Benazzi, Stefano; Ryan, Timothy M.			A 3.8-million-year-old hominin cranium from Woranso-Mille, Ethiopia	NATURE			English	Article							AUSTRALOPITHECUS-AFARENSIS; MIDDLE AWASH; UPPER MIOCENE; CENTRAL AFAR; ALLIA BAY; FOSSILS; RECONSTRUCTION; MORPHOLOGY; ANAMENSIS; KANAPOI	The cranial morphology of the earliest known hominins in the genus Australopithecus remains unclear. The oldest species in this genus (Australopithecus anamensis, specimens of which have been dated to 4.2-3.9 million years ago) is known primarily from jaws and teeth, whereas younger species (dated to 3.5-2.0 million years ago) are typically represented by multiple skulls. Here we describe a nearly complete hominin cranium from Woranso-Mille (Ethiopia) that we date to 3.8 million years ago. We assign this cranium to A. anamensis on the basis of the taxonomically and phylogenetically informative morphology of the canine, maxilla and temporal bone. This specimen thus provides the first glimpse of the entire craniofacial morphology of the earliest known members of the genus Australopithecus. We further demonstrate that A. anamensis and Australopithecus afarensis differ more than previously recognized and that these two species overlapped for at least 100,000 years-contradicting the widely accepted hypothesis of anagenesis.	[Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Dept Phys Anthropol, Cleveland, OH 44106 USA; [Melillo, Stephanie M.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Vazzana, Antonino; Benazzi, Stefano] Univ Bologna, Dept Cultural Heritage, Ravenna, Italy; [Ryan, Timothy M.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	Cleveland Museum of Natural History; Max Planck Society; University of Bologna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Haile-Selassie, Y (corresponding author), Cleveland Museum Nat Hist, Dept Phys Anthropol, Cleveland, OH 44106 USA.; Melillo, SM (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	yhaileselassie@cmnh.org; stephanie_melillo@eva.mpg.de	Benazzi, Stefano/AAH-3923-2020	Melillo, Stephanie/0000-0002-1154-1772	US National Science Foundation [BCS-1124705, BCS-1124713, BCS-1124716, BCS-1125157, BCS-1125345]; Cleveland Museum of Natural History; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [ERC-724046-SUCCESS]; Max Planck Institute for Evolutionary Anthropology, Department of Human Evolution	US National Science Foundation(National Science Foundation (NSF)); Cleveland Museum of Natural History; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Max Planck Institute for Evolutionary Anthropology, Department of Human Evolution	We thank the Authority for Research and Conservation of Cultural Heritage (ARCCH) for permission to conduct field and laboratory work; the Afar people of Woranso-Mille and the Mille District administration for their hospitality; the project's fieldwork crew members for their tireless support of field activities; The National Museum of Kenya, National Museum of Tanzania, Ditsong Museum and the Evolutionary Studies Institute of South Africa for access to original hominin specimens in their care; Max Planck Institute for Evolutionary Anthropology for access to comparative hominin computed tomography scan data; T. White, G. Suwa and B. Asfaw for access to the original A. ramidus material and for providing images and unpublished measurements; M. Brunet and F. Guy for images and unpublished measurements of S. tchadensis; W. H. Kimbel for informative discussions and for access to a surface model of the A.L. 444-2 cranium; D. Lieberman (the Peabody Museum (Harvard)), R. Beutel (Phyletisches Museum Jena), C. Funk (Museum fur Naturkunde), M. Tocheri (National Museum of Natural History (Smithsonian)), U. Olbrich-Schwarz (the Max Planck Institute for Evolutionary Anthropology) for the use of computed tomography scans of extant apes; A. Girmaye, M. Endalamaw, Y. Assefa, T. Getachew, S. Melaku and G. Tekle of ARCCH for access to the fossil collections housed in the Paleoanthropology Laboratory in Addis Ababa; T. Stecko from the Penn State Center for Quantitative Imaging for assistance with computed tomography scanning; and N. Meisel and D. N. Kaweesa (Made By Design Lab (Pennsylvania State University)) for assistance in 3D printing. This research was supported by grants from the US National Science Foundation (BCS-1124705, BCS-1124713, BCS-1124716, BCS-1125157 and BCS-1125345) and The Cleveland Museum of Natural History. Y. H.-S. was also supported by W. J. and L. Hlavin, T. and K. Leiden, and E. Lincoln. S.B. was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC-724046-SUCCESS; http://www.erc-success.eu). S.M.M.was supported by the Max Planck Institute for Evolutionary Anthropology, Department of Human Evolution.	ASFAW B, 1987, J HUM EVOL, V16, P611, DOI 10.1016/0047-2484(87)90016-9; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P154, DOI 10.1002/ajpa.22376; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Brunet M, 1996, CR ACAD SCI II A, V322, P907; Dembo M, 2015, P ROY SOC B-BIOL SCI, V282, P133, DOI 10.1098/rspb.2015.0943; FLEAGLE JG, 1991, J HUM EVOL, V21, P145, DOI 10.1016/0047-2484(91)90005-G; Guy F, 2005, P NATL ACAD SCI USA, V102, P18836, DOI 10.1073/pnas.0509564102; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Y, 2016, J HUM EVOL, V100, P35, DOI 10.1016/j.jhevol.2016.08.003; Haile-Selassie Y, 2016, P NATL ACAD SCI USA, V113, P6364, DOI 10.1073/pnas.1521266113; Haile-Selassie Y, 2015, NATURE, V521, P483, DOI 10.1038/nature14448; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Haile-Selassie Y, 2010, PHILOS T R SOC B, V365, P3323, DOI 10.1098/rstb.2010.0064; Haile-Selassie Y, 2010, AM J PHYS ANTHROPOL, V141, P406, DOI 10.1002/ajpa.21159; Kappelman J, 1996, J HUM EVOL, V30, P139, DOI 10.1006/jhev.1996.0010; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; KIMBEL WH, 1982, AM J PHYS ANTHROPOL, V57, P453, DOI 10.1002/ajpa.1330570404; KIMBEL WH, 1994, NATURE, V368, P449, DOI 10.1038/368449a0; KIMBEL WH, 1984, AM J PHYS ANTHROPOL, V64, P337, DOI 10.1002/ajpa.1330640403; Kimbel WH, 2006, J HUM EVOL, V51, P134, DOI 10.1016/j.jhevol.2006.02.003; Kimbel WH, 2017, J HUM EVOL, V107, P94, DOI 10.1016/j.jhevol.2017.03.011; Kimbel WH, 2010, PHILOS T R SOC B, V365, P3365, DOI 10.1098/rstb.2010.0070; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Lockwood CA, 1999, J HUM EVOL, V36, P637, DOI 10.1006/jhev.1999.0299; Manthi FK, 2012, S AFR J SCI, V108, P35, DOI 10.4102/sajs.v108i3/4.724; MARTIN RB, 1988, MET IONS BIOL SYST, V24, P1; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Saylor BZ, 2019, NATURE, V573, P220, DOI 10.1038/s41586-019-1514-7; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; Ward CV, 2020, J HUM EVOL, V140, DOI 10.1016/j.jhevol.2017.07.008; Ward CV, 2013, J HUM EVOL, V65, P501, DOI 10.1016/j.jhevol.2013.05.006; Ward CV, 2014, J HUM EVOL, V73, P98, DOI 10.1016/j.jhevol.2014.05.008; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2016, AM J PHYS ANTHROPOL, V159, P37, DOI 10.1002/ajpa.22902; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	50	31	32	1	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					214	+		10.1038/s41586-019-1513-8	http://dx.doi.org/10.1038/s41586-019-1513-8			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31462770	Green Submitted			2022-12-28	WOS:000485415400045
J	Lardennois, A; Pasti, G; Ferraro, T; Llense, F; Mahou, P; Pontabry, J; Rodriguez, D; Kim, S; Ono, S; Beaurepaire, E; Gally, C; Labouesse, M				Lardennois, Alicia; Pasti, Gabriella; Ferraro, Teresa; Llense, Flora; Mahou, Pierre; Pontabry, Julien; Rodriguez, David; Kim, Samantha; Ono, Shoichiro; Beaurepaire, Emmanuel; Gally, Christelle; Labouesse, Michel			An actin-based viscoplastic lock ensures progressive body-axis elongation	NATURE			English	Article							VAB-10 SPECTRAPLAKIN; FUNCTIONAL-ANALYSIS; ELEGANS; MORPHOGENESIS; PROTEINS; GENOME; GROWTH; CELLS; FHOD1	Body-axis elongation constitutes a key step in animal development, laying out the final form of the entire animal. It relies on the interplay between intrinsic forces generated by molecular motors(1-3), extrinsic forces exerted by adjacent cells(4-7) and mechanical resistance forces due to tissue elasticity or friction(8-10). Understanding how mechanical forces influence morphogenesis at the cellular and molecular level remains a challenge(1). Recent work has outlined how small incremental steps power cell-autonomous epithelial shape changes(1-3), which suggests the existence of specific mechanisms that stabilize cell shapes and counteract cell elasticity. Beyond the twofold stage, embryonic elongation in Caenorhabditis elegans is dependent on both muscle activity(7) and the epidermis; the tension generated by muscle activity triggers a mechanotransduction pathway in the epidermis that promotes axis elongation(7). Here we identify a network that stabilizes cell shapes in C. elegans embryos at a stage that involves non-autonomous mechanical interactions between epithelia and contractile cells. We searched for factors genetically or molecularly interacting with the p21-activating kinase homologue PAK-1 and acting in this pathway, thereby identifying the a-spectrin SPC-1. Combined absence of PAK-1 and SPC-1 induced complete axis retraction, owing to defective epidermal actin stress fibre. Modelling predicts that a mechanical viscoplastic deformation process can account for embryo shape stabilization. Molecular analysis suggests that the cellular basis for viscoplasticity originates from progressive shortening of epidermal microfilaments that are induced by muscle contractions relayed by actin-severing proteins and from formin homology 2 domain-containing protein 1 (FHOD-1) formin bundling. Our work thus identifies an essential molecular lock acting in a developmental ratchet-like process.	[Lardennois, Alicia; Ferraro, Teresa; Llense, Flora; Labouesse, Michel] Sorbonne Univ, IBPS, CNRS, UMR7622, Paris, France; [Pasti, Gabriella; Pontabry, Julien; Rodriguez, David; Kim, Samantha; Gally, Christelle; Labouesse, Michel] Univ Strasbourg, Dev & Stem Cells Dept, IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France; [Mahou, Pierre; Beaurepaire, Emmanuel] Ecole Polytech, CNRS, UMR7645, Lab Opt & Biosci,INSERM,U1182, Paris, France; [Pontabry, Julien] RS2D, Mundolsheim, France; [Ono, Shoichiro] Emory Univ, Sch Med, Dept Pathol, Winship Canc Inst, Atlanta, GA 30322 USA; [Ono, Shoichiro] Emory Univ, Sch Med, Dept Cell Biol, Winship Canc Inst, Atlanta, GA USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Emory University; Emory University	Labouesse, M (corresponding author), Sorbonne Univ, IBPS, CNRS, UMR7622, Paris, France.; Labouesse, M (corresponding author), Univ Strasbourg, Dev & Stem Cells Dept, IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France.	michel.labouesse@sorbonne-universite.fr	Ono, Shoichiro/A-6475-2015; Beaurepaire, Emmanuel/C-6343-2014; Mahou, Pierre/F-2089-2017	Ono, Shoichiro/0000-0002-4763-0398; Beaurepaire, Emmanuel/0000-0002-2082-8214; Mahou, Pierre/0000-0003-4452-1011; labouesse, michel/0000-0001-7995-5843; Lardennois, Alicia/0000-0002-5054-7448	NIH Office of Research Infrastructure Programs [P40 OD010440]; Agence Nationale pour la Recherche; European Research Council [294744]; Israel-France Maimonide exchange program grants; University Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale [FDT201805005501]; CNRS, University of Strasbourg; UPMC; UPMC [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]; Agence Nationale de la Recherche [ANR-11-EQPX-0029 Morphoscope2]; National Institutes of Health [AR048615]; Centre National de la Recherche Scientifique (CNRS); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Israel-France Maimonide exchange program grants; University Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS, University of Strasbourg; UPMC; UPMC; Agence Nationale de la Recherche(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank A. Spang, S. Grill, Y. Bellaiche and R. Voituriez for critical comments on the manuscript and M. Gettings for improving the English. We also thank the Caenorhabditis Genetics Center (funded by the NIH Office of Research Infrastructure Programs P40 OD010440) and National BioResource Project at Tokyo Women's Medical University for strains, the IBPS Imaging Facility for advice. This work was supported by the Agence Nationale pour la Recherche, the European Research Council (grant no. 294744), Israel-France Maimonide exchange program grants, and installation funds from the Centre National de la Recherche Scientifique (CNRS) and University Pierre et Marie Curie (UPMC) to M.L. A.L. was supported by a fellowship from the Fondation pour la Recherche Medicale (FDT201805005501). This work was also made possible by institutional funds from the CNRS, University of Strasbourg and UPMC, the grant ANR-10-LABX-0030-INRT, which is a French State fund managed by the Agence Nationale de la Recherche under the framework programme Investissements d'Avenir labelled ANR-10-IDEX-0002-02 to the IGBMC. The work of P. M. and E. B. was partly supported by the Agence Nationale de la Recherche (contract ANR-11-EQPX-0029 Morphoscope2), the work of S.O. was partly supported by the National Institutes of Health (grant AR048615).	Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bonakdar N, 2016, NAT MATER, V15, P1090, DOI [10.1038/nmat4689, 10.1038/NMAT4689]; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BRENNER S, 1974, GENETICS, V77, P71; Collinet C, 2015, NAT CELL BIOL, V17, P1247, DOI 10.1038/ncb3226; Costa M, 1997, DEV BIOL, V184, P373, DOI 10.1006/dbio.1997.8530; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Dierkes K, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.148102; Doubrovinski K, 2017, P NATL ACAD SCI USA, V114, P1051, DOI 10.1073/pnas.1616659114; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gally C, 2016, METHOD ENZYMOL, V569, P407, DOI 10.1016/bs.mie.2015.05.005; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Gilmour D, 2017, NATURE, V541, P311, DOI 10.1038/nature21348; Gomes JE, 2013, J CELL BIOL, V202, P431, DOI 10.1083/jcb.201304174; Gonzalez R. C., 2006, PEARSON ED, V3rd, P8; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lei MM, 2012, J CELL BIOL, V198, P87, DOI 10.1083/jcb.201202053; Lye CM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002292; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Matthews I, 2004, IEEE T PATTERN ANAL, V26, P810, DOI 10.1109/TPAMI.2004.16; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; Munoz JJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012708; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Naganathan SR, 2018, ELIFE, V7, DOI 10.7554/eLife.37677; Praitis V, 2005, DEV BIOL, V283, P157, DOI 10.1016/j.ydbio.2005.04.002; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Schonichen A, 2013, J CELL SCI, V126, P1891, DOI 10.1242/jcs.126706; Simoes SD, 2014, J CELL BIOL, V204, P575, DOI 10.1083/jcb.201307070; Vuong-Brender TTK, 2017, DEVELOPMENT, V144, P4336, DOI 10.1242/dev.150383; Vanneste Chrisotpher A, 2013, Worm, V2, pe25040, DOI 10.4161/worm.25040; Vasquez CG, 2014, J CELL BIOL, V206, P435, DOI 10.1083/jcb.201402004; Vuong-Brender TTK, 2016, CURR TOP DEV BIOL, V116, P597, DOI 10.1016/bs.ctdb.2015.11.012; Vuong-Brender TTK, 2017, ELIFE, V6, DOI [10.7554/eLife.23866, 10.17554/eLife.23866, 10.7554/elife.23866]; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	40	33	33	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					266	+		10.1038/s41586-019-1509-4	http://dx.doi.org/10.1038/s41586-019-1509-4			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31462781	Green Submitted, Green Accepted			2022-12-28	WOS:000485415400056
J	Brittenden, J; Cooper, D; Dimitrova, M; Scotland, G; Cotton, SC; Elders, A; MacLennan, G; Ramsay, CR; Norrie, J; Burr, JM; Campbell, B; Bachoo, P; Chetter, I; Gough, M; Earnshaw, J; Lees, T; Scott, J; Baker, SA; Tassie, E; Francis, J; Campbell, MK				Brittenden, Julie; Cooper, David; Dimitrova, Maria; Scotland, Graham; Cotton, Seonaidh C.; Elders, Andrew; MacLennan, Graeme; Ramsay, Craig R.; Norrie, John; Burr, Jennifer M.; Campbell, Bruce; Bachoo, Paul; Chetter, Ian; Gough, Michael; Earnshaw, Jonothan; Lees, Tim; Scott, Julian; Baker, Sara A.; Tassie, Emma; Francis, Jill; Campbell, Marion K.			Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOVENOUS LASER-ABLATION; GREAT SAPHENOUS-VEIN; GUIDED FOAM SCLEROTHERAPY; QUALITY-OF-LIFE; CLINICAL-TRIAL; COST-EFFECTIVENESS; FOLLOW-UP; CONVENTIONAL SURGERY; HIGH LIGATION; HEALTH	Background Endovenous laser ablation and ultrasound-guided foam sclerotherapy are recommended alternatives to surgery for the treatment of primary varicose veins, but their long-term comparative effectiveness remains uncertain. Methods In a randomized, controlled trial involving 798 participants with primary varicose veins at 11 centers in the United Kingdom, we compared the outcomes of laser ablation, foam sclerotherapy, and surgery. Primary outcomes at 5 years were disease-specific quality of life and generic quality of life, as well as cost-effectiveness based on models of expected costs and quality-adjusted life-years (QALYs) gained that used data on participants' treatment costs and scores on the EuroQol EQ-5D questionnaire. Results Quality-of-life questionnaires were completed by 595 (75%) of the 798 trial participants. After adjustment for baseline scores and other covariates, scores on the Aberdeen Varicose Vein Questionnaire (on which scores range from 0 to 100, with lower scores indicating a better quality of life) were lower among patients who underwent laser ablation or surgery than among those who underwent foam sclerotherapy (effect size [adjusted differences between groups] for laser ablation vs. foam sclerotherapy, -2.86; 95% confidence interval [CI], -4.49 to -1.22; P<0.001; and for surgery vs. foam sclerotherapy, -2.60; 95% CI, -3.99 to -1.22; P<0.001). Generic quality-of-life measures did not differ among treatment groups. At a threshold willingness-to-pay ratio of 20,000 pound ($28,433 in U.S. dollars) per QALY, 77.2% of the cost-effectiveness model iterations favored laser ablation. In a two-way comparison between foam sclerotherapy and surgery, 54.5% of the model iterations favored surgery. Conclusions In a randomized trial of treatments for varicose veins, disease-specific quality of life 5 years after treatment was better after laser ablation or surgery than after foam sclerotherapy. The majority of the probabilistic cost-effectiveness model iterations favored laser ablation at a willingness-to-pay ratio of 20,000 pound ($28,433) per QALY.	[Brittenden, Julie] Univ Glasgow, Inst Cardiovasc Res, Glasgow G81 4HX, Lanark, Scotland; [Elders, Andrew] Glasgow Caledonian Univ, Inst Appl Hlth Res, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow, Lanark, Scotland; [Cooper, David; Cotton, Seonaidh C.; MacLennan, Graeme; Ramsay, Craig R.; Campbell, Marion K.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Dimitrova, Maria; Scotland, Graham; Tassie, Emma] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [Bachoo, Paul] NHS Grampian, Aberdeen Royal Infirm, Dept Vasc Surg, Aberdeen, Scotland; [Norrie, John] Univ Edinburgh, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Burr, Jennifer M.] Univ St Andrews, Sch Med Med & Biol Sci, St Andrews, Fife, Scotland; [Campbell, Bruce] Royal Devon & Exeter Hosp, Dept Vasc Surg, Exeter, Devon, England; [Chetter, Ian] Hull Royal Infirm, Dept Vasc Surg, Kingston Upon Hull, N Humberside, England; [Gough, Michael] Univ Leeds, Sch Surg, Leeds, W Yorkshire, England; [Scott, Julian] St James Univ Hosp, Vasc Surg, Leeds, W Yorkshire, England; [Earnshaw, Jonothan] Gloucestershire Royal Hosp, Vasc Surg, Gloucester, England; [Lees, Tim] Freeman Rd Hosp, Vasc Surg, Newcastle Upon Tyne, Tyne & Wear, England; [Baker, Sara A.] Royal Bournemouth Hosp, Vasc Surg Unit, Bournemouth, Dorset, England; [Francis, Jill] City Univ London, Sch Hlth Sci, London, England	University of Glasgow; Glasgow Caledonian University; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Edinburgh; University of St Andrews; University of Exeter; University of Hull; University of Leeds; Saint James's University Hospital; Gloucestershire Royal Hospital; Newcastle Freeman Hospital; Newcastle University - UK; City University London	Brittenden, J (corresponding author), Univ Glasgow, Inst Cardiovasc Res, Glasgow G81 4HX, Lanark, Scotland.	julie.brittenden@glasgow.ac.uk	Francis, Jill/AHE-6998-2022; Ramsay, Craig/AAD-8249-2021; Campbell, Marion/ABB-7063-2020; Elders, Andrew/N-4195-2015	Ramsay, Craig/0000-0003-4043-7349; chetter, ian/0000-0002-2566-6859; Campbell, Marion/0000-0001-5386-4097; MacLennan, Graeme/0000-0002-1039-5646; Elders, Andrew/0000-0003-4172-4702; Francis, Jill/0000-0001-5784-8895; Burr, Jennifer/0000-0002-9478-738X	Health Technology Assessment Programme [06/45/02] Funding Source: Medline; Department of Health [06/45/02, 06/45/501] Funding Source: Medline; Chief Scientist Office [HERU1, HSRU1] Funding Source: Medline	Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Department of Health; Chief Scientist Office		[Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19270; Beresford T, 2003, PHLEBOLOGY, V18, P35, DOI 10.1258/026835503321236885; Biemans AAM, 2013, J VASC SURG, V58, P727, DOI 10.1016/j.jvs.2012.12.074; Brittenden J, 2014, NEW ENGL J MED, V371, P1218, DOI 10.1056/NEJMoa1400781; Carradice D, 2011, BRIT J SURG, V98, P501, DOI 10.1002/bjs.7394; Carroll C, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17480; Christenson JT, 2010, J VASC SURG, V52, P1234, DOI 10.1016/j.jvs.2010.06.104; Darwood RJ, 2008, BRIT J SURG, V95, P294, DOI 10.1002/bjs.6101; Garratt A M, 1993, Qual Health Care, V2, P5, DOI 10.1136/qshc.2.1.5; Garratt AM, 1996, QUAL LIFE RES, V5, P223, DOI 10.1007/BF00434744; Gauw SA, 2016, J VASC SURG, V63, P420, DOI 10.1016/j.jvs.2015.08.084; Gohel MS, 2010, BRIT J SURG, V97, P1815, DOI 10.1002/bjs.7256; Klem TMAL, 2009, EUR J VASC ENDOVASC, V37, P232, DOI 10.1016/j.ejvs.2008.08.025; Lattimer CR, 2012, EUR J VASC ENDOVASC, V43, P594, DOI 10.1016/j.ejvs.2012.01.032; Lawaetz M, 2017, INT ANGIOL, V36, P281, DOI 10.23736/S0392-9590.17.03827-5; Marsden G, 2015, EUR J VASC ENDOVASC, V50, P794, DOI 10.1016/j.ejvs.2015.07.034; National Institute of Health and Care Excellence, 2013, VAR VEINS DIAGN MAN; Rasmussen LH, 2011, BRIT J SURG, V98, P1079, DOI 10.1002/bjs.7555; Rasmussen LH, 2010, EUR J VASC ENDOVASC, V39, P630, DOI 10.1016/j.ejvs.2009.11.040; Rasmussen Lars, 2013, J Vasc Surg Venous Lymphat Disord, V1, P349, DOI 10.1016/j.jvsv.2013.04.008; Rasmussen L, 2013, J VASC SURG, V58, P421, DOI 10.1016/j.jvs.2012.12.048; Rass K, 2015, EUR J VASC ENDOVASC, V50, P648, DOI 10.1016/j.ejvs.2015.07.020; Rass K, 2012, ARCH DERMATOL, V148, P49, DOI 10.1001/archdermatol.2011.272; Samuel N, 2013, ANN SURG, V257, P419, DOI 10.1097/SLA.0b013e318275f4e4; Shadid N, 2012, BRIT J SURG, V99, P1062, DOI 10.1002/bjs.8781; Smith JJ, 1999, J VASC SURG, V30, P710, DOI 10.1016/S0741-5214(99)70110-2; Tassie E, 2014, BRIT J SURG, V101, P1532, DOI 10.1002/bjs.9595; Vahaaho S, 2018, BRIT J SURG, V105, P686, DOI 10.1002/bjs.10757; van der Velden SK, 2015, BRIT J SURG, V102, P1184, DOI 10.1002/bjs.9867; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	30	36	40	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					912	922		10.1056/NEJMoa1805186	http://dx.doi.org/10.1056/NEJMoa1805186			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW9PR	31483962	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000485326200006
J	Iakoucheva, LM; Muotri, AR; Sebat, J				Iakoucheva, Lilia M.; Muotri, Alysson R.; Sebat, Jonathan			Getting to the Cores of Autism	CELL			English	Review							DE-NOVO MUTATIONS; SPECTRUM DISORDER; TRANSCRIPTIONAL REGULATION; BRAIN-DEVELOPMENT; PROTEIN NETWORK; ONSET SEIZURES; GENETIC RISK; MOUSE MODEL; NEURONS; RARE	The genetic architecture of autism spectrum disorder (ASD) is itself a diverse allelic spectrum that consists of rare de novo or inherited variants in hundreds of genes and common polygenic risk at thousands of loci. ASD suscepnility genes are interconnected at the level of transcriptional and protein networks, and many function as genetic regulators of neurodevelopment or synaptic proteins that regulate neural activity. So that the core underlying neuropathologies can be further elucidated, we emphasize the importance of first defining subtypes of ASD on the basis of the phenotypic signatures of genes in model systems and humans.	[Iakoucheva, Lilia M.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Muotri, Alysson R.; Sebat, Jonathan] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Psychiat Genom, La Jolla, CA 92093 USA; [Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat, Rady Childrens Hosp San Diego, La Jolla, CA 92093 USA; [Muotri, Alysson R.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [Muotri, Alysson R.] CARTA, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Sebat, J (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Beyster Ctr Psychiat Genom, La Jolla, CA 92093 USA.	jsebat@ucsd.edu		Iakoucheva, Lilia/0000-0002-4542-5219	NIH [R21MH113179, U01MH109501, R01MH113715, R01MH109885, R01MH108528, R21MH104766]; Simons Foundation Autism Research Initiative (SFARI) [606768]; SFARI [345469]; NARSAD Independent Investigator Grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH113715, U01MH109501, U01MH119746, R01MH108528, R21MH113179, R01MH109885, R01MH105524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative (SFARI); SFARI; NARSAD Independent Investigator Grant(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Beyster Center for Psychiatric Genomics is supported by a gift from the Beyster Family Foundation. J.S. is supported by grants from the NIH (R21MH113179, U01MH109501, and R01MH113715) and the Simons Foundation Autism Research Initiative (SFARI) (606768). L.I. is supported by NIH (R01MH109885, R01MH108528, and R21MH104766 and SFARI (345469). A.M. is supported by SFARI (345469) and a NARSAD Independent Investigator Grant.	Adviento B, 2014, J MED GENET, V51, P10, DOI 10.1136/jmedgenet-2013-101951; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9; [Anonymous], 2018, NESTED OSCILLATORY D, DOI DOI 10.1101/358622; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Araujo DJ, 2015, GENE DEV, V29, P2081, DOI 10.1101/gad.267989.115; Archer HL, 2006, J MED GENET, V43, P729, DOI 10.1136/jmg.2006.041467; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bergen SE, 2019, AM J PSYCHIAT, V176, P29, DOI 10.1176/appi.ajp.2018.17040467; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Blizinsky KD, 2016, P NATL ACAD SCI USA, V113, P8520, DOI 10.1073/pnas.1607014113; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brandler WM, 2018, SCIENCE, V360, P327, DOI 10.1126/science.aan2261; Brandler WM, 2016, AM J HUM GENET, V98, P667, DOI 10.1016/j.ajhg.2016.02.018; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Corominas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4650; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Courcet JB, 2012, J MED GENET, V49, P731, DOI 10.1136/jmedgenet-2012-101251; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Cox NJ., 2017, J PSYCHIAT BRAIN SCI, V2, pS5; Cox R. A., 1990, CLIN METHODS HIST PH, V3rd; Crespi BJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00300; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; D'Angelo D, 2016, JAMA PSYCHIAT, V73, P20, DOI 10.1001/jamapsychiatry.2015.2123; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2015, HUM MOL GENET, V24, pR24, DOI 10.1093/hmg/ddv273; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deliu E, 2018, NAT NEUROSCI, V21, P1717, DOI 10.1038/s41593-018-0266-2; Deneault E, 2019, STEM CELL REP, V12, P427, DOI 10.1016/j.stemcr.2019.01.008; Deneault E, 2019, ELIFE, V8, DOI 10.7554/eLife.40092; Deneault E, 2018, STEM CELL REP, V11, P1211, DOI 10.1016/j.stemcr.2018.10.003; Deshpande A, 2018, DEV NEUROBIOL, V78, P519, DOI 10.1002/dneu.22587; Deshpande A, 2017, CELL REP, V21, P2678, DOI 10.1016/j.celrep.2017.11.037; Doers ME, 2014, STEM CELLS DEV, V23, P1777, DOI 10.1089/scd.2014.0030; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Durak O, 2016, NAT NEUROSCI, V19, P1477, DOI 10.1038/nn.4400; Ernst C, 2016, TRENDS NEUROSCI, V39, P290, DOI 10.1016/j.tins.2016.03.001; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Faridar A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-57; Feliciano P, 2018, NEURON, V97, P488, DOI 10.1016/j.neuron.2018.01.015; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Franke B, 2016, NAT NEUROSCI, V19, P420, DOI 10.1038/nn.4228; French JA, 2016, LANCET, V388, P2153, DOI 10.1016/S0140-6736(16)31419-2; Gamsiz ED, 2013, AM J HUM GENET, V93, P103, DOI 10.1016/j.ajhg.2013.06.004; Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Georgiades S, 2013, J CHILD PSYCHOL PSYC, V54, P206, DOI 10.1111/j.1469-7610.2012.02588.x; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Grove J., 2017, BIORXIV; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Gupta S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6748; Gur RE, 2017, MOL PSYCHIATR, V22, P1664, DOI 10.1038/mp.2017.161; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hippolyte L, 2016, BIOL PSYCHIAT, V80, P129, DOI 10.1016/j.biopsych.2015.10.021; Iacono WG, 2014, PSYCHOPHYSIOLOGY, V51, P1339, DOI 10.1111/psyp.12358; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; Iossifov I, 2015, P NATL ACAD SCI USA, V112, pE5600, DOI 10.1073/pnas.1516376112; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lin A, 2017, J NEUROSCI, V37, P6183, DOI 10.1523/JNEUROSCI.3759-16.2017; Lin GN, 2015, NEURON, V85, P742, DOI 10.1016/j.neuron.2015.01.010; Liu X., 2018, BIORXIV; Lugtenberg D, 2009, EUR J HUM GENET, V17, P444, DOI 10.1038/ejhg.2008.208; Luo Y., 2018, BIOINFORMATICS; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martin HC, 2018, SCIENCE, V362, P1161, DOI 10.1126/science.aar6731; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Monks S, 2014, SCHIZOPHR RES, V153, P231, DOI 10.1016/j.schres.2014.01.020; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Niemi MEK, 2018, NATURE, V562, P268, DOI 10.1038/s41586-018-0566-4; Notwell JH, 2016, GENOME RES, V26, P1013, DOI 10.1101/gr.203612.115; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Peter D, 2017, GENE DEV, V31, P1147, DOI 10.1101/gad.299420.117; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pizzo L, 2019, GENET MED, V21, P816, DOI 10.1038/s41436-018-0266-3; Polleux F, 2007, NAT REV NEUROSCI, V8, P331, DOI 10.1038/nrn2118; Pucilowska J, 2015, J NEUROSCI, V35, P3190, DOI 10.1523/JNEUROSCI.4864-13.2015; Qiu Y., 2019, BIORXIV, DOI [10.1101/540732, DOI 10.1101/540732]; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Satterstrom FK, 2018, BIORXIV, DOI 10.1101/277707; Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009; Vasileiou G, 2015, AM J HUM GENET, V97, P445, DOI 10.1016/j.ajhg.2015.08.002; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067; Wang HS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00028; Weiner DJ, 2017, NAT GENET, V49, P978, DOI 10.1038/ng.3863; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wray NR, 2018, CELL, V173, P1573, DOI 10.1016/j.cell.2018.05.051; Yi F, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2669; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zaslaysky K, 2019, NAT NEUROSCI, V22, P556, DOI 10.1038/s41593-019-0365-8	123	109	114	7	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2019	178	6					1287	1298		10.1016/j.cell.2019.07.037	http://dx.doi.org/10.1016/j.cell.2019.07.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	IV0QF	31491383	Bronze, Green Accepted			2022-12-28	WOS:000483983000007
J	Mahase, E				Mahase, Elisabeth			Obesity: raising price of sugary snacks may be more effective than soft drink tax	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BRIGGS ADM, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6189; HAWKES N, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I1661; Public Health England, 2018, NATL DIET NUTR SURVE; Scheelbeek PFD, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4786	4	1	1	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2019	366								l5436	10.1136/bmj.l5436	http://dx.doi.org/10.1136/bmj.l5436			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1GZ	31488425				2022-12-28	WOS:000485441400006
J	Santiago-Lopez, A				Santiago-Lopez, Angel			PhD project tips	NATURE			English	Editorial Material									[Santiago-Lopez, Angel] Georgia Inst Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Santiago-Lopez, A (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.								0	0	0	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2019	573	7772					153	153		10.1038/d41586-018-07860-6	http://dx.doi.org/10.1038/d41586-018-07860-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0KI	31481765	Bronze			2022-12-28	WOS:000483967700054
J	Yoshida, N; Tsuchida, Y				Yoshida, Naoki; Tsuchida, Yoshihiko			Boxer's Fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yoshida, Naoki] Tohoku Univ Hosp, Sendai, Miyagi, Japan; [Tsuchida, Yoshihiko] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan	Tohoku University	Yoshida, N (corresponding author), Tohoku Univ Hosp, Sendai, Miyagi, Japan.	naoki.yoshida.d6@tohoku.ac.jp	Badheka, Aditya/V-4490-2019	Badheka, Aditya/0000-0002-9599-0996; Yoshida, Naoki/0000-0002-7954-1445					0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2019	381	10					969	969		10.1056/NEJMicm1813737	http://dx.doi.org/10.1056/NEJMicm1813737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IW9PR	31483967				2022-12-28	WOS:000485326200011
J	Foster, MT; Moxon, CA; Weir, E; Sinha, A				Foster, Mitchell T.; Moxon, Christopher A.; Weir, Elaine; Sinha, Ajay			Dermal sinus tracts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MAGNETIC-RESONANCE; SPINAL DYSRAPHISM		[Foster, Mitchell T.; Sinha, Ajay] Alder Hey NHS Fdn Trust, Dept Neurosurg, Liverpool L12 2AP, Merseyside, England; [Moxon, Christopher A.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Ctr Integrat Parasitol, Glasgow, Lanark, Scotland; [Moxon, Christopher A.] NHS Greater Glasgow & Clyde, Royal Hosp Children, Dept Pediat, Glasgow, Lanark, Scotland; [Weir, Elaine] Alder Hey NHS Fdn Trust, Dept Paediat Med, Liverpool, Merseyside, England	Alder Hey Children's NHS Foundation Trust; University of Glasgow; Alder Hey Children's NHS Foundation Trust	Foster, MT (corresponding author), Alder Hey NHS Fdn Trust, Dept Neurosurg, Liverpool L12 2AP, Merseyside, England.	mitchell.foster@doctors.org.uk						Ackerman LL, 2003, PEDIATRICS, V112, P641, DOI 10.1542/peds.112.3.641; Chern JJ, 2012, J NEUROSURG-PEDIATR, V10, P150, DOI 10.3171/2012.5.PEDS11564; Dho YS, 2015, J KOREAN NEUROSURG S, V57, P225, DOI 10.3340/jkns.2015.57.3.225; Dias MS, 2010, AAP NEWS, V31, P39; Emami-Naeini Parisa, 2008, Ther Clin Risk Manag, V4, P1143; Kumar J, 2017, WORLD J RADIOL, V9, P178, DOI 10.4329/wjr.v9.i4.178; Morioka T, 2017, NEUROPATHOLOGY, V37, P385, DOI 10.1111/neup.12382; Mostafa Mohammed, 2013, World J Clin Pediatr, V2, P26, DOI 10.5409/wjcp.v2.i3.26; Radmanesh F, 2010, CHILD NERV SYST, V26, P349, DOI 10.1007/s00381-009-0962-z; Ramnarayan R, 2006, CHILD NERV SYST, V22, P1220, DOI 10.1007/s00381-006-0073-z; Shaikh S, 2016, OXF MED CASE REP, P199, DOI 10.1093/omcr/omw052; Vankipuram S, 2017, BMJ CASE REP, V2017, DOI 10.1136/bcr-2017-222366.29269365	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l5202	10.1136/bmj.l5202	http://dx.doi.org/10.1136/bmj.l5202			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1FO	31484633				2022-12-28	WOS:000485437600003
J	Tong, TYN; Appleby, PN; Bradbury, KE; Perez-Cornago, A; Travis, RC; Clarke, R; Key, TJ				Tong, Tammy Y. N.; Appleby, Paul N.; Bradbury, Kathryn E.; Perez-Cornago, Aurora; Travis, Ruth C.; Clarke, Robert; Key, Timothy J.			Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIETARY ASSESSMENT METHODS; CROSS-SECTIONAL ANALYSIS; WEIGHED RECORDS; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; PLASMA-CONCENTRATIONS; SERUM CONCENTRATIONS; HEMORRHAGIC STROKE; CHOLESTEROL LEVELS; ADVENTIST HEALTH	OBJECTIVE To examine the associations of vegetarianism with risks of ischaemic heart disease and stroke. DESIGN Prospective cohort study. SETTING The EPIC-Oxford study, a cohort in the United Kingdom with a large proportion of non-meat eaters, recruited across the country between 1993 and 2001. PARTICIPANTS 48 188 participants with no history of ischaemic heart disease, stroke, or angina (or cardiovascular disease) were classified into three distinct diet groups: meat eaters (participants who consumed meat, regardless of whether they consumed fish, dairy, or eggs; n=24 428), fish eaters (consumed fish but no meat; n=7506), and vegetarians including vegans (n=16 254), based on dietary information collected at baseline, and subsequently around 2010 (n=28 364). MAIN OUTCOME MEASURES Incident cases of ischaemic heart disease and stroke (including ischaemic and haemorrhagic types) identified through record linkage until 2016. RESULTS Over 18.1 years of follow-up, 2820 cases of ischaemic heart disease and 1072 cases of total stroke (519 ischaemic stroke and 300 haemorrhagic stroke) were recorded. After adjusting for sociodemographic and lifestyle confounders, fish eaters and vegetarians had 13% (hazard ratio 0.87, 95% confidence interval 0.77 to 0.99) and 22% (0.78, 0.70 to 0.87) lower rates of ischaemic heart disease than meat eaters, respectively (P<0.001 for heterogeneity). This difference was equivalent to 10 fewer cases of ischaemic heart disease (95% confidence interval 6.7 to 13.1 fewer) in vegetarians than in meat eaters per 1000 population over 10 years. The associations for ischaemic heart disease were partly attenuated after adjustment for self reported high blood cholesterol, high blood pressure, diabetes, and body mass index (hazard ratio 0.90, 95% confidence interval 0.81 to 1.00 in vegetarians with all adjustments). By contrast, vegetarians had 20% higher rates of total stroke (hazard ratio 1.20, 95% confidence interval 1.02 to 1.40) than meat eaters, equivalent to three more cases of total stroke (95% confidence interval 0.8 to 5.4 more) per 1000 population over 10 years, mostly due to a higher rate of haemorrhagic stroke. The associations for stroke did not attenuate after further adjustment of disease risk factors. CONCLUSIONS In this prospective cohort in the UK, fish eaters and vegetarians had lower rates of ischaemic heart disease than meat eaters, although vegetarians had higher rates of haemorrhagic and total stroke.	[Tong, Tammy Y. N.; Appleby, Paul N.; Bradbury, Kathryn E.; Perez-Cornago, Aurora; Travis, Ruth C.; Key, Timothy J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Richard Doll Bldg, Oxford OX3 7LF, England; [Clarke, Robert] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Clarke, Robert] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Tong, TYN (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	tammy.tong@ndph.ox.ac.uk	Bradbury, Kathryn/I-2132-2019; Tong, Tammy YN/I-8770-2019; Perez-Cornago, Aurora/C-1097-2016	Bradbury, Kathryn/0000-0003-3345-7333; Tong, Tammy YN/0000-0002-0284-8959; Perez-Cornago, Aurora/0000-0002-5652-356X	UK Medical Research Council [MR/M012190/1]; Wellcome Trust Our Planet Our Health (Livestock, Environment, and People) [LEAP 205212/Z/16/Z]; Girdlers' New Zealand Health Research Council Fellowship; MRC [G0700474, MR/K02700X/1, MR/M012190/1, G9900923] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Our Planet Our Health (Livestock, Environment, and People); Girdlers' New Zealand Health Research Council Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work is supported by the UK Medical Research Council MR/M012190/1 and Wellcome Trust Our Planet Our Health (Livestock, Environment, and People, LEAP 205212/Z/16/Z). KEB is supported by the Girdlers' New Zealand Health Research Council Fellowship.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2015, CIRCULATION, DOI DOI 10.1161/CIR.0000000000000207; Appleby PN, 2016, P NUTR SOC, V75, P287, DOI 10.1017/S0029665115004334; Appleby PN, 2016, AM J CLIN NUTR, V103, P218, DOI 10.3945/ajcn.115.119461; Appleby PN, 1999, AM J CLIN NUTR, V70, p525S, DOI 10.1093/ajcn/70.3.525s; Appleby PN, 2002, PUBLIC HEALTH NUTR, V5, P645, DOI 10.1079/PHN2002332; Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bates B, 2014, NATIONAL DIET AND NU; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Bradbury KE, 2014, EUR J CLIN NUTR, V68, P178, DOI 10.1038/ejcn.2013.248; Chang-Claude J, 2005, CANCER EPIDEM BIOMAR, V14, P963, DOI 10.1158/1055-9965.EPI-04-0696; Chiu YF, 2015, BRIT J NUTR, V114, P1313, DOI 10.1017/S0007114515002937; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Crowe FL, 2012, EUR J CLIN NUTR, V66, P950, DOI 10.1038/ejcn.2012.51; Crowe FL, 2013, AM J CLIN NUTR, V97, P597, DOI 10.3945/ajcn.112.044073; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dinu M, 2017, CRIT REV FOOD SCI, V57, P3640, DOI 10.1080/10408398.2016.1138447; DONG H, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0137533; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gilsing AMJ, 2010, EUR J CLIN NUTR, V64, P933, DOI 10.1038/ejcn.2010.142; Hindy G, 2018, STROKE, V49, P820, DOI 10.1161/STROKEAHA.117.019653; Holland B, 1991, MCCANCE AND WIDDOWSO; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Kinjo Y, 1999, J Epidemiol, V9, P268; Lacey B, 2018, LANCET GLOB HEALTH, V6, pE641, DOI [10.1016/S2214-109X(18)30217-1, 10.1016/s2214-109x(18)30217-1]; Leahy E, 2010, ESRI WORKING PAPER 3; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; McGreevy C, 2011, ANN INTERN MED, V155, P820, DOI 10.7326/0003-4819-155-12-201112200-00004; Ministry of Agriculture Fisheries and Food, 1993, FOOD PORTION SIZES; Orlich MJ, 2013, JAMA INTERN MED, V173, P1230, DOI 10.1001/jamainternmed.2013.6473; Rosell MS, 2005, AM J CLIN NUTR, V82, P327, DOI 10.1093/ajcn/82.2.327; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Sauvaget C, 2004, STROKE, V35, P1531, DOI 10.1161/01.STR.0000130426.52064.09; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74; Sobiecki JG, 2016, NUTR RES, V36, P464, DOI 10.1016/j.nutres.2015.12.016; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Sun LL, 2019, NAT MED, V25, P569, DOI 10.1038/s41591-019-0366-x; TAKEYA Y, 1984, STROKE, V15, P15, DOI 10.1161/01.STR.15.1.15; The Vegan Society, 2016, FIND OUT HOW MANY VE; THOROGOOD M, 1987, BMJ-BRIT MED J, V295, P351, DOI 10.1136/bmj.295.6594.351; Tong TYN, 2018, AM J CLIN NUTR, V107, P909, DOI 10.1093/ajcn/nqy042; Tong TYN, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018245; Tonstad S, 2013, NUTR METAB CARDIOVAS, V23, P292, DOI 10.1016/j.numecd.2011.07.004; Townsend P., 1979, POVERTY IN THE UNITE; Wang X, 2013, STROKE, V44, P1833, DOI 10.1161/STROKEAHA.113.001326; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wilson NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080277; Wright FL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-161; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460	62	60	61	3	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2019	366								l4897	10.1136/bmj.l4897	http://dx.doi.org/10.1136/bmj.l4897			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX1FO	31484644	Green Published, hybrid			2022-12-28	WOS:000485437600002
J	Molitor, N; Steffel, J; Duru, F; Saguner, AM				Molitor, Nadine; Steffel, Jan; Duru, Firat; Saguner, Ardan M.			Salty water stymies shock from an implantable defibrillator?	LANCET			English	Editorial Material									[Molitor, Nadine; Steffel, Jan; Duru, Firat; Saguner, Ardan M.] Univ Hosp, Univ Heart Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Saguner, AM (corresponding author), Univ Hosp, Univ Heart Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland.	ardan.saguner@usz.ch	Saguner, Ardan M./AAV-3624-2020	Duru, Firat/0000-0002-4748-0158; Molitor, Nadine/0000-0003-2544-7354					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2019	394	10200					780	780		10.1016/S0140-6736(19)31876-8	http://dx.doi.org/10.1016/S0140-6736(19)31876-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UW	31478501				2022-12-28	WOS:000483011400030
J	Pennisi, E				Pennisi, Elizabeth			THE ALLURE OF MONKEYFLOWERS	SCIENCE			English	Editorial Material																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2019	365	6456					854	857		10.1126/science.365.6456.854	http://dx.doi.org/10.1126/science.365.6456.854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV0NL	31467205				2022-12-28	WOS:000483975800022
J	Cook, R; Lamont, T; Martin, R				Cook, Rob; Lamont, Tara; Martin, Rosie		NIHR Dissemination Ctr	Smartphones can improve adherence rates for TB treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study Story A, Aldridge R, Smith C, et al. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.	[Cook, Rob; Martin, Rosie] Bazian, Economist Intelligence Unit Healthcare, London, England; [Lamont, Tara] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com						National Institute for Health and Care Excellence, 2016, TUB NG33; Public Health England, 2018, TUB ENGL 2018 PRES D; WHO, 2017, TREATMENT TUBERCULOS; World Health Organization, 2018, GLOB TUB REP 2018 EX	4	1	1	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2019	366								l4920	10.1136/bmj.l4920	http://dx.doi.org/10.1136/bmj.l4920			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HS	31466942				2022-12-28	WOS:000483892600003
J	Zhou, F; Wang, R; Yuan, P; Ren, YX; Mao, YU; Li, R; Lian, Y; Li, JS; Wen, L; Yan, LY; Qiao, J; Tang, FC				Zhou, Fan; Wang, Rui; Yuan, Peng; Ren, Yixin; Mao, Yunuo; Li, Rong; Lian, Ying; Li, Junsheng; Wen, Lu; Yan, Liying; Qiao, Jie; Tang, Fuchou			Reconstituting the transcriptome and DNA methylome landscapes of human implantation	NATURE			English	Article							X-CHROMOSOME; SELF-ORGANIZATION; MOUSE; HETEROGENEITY; COORDINATE; EXPRESSION; MAMMALS; EMBRYO; GENES; CELLS	Implantation is a milestone event during mammalian embryogenesis. Implantation failure is a considerable cause of early pregnancy loss in humans(1). Owing to the difficulty of obtaining human embryos early after implantation in vivo, it remains unclear how the gene regulatory network and epigenetic mechanisms control the implantation process. Here, by combining an in vitro culture system for the development human embryos after implantation and single-cell multi-omics sequencing technologies, more than 8,000 individual cells from 65 human peri-implantation embryos were systematically analysed. Unsupervised dimensionality reduction and clustering algorithms of the transcriptome data show stepwise implantation routes for the epiblast, primitive endoderm and trophectoderm lineages, suggesting robust preparation for the proper establishment of a mother-to-offspring connection during implantation. Female embryos showed initiation of random X chromosome inactivation based on analysis of parental allele-specific expression of X-chromosome-linked genes during implantation. Notably, using single-cell triple omics sequencing analysis, the re-methylation of the genome in cells from the primitive endoderm lineage was shown to be much slower than in cells of both epiblast and trophectoderm lineages during the implantation process, which indicates that there are distinct re-establishment features in the DNA methylome of the epiblast and primitive endoderm-even though both lineages are derived from the inner cell mass. Collectively, our work provides insights into the complex molecular mechanisms that regulate the implantation of human embryos, and helps to advance future efforts to understanding early embryonic development and reproductive medicine.	[Zhou, Fan; Wang, Rui; Yuan, Peng; Ren, Yixin; Mao, Yunuo; Li, Rong; Lian, Ying; Li, Junsheng; Wen, Lu; Yan, Liying; Qiao, Jie; Tang, Fuchou] Peking Univ, Sch Life Sci, Hosp 3, Beijing Adv Innovat Ctr Genom,Dept Obstet & Gynec, Beijing, Peoples R China; [Zhou, Fan; Wang, Rui; Mao, Yunuo; Wen, Lu; Yan, Liying; Qiao, Jie; Tang, Fuchou] Peking Univ, Hosp 3, Biomed Pioneering Innovat Ctr, Beijing, Peoples R China; [Zhou, Fan; Wang, Rui; Mao, Yunuo; Wen, Lu; Yan, Liying; Qiao, Jie; Tang, Fuchou] Peking Univ, Hosp 3, Ctr Reprod Med, Beijing, Peoples R China; [Yuan, Peng; Ren, Yixin; Li, Rong; Lian, Ying; Li, Junsheng; Yan, Liying; Qiao, Jie; Tang, Fuchou] Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China; [Yuan, Peng; Ren, Yixin; Li, Rong; Lian, Ying; Li, Junsheng; Yan, Liying; Qiao, Jie; Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China; [Yan, Liying; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China; [Qiao, Jie; Tang, Fuchou] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Qiao, Jie; Tang, Fuchou] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Qiao, J; Tang, FC (corresponding author), Peking Univ, Sch Life Sci, Hosp 3, Beijing Adv Innovat Ctr Genom,Dept Obstet & Gynec, Beijing, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Peking Univ, Hosp 3, Biomed Pioneering Innovat Ctr, Beijing, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Peking Univ, Hosp 3, Ctr Reprod Med, Beijing, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China.; Qiao, J (corresponding author), Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China.; Qiao, J; Tang, FC (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.	jie.qiao@263.net; tangfuchou@pku.edu.cn		Qiao, Jie/0000-0003-2126-1376	Beijing Municipal Science and Technology Commission [Z181100001318001]; National Natural Science Foundation of China [81521002, 31625018, 81730078]; National Basic Research Program of China [2017YFA0102702, 2018YFA0107601]; Young Elite Scientists Sponsorship Program by China Association for Science and Technology [YESS20160129]; Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences; China Postdoctoral Science Foundation [2017M610015, 2017T100015]; Beijing Advanced Innovation Center for Genomics at Peking University	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Young Elite Scientists Sponsorship Program by China Association for Science and Technology; Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Advanced Innovation Center for Genomics at Peking University	We thank D. Xie and J. Zhou for discussions and Y. Hu, X. Fan, D. Liu, Y. Yuan and Y. Cui for technical help in pilot experiments; C. Shan from National Center for Protein Sciences at Peking University for immunofluorescence imaging and analysis. This work was supported by grants from the Beijing Municipal Science and Technology Commission (Z181100001318001), the National Natural Science Foundation of China (81521002, 31625018 and 81730078) and National Basic Research Program of China (2017YFA0102702 and 2018YFA0107601). F.Z. was supported by Young Elite Scientists Sponsorship Program by China Association for Science and Technology (YESS20160129), the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences and the grant from China Postdoctoral Science Foundation (2017M610015 and 2017T100015). F.Z. was a Bayer Postdoc of the Bayer-Peking University Center for Translational Research. This work was supported by the Beijing Advanced Innovation Center for Genomics at Peking University. Part of the computational analyses was performed on the High Performance Computing Platform of the Center for Life Science.	Bian SH, 2018, SCIENCE, V362, P1060, DOI 10.1126/science.aao3791; Brockdorff N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019406; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; Dickens BM, 2008, MED LAW, V27, P179; Gao S, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0105-4; Gerovska D, 2016, MOL HUM REPROD, V22, P208, DOI 10.1093/molehr/gav072; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hou Y, 2016, CELL RES, V26, P304, DOI 10.1038/cr.2016.23; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Li YC, 2013, DEVELOPMENT, V140, P3965, DOI 10.1242/dev.092155; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; National Research Council and Institute of Medicine of the National Acadamies, 2010, FIN REP NAT AC HUM E; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Qiu W, 2005, BIOL REPROD, V72, P954, DOI 10.1095/biolreprod.104.036772; Sangrithi MN, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800024; Shahbazi MN, 2017, NATURE, V552, P239, DOI 10.1038/nature24675; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Stirparo GG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158501; Vallot C, 2017, CELL STEM CELL, V20, P102, DOI 10.1016/j.stem.2016.10.014; Yadgary L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-690; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195	26	127	131	11	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 29	2019	572	7771					660	+		10.1038/s41586-019-1500-0	http://dx.doi.org/10.1038/s41586-019-1500-0			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU2JG	31435013				2022-12-28	WOS:000483405500055
J	Wise, J				Wise, Jacqui			Price hike makes access to patient data unaffordable, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McDonald T, 2019, BMJ	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2019	366								l5305	10.1136/bmj.l5305	http://dx.doi.org/10.1136/bmj.l5305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU9HJ	31462493				2022-12-28	WOS:000483891600008
J	Kuehn, B				Kuehn, Bridget			Less Addictive Cigarettes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					718	718		10.1001/jama.2019.11369	http://dx.doi.org/10.1001/jama.2019.11369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454020				2022-12-28	WOS:000483652500012
J	Slomski, A				Slomski, Anita			Improving Stroke Preparedness Among Blacks and Hispanics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2019	322	8					717	717		10.1001/jama.2019.12351	http://dx.doi.org/10.1001/jama.2019.12351			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU5UJ	31454040				2022-12-28	WOS:000483652500008
J	Patel, AA; Huffman, MD				Patel, Anushka A.; Huffman, Mark D.			Progressing polypills beyond concepts to outcomes	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE; INCOME COUNTRIES; MIDDLE-INCOME; PREVENTION; RISK; METAANALYSIS		[Patel, Anushka A.; Huffman, Mark D.] Univ New South Wales, George Inst Global Hlth, Sydney, NSW 2042, Australia; [Huffman, Mark D.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Northwestern University; Feinberg School of Medicine	Patel, AA (corresponding author), Univ New South Wales, George Inst Global Hlth, Sydney, NSW 2042, Australia.	apatel@georgeinstitute.org		Patel, Anushka/0000-0003-3825-4092				Bahiru E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009868.pub3; Huffman MD, 2017, LANCET, V389, P1055, DOI 10.1016/S0140-6736(17)30553-6; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Praveen D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6142-x; Roshandel G, 2019, LANCET, V394, P672, DOI 10.1016/S0140-6736(19)31791-X; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; World Health Organization, 2002, SEC PREV NONC DIS LO; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zheng SL, 2019, JAMA-J AM MED ASSOC, V321, P277, DOI 10.1001/jama.2018.20578	11	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2019	394	10199					617	619		10.1016/S0140-6736(19)31953-1	http://dx.doi.org/10.1016/S0140-6736(19)31953-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IT6UU	31448725				2022-12-28	WOS:000483011200013
J	Ballard, TC; Michalak, AM; McIsaac, GF; Rabalais, NN; Turner, RE				Ballard, Tristan C.; Michalak, Anna M.; McIsaac, Gregory F.; Rabalais, Nancy N.; Turner, R. Eugene			Comment on "Legacy nitrogen may prevent achievement of water quality goals in the Gulf of Mexico"	SCIENCE			English	Editorial Material							MISSISSIPPI RIVER; NITRATE LOSS; FERTILIZER	Van Meter et al. (Reports, 27 April 2018, p. 427) warn that achieving nitrogen reduction goals in the Gulf of Mexico will take decades as a result of legacy nitrogen effects. We discuss limitations of the modeling approach and demonstrate that legacy effects ranging from a few years to decades are equally consistent with observations. The presented time scales for system recovery are therefore highly uncertain.	[Ballard, Tristan C.; Michalak, Anna M.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Ballard, Tristan C.; Michalak, Anna M.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [McIsaac, Gregory F.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Rabalais, Nancy N.; Turner, R. Eugene] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Carnegie Institution for Science; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; Louisiana State University System; Louisiana State University	Ballard, TC (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.; Ballard, TC (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.	tballard@stanford.edu	Rabalais, Nancy N./AAD-2119-2021	McIsaac, Gregory/0000-0001-7761-6231; Ballard, Tristan/0000-0002-7110-3598; Rabalais, Nancy N./0000-0002-1514-837X				Castellano MJ, 2014, P NATL ACAD SCI USA, V111, pE766, DOI 10.1073/pnas.1321350111; David MB, 1997, J ENVIRON QUAL, V26, P1038, DOI 10.2134/jeq1997.00472425002600040015x; Donner SD, 2007, LIMNOL OCEANOGR, V52, P856, DOI 10.4319/lo.2007.52.2.0856; Dortch Q., 2001, COASTAL HYPOXIA CONS; Goolsby D.A., 1999, FLUX SOURCES NUTRIEN; Jaynes DB, 2004, J ENVIRON QUAL, V33, P669, DOI 10.2134/jeq2004.0669; Jaynes DB, 2001, J ENVIRON QUAL, V30, P1305, DOI 10.2134/jeq2001.3041305x; McIsaac GF, 2016, J ENVIRON QUAL, V45, P1268, DOI 10.2134/jeq2015.10.0531; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Rabalais NN, 2004, MAR POLLUT BULL, V49, P537, DOI 10.1016/j.marpolbul.2004.03.017; Sinha E, 2016, ENVIRON SCI TECHNOL, V50, P12874, DOI 10.1021/acs.est.6b04455; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Swaney DP, 2018, SCI TOTAL ENVIRON, V635, P498, DOI 10.1016/j.scitotenv.2018.04.027; Turner RE, 2004, MAR POLLUT BULL, V49, P548, DOI 10.1016/j.marpolbul.2004.03.013; Van Meter KJ, 2018, SCIENCE, V360, P427, DOI 10.1126/science.aar4462; Van Meter KJ, 2017, GLOBAL BIOGEOCHEM CY, V31, P2, DOI 10.1002/2016GB005498; Van Meter KJ, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035014	17	6	6	5	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2019	365	6455			SI				eaau8401	10.1126/science.aau8401	http://dx.doi.org/10.1126/science.aau8401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS9JH	31439764	Green Published			2022-12-28	WOS:000482464000001
J	Dyer, C				Dyer, Clare			GP is struck off after writing to colleague's patients claiming she had treated them inappropriately	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2019	366								l5278	10.1136/bmj.l5278	http://dx.doi.org/10.1136/bmj.l5278			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DN	31444172				2022-12-28	WOS:000482882800007
J	Houston, R; Ball, SL; Adams, J; Ball, SL				Houston, Rory; Ball, Sarah L.; Adams, James; Ball, Stephen L.			Managing a patient with pain and facial swelling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANDIBULAR FRACTURES		[Houston, Rory; Adams, James] Newcastle Upon Tyne Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Ball, Sarah L.] Newcastle Dent Hosp & Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Ball, Stephen L.] Newcastle Univ & Hosp, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Houston, R (corresponding author), Newcastle Upon Tyne Hosp, Newcastle Upon Tyne, Tyne & Wear, England.	r.houston@hotmail.co.uk						Katsarelis H, 2016, BRIT J ORAL MAX SURG, V54, P796, DOI 10.1016/j.bjoms.2016.05.017; Ogundare BO, 2003, J ORAL MAXIL SURG, V61, P713, DOI 10.1053/joms.2003.50118; Perez R, 2011, CRANIOMAX TRAUM REC, V4, P69, DOI 10.1055/s-0031-1272903; Rashid A, 2013, BRIT J ORAL MAX SURG, V51, P794, DOI 10.1016/j.bjoms.2013.04.007	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2019	366								l4519	10.1136/bmj.l4519	http://dx.doi.org/10.1136/bmj.l4519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IT5DJ	31439543				2022-12-28	WOS:000482882300001
J	Zhou, PP; Chen, LY; Liu, Y; Sochnikov, I; Bollinger, AT; Han, MG; Zhu, YM; He, X; Bozovic, I; Natelson, D				Zhou, Panpan; Chen, Liyang; Liu, Yue; Sochnikov, Ilya; Bollinger, Anthony T.; Han, Myung-Geun; Zhu, Yimei; He, Xi; Bozovic, Ivan; Natelson, Douglas			Electron pairing in the pseudogap state revealed by shot noise in copper oxide junctions	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTIVITY; TRANSITION-TEMPERATURE; CHARGE; LA2-XSRXCUO4; INSULATOR; PARTICLE; GAP	In the quest to understand high-temperature superconductivity in copper oxides, debate has been focused on the pseudogap-a partial energy gap that opens over portions of the Fermi surface in the 'normal' state above the bulk critical temperature(1). The pseudogap has been attributed to precursor superconductivity, to the existence of preformed pairs and to competing orders such as charge-density waves(1-4). A direct determination of the charge of carriers as a function of temperature and bias could help resolve among these alternatives. Here we report measurements of the shot noise of tunnelling current in high-quality La2-xSrxCuO4/La2CuO4/La2-xSrxCuO4 (LSCO/LCO/LSCO) heterostructures fabricated using atomic layer-by-layer molecular beam epitaxy at several doping levels. The data delineate three distinct regions in the bias voltage-temperature space. Well outside the superconducting gap region, the shot noise agrees quantitatively with independent tunnelling of individual charge carriers. Deep within the superconducting gap, shot noise is greatly enhanced, reminiscent of multiple Andreev reflections5-7. Above the critical temperature and extending to biases much larger than the superconducting gap, there is a broad region in which the noise substantially exceeds theoretical expectations for single-charge tunnelling, indicating pairing of charge carriers. These pairs are detectable deep into the pseudogap region of temperature and bias. The presence of these pairs constrains current models of the pseudogap and broken symmetry states, while phase fluctuations limit the domain of superconductivity.	[Zhou, Panpan; Liu, Yue; Natelson, Douglas] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Chen, Liyang] Rice Univ, Appl Phys Grad Program, Houston, TX USA; [Sochnikov, Ilya] Univ Connecticut, Dept Phys, Storrs, CT USA; [Bollinger, Anthony T.; Han, Myung-Geun; Zhu, Yimei; Bozovic, Ivan] Brookhaven Natl Lab, Upton, NY 11973 USA; [He, Xi; Bozovic, Ivan] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Liu, Yue] CALTECH, Dept Phys, Pasadena, CA 91125 USA	Rice University; Rice University; University of Connecticut; United States Department of Energy (DOE); Brookhaven National Laboratory; Yale University; California Institute of Technology	Natelson, D (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.; Bozovic, I (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.; Bozovic, I (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	bozovic@bnl.gov; natelson@rice.edu	Han, Myung-Geun/AAD-6479-2019	Natelson, Douglas/0000-0003-2370-9859; Liu, Yue/0000-0002-5965-0644	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4410]; US state of Connecticut; US Department of Energy, Basic Energy Sciences, Experimental Condensed Matter Physics award [DE-FG02-06ER46337]; National Science Foundation [DMR-1704264]	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation's EPiQS Initiative; US state of Connecticut; US Department of Energy, Basic Energy Sciences, Experimental Condensed Matter Physics award(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	Y. Zhang helped with TEM sample preparation and S. Yang with STEM EDX spectroscopy data acquisition. We are also grateful to P. Lee, S. Kivelson, D. Scalapino, J. Kono, M. Foster, T. C. Wu, J. C. Cuevas, P. Samuelsson, A. Gozar and I. Drozdov for their comments and questions. The research at Brookhaven National Laboratory, including heterostructure synthesis and characterization and device fabrication, was supported by the US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. X.H. was supported by the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4410. The work at the University of Connecticut was supported by the US state of Connecticut. The research at Rice University was supported by the US Department of Energy, Basic Energy Sciences, Experimental Condensed Matter Physics award DE-FG02-06ER46337. Some of the Rice noise measurement hardware were acquired through National Science Foundation award DMR-1704264.	Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3; Bastiaans KM, 2018, NAT PHYS, V14, P1183, DOI 10.1038/s41567-018-0300-z; Berg E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115004; Bilbro LS, 2011, NAT PHYS, V7, P298, DOI [10.1038/nphys1912, 10.1038/NPHYS1912]; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Bozovic I, 2003, NATURE, V422, P873, DOI 10.1038/nature01544; Bozovic I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.157002; Bozovic I, 2016, NATURE, V536, P309, DOI 10.1038/nature19061; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; CHAKRAVARTY S, 1993, SCIENCE, V261, P337, DOI 10.1126/science.261.5119.337; Cron R, 2001, PHYS REV LETT, V86, P4104, DOI 10.1103/PhysRevLett.86.4104; Cuevas JC, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.227003; dePicciotto R, 1997, NATURE, V389, P162, DOI 10.1038/38241; Dieleman P, 1997, PHYS REV LETT, V79, P3486, DOI 10.1103/PhysRevLett.79.3486; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; Greibe T, 2009, J PHYS CONF SER, V150, DOI 10.1088/1742-6596/150/5/052063; Greibe T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.097001; Hamidian MH, 2016, NATURE, V532, P343, DOI 10.1038/nature17411; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kohsaka Y, 2012, NAT PHYS, V8, P534, DOI 10.1038/nphys2321; Kondo T, 2011, NAT PHYS, V7, P21, DOI 10.1038/NPHYS1851; Lee J, 2009, SCIENCE, V325, P1099, DOI 10.1126/science.1176369; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lee PA, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031017; Li L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054510; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Logvenov G, 2009, SCIENCE, V326, P699, DOI 10.1126/science.1178863; Negri O, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.214504; Reber TJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.060506; Ronen Y, 2016, P NATL ACAD SCI USA, V113, P1743, DOI 10.1073/pnas.1515173113; Rousseeuw P.J., 2005, ROBUST REGRESSION OU; Saminadayar L, 1997, PHYS REV LETT, V79, P2526, DOI 10.1103/PhysRevLett.79.2526; Smadici S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107004; Tewari S, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.5003391; Uchida S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.010002; Uzawa Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017002; Wu J, 2017, NATURE, V547, P432, DOI 10.1038/nature23290; Yacoby Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.014108	44	31	31	12	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2019	572	7770					493	+		10.1038/s41586-019-1486-7	http://dx.doi.org/10.1038/s41586-019-1486-7			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS5UZ	31435059	Green Submitted			2022-12-28	WOS:000482219600038
J	Mehta, SR; Wood, DA; Storey, RF; Mehran, R; Bainey, KR; Nguyen, H; Meeks, B; Di Pasquale, G; Lopez-Sendon, J; Faxon, DP; Mauri, L; Rao, SV; Feldman, L; Steg, PG; Avezum, A; Sheth, T; Pinilla-Echeverri, N; Moreno, R; Campo, G; Wrigley, B; Kedev, S; Sutton, A; Oliver, R; Rodes-Cabau, J; Stankovic, G; Welsh, R; Lavi, S; Cantor, WJ; Wang, J; Nakamya, J; Bangdiwala, SI; Cairns, JA				Mehta, Shamir R.; Wood, David A.; Storey, Robert F.; Mehran, Roxana; Bainey, Kevin R.; Nguyen, Helen; Meeks, Brandi; Di Pasquale, Giuseppe; Lopez-Sendon, Jose; Faxon, David P.; Mauri, Laura; Rao, Sunil V.; Feldman, Laurent; Steg, P. Gabriel; Avezum, Alvaro; Sheth, Tej; Pinilla-Echeverri, Natalia; Moreno, Raul; Campo, Gianluca; Wrigley, Benjamin; Kedev, Sasko; Sutton, Andrew; Oliver, Richard; Rodes-Cabau, Josep; Stankovic, Goran; Welsh, Robert; Lavi, Shahar; Cantor, Warren J.; Wang, Jia; Nakamya, Juliet; Bangdiwala, Shrikant I.; Cairns, John A.		COMPLETE Trial Steering Comm	Complete Revascularization with Multivessel PCI for Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ST-SEGMENT ELEVATION; CORONARY-ARTERY-DISEASE; ONLY REVASCULARIZATION; RANDOMIZED-TRIAL; TASK-FORCE; ANGIOPLASTY; STRATEGIES; MANAGEMENT; INTERVENTION; ASSOCIATION	Background In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction. Whether PCI of nonculprit lesions further reduces the risk of such events is unclear. Methods We randomly assigned patients with STEMI and multivessel coronary artery disease who had undergone successful culprit-lesion PCI to a strategy of either complete revascularization with PCI of angiographically significant nonculprit lesions or no further revascularization. Randomization was stratified according to the intended timing of nonculprit-lesion PCI (either during or after the index hospitalization). The first coprimary outcome was the composite of cardiovascular death or myocardial infarction; the second coprimary outcome was the composite of cardiovascular death, myocardial infarction, or ischemia-driven revascularization. Results At a median follow-up of 3 years, the first coprimary outcome had occurred in 158 of the 2016 patients (7.8%) in the complete-revascularization group as compared with 213 of the 2025 patients (10.5%) in the culprit-lesion-only PCI group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.91; P=0.004). The second coprimary outcome had occurred in 179 patients (8.9%) in the complete-revascularization group as compared with 339 patients (16.7%) in the culprit-lesion-only PCI group (hazard ratio, 0.51; 95% CI, 0.43 to 0.61; P<0.001). For both coprimary outcomes, the benefit of complete revascularization was consistently observed regardless of the intended timing of nonculprit-lesion PCI (P=0.62 and P=0.27 for interaction for the first and second coprimary outcomes, respectively). Conclusions Among patients with STEMI and multivessel coronary artery disease, complete revascularization was superior to culprit-lesion-only PCI in reducing the risk of cardiovascular death or myocardial infarction, as well as the risk of cardiovascular death, myocardial infarction, or ischemia-driven revascularization. (Funded by the Canadian Institutes of Health Research and others; COMPLETE ClinicalTrials.gov number, NCT01740479.). Patients with ST-segment elevation MI and multivessel coronary disease who had undergone successful culprit-lesion PCI were assigned to a strategy of either PCI of all other suitable stenoses or no further revascularization. At 3 years, the risk of cardiovascular death or new MI was lower with complete revascularization.	[Mehta, Shamir R.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Wood, David A.; Cairns, John A.] Univ British Columbia, Vancouver, BC, Canada	McMaster University; Population Health Research Institute; University of British Columbia	Mehta, SR (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	smehta@mcmaster.ca	Kedev, Sasko/ABB-2637-2021; Pinto, Fausto/G-9363-2015; Pinilla, Natalia/AAV-9767-2021; Bainey, Kevin/ABA-4046-2021; mauri, laura/GPS-4868-2022; Lavi, Shahar/G-3317-2011; Moris, Cesar/AAG-2018-2020; Stankovic, Goran/Q-8507-2019; Mehran, Roxana/ABF-4160-2021; Moreno, Raul/AAB-9983-2021; Avezum, Alvaro/AAP-7687-2020; Welsh, Robert/ABH-3526-2021; Avanzas, Pablo/B-6811-2008; Cairns, John/AAI-8744-2021; Feldman, Laurent/AGM-4472-2022; Storey, Robert/AAA-6853-2019; Pereira, Helder/B-6870-2014	Kedev, Sasko/0000-0003-4844-6434; Pinto, Fausto/0000-0002-8034-4529; Lavi, Shahar/0000-0002-6105-8084; Moris, Cesar/0000-0002-2871-190X; Stankovic, Goran/0000-0002-9414-0885; Avanzas, Pablo/0000-0002-4958-6108; AVEZUM, ALVARO/0000-0002-3073-6890; Storey, Robert/0000-0002-6677-6229; Pereira, Helder/0000-0001-8656-4883; Campo, Gianluca/0000-0002-5150-188X; Moreno, Raul/0000-0001-7179-1426	Canadian Institutes of Health Research; AstraZeneca; Boston Scientific; Population Health Research Institute; PlaqueTec; Thromboserin; Glycardial Diagnostics; Abbott Laboratories; Bayer; CSL Behring; Daiichi-Sankyo; Medtronic; Novartis; OrbusNeich; Bristol-Myers Squibb; Bayer-Janssen; Merck; Sanofi; Amarin; Servier; Boehringer Ingelheim	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca); Boston Scientific(Boston Scientific); Population Health Research Institute; PlaqueTec; Thromboserin; Glycardial Diagnostics; Abbott Laboratories(Abbott Laboratories); Bayer(Bayer AG); CSL Behring; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Medtronic(Medtronic); Novartis(Novartis); OrbusNeich; Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer-Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech IncBayer AG); Merck(Merck & Company); Sanofi; Amarin; Servier(Servier); Boehringer Ingelheim(Boehringer Ingelheim)	Supported by the Canadian Institutes of Health Research, with additional support from AstraZeneca, Boston Scientific, and the Population Health Research Institute.; Dr. Mehta reports receiving grant support from AstraZeneca; Dr. Storey, receiving grant support and consulting fees from PlaqueTec, Thromboserin, and Glycardial Diagnostics, consulting fees and honoraria from Bayer and Bristol-Myers SquibbPfizer, grant support, consulting fees, and honoraria from AstraZeneca, and consulting fees from Novartis, Idorsia, Haemonetics, and Amgen; Dr. Mehran, receiving grant support, lecture fees, and consulting fees, paid to her institution, from Abbott Laboratories, grant support, paid to her institution, from AstraZeneca, Bayer, CSL Behring, Daiichi-Sankyo, Medtronic, Novartis, and OrbusNeich, grant support, paid to her institution, and advisory-board fees, paid to her institution, from Bristol-Myers Squibb, consulting fees from Boston Scientific, Medscape (WebMD), Siemens Medical Solutions, Roivant Services, Sanofi, and Janssen Scientific Affairs, advisory-board fees from PLx Opco, consulting fees, paid to her institution, from Spectranetics (Philips Volcano), advisory-board fees and lecture fees from Medtelligence (Janssen Scientific Affairs), and fees for serving on a data and safety monitoring board, paid to her institution, from Watermark Research Partners, serving as a consultant and receiving nonfinancial support from Regeneron, and holding equity in Claret Medical and Elixir Medical; Dr. Mauri, being employed by Medtronic; Dr. Steg, receiving grant support and steering-committee fees from Bayer-Janssen, grant support and lecture fees from Merck, grant support, consulting fees, and lecture fees from Sanofi, grant support, steering-committee fees, and consulting fees from Amarin, lecture fees and consulting fees from Amgen, consulting fees, lecture fees, and eventcommittee fees from Bristol-Myers Squibb, steering-committee fees from Boehringer Ingelheim and Idorsia, event-committee fees from Pfizer, steering-committee fees and consulting fees from Novartis, consulting fees from Regeneron and Eli Lilly, fees for serving as trial cochair and consulting fees from AstraZeneca, and grant support, fees for serving as chair of a datamonitoring committee, and fees for serving as chair of a registry from Servier; Dr. Pinilla-Echeverri, receiving lecture fees from Abbott and consulting fees and advisory-board fees from Conavi; Dr. Moreno, receiving lecture fees, advisory-board fees, and fees for attending scientific meetings from Boston Scientific, Abbott Vascular, and Biosensors, lecture fees and fees for attending scientific meetings from Daiichi-Sankyo, lecture fees and advisory-board fees from Astra, Ferrer, and Biotronik, and advisory-board fees from Terumo and Medtronic; Dr. Welsh, receiving grant support and honoraria from AstraZeneca, Bayer, and Boehringer Ingelheim; and Dr. Cairns, receiving steeringcommittee fees from Abbott. No other potential conflict of interest relevant to this article was reported.	Bainey KR, 2016, CAN J CARDIOL, V32, P1542, DOI 10.1016/j.cjca.2016.02.077; Bainey KR, 2014, AM HEART J, V167, P1, DOI 10.1016/j.ahj.2013.09.018; Bates ER, 2016, J AM COLL CARDIOL, V68, P1066, DOI 10.1016/j.jacc.2016.05.086; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Elgendy IY, 2017, JACC-CARDIOVASC INTE, V10, P315, DOI 10.1016/j.jcin.2016.11.047; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mehta SR, 2019, AM HEART J, V215, P157, DOI 10.1016/j.ahj.2019.06.006; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Park DW, 2014, J AM COLL CARDIOL, V63, pA161, DOI 10.1016/S0735-1097(14)60161-3; Smits PC, 2017, NEW ENGL J MED, V376, P1234, DOI 10.1056/NEJMoa1701067; Takano M, 2005, J AM COLL CARDIOL, V45, P652, DOI 10.1016/j.jacc.2004.09.077; Tarantini G, 2016, JACC-CARDIOVASC INTE, V9, P1765, DOI 10.1016/j.jcin.2016.06.012; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Vogel B, 2017, NAT REV CARDIOL, V14, P665, DOI 10.1038/nrcardio.2017.88; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wong GC, 2019, CAN J CARDIOL, V35, P107, DOI 10.1016/j.cjca.2018.11.031; Wood DA, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005215	25	320	330	6	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2019	381	15					1411	1421		10.1056/NEJMoa1907775	http://dx.doi.org/10.1056/NEJMoa1907775			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC9YG	32294354	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000489631900006
J	Bogaty, P; Brophy, JM				Bogaty, Peter; Brophy, James M.			Complete Revascularization with Multivessel PCI for Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							CORONARY-ARTERY-DISEASE; ANGIOPLASTY; DEFINITION; IMPACT	To the Editor: Mehta et al. (Oct. 10 issue)(1) report that complete revascularization was superior to culprit-lesion-only percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease in the Complete versus Culprit-Only Revascularization Strategies to Treat Multivessel Disease after Early PCI for STEMI (COMPLETE) trial. Mehta and colleagues note that the culprit-lesion-only PCI group received "medical therapy with no further revascularization, regardless of whether there was evidence of ischemia on noninvasive testing." The crossover rate to complete revascularization among these patients was only 4.7% within 45 days. However, guidelines support risk stratification based . . .	[Bogaty, Peter] Laval Univ, Quebec City, PQ, Canada; [Brophy, James M.] McGill Univ, Montreal, PQ, Canada	Laval University; McGill University	Bogaty, P (corresponding author), Laval Univ, Quebec City, PQ, Canada.	peter.bogaty@fmed.ulaval.ca	Kedev, Sasko/ABB-2637-2021; Pinto, Fausto/G-9363-2015; Pinilla, Natalia/AAV-9767-2021; Bainey, Kevin/ABA-4046-2021; mauri, laura/GPS-4868-2022; Lavi, Shahar/G-3317-2011; Moris, Cesar/AAG-2018-2020; Stankovic, Goran/Q-8507-2019; Mehran, Roxana/ABF-4160-2021; Moreno, Raul/AAB-9983-2021; Avezum, Alvaro/AAP-7687-2020; Welsh, Robert/ABH-3526-2021; Avanzas, Pablo/B-6811-2008; Cairns, John/AAI-8744-2021; Feldman, Laurent/AGM-4472-2022; Storey, Robert/AAA-6853-2019; Pereira, Helder/B-6870-2014	Kedev, Sasko/0000-0003-4844-6434; Pinto, Fausto/0000-0002-8034-4529; Lavi, Shahar/0000-0002-6105-8084; Moris, Cesar/0000-0002-2871-190X; Stankovic, Goran/0000-0002-9414-0885; Avanzas, Pablo/0000-0002-4958-6108; AVEZUM, ALVARO/0000-0002-3073-6890; Storey, Robert/0000-0002-6677-6229; Pereira, Helder/0000-0001-8656-4883; Campo, Gianluca/0000-0002-5150-188X; Moreno, Raul/0000-0001-7179-1426				Bogaty P, 2020, NEW ENGL J MED, V382, P1568, DOI [10.1056/NEJMoa1907775, 10.1056/NEJMc2000278]; Burgess SN, 2018, AM HEART J, V205, P31, DOI 10.1016/j.ahj.2018.07.017; Doenst T, 2019, J AM COLL CARDIOL, V73, P964, DOI 10.1016/j.jacc.2018.11.053; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Braga CG, 2017, INT J CARDIOL, V243, P21, DOI 10.1016/j.ijcard.2017.04.054; Gupta A, 2018, INT J CARDIOL, V252, P63, DOI 10.1016/j.ijcard.2017.07.041; Head SJ, 2018, LANCET, V391, P939, DOI 10.1016/S0140-6736(18)30423-9; Hideo-Kajita A, 2018, INT J CARDIOVAS IMAG, V34, P1349, DOI 10.1007/s10554-018-1362-9; JS M Hochman, 2019, AM HEART ASS SCI SES; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Pavasini R., 2019, EUR HEART J; Smits PC, 2017, NEW ENGL J MED, V376, P1234, DOI 10.1056/NEJMoa1701067; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Toth G, 2014, EUR HEART J, V35, P2831, DOI 10.1093/eurheartj/ehu094; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Wood DA, 2019, J AM COLL CARDIOL, V74, P2713, DOI 10.1016/j.jacc.2019.09.051; Zeitouni M, 2018, EUR HEART J, V39, P1100, DOI 10.1093/eurheartj/ehx799; Zimmermann FM, 2019, EUR HEART J, V40, P180, DOI 10.1093/eurheartj/ehy812	19	320	330	6	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2020	382	16					1568	1568		10.1056/NEJMc2000278	http://dx.doi.org/10.1056/NEJMc2000278			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LC	32294354	Green Published, Green Accepted			2022-12-28	WOS:000527733300018
